Citrus Sinensis ID: 005999
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 665 | 2.2.26 [Sep-21-2011] | |||||||
| Q93Y06 | 669 | Probable inactive recepto | yes | no | 0.948 | 0.943 | 0.639 | 0.0 | |
| Q84MA9 | 652 | Inactive leucine-rich rep | no | no | 0.875 | 0.892 | 0.427 | 1e-124 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.861 | 0.855 | 0.395 | 2e-95 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.881 | 0.890 | 0.374 | 2e-92 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.833 | 0.845 | 0.350 | 2e-88 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.884 | 0.908 | 0.349 | 2e-82 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.875 | 0.909 | 0.339 | 9e-82 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.849 | 0.882 | 0.354 | 1e-81 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.878 | 0.892 | 0.349 | 7e-80 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.819 | 0.869 | 0.325 | 6e-74 |
| >sp|Q93Y06|Y5720_ARATH Probable inactive receptor kinase At5g67200 OS=Arabidopsis thaliana GN=At5g67200 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/651 (63%), Positives = 493/651 (75%), Gaps = 20/651 (3%)
Query: 26 PPITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFG 85
P NSLLPSDAV+LLSFKS AD +NKLLY+L ER+DYCQW+GVKCAQGR+VR VL G
Sbjct: 24 PNYFNSLLPSDAVALLSFKSTADLDNKLLYSLTERYDYCQWRGVKCAQGRIVRLVLSGVG 83
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSL 145
LRG F TL+RLDQLRVLSL NNSL GPIPDLS L+NLKSL LSRN FSGAFP SILSL
Sbjct: 84 LRGYFSSATLSRLDQLRVLSLENNSLFGPIPDLSHLVNLKSLFLSRNQFSGAFPPSILSL 143
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
HRL IL +S+NN +G IP + ALDRL SL L++NRF+GT+P LNQ FL FNVSGNNLT
Sbjct: 144 HRLMILSISHNNFSGSIPSEINALDRLTSLNLDFNRFNGTLPSLNQSFLTSFNVSGNNLT 203
Query: 206 GQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPN-ATSPPRPLGQSAQSQ- 263
G +P TPTL +FDASSF NP LCG++IN+AC RSPFF S N TS PLGQSAQ+Q
Sbjct: 204 GVIPVTPTLSRFDASSFRSNPGLCGEIINRACASRSPFFGSTNKTTSSEAPLGQSAQAQN 263
Query: 264 -GILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVC--IFLLI--RRSSEGRNSKEPST 318
G +V+ P + K GL+LG + G A L+ +C +F L+ +R+ +G P
Sbjct: 264 GGAVVIPPVVTKKKGKESGLVLGFTAGLASLIVLGLCLVVFSLVIKKRNDDGIYEPNPKG 323
Query: 319 ASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCA 378
+ + ++ RT V + + + +VQ +E ++ I SG+LVFC
Sbjct: 324 EASLSQQQQSQNQTPRT-RAVPVLNSDTESQKREKEVQFQE----TEQRIPNSGNLVFC- 377
Query: 379 GESE---VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFE 435
GES +Y++EQLMRASAELLGRGS+G TYKAVLDN LIVTVKR DA KTA TS EAFE
Sbjct: 378 GESRSQGMYTMEQLMRASAELLGRGSVGITYKAVLDNQLIVTVKRLDAAKTAVTSEEAFE 437
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCL 495
HME VGGL H NLVPIR+YFQ+ GERL+IYDY PNGSLFNLIHGSRS RAKPLHWTSCL
Sbjct: 438 NHMEIVGGLRHTNLVPIRSYFQSNGERLIIYDYHPNGSLFNLIHGSRSSRAKPLHWTSCL 497
Query: 496 KIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV--EDPD 552
KIAEDVAQGL YIH+ +S L+HGNLKS+N+LLG DFEA LTDYCLSVL+DSSS +DPD
Sbjct: 498 KIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDYCLSVLTDSSSASPDDPD 557
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VD 611
+ +YKAPEIRKSSRR TSK DVY+FGVL+ ELLTGK+ S+HP++AP DML+WVR MR +
Sbjct: 558 SSSYKAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPFMAPHDMLDWVRAMREEE 617
Query: 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662
+G E+NRLGM+TE A +C + SPEQRP M QV+KMIQEIKESVMAE+N F
Sbjct: 618 EGTEDNRLGMMTETACLCRVTSPEQRPTMRQVIKMIQEIKESVMAEENDPF 668
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q84MA9|Y1063_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At1g60630 OS=Arabidopsis thaliana GN=At1g60630 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1150), Expect = e-124, Method: Compositional matrix adjust.
Identities = 270/631 (42%), Positives = 376/631 (59%), Gaps = 49/631 (7%)
Query: 35 SDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVK-CAQGRVVRFVLQSFGLRGTFPPN 93
SD +LLS KS D N + + D C W+GVK C +GRV + VL++ L G+
Sbjct: 24 SDVEALLSLKSSIDPSNSIPW---RGTDPCNWEGVKKCMKGRVSKLVLENLNLSGSLNGK 80
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
+L +LDQLRVLS NSL+G IP+LS L+NLKSL L+ N FSG FP S+ SLHRL + L
Sbjct: 81 SLNQLDQLRVLSFKGNSLSGSIPNLSGLVNLKSLYLNDNNFSGEFPESLTSLHRLKTVVL 140
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPT 213
S N +G IP +L L RLY+ ++ N FSG++PPLNQ L FNVS N L+G +P T
Sbjct: 141 SRNRFSGKIPSSLLRLSRLYTFYVQDNLFSGSIPPLNQATLRFFNVSNNQLSGHIPPTQA 200
Query: 214 LLKFDASSFSMNPNLCGKVINKACRPRSPFFESPNATSPPRPLGQSAQSQGILVLSPPSP 273
L +F+ SSF+ N LCG I +C + +P+A P P+ ++
Sbjct: 201 LNRFNESSFTDNIALCGDQIQNSCNDTTGITSTPSA-KPAIPVAKT-------------- 245
Query: 274 RNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFNEGTTYPEPESS 333
R+ K G+I G G +++ + L+ R ++ +E E + +
Sbjct: 246 RSRTKLIGIISGSICGGILILLLTFLLICLLWRRKRSKSKREE-----RRSKRVAESKEA 300
Query: 334 RTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRAS 393
+TA T + G K + + + + EE ++G+ + R ++V Y+++ L++AS
Sbjct: 301 KTAETEE-GTSDQKNKRFSWEKESEEGSVGTLVFLGRDITVV-------RYTMDDLLKAS 352
Query: 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
AE LGRG++G+TYKAV+++ I+TVKR + F++H+E +G L HPNLVP+R
Sbjct: 353 AETLGRGTLGSTYKAVMESGFIITVKRL--KDAGFPRMDEFKRHIEILGRLKHPNLVPLR 410
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
AYFQAK E L++YDY PNGSLF+LIHGS+ S KPLHWTSCLKIAED+A GL YIH+
Sbjct: 411 AYFQAKEECLLVYDYFPNGSLFSLIHGSKVSGSGKPLHWTSCLKIAEDLAMGLVYIHQNP 470
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA--YKAPEIRKSSRRATS 570
L HGNLKSSNVLLG DFE+ LTDY LS L D S+ED + YKAPE R + +T
Sbjct: 471 GLTHGNLKSSNVLLGPDFESCLTDYGLSDLHDPYSIEDTSAASLFYKAPECRDLRKASTQ 530
Query: 571 KSDVYAFGVLLLELLTGKHPSQ---HPYLAPPDMLEWVRTMRVDD-------GREENRLG 620
+DVY+FGVLLLELLTG+ + H Y + D+ WVR +R ++ E +L
Sbjct: 531 PADVYSFGVLLLELLTGRTSFKDLVHKYGS--DISTWVRAVREEETEVSEELNASEEKLQ 588
Query: 621 MLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651
L +A+ C PE RPAM +VLKM+++ +
Sbjct: 589 ALLTIATACVAVKPENRPAMREVLKMVKDAR 619
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (898), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 258/652 (39%), Positives = 355/652 (54%), Gaps = 79/652 (12%)
Query: 35 SDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNT 94
+D+ +LL+FK ADS KL + N + CQW GV C + RV R VL+ L G+ ++
Sbjct: 30 TDSETLLNFKLTADSTGKL-NSWNTTTNPCQWTGVSCNRNRVTRLVLEDINLTGSI--SS 86
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
LT L LRVLSL +N+L+GPIP+LS+L LK L LS N FSG FP SI SL RL LDLS
Sbjct: 87 LTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLS 146
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTL 214
+NN +G IP +LT L L +L+LE NRFSG +P +N L FNVSGNN GQ+P +L
Sbjct: 147 FNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPN--SL 204
Query: 215 LKFDASSFSMNPNLCGKVINKACRPRSPFFESPNATSPPRPLGQSAQSQGILVLSPPSP- 273
+F S F+ NP+LCG + K + S + T P RP A P SP
Sbjct: 205 SQFPESVFTQNPSLCGAPLLKCTKLSS------DPTKPGRPDEAKASPLNKPETVPSSPT 258
Query: 274 -------RNDHKRRGLI--LGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFNEG 324
N+ R I + + +G +++SF+ + N K+ S E
Sbjct: 259 SIHGGDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEK 318
Query: 325 TTY---PEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGES 381
Y P P S++ N + G +VF G +
Sbjct: 319 IVYSSNPYPTSTQNNNNQ-------------------------NQQVGDKGKMVFFEG-T 352
Query: 382 EVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAV 441
+ LE L+RASAE+LG+G GT YKAVL++ V VKR T E FEQ ME +
Sbjct: 353 RRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKE-FEQQMEVL 411
Query: 442 GGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
G L H NLV ++AY+ A+ E+L++YDY PNGSLF L+HG+R PL WT+ LKIA
Sbjct: 412 GRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGA 471
Query: 502 AQGLAYIH---RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKA 558
A+GLA+IH + L HG++KS+NVLL AR++D+ LS+ + S +V + Y+A
Sbjct: 472 ARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKSN--GYRA 529
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ----HPYLAPPDMLEWVRT------- 607
PE+ R+ T KSDVY+FGVLLLE+LTGK P+ H A D+ WV++
Sbjct: 530 PEL-IDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGA-VDLPRWVQSVVREEWT 587
Query: 608 --------MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651
MR D EE +G+L ++A C+ + + RP M V+K+I++I+
Sbjct: 588 AEVFDLELMRYKD-IEEEMVGLL-QIAMACTAVAADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 243/649 (37%), Positives = 347/649 (53%), Gaps = 63/649 (9%)
Query: 30 NSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCA--QGRVVRFVLQSFGLR 87
NS ++ +LL+F + EN+L + NE C W GV+C Q + L GL
Sbjct: 22 NSESTAEKQALLTFLQQIPHENRLQW--NESDSACNWVGVECNSNQSSIHSLRLPGTGLV 79
Query: 88 GTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLH 146
G P +L RL +LRVLSL +N L+G IP D S+L +L+SL L N FSG FP S L+
Sbjct: 80 GQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLN 139
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206
L LD+S NN TG IP ++ L L L L N FSG +P ++ LV FNVS NNL G
Sbjct: 140 NLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLG-LVDFNVSNNNLNG 198
Query: 207 QVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPNATSPPRPLGQSAQSQGIL 266
+P + L +F A SF+ N +LCG + K C+ FF SP+ P P
Sbjct: 199 SIPSS--LSRFSAESFTGNVDLCGGPL-KPCKS---FFVSPS----PSP----------- 237
Query: 267 VLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFNEGTT 326
L PS R K+ L + V + + + L + R + + A T
Sbjct: 238 SLINPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEAR----TK 293
Query: 327 YPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSL 386
P+P T N + + +V +G +T LVF G + L
Sbjct: 294 QPKPAGVATRNV----DLPPGASSSKEEVTGTSSGMGGET---ERNKLVFTEGGVYSFDL 346
Query: 387 EQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH 446
E L+RASAE+LG+GS+GT+YKAVL+ V VKR K S + FE ME VG + H
Sbjct: 347 EDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL---KDVMASKKEFETQMEVVGKIKH 403
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
PN++P+RAY+ +K E+L+++D+ P GSL L+HGSR PL W + ++IA A+GLA
Sbjct: 404 PNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLA 463
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA-YKAPEIRKSS 565
++H ++ L+HGN+K+SN+LL + + ++DY L+ L +SS P+ +A Y APE+ + +
Sbjct: 464 HLHVSAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSS--PPNRLAGYHAPEVLE-T 520
Query: 566 RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRT---------------MR 609
R+ T KSDVY+FGVLLLELLTGK P+Q D+ WV + MR
Sbjct: 521 RKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMR 580
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
+ EE + L ++A C P+QRP M +VL+MI+++ S +D
Sbjct: 581 YHNIEEE--MVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSETTDD 627
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 216/616 (35%), Positives = 329/616 (53%), Gaps = 62/616 (10%)
Query: 64 CQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLI 122
C W GVKC RV L L G P L QLR LSL N+L+G +P DLS+
Sbjct: 62 CNWAGVKCESNRVTALRLPGVALSGDIPEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSS 121
Query: 123 NLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182
NL+ L L N FSG P + SL L L+L+ N+ TG I T L +L +L LE N+
Sbjct: 122 NLRHLYLQGNRFSGEIPEVLFSLSHLVRLNLASNSFTGEISSGFTNLTKLKTLFLENNQL 181
Query: 183 SGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSP 242
SG++P L+ P LV FNVS N+L G +P+ L +F++ SF + +LCGK + K C P
Sbjct: 182 SGSIPDLDLP-LVQFNVSNNSLNGSIPKN--LQRFESDSF-LQTSLCGKPL-KLC----P 232
Query: 243 FFESPNATSPPRPLGQSAQSQGILVLSPPSPRNDHKRR-----------GLILGLSIGFA 291
E T P +P ++ PPS +++ G+++G +GFA
Sbjct: 233 DEE----TVPSQPTSGGNRT-------PPSVEGSEEKKKKNKLSGGAIAGIVIGCVVGFA 281
Query: 292 VLVSFLVCIFLLIRRSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETK 351
++V L+ + L ++S++ + + ST E + E+ N V T
Sbjct: 282 LIV--LILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTG 339
Query: 352 ANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLD 411
K + G+ K+ LVF ++V+ LE L+RASAE+LG+G+ GT YKAVLD
Sbjct: 340 NGKA-----SEGNGPATKK---LVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLD 391
Query: 412 NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471
+V VKR AD + F++ +E VG + H NLVP+RAY+ ++ E+L++YD+ P
Sbjct: 392 AVTVVAVKRLKDVMMAD---KEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPM 448
Query: 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-RASWLIHGNLKSSNVLLGADF 530
GSL L+HG+R PL+W +IA A+GL Y+H + + HGN+KSSN+LL
Sbjct: 449 GSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHGNIKSSNILLTKSH 508
Query: 531 EARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+A+++D+ L+ L SS+ Y+APE+ +R + K DVY+FGV+LLEL+TGK P
Sbjct: 509 DAKVSDFGLAQLVGSSATNPNRATGYRAPEV-TDPKRVSQKGDVYSFGVVLLELITGKAP 567
Query: 591 SQHPYLAPP-DMLEWVRTMRVDDGR--------------EENRLGMLTEVASVCSLKSPE 635
S D+ WV+++ D+ R EE + + ++ C+ + P+
Sbjct: 568 SNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPD 627
Query: 636 QRPAMWQVLKMIQEIK 651
QRP M +V++ ++ ++
Sbjct: 628 QRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 225/644 (34%), Positives = 325/644 (50%), Gaps = 56/644 (8%)
Query: 33 LPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPP 92
L +D +LLSF+S LL+ + + C W GV C GRV L L G P
Sbjct: 31 LAADKSALLSFRSAVGGRT-LLWDVKQT-SPCNWTGVLCDGGRVTALRLPGETLSGHIPE 88
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
L QLR LSL N LTG +P DL S +L+ L L N FSG P + SL L L
Sbjct: 89 GIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRL 148
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPET 211
+L+ N +G I L RL +L LE N+ S L FNVS N L G +P++
Sbjct: 149 NLAENEFSGEISSGFKNLTRLKTLYLENNKLS-GSLLDLDLSLDQFNVSNNLLNGSIPKS 207
Query: 212 PTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPNATSPPRPLGQSAQSQGILVLSPP 271
L KFD+ SF + +LCGK + C S T P +P+ G + S
Sbjct: 208 --LQKFDSDSF-VGTSLCGKPL-VVC--------SNEGTVPSQPI-SVGNIPGTVEGSEE 254
Query: 272 SPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFNEGTTYPEPE 331
+ G I G+ IG V +S +V I +++ R ++ A+
Sbjct: 255 KKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKH-------- 306
Query: 332 SSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGS----LVFCAGESEVYSLE 387
+ ++ K VE N+ V E + + ++ + S LVF ++V+ LE
Sbjct: 307 -----HEVEIPGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLE 361
Query: 388 QLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHP 447
L+RASAE+LG+G+ GT YKAVLD +V VKR AD F++ +E VG + H
Sbjct: 362 DLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMAD---REFKEKIEVVGAMDHE 418
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
NLVP+RAY+ + E+L++YD+ P GSL L+HG++ PL+W IA A+GL Y
Sbjct: 419 NLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDY 478
Query: 508 IHRASWL-IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSR 566
+H L HGN+KSSN+LL +AR++D+ L+ L +SS Y+APE+ R
Sbjct: 479 LHSQDPLSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEV-TDPR 537
Query: 567 RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDGREE---NRLGML 622
R + K+DVY+FGV+LLELLTGK PS D+ WV ++ ++ R E + L +
Sbjct: 538 RVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSI 597
Query: 623 TEVASV-------------CSLKSPEQRPAMWQVLKMIQEIKES 653
V SV C+ + P++RP M +V++ IQE+++S
Sbjct: 598 ETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQS 641
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (780), Expect = 9e-82, Method: Compositional matrix adjust.
Identities = 232/683 (33%), Positives = 350/683 (51%), Gaps = 101/683 (14%)
Query: 2 TTKTAPFFSLLLFSLLHSTATAQYPPITNSLLPSDAVSLLSFKSKADSENKLLYALNERF 61
++ TA + F LL +TA + ++ L SD +LL+F + KL + N+
Sbjct: 3 SSHTAFVAASFFFLLLAATAV-----LVSADLASDEQALLNFAASVPHPPKLNW--NKNL 55
Query: 62 DYCQ-WQGVKCAQG----RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP 116
C W G+ C + RVV L GL G+ PP TL +LD L+VLSL +NSL G +P
Sbjct: 56 SLCSSWIGITCDESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLP 115
Query: 117 -DLSSLINLKSLSLSRNFFSGAFPLSILSL--HRLTILDLSYNNLTGLIPVNLTALDRLY 173
D+ SL +L+ L L N FSG + L +L +LDLSYN+L+G IP L L ++
Sbjct: 116 SDILSLPSLEYLYLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQIT 175
Query: 174 SLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVI 233
L L+ N F G + L+ P + V N+S NNL+G +PE L K SF N LCG +
Sbjct: 176 VLYLQNNSFDGPIDSLDLPSVKVVNLSYNNLSGPIPEH--LKKSPEYSFIGNSLLCGPPL 233
Query: 234 NKACRPRSPFFESPNATSP----PRPLGQSAQSQGILVLSPPSPRNDHKRRGLILGLSIG 289
N AC S A SP PRPL ++ P + + I+ + +G
Sbjct: 234 N-AC--------SGGAISPSSNLPRPLTENLH-----------PVRRRQSKAYIIAIVVG 273
Query: 290 FAVLVSFLVCIFL--LIRRSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIK 347
+V V FL +FL L++++ + E TQ+G
Sbjct: 274 CSVAVLFLGIVFLVCLVKKTKKEEGGGE--------------------GVRTQMG----- 308
Query: 348 VETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYK 407
N + ++ G Q L F + + LE L++ASAE+LG+GS GT YK
Sbjct: 309 ---GVNSKKPQDFGSGVQD--PEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYK 363
Query: 408 AVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIY 466
AVL++ V VKR + S + FEQ ME VG ++ H N VP+ AY+ +K E+L++Y
Sbjct: 364 AVLEDTTAVVVKRL---REVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVY 420
Query: 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL 526
Y GSLF ++HG+R R + W + +KIA ++ ++Y+H + +HG++KSSN+LL
Sbjct: 421 KYMTKGSLFGIMHGNRGDRG--VDWETRMKIATGTSKAISYLHSLKF-VHGDIKSSNILL 477
Query: 527 GADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586
D E L+D L L + + P T+ Y APE+ + +RR + +SDVY+FGV++LE+LT
Sbjct: 478 TEDLEPCLSDTSLVTLFNLPT-HTPRTIGYNAPEVIE-TRRVSQRSDVYSFGVVILEMLT 535
Query: 587 GKHPSQHPYLAPP----DMLEWVRTMRVDD--------------GREENRLGMLTEVASV 628
GK P P L D+ WVR++ ++ EE + ML ++A
Sbjct: 536 GKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQML-QLALA 594
Query: 629 CSLKSPEQRPAMWQVLKMIQEIK 651
C ++PE RP M +V +MI++++
Sbjct: 595 CVARNPESRPKMEEVARMIEDVR 617
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 230/649 (35%), Positives = 334/649 (51%), Gaps = 84/649 (12%)
Query: 33 LPSDAVSLLSFKSKADSENKLLYALNERFDYC-QWQGVKCAQ--GRVVRFVLQSFGLRGT 89
+ SD +LL F S KL + N C W G+ C++ RV L GL G
Sbjct: 25 IESDKQALLEFASLVPHSRKLNW--NSTIPICASWTGITCSKNNARVTALRLPGSGLYGP 82
Query: 90 FPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
P T +LD LR++SL +N L G IP + SL ++SL N FSG P +LS HRL
Sbjct: 83 LPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGTIP-PVLS-HRL 140
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQV 208
LDLS N+L+G IP +L L +L L L+ N SG +P L P L N+S NNL G V
Sbjct: 141 VNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNL-PPRLKYLNLSFNNLNGSV 199
Query: 209 PETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPNATSPPRPLGQSAQSQGILVL 268
P + + F ASSF N LCG +P P T+ P P S +
Sbjct: 200 PSS--VKSFPASSFQGNSLLCG----------APLTPCPENTTAPSP---SPTTPTEGPG 244
Query: 269 SPPSPRNDHKR---RGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFNEGT 325
+ R K+ G I+G+++G +VL+ ++ I L ++ R+ + STA
Sbjct: 245 TTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLC--CAKKRDGGQDSTA------ 296
Query: 326 TYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYS 385
P+ + R+ N + EE G Q K LVF G S +
Sbjct: 297 -VPKAKPGRSDN------------------KAEEFGSGVQEAEKNK--LVFFEGSSYNFD 335
Query: 386 LEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS 445
LE L+RASAE+LG+GS GTTYKA+L+ V VKR K FEQ MEAVG +S
Sbjct: 336 LEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRL---KEVAAGKREFEQQMEAVGRIS 392
Query: 446 -HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
H N+ P+RAY+ +K E+L++YDY G+ L+HG+ L W + L+I + A+G
Sbjct: 393 PHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARG 452
Query: 505 LAYIHRASW--LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIR 562
+++IH AS L+HGN+KS NVLL + ++D+ ++ L ++ ++ Y+APE
Sbjct: 453 ISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAI 512
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHPSQ---HPYLAPPDMLEWVRT------------ 607
+ +R+ T KSDVY+FGVLLLE+LTGK + H + D+ +WV++
Sbjct: 513 E-TRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVV--DLPKWVQSVVREEWTGEVFD 569
Query: 608 ---MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
++ EE + ML ++A C K P+ RP+M +V+ M++EI+ S
Sbjct: 570 VELIKQQHNVEEEMVQML-QIAMACVSKHPDSRPSMEEVVNMMEEIRPS 617
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 7e-80, Method: Compositional matrix adjust.
Identities = 235/673 (34%), Positives = 343/673 (50%), Gaps = 89/673 (13%)
Query: 8 FFSLLLFSLLHSTATAQYPPITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQ-W 66
F S L S L T T I + L SD +LL+F + +L + N C+ W
Sbjct: 22 FLSTCLVSFLFVTTTFCSYAIAD--LNSDRQALLAFAASVPHLRRLNW--NSTNHICKSW 77
Query: 67 QGVKC-AQGRVVRFV-LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLIN 123
GV C + G V + L GL G PPNTL +L+ LR+LSL +N L+G +P D+ SL +
Sbjct: 78 VGVTCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPS 137
Query: 124 LKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
L + L N FSG P S +S +L ILDLS+N+ TG IP L +L L L+ N+ S
Sbjct: 138 LDYIYLQHNNFSGEVP-SFVS-RQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLS 195
Query: 184 GTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPF 243
G VP L+ L N+S N+L G +P L F +SSFS N LCG + P
Sbjct: 196 GPVPNLDTVSLRRLNLSNNHLNGSIPSA--LGGFPSSSFSGNTLLCGLPLQPCATSSPPP 253
Query: 244 FESPNATSPPRPLGQSAQSQGILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFLL 303
+P+ ++PP PP P + +R L + I A + L+ + +
Sbjct: 254 SLTPHISTPPL---------------PPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITV 298
Query: 304 IRRSS--EGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMA 361
I + ++ +E S +KV+T K + E
Sbjct: 299 IILCCCIKKKDKREDSI---------------------------VKVKTLTEKAKQE--- 328
Query: 362 IGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRF 421
GS LVF G S + LE L+RASAE+LG+GS GT YKAVL+ V VKR
Sbjct: 329 FGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRL 388
Query: 422 DANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHG 480
K FEQ ME + + +HP++VP+RAY+ +K E+L++ DY P G+L +L+HG
Sbjct: 389 ---KEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHG 445
Query: 481 SRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW--LIHGNLKSSNVLLGADFEARLTDYC 538
+R PL W S +KI A+G+A++H A HGN+KSSNV++ + +A ++D+
Sbjct: 446 NRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFG 505
Query: 539 LSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP 598
L+ L + + Y+APE+ + +R+ T KSDVY+FGVL+LE+LTGK P Q P +
Sbjct: 506 LTPLM-AVPIAPMRGAGYRAPEVME-TRKHTHKSDVYSFGVLILEMLTGKSPVQSP--SR 561
Query: 599 PDMLE---WVRT---------------MRVDDGREENRLGMLTEVASVCSLKSPEQRPAM 640
DM++ WV++ MR + EE + + ++A C + PE RP M
Sbjct: 562 DDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEE--MVQMLQIAMACVAQVPEVRPTM 619
Query: 641 WQVLKMIQEIKES 653
V++MI+EI+ S
Sbjct: 620 DDVVRMIEEIRVS 632
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 6e-74, Method: Compositional matrix adjust.
Identities = 198/609 (32%), Positives = 314/609 (51%), Gaps = 64/609 (10%)
Query: 64 CQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLI 122
C W GV C GRV L GL G+ P + L QL+ LSL NSL+GPIP D S+L+
Sbjct: 55 CNWHGVHCDAGRVTALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLV 114
Query: 123 NLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182
L+ L L N FSG P + +L + ++L N +G IP N+ + RL +L LE N+
Sbjct: 115 LLRYLYLQGNAFSGEIPSLLFTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQL 174
Query: 183 SGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSP 242
SG +P + P L FNVS N L G +P + L + ++F N LCGK ++ C SP
Sbjct: 175 SGPIPEITLP-LQQFNVSSNQLNGSIPSS--LSSWPRTAFEGN-TLCGKPLD-TCEAESP 229
Query: 243 FFESPNATSPPRPLGQSAQSQGILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFL 302
+A P P P +D G I+G+ IG V + L+ I
Sbjct: 230 --NGGDAGGPNTP--------------PEKKDSDKLSAGAIVGIVIGCVVGLLLLLLILF 273
Query: 303 LIRRSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAI 362
+ R + KE + S N E + ++ + + + V A E A+
Sbjct: 274 CLCR----KRKKEENVPSRNV-----EAPVAAATSSAAIPKETVVVVPPAKATGSESGAV 324
Query: 363 GSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFD 422
L F + L+ L++ASAE+LG+G++G++YKA ++ L+V VKR
Sbjct: 325 NKD--------LTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRL- 375
Query: 423 ANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR 482
+ + F + + +G +SH NLV + AY+ ++ E+L++++Y GSL ++HG++
Sbjct: 376 --RDVVVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNK 433
Query: 483 SIRAKPLHWTSCLKIAEDVAQGLAYIH-RASWLIHGNLKSSNVLLGADFEARLTDYCLSV 541
PL+W + IA A+ ++Y+H R HGN+KSSN+LL +EA+++DY L+
Sbjct: 434 GNGRTPLNWETRAGIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAP 493
Query: 542 LSDSSSVEDPDTV-AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPS-QHPYLAPP 599
+ S+S P+ + Y+APEI +R+ + K+DVY+FGVL+LELLTGK P+ Q
Sbjct: 494 IISSTSA--PNRIDGYRAPEI-TDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEGV 550
Query: 600 DMLEWVRTM---------------RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVL 644
D+ WV+++ R EN + +L ++ C+ + P+ RP+M +V
Sbjct: 551 DLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLL-KIGMSCTAQFPDSRPSMAEVT 609
Query: 645 KMIQEIKES 653
++I+E+ S
Sbjct: 610 RLIEEVSHS 618
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 665 | ||||||
| 225438793 | 671 | PREDICTED: probable inactive receptor ki | 0.944 | 0.935 | 0.686 | 0.0 | |
| 255585113 | 635 | receptor protein kinase, putative [Ricin | 0.911 | 0.954 | 0.686 | 0.0 | |
| 77417486 | 666 | putative receptor kinase [Malus x domest | 0.936 | 0.935 | 0.691 | 0.0 | |
| 224094286 | 627 | predicted protein [Populus trichocarpa] | 0.894 | 0.948 | 0.670 | 0.0 | |
| 224084384 | 662 | predicted protein [Populus trichocarpa] | 0.942 | 0.947 | 0.667 | 0.0 | |
| 449448304 | 657 | PREDICTED: probable inactive receptor ki | 0.960 | 0.972 | 0.644 | 0.0 | |
| 297794267 | 667 | hypothetical protein ARALYDRAFT_496879 [ | 0.950 | 0.947 | 0.642 | 0.0 | |
| 18425163 | 669 | putative inactive receptor kinase [Arabi | 0.948 | 0.943 | 0.639 | 0.0 | |
| 10177607 | 651 | receptor protein kinase-like protein [Ar | 0.927 | 0.947 | 0.632 | 0.0 | |
| 196166341 | 683 | SMA9 [Malus x domestica] | 0.918 | 0.894 | 0.639 | 0.0 |
| >gi|225438793|ref|XP_002283167.1| PREDICTED: probable inactive receptor kinase At5g67200 isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 883 bits (2282), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/650 (68%), Positives = 512/650 (78%), Gaps = 22/650 (3%)
Query: 27 PITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGL 86
P +SLLPSDAVSLLSFK+KAD +NKLLY LNERFDYCQW+GVKC QGRVVRF Q FGL
Sbjct: 33 PSVSSLLPSDAVSLLSFKAKADLDNKLLYTLNERFDYCQWRGVKCVQGRVVRFDTQGFGL 92
Query: 87 RGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLH 146
RG F PNTLTRLDQLRVLSLHNNSL+GPIPDL++L+NLKSL L N FSG FP SILSLH
Sbjct: 93 RGYFAPNTLTRLDQLRVLSLHNNSLSGPIPDLAALVNLKSLFLDHNSFSGYFPPSILSLH 152
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206
RL ILDLS+NNLTGLIPV L+ LDRL SL+LEWN+F+GTVPPLNQ L++FNVSGNNLTG
Sbjct: 153 RLRILDLSHNNLTGLIPVELSGLDRLSSLRLEWNQFNGTVPPLNQSSLLIFNVSGNNLTG 212
Query: 207 QVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPN----ATSPPRPLGQSAQS 262
+P TPTL +F SSFS NPNLCG++INK CR SPFFESP A P PL QS Q+
Sbjct: 213 PIPVTPTLSRFGVSSFSWNPNLCGEIINKQCRSSSPFFESPGVRAGAAPSPTPLWQSTQA 272
Query: 263 QGILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFN 322
QG+ VLS PS + H LILG IG VL+ LVC+F L+ + S P
Sbjct: 273 QGV-VLSTPSSKK-HVGTPLILGFVIGMGVLIVSLVCLFALVCKHSRKTPKSNPMPEPKA 330
Query: 323 EGTTYPEPESSR----TANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCA 378
E PEP + NT ++ + + ++E +A +VQ ++ +SG+LVFC
Sbjct: 331 EAEAEPEPVMAALDMCNTNTAEMRQQENEMEGEAKRVQ---------QVVGKSGNLVFCV 381
Query: 379 GESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHM 438
GE ++Y+L+QLMRASAE+LGRGSIGTTYKAVLDN LIV+VKR DA+KTA TS E FE+HM
Sbjct: 382 GEPQLYNLDQLMRASAEMLGRGSIGTTYKAVLDNQLIVSVKRLDASKTAITSGEVFERHM 441
Query: 439 EAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIA 498
E+VGGL HPNLVPIRAYFQAK ERLVIYDYQPNGSLF+LIHGSRS RAKPLHWTSCLKIA
Sbjct: 442 ESVGGLRHPNLVPIRAYFQAKEERLVIYDYQPNGSLFSLIHGSRSTRAKPLHWTSCLKIA 501
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKA 558
EDVAQGLAYIH+AS L+HGNLKSSNVLLGADFEA +TDYCL+ L+D + E+PD+ Y+A
Sbjct: 502 EDVAQGLAYIHQASKLVHGNLKSSNVLLGADFEACITDYCLAALADLPANENPDSAGYRA 561
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618
PE RKSSRRAT+KSDVYAFGVLLLELL+GK PSQHP+LAP DM WVR MR DDG E+NR
Sbjct: 562 PETRKSSRRATAKSDVYAFGVLLLELLSGKPPSQHPFLAPTDMSGWVRAMRDDDGGEDNR 621
Query: 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDN---AAFGYS 665
L +L EVASVCSL SPEQRPAMWQV KMIQEIK S+M EDN A+FG+S
Sbjct: 622 LALLVEVASVCSLTSPEQRPAMWQVSKMIQEIKNSIMVEDNSGGASFGFS 671
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585113|ref|XP_002533262.1| receptor protein kinase, putative [Ricinus communis] gi|223526918|gb|EEF29124.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/644 (68%), Positives = 514/644 (79%), Gaps = 38/644 (5%)
Query: 29 TNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRG 88
T L+PSDAVSLLSFKS AD +NKLLY L+ERFDYCQWQGVKCAQGRVVR L+SF LRG
Sbjct: 23 TTYLIPSDAVSLLSFKSNADLDNKLLYTLHERFDYCQWQGVKCAQGRVVRVALESFSLRG 82
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
TF P +L+RLDQLRVLSL NNSLTGP+PDLS L NLKSL LS N FS +FP SIL LHRL
Sbjct: 83 TFAPYSLSRLDQLRVLSLQNNSLTGPVPDLSPLYNLKSLFLSHNSFSASFPPSILFLHRL 142
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQV 208
T+LDLS+NN TG IPV L++LDRL SL+LE+NRF+GT+PPLNQ L FNVSGNNLTG +
Sbjct: 143 TVLDLSFNNFTGSIPVQLSSLDRLNSLQLEFNRFNGTLPPLNQSLLAFFNVSGNNLTGPI 202
Query: 209 PETPTLLKFDASSFSMNPNLCGKVINKAC-RPRSPFFESPNATSPPRPLGQSAQSQG--- 264
P TPTL KFD SSFS+NP+LCG++INKAC R RSPFF+SPNATSP PLGQSA ++G
Sbjct: 203 PLTPTLSKFDTSSFSLNPDLCGEIINKACARLRSPFFDSPNATSPAAPLGQSATAEGGGG 262
Query: 265 ILVLSPP---SPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASF 321
++VLSPP SP+ HKR +ILG ++G A+ N KE T+
Sbjct: 263 VVVLSPPASSSPKK-HKRTSVILGFAVGVAL--------------KQTDSNEKEKRTS-- 305
Query: 322 NEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGES 381
+PE+ Q+ + ++ ++TK + ++++E+ ++SG L+FC
Sbjct: 306 -------QPEAFINTKNDQI-QVEMNMQTK-DVIEIQELKKP-----QKSGGLIFCGNMR 351
Query: 382 EVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAV 441
++Y+LEQLMRASAELLGRG+IGTTYKAVLDN LIVTVKR DA+KTA TSA+AFE HMEAV
Sbjct: 352 QMYTLEQLMRASAELLGRGTIGTTYKAVLDNQLIVTVKRLDASKTAVTSADAFESHMEAV 411
Query: 442 GGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
GGL HPNLVPI AYFQAKGERLV+Y+YQPNGSL NLIHGSRS RAKPLHWTSCLKIAEDV
Sbjct: 412 GGLKHPNLVPIVAYFQAKGERLVMYEYQPNGSLSNLIHGSRSTRAKPLHWTSCLKIAEDV 471
Query: 502 AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEI 561
AQGLAYIH+AS L+HG+LKSSNVLLG DFEA +TDYCL+ L+D+S+ EDPD+ A KAPE
Sbjct: 472 AQGLAYIHQASKLVHGDLKSSNVLLGPDFEACITDYCLASLADTSTTEDPDSTACKAPET 531
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621
R S+RRATSKSDVYAFGVLLLELLTGKHPS HP+LAP DML+WVRT+R DG E+N+LGM
Sbjct: 532 RNSNRRATSKSDVYAFGVLLLELLTGKHPSHHPFLAPADMLDWVRTVREGDGAEDNQLGM 591
Query: 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFGYS 665
LTEVASVCSL SPEQRPAMWQVLKMI EIKESVM EDNAA GYS
Sbjct: 592 LTEVASVCSLTSPEQRPAMWQVLKMIHEIKESVMVEDNAAAGYS 635
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|77417486|gb|ABA82078.1| putative receptor kinase [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2247), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/636 (69%), Positives = 523/636 (82%), Gaps = 13/636 (2%)
Query: 36 DAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTL 95
DAV+LLSFKS+AD NKLLY LNERFDYCQWQGVKC+QGRVVR+VLQSF LRG+FPP+TL
Sbjct: 37 DAVALLSFKSQADLNNKLLYTLNERFDYCQWQGVKCSQGRVVRYVLQSFSLRGSFPPDTL 96
Query: 96 TRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155
+RLDQLRVLSLHNNSL+GPIPDLS L NLKSL L+RN FSG FP SIL++HRLT+LDLS+
Sbjct: 97 SRLDQLRVLSLHNNSLSGPIPDLSPLQNLKSLFLNRNSFSGFFPPSILAIHRLTVLDLSF 156
Query: 156 NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLL 215
N+L+G IP NL+ LDRL SL+L+ NRF+G++P LNQ FL++FNVS NNLTG VP P+L
Sbjct: 157 NDLSGPIPDNLSGLDRLTSLQLQSNRFNGSLPGLNQSFLLIFNVSFNNLTGPVP--PSLS 214
Query: 216 KFDASSFSMNPNLCGKVINKACRPRSPFFESPNA--TSPP-RPLGQS-AQSQGILVLSPP 271
+FDASSF +NP LCG+ +N+ACR +PFFES NA TSP PLG+S AQSQG+ VLSPP
Sbjct: 215 RFDASSFQLNPGLCGETVNRACRLHAPFFESRNASSTSPASEPLGESTAQSQGV-VLSPP 273
Query: 272 SPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEG--RNSKEPSTASFNEGTTYPE 329
SP+N HK+ G+ILG++IG ++LV+ ++C+F + R ++ +PS + +
Sbjct: 274 SPKN-HKKTGVILGVAIGVSLLVAAVLCLFAVARNHNKTITYTDTKPSPITSPANRIHSN 332
Query: 330 PESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQL 389
P + RT Q+ E + +V ++KV+ E A + I RSG+L+FC GE+++YSLEQL
Sbjct: 333 PNNFRTIEA-QIPE-RREVVQFSDKVKTVEQAAPPRA-IPRSGNLIFCYGEAQLYSLEQL 389
Query: 390 MRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
MRASAELLGRGSIGTTYKAVLDN LIVTVKR DA KTA TS EAFE+HM+ VGGL HP L
Sbjct: 390 MRASAELLGRGSIGTTYKAVLDNQLIVTVKRLDAGKTAITSGEAFEEHMDVVGGLRHPYL 449
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
VP+RAYFQAKGERLVIYDYQPNGSLFNLIHGS+S RA+PLHWTSCLKIAEDVAQGLAYIH
Sbjct: 450 VPVRAYFQAKGERLVIYDYQPNGSLFNLIHGSKSTRARPLHWTSCLKIAEDVAQGLAYIH 509
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRAT 569
++S LIHGNLKSSNVLLG DFEA LTDY L+ +D+S+ EDPD+ YKAPEIRKSSRRAT
Sbjct: 510 QSSSLIHGNLKSSNVLLGGDFEACLTDYGLAFFADTSANEDPDSAGYKAPEIRKSSRRAT 569
Query: 570 SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629
SKSDVYAFG+LLLELLTGKHPSQHP L P D+ +WVR MR DD ++N+LGMLTEVA +C
Sbjct: 570 SKSDVYAFGILLLELLTGKHPSQHPLLVPTDVPDWVRVMRDDDVGDDNQLGMLTEVACIC 629
Query: 630 SLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFGYS 665
SL SPEQRPAMWQVLKMIQEIKESVM +DNA G+S
Sbjct: 630 SLTSPEQRPAMWQVLKMIQEIKESVMTDDNADVGFS 665
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224094286|ref|XP_002310125.1| predicted protein [Populus trichocarpa] gi|222853028|gb|EEE90575.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2188), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/643 (67%), Positives = 502/643 (78%), Gaps = 48/643 (7%)
Query: 29 TNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRG 88
T L P DAVS+LSFKSKAD +NKL Y LNER+DYCQWQG+KCAQGRVVR VLQ FGLRG
Sbjct: 27 TTYLPPLDAVSILSFKSKADLDNKLFYTLNERYDYCQWQGIKCAQGRVVRVVLQGFGLRG 86
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
TFPP TL+RLDQLRVLSL NNSL GPIPDLS L NLKSL L+ N FS +FP SIL LHRL
Sbjct: 87 TFPPFTLSRLDQLRVLSLQNNSLCGPIPDLSPLFNLKSLFLNHNSFSASFPPSILLLHRL 146
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQV 208
TILDLSYNNL G +PVNL++LDRL SL+LE+N+F+GT+P L+ LV FNVSGNNLTG +
Sbjct: 147 TILDLSYNNLAGQLPVNLSSLDRLNSLQLEFNQFNGTLPSLDLRLLVFFNVSGNNLTGPI 206
Query: 209 PETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPNATSPPR----PLGQSAQSQG 264
P TPTL +FD SSFS+NP LCG++INKAC+PRSPFF+S + + P GQSAQ+ G
Sbjct: 207 PLTPTLSRFDTSSFSLNPFLCGEIINKACKPRSPFFDSSASPTASSPAGVPFGQSAQAGG 266
Query: 265 ILVLS--PPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFN 322
+V+S PPS + R G++LG ++G +VL + + R+++E
Sbjct: 267 GVVVSITPPS-KQKPSRSGVVLGFTVGVSVL------------KQKQERHAEE------- 306
Query: 323 EGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESE 382
E E T T+ E ++ KA K SGSLVFC G+++
Sbjct: 307 ------EKEQVVTGTTSPAKEGLVQQVRKAEK----------------SGSLVFCGGKTQ 344
Query: 383 VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG 442
VY+LEQLMRASAELLGRG+IGTTYKAVLDN LIVTVKR DA+KTA TS++ FE+HM+ VG
Sbjct: 345 VYTLEQLMRASAELLGRGTIGTTYKAVLDNQLIVTVKRLDASKTAITSSDVFERHMDVVG 404
Query: 443 GLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA 502
L HPNLVPI AYFQAKGERLVI+DYQPNGSLFNLIHGSRS RAKPLHWTSCLKIAEDVA
Sbjct: 405 ALRHPNLVPIAAYFQAKGERLVIFDYQPNGSLFNLIHGSRSTRAKPLHWTSCLKIAEDVA 464
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIR 562
QGLAYIH+ S L+HGNLKS+NVLLGADFEA +TDYCL++L+D+SS E+PD+ A KAPE R
Sbjct: 465 QGLAYIHQTSNLVHGNLKSANVLLGADFEACITDYCLAMLADTSSSENPDSAACKAPETR 524
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622
K+SRRATSKSDVYAFGVLLLELLTGKHPSQHPYL P DML+WVRT+R D ++N+LGML
Sbjct: 525 KASRRATSKSDVYAFGVLLLELLTGKHPSQHPYLVPADMLDWVRTVRDDGSGDDNQLGML 584
Query: 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFGYS 665
TEVASVCSL SPEQRPAMWQVLKMIQEIK++VM EDNAA GYS
Sbjct: 585 TEVASVCSLTSPEQRPAMWQVLKMIQEIKDNVMVEDNAADGYS 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224084384|ref|XP_002307280.1| predicted protein [Populus trichocarpa] gi|222856729|gb|EEE94276.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/647 (66%), Positives = 508/647 (78%), Gaps = 20/647 (3%)
Query: 29 TNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRG 88
T LP D VS+LSFKSKAD +NKL Y LNERF+YCQWQG+KCAQGRVVR LQS GLRG
Sbjct: 26 TTDRLPPDVVSILSFKSKADLDNKLFYTLNERFEYCQWQGIKCAQGRVVRVALQSSGLRG 85
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
TFPP +L+ LDQLRVLSL NN+L+GPIPDLS L NLKSL L+ N F G FP SIL LHRL
Sbjct: 86 TFPPFSLSWLDQLRVLSLQNNTLSGPIPDLSPLFNLKSLILNHNSFCGYFPPSILLLHRL 145
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQV 208
TILDLSYNNL G IPVNL++LDRL SLKLE+N+F+GTVP L+ L FNVSGNNLTG +
Sbjct: 146 TILDLSYNNLNGPIPVNLSSLDRLNSLKLEFNQFNGTVPSLDLGLLFFFNVSGNNLTGPI 205
Query: 209 PETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFES---PNATSPPR-PLGQSAQSQG 264
P TPTL +FD SSFS+NP+LCG++INK+C+PRSPF +S PNA +P P GQSAQ+QG
Sbjct: 206 PVTPTLSRFDTSSFSLNPDLCGEIINKSCKPRSPFLDSSASPNAITPAGVPFGQSAQAQG 265
Query: 265 ILVLS--PPSPRNDHKRRGLILGLSIGFAVLVSFLVCI-FLLIRRSSEGRNSKEPSTASF 321
+V+S PPS + + R ++LG +IG ++LV L+CI FLL+++ + R +E A
Sbjct: 266 GVVVSITPPS-KQKYNRSSVVLGFTIGVSLLVLSLLCIGFLLVKKQKKERRVEEKEQAM- 323
Query: 322 NEGTTYPEPESSRTANTTQV---GECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCA 378
GT+ P S+ A ++V G I E K VQ A +RSGSLVFC
Sbjct: 324 -TGTSSPVRIHSKPAMQSEVVEKGHETINTEAKEGLVQQVRRA-------ERSGSLVFCG 375
Query: 379 GESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHM 438
G+++VY+LEQLMRASAELLGRG+IGTTYKAVLDN LIVTVKR DA KTA TS++ FE+HM
Sbjct: 376 GKAQVYTLEQLMRASAELLGRGTIGTTYKAVLDNQLIVTVKRLDAGKTAITSSDVFERHM 435
Query: 439 EAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIA 498
+ VG L H NLVPI AYFQAKGERLV+YDYQPNGSLFNLIHGSRS RAKPLHWTSCLKIA
Sbjct: 436 DVVGELRHLNLVPIAAYFQAKGERLVLYDYQPNGSLFNLIHGSRSTRAKPLHWTSCLKIA 495
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKA 558
EDVA+GLAYIH+ S L+HGNLKS+NVLLGADFEA +TDY L++L+D+SS EDPD+ A KA
Sbjct: 496 EDVAEGLAYIHQMSNLVHGNLKSANVLLGADFEACITDYSLALLADTSSSEDPDSAACKA 555
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618
PE RKSS +AT+KSDVYAFGVLLLELLTGKHPSQHPYL P DML+WVR +R D G ++N
Sbjct: 556 PETRKSSHQATAKSDVYAFGVLLLELLTGKHPSQHPYLVPADMLDWVRAVRDDGGGDDNH 615
Query: 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFGYS 665
LGM+TE+A +C L SPEQRPA WQVLKMIQEIK+ VM ED AA G S
Sbjct: 616 LGMITELACICRLTSPEQRPAAWQVLKMIQEIKDCVMVEDKAAVGNS 662
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448304|ref|XP_004141906.1| PREDICTED: probable inactive receptor kinase At5g67200-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 839 bits (2167), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/661 (64%), Positives = 507/661 (76%), Gaps = 22/661 (3%)
Query: 8 FFSLLLFSLLHSTATA---QYPPITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYC 64
F S LLF ++A+ Q PP + LLPSDAVSLLSFKSKAD NKLLY LNERFDYC
Sbjct: 15 FCSFLLFFPFFTSASGFDFQIPP-EDLLLPSDAVSLLSFKSKADLNNKLLYTLNERFDYC 73
Query: 65 QWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINL 124
QWQGVKC QGRVVR VLQSFGLRGT PNT+++LDQLR+LSLHNNSL GPIPDLS L NL
Sbjct: 74 QWQGVKCVQGRVVRLVLQSFGLRGTLAPNTVSQLDQLRILSLHNNSLEGPIPDLSRLFNL 133
Query: 125 KSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG 184
KSL L RN F G+FP SIL+LHRL LDLSYN TG +PV L++LDRL +L+LEWN F+G
Sbjct: 134 KSLFLGRNSFVGSFPPSILTLHRLQTLDLSYNRFTGPLPVRLSSLDRLITLRLEWNGFNG 193
Query: 185 TVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFF 244
++PPLNQ FL V NV+GNNLTGQ+P TPTL +F+ SSF NP+LCG+++NKAC +PFF
Sbjct: 194 SIPPLNQSFLEVLNVTGNNLTGQIPVTPTLSRFNTSSFFWNPDLCGEIVNKACHSPAPFF 253
Query: 245 ESPNATSPPR-PLGQSAQSQGILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFLL 303
E+ NAT PP P QSAQSQ +L P HK G+ILGLS+G AVLV+ ++C F +
Sbjct: 254 ETSNATPPPSIPSVQSAQSQDVLF--SPVTHAKHKETGMILGLSVGAAVLVAGVLC-FYV 310
Query: 304 IRRSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIG 363
R+ + + + + F T + ++ N G+ + + K + EEM
Sbjct: 311 AARTQRSQTTSKRAMPQFETETNF---STASAMNDRLEGKGEFIAKVKGS----EEMQK- 362
Query: 364 SQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDA 423
+SG+L+FC GE+E+++LEQLMRASAELLGRG++GTTYKAVL N LIVTVKR DA
Sbjct: 363 ----THKSGNLIFCEGEAELFNLEQLMRASAELLGRGTMGTTYKAVLCNQLIVTVKRLDA 418
Query: 424 NKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRS 483
KTA TS+E F++H+ AVG L HPNLVP+RAYFQAKGERLV+YDYQPNGSL+NLIHGSRS
Sbjct: 419 TKTATTSSEVFDRHLGAVGALRHPNLVPVRAYFQAKGERLVVYDYQPNGSLYNLIHGSRS 478
Query: 484 IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543
RAKPLHWTSCLKIAED+AQG+AYIH+AS LIHGNLKSSNVLLGA+FEA LTDY LS L+
Sbjct: 479 ARAKPLHWTSCLKIAEDLAQGIAYIHQASRLIHGNLKSSNVLLGAEFEACLTDYGLSALA 538
Query: 544 DSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE 603
+ + EDPD Y APE RKSSR AT KSDVYA+GVLLLELLTG+HP+ HP+L P DM E
Sbjct: 539 E--AYEDPDCSRYHAPETRKSSRNATQKSDVYAYGVLLLELLTGRHPAHHPFLEPTDMPE 596
Query: 604 WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFG 663
WVR +R DDG + N+LGMLTEVAS+CS SPEQRPAMWQVLKMI EIKESVM ED+ + G
Sbjct: 597 WVRVVREDDGGDSNQLGMLTEVASICSTTSPEQRPAMWQVLKMILEIKESVMTEDSESSG 656
Query: 664 Y 664
+
Sbjct: 657 F 657
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297794267|ref|XP_002865018.1| hypothetical protein ARALYDRAFT_496879 [Arabidopsis lyrata subsp. lyrata] gi|297310853|gb|EFH41277.1| hypothetical protein ARALYDRAFT_496879 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/651 (64%), Positives = 488/651 (74%), Gaps = 19/651 (2%)
Query: 26 PPITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFG 85
P NSLLPSDAV+LLSFKS AD +NKLLY+L ER+DYCQW+GVKCAQGR+VR VL G
Sbjct: 21 PNYFNSLLPSDAVALLSFKSTADLDNKLLYSLTERYDYCQWRGVKCAQGRIVRLVLSGVG 80
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSL 145
LRG F TL+RLDQLRVLSL NNSL GPIPDLS L+NLKSL LSRN FSG FP SILSL
Sbjct: 81 LRGYFSSATLSRLDQLRVLSLENNSLFGPIPDLSHLVNLKSLFLSRNQFSGTFPPSILSL 140
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
HRL IL LS NN +G IP + ALDRL SL LE+NRF+GT+PPLNQ FL FNVSGNNLT
Sbjct: 141 HRLMILSLSRNNFSGSIPSEINALDRLTSLNLEFNRFNGTLPPLNQSFLTSFNVSGNNLT 200
Query: 206 GQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPN-ATSPPRPLGQSAQSQ- 263
G +P TPTL +FDASSF NP LCG++IN+AC RSPFF S N TS PLGQSAQ+Q
Sbjct: 201 GVIPVTPTLSRFDASSFKSNPGLCGEIINRACASRSPFFGSTNKTTSSEPPLGQSAQAQN 260
Query: 264 -GILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVC--IFLLI--RRSSEGRNSKEPST 318
G +++SP + K GL+LG + G A L+ +C +F L+ +R+ +G P
Sbjct: 261 GGAVIISPVVTKKKGKESGLVLGFTAGLASLIVLGLCLVVFSLVIKKRNDDGIFEPNPKG 320
Query: 319 ASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCA 378
+ + T V + + VQ +E ++ I SG+LVFC
Sbjct: 321 EASLSQQQQQSQNQTPRTRTVPVLNSDSESHKREKDVQFQE----TEQRIPNSGNLVFC- 375
Query: 379 GESE---VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFE 435
GES +Y++EQLMRASAELLGRGS+G TYKAVLDN LIVTVKR DA KTA TS EAFE
Sbjct: 376 GESRSQGMYTMEQLMRASAELLGRGSVGITYKAVLDNQLIVTVKRLDAAKTAVTSEEAFE 435
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCL 495
HME VGGL H NLVPIRAYFQ+ GERL+IYDY PNGSLFNLIHGSRS RAKPLHWTSCL
Sbjct: 436 NHMEIVGGLRHTNLVPIRAYFQSNGERLIIYDYHPNGSLFNLIHGSRSSRAKPLHWTSCL 495
Query: 496 KIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV--EDPD 552
KIAEDVAQGL YIH+ +S L+HGNLKS+N+LLG DFEA LTDYCLSVL+DSSS +DPD
Sbjct: 496 KIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDYCLSVLTDSSSASPDDPD 555
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VD 611
+ +YKAPEIRKSSRR TSK DVY+FGVL+ ELLTGK+ S+HP++AP DML+WVR MR +
Sbjct: 556 SSSYKAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPFMAPHDMLDWVRAMREEE 615
Query: 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662
+G E+NRLGM+TE A +C + SPEQRP M QV+KMIQEIKESVMAE+N F
Sbjct: 616 EGTEDNRLGMMTETACLCRVTSPEQRPTMRQVIKMIQEIKESVMAEENDPF 666
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18425163|ref|NP_569046.1| putative inactive receptor kinase [Arabidopsis thaliana] gi|75163506|sp|Q93Y06.1|Y5720_ARATH RecName: Full=Probable inactive receptor kinase At5g67200; Flags: Precursor gi|16649055|gb|AAL24379.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|28059128|gb|AAO30018.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|332010930|gb|AED98313.1| putative inactive receptor kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/651 (63%), Positives = 493/651 (75%), Gaps = 20/651 (3%)
Query: 26 PPITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFG 85
P NSLLPSDAV+LLSFKS AD +NKLLY+L ER+DYCQW+GVKCAQGR+VR VL G
Sbjct: 24 PNYFNSLLPSDAVALLSFKSTADLDNKLLYSLTERYDYCQWRGVKCAQGRIVRLVLSGVG 83
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSL 145
LRG F TL+RLDQLRVLSL NNSL GPIPDLS L+NLKSL LSRN FSGAFP SILSL
Sbjct: 84 LRGYFSSATLSRLDQLRVLSLENNSLFGPIPDLSHLVNLKSLFLSRNQFSGAFPPSILSL 143
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
HRL IL +S+NN +G IP + ALDRL SL L++NRF+GT+P LNQ FL FNVSGNNLT
Sbjct: 144 HRLMILSISHNNFSGSIPSEINALDRLTSLNLDFNRFNGTLPSLNQSFLTSFNVSGNNLT 203
Query: 206 GQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPN-ATSPPRPLGQSAQSQ- 263
G +P TPTL +FDASSF NP LCG++IN+AC RSPFF S N TS PLGQSAQ+Q
Sbjct: 204 GVIPVTPTLSRFDASSFRSNPGLCGEIINRACASRSPFFGSTNKTTSSEAPLGQSAQAQN 263
Query: 264 -GILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVC--IFLLI--RRSSEGRNSKEPST 318
G +V+ P + K GL+LG + G A L+ +C +F L+ +R+ +G P
Sbjct: 264 GGAVVIPPVVTKKKGKESGLVLGFTAGLASLIVLGLCLVVFSLVIKKRNDDGIYEPNPKG 323
Query: 319 ASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCA 378
+ + ++ RT V + + + +VQ +E ++ I SG+LVFC
Sbjct: 324 EASLSQQQQSQNQTPRT-RAVPVLNSDTESQKREKEVQFQE----TEQRIPNSGNLVFC- 377
Query: 379 GESE---VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFE 435
GES +Y++EQLMRASAELLGRGS+G TYKAVLDN LIVTVKR DA KTA TS EAFE
Sbjct: 378 GESRSQGMYTMEQLMRASAELLGRGSVGITYKAVLDNQLIVTVKRLDAAKTAVTSEEAFE 437
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCL 495
HME VGGL H NLVPIR+YFQ+ GERL+IYDY PNGSLFNLIHGSRS RAKPLHWTSCL
Sbjct: 438 NHMEIVGGLRHTNLVPIRSYFQSNGERLIIYDYHPNGSLFNLIHGSRSSRAKPLHWTSCL 497
Query: 496 KIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV--EDPD 552
KIAEDVAQGL YIH+ +S L+HGNLKS+N+LLG DFEA LTDYCLSVL+DSSS +DPD
Sbjct: 498 KIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDYCLSVLTDSSSASPDDPD 557
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VD 611
+ +YKAPEIRKSSRR TSK DVY+FGVL+ ELLTGK+ S+HP++AP DML+WVR MR +
Sbjct: 558 SSSYKAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPFMAPHDMLDWVRAMREEE 617
Query: 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662
+G E+NRLGM+TE A +C + SPEQRP M QV+KMIQEIKESVMAE+N F
Sbjct: 618 EGTEDNRLGMMTETACLCRVTSPEQRPTMRQVIKMIQEIKESVMAEENDPF 668
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177607|dbj|BAB10954.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/647 (63%), Positives = 485/647 (74%), Gaps = 30/647 (4%)
Query: 26 PPITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFG 85
P NSLLPSDAV+LLSFKS AD +NKLLY+L ER+DYCQW+GVKCAQGR+VR VL G
Sbjct: 24 PNYFNSLLPSDAVALLSFKSTADLDNKLLYSLTERYDYCQWRGVKCAQGRIVRLVLSGVG 83
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSL 145
LRG F TL+RLDQLRVLSL NNSL GPIPDLS L+NLKSL LSRN FSGAFP SILSL
Sbjct: 84 LRGYFSSATLSRLDQLRVLSLENNSLFGPIPDLSHLVNLKSLFLSRNQFSGAFPPSILSL 143
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
HRL IL +S+NN +G IP + ALDRL SL L++NRF+GT+P LNQ FL FNVSGNNLT
Sbjct: 144 HRLMILSISHNNFSGSIPSEINALDRLTSLNLDFNRFNGTLPSLNQSFLTSFNVSGNNLT 203
Query: 206 GQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPN-ATSPPRPLGQSAQSQ- 263
G +P TPTL +FDASSF NP LCG++IN+AC RSPFF S N TS PLGQSAQ+Q
Sbjct: 204 GVIPVTPTLSRFDASSFRSNPGLCGEIINRACASRSPFFGSTNKTTSSEAPLGQSAQAQN 263
Query: 264 -GILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFN 322
G +V+ P + +LGL + +V ++ +R+ +G P +
Sbjct: 264 GGAVVIPPVVTKKK------VLGLCL--------VVFSLVIKKRNDDGIYEPNPKGEASL 309
Query: 323 EGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESE 382
+ ++ RT V + + + +VQ +E ++ I SG+LVFC GES
Sbjct: 310 SQQQQSQNQTPRT-RAVPVLNSDTESQKREKEVQFQE----TEQRIPNSGNLVFC-GESR 363
Query: 383 ---VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHME 439
+Y++EQLMRASAELLGRGS+G TYKAVLDN LIVTVKR DA KTA TS EAFE HME
Sbjct: 364 SQGMYTMEQLMRASAELLGRGSVGITYKAVLDNQLIVTVKRLDAAKTAVTSEEAFENHME 423
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAE 499
VGGL H NLVPIR+YFQ+ GERL+IYDY PNGSLFNLIHGSRS RAKPLHWTSCLKIAE
Sbjct: 424 IVGGLRHTNLVPIRSYFQSNGERLIIYDYHPNGSLFNLIHGSRSSRAKPLHWTSCLKIAE 483
Query: 500 DVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV--EDPDTVAY 556
DVAQGL YIH+ +S L+HGNLKS+N+LLG DFEA LTDYCLSVL+DSSS +DPD+ +Y
Sbjct: 484 DVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDYCLSVLTDSSSASPDDPDSSSY 543
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDGRE 615
KAPEIRKSSRR TSK DVY+FGVL+ ELLTGK+ S+HP++AP DML+WVR MR ++G E
Sbjct: 544 KAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPFMAPHDMLDWVRAMREEEEGTE 603
Query: 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662
+NRLGM+TE A +C + SPEQRP M QV+KMIQEIKESVMAE+N F
Sbjct: 604 DNRLGMMTETACLCRVTSPEQRPTMRQVIKMIQEIKESVMAEENDPF 650
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|196166341|gb|ACG70793.1| SMA9 [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/635 (63%), Positives = 488/635 (76%), Gaps = 24/635 (3%)
Query: 48 DSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLH 107
D NKLLY LNERFDYCQWQGVKC+QGRVVRFVLQSF LRG+FPP+TL+RLDQLRVLSLH
Sbjct: 55 DLNNKLLYTLNERFDYCQWQGVKCSQGRVVRFVLQSFSLRGSFPPDTLSRLDQLRVLSLH 114
Query: 108 NNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLT 167
NNSL+GPIPDLS L NLKSL L+RN FSG FP SIL+LHRLT+LDLS+N+L+G IP NL+
Sbjct: 115 NNSLSGPIPDLSPLQNLKSLFLNRNSFSGFFPPSILALHRLTVLDLSFNDLSGPIPDNLS 174
Query: 168 ALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227
LDRL SL+L+ NRF+G++P LNQ FL++FNVS NNLT VP P+L +FDASSF +NP
Sbjct: 175 GLDRLTSLQLQSNRFNGSLPGLNQSFLLIFNVSFNNLTRPVP--PSLSRFDASSFQLNPG 232
Query: 228 LCGKVINKACRPRSPFFESPNA--TSPP-RPLGQS-AQSQGILVLSPPSPRNDHKRRGLI 283
LCG+ +N+ACR +PFFES NA TSP PLG+S AQSQG+ VLSPPSP+N HK+ G+I
Sbjct: 233 LCGETVNRACRLHAPFFESRNASSTSPASEPLGESTAQSQGV-VLSPPSPKN-HKKTGVI 290
Query: 284 LGLSIGFAVLVSFLVCIFLLIRRSSEG--RNSKEPSTASFNEGTTYPEPESSRTANTTQV 341
LG++IG ++LV+ ++C+ + R ++ +PS + + P + RT Q+
Sbjct: 291 LGVAIGVSLLVAAVLCLSAVARNHNKTITYTDTKPSPITSPANRIHSNPNNFRTIEA-QI 349
Query: 342 GECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGS 401
E + V+ ++KV+ E A + I RSG+L+FC GE+++YSLEQLMRASAELLGRGS
Sbjct: 350 PERREAVQF-SDKVKTIEQAAPPRA-IPRSGNLIFCYGEAQLYSLEQLMRASAELLGRGS 407
Query: 402 IGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KG 460
IGTTYKAVLDN LIVTVKR DA KTA TS EAFE+HM+ VGGL HP LVP+
Sbjct: 408 IGTTYKAVLDNQLIVTVKRLDAGKTAITSGEAFEEHMDVVGGLRHPYLVPLDDVSSCFNN 467
Query: 461 ERLVIYDYQ--PNGSLFNL--------IHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
R+ +Y L + I GS+S RA+PLHWTSCLKIAEDVAQGLAYIH+
Sbjct: 468 RRVTVYSCHLSVRKQLAGVSGIVTCENIMGSKSTRARPLHWTSCLKIAEDVAQGLAYIHQ 527
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATS 570
+S LIHGNLKSSNVLLG DFEA LTDY L+ +D+ + EDPD+ YKAPEIRKSSRRATS
Sbjct: 528 SSSLIHGNLKSSNVLLGGDFEACLTDYGLAFFADTCANEDPDSAGYKAPEIRKSSRRATS 587
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630
KSDVYAFG+LLLELLTGKHPSQHP L P D+ +WVR MR DD ++N+LGMLTEVA +CS
Sbjct: 588 KSDVYAFGILLLELLTGKHPSQHPLLVPTDVPDWVRVMRDDDVGDDNQLGMLTEVACICS 647
Query: 631 LKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFGYS 665
L SPEQRPAMWQVLKMIQEIKESVM +DNA G+S
Sbjct: 648 LTSPEQRPAMWQVLKMIQEIKESVMTDDNADVGFS 682
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 665 | ||||||
| TAIR|locus:2155508 | 669 | AT5G67200 [Arabidopsis thalian | 0.947 | 0.941 | 0.611 | 4.2e-198 | |
| TAIR|locus:2074830 | 660 | AT3G50230 [Arabidopsis thalian | 0.921 | 0.928 | 0.544 | 1.4e-167 | |
| TAIR|locus:2167781 | 669 | AT5G43020 [Arabidopsis thalian | 0.784 | 0.780 | 0.434 | 3.3e-102 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.412 | 0.408 | 0.413 | 2.1e-92 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.445 | 0.452 | 0.398 | 3.2e-79 | |
| TAIR|locus:2196464 | 663 | AT1G10850 [Arabidopsis thalian | 0.768 | 0.770 | 0.392 | 4.2e-79 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.452 | 0.470 | 0.379 | 1.1e-78 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.389 | 0.404 | 0.390 | 1.4e-76 | |
| TAIR|locus:2036499 | 652 | AT1G60630 [Arabidopsis thalian | 0.762 | 0.777 | 0.381 | 9.3e-75 | |
| TAIR|locus:2024517 | 587 | AT1G64210 [Arabidopsis thalian | 0.353 | 0.400 | 0.382 | 1.6e-74 |
| TAIR|locus:2155508 AT5G67200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1918 (680.2 bits), Expect = 4.2e-198, P = 4.2e-198
Identities = 399/652 (61%), Positives = 474/652 (72%)
Query: 26 PPITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFG 85
P NSLLPSDAV+LLSFKS AD +NKLLY+L ER+DYCQW+GVKCAQGR+VR VL G
Sbjct: 24 PNYFNSLLPSDAVALLSFKSTADLDNKLLYSLTERYDYCQWRGVKCAQGRIVRLVLSGVG 83
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDXXXXXXXXXXXXXRNFFSGAFPLSILSL 145
LRG F TL+RLDQLRVLSL NNSL GPIPD RN FSGAFP SILSL
Sbjct: 84 LRGYFSSATLSRLDQLRVLSLENNSLFGPIPDLSHLVNLKSLFLSRNQFSGAFPPSILSL 143
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
HRL IL +S+NN +G IP + ALDRL SL L++NRF+GT+P LNQ FL FNVSGNNLT
Sbjct: 144 HRLMILSISHNNFSGSIPSEINALDRLTSLNLDFNRFNGTLPSLNQSFLTSFNVSGNNLT 203
Query: 206 GQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPN-ATSPPRPLGQSAQSQ- 263
G +P TPTL +FDASSF NP LCG++IN+AC RSPFF S N TS PLGQSAQ+Q
Sbjct: 204 GVIPVTPTLSRFDASSFRSNPGLCGEIINRACASRSPFFGSTNKTTSSEAPLGQSAQAQN 263
Query: 264 -GILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVC--IFLLI--RRSSEGRNSKEPS- 317
G +V+ P + K GL+LG + G A L+ +C +F L+ +R+ +G P
Sbjct: 264 GGAVVIPPVVTKKKGKESGLVLGFTAGLASLIVLGLCLVVFSLVIKKRNDDGIYEPNPKG 323
Query: 318 TASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFC 377
AS ++ + ++T T V + +T++ K + E ++ I SG+LVFC
Sbjct: 324 EASLSQ----QQQSQNQTPRTRAVPV--LNSDTESQKREKEVQFQETEQRIPNSGNLVFC 377
Query: 378 AGESE---VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAF 434
GES +Y++EQLMRASAELLGRGS+G TYKAVLDN LIVTVKR DA KTA TS EAF
Sbjct: 378 -GESRSQGMYTMEQLMRASAELLGRGSVGITYKAVLDNQLIVTVKRLDAAKTAVTSEEAF 436
Query: 435 EQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC 494
E HME VGGL H NLVPIR+YFQ+ GERL+IYDY PNGSLFNLIHGSRS RAKPLHWTSC
Sbjct: 437 ENHMEIVGGLRHTNLVPIRSYFQSNGERLIIYDYHPNGSLFNLIHGSRSSRAKPLHWTSC 496
Query: 495 LKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCXXXXXXXXXXX--XP 551
LKIAEDVAQGL YIH+ +S L+HGNLKS+N+LLG DFEA LTDYC P
Sbjct: 497 LKIAEDVAQGLYYIHQTSSALVHGNLKSTNILLGQDFEACLTDYCLSVLTDSSSASPDDP 556
Query: 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD 611
D+ +YKAPEIRKSSRR TSK DVY+FGVL+ ELLTGK+ S+HP++AP DML+WVR MR +
Sbjct: 557 DSSSYKAPEIRKSSRRPTSKCDVYSFGVLIFELLTGKNASRHPFMAPHDMLDWVRAMREE 616
Query: 612 D-GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662
+ G E+NRLGM+TE A +C + SPEQRP M QV+KMIQEIKESVMAE+N F
Sbjct: 617 EEGTEDNRLGMMTETACLCRVTSPEQRPTMRQVIKMIQEIKESVMAEENDPF 668
|
|
| TAIR|locus:2074830 AT3G50230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1630 (578.8 bits), Expect = 1.4e-167, P = 1.4e-167
Identities = 359/659 (54%), Positives = 439/659 (66%)
Query: 27 PITN---SLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQS 83
P TN S LPSDAV+LLSFKS AD +NKLLY+L E +DYCQW+GV C+Q RVVR +L
Sbjct: 24 PATNYFDSFLPSDAVALLSFKSTADLDNKLLYSLTEPYDYCQWRGVDCSQDRVVRLILDG 83
Query: 84 FGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDXXXXXXXXXXXXXRNFFSGAFPLSIL 143
GLRG+F P TL+RLDQLRVLSL NNS++G IPD +N FSG SIL
Sbjct: 84 VGLRGSFSPETLSRLDQLRVLSLENNSISGSIPDLSPLVNLKTLTLSKNGFSGTLSSSIL 143
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNN 203
SL RLT LDLS+NN +G IP + AL RL SL LE+NR +GT+PPLN L+ FNVS NN
Sbjct: 144 SLRRLTELDLSFNNFSGEIPSGINALSRLSSLNLEFNRLNGTLPPLNLSSLISFNVSSNN 203
Query: 204 LTGQVPETPTLLKFDASSFSMNPNLCGKVINKAC--RPRSPFFESP---------NATSP 252
LTG VP T TLL+F+ASSFS NP LCG++IN++C SPFF SP +A+S
Sbjct: 204 LTGLVPLTKTLLRFNASSFSSNPGLCGEIINRSCGLHSSSPFFGSPKPNTTSSTSSASSS 263
Query: 253 PRPLGQSAQSQGILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRN 312
P+ QS Q+ ++ PP + K L+LG +IG A L+ +C+ + S +N
Sbjct: 264 EAPVIQSEQNGEAAMIVPPVVKKV-KNGWLVLGFTIGLASLIVLGLCLVVF---SLFIKN 319
Query: 313 SKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSG 372
+E T P+ E E K K+Q + A S+ I R+G
Sbjct: 320 RREDYDDVI---ITQPKREE----------------ENKEIKIQFQTTAPSSKKRIPRNG 360
Query: 373 SLVFCA----GESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD 428
L+FC G +Y+++QLMRASAELLGRGS+GTTYKAV+ N +IVTVKRF +KTA
Sbjct: 361 DLIFCGEGGGGGEAMYTVDQLMRASAELLGRGSVGTTYKAVMVNQMIVTVKRFAPSKTAI 420
Query: 429 TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKP 488
TS FE ME VGGL HPNLVP++AYFQ+ GERLVIY+YQPNGSLFNLIHGSR+ +AKP
Sbjct: 421 TSDLEFENQMEIVGGLKHPNLVPVKAYFQSNGERLVIYEYQPNGSLFNLIHGSRTSKAKP 480
Query: 489 LHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCXXXXXXXXXX 548
LHWTSCLKIAEDVAQ L YIH++S HGNLKS+N+LLG DFEA +TDYC
Sbjct: 481 LHWTSCLKIAEDVAQALHYIHQSSAKFHGNLKSTNILLGHDFEACVTDYCLSVLTDSSVP 540
Query: 549 -XXPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR 606
PD +YKAPEIRKS+ R TSK DVY+FGV LLELLTGK S+ P + P DML+WVR
Sbjct: 541 PNDPDISSYKAPEIRKSTDSRPTSKCDVYSFGVFLLELLTGKTASRQPIMEPNDMLDWVR 600
Query: 607 TMRVDDGR--EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV-MAEDNAAF 662
MR ++ R EEN L M+T+ A +C + SPEQRP M +V+KMIQEIK SV M E+N F
Sbjct: 601 AMRQEEERSKEENGLEMMTQTACLCRVTSPEQRPTMKEVIKMIQEIKGSVVMTEENEKF 659
|
|
| TAIR|locus:2167781 AT5G43020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 3.3e-102, P = 3.3e-102
Identities = 255/587 (43%), Positives = 328/587 (55%)
Query: 115 IPDXXXXXXXXXXXXXRNF-FSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173
IPD +N +G P L L L L +N+ +G P+++ A RL
Sbjct: 92 IPDSVNKLDQLRVLSLKNTSLTGPLP-DFSGLVNLKSLFLDHNSFSGSFPLSVLAFHRLR 150
Query: 174 SLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNLTGQVP--ETPTLLKFDASSFSMNPNLC 229
+L +N +G +P + L+ + N G VP TL F+ S +N NL
Sbjct: 151 TLDFSFNNLTGPIPSGLVLSDRLIYLRLDSNRFNGPVPPLNQSTLHTFNVS---VN-NLT 206
Query: 230 GKVINKACRPR---SPFFESPN-------------------ATSPPRPLGQSAQSQGILV 267
G V R S F ++PN T+ P P Q I
Sbjct: 207 GAVPVTTVLLRFGISSFLKNPNLCGEIVHKECNPRAKFFTPVTAAPSPKMVLGQIAQIGG 266
Query: 268 LSPPSP-RNDHKRRGLILGLSIGFAVLVSFLVCIFLLIRRSSEGRNSKEPSTASFNEGTT 326
P +N H R +ILG G +L + C+ ++R R SK E T
Sbjct: 267 ARLSRPSQNKHSRFFVILGFISGAFILFISVACLIGAVKR----RRSKTEKQKG-KESTA 321
Query: 327 YPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSL 386
+++ TA E + ++E K K+Q +SGSLVFCAGE+ VY++
Sbjct: 322 VVTFDAAETAEVAAAIEQESEIEEKVKKLQAT-----------KSGSLVFCAGEAHVYTM 370
Query: 387 EQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH 446
+QLM ASAELLGRG++GTTYKA+LD+ LIVTVKR DA + A + FE HME+VG L H
Sbjct: 371 DQLMTASAELLGRGTVGTTYKALLDSRLIVTVKRLDAIRLAGVGRDKFEHHMESVGALGH 430
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
PNLVP+RAYFQAK ERL+IYDY PNGSL +L+HG++S RA PLHWTSCLKIAEDVAQGL+
Sbjct: 431 PNLVPLRAYFQAKEERLLIYDYLPNGSLSSLVHGTKSSRATPLHWTSCLKIAEDVAQGLS 490
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCXXXXXXXXXXXX------PDTVAYKAPE 560
YIH+A L+HGNLKSSNVLLG DFEA + DYC D AYK PE
Sbjct: 491 YIHQAWQLVHGNLKSSNVLLGQDFEACIADYCLVALATNPPLTSNDGQEDADAAAYKPPE 550
Query: 561 IR-KSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREEN-- 617
R KS + K+DVY+FG+LLLELLTGK PS+ P L +M+EWVR +R ++G ++N
Sbjct: 551 ARHKSLNYQSVKADVYSFGILLLELLTGKQPSKIPVLPLDEMIEWVRKVR-EEGEKKNGN 609
Query: 618 ------RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
+ GMLTEVA CSL SPEQRP MWQVLKM+QEIKE+ + E+
Sbjct: 610 WREDRDKFGMLTEVAVACSLASPEQRPTMWQVLKMLQEIKEAAVMEE 656
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 2.1e-92, Sum P(2) = 2.1e-92
Identities = 124/300 (41%), Positives = 174/300 (58%)
Query: 372 GSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSA 431
G +VF G + LE L+RASAE+LG+G GT YKAVL++ V VKR T
Sbjct: 344 GKMVFFEGTRR-FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKK 402
Query: 432 EAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHW 491
E FEQ ME +G L H NLV ++AY+ A+ E+L++YDY PNGSLF L+HG+R PL W
Sbjct: 403 E-FEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDW 461
Query: 492 TSCLKIAEDVAQGLAYIH---RASWLIHGNLKSSNVLLGADFEARLTDYCXXXXXXXXXX 548
T+ LKIA A+GLA+IH + L HG++KS+NVLL AR++D+
Sbjct: 462 TTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTV 521
Query: 549 XXPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ----HPYLAPPDMLEW 604
+ Y+APE+ R+ T KSDVY+FGVLLLE+LTGK P+ H A D+ W
Sbjct: 522 AKSN--GYRAPELI-DGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAV-DLPRW 577
Query: 605 VRTM-RVDDGRE------------ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651
V+++ R + E E + L ++A C+ + + RP M V+K+I++I+
Sbjct: 578 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIR 637
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 3.2e-79, Sum P(2) = 3.2e-79
Identities = 131/329 (39%), Positives = 187/329 (56%)
Query: 346 IKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTT 405
+KV+T K + E GS LVF G S + LE L+RASAE+LG+GS GT
Sbjct: 316 VKVKTLTEKAKQE---FGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTA 372
Query: 406 YKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLV 464
YKAVL+ V VKR K FEQ ME + + +HP++VP+RAY+ +K E+L+
Sbjct: 373 YKAVLEESTTVVVKRL---KEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLM 429
Query: 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW--LIHGNLKSS 522
+ DY P G+L +L+HG+R PL W S +KI A+G+A++H A HGN+KSS
Sbjct: 430 VCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSS 489
Query: 523 NVLLGADFEARLTDYCXXXXXXXXXXXXPDTVA-YKAPEIRKSSRRATSKSDVYAFGVLL 581
NV++ + +A ++D+ P A Y+APE+ ++ R+ T KSDVY+FGVL+
Sbjct: 490 NVIMKQESDACISDF--GLTPLMAVPIAPMRGAGYRAPEVMET-RKHTHKSDVYSFGVLI 546
Query: 582 LELLTGKHPSQHPYLAPPDMLE---WVR-------TMRVDD-------GREENRLGMLTE 624
LE+LTGK P Q P + DM++ WV+ T V D EE + ML +
Sbjct: 547 LEMLTGKSPVQSP--SRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQML-Q 603
Query: 625 VASVCSLKSPEQRPAMWQVLKMIQEIKES 653
+A C + PE RP M V++MI+EI+ S
Sbjct: 604 IAMACVAQVPEVRPTMDDVVRMIEEIRVS 632
|
|
| TAIR|locus:2196464 AT1G10850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 795 (284.9 bits), Expect = 4.2e-79, P = 4.2e-79
Identities = 218/556 (39%), Positives = 302/556 (54%)
Query: 132 NFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--L 189
N SG+ P ++ L L + L+ NN +G P +LT+L RL ++ L NR SG +P L
Sbjct: 105 NSLSGSIP-NLSGLVNLKSVYLNDNNFSGDFPESLTSLHRLKTIFLSGNRLSGRIPSSLL 163
Query: 190 NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPN-LCGKV-INKACRP--RSPFF 244
L NV N TG +P T L++ F+++ N L G++ + +A + S F
Sbjct: 164 RLSRLYTLNVEDNLFTGSIPPLNQTSLRY----FNVSNNKLSGQIPLTRALKQFDESSFT 219
Query: 245 ESPNATSPP--RPLGQSAQSQGILVLSPPSPRNDHKRRGLILGLSIGFAVLVSFLVCIFL 302
+ P G S P S ++ K G+I G S+ VLV L+ L
Sbjct: 220 GNVALCGDQIGSPCGISPAPSAKPTPIPKSKKSKAKLIGIIAG-SVAGGVLVLILLLTLL 278
Query: 303 LIRRSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAI 362
++ + RN + +G E E + TA T + E K + + + EE A+
Sbjct: 279 IVCWRRKRRNQ---APREDRKGKGIAEAEGATTAETERDIERK---DRGFSWERGEEGAV 332
Query: 363 GSQTLIKRSGSLVFCAGESEV-YSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRF 421
G+ + S S GE+ V Y++E L++ASAE LGRG++G+TYKAV+++ IVTVKR
Sbjct: 333 GTLVFLGTSDS-----GETVVRYTMEDLLKASAETLGRGTLGSTYKAVMESGFIVTVKRL 387
Query: 422 DANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGS 481
E F++H+E +G L HPNLVP+RAYFQAK ERL++YDY PNGSLF LIHG+
Sbjct: 388 --KNARYPRMEEFKRHVEILGQLKHPNLVPLRAYFQAKEERLLVYDYFPNGSLFTLIHGT 445
Query: 482 R-SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCXX 540
R S KPLHWTSCLKIAED+A L YIH+ L HGNLKSSNVLLG DFE+ LTDY
Sbjct: 446 RASGSGKPLHWTSCLKIAEDLASALLYIHQNPGLTHGNLKSSNVLLGPDFESCLTDYGLS 505
Query: 541 XXXXXXXXXXPDTVA--YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA- 597
V+ YKAPE R + +T +DVY+FGVLLLELLTG+ P Q
Sbjct: 506 TLHDPDSVEETSAVSLFYKAPECRDPRKASTQPADVYSFGVLLLELLTGRTPFQDLVQEY 565
Query: 598 PPDMLEWVRTMRVDD---GRE---------ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
D+ WVR +R ++ G E E +L L +A+VC P+ RP M +VLK
Sbjct: 566 GSDISRWVRAVREEETESGEEPTSSGNEASEEKLQALLSIATVCVTIQPDNRPVMREVLK 625
Query: 646 MIQEIKESVMAEDNAA 661
M+++ + N++
Sbjct: 626 MVRDARAEAPFSSNSS 641
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 1.1e-78, Sum P(2) = 1.1e-78
Identities = 124/327 (37%), Positives = 180/327 (55%)
Query: 345 KIKVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGT 404
K K NK EE G Q K LVF G S + LE L+RASAE+LG+GS GT
Sbjct: 299 KAKPGRSDNKA--EEFGSGVQEAEKNK--LVFFEGSSYNFDLEDLLRASAEVLGKGSYGT 354
Query: 405 TYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERL 463
TYKA+L+ V VKR K FEQ MEAVG +S H N+ P+RAY+ +K E+L
Sbjct: 355 TYKAILEEGTTVVVKRL---KEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKL 411
Query: 464 VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW--LIHGNLKS 521
++YDY G+ L+HG+ L W + L+I + A+G+++IH AS L+HGN+KS
Sbjct: 412 LVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKS 471
Query: 522 SNVLLGADFEARLTDYCXXXXXXXXXXXXPDTVAYKAPEIRKSSRRATSKSDVYAFGVLL 581
NVLL + ++D+ ++ Y+APE ++ R+ T KSDVY+FGVLL
Sbjct: 472 PNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIET-RKHTQKSDVYSFGVLL 530
Query: 582 LELLTGKHPSQHP-YLAPPDMLEWVRTM-------RVDD-------GREENRLGMLTEVA 626
LE+LTGK + + D+ +WV+++ V D E + + ++A
Sbjct: 531 LEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIA 590
Query: 627 SVCSLKSPEQRPAMWQVLKMIQEIKES 653
C K P+ RP+M +V+ M++EI+ S
Sbjct: 591 MACVSKHPDSRPSMEEVVNMMEEIRPS 617
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 478 (173.3 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 112/287 (39%), Positives = 168/287 (58%)
Query: 384 YSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG 443
+ LE L++ASAE+LG+GS GT YKAVL++ V VKR + S + FEQ ME VG
Sbjct: 340 FDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRL---REVVASKKEFEQQMEIVGK 396
Query: 444 LS-HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA 502
++ H N VP+ AY+ +K E+L++Y Y GSLF ++HG+R R + W + +KIA +
Sbjct: 397 INQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDRG--VDWETRMKIATGTS 454
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCXXXXXXXXXXXXPDTVAYKAPEIR 562
+ ++Y+H + +HG++KSSN+LL D E L+D P T+ Y APE+
Sbjct: 455 KAISYLHSLKF-VHGDIKSSNILLTEDLEPCLSD-TSLVTLFNLPTHTPRTIGYNAPEVI 512
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP----DMLEWVR-------TMRVD 611
++ RR + +SDVY+FGV++LE+LTGK P P L D+ WVR T V
Sbjct: 513 ET-RRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVF 571
Query: 612 DGR-------EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651
D EE + ML ++A C ++PE RP M +V +MI++++
Sbjct: 572 DVELLKFQNIEEEMVQML-QLALACVARNPESRPKMEEVARMIEDVR 617
|
|
| TAIR|locus:2036499 AT1G60630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
Identities = 213/558 (38%), Positives = 306/558 (54%)
Query: 132 NFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--L 189
N SG+ P ++ L L L L+ NN +G P +LT+L RL ++ L NRFSG +P L
Sbjct: 96 NSLSGSIP-NLSGLVNLKSLYLNDNNFSGEFPESLTSLHRLKTVVLSRNRFSGKIPSSLL 154
Query: 190 NQPFLVVFNVSGNNLTGQVP--ETPTLLKFDASSFSMNPNLCG-KVINKACRPRSPFFES 246
L F V N +G +P TL F+ S+ ++ ++ + +N+ S F ++
Sbjct: 155 RLSRLYTFYVQDNLFSGSIPPLNQATLRFFNVSNNQLSGHIPPTQALNRF--NESSFTDN 212
Query: 247 PNATSPPRPLGQSAQSQGILVLSPPSP-------RNDHKRRGLILGLSIGFAVLVSFLVC 299
A + + GI P R+ K G+I G SI +L+ L+
Sbjct: 213 I-ALCGDQIQNSCNDTTGITSTPSAKPAIPVAKTRSRTKLIGIISG-SICGGILI--LLL 268
Query: 300 IFLLIRRSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEE 359
FLLI + SK S E + ++TA T + G K + + + + EE
Sbjct: 269 TFLLICLLWRRKRSK--SKREERRSKRVAESKEAKTAETEE-GTSDQKNKRFSWEKESEE 325
Query: 360 MAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVK 419
++G+ + R ++V Y+++ L++ASAE LGRG++G+TYKAV+++ I+TVK
Sbjct: 326 GSVGTLVFLGRDITVVR-------YTMDDLLKASAETLGRGTLGSTYKAVMESGFIITVK 378
Query: 420 RFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIH 479
R + F++H+E +G L HPNLVP+RAYFQAK E L++YDY PNGSLF+LIH
Sbjct: 379 RL--KDAGFPRMDEFKRHIEILGRLKHPNLVPLRAYFQAKEECLLVYDYFPNGSLFSLIH 436
Query: 480 GSR-SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYC 538
GS+ S KPLHWTSCLKIAED+A GL YIH+ L HGNLKSSNVLLG DFE+ LTDY
Sbjct: 437 GSKVSGSGKPLHWTSCLKIAEDLAMGLVYIHQNPGLTHGNLKSSNVLLGPDFESCLTDY- 495
Query: 539 XXXXXXXXXXXXPDTVA----YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ-- 592
DT A YKAPE R + +T +DVY+FGVLLLELLTG+ +
Sbjct: 496 -GLSDLHDPYSIEDTSAASLFYKAPECRDLRKASTQPADVYSFGVLLLELLTGRTSFKDL 554
Query: 593 -HPYLAPPDMLEWVRTMRVDD-------GREENRLGMLTEVASVCSLKSPEQRPAMWQVL 644
H Y + D+ WVR +R ++ E +L L +A+ C PE RPAM +VL
Sbjct: 555 VHKYGS--DISTWVRAVREEETEVSEELNASEEKLQALLTIATACVAVKPENRPAMREVL 612
Query: 645 KMIQEIK-ESVMAEDNAA 661
KM+++ + E+ + N++
Sbjct: 613 KMVKDARAEAALFSFNSS 630
|
|
| TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 1.6e-74, Sum P(3) = 1.6e-74
Identities = 94/246 (38%), Positives = 139/246 (56%)
Query: 369 KRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD 428
+ G ++F G + ++ L+ L+ +SAE+LG+G+ GTTYK +++ V VKR K
Sbjct: 285 EEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRL---KEVV 341
Query: 429 TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRS-IRAK 487
FEQ ME +G + H N+ ++AY+ +K ++L +Y Y +GSLF ++HG+R
Sbjct: 342 VGRREFEQQMEIIGMIRHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGNRGRYHRV 401
Query: 488 PLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCXXXXXXXXX 547
PL W + L+IA A+GLA IH + IHGN+KSSN+ L + + D
Sbjct: 402 PLDWDARLRIATGAARGLAKIHEGKF-IHGNIKSSNIFLDSQCYGCIGDVGLTTIMRSLP 460
Query: 548 XXXPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-----DML 602
T Y APEI +RR+T SDVY+FGV+LLELLTGK P L P D+
Sbjct: 461 QTTCLTSGYHAPEIT-DTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGGENMDLA 519
Query: 603 EWVRTM 608
W+R++
Sbjct: 520 SWIRSV 525
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q93Y06 | Y5720_ARATH | No assigned EC number | 0.6390 | 0.9488 | 0.9431 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 665 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 2e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-04 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.001 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.002 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.003 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.003 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.003 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.004 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.004 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.004 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.004 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
LG G GT Y A V +K + + E + +E + L+HPN+V +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS-SSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 456 FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515
F+ + ++ +Y GSL +L+ L L+I + +GL Y+H +I
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKE----NEGKLSEDEILRILLQILEGLEYLHSNG-II 114
Query: 516 HGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEIRKSSRRATSK 571
H +LK N+LL +D + +L D+ LS L S T AY APE+ + K
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 572 SDVYAFGVLLLEL 584
SD+++ GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 76/261 (29%), Positives = 115/261 (44%), Gaps = 19/261 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEA--VGGLSHPNLVP 451
LG GS GT YKA IV VK K ++ S + E + LSHPN+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKIL--KKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ F+ K ++ +Y G LF+ + R PL KIA + +GL Y+H
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEIRKSSRR 567
+IH +LK N+LL + ++ D+ L+ SS T Y APE+
Sbjct: 118 G-IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNG 175
Query: 568 ATSKSDVYAFGVLLLELLTGKHP-SQHPYLAPPDMLEWVRTMRVDDGREENRLGM--LTE 624
K DV++ GV+L ELLTGK P S L ++ + ++ + G +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 625 VASVCSLKSPEQRPAMWQVLK 645
+ C K P +RP ++L+
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 395 ELLGRGSIGTTYKAVLDN-----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+ LG G+ G YK L + V VK + + E F + + L HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNI 63
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
V + + +++ +Y P G L + + R R K L + L A +A+G+ Y+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSS 565
+ IH +L + N L+G + +++D+ LS + + APE K
Sbjct: 121 SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE- 178
Query: 566 RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624
+ TSKSDV++FGVLL E+ T G+ P +P ++ ++LE+++ R E
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSNAEVLEYLKK----GYRLPKPPNCPPE 232
Query: 625 VASV---CSLKSPEQRPAMWQVLKMI 647
+ + C + PE RP ++++++
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/266 (24%), Positives = 122/266 (45%), Gaps = 26/266 (9%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+ LG G+ G YK L + V VK + + E F + + L HPN+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNV 63
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
V + + ++ +Y G L + + +R L + L A +A+G+ Y+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQIARGMEYLE 119
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYK--APEIRKSS 565
+ IH +L + N L+G + +++D+ LS + D + + + APE K
Sbjct: 120 SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE- 177
Query: 566 RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624
+ TSKSDV++FGVLL E+ T G+ P +P ++ ++LE+++ R E
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEVLEYLKN----GYRLPQPPNCPPE 231
Query: 625 VASV---CSLKSPEQRPAMWQVLKMI 647
+ + C + PE RP ++++++
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 62/259 (23%), Positives = 104/259 (40%), Gaps = 19/259 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG GS G Y A +V +K K E + ++ + L HPN+V +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F+ + + ++ +Y G LF+L+ + + L Y+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL---SEDEAR--FYLRQILSALEYLHSK-G 117
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--TVAYKAPEIRKSSRRATSK 571
++H +LK N+LL D +L D+ L+ D T Y APE+ +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGKA 176
Query: 572 SDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS--VC 629
D+++ GV+L ELLTGK P+ +LE + + ++ A +
Sbjct: 177 VDIWSLGVILYELLTGK----PPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232
Query: 630 SL--KSPEQRPAMWQVLKM 646
L K PE+R + L+
Sbjct: 233 KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 39/266 (14%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+ LG G+ G YK L V VK + + E F + + LSHPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-EEFLEEASIMKKLSHPNI 63
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
V + ++ +Y P G L + + L L++A +A+G+ Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG--EKLTLKDL--LQMALQIAKGMEYLE 119
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDT---VAYKAPE-IRK 563
+ +H +L + N L+ + +++D+ LS + D + + + APE ++
Sbjct: 120 SKN-FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDMLEWVRTMRVDDGREENRL-- 619
+ TSKSDV++FGVLL E+ T + PY ++ ++LE + DG RL
Sbjct: 179 --GKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEEVLELLE-----DGY---RLPR 225
Query: 620 --GMLTEVASV---CSLKSPEQRPAM 640
E+ + C PE RP
Sbjct: 226 PENCPDELYELMLQCWAYDPEDRPTF 251
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 30/273 (10%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNL 449
+ LG G+ G YK L V VK + A + F + + L HPN+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC----LKIAEDVAQGL 505
V + + ++ +Y G L + + SR + P T L A +A+G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT-----VAYKAPE 560
Y+ +H +L + N L+G D +++D+ LS T + + APE
Sbjct: 119 EYLASKK-FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 561 -IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618
++ TSKSDV++FGVLL E+ T G P +P L+ ++LE++R R
Sbjct: 178 SLKD--GIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEVLEYLR----KGYRLPKP 229
Query: 619 LGMLTEVASV---CSLKSPEQRPAMWQVLKMIQ 648
E+ + C PE RP ++++ ++
Sbjct: 230 EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
ELLGRGS G+ Y A+ D ++ VK + + ++ EA E+ + + L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 454 AYF-----QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
Y+ + K + +Y GSL +L+ + L K + +GLAY+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLPEPVIRKYTRQILEGLAYL 117
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKAPE-IR 562
H ++H ++K +N+L+ +D +L D+ + + T + APE IR
Sbjct: 118 HSNG-IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP 590
+D+++ G ++E+ TGK P
Sbjct: 177 GE--EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+L+GRG+ G YK + L+ V +K+ K + + ++ Q ++ + L HPN+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ +I +Y NGSL +I + P + V QGLAY+H
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHEQG- 119
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPE-IRKSSRRAT 569
+IH ++K++N+L D +L D+ ++ + S +D T + APE I S A+
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG--AS 177
Query: 570 SKSDVYAFGVLLLELLTGKHP 590
+ SD+++ G ++ELLTG P
Sbjct: 178 TASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.9 bits (242), Expect = 6e-22
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 28/274 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHP-NLVPI 452
LG GS G Y A + +V +K + E F + ++ + L+HP N+V +
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+FQ +G ++ +Y GSL +L+ + R PL + L I + L Y+H
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 513 WLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSSVEDPD---------TVAYKAPEI- 561
+IH ++K N+LL D +L D+ L+ L T Y APE+
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 562 -RKSSRRATSKSDVYAFGVLLLELLTGKHPSQ--HPYLAPPDMLEWVR-------TMRVD 611
S A+S SD+++ G+ L ELLTG P + A L+ + +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
E +++ K P+ R + L
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-21
Identities = 59/129 (45%), Positives = 74/129 (57%), Gaps = 4/129 (3%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILS 144
L G P +L L L+ L L+ N L+GPIP + SL L SL LS N SG P ++
Sbjct: 248 LTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGN 202
L L IL L NN TG IPV LT+L RL L+L N+FSG +P L V ++S N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 203 NLTGQVPET 211
NLTG++PE
Sbjct: 367 NLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 70/275 (25%), Positives = 125/275 (45%), Gaps = 42/275 (15%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E++G G+ Y A+ L N+ V +KR D K TS + + ++A+ +HPN+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F E ++ Y GSL +++ S L + ++V +GL Y+H
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG- 122
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP------------DTVAYKAPEI 561
IH ++K+ N+LLG D ++ D+ +S +S+ D T + APE+
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVS-----ASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHP-SQHPYL---------APPDMLEWVRTMRVD 611
+ K+D+++FG+ +EL TG P S++P + PP + +
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSL---------E 228
Query: 612 DGREENRLG-MLTEVASVCSLKSPEQRPAMWQVLK 645
G + + ++ S+C K P +RP ++LK
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-20
Identities = 72/221 (32%), Positives = 89/221 (40%), Gaps = 52/221 (23%)
Query: 40 LLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFV------------------- 80
LLSFKS + K L N D C WQG+ C V +
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLP 93
Query: 81 ------LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFF 134
L + L G P + T LR L+L NN+ TG IP S+ NL++L LS N
Sbjct: 94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR-GSIPNLETLDLSNNML 152
Query: 135 SGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP------- 187
SG P I S L +LDL N L G IP +LT L L L L N+ G +P
Sbjct: 153 SGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMK 212
Query: 188 PLNQPFLVVFNVSG-------------------NNLTGQVP 209
L +L N+SG NNLTG +P
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 62/270 (22%), Positives = 114/270 (42%), Gaps = 28/270 (10%)
Query: 397 LGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
LG+GS G YK I +K+ + + + + ++ + P +V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKCYGA 67
Query: 456 FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTS--CLKIAEDVAQGLAYIHRASW 513
F +GE ++ +Y GSL + K IA + +GL Y+H
Sbjct: 68 FYKEGEISIVLEYMDGGSL-------ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEIRKSSRRATS 570
+IH ++K SN+L+ + E ++ D+ +S + +++ + TV Y +PE R +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSY 179
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDG-----REENRLGMLTE 624
+D+++ G+ LLE GK P PP + M+ + DG E +
Sbjct: 180 AADIWSLGLTLLECALGKFP-----FLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234
Query: 625 VASVCSLKSPEQRPAMWQVL--KMIQEIKE 652
S C K P++RP+ ++L I++
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 7e-19
Identities = 58/166 (34%), Positives = 77/166 (46%), Gaps = 26/166 (15%)
Query: 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
L++LSL N G +PD L++L LSRN FSGA P + SL L L LS N L+
Sbjct: 453 SLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 160 GLIPVNLTALDRLYSLKLEWNRFSGTVP-----------------------PLN---QPF 193
G IP L++ +L SL L N+ SG +P P N
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572
Query: 194 LVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKACRP 239
LV N+S N+L G +P T L +AS+ + N +LCG P
Sbjct: 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 74/256 (28%), Positives = 120/256 (46%), Gaps = 34/256 (13%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
LG G G + + V VK K S EAF Q + + L H LV + A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIH 516
+ ++ +Y GSL + + +S K L + +A +A+G+AY+ + IH
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN-YIH 126
Query: 517 GNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK---------APEIRKSSRR 567
+L + N+L+G + ++ D+ L+ L +ED + A + APE + R
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL-----IEDDEYTAREGAKFPIKWTAPEA-ANYGR 180
Query: 568 ATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV----RTMRVDDGREENRLGML 622
T KSDV++FG+LL E++T G+ P +P + ++LE V R R + EE L
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVP--YPGMTNREVLEQVERGYRMPRPPNCPEE-----L 233
Query: 623 TEVASVCSLKSPEQRP 638
++ C K PE+RP
Sbjct: 234 YDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 30/263 (11%)
Query: 395 ELLGRGSIGTTYKA-VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS---HPNLV 450
E +G+G G YKA V +K S E E+ + + L HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIK-----LESKEKKEKIINEIQILKKCKHPNIV 60
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ K E ++ ++ GSL +L+ + L + + +++ +GL Y+H
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPE-IRKSS 565
+IH ++K++N+LL +D E +L D+ LS S + +T+ + APE I
Sbjct: 117 NG-IIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGK- 172
Query: 566 RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625
K+D+++ G+ +EL GK P + L P M + N E
Sbjct: 173 -PYDYKADIWSLGITAIELAEGKPP--YSELPP--MKALFKIATNGPPGLRNPEKWSDEF 227
Query: 626 A---SVCSLKSPEQRPAMWQVLK 645
C K+PE+RP Q+LK
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+ +G+GS G Y D L V +K D + ++ E ++ + L+HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYV-LKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKP------LHWTS--CLKIAEDVAQG 504
F+ KG+ ++ +Y G L I + KP L W CL
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCL--------A 115
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAP 559
L Y+H ++H ++K N+ L ++ +L D+ +S VLS + + TV Y +P
Sbjct: 116 LKYLHSRK-ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK--TVVGTPYYLSP 172
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
E+ ++ + KSD+++ G +L EL T KHP
Sbjct: 173 ELCQN-KPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 397 LGRGSIGTTYKAVLDNH-----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
LG G G D V VK + + + FE+ +E + L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENIVK 70
Query: 452 IRAYFQAKGER--LVIYDYQPNGSLFNLIHGSRS-IRAKPLHWTSCLKIAEDVAQGLAYI 508
+ + G R +I +Y P+GSL + + R I K L L + + +G+ Y+
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMDYL 125
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSS---SVEDPDT--VAYKAPEIR 562
+ IH +L + N+L+ ++ +++D+ L+ VL + V++P + + APE
Sbjct: 126 G-SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHPSQHP 594
+ + +S SDV++FGV L EL T PSQ P
Sbjct: 185 -RTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-17
Identities = 52/122 (42%), Positives = 70/122 (57%), Gaps = 3/122 (2%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
PN+LT L L L+L +N L G IP +L + +LK + L N SG P I L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNLTGQV 208
LDL YNNLTG IP +L L L L L N+ SG +PP + L+ ++S N+L+G++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 209 PE 210
PE
Sbjct: 301 PE 302
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 33/266 (12%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
LG+G G + + V +K K EAF Q + + L H LVP+ A
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIH 516
+ ++ ++ GSL + + + K L + +A +A G+AYI R ++ IH
Sbjct: 71 SEE-PIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERMNY-IH 125
Query: 517 GNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---------YKAPEIRKSSRR 567
+L+++N+L+G + ++ D+ L+ L +ED + A + APE R
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARL-----IEDNEYTARQGAKFPIKWTAPEAALYGR- 179
Query: 568 ATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVR---TMRVDDGREENRLGMLT 623
T KSDV++FG+LL EL+T G+ P +P + ++LE V M G E+ L
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP--YPGMVNREVLEQVERGYRMPCPQGCPES----LH 233
Query: 624 EVASVCSLKSPEQRPAMWQVLKMIQE 649
E+ +C K P++RP + +++
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 71/252 (28%), Positives = 122/252 (48%), Gaps = 26/252 (10%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
LG G G + +N V VK K S +AF + + L H LV + A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 457 QAKGERLVIYDYQPNGSLFNLI---HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ +I +Y GSL + + G + + K + +++ +A+G+AYI R ++
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA------QIAEGMAYIERKNY 124
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDT---VAYKAPE-IRKSSRRA 568
IH +L+++NVL+ ++ D+ L+ V+ D+ + + APE I S
Sbjct: 125 -IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--F 181
Query: 569 TSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV-RTMRVDDGREENRLGMLTEVA 626
T KSDV++FG+LL E++T GK P +P ++ D++ + R R+ R EN L ++
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIP--YPGMSNSDVMSALQRGYRMP--RMENCPDELYDIM 237
Query: 627 SVCSLKSPEQRP 638
C + E+RP
Sbjct: 238 KTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 71/254 (27%), Positives = 127/254 (50%), Gaps = 27/254 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ LG G G + + H V +K K S EAF + L HP LV + A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ +I +Y NGSL + + I+ L + +A +A+G+A+I R ++
Sbjct: 69 VV-TQEPIYIITEYMENGSLVDFLKTPEGIK---LTINKLIDMAAQIAEGMAFIERKNY- 123
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPE--IRKSSRRA---- 568
IH +L+++N+L+ ++ D+ L+ L +ED + A + + I+ ++ A
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARL-----IEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 569 --TSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV-RTMRVDDGREENRLGMLTE 624
T KSDV++FG+LL E++T G+ P +P + P++++ + R R+ R +N L E
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIP--YPGMTNPEVIQNLERGYRMP--RPDNCPEELYE 234
Query: 625 VASVCSLKSPEQRP 638
+ +C + PE+RP
Sbjct: 235 LMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G+GS G +K V + + +K+ D +K E + L ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F KG+ ++ +Y NG L L+ R +PL + + GLA++H
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLK---MQRGRPLPEDQVWRFFIQILLGLAHLHSKK- 121
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSSRRATS 570
++H ++KS N+ L A ++ D ++ +LSD+++ + T Y +PE+ + +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED-KPYNE 180
Query: 571 KSDVYAFGVLLLELLTGKHP 590
KSDV+A GV+L E TGKHP
Sbjct: 181 KSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 72/253 (28%), Positives = 120/253 (47%), Gaps = 29/253 (11%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
LG+G G + + V +K K S EAF Q + + L H LV + A
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIH 516
+ ++ +Y GSL + + G K L + +A +A G+AY+ R ++ +H
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMNY-VH 125
Query: 517 GNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---------YKAPEIRKSSRR 567
+L+++N+L+G + ++ D+ L+ L +ED + A + APE R
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARL-----IEDNEYTARQGAKFPIKWTAPEAALYGR- 179
Query: 568 ATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV-RTMRVDDGREENRLGMLTEV 625
T KSDV++FG+LL EL T G+ P +P + ++L+ V R R+ E L ++
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMPCPPECPE--SLHDL 235
Query: 626 ASVCSLKSPEQRP 638
C K PE+RP
Sbjct: 236 MCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 25/260 (9%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
LG G G + + V +K + S + F + + + LSHPNLV +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIH 516
+ ++ +Y NG L N + + L + DV + + Y+ + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEAMEYLESNGF-IH 123
Query: 517 GNLKSSNVLLGADFEARLTDYCLS--VLSD--SSSVEDPDTVAYKAPEIRKSSRRATSKS 572
+L + N L+G D +++D+ L+ VL D +SS V + PE+ SR +SKS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKS 182
Query: 573 DVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT-MRVDDGREENRLGMLTEVASV-- 628
DV++FGVL+ E+ + GK P + + +++E V R+ + TEV ++
Sbjct: 183 DVWSFGVLMWEVFSEGKMP--YERFSNSEVVESVSAGYRLYRPKLAP-----TEVYTIMY 235
Query: 629 -CSLKSPEQRPAMWQVLKMI 647
C + PE RPA ++L +
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA---DTSA-----EAFEQHMEAVGGLS 445
EL+G+G+ G Y A+ + ++ VK+ + T S +A +E + L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 446 HPNLVPIRAY--FQAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA 502
H N+V Y F+ E L I+ +Y P GS+ GS E V
Sbjct: 67 HLNIV---QYLGFETTEEYLSIFLEYVPGGSI-----GSCLRTYGRFEEQLVRFFTEQVL 118
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYK 557
+GLAY+H ++H +LK+ N+L+ AD +++D+ +S SD D + +V +
Sbjct: 119 EGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 558 APEIRKSSRRATS-KSDVYAFGVLLLELLTGKHP 590
APE+ S + S K D+++ G ++LE+ G+ P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 40/269 (14%)
Query: 388 QLMRASAEL---LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL 444
++ R S +L LG G G + A + H V VK K S EAF + L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTL 58
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
H LV + A K +I ++ GSL + + + +PL + + +A+G
Sbjct: 59 QHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPL--PKLIDFSAQIAEG 114
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA--------- 555
+A+I + ++ IH +L+++N+L+ A ++ D+ L+ + +ED + A
Sbjct: 115 MAFIEQRNY-IHRDLRAANILVSASLVCKIADFGLARV-----IEDNEYTAREGAKFPIK 168
Query: 556 YKAPE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV----RTMR 609
+ APE I S T KSDV++FG+LL+E++T G+ P +P ++ P+++ + R R
Sbjct: 169 WTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALERGYRMPR 224
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRP 638
++ EE L + C PE+RP
Sbjct: 225 PENCPEE-----LYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 32/265 (12%)
Query: 388 QLMRASAEL---LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL 444
++ R S +L LG G G + + + V VK K S E+F + + + L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKL 58
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
H LV + A ++ ++ +Y GSL + + + + L + + +A VA G
Sbjct: 59 RHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAG 114
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA--------- 555
+AYI R ++ IH +L+S+N+L+G ++ D+ L+ L +ED + A
Sbjct: 115 MAYIERMNY-IHRDLRSANILVGDGLVCKIADFGLARL-----IEDNEYTARQGAKFPIK 168
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV-RTMRVDDG 613
+ APE R T KSDV++FG+LL EL+T G+ P +P + ++LE V R R+
Sbjct: 169 WTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVP--YPGMNNREVLEQVERGYRMP-- 223
Query: 614 REENRLGMLTEVASVCSLKSPEQRP 638
++ L E+ C K PE+RP
Sbjct: 224 CPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 444 LSHPNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA 502
++HP +V + FQ + E+L ++ +Y P G LF+ + + + AE +
Sbjct: 50 INHPFIVKLHYAFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAAE-IV 103
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDP-DTVAYKAP 559
L Y+H +I+ +LK N+LL AD +LTD+ L+ + S+ S T Y AP
Sbjct: 104 LALEYLHSLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAP 162
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
E+ + D ++ GVLL E+LTGK P
Sbjct: 163 EV-LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 65/258 (25%), Positives = 122/258 (47%), Gaps = 21/258 (8%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
+G G G + V +K + S E F + + + LSHP LV +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIH 516
+ +++++ +G L + + R ++ CL DV +G+AY+ ++ +IH
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL----DVCEGMAYLESSN-VIH 123
Query: 517 GNLKSSNVLLGADFEARLTDYCLS--VLSD--SSSVEDPDTVAYKAPEIRKSSRRATSKS 572
+L + N L+G + +++D+ ++ VL D +SS V + +PE+ S+ +SKS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY-SSKS 182
Query: 573 DVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG--MLTEVASVC 629
DV++FGVL+ E+ + GK P ++ + E V T+ + RL + E+ C
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETINAGFRLYKPRLASQSVYELMQHC 237
Query: 630 SLKSPEQRPAMWQVLKMI 647
+ PE RP+ +L +
Sbjct: 238 WKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 42/217 (19%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVK--RFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G G+ G Y AV LD ++ VK R N + + M+ + L HPNLV
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK--TIKEIADEMKVLELLKHPNLV--- 62
Query: 454 AYF--QAKGERLVIY-DYQPNGSLFNLIHGSRS-----IRAKPLHWTSCLKIAEDVAQGL 505
Y+ + E++ I+ +Y G+L L+ R IR L GL
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE----------GL 112
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDY-CLSVLSDSSSVEDPD------TVAYKA 558
AY+H ++H ++K +N+ L + +L D+ C L ++++ + T AY A
Sbjct: 113 AYLHSHG-IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 559 PEIRKSSR-----RATSKSDVYAFGVLLLELLTGKHP 590
PE+ + RA +D+++ G ++LE+ TGK P
Sbjct: 172 PEVITGGKGKGHGRA---ADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-15
Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 396 LLGRGSIGTTYKA-VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
++ RG G +YK + N + VK ++ + M G L HPN+V +
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEI---NDVNSIPSSEIADM---GKLQHPNIVKLIG 750
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-RAS- 512
+++ +I++Y +L ++ L W KIA +A+ L ++H R S
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVAYKAPEIRKSSRRATSK 571
++ GNL +++ E L LS+ + + + AY APE R++ + T K
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL---RLSLPGLLCTDTKCFISSAYVAPETRET-KDITEK 858
Query: 572 SDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR--------------TMRVDDGREEN 617
SD+Y FG++L+ELLTGK P+ + ++EW R ++R D +N
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648
+ + +A C+ P RP VLK ++
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 34/276 (12%)
Query: 385 SLEQLMRASAELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAE--AFEQHMEA 440
LE L LG G+ G K I+ VK A + ++
Sbjct: 2 DLEYLGE-----LGAGNSGVVSKVLHRPTGK-IMAVKTIRLEIN---EAIQKQILRELDI 52
Query: 441 VGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAED 500
+ + P +V F G+ + +Y GSL ++ P KIA
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILG--KIAVA 108
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAP 559
V +GL Y+H +IH ++K SN+L+ + + +L D+ +S L +S + T +Y AP
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAP 168
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP---SQHPYLAPPDMLEWVRTMRVDDGREE 616
E R + KSD+++ G+ L+EL TG+ P P ++L+++ V++
Sbjct: 169 E-RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI----VNE--PP 221
Query: 617 NRL------GMLTEVASVCSLKSPEQRPAMWQVLKM 646
RL + ++C +K P +RP+ ++L+
Sbjct: 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 68/248 (27%), Positives = 119/248 (47%), Gaps = 26/248 (10%)
Query: 416 VTVKRFDANKTA------DTSAEAFEQHMEAVGGLSHPNLVPIRAYF-QAKGERLVIYDY 468
V + + NK A D +A+AF + L H NLV + + KG ++ +Y
Sbjct: 22 VMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81
Query: 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528
GSL + + RS L LK + DV + + Y+ A+ +H +L + NVL+
Sbjct: 82 MAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL-EANNFVHRDLAARNVLVSE 137
Query: 529 DFEARLTDYCLSVLSDSSSVEDPDT--VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586
D A+++D+ L+ ++SS +D V + APE + + +T KSDV++FG+LL E+ +
Sbjct: 138 DNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYS 194
Query: 587 -GKHPSQHPYLAPPDMLEWVRT---MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQ 642
G+ P +P + D++ V M DG ++ +V C RP+ Q
Sbjct: 195 FGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPP----VVYDVMKQCWHLDAATRPSFLQ 248
Query: 643 VLKMIQEI 650
+ + ++ I
Sbjct: 249 LREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 22/233 (9%)
Query: 425 KTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI 484
K S + F + + + LSH LV + + ++ +Y NG L N +
Sbjct: 37 KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-- 94
Query: 485 RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VL 542
K + L++ +DV +G+AY+ + IH +L + N L+ +++D+ LS VL
Sbjct: 95 --KRFQPSQLLEMCKDVCEGMAYLESKQF-IHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151
Query: 543 SD--SSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPP 599
D +SSV V + PE+ S+ +SKSDV+AFGVL+ E+ + GK P +
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMP--YERFNNS 208
Query: 600 DMLEWVRTMRVDDGREENRLGMLTE----VASVCSLKSPEQRPAMWQVLKMIQ 648
+ +E +V G R + +E + C + E+RP Q+L I+
Sbjct: 209 ETVE-----KVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 25/260 (9%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
LG G G + + V +K A S E F + + + LSHP LV +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIK---AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIH 516
+ ++ ++ NG L N + + +K + + C +DV +G+ Y+ R S+ IH
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC----QDVCEGMEYLERNSF-IH 123
Query: 517 GNLKSSNVLLGADFEARLTDYCLS--VLSD----SSSVEDPDTVAYKAPEIRKSSRRATS 570
+L + N L+ + +++D+ ++ VL D SS + P V + PE+ S+ +S
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFSK-YSS 180
Query: 571 KSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT--EVAS 627
KSDV++FGVL+ E+ T GK P E V + +L +T EV
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMP-----FEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235
Query: 628 VCSLKSPEQRPAMWQVLKMI 647
C + PE RP ++L+ I
Sbjct: 236 SCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 39/85 (45%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 104 LSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLI 162
L L N L G IP D+S L +L+S++LS N G P S+ S+ L +LDLSYN+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 163 PVNLTALDRLYSLKLEWNRFSGTVP 187
P +L L L L L N SG VP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456
LG G G ++ + N + V +K ++ + F++ ++A+ L H +L+ + A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIH 516
+I + GSL + RS + L S + +A VA+G+AY+ IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLE-EQNSIH 127
Query: 517 GNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYK--APEIRKSSRRATSKSD 573
+L + N+L+G D ++ D+ L+ ++ + + + YK APE S ++KSD
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA-ASHGTFSTKSD 186
Query: 574 VYAFGVLLLELLT-GKHP 590
V++FG+LL E+ T G+ P
Sbjct: 187 VWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 69/266 (25%), Positives = 121/266 (45%), Gaps = 31/266 (11%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+G+G G V VK + TA A+AF + L HPNLV +
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK-VAVKCLKDDSTA---AQAFLAEASVMTTLRHPNLVQLLG 67
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKI-AEDVAQGLAYIHRASW 513
++ +Y GSL + + RS R + + + A DV +G+ Y+
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYL---RS-RGRAVITLAQQLGFALDVCEGMEYLE-EKN 122
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED----PDTVAYKAPE-IRKSSRRA 568
+H +L + NVL+ D A+++D+ L+ ++S +D P V + APE +R+ +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLA--KEASQGQDSGKLP--VKWTAPEALREK--KF 176
Query: 569 TSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT---MRVDDGREENRLGMLTE 624
++KSDV++FG+LL E+ + G+ P +P + D++ V M +G + +
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHVEKGYRMEAPEGCP----PEVYK 230
Query: 625 VASVCSLKSPEQRPAMWQVLKMIQEI 650
V C P +RP Q+ + + I
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 45/228 (19%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDA------NKTADTSAEAFEQHMEAVGGLS-H 446
+++G GS T A + + +K D K E E + L+ H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK-----EVLTRLNGH 61
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIH--GSRSIRAKPLHWTSCLKIAEDVAQG 504
P ++ + FQ + + +Y PNG L I GS + A ++
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-------CTRFYAAEILLA 114
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK--APEIR 562
L Y+H +IH +LK N+LL D ++TD+ + + D +S + + +I
Sbjct: 115 LEYLHSKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 563 KSSRRATS--------------------KSDVYAFGVLLLELLTGKHP 590
K+ RR S SD++A G ++ ++LTGK P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 24/264 (9%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E +G+G+ G YK VL + V VK + D + F Q E + HPN+V +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRS-IRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
K ++ + P GSL + ++ + K L L+++ D A G+ Y+ +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGMEYLESKN- 113
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKAPEIRKSSRRA 568
IH +L + N L+G + +++D+ +S + D + + APE R
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY- 172
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG-REENRLGMLTEVAS 627
TS+SDV+++G+LL E + PY P M R++ G R E+
Sbjct: 173 TSESDVWSYGILLWETFSL---GDTPY---PGMSNQQTRERIESGYRMPAPQLCPEEIYR 226
Query: 628 V---CSLKSPEQRPAMWQVLKMIQ 648
+ C PE RP+ ++ +Q
Sbjct: 227 LMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 69/256 (26%), Positives = 115/256 (44%), Gaps = 18/256 (7%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E +G+GS G +K + DN +V +K D + D E +Q + + P +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKY 67
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ + +I +Y GS +L+ PL T I ++ +GL Y+H
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSEK 121
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSSRRAT 569
IH ++K++NVLL E +L D+ ++ L+D+ + T + APE+ K S
Sbjct: 122 -KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-D 179
Query: 570 SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629
SK+D+++ G+ +EL G+ P H L P +L ++ E N L E C
Sbjct: 180 SKADIWSLGITAIELAKGEPP--HSELHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEAC 236
Query: 630 SLKSPEQRPAMWQVLK 645
K P RP ++LK
Sbjct: 237 LNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 391 RASAEL---LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHP 447
R S +L LG G G ++ + +N V VK K + F + + L HP
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHP 61
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
L+ + A + ++ + GSL + G + L + +A VA G+AY
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAY 118
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDS---SSVEDPDTVAYKAPEIRK 563
+ ++ IH +L + NVL+G + ++ D+ L+ V+ + + + + APE
Sbjct: 119 LEAQNY-IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 564 SSRRATSKSDVYAFGVLLLELLT-GKHP 590
+R + KSDV++FG+LL E++T G+ P
Sbjct: 178 YNR-FSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 398 GRGSIGTTYKAVLDNHL---IVTVKRFDANKTADT--SAEAFEQHM---EAVGGLSHPNL 449
GRG+ G YKA N +K+F +K T S A + E L H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE----LKHENV 64
Query: 450 VPIRAYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLK-IAEDVAQGLA 506
V + F ++ V ++DY + L+ +I R + + S +K + + G+
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIP-PSMVKSLLWQILNGVH 122
Query: 507 YIHRASWLIHGNLKSSNVLLGADFE------------ARLTDYCLSVLSDSSSVEDPDTV 554
Y+H ++W++H +LK +N+L+ + ARL + L L+D DP V
Sbjct: 123 YLH-SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD----LDPVVV 177
Query: 555 A--YKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586
Y+APE+ +R T D++A G + ELLT
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 397 LGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
LG G+ GT YK V + V +K +T+ + + + + HP++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVV- 72
Query: 452 IRAYFQAKGERL-VIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAEDVAQGLAYI- 508
R ++ +I P G L + + + +I ++ L L +A+G++Y+
Sbjct: 73 -RLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWCVQIAKGMSYLE 126
Query: 509 -HRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK---------A 558
R L+H +L + NVL+ ++TD+ L+ L D D + A
Sbjct: 127 EKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV----DEKEYHAEGGKVPIKWMA 179
Query: 559 PE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
E I R T KSDV+++GV + EL+T G P
Sbjct: 180 LESILH--RIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 19/177 (10%)
Query: 496 KIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVEDPD 552
KIAE V +GL+Y+H +IH ++K SN+LL + +L D+ +S V S + +
Sbjct: 109 KIAESVLKGLSYLHSRK-IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--G 165
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP---SQHPYLAPPDMLEWVRTMR 609
T Y APE R + + SDV++ G+ LLE+ + P P L P ++L ++ M
Sbjct: 166 TSFYMAPE-RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224
Query: 610 VDDGREENRLGM-----LTEVASVCSLKSPEQRPAMWQVLK----MIQEIKESVMAE 657
+ ++E G+ + C K P +RP W +L+ Q K+ MA+
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 67/260 (25%), Positives = 127/260 (48%), Gaps = 23/260 (8%)
Query: 395 ELLGRGSIGTTYKAVLDNHLI---VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
E++G G G AVL V VK N D +A+AF + + L H NLV
Sbjct: 12 EIIGEGEFG----AVLQGEYTGQKVAVK----NIKCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ G +V+ + G+L N + +R + L+ + DVA+G+ Y+
Sbjct: 64 LLGVILHNGLYIVM-ELMSKGNLVNFLR-TRGRALVSV--IQLLQFSLDVAEGMEYLESK 119
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSK 571
L+H +L + N+L+ D A+++D+ L+ + V + APE K ++ +SK
Sbjct: 120 K-LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKH-KKFSSK 177
Query: 572 SDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV-RTMRVDDGREENRLGMLTEVASVC 629
SDV+++GVLL E+ + G+ P +P ++ ++ E V + R++ E + + + C
Sbjct: 178 SDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECVEKGYRMEP--PEGCPADVYVLMTSC 233
Query: 630 SLKSPEQRPAMWQVLKMIQE 649
P++RP+ ++ + +++
Sbjct: 234 WETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 73/300 (24%), Positives = 132/300 (44%), Gaps = 42/300 (14%)
Query: 395 ELLGRGSIGTTYKAVLDN---HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLV 450
+++G G+ G KA + + +KR + D + F +E + L HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 71
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKP-----------LHWTSCLKIAE 499
+ + +G + +Y P+G+L + + SR + P L L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS----VLSDSSSVEDPDTVA 555
DVA+G+ Y+ + + IH +L + N+L+G ++ A++ D+ LS V + P V
Sbjct: 132 DVARGMDYLSQKQF-IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VR 188
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP-----SQHPYLAPPDMLEWVRTMR 609
+ A E S T+ SDV+++GVLL E+++ G P Y P + +
Sbjct: 189 WMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 247
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVL----KMIQEIKESVMAEDNAAFGYS 665
DD + ++ C + P +RP+ Q+L +M++E K V F Y+
Sbjct: 248 CDD--------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 299
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 396 LLGRGS----IGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
L+G+ I K N L V VK+ + + + + +Q + L HPN++P
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLK------IAEDVAQGL 505
F E V+ GS +L+ H+ L I +DV L
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKT---------HFPEGLPELAIAFILKDVLNAL 114
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTD--YCLSVLSD---SSSVEDPDTVAYK--- 557
YIH IH ++K+S++LL D + L+ Y +S++ V D + K
Sbjct: 115 DYIHSKG-FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 558 --APEI-RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+PE+ +++ + KSD+Y+ G+ EL G P
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+LLG G GT +K + D+ I + +++ + + HM A+G L H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI-- 508
+ +LV P GSL + + R C++IA +G+ Y+
Sbjct: 73 RLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA----KGMYYLEE 127
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSS--- 565
HR ++H NL + N+LL +D ++ D+ ++ L PD Y E +
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLL------YPDDKKYFYSEHKTPIKWM 178
Query: 566 -------RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAP-PDMLE 603
R T +SDV+++GV + E+++ G P PD+LE
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 49/280 (17%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPI 452
E++G G+ G YKA +V +K D + + E ++ + S HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYSNHPNIATF 68
Query: 453 R-AYFQAK-----GERLVIYDYQPNGSLFNLIHGSRSI-RAKPLHWTSCLKIAEDVAQGL 505
A+ + + ++ + GS+ +L+ G R + W + I + +GL
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGL 126
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS------SSVEDPDTVAYKAP 559
AY+H + +IH ++K N+LL + E +L D+ +S DS + + P + AP
Sbjct: 127 AYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP---YWMAP 182
Query: 560 EI--RKSSRRAT--SKSDVYAFGVLLLELLTGKHP--SQHPYLA--------PPDMLEWV 605
E+ A+ ++SDV++ G+ +EL GK P HP A PP +
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK--- 239
Query: 606 RTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
EN + S C +K+ EQRP M ++L+
Sbjct: 240 --------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 395 ELLGRGSIGTTY--KAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+ +G GS G Y KA D+ V +K D K EA ++ + + + HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAEDVAQGLAYIH 509
A FQ G ++ +Y G L I+ R + + L W ++ GL +IH
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV------QISLGLKHIH 118
Query: 510 RASWLIHGNLKSSNVLLGAD-FEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSS 565
++H ++KS N+ L + A+L D+ ++ L+DS + T Y +PEI + +
Sbjct: 119 DRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ-N 176
Query: 566 RRATSKSDVYAFGVLLLELLTGKHP 590
R +K+D+++ G +L EL T KHP
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 54/277 (19%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRF---DANKTADTSAEAFEQHMEAVGGLSHPNLV 450
ELLG GS G+ Y+ + LD+ VK D +T + + EQ + + L HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 451 PIRAYFQAK-GERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
+ + + L I+ + P GSL L+ + + GL Y+
Sbjct: 66 --QYLGTEREEDNLYIFLELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYL 118
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLS----VLSDSSSVEDPDTVAYKAPEIRKS 564
H +H ++K +N+L+ + +L D+ ++ S + S + + + APE+
Sbjct: 119 H-DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKG--SPYWMAPEVIAQ 175
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP-SQ---------------HPYLAPPDMLEWVRTM 608
+D+++ G +LE+ TGK P SQ P PD L
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP--PIPDHLS----- 228
Query: 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
D+ ++ C + P RP ++L+
Sbjct: 229 --DEAKDFILK---------CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 397 LGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+G GS G KA+L ++ +K + +K + E + + + + HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI---RAKPLHW--TSCLKIAEDVAQGLAY 507
+ F+ G ++ DY G L+ I+ R + + L W CL L +
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL--------ALKH 116
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEIR 562
+H ++H ++KS N+ L D +L D+ ++ VL +S+VE T Y +PEI
Sbjct: 117 VHDRK-ILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEIC 173
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKH 589
+ +R +KSD++A G +L E+ T KH
Sbjct: 174 E-NRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-12
Identities = 51/144 (35%), Positives = 69/144 (47%), Gaps = 27/144 (18%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
P + +L L +L L +N+ TG IP L+SL L+ L L N FSG P ++ + LT+
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---------------------L 189
LDLS NNLTG IP L + L+ L L N G +P L
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 190 NQPF----LVVF-NVSGNNLTGQV 208
F LV F ++S NNL G++
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 397 LGRGSIGTTYKAV------LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
LG G G KA + V VK N ++ + + ++HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVI 66
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIR-------------------AKPLHW 491
+ G L+I +Y GSL + + SR + + L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 492 TSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSV- 548
+ A +++G+ Y+ L+H +L + NVL+ + +++D+ LS V + S V
Sbjct: 127 GDLISFAWQISRGMQYLAEMK-LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 549 --EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV 605
+ V + A E T++SDV++FGVLL E++T G +P +P +AP + +
Sbjct: 186 RSKGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPERLFNLL 242
Query: 606 RT-MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
+T R++ R EN + + C + P++RP + K ++++
Sbjct: 243 KTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 44/296 (14%)
Query: 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HP 447
+++G G+ G +A++ N I +K F ++ F +E + L HP
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----ASENDHRDFAGELEVLCKLGHHP 63
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPL----HWTSC-------LK 496
N++ + + +G + +Y P G+L + + SR + P H T+ L+
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS----VLSDSSSVEDPD 552
A DVA G+ Y+ + IH +L + NVL+G + +++ D+ LS V + P
Sbjct: 124 FASDVATGMQYLSEKQF-IHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP- 181
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP-----SQHPYLAPPDMLEWVR 606
V + A E S T+KSDV++FGVLL E+++ G P Y P +
Sbjct: 182 -VRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239
Query: 607 TMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662
DD + E+ C P +RP Q+ + + E+ A N A
Sbjct: 240 PRNCDD--------EVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMAL 287
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 42/268 (15%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E +G+GS G YK + DN +V +K D + D E +Q + + P I
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPY---I 64
Query: 453 RAYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
Y+ + KG +L +I +Y GS +L+ + PL T I ++ +GL Y+H
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLH 118
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSSR 566
+ IH ++K++NVLL + +L D+ ++ L+D+ + T + APE+ K S
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 567 RATSKSDVYAFGVLLLELLTGKHPSQ--HP----YLAP---PDMLEWVRTMRVDDGREEN 617
K+D+++ G+ +EL G+ P+ HP +L P P LE G+
Sbjct: 178 Y-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE---------GQYSK 227
Query: 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645
E C K P RP ++LK
Sbjct: 228 P---FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 45/196 (22%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
+G G+ G YKA IV +K+ ++ + + ++ + L+HPN++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 456 FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515
F+ KG+ +++++ + L+ LI R + L + + QGLA+ H ++
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSH-GIL 120
Query: 516 HGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKSSRRATSKS 572
H +LK N+L+ + +L D+ L+ S V Y+APE+ + ++
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 573 DVYAFGVLLLELLTGK 588
D+++ G + ELL+ +
Sbjct: 181 DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-12
Identities = 41/111 (36%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 66 WQGVKCAQGRVVR--FV----LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DL 118
W G C F+ L + GLRG F PN +++L L+ ++L NS+ G IP L
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRG-FIPNDISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 119 SSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTAL 169
S+ +L+ L LS N F+G+ P S+ L L IL+L+ N+L+G +P L
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 64/275 (23%), Positives = 122/275 (44%), Gaps = 32/275 (11%)
Query: 396 LLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAE-AFEQHMEAVGGLSHPN 448
LGRG G + A +V VK KT D + + F + ++ LSH N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSL--FNLIHGSRSIRAKPLHWTS--CLKIAEDVAQG 504
+V + + +I +Y G L F S+ + KP ++ + + +A G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK------- 557
+ ++ A +H +L + N L+ + E ++ S+LS S V + + +
Sbjct: 130 MDHLSNAR-FVHRDLAARNCLVSSQREVKV-----SLLSLSKDVYNSEYYKLRNALIPLR 183
Query: 558 --APEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR 614
APE + +T KSDV++FGVL+ E+ T G+ P L+ ++L ++ +++
Sbjct: 184 WLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELP--FYGLSDEEVLNRLQAGKLELPV 240
Query: 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649
E L ++ + C +P+ RP+ +++ + E
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 396 LLGRGSIGTTYKAVLDNHLIVTVKR-----FDANKTADTSAEAFEQHMEAV------GGL 444
LG+GS G+ YK VKR F A K D + + ++ +AV +
Sbjct: 7 KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 445 SHPNLVPIRAYFQAKGERLVI-YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
+HPN++ + F G +L I +Y P G L I + R K + +I + +
Sbjct: 57 NHPNIISYKEAF-LDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLR 114
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIR 562
GL +H ++H +LKS+N+LL A+ ++ D +S VL + + T Y APE+
Sbjct: 115 GLQALH-EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW 173
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP 590
K R + KSD+++ G LL E+ T P
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 43/269 (15%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E +G+GS G YKA+ D +V +K D + A+ E +Q ++ + P I
Sbjct: 7 ECIGKGSFGEVYKAI-DKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPY---I 61
Query: 453 RAYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
Y+ + KG +L +I +Y GS +L+ + L T I +V GL Y+H
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLH 115
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDP--DTVAYKAPE-IRKSS 565
IH ++K++N+LL + + +L D+ +S L+ + S + T + APE I++S
Sbjct: 116 EEG-KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 566 RRATSKSDVYAFGVLLLELLTGKHPSQ--HP----YLAP---PDMLEWVRTMRVDDGREE 616
K+D+++ G+ +EL G+ P HP +L P P LE G +
Sbjct: 175 Y--DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE---------GNKF 223
Query: 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
++ + S+C K P++RP+ ++LK
Sbjct: 224 SKP--FKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
ELLG+G+ G +K L + V VK + + + F + HPN+V +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ ++ + P G + + + ++ K L +K A D A G+AY+ +
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLESKN- 113
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSD----SSSVEDPDTVAYKAPEIRKSSRRAT 569
IH +L + N L+G + +++D+ +S D SSS + + APE R +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY-S 172
Query: 570 SKSDVYAFGVLLLELLT 586
S+SDV+++G+LL E +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH-P 447
+++G G+ G KA + + I +K + + F +E + L H P
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHP 56
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPL----HWTSC-------LK 496
N++ + + +G + +Y P+G+L + + SR + P + T+ L
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS----VLSDSSSVEDPD 552
A DVA+G+ Y+ + + IH +L + N+L+G ++ A++ D+ LS V + P
Sbjct: 117 FAADVARGMDYLSQKQF-IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP- 174
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586
V + A E S T+ SDV+++GVLL E+++
Sbjct: 175 -VRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 45/221 (20%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFE---------QHMEAVGGLSHP 447
+GRG+ G YKA KR D D + + E + + + L HP
Sbjct: 9 VGRGTYGHVYKA----------KRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHP 58
Query: 448 NLVPIRAYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRA--KPLHWTSCL--KIAEDV 501
N++ ++ F + +R V ++DY + L+++I R+ +A KP+ + + +
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 502 AQGLAYIHRASWLIHGNLKSSNVL-LGADFE-----------ARLTDYCLSVLSDSSSVE 549
G+ Y+H A+W++H +LK +N+L +G E ARL + L L+D
Sbjct: 118 LDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL---- 172
Query: 550 DPDTVA--YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
DP V Y+APE+ +R T D++A G + ELLT +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHP 447
LG G+ G + ++ +V VK +TA A + FE+ E + H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNFQHE 68
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAK-------PLHWTSCLKIA 498
N+V +++++Y +G L + HG + K L + L+IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLS-DSSSVE------ 549
+A G+ Y+ + +H +L + N L+G D ++ D+ +S V + D V
Sbjct: 129 VQIASGMVYL-ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 550 ----DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
P+++ Y R+ T++SDV++FGV+L E+ T GK P
Sbjct: 188 IRWMPPESIMY---------RKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 62/261 (23%), Positives = 121/261 (46%), Gaps = 21/261 (8%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
EL+GRG+ G Y+ V +V +K + + T D ++ + + L I
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGR-VVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 453 RAYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
Y+ + KG RL +I +Y GS+ L+ +A P+ I +V L YIH
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLM------KAGPIAEKYISVIIREVLVALKYIH 118
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKSSR 566
+ +IH ++K++N+L+ +L D+ ++ L + +S + V + APE+ +
Sbjct: 119 KVG-VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 567 RATSKSDVYAFGVLLLELLTGKHP-SQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625
+K+D+++ G+ + E+ TG P S ++ + R++D +L E
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED---NGYSKLLREF 234
Query: 626 ASVCSLKSPEQRPAMWQVLKM 646
+ C + P++R + ++LK
Sbjct: 235 VAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 62/259 (23%), Positives = 115/259 (44%), Gaps = 22/259 (8%)
Query: 397 LGRGSIG--TTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
LG+G+ G T Y+ D+ L+V K + + ++ + + L HPN++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIA--EDVAQGLAYIHRAS 512
+F L+ +Y G+L++ I +R K + + + + ++YIH+A
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSSRRAT 569
L H ++K+ N+ L +L D+ +S +L S+ + T Y +PE+ + +
Sbjct: 122 IL-HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-VKYN 179
Query: 570 SKSDVYAFGVLLLELLTGKH--PSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627
KSD++A G +L ELLT K + +P +++ T V E L +
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE-----LISLVH 234
Query: 628 VCSLKSPEQRPAMWQVLKM 646
+ PE+RP +VL
Sbjct: 235 SLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 64/244 (26%), Positives = 112/244 (45%), Gaps = 21/244 (8%)
Query: 416 VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLF 475
V VK A+ T D F Q ++ L+HPN++ L++ ++ P G L
Sbjct: 25 VVVKELRASATPD-EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLK 83
Query: 476 NLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLT 535
N + +R + A+ ++A +VA GL ++H+A + IH +L N L AD ++
Sbjct: 84 NYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF-IHSDLALRNCQLTADLSVKIG 142
Query: 536 DYCLSVL---SDSSSVEDPDTVAYK--APEIRKS------SRRATSKSDVYAFGVLLLEL 584
DY L++ D +D V + APE+ + + T KS++++ GV + EL
Sbjct: 143 DYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 585 LT-GKHPSQHPYLAPPDMLEWV---RTMRVDDGREENRLG-MLTEVASVCSLKSPEQRPA 639
T P +P L+ +L+ V + +++ + + + EV C L PE RP
Sbjct: 203 FTAADQP--YPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPT 259
Query: 640 MWQV 643
+V
Sbjct: 260 AEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 76/280 (27%), Positives = 115/280 (41%), Gaps = 45/280 (16%)
Query: 395 ELLGRGSIGTTYK----AVLDNHLI---VTVKRFDANKTADTSAEAFEQHMEAVG----G 443
E LG G+ G YK N L + V K ++ + V
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 444 LSHPNLVPIRAYFQAKGERLVIY----DYQPNGSLFNLIHGSRSIRAKPLHWTS--CLKI 497
L HPN+V F + +RL I + P G FN S++ K +T I
Sbjct: 66 LRHPNIVRYYKTF-LENDRLYIVMDLIEGAPLGEHFN------SLKEKKQRFTEERIWNI 118
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VEDPDTVA 555
+ L Y+H+ ++H +L +N++LG D + +TD+ L+ S T+
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP----DMLEWVRTMRVD 611
Y PEI K + K+DV+AFG +L ++ T L PP +ML + T V+
Sbjct: 179 YSCPEIVK-NEPYGEKADVWAFGCILYQMCT---------LQPPFYSTNMLS-LATKIVE 227
Query: 612 DGREENRLGM----LTEVASVCSLKSPEQRPAMWQVLKMI 647
E GM +T+V + C E RP + QV MI
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 397 LGRGSIGTTYKAVLDNH-LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
LG G G Y+ V + L V VK K E F + + + HPNLV +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 456 FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515
+ +I ++ G+L + + R + ++ L +A ++ + Y+ + ++ I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF-I 126
Query: 516 HGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSSRRATSK 571
H +L + N L+G + ++ D+ LS L + + + APE + + + K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIK 185
Query: 572 SDVYAFGVLLLELLT 586
SDV+AFGVLL E+ T
Sbjct: 186 SDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
P +V F + + ++ GSL + + P+ KIA V +GL
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRI-----YKKGGPIPVEILGKIAVAVVEGLT 117
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKSS 565
Y++ ++H ++K SN+L+ + + +L D+ +S L +S + T Y +PE R
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPE-RIQG 176
Query: 566 RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------GREENRL 619
+ T KSDV++ G+ ++EL GK P D M + D RL
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFS---NIDDDGQDDPMGILDLLQQIVQEPPPRL 233
Query: 620 ------GMLTEVASVCSLKSPEQRPAMWQVLKM---IQEIKES 653
L + C LK P +RP Q+ M IQ ++ S
Sbjct: 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 42/268 (15%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E +G+GS G +K + DN +V +K D + D E +Q + + P +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKY 67
Query: 453 RAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ KG +L +I +Y GS +L+ RA P + +++ +GL Y+H
Sbjct: 68 YGSY-LKGTKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSSRRA 568
IH ++K++NVLL + +L D+ ++ L+D+ + T + APE+ + S
Sbjct: 121 K-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY- 178
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQH----------PYLAPPDML-EWVRTMRVDDGREEN 617
SK+D+++ G+ +EL G+ P+ P PP + E+ + +
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK-------- 230
Query: 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645
E C K P RP ++LK
Sbjct: 231 ------EFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 45/150 (30%), Positives = 68/150 (45%), Gaps = 17/150 (11%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
+PN + + ++I DY +G LF+L+ + KI + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA-----EVKKIIRQLVEAL 122
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEAR----LTDYCLSVLSDSSSVEDPDTVAYKAPEI 561
+H+ + +IH ++K NVL A+ L DY L + + S D T+ Y +PE
Sbjct: 123 NDLHKHN-IIHNDIKLENVLY---DRAKDRIYLCDYGLCKIIGTPSCYD-GTLDYFSPE- 176
Query: 562 RKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
K S D +A GVL ELLTGKHP
Sbjct: 177 -KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 50/160 (31%), Positives = 82/160 (51%), Gaps = 26/160 (16%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV-- 501
++HP +V + FQ +G+ +I D+ G LF + +K + +T EDV
Sbjct: 55 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-------SKEVMFTE-----EDVKF 102
Query: 502 -----AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVEDPDT 553
A L ++H +I+ +LK N+LL + +LTD+ LS + + + T
Sbjct: 103 YLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT 161
Query: 554 VAYKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHPSQ 592
V Y APE+ +RR ++S D ++FGVL+ E+LTG P Q
Sbjct: 162 VEYMAPEV--VNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 71/224 (31%), Positives = 103/224 (45%), Gaps = 60/224 (26%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKR-FDA--NKTAD---TSAE-AFEQHMEAVGGLSHPN 448
LG+G+ G +KA+ +V +K+ FDA N T D T E F Q + HPN
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIMFLQELG-----DHPN 68
Query: 449 LVPIRAYFQAKGER---LVIYDYQPNGSLFNLI----HGSRSIRAKPLHWTSCLKIAEDV 501
+V + +A+ ++ LV F + H IRA I EDV
Sbjct: 69 IVKLLNVIKAENDKDIYLV----------FEYMETDLH--AVIRAN---------ILEDV 107
Query: 502 ---------AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL--SVLSDSSSVED 550
+ L YIH + +IH +LK SN+LL +D +L D+ L S+ + E+
Sbjct: 108 HKRYIMYQLLKALKYIHSGN-VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 551 P---DTVA---YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
P D VA Y+APEI S R T D+++ G +L E+L GK
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLS---HPNLVPI 452
LG G+ G YKA F A K +E E M + LS HPN+V +
Sbjct: 13 LGDGAFGKVYKAQHK-----ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ + + ++ ++ G+L +++ + L + + + L ++H
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS-H 122
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEI----RKS 564
+IH +LK+ N+LL D + +L D+ +S + S+++ DT + APE+
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP 590
K+D+++ G+ L+EL + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 31/225 (13%)
Query: 443 GLSHPNLVPI-RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTS---CLKIA 498
GLSH N++PI + V+Y Y G+L + R A S + +A
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVEDPDT-- 553
+A G++Y+H+ +IH ++ + N ++ + + ++TD LS D + D +
Sbjct: 124 IQIACGMSYLHKRG-VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 554 VAYKAPE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVD 611
V + A E + + +S SDV++FGVLL EL+T G+ P + + P +M +++
Sbjct: 183 VKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTP--YVEIDPFEMAAYLK----- 233
Query: 612 DGREENRLGM-------LTEVASVCSLKSPEQRPAMWQVLKMIQE 649
DG RL L V + C PE+RP+ Q+++ + +
Sbjct: 234 DGY---RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 32/277 (11%)
Query: 396 LLGRGSIGTTYKAVLDNHLI-------VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
LG G+ G Y+ + L V VK T E F + + +HPN
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHPN 60
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKP--LHWTSCLKIAEDVAQGLA 506
+V + + +I + G L + + +R R P L L I DVA+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 507 YIHRASWLIHGNLKSSNVLL-----GADFEARLTDYCLS---VLSDSSSVEDPD--TVAY 556
Y+ + + IH +L + N L+ AD ++ D+ L+ SD E V +
Sbjct: 121 YLEQMHF-IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR- 614
APE + T++SDV++FGVL+ E+LT G+ P +P L ++L+ V GR
Sbjct: 180 MAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQP--YPALNNQEVLQHVTA----GGRL 232
Query: 615 --EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649
EN + ++ + C + P +RP ++ +++Q
Sbjct: 233 QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 45/221 (20%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFE---------QHMEAVGGLSHP 447
+GRG+ G YKA KR D + + + E + + + L HP
Sbjct: 9 VGRGTYGHVYKA----------KRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHP 58
Query: 448 NLVPIRAYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRA--KPLHWTSCL--KIAEDV 501
N++ ++ F + +R V ++DY + L+++I R+ +A KP+ + + +
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 502 AQGLAYIHRASWLIHGNLKSSNVL-LGADFE-----------ARLTDYCLSVLSDSSSVE 549
G+ Y+H A+W++H +LK +N+L +G E ARL + L L+D
Sbjct: 118 LDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL---- 172
Query: 550 DPDTVA--YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
DP V Y+APE+ +R T D++A G + ELLT +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
++LG G G+ + L L V VK + + E F + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 451 P-IRAYFQAKGER-----LVIYDYQPNGSLFNLIHGSRSIRAKPLHWT--SCLKIAEDVA 502
I F+A + +VI + +G L + + SR + P + LK D+A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR-LGGLPEKLPLQTLLKFMVDIA 123
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIR 562
G+ Y+ ++ IH +L + N +L D + D+ LS S Y+ I
Sbjct: 124 LGMEYLSNRNF-IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY-------YRQGRIA 175
Query: 563 K-----------SSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT-MR 609
K + R TSKSDV+AFGV + E+ T G+ P +P + ++ +++R R
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHEIYDYLRHGNR 233
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
+ + E+ L L ++ C P+ RP ++ ++++ I
Sbjct: 234 LK--QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
P +V F + GE + ++ GSL ++ ++ I + L K++ V +GLA
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLA 117
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKSS 565
Y+ ++H ++K SN+L+ + E +L D+ +S L DS + T +Y +PE R
Sbjct: 118 YLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQG 176
Query: 566 RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE 603
+ +SD+++ G+ L+EL G++P + PPD E
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP-----IPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
E LG G+ G YK L + V +K N E F Q E + L HPN
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDLQHPN 69
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSL--FNLIHGSRS---------IRAKPLHWTSCLKI 497
+V + + ++++Y +G L F + + S L + L I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV-----EDPD 552
A +A G+ Y+ + +H +L + N L+G +++D+ LS S+ +
Sbjct: 130 AIQIAAGMEYL-SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLEL 584
V + PE + T++SD+++FGV+L E+
Sbjct: 189 PVRWMPPEAILYGK-FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 45/270 (16%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG GS G+ YKA+ + +V +K + + + + P +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYY 64
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ + ++ +Y GS+ +++ I K L I +GL Y+H
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLHSNK- 119
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEIRKSSRRA 568
IH ++K+ N+LL + +A+L D+ +S L+D+ + +TV + APE+ +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY- 176
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQ--HPYLA-------PPDML----EWVRTMRVDDGRE 615
+K+D+++ G+ +E+ GK P HP A PP L +W E
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW--------SPE 228
Query: 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
N C +K PE+RP+ Q+L+
Sbjct: 229 FNDF------VKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 11/151 (7%)
Query: 443 GLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL-FNLIHGSRSIRAKPLHWTSCLKIAEDV 501
L+HP LV + FQ + ++ D G L ++L + + W +
Sbjct: 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI------ 109
Query: 502 AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL--SDSSSVEDPDTVAYKAP 559
L Y+H +IH ++K N+LL +TD+ ++ D+ + T Y AP
Sbjct: 110 VLALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
E+ + + D ++ GV E L GK P
Sbjct: 169 EVLC-RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 395 ELLGRGSIGT----TYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+ LG GS G + + V VK ++K +D + F + + L H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLI 59
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLH--WTSCLKIAEDVAQGLAYI 508
+ +V + P GSL + + + + ++IA G+ Y+
Sbjct: 60 RLYGVVLTHPLMMV-TELAPLGSLLDRLRKDA-LGHFLISTLCDYAVQIAN----GMRYL 113
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVEDPDT---VAYKAPE-I 561
+ IH +L + N+LL +D + ++ D+ L ++ V + A+ APE +
Sbjct: 114 E-SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 562 RKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
R R + SDV+ FGV L E+ T G+ P
Sbjct: 173 RT--RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANK-TADTSAE--AFEQHMEAVGGLSHPNLV 450
+LLG+G+ G Y +D + VK+ + + +T E A E ++ + L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 451 PIRAYFQAKGERLVIY---DYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGL 505
Y+ + + +Y P GS+ + + +G L T K + +G+
Sbjct: 68 ---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGV 117
Query: 506 AYIHRASWLIHGNLKSSNVLLG-------ADFEA--RLTDYCLSVLSDSSSVEDPDTVAY 556
Y+H + ++H ++K +N+L DF A RL C S S P +
Sbjct: 118 EYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY---W 173
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+PE+ S K+DV++ G ++E+LT K P
Sbjct: 174 MSPEV-ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 69/259 (26%), Positives = 114/259 (44%), Gaps = 33/259 (12%)
Query: 395 ELLGRGSIGTTYKA-VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E+LG G+ GT YKA L I+ VK + T + + + +E + P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE-LEILYKCDSPYIIGFY 65
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F + + ++ GSL R P H +IA V +GL Y+ W
Sbjct: 66 GAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLG--RIAVAVVKGLTYL----W 112
Query: 514 ---LIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVAYKAPEIRKSSRRAT 569
++H ++K SN+L+ + +L D+ +S L +S + T AY APE R S +
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE-RISGEQYG 171
Query: 570 SKSDVYAFGVLLLELLTGKHP-----SQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624
SDV++ G+ +EL G+ P L P +L+ + VD+ +G +E
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI----VDEDPPVLPVGQFSE 227
Query: 625 V----ASVCSLKSPEQRPA 639
+ C K P++RPA
Sbjct: 228 KFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 49/214 (22%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++G G G ++ +L + V +K T + + F +G SH N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNII 69
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTS--CLKIAEDVAQGLAYI 508
+ ++I +Y NG+L + +R ++S + + +A G+ Y+
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGAL------DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDT----------VAYK 557
++ +H +L + N+L+ ++ E +++D+ LS VL D DP+ + +
Sbjct: 124 SDMNY-VHRDLAARNILVNSNLECKVSDFGLSRVLED-----DPEGTYTTSGGKIPIRWT 177
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
APE + R+ TS SDV++FG+++ E+++ G+ P
Sbjct: 178 APEA-IAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 46/145 (31%), Positives = 63/145 (43%), Gaps = 26/145 (17%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
P L L L L +NSL G IP L + +L+ + L N FSG P L +
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 151 LDLSYNNLTGLIPV------NLTALD-----------------RLYSLKLEWNRFSGTVP 187
LD+S NNL G I +L L RL +L L N+FSG VP
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVP 492
Query: 188 P--LNQPFLVVFNVSGNNLTGQVPE 210
+ L+ +S N L+G++P+
Sbjct: 493 RKLGSLSELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 397 LGRGSIGTTYKA-VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
+G G+ G +KA + V +K+ + + ++A+ HP +V +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 456 FQAKGERLVI-YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
F G V+ +Y P L ++ +PL + +G+AY+H +
Sbjct: 68 F-PHGSGFVLVMEYMP-SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG-I 120
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYKAPEIRKSSRR 567
+H +LK +N+L+ AD ++ D+ L+ L E+P T Y+APE+ +R+
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSE---EEPRLYSHQVATRWYRAPELLYGARK 177
Query: 568 ATSKSDVYAFGVLLLELLTG 587
D++A G + ELL G
Sbjct: 178 YDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHME--AVGGL----SHPNL 449
LG G+ G+ Y A + +V +K+ K S +E+ M V L HPN+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM---KKKFYS---WEECMNLREVKSLRKLNEHPNI 60
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
V ++ F+ E +++Y G+L+ L+ + + KP + I + QGLA+IH
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT--VA---YKAPEIRKS 564
+ + H +LK N+L+ ++ D+ L+ S P T V+ Y+APEI
Sbjct: 117 KHGFF-HRDLKPENLLVSGPEVVKIADFGLAREIRSR---PPYTDYVSTRWYRAPEILLR 172
Query: 565 SRRATSKSDVYAFGVLLLELLTGK 588
S +S D++A G ++ EL T +
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 43/279 (15%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADT-SAEAFEQHMEAVGGLSHPN- 448
++G+G G Y L + VK N+ D E F + + SHPN
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHG-SRSIRAKPLHWTSCLKIAEDVAQGLAY 507
L + ++G LV+ Y +G L N I + + K L + VA+G+ Y
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEY 113
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLS---------VLSDSSSVEDPDTVAYKA 558
+ + +H +L + N +L F ++ D+ L+ + + + + P V + A
Sbjct: 114 LASKKF-VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKWMA 170
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618
E ++ ++ T+KSDV++FGVLL EL+T P PY PD+ + T+ + GR R
Sbjct: 171 LESLQT-QKFTTKSDVWSFGVLLWELMTRGAP---PY---PDVDSFDITVYLLQGR---R 220
Query: 619 LGM-------LTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
L L EV C PE RP +++ I++I
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 46/224 (20%)
Query: 395 ELLGRGSIGTTYKAV--LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG---------- 442
+ LG G+ YKA IV +K+ + ++ + +
Sbjct: 6 KKLGEGTYAVVYKARDKETGR-IVAIKKIKLGE--------RKEAKDGINFTALREIKLL 56
Query: 443 -GLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
L HPN++ + F K +++++ L +I +SI P S + +
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYMLMT--- 111
Query: 502 AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--------T 553
+GL Y+H +W++H +LK +N+L+ +D +L D+ L+ S P+ T
Sbjct: 112 LRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFGLA-----RSFGSPNRKMTHQVVT 165
Query: 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA 597
Y+APE+ +R D+++ G + ELL P+L
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-----PFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 41/196 (20%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 406 YKAVLDNHLIV--TVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERL 463
YK + +N ++ T K+F +K + E ++ + + N++ I + + L
Sbjct: 37 YKGIFNNKEVIIRTFKKF--HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 464 ----VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNL 519
+I +Y G L ++ + + K + L +A D +GL +++ + + NL
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFK-----TKLDMAIDCCKGLYNLYKYTNKPYKNL 149
Query: 520 KSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKS--SRRATSKSDVYAF 577
S + L+ +++ ++ + L + S ++ + + Y + ++ S T K D+Y+
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSL 208
Query: 578 GVLLLELLTGKHPSQH 593
GV+L E+ TGK P ++
Sbjct: 209 GVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
++LG G+ GT YK + + V +K + + E ++ + + + HP+L
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMASMDHPHL 71
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
V + + +LV P+G L + +H + L C++IA +G+ Y+
Sbjct: 72 VRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA----KGMMYLE 126
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE-DPD----TVAYKAPEIRKS 564
L+H +L + NVL+ + ++TD+ L+ L + E + D + + A E
Sbjct: 127 ERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC-IH 184
Query: 565 SRRATSKSDVYAFGVLLLELLT--GKHPSQHPYLAPPDMLE 603
R+ T +SDV+++GV + EL+T GK P PD+LE
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 415 IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER--LVIYDYQPNG 472
+V VK + +++ + + L H N+V + +G + +I +Y P G
Sbjct: 35 MVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93
Query: 473 SLFNLIHGSRSIRAKPLHWTSCLKI---AEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD 529
SL + + P H + ++ A+ + +G+AY+H + IH +L + NVLL D
Sbjct: 94 SLRDYL---------PKHKLNLAQLLLFAQQICEGMAYLHSQHY-IHRDLAARNVLLDND 143
Query: 530 FEARLTDYCLSVLSDSSSV-----EDPDT-VAYKAPEIRKSSRRATSKSDVYAFGVLLLE 583
++ D+ L+ ED D+ V + A E K ++ + + SDV++FGV L E
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYE 202
Query: 584 LLTGKHPSQHPYLAPPDMLE 603
LLT Q P +M+
Sbjct: 203 LLTHCDSKQSPPKKFEEMIG 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 396 LLGRGSIGTTYKA---------------VLDNHLIVTVKRFDANKTADTSAEAFEQHMEA 440
+LG+G G ++ VL IV + TA T AE +EA
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAE--RNILEA 56
Query: 441 VGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAED 500
V HP +V + FQ G+ +I +Y G LF +H R + T+C ++E
Sbjct: 57 V---KHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MHLER--EGIFMEDTACFYLSE- 108
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL---SVLSDSSSVEDPDTVAYK 557
++ L ++H+ +I+ +LK N+LL A +LTD+ L S+ + + T+ Y
Sbjct: 109 ISLALEHLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYM 167
Query: 558 APEI--RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
APEI R +A D ++ G L+ ++LTG P
Sbjct: 168 APEILMRSGHGKAV---DWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 71/286 (24%), Positives = 128/286 (44%), Gaps = 45/286 (15%)
Query: 397 LGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+G+G+ G ++A + +V VK +AD A+ F++ + HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDHPNIV 71
Query: 451 PIRAYFQAKGERL-VIYDYQPNGSLFN------------LIHGSRSIRAK-----PLHWT 492
+ A G+ + ++++Y G L L H + S R PL T
Sbjct: 72 KLLGVC-AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 493 SCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVE 549
L IA+ VA G+AY+ + +H +L + N L+G + ++ D+ LS +D
Sbjct: 131 EQLCIAKQVAAGMAYLSERKF-VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 550 DPDTVAYK-APEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDMLEWVR 606
+ D + + P R T++SDV+A+GV+L E+ + PY +A +++ +VR
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---YGMQPYYGMAHEEVIYYVR 246
Query: 607 TMRVDDGR----EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648
DG +N L + +C K P RP+ + +++Q
Sbjct: 247 -----DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 48/272 (17%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG-------GLS 445
E +G G+ G YKA V +K+ K Q+ E +
Sbjct: 25 EKIGEGASGEVYKATDRATGKE-VAIKKMRLRK----------QNKELIINEILIMKDCK 73
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIA---EDVA 502
HPN+V + E V+ +Y GSL ++I + +P +IA +V
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-------QIAYVCREVL 126
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTD--YC--LS--VLSDSSSVEDPDTVAY 556
QGL Y+H + +IH ++KS N+LL D +L D + L+ +S V P +
Sbjct: 127 QGLEYLHSQN-VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP---YW 182
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDM--LEWVRTMRVDDGR 614
APE+ K K D+++ G++ +E+ G + PYL P + L + T + +
Sbjct: 183 MAPEVIKRKDYGP-KVDIWSLGIMCIEMAEG----EPPYLREPPLRALFLITTKGIPPLK 237
Query: 615 EENRLG-MLTEVASVCSLKSPEQRPAMWQVLK 645
+ + + C +K PE+RP+ ++L+
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 34/163 (20%)
Query: 446 HPNLVPIRAYFQAKGERL----VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
H N++ IR + G V+ D + L ++IH +PL E+
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD-----QPL--------TEEH 108
Query: 502 AQ--------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD- 552
+ GL YIH A+ +IH +LK SN+L+ D E R+ D+ ++ SS E
Sbjct: 109 IRYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 553 ------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKH 589
T Y+APE+ S T+ D+++ G + E+L +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E +G+G+ GT + A+ D V N E + + L +PN+V
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
F E V+ +Y GSL +++ + A+ + + Q L ++H A+ +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ------IAAVCRECLQALEFLH-ANQV 136
Query: 515 IHGNLKSSNVLLGADFEARLTD--YCLSVLSDSSSVED-PDTVAYKAPEIRKSSRRATS- 570
IH ++KS NVLLG D +LTD +C + + S T + APE+ +R+A
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV--VTRKAYGP 194
Query: 571 KSDVYAFGVLLLELLTGKHP 590
K D+++ G++ +E++ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 395 ELLGRGSIGTT----YKAVLDNH-LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+ LG+G+ G+ Y + DN +V VK+ + FE+ +E + L H N+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNI 67
Query: 450 VPIRAYFQAKGER--LVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGL 505
V + + G R ++ +Y P GSL + + H R K L + S + +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL----SDSSSVEDP--DTVAYKAP 559
Y+HR +L + N+L+ ++ ++ D+ L+ + + V +P + + AP
Sbjct: 128 RYVHR-------DLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHP 594
E S+ + + SDV++FGV+L EL T S P
Sbjct: 181 ESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSP 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 66/285 (23%), Positives = 126/285 (44%), Gaps = 52/285 (18%)
Query: 397 LGRGSIGTTYKAVLDN------HLIVTVKRF-DANKTADTSAEAFEQHMEAVGGLSHPNL 449
LG G+ G + A N ++V VK D A + F++ E + L H ++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHI 69
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSL--FNLIHGSRS---IRAKPLH------WTSCLKIA 498
V +++++Y +G L F HG + + +P + L IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVED----- 550
+A G+ Y+ + +H +L + N L+GA+ ++ D+ +S +D V
Sbjct: 130 SQIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 551 -----PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEW 604
P+++ Y R+ T++SDV++FGV+L E+ T GK P L+ +++E
Sbjct: 189 IRWMPPESIMY---------RKFTTESDVWSFGVILWEIFTYGKQPWFQ--LSNTEVIEC 237
Query: 605 VRTMRVDDGREENRL--GMLTEVASVCSLKSPEQRPAMWQVLKMI 647
+ RV E R+ + ++ C + P+QR + ++ K++
Sbjct: 238 ITQGRV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 61/281 (21%), Positives = 129/281 (45%), Gaps = 45/281 (16%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAE-----AFEQHMEAVGGLSHPNLVP 451
LG+GS G Y+ + + + A KT + SA F + G + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAK--------PLHWTSCLKIAEDVAQ 503
+ LV+ + +G L + + RS+R + P +++A ++A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYL---RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----------T 553
G+AY++ A +H +L + N ++ DF ++ D+ ++ + + D
Sbjct: 131 GMAYLN-AKKFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLP 184
Query: 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDMLEWVRTMRVD 611
V + APE K T+ SD+++FGV+L E+ + ++ PY L+ +L++V +D
Sbjct: 185 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITS---LAEQPYQGLSNEQVLKFV----MD 236
Query: 612 DG---REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649
G + +N +T++ +C +P+ RP +++ ++++
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
GL YIH A+ ++H +LK N+L+ AD E ++ D+ L+ + E+ T Y
Sbjct: 117 GLKYIHSAN-VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
+APEI S + T DV++ G +L ELL K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 23/201 (11%)
Query: 399 RGSIGTTY----KAVLDNHLIVTVKRFD---ANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
+G+ G+ Y ++ D I +K+ D N+ + AE ++ P +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES----PYVAK 61
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ FQ+K ++ +Y G +LI +++ P W + IAE V G+ +H+
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDW-AKQYIAE-VVLGVEDLHQR 116
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYKAPEIRKSSRRAT 569
+IH ++K N+L+ +LTD+ LS L + V PD Y APE
Sbjct: 117 G-IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD---YLAPET-ILGVGDD 171
Query: 570 SKSDVYAFGVLLLELLTGKHP 590
SD ++ G ++ E L G P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRF-------DANKTADTSAEAFEQHMEAVGGLSHP 447
L+G GS G+ Y + + ++ VK+ + + +A + + + L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 448 NLVPIRAYF--QAKGERLVIY-DYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVA 502
N+V Y + L I+ +Y P GS+ L+ +G+ T +
Sbjct: 67 NIV---QYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-------FEETLVRNFVRQIL 116
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS------VLSDSSSVEDPD---T 553
+GL Y+H +IH ++K +N+L+ +++D+ +S LS ++ P +
Sbjct: 117 KGLNYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
V + APE+ K + T K+D+++ G L++E+LTGKHP
Sbjct: 176 VFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 54/295 (18%)
Query: 388 QLMRASAEL---LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQH---MEA- 440
++ R S L LG G+ G Y+ + V+ A KT S ++ MEA
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 441 -VGGLSHPNLVP-IRAYFQAKGERLVIYDYQPNGSLFNLIHGSR--SIRAKPLHWTSCLK 496
+ +H N+V I F+ + R ++ + G L + + +R R L L
Sbjct: 62 IMSKFNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDT 553
A DVA+G Y+ + IH ++ + N LL G A++ D+ ++ D
Sbjct: 121 CARDVAKGCKYLEENHF-IHRDIAARNCLLTCKGPGRVAKIADFGMA--------RD--- 168
Query: 554 VAYKAPEIRKSSRRA----------------TSKSDVYAFGVLLLELLT-GKHPSQHPYL 596
Y+A RK R TSK+DV++FGVLL E+ + G P +P
Sbjct: 169 -IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP--YPGR 225
Query: 597 APPDMLEWVRTMRVDDGREENRLGMLTEVASV---CSLKSPEQRPAMWQVLKMIQ 648
+++E+V GR + G V + C +PE RP +L+ IQ
Sbjct: 226 TNQEVMEFV----TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
P +V F + GE + ++ GSL ++ + I L KI+ V +GL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLT 113
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKSS 565
Y+ ++H ++K SN+L+ + E +L D+ +S L DS + T +Y +PE R
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQG 172
Query: 566 RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE 603
T +SD+++ G+ L+E+ G++P + PPD E
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYP-----IPPPDAKE 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 63/278 (22%), Positives = 126/278 (45%), Gaps = 39/278 (14%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEA-----FEQHMEAVGGLSHPNLVP 451
LG+GS G Y+ + + + A KT + +A F + + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAK--------PLHWTSCLKIAEDVAQ 503
+ LVI + G L + + RS+R + P +++A ++A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYL---RSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----------T 553
G+AY++ A+ +H +L + N ++ DF ++ D+ ++ + + D
Sbjct: 131 GMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLP 184
Query: 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDMLEWVRTMRVD 611
V + +PE K T+ SDV++FGV+L E+ T ++ PY ++ +L +V +
Sbjct: 185 VRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT---LAEQPYQGMSNEQVLRFVMEGGLL 240
Query: 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649
D + +N ML E+ +C +P+ RP+ +++ I+E
Sbjct: 241 D-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 11/198 (5%)
Query: 395 ELLGRGSIGTTYKA-VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
++G G+ G K IV +K+F ++ + + + ++ + L H N+V ++
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F+ KG ++++Y +L L+ S P + Q +AY H +
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVR--SYIWQLLQAIAYCHSHN- 120
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA---YKAPEIRKSSRRAT 569
+IH ++K N+L+ +L D+ + L + D VA Y+APE+
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 570 SKSDVYAFGVLLLELLTG 587
DV+A G ++ ELL G
Sbjct: 181 KPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 62/274 (22%), Positives = 116/274 (42%), Gaps = 40/274 (14%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS----HPNLV 450
EL+G G+ G YK H V + A K D + + E+ + + L H N+
Sbjct: 12 ELVGNGTYGQVYKG---RH--VKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 451 PIRAYFQAKG------ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
F K + ++ ++ GS+ +LI ++ K W + I ++ +G
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIA--YICREILRG 123
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEI 561
L+++H+ +IH ++K NVLL + E +L D+ +S D + + + APE+
Sbjct: 124 LSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182
Query: 562 RKSSRRATS----KSDVYAFGVLLLELLTGK------HPSQHPYLAPPDMLEWVRTMRVD 611
+ KSD+++ G+ +E+ G HP + +L P + R+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-----PAPRLK 237
Query: 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
+ + E C +K+ QRP Q++K
Sbjct: 238 SKKWSKKFQSFIE---SCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 61/267 (22%), Positives = 117/267 (43%), Gaps = 27/267 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVG---GLSHPNLV 450
E+LG+G+ GT Y + + ++ VK+ + + + + + +E+ E V L H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ ++ P GS+ ++++ R PL K + + G+AY+H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDY------CLSVLSDSSS---VEDPDTVAYKAPEI 561
++H ++K +NV+L + +L D+ L + S T + APE+
Sbjct: 121 NC-VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHP-SQHPYLAPPDMLEWVRTM--RVDDGREENR 618
S KSD+++ G + E+ TGK P + LA + R + R+ D
Sbjct: 180 INESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238
Query: 619 LGMLTEVASVCSLKSPEQRPAMWQVLK 645
+ +T C + +RP+ Q+L+
Sbjct: 239 IDFVT----SCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 61/283 (21%), Positives = 116/283 (40%), Gaps = 57/283 (20%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLI----VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
+ LG G+ + Y+A V L+ VT R +++ + EA + + + L+HP+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-VEALRKEIRLMARLNHPH 64
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
++ + + ++ GS+ +L+ + + E + +GL+Y+
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYL 119
Query: 509 HRASWLIHGNLKSSNVLLG--------ADF--EARLTDYCLSVLSDSSSVEDP--DTVAY 556
H +IH ++K +N+L+ ADF ARL + + + + T+A+
Sbjct: 120 HENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLA----AKGTGAGEFQGQLLGTIAF 174
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP------SQHPYL--------APPDML 602
APE+ + + S DV++ G +++E+ T K P S H L P +
Sbjct: 175 MAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
E + L +V C PE RP ++LK
Sbjct: 234 EHLSP-------------GLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 397 LGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+G GS G Y A V ++ ++ K + K ++ + + + + L HPN + R
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ + ++ +Y GS +L+ + KPL + QGLAY+H + +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSHN-M 136
Query: 515 IHGNLKSSNVLLGADFEARLTDY-CLSVLSDSSSVEDPDTVAYKAPEI--RKSSRRATSK 571
IH ++K+ N+LL +L D+ S+++ ++ T + APE+ + K
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF--VGTPYWMAPEVILAMDEGQYDGK 194
Query: 572 SDVYAFGVLLLELLTGKHP 590
DV++ G+ +EL K P
Sbjct: 195 VDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 42/224 (18%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEA----FEQHMEAVGGLSHPNLVPI 452
LG G+ G + A N L K A K ++E+ F++ E + L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 453 RAYFQAKGERLVIYDYQPNGSL----------FNLIHGSRSIRAKPLHWTSCLKIAEDVA 502
L++++Y +G L ++ G + L L IA +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE------------- 549
G+ Y+ + +H +L + N L+G ++ D+ +S D S +
Sbjct: 133 SGMVYLASLHF-VHRDLATRNCLVGQGLVVKIGDFGMS--RDIYSTDYYRVGGRTMLPIR 189
Query: 550 --DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
P+++ Y R+ T++SD+++FGV+L E+ T GK P
Sbjct: 190 WMPPESILY---------RKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 16/172 (9%)
Query: 425 KTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRS 483
KTA+ T E Q +EAV P LV + FQ + +I DY G LF ++
Sbjct: 46 KTAEHTRTE--RQVLEAVRR--CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH 101
Query: 484 IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543
+ + IAE V L ++H+ +I+ ++K N+LL ++ LTD+ LS
Sbjct: 102 FTESEVR----VYIAEIVL-ALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155
Query: 544 DSSSVEDPD----TVAYKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
+ E T+ Y APE+ + K+ D ++ GVL ELLTG P
Sbjct: 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 44/224 (19%)
Query: 397 LGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
LG G+ G + A N ++V VK +D + + F + E + L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAELLTNLQHEHIV 70
Query: 451 PIRAYFQAKGERLVIYDYQPNGSL--FNLIHGSRSI---RAKP---LHWTSCLKIAEDVA 502
+++++Y +G L F HG ++ L + L IA+ +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE------------- 549
G+ Y+ + +H +L + N L+G + ++ D+ +S D S +
Sbjct: 131 AGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPIR 187
Query: 550 --DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
P+++ Y R+ T++SDV++ GV+L E+ T GK P
Sbjct: 188 WMPPESIMY---------RKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G+G+ GT Y A+ + V +K+ N E + + HPN+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLK------IAEDVAQGLAY 507
+ E V+ +Y GSL +++ +C+ + + Q L +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVT------------ETCMDEGQIAAVCRECLQALEF 130
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTD--YCLSVLSDSSSVED-PDTVAYKAPEIRKS 564
+H ++ +IH ++KS N+LLG D +LTD +C + + S T + APE+
Sbjct: 131 LH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV--V 187
Query: 565 SRRATS-KSDVYAFGVLLLELLTGKHP 590
+R+A K D+++ G++ +E++ G+ P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 70/270 (25%), Positives = 115/270 (42%), Gaps = 54/270 (20%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
+G G+ G YKA + +V +K E +Q + + HPN+V AY
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNIV---AY 65
Query: 456 FQA--KGERLVI-YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIA---EDVAQGLAYIH 509
F + + ++L I +Y GSL ++ +R PL S L+IA + +GLAY+H
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PL---SELQIAYVCRETLKGLAYLH 118
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSSR 566
+ IH ++K +N+LL D + +L D+ +S L+ + + T + APE+ R
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 567 RA--TSKSDVYAFGVLLLELLTGKHP--SQHPYLA---------PPDMLE----WVRTMR 609
+ K D++A G+ +EL + P HP A PP L+ W
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPA 639
+ C K P++RP
Sbjct: 238 --------------DFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
P +V F + GE + ++ GSL ++ + I + L K++ V +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLT 117
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKSS 565
Y+ ++H ++K SN+L+ + E +L D+ +S L DS + T +Y +PE R
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE-RLQG 176
Query: 566 RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE 603
+ +SD+++ G+ L+E+ G++P + PPD E
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP-----IPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++G G G + L + V +K A + + F +G HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNII 68
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ ++I +Y NGSL + R K + + +A G+ Y+
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGK-FTVGQLVGMLRGIASGMKYLSE 124
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVED------------PDTVAYK 557
++ +H +L + N+L+ ++ +++D+ LS L DS + P+ +AY
Sbjct: 125 MNY-VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY- 182
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
R+ TS SDV++FG+++ E+++ G+ P
Sbjct: 183 --------RKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 64/303 (21%)
Query: 397 LGRGSIGTTYKAVLDNHL--IVTVKRFD-ANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G GS G Y A ++H +V VK+ + K + + + ++ + L HPN + +
Sbjct: 29 IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ + ++ +Y GS +L+ + KPL I QGLAY+H +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP-----DTVAYKAPEI--RKSSR 566
+IH ++K+ N+LL + +L D+ S+S P T + APE+
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADF------GSASKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 567 RATSKSDVYAFGVLLLELLTGKHP-------SQHPYLAPPDML-----EWVRTMRVDDGR 614
+ K DV++ G+ +EL K P S ++A D EW + R
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR----- 250
Query: 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLK---------------MIQEIKESVMAEDN 659
C K P++RPA ++L+ +IQ K++V DN
Sbjct: 251 ---------GFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDN 301
Query: 660 AAF 662
+
Sbjct: 302 LQY 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 396 LLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
+LG+GS G A L I +K+ + D E+ + A+ HP L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ FQ K + +Y G L I S + + ++ GL ++H+
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAA-----EIICGLQFLHK- 114
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDY--C-LSVLSDSSSVEDPDTVAYKAPEIRKSSRRA 568
+I+ +LK NVLL D ++ D+ C ++ + + T Y APEI K +
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 569 TSKSDVYAFGVLLLELLTGKHP 590
S D ++FGVLL E+L G+ P
Sbjct: 175 ES-VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFE-QHMEAV--GGLSHPNLVPI 452
++G GS G +A+L H+ K S+ A E EAV + HPN+V
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ F+A G ++ +Y G L I + R K + L+ + G+ +IH
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKI---KLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 513 WLIHGNLKSSNVLLGADFEARLTDY-CLSVLSD--SSSVEDPDTVAYKAPEIRKSSRRAT 569
++H ++KS N+ L + + +L D+ +L+ + + T Y PEI ++
Sbjct: 121 -VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN-MPYN 178
Query: 570 SKSDVYAFGVLLLELLTGKHPSQ 592
+KSD+++ G +L EL T KHP Q
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 396 LLGRGSIGTT----YKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
+LG+GS G K + + + +K+ + D E+ + A+ G HP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAEDVAQGLAYI 508
+ + FQ K + +Y G L I S RA+ A ++ GL ++
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR--------FYAAEIVLGLQFL 112
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVEDPDTVAYKAPEIRKSS 565
H +I+ +LK NVLL ++ ++ D+ + +L ++ T Y APEI S
Sbjct: 113 HERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL-SY 170
Query: 566 RRATSKSDVYAFGVLLLELLTGKHP 590
+ D +A GVLL E+L G+ P
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 496 KIAEDVAQ--------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547
K++ED Q GL YIH A +IH +LK N+ + D E ++ D+ L+ +DS
Sbjct: 114 KLSEDRIQFLVYQMLKGLKYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172
Query: 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
T Y+APE+ + T D+++ G ++ E+LTGK
Sbjct: 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 33/211 (15%)
Query: 396 LLGRGSIGTTYKAVLDNHLIVT--------VKRFDANKTADTSAEAFEQHM-EAVGGLSH 446
++GRGS Y VL L T +K+ N D E+H+ E +H
Sbjct: 2 VIGRGS----YAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS--NH 55
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
P LV + + FQ + + ++ G L + H R + H + +++ L
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEH---ARFYSAEISLALN 110
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA-------YKAP 559
++H +I+ +LK NVLL A+ +LTDY + + DT + Y AP
Sbjct: 111 FLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMC----KEGIRPGDTTSTFCGTPNYIAP 165
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
EI + S D +A GVL+ E++ G+ P
Sbjct: 166 EILRGEDYGFS-VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 61/277 (22%), Positives = 114/277 (41%), Gaps = 40/277 (14%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNLVPIRA 454
+G+G YKA+ L + +V +K+ + D A + + ++ + L HPN++ A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
F E ++ + G L +I + + + + + K + L ++H +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR-I 127
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPE-IRKSSRRATS 570
+H ++K +NV + A +L D L S + V Y +PE I ++
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY--NF 185
Query: 571 KSDVYAFGVLLLELLTGKHP---------------SQHPYLAPPDMLEWVRTMRVDDGRE 615
KSD+++ G LL E+ + P + Y PP + D E
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PP--------LPADHYSE 235
Query: 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
E L ++ S C PE+RP + VL++ +E+
Sbjct: 236 E-----LRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIR 562
+GL YIH A +IH +LK SNV + D E R+ D+ L+ +D T Y+APEI
Sbjct: 129 RGLKYIHSAG-IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIM 187
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGK 588
+ D+++ G ++ ELL GK
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
P LV + FQ + +I DY G LF H S+ R K + E + L
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFT--HLSQRERFKEQEVQ--IYSGE-IVLALE 119
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP----DTVAYKAPEIR 562
++H+ +I+ ++K N+LL ++ LTD+ LS VE T+ Y AP+I
Sbjct: 120 HLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 563 KSSRRATSKS-DVYAFGVLLLELLTGKHP 590
+ K+ D ++ GVL+ ELLTG P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 36/233 (15%)
Query: 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
++LG+GS G + A L I +K+ D E+ + ++ HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLT 59
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKI--------AEDVA 502
+ FQ K + +Y G L H SC K A ++
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLM-------------FHIQSCHKFDLPRATFYAAEII 106
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL---SVLSDSSSVEDPDTVAYKAP 559
GL ++H + +++ +LK N+LL D ++ D+ + ++L D+ + T Y AP
Sbjct: 107 CGLQFLH-SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD 612
EI + TS D ++FGVLL E+L G+ P D E +++R+D+
Sbjct: 166 EILLGQKYNTS-VDWWSFGVLLYEMLIGQSP-----FHGHDEEELFQSIRMDN 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 49/278 (17%)
Query: 392 ASAELLGRGSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
A + LG G G+ + L D+ L V VK + E F + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 449 LVPIRAYFQAKGER------LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTS--CLKIAED 500
++ + E +VI + +G L + + SR + P + + +K D
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPE 560
+A G+ Y+ S+ IH +L + N +L + + D+ LS + + D Y+
Sbjct: 121 IASGMEYLSSKSF-IHRDLAARNCMLNENMNVCVADFGLS-----KKIYNGDY--YRQGR 172
Query: 561 IRK-----------SSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTM 608
I K + R T+KSDV++FGV + E+ T G+ P +P + ++ +++
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSEIYDYL--- 227
Query: 609 RVDDGREENRLGM-------LTEVASVCSLKSPEQRPA 639
R+ NRL L + S C L +P+ RP+
Sbjct: 228 -----RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E +G+G+ GT Y A +D V N E + + +PN+V
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ E V+ +Y GSL +++ + + + + Q L ++H ++ +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH-SNQV 137
Query: 515 IHGNLKSSNVLLGADFEARLTD--YCLSVLSDSSS-VEDPDTVAYKAPEIRKSSRRATS- 570
IH ++KS N+LLG D +LTD +C + + S T + APE+ +R+A
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV--VTRKAYGP 195
Query: 571 KSDVYAFGVLLLELLTGKHP 590
K D+++ G++ +E++ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 396 LLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
++GRGS L + + VK+ N D E+H+ +HP LV
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVG 60
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ + FQ + + +Y G L + R + + + S +++ L Y+H
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-----EISLALNYLHER 115
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED-PDTVAYKAPEIRKSSRRA 568
+I+ +LK NVLL ++ +LTDY C L + T Y APEI +
Sbjct: 116 G-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 569 TSKSDVYAFGVLLLELLTGKHP 590
S D +A GVL+ E++ G+ P
Sbjct: 175 FS-VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
P +V + FQ K ++ +Y P G L +L+ ++ + + IAE +
Sbjct: 50 AQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVAR-IYIAE-IVL 104
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--------VLSDSSSVEDPDTVA 555
L Y+H +IH +LK N+L+ ++ +LTD+ LS + + ED V
Sbjct: 105 ALEYLHSNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 556 ---YKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
Y APE+ + SK+ D ++ G +L E L G P
Sbjct: 164 TPDYIAPEVIL--GQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 396 LLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+LG G+ GT YK + + + V +K N + + E ++ + G+ P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY-VMAGVGSPYVC 72
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIH------GSRSIRAKPLHWTSCLKIAEDVAQG 504
+ +LV P G L + + GS+ + L+W C++IA +G
Sbjct: 73 RLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDL----LNW--CVQIA----KG 121
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE---DPDTVAYKAPEI 561
++Y+ L+H +L + NVL+ + ++TD+ L+ L D E D V K +
Sbjct: 122 MSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 562 RKS-SRRATSKSDVYAFGVLLLELLT-GKHPSQH-PYLAPPDMLE 603
RR T +SDV+++GV + EL+T G P P PD+LE
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 496 KIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDS-SSVEDPDT 553
KIA + + L Y+H +IH ++K SNVL+ + + +L D+ +S L DS + D
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGC 166
Query: 554 VAYKAPEIRKSSRRATS---KSDVYAFGVLLLELLTGKHP 590
Y APE KSDV++ G+ ++EL TG+ P
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 494 CLKIAEDVAQ--------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545
C K+ +D Q GL YIH A +IH +LK SN+ + D E ++ D+ L+ +D
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172
Query: 546 SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
T Y+APEI + D+++ G ++ ELLTG+
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS------VEDPDTVAYK 557
GL YIH A+ ++H +LK SN+LL + + ++ D+ L+ ++D E T Y+
Sbjct: 118 GLKYIHSAN-VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
APEI +S+ T D+++ G +L E+L+ +
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 56/288 (19%)
Query: 395 ELLGRGSIGTTYKAV---LDNH---LIVTVKRFDANKT----ADTSAEAFEQHMEAVGGL 444
+ LG G+ G KA LDN V VK + T +D +E E M+ +G
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE-MEM-MKMIG-- 73
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI--RAKPL------------H 490
H N++ + +G V+ +Y +G+L + + R A P
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 491 WTSCLKIAEDVAQGLAYIHRASW-LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549
S A VA+G+ ++ AS IH +L + NVL+ D ++ D+ L+ +
Sbjct: 134 LVSF---AYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLA-----RDIH 183
Query: 550 DPD----------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAP 598
D V + APE R T +SDV++FGVLL E+ T G S +P +
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLG--GSPYPGIPV 240
Query: 599 PDMLEWVRT-MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
++ + ++ R++ + +N L + C + P QRP Q+++
Sbjct: 241 EELFKLLKEGYRME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 33/88 (37%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPE 560
GL YIH A +IH +LK SN+ + D E ++ D+ L+ +D E VA Y+APE
Sbjct: 130 GLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPE 185
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGK 588
I + D+++ G ++ ELLTGK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 60/301 (19%)
Query: 397 LGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+G GS G Y A V N ++ K + K ++ + + ++ + + HPN + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ + ++ +Y GS +L+ + KPL I QGLAY+H + +
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSHN-M 146
Query: 515 IHGNLKSSNVLLGADFEARLTDY-CLSVLSDSSSVEDPDTVAYKAPEI--RKSSRRATSK 571
IH ++K+ N+LL + +L D+ S+ S ++S T + APE+ + K
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSF--VGTPYWMAPEVILAMDEGQYDGK 204
Query: 572 SDVYAFGVLLLELLTGKHP---------------SQHPYLAPPDMLEWVRTMRVDDGREE 616
DV++ G+ +EL K P ++ P L + ++ R VD
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF-VDS---- 259
Query: 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLK---------------MIQEIKESVMAEDNAA 661
C K P+ RP ++LK +IQ K++V DN
Sbjct: 260 ------------CLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDNLQ 307
Query: 662 F 662
+
Sbjct: 308 Y 308
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 29/273 (10%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKT---ADTSAEAFEQHMEA--VGGLSHPNLVP 451
LG+GS G Y+ + + + A KT + E E EA + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAK--------PLHWTSCLKIAEDVAQ 503
+ LV+ + G L + + RS R + P +++A ++A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYL---RSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT-----VAYKA 558
G+AY+ A +H +L + N ++ D ++ D+ ++ + V + A
Sbjct: 131 GMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDMLEWVRTMRVDDGREE 616
PE K T+KSDV++FGV+L E+ T ++ PY L+ ++L++V D E
Sbjct: 190 PESLKDGV-FTTKSDVWSFGVVLWEMAT---LAEQPYQGLSNEEVLKFVIDGGHLD-LPE 244
Query: 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649
N L E+ +C +P+ RP +++ +++
Sbjct: 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 444 LSHPNLVPIR--AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLK-IAED 500
L HPN+V ++ + KG ++++Y + L L+ S ++ +K +
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD-SPEVKFTESQ----IKCYMKQ 108
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD------TV 554
+ +GL Y+H ++H ++K SN+L+ D +L D+ L+ + D T+
Sbjct: 109 LLEGLQYLHSNG-ILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYTNRVITL 165
Query: 555 AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
Y+ PE+ + R + D+++ G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/165 (29%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 429 TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKP 488
T FEQ S+P LV + + FQ ++ +Y G L + H R +
Sbjct: 44 TEKHVFEQ------ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPE 95
Query: 489 LHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSS 546
H A ++ L ++H +I+ +LK NVLL AD +LTDY C L
Sbjct: 96 EH---ARFYAAEICIALNFLHERG-IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151
Query: 547 SVED-PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ T Y APEI + S D +A GVL+ E++ G+ P
Sbjct: 152 TTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 63/259 (24%), Positives = 117/259 (45%), Gaps = 23/259 (8%)
Query: 397 LGRGSIG--TTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+G+GS G + + D V +K+ + + +A EQ + + L HPN+V R
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 455 YFQAK-GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
++ + G ++ + G L+ H + + K L ++ +A L Y+H
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLY---HKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH- 122
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDP--DTVAYKAPEIRKSSRRATS 570
++H +LK+ NV L ++ D ++ VL + + T Y +PE+ S++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF-SNKPYNY 181
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGR----EENRLGMLTEVA 626
KSDV+A G + E+ T KH DM V R+ +G+ ++ L E+
Sbjct: 182 KSDVWALGCCVYEMATLKHA-----FNAKDMNSLV--YRIIEGKLPPMPKDYSPELGELI 234
Query: 627 SVCSLKSPEQRPAMWQVLK 645
+ K PE+RP++ +L+
Sbjct: 235 ATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 29/107 (27%), Positives = 57/107 (53%), Gaps = 1/107 (0%)
Query: 482 RSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV 541
R + ++PL + +GL Y+H A ++H +LK SN+L+ + + ++ D+ L+
Sbjct: 98 RLLTSRPLEKQFIQYFLYQILRGLKYVHSAG-VVHRDLKPSNILINENCDLKICDFGLAR 156
Query: 542 LSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
+ D T Y+APEI + ++ + D+++ G + E+L GK
Sbjct: 157 IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G+G+ GT Y A+ + V +K+ N E + + +PN+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ E V+ +Y GSL +++ + + + + Q L ++H ++
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLH-SNQ 135
Query: 514 LIHGNLKSSNVLLGADFEARLTD--YCLSVLSDSSSVED-PDTVAYKAPEIRKSSRRATS 570
+IH ++KS N+LLG D +LTD +C + + S T + APE+ +R+A
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV--VTRKAYG 193
Query: 571 -KSDVYAFGVLLLELLTGKHP 590
K D+++ G++ +E++ G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 58/254 (22%), Positives = 112/254 (44%), Gaps = 14/254 (5%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
++GRG+ G + + +V +K+ + A + + + LSHPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
F +++ +Y P G+L I + L + L + L ++H +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH-TKLI 122
Query: 515 IHGNLKSSNVLLGA-DFEARLTDYCLS--VLSDSSSVEDPDTVAYKAPEIRKSSRRATSK 571
+H +LK+ N+LL ++ D+ +S + S S + T Y +PE+ + + K
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE-GKPYNQK 181
Query: 572 SDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR-TMRVDDGREENRLGMLTEVASVCS 630
SD++A G +L EL + K + L P +L+ + T R L L + S+ +
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTFAPISDRYSPDLRQL--ILSMLN 238
Query: 631 LKSPEQRPAMWQVL 644
L P +RP + Q++
Sbjct: 239 LD-PSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 3e-07
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP---DTVA---YK 557
GL Y+H A+ +IH +LK SN+L+ ++ + ++ D+ L+ D E + V Y+
Sbjct: 115 GLKYLHSAN-VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKH 589
APE+ SS R T D+++ G + ELLT K
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 38/151 (25%), Positives = 76/151 (50%), Gaps = 17/151 (11%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
H N+V + + E V+ ++ G+L +++ +R L+ + E V Q L
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQAL 130
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTD--YCLSVLSD----SSSVEDPDTVAYKAP 559
Y+H + +IH ++KS ++LL D +L+D +C + D S V P + AP
Sbjct: 131 CYLH-SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP---YWMAP 186
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
E+ + T + D+++ G++++E++ G+ P
Sbjct: 187 EVISRTPYGT-EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 395 ELLGRGSIGTT----YKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++GRG+ G +K+ + + + +F+ K +D++ F + + + + P +V
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 106
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ FQ ++ +Y P G L NL+ S P W +V L IH
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWAKFY--TAEVVLALDAIHS 160
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEIRKSS- 565
LIH ++K N+LL +L D+ + D + + DT Y +PE+ KS
Sbjct: 161 MG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 566 --RRATSKSDVYAFGVLLLELLTGKHP 590
+ D ++ GV L E+L G P
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 46/211 (21%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
E++G G G + L + V +K + T + F +G HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNII 68
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ ++I ++ NG+L + + + + + L+ +A G+ Y+
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLR---GIAAGMKYLSE 124
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPD---------TVAYKAPE 560
++ +H +L + N+L+ ++ +++D+ LS L D +S DP + + APE
Sbjct: 125 MNY-VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPIRWTAPE 181
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
+ R+ TS SDV+++G+++ E+++ G+ P
Sbjct: 182 A-IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 5e-07
Identities = 25/60 (41%), Positives = 30/60 (50%)
Query: 123 NLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182
NLKSL LS N + + L L +LDLS NNLT + P + L L SL L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 39/164 (23%), Positives = 81/164 (49%), Gaps = 27/164 (16%)
Query: 441 VGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWT--SCLKIA 498
+G HPN++ + +++ +Y NGSL + R +T + +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGML 112
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDT---- 553
+A G+ Y+ + +H +L + N+L+ ++ +++D+ LS VL D DP+
Sbjct: 113 RGIASGMKYLSDMGY-VHRDLAARNILVNSNLVCKVSDFGLSRVLED-----DPEAAYTT 166
Query: 554 ------VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
+ + APE + R+ TS SDV+++G+++ E+++ G+ P
Sbjct: 167 RGGKIPIRWTAPEA-IAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 43/158 (27%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 439 EAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIA 498
E HP LV + A FQ + + +Y G L IH + + + +C
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC---- 109
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV----LSDSSSVEDPDTV 554
V GL Y+H +++ +LK N+LL + ++ D+ L D +S T
Sbjct: 110 --VVLGLQYLHENK-IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF-CGTP 165
Query: 555 AYKAPEI--RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ APE+ S RA D + GVL+ E+L G+ P
Sbjct: 166 EFLAPEVLTETSYTRAV---DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 385 SLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKT-----ADTSAEAFEQHME 439
SL +L R + +G G+ GT YK + H R A K DT + +E
Sbjct: 72 SLSELERVN--RIGSGAGGTVYKVI---HR--PTGRLYALKVIYGNHEDTVRRQICREIE 124
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAE 499
+ ++HPN+V F GE V+ ++ GSL G+ + L +A
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLA-----DVAR 175
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDS-----SSVEDPDT 553
+ G+AY+HR ++H ++K SN+L+ + ++ D+ +S +L+ + SSV T
Sbjct: 176 QILSGIAYLHRRH-IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GT 231
Query: 554 VAYKAPEIRKSSRRATSKSDVYA-----FGVLLLELLTGKHP 590
+AY +PE R ++ D YA GV +LE G+ P
Sbjct: 232 IAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 10/148 (6%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
HP L + FQ K + +Y G L I SR + A +V L
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-----YAAEVTLAL 109
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL---SVLSDSSSVEDPDTVAYKAPEIR 562
++HR +I+ +LK N+LL A+ +L D+ + +L+ ++ T Y APEI
Sbjct: 110 MFLHRHG-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ S D +A GVL+ E++ G+ P
Sbjct: 169 QELEYGPS-VDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADT-SAEAFEQHMEAVGGLS---HPNLVPI 452
LG G+ G YKA ++ A K DT S E E +M + L+ HPN+V +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA-----AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
F + ++ ++ G++ ++ +PL + + + L Y+H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEI----RKS 564
+IH +LK+ N+L D + +L D+ +S ++ +++ D T + APE+
Sbjct: 124 -IIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML 602
R K+DV++ G+ L+E+ + P H L P +L
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPP--HHELNPMRVL 217
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 64/300 (21%)
Query: 397 LGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS---HPNLVP 451
+G GS G Y A V N +V +K+ + + S E ++ ++ V L HPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNE-VVAIKKM--SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ + + ++ +Y GS +++ + KPL I QGLAY+H
Sbjct: 80 YKGCYLREHTAWLVMEYCL-GSASDIL----EVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP-----DTVAYKAPEI--RKS 564
IH ++K+ N+LL +L D+ S+S+ P T + APE+
Sbjct: 135 E-RIHRDIKAGNILLTEPGTVKLADF------GSASLVSPANSFVGTPYWMAPEVILAMD 187
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP-------SQHPYLA---PPDMLEWVRTMRVDDGR 614
+ K DV++ G+ +EL K P S ++A P T+ +D
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP-------TLSSNDWS 240
Query: 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLK---------------MIQEIKESVMAEDN 659
+ R C K P+ RP+ ++LK +IQ K++V DN
Sbjct: 241 DYFR-----NFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDN 295
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 45/211 (21%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
HPN+V + + + E V+ ++ G+L +++ +R ++ + V + L
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKAL 128
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTD--YCLSVLSDSSSVEDPD------TVAYK 557
+++H A +IH ++KS ++LL +D +L+D +C V S E P T +
Sbjct: 129 SFLH-AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV-----SKEVPRRKSLVGTPYWM 182
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHP--SQHPYLAPPDMLEWVRTMRVDDGRE 615
APE+ T + D+++ G++++E++ G+ P ++ P A ++ +R +
Sbjct: 183 APEVISRLPYGT-EVDIWSLGIMVIEMVDGEPPYFNEPPLQA----MKRIRDNLPPKLKN 237
Query: 616 ENRLG-MLTEVASVCSLKSPEQRPAMWQVLK 645
+++ L ++ P QR ++L
Sbjct: 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 14/100 (14%)
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---- 552
+ + +GL Y+H +++IH +LK SN+LL ++ D+ L+ + P
Sbjct: 113 LMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLA-----RTYGLPAKPMT 166
Query: 553 ----TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
T+ Y+APE+ T+ D++A G +L ELL K
Sbjct: 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 63/245 (25%), Positives = 92/245 (37%), Gaps = 69/245 (28%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEA---------FEQHMEAVGGLS 445
+LLG+G +G + L T K F A K D EQ + A L
Sbjct: 7 KLLGKGDVGRVFLV----RLKGTGKLF-ALKVLDKKEMIKRNKVKRVLTEQEILAT--LD 59
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ-- 503
HP L + A FQ + ++ DY P G LF L+ + +P CL E+VA+
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLL------QRQP---GKCLS--EEVARFY 108
Query: 504 ------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----------- 546
L Y+H +++ +LK N+LL L+D+ LS SD
Sbjct: 109 AAEVLLALEYLH-LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 547 ------SVEDPDTVA---------------YKAPEIRKSSRRATSKSDVYAFGVLLLELL 585
+ +T + Y APE+ S D + G+LL E+L
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEML 226
Query: 586 TGKHP 590
G P
Sbjct: 227 YGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 397 LGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTS-AEAFEQHMEAVGGL-SHPN 448
LG G+ G +A D + V VK TA +S EA ++ + L +H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP--TAHSSEREALMSELKIMSHLGNHEN 100
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
+V + G LVI +Y G L N + R L L + VA+G+A++
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFL 157
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDT---VAYKAPEIRK 563
+ IH +L + NVLL ++ D+ L+ +++DS+ V + V + APE
Sbjct: 158 ASKN-CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE-SI 215
Query: 564 SSRRATSKSDVYAFGVLLLELLT 586
+ T +SDV+++G+LL E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 40/252 (15%)
Query: 414 LIVTVK--RFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471
++V VK R DA+ A E F + ++ + LS PN+ + +I +Y N
Sbjct: 47 VLVAVKVLRPDASDNA---REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 472 GSL------FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVL 525
G L + +K L +++ L +A +A G+ Y+ + +H +L + N L
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-FVHRDLATRNCL 162
Query: 526 LGADFEARLTDYCLS---VLSDSSSVEDPDTVAYKAP-EIRKSS------RRATSKSDVY 575
+G ++ ++ D+ +S SD V+ +AP IR + + T+KSDV+
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYRVQG------RAPLPIRWMAWESVLLGKFTTKSDVW 216
Query: 576 AFGVLLLELLT--GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM-------LTEVA 626
AFGV L E+LT + P +H L ++E DDGR+ L + E+
Sbjct: 217 AFGVTLWEILTLCREQPYEH--LTDQQVIENAGHFFRDDGRQI-YLPRPPNCPKDIYELM 273
Query: 627 SVCSLKSPEQRP 638
C + E RP
Sbjct: 274 LECWRRDEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 50/296 (16%)
Query: 397 LGRGSIGTTYKAVL--------DNHLIVTVKRFDANKT----ADTSAEAFEQHMEAVGGL 444
LG G G +A D + V VK N T AD +E + M+ +G
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--ELMKLIG-- 75
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-----------SIRAKPLHWTS 493
H N++ + +G VI +Y G+L + R + + L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 494 CLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD- 552
+ A VA+G+ Y+ + IH +L + NVL+ D ++ D+ L+ V D D
Sbjct: 136 LVSCAYQVARGMEYL-ESRRCIHRDLAARNVLVTEDNVMKIADFGLA-----RGVHDIDY 189
Query: 553 ---------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDML 602
V + APE R T +SDV++FG+L+ E+ T G P +P + ++
Sbjct: 190 YKKTSNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSP--YPGIPVEELF 246
Query: 603 EWVRT-MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657
+ +R R+D + N L + C P QRP Q+++ + ++ +V E
Sbjct: 247 KLLREGHRMD--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 4/88 (4%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VEDPDTVAYKAPE 560
GL YIH A+ ++H +LK SN+LL A+ + ++ D+ L+ + E T Y+APE
Sbjct: 120 GLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGK 588
+ + T+ DV++ G + ELL K
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 444 LSHPNLVPIRAYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
+SHP + IR ++ +R + + +Y P G LF+ + S ++ L A ++
Sbjct: 58 VSHPFI--IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN-----STGLFYASEI 110
Query: 502 AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSV--EDPDTVAYKA 558
L Y+H +++ +LK N+LL + +LTD+ + L D + P+ Y A
Sbjct: 111 VCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE---YLA 166
Query: 559 PEI--RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
PE+ K +A D +A G+L+ E+L G P
Sbjct: 167 PEVIQSKGHNKAV---DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADT-SAEAFEQHM---EAVGGLSHPNLVPI 452
LG G+ G YKA + A K +T S E E +M E + +HP +V +
Sbjct: 20 LGDGAFGKVYKAKNKETGALA-----AAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 453 RAYFQAKGERLVIYDYQPNGSL-FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
F G+ ++ ++ P G++ ++ R + +P C ++ E L Y+H
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVICRQMLE----ALQYLHSM 129
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSSRR 567
+IH +LK+ NVLL D + +L D+ +S + +++ D T + APE+
Sbjct: 130 K-IIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 568 ATS----KSDVYAFGVLLLELLTGKHPSQHPYLAPPDML 602
+ K+D+++ G+ L+E+ + P H L P +L
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP--HHELNPMRVL 224
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 57/261 (21%), Positives = 109/261 (41%), Gaps = 12/261 (4%)
Query: 397 LGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVPIR 453
+GRG Y+A +LD + V +K+ D A A + ++ + L+HPN++
Sbjct: 10 IGRGQFSEVYRATCLLD-GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI-HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
A F E ++ + G L +I H + R P + K + L ++H +
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK--TVWKYFVQLCSALEHMH-SR 125
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKSSRRAT 569
++H ++K +NV + A +L D L S + V Y +PE R
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYN 184
Query: 570 SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629
KSD+++ G LL E+ + P + + + + ++ L ++ ++C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244
Query: 630 SLKSPEQRPAMWQVLKMIQEI 650
PE+RP + V + + +
Sbjct: 245 INPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 45/279 (16%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E +G+GS GT K D ++V K D + + + + L HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILV-WKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV-- 62
Query: 453 RAYFQ----AKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
Y+ + L I +Y G L LI + R K + +I + L
Sbjct: 63 -RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALYE 120
Query: 508 IHRASW----LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSS-----VEDPDTVAYK 557
H S ++H +LK +N+ L A+ +L D+ L+ +L SS V P Y
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP---YYM 177
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHP---SQHPYLAPPDMLEWVRTMRVDDGR 614
+PE + KSD+++ G L+ EL P LA ++ +G+
Sbjct: 178 SPEQ-LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA----------SKIKEGK 226
Query: 615 EENRLGM-----LTEVASVCSLKSPEQRPAMWQVLKMIQ 648
R+ L EV P++RP+ ++L++
Sbjct: 227 -FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
P LV + FQ + + +I DY G +F ++ + + + S ++ L
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS-----GEIILALE 119
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP----DTVAYKAPEIR 562
++H+ +++ ++K N+LL ++ LTD+ LS S E T+ Y APEI
Sbjct: 120 HLHKLG-IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ D ++ G+L+ ELLTG P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 394 AELLGRGSIGTT---YKAVLDNHLIVTVKRFDANKTADTSAE--AFEQHMEAVGGLSHPN 448
+LLG+G+ G Y L +FD + +TS E A E ++ + L H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE-SPETSKEVSALECEIQLLKNLQHER 65
Query: 449 LVPIRAYFQAKGER-LVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
+V + + E+ L I+ +Y P GS+ + + ++ + K + +G++
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-----SVTRKYTRQILEGMS 120
Query: 507 YIHRASWLIHGNLKSSNVL--------LGADFEA--RLTDYCLSVLSDSSSVEDPDTVAY 556
Y+H ++ ++H ++K +N+L LG DF A RL C+S S P +
Sbjct: 121 YLH-SNMIVHRDIKGANILRDSAGNVKLG-DFGASKRLQTICMSGTGIRSVTGTP---YW 175
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+PE+ S K+DV++ G ++E+LT K P
Sbjct: 176 MSPEV-ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLF-NLIHGSR--SIRAKPLHWTSCLKIAEDVAQ 503
P +V ++ FQ + ++ DY G LF +L R RAK IAE V
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAK-------FYIAELVL- 107
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV--LSDSSSVED-PDTVAYKAPE 560
L ++H+ +++ +LK N+LL A L D+ LS L+D+ + T Y APE
Sbjct: 108 ALEHLHKYD-IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ + T D ++ GVL+ E+ G P
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 35/177 (19%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIR-----AKPLH-WTSC--- 494
L HP +VP+ + + +Y P + L +S+ +K L TS
Sbjct: 59 LIHPGIVPV---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 495 LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL------------ 542
L I + + Y+H L H +LK N+LLG E + D+ ++
Sbjct: 116 LSIFHKICATIEYVHSKGVL-HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 543 -----SDSSSVEDPD----TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
SS+ P T Y APE R A+ +D+YA GV+L ++LT P
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPE-RLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 10/145 (6%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDP-DTVA 555
A ++ GL +H+ +++ +LK N+LL R++D L+V + + +++ TV
Sbjct: 108 AAEICCGLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615
Y APE+ K+ R T D +A G LL E++ G+ P Q E V + V + +E
Sbjct: 167 YMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQR--KKKIKREEVERL-VKEVQE 222
Query: 616 ENRLGMLTEVASVCSL---KSPEQR 637
E + S+C + K P++R
Sbjct: 223 EYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 28/61 (45%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 100 QLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
L+ L L NN LT IPD L NLK L LS N + P + L L LDLS NN
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 158 L 158
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
+ HP LV + FQ ++ +Y P G LF+ + R P A+ V
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVA-RFYAAQ-VVL 112
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED--------PDTVA 555
L Y+H +++ +LK N+LL +D ++TD+ + V+ P+
Sbjct: 113 ALEYLHSLD-IVYRDLKPENLLLDSDGYIKITDFGFAKR-----VKGRTYTLCGTPE--- 163
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APEI S+ D +A G+L+ E+L G P
Sbjct: 164 YLAPEI-ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 61/276 (22%), Positives = 112/276 (40%), Gaps = 47/276 (17%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
E LG + G YK L D+ +V +K E F+Q + L HPN+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNI 69
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC--------------- 494
V + + ++++Y G L + I P C
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFL-----IMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 495 --LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVED 550
L IA +A G+ Y+ + + +H +L + N+L+G +++D LS + S
Sbjct: 125 DFLHIAIQIAAGMEYL-SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 551 PDT---VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDMLEWV 605
P + + + PE + ++ SD+++FGV+L E+ + PY + +++E V
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSF---GLQPYYGFSNQEVIEMV 239
Query: 606 RTMRVDDGREE---NRLGMLTEVASVCSLKSPEQRP 638
R ++ E+ ++TE C + P +RP
Sbjct: 240 RKRQLLPCSEDCPPRMYSLMTE----CWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 44/277 (15%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G+G+ G YK + + VK D D EA ++++ +HPN+V
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP--NHPNVVKFY 85
Query: 454 AYFQ-----AKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
F G+ ++ + GS+ L+ G I + L I GL ++
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHL 144
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEI---- 561
H + +IH ++K +N+LL + +L D+ +S S+ + +V + APE+
Sbjct: 145 HN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHP--SQHPYLA--------PPDML---EWVRTM 608
++ ++ DV++ G+ +EL G P HP PP +L +W R+
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRS- 262
Query: 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
S C +K E RP++ +L+
Sbjct: 263 -------------FNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 64/280 (22%), Positives = 114/280 (40%), Gaps = 52/280 (18%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS----HPNLV 450
E++G G+ G YK H V + A K D + + E+ + L H N+
Sbjct: 22 EVVGNGTYGQVYKG---RH--VKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 451 PIRAYFQAKG------ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
F K + ++ ++ GS+ +L+ ++ K W + I ++ +G
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-DWIA--YICREILRG 133
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEI 561
LA++H A +IH ++K NVLL + E +L D+ +S D + T + APE+
Sbjct: 134 LAHLH-AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192
Query: 562 RKSSRRATS----KSDVYAFGVLLLELLTGKHP--SQHPYLA-------PPDML---EWV 605
+ +SD+++ G+ +E+ G P HP A PP L +W
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252
Query: 606 RTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
+ + C +K+ RP+ Q+LK
Sbjct: 253 KK--------------FIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 44/223 (19%), Positives = 84/223 (37%), Gaps = 39/223 (17%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG------------- 442
LG G+ G KA IV +K+ + + Q + G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS-NDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 443 GLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA 502
+ H N++ + + ++ D L ++ R IR C I +
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV--DRKIRLTESQ-VKC--ILLQIL 129
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS------VLSDSSSVEDPD---- 552
GL +H + +H +L +N+ + + ++ D+ L+ SD+ S ++
Sbjct: 130 NGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 553 -------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
T+ Y+APE+ + + D+++ G + ELLTGK
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
AE LG G+ + VL + V + R D KTA F + ++ + L +PN++ +
Sbjct: 30 AEFLGEGAPEFDGQPVL---VAVKMLRADVTKTARND---FLKEIKIMSRLKNPNIIRLL 83
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLH--------WTSCLKIAEDVAQGL 505
+ +I +Y NG L N R I + H + L +A +A G+
Sbjct: 84 GVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM 142
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--------SVEDPDTVAYK 557
Y+ ++ +H +L + N L+G + ++ D+ +S S +V +A++
Sbjct: 143 KYLASLNF-VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLT 586
+ + K T+ SDV+AFGV L E+ T
Sbjct: 202 SILLGK----FTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQ---HMEAVGGLSHPNLVPIR 453
LG+G+ G+ YK VL VT+ + D S F Q ++ + P +V
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKAVSPYIVDFY 65
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F +G + +Y GSL L G + P +I V +GL ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR--RITYAVVKGLKFLKEEHN 123
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKS---SRRAT 569
+IH ++K +NVL+ + + +L D+ +S L S + + +Y APE KS ++ T
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 570 --SKSDVYAFGVLLLELLTGKHP 590
+SDV++ G+ +LE+ G++P
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRK 563
GL YIH A +IH +LK N+ + D E ++ D+ L+ +D+ T Y+APE+
Sbjct: 129 GLKYIHSAG-IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL 187
Query: 564 SSRRATSKSDVYAFGVLLLELLTGK 588
+ D+++ G ++ E+LTGK
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 55/261 (21%), Positives = 109/261 (41%), Gaps = 10/261 (3%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNLVPIRA 454
+GRG Y+A L + V +K+ + D A + + ++ + L+HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 455 YFQAKGERLVIYDYQPNGSLFNLI-HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F E ++ + G L +I + + R P + K + + ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPER--TVWKYFVQLCSAVEHMH-SRR 126
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKSSRRATS 570
++H ++K +NV + A +L D L S + V Y +PE R
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNF 185
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630
KSD+++ G LL E+ + P + + + + E+ L E+ S+C
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCI 245
Query: 631 LKSPEQRPAMWQVLKMIQEIK 651
P+QRP + V ++ +++
Sbjct: 246 YPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 17/96 (17%)
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---------- 552
+GL Y+H A L H ++K N+L+ ++ ++ D+ L+ VE+PD
Sbjct: 114 RGLKYLHSAGIL-HRDIKPGNLLVNSNCVLKICDFGLA------RVEEPDESKHMTQEVV 166
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
T Y+APEI SR TS D+++ G + ELL +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL---SVLSDSSSVEDPDTV 554
A ++ GL ++H + +I+ +LK NV+L D ++ D+ + +V D+ + T
Sbjct: 102 AAEIVCGLQFLH-SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160
Query: 555 AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APEI + + S D ++FGVLL E+L G+ P
Sbjct: 161 DYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDP-DTVA 555
A ++ GL +HR + ++ +LK N+LL R++D L+V + + S+ TV
Sbjct: 108 AAEILCGLEDLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615
Y APE+ + R S D + G L+ E++ G Q P+ + ++ R E
Sbjct: 167 YMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEG----QSPFRGRKEKVKREEVDRRVLETE 221
Query: 616 ENRLGMLTEVA-SVCSL---KSPEQR 637
E +E A S+C + K P+QR
Sbjct: 222 EVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 395 ELLGRGSIGTT----YKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++GRG+ G +K+ + + + +F+ K +D++ F + + + + P +V
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVV 106
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ FQ ++ +Y P G L NL+ +T+ + +A D + +IHR
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 166
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSD-----SSSVEDPDTVAYKAPEIRK 563
++K N+LL +L D+ C+ + + ++V PD Y +PE+ K
Sbjct: 167 -------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD---YISPEVLK 216
Query: 564 SSR---RATSKSDVYAFGVLLLELLTGKHP 590
S + D ++ GV L E+L G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 396 LLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN--- 448
+LG+G G+ +A L + V VK A+ + + E F + + HPN
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 449 LVPIRAYFQAKGE---RLVIYDYQPNGSLFNLIHGSRSIRAKP--LHWTSCLKIAEDVAQ 503
L+ + +AKG +VI + +G L + SR I +P L + ++ D+A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-------VLSDSSSVEDPDTVAY 556
G+ Y+ + IH +L + N +L + + D+ LS + + P V +
Sbjct: 125 GMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP--VKW 181
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY 595
A E + T+ SDV+AFGV + E++T Q PY
Sbjct: 182 LALE-SLADNVYTTHSDVWAFGVTMWEIMT---RGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 24/202 (11%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDAN-------KTADTSAEAFEQHMEAVGGLSHPN 448
+G GS G +K + IV +K+F + K A +Q L HPN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQ-------LKHPN 61
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
LV + F+ K + ++++Y + L L ++ R P H KI Q + +
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEH--LIKKIIWQTLQAVNFC 116
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKSS 565
H IH ++K N+L+ + +L D+ + + + D VA Y+APE+
Sbjct: 117 H-KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 566 RRATSKSDVYAFGVLLLELLTG 587
+ DV+A G + ELLTG
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++GRG+ G L N + + +++ K A+T+ F + + + + +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC--FREERDVLVNGDNQWIT 64
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHG--SRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
+ FQ + ++ DY G L L+ R + + + IA D L Y+
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSD-----SSSVEDPDTVAYKAPEI 561
HR ++K N+L+ + RL D+ CL ++ D S +V PD Y +PEI
Sbjct: 125 HR-------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD---YISPEI 174
Query: 562 RKSSR----RATSKSDVYAFGVLLLELLTGKHP 590
++ + + D ++ GV + E+L G+ P
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 24/166 (14%)
Query: 496 KIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDS-SSVEDPDT 553
KIA + L Y+ +IH ++K SN+LL + +L D+ +S L DS + D
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 554 VAYKAPEIRKSSRRATS--KSDVYAFGVLLLELLTGKHP-----------SQHPYLAPPD 600
Y APE S R +SDV++ G+ L E+ TGK P +Q PP
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP- 229
Query: 601 MLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646
+ + RE + + + C +K +RP ++L+
Sbjct: 230 ------ILSNSEEREFS-PSFVNFINL-CLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 21/199 (10%)
Query: 395 ELLGRGSIGTTYKAVL--DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E +GRG+ G + L DN V VK D A+ F Q + SHPN+V +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTP-VAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRL 58
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIH--GSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
K ++ + G + G R ++ K L +++ E+ A G+ Y+
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKEL-----IQMVENAAAGMEYLE- 111
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLS------VLSDSSSVEDPDTVAYKAPEIRKS 564
+ IH +L + N L+ +++D+ +S V + + ++ V + APE
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PVKWTAPEALNY 170
Query: 565 SRRATSKSDVYAFGVLLLE 583
R +S+SDV++FG+LL E
Sbjct: 171 GRY-SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 396 LLGRGSIGTTY----KAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
+LG+GS G K + + I +K+ + D E+ + A+ G P L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQ 65
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ + FQ + +Y G L + + R K H + A ++A GL ++H +
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPH---AVFYAAEIAIGLFFLH-S 119
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED----PDTVAYKAPEIRKSS 565
+I+ +LK NV+L ++ ++ D+ C + D + + PD Y APEI
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD---YIAPEIIAYQ 176
Query: 566 RRATSKSDVYAFGVLLLELLTGKHP 590
S D +AFGVLL E+L G+ P
Sbjct: 177 PYGKS-VDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 394 AELLGRGSIGTTY---KAVLDNHLIVTVKRFDANKTADTSAE--AFEQHMEAVGGLSHPN 448
+LLG+G+ G Y A L V +FD ++ +TS E A E ++ + L H
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDP-ESPETSKEVNALECEIQLLKNLLHER 65
Query: 449 LVPIRAYFQAKGERL--VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
+V + ER + ++ P GS+ + + ++ K + +G++
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-----KYTRQILEGVS 120
Query: 507 YIHRASWLIHGNLKSSNVL--------LGADFEA--RLTDYCLSVLSDSSSVEDPDTVAY 556
Y+H ++ ++H ++K +N+L LG DF A RL CLS S P +
Sbjct: 121 YLH-SNMIVHRDIKGANILRDSVGNVKLG-DFGASKRLQTICLSGTGMKSVTGTP---YW 175
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+PE+ S K+D+++ G ++E+LT K P
Sbjct: 176 MSPEV-ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-06
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 35/176 (19%)
Query: 434 FEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAK-----P 488
F + L HPN+V + +A L ++F + G R++R
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLF--------AVFEYVPG-RTLREVLAADGA 75
Query: 489 LHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDS 545
L ++ V LA H ++H +LK N+++ G A++ D+ + L
Sbjct: 76 LPAGETGRLMLQVLDALACAHNQG-IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-- 132
Query: 546 SSVEDPD------------TVAYKAPE-IRKSSRRATSKSDVYAFGVLLLELLTGK 588
V D D T Y APE +R T SD+YA+G++ LE LTG+
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP--VTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 32/84 (38%), Positives = 51/84 (60%), Gaps = 10/84 (11%)
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP------DTVAYKAPEIRKSSRR 567
+IH ++KS+N+LL ++ +L D+ S + +++V D T Y APEI + R+
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGTPYYVAPEIWR--RK 220
Query: 568 ATSK-SDVYAFGVLLLELLTGKHP 590
SK +D+++ GVLL ELLT K P
Sbjct: 221 PYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVK--RFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
E LG G+ T YK IV +K DA + ++A + + + L H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI---REISLMKELKHENIVR 62
Query: 452 IRAYFQAKGERLVIYDYQPNG-SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ + + +++++Y + HG R L + + +G+A+ H
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGIAFCHE 118
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLS------VLSDSSSVEDPDTVAYKAPEIRKS 564
L H +LK N+L+ E +L D+ L+ V + S+ V T+ Y+AP++
Sbjct: 119 NRVL-HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLG 174
Query: 565 SRRATSKSDVYAFGVLLLELLTGK 588
SR ++ D+++ G ++ E++TG+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 397 LGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
LG G+ G+ K V + V VK A E F + + L HP +V +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE-FLREASVMAQLDHPCIVRL 61
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ + LV+ + P G L + R I L ++A VA G+AY+ +
Sbjct: 62 IGVCKGEPLMLVM-ELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-SK 114
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK------APE---IRK 563
+H +L + NVLL +A+++D+ +S + S T A + APE K
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 564 SSRRATSKSDVYAFGVLLLELLT-GKHP 590
S SKSDV+++GV L E + G P
Sbjct: 175 FS----SKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 35/213 (16%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+LG+G+ G Y A L + + +K + + + + L H N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAK--PL--HWTSCLKIAEDVAQGLAYIHR 510
G + + P GSL L+ R+K PL + + + + + +GL Y+H
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 511 ASWLIHGNLKSSNVLLG--------ADF--EARLT--DYCLSVLSDSSSVEDPDTVAYKA 558
++H ++K NVL+ +DF RL + C + T+ Y A
Sbjct: 127 NQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG--------TLQYMA 177
Query: 559 PE-IRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
PE I K R + +D+++ G ++E+ TGK P
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG GS T YK N +V +K + T A + + GL H N+V +
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIRE-ASLLKGLKHANIVLLH 69
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGS--RSIRAKP--LHWTSCLKIAEDVAQGLAYIH 509
K ++++Y +H + + P LH + + +GL+YIH
Sbjct: 70 DIIHTKETLTLVFEY---------VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCL----SVLSDSSSVEDPDTVAYKAPEIRKSS 565
+ +++H +LK N+L+ E +L D+ L SV S + S E T+ Y+ P++ S
Sbjct: 121 Q-RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE-VVTLWYRPPDVLLGS 178
Query: 566 RRATSKSDVYAFGVLLLELLTG 587
++ D++ G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 45/155 (29%), Positives = 66/155 (42%), Gaps = 20/155 (12%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
L HP LV + FQ + + DY G LF + R + A +VA
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-----YAAEVAS 107
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA-------Y 556
+ Y+H + +I+ +LK N+LL + LTD+ L VE +T + Y
Sbjct: 108 AIGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLC----KEGVEPEETTSTFCGTPEY 162
Query: 557 KAPEI-RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
APE+ RK T D + G +L E+L G P
Sbjct: 163 LAPEVLRKEPYDRT--VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 49/276 (17%)
Query: 397 LGRGSIGTTYKAVLDNH-----------LIVTVKRFDANKTADTSAEAFEQHMEAVGGLS 445
LG+G+ YK VL + V +K ++ AF + + LS
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS---LAFFETASLMSQLS 59
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC-LKIAEDVAQG 504
H +LV + +V +Y G L +H R K L +A+ +A
Sbjct: 60 HKHLVKLYGVCVRDENIMVE-EYVKFGPLDVFLH-----REKNNVSLHWKLDVAKQLASA 113
Query: 505 LAYIHRASWLIHGNLKSSNVLL-------GADFEARLTD--YCLSVLSDSSSVEDPDTVA 555
L Y+ L+HGN+ N+L+ G +L+D ++VLS VE +A
Sbjct: 114 LHYLEDKK-LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIA 172
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR 614
+ IR T +D ++FG LLE+ + G+ P L+ + + +
Sbjct: 173 PEC--IRNGQASLTIAADKWSFGTTLLEICSNGEEPLST--LSSSEKERFYQD------- 221
Query: 615 EENRLGM-----LTEVASVCSLKSPEQRPAMWQVLK 645
++RL M L + + C P +RP+ +L+
Sbjct: 222 -QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 395 ELLGRGSIGTTYKAV--LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E LG GS T YK + ++ L V +K A + + GL H N+V +
Sbjct: 11 EKLGEGSYATVYKGISRINGQL-VALKVISMKTEEGVPFTAIRE-ASLLKGLKHANIVLL 68
Query: 453 RAYFQAKGERLVIYDY-QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
K +++Y + + + + H LH + + +GLAYIH
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQH------PGGLHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCL----SVLSDSSSVEDPDTVAYKAPEIRKSSRR 567
++H +LK N+L+ E +L D+ L S+ S + S E T+ Y+ P++ +
Sbjct: 123 H-ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180
Query: 568 ATSKSDVYAFGVLLLELLTGK 588
+S D++ G + +E+L G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 36/148 (24%), Positives = 70/148 (47%), Gaps = 10/148 (6%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
HP L ++ FQ K + +Y G LF H SR + ++ L
Sbjct: 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELF--FHLSRE---RVFSEDRTRFYGAEIVSAL 108
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED-PDTVAYKAPEIR 562
Y+H +++ +LK N++L D ++TD+ C ++D+++++ T Y APE+
Sbjct: 109 DYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ + + D + GV++ E++ G+ P
Sbjct: 168 EDNDYGRA-VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
H N+V + + E V+ ++ G+L +++ +R + T CL V + L
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLS----VLRAL 131
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTD--YCLSVLSDSSSVEDPD------TVAYK 557
+Y+H +IH ++KS ++LL +D +L+D +C V S E P T +
Sbjct: 132 SYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQV-----SKEVPKRKSLVGTPYWM 185
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617
APE+ T + D+++ G++++E++ G + PY P + + MR
Sbjct: 186 APEVISRLPYGT-EVDIWSLGIMVIEMIDG----EPPYFNEPPL----QAMRRIRDNLPP 236
Query: 618 RLGMLTEVASVCS-------LKSPEQRPAMWQVLK 645
R+ +V+SV ++ P QR ++L+
Sbjct: 237 RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 4/97 (4%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVED-PDTVA 555
A + GL ++H+ +++ +LK NVLL R++D L+V L ++ T
Sbjct: 101 AAQIICGLEHLHQRR-IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ 592
Y APE+ + D +A G L E++ G+ P +
Sbjct: 160 YMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 395 ELLGRGSIGTT----YKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN-- 448
+++GRG+ G +K+ + + + +F+ K +D++ E+ + A H N
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-----HANSE 103
Query: 449 -LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+V + FQ ++ +Y P G L NL+ + I P W AE V L
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDI---PEKWAR-FYTAE-VVLALDA 157
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSD-----SSSVEDPDTVAYKAPE 560
IH IH ++K N+LL +L D+ C+ + ++ ++V PD Y +PE
Sbjct: 158 IHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD---YISPE 213
Query: 561 IRKSSRRAT---SKSDVYAFGVLLLELLTGKHP 590
+ KS + D ++ GV L E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 46/158 (29%), Positives = 68/158 (43%), Gaps = 26/158 (16%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAED 500
+ HP LV + FQ + + DY G LF + RS RA+ A +
Sbjct: 53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAE 104
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA----- 555
+A L Y+H + +I+ +LK N+LL + LTD+ L +E T +
Sbjct: 105 IASALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLC----KEGIEHSKTTSTFCGT 159
Query: 556 --YKAPE-IRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APE +RK T D + G +L E+L G P
Sbjct: 160 PEYLAPEVLRKQPYDRT--VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 56/270 (20%), Positives = 110/270 (40%), Gaps = 43/270 (15%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
+G G+ G YKA ++ + +K D +Q + + H N+V
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF--AVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 456 FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515
+ + + + ++ GSL ++ H + PL + ++ + QGL Y+H +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG-KM 128
Query: 516 HGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEIRKSSRRA--TS 570
H ++K +N+LL + +L D+ +S ++ + T + APE+ R+
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188
Query: 571 KSDVYAFGVLLLELLTGKHP--SQHPYLA----------PP---DMLEWVRTMRVDDGRE 615
D++A G+ +EL + P HP A PP D ++W
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW----------- 237
Query: 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
N ++A K+P++RP ++L+
Sbjct: 238 SNSFHHFVKMALT---KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 38/274 (13%)
Query: 395 ELLGRGSIGTTYKAVLD--NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
E +G+G+ G +K VL+ N VK D D EA ++A+ HPN+V
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DHPNVVKF 80
Query: 453 RAYFQAK----GERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+ K G++L ++ + GS+ +L+ G R + + I + GL +
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQH 139
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKS 564
+H IH ++K +N+LL + +L D+ +S S+ + +V + APE+
Sbjct: 140 LHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 565 SRRATS----KSDVYAFGVLLLELLTGKHP--SQHPYLA-------PPDMLEWVRTMRVD 611
++ S + DV++ G+ +EL G P HP A PP L +
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNE 258
Query: 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
+ C K E+RP + +L+
Sbjct: 259 ----------FNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 29/193 (15%)
Query: 416 VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLF 475
VTV+R + + + + +HPN+VP RA F A E V+ + GS
Sbjct: 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87
Query: 476 NLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533
+LI H + + + I + V + L YIH + +H ++K+S++L+ D +
Sbjct: 88 DLICTHFMDGMSELAIAY-----ILQGVLKALDYIHHMGY-VHRSVKASHILISVDGKV- 140
Query: 534 LTDYCLSVLSDSSS----------VEDPDTVAYK-----APEIRKSSRRA-TSKSDVYAF 577
LS L + S V D + K +PE+ + + + +KSD+Y+
Sbjct: 141 ----YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 578 GVLLLELLTGKHP 590
G+ EL G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL---SVLSDSSSVEDPDTV 554
A ++A GL ++H +I+ +LK NV+L A+ ++ D+ + ++ ++ T
Sbjct: 107 AAEIAIGLFFLHSKG-IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP 165
Query: 555 AYKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
Y APEI + + KS D +AFGVLL E+L G+ P
Sbjct: 166 DYIAPEI--IAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 397 LGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEAFE----QHMEAVGGLSHPNLV 450
+G G+ G YKA D +V +K+ D E F + ++ + L+H N+V
Sbjct: 15 IGEGTYGQVYKAR-DKDTGELVALKKV----RLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 451 PIRA----------YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAED 500
++ + + KG ++++Y + L L+ S + H S +K
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLE-SGLVHFSEDHIKSFMK---Q 124
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VEDPDTVAY 556
+ +GL Y H+ ++L H ++K SN+LL + +L D+ L+ L +S T+ Y
Sbjct: 125 LLEGLNYCHKKNFL-HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
+ PE+ R DV++ G +L EL T K
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 496 KIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDS-SSVEDPDT 553
K+ + + L Y+ +IH ++K SN+LL A +L D+ +S L DS +
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 554 VAYKAPEIRKSSRRATSK----SDVYAFGVLLLELLTGKHP 590
AY APE R K +DV++ G+ L+EL TG+ P
Sbjct: 178 AAYMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 416 VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLV--IYDYQPNGS 473
V VK + A+ ++ +E + L H N+V + G + I ++ P+GS
Sbjct: 36 VAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94
Query: 474 LFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEA 532
L L I K K A + +G+ Y+ + +H +L + NVL+ ++ +
Sbjct: 95 LKEYLPRNKNKINLKQQL-----KYAVQICKGMDYLGSRQY-VHRDLAARNVLVESEHQV 148
Query: 533 RLTDYCL--SVLSDS---SSVEDPDT-VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586
++ D+ L ++ +D + +D D+ V + APE S+ + SDV++FGV L ELLT
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 59/269 (21%), Positives = 118/269 (43%), Gaps = 32/269 (11%)
Query: 395 ELLGRGSIGTTYKA----VLDNHLI----VTVKRFDANKTADTSAEAFEQHMEAVGGLSH 446
E LG+G+ +K V D + V +K D K+ +E+F + + LSH
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD--KSHRNYSESFFEAASMMSQLSH 58
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
+LV E +++ +Y GSL + +++ + W L++A+ +A L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWK--LEVAKQLAWALH 114
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD---SSSVEDPDT----VAYKAP 559
++ L HGN+ + NVLL + + + + LSD S +V + + + P
Sbjct: 115 FLEDKG-LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619
E ++ + + +D ++FG L E+ +G P L+ + ++ + R +
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGD-------KPLSALDSQKKLQFYEDRHQLPA 226
Query: 620 GMLTEVASV---CSLKSPEQRPAMWQVLK 645
TE+A++ C P+ RP+ +++
Sbjct: 227 PKWTELANLINQCMDYEPDFRPSFRAIIR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 24/250 (9%)
Query: 414 LIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472
+ V VK + T D S E M + G H N++ + G V+ +Y G
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 473 SLFNLIHGSR-----------SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKS 521
+L + R + + L + + A VA+G+ Y+ IH +L +
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-CIHRDLAA 162
Query: 522 SNVLLGADFEARLTDYCLSVLSDSSSVEDPDT-----VAYKAPEIRKSSRRATSKSDVYA 576
NVL+ D ++ D+ L+ + T V + APE R T +SDV++
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWS 221
Query: 577 FGVLLLELLTGKHPSQHPYLAPPDMLEWVRT-MRVDDGREENRLGMLTEVASVCSLKSPE 635
FGVLL E+ T S +P + ++ + ++ R+D + N L + C P
Sbjct: 222 FGVLLWEIFT-LGGSPYPGIPVEELFKLLKEGHRMD--KPANCTHELYMIMRECWHAVPS 278
Query: 636 QRPAMWQVLK 645
QRP Q+++
Sbjct: 279 QRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 42/278 (15%)
Query: 395 ELLGRGSIGTTYKAVL-------------DNHLIVTVKRFDANKTADTSAEAFE--QHME 439
E LGRG+ Y +L + + V +K D + D S FE M
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMR 59
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAE 499
V SH ++V + E +++ ++ G L +H + P W K+A+
Sbjct: 60 QV---SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP--WK--FKVAK 112
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEA----RLTD--YCLSVLSDSSSVED 550
+A L+Y+ L+HGN+ + N+LL G D E +L+D ++VLS VE
Sbjct: 113 QLASALSYLEDKD-LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE- 170
Query: 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLEL-LTGKHPSQHPYLAPPDMLEWVRTMR 609
+ + APE + S+ + +D ++FG L E+ G+ P + LA + + M
Sbjct: 171 --RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML 228
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647
V +E L ++ + C P QRP +++ I
Sbjct: 229 VTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
HP L ++ FQ + +Y G LF H SR + ++ L
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRE---RVFSEDRARFYGAEIVSAL 108
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED-PDTVAYKAPEIR 562
Y+H +++ +LK N++L D ++TD+ C + D ++++ T Y APE+
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 168
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP---SQHPYLAPPDMLEWVRTMRVDDGREENRL 619
+ + + D + GV++ E++ G+ P H L ++E +R R ++ L
Sbjct: 169 EDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLL 227
Query: 620 GMLTEVASVCSLKSPEQR 637
L + K P+QR
Sbjct: 228 SGLLK-------KDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 394 AELLGRGSIGTTY---KAVLDNHLIVTVKRFDANKTADTSAE--AFEQHMEAVGGLSHPN 448
+LLGRG+ G Y A L V FD + + +TS E A E ++ + L H
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD-SQETSKEVNALECEIQLLKNLRHDR 65
Query: 449 LVPIRAYFQAKGER-LVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
+V + E+ L I+ +Y P GS+ + + ++ + + QG++
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-----RYTRQILQGVS 120
Query: 507 YIHRASWLIHGNLKSSNVL--------LGADFEA--RLTDYCLSVLSDSSSVEDPDTVAY 556
Y+H ++ ++H ++K +N+L LG DF A R+ C+S S P +
Sbjct: 121 YLH-SNMIVHRDIKGANILRDSAGNVKLG-DFGASKRIQTICMSGTGIKSVTGTP---YW 175
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+PE+ S K+DV++ ++E+LT K P
Sbjct: 176 MSPEV-ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 65/304 (21%), Positives = 107/304 (35%), Gaps = 94/304 (30%)
Query: 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+G G G Y+ V + + V VK T+ + E F Q + HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 451 ---------PI------------RAYFQAKGER-----LVIYDYQPNGSLFNLIHGSRSI 484
P+ R+Y Q L++Y YQ
Sbjct: 71 KLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ--------------- 115
Query: 485 RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544
++ LAY+ +H ++ + NVL+ + +L D+ LS +
Sbjct: 116 ----------------LSTALAYLESKR-FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
Query: 545 SSSVEDPDTVA----YKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPP 599
S + APE + RR TS SDV+ FGV + E+L G P Q
Sbjct: 159 DESYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ------- 210
Query: 600 DMLEWVRT----MRVDDGREENRLGM-------LTEVASVCSLKSPEQRPAMWQVLKMIQ 648
V+ R+++G RL M L + + C P +RP ++ +
Sbjct: 211 ----GVKNNDVIGRIENG---ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
Query: 649 EIKE 652
+I +
Sbjct: 264 DILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 3/98 (3%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVAY 556
A ++ GL ++H ++++ +LK +N+LL R++D L+ S T Y
Sbjct: 103 ATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGY 161
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP-SQH 593
APE+ + S +D ++ G +L +LL G P QH
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 29/248 (11%)
Query: 416 VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLF 475
V VK + + + F + + L H NL+ L++ ++ P G L
Sbjct: 25 VVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 476 NLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLT 535
+ R T+ ++A ++A GL ++H+ ++ IH +L N LL AD ++
Sbjct: 84 GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF-IHSDLALRNCLLTADLTVKIG 142
Query: 536 DYCLS---------VLSDSSSVEDPDTVAYKAPEIRKSSR------RATSKSDVYAFGVL 580
DY LS V D V + + APE+ T +S+V++ GV
Sbjct: 143 DYGLSHNKYKEDYYVTPDQLWV----PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198
Query: 581 LLELLT-GKHPSQHPYLAPPDMLEWV---RTMRVDDGREENRLG-MLTEVASVCSLKSPE 635
+ EL G P + +L+ +L + + +++ R + L EV C L+ PE
Sbjct: 199 IWELFELGSQP--YRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PE 255
Query: 636 QRPAMWQV 643
QRP+ +V
Sbjct: 256 QRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 45/200 (22%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVK--RFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
E +G G+ G YKA +V +K R D S E + + L+HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE--ISLLKELNHPNIVK 63
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ + + +++++ + L + S + PL + QGLA+ H +
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDAS-PLSGIPLPLIK--SYLFQLLQGLAFCH-S 118
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSV---LSDSSSVEDPDTVAYKAPEIRKSSRRA 568
++H +LK N+L+ + +L D+ L+ + + + T+ Y+APEI +
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 569 TSKSDVYAFGVLLLELLTGK 588
++ D+++ G + E++T +
Sbjct: 179 STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 1e-04
Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS------VLSDSSSVEDPDTVAY 556
+GLAY H ++H +LK N+L+ D +L D+ L+ + + + V T+ Y
Sbjct: 109 RGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWY 164
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
+APEI S+ ++ D+++ G + E++TGK
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 59/269 (21%), Positives = 106/269 (39%), Gaps = 43/269 (15%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
+G G+ G YKA L + VK D S +Q + V H N+V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFGS 74
Query: 456 FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515
+ ++ + + +Y GSL ++ H + PL + + QGLAY+H +
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKGKM- 128
Query: 516 HGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEIRKSSRRA--TS 570
H ++K +N+LL + + +L D+ ++ ++ + T + APE+ +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 571 KSDVYAFGVLLLELLTGKHP--SQHPYLA----------PP---DMLEWVRTMRVDDGRE 615
D++A G+ +EL + P HP A PP D +W T
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH------ 242
Query: 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVL 644
+ K+P++RP ++L
Sbjct: 243 --------NFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 30/256 (11%)
Query: 416 VTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474
V VK ++ T D S E M + G H N++ + G VI +Y G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 475 FNLIHGSR-----------SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSN 523
+ R + + L + + A VA+G+ Y+ IH +L + N
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-CIHRDLAARN 170
Query: 524 VLLGADFEARLTDYCLS-------VLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYA 576
VL+ D ++ D+ L+ +++ P V + APE R T +SDV++
Sbjct: 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEAL-FDRIYTHQSDVWS 227
Query: 577 FGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT-MRVDDGREENRLGMLTEVASVCSLKSP 634
FGVLL E+ T G P +P + ++ + ++ R+D + N L + C P
Sbjct: 228 FGVLLWEIFTLGGSP--YPGVPVEELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVP 283
Query: 635 EQRPAMWQVLKMIQEI 650
QRP Q+++ + I
Sbjct: 284 SQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 45/179 (25%)
Query: 447 PNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAK--PLHWTSCLKIAEDVAQ 503
P +V + FQ + E L ++ +Y P G L NL+ IR P IAE V
Sbjct: 61 PWIVKLYYSFQDE-EHLYLVMEYMPGGDLMNLL-----IRKDVFPEETARFY-IAELVL- 112
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-----------VLSDSSSVEDPD 552
L +H+ + IH ++K N+L+ AD +L D+ L L+DS ++ D
Sbjct: 113 ALDSVHKLGF-IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 553 ---------------------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
T Y APE+ + + D ++ GV+L E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 22/156 (14%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAED 500
+ HP LV + FQ + + D+ G LF + RS RA+ AE
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRAR-------FYAAE- 104
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV-----A 555
+A L Y+H + +++ +LK N+LL + LTD+ L + + D T
Sbjct: 105 IASALGYLHSIN-IVYRDLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPE 161
Query: 556 YKAPE-IRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APE IRK T D + G +L E+L G P
Sbjct: 162 YLAPEVIRKQPYDNT--VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 8/93 (8%)
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDS-SSVEDPDTVA---Y 556
+ L YIH A+ + H +LK N+L AD + ++ D+ L+ +D+ +++ D VA Y
Sbjct: 114 RALKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 557 KAPEIRKS-SRRATSKSDVYAFGVLLLELLTGK 588
+APE+ S + T D+++ G + E+LTGK
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 8/93 (8%)
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSSS------VEDPDTVA 555
+GL YIH A+ ++H +LK +NV + D ++ D+ L+ + D E T
Sbjct: 125 RGLKYIHSAN-VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
Y++P + S T D++A G + E+LTGK
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDAN---KTADTSAEAFEQHMEAVGGLSHPNLV 450
+LG+GS G A L ++ + VK + + D E+ + ++ +HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFLT 59
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ FQ + ++ G L I SR + AE + L ++H
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAAE-ITSALMFLHD 114
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSD----SSSVEDPDTVAYKAPEIRKS 564
+I+ +LK NVLL + +L D+ C + + S+ PD Y APEI +
Sbjct: 115 KG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD---YIAPEILQE 170
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP 590
S D +A GVLL E+L G P
Sbjct: 171 MLYGPS-VDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 39/156 (25%), Positives = 63/156 (40%), Gaps = 25/156 (16%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
LSHP +V + FQ + + ++ G LF H + DVA+
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT-------------HLRKAGRFPNDVAK 121
Query: 504 --------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA 555
Y+H +I+ +LK N+LL ++TD+ + + T
Sbjct: 122 FYHAELVLAFEYLHSKD-IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE 180
Query: 556 YKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
Y APE+ +S + K+ D + GVLL E + G P
Sbjct: 181 YLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSA---EAFEQHMEA-----VGGLSH 446
+++G+GS G K +L H ++F A K A + E+H+ + + + H
Sbjct: 1 KVIGKGSFG---KVLLARHK--AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAEDVAQ 503
P LV + FQ + + DY G LF + R RA+ A ++A
Sbjct: 56 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR--------FYAAEIAS 107
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL---SVLSDSSSVEDPDTVAYKAPE 560
L Y+H + +++ +LK N+LL + LTD+ L ++ + ++ T Y APE
Sbjct: 108 ALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166
Query: 561 I--RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ ++ R D + G +L E+L G P
Sbjct: 167 VLHKQPYDRTV---DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 57/260 (21%), Positives = 113/260 (43%), Gaps = 29/260 (11%)
Query: 397 LGRGSIGTTYKAVLDNH-LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY 455
+G GS G A + + +V VK+ D K E + + H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 456 FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515
+ E V+ ++ G+L +++ +R + CL V + L+ +H A +I
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--AVCLA----VLKALSVLH-AQGVI 138
Query: 516 HGNLKSSNVLLGADFEARLTD--YCLSVLSDSSSVED-PDTVAYKAPEIRKSSRRATSKS 572
H ++KS ++LL D +L+D +C V + + T + APE+ S +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL-ISRLPYGPEV 197
Query: 573 DVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS-- 630
D+++ G++++E++ G + PY P + + M++ +L L +V+
Sbjct: 198 DIWSLGIMVIEMVDG----EPPYFNEPPL----KAMKMIRDNLPPKLKNLHKVSPSLKGF 249
Query: 631 -----LKSPEQRPAMWQVLK 645
++ P QR ++LK
Sbjct: 250 LDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 16/200 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
L+G GS G K + IV +K+F ++ + + + + L H NLV +
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 454 AYFQAKGERLVIYDYQPNGSLFNL---IHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
F+ K +++++ + L +L +G R + + + +G+ + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHS 118
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKSSRR 567
+ +IH ++K N+L+ +L D+ + + D VA Y+APE+ +
Sbjct: 119 HN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 568 ATSKSDVYAFGVLLLELLTG 587
D++A G L+ E+LTG
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLH-WTSCLKIAEDVAQGL 505
PN+V + Y ++ ++ + G L++ I +I + + W + + +A D
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSS 565
+HR + +L +N+LL +LT + + S + Y APE+ S
Sbjct: 101 --LHREGIVCR-DLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGIS 157
Query: 566 RRATSKSDVYAFGVLLLELLTGK-----HPS---QHPYLAPPDML 602
T D ++ G +L ELLTGK HPS H L P+ +
Sbjct: 158 EE-TEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 39.0 bits (92), Expect = 2e-04
Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLS 141
L L L NN +T +P LS+L NL++L LS N + PLS
Sbjct: 2 NLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKITDLSPLS 42
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDP-DTVA 555
A ++ GL +HR +++ +LK N+LL R++D L+V + + ++ TV
Sbjct: 108 AAEITCGLEDLHRER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ 592
Y APE+ K+ R S D + G L+ E++ GK P +
Sbjct: 167 YMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 47/175 (26%), Positives = 87/175 (49%), Gaps = 24/175 (13%)
Query: 488 PLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDS 545
PL L+ + VAQG+ ++ + IH ++ + NVLL A++ D+ L+ +++DS
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL-ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 546 SSVEDPDT---VAYKAPE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPD 600
+ V + V + APE I T +SDV+++G+LL E+ + GK P P
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFSLGKSPY-------PG 317
Query: 601 MLEWVRTMR-VDDGREENR-----LGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649
+L + + V G + +R + + + +L+ P +RP Q+ ++IQ
Sbjct: 318 ILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLE-PTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 43/209 (20%), Positives = 91/209 (43%), Gaps = 34/209 (16%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
++G G+ G K + IV +K+F ++ + E + ++ + L N+V ++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 455 YFQAKGERLVIYDY-----------QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
F+ +G+ ++++Y PNG + K +HW C K
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW--CHK------- 118
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYC----LSVLSDSSSVEDPDTVAYKAP 559
+ ++H ++K N+L+ + +L D+ LS S+++ E T Y++P
Sbjct: 119 --------NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGK 588
E+ + + D+++ G +L EL G+
Sbjct: 171 ELLLGAPYGKA-VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 59/254 (23%), Positives = 106/254 (41%), Gaps = 26/254 (10%)
Query: 416 VTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474
V VK + T D S E M + G H N++ + G VI +Y G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNL 108
Query: 475 FNLIHGSR-----------SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSN 523
+ R + + + + + VA+G+ Y+ + IH +L + N
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL-ASQKCIHRDLAARN 167
Query: 524 VLLGADFEARLTDYCLSVLSDSSSVEDPDT-----VAYKAPEIRKSSRRATSKSDVYAFG 578
VL+ + ++ D+ L+ ++ T V + APE R T +SDV++FG
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFG 226
Query: 579 VLLLELLT-GKHPSQHPYLAPPDMLEWVRT-MRVDDGREENRLGMLTEVASVCSLKSPEQ 636
VL+ E+ T G P +P + ++ + ++ R+D + N L + C P
Sbjct: 227 VLMWEIFTLGGSP--YPGIPVEELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAIPSH 282
Query: 637 RPAMWQVLKMIQEI 650
RP Q+++ + I
Sbjct: 283 RPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 47/205 (22%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 397 LGRGSIGTTYKA---VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ T YK + DN + + R + + A +A + + + L H N+V +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI---REVSLLKDLKHANIVTLH 70
Query: 454 AYFQAKGERLVIYDY------QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+ ++++Y Q N I+ +H + +GL Y
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSIN---------MHNVKLFLF--QLLRGLNY 119
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCL----SVLSDSSSVEDPDTVAYKAPEIRK 563
HR ++H +LK N+L+ E +L D+ L S+ + + S E T+ Y+ P+I
Sbjct: 120 CHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL 177
Query: 564 SSRRATSKSDVYAFGVLLLELLTGK 588
S +++ D++ G + E+ TG+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 50/209 (23%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 397 LGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ GT K + + V VK + + + + L +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+A+ LV+ + G L + ++ + K + ++ V+ G+ Y+ ++
Sbjct: 63 GICEAESWMLVM-ELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEETNF 116
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDT-----VAYKAPEIRKSSRR 567
+H +L + NVLL A+++D+ LS L + T V + APE + +
Sbjct: 117 -VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYK 174
Query: 568 ATSKSDVYAFGVLLLELLTGKHPSQHPYL 596
+SKSDV++FGVL+ E + Q PY
Sbjct: 175 FSSKSDVWSFGVLMWEAFS---YGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 2/96 (2%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVAY 556
A ++ GL ++H ++++ +LK +N+LL R++D L+ S T Y
Sbjct: 103 AAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGY 161
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ 592
APE+ + S +D ++ G +L +LL G P +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 11/99 (11%)
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED----P 551
A +++ GL ++HR +I+ +LK NV+L ++ ++ D+ C + D + P
Sbjct: 107 AAEISVGLFFLHRRG-IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTP 165
Query: 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
D Y APEI S D +A+GVLL E+L G+ P
Sbjct: 166 D---YIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSL-FNLIH-GSRSIR-AKPLHWTSCLKIAED 500
++ P +V + F++K ++ G L +++ + G R + + +H+++
Sbjct: 50 VNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA------Q 103
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSV-EDPDTVAYKA 558
+ G+ ++H +++ ++K NVLL RL+D L+V L D ++ + T Y A
Sbjct: 104 ITCGILHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMA 162
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618
PEI K + D +A G + E++ G+ P + + E R D+ + E++
Sbjct: 163 PEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDEVKFEHQ 220
Query: 619 LGMLTEVASVCSL---KSPEQR 637
E +C L K PE R
Sbjct: 221 -NFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 44/204 (21%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
++G GS G Y+A+ +D V +K+ + + + + + L+H N++ ++
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKD 126
Query: 455 YFQAKGERL--------VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
Y+ + + V+ ++ P + H +R+ A PL + + + LA
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLY--SYQLCRALA 184
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEA-RLTDY--CLSVLSDSSSVEDPDTVAYKAPEIRK 563
YIH + ++ H +LK N+L+ + +L D+ ++L+ SV + Y+APE+
Sbjct: 185 YIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243
Query: 564 SSRRATSKSDVYAFGVLLLELLTG 587
+ T+ D+++ G ++ E++ G
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 38/126 (30%), Positives = 57/126 (45%), Gaps = 4/126 (3%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
++L+ L L L L NN L + +L NL++L LS N S S+ SL L L
Sbjct: 225 LSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLREL 282
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPET 211
DLS N+L+ +P L AL L L + L +++ N +N PE
Sbjct: 283 DLSGNSLSNALP--LIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEA 340
Query: 212 PTLLKF 217
++L+
Sbjct: 341 LSILES 346
|
Length = 394 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 26/190 (13%)
Query: 414 LIVTVK--RFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471
++V VK R DANK A F + ++ + L PN++ + A +I +Y N
Sbjct: 47 VLVAVKMLREDANKNARND---FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 472 GSLFNLI------HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVL 525
G L + + + +++ + +A +A G+ Y+ ++ +H +L + N L
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF-VHRDLATRNCL 162
Query: 526 LGADFEARLTDYCLS---VLSDSSSVEDPDTVAYKAPEIRKSSRRA------TSKSDVYA 576
+G ++ ++ D+ +S D ++ + IR S + T+ SDV+A
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP-----IRWMSWESILLGKFTTASDVWA 217
Query: 577 FGVLLLELLT 586
FGV L E+LT
Sbjct: 218 FGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++GRG+ G + + + + + +++ K A+T+ E+++ G +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW--IT 64
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ------- 503
+ FQ + ++ DY G L L+ ++ ED+A+
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED------------RLPEDMARFYIAEMV 112
Query: 504 -GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSD-----SSSVEDPDTVA 555
+ IH+ + +H ++K NVLL + RL D+ CL + D S +V PD
Sbjct: 113 LAIHSIHQLHY-VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD--- 168
Query: 556 YKAPEIRKSSRRATSK----SDVYAFGVLLLELLTGKHP 590
Y +PEI ++ K D ++ GV + E+L G+ P
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 36/265 (13%)
Query: 414 LIVTVK--RFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471
L+V VK R DANK A F + ++ + L PN++ + + +I +Y N
Sbjct: 47 LLVAVKILRPDANKNARND---FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 472 GSLFNLIHGSRSIRAKP---------------LHWTSCLKIAEDVAQGLAYIHRASWLIH 516
G L N S + K + ++S L +A +A G+ Y+ ++ +H
Sbjct: 104 GDL-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF-VH 161
Query: 517 GNLKSSNVLLGADFEARLTDYCLS---VLSDSSSVEDPDT--VAYKAPEIRKSSRRATSK 571
+L + N L+G + ++ D+ +S D ++ + + A E + T+
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTA 220
Query: 572 SDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM-------LTE 624
SDV+AFGV L E+L + L ++E D GR+ L L E
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV-YLFRPPPCPQGLYE 279
Query: 625 VASVCSLKSPEQRPAMWQVLKMIQE 649
+ C + +RP+ + + E
Sbjct: 280 LMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 23/225 (10%)
Query: 431 AEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLH 490
A AF + + +SH +L + E +++ ++ +G L + + P+
Sbjct: 60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVA 117
Query: 491 WTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL-------GADFEARLTD--YCLSV 541
W + +A+ +A L+Y+ + L+HGN+ + N+LL G +L+D +
Sbjct: 118 WK--ITVAQQLASALSYLEDKN-LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174
Query: 542 LSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLEL-LTGKHPSQHPYLAPPD 600
LS VE + + APE ++ +D ++FG LLE+ G+ P + P
Sbjct: 175 LSREERVE---RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER--TPS- 228
Query: 601 MLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
E R E L + S C P QRP+ +L+
Sbjct: 229 --EKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 30/86 (34%), Positives = 49/86 (56%), Gaps = 6/86 (6%)
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPD----TVAYKAPEIRKSSRRA 568
++H +LKS+N+ L +L D+ S SDS S++ T Y APE+ + +R
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRY 248
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHP 594
+ K+D+++ GV+L ELLT P + P
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGP 274
|
Length = 478 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 483 SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542
+ R++PL L I + + +GL Y+H A +IH ++K+ N+ + + C+ L
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKTENIFIND-----VDQVCIGDL 201
Query: 543 SDSS-SVEDPD------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELL 585
+ V P TV APE+ + SK+D+++ G++L E+L
Sbjct: 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 20/198 (10%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
HP L ++ FQ + +Y G LF H SR + ++ L
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRE---RVFTEERARFYGAEIVSAL 108
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED-PDTVAYKAPEIR 562
Y+H +++ ++K N++L D ++TD+ C +SD ++++ T Y APE+
Sbjct: 109 EYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP---SQHPYLAPPDMLEWVRTMRVDDGREENRL 619
+ + + D + GV++ E++ G+ P H L ++E +R R ++ L
Sbjct: 168 EDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 226
Query: 620 GMLTEVASVCSLKSPEQR 637
L + K P+QR
Sbjct: 227 AGLLK-------KDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 397 LGRGSIG----TTYKAVLDNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVP 451
LG GS G TYK ++ V +KRF+ +K + + + ++HP V
Sbjct: 38 LGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA-----QGLA 506
+ F+ + ++ ++ G F + ++ C A+ V Q L
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND----VGCFYAAQIVLIFEYLQSLN 151
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSR 566
++R +LK N+LL D ++TD+ + + D+ + T Y APEI +
Sbjct: 152 IVYR-------DLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVG 204
Query: 567 RATSKSDVYAFGVLLLELLTGKHP--SQHPYLAPPDMLE 603
+ +D + G+ + E+L G P + P L +LE
Sbjct: 205 HGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE 242
|
Length = 340 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 29/207 (14%)
Query: 397 LGRGSIGTTYKAVLDNHLIVTV-KRFDANKTADTSAEAFEQHM----EAVGGLSHPNLVP 451
LG G G + + K +T ++H+ E + +HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG---QQEHIFSEKEILEECNHPFIVK 57
Query: 452 IRAYFQAKGERLVIY---DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
+ F+ ++ IY +Y G L+ ++ R +T+ IA V Y+
Sbjct: 58 LYRTFK---DKKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIAC-VVLAFEYL 109
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDY-CLSVLSDSSS----VEDPDTVAYKAPEIRK 563
H +I+ +LK N+LL ++ +L D+ L P+ Y APEI
Sbjct: 110 HNRG-IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE---YVAPEIIL 165
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHP 590
+ S D ++ G+LL ELLTG+ P
Sbjct: 166 NKGYDFS-VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 40/135 (29%), Positives = 57/135 (42%), Gaps = 2/135 (1%)
Query: 72 AQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSR 131
V R L P++L+RL L +LS S +L +L+ L SL L+
Sbjct: 43 ESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNL 102
Query: 132 NFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ 191
N +L L LT LDL NN+T + P+ L L L N+ PL
Sbjct: 103 NRLRS-NISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRN 161
Query: 192 -PFLVVFNVSGNNLT 205
P L ++S N+L+
Sbjct: 162 LPNLKNLDLSFNDLS 176
|
Length = 394 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 27/92 (29%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL----SVLSDSSSVEDPDTVAY 556
+ +GLAY HR ++H +LK N+L+ E +L D+ L SV + + S E T+ Y
Sbjct: 113 ILRGLAYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE-VVTLWY 170
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
+ P++ S +++ D++ G + E+ +G+
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 24/98 (24%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLG-------ADFE-AR-----LTDYCLSVLSDSSSVED 550
G+A++H +W++H +LK+SN+LL DF AR L Y V+
Sbjct: 118 GVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-------- 168
Query: 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
T+ Y+APE+ ++ ++ D+++ G + ELLT K
Sbjct: 169 --TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 21/105 (20%)
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSS-----SVE 549
+A D L Y+HR ++K NVLL + RL D+ CL +L+D + +V
Sbjct: 113 LAIDSVHQLGYVHR-------DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVG 165
Query: 550 DPDTVAYKAPEIRKSSRRATSK----SDVYAFGVLLLELLTGKHP 590
PD Y +PEI ++ + D ++ GV + E+L G+ P
Sbjct: 166 TPD---YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 44/152 (28%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 43 FKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLR---GTFPPNTLTRLD 99
+ K D + ++ + L E FDY + R++R+ + LR F P L +L
Sbjct: 566 YTKKWDQKKEVRWHLPEGFDYLP------PKLRLLRW--DKYPLRCMPSNFRPENLVKLQ 617
Query: 100 Q-----------------LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSI 142
LR + L + IPDLS NL++L LS P SI
Sbjct: 618 MQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSI 677
Query: 143 LSLHRLTILDLSY-NNLTGL-IPVNLTALDRL 172
L++L LD+S NL L +NL +L RL
Sbjct: 678 QYLNKLEDLDMSRCENLEILPTGINLKSLYRL 709
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 32/147 (21%), Positives = 55/147 (37%), Gaps = 33/147 (22%)
Query: 472 GSLFNLIHGSRSIRA--KPLH---------WTSCLKIAEDVAQGLAYIHRASWLIHGNLK 520
G L + G I P W L++A ++A A +H ++ G++
Sbjct: 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVV-GDVN 144
Query: 521 SSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV--------AYKAPEIRK----SSRRA 568
++ L+ D + L D SDS + T+ + PE++
Sbjct: 145 QNSFLVSDDSKVVLVD------SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFER 198
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPY 595
T+ D + VL+ LL G +HPY
Sbjct: 199 TANHDNFGLAVLIFHLLFG---GRHPY 222
|
Length = 637 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 27/90 (30%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL----SVLSDSSSVEDPDTVAYKA 558
+GL+Y H+ ++H +LK N+L+ E +L D+ L SV + + S E T+ Y+
Sbjct: 114 RGLSYCHKRK-ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRP 171
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
P++ S ++ D++ G +L E+ TG+
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 397 LGRGSIGTTY-----KAVLDNHLIV----TVKRFDANKTADTSAEAFEQHMEAVGGLSHP 447
LG+GS GT Y KAV + L V V + N+T + EA + + L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA-----QLLSKLDHP 62
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIH-----GSRSIRAKPLHWTSCLKIAEDVA 502
+V A F + +I +Y L + G + W L +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVEDPDTVAYKAP 559
G+ Y+H+ ++H +LK+ N+ L + ++ D+ +S L S + T Y +P
Sbjct: 118 -GVHYMHQRR-ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKH 589
E K + SKSD+++ G +L E+ H
Sbjct: 175 EALK-HQGYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 46/207 (22%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 397 LGRGSIGTTYKAV--LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
LG G+ G K V + I + N+ + + + E + L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+A+ LV+ + G L + G + + ++ +++ V+ G+ Y+ ++
Sbjct: 63 VCEAEALMLVM-EMASGGPLNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGKNF- 116
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDT-----VAYKAPEIRKSSRRA 568
+H +L + NVLL A+++D+ LS L S + + + APE + R+
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC-INFRKF 175
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPY 595
+S+SDV+++G+ + E + Q PY
Sbjct: 176 SSRSDVWSYGITMWEAFSY---GQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
++LG G+ GT YK + + V +K + + E ++ + + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY-VMASVDNPHV 71
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+ +L I P G L + + H L+W C++IA +G+ Y
Sbjct: 72 CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----KGMNY 124
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE---DPDTVAYKAPEIRKS 564
+ L+H +L + NVL+ ++TD+ L+ L + E + V K +
Sbjct: 125 LEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 565 SRRA-TSKSDVYAFGVLLLELLT-GKHP 590
R T +SDV+++GV + EL+T G P
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL----SVLSDSSSVEDPDTVAYKAP 559
GLAY H+ L H +LK N+L+ E +L D+ L SV S + S E T+ Y+ P
Sbjct: 115 GLAYCHQRRVL-HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPP 172
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTG 587
++ S ++ D++ G + E+ TG
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVED--PDTVAYK 557
+ GL ++H+ +I+ +LK NVLL D R++D L+V L D S T +
Sbjct: 106 IISGLEHLHQRR-IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
APE+ + S D +A GV L E++ + P
Sbjct: 165 APELLQGEEYDFS-VDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 23/87 (26%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA--YKAPEI 561
G+ ++H A +IH +LK SN+++ +D ++ D+ L+ + +S + P V Y+APE+
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGK 588
D+++ G ++ E++ G
Sbjct: 197 -ILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 2/63 (3%)
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208
L L L G IP +++ L L S+ L N G +PP + L V ++S N+ G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 209 PET 211
PE+
Sbjct: 483 PES 485
|
Length = 623 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRF---DANKTADTSAEAFEQHMEAVGGLSHPNLV 450
E +G G+ GT +KA + H IV +KR D ++ +SA + + + L H N+V
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL---REICLLKELKHKNIV 62
Query: 451 PIRAYFQAKGERLVIYDY--QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
+ + + ++++Y Q F+ S + +GLA+
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQDLKKYFD------SCNGDIDPEI-VKSFMFQLLKGLAFC 115
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLS------VLSDSSSVEDPDTVAYKAPEIR 562
H + L H +LK N+L+ + E +L D+ L+ V S+ V T+ Y+ P++
Sbjct: 116 HSHNVL-HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPPDVL 171
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP 590
++ ++ D+++ G + EL P
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 30/158 (18%)
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ-- 503
HP L ++ FQ + +Y G LF H + +ED A+
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELF-------------FHLSRERVFSEDRARFY 100
Query: 504 ------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED-PDTV 554
L Y+H +++ +LK N++L D ++TD+ C +SD ++++ T
Sbjct: 101 GAEIVSALGYLHSCD-VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 555 AYKAPEIRKSSR--RATSKSDVYAFGVLLLELLTGKHP 590
Y APE+ + + RA D + GV++ E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 22/198 (11%)
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLF-NLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
P +VP++ FQ+ + ++ + G LF +L R ++ +T+ L A +
Sbjct: 53 PFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEI 561
I+R +LK N+LL L D+ L L+ + +T Y APE+
Sbjct: 113 NVIYR-------DLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPEL 164
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT--MRVDDGREENRL 619
T D + GVLL E+LTG P + +M + +R DG + +
Sbjct: 165 L-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--NEMYRKILQEPLRFPDGFDRDAK 221
Query: 620 GMLTEVASVCSLKSPEQR 637
+L + S + P +R
Sbjct: 222 DLLIGLLS----RDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 29/157 (18%)
Query: 453 RAYFQAKGERLVIYDYQPNGS---LFNLIHGSRSIRAKPLH-----WTSCLKIAE----- 499
R F+A E+ + G LF+ S S P W S L + +
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 500 -DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV---- 554
VA+G+ ++ IH +L + N+LL + ++ D+ L+ +DPD V
Sbjct: 181 FQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLA----RDIYKDPDYVRKGS 235
Query: 555 -----AYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586
+ APE + T++SDV++FGVLL E+ +
Sbjct: 236 ARLPLKWMAPE-SIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 665 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.56 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.55 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.53 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.5 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.49 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.48 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.29 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.24 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.23 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.16 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.15 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.13 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.06 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.98 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.97 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.89 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.88 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.62 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.43 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.37 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.35 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.3 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.29 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.14 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.14 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-59 Score=557.23 Aligned_cols=242 Identities=28% Similarity=0.486 Sum_probs=197.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .++..||||++...... ...|++.+++++|||||+++++|.+++..++||||+++|+
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 5799999999999996 57889999998654321 1345888999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH---RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH---~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 550 (665)
|.++++ .++|.++.+|+.||++||+||| +.+ |+||||||+||+++.++.+++. ||....... ....
T Consensus 770 L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-~~~~ 838 (968)
T PLN00113 770 LSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPA-VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-DTKC 838 (968)
T ss_pred HHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCC-eecCCCCHHhEEECCCCceEEE-ecccccccc-CCCc
Confidence 999986 2789999999999999999999 446 9999999999999999888875 665533322 1223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--------------Cchh
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--------------GREE 616 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------------~~~~ 616 (665)
.+|+.|+|||++. +..++.|+|||||||++|||+||+.||+........+.+|.+...... ....
T Consensus 839 ~~t~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 839 FISSAYVAPETRE-TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred cccccccCccccc-CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 5789999999987 677999999999999999999999999765544456666654322111 1123
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.....+.+++.+||+.||++||||.|+++.|+++.+..
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 44557889999999999999999999999999887633
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=407.59 Aligned_cols=268 Identities=37% Similarity=0.655 Sum_probs=224.7
Q ss_pred CCcccCHHHHHHHH-----HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeE
Q 005999 380 ESEVYSLEQLMRAS-----AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454 (665)
Q Consensus 380 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 454 (665)
....|++.++..|+ .++||+|+||.||+|.+.++..||||++....... .++|.+|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 34679999999998 36899999999999999999999999887665432 455999999999999999999999
Q ss_pred EEEeCC-eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCceEeCCCCc
Q 005999 455 YFQAKG-ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS--WLIHGNLKSSNVLLGADFE 531 (665)
Q Consensus 455 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~iiH~Dlk~~Nill~~~~~ 531 (665)
||.+.+ +.++|||||++|+|.++++..... +++|.+|++||.++|+||+|||+.. +|||||||++|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 599999999999999999964321 8999999999999999999999954 5999999999999999999
Q ss_pred eEEeecccccccCC-CCCC--C-CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-CCccHHHHHH
Q 005999 532 ARLTDYCLSVLSDS-SSVE--D-PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYL-APPDMLEWVR 606 (665)
Q Consensus 532 ~kl~Dfgl~~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~-~~~~~~~~~~ 606 (665)
+||+|||+++.... .... . .||.+|+|||++. .+..+.|+|||||||+|+||+||+.|.+.... ....+.+|..
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~-~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS-TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCccccceeeecCCCCccCChhhhc-cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999976654 3222 2 7999999999997 57899999999999999999999998876442 2334777754
Q ss_pred hhccCC-------------Cchh-hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 607 TMRVDD-------------GREE-NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 607 ~~~~~~-------------~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
...... .... .....+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 433332 1111 3556688999999999999999999999999766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=400.02 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=221.7
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-eEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG-ERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gs 473 (665)
+.+|+|+||+||+|.+.+...||||++..........+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 559999999999999998888999999877655555789999999999999999999999999887 7999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~---~~~~ 549 (665)
|.++++.. ....+++..+++|+.|||+||.|||++++||||||||+|||++.++ ++||+|||+++.... ....
T Consensus 127 L~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~ 203 (362)
T KOG0192|consen 127 LSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTS 203 (362)
T ss_pred HHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccC
Confidence 99999853 3567999999999999999999999987789999999999999998 999999999977664 3344
Q ss_pred CCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
..||..|||||++.. ...|+.|+||||||+++|||+||+.||..... .+....+.........+..++..+..++.+
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRPPIPKECPPHLSSLMER 281 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 579999999999974 35799999999999999999999999987432 334333333333333455588899999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 629 CSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
||+.||+.||++.+++..|+.+......
T Consensus 282 CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred hCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 9999999999999999999999887664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=374.39 Aligned_cols=255 Identities=27% Similarity=0.364 Sum_probs=215.1
Q ss_pred ccCHHHHHHHHHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-
Q 005999 383 VYSLEQLMRASAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG- 460 (665)
Q Consensus 383 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 460 (665)
.++..|+++ .+.||+|..|+|||+.++ +++.+|+|++.... .....+++.+|++++++++||+||++||.|..++
T Consensus 75 ~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 75 GISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred ccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 355566654 377999999999999965 78999999995544 3466788999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
...++||||++|+|.+++.. .+.+++...-+|+.+|++||.|||+..+||||||||+|||++..|++||||||.+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccccc
Confidence 59999999999999999874 3568999999999999999999997444999999999999999999999999999
Q ss_pred cccCCC-CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--Cchh-
Q 005999 541 VLSDSS-SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREE- 616 (665)
Q Consensus 541 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~- 616 (665)
....+. ..+.+||..|||||.+. +..|+.++||||||++++|+.+|+.||........+..+....+.... ..++
T Consensus 227 ~~lvnS~a~tfvGT~~YMsPERi~-g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 227 GILVNSIANTFVGTSAYMSPERIS-GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred HHhhhhhcccccccccccChhhhc-CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 766554 35668999999999998 678999999999999999999999999875333344444444433322 2333
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
..+.+++.|+..||++||.+|||+.|++++
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 488899999999999999999999999873
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=354.57 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=213.0
Q ss_pred HHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeE-EEEeCCe-EEEEEEe
Q 005999 392 ASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA-YFQAKGE-RLVIYDY 468 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~e~ 468 (665)
...++||+|.||+|||+. ..+|..+|.|.++-........+++..|+.+|++|+|||||++++ -|.++.+ .++||||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence 345789999999999998 678999999999876666677888999999999999999999998 4555555 8899999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR---ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~---~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
+.+|+|.+.++..+. ..+.+++.++|+++.|++.||++||. ++.|+||||||.||+++.+|.|||+|||++++.+.
T Consensus 102 c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 999999999985443 45679999999999999999999998 23489999999999999999999999999988876
Q ss_pred CC---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 546 SS---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 546 ~~---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
.. ..-+|||.||+||.+. +..|+.|+||||+||++|||+.-++||.+. ...++...+.......-..+.++..+
T Consensus 181 ~~tfA~S~VGTPyYMSPE~i~-~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p~~~YS~~l 257 (375)
T KOG0591|consen 181 KTTFAHSLVGTPYYMSPERIH-ESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLPDEHYSTDL 257 (375)
T ss_pred hhHHHHhhcCCCcccCHHHHh-cCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCcHHHhhhHH
Confidence 43 3347999999999998 678999999999999999999999999873 22244444444333223447888999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
.++|..|+..||+.||+...++..++.
T Consensus 258 ~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHccCCcccCCCcchHHHHHHH
Confidence 999999999999999997666665554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=368.45 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=207.3
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhH-----HHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTS-----AEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.|-+|. .++++.||||.+++....... .....+|+++|++|+|||||+++++|+..+..|||||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 4679999999999998 568999999999876544322 2335799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC---CceEEeecccccccC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD---FEARLTDYCLSVLSD 544 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~ 544 (665)
|+.||+|.+.+-. .+.+.+....-+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+...
T Consensus 257 ~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~G-I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 257 YVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQG-IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred EecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcC-cccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 9999999999874 345777788899999999999999999 9999999999999765 789999999999886
Q ss_pred CCC--CCCCCCCcccCCccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--Cchhhh
Q 005999 545 SSS--VEDPDTVAYKAPEIRKSSR--RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENR 618 (665)
Q Consensus 545 ~~~--~~~~gt~~y~aPE~~~~~~--~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 618 (665)
... .+-.||+.|.|||++.+.+ .+..|+|+||+||++|-+++|.+||.+.. .+..+.+.+....... ....+.
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~-~~~sl~eQI~~G~y~f~p~~w~~I 409 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY-TDPSLKEQILKGRYAFGPLQWDRI 409 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc-CCccHHHHHhcCcccccChhhhhh
Confidence 554 3446999999999987432 23458899999999999999999998753 2334666666655544 346677
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
++...++|.+||..||++|||+.|+++
T Consensus 410 seea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 410 SEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 888999999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=377.27 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=215.9
Q ss_pred HHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 391 RASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 391 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
....+.||+|.||.||.|.+++...||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..++.++||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 34457899999999999999999899999998764 556788999999999999999999999999889999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED 550 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 550 (665)
.|+|.+++... .+..+...+.+.++.|||+|++||++++ +|||||.++|||++++..+||+|||+++...+.....
T Consensus 285 ~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~-~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN-YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC-ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999852 4566888999999999999999999999 9999999999999999999999999999655443221
Q ss_pred ----CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 551 ----PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 551 ----~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
.-...|.|||.+. ...++.|+|||||||+||||+| |+.||... ...++.+.+.....- ..++.++..+.++
T Consensus 361 ~~~~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--sn~ev~~~le~GyRl-p~P~~CP~~vY~l 436 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--SNEEVLELLERGYRL-PRPEGCPDEVYEL 436 (468)
T ss_pred cCCCCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCC--CHHHHHHHHhccCcC-CCCCCCCHHHHHH
Confidence 1246799999998 6789999999999999999998 88887652 333555555543332 3567899999999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+..||+.+|++|||++.+...|+++...
T Consensus 437 M~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999999999888887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=379.14 Aligned_cols=241 Identities=22% Similarity=0.399 Sum_probs=209.3
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.++||+|||+.||+++. ..|+.||+|++.+.... ....+.+.+||++.++|+|||||+++++|++..++|+|.|+|..
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 47899999999999996 89999999999764322 24567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
++|.++++ ..+++++.++..++.||+.||.|||+.+ |+|||||..|++++++.+|||+|||+|..... ...
T Consensus 103 ~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~~~-IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 103 GSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHSLG-IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred ccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHhcC-ceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 99999988 3467999999999999999999999999 99999999999999999999999999977663 345
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-CchhhhHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-GREENRLGMLTEVAS 627 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 627 (665)
+-.|||.|.|||++. ....+..+||||+||+||-|+.|++||+.. .+.+..+.+.... ..+...+....+||.
T Consensus 177 TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~Ik~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKIKLNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred eecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHHHhcCcccccccCHHHHHHHH
Confidence 557999999999997 677899999999999999999999999862 3333333333222 345567778999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~ 646 (665)
++|++||.+|||+.+|+..
T Consensus 251 ~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHhcCCcccCCCHHHHhcC
Confidence 9999999999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.48 Aligned_cols=240 Identities=21% Similarity=0.338 Sum_probs=195.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|++ +++..||||.+..........+....|+.+|+.++|||||+++++++.++..|+|||||.|||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 4499999999999995 467999999998776566778889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC------CceEEeecccccccCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD------FEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~------~~~kl~Dfgl~~~~~~~~ 547 (665)
|.++++. .+.+++.++..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+...+..
T Consensus 96 Ls~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~-IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 96 LSDYIRR-----RGRLPEATARHFMQQLASALQFLHENN-IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 9999984 346999999999999999999999999 9999999999999864 468999999999887654
Q ss_pred C--CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-chhhhHHHHHH
Q 005999 548 V--EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG-REENRLGMLTE 624 (665)
Q Consensus 548 ~--~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 624 (665)
. +-.|++.|||||++. .++|+.|+|+||+|+++|++++|+.||+.. ...++...++....... ..........+
T Consensus 170 ~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~--t~~eL~~~~~k~~~~~~~~~~~~s~~~~~ 246 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAE--TPKELLLYIKKGNEIVPVLPAELSNPLRE 246 (429)
T ss_pred HHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCcccc--CHHHHHHHHhccccccCchhhhccCchhh
Confidence 2 335999999999997 688999999999999999999999999863 23344444443322221 12222333445
Q ss_pred HHHHcccCCCCCCCCHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQV 643 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~ev 643 (665)
++...+..+|.+|-+..+-
T Consensus 247 Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 247 LLISLLQRNPKDRISFEDF 265 (429)
T ss_pred hhhHHHhcCccccCchHHh
Confidence 6666666666666554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=386.69 Aligned_cols=264 Identities=23% Similarity=0.414 Sum_probs=224.9
Q ss_pred ccCHHHHHHHHHhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE
Q 005999 383 VYSLEQLMRASAELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456 (665)
Q Consensus 383 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 456 (665)
.|+..++.+ .+.||+|+||.||+|... +...||||.++.... .+..++|++|++++..++|||||+++|+|
T Consensus 482 ~i~r~~i~~--~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIVF--KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred Eechhheee--hhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 344444433 367999999999999843 466899999987664 34678999999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC
Q 005999 457 QAKGERLVIYDYQPNGSLFNLIHGSRSI-----R----AKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG 527 (665)
Q Consensus 457 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~ 527 (665)
.+++..+||+|||..|||.++|...... . ..+++..+.+.||.|||.||.||.++. +|||||..+|+|++
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-FVHRDLATRNCLVG 637 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-ccccchhhhhceec
Confidence 9999999999999999999999743321 1 234899999999999999999999998 99999999999999
Q ss_pred CCCceEEeecccccccCCCCCCCCC-----CCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccH
Q 005999 528 ADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDM 601 (665)
Q Consensus 528 ~~~~~kl~Dfgl~~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 601 (665)
++..|||+|||+++..-.......+ ..+|||||.+. .+.++.++|||||||+|||+++ |+.||.. ....++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~g--lSn~EV 714 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYG--LSNQEV 714 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCcccc--cchHHH
Confidence 9999999999999876655554443 46899999998 6789999999999999999997 9999876 355677
Q ss_pred HHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 602 LEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+.++.... -.-++.++..+..|+..||+..|++||+++||-..|+...+..
T Consensus 715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 777776655 4578899999999999999999999999999999999876654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=335.98 Aligned_cols=245 Identities=20% Similarity=0.301 Sum_probs=202.2
Q ss_pred HHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
...++|+|+||+|||++. ++|+.||||+|.....++...+-..+|+++|++++|+|+|.++++|......++|+||++.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 345799999999999994 5799999999988877667777789999999999999999999999999999999999988
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-C--C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-S--V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~--~ 548 (665)
++.+-+... ..-++...+.++++|++.|+.|+|+++ +|||||||+|||++.+|.+||||||+|+..... . +
T Consensus 86 -TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk~n-~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 86 -TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCHKNN-CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred -HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhhcC-eecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 555555432 344788899999999999999999999 999999999999999999999999999877632 2 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH-hhccCC---------------
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR-TMRVDD--------------- 612 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~--------------- 612 (665)
..+.|.+|+|||.+.+..+|...+||||+||++.||++|.+.|.+. ++.+....++ .+..-.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 2367999999999987789999999999999999999999988652 3333322222 221111
Q ss_pred -------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++..|++.||++|++.+|++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 011233456889999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=345.02 Aligned_cols=233 Identities=22% Similarity=0.317 Sum_probs=198.3
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhh-HHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADT-SAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.++||+|+||.||.++. ++++.+|+|++++....+. ..+..+.|..+|.+++||.||+++..|++.+..|+|+||+.|
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 47899999999999994 5788999999987755433 466788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|.|+.+|++ ...+++..+.-++.+|+.||.|||+.+ ||||||||+|||+|++|+++|+|||+++..-. ...
T Consensus 110 GeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~g-IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 110 GELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKG-IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred ccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHeeecCCCcEEEeccccchhcccCCCccc
Confidence 999999983 456899999999999999999999999 99999999999999999999999999974422 223
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-C-chhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-G-REENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li 626 (665)
+..||+.|||||++. ...|+..+|+||+|+++|||++|.+||... +...+.+.+.... . .+...+...++++
T Consensus 184 tfcGT~eYmAPEil~-~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILL-GKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred cccCCccccChHHHh-cCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 347999999999998 678999999999999999999999999763 3333333333332 2 2233566789999
Q ss_pred HHcccCCCCCCC
Q 005999 627 SVCSLKSPEQRP 638 (665)
Q Consensus 627 ~~cl~~dP~~RP 638 (665)
.+.+..||++|-
T Consensus 258 ~~LL~rdp~~RL 269 (357)
T KOG0598|consen 258 KKLLKRDPRQRL 269 (357)
T ss_pred HHHhccCHHHhc
Confidence 999999999996
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.51 Aligned_cols=263 Identities=17% Similarity=0.265 Sum_probs=215.2
Q ss_pred CcccCHHHHHHHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-
Q 005999 381 SEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQA- 458 (665)
Q Consensus 381 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~- 458 (665)
.+.++.+++.......+|+|++|.||+|.+ +++.||||+++...... ...+.+.+|+.++++++||||+++++++.+
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 345666777666567899999999999998 56789999997654322 224678899999999999999999999877
Q ss_pred ---CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEE
Q 005999 459 ---KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARL 534 (665)
Q Consensus 459 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl 534 (665)
....++||||+++|+|.+++.. ...+++...+.++.|++.||+|||+. + ++||||||+||++++++.+||
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTN-KPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCC-CCCCcCChhhEEECCCCcEEE
Confidence 3478899999999999999974 34688999999999999999999985 6 889999999999999999999
Q ss_pred eecccccccCCCCCCCCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC
Q 005999 535 TDYCLSVLSDSSSVEDPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG 613 (665)
Q Consensus 535 ~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 613 (665)
+|||++...........++..|+|||++.. ...++.++|||||||++|||++|+.||... ...++...+........
T Consensus 165 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--~~~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--TTKEIYDLIINKNNSLK 242 (283)
T ss_pred cccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcCCCCC
Confidence 999999876655555578899999999863 257899999999999999999999999763 22233333322222222
Q ss_pred chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 614 REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 614 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
.+...+..+.+++.+||+.||++|||+.|+++.|+....
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 333567789999999999999999999999999988753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=347.20 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=202.6
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC--eEEEEEEec
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG--ERLVIYDYQ 469 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~ 469 (665)
..+.||+|+||+||++... +|+..|||....... ...+.+++|+.+|++++|||||+++|...... .+++.|||+
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4578999999999999965 488999999876633 22677899999999999999999999855544 689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccCC---
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDS--- 545 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~--- 545 (665)
++|+|.+++.... + .+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 99 ~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g-~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 99 PGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKG-IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred CCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCC-EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999998542 2 6999999999999999999999999 999999999999999 79999999999876652
Q ss_pred ---CCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 546 ---SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 546 ---~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
......||+.|||||++..+.....++||||+||++.||+||++||.........+....... .....++..+...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIPDSLSDEA 252 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCCcccCHHH
Confidence 123356999999999997432334589999999999999999999986411111111111111 1123455677889
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
.+|+.+|+.+||++||||.++++.-.-..
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 99999999999999999999998765443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=343.11 Aligned_cols=243 Identities=25% Similarity=0.408 Sum_probs=203.3
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||.|..++||+|+ ...++.||||++...+.... .+.+++|+..|+.++||||++++..|..+...++||.||.+|
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCC
Confidence 4679999999999999 45679999999988776433 788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
++.++++... ..-+++..+..|++++++||.|||+++ -||||||+.||||+.+|.|||+|||.+..+....
T Consensus 110 S~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G-~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 110 SLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNG-HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred cHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcC-ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 9999998542 233899999999999999999999999 8999999999999999999999999875543321
Q ss_pred --CCCCCCCcccCCcc-ccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC----------Cc
Q 005999 548 --VEDPDTVAYKAPEI-RKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----------GR 614 (665)
Q Consensus 548 --~~~~gt~~y~aPE~-~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------~~ 614 (665)
...+||+.|||||+ ......|+.|+||||||++..||.+|..||.... .+......+.... +.
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p----PmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP----PMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC----hHHHHHHHhcCCCCCcccccCChHH
Confidence 22368999999999 5556789999999999999999999999998632 1211122222111 22
Q ss_pred hhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 615 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.......+++++..||.+||++|||+.++++
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 3344567999999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.35 Aligned_cols=240 Identities=24% Similarity=0.361 Sum_probs=205.1
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhh-HHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADT-SAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+|++|++|+ .+.+..||||++.+....++ ..+.+..|-++|.+| .||.|++|+..|+++...|+|+||+++
T Consensus 79 ~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~n 158 (604)
T KOG0592|consen 79 KILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPN 158 (604)
T ss_pred heeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCC
Confidence 679999999999999 56799999999976654333 345677788889889 999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.++|++ -+.+++.....++.+|+.||+|||+.| ||||||||+|||+|+|+++||+|||.++.+.+..
T Consensus 159 Gdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~G-IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 159 GDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNG-IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred CcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 999999984 467899999999999999999999999 9999999999999999999999999997664321
Q ss_pred ------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCch
Q 005999 548 ------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615 (665)
Q Consensus 548 ------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (665)
..-+||..|.+||++. ....+..+|+|+|||++|+|+.|++||.... +..-..+-+..+...+
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~N----eyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAAN----EYLIFQKIQALDYEFP 307 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCcccc----HHHHHHHHHHhcccCC
Confidence 1135899999999997 6788999999999999999999999998642 3333333334445567
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+..+..+.+|+.+.|..||.+|+|.+||.+
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 777788999999999999999999988865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=343.69 Aligned_cols=248 Identities=19% Similarity=0.304 Sum_probs=204.9
Q ss_pred HHHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEE
Q 005999 391 RASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYD 467 (665)
Q Consensus 391 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 467 (665)
+...++||+|.||.||+|+ ..+|+.||+|++......+.......+||.+|++|+||||+++.+...+. +.+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 3445789999999999999 67899999999988776666777788999999999999999999998876 78999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
||+. ||.-++.. ....+++.++..+++|++.||+|||+++ |.|||||.+|||||.+|.+||+|||+|+++....
T Consensus 199 YMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g-vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 199 YMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG-VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred cccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC-eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9998 99988874 3557999999999999999999999999 9999999999999999999999999999776543
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-----------
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----------- 612 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 612 (665)
+..+-|.+|+|||++.+...|+.++|+||.||||.||+.|++.|++..+- .++-...+-...+.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhccccccCCc
Confidence 23356999999999998889999999999999999999999998763210 01111111100000
Q ss_pred --------C-------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --------G-------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --------~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+....+|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 12233456788999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=347.31 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=205.0
Q ss_pred HHHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCC-eEEEEEE
Q 005999 391 RASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKG-ERLVIYD 467 (665)
Q Consensus 391 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~e 467 (665)
+...+.||.|+||.||+|. ...++.||||+++..... ...-.=.+|+..|++|+ ||||+++.+++.+.+ ..|+|||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 4456789999999999999 567889999999766532 22222357999999998 999999999998887 9999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
||+. +|+++++. +...+++..+..|+.||++||+|+|+.| +.|||+||+|||+.....+||+|||+|+......
T Consensus 91 ~Md~-NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~G-fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 91 FMDC-NLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKHG-FFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred hhhh-hHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhcC-cccccCChhheEecccceeEecccccccccccCC
Confidence 9977 99999985 3578999999999999999999999999 9999999999999999999999999998876543
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-------------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------- 612 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------- 612 (665)
++.+.|.+|+|||++.....|+.+.|||++||+++|+.+-++.|.+.. +-+++......+..+.
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-E~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-EIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-HHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 445789999999999888899999999999999999999998887632 1123322222222211
Q ss_pred --------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 --------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 --------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
......+.+..+++.+|++-||++|||+.|++++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0122356778999999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=316.10 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=207.6
Q ss_pred HHHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 391 RASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 391 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+...+.+|+|.||.||+|+ ..+|+.||||+++.....+.......+||..|+.++|+||+.++++|...+...+|+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 3445789999999999999 568999999999887655555667789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
+. +|+..++. +...++..++..++.++++|++|||++. |+||||||+|+|++.+|.+||+|||+++.......
T Consensus 84 ~t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~-IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 84 PT-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKW-ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhh-hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 87 99999975 4567999999999999999999999999 99999999999999999999999999988765432
Q ss_pred --CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-------------
Q 005999 549 --EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG------------- 613 (665)
Q Consensus 549 --~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------------- 613 (665)
..+-|..|+|||.+.+.+.|+..+||||.||++.||+-|.+-|.+. .+-+++....+.+..+..
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 2257899999999998899999999999999999999988766542 122233333333332220
Q ss_pred ------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 614 ------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 614 ------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
..........+++..++..||.+|+|+.|++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 112334567999999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=355.60 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=213.0
Q ss_pred ccCHHHHHHHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeE
Q 005999 383 VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 383 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 462 (665)
.+.++++ ...+.||+|.||+||+|.+.+. ||||++..........+.|++|+..+++-+|.||+=+.|||..++.
T Consensus 388 eIp~~ev--~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEV--LLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHh--hccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 3444444 3457899999999999998764 9999998887777888999999999999999999999999999887
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
.+|+-+|+|-+|+.++|-. ...++..+.+.|+.||++|+.|||.++ |||||||+.||++.+++.|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~-IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKN-IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhh-hhhhhccccceEEccCCcEEEecccceee
Confidence 9999999999999999953 356888999999999999999999999 99999999999999999999999999854
Q ss_pred cCCC-----CCCCCCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---
Q 005999 543 SDSS-----SVEDPDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--- 612 (665)
Q Consensus 543 ~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--- 612 (665)
.... -....|...|||||++.. ...|++.+||||||+|+|||+||..||... ..+++.-++.......
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEEEecccccCccch
Confidence 3221 122346788999999873 346899999999999999999999999831 1122222222221111
Q ss_pred CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 613 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
....+++.++.+|+..||..++++||.+.+++..|+++...
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 13456778999999999999999999999999999988763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=352.27 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=208.3
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+.|.||.|. ..+++.||||++..... ...+-+.+|+.+|+..+|+|||++++.|...++.++|||||+||
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 3679999999999998 55788899999987764 44567889999999999999999999999889999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+.+.. ..+++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++....... .+
T Consensus 356 sLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~g-IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 356 SLTDVVTK------TRMTEGQIAAICREILQGLKFLHARG-IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred chhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcc-eeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 99999864 34899999999999999999999999 9999999999999999999999999997665432 44
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
.+||+.|||||+.. ...|.+|+||||||++++||+-|.+||-.. .+- .+..............+..+..+.+|+.+
T Consensus 429 mVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE--~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCC--ChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 57999999999987 678999999999999999999999998651 121 33333334444445677888899999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
||..|+++||++.|+|+
T Consensus 506 cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLE 522 (550)
T ss_pred HhhcchhcCCCHHHHhc
Confidence 99999999999999987
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=346.12 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=214.4
Q ss_pred HHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 392 ASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
...+.||+|.||.||||+ ..+.+.||+|.+.+....+...+.+.+|++++++++||||+.++++|+...+.++|+||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 344679999999999999 5578899999999888878888899999999999999999999999999999999999998
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
| +|+.++. .+..++++.+..+++|++.||.|||+.+ |.|||+||+|||++..+++|++|||+++.+....
T Consensus 85 g-~L~~il~-----~d~~lpEe~v~~~a~~LVsaL~yLhs~r-ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 85 G-DLFTILE-----QDGKLPEEQVRAIAYDLVSALYYLHSNR-ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred h-hHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHhcC-cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 8 9999998 4567999999999999999999999999 9999999999999999999999999998876533
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-chhhhHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG-REENRLGMLTEVA 626 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 626 (665)
....|||-|||||+.. ++.|+..+|.||+||++||+++|++||.. ..+.+.++.+..++. .+...+..+..++
T Consensus 158 tsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v~~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPVKPPSTASSSFVNFL 231 (808)
T ss_pred eeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCCCCcccccHHHHHHH
Confidence 2235999999999998 78999999999999999999999999975 356666666555543 3456677899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
...+.+||.+|.|-.+++.
T Consensus 232 ~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHhhcChhhcccHHHHhc
Confidence 9999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.88 Aligned_cols=256 Identities=21% Similarity=0.350 Sum_probs=201.9
Q ss_pred HHhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC-CeEEE
Q 005999 393 SAELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK-GERLV 464 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~l 464 (665)
..+.||+|+||.||+|.. .++..||+|++..... ....+.+.+|+.++..+ +||||++++++|... +..++
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMV 89 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEE
Confidence 346799999999999974 2356899999875432 23456788999999999 899999999988764 46889
Q ss_pred EEEecCCCCHHHHHhcCCCC---------------------------------------------------------CCC
Q 005999 465 IYDYQPNGSLFNLIHGSRSI---------------------------------------------------------RAK 487 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~ 487 (665)
||||+++|+|.+++...+.. ...
T Consensus 90 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (338)
T cd05102 90 IVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKS 169 (338)
T ss_pred EEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccC
Confidence 99999999999998753210 023
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----CCCCCCCcccCCccc
Q 005999 488 PLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIR 562 (665)
Q Consensus 488 ~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~ 562 (665)
++++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....... ....+++.|+|||++
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 5888899999999999999999999 9999999999999999999999999997543221 122356789999998
Q ss_pred cCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHH
Q 005999 563 KSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMW 641 (665)
Q Consensus 563 ~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 641 (665)
. +..++.++|||||||++|||++ |..||...... ..+...+.... ....+...+..+.+++.+||+.||++|||+.
T Consensus 249 ~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 325 (338)
T cd05102 249 F-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGT-RMRAPENATPEIYRIMLACWQGDPKERPTFS 325 (338)
T ss_pred h-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 7 5678999999999999999997 99999763221 12222222111 1122345567899999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 005999 642 QVLKMIQEIKES 653 (665)
Q Consensus 642 evl~~L~~~~~~ 653 (665)
|+++.|+++...
T Consensus 326 el~~~l~~~~~~ 337 (338)
T cd05102 326 ALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHhc
Confidence 999999988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.04 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=209.5
Q ss_pred ccCHHHHHHHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeE
Q 005999 383 VYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 383 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 462 (665)
.+.++++.. .+.||.|+.|.||+|++++ +.||||+++..+ +.+|.-|++|+||||+.+.|+|....-+
T Consensus 120 eiPFe~IsE--LeWlGSGaQGAVF~Grl~n-etVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISE--LEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhh--hhhhccCcccceeeeeccC-ceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 344444422 3679999999999999875 479999886544 3567889999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+||||||..|-|.+.|+. +..++......|..+||.|++|||... |||||||+-||||..+..|||+|||-++.
T Consensus 188 CIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~hK-IIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLHK-IIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred EEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHhh-HhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999999984 456888889999999999999999988 99999999999999999999999999977
Q ss_pred cCCCCCC--CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 543 SDSSSVE--DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 543 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
..+..+. -.||..|||||+++ ....++|+||||||||||||+||..||.+..... +.--+.........+..+++
T Consensus 262 ~~~~STkMSFaGTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--IIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 262 LSDKSTKMSFAGTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--IIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred hhhhhhhhhhhhhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchhe--eEEeccCCcccccCcccCch
Confidence 6654332 36999999999998 7789999999999999999999999997632110 00001111111235678889
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccC
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 658 (665)
.+.-|+++||+..|.+||++++++..|.-...++....
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~t 376 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTT 376 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhccc
Confidence 99999999999999999999999999987766665443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.20 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=212.8
Q ss_pred hHhCcccceEEEEEEECC--e---EEEEEEEecC-CCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLDN--H---LIVTVKRFDA-NKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|.+.. + ..||||..+. ....+...++|.+|.++|++++|||||+++|+...+...++|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 789999999999999542 2 2389999886 334456778999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV 548 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 548 (665)
|.||+|.++++.. ...++..+++.++.+.|.||+|||+++ ++||||.++|+|++.++.+||+|||++........
T Consensus 243 ~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~-~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 243 CNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKN-CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred cCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCC-CcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 9999999999853 336999999999999999999999999 99999999999999999999999999866542111
Q ss_pred C---CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 549 E---DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 549 ~---~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
. ..-..+|+|||.+. ...+++++|||||||++||+++ |..||... ...++..++......-..+...+..+..
T Consensus 318 ~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--~~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--KNYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred ccccccCcceecChhhhc-cCccccccchhheeeeEEeeeccCCCCCCCC--CHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 1 12357899999998 4589999999999999999998 78888763 3335555553333333445577888999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
++.+|+..+|++||+|.++.+.|+.+......
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999877654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=315.47 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=207.6
Q ss_pred ccCHHHHHHHHHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC
Q 005999 383 VYSLEQLMRASAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG 460 (665)
Q Consensus 383 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 460 (665)
.+++++.+. .+.||.|+||.|.+++. .+|..+|+|+++....-+ ...+...+|..+|+.+.||.++++++.|.+.+
T Consensus 40 ~~~l~dfe~--~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 40 PYSLQDFER--LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred Ccchhhhhh--eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 367776543 47799999999999995 478899999998765433 24566788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
..||||||++||.|+.++++ .+++++..+..++.||+.||+|||+.+ |++|||||+|||+|.+|++||+|||+|
T Consensus 118 ~lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~-iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLD-IIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred eEEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcC-eeeccCChHHeeeccCCcEEEEeccce
Confidence 99999999999999999984 456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 541 VLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 541 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
+.......+-.|||.|+|||.+. .+.+..++|+|||||++|||+.|.+||.... ..++.+.+.. ..-..+.....
T Consensus 192 K~v~~rT~TlCGTPeYLAPEii~-sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--~~~iY~KI~~--~~v~fP~~fs~ 266 (355)
T KOG0616|consen 192 KRVSGRTWTLCGTPEYLAPEIIQ-SKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--PIQIYEKILE--GKVKFPSYFSS 266 (355)
T ss_pred EEecCcEEEecCCccccChHHhh-cCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--hHHHHHHHHh--CcccCCcccCH
Confidence 99888766668999999999997 6789999999999999999999999997643 2344433332 22234566677
Q ss_pred HHHHHHHHcccCCCCCC
Q 005999 621 MLTEVASVCSLKSPEQR 637 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~R 637 (665)
.+.+|+...++.|-.+|
T Consensus 267 ~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 267 DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHHHhhhhHhh
Confidence 89999999999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=371.43 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=215.3
Q ss_pred HhHhCcccceEEEEEEECC------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|.||.||+|...+ ...||||.+..... .+...+|.+|..+|+.++|||||+++|++.+.+.+++++|
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 4679999999999999543 23589999876654 4667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 468 YQPNGSLFNLIHGSRSI--RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
||.+|+|..+|++.+.. ....++....+.++.|||+|++||++++ +|||||..+|+|+++...|||+|||+|+.+-.
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~ 854 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-FVHRDLAARNCLLDERRVVKIADFGLARDIYD 854 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-CcCcchhhhheeecccCcEEEcccchhHhhhh
Confidence 99999999999876432 2456889999999999999999999999 99999999999999999999999999984433
Q ss_pred CCCCCC-----CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhH
Q 005999 546 SSVEDP-----DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619 (665)
Q Consensus 546 ~~~~~~-----gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (665)
...... -..+|||||.+. .+.++.|+|||||||++||++| |..||.+. ...++...+.... .-+.+..++
T Consensus 855 ~~yyr~~~~a~lPvkWm~PEsl~-d~iFtskSDvWsFGVllWEifslG~~PY~~~--~n~~v~~~~~~gg-RL~~P~~CP 930 (1025)
T KOG1095|consen 855 KDYYRKHGEAMLPVKWMPPESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--SNFEVLLDVLEGG-RLDPPSYCP 930 (1025)
T ss_pred chheeccCccccceecCCHHHHh-hcccccccchhhhHHHHHHHHhCCCCCCCCc--chHHHHHHHHhCC-ccCCCCCCC
Confidence 322211 246899999998 5789999999999999999998 88888763 2334444333222 335678899
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
..+.+++..||+.+|++||++..+++.+..+.+.....
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 99999999999999999999999999999887766543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.67 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=202.3
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCch---hhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA---DTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||.|. ..+++.||+|.+...... ....+.+.+|+.++++++ ||||+++++++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 3679999999999997 457899999977654221 133556778999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccC---
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSD--- 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~--- 544 (665)
+.||+|++++.. ..++.+..+..++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~g-i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 102 CSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRG-IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred cCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 999999999984 356888999999999999999999999 9999999999999999 999999999998773
Q ss_pred CCCCCCCCCCcccCCccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhh-HHHH
Q 005999 545 SSSVEDPDTVAYKAPEIRKSSR-RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR-LGML 622 (665)
Q Consensus 545 ~~~~~~~gt~~y~aPE~~~~~~-~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l 622 (665)
....+..||+.|+|||++.+.. +...++||||+||+||.|++|+.||++. ....+...+..... ..+... +..+
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--~~~~l~~ki~~~~~--~~p~~~~S~~~ 251 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--NVPNLYRKIRKGEF--KIPSYLLSPEA 251 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--cHHHHHHHHhcCCc--cCCCCcCCHHH
Confidence 3345567999999999998544 3358899999999999999999999872 22233322222222 233333 7789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
..++.+|+..||.+|+|+.|++ .-.-++
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 9999999999999999999999 433333
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.49 Aligned_cols=251 Identities=20% Similarity=0.399 Sum_probs=215.7
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.++||.|.||.||+|+++ ....||||.++.... +..+.+|..|..+|.+++||||++|.|+......+++|+|||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence 468999999999999964 356899999988775 355678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 549 (665)
++|+|..+|+. +++++++.+...++++||.|++||.+.+ +|||||..+|||++.+..+|++|||+++...+....
T Consensus 713 ENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLsdm~-YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 713 ENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLSDMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHhhcC-chhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999999985 4567999999999999999999999999 999999999999999999999999999877554311
Q ss_pred C---C-C--CCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 550 D---P-D--TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 550 ~---~-g--t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
. . | ..+|.|||.+. ..+++.++|||||||+|||.++ |..||=+ ....++...+...... ..+.+++..|
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWd--mSNQdVIkaIe~gyRL-PpPmDCP~aL 863 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWD--MSNQDVIKAIEQGYRL-PPPMDCPAAL 863 (996)
T ss_pred cccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccc--cchHHHHHHHHhccCC-CCCCCCcHHH
Confidence 1 1 2 36899999997 7899999999999999999885 8888744 2344555555443322 4567899999
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+|+..||++|-.+||.+.|++..|..+..+-
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 99999999999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.60 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=209.5
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.++||+|.||.|.++...++..||||.++.... +....+|.+|+++|.+|+||||+.++|+|..++.+++|+|||++|+
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 688999999999999999999999999988765 2346889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC---
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED--- 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--- 550 (665)
|.+++.+... ..+.-.....|+.||+.|++||.+.+ ++||||.++|+|+|.++++||+|||+++..-......
T Consensus 622 LnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~n-fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 622 LNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLN-FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred HHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhc-hhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 9999986432 22455567789999999999999999 9999999999999999999999999997554433322
Q ss_pred --CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHH--hCCCCCCCCCCCCccHHHHHHhhccCC------CchhhhHH
Q 005999 551 --PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELL--TGKHPSQHPYLAPPDMLEWVRTMRVDD------GREENRLG 620 (665)
Q Consensus 551 --~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ell--tg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 620 (665)
+-..+|||+|.+. .++++.++|||+||+++||++ +...||... .+.++.+-...+.... ..+.-++.
T Consensus 698 r~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~l--t~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 698 RAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQL--TDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhh--hHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 2357899999988 578999999999999999986 467788753 3445555444443333 24667788
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.+.+++.+||..|-++||+++++...|++.
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 899999999999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=336.33 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=202.2
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
++||+|.||.||+|.. ..++.||+|++..... +...+++.+|+.++.+++++||.++|+.|..+...+++||||.||+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 6799999999999994 5789999999977654 3556788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
+.+.++. +..+.+..+.-|+.++..|+.|||.++ .+|||||+.|||+..+|.|||+|||.+....... .+-
T Consensus 98 v~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~-kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 98 VLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEK-KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred hhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcc-eecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 9999974 334477777788999999999999999 9999999999999999999999999997665432 345
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
+||+.|||||++. ...|+.|+||||||++.+||.+|.+|+...+.. .+.-.+.. ..+.......+..+++|+..||
T Consensus 172 vGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--rvlflIpk-~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 172 VGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--RVLFLIPK-SAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred cccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcc--eEEEeccC-CCCCccccccCHHHHHHHHHHh
Confidence 7999999999998 678999999999999999999999999764321 11111111 1111233366778999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
++||+.||++.++++
T Consensus 248 ~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLK 262 (467)
T ss_pred hcCcccCcCHHHHhh
Confidence 999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=341.53 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=210.4
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCC-CchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDAN-KTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
++.||+|+.|.|-.|. ..+|+.+|||.+... ...+.....+++|+-+|+-+.|||+++++++|++..++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 3679999999999998 578999999999776 33333456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VE 549 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 549 (665)
|.|++++- ..+++++.+..+++.||+.|+.|||..+ |+||||||+|+|+|..+.+||+|||+|....+.. .+
T Consensus 97 GELFdylv-----~kG~l~e~eaa~ff~QIi~gv~yCH~~~-icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 97 GELFDYLV-----RKGPLPEREAAHFFRQILDGVSYCHAFN-ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred chhHHHHH-----hhCCCCCHHHHHHHHHHHHHHHHHhhhc-ceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence 99999987 3467999999999999999999999999 9999999999999999999999999997665543 34
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..|++.|.+||++.+..+...++||||.|||||.|+||+.||++. ....+...++....+ .+.+.+.+.++|+++|
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLlKV~~G~f~--MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLLKVQRGVFE--MPSNISSEAQDLLRRM 246 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHHHHHHHHcCccc--CCCcCCHHHHHHHHHH
Confidence 569999999999986666678999999999999999999999852 223444444444433 4577888999999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L 647 (665)
+..||++|.|++||++.-
T Consensus 247 l~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHP 264 (786)
T ss_pred hccCccccccHHHHhhCc
Confidence 999999999999999853
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=342.54 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=203.8
Q ss_pred HHHHHhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeE
Q 005999 390 MRASAELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 390 ~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 462 (665)
.+...+.||+|+||.||+|.. .++..||+|+++..... ...+.+.+|+++++.+ +|+||++++++|...+..
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 334467899999999999873 23457999999765432 3456788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCC-----------------------------------------------------------
Q 005999 463 LVIYDYQPNGSLFNLIHGSRS----------------------------------------------------------- 483 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 483 (665)
++||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864211
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-----CCCC
Q 005999 484 ------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV-----EDPD 552 (665)
Q Consensus 484 ------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----~~~g 552 (665)
....++++..+++++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++........ ...+
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 01235788999999999999999999999 99999999999999999999999999865533221 1124
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
+..|+|||++. ...++.++|||||||++|||++ |+.||..... .......+... .....+...+..+.+++.+||+
T Consensus 277 ~~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 277 PVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-NSKFYKMVKRG-YQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred ccceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccc-cHHHHHHHHcc-cCccCCCCCCHHHHHHHHHHcC
Confidence 56799999986 5678999999999999999997 9999976322 11222222221 1112233446789999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHH
Q 005999 632 KSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 632 ~dP~~RPt~~evl~~L~~~~ 651 (665)
.||++|||+.++++.|+++.
T Consensus 354 ~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 354 LEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=329.69 Aligned_cols=245 Identities=17% Similarity=0.243 Sum_probs=198.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++.. .+++.||+|.+...... ......+.+|++++++++|+||+++++++.+++..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 5799999999999985 57889999998654322 123446788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... ...
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05631 86 DLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161 (285)
T ss_pred cHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence 999887632 2345899999999999999999999999 9999999999999999999999999997654322 234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
.||..|+|||++. +..++.++|||||||++|||++|+.||........ .+...+.. .........+..+.+|+.+
T Consensus 162 ~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 162 VGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHH
Confidence 6899999999987 66789999999999999999999999986432111 11111111 1112334566789999999
Q ss_pred cccCCCCCCCC-----HHHHHHH
Q 005999 629 CSLKSPEQRPA-----MWQVLKM 646 (665)
Q Consensus 629 cl~~dP~~RPt-----~~evl~~ 646 (665)
||+.||++||+ ++|+++.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999997 7888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=307.00 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=212.7
Q ss_pred HHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-----CCeEEEEE
Q 005999 393 SAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-----KGERLVIY 466 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~ 466 (665)
..+.||+|||+.||.+. ..++..+|+|++.... .+..+..++|++..++++|||+++++++... ..+.|+++
T Consensus 25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 34679999999999998 6788899999997766 3566778999999999999999999988643 34689999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
+|...|+|.+.+.... .++..+++.++++|+.+|++||++||+.. +++||||||.|||+.+.+.+++.|||.+....-
T Consensus 103 Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred ehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 9999999999998643 35668999999999999999999999964 699999999999999999999999999865543
Q ss_pred CC------------CCCCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC
Q 005999 546 SS------------VEDPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD 611 (665)
Q Consensus 546 ~~------------~~~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 611 (665)
.. .....|..|+|||.+. .+...++++|||||||++|+||.|..||+..+...+.+.-.+......
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s 261 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQIS 261 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccc
Confidence 21 1224689999999875 244578999999999999999999999987766555554444443333
Q ss_pred CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 612 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
......+++.+.+++..|++.||.+||++.+++..+..+.
T Consensus 262 ~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 262 IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 3444458889999999999999999999999999988754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.18 Aligned_cols=242 Identities=21% Similarity=0.317 Sum_probs=200.4
Q ss_pred HHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 393 SAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
....||+|+||.||+|+ .++|..+|+|++++..-.. ...+.++.|-.+|...++|+||+++..|++..+.||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 34789999999999999 4579999999998764322 235667889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC-----
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS----- 545 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~----- 545 (665)
||++..+|. +...|++..+..++.+++.|++.+|+.| +|||||||+|+|||..|++||+|||++.-...
T Consensus 225 GGD~mTLL~-----~~~~L~e~~arfYiaE~vlAI~~iH~~g-yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 225 GGDMMTLLM-----RKDTLTEDWARFYIAETVLAIESIHQLG-YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred CccHHHHHH-----hcCcCchHHHHHHHHHHHHHHHHHHHcC-cccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999997 3567999999999999999999999999 99999999999999999999999999732100
Q ss_pred --------------------C-----C--------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHH
Q 005999 546 --------------------S-----S--------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVL 580 (665)
Q Consensus 546 --------------------~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvv 580 (665)
. . ...+|||.|||||++. +..|+..+|+||+|||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-GKGYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-cCCCCccccHHHHHHH
Confidence 0 0 0124899999999998 6779999999999999
Q ss_pred HHHHHhCCCCCCCCCCC--CccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 005999 581 LLELLTGKHPSQHPYLA--PPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPA---MWQVL 644 (665)
Q Consensus 581 l~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl 644 (665)
||||+.|.+||...... ...+..|...+..+. ......+..+||.+|+. ||++|.- ++||.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999874332 236666666555544 33344778999999999 9999965 55554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=311.42 Aligned_cols=247 Identities=19% Similarity=0.233 Sum_probs=202.2
Q ss_pred HHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEe
Q 005999 392 ASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDY 468 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 468 (665)
...+.|++|+||.||+|. ..+++.||+|+++.....+.-.-.-.+||.+|.+++|||||.+..+... -+.+|+||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 445889999999999999 4579999999998776544444456789999999999999999998765 3579999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
|+. ||..+++.- .+++...+..-+..|+++|++|||++. |+|||||++|+|+...|.+||+|||+|+.++.+.
T Consensus 159 ~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~w-ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 159 VEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNW-ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhce-eEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 988 999999853 367888999999999999999999999 9999999999999999999999999999887763
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC------------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG------------ 613 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------------ 613 (665)
+..+-|.+|+|||.+.+...|++..|+||+|||+.|++++++-|.+.. +..++....+.+..+..
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHHhCCCccccCCCccccchh
Confidence 233568999999999988899999999999999999999998887532 22233333333222210
Q ss_pred ----------------ch-hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 ----------------RE-ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 ----------------~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+. ....+.-.+|+...+..||.+|-|+.|.++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 012356678999999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.92 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=213.5
Q ss_pred cccCHHHHHHHHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC
Q 005999 382 EVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK 459 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 459 (665)
+.+++++.+ .++.||+|.||.||.|+ .+++-.||+|++.+..... ....++++|+++-+.|+||||++++++|.+.
T Consensus 17 ~~~~l~dfe--igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLDDFE--IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchhhcc--ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 345555543 35789999999999999 5578899999986654322 3456789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 460 GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
...|+++||..+|+++..+... ....+++.....++.|+|.|+.|+|..+ |+||||||+|+|++.++..|++|||.
T Consensus 95 ~riyLilEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~k~-VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHLKR-VIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhccCC-cccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999999999854 3456888888999999999999999999 99999999999999999999999999
Q ss_pred ccccCCC-CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 540 SVLSDSS-SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 540 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
+...... ..+..||..|.+||+.. +..++.++|+|++|++.||++.|.+||+... ..+...-++.... ..+...
T Consensus 171 sV~~p~~kR~tlcgt~dyl~pEmv~-~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~--~~p~~i 245 (281)
T KOG0580|consen 171 SVHAPSNKRKTLCGTLDYLPPEMVE-GRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDL--KFPSTI 245 (281)
T ss_pred eeecCCCCceeeecccccCCHhhcC-CCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccc--cCCccc
Confidence 9766433 33446999999999987 7789999999999999999999999998743 3344444443332 234677
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+....++|.+|+.++|.+|.+..|++..
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhhh
Confidence 7889999999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.87 Aligned_cols=247 Identities=20% Similarity=0.367 Sum_probs=202.2
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|.+. .+..||+|.++..... ...+.+.+|+..+++++||||+++++++..++..++||||+
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 467999999999999753 4678999999765432 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+.......
T Consensus 89 ~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~-iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 89 SNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG-YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 999999998742 346899999999999999999999999 9999999999999999999999999875432221
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
....++..|+|||++. +..++.++|||||||++||+++ |+.||... ...++...+..... ...+...+..+.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDM--SGQDVIKAVEDGFR-LPAPRNCPNLLHQ 239 (266)
T ss_pred cccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCC-CCCCCCCCHHHHH
Confidence 1123467899999987 5678999999999999999875 99999753 22233333332211 1234556788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
++.+||+.+|++||++.|+++.|+++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.92 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=197.9
Q ss_pred HhHhCcccceEEEEEEEC-----------------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-----------------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 456 (665)
.+.||+|+||.||++.+. ++..||+|.+..... ......+.+|++++.+++||||+++++++
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 357999999999999753 234799999876543 33456789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCC
Q 005999 457 QAKGERLVIYDYQPNGSLFNLIHGSRS--------------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSS 522 (665)
Q Consensus 457 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~ 522 (665)
.+.+..++||||+.+|+|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-ivH~dlkp~ 167 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRDLATR 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-ccccCcchh
Confidence 999999999999999999999864321 11235788899999999999999999999 999999999
Q ss_pred ceEeCCCCceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 005999 523 NVLLGADFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT--GKHPSQHPY 595 (665)
Q Consensus 523 Nill~~~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt--g~~P~~~~~ 595 (665)
|||+++++.+||+|||++....... ....++..|+|||++. ...++.++||||||+++|||++ +..||...
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~- 245 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYGEL- 245 (304)
T ss_pred heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccCCCCCCcC-
Confidence 9999999999999999987553322 1123477899999986 5678999999999999999987 55677653
Q ss_pred CCCccHHHHHHhhccC------CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 596 LAPPDMLEWVRTMRVD------DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 596 ~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
...+....+...... ...+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 246 -TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred -CHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 222332222221111 1123355678999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=335.94 Aligned_cols=239 Identities=18% Similarity=0.256 Sum_probs=196.9
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.||+|+||.||++.. .+++.||+|+++.... .......+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999985 4788999999875432 12334567889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 82 L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 82 LFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCD-VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 9999873 346899999999999999999999999 999999999999999999999999998653221 2233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++. +..++.++|||||||++|||++|+.||.... ...+...+.. .....+...+..+.+++.+||
T Consensus 156 ~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L 230 (323)
T cd05571 156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILM--EEIRFPRTLSPEAKSLLAGLL 230 (323)
T ss_pred ecCccccChhhhc-CCCCCccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHc
Confidence 5899999999987 5678999999999999999999999996521 1122222221 112234456778999999999
Q ss_pred cCCCCCCC-----CHHHHHH
Q 005999 631 LKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RP-----t~~evl~ 645 (665)
+.||++|| ++.++++
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHc
Confidence 99999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=331.20 Aligned_cols=241 Identities=18% Similarity=0.235 Sum_probs=200.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.++...++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 57999999999999965 6889999998654321 234566889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++...........|
T Consensus 87 ~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g 160 (291)
T cd05612 87 ELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG 160 (291)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence 99999874 345888999999999999999999999 999999999999999999999999999776555445568
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
|+.|+|||++. +..++.++|||||||++|||++|+.||.... .....+.+.... ...+...+..+.+++.+||+.
T Consensus 161 t~~y~aPE~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 161 TPEYLAPEVIQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDDN--PFGIYEKILAGK--LEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred ChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC--cCCCccCCHHHHHHHHHHcCC
Confidence 99999999987 5678999999999999999999999997532 223333222221 122334466799999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 005999 633 SPEQRPA-----MWQVLKM 646 (665)
Q Consensus 633 dP~~RPt-----~~evl~~ 646 (665)
||.+||+ +.|+++.
T Consensus 236 dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CHHHccCCccCCHHHHhcC
Confidence 9999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=316.62 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=209.4
Q ss_pred HHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 392 ASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+..+.||+|.||.|-+|. ...|+.||||.+++.+.. ++..-.+++||++|+.|+||||+.++++|++.+.+.+||||.
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYa 135 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYA 135 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEec
Confidence 345789999999999998 578999999999877553 234556899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+|.|++++.+ .+.+++.+...++.||..|+.|+|+++ ++|||||.+|||+|+++.+||+|||++..+....
T Consensus 136 S~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknr-VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 136 SGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNR-VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred CCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhcc-ceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 99999999985 456999999999999999999999999 9999999999999999999999999998776554
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
.+-.|++-|.+||...+..+-.+.+|-||+||+||-|..|..||++. +....++++..-.......+....-||+
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~GaYrEP~~PSdA~gLIR 284 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGAYREPETPSDASGLIR 284 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhcccccCCCCCchHHHHHH
Confidence 23468999999999986666678999999999999999999999862 3444444443333333445566788999
Q ss_pred HcccCCCCCCCCHHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~L 647 (665)
.||..+|++|-|+.+|....
T Consensus 285 wmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHhcCcccchhHHHHhhhh
Confidence 99999999999999998754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=338.28 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=202.0
Q ss_pred HHhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEE
Q 005999 393 SAELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVI 465 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 465 (665)
..+.||+|+||.||+|.. +++..||||+++.... ....+.+.+|++++..+ +||||++++++|.+.+..++|
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv 117 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVI 117 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceee
Confidence 357899999999999963 3466899999875443 23456788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCC-------------------------------------------------------------
Q 005999 466 YDYQPNGSLFNLIHGSRSI------------------------------------------------------------- 484 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 484 (665)
|||+++|+|.++++..+..
T Consensus 118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (375)
T cd05104 118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ 197 (375)
T ss_pred ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence 9999999999998743210
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-----CC
Q 005999 485 ---------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV-----ED 550 (665)
Q Consensus 485 ---------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----~~ 550 (665)
....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ ..
T Consensus 198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 276 (375)
T cd05104 198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276 (375)
T ss_pred ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCC
Confidence 1235789999999999999999999999 99999999999999999999999999876543221 11
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++|||||||++|||++ |..||.... ........+...... ..+...+..+.+++.+|
T Consensus 277 ~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~c 353 (375)
T cd05104 277 RLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMP-VDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSC 353 (375)
T ss_pred CCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC-chHHHHHHHHhCccC-CCCCCCCHHHHHHHHHH
Confidence 2456799999987 5678999999999999999998 888886532 122333333322211 12234466799999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~ 650 (665)
|+.||++||++.|+++.|++.
T Consensus 354 l~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 354 WDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=326.42 Aligned_cols=244 Identities=30% Similarity=0.504 Sum_probs=196.0
Q ss_pred hHhCcccceEEEEEEEC-----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|.||.||+|.+. .+..|+||.++.... ....+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cccceeeeeccccccccccccccccccccccccccccccccc
Confidence 56999999999999976 477899999965433 344788999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.++++.. ....+++..++.|+.||+.||+|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN-IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT-EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc---cccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence 999999999864 2456899999999999999999999998 9999999999999999999999999987763221
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
........|+|||.+. ...++.++||||||+++|||++ |+.||... ...++...+...... ..+...+..+.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEIIEKLKQGQRL-PIPDNCPKDIY 235 (259)
T ss_dssp EESTTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHHHHHHTTEET-TSBTTSBHHHH
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccccccccccc--ccccccccccccccc-eeccchhHHHH
Confidence 2223567899999987 4568999999999999999999 77888653 233444444333322 23445677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L 647 (665)
+++..||+.||++|||+.++++.|
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.48 Aligned_cols=242 Identities=21% Similarity=0.246 Sum_probs=200.3
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++||||+.+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 367999999999999965 6889999998654321 23346688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 103 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 176 (329)
T PTZ00263 103 GELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKD-IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC 176 (329)
T ss_pred ChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcceec
Confidence 999999874 345788889999999999999999999 99999999999999999999999999987765555557
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+..+.+.... ...+...+..+.+++.+||+
T Consensus 177 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~ 251 (329)
T PTZ00263 177 GTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--PFRIYEKILAGR--LKFPNWFDGRARDLVKGLLQ 251 (329)
T ss_pred CChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCC--cCCCCCCCHHHHHHHHHHhh
Confidence 899999999987 5678999999999999999999999996521 112222222211 12233456678999999999
Q ss_pred CCCCCCCC-----HHHHHHH
Q 005999 632 KSPEQRPA-----MWQVLKM 646 (665)
Q Consensus 632 ~dP~~RPt-----~~evl~~ 646 (665)
.||++||+ +.|++..
T Consensus 252 ~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 252 TDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCHHHcCCCCCCCHHHHhcC
Confidence 99999997 6787753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.95 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=198.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... ++..+|+|.+..... ....+.+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 367999999999999965 678899999876532 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVEDP 551 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 551 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+.|+||||||+||+++.++.+||+|||++...... .....
T Consensus 89 ~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (331)
T cd06649 89 SLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163 (331)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCC
Confidence 99999974 3458899999999999999999998644999999999999999999999999998655432 23345
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHH---------------------------
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEW--------------------------- 604 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~--------------------------- 604 (665)
+|+.|+|||++. +..++.++|||||||++|||++|+.||..... .++...
T Consensus 164 g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 164 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccccCCccccCcccccccccc
Confidence 899999999987 56789999999999999999999999964321 111110
Q ss_pred -------------------HHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 605 -------------------VRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 605 -------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
+.............+..+.+|+.+||+.||++|||+.|+++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 1000000011123456799999999999999999999998854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.35 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=206.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .++..||+|.+..... .....+.+.+|++++++++||||+++++++.+.+..++++||+++|
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08228 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAG 87 (267)
T ss_pred eeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCC
Confidence 5799999999999985 4788999998764322 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 88 ~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 165 (267)
T cd08228 88 DLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165 (267)
T ss_pred cHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhc
Confidence 99998864221 2345888999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+++.|+|||.+. +..++.++||||||+++|||++|+.||........++...+.............+..+.+++.+|
T Consensus 166 ~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 244 (267)
T cd08228 166 LVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMC 244 (267)
T ss_pred CCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHH
Confidence 35788999999986 56788999999999999999999999865332222333333322222223345567899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~ 651 (665)
|+.+|++||++.||++.++.++
T Consensus 245 l~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 245 IYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.41 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=194.7
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh------------hHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD------------TSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-- 458 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-- 458 (665)
.+.||+|.||.|-+|.. .+++.||||++.+..... ...+..++||.+|++++|||||+|+++..+
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 46799999999999994 578999999996543211 123678999999999999999999999876
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeec
Q 005999 459 KGERLVIYDYQPNGSLFNLIHGSRSIRAKP-LHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY 537 (665)
Q Consensus 459 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Df 537 (665)
.+..|||+|||..|.+...- ...+ +++.++++++.++..||+|||.++ ||||||||+|+|++++|+|||+||
T Consensus 182 s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~Qg-iiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHYQG-IIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEEcCCCcEEeecc
Confidence 45899999999999886542 3344 999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCC--------CCCCCCCcccCCccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH
Q 005999 538 CLSVLSDSSS--------VEDPDTVAYKAPEIRKSSR---RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR 606 (665)
Q Consensus 538 gl~~~~~~~~--------~~~~gt~~y~aPE~~~~~~---~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 606 (665)
|.+....... ...+|||.|+|||....+. ....+.||||+||+||.|+.|+.||-+.+ .-++.+.+.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~~~l~~KIv 332 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--ELELFDKIV 332 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--HHHHHHHHh
Confidence 9987552221 2247999999999877422 34678899999999999999999997632 112222222
Q ss_pred hhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 607 TMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 607 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
..........+....+.+||.++|.+||++|.+..+|.....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 221121223345678999999999999999999999876543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.29 Aligned_cols=238 Identities=19% Similarity=0.251 Sum_probs=193.9
Q ss_pred hCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||+|+||.||+|... +++.||+|++..... .....+.+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 578899999865321 223456678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVEDP 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~ 551 (665)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHKFN-VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 999874 345889999999999999999999999 999999999999999999999999998653221 12235
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
||+.|+|||++. +..++.++|||||||++|||++|+.||.... ...+...+. ......+...+..+.+++.+||+
T Consensus 155 gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~ 229 (312)
T cd05585 155 GTPEYLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--VNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLS 229 (312)
T ss_pred CCcccCCHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCCC--HHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcC
Confidence 899999999987 5678999999999999999999999997531 112222111 11222344566789999999999
Q ss_pred CCCCCCCC---HHHHHH
Q 005999 632 KSPEQRPA---MWQVLK 645 (665)
Q Consensus 632 ~dP~~RPt---~~evl~ 645 (665)
.||++||+ +.|++.
T Consensus 230 ~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 230 RDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHcCCCCCHHHHHc
Confidence 99999975 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=334.20 Aligned_cols=240 Identities=23% Similarity=0.366 Sum_probs=193.3
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++|+||+++++++...+..++||||+.+|
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 478999999999999854 688999999865432 244567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+.. ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....... ..
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRRH-IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEcccccceecccccccccc
Confidence 986532 2456778899999999999999999 9999999999999999999999999987654322 23
Q ss_pred CCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--cCCCchhhhHHHHH
Q 005999 550 DPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--VDDGREENRLGMLT 623 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 623 (665)
..||..|+|||++.. +...+.++|||||||++|||++|+.||.... ..+......... .........+..+.
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR--QGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 468999999998742 2334568999999999999999999997422 122222222111 11123345567899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+++.+||+.||++|||+.|+++.
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999874
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=348.17 Aligned_cols=250 Identities=26% Similarity=0.304 Sum_probs=204.8
Q ss_pred HhHhCcccceEEEEEEECCe-EEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeE-EEEe------CCeEEE
Q 005999 394 AELLGRGSIGTTYKAVLDNH-LIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRA-YFQA------KGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~~~~~l 464 (665)
.++|.+|||+.||.|....+ ..+|+|++-.. ++...+.+++||++|++|+ |+|||.+++ .... .-+++|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 46899999999999997665 99999998766 3577888999999999995 999999999 3321 137889
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
+||||.||.|-+++..+- ...|++.++++|+.|+++|+++||... +|||||||-+||||+.+++.||||||.+...
T Consensus 120 LmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred ehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 999999999999998542 234999999999999999999999965 7999999999999999999999999998543
Q ss_pred CCCCC------------CCCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc
Q 005999 544 DSSSV------------EDPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR 609 (665)
Q Consensus 544 ~~~~~------------~~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 609 (665)
-.... ....|+.|+|||++. ++..+++|+|||+|||+||-|+....||++... + .|....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----l--aIlng~ 270 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----L--AILNGN 270 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----e--eEEecc
Confidence 22221 123589999999865 466789999999999999999999999987421 1 011122
Q ss_pred cCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 610 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
........++..+.+||+.||+.||.+||++.+|++.+.++.+.-
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 222334678889999999999999999999999999999886643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=334.17 Aligned_cols=242 Identities=19% Similarity=0.221 Sum_probs=199.3
Q ss_pred HhHhCcccceEEEEEEECC--eEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLDN--HLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
.+.||+|+||.||+|...+ +..||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++||||+.
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 3679999999999998543 36899999865432 12334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED 550 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 550 (665)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++..........
T Consensus 115 ~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~ 188 (340)
T PTZ00426 115 GGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL 188 (340)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEecCCCCeecCCCccee
Confidence 9999999974 346889999999999999999999999 9999999999999999999999999998776555555
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+... ....+...+..+.+++.+|+
T Consensus 189 ~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l 263 (340)
T PTZ00426 189 CGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANE--PLLIYQKILEG--IIYFPKFLDNNCKHLMKKLL 263 (340)
T ss_pred cCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCCC--HHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHc
Confidence 7899999999987 5678899999999999999999999997531 11222222211 11223445667899999999
Q ss_pred cCCCCCCC-----CHHHHHHH
Q 005999 631 LKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RP-----t~~evl~~ 646 (665)
+.||++|+ +++|+++.
T Consensus 264 ~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 264 SHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ccCHHHcCCCCCCCHHHHHcC
Confidence 99999995 89988764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.63 Aligned_cols=239 Identities=18% Similarity=0.249 Sum_probs=196.1
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.||+|+||.||++.. .++..||+|++..... .......+.+|++++++++||||++++++|...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 589999999999985 4688999999875432 12344567789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 82 LFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 9998863 346899999999999999999999999 999999999999999999999999998653221 1223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+. ......+...+..+.+++.+||
T Consensus 156 ~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L 230 (323)
T cd05595 156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELIL--MEEIRFPRTLSPEAKSLLAGLL 230 (323)
T ss_pred cCCcCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHc
Confidence 5899999999987 5678999999999999999999999997532 112222211 1112234456778999999999
Q ss_pred cCCCCCCC-----CHHHHHH
Q 005999 631 LKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RP-----t~~evl~ 645 (665)
+.||++|| ++.++++
T Consensus 231 ~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 231 KKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred cCCHHHhCCCCCCCHHHHHc
Confidence 99999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=321.57 Aligned_cols=250 Identities=23% Similarity=0.405 Sum_probs=203.9
Q ss_pred HhHhCcccceEEEEEEECC------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|.... ...|++|.+..... ....+.+.+|++.+++++||||+++++++...+..+++||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence 3679999999999998532 35799999875543 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEee
Q 005999 468 YQPNGSLFNLIHGSRSIRA-----------KPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTD 536 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~D 536 (665)
|+++|+|.+++........ ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccccceEEEcCCCcEEECC
Confidence 9999999999975322111 46889999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhcc
Q 005999 537 YCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRV 610 (665)
Q Consensus 537 fgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 610 (665)
||++....... ....+++.|+|||++. ...++.++|||||||++|||++ |..||.... ..++...+.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--~~~~~~~i~~~~~ 244 (283)
T cd05048 168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--NQEVIEMIRSRQL 244 (283)
T ss_pred CcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcCCc
Confidence 99987553322 1224578899999886 5678999999999999999998 999987532 2344444432221
Q ss_pred CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 611 DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 611 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
. ..+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 245 ~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 245 L-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred C-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 2345677889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.61 Aligned_cols=245 Identities=25% Similarity=0.422 Sum_probs=203.0
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||.||+|...++..|++|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++|+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 46799999999999998888889999986543 345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----C
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----E 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~ 549 (665)
|.++++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .
T Consensus 88 L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 88 LLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN-YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred HHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 99998743 2356888999999999999999999999 99999999999999999999999999976644221 1
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
..++..|+|||++. ...++.++|||||||++|||++ |+.||... ...+....+..... .......+..+.+++.+
T Consensus 164 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 164 AKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--SNSDVMSALQRGYR-MPRMENCPDELYDIMKT 239 (261)
T ss_pred CccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHH
Confidence 23466899999986 5678899999999999999998 99998652 22233333332211 12233566789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~ 649 (665)
|++.+|++||++.++.+.|++
T Consensus 240 ~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 240 CWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=329.59 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=212.5
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe-EEEEEEecC
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE-RLVIYDYQP 470 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~ 470 (665)
..+.+|+|+||.++.++.+ ++..+++|.+......+..++...+|+.++++++|||||.+.+.|.+++. .++||+|++
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 3478999999999999844 57789999998877766777789999999999999999999999999888 999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
||++.+.+...+ +..++++.+..|+.|++.|++|||++. |.|||||+.||+++.+..|||+|||+|+.+....
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~-iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR-VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh-hhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence 999999998754 567999999999999999999999887 9999999999999999999999999998887653
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC--CCchhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD--DGREENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 625 (665)
...+||+.||.||.+. +..|..|+||||+||++|||++-+++|... ++...+...... ...+..++..+..+
T Consensus 164 ~tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred heecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhccCCCCCccccHHHHHH
Confidence 4457999999999987 789999999999999999999999999874 232222222221 24566788899999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~ 646 (665)
+..|+..+|+.||++.+++.+
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.47 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=207.1
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||++.. .++..++||.+..... .....+.+.+|+.+++.++|+||+++++++.+++..+++|||+++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 46799999999999994 5788999998865432 223456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 548 (665)
++|.+++.... .....+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 87 ~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd08229 87 GDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164 (267)
T ss_pred CCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccc
Confidence 99999986422 13456899999999999999999999999 9999999999999999999999999986654322 1
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...++..|+|||++. +..++.++||||||+++|||++|..||.............+.............+..+.+++.+
T Consensus 165 ~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T cd08229 165 SLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243 (267)
T ss_pred cccCCcCccCHHHhc-CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHH
Confidence 235788999999986 5678899999999999999999999986532222222222222222222234466789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
|++.||++|||+.+|++.+++++
T Consensus 244 ~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 244 CINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hcCCCcccCCCHHHHHHHHhhhc
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.24 Aligned_cols=243 Identities=18% Similarity=0.199 Sum_probs=200.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 57999999999999965 5889999998754321 123456888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...........|
T Consensus 87 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g 160 (333)
T cd05600 87 DFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELG-YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG 160 (333)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence 99999973 345889999999999999999999999 999999999999999999999999999776554455578
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--C----chhhhHHHHHHHH
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--G----REENRLGMLTEVA 626 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~l~~li 626 (665)
|+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+....... . .....+..+.+++
T Consensus 161 t~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 161 SPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred CccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCC--HHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 99999999987 5688999999999999999999999997532 122222222111111 0 1123467799999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~ 646 (665)
.+|+..+|++||++.|+++.
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHhhChhhhcCCHHHHHhC
Confidence 99999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.39 Aligned_cols=241 Identities=25% Similarity=0.398 Sum_probs=198.4
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 86 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence 5699999999999998888889999886443 2345788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~ 550 (665)
.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+....... ...
T Consensus 87 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05114 87 LNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNS-FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161 (256)
T ss_pred HHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence 9998742 235889999999999999999999999 9999999999999999999999999886543221 112
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+...... ..+...+..+.+++.+|
T Consensus 162 ~~~~~y~aPE~~~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~c 237 (256)
T cd05114 162 KFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEMISRGFRL-YRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCchhhCChhhcc-cCccchhhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHH
Confidence 3456899999986 5678999999999999999999 89998653 222333333322111 12333456799999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L 647 (665)
|+.+|++||++.|+++.|
T Consensus 238 ~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 238 WHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ccCCcccCcCHHHHHHhh
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=334.87 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=203.4
Q ss_pred HHHhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEE
Q 005999 392 ASAELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 464 (665)
...++||+|+||.||+|... .+..||||++..... ....+.+.+|+++++++. ||||++++++|.+.+..++
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 34578999999999999852 234799999976543 234567899999999995 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCC------------------------------------------------------------
Q 005999 465 IYDYQPNGSLFNLIHGSRSI------------------------------------------------------------ 484 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~------------------------------------------------------------ 484 (665)
||||+++|+|.++++..+..
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999999998753210
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 485 -------------------------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 485 -------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-CVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHhEEEeCCCEEE
Confidence 1134788889999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHh
Q 005999 534 LTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT 607 (665)
Q Consensus 534 l~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 607 (665)
|+|||++....... ....++..|+|||++. +..++.++|||||||++|||++ |..||..... ...+...+..
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-~~~~~~~~~~ 355 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-DSTFYNKIKS 355 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-hHHHHHHHhc
Confidence 99999987543321 1223567899999987 5678999999999999999997 9999875321 1122222222
Q ss_pred hccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 608 MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 608 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
.. ........+..+.+++.+||+.||++||++.++.+.|+++.+
T Consensus 356 ~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 356 GY-RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CC-CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11 112334567789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.67 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=199.6
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-----CCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-----KGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~ 468 (665)
+.||+|+||.|+.+.. .+|+.||||++..........+...+|+.+++.++|+||+.+.+.+.. -..+|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 5799999999999984 578999999998666556677888999999999999999999999855 3578999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS--- 545 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~--- 545 (665)
|+. +|.+.++. .+.++..++..+++||++||+|+|+.+ |+||||||+|++++.++.+||+|||+|+..+.
T Consensus 108 Met-DL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAn-ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 108 MET-DLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSAN-VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred Hhh-HHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhccc-ccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 954 99999984 345899999999999999999999999 99999999999999999999999999988753
Q ss_pred --CCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-------------Ccc---------H
Q 005999 546 --SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA-------------PPD---------M 601 (665)
Q Consensus 546 --~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~-------------~~~---------~ 601 (665)
..++.+.|..|+|||.+.....|+...||||.||++.||++|++-|.+...- +.+ .
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 2245567999999999888889999999999999999999999988753210 000 1
Q ss_pred HHHHHhhccCCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 602 LEWVRTMRVDDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 602 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+++....... ..........+++.+||..||.+|+|++|+++
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111111110 11234456889999999999999999999987
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.02 Aligned_cols=244 Identities=20% Similarity=0.328 Sum_probs=200.4
Q ss_pred HhCcccceEEEEEEE---CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|.+ +++..+|+|+++.........+.+.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 489999999999964 367889999987665444566789999999999999999999998864 4678999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETN-FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999863 245889999999999999999999999 99999999999999999999999999876543221
Q ss_pred --CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 549 --EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 549 --~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
...++..|+|||.+. ...++.++|||||||++|||++ |+.||... ...+....++.... ...+...+..+.++
T Consensus 155 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~l 230 (257)
T cd05116 155 KTHGKWPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIESGER-MECPQRCPPEMYDL 230 (257)
T ss_pred cCCCCCCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHCCCC-CCCCCCCCHHHHHH
Confidence 112357899999886 5678889999999999999998 99999753 22344444443221 22344567789999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
+.+|++.||++||++.+|.+.|++.
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.12 Aligned_cols=246 Identities=18% Similarity=0.200 Sum_probs=196.6
Q ss_pred hCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||+|+||+||++... +++.||+|.+...... ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 6889999998654321 12335677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VEDP 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~ 551 (665)
.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR-IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 98875322 13456899999999999999999999999 9999999999999999999999999986554322 2235
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc-cCCCchhhhHHHHHHHHHHcc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl 630 (665)
||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......... .....+...+..+.+++.+||
T Consensus 159 g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 159 GTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 889999999987 5678999999999999999999999997532211 1111111111 111233456778999999999
Q ss_pred cCCCCCCC-----CHHHHHHH
Q 005999 631 LKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RP-----t~~evl~~ 646 (665)
+.||++|| +++++++.
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 77788763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=329.57 Aligned_cols=240 Identities=19% Similarity=0.263 Sum_probs=197.1
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.||+|+||.||++.. .++..||+|++..... .......+.+|+++++.++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 589999999999985 4688999999875432 12345667889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 82 LFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 9998863 346899999999999999999999999 999999999999999999999999998653221 1223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+. ......+...+..+.+++.+||
T Consensus 156 ~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~--~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L 230 (328)
T cd05593 156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELIL--MEDIKFPRTLSADAKSLLSGLL 230 (328)
T ss_pred cCCcCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCC--HHHHHHHhc--cCCccCCCCCCHHHHHHHHHHc
Confidence 5899999999987 5678999999999999999999999996531 112222221 1112234456678999999999
Q ss_pred cCCCCCCC-----CHHHHHHH
Q 005999 631 LKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RP-----t~~evl~~ 646 (665)
+.||++|| ++.|+++.
T Consensus 231 ~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 231 IKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHcCCCCCCCHHHHhcC
Confidence 99999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.32 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=201.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... .+..|++|.+.... ...+.+.+|++++++++|+||+++++++..++..+++|||+++++
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 57999999999999854 58889999986543 345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC----
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE---- 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~---- 549 (665)
|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 89 L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 89 LLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred HHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 99998743 2346899999999999999999999999 999999999999999999999999998766543211
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...+..|+|||++. +..++.++|||||||++|||++ |..||.... ..+....+... .....+...+..+.+++.+
T Consensus 165 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 165 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKG-YRMERPEGCPPKVYELMRA 240 (263)
T ss_pred CCCccccCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCC-CCCCCCCCCCHHHHHHHHH
Confidence 12356799999886 5678999999999999999998 999986521 12222222221 1122345567789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~~ 650 (665)
|++.+|++||++.|+++.|+++
T Consensus 241 cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HccCCcccCCCHHHHHHHHHhh
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=314.43 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=207.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.|++|.++..... ....+.+.+|++++++++|+|++++++++..++..++||||+++|
T Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (267)
T cd08224 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAG 87 (267)
T ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCC
Confidence 56999999999999976 7889999988653322 234667899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++..... ....+++.+++.++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++....... ..
T Consensus 88 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 165 (267)
T cd08224 88 DLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR-IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 165 (267)
T ss_pred CHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecCCcChhhEEECCCCcEEEeccceeeeccCCCcccce
Confidence 99999864321 3456899999999999999999999999 9999999999999999999999999986554322 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..++..|+|||.+. +..++.++|||||||++|+|++|+.||........++.+...............+..+.+++.+|
T Consensus 166 ~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 244 (267)
T cd08224 166 LVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRC 244 (267)
T ss_pred ecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHH
Confidence 35788899999886 56789999999999999999999999865332222222222222222222235667899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~ 651 (665)
+..+|++|||+.++++.|++++
T Consensus 245 l~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 245 INPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.49 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=198.0
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
.||+|+||.||+|.. .+++.+|+|.+..... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 589999999999986 4788899998865432 34456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC-----
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE----- 549 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~----- 549 (665)
.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKH-CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999864 2345889999999999999999999999 999999999999999999999999998654432211
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...+..|+|||.+. +..++.++|||||||++|||++ |..||.... .......+... .....+...+..+.+++.+
T Consensus 156 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 156 KQIPVKWTAPEALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANLS--NQQTREAIEQG-VRLPCPELCPDAVYRLMER 231 (252)
T ss_pred CCCceeecCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccC--HHHHHHHHHcC-CCCCCcccCCHHHHHHHHH
Confidence 11245699999987 5668999999999999999997 888886532 12222222221 1112344567789999999
Q ss_pred cccCCCCCCCCHHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~ 648 (665)
|++.+|++|||+.|+++.|+
T Consensus 232 ~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=327.78 Aligned_cols=240 Identities=20% Similarity=0.276 Sum_probs=195.1
Q ss_pred hHhCcccceEEEEEEE----CCeEEEEEEEecCCCc--hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKT--ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||++.. ..++.||+|+++.... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4699999999999985 3578899999875422 122345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-- 546 (665)
+++|+|.+++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999873 345788888899999999999999999 999999999999999999999999998643221
Q ss_pred -CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 547 -SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 547 -~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+.. .....+...+..+.++
T Consensus 156 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~pf~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~l 230 (323)
T cd05584 156 VTHTFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--RKKTIDKILK--GKLNLPPYLTPEARDL 230 (323)
T ss_pred cccccCCCccccChhhcc-CCCCCCcceecccHHHHHHHhcCCCCCCCCC--HHHHHHHHHc--CCCCCCCCCCHHHHHH
Confidence 12235899999999987 5678899999999999999999999997532 1122222211 1122344556779999
Q ss_pred HHHcccCCCCCCC-----CHHHHHH
Q 005999 626 ASVCSLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RP-----t~~evl~ 645 (665)
+.+|++.||++|| ++.++++
T Consensus 231 i~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 231 LKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHcccCHhHcCCCCCCCHHHHhc
Confidence 9999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.29 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=206.4
Q ss_pred HHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 391 RASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 391 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+...+.||+|+||.||+|...++..+++|.+..... ...+.+.+|+.+++.++|+||+++++++.+....++||||++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 344578999999999999988899999999876542 345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+++|.+++... ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||.+.......
T Consensus 86 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 86 KGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN-SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred cCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 99999999753 2456899999999999999999999999 9999999999999999999999999986654322
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....++..|+|||.+. ...++.++||||||+++|+|++ |+.||.... ..+....+.... ........+..+.+++
T Consensus 162 ~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~i 237 (261)
T cd05148 162 SDKKIPYKWTAPEAAS-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITAGY-RMPCPAKCPQEIYKIM 237 (261)
T ss_pred cCCCCceEecCHHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHhCC-cCCCCCCCCHHHHHHH
Confidence 1223567899999886 5678899999999999999998 899986532 223333333211 1123446677899999
Q ss_pred HHcccCCCCCCCCHHHHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
.+|++.||++|||+.++++.|+.
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhc
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.06 Aligned_cols=242 Identities=17% Similarity=0.262 Sum_probs=194.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||++... +++.||+|++......+...+.+.+|++++++++||||+++++++..++..++||||++++.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 57999999999999975 67889999997665444556678899999999999999999999999999999999999877
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 549 (665)
+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 87 l~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 87 LELLEE-----MPNGVPPEKVRSYIYQLIKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred HHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 765543 2345889999999999999999999999 9999999999999999999999999987654321 12
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc------------C------
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV------------D------ 611 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------~------ 611 (665)
..+++.|+|||++. +..++.++|||||||++|||++|+.||....... .... +..... .
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 161 YVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFT-IQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhCCCCHHHHHhhhccchhccc
Confidence 35789999999987 5678999999999999999999999997532111 1111 100000 0
Q ss_pred ---CC---------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 ---DG---------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 ---~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.. .....+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 01124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.02 Aligned_cols=244 Identities=20% Similarity=0.285 Sum_probs=195.7
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..+.||+|+||.||++... ++..+|+|.+..... ....+.+.+|++++++++||||++++++|.+++..++||||+++
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCC
Confidence 3467999999999999965 678899998876532 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVED 550 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 550 (665)
|+|.+++.. ...+++..+..++.|++.||+|||+.+.|+||||||+||+++.++.+||+|||++...... ....
T Consensus 88 ~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 88 GSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 999999974 3458889999999999999999998534999999999999999999999999998655332 2234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHH---------------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE--------------------------- 603 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~--------------------------- 603 (665)
.++..|+|||++. +..++.++|||||||++|||++|+.||...... ++..
T Consensus 163 ~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 163 VGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK--ELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred CCCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh--HHHHHhcCcccCCccccccCcccCCccchhh
Confidence 5889999999987 567899999999999999999999998753211 1100
Q ss_pred -----------------HHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 604 -----------------WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 604 -----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
++.............+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000000000011123467899999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.13 Aligned_cols=249 Identities=22% Similarity=0.390 Sum_probs=203.3
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|... ++..||+|.++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence 477999999999999853 347899999876543 2345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecc
Q 005999 468 YQPNGSLFNLIHGSRS---------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYC 538 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfg 538 (665)
|+++++|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~kl~d~g 167 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-FVHRDLATRNCLVGYDLVVKIGDFG 167 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eeccccccceEEEcCCCeEEECCcc
Confidence 9999999999975321 12345889999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCC
Q 005999 539 LSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDD 612 (665)
Q Consensus 539 l~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 612 (665)
++....... ....+++.|+|||++. +..++.++|||||||++|||++ |+.||.... ..+....+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~~~~~~~~~- 243 (280)
T cd05049 168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIECITQGRLL- 243 (280)
T ss_pred cceecccCcceecCCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCcC-
Confidence 986543221 1223467899999987 5678999999999999999998 999986532 22333333322221
Q ss_pred CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 613 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
......+..+.+++.+||+.||++||++.|+++.|+
T Consensus 244 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 223456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.16 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=196.2
Q ss_pred HhHhCcccceEEEEEEE----CCeEEEEEEEecCCCc--hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKT--ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||++.. .++..||+|++..... .....+.+.+|+.++..+ +|+||+++++++..++..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 36799999999999875 3678999999865322 123345678899999999 5999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 85 DYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLG-IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred eCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999873 345889999999999999999999999 999999999999999999999999998654322
Q ss_pred C----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCCCchhhhHH
Q 005999 547 S----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 547 ~----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 620 (665)
. ....||+.|+|||++.+...++.++|||||||++|||++|+.||........ .+...+. ......+...+.
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDPPFPSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCH
Confidence 1 2235899999999987444578899999999999999999999975322211 1221111 112223445677
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RP-----t~~evl~~ 646 (665)
.+.+++.+||+.||++|| +++++++.
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 899999999999999999 77788753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.33 Aligned_cols=250 Identities=18% Similarity=0.290 Sum_probs=200.4
Q ss_pred HhHhCcccceEEEEEEEC-CeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||+|.+. ++. .||+|.++.... ....+.+.+|+.+++.++||||+++++++... ..++++||
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 467999999999999853 333 489999865432 34456788999999999999999999999765 56799999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV 548 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 548 (665)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~-iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 90 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred CCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 9999999999742 345889999999999999999999999 99999999999999999999999999976543221
Q ss_pred -----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 549 -----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 549 -----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
....+..|+|||++. ...++.++|||||||++|||++ |+.||.... ..++........ ....+..++..+
T Consensus 165 ~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (316)
T cd05108 165 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGE-RLPQPPICTIDV 240 (316)
T ss_pred ceeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhCCC-CCCCCCCCCHHH
Confidence 112356899999987 5678999999999999999998 999987531 123333222211 112234456779
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+++.+||..+|++||++.+++..+..+..+.
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.70 Aligned_cols=237 Identities=23% Similarity=0.313 Sum_probs=194.3
Q ss_pred hHhCcccceEEEEEEE----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||++.. .++..||+|++............+.+|++++++++||||+++++++.+++..++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 367899999997654333344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---C
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---S 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~ 547 (665)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999999863 346899999999999999999999999 999999999999999999999999998765433 1
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+.. .....+...+..+.+++.
T Consensus 156 ~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~i~~--~~~~~p~~~~~~~~~li~ 230 (318)
T cd05582 156 YSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--RKETMTMILK--AKLGMPQFLSPEAQSLLR 230 (318)
T ss_pred ecccCChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCCC--HHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 2335899999999987 5678899999999999999999999997531 1222222221 112234455677999999
Q ss_pred HcccCCCCCCCCHHH
Q 005999 628 VCSLKSPEQRPAMWQ 642 (665)
Q Consensus 628 ~cl~~dP~~RPt~~e 642 (665)
+||+.||++||++.+
T Consensus 231 ~~l~~~P~~R~~a~~ 245 (318)
T cd05582 231 ALFKRNPANRLGAGP 245 (318)
T ss_pred HHhhcCHhHcCCCCC
Confidence 999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=317.53 Aligned_cols=253 Identities=22% Similarity=0.402 Sum_probs=204.8
Q ss_pred HhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 46799999999999974 235678999886543 2445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 468 YQPNGSLFNLIHGSRS--------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
|+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~ 166 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGM 166 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcEEeccCCc
Confidence 9999999999974321 12235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCC
Q 005999 540 SVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG 613 (665)
Q Consensus 540 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 613 (665)
+....... ....++..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+....+...... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--~~~~~~~i~~~~~~-~ 242 (288)
T cd05093 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIECITQGRVL-Q 242 (288)
T ss_pred cccccCCceeecCCCCCccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCcC-C
Confidence 87553322 1223467899999987 5678999999999999999998 899986532 22333333322211 1
Q ss_pred chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 614 REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 614 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
.....+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2334567799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.90 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=202.1
Q ss_pred HHHhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEe-CCeEE
Q 005999 392 ASAELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQA-KGERL 463 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~~~~ 463 (665)
...+.||+|+||.||+|... +++.||+|+++.... ....+.+.+|+.++.++ +|+||++++++|.. +...+
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 34578999999999999632 347899999875443 23345678899999999 89999999998865 45688
Q ss_pred EEEEecCCCCHHHHHhcCCCC--------------------------------------------------------CCC
Q 005999 464 VIYDYQPNGSLFNLIHGSRSI--------------------------------------------------------RAK 487 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~ 487 (665)
+++||+++|+|.+++...... ...
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999998643210 013
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----CCCCCCCcccCCccc
Q 005999 488 PLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIR 562 (665)
Q Consensus 488 ~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~ 562 (665)
.++|..+.+++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....... ....++..|+|||++
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~-ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 6899999999999999999999999 9999999999999999999999999997653221 112356789999998
Q ss_pred cCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHH
Q 005999 563 KSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMW 641 (665)
Q Consensus 563 ~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 641 (665)
. +..++.++|||||||++|||++ |+.||..... ...+...+..... ...+...+..+.+++.+||+.+|++||++.
T Consensus 248 ~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 248 F-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-DEEFCRRLKEGTR-MRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred c-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-cHHHHHHHhccCC-CCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 7 5679999999999999999998 9999875322 1222222222111 112334566799999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 005999 642 QVLKMIQEIKES 653 (665)
Q Consensus 642 evl~~L~~~~~~ 653 (665)
|+++.|+++.+.
T Consensus 325 ell~~l~~~~~~ 336 (337)
T cd05054 325 ELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHHHhc
Confidence 999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.38 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=201.8
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|++|.||+|...++..||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05068 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88 (261)
T ss_pred EEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence 6799999999999998888889999987543 2356688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-CCC--
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV-EDP-- 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~-- 551 (665)
.+++... ....+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||++........ ...
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05068 89 LEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQN-YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164 (261)
T ss_pred HHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence 9998743 2346899999999999999999999999 99999999999999999999999999876543221 112
Q ss_pred -CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 -DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 -gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.+..|+|||++. +..++.++||||||+++|||++ |+.||... ........+.... ........+..+.+++.+|
T Consensus 165 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 240 (261)
T cd05068 165 KFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--TNAEVLQQVDQGY-RMPCPPGCPKELYDIMLDC 240 (261)
T ss_pred cCceeccCccccc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHH
Confidence 235799999887 5678999999999999999999 99998653 1222333222211 1123345667899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~ 649 (665)
++.+|++||++.++++.|++
T Consensus 241 l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 241 WKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred hhcCcccCCCHHHHHHHHhc
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.68 Aligned_cols=243 Identities=20% Similarity=0.281 Sum_probs=193.8
Q ss_pred hCcccceEEEEEEE-CCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||+|+||.||++.. .+++.||+|++....... ...+.+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999985 468899999986533211 2234556799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VEDPD 552 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~~g 552 (665)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....+
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC-EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence 9988643 2345889999999999999999999999 9999999999999999999999999987654322 23458
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHHHHcc
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVASVCS 630 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl 630 (665)
+..|+|||++. +..++.++||||+||++|||++|+.||....... ............. ......+..+.+++.+||
T Consensus 157 ~~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 234 (277)
T cd05607 157 TNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEVKFEHQNFTEESKDICRLFL 234 (277)
T ss_pred CCCccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccccccccccCCHHHHHHHHHHh
Confidence 89999999987 5569999999999999999999999987532211 1112212111111 112345677999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
+.||++||+++|+++
T Consensus 235 ~~~P~~R~~~~~~~~ 249 (277)
T cd05607 235 AKKPEDRLGSREKND 249 (277)
T ss_pred ccCHhhCCCCccchh
Confidence 999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.50 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=197.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-----eEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG-----ERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~ 468 (665)
+++|+|+||.||+|.+. +++.||||+.-.... .-.+|+++|++++|||||++..+|.... ...+||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 68999999999999954 568999999865543 2246899999999999999999886533 23489999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~ 547 (665)
|+. +|.+.++.. ......++.-.+.-+.+||.+||+|||+.+ |+||||||+|+|+|.+ |.+||||||.|+......
T Consensus 104 mP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 104 MPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSHG-ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred chH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhcC-cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 998 999998742 112345666777789999999999999988 9999999999999965 999999999998765433
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC------------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG------------ 613 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------------ 613 (665)
.....|..|+|||.+.+...|+.+.||||.|||+.||+-|++-|.+. ....++.+.++.+..+..
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 33457899999999998889999999999999999999999988762 222355555554443320
Q ss_pred --------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHhh
Q 005999 614 --------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIKES 653 (665)
Q Consensus 614 --------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~ 653 (665)
.....+.+..+|+.+++..+|.+|.++.|++. ...++++.
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 12344567899999999999999999999985 44555444
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.60 Aligned_cols=242 Identities=17% Similarity=0.282 Sum_probs=192.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..||+|+++.... ......+.+|++++++++||||+++++++..++..++||||+.+ +
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 88 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D 88 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence 57999999999999854 688999999865432 12344577899999999999999999999999999999999975 9
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....... ...
T Consensus 89 l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~ 163 (288)
T cd07871 89 LKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK-ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163 (288)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence 99988642 345788999999999999999999999 9999999999999999999999999986543221 233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-C------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-D------------------ 611 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~------------------ 611 (665)
.+++.|+|||++.+...++.++||||+||++|||++|+.||..... .+....+..... .
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 5789999999987556789999999999999999999999975321 111111110000 0
Q ss_pred --C-------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 --D-------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 --~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. ......+....+++.+|++.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.22 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=197.5
Q ss_pred HhHhCcccceEEEEEEEC-C-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-N-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... + +..|++|.+.... ......+++|+.+++.++||||+++++++..++..++||||+++
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g 149 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence 367999999999999843 3 6778888764433 23445678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.++++... ....++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 150 g~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 150 GDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK-MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 99999886422 13456889999999999999999999999 9999999999999999999999999997654322
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..++...+...... ..+...+..+.+++
T Consensus 228 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--~~~~~~~~~~~~~~-~~~~~~s~~~~~li 303 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKGPS--QREIMQQVLYGKYD-PFPCPVSSGMKALL 303 (478)
T ss_pred ccccCCCccccCHhHhC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC-CCCccCCHHHHHHH
Confidence 2234899999999987 5678999999999999999999999997531 12222222221111 12334567799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.||++||++.+++.
T Consensus 304 ~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHhccChhhCcCHHHHHh
Confidence 9999999999999999875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=312.96 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=203.5
Q ss_pred HhHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe------EE
Q 005999 394 AELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE------RL 463 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 463 (665)
.+.||+|+||.||+|.... +..||+|+++.........+.+.+|++.++.++||||+++++++..... .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 3679999999999998542 3679999997655444556778999999999999999999998866544 78
Q ss_pred EEEEecCCCCHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 464 VIYDYQPNGSLFNLIHGSRSI-RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+++||+++|+|.+++...+.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 162 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-FIHRDLAARNCMLREDMTVCVADFGLSKK 162 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchheEEECCCCeEEECCccceee
Confidence 999999999999998643321 2346899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCC-----CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 543 SDSSSVE-----DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 543 ~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
....... ...+..|+|||++. ...++.++|||||||++|||++ |..||... ...+..+.+..... ...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~ 238 (273)
T cd05035 163 IYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGV--ENHEIYDYLRHGNR-LKQPE 238 (273)
T ss_pred ccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCc
Confidence 5433211 12456899999986 5678999999999999999999 88888653 22234443332211 12344
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
..+..+.+++.+|++.||++|||+.|+++.|+++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 5677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=313.14 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=200.2
Q ss_pred HhHhCcccceEEEEEEECCe---EEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEE
Q 005999 394 AELLGRGSIGTTYKAVLDNH---LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 464 (665)
.+.||+|+||.||+|...+. ..+|+|.++.........+.+.+|+++++.++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 36799999999999986543 3689999876544445567889999999999999999999987432 24689
Q ss_pred EEEecCCCCHHHHHhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 465 IYDYQPNGSLFNLIHGSRS-IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
++||+.+|+|.+++...+. .....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 162 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-FIHRDLAARNCMLNENMNVCVADFGLSKKI 162 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhheEEcCCCCEEECCCCccccc
Confidence 9999999999998753322 12345899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 544 DSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 544 ~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
..... ...+++.|+|||+.. ...++.++|||||||++|||++ |+.||... ....+...+...... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~ 238 (272)
T cd05075 163 YNGDYYRQGRIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDYLRQGNRL-KQPPD 238 (272)
T ss_pred CcccceecCCcccCCcccCCHHHcc-CCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCC
Confidence 43221 123467899999987 5678999999999999999999 88898652 222333333322111 12345
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 667799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=326.92 Aligned_cols=257 Identities=20% Similarity=0.318 Sum_probs=202.9
Q ss_pred HHHHHhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeE
Q 005999 390 MRASAELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGER 462 (665)
Q Consensus 390 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 462 (665)
.....+.||+|+||.||+|.+. .+..||+|+++..... ...+.+.+|++++.++. ||||+++++++...+..
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 3345688999999999999853 3468999999765432 33456889999999997 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCC-----------------------------------------------------------
Q 005999 463 LVIYDYQPNGSLFNLIHGSRS----------------------------------------------------------- 483 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 483 (665)
++|+||+++|+|.++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975321
Q ss_pred ----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC
Q 005999 484 ----------------------------------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD 529 (665)
Q Consensus 484 ----------------------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~ 529 (665)
.....+++..++.++.||+.||+|||+.+ ++||||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-CVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-cCcccCCcceEEEeCC
Confidence 01124678888999999999999999998 9999999999999999
Q ss_pred CceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHH
Q 005999 530 FEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 530 ~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 603 (665)
+.+||+|||++....... ....++..|+|||++. ...++.++|||||||++|||++ |..||..... ......
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-~~~~~~ 353 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-NEQFYN 353 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhc-CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-hHHHHH
Confidence 999999999987543211 1223567899999987 5678999999999999999998 8889865321 111222
Q ss_pred HHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 604 WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
.+... .....+...+..+.+++.+||..+|++||++.||++.|+.+.
T Consensus 354 ~~~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 354 AIKRG-YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 22111 111223345678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.87 Aligned_cols=243 Identities=21% Similarity=0.281 Sum_probs=193.7
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... +++.||+|+++.... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5899999999999954 678899999976432 123445677888888776 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~ 549 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 82 DLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 99998863 346899999999999999999999999 99999999999999999999999999865322 1223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---CccHHHHHHhh--ccCCCchhhhHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA---PPDMLEWVRTM--RVDDGREENRLGMLTE 624 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 624 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||...... ......++... ......+...+..+.+
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 35899999999987 667899999999999999999999999632211 11111221111 1112234456677899
Q ss_pred HHHHcccCCCCCCCC------HHHHHH
Q 005999 625 VASVCSLKSPEQRPA------MWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt------~~evl~ 645 (665)
++.+||+.||++||+ +.++++
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=310.70 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=198.8
Q ss_pred HHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 393 SAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..+.||+|+||.||++..+++..+|+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++|+||++++
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 346799999999999998877789999986543 23356788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC---
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE--- 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~--- 549 (665)
+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 85 CLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNG-FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999998742 236899999999999999999999999 999999999999999999999999998655432211
Q ss_pred -CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 550 -DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 550 -~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
..++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+..... ...+...+..+.+++.
T Consensus 160 ~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 235 (256)
T cd05059 160 GTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--SNSEVVESVSAGYR-LYRPKLAPTEVYTIMY 235 (256)
T ss_pred CCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHH
Confidence 12345799999987 5678999999999999999999 89998653 22233333322111 1223446778999999
Q ss_pred HcccCCCCCCCCHHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~L 647 (665)
+|+..+|++|||+.|+++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=307.74 Aligned_cols=243 Identities=23% Similarity=0.369 Sum_probs=199.8
Q ss_pred HhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCHH
Q 005999 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLF 475 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 475 (665)
+||+|+||.||+|...++..+|+|.+..... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 6899999999999988888999999876543 234456889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----CCC
Q 005999 476 NLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----EDP 551 (665)
Q Consensus 476 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~~ 551 (665)
+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK----KDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 998642 245789999999999999999999999 99999999999999999999999999865443221 123
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
++..|+|||++. +..++.++||||||+++||+++ |..||.... .......+.... ........+..+.+++.+|+
T Consensus 156 ~~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 156 IPIKWTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPYPGMT--NQQAREQVEKGY-RMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred CcccccCHHHhc-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 456799999986 5678999999999999999998 999986532 222222222211 11223456678999999999
Q ss_pred cCCCCCCCCHHHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~L~ 648 (665)
+.+|++||++.|+++.|.
T Consensus 232 ~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 232 DYKPENRPKFSELQKELA 249 (250)
T ss_pred ccCcccCCCHHHHHHHhc
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=308.99 Aligned_cols=243 Identities=19% Similarity=0.370 Sum_probs=197.2
Q ss_pred hCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 397 LGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
||+|+||.||+|.+. .+..||+|++..... ....+.+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999753 456799999875532 3445678999999999999999999998864 46899999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-----
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----- 548 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 548 (665)
|.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKN-FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcC-eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 346899999999999999999999999 99999999999999999999999999865433211
Q ss_pred -CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 549 -EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 549 -~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
...++..|+|||++. ...++.++|||||||++||+++ |+.||... ...+....+..... ...+...+..+.+++
T Consensus 156 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 231 (257)
T cd05115 156 SAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--KGPEVMSFIEQGKR-LDCPAECPPEMYALM 231 (257)
T ss_pred CCCCCCcccCCHHHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--CHHHHHHHHHCCCC-CCCCCCCCHHHHHHH
Confidence 112356899999886 5678999999999999999996 99998753 22233333332221 223445677899999
Q ss_pred HHcccCCCCCCCCHHHHHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.+||..+|++||++.+|.+.|+++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHcCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.97 Aligned_cols=242 Identities=25% Similarity=0.364 Sum_probs=198.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||+.+|+|
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 5699999999999998877789999987543 2345688999999999999999999999998899999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----CC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----ED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~ 550 (665)
.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.+........ ..
T Consensus 87 ~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05113 87 LNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQ-FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161 (256)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence 9998742 236899999999999999999999999 99999999999999999999999999865533221 12
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+....+...... ......+..+.+++.+|
T Consensus 162 ~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~c 237 (256)
T cd05113 162 KFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKVSQGLRL-YRPHLASEKVYAIMYSC 237 (256)
T ss_pred ccChhhCCHHHHh-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHH
Confidence 3456799999986 5668899999999999999998 999986532 22333333222111 12334567899999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~ 648 (665)
|+.+|++||++.++++.|+
T Consensus 238 l~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 238 WHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCcccCCCHHHHHHhhC
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.17 Aligned_cols=253 Identities=18% Similarity=0.261 Sum_probs=202.1
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCC-eeeeeEEEEeCC------eEEEE
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN-LVPIRAYFQAKG------ERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv 465 (665)
.++||+|+||+||+|+ ..+|+.||+|++......+.......+|+.++++++|+| |+++++++.... ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 4679999999999999 567889999999877654444456689999999999999 999999998876 78999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
+||++. +|..++....... ..++...+..++.||+.||+|||+.+ |+||||||+|||++++|.+||+|||+|+...-
T Consensus 96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~-IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG-ILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 999977 9999998643211 34666889999999999999999999 99999999999999999999999999976653
Q ss_pred CC---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC---------
Q 005999 546 SS---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--------- 613 (665)
Q Consensus 546 ~~---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--------- 613 (665)
+. ...+.|..|+|||++.+...|+...||||+||+++||+++++-|..... ..++....+....+..
T Consensus 173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCccCCCCcccc
Confidence 32 3346899999999999777899999999999999999999988876321 2233333332222210
Q ss_pred ---------------ch---hhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHH
Q 005999 614 ---------------RE---ENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQEI 650 (665)
Q Consensus 614 ---------------~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 650 (665)
.. ........+++.+|++.+|.+|.|+..++++ +.++
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00 1111367899999999999999999999986 5444
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=314.92 Aligned_cols=252 Identities=23% Similarity=0.407 Sum_probs=204.0
Q ss_pred hHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|.. .++..+++|.+..... ...+.+.+|++.+++++|+||+++++++...+..++||||
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 5799999999999974 2456788898865442 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeec
Q 005999 469 QPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY 537 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Df 537 (665)
+++++|.+++..... .....+++..++.++.||+.|++|||+++ |+||||||+||+++.++.++|+||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~df 167 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGANLLVKIGDF 167 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcEEECCC
Confidence 999999999975321 12245899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccC
Q 005999 538 CLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVD 611 (665)
Q Consensus 538 gl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 611 (665)
|++....... ....++..|+|||++. +..++.++|||||||++|||+| |+.||.... ..+..+.+......
T Consensus 168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~~~ 244 (291)
T cd05094 168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--NTEVIECITQGRVL 244 (291)
T ss_pred CcccccCCCceeecCCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhCCCCC
Confidence 9986553322 2223577899999887 5678999999999999999998 999986532 22333333222111
Q ss_pred CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 612 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
......+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 245 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 245 -ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 12334567899999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=310.63 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=200.6
Q ss_pred hHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|++|.||+|.+.+ ...||+|.+...... ...+.+.+|+..+++++||||+++++++.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 358999999999998643 336899999776543 456788999999999999999999999988 88999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLESKR-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHhCC-ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999997532 146899999999999999999999999 9999999999999999999999999987654321
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....++..|+|||++. +..++.++|||||||++|||++ |+.||... ...+....+.............+..+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--SGSQILKKIDKEGERLERPEACPQDIY 231 (257)
T ss_pred ecccCCCCCceecCHHHhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence 1224677899999886 5678999999999999999998 99998653 222333333322222223345667899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
+++.+|++.+|++||++.|+++.|.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.75 Aligned_cols=244 Identities=20% Similarity=0.285 Sum_probs=191.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++.++...++||||+. ++
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 67999999999999965 6889999998754432 223456789999999999999999999999999999999996 58
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++...... ....
T Consensus 89 l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 163 (303)
T cd07869 89 LCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163 (303)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCC
Confidence 88887642 345888999999999999999999999 999999999999999999999999998654322 1234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------------ 612 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 612 (665)
.+|+.|+|||++.+...++.++||||+||++|||++|+.||.........+...........
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 57899999998875556889999999999999999999999753211111111111100000
Q ss_pred -----C------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -----G------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -----~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 00012346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=310.53 Aligned_cols=247 Identities=21% Similarity=0.399 Sum_probs=202.8
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|.+. +...|++|.++.... ......|.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 367999999999999864 245799999875543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++++|.+++... ...+++..++.++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 88 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 88 ENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred CCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 999999998742 236899999999999999999999999 9999999999999999999999999997664211
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....++..|+|||.+. +..++.++||||||+++|||++ |..||... ...+....+..... .......+..+.
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~ 238 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDM--SNQDVIKAVEDGYR-LPPPMDCPSALY 238 (266)
T ss_pred eeccCCCCCccccChhhhc-cCCCccccchHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHcCCC-CCCCCCCCHHHH
Confidence 1123457899999886 5678999999999999999998 99998652 22233333332211 122345677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
+++.+|++.+|++||++.|+++.|+++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=327.91 Aligned_cols=240 Identities=18% Similarity=0.249 Sum_probs=196.0
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.||+|+||.||++.. .++..||+|.+..... .......+.+|++++..++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999985 4788999999875432 12334567789999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~ 549 (665)
|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~-ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 82 LFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 9998863 3468999999999999999999997 67 99999999999999999999999999864322 1123
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+.. .....+...+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~ 230 (325)
T cd05594 156 FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILM--EEIRFPRTLSPEAKSLLSGL 230 (325)
T ss_pred ccCCcccCCHHHHc-cCCCCCccccccccceeeeeccCCCCCCCCC--HHHHHHHHhc--CCCCCCCCCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997532 1222222221 11123445667899999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 005999 630 SLKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RP-----t~~evl~~ 646 (665)
|+.||++|+ ++.++++.
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcC
Confidence 999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.86 Aligned_cols=260 Identities=22% Similarity=0.366 Sum_probs=215.3
Q ss_pred cccCHHHHHHHHHhHhCcccceEEEEEEECC-----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE
Q 005999 382 EVYSLEQLMRASAELLGRGSIGTTYKAVLDN-----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 456 (665)
..|.+..-.....++||+|-||.||+|.+.+ .-.||||..+..... ...+.|.+|..+|+.++||||++++|+|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 3444444344457899999999999998532 346889988776553 4478899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEee
Q 005999 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTD 536 (665)
Q Consensus 457 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~D 536 (665)
.+.. .++|||.++-|.|..+++. ....++..+...+++||+.||+|||+.. ++||||..+|||+.....|||+|
T Consensus 461 ~e~P-~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkr-fVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 461 VEQP-MWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKR-FVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred eccc-eeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhc-hhhhhhhhhheeecCcceeeecc
Confidence 8764 7899999999999999985 3456888899999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCCCCC----CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccC
Q 005999 537 YCLSVLSDSSSVEDP----DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVD 611 (665)
Q Consensus 537 fgl~~~~~~~~~~~~----gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 611 (665)
||+++.+++...... -...|||||.+. ...++.++|||.|||+|||++. |..||+.....+ +...+.. ...
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--VI~~iEn-GeR 610 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--VIGHIEN-GER 610 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccc--eEEEecC-CCC
Confidence 999999887665443 246799999987 7889999999999999999975 999998743322 1111111 111
Q ss_pred CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 612 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
.+.+++++..+..++.+||+.||.+||.+.|+...|.++.+
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 24577899999999999999999999999999999999977
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=311.14 Aligned_cols=239 Identities=23% Similarity=0.345 Sum_probs=189.1
Q ss_pred HhCcccceEEEEEEECC-------------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeE
Q 005999 396 LLGRGSIGTTYKAVLDN-------------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 462 (665)
.||+|+||.||+|.... ...|++|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 58999999999998432 2358888876543 23455788899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc-------eEEe
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE-------ARLT 535 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~-------~kl~ 535 (665)
++||||+++|+|..++... ...+++..+++++.||+.||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKD-LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCC-eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999988642 345899999999999999999999999 999999999999987654 8999
Q ss_pred ecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCccHHHHHHhhccCCCc
Q 005999 536 DYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELL-TGKHPSQHPYLAPPDMLEWVRTMRVDDGR 614 (665)
Q Consensus 536 Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 614 (665)
|||++...... ....++..|+|||++..+..++.++|||||||++|||+ +|+.|+..... .+...... .....
T Consensus 155 d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~---~~~~~ 228 (262)
T cd05077 155 DPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--AEKERFYE---GQCML 228 (262)
T ss_pred CCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--hHHHHHHh---cCccC
Confidence 99998655332 22357788999998865567899999999999999998 58888764211 11111111 11111
Q ss_pred hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 615 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
.......+.+++.+||+.||++||++.++++.|
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 222345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.31 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=199.9
Q ss_pred HHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 393 SAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 3467999999999999988888899999876543 3456889999999999999999999885 45688999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.++++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 86 SLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN-YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 999999743 2345899999999999999999999999 99999999999999999999999999976543221
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
...++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+.... ....+...+..+.+++.
T Consensus 162 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 162 GAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGM--NNREVLEQVERGY-RMPCPQDCPISLHELML 237 (260)
T ss_pred CCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC-CCCCCCcCCHHHHHHHH
Confidence 112456799999886 5678999999999999999999 88998652 2223333332211 11223455678999999
Q ss_pred HcccCCCCCCCCHHHHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~L~~ 649 (665)
+|+.++|++|||+.++.+.|+.
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.20 Aligned_cols=234 Identities=22% Similarity=0.287 Sum_probs=190.7
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|..+ +++.||+|++..... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5899999999999964 678999999865422 123345667788888776 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~ 549 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~-ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 82 DLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred hHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 99999874 345889999999999999999999999 99999999999999999999999999865322 1223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..++...+... ....+...+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~ 230 (320)
T cd05590 156 FCGTPDYIAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILND--EVVYPTWLSQDAVDILKAF 230 (320)
T ss_pred cccCccccCHHHHc-CCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcC--CCCCCCCCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997532 22333333221 1122334567799999999
Q ss_pred ccCCCCCCCCH
Q 005999 630 SLKSPEQRPAM 640 (665)
Q Consensus 630 l~~dP~~RPt~ 640 (665)
++.||++||++
T Consensus 231 L~~dP~~R~~~ 241 (320)
T cd05590 231 MTKNPTMRLGS 241 (320)
T ss_pred cccCHHHCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.56 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=204.5
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|... ....+++|.+..... ....+.+.+|+.+++.++||||+++++++..++..++++|
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 367999999999999842 335788888865543 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC
Q 005999 468 YQPNGSLFNLIHGSRSI-------------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~ 528 (665)
|+.+|+|.+++...+.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~dikp~nill~~ 162 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-LVHRDLAARNVLVAE 162 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-eehhhhhhheEEEcC
Confidence 99999999998753211 1245889999999999999999999999 999999999999999
Q ss_pred CCceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005999 529 DFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDML 602 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 602 (665)
++.+||+|||++....... ....++..|+|||++. +..++.++||||||+++|||++ |+.||... ....+.
T Consensus 163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~ 239 (290)
T cd05045 163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--APERLF 239 (290)
T ss_pred CCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHHHHHhcCCCCCCCC--CHHHHH
Confidence 9999999999986543221 1123467899999886 5678999999999999999998 99998652 223444
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+.+.... ....+...+..+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 240 NLLKTGY-RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHhCCC-CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 4433221 1123445667899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.52 Aligned_cols=243 Identities=20% Similarity=0.284 Sum_probs=194.5
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||++... ++..||+|+++..... ....+.+..|..++.++ +||||+++++++.+....++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999854 6889999999764322 23345678899999888 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~ 549 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 82 DLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 99998863 346899999999999999999999999 99999999999999999999999999864221 1223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC---ccHHHHHHhhc--cCCCchhhhHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP---PDMLEWVRTMR--VDDGREENRLGMLTE 624 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~l~~ 624 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||+...... .....+..... .....+...+..+.+
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 156 FCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred ccCCccccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 35899999999987 5678999999999999999999999996422111 11111111111 111233455677999
Q ss_pred HHHHcccCCCCCCCC------HHHHHH
Q 005999 625 VASVCSLKSPEQRPA------MWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt------~~evl~ 645 (665)
++.+||+.||++||+ +.|+++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=317.05 Aligned_cols=244 Identities=16% Similarity=0.254 Sum_probs=188.4
Q ss_pred HhHhCcccceEEEEEEE--CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC---CCCCeeeeeEEEEe-----CCeEE
Q 005999 394 AELLGRGSIGTTYKAVL--DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL---SHPNLVPIRAYFQA-----KGERL 463 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~ 463 (665)
.+.||+|+||.||+|.. .++..||+|+++.....+.....+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 35799999999999985 3568899999876544333344555676666555 79999999999852 45689
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 464 VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
+||||+. ++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~-iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred EEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 9999997 5999998743 2345899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccCC--------
Q 005999 544 DSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVDD-------- 612 (665)
Q Consensus 544 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~-------- 612 (665)
.... ....+|+.|+|||++. ...++.++|||||||++|||++|++||.... ..+....+... ....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCCcccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhchhhh
Confidence 4332 2335789999999986 5678999999999999999999999997632 11111111111 0000
Q ss_pred ----------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ----------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 001124456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=298.01 Aligned_cols=244 Identities=22% Similarity=0.316 Sum_probs=205.4
Q ss_pred HHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..+.||+|.|+.||+.. ..+|+.+|+|.+...+......+++++|+++-+.|+||||+++...+.+.+..|+|+|+|.|
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 34679999999999987 45788999999877666556778899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCCCC-
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~- 547 (665)
++|..-|-.+ ..+++..+-..+.||+++|.|+|.++ |+|||+||+|+++-. ..-+||+|||++.......
T Consensus 95 ~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~-IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 95 GELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG-IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred hHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 9998766531 34677778889999999999999999 999999999999953 3469999999998777443
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGMLTE 624 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 624 (665)
....|||+|||||+++ ...|+..+|||+.||+||-|+.|.+||.+. +..++.+.+.....+-+ ..........+
T Consensus 169 ~~G~~GtP~fmaPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~--~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred cccccCCCcccCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCc--cHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 3347999999999998 567899999999999999999999999752 33466666655444332 45566778999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~ 645 (665)
++++||..||.+|.|+.|.++
T Consensus 246 LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHhccChhhhccHHHHhC
Confidence 999999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.52 Aligned_cols=244 Identities=22% Similarity=0.328 Sum_probs=190.5
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-----CeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-----GERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 467 (665)
.+.||+|+||.||+|.. .++..||+|++............+.+|++++++++||||+++++++... ...++|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 35799999999999995 4688999999875433333455688999999999999999999988543 25799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 85 LME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred cCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 995 699998863 345899999999999999999999999 9999999999999999999999999986543211
Q ss_pred ------CCCCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH---------------
Q 005999 548 ------VEDPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV--------------- 605 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~--------------- 605 (665)
....+|+.|+|||++.. ...++.++|||||||++|||++|+.||..... ......+
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHh
Confidence 22358999999998763 25688999999999999999999999965321 0110000
Q ss_pred ---------HhhccCCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 606 ---------RTMRVDDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 606 ---------~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
........ .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 011234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.74 Aligned_cols=243 Identities=19% Similarity=0.265 Sum_probs=192.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||+||+|.. .++..||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 5799999999999985 5678999999975432 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS------ 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~------ 546 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++......
T Consensus 87 ~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 87 DMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMG-FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999874 345888889999999999999999999 999999999999999999999999987432100
Q ss_pred --------------------------------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHH
Q 005999 547 --------------------------------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLL 582 (665)
Q Consensus 547 --------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ 582 (665)
.....||+.|+|||++. +..++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhHHH
Confidence 01235899999999987 567899999999999999
Q ss_pred HHHhCCCCCCCCCCCCccHHHHHHhhc--cCCCchhhhHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 005999 583 ELLTGKHPSQHPYLAPPDMLEWVRTMR--VDDGREENRLGMLTEVASV--CSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 583 elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl~~ 646 (665)
||++|+.||..... ......+.... .........+..+.+++.+ |+..++..||++.|++..
T Consensus 240 elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 240 EMLVGQPPFLAPTP--TETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHhCCCCCcCCCH--HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999976321 11111111111 1111222355678889988 556677779999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.38 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=208.0
Q ss_pred HHHHHHhHhCcccceEEEEEEE--------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC
Q 005999 389 LMRASAELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK 459 (665)
Q Consensus 389 ~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 459 (665)
..+...+.||+|+||.||+|.. .++..|++|.+..... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 3334457899999999999973 1345799999865432 24456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC
Q 005999 460 GERLVIYDYQPNGSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~ 528 (665)
+..++||||+++|+|.+++...+.. ....+++.+++.++.||+.||+|||+.+ ++||||||+||++++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Nili~~ 172 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-CIHRDLAARNVLVTE 172 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-eeecccccceEEEcC
Confidence 9999999999999999999754321 1245889999999999999999999999 999999999999999
Q ss_pred CCceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005999 529 DFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDML 602 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 602 (665)
++.+||+|||++....... ....++..|+|||++. +..++.++||||||+++|||++ |..||... ...++.
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~ 249 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELF 249 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHHHH
Confidence 9999999999987654321 1123467899999886 5678999999999999999998 78887542 122333
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
..+..... .......+..+.+++.+||+.+|++|||+.|+++.|+++..-.+.
T Consensus 250 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 250 KLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHcCCc-CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 33322111 123345677899999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=309.18 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=200.0
Q ss_pred hHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|.... +..+|+|.+...... ...+.+.+|++++++++|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 368999999999997432 268999998766543 455678899999999999999999998764 46799999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC-
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE- 549 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 549 (665)
+|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKH-FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcC-eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999999742 36899999999999999999999999 999999999999999999999999998755432211
Q ss_pred -----CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 550 -----DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 550 -----~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
..++..|+|||.+. +..++.++|||||||++|||++ |+.||... ...++...+..... ...+...+..+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~ 228 (257)
T cd05060 153 RATTAGRWPLKWYAPECIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAMLESGER-LPRPEECPQEIY 228 (257)
T ss_pred ccccCccccccccCHHHhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCCc-CCCCCCCCHHHH
Confidence 12346799999986 5678999999999999999998 99998753 22344444433322 123445667899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
+++.+|+..+|++||++.++++.|+++.
T Consensus 229 ~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 229 SIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.89 Aligned_cols=240 Identities=22% Similarity=0.297 Sum_probs=194.0
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... +++.||+|++..... .....+.+..|.+++..+ +||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5899999999999865 578999999875422 123345567788888766 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 82 DLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHG-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 99998873 345889999999999999999999999 999999999999999999999999998653221 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+.. .....+...+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~ 230 (321)
T cd05591 156 FCGTPDYIAPEILQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEADN--EDDLFESILH--DDVLYPVWLSKEAVSILKAF 230 (321)
T ss_pred cccCccccCHHHHc-CCCCCCccceechhHHHHHHhcCCCCCCCCC--HHHHHHHHHc--CCCCCCCCCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997532 2223222221 11122334567799999999
Q ss_pred ccCCCCCCC-------CHHHHHHH
Q 005999 630 SLKSPEQRP-------AMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RP-------t~~evl~~ 646 (665)
|+.||++|| ++.++++.
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcC
Confidence 999999999 77888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.61 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=198.3
Q ss_pred HhHhCcccceEEEEEEEC-CeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||+||+|.+. ++. .+++|.+..... .....++..|+..+++++||||+++++++.. ...++++||
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 367999999999999863 333 477787754322 2344677888889999999999999998864 457889999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 90 SPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHR-MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 9999999999742 346899999999999999999999999 9999999999999999999999999997553221
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
....++..|+|||++. +..++.++|||||||++||+++ |+.||.... ...+.+.+...... .....++..+
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (279)
T cd05111 165 KYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEVPDLLEKGERL-AQPQICTIDV 240 (279)
T ss_pred ccccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCcC-CCCCCCCHHH
Confidence 1223567899999987 5678999999999999999998 999987532 22333333322211 2233455678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+++.+|+..||++|||+.|+++.|+.+.++.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 89999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.73 Aligned_cols=251 Identities=19% Similarity=0.310 Sum_probs=202.1
Q ss_pred HHhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEE
Q 005999 393 SAELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 466 (665)
..+.||+|+||.||+|... .+..||+|++..... ....+.+.+|+.++++++||||+++++++......++++
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 3578999999999999853 357899999975543 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEe
Q 005999 467 DYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLT 535 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~ 535 (665)
||+.+++|.+++..... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-i~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-VVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhheEecCCCceEec
Confidence 99999999999853210 11235888999999999999999999999 9999999999999999999999
Q ss_pred ecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhc
Q 005999 536 DYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMR 609 (665)
Q Consensus 536 Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 609 (665)
|||++....... ....+++.|+|||.+. +..++.++|||||||++|||++ |..||... ...+..+.+....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--~~~~~~~~i~~~~ 243 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVIEMIRNRQ 243 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCC
Confidence 999986553322 1223567899999986 5668999999999999999998 88888653 2223333333322
Q ss_pred cCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 610 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
.. ......+..+.+++.+|++.+|++||++.+++..|++
T Consensus 244 ~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 244 VL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 2345677889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.75 Aligned_cols=239 Identities=22% Similarity=0.307 Sum_probs=190.3
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhC-CCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGG-LSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... +++.||+|+++..... ....+.+..|..++.. .+||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999964 5788999998754321 2233445566666664 48999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 82 DLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKG-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 99999874 245888999999999999999999999 999999999999999999999999998654321 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..++...+... ....+...+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~--~~~~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 156 FCGTPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGED--EDELFDSILND--RPHFPRWISKEAKDCLSKL 230 (316)
T ss_pred ccCCccccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC--CCCCCCCCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997531 12222222211 1123344567789999999
Q ss_pred ccCCCCCCCCHH-HHHH
Q 005999 630 SLKSPEQRPAMW-QVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~-evl~ 645 (665)
|+.||++||++. ++++
T Consensus 231 l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 231 FERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ccCCHHHcCCChHHHHc
Confidence 999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.17 Aligned_cols=246 Identities=19% Similarity=0.248 Sum_probs=198.0
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++.. .+++.||+|.+....... .....+.+|+.++++++||||+++++++.+++..++||||+.+|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 5799999999999985 468899999986543221 23355778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... ...
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05605 86 DLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR 161 (285)
T ss_pred cHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccc
Confidence 999988642 2346899999999999999999999999 9999999999999999999999999987654322 233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c 629 (665)
.|++.|+|||++. +..++.++||||+||++|||++|+.||....... ........... ........+..+.+++.+|
T Consensus 162 ~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 162 VGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 6889999999987 5678999999999999999999999997632211 11111111111 1122345667899999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 005999 630 SLKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RP-----t~~evl~~ 646 (665)
++.||++|| ++.++++.
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcC
Confidence 999999999 88888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.87 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=197.4
Q ss_pred HhHhCcccceEEEEEEE-----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 466 (665)
.+.||+|+||+||++.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++... ...+++|
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 36799999999988653 3577899999876532 23456788999999999999999999998653 4678999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 88 e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 88 EYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred cCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999863 24899999999999999999999999 999999999999999999999999998765432
Q ss_pred CC------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccH----------HHHHHhh--
Q 005999 547 SV------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDM----------LEWVRTM-- 608 (665)
Q Consensus 547 ~~------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~----------~~~~~~~-- 608 (665)
.. ...++..|+|||.+. ...++.++||||||+++|||++|+.|+........+. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 21 123456799999886 5678999999999999999999999986532111010 0000000
Q ss_pred ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 609 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
......+...+..+.+++.+|++.+|++|||++++++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0001123445678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.49 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=199.5
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|... .+..||+|++..... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 467999999999998753 356799999865432 2345668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 468 YQPNGSLFNLIHGSRSI-----RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
|+++|+|.+++...+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~vH~dlkp~Nil~~~~~~~~l~dfg~~~~ 168 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRD 168 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCcchheEEEcCCCCEEECCCCCccc
Confidence 99999999998753211 1234688899999999999999999999 99999999999999999999999999865
Q ss_pred cCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 543 SDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 543 ~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
...... ...++..|+|||++. +..++.++|||||||++|||++ |..||... ...+....+..... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~~-~~~~~ 244 (277)
T cd05062 169 IYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--SNEQVLRFVMEGGL-LDKPD 244 (277)
T ss_pred cCCcceeecCCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCc-CCCCC
Confidence 433221 123467899999987 5678999999999999999999 78888653 22233333222111 12344
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
..+..+.+++.+|++.||++|||+.|+++.|++
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 245 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 566789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=308.48 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=201.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... ++..|++|.+..........+.+.+|++++++++||||+++++++.+++..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 56999999999999864 68899999987654444566788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.++++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 86 L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~-i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (256)
T cd08529 86 LHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI 161 (256)
T ss_pred HHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcc
Confidence 99999753 2356899999999999999999999999 9999999999999999999999999987654332 123
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+++.|+|||+.. +..++.++||||||+++|||++|+.||.... .......+...... ......+..+.+++.+|+
T Consensus 162 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 162 VGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKIIRGVFP-PVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred ccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCC-CCccccCHHHHHHHHHHc
Confidence 4788999999987 5668899999999999999999999997532 22222222221111 123356678999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~ 646 (665)
+.+|++||++.++++.
T Consensus 238 ~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 238 TKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=310.26 Aligned_cols=244 Identities=26% Similarity=0.458 Sum_probs=200.3
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|++++++++|+||+++++++. ++..+++|||+.+++
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGS 86 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCC
Confidence 467999999999999988889999999875542 3457889999999999999999999874 456899999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----C
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----E 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~ 549 (665)
|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........ .
T Consensus 87 L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 87 LVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 99998643 3456899999999999999999999999 99999999999999999999999999876552221 1
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
..++..|+|||++. ...++.++||||||+++||+++ |+.||... ...+....+..... .......+..+.+++.+
T Consensus 163 ~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 163 AKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGM--TNPEVIQNLERGYR-MPRPDNCPEELYELMRL 238 (260)
T ss_pred CcccccccCHHHhc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHcCCC-CCCCCCCCHHHHHHHHH
Confidence 23467899999986 5668899999999999999999 99999753 22233333322211 12234456789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~ 649 (665)
|++.+|++||+++++++.|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 239 CWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.65 Aligned_cols=248 Identities=27% Similarity=0.450 Sum_probs=205.1
Q ss_pred hHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|.... +..+++|.+....... ..+.+.+|++.+..++|+||+++++++..+...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 368999999999999653 7889999997665433 46788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 471 NGSLFNLIHGSRSI----RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 471 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
+++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.+......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999753210 1367899999999999999999999999 999999999999999999999999999766543
Q ss_pred C-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 547 S-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 547 ~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
. ....++..|+|||.+. ...++.++||||+|+++|||++ |+.||... ...++...+.... ....+...+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~ 234 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEEVLEYLRKGY-RLPKPEYCPD 234 (262)
T ss_pred cccccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCC-CCCCCccCCh
Confidence 2 2234678999999887 4578999999999999999999 69998764 2233434333211 1123445577
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
.+.+++.+|+..+|++|||+.|+++.|+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 8999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=313.14 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=205.8
Q ss_pred HhHhCcccceEEEEEEECC-----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDN-----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 467 (665)
.+.||+|+||.||+|...+ +..|++|++..... ....+.+.+|+.++++++|+||+++++++.. +...++++|
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 3679999999999999765 78899999875432 3445678899999999999999999998766 567899999
Q ss_pred ecCCCCHHHHHhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 468 YQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
|+++|+|.+++...+.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kl~d~g~~~~~~ 168 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-VIHKDIAARNCVIDEELQVKITDNALSRDLF 168 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCHhhEEEcCCCcEEECCCCCccccc
Confidence 99999999998754321 1256899999999999999999999999 9999999999999999999999999997553
Q ss_pred CCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 545 SSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 545 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
... ....++..|+|||++. +..++.++|||||||++||+++ |+.||... ...++..++...... ......
T Consensus 169 ~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~ 244 (280)
T cd05043 169 PMDYHCLGDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEMAAYLKDGYRL-AQPINC 244 (280)
T ss_pred CCceEEeCCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHHHHHHHcCCCC-CCCCcC
Confidence 321 1223567899999986 5678999999999999999999 99998753 222343333322111 123345
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+..+.+++.+|+..||++|||+.|+++.|+.+.+.
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 245 PDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 67899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.69 Aligned_cols=246 Identities=26% Similarity=0.436 Sum_probs=198.8
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ...++||||+++|+
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~ 86 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 86 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCc
Confidence 467999999999999987777899999875432 34568899999999999999999998754 56789999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----C
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----E 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~ 549 (665)
|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+........ .
T Consensus 87 L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 87 LLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 99999743 2345789999999999999999999999 99999999999999999999999999876543322 1
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
..++..|+|||+.. ...++.++||||||+++|||++ |+.||.... ..+....+.... ........+..+.+++.+
T Consensus 163 ~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 163 AKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGY-RMPCPPECPESLHDLMCQ 238 (262)
T ss_pred CcccceecCHhHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhcCC-CCCCccccCHHHHHHHHH
Confidence 23566799999886 5678999999999999999999 888886532 122222221111 112234566789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
|++.||++||++.++++.|++..
T Consensus 239 ~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 239 CWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.90 Aligned_cols=239 Identities=23% Similarity=0.344 Sum_probs=189.0
Q ss_pred HhCcccceEEEEEEEC-------------------------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCee
Q 005999 396 LLGRGSIGTTYKAVLD-------------------------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 450 (665)
.||+|+||.||+|... ....|++|++..... ...+.+.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 4899999999999742 123588888865432 3446788899999999999999
Q ss_pred eeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC
Q 005999 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF 530 (665)
Q Consensus 451 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~ 530 (665)
++++++.++...++||||+++|+|..++.. ....+++..++.++.||++||+|||+++ |+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDKN-LVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCC-ccCCCCCcccEEEeccC
Confidence 999999999999999999999999999864 2346889999999999999999999999 99999999999997643
Q ss_pred -------ceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCccHH
Q 005999 531 -------EARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELL-TGKHPSQHPYLAPPDML 602 (665)
Q Consensus 531 -------~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ell-tg~~P~~~~~~~~~~~~ 602 (665)
.+|++|||++...... ....++..|+|||.+.....++.++|||||||++||++ +|+.||.... .....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~ 231 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT--PSEKE 231 (274)
T ss_pred cccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC--hHHHH
Confidence 3899999987544322 22356788999998875566899999999999999995 7999987532 12222
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
...... ...+......+.+++.+||+.+|++|||+.++++.|
T Consensus 232 ~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RFYEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222211 111222345689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.06 Aligned_cols=250 Identities=24% Similarity=0.417 Sum_probs=197.7
Q ss_pred HhCcccceEEEEEEECC-e--EEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 396 LLGRGSIGTTYKAVLDN-H--LIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.||+|+||.||+|...+ + ..+++|.++.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999998643 3 3568888864432 24456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 472 GSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 472 gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
|+|.+++...+.. ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+|++|||++
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccccceEEEcCCCeEEECCCCCc
Confidence 9999999754321 1235889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 541 VLSDSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 541 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
....... .....+..|+|||++. ...++.++|||||||++|||++ |..||... ...+....+.... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~--~~~~~~~~~~~~~-~~~~~~~ 235 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGY-RLEKPLN 235 (270)
T ss_pred cccchhhhccCCCCccccCChHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccc--CHHHHHHHHhCCC-CCCCCCc
Confidence 5332211 1112356799999986 5678999999999999999997 99998652 1122222222111 1122334
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
.+..+.+++.+|++.+|.+|||+.|++..|+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 5567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=311.55 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=192.4
Q ss_pred HhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... .+..+++|.++.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 5899999999999854 345789998876543 233457888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.++++..+.......++..+..++.|++.|++|||+.+ ++||||||+||+++.++++||+|||++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 9999997543323345677888899999999999999999 9999999999999999999999999986543321
Q ss_pred CCCCCCCcccCCccccCC------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHH-HHhhccC---CCchh
Q 005999 548 VEDPDTVAYKAPEIRKSS------RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEW-VRTMRVD---DGREE 616 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~------~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~-~~~~~~~---~~~~~ 616 (665)
....++..|+|||++... ..++.++||||||+++|||++ |+.||..... .+.... +...... .....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHhhcccCCCCCCccCC
Confidence 112357789999987521 135789999999999999996 9999975322 222111 1111110 11122
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
..+..+.+++.+|+ .+|++|||+.||+..|+
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 34566889999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.42 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=205.1
Q ss_pred HHHhHhCcccceEEEEEEEC--------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeE
Q 005999 392 ASAELLGRGSIGTTYKAVLD--------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 462 (665)
...+.||+|+||.||++... ....+|+|.++.... ......+.+|++++.++ +||||+++++++..++..
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34578999999999999742 235699999876532 23456688899999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE 531 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~ 531 (665)
++||||+++|+|.+++...+.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTEDNV 178 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHHheEEcCCCc
Confidence 9999999999999999754321 1235899999999999999999999998 999999999999999999
Q ss_pred eEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHH
Q 005999 532 ARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV 605 (665)
Q Consensus 532 ~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 605 (665)
+||+|||.+....... ....++..|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+
T Consensus 179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--~~~~~~~~~ 255 (307)
T cd05098 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLL 255 (307)
T ss_pred EEECCCcccccccccchhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--CHHHHHHHH
Confidence 9999999986554321 1112346899999887 5678999999999999999998 88888642 112333333
Q ss_pred HhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 606 RTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 606 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.... ....+...+..+.+++.+|+..+|++|||+.|+++.|+++....
T Consensus 256 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 256 KEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 2221 11234456678999999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.67 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=202.4
Q ss_pred hHhCcccceEEEEEEECC-e--EEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDN-H--LIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|...+ + ..+++|.++.... ....+.+.+|++++.++ +||||+++++++.+.+..++++||++
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 579999999999998643 3 2468888764332 23456788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 471 NGSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 471 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
+|+|.++++..+.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~ 165 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-FIHRDLAARNVLVGENLASKIADFGL 165 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCcCCcceEEECCCCeEEECCcCC
Confidence 99999999753311 1235889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC--CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 540 SVLSDSSSVE--DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 540 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
+......... ...+..|+|||++. ...++.++|||||||++|||++ |..||.... ..+....+.... ....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--~~~~~~~~~~~~-~~~~~~ 241 (297)
T cd05089 166 SRGEEVYVKKTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGY-RMEKPR 241 (297)
T ss_pred CccccceeccCCCCcCccccCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC-CCCCCC
Confidence 8643322111 12345799999886 5678999999999999999997 999997532 222222222111 112234
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
..+..+.+++.+|++.+|.+||++.++++.|+.+.+...+
T Consensus 242 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 242 NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 5667899999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=336.89 Aligned_cols=246 Identities=22% Similarity=0.281 Sum_probs=199.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC--------eEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG--------ERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~lv 465 (665)
+.||+|+||+||+|.. .+++.||||++............+.+|+..+..++|+||+++++.+...+ ..++|
T Consensus 38 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV 117 (496)
T PTZ00283 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117 (496)
T ss_pred EEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEE
Confidence 5799999999999984 57889999999766544455667889999999999999999988775432 36799
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+++|+|.++++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~-IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAA 195 (496)
T ss_pred EeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence 99999999999987432 23456899999999999999999999999 99999999999999999999999999865533
Q ss_pred C-----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 546 S-----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 546 ~-----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
. .....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..++...+..... ...+...+.
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--~~~~~~~~~~~~~-~~~~~~~~~ 271 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGEN--MEEVMHKTLAGRY-DPLPPSISP 271 (496)
T ss_pred cccccccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHhcCCC-CCCCCCCCH
Confidence 2 12335899999999987 5678999999999999999999999997531 1122222211111 123445677
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+.+++.+||+.||++||++.++++.
T Consensus 272 ~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 272 EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 89999999999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.67 Aligned_cols=239 Identities=21% Similarity=0.336 Sum_probs=191.6
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhC-CCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGG-LSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... +++.||+|+++..... +...+.+..|..++.. ++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999965 5788999998754321 1233445667777775 49999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~ 549 (665)
+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 82 DLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKG-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 99999873 245888999999999999999999999 99999999999999999999999999864321 1223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..++...+..... ..+...+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~ 230 (316)
T cd05619 156 FCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMDNP--CYPRWLTREAKDILVKL 230 (316)
T ss_pred ecCCccccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997531 2233333322211 12334566789999999
Q ss_pred ccCCCCCCCCHH-HHHH
Q 005999 630 SLKSPEQRPAMW-QVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~-evl~ 645 (665)
|+.||++||++. ++.+
T Consensus 231 l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 231 FVREPERRLGVKGDIRQ 247 (316)
T ss_pred hccCHhhcCCChHHHHc
Confidence 999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.44 Aligned_cols=239 Identities=22% Similarity=0.296 Sum_probs=194.3
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... ++..||+|+++..... ....+.+.+|.+++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999865 5788999998754321 23345567888888877 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...... ...
T Consensus 82 ~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 82 DLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 99998873 346899999999999999999999999 999999999999999999999999998643221 122
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+++.|+|||++. +..++.++|||||||++|||++|+.||.... ...+...+... ....+...+..+.+++.+|
T Consensus 156 ~~g~~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~ 230 (318)
T cd05570 156 FCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--EDELFQSILED--EVRYPRWLSKEAKSILKSF 230 (318)
T ss_pred eecCccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcC--CCCCCCcCCHHHHHHHHHH
Confidence 35889999999987 5678999999999999999999999997531 22222222211 1122344567899999999
Q ss_pred ccCCCCCCCCH-----HHHHH
Q 005999 630 SLKSPEQRPAM-----WQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~-----~evl~ 645 (665)
|+.||++||++ .++++
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhc
Confidence 99999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.22 Aligned_cols=242 Identities=18% Similarity=0.275 Sum_probs=198.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++..++||||+++++++.+++..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 57999999999999965 68899999997543222 34567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g-iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 87 DLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG-FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999742 56889999999999999999999999 9999999999999999999999999986554322
Q ss_pred ---------------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 005999 548 ---------------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPD 600 (665)
Q Consensus 548 ---------------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~ 600 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~--~~~ 237 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDT--LQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCC--HHH
Confidence 2235899999999987 5688999999999999999999999997632 111
Q ss_pred HHHHHHhhccCC--CchhhhHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 005999 601 MLEWVRTMRVDD--GREENRLGMLTEVASVCSLKSPEQRPA-MWQVLKM 646 (665)
Q Consensus 601 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 646 (665)
....+....... ......+..+.+++.+|+. ||++||+ +.|+++.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111110111 1122357789999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.61 Aligned_cols=244 Identities=24% Similarity=0.395 Sum_probs=198.4
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEE-eCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ-AKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. .+...++++||++++
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 367999999999999876 5678999886432 3456889999999999999999999764 456789999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++............
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 161 (256)
T cd05082 86 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161 (256)
T ss_pred cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence 999998743 2345889999999999999999999999 999999999999999999999999998765444333445
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
+..|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+.... ........+..+.+++.+|++
T Consensus 162 ~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05082 162 PVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY-KMDAPDGCPPVVYDVMKQCWH 237 (256)
T ss_pred ceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHhc
Confidence 67899999986 5678999999999999999997 99998642 1223333332211 112334567789999999999
Q ss_pred CCCCCCCCHHHHHHHHHHH
Q 005999 632 KSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 632 ~dP~~RPt~~evl~~L~~~ 650 (665)
.+|++|||+.++++.|+++
T Consensus 238 ~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 238 LDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CChhhCcCHHHHHHHHhcC
Confidence 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.43 Aligned_cols=244 Identities=19% Similarity=0.287 Sum_probs=198.3
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh---hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD---TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|++|.||++.. .++..+++|.+....... ...+.+.+|++++++++||||+++++++.+++..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 46799999999999985 468899999986543221 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 87 ~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 87 PGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred CCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999874 345888999999999999999999999 9999999999999999999999999986543321
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....++..|+|||++. +..++.++||||+|+++|||++|+.||.... .................+...+..+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cccccCCCcCccccCcceec-cCCCCchhhhHHHHHHHHHHHhCCCCccccc--hHHHHHHHhccCCCCCCCccCCHHHH
Confidence 1234678899999987 5668999999999999999999999986531 11111111111112223445677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+++.+||..+|++|||+.|+++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.61 Aligned_cols=249 Identities=22% Similarity=0.388 Sum_probs=200.7
Q ss_pred hHhCcccceEEEEEEE-----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|.. .++..+++|.+..... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 6799999999999984 3567899999875433 244567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeec
Q 005999 470 PNGSLFNLIHGSRS------------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY 537 (665)
Q Consensus 470 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Df 537 (665)
++++|.+++..... .....+++.+.+.++.|++.||+|||+++ ++||||||+||++++++.+||+||
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~nili~~~~~~kl~df 168 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-FVHKDLAARNILIGEQLHVKISDL 168 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-eehhccccceEEEcCCCcEEeccc
Confidence 99999999863211 01235788999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccC
Q 005999 538 CLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVD 611 (665)
Q Consensus 538 gl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 611 (665)
|++....... ....++..|+|||++. +..++.++|||||||++|||++ |..||... ....+.+.+.....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~- 244 (283)
T cd05090 169 GLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--SNQEVIEMVRKRQL- 244 (283)
T ss_pred cccccccCCcceecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCc-
Confidence 9986553321 1223466799999986 5678999999999999999998 99898652 22233343332221
Q ss_pred CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 612 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
...+...+..+.+++.+|++.||++||++.++.+.|+.
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 12344567789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.45 Aligned_cols=239 Identities=22% Similarity=0.299 Sum_probs=191.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... ++..||+|.++..... ....+.+..|..++... +||||+++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 35899999999999965 6789999998754321 12344566677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC---CCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD---SSSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~---~~~~ 548 (665)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.... ....
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999999873 345888999999999999999999999 9999999999999999999999999986432 1223
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++||||+||++|||++|+.||... ....+.+.+.... ...+...+..+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 229 (316)
T cd05620 155 TFCGTPDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVDT--PHYPRWITKESKDILEK 229 (316)
T ss_pred ccCCCcCccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCC--CCCCCCCCHHHHHHHHH
Confidence 345899999999987 567899999999999999999999999753 2223333332211 12233456679999999
Q ss_pred cccCCCCCCCCHH-HHH
Q 005999 629 CSLKSPEQRPAMW-QVL 644 (665)
Q Consensus 629 cl~~dP~~RPt~~-evl 644 (665)
||+.||++||++. +++
T Consensus 230 ~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 230 LFERDPTRRLGVVGNIR 246 (316)
T ss_pred HccCCHHHcCCChHHHH
Confidence 9999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.63 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=202.2
Q ss_pred hHhCcccceEEEEEEEC-CeE--EEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHL--IVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|... ++. .+++|.+..... ....+.+.+|++++.++ +|+||+++++++..++..++|+||++
T Consensus 13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeecCCCCceEEEEEEccCCceeeEEEEEecccCC-HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 67999999999999854 343 467777754332 34456788999999999 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 471 NGSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 471 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
+|+|.++++..+.. ....+++.+++.++.|++.|++|||+.+ ++||||||+|||+++++.+||+|||+
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dlkp~Nili~~~~~~kl~dfg~ 170 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGL 170 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEecCCCcEEeCcccc
Confidence 99999999754321 1235889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC--CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 540 SVLSDSSSVE--DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 540 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
+......... ...+..|+|||++. ...++.++|||||||++|||+| |..||.... ..+....+.... ......
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~ 246 (303)
T cd05088 171 SRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGY-RLEKPL 246 (303)
T ss_pred CcccchhhhcccCCCcccccCHHHHh-ccCCcccccchhhhhHHHHHHhcCCCCcccCC--hHHHHHHHhcCC-cCCCCC
Confidence 8643221111 12356799999886 5668899999999999999998 999986532 122222222111 111223
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
..+..+.+++.+|++.+|++||++.+++..|+.+.+.....
T Consensus 247 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 247 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 45667999999999999999999999999999887766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.26 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=202.2
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||.||+|... ++.|++|.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 467999999999999876 67899999976542 45678899999999999999999999998899999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT 553 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt 553 (665)
|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+............+
T Consensus 87 L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 87 LVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN-FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred HHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 99998743 2236899999999999999999999999 9999999999999999999999999987765443333456
Q ss_pred CcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 554 ~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
..|+|||++. ...++.++||||||+++||+++ |+.||... ...++...+..... .......+..+.+++.+|+..
T Consensus 163 ~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~ 238 (256)
T cd05039 163 VKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVEKGYR-MEAPEGCPPEVYKVMKDCWEL 238 (256)
T ss_pred ccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcCCC-CCCccCCCHHHHHHHHHHhcc
Confidence 7899999987 5678899999999999999997 99998653 12233332222111 122345577899999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 005999 633 SPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 633 dP~~RPt~~evl~~L~~ 649 (665)
+|++|||+.|+++.|+.
T Consensus 239 ~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 239 DPAKRPTFKQLREQLAL 255 (256)
T ss_pred ChhhCcCHHHHHHHHhc
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=311.64 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=191.4
Q ss_pred HhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... ....+++|.+..... ......+.+|++.++.++|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 4899999999999753 345688888764432 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-----S 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~ 547 (665)
+|.+++...+.......++...+.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++...... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-EecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 9999997654333344678888999999999999999999 999999999999999999999999998653221 1
Q ss_pred CCCCCCCcccCCccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccH-HHHHHhhccC---CCchh
Q 005999 548 VEDPDTVAYKAPEIRKS------SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDM-LEWVRTMRVD---DGREE 616 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~------~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~-~~~~~~~~~~---~~~~~ 616 (665)
....++..|+|||++.. ...++.++|||||||++|||++ |..||.... ..+. ...+...... .....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--DEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhhccCccCCCCcccc
Confidence 12235677999998642 2356889999999999999999 788886532 1121 1111111111 11233
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
..+..+.+++..|+ .||++|||+.||++.|
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 55677888999999 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=321.27 Aligned_cols=238 Identities=23% Similarity=0.289 Sum_probs=191.7
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|.. .++..||+|+++..... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 589999999999985 46788999999765322 23455678899999888 7999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~ 549 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 ~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 82 DLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERG-IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 99998863 346899999999999999999999999 99999999999999999999999999865322 2223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-ccHHHHHHh--hccCCCchhhhHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP-PDMLEWVRT--MRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~l~~li 626 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||....... ......+.. .......+...+..+.+++
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 45899999999987 6678999999999999999999999996432211 111111111 1111223445567789999
Q ss_pred HHcccCCCCCCCCH
Q 005999 627 SVCSLKSPEQRPAM 640 (665)
Q Consensus 627 ~~cl~~dP~~RPt~ 640 (665)
.+||+.||++||++
T Consensus 235 ~~~L~~dP~~R~~~ 248 (327)
T cd05617 235 KGFLNKDPKERLGC 248 (327)
T ss_pred HHHhccCHHHcCCC
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.29 Aligned_cols=235 Identities=21% Similarity=0.260 Sum_probs=187.9
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHH-HHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHME-AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||+||+|... +++.||+|++...... ....+.+..|.. +++.++||||+++++++.+.+..++||||+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5899999999999964 6889999998654221 122334444444 567899999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~g-ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 82 ELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 99999873 346888999999999999999999999 999999999999999999999999998653221 222
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..++...+.. .........+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~ 230 (323)
T cd05575 156 FCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--TAEMYDNILN--KPLRLKPNISVSARHLLEGL 230 (323)
T ss_pred ccCChhhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCCC--HHHHHHHHHc--CCCCCCCCCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997521 1122222211 11122334577899999999
Q ss_pred ccCCCCCCCCHH
Q 005999 630 SLKSPEQRPAMW 641 (665)
Q Consensus 630 l~~dP~~RPt~~ 641 (665)
++.||++||++.
T Consensus 231 l~~~p~~R~~~~ 242 (323)
T cd05575 231 LQKDRTKRLGAK 242 (323)
T ss_pred hhcCHHhCCCCC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=294.55 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=203.8
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCch------hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEE
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA------DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 465 (665)
.+.||.|..++|-+.. ..++..+|+|++...... ....+.-.+|+.+|+++ .||+|+.+.++|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 4679999999999887 457888999998643322 23345667899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
+|.|+.|.|+|++.. ...++++...+|+.|+.+|+.|||.++ |+||||||+|||+|++.++||+|||++.....
T Consensus 102 Fdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~-IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARN-IVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhh-hhhcccChhheeeccccceEEeccceeeccCC
Confidence 999999999999984 456899999999999999999999999 99999999999999999999999999987766
Q ss_pred CCC--CCCCCCcccCCcccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--Cchh
Q 005999 546 SSV--EDPDTVAYKAPEIRK-----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREE 616 (665)
Q Consensus 546 ~~~--~~~gt~~y~aPE~~~-----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~ 616 (665)
+.. .-.|||+|+|||.++ ....|+..+|+|+.||+||-|+.|.+||-+. ..--+...+.....+. ....
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHHHHhcccccCCcchh
Confidence 543 346999999999865 3456889999999999999999999998652 1113333344333332 3456
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+++....++|.+||+.||++|.|++|++.
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 77788999999999999999999999987
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=320.67 Aligned_cols=239 Identities=21% Similarity=0.280 Sum_probs=191.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHH---HhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEA---VGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... +++.||+|+++..... ....+.+.+|+++ +++++||||+++++++...+..++||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 57999999999999854 6889999999754321 1233455566554 46778999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---C
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---S 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~ 546 (665)
++|+|..+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..... .
T Consensus 85 ~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 85 AGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK-IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 99999988753 35899999999999999999999999 99999999999999999999999999864322 1
Q ss_pred CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 547 SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 547 ~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
.....|++.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+... ....+...+..+.+++
T Consensus 158 ~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~--~~~~p~~~~~~~~~li 232 (324)
T cd05589 158 TSTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--EEEVFDSIVND--EVRYPRFLSREAISIM 232 (324)
T ss_pred ccccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence 22345899999999987 5678999999999999999999999997531 12222222221 1123345667799999
Q ss_pred HHcccCCCCCCC-----CHHHHHH
Q 005999 627 SVCSLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RP-----t~~evl~ 645 (665)
.+||+.||++|| ++.++++
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.57 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=201.6
Q ss_pred HHHhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEE
Q 005999 392 ASAELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 464 (665)
...+.||+|+||.||++.. ..+..+|+|+++.... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 3457899999999999974 2356799999876543 23456789999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
||||+.+|+|.++++... ...+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.++++|||++....
T Consensus 117 v~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999999997432 234899999999999999999999999 9999999999999999999999999987553
Q ss_pred CCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 545 SSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 545 ~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
.... ...++..|+|||.+. +..++.++|||||||++|||++ |+.||..... ...+...+..... .......
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~ 269 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIKEGYR-MAQPEHA 269 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHHHHHcCCc-CCCCCCC
Confidence 3211 123467899999886 5678999999999999999998 9999875321 1122222222111 1222344
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 66799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.52 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=203.2
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||++... ....+|+|.+...... .....+.+|++++.++ +|+||+++++++..++..+++|
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence 467999999999999853 3468999998765432 3445688999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEe
Q 005999 467 DYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLT 535 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~ 535 (665)
||+++|+|.++++..+. .....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~Nil~~~~~~~kL~ 174 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-CIHRDLAARNVLVTEDHVMKIA 174 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-ccccccceeeEEEcCCCeEEeC
Confidence 99999999999974321 13456899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhc
Q 005999 536 DYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMR 609 (665)
Q Consensus 536 Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 609 (665)
|||++....... ....++..|+|||++. +..++.++|||||||++|||++ |..||... ...++...+....
T Consensus 175 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~ 251 (293)
T cd05053 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFKLLKEGY 251 (293)
T ss_pred ccccccccccccceeccCCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCC--CHHHHHHHHHcCC
Confidence 999987654322 1122456799999876 5678999999999999999997 98888652 1223333222211
Q ss_pred cCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 610 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
....+...+..+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 252 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 252 -RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11233455678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=313.93 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=205.5
Q ss_pred HHhHhCcccceEEEEEEEC--------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEE
Q 005999 393 SAELLGRGSIGTTYKAVLD--------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERL 463 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 463 (665)
..+.||+|+||.||++... ....+|+|.+..... ......+.+|+++++++ +||||+++++++..++..+
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 4578999999999999742 355789999875443 23456788999999999 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCce
Q 005999 464 VIYDYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEA 532 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~ 532 (665)
+++||+++|+|.+++...+. .....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~~~~ 173 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-CIHRDLAARNVLVTEDNVM 173 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-eeeccccceeEEEcCCCcE
Confidence 99999999999999975321 12345899999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHH
Q 005999 533 RLTDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVR 606 (665)
Q Consensus 533 kl~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 606 (665)
||+|||++........ ...++..|+|||++. +..++.++|||||||++|||++ |..||... ...++...+.
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~--~~~~~~~~~~ 250 (314)
T cd05099 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGI--PVEELFKLLR 250 (314)
T ss_pred EEccccccccccccccccccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHH
Confidence 9999999976543211 112346799999987 5678999999999999999999 88888652 1223333332
Q ss_pred hhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 607 TMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 607 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.... .......+..+.+++.+|++.+|++|||+.|+++.|+++.....
T Consensus 251 ~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 251 EGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred cCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 2111 12234556789999999999999999999999999999977554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.71 Aligned_cols=235 Identities=23% Similarity=0.305 Sum_probs=195.0
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
..+||+|.||+|+++..+ +++.+|||++++...- +...+..+.|-+++... +||.+++++..|+..++.|+||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 468999999999999965 6889999999877543 23455666777776655 69999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC---CCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD---SSS 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~---~~~ 547 (665)
||++..+.+ ...+++..+..++..|+.||+|||+++ ||+||||.+|||+|.+|++||+|||+++..- ...
T Consensus 453 Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~-IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 453 GGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENG-IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred CCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcC-ceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence 999554443 356999999999999999999999999 9999999999999999999999999996542 233
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
.+-.||+.|||||++. +..|+..+|+|||||+||||+.|..||.+. ++.++-+.+... +...+...+.+...+++
T Consensus 526 sTfCGTpey~aPEil~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d--~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVND--EVRYPRFLSKEAIAIMR 600 (694)
T ss_pred ccccCChhhcChhhhc-cCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcC--CCCCCCcccHHHHHHHH
Confidence 3446999999999997 789999999999999999999999999863 233444333321 22345667778999999
Q ss_pred HcccCCCCCCCCH
Q 005999 628 VCSLKSPEQRPAM 640 (665)
Q Consensus 628 ~cl~~dP~~RPt~ 640 (665)
+++.++|++|.-+
T Consensus 601 ~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 601 RLLRKNPEKRLGS 613 (694)
T ss_pred HHhccCcccccCC
Confidence 9999999999876
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=305.17 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=194.7
Q ss_pred hHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEE-eCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ-AKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... +...+|+|++..... ....+.+.+|+.+++.++||||+++++++. .++..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999853 346799998864332 234567889999999999999999999875 455688999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK-FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999742 234677888899999999999999998 9999999999999999999999999986543211
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTG-KHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
....++..|+|||++. ...++.++|||||||++|||++| .+||... ...+....+..... .......+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQGRR-LLQPEYCPDP 230 (262)
T ss_pred eecccccCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCCC-CCCCCcCCHH
Confidence 1223467899999886 56789999999999999999995 5556532 22233333222111 1123345678
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.80 Aligned_cols=243 Identities=27% Similarity=0.457 Sum_probs=198.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..+++|.+.... ...+.+.+|++++++++|+|++++++++.. +..+++|||+.+|+|
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L 87 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSL 87 (260)
T ss_pred eeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCH
Confidence 5699999999999998777789999886543 234568899999999999999999998754 567899999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----CC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----ED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~ 550 (665)
.++++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+........ ..
T Consensus 88 ~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 88 LDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN-YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 9999743 2345889999999999999999999999 99999999999999999999999999876543221 12
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||+.. +..++.++||||||+++|||++ |+.||.... ..+....+.... ........+..+.+++.+|
T Consensus 164 ~~~~~y~~Pe~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 164 KFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQVERGY-RMPCPQGCPESLHELMKLC 239 (260)
T ss_pred ccchhhCCHHHhc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CCCCCcccCHHHHHHHHHH
Confidence 3567899999886 5678999999999999999999 899987532 223333332211 1122345677899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~ 649 (665)
+++||++||+++++++.|++
T Consensus 240 l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 240 WKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.86 Aligned_cols=238 Identities=20% Similarity=0.253 Sum_probs=188.7
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHH-HHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHM-EAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||+||+|... +++.||+|++...... ......+..|. .+++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999965 5778999998654221 12223334443 4568889999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~g-iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 82 ELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 99999874 345778888889999999999999999 999999999999999999999999998643221 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+.. .........+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~ 230 (325)
T cd05602 156 FCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILN--KPLQLKPNITNSARHLLEGL 230 (325)
T ss_pred ccCCccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCC--HHHHHHHHHh--CCcCCCCCCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997521 2222222221 11223345677899999999
Q ss_pred ccCCCCCCCCHHHHH
Q 005999 630 SLKSPEQRPAMWQVL 644 (665)
Q Consensus 630 l~~dP~~RPt~~evl 644 (665)
++.||.+||++.+.+
T Consensus 231 l~~~p~~R~~~~~~~ 245 (325)
T cd05602 231 LQKDRTKRLGAKDDF 245 (325)
T ss_pred cccCHHHCCCCCCCH
Confidence 999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.53 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=201.3
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|... .+..|++|.+..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 467999999999999854 246899999865542 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 468 YQPNGSLFNLIHGSRSI-----RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
|+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~di~p~nill~~~~~~kl~dfg~~~~ 168 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLTVKIGDFGMTRD 168 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccChheEEEcCCCCEEECCcccchh
Confidence 99999999999753321 1235789999999999999999999999 99999999999999999999999999865
Q ss_pred cCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 543 SDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 543 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
..... ....++..|+|||.+. ...++.++|||||||++||+++ |+.||... ...+....+.... ....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~ 244 (277)
T cd05032 169 IYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEEVLKFVIDGG-HLDLPE 244 (277)
T ss_pred hccCcccccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCCCCccC--CHHHHHHHHhcCC-CCCCCC
Confidence 53322 1223577899999886 5678999999999999999998 99998652 2223333333211 112344
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
..+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 56788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.36 Aligned_cols=247 Identities=18% Similarity=0.394 Sum_probs=200.7
Q ss_pred HhHhCcccceEEEEEEEC-C---eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD-N---HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|... + ...+++|.++.... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 367999999999999864 2 23789998865432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 549 (665)
++++|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||++.........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 89 ENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMN-YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 999999998742 346899999999999999999999999 999999999999999999999999998655432211
Q ss_pred ------CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 550 ------DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 550 ------~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
...+..|+|||++. ...++.++|||||||++|||++ |+.||.... ..+....+.... ........+..+
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~~~~~~i~~~~-~~~~~~~~~~~~ 239 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAINDGF-RLPAPMDCPSAV 239 (268)
T ss_pred ceeccCCCcCceecCHHHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhcCC-CCCCCCCCCHHH
Confidence 11245799999987 5678999999999999999997 999986532 223333333221 112334566789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.+++.+|++.+|++||++.++++.|+++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=303.04 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=191.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHh--CCCCCCeeeeeEEEEeCC----eEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG--GLSHPNLVPIRAYFQAKG----ERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~e~ 468 (665)
+++|+|.||.||||.+.+ +.||||+|... ..+.|.+|-++.+ .++|+||++++++-.... ++++|+||
T Consensus 216 eli~~Grfg~V~KaqL~~-~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred HHhhcCccceeehhhccC-ceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 679999999999999876 68999999653 3456666666655 459999999999865444 89999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA--------SWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
.+.|+|.++++. ..++|....+|+..+++||+|||+. .+|+|||||++|||+..|+++.|+|||+|
T Consensus 290 h~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 290 HPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred ccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999974 4699999999999999999999973 25999999999999999999999999999
Q ss_pred cccCCCC-----CCCCCCCcccCCccccCCCCCC-----CcchHHHHHHHHHHHHhCCCC--------CCCCCC----CC
Q 005999 541 VLSDSSS-----VEDPDTVAYKAPEIRKSSRRAT-----SKSDVYAFGVLLLELLTGKHP--------SQHPYL----AP 598 (665)
Q Consensus 541 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~-----~k~DvwSlGvvl~elltg~~P--------~~~~~~----~~ 598 (665)
....... ...+||.+|||||++.+.-.+. .+.||||+|.|+|||++.-.- |+-++. ..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 7665432 2347999999999988533333 368999999999999985432 332322 12
Q ss_pred c---cHHHHHHhhccCCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 599 P---DMLEWVRTMRVDDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 599 ~---~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
. ++.+.+........ .....+..+.+.+..||+.||+.|.|+.=|-+.+.++...
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 2 33333322222211 1224567799999999999999999999888888777543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=326.62 Aligned_cols=243 Identities=17% Similarity=0.219 Sum_probs=190.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||+||++... +++.||+|++...... ......+.+|+.++.+++|+||+++++.+.+....++||||+++|
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 86 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence 57999999999999854 6889999998654321 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 87 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~g-ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 87 DMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLG-FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999973 346899999999999999999999999 9999999999999999999999999986432210
Q ss_pred ---------------------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 005999 548 ---------------------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHP 594 (665)
Q Consensus 548 ---------------------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~ 594 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 1235899999999987 567899999999999999999999999753
Q ss_pred CCCCccHHHHHHhhccCC--CchhhhHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 005999 595 YLAPPDMLEWVRTMRVDD--GREENRLGMLTEVASVCSL--KSPEQRPAMWQVLKM 646 (665)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 646 (665)
. ..+....+....... ......+..+.+++.+++. .++..||++.|+++.
T Consensus 240 ~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 240 T--PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred C--HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 2 122222222111111 1111234567778877543 334456999999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.24 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=214.8
Q ss_pred HhHhCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..+||-|.||.||.|.|+. ...||||.++... ...++|.+|..+|+.++|||+|+++|+|..+...|||+|||..|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 5789999999999999764 6689999997665 56789999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC-C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED-P 551 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~ 551 (665)
+|.++++++ ....++--..+.++.||..|++||..++ +|||||..+|+|+.++..|||+|||+++++.....+. .
T Consensus 349 NLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkkn-FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 349 NLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred cHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 999999876 3445666678899999999999999999 9999999999999999999999999999997765433 2
Q ss_pred C---CCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 552 D---TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 552 g---t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
| ...|.|||-+. ...++.|+|||+|||+|||+.| |..||... +..++...+.... .-+.++.++..+.+|++
T Consensus 425 GAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--dlSqVY~LLEkgy-RM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYGLLEKGY-RMDGPEGCPPKVYELMR 500 (1157)
T ss_pred CccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCc--cHHHHHHHHhccc-cccCCCCCCHHHHHHHH
Confidence 3 46799999887 6789999999999999999986 77887653 2224444433322 22467789999999999
Q ss_pred HcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 628 VCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
.||+-.|.+||++.|+-+.++.+..+...
T Consensus 501 aCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred HHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 99999999999999999999999776543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.78 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=198.5
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|... .+..|++|.+..... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 57999999999999864 366889998865433 23446788999999999999999999999998899999999
Q ss_pred cCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC---ceEEeeccccccc
Q 005999 469 QPNGSLFNLIHGSRSI--RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF---EARLTDYCLSVLS 543 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~ 543 (665)
+++++|.++++..+.. ....+++..+++++.||+.||+|||+.+ ++||||||+||+++.++ .+||+|||++...
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~ 169 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchheEEEeccCCCcceEeccCcccccc
Confidence 9999999999754321 2235899999999999999999999999 99999999999998654 5999999998765
Q ss_pred CCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 544 DSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 544 ~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
..... ....+..|+|||++. +..++.++|||||||++|||++ |+.||.... ..++...+.... ....+..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~-~~~~~~~ 245 (277)
T cd05036 170 YRASYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEFVTGGG-RLDPPKG 245 (277)
T ss_pred CCccceecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcCC-cCCCCCC
Confidence 33221 112346799999986 5679999999999999999997 999987532 223333322211 1122345
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
.+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 246 ~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 246 CPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 5678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.82 Aligned_cols=241 Identities=18% Similarity=0.268 Sum_probs=194.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||||++..... .......+.+|++++..++||||+++++++.++...++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 67999999999999964 688999999975422 1233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 87 DMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLG-YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred HHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999874 345899999999999999999999999 9999999999999999999999999986432110
Q ss_pred ------------------------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 005999 548 ------------------------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPS 591 (665)
Q Consensus 548 ------------------------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~ 591 (665)
....||+.|+|||++. ...++.++|||||||++|||++|+.||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 0124899999999987 567899999999999999999999999
Q ss_pred CCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 005999 592 QHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVASVCSLKSPEQRPA---MWQVLK 645 (665)
Q Consensus 592 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 645 (665)
.... .......+....... ......+..+.+++.+|+. +|.+|++ +.|+++
T Consensus 240 ~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 240 CSDN--PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCC--HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 7532 112222221111111 1122346678999999996 9999998 888877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=303.36 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=200.3
Q ss_pred HhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCHH
Q 005999 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLF 475 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 475 (665)
+||+|+||.||++...+++.|++|.+...... ...+.+.+|++++++++|+||+++++++.+....++|+||+.+++|.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 68999999999999777899999998765543 45567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-----CC
Q 005999 476 NLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV-----ED 550 (665)
Q Consensus 476 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----~~ 550 (665)
+++... ...+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998642 345788999999999999999999999 99999999999999999999999999875542211 11
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+..|+|||.+. +..++.++|||||||++|||++ |..||.... .......+.... ....+...+..+.+++.+|
T Consensus 156 ~~~~~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 156 QIPIKWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERIESGY-RMPAPQLCPEEIYRLMLQC 231 (251)
T ss_pred cceeccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHHhcCC-CCCCCccCCHHHHHHHHHH
Confidence 2356799999886 5678999999999999999999 888886532 223333332211 1122345567899999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~ 648 (665)
+..+|++|||+.|+++.|+
T Consensus 232 l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 232 WAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hccChhhCcCHHHHHHHhh
Confidence 9999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=300.68 Aligned_cols=243 Identities=24% Similarity=0.328 Sum_probs=197.4
Q ss_pred HHhHhCcccceEEEEEEECC-eEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 393 SAELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
..+.||+|.-|+||++.+++ +..+|+|++.+..... ........|-+||+.++||.++.||+.|+.++..+++||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 34789999999999999765 5899999998765432 233456678889999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC------
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD------ 544 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~------ 544 (665)
||+|..+++.+ .++.+++..+..++.+|+-||+|||-.| ||.|||||+|||+.++|++.|+||.++....
T Consensus 161 GGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlG-ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 161 GGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLG-IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhc-eeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 99999998865 4677999999999999999999999999 9999999999999999999999999863110
Q ss_pred -C--------------------------C-CC-------------------------CCCCCCcccCCccccCCCCCCCc
Q 005999 545 -S--------------------------S-SV-------------------------EDPDTVAYKAPEIRKSSRRATSK 571 (665)
Q Consensus 545 -~--------------------------~-~~-------------------------~~~gt~~y~aPE~~~~~~~~~~k 571 (665)
. . .. .-+||-.|+|||++. +...+.+
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~-G~GHgsA 315 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR-GEGHGSA 315 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee-cCCCCch
Confidence 0 0 00 013688899999998 6778899
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHHHHHHHHHcccCCCCCCCC----HHHHH
Q 005999 572 SDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGMLTEVASVCSLKSPEQRPA----MWQVL 644 (665)
Q Consensus 572 ~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl 644 (665)
+|+|+|||++|||+.|..||.+... ...+. .+..+. ......+...++||++.|.+||.+|.. +.||.
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~----NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNN-KETLR----NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCc-hhhHH----HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999987432 11222 222222 122355688999999999999999988 77765
Q ss_pred H
Q 005999 645 K 645 (665)
Q Consensus 645 ~ 645 (665)
+
T Consensus 391 ~ 391 (459)
T KOG0610|consen 391 R 391 (459)
T ss_pred c
Confidence 4
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=310.68 Aligned_cols=240 Identities=20% Similarity=0.326 Sum_probs=189.3
Q ss_pred HhCcccceEEEEEEECC--------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 396 LLGRGSIGTTYKAVLDN--------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 58999999999998532 2247777765432 2345678889999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc--------eEEeeccc
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE--------ARLTDYCL 539 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~--------~kl~Dfgl 539 (665)
|+++|+|.++++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||+
T Consensus 80 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 80 YVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKG-LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred cCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999743 235889999999999999999999999 999999999999987765 69999998
Q ss_pred ccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 540 SVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK-HPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 540 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
+....... ...++..|+|||++.....++.++|||||||++|||++|. .|+.... ......... .....+...
T Consensus 155 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--~~~~~~~~~---~~~~~~~~~ 228 (258)
T cd05078 155 SITVLPKE-ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--SQKKLQFYE---DRHQLPAPK 228 (258)
T ss_pred ccccCCch-hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--HHHHHHHHH---ccccCCCCC
Confidence 86554322 2357788999999875556899999999999999999995 5554321 111111111 111223334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
...+.+++.+||+.||++|||++++++.|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=326.71 Aligned_cols=242 Identities=22% Similarity=0.324 Sum_probs=201.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCC--CchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe--EEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDAN--KTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE--RLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~~ 469 (665)
.+||+|+|-+||||... +|..||.-.++.. .......+.|..|+++|+.|+||||++++.+|.+... ..+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 56999999999999853 5666764433322 2223445889999999999999999999999987554 78999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeCC-CCceEEeecccccccCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~ 547 (665)
..|+|..|+++ .+.++.+.+..|+.||++||.|||++. ||||||||..||+|+. .|.|||+|+|+|.......
T Consensus 126 TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 126 TSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999985 355778899999999999999999965 7999999999999985 5899999999998877654
Q ss_pred CC-CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 VE-DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 ~~-~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
.. ..|||.|||||++. ..|++.+||||||++|+||.|+..||..- ....++...+.....+.....-....+++||
T Consensus 201 aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSEC-TNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhh-CCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 33 58999999999986 57999999999999999999999999763 2344777767666666544444456799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+|+.. .++|||+.|+|+
T Consensus 278 ekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhcC-chhccCHHHHhh
Confidence 999999 999999999987
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.91 Aligned_cols=250 Identities=20% Similarity=0.327 Sum_probs=201.8
Q ss_pred hHhCcccceEEEEEEE-CCeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVL-DNHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||+||+|.+ .++. .||+|.+..... ....+.+.+|+.++..++|+||+++++++... ..++++||+
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~ 90 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLM 90 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcC
Confidence 6799999999999984 3443 479999875543 23456788999999999999999999998764 477999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
++|+|.++++.. ...+++..++.++.||+.||+|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 91 ~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 91 PYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred CCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 999999998742 346899999999999999999999999 99999999999999999999999999876543221
Q ss_pred ----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 549 ----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 549 ----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
...++..|+|||... +..++.++|||||||++|||++ |..||+.. ....+..++...... ......+..+.
T Consensus 166 ~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~ 241 (279)
T cd05109 166 YHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEKGERL-PQPPICTIDVY 241 (279)
T ss_pred eecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHCCCcC-CCCccCCHHHH
Confidence 123467899999986 5678999999999999999998 89998653 222344444432221 22345667899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
+++.+||+.||++||++.|+++.|+++...-.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 99999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.11 Aligned_cols=244 Identities=19% Similarity=0.279 Sum_probs=194.5
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-----eEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG-----ERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 467 (665)
.+.||+|+||.||++.. .+++.||+|++..........+.+.+|+++++.++|+||+++++++.... ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 36799999999999995 57889999998755433345567889999999999999999999998776 7899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 85 LMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG-ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred ccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 997 588888763 346899999999999999999999999 9999999999999999999999999987553321
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh---------------
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM--------------- 608 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~--------------- 608 (665)
....+++.|+|||++.+...++.++||||+||++|||++|+.||..... .+....+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 2235788999999987555689999999999999999999999975321 1111111100
Q ss_pred ----c----cCC-------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 609 ----R----VDD-------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 609 ----~----~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
. ... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 000 0112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.26 Aligned_cols=245 Identities=20% Similarity=0.297 Sum_probs=195.3
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|.. .+++.||+|++..... .....+++|+.++++++||||+++++++..++..++|+||++++
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 46799999999999995 5788999999865432 33456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.++++. ...+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++....... ..
T Consensus 92 ~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 92 SLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKG-KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 99999873 345889999999999999999999999 9999999999999999999999999987654322 22
Q ss_pred CCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh-hccCC-CchhhhHHHHHHH
Q 005999 550 DPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT-MRVDD-GREENRLGMLTEV 625 (665)
Q Consensus 550 ~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~l~~l 625 (665)
..++..|+|||.+. ....++.++|||||||++|||++|+.||........ ...+... ..... ......+..+.++
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCCCCCCccccccCHHHHHH
Confidence 35788999999874 234478899999999999999999999864321111 1000000 01000 1122345689999
Q ss_pred HHHcccCCCCCCCCHHHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L 647 (665)
+.+||+.+|++||+++++++.|
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcCC
Confidence 9999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=309.17 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=199.6
Q ss_pred HHHhHhCcccceEEEEEEE-----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEE
Q 005999 392 ASAELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLV 464 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 464 (665)
...+.||+|+||.||++.. .++..||+|.++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 4456799999999999974 3578899999875543 33456789999999999999999999998875 56889
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
||||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 86 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g-i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 86 IMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999998642 235899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCC------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC----------CCccHHHHHHhh
Q 005999 545 SSS------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYL----------APPDMLEWVRTM 608 (665)
Q Consensus 545 ~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~----------~~~~~~~~~~~~ 608 (665)
... ....++..|+|||++. +..++.++|||||||++|||++++.|+..+.. ........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 322 1223567799999886 56789999999999999999998876533211 011111111111
Q ss_pred ccC--CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 609 RVD--DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 609 ~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
... .......+..+.+|+.+|++.+|++|||+.++++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111 112334677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.98 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=199.2
Q ss_pred HhHhCcccceEEEEEEECC-----------------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE
Q 005999 394 AELLGRGSIGTTYKAVLDN-----------------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 456 (665)
.+.||+|+||.||+|...+ +..||+|.+...... ...+.+.+|++++++++||||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 4679999999999987532 346899998765432 4466789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC
Q 005999 457 QAKGERLVIYDYQPNGSLFNLIHGSRSI------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF 530 (665)
Q Consensus 457 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~ 530 (665)
..++..++++||+.+++|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-FVHRDLATRNCLVGKNY 167 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhceeecCCC
Confidence 9999999999999999999999754321 1236899999999999999999999999 99999999999999999
Q ss_pred ceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCccHHH
Q 005999 531 EARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT--GKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 531 ~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~ 603 (665)
.++|+|||++....... ....++..|+|||++. ...++.++|||||||++|||++ |..||... ...+...
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~--~~~~~~~ 244 (296)
T cd05051 168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHL--TDQQVIE 244 (296)
T ss_pred ceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCc--ChHHHHH
Confidence 99999999986543321 1223567899999987 5578999999999999999998 66777542 1222222
Q ss_pred HHHhhcc------CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 604 WVRTMRV------DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 604 ~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
....... ........+..+.+++.+|++.||++|||+.|+++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 245 NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2222110 01123344578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.69 Aligned_cols=242 Identities=20% Similarity=0.335 Sum_probs=204.8
Q ss_pred HHHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 392 ASAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
...++||+|+||.||+|.+ .+|..+|||.+... ...+++.+|+.+|.+++.|++|++||.|......++|||||-
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3456899999999999984 57999999998544 456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
.|++.+.++. +.+++++.++..++.+.++||+|||... -||||||..|||++.+|++||+|||.+....+..
T Consensus 112 AGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~-KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLK-KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHH-HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999985 4578999999999999999999999988 7999999999999999999999999996665532
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccCCCchhhhHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 626 (665)
.+..||+.|||||++. .-.|+.++||||+|++..||..|++||.+.+.-..-+ ++... .+....++..+..+.+++
T Consensus 187 NTVIGTPFWMAPEVI~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--MIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIE-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--MIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred CccccCcccccHHHHH-HhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--eccCCCCCCCCChHhhhhHHHHHH
Confidence 3457999999999998 6779999999999999999999999998643211100 01111 111135677888999999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
++||-+.|++|-|+.++++
T Consensus 264 ~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHhcCCHHHHHHHHHHhh
Confidence 9999999999999999876
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.04 Aligned_cols=245 Identities=27% Similarity=0.448 Sum_probs=201.6
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||.||+|..+++..+++|.+.... ...+.+.+|+.++++++|+||+++++++..+...++||||+++++
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 46799999999999998888889999987544 334678899999999999999999999999899999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 549 (665)
|.+++... ....+++.++..++.|++.|++|||+++ ++|+||||+||++++++.+||+|||.+....... ..
T Consensus 88 L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 88 LLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN-YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred HHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 99999753 2346899999999999999999999999 9999999999999999999999999987654321 11
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...+..|+|||.+. +..++.++||||+|+++||+++ |+.||... ........+.... ....+...+..+.+++.+
T Consensus 164 ~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 164 AKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--TNREVLEQVERGY-RMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred cCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHH
Confidence 22456899999987 5678999999999999999998 99998642 2222333222211 112233446789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~ 649 (665)
|++.+|++||++.++++.|+.
T Consensus 240 ~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 240 CWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcccCcccCCCHHHHHHHHhc
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.04 Aligned_cols=242 Identities=16% Similarity=0.220 Sum_probs=192.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+....++||||+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg 86 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG 86 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence 6799999999999985 4788999999865322 1234566888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS------ 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~------ 546 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 87 DLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLG-FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999873 345888999999999999999999999 999999999999999999999999998532110
Q ss_pred --------------------------------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHH
Q 005999 547 --------------------------------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLL 582 (665)
Q Consensus 547 --------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ 582 (665)
.....||+.|+|||++. +..++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceeeEecchhhh
Confidence 00135899999999987 567899999999999999
Q ss_pred HHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 005999 583 ELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGMLTEVASVCSLKSPEQR---PAMWQVLKM 646 (665)
Q Consensus 583 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~ 646 (665)
||++|+.||.... ..+....+........ .....+..+.+++.+|+. +|.+| +++.|++..
T Consensus 240 elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 240 ECLIGWPPFCSEN--SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhcCCCCCCCCC--HHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999997532 1122221211111111 112345678999999997 67765 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=307.39 Aligned_cols=246 Identities=20% Similarity=0.324 Sum_probs=197.4
Q ss_pred HHHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 392 ASAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
...+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 34577999999999999965 57788999886543 2445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---C
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---S 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~ 547 (665)
+++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++++||+|||++...... .
T Consensus 86 ~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 86 GGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 9999998764 2346899999999999999999999999 999999999999999999999999998654322 1
Q ss_pred CCCCCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 VEDPDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....++..|+|||++. .+..++.++|||||||++|||++|+.||.... ..................+...+..+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 2235788999999874 23457789999999999999999999987532 111122221111111122334567899
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~ 645 (665)
+++.+||+.||++||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.24 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=200.3
Q ss_pred HHHHhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC-CeE
Q 005999 391 RASAELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK-GER 462 (665)
Q Consensus 391 ~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~ 462 (665)
+...+.||+|+||.||+|.. .+++.||||+++.... ......+.+|+.++.++ +||||+++++++... ...
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 34457899999999999973 3577899999975443 23345688999999999 789999999988654 467
Q ss_pred EEEEEecCCCCHHHHHhcCCCC----------------------------------------------------------
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSI---------------------------------------------------------- 484 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------- 484 (665)
+++|||+++|+|.++++..+..
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 8999999999999998743210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----CCCCCCCc
Q 005999 485 ----RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-----VEDPDTVA 555 (665)
Q Consensus 485 ----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~ 555 (665)
....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....... ....++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0134788899999999999999999999 9999999999999999999999999986543221 11234567
Q ss_pred ccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCC
Q 005999 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSP 634 (665)
Q Consensus 556 y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 634 (665)
|+|||++. +..++.++||||||+++|||++ |..||...... ......+..... ...+...+..+.+++..||+.||
T Consensus 247 y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~cl~~~p 323 (343)
T cd05103 247 WMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEP 323 (343)
T ss_pred eECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCC-CCCCCCCCHHHHHHHHHHccCCh
Confidence 99999886 5678999999999999999997 99998653211 122222211111 11223345678999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhh
Q 005999 635 EQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 635 ~~RPt~~evl~~L~~~~~~ 653 (665)
++|||+.|+++.|+.+.+.
T Consensus 324 ~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 324 SQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=305.64 Aligned_cols=247 Identities=19% Similarity=0.394 Sum_probs=200.7
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|... .+..+|+|.++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 367999999999999853 344799999875443 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 549 (665)
++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++.........
T Consensus 88 ~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 88 ENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 999999999742 346899999999999999999999999 999999999999999999999999998765432211
Q ss_pred ------CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 550 ------DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 550 ------~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
..++..|+|||++. +..++.++||||||+++||+++ |+.||.... ..+....+..... .......+..+
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--NQDVIKAIEEGYR-LPAPMDCPAAL 238 (267)
T ss_pred eeecCCCccceeecCHhHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCC--HHHHHHHHhCCCc-CCCCCCCCHHH
Confidence 11246799999987 5678999999999999999886 999986532 2233333332211 12233456789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.+++.+|++.+|++||++.++++.|+++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 239 HQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.17 Aligned_cols=248 Identities=22% Similarity=0.382 Sum_probs=199.7
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||++... ++..+++|.+.... ....+.+.+|++++++++|+||+++++++.+....++++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 467999999999999642 46678899876543 2445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeec
Q 005999 468 YQPNGSLFNLIHGSRS----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY 537 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Df 537 (665)
|+++|+|.+++..... .....+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+||+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~nil~~~~~~~kL~df 166 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-FVHRDLATRNCLVGQGLVVKIGDF 166 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-eecccccHhhEEEcCCCCEEECCC
Confidence 9999999999875321 11235899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccC
Q 005999 538 CLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVD 611 (665)
Q Consensus 538 gl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 611 (665)
|++....... ....+++.|+|||++. +..++.++|||||||++|||++ |++||.... ..+....+.....
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~- 242 (280)
T cd05092 167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--NTEAIECITQGRE- 242 (280)
T ss_pred CceeEcCCCceeecCCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--HHHHHHHHHcCcc-
Confidence 9986543322 1123467899999886 5678999999999999999998 899986532 2222222222211
Q ss_pred CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 612 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
...+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 243 LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1223456678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.67 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=195.4
Q ss_pred hHhCcc--cceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRG--SIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
++||+| +|++||++.. .+++.||+|++..........+.+.+|+++++.++||||++++++|..++..++|+||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 579999 7899999985 5789999999976654445556788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----- 546 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----- 546 (665)
|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||+........
T Consensus 84 ~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 84 GSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999998642 2235899999999999999999999999 999999999999999999999999865332111
Q ss_pred -----CCCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc----------
Q 005999 547 -----SVEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV---------- 610 (665)
Q Consensus 547 -----~~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---------- 610 (665)
.....++..|+|||++... ..++.++|||||||++|||++|+.||....... ...........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCccccccccchhh
Confidence 1122456779999998633 458899999999999999999999997532111 00000000000
Q ss_pred -------------------------C--------CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHH
Q 005999 611 -------------------------D--------DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIK 651 (665)
Q Consensus 611 -------------------------~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 651 (665)
. .......+..+.+++.+||+.||++|||++|+++ .++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0 0011123457899999999999999999999987 344443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.57 Aligned_cols=244 Identities=18% Similarity=0.231 Sum_probs=195.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||++... ++..||+|++...... ....+.+.+|+.+++.++||||+++++++.++...++||||+++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 467999999999999864 6889999998653221 22345578899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 128 g~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 128 GDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred CcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 999999863 24778888899999999999999999 9999999999999999999999999987654321
Q ss_pred CCCCCCCcccCCccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSS---RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGML 622 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~---~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 622 (665)
....||+.|+|||++... ..++.++|||||||++|||++|+.||.... .......+....... ......+..+
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--HHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 234589999999987632 247889999999999999999999997532 112222222111111 1222456789
Q ss_pred HHHHHHcccCCCCC--CCCHHHHHHH
Q 005999 623 TEVASVCSLKSPEQ--RPAMWQVLKM 646 (665)
Q Consensus 623 ~~li~~cl~~dP~~--RPt~~evl~~ 646 (665)
.+++.+||+.+|++ ||++.|+++.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcC
Confidence 99999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.49 Aligned_cols=238 Identities=19% Similarity=0.237 Sum_probs=189.0
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHH-HHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHME-AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|.. .+++.+|+|++...... ....+.+..|.. +++.++||||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3589999999999985 46889999998654221 123344555554 56788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..... ...
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g-ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSIN-IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 999998863 346899999999999999999999999 99999999999999999999999999864322 122
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+.. .........+..+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 155 TFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--DVAEMYDNILH--KPLVLRPGASLTAWSILEE 229 (325)
T ss_pred cccCChhhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCC--CHHHHHHHHHc--CCccCCCCCCHHHHHHHHH
Confidence 335899999999987 567899999999999999999999999752 11222222221 1112233456678899999
Q ss_pred cccCCCCCCCCHHHH
Q 005999 629 CSLKSPEQRPAMWQV 643 (665)
Q Consensus 629 cl~~dP~~RPt~~ev 643 (665)
|++.+|++||++++.
T Consensus 230 ll~~~p~~R~~~~~~ 244 (325)
T cd05604 230 LLEKDRQRRLGAKED 244 (325)
T ss_pred HhccCHHhcCCCCCC
Confidence 999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=328.70 Aligned_cols=241 Identities=19% Similarity=0.250 Sum_probs=190.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 6799999999999985 4688999999865432 1234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS------ 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~------ 546 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++......
T Consensus 87 ~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~-ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 87 DMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999874 245788889999999999999999999 999999999999999999999999986421100
Q ss_pred --------------------------------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHH
Q 005999 547 --------------------------------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLL 582 (665)
Q Consensus 547 --------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ 582 (665)
.....||+.|+|||++. +..++.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeEEechHHHH
Confidence 01124889999999987 567899999999999999
Q ss_pred HHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 005999 583 ELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVASVCSLKSPEQRPA---MWQVLK 645 (665)
Q Consensus 583 elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 645 (665)
||++|+.||.... ..+....+....... ......+....+++.+++ .+|++|++ +.|+++
T Consensus 240 elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 240 EMLVGQPPFLAQT--PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHhCCCCCCCCC--HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999997532 111111111111111 122344567788888876 59999987 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.25 Aligned_cols=243 Identities=16% Similarity=0.241 Sum_probs=196.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||+||++... +++.||+|+++.... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG 86 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence 57999999999999854 688999999975432 2234566889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~ 548 (665)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 87 ~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 161 (330)
T cd05601 87 DLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161 (330)
T ss_pred CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence 999999743 246899999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred CCCCCCcccCCccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHH
Q 005999 549 EDPDTVAYKAPEIRKS-----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGM 621 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~-----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 621 (665)
...+|+.|+|||++.. ...++.++|||||||++|||++|+.||.... .......+....... ......+..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--SAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--HHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 2358999999998752 3457889999999999999999999997532 112212121111111 112245677
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++..|++ +|++|||+.++++
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhC
Confidence 9999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=315.26 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=205.3
Q ss_pred HHHHHhHhCcccceEEEEEEEC--------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCC
Q 005999 390 MRASAELLGRGSIGTTYKAVLD--------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKG 460 (665)
Q Consensus 390 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 460 (665)
.+...+.||+|+||.||+|... .+..||+|.+..... ....+.+.+|+++++++ +||||+++++++..++
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 3344578999999999999742 234689998875432 24456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD 529 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~ 529 (665)
..++++||+++|+|.+++...+. .....+++.+++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Nill~~~ 170 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-CIHRDLAARNVLVTED 170 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceEEEcCC
Confidence 99999999999999999875321 12346889999999999999999999999 9999999999999999
Q ss_pred CceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHH
Q 005999 530 FEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 530 ~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 603 (665)
+.+||+|||++....... ....++..|+|||++. +..++.++|||||||++|||++ |..||... ...+...
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~ 247 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEELFK 247 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhc-cCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--CHHHHHH
Confidence 999999999987654322 1122356799999986 5678999999999999999998 88888652 1122322
Q ss_pred HHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 604 WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+.... ........+..+.+++.+|++.+|++|||+.|+++.|+.+....
T Consensus 248 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 248 LLKEGH-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 222211 11223455678999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.17 Aligned_cols=240 Identities=21% Similarity=0.282 Sum_probs=192.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCC-CeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHP-NLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|++..... .....+.+..|.+++..++|+ +|+++++++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 57999999999999865 577899999875432 123445678889999989665 588899999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..... ...
T Consensus 86 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 86 GDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 999999873 345889999999999999999999999 99999999999999999999999999864321 122
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++||||+||++|||++|+.||.... ..+....+... ....+...+..+.+++.+
T Consensus 160 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQSIMEH--NVSYPKSLSKEAVSICKG 234 (324)
T ss_pred eecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence 335899999999987 5678999999999999999999999997532 22333322221 122344566778999999
Q ss_pred cccCCCCCCCCH-----HHHHH
Q 005999 629 CSLKSPEQRPAM-----WQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~-----~evl~ 645 (665)
||+.||++|++. .++++
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999986 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=307.00 Aligned_cols=240 Identities=23% Similarity=0.280 Sum_probs=194.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++..++..++||||+++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 5799999999999984 5788899999865432 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVEDPD 552 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~g 552 (665)
|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...... .....+
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCC
Confidence 97552 3678888999999999999999999 999999999999999999999999998755433 233468
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhc---cCCCchhhhHHHHHHHHH
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMR---VDDGREENRLGMLTEVAS 627 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~l~~li~ 627 (665)
+..|+|||++. +..++.++||||||+++|||++|+.||........ .......... .........+..+.+++.
T Consensus 156 ~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 156 TNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred ChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 89999999987 56789999999999999999999999975332211 1111111111 111112335567999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~ 646 (665)
+|++.+|++||++.|+++.
T Consensus 235 ~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 235 QCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHhhCChhhCCCHHHHhcC
Confidence 9999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.37 Aligned_cols=235 Identities=21% Similarity=0.249 Sum_probs=187.1
Q ss_pred HhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHH-HHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHM-EAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|... +++.||+|++...... ......+.+|. .+++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999964 6789999998654321 12233444554 4678899999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 82 ELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 99998863 345788889999999999999999999 999999999999999999999999998653221 222
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ...+...+.. .....+...+..+.+++.+|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~ 230 (321)
T cd05603 156 FCGTPEYLAPEVLR-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--VSQMYDNILH--KPLQLPGGKTVAACDLLVGL 230 (321)
T ss_pred ccCCcccCCHHHhc-CCCCCCcCcccccchhhhhhhcCCCCCCCCC--HHHHHHHHhc--CCCCCCCCCCHHHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997531 1122222221 11123345566799999999
Q ss_pred ccCCCCCCCCHH
Q 005999 630 SLKSPEQRPAMW 641 (665)
Q Consensus 630 l~~dP~~RPt~~ 641 (665)
++.||.+||++.
T Consensus 231 l~~~p~~R~~~~ 242 (321)
T cd05603 231 LHKDQRRRLGAK 242 (321)
T ss_pred ccCCHhhcCCCC
Confidence 999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=329.86 Aligned_cols=242 Identities=18% Similarity=0.231 Sum_probs=191.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++|+||+++++.+.+++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 5799999999999985 46889999998654221 123456888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS------ 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~------ 546 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 87 DMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999974 345788888999999999999999999 999999999999999999999999987422100
Q ss_pred ----------------------------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh
Q 005999 547 ----------------------------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586 (665)
Q Consensus 547 ----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt 586 (665)
.....||+.|+|||++. +..++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-CCCCCcceeeeeccceeeehhh
Confidence 01125899999999987 5678999999999999999999
Q ss_pred CCCCCCCCCCCCccHHHHHHhhccC--CCchhhhHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 005999 587 GKHPSQHPYLAPPDMLEWVRTMRVD--DGREENRLGMLTEVASVCSLKSPEQRP---AMWQVLKM 646 (665)
Q Consensus 587 g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 646 (665)
|+.||.... ..+....+...... .......+..+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 240 G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADT--PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCC--HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999997632 11221111111111 1122345667888898876 5999999 89999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.82 Aligned_cols=246 Identities=19% Similarity=0.245 Sum_probs=197.0
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||+||+|.. .+++.+|+|.+....... ...+.+.+|++++++++|+||+++.+++..++..++||||++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 5699999999999985 468899999986543322 23455778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....... ...
T Consensus 86 ~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~-iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 86 DLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred cHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 999988642 2346899999999999999999999999 9999999999999999999999999986553322 234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++|+|||||++|||++|+.||...... ............ ........+..+.+|+.+|
T Consensus 162 ~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 162 VGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 5899999999986 567899999999999999999999999753211 111111111111 1122344566789999999
Q ss_pred ccCCCCCCCC-----HHHHHHH
Q 005999 630 SLKSPEQRPA-----MWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt-----~~evl~~ 646 (665)
++.||++||+ +.+++..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcC
Confidence 9999999999 6677663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=310.00 Aligned_cols=248 Identities=21% Similarity=0.376 Sum_probs=195.2
Q ss_pred HhHhCcccceEEEEEEEC-----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 466 (665)
.+.||+|+||.||++..+ ++..|++|++.... ....+.+.+|++++++++||||+++++++.. ....++|+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 367999999999999743 57789999987554 2445678999999999999999999998754 34688999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 87 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 87 EYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999998742 245899999999999999999999999 999999999999999999999999998765432
Q ss_pred CC------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---------C--c---cHHHHHH
Q 005999 547 SV------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA---------P--P---DMLEWVR 606 (665)
Q Consensus 547 ~~------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~---------~--~---~~~~~~~ 606 (665)
.. ...++..|+|||++. +..++.++|||||||++|||++|..|+...... . . .+.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 21 112344699999986 567899999999999999999987765432110 0 0 0111111
Q ss_pred hhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 607 TMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 607 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
... ........+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 241 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 110 1112344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.96 Aligned_cols=241 Identities=20% Similarity=0.329 Sum_probs=197.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++..+...++||||+++++
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 5699999999999985 4688999999876543 334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 104 L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g-i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 104 LTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 9999863 34788999999999999999999999 9999999999999999999999999986543321 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+++.|+|||++. +..++.++|||||||++|||++|+.||...... ....................+..+.+++.+||
T Consensus 177 ~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 177 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred cCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-HhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 5788999999987 566889999999999999999999999753211 11222221111111223455677999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~ 646 (665)
..+|++||++.|+++.
T Consensus 255 ~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 255 DMDVEKRGSAKELLQH 270 (296)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.68 Aligned_cols=244 Identities=19% Similarity=0.278 Sum_probs=197.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... +++.||+|.+....... ...+.+.+|+.++++++|+||+++++.+.+++..++||||++++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 56999999999999854 68899999986543222 23345778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....... ...
T Consensus 86 ~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 86 DLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred cHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 999988642 2345899999999999999999999999 9999999999999999999999999986654322 234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
.|+..|+|||++. +..++.++|||||||++|||++|+.||........ .......... .......+..+.+++.+
T Consensus 162 ~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 162 VGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--EEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCccccChHHHc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--hhcCccCCHHHHHHHHH
Confidence 6899999999987 56789999999999999999999999976322111 1111111111 11233456679999999
Q ss_pred cccCCCCCCCC-----HHHHHH
Q 005999 629 CSLKSPEQRPA-----MWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt-----~~evl~ 645 (665)
||+.||++||| +.|+++
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHc
Confidence 99999999999 889887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.62 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=195.9
Q ss_pred HhHhCcccceEEEEEEECC---------------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLDN---------------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA 458 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 458 (665)
.+.||+|+||.||++...+ ...||+|.++.... ....+.+.+|++++++++|+|++++++++..
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 88 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 4679999999999987532 23589999876533 3445678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc
Q 005999 459 KGERLVIYDYQPNGSLFNLIHGSRSI-------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE 531 (665)
Q Consensus 459 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~ 531 (665)
++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nill~~~~~ 167 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGNHYT 167 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-eeccccChhhEEEcCCCc
Confidence 99999999999999999998643210 1124788999999999999999999999 999999999999999999
Q ss_pred eEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCccHHHH
Q 005999 532 ARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT--GKHPSQHPYLAPPDMLEW 604 (665)
Q Consensus 532 ~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~~ 604 (665)
+||+|||++....... ....++..|+|||++. ...++.++|||||||++|||++ |..||.... ..+....
T Consensus 168 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--~~~~~~~ 244 (295)
T cd05097 168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--DEQVIEN 244 (295)
T ss_pred EEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--hHHHHHH
Confidence 9999999986543221 1123467899999886 5678999999999999999998 556765422 2222222
Q ss_pred HHhhccC------CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 605 VRTMRVD------DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 605 ~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
+...... .......+..+.+++.+|++.||++||++.+|++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2111110 1123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.10 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=190.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... ++..||+|++...... ....+.+..|..++..+ +|++|+++++++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 57999999999999865 5778999998754321 22334566777777777 689999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..... ...
T Consensus 86 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 86 GDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 999999863 345889999999999999999999999 99999999999999999999999999865322 122
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||.... ...+...+.... ...+...+..+.+++.+
T Consensus 160 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~--~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHN--VAYPKSMSKEAVAICKG 234 (323)
T ss_pred cCCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC--CCCCCcCCHHHHHHHHH
Confidence 345899999999987 5678999999999999999999999997532 223333332221 12334566789999999
Q ss_pred cccCCCCCCCCH
Q 005999 629 CSLKSPEQRPAM 640 (665)
Q Consensus 629 cl~~dP~~RPt~ 640 (665)
|++.||++|++.
T Consensus 235 ~l~~~p~~R~~~ 246 (323)
T cd05616 235 LMTKHPGKRLGC 246 (323)
T ss_pred HcccCHHhcCCC
Confidence 999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=305.55 Aligned_cols=247 Identities=19% Similarity=0.402 Sum_probs=200.5
Q ss_pred HhHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|.... +..|++|.+..... ....+.|..|+.++++++||||+++++++.++...++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 3679999999999998642 34699999875532 345677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 549 (665)
++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g-~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 88 ENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred CCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 999999998742 345899999999999999999999999 999999999999999999999999998655432111
Q ss_pred -----CC---CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 550 -----DP---DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 550 -----~~---gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
.. .+..|+|||++. +..++.++|||||||++||+++ |..||... ...+...++.... ........+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~--~~~~~~~~i~~~~-~~~~~~~~~~ 238 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVINAIEQDY-RLPPPMDCPT 238 (269)
T ss_pred cccccccCCCcceeecCHhHhc-cCcccchhhhhhhHHHHHHHhcCCCCCCCCC--CHHHHHHHHHcCC-cCCCcccCCH
Confidence 01 135799999986 5678999999999999999886 99998653 2223444433221 1122345667
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.+.+++.+|+..+|++||++.+++..|+.+
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.48 Aligned_cols=243 Identities=22% Similarity=0.350 Sum_probs=200.7
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCC-CchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDAN-KTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+-||.|+||.||-|. ..+.+.||||++... +......+++.+|+.+|++++|||++.+.|+|..+...++|||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 569999999999999 457889999999654 33334567899999999999999999999999999999999999976
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+-.|++.- ..+++.+-.+..|+.+.+.||+|||+.+ .||||||..|||+++.|.|||+|||.+..+.+.. .-+|
T Consensus 111 SAsDlleV----hkKplqEvEIAAi~~gaL~gLaYLHS~~-~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-sFvG 184 (948)
T KOG0577|consen 111 SASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN-RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-SFVG 184 (948)
T ss_pred cHHHHHHH----HhccchHHHHHHHHHHHHHHHHHHHHhh-HHhhhccccceEecCCCeeeeccccchhhcCchh-cccC
Confidence 77777653 3467999999999999999999999999 9999999999999999999999999998776544 3489
Q ss_pred CCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 553 TVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 553 t~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
||.|||||++. ..++|+-|+||||+|++..||.-.++|+-..+. -..+.. +.....+.-...+.+..+++|+..||
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYH-IAQNesPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYH-IAQNESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHH-HHhcCCCCCCCchhHHHHHHHHHHHH
Confidence 99999999875 356899999999999999999999999754210 011111 11111111235567788999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~ 646 (665)
++-|.+|||..++++.
T Consensus 263 qKipqeRptse~ll~H 278 (948)
T KOG0577|consen 263 QKIPQERPTSEELLKH 278 (948)
T ss_pred hhCcccCCcHHHHhhc
Confidence 9999999999998763
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.13 Aligned_cols=236 Identities=15% Similarity=0.200 Sum_probs=186.8
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++.. .+++.||+|... .+.+.+|++++++++||||++++++|..+...++|+|++. +
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 36799999999999985 468889999643 2346789999999999999999999999999999999985 6
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC----CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----SV 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----~~ 548 (665)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 168 ~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~-IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 168 DLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENR-IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 89988863 245889999999999999999999999 999999999999999999999999998653321 12
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC------CccHHHHHHhhcc------------
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA------PPDMLEWVRTMRV------------ 610 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~------~~~~~~~~~~~~~------------ 610 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||...... ...+...+.....
T Consensus 242 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 242 GWAGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred cccCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 235899999999987 567899999999999999999999886432110 0011111110000
Q ss_pred --------------CC-C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 --------------DD-G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 --------------~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.. . .....+..+.+++.+||+.||++|||+.|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0 01123557889999999999999999999986
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=302.44 Aligned_cols=241 Identities=22% Similarity=0.390 Sum_probs=197.4
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||++...++..+++|.+..... ....+.+|++++++++|||++++++++......++|+||+.+++|
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 57999999999999987777899998865432 345688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----CC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----ED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~ 550 (665)
.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.+........ ..
T Consensus 87 ~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 161 (256)
T cd05112 87 SDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN-VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161 (256)
T ss_pred HHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence 9998742 345789999999999999999999999 99999999999999999999999999865433221 12
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++.+|+|||++. +..++.++||||||+++|||++ |+.||.... ...+.+.+..... ...+...+..+.+++.+|
T Consensus 162 ~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 162 KFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETINAGFR-LYKPRLASQSVYELMQHC 237 (256)
T ss_pred ccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHH
Confidence 2456899999886 5678899999999999999998 999987521 2233333322111 112233567899999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L 647 (665)
|+.+|++|||+.|+++.|
T Consensus 238 l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 238 WKERPEDRPSFSLLLHQL 255 (256)
T ss_pred cccChhhCCCHHHHHHhh
Confidence 999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=303.65 Aligned_cols=245 Identities=18% Similarity=0.276 Sum_probs=195.2
Q ss_pred HHHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 392 ASAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
...+.||+|+||.||+|.. .++..||+|.++.... .....+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 3457899999999999985 4688999999865532 334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+++|.+++.. ...+++.+++.++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 90 GGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKG-KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999999873 346899999999999999999999999 9999999999999999999999999986543321
Q ss_pred CCCCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHH
Q 005999 548 VEDPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLT 623 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 623 (665)
....++..|+|||++. ....++.++|||||||++|||++|+.||....... ............. ......+..+.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhccCCCCCcccccCCCCHHHH
Confidence 2235789999999864 23457889999999999999999999986432111 1111111110111 01123456789
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~ 645 (665)
+++.+|++.+|++||++.++++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhc
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.24 Aligned_cols=257 Identities=20% Similarity=0.310 Sum_probs=211.3
Q ss_pred HHHHHHHHhHhCcccceEEEEEEE-CCe----EEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe
Q 005999 387 EQLMRASAELLGRGSIGTTYKAVL-DNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE 461 (665)
Q Consensus 387 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 461 (665)
+|.+....++||+|+||+||+|.+ ..+ -.||+|++..... ....+++..|+..|.+++|||+++++|+|....
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 444445568899999999999984 333 3678888865443 355678899999999999999999999998876
Q ss_pred EEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccc
Q 005999 462 RLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV 541 (665)
Q Consensus 462 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~ 541 (665)
..+|++||+.|+|.++++.. ...+-....+.|..|||+||.|||++. ++||||..+|||+..-.++|+.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~qr-lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEEQR-LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhcc-hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 78999999999999999864 345777889999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCCC-----CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCch
Q 005999 542 LSDSSSVEDP-----DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615 (665)
Q Consensus 542 ~~~~~~~~~~-----gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (665)
.......+.. -.+.|||-|.+. ...|+.++|||||||++||+|| |..|++... ..++.+.++.... -..+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~geR-LsqP 922 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGER-LSQP 922 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhcccc-CCCC
Confidence 8766543321 246799999887 6789999999999999999998 888987632 2244444433322 3456
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
..+...+..++.+||..|++.||+++++...+.++..+-
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 677888999999999999999999999999999886654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.69 Aligned_cols=244 Identities=18% Similarity=0.241 Sum_probs=193.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||++... +++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999965 5788999998643221 22345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 128 g~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~-IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 128 GDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred CcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 999999863 24788889999999999999999999 9999999999999999999999999997654322
Q ss_pred CCCCCCCcccCCccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSS---RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGML 622 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~---~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 622 (665)
....||+.|+|||++... ..++.++||||+||++|||++|+.||.... .......+....... ......+..+
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--LVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 234589999999998632 237889999999999999999999997532 111112121111111 1222456778
Q ss_pred HHHHHHcccCCCCC--CCCHHHHHHH
Q 005999 623 TEVASVCSLKSPEQ--RPAMWQVLKM 646 (665)
Q Consensus 623 ~~li~~cl~~dP~~--RPt~~evl~~ 646 (665)
.+++..|+..++.. ||++.|+++.
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcC
Confidence 99999999855543 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.96 Aligned_cols=245 Identities=20% Similarity=0.282 Sum_probs=185.8
Q ss_pred hHhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 469 (665)
.+||+|+||+||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 57999999999999854 467899999865432 2346789999999999999999999864 45688999998
Q ss_pred CCCCHHHHHhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe----CCCCceEEeeccccc
Q 005999 470 PNGSLFNLIHGSRS----IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSV 541 (665)
Q Consensus 470 ~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill----~~~~~~kl~Dfgl~~ 541 (665)
.+ +|.+++...+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 65 89888753321 12335899999999999999999999999 9999999999999 456789999999997
Q ss_pred ccCCCC------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--------cHHHHHHh
Q 005999 542 LSDSSS------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--------DMLEWVRT 607 (665)
Q Consensus 542 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--------~~~~~~~~ 607 (665)
...... ....+|+.|+|||++.+...++.++||||+||++|||++|++||........ .+......
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 654321 2235789999999987556689999999999999999999999964322100 11111110
Q ss_pred hccCC-------------------------C----------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 608 MRVDD-------------------------G----------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 608 ~~~~~-------------------------~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..... . ........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0 00011235789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=304.25 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=192.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC------CeEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK------GERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~~~~lv 465 (665)
.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++... ...+++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 467999999999999854 68889999986543 2345678899999998 799999999998753 468899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+.+++|.+++... ....+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 88 MEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 9999999999998743 2346889999999999999999999999 99999999999999999999999999876543
Q ss_pred C---CCCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 546 S---SVEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 546 ~---~~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
. .....++..|+|||++.. ...++.++|||||||++|||++|+.||..... ....................
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRALFLIPRNPAPRLKSKKW 241 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--HHHHHHHhcCCCCCCCCCCc
Confidence 2 122357889999998752 23578899999999999999999999864321 11111111111111123345
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+..+.+++.+||..+|.+|||+.|+++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 678999999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=308.71 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=199.5
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 367999999999999853 467899999875543 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC
Q 005999 468 YQPNGSLFNLIHGSRS-----------------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF 530 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~ 530 (665)
|+++|+|.+++..... .....+++..++.++.|++.||+|||+++ ++||||||+||++++++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-i~H~dl~p~nil~~~~~ 167 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-FVHRDLATRNCLVGENM 167 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-eecccccHhheEecCCC
Confidence 9999999999974211 11235788999999999999999999999 99999999999999999
Q ss_pred ceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHH
Q 005999 531 EARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEW 604 (665)
Q Consensus 531 ~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 604 (665)
.++|+|||++....... .....+..|+|||.+. +..++.++|||||||++|||++ |..||.... ..+....
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--~~~~~~~ 244 (288)
T cd05050 168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--HEEVIYY 244 (288)
T ss_pred ceEECccccceecccCccccccCCCccChhhcCHHHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH
Confidence 99999999986543221 1123456799999886 5678999999999999999997 888886421 1233332
Q ss_pred HHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 605 VRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 605 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
+...... ..+...+..+.+++.+|++.||++|||+.|+++.|++
T Consensus 245 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 245 VRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2221111 1233556789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.48 Aligned_cols=249 Identities=22% Similarity=0.385 Sum_probs=201.0
Q ss_pred hHhCcccceEEEEEEEC-----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 467 (665)
+.||+|+||.||+|.++ ++..+|+|++...... ...+.+.+|++++++++|+||+++++++.. ....+++||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 67999999999999854 3688999999766543 356789999999999999999999999887 557899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 89 ~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 89 YLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQR-YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred cCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999999753 235899999999999999999999999 9999999999999999999999999997665321
Q ss_pred C------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC----------ccHHHHHHhhccC
Q 005999 548 V------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP----------PDMLEWVRTMRVD 611 (665)
Q Consensus 548 ~------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~----------~~~~~~~~~~~~~ 611 (665)
. ...++..|+|||++. +..++.++||||||+++|||++|+.|+....... .....+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred cceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 1 123456799999886 5678899999999999999999999986533221 1111222111111
Q ss_pred C--CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 612 D--GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 612 ~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
. .....++..+.+++.+|++.+|++|||+.|++++|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 12344567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=303.36 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=189.8
Q ss_pred hHhCcccceEEEEEEECCeE-----------EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEE
Q 005999 395 ELLGRGSIGTTYKAVLDNHL-----------IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERL 463 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 463 (665)
+.||+|+||.||+|...+.. .+++|.+..... ....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36899999999999975432 577777654432 25778899999999999999999999988 7789
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-------ceEEee
Q 005999 464 VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-------EARLTD 536 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-------~~kl~D 536 (665)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 77 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKK-LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC-eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999998743 226889999999999999999999999 99999999999999887 799999
Q ss_pred cccccccCCCCCCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCc
Q 005999 537 YCLSVLSDSSSVEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR 614 (665)
Q Consensus 537 fgl~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 614 (665)
||++..... .....++..|+|||++... ..++.++|||||||++|||++ |..||.... ......+... ....
T Consensus 152 fg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--~~~~~~~~~~---~~~~ 225 (259)
T cd05037 152 PGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--SSEKERFYQD---QHRL 225 (259)
T ss_pred CCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--chhHHHHHhc---CCCC
Confidence 999876544 2223466789999998743 368899999999999999999 577776542 1122222111 1111
Q ss_pred hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 615 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
.......+.+++.+|+..+|++|||+.|+++.|+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1112267899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.52 Aligned_cols=252 Identities=21% Similarity=0.366 Sum_probs=199.0
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|..+ .+..||+|.+...... .....+.+|+..+++++||||+++++++.+....++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 467999999999999743 2557999988655432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 468 YQPNGSLFNLIHGSRSI-----RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
|+++|+|.+++...... ....+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dikp~nili~~~~~~~L~Dfg~~~~ 168 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRD 168 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCCChheEEEcCCCcEEECcCCcccc
Confidence 99999999999743211 1234577788999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 543 SDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 543 ~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
...... ...++..|+|||++. +..++.++|||||||++|||++ |..||... ...+....+.... ....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--~~~~~~~~~~~~~-~~~~~~ 244 (288)
T cd05061 169 IYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--SNEQVLKFVMDGG-YLDQPD 244 (288)
T ss_pred ccccccccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCCCCC
Confidence 433221 123456799999987 5678999999999999999998 78888653 2223333222111 112234
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 651 (665)
..+..+.+++.+|++.||++|||+.|+++.|++..
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 55678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=311.29 Aligned_cols=250 Identities=16% Similarity=0.287 Sum_probs=195.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..||+|+++.... ......+.+|++++++++||||+++++++..++..++||||+.+ +
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 57999999999999854 677899999875543 22334577899999999999999999999999999999999976 8
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 90 l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 164 (309)
T cd07872 90 LKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164 (309)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECccccceecCCCccccccc
Confidence 88887642 345788999999999999999999999 9999999999999999999999999986543321 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc--------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-------------------- 610 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------------------- 610 (665)
.+++.|+|||++.+...++.++|||||||++|||+||+.||......+ .+....+....
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 578899999988755678999999999999999999999997532111 11111100000
Q ss_pred CC-------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHh
Q 005999 611 DD-------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIKE 652 (665)
Q Consensus 611 ~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 652 (665)
.. ......+..+.+++.+|++.||++|||+.|+++ .++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 00 001123567889999999999999999999988 4444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=309.78 Aligned_cols=243 Identities=32% Similarity=0.493 Sum_probs=198.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||++... +++.+|+|++..............+|+.++++++||||+++++++..+...++||||+.+++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 57999999999999965 56789999998876554544455669999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc---CCCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS---DSSSVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~---~~~~~~~ 550 (665)
|.+++. ....+++..++.++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+... .......
T Consensus 85 L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~-i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 85 LQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHSKG-IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp HHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHHTT-EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred cccccc-----cccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 999997 2356899999999999999999999999 999999999999999999999999998753 1222334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-----CchhhhHHHHHHH
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-----GREENRLGMLTEV 625 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l 625 (665)
.++..|+|||++..+..++.++||||+|+++|+|++|+.||... ...+............ .........+.++
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 57899999999864577899999999999999999999999864 1112222221111111 1112224789999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||+.||++||++.++++
T Consensus 237 i~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=313.79 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=204.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|.||.||++..+ +|+.+|+|.+.+.... ....+.+.+|+.+|+++. |||||.++++|++...+++|||++.|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 67999999999999966 4999999999766542 224578999999999998 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC----CceEEeecccccccCCC-
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD----FEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~----~~~kl~Dfgl~~~~~~~- 546 (665)
|.|++.+... .+++.....++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||++......
T Consensus 121 GeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g-vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 121 GELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG-VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred chHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 9999998743 2899999999999999999999999 9999999999999643 47999999999887762
Q ss_pred -CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--cCCCchhhhHHHHH
Q 005999 547 -SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--VDDGREENRLGMLT 623 (665)
Q Consensus 547 -~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 623 (665)
.....||+.|+|||++. ...|+..+||||+||++|.|++|.+||..... ......+.... .........+..+.
T Consensus 194 ~~~~~~Gtp~y~APEvl~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~--~~~~~~i~~~~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLG-GRPYGDEVDVWSIGVILYILLSGVPPFWGETE--FEIFLAILRGDFDFTSEPWDDISESAK 270 (382)
T ss_pred eEeeecCCccccCchhhc-CCCCCcccchhHHHHHHHHHhhCCCCCcCCCh--hHHHHHHHcCCCCCCCCCccccCHHHH
Confidence 34457999999999987 57899999999999999999999999987432 12222222222 22245667788899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~ 646 (665)
++++.|+..||.+|+|+.++++.
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcC
Confidence 99999999999999999999984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.44 Aligned_cols=244 Identities=20% Similarity=0.252 Sum_probs=192.6
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 466 (665)
.+.||+|+||.||+|.. .++..||+|++..........+.+.+|++++++++||||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 46799999999999985 5678999999876543334456677899999999999999999987543 3568899
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
|++ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 100 NLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG-IIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 987 7799888752 35899999999999999999999999 999999999999999999999999999877665
Q ss_pred CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--------------
Q 005999 547 SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-------------- 612 (665)
Q Consensus 547 ~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-------------- 612 (665)
.....+|+.|+|||++.....++.++|||||||++|||++|+.||...... ..+...........
T Consensus 172 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 555678999999999875467899999999999999999999999653210 01111100000000
Q ss_pred --------C------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 --------G------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 --------~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
. ........+.+++.+|+..||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 001123457899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.85 Aligned_cols=240 Identities=18% Similarity=0.240 Sum_probs=187.2
Q ss_pred hCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC---CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 397 LGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL---SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
||+|+||+||+|... ++..||+|++...... ......+..|..++.+. +||||+++++++.+....++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999854 6889999998643221 12223344566666554 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~ 548 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYD-IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999873 346889999999999999999999999 999999999999999999999999998653221 22
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++.....++.++|||||||++|||++|+.||.... ..++...+...... ......+..+.+++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~ 231 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--TQQMYRNIAFGKVR-FPKNVLSDEGRQFVKG 231 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--HHHHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence 34589999999998744568999999999999999999999996531 11222222211111 1122346678999999
Q ss_pred cccCCCCCCC----CHHHHHH
Q 005999 629 CSLKSPEQRP----AMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RP----t~~evl~ 645 (665)
||+.||++|| ++.|+++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhc
Confidence 9999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=302.26 Aligned_cols=242 Identities=24% Similarity=0.405 Sum_probs=196.9
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||.||++.. .+..||+|.+.... ..+.+.+|+.++++++|||++++++++..++ .++||||+++++
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~ 84 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGN 84 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCC
Confidence 46799999999999875 56679999986532 3457889999999999999999999987654 789999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT 553 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt 553 (665)
|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++............+
T Consensus 85 L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 85 LVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK-LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred HHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 99999743 2345889999999999999999999999 9999999999999999999999999987654433333456
Q ss_pred CcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 554 ~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+....+..... .......+..+.+++.+|++.
T Consensus 161 ~~y~~pe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~ 236 (254)
T cd05083 161 VKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--LKEVKECVEKGYR-MEPPEGCPADVYVLMTSCWET 236 (254)
T ss_pred ceecCHHHhc-cCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--HHHHHHHHhCCCC-CCCCCcCCHHHHHHHHHHcCC
Confidence 7899999886 5678999999999999999997 999987532 1233333322211 122345667899999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 005999 633 SPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 633 dP~~RPt~~evl~~L~~ 649 (665)
+|++||++.++++.|++
T Consensus 237 ~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 237 EPKKRPSFHKLREKLEK 253 (254)
T ss_pred ChhhCcCHHHHHHHHcc
Confidence 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=301.53 Aligned_cols=244 Identities=23% Similarity=0.317 Sum_probs=199.0
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... ++..+++|.++.... ....+.+.+|+.++++++|+||+++++++.+++..++++||+++|
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 357999999999999854 688899999865443 234567888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++... ....+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++++|||.+....... ..
T Consensus 84 ~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 84 DLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred cHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999988643 2345788999999999999999999999 9999999999999999999999999986554322 23
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+++.|+|||++. +..++.++||||||+++|+|++|+.||.... .......+...... ..+...+..+.+++.+|
T Consensus 160 ~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 160 YVGTPYYVPPEIWE-NMPYNNKSDIWSLGCILYELCTLKHPFQANS--WKNLILKVCQGSYK-PLPSHYSYELRSLIKQM 235 (255)
T ss_pred ccCCccccCHHHHc-cCCcCchhhhhhhchhheehhhccCCCCCCC--HHHHHHHHhcCCCC-CCCcccCHHHHHHHHHH
Confidence 35788999999987 5678999999999999999999999997521 11222222211111 12334566799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|+.||++||++.|++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.77 Aligned_cols=243 Identities=21% Similarity=0.364 Sum_probs=197.0
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCch----hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA----DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|...+++.+|+|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++++||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 4679999999999999888889999988654321 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--- 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--- 546 (665)
++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 85 PGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNC-VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999973 245788999999999999999999999 999999999999999999999999988654211
Q ss_pred ------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccCCCchhhhH
Q 005999 547 ------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVDDGREENRL 619 (665)
Q Consensus 547 ------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 619 (665)
.....++..|+|||++. +..++.++|||||||++|||++|+.||...... .... .+... ......+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-AAMF-YIGAHRGLMPRLPDSFS 235 (265)
T ss_pred ccccccccccCCCccccChhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCChH-HHHH-HhhhccCCCCCCCCCCC
Confidence 11234788999999987 567889999999999999999999999753211 1111 11111 11112344567
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 78999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.52 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=196.6
Q ss_pred HhHhCcccceEEEEEEEC-----------------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-----------------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 456 (665)
.+.||+|+||.||++... +...+|+|++..... ....+.+.+|++++++++|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIRLLAVC 88 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 357999999999998532 345789999875532 34456789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC
Q 005999 457 QAKGERLVIYDYQPNGSLFNLIHGSRSI------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF 530 (665)
Q Consensus 457 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~ 530 (665)
..++..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dlkp~Nili~~~~ 167 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-FVHRDLATRNCLVGKNY 167 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-eecccCChheEEEcCCC
Confidence 9999999999999999999998753311 1235788899999999999999999999 99999999999999999
Q ss_pred ceEEeecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCccHHH
Q 005999 531 EARLTDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT--GKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 531 ~~kl~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~ 603 (665)
.++|+|||++........ ....+..|+|||+.. ...++.++|||||||++|||++ |..||.... ..+...
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~--~~~~~~ 244 (296)
T cd05095 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS--DEQVIE 244 (296)
T ss_pred CEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-cCCccchhhhhHHHHHHHHHHHhCCCCCccccC--hHHHHH
Confidence 999999999875533221 112356899999876 4678999999999999999998 677876432 122221
Q ss_pred HHHh----hcc--CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 604 WVRT----MRV--DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 604 ~~~~----~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
.... ... ....+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111 000 01123345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.86 Aligned_cols=245 Identities=21% Similarity=0.307 Sum_probs=201.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||.+.. .++..+++|.+..........+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 6799999999999884 568889999987655444556778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....... ...
T Consensus 86 L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (256)
T cd08221 86 LYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAG-ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161 (256)
T ss_pred HHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChHhEEEeCCCCEEECcCcceEEccccccccccc
Confidence 99999743 2356899999999999999999999999 9999999999999999999999999986654332 233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+++.|+|||+.. +..++.++||||||+++|||++|+.||.... ..+....+...... ......+..+.+++.+|+
T Consensus 162 ~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 162 VGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATN--PLNLVVKIVQGNYT-PVVSVYSSELISLVHSLL 237 (256)
T ss_pred CCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCC-CCccccCHHHHHHHHHHc
Confidence 5789999999986 5568889999999999999999999986521 12222222211111 122445677999999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~L 647 (665)
..+|++||++.|+++.+
T Consensus 238 ~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 238 QQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCcccCCCHHHHhhCc
Confidence 99999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.39 Aligned_cols=243 Identities=25% Similarity=0.441 Sum_probs=199.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+++++|
T Consensus 12 ~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 87 (260)
T cd05073 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL 87 (260)
T ss_pred eEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcH
Confidence 6799999999999998777889999886543 345678899999999999999999999887 778999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----CC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----ED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~ 550 (665)
.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+........ ..
T Consensus 88 ~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 163 (260)
T cd05073 88 LDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163 (260)
T ss_pred HHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence 9999753 2345788999999999999999999998 99999999999999999999999999865533221 12
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. ...++.++|+|||||++|++++ |+.||... ...++...+..... .......+..+.+++.+|
T Consensus 164 ~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~ 239 (260)
T cd05073 164 KFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGYR-MPRPENCPEELYNIMMRC 239 (260)
T ss_pred cccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhCCCC-CCCcccCCHHHHHHHHHH
Confidence 2456799999987 5678999999999999999998 99998652 22233333332211 122345667899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~ 649 (665)
++.+|++||++.++.+.|+.
T Consensus 240 l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 240 WKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCcccCcCHHHHHHHHhc
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.00 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=200.2
Q ss_pred HhHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|...+ ...|++|....... ....+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 4679999999999998543 34688998865543 2445678999999999999999999999875 4578999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 89 PLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR-FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 999999999742 235899999999999999999999999 99999999999999999999999999876543321
Q ss_pred ---CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 549 ---EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 549 ---~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
...++..|+|||.+. ...++.++||||||+++||+++ |+.||.... ..+....+..... ...+...+..+.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (270)
T cd05056 164 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVK--NNDVIGRIENGER-LPMPPNCPPTLYS 239 (270)
T ss_pred ecCCCCccccccChhhhc-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 112346799999886 5678999999999999999986 999997532 1222222222111 1233456778999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
++.+|+..+|++|||+.++++.|+++.++
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.69 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=197.4
Q ss_pred HhHhCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|...+ +..+++|.+.... ..+.+.+|++++++++|+||+++++++.++...++++||+.++
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 4679999999999999764 7889999986543 2678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++....... ..
T Consensus 84 ~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 84 SVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK-KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 999998642 356899999999999999999999999 9999999999999999999999999987654432 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 628 (665)
..++..|+|||++. +..++.++||||||+++|||++|+.||...... .....+..... ........+..+.+++.+
T Consensus 159 ~~~~~~y~~PE~~~-~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 159 VIGTPFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--RAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccCCccccCHHHHh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--hhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 34788999999986 567899999999999999999999998753211 11111111111 111233455679999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
|++.||++|||+.|+++
T Consensus 236 ~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 236 CLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHhcChhhCcCHHHHhc
Confidence 99999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=303.77 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=197.6
Q ss_pred HhCcccceEEEEEEECC-------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 396 LLGRGSIGTTYKAVLDN-------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.||+|+||.||+|...+ +..+++|.+..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998542 35789998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-----ceEEeeccccc
Q 005999 469 QPNGSLFNLIHGSRSI--RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-----EARLTDYCLSV 541 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-----~~kl~Dfgl~~ 541 (665)
+++++|.+++...... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-cccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9999999999743221 2244789999999999999999999999 99999999999999877 89999999986
Q ss_pred ccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCch
Q 005999 542 LSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615 (665)
Q Consensus 542 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (665)
...... ....++..|+|||++. +..++.++|||||||++|||++ |+.||... ...+....+.... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~-~~~~~ 235 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQEVLQHVTAGG-RLQKP 235 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCccc--CHHHHHHHHhcCC-ccCCc
Confidence 543221 1223467899999987 5678999999999999999998 99998642 1223333322211 11223
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
...+..+.+++.+||..+|++||++.++++.|++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 4567789999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=325.87 Aligned_cols=248 Identities=17% Similarity=0.271 Sum_probs=189.1
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--------CeEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--------GERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~l 464 (665)
.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++... ...++
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 46799999999999986 468899999885432 2235799999999999999999887432 24668
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeeccccccc
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLS 543 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~ 543 (665)
||||+++ +|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 145 vmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~-IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 9999985 78777653211 3456899999999999999999999999 99999999999999664 7999999999765
Q ss_pred CCC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---------
Q 005999 544 DSS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--------- 612 (665)
Q Consensus 544 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------- 612 (665)
... .....+|+.|+|||++.+...++.++|||||||++|||++|++||..... ...+...+.......
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhch
Confidence 432 23346899999999987555789999999999999999999999975321 112222211110000
Q ss_pred -----------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHH
Q 005999 613 -----------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIK 651 (665)
Q Consensus 613 -----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~ 651 (665)
..+...+..+.+|+.+||..||.+|||+.|+++ .++++.
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 011234567899999999999999999999985 344443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=336.93 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=200.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... +...+.+.+|++++++++||||+++++++.+++..++||||++||
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGG 87 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGY 87 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCC
Confidence 57999999999999864 5889999999754322 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 473 SLFNLIHGSRS------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 473 sL~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
+|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 SL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~ 166 (932)
T PRK13184 88 TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166 (932)
T ss_pred CHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchheEEEcCCCCEEEEecCcceecccc
Confidence 99999864211 11234677888999999999999999999 999999999999999999999999998655110
Q ss_pred ---------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005999 547 ---------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV 605 (665)
Q Consensus 547 ---------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 605 (665)
.....||+.|+|||++. +..++.++|||||||++|||+||+.||...... .... .
T Consensus 167 ~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~--ki~~-~ 242 (932)
T PRK13184 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKGR--KISY-R 242 (932)
T ss_pred cccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--hhhh-h
Confidence 01124899999999987 567899999999999999999999999753211 1111 1
Q ss_pred HhhccCC--CchhhhHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHhh
Q 005999 606 RTMRVDD--GREENRLGMLTEVASVCSLKSPEQRP-AMWQVLKMIQEIKES 653 (665)
Q Consensus 606 ~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~ 653 (665)
....... ......+..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 243 ~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 243 DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111 11234567799999999999999995 677788888877654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=306.81 Aligned_cols=246 Identities=18% Similarity=0.275 Sum_probs=194.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... ++..||+|++..........+.+.+|+.++++++||||+++++++.+++..++|+||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 56999999999999964 68899999987654433445678889999999999999999999999999999999997 58
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 85 l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (285)
T cd07861 85 LKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR-VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE 161 (285)
T ss_pred HHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCC
Confidence 998886432 2356899999999999999999999999 9999999999999999999999999986543321 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--------------------c
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--------------------V 610 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--------------------~ 610 (665)
.+++.|+|||++.+...++.++|||||||++|||+||+.||...... ........... .
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
T cd07861 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240 (285)
T ss_pred cccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence 46889999998865556789999999999999999999999753211 01111000000 0
Q ss_pred C-C-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 D-D-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 ~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. . ......+..+.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0 011224567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.05 Aligned_cols=245 Identities=21% Similarity=0.315 Sum_probs=195.5
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++||||+++
T Consensus 16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 3467999999999999965 58889999986543 24466788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 548 (665)
++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 94 ~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 94 GAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC-eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 9999887632 345899999999999999999999999 9999999999999999999999999886543221 2
Q ss_pred CCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
...+++.|+|||++.. ...++.++|||||||++|||++|+.||..... .....................+..+.+
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 2347889999998742 34467899999999999999999999865321 111111111111111123345567999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~ 645 (665)
++.+||+.+|++||++.|+++
T Consensus 248 li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhc
Confidence 999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.72 Aligned_cols=241 Identities=25% Similarity=0.388 Sum_probs=198.4
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||.|+||.||+|... +++.|++|.+..... ......+.+|+++++.++|+||+++++++.++...++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 467999999999999954 688999999875532 234566889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.++++. ..+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 85 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 85 SCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEG-KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred cHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999873 26899999999999999999999999 9999999999999999999999999987665432 23
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..++..|+|||++. +..++.++||||||+++|||+||+.||.... .......+.............+..+.+++.+|
T Consensus 158 ~~~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 158 FVGTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLH--PMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCc--hHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 35788899999987 5568999999999999999999999997532 12222222221111111112567799999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|..+|++|||++++++
T Consensus 235 l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 235 LNKDPKERPSAKELLK 250 (274)
T ss_pred hhCChhhCcCHHHHhh
Confidence 9999999999999977
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.41 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=197.9
Q ss_pred HHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|++++++++||||+++++++..+...++|+||+++
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence 346799999999999985 4678899999875443 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 548 (665)
++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++....... .
T Consensus 87 ~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~-ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 87 GSALDLLKP------GPLEETYIATILREILKGLDYLHSER-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC-eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 999998853 35888999999999999999999999 9999999999999999999999999986654322 1
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...++..|+|||++. +..++.++|||||||++|||++|+.|+.... .......+.... ........+..+.+++.+
T Consensus 160 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 160 TFVGTPFWMAPEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLH--PMRVLFLIPKNS-PPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred cccCcccccCHHHhC-cCCCchhhhHHHHHHHHHHHHhCCCCCcccc--hhhHHhhhhcCC-CCCCCcccCHHHHHHHHH
Confidence 224688899999987 5678899999999999999999999986532 112222221111 111233456779999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~ 646 (665)
|++.+|++||++.|+++.
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 236 CLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HccCCcccCcCHHHHHHh
Confidence 999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=313.67 Aligned_cols=235 Identities=20% Similarity=0.288 Sum_probs=190.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+..|..++..+. |++|+++++++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 57999999999999854 6889999998754321 233456778888888885 57788899999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~ 548 (665)
|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 86 g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~-ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 86 GDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRG-IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 999999873 346899999999999999999999999 999999999999999999999999998653222 12
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++||||+||++|||++|+.||.... .......+... ....+...+..+.+++.+
T Consensus 160 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~--~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--EDELFQSIMEH--NVSYPKSLSKEAVSICKG 234 (323)
T ss_pred CccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhC--CCCCCccCCHHHHHHHHH
Confidence 335899999999987 5678999999999999999999999997532 22233322221 112334556778999999
Q ss_pred cccCCCCCCCCH
Q 005999 629 CSLKSPEQRPAM 640 (665)
Q Consensus 629 cl~~dP~~RPt~ 640 (665)
|++++|++|++.
T Consensus 235 ~l~~~p~~R~~~ 246 (323)
T cd05615 235 LMTKHPSKRLGC 246 (323)
T ss_pred HcccCHhhCCCC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.66 Aligned_cols=245 Identities=21% Similarity=0.331 Sum_probs=197.8
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~ 471 (665)
.+.||+|++|.||++... +++.+++|++..........+.+.+|++++++++|+|++++++.+.. +...+++|||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 367999999999999854 57789999987654444556678899999999999999999998864 4467899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 548 (665)
++|.+++... ....+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~-i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 85 GDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH-ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred CcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999998743 2346899999999999999999999999 9999999999999999999999999986654321 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...+++.|+|||++. +..++.++||||||+++|||++|+.||.... .......+..... .......+..+.+++.+
T Consensus 161 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 161 TLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKD--MNSLVYRIIEGKL-PPMPKDYSPELGELIAT 236 (257)
T ss_pred cccCCcCccChhHhc-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCC-CCCccccCHHHHHHHHH
Confidence 234788999999987 5678899999999999999999999987532 1122111111111 12334566789999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~ 646 (665)
|++.+|++|||+.|+++.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HhccCcccCCCHHHHhcC
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.00 Aligned_cols=242 Identities=19% Similarity=0.261 Sum_probs=189.8
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------eEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------ERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 466 (665)
.+.||+|+||.||++.. .++..||+|++..........+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 36799999999999985 46889999999765444455667889999999999999999999986543 579999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+.+ +|.+.++. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 99976 67766642 3788889999999999999999999 999999999999999999999999998654332
Q ss_pred --CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHH------------------HH
Q 005999 547 --SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEW------------------VR 606 (665)
Q Consensus 547 --~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~------------------~~ 606 (665)
.....+|+.|+|||++. +..++.++|||||||++|||++|+.||...... ..+... +.
T Consensus 177 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred ccCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 22345789999999987 667899999999999999999999999753210 000000 00
Q ss_pred hhccCC---------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 607 TMRVDD---------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 607 ~~~~~~---------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
...... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0011123568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.99 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=201.2
Q ss_pred HHHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 392 ASAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
...+.||+|+||+||++.. +++..||+|++..... ....+.+.+|+++++.++||||+++++++......++||||++
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 3457899999999999985 4688899998865432 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVE 549 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 549 (665)
+++|.+++.. ...+++..+..++.+++.||.|||+...++||||+|+||++++++.++|+|||++...... ...
T Consensus 87 ~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~ 161 (284)
T cd06620 87 CGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161 (284)
T ss_pred CCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence 9999999873 3468999999999999999999998433999999999999999999999999998654322 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC------CccHHHHHHhhccCCC---chhhhHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA------PPDMLEWVRTMRVDDG---REENRLG 620 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~ 620 (665)
..++..|+|||++. +..++.++|||||||++||+++|+.||...... ...+............ .....+.
T Consensus 162 ~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 35889999999986 557889999999999999999999999754321 1122333333322211 1223566
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
.+.+++.+|+++||++|||+.|+++..
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 799999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=320.31 Aligned_cols=242 Identities=22% Similarity=0.376 Sum_probs=199.8
Q ss_pred HhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+||+|.||+||-|+ ..+...+|||.+....+ ...+-+.+||..-++|+|.|||+++|.+.+++..-+.||.++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 69999999999999 45677899999866553 4456688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC-CCCceEEeecccccccCCC---CC
Q 005999 475 FNLIHGSRSIRAKPL--HWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG-ADFEARLTDYCLSVLSDSS---SV 548 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~---~~ 548 (665)
.+++.. +=+++ .+.++-.+.+||++||.|||++. |+|||||-.|||++ -.|.+||+|||-++....- ..
T Consensus 660 SsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLHen~-IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 660 SSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLHENK-IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred HHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhhhcc-eeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 999974 22345 77788889999999999999999 99999999999997 4689999999998765431 22
Q ss_pred CCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
+-.||..|||||++..+ ..|..++|||||||++.||.||++||.........+-. +.........+++.+.....+|.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcceecCCCCcHHHHHHHHHHHH
Confidence 33699999999999754 35899999999999999999999999764322222111 12222333457788888999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~ 645 (665)
+|+.+||..||++.++++
T Consensus 814 rcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHcCCCcccCccHHHhcc
Confidence 999999999999999986
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.71 Aligned_cols=244 Identities=21% Similarity=0.279 Sum_probs=195.4
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... ++..+++|.+..... ....+.+.+|++++.+++||||+++++++.+++..++||||++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 357999999999999854 678899998865432 234566889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~ 550 (665)
+|.++++. ...+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++...... ....
T Consensus 85 ~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 85 SLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCC-EEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 99999974 24588999999999999999999984 6 999999999999999999999999998655332 2333
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH-------------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV------------------------- 605 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~------------------------- 605 (665)
.++..|+|||++. +..++.++|||||||++|||++|+.||.... ........
T Consensus 159 ~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 159 VGTRSYMSPERLQ-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCcCccChhHhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 5788999999986 5678999999999999999999999986421 11111111
Q ss_pred --------HhhccCC---CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 606 --------RTMRVDD---GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 606 --------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
+...... ......+..+.+++.+|+..+|++|||+.|+++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000 01112455789999999999999999999998863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.20 Aligned_cols=246 Identities=21% Similarity=0.346 Sum_probs=198.4
Q ss_pred HHHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 392 ASAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
...+.||+|+||.||++... ++..+++|.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 8 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 44577999999999999964 68899999986543 2445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 86 GGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHK-VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 99999998742 346899999999999999999999999 9999999999999999999999999876543321
Q ss_pred CCCCCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHH
Q 005999 548 VEDPDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGML 622 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 622 (665)
....++..|+|||++. ....++.++||||||+++|||++|+.||.... .......+..... ....+...+..+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--PMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--HHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 2234788999999864 13456789999999999999999999987531 1111111111111 112233456789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+++.+||+.+|++||++.++++.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcC
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=279.96 Aligned_cols=269 Identities=20% Similarity=0.255 Sum_probs=208.3
Q ss_pred cccCceeeccCCCcccCHHHHHHHHHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CC
Q 005999 369 KRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SH 446 (665)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h 446 (665)
+.++.+....+....-.++|++.. ..||.|+.|.|++++.. .|...|||.+...... +..+.+...++++.+. +.
T Consensus 74 ~~tg~lti~~g~r~~~dindl~~l--~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dc 150 (391)
T KOG0983|consen 74 KQTGYLTIGGGQRYQADINDLENL--GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDC 150 (391)
T ss_pred CCceeEEecCCcccccChHHhhhH--HhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCC
Confidence 456666666566677778887654 56999999999999954 6889999999766543 3445566667766555 48
Q ss_pred CCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe
Q 005999 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL 526 (665)
Q Consensus 447 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill 526 (665)
|+||+.+|||..+..+++.||.|.. .+..+++. -.+++++..+-++...+++||.||.++..|+|||+||+|||+
T Consensus 151 pyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl 225 (391)
T KOG0983|consen 151 PYIVQCFGYFITNTDVFICMELMST-CAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 225 (391)
T ss_pred CeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE
Confidence 9999999999999999999998854 56666653 235688888888999999999999887669999999999999
Q ss_pred CCCCceEEeecccccccCCC--CCCCCCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHH
Q 005999 527 GADFEARLTDYCLSVLSDSS--SVEDPDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML 602 (665)
Q Consensus 527 ~~~~~~kl~Dfgl~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 602 (665)
|+.|.+|+||||++..+-++ .....|.+.|||||.+.. ...|+.++||||||++++||.||+.||..-..+-..+.
T Consensus 226 De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 226 DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 99999999999999665443 234468899999998763 34689999999999999999999999986432222333
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.......+........+..+.+|+..||.+|+.+||.+.++++
T Consensus 306 kvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 306 KVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2222111111223346788999999999999999999999886
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.42 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=201.8
Q ss_pred HhHhCcccceEEEEEEEC-Ce----EEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||+|... ++ ..+++|.+..... ....+.+.+|+..+++++||||+++++++.. ...++|+||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEec
Confidence 467999999999999854 23 3588998865543 3455678899999999999999999999987 788999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV 548 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 548 (665)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||.+........
T Consensus 90 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 90 MPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred CCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 9999999998742 335899999999999999999999998 99999999999999999999999999876543221
Q ss_pred -----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 549 -----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 549 -----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
...++..|+|||.+. ...++.++||||||+++||+++ |+.||.... ..++...+..... ...+...+..+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (279)
T cd05057 165 EYHAEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDLLEKGER-LPQPPICTIDV 240 (279)
T ss_pred ceecCCCcccccccCHHHhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHhCCCC-CCCCCCCCHHH
Confidence 112356799999886 5678999999999999999998 999987632 2234444432211 12233455678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
.+++.+||..+|++||++.++++.|+++...
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.67 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=195.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++|+|++++++++......++||||++++.
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 56999999999999965 68899999987554333344567899999999999999999999999999999999999988
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|..++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ...
T Consensus 87 l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 87 LNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHN-CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred HHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 8887652 345899999999999999999999999 9999999999999999999999999997664432 123
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--------------------c
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--------------------V 610 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--------------------~ 610 (665)
.++..|+|||++.+...++.++||||||+++|||++|+.||......+ .......... .
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 467889999998755668899999999999999999999997532211 1111111000 0
Q ss_pred CCC--------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 DDG--------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 ~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
... .....+..+.+++.+||+.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 01233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.57 Aligned_cols=244 Identities=16% Similarity=0.235 Sum_probs=187.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC---CCCCeeeeeEEEEe-----CCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL---SHPNLVPIRAYFQA-----KGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~lv 465 (665)
+.||+|+||.||+|... +++.||+|.++...........+.+|+++++++ +||||+++++++.. ....+++
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 56999999999999854 688999999875433222233455666666554 79999999998864 2457899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+.+ +|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 86 FEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred Eccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 999985 899988743 2345899999999999999999999999 99999999999999999999999999876543
Q ss_pred CC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-----------
Q 005999 546 SS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----------- 612 (665)
Q Consensus 546 ~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 612 (665)
.. ....+|..|+|||++. +..++.++||||+||++|||++|++||..... ...+...........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred cccCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHHHHHHHhCCCChhhCccccccc
Confidence 32 2335789999999987 56789999999999999999999999865321 111111111110000
Q ss_pred -------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+|++.||++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.57 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=199.9
Q ss_pred HhHhCcccceEEEEEEEC-CeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||+|... ++. .+|+|.+..... ......+.+|+.++++++||||+++++++... ..++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 467999999999999853 343 478888865433 23345688999999999999999999998754 46799999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV 548 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 548 (665)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||++........
T Consensus 90 ~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 90 MPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred cCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC-eeccccccceeeecCCCceEEccccccccccCccc
Confidence 9999999998742 345889999999999999999999999 99999999999999999999999999976543221
Q ss_pred -----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 549 -----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 549 -----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
...++..|+|||++. +..++.++|||||||++|||++ |+.||.... ..+...++..... .......+..+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (303)
T cd05110 165 EYNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKGER-LPQPPICTIDV 240 (303)
T ss_pred ccccCCCccccccCCHHHhc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCCC-CCCCCCCCHHH
Confidence 123467899999986 6678999999999999999997 889986531 1233333332211 12233456779
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.+++.+|+..+|++||++.++++.|+++.++..
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 999999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=299.99 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=198.3
Q ss_pred HhHhCcccceEEEEEEECC--eEEEEEEEecCCC--------chhhHHHHHHHHHHHHhC-CCCCCeeeeeEEEEeCCeE
Q 005999 394 AELLGRGSIGTTYKAVLDN--HLIVTVKRFDANK--------TADTSAEAFEQHMEAVGG-LSHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~ 462 (665)
.+.||+|+||.||+|.... +..+|+|.+.... ........+.+|+.++.+ ++||||+++++++.+++..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999654 7789999875332 122344567788888865 7999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCCceEEeeccccc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSV 541 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~ 541 (665)
+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|||.+.
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc-eeecCCCHHHEEECCCCcEEEeccccee
Confidence 999999999999998753221 34568999999999999999999997 56 9999999999999999999999999987
Q ss_pred ccCCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhH
Q 005999 542 LSDSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619 (665)
Q Consensus 542 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (665)
...... ....++..|+|||++. +..++.++||||||+++|||++|+.||.... .......+.............+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 163 QKQPESKLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTN--MLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred ecccccccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccC--HHHHHHHHhhccCCcCCcccCC
Confidence 655432 2335788999999987 5668999999999999999999999986531 1122222222111111222456
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
..+.+++.+|++.||++||++.|+..+++
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 78999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.47 Aligned_cols=242 Identities=18% Similarity=0.239 Sum_probs=191.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.++.+++||||+++++.+.+++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 57999999999999864 688999999865322 1234566888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS------ 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~------ 546 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++......
T Consensus 87 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~g-ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 87 DMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLG-FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999873 345889999999999999999999999 999999999999999999999999997543211
Q ss_pred --------------------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 005999 547 --------------------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHP 594 (665)
Q Consensus 547 --------------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~ 594 (665)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeecccCCCCCCCC
Confidence 01235899999999987 677899999999999999999999999753
Q ss_pred CCCCccHHHHHHhhccCC--CchhhhHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 005999 595 YLAPPDMLEWVRTMRVDD--GREENRLGMLTEVASVCSLKSPEQRPA---MWQVLKM 646 (665)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 646 (665)
. .......+....... ......+..+.+++.+++. ||++|++ +.|+++.
T Consensus 240 ~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 240 T--PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred C--HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 2 112222222111111 1112245678888888774 9999985 6676653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.04 Aligned_cols=246 Identities=19% Similarity=0.271 Sum_probs=195.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 471 (665)
+.||+|+||+||++... ++..+|+|.+............+..|+.++.+++|||||+++++|.+ ...+++||||+++
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 67999999999999954 67789999987655444556778999999999999999999998865 3568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CeeccCCCCCceEeCCC----------------
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS------WLIHGNLKSSNVLLGAD---------------- 529 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------~iiH~Dlk~~Nill~~~---------------- 529 (665)
|+|.++|..... ....+++..++.|+.||+.||+|||+.+ +|+||||||+|||++.+
T Consensus 99 GSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng 177 (1021)
T PTZ00266 99 GDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177 (1021)
T ss_pred CcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence 999999874321 2346999999999999999999999832 29999999999999642
Q ss_pred -CceEEeecccccccCCCC--CCCCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005999 530 -FEARLTDYCLSVLSDSSS--VEDPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV 605 (665)
Q Consensus 530 -~~~kl~Dfgl~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 605 (665)
+.+||+|||++....... ....+|+.|+|||++.. ...++.++|||||||++|||++|+.||.... .....+
T Consensus 178 ~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~----~~~qli 253 (1021)
T PTZ00266 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN----NFSQLI 253 (1021)
T ss_pred CCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC----cHHHHH
Confidence 348999999997654322 23468999999998753 3457899999999999999999999997532 222222
Q ss_pred HhhccCC-CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 606 RTMRVDD-GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 606 ~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+.... ......+..+.+||..||+.+|++||++.|++.
T Consensus 254 ~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 254 SELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2222111 112345677999999999999999999999984
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.47 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=196.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||.|+||.||+|.. .+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 5699999999999984 5788999999865433 335678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 103 L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~-i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 103 LTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 9998863 34899999999999999999999999 9999999999999999999999999986544322 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.++..|+|||.+. +..++.++|||||||++|+|++|+.||...... ..+.................+..+.+++.+||
T Consensus 176 ~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 176 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred CCCccccCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 5788999999986 567889999999999999999999999763211 11111111111111234456678999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
..||++||++.++++
T Consensus 254 ~~dp~~Rpt~~~il~ 268 (296)
T cd06655 254 EMDVEKRGSAKELLQ 268 (296)
T ss_pred hcChhhCCCHHHHhh
Confidence 999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.50 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=193.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
..||+|+||.||+|.. .++..|++|.+..... ...+.+.+|+.++++++|+||+++++++..++..++|+||+++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 3699999999999985 4677899998865542 345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccCCC---C
Q 005999 474 LFNLIHGSRSIRAKPL--HWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSS---S 547 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~---~ 547 (665)
|.+++... ...+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||.+...... .
T Consensus 92 L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 92 LSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred HHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 99998742 1234 77888899999999999999999 999999999999986 679999999998654322 1
Q ss_pred CCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....+++.|+|||++... ..++.++||||||+++|||++|+.||............ ..........+......+.+++
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHH
Confidence 223478899999987532 24788999999999999999999998653211111111 1111111123345567799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.+|++|||+.|++.
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHcCCCchhCCCHHHHHh
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.37 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=198.7
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..+.||+|+||.||++... ++..||+|.+..... ....+.+.+|++++++++|+||+++++++..++..++|+||+++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 3467999999999999965 788999998865432 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVE 549 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 549 (665)
++|.+++.... ....+++..+..++.|++.||.|||++ + |+||||||+||+++.++.++|+|||++...... ...
T Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (286)
T cd06622 84 GSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN-IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT 160 (286)
T ss_pred CCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC-EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcccc
Confidence 99999987421 234689999999999999999999975 6 999999999999999999999999998655332 233
Q ss_pred CCCCCcccCCccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc--CCCchhhhHHHH
Q 005999 550 DPDTVAYKAPEIRKSS-----RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV--DDGREENRLGML 622 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~-----~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 622 (665)
..++..|+|||.+.+. ..++.++|||||||++|||++|+.||.... .......+..... ....+...+..+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--YANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc--hhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 4578899999987532 235889999999999999999999997532 1222222221111 112333467789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+++.+|++.+|++||++.+++..
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcC
Confidence 999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=302.93 Aligned_cols=242 Identities=21% Similarity=0.308 Sum_probs=206.0
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|.|++|-+|+ .-.|+.||||++.+.+........+.+|++.|+.++|||||++|++...+...|+|+|.-++|+
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 579999999999998 4489999999999988877777889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC-CCCceEEeecccccccCCCC--CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG-ADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
|+++|-+ ...-+.+....+++.||+.|+.|+|+.. ++||||||+||.+- .-|-|||+|||++....+.. .+.
T Consensus 104 l~DyImK----He~Gl~E~La~kYF~QI~~AI~YCHqLH-VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~Ts 178 (864)
T KOG4717|consen 104 LFDYIMK----HEEGLNEDLAKKYFAQIVHAISYCHQLH-VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTS 178 (864)
T ss_pred HHHHHHh----hhccccHHHHHHHHHHHHHHHHHHhhhh-hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcc
Confidence 9999975 3455889999999999999999999999 99999999998875 56899999999996665543 345
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.|+..|-|||.+.+..+..+++||||+||+||-|.+|++||+..... +-..++..... ..+...+.+.++||..||
T Consensus 179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--ETLTmImDCKY--tvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--ETLTMIMDCKY--TVPSHVSKECRDLIQSML 254 (864)
T ss_pred cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--hhhhhhhcccc--cCchhhhHHHHHHHHHHH
Confidence 68999999999986666678899999999999999999999875422 22222222222 235566778899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
..||++|-+.+||+.
T Consensus 255 vRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVS 269 (864)
T ss_pred hcCchhhccHHHHhc
Confidence 999999999999875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.97 Aligned_cols=243 Identities=20% Similarity=0.304 Sum_probs=197.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc---hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT---ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|... ++..|++|.+..... .+...+.+.+|++++++++|+||+++++++.++...++++||++
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 57999999999999965 788999999865432 12345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--C
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--V 548 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~ 548 (665)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+....... .
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 86 GGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRN-TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 9999999873 245889999999999999999999999 9999999999999999999999999986554332 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...++..|+|||.+.....++.++|+||||+++|+|++|+.||.... ..+....+.........+...+..+.+++.+
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34578899999988633338899999999999999999999987632 1111111111111112334456779999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
|++.+|++||++.+++.
T Consensus 238 ~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 238 CLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhhcCcccCcCHHHHhc
Confidence 99999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=298.02 Aligned_cols=242 Identities=22% Similarity=0.376 Sum_probs=198.2
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|+.++++++|+||+++++++.++...++||||+++
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 3467999999999999864 688999999875433 24456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 548 (665)
|+|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++....... .
T Consensus 87 ~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~-ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 87 GSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 999999863 34788899999999999999999999 9999999999999999999999999986554322 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...++..|+|||++. +..++.++|||||||++|||++|+.||.... .......+... .........+..+.+++.+
T Consensus 160 ~~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 160 TFVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMH--PMRVLFLIPKN-NPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred cccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcC--hHhHhhhhhcC-CCCCCchhhhHHHHHHHHH
Confidence 224678899999987 5678999999999999999999999987532 11111111111 1112334566789999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~ 646 (665)
||+.+|++||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 236 CLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HcccCcccCcCHHHHHhC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.69 Aligned_cols=245 Identities=21% Similarity=0.332 Sum_probs=204.9
Q ss_pred HHHhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 392 ASAELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
...++||+|.||+|++|.|+ +...||||.++...... ...+|.+|+.+|.+|+|+|+++|||+..+ ....||+|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34578999999999999975 24578999998766533 67889999999999999999999999988 56789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
.++.|+|.+.|+.. ....|.....-.++.|||.||.||..++ .|||||..+|+|+-..-.|||+|||+.+......
T Consensus 191 LaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr-lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR-LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh-hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999862 4456888888899999999999999999 9999999999999998899999999998776543
Q ss_pred CCCC------CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 548 VEDP------DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 548 ~~~~------gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
.... -...|.|||.+. ...++.++|||+|||++|||+| |..||-+. ...++.+.++ .......+..+++
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~~iD-~~erLpRPk~cse 342 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILKNID-AGERLPRPKYCSE 342 (1039)
T ss_pred cceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHHhcc-ccccCCCCCCChH
Confidence 2211 245799999998 7889999999999999999997 77888652 2335555554 2222345778899
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.|.+++..||..+|++|||+..+.+.
T Consensus 343 dIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHh
Confidence 99999999999999999999999843
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.96 Aligned_cols=244 Identities=22% Similarity=0.335 Sum_probs=199.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.+|++.. .+++.|++|++..........+.+.+|++++++++||||+++++++.+.+..++|+||+.+++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 5799999999999985 468899999987554334455678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ....+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 86 l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 161 (256)
T cd08218 86 LYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC 161 (256)
T ss_pred HHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhc
Confidence 99998743 2335788999999999999999999999 9999999999999999999999999987654422 123
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+++.|+|||+.. +..++.++|||||||++|+|++|+.||... ...+....+..... .......+..+.+++.+|+
T Consensus 162 ~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 162 IGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred cCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCC--CHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHHh
Confidence 4788899999986 567889999999999999999999998652 11122221111111 1123455678999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~ 646 (665)
+.+|++||++.||++.
T Consensus 238 ~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 238 KRNPRDRPSVNSILEK 253 (256)
T ss_pred hCChhhCcCHHHHhhC
Confidence 9999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.42 Aligned_cols=241 Identities=20% Similarity=0.327 Sum_probs=197.2
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++.. .++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 36799999999999995 5788999999875443 33466889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 102 ~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~-i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 102 SLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred CHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99999863 34788999999999999999999999 9999999999999999999999999986654322 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+++.|+|||.+. +..++.++|||||||++|++++|+.||....... ...................+..+.+++.+|
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred ccCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-heeeeccCCCCCCCCccccCHHHHHHHHHH
Confidence 35788999999987 5678899999999999999999999997532211 111111111111123345567789999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|..+|++||++.++++
T Consensus 253 l~~~p~~Rps~~~il~ 268 (297)
T cd06656 253 LEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCChhhCcCHHHHhc
Confidence 9999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.96 Aligned_cols=242 Identities=17% Similarity=0.220 Sum_probs=190.4
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 466 (665)
.+.||+|+||.||++.. ..++.||+|++..........+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 36799999999999985 4688899999976554445566778899999999999999999988643 3579999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+.+ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 99976 67777642 3788899999999999999999999 999999999999999999999999999765443
Q ss_pred C--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh-----------------
Q 005999 547 S--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT----------------- 607 (665)
Q Consensus 547 ~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~----------------- 607 (665)
. ....+|+.|+|||++. +..++.++|||||||++|||++|+.||...... ......+..
T Consensus 173 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred cccCCccccCCccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 2 2335899999999987 667899999999999999999999999753210 011100000
Q ss_pred -hccCC---------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 608 -MRVDD---------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 608 -~~~~~---------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
..... .........+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 0011224568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.16 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=199.1
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|..+ +...+++|.+..... ....+.+.+|++++++++|+||+++++++.+....++||||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 56999999999999854 346789998865432 22456789999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhcCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 469 QPNGSLFNLIHGSRSIR----AKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
+++|+|.++++..+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++....
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~ 168 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-FVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-cccCcCccceEEEeCCCcEEEcccccccccC
Confidence 99999999997543111 126899999999999999999999999 9999999999999999999999999986443
Q ss_pred CCC----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhH
Q 005999 545 SSS----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619 (665)
Q Consensus 545 ~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (665)
... ....++..|+|||.+. +..++.++||||||+++|||++ |..||... ....+.................+
T Consensus 169 ~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 245 (275)
T cd05046 169 NSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGL--SDEEVLNRLQAGKLELPVPEGCP 245 (275)
T ss_pred cccccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCcccc--chHHHHHHHHcCCcCCCCCCCCC
Confidence 221 1123467799999886 4567899999999999999998 78888642 22233333332222222334567
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
..+.+++.+|++.+|++|||+.|++..|+
T Consensus 246 ~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 246 SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=298.51 Aligned_cols=241 Identities=22% Similarity=0.353 Sum_probs=195.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh-------hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD-------TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 466 (665)
..||+|+||.||+|.. .++..+++|.+....... ...+.+.+|+.++++++||||+++++++.+.+..++++
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 5799999999999985 467889999886543221 22356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+......
T Consensus 86 e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~-ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 86 EYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcC-cccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999974 245888999999999999999999999 999999999999999999999999998665421
Q ss_pred C---------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 547 S---------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 547 ~---------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
. ....++..|+|||.+. +..++.++||||+||++|||++|+.||..... ......+.. ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~~~~~~ 235 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFKIGE-NASPEIPSN 235 (267)
T ss_pred cccCCccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHHHHHhc-cCCCcCCcc
Confidence 1 1123678899999987 56788999999999999999999999976321 111111111 111123345
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+..+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 6778999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=306.40 Aligned_cols=245 Identities=18% Similarity=0.260 Sum_probs=192.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +|..+++|++............+.+|++++++++||||+++++++.+....++|+||+.+ +
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-D 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-C
Confidence 56999999999999964 688999999875543333345677899999999999999999999999999999999974 8
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 85 l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 85 LKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHN-VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 88887642 345899999999999999999999999 9999999999999999999999999987554321 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC--------------C---C
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD--------------D---G 613 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------------~---~ 613 (665)
.++..|+|||++.+...++.++|||||||++|||+||..|+.........+....+..... . .
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 5688999999987555678999999999999999999998643221111111111100000 0 0
Q ss_pred ---------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 ---------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 01123567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.32 Aligned_cols=242 Identities=19% Similarity=0.324 Sum_probs=190.5
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCch---hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA---DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 467 (665)
.+.||+|+||.||+|.. .++..|++|++...... ....+.+.+|+.++++++||||+++++++.+ +...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 36799999999999985 46889999988644321 2334568899999999999999999999875 357889999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~-i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 87 YMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred CCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 9999999999873 235788999999999999999999999 9999999999999999999999999986543211
Q ss_pred ------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 548 ------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
....++..|+|||++. +..++.++|||||||++|||++|+.||..... ...... ..........+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-MAAIFK-IATQPTNPQLPSHISEH 237 (266)
T ss_pred ccCCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccch-HHHHHH-HhcCCCCCCCchhcCHH
Confidence 1224788999999987 56789999999999999999999999975311 111111 11111111223344566
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++ +|+..+|++||+++|+++
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhc
Confidence 77787 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=318.28 Aligned_cols=244 Identities=18% Similarity=0.232 Sum_probs=192.3
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||++... +++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999965 678899999864322 122345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 128 g~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 128 GDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred CcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccc
Confidence 999999863 24788888899999999999999999 9999999999999999999999999997654322
Q ss_pred CCCCCCCcccCCccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSS---RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGML 622 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~---~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 622 (665)
....||+.|+|||++... ..++.++|||||||++|||++|+.||.... .......+....... ......+..+
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 234589999999998632 237889999999999999999999997531 111222221111111 1223467789
Q ss_pred HHHHHHcccCCCCC--CCCHHHHHHH
Q 005999 623 TEVASVCSLKSPEQ--RPAMWQVLKM 646 (665)
Q Consensus 623 ~~li~~cl~~dP~~--RPt~~evl~~ 646 (665)
.+++..|+..++.+ ||++.|+++.
T Consensus 279 ~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 279 KNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 99999999844432 7899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.51 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=187.4
Q ss_pred HhCcccceEEEEEEECCe---EEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLDNH---LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||++...++ ..+++|.+..... ....+.+.+|+..++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999975433 3456676654432 234567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-----S 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~ 547 (665)
+|.++++.... .....++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN-FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC-eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999975322 2334677778899999999999999999 999999999999999999999999987542211 1
Q ss_pred CCCCCCCcccCCccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHH-HHHhhcc---CCCchh
Q 005999 548 VEDPDTVAYKAPEIRKS------SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLE-WVRTMRV---DDGREE 616 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~------~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~-~~~~~~~---~~~~~~ 616 (665)
....++..|+|||++.. ...++.++|||||||++|||++ |..||.... ..+... .+..... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhhcccccCCCccCC
Confidence 22346789999998742 1235789999999999999997 566775421 112111 1111111 111223
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
.....+.+++..|+ .+|++||+++|+++.|.
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 35667889999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=298.34 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=199.1
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------eEE
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------ERL 463 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 463 (665)
.+.||+|+||.||+|... .+..||+|++..........+.+.+|++++++++||||+++++++.... ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 357999999999999853 3688999999766544455677889999999999999999999886532 247
Q ss_pred EEEEecCCCCHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 464 VIYDYQPNGSLFNLIHGSRSI-RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+++||+.+|+|.+++...+.. ....+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+|++|||++..
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~nili~~~~~~kl~dfg~~~~ 162 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGLSKK 162 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccchhhEEEcCCCCEEECccccccc
Confidence 889999999999887543211 2235789999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 543 SDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 543 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
..... ....+++.|++||.+. ...++.++|||||||++|||++ |+.||.... ..+...++..... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~ 238 (273)
T cd05074 163 IYSGDYYRQGCASKLPVKWLALESLA-DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYLIKGNR-LKQPP 238 (273)
T ss_pred ccCCcceecCCCccCchhhcCHhHHh-cCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHHHHHcCCc-CCCCC
Confidence 53321 1123457899999886 5678899999999999999999 888886532 2233333322211 11223
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
..+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 4567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.62 Aligned_cols=243 Identities=21% Similarity=0.328 Sum_probs=198.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||++.. .++..+++|++..........+.+.+|++++++++|||++++++.+..++..++|+||+++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 5799999999999985 478889999987654444556788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccCCCC--CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
|.+++... ....+++..+.+++.+++.||+|||+++ ++|+||+|+||+++++ +.+||+|||.+....... ...
T Consensus 86 L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (256)
T cd08220 86 LAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV 161 (256)
T ss_pred HHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccccc
Confidence 99999753 2345899999999999999999999999 9999999999999865 468999999987654432 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.++..|+|||.+. ...++.++||||||+++|+|++|+.||.... .......+.... ........+..+.+++.+||
T Consensus 162 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 162 VGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAAN--LPALVLKIMSGT-FAPISDRYSPDLRQLILSML 237 (256)
T ss_pred ccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCc--hHHHHHHHHhcC-CCCCCCCcCHHHHHHHHHHc
Confidence 5788999999987 5668899999999999999999999987532 112222222111 11223345678999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
+.+|++|||+.|++.
T Consensus 238 ~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 238 NLDPSKRPQLSQIMA 252 (256)
T ss_pred cCChhhCCCHHHHhh
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.20 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=185.4
Q ss_pred hHhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 469 (665)
..||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++|+||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 46999999999999864 457899998865432 2356789999999999999999999854 55788999998
Q ss_pred CCCCHHHHHhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe----CCCCceEEeeccccc
Q 005999 470 PNGSLFNLIHGSRS----IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSV 541 (665)
Q Consensus 470 ~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill----~~~~~~kl~Dfgl~~ 541 (665)
.+ +|.+++...+. .....+++..+..++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++.
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 75 88887753221 12335889999999999999999999999 9999999999999 566799999999997
Q ss_pred ccCCCC------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC--------ccHHHHHHh
Q 005999 542 LSDSSS------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP--------PDMLEWVRT 607 (665)
Q Consensus 542 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~--------~~~~~~~~~ 607 (665)
...... ....+|+.|+|||++.+...++.++|||||||++|||+||++||....... ..+......
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 654322 123478899999998755668999999999999999999999996432110 011111110
Q ss_pred hccCC-----------------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 608 MRVDD-----------------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 608 ~~~~~-----------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..... .........+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000112345788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.74 Aligned_cols=254 Identities=17% Similarity=0.302 Sum_probs=204.2
Q ss_pred CcccCHHHHHHHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC
Q 005999 381 SEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK 459 (665)
Q Consensus 381 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 459 (665)
...+.+..-++...++||+||.+.||++...+...+|+|++.....+.....-|.+|+..|.+| .|.+|+++++|-..+
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 3556667777788899999999999999988888999999888777778889999999999999 789999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 460 GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
+..||||||-+- +|..+|+... .....| .+..+.+|++.|+.+.|+.+ |||.||||.|+|+- .|.+||+|||+
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH~~g-IVHSDLKPANFLlV-kG~LKLIDFGI 505 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIHQHG-IVHSDLKPANFLLV-KGRLKLIDFGI 505 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHHHhc-eeecCCCcccEEEE-eeeEEeeeech
Confidence 999999998644 9999998532 223334 67889999999999999999 99999999999986 46999999999
Q ss_pred ccccCCCCC-----CCCCCCcccCCccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 005999 540 SVLSDSSSV-----EDPDTVAYKAPEIRKSS----------RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEW 604 (665)
Q Consensus 540 ~~~~~~~~~-----~~~gt~~y~aPE~~~~~----------~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 604 (665)
|..+....+ ..+||+.||+||.+... -..++++||||+||+||+|+.|++||.+.. ....-
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----n~~aK 581 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----NQIAK 581 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----HHHHH
Confidence 987765543 23699999999987621 125689999999999999999999997531 12222
Q ss_pred HHhhccCC---Cch-hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 605 VRTMRVDD---GRE-ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 605 ~~~~~~~~---~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+..+..+. .++ ......+.++++.||+.||++||+..|+++
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 22222221 111 111223899999999999999999999986
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=298.13 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=197.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... ++..|++|.++.........+.+.+|++++++++|+||+++++++.+.+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 367999999999999854 6889999999766554456778999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 85 TLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHG-IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred cHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 99999873 245788899999999999999999999 99999999999999999999999999876543221
Q ss_pred ---CCCCCCcccCCccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCc--hhhhHHH
Q 005999 549 ---EDPDTVAYKAPEIRKSSR--RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGR--EENRLGM 621 (665)
Q Consensus 549 ---~~~gt~~y~aPE~~~~~~--~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 621 (665)
...++..|+|||++.... .++.++||||||+++||+++|+.||.... ........+.. ...... ....+..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-NEFQIMFHVGA-GHKPPIPDSLQLSPE 236 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-chHHHHHHHhc-CCCCCCCcccccCHH
Confidence 134678999999986322 27889999999999999999999997532 11111111111 111111 2223677
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhc
Confidence 899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.09 Aligned_cols=245 Identities=16% Similarity=0.212 Sum_probs=191.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.++..++|+||+++++++.+++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 57999999999999954 688999999865322 1233456888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (331)
T cd05597 87 DLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG-YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161 (331)
T ss_pred cHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence 999999742 345889999999999999999999999 99999999999999999999999999865443221
Q ss_pred CCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHH
Q 005999 549 EDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGM 621 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 621 (665)
...||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ..+....+....... ......+..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 2358999999999852 2457889999999999999999999997531 111111111111101 112235677
Q ss_pred HHHHHHHcccCC--CCCCCCHHHHHHH
Q 005999 622 LTEVASVCSLKS--PEQRPAMWQVLKM 646 (665)
Q Consensus 622 l~~li~~cl~~d--P~~RPt~~evl~~ 646 (665)
+.+++.+|+..+ +..||++.++++.
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcC
Confidence 899999977543 3347899999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=297.01 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=202.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 471 (665)
+.||.|+||.||++.. .++..+++|.+..........+.+.+|++++++++|+||+++++++.. +...+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 5699999999999985 467889999987655445556778899999999999999999998764 4567899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-----RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
++|.+++...+. ....+++..++.++.||+.||+||| +.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 86 GDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-ceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999875322 3457899999999999999999999 888 999999999999999999999999998766543
Q ss_pred C---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 547 S---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 547 ~---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
. ....+++.|+|||++. ...++.++||||||+++|+|++|+.||.... ...+.+.+..... ...+...+..+.
T Consensus 164 ~~~~~~~~~~~~~~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKF-RRIPYRYSSELN 239 (265)
T ss_pred cccccccccCCCccChhhhc-CCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCC-CCCccccCHHHH
Confidence 3 2335789999999987 5668899999999999999999999997632 2344443333222 123445677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+++.+|++.+|++||++.+|++.
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhC
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.67 Aligned_cols=242 Identities=16% Similarity=0.222 Sum_probs=190.0
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 466 (665)
.+.||+|+||.||++.. ..++.||||++..........+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 36799999999999985 4678899999976544445556788899999999999999999987543 3579999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+.+ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 99975 78777642 3788899999999999999999999 999999999999999999999999999765443
Q ss_pred C--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc--------------
Q 005999 547 S--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-------------- 610 (665)
Q Consensus 547 ~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------------- 610 (665)
. ....+|..|+|||++. +..++.++|||||||++|||++|+.||...... ..+...+.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CcccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 2 2335899999999987 667899999999999999999999999753210 011111110000
Q ss_pred ----CC---------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 ----DD---------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 ----~~---------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. .........+.+++.+|++.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0011123468899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.07 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=196.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|++++++++||||+++++++.+....+++|||+.+++
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 56999999999999864 577899999876543 355778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+....... ...
T Consensus 87 l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 87 LQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETG-KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 99998742 246889999999999999999999999 9999999999999999999999999986654322 223
Q ss_pred CCCCcccCCccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh-hccCC-CchhhhHHHHHHH
Q 005999 551 PDTVAYKAPEIRKSSR---RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT-MRVDD-GREENRLGMLTEV 625 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~---~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~l~~l 625 (665)
.++..|+|||.+. .. .++.++||||||+++|||++|+.||....... ........ ..... ......+..+.++
T Consensus 162 ~~~~~y~~Pe~~~-~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 162 IGTPYWMAPEVAA-VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-ALFLISKSNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred cCCccccCchhhc-ccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCccccchhhhhHHHHHH
Confidence 5788899999886 33 68889999999999999999999987532111 11111111 01110 1233456779999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+|+..+|++|||+.+++.
T Consensus 240 i~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=297.29 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=199.1
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||+||+|.. .++..+++|++....... ..+.+.+|++.++.++|+||+++++.+..+...++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 35699999999999995 467889999987654433 5677899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 85 ~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~-i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 85 SLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG-QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred cHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 9999997431 1246899999999999999999999999 99999999999999999999999999865543221
Q ss_pred ---CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCc---hhhhHHHH
Q 005999 549 ---EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGR---EENRLGML 622 (665)
Q Consensus 549 ---~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 622 (665)
...++..|+|||++.....++.++|||||||++|||++|+.||...... ..+............. ....+..+
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCCcCCccccccccHHH
Confidence 2247889999999874447899999999999999999999999753221 1122222211111111 12456779
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+++.+|+..||++||++.|+++
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=296.31 Aligned_cols=242 Identities=20% Similarity=0.244 Sum_probs=197.4
Q ss_pred hCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||.|+||.||++... ++..+++|++...... ....+.+.+|+.++++++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 4789999998754432 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVEDPD 552 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~~g 552 (665)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....+
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~-~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRG-IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccC
Confidence 999974 235888999999999999999999999 999999999999999999999999998766543 222357
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
+..|++||.+. ...++.++|+||+|+++|||++|+.||.....+..+....+.........+...+..+.+++.+||+.
T Consensus 155 ~~~~~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 155 TPEYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CcCccChhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 88999999986 56789999999999999999999999976432222222222211122223334467899999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 005999 633 SPEQRPA-----MWQVLK 645 (665)
Q Consensus 633 dP~~RPt-----~~evl~ 645 (665)
+|++||+ +.|+++
T Consensus 234 ~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 234 NPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ChhhCcCCcccCHHHHhc
Confidence 9999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=298.92 Aligned_cols=242 Identities=21% Similarity=0.376 Sum_probs=196.2
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC---CCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS---HPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|.. .++..+++|.+..... ....+.+.+|+.++++++ |||++++++++..+...++||||+
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 36799999999999995 5788999999865432 234456788999998886 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 85 EGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVG-VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred CCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 99999999863 25889999999999999999999999 9999999999999999999999999986654332
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....++..|+|||++..+..++.++|||||||++|+|++|+.||..... ......+.............+..+.+++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--FRAMMLIPKSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--hhhhhccccCCCCCCCcccCCHHHHHHH
Confidence 2235788999999887555678999999999999999999999975321 1111111111111111223567899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+|++.||++||++.|+++
T Consensus 236 ~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 236 AACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHcCCCcccCcCHHHHhh
Confidence 9999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=300.17 Aligned_cols=245 Identities=20% Similarity=0.294 Sum_probs=197.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .++..|++|++..........+.+.+|+.++++++||||+++++++..+...++|+||+ +++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 5699999999999996 46889999999776544455677899999999999999999999999999999999999 999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 549 (665)
|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 85 LSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 99998743 256899999999999999999999999 9999999999999999999999999987654432 23
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-------------------
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV------------------- 610 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------------- 610 (665)
..++..|+|||++.....++.++||||+|+++|||++|++||..... ...+.........
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 35788999999987555678999999999999999999887754211 0111111110000
Q ss_pred -CC-------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 -DD-------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 -~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. ....+.+..+.+++.+|++.+|++||+++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0012345788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=295.52 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=199.7
Q ss_pred hHhCcccceEEEEEEECC-----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDN-----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||++...+ +..||+|.+...... ...+.+.+|++.+.+++|+||+++++++.+.+..+++|||+
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 579999999999999653 478999999665432 25678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 549 (665)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~-~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 84 EGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred CCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCC-eeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999987421 122899999999999999999999999 999999999999999999999999998665443211
Q ss_pred ----CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 550 ----DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 550 ----~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
..++..|+|||.+. ...++.++||||+|+++|||++ |+.||... ...++.+.+...... ......+..+.+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (258)
T smart00219 160 KKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGYRL-PKPENCPPEIYK 235 (258)
T ss_pred ccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCC-CCCCcCCHHHHH
Confidence 23678899999885 6678999999999999999998 78887652 222333333332222 233446778999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L 647 (665)
++.+|+..||++|||+.|+++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.73 Aligned_cols=241 Identities=22% Similarity=0.364 Sum_probs=195.9
Q ss_pred HhHhCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..-||.|+||.||+|..++ +...|.|++.... +...++|.-||++|..++||+||++++.|..++..+++.|||.||
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 3458999999999998654 4445566664433 356778999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
.+...+-. -+..+++.++.-+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+...... ...
T Consensus 115 AVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs~~-iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 115 AVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHSQN-IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred hHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhhcc-hhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 99987754 3467999999999999999999999999 999999999999999999999999998543321 233
Q ss_pred CCCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHHH
Q 005999 550 DPDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGML 622 (665)
Q Consensus 550 ~~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 622 (665)
-.|||+|||||+.. ....|+.++||||||++|.||..+.+|..... .+...++....+. ..+......+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHHHhhcCCCcccCcchhhhHH
Confidence 47999999999754 25679999999999999999999999966421 2222222111111 2466777889
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+|+.+||.+||..||++.++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhh
Confidence 99999999999999999999975
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=299.76 Aligned_cols=244 Identities=19% Similarity=0.236 Sum_probs=190.4
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCchhh-HHHHHHHHHH---HHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADT-SAEAFEQHME---AVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+||+|+||.||++.. .++..+|+|.+........ ....+.+|.. ++...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 4688999999865433212 1222334433 3444589999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVE 549 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 549 (665)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...... ...
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccC
Confidence 9999999873 346899999999999999999999999 999999999999999999999999998654332 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..++..|+|||.+..+..++.++||||+||++|||++|+.||.............. ........+...+..+.+++.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHHH
Confidence 45899999999876455688999999999999999999999975432221111111 11112223445677899999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 005999 630 SLKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RP-----t~~evl~~ 646 (665)
+..||++|| |++|+++.
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhC
Confidence 999999999 69988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=298.06 Aligned_cols=245 Identities=20% Similarity=0.349 Sum_probs=197.0
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCch----hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA----DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||++.. .+++.+|+|.+...... ....+.+++|+..+++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 36799999999999984 67889999998654321 12356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSSS 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~ 547 (665)
+++++|.+++.. ..++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 85 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~-i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 85 MAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred cCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999874 246889999999999999999999999 99999999999998776 59999999986654321
Q ss_pred -------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCCCchhhhH
Q 005999 548 -------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDGREENRL 619 (665)
Q Consensus 548 -------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 619 (665)
....++..|+|||.+. +..++.++||||+|+++|+|++|+.||........ ...............+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1224678999999986 56788999999999999999999999965322111 11111111111223344566
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+.+++.+|+..+|++||++.|+++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 78999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=303.21 Aligned_cols=242 Identities=18% Similarity=0.285 Sum_probs=192.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.++++++||||+++++++..++..++|+||+. ++
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 56999999999999864 6788999998654432 233456789999999999999999999999999999999997 59
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++....... ...
T Consensus 90 l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (301)
T cd07873 90 LKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164 (301)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence 99988642 345788999999999999999999999 9999999999999999999999999986543222 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc--------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-------------------- 610 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------------------- 610 (665)
.+++.|+|||++.....++.++|||||||++|||++|+.||..... .+....+.....
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 4688999999887555688899999999999999999999975321 111111110000
Q ss_pred -CC-------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 -DD-------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 -~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.. ......+..+.+++.+|++.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 001234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.70 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=194.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++|+||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 67999999999999975 58899999987654433445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.++... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 87 l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 87 LDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred HHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 9887753 234899999999999999999999999 9999999999999999999999999987654322 123
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH---h-----------------hcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR---T-----------------MRV 610 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~---~-----------------~~~ 610 (665)
.++..|+|||++.+...++.++||||||+++|||++|++||...... ........ . ...
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 46788999999875556788999999999999999999998643210 00000000 0 000
Q ss_pred CC--------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 DD--------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 ~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.. ......+..+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 001234567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.50 Aligned_cols=238 Identities=18% Similarity=0.217 Sum_probs=187.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... .++.||+|.... ..+.+|++++++++|+||+++++++..++..++|||++. +
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 467999999999999965 577899996322 235689999999999999999999999999999999995 6
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 245 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 245 DLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 999888642 346999999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC------CccHHHHHHhhccCCC-c------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA------PPDMLEWVRTMRVDDG-R------ 614 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~------~~~~~~~~~~~~~~~~-~------ 614 (665)
....||+.|+|||++. +..++.++|||||||++|||++|..|+...... ..++...++....... .
T Consensus 320 ~~~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 1235899999999987 567899999999999999999988764322111 1123333332211100 0
Q ss_pred -------------------------hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 615 -------------------------EENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 615 -------------------------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00122368899999999999999999999874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=304.41 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=196.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... ++..+|+|.+....... ...+.+.+|++.++.++|+||+++++++.+....++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 56999999999999965 58899999997654332 34567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (316)
T cd05574 87 ELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162 (316)
T ss_pred CHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChHHeEEcCCCCEEEeecchhhccccccccccc
Confidence 999998743 2356899999999999999999999999 9999999999999999999999999875432211
Q ss_pred ---------------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 005999 548 ---------------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPD 600 (665)
Q Consensus 548 ---------------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~ 600 (665)
....|+..|+|||++. +..++.++||||||+++|+|++|+.||..... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~ 240 (316)
T cd05574 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR-DET 240 (316)
T ss_pred ccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCch-HHH
Confidence 1124678899999987 56789999999999999999999999975321 111
Q ss_pred HHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 005999 601 MLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPA----MWQVLK 645 (665)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 645 (665)
+..... ...........+..+.+++.+|+..||++||+ +.|++.
T Consensus 241 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FSNILK-KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHhc-CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111111 11111112225778999999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=296.31 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=201.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... +++.+++|++..... ....+.+.+|++++++++||||+++++++..+...++++||+.++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 467999999999999965 688899999876543 245567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 550 (665)
+|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+....... ...
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~-i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC-eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 9999997532 568899999999999999999999 88 9999999999999999999999999986543221 124
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGMLTEVAS 627 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~ 627 (665)
.++..|+|||++. +..++.++||||||+++|+|++|+.||.............++...... ......+..+.+++.
T Consensus 160 ~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence 5788999999986 567899999999999999999999998764322233333333222211 112225677999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~ 645 (665)
+|+..+|++|||+.|++.
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 239 LCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHcCCCchhCcCHHHHhh
Confidence 999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=300.82 Aligned_cols=240 Identities=21% Similarity=0.251 Sum_probs=198.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... +++.+|+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 57999999999999854 6889999998654322 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...........+
T Consensus 87 ~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (290)
T cd05580 87 ELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLD-IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160 (290)
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence 99999874 356889999999999999999999999 999999999999999999999999999776655445568
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
++.|+|||.+. +...+.++||||||+++|+|++|+.||.... .......+.. .....+...+..+.+++.+||..
T Consensus 161 ~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 161 TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILE--GKVRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc--CCccCCccCCHHHHHHHHHHccC
Confidence 89999999886 5578899999999999999999999987532 1222222221 11122334567899999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 005999 633 SPEQRP-----AMWQVLK 645 (665)
Q Consensus 633 dP~~RP-----t~~evl~ 645 (665)
||++|| +++|+++
T Consensus 236 ~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CHHHccCcccCCHHHHHc
Confidence 999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.67 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=194.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCC-chhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANK-TADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... +++.|++|.+.... ......+.+.+|+++++.++||||+++++++.+++..++|+||+.
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 367999999999999864 68899999986443 223345678899999999999999999999999999999999997
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|++.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++...... ....
T Consensus 99 g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~-i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-~~~~ 172 (307)
T cd06607 99 GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHE-RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NSFV 172 (307)
T ss_pred CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEECCCCCEEEeecCcceecCCC-CCcc
Confidence 5787777532 345899999999999999999999999 999999999999999999999999998765433 2335
Q ss_pred CCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
++..|+|||++.+ ...++.++||||||+++|||++|+.||.... .......+.............+..+.+++.+|
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence 7889999998742 3568889999999999999999999986531 11111111111111112334567799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|+.+|++||++.+++..
T Consensus 251 l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 251 LQKIPQDRPSSEELLKH 267 (307)
T ss_pred hcCChhhCcCHHHHhcC
Confidence 99999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.78 Aligned_cols=238 Identities=19% Similarity=0.268 Sum_probs=189.6
Q ss_pred HhHhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
.+.||+|+||.||++... .+..|++|.+.... ...+|++++++++||||+++++++......++||||+.
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 467999999999999753 35788999875432 34679999999999999999999999999999999986
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 170 -~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~g-ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 170 -CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHGRG-IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred -CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 58998885 2356899999999999999999999999 9999999999999999999999999986554322
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC--ccHHHHHHhhccCC-----------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP--PDMLEWVRTMRVDD----------- 612 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~----------- 612 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ..+...++......
T Consensus 243 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 2235899999999987 5678999999999999999999999986532211 12222111111000
Q ss_pred ---------------Cc-----hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 ---------------GR-----EENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 ---------------~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. ....+..+.+++.+|+..||++|||+.|++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 01224568889999999999999999999874
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=301.14 Aligned_cols=245 Identities=19% Similarity=0.285 Sum_probs=194.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... ++..|++|++..........+.+.+|++++++++||||+++++++.+++..++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 56899999999999864 68899999987654434445678899999999999999999999999999999999996 58
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++....... ...
T Consensus 85 l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (284)
T cd07860 85 LKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160 (284)
T ss_pred HHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccc
Confidence 99988643 2356899999999999999999999999 9999999999999999999999999986554321 222
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------------ 612 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 612 (665)
.++..|+|||++.+...++.++|||||||++|||+||+.||..... ........+......
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 4678899999887555578899999999999999999999865321 111111111111000
Q ss_pred --------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=303.06 Aligned_cols=240 Identities=20% Similarity=0.325 Sum_probs=195.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
..||+|+||.||++.. .++..||+|.+.... ....+.+.+|+..+++++|+||+++++.+...+..++||||+++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 5699999999999985 467899999986543 2445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ...
T Consensus 106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 9998853 34788999999999999999999999 9999999999999999999999999986543221 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-CCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD-DGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++||||||+++|||++|+.||.... .......+...... .......+..+.+++.+|
T Consensus 179 ~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 179 VGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--PLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 4788999999986 5678899999999999999999999987521 11211222211111 112224456789999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
+..||++|||+.|+++.
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.37 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=192.0
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEE-----eCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQ-----AKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~e 467 (665)
+.||+|+||.||++.. .+++.+++|++.... .....+.+|+.+++++ +||||+++++++. .++..++|||
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 5699999999999985 467889999876533 2235677899999999 7999999999874 3457899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 546 (665)
|+++++|.++++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 101 LCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred ecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC-ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 9999999998864221 3356889999999999999999999999 999999999999999999999999998665432
Q ss_pred --CCCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 547 --SVEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 547 --~~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
.....++..|+|||++.. ...++.++||||+||++|||++|+.||...... ..+.............+...+.
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 257 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RALFKIPRNPPPTLHQPELWSN 257 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-HHHhhccccCCCcccCCCCcCH
Confidence 123358899999998752 244788999999999999999999998753211 1111111111111112233456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
.+.+++.+|++.||++|||+.|+++..
T Consensus 258 ~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 258 EFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 799999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=299.39 Aligned_cols=246 Identities=23% Similarity=0.390 Sum_probs=194.0
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCch--------hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA--------DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 464 (665)
.+.||+|+||.||+|.. .+++.+|+|.++..... ....+.+.+|+.++++++|||++++++++......++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 36799999999999985 46889999988643211 1123567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++++|||++....
T Consensus 86 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC-eeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 99999999999998742 46888999999999999999999999 9999999999999999999999999986554
Q ss_pred CC-----CCCCCCCCcccCCccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC---CCch
Q 005999 545 SS-----SVEDPDTVAYKAPEIRKSSR-RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD---DGRE 615 (665)
Q Consensus 545 ~~-----~~~~~gt~~y~aPE~~~~~~-~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~ 615 (665)
.. .....++..|+|||.+.... .++.++||||||+++||+++|+.||...... ....+........ ....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccccCCcCCcccc
Confidence 32 12234788999999876432 4789999999999999999999998642110 1111111110000 1112
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
...+..+.+++.+|+..+|++||++.|+++.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 2446789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.39 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=195.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
..||+|+||.||++.. .++..|++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 4699999999999985 4688999999865432 335668899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9998752 35889999999999999999999999 9999999999999999999999999986543321 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-CCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD-DGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++|||||||++|||++|+.||.... .......+...... .......+..+.+++.+|
T Consensus 178 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 178 VGTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 5788999999987 5678999999999999999999999987521 11222222211111 112234566799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
++.+|++||++.|+++.
T Consensus 255 l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 255 LTREPQERATAQELLDH 271 (297)
T ss_pred hcCCcccCcCHHHHhhC
Confidence 99999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=299.35 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=191.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHH-HhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEA-VGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... ++..||+|++......+. ...+..|+.. ++.++||||+++++++..++..+++|||++ |
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 56999999999999965 689999999876543222 3344455554 666799999999999999999999999997 5
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 549 (665)
+|.+++..... ....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (283)
T cd06617 85 SLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI 162 (283)
T ss_pred cHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC-eecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 88888764322 235689999999999999999999997 7 9999999999999999999999999987654322 22
Q ss_pred CCCCCcccCCccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSS---RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~---~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
..++..|+|||.+.+. ..++.++|+|||||++|||++|+.||.........+...... ..........+..+.+++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 241 (283)
T cd06617 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPAEKFSPEFQDFV 241 (283)
T ss_pred ccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCccccCHHHHHHH
Confidence 3578899999987531 346889999999999999999999986532211222222211 111112234567899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||..+|++||++.++++
T Consensus 242 ~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 242 NKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=289.71 Aligned_cols=256 Identities=24% Similarity=0.335 Sum_probs=211.3
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 466 (665)
.-++-+|.||.||+|.+. +.+.|.+|.++...+ +.....+.+|.-.+..+.|||+.++.+++.+ ....+++|
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 346889999999999643 455677777765543 3445668888889999999999999999765 45788999
Q ss_pred EecCCCCHHHHHhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 467 DYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
.++.-|+|..++..++.. ..+.++-.+...++.|++.|++|||+.+ |||.||..+|++||+..++||+|=.+++..
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-VIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-cccchhhhhcceehhheeEEeccchhcccc
Confidence 999999999999866543 2345777788889999999999999999 999999999999999999999999998765
Q ss_pred CCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 544 DSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 544 ~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
-+... .......||+||.+. ...|+..+|||||||+||||+| |+.||.+. ++.++..++++.... ..+.+
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeI--DPfEm~~ylkdGyRl-aQP~N 522 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEI--DPFEMEHYLKDGYRL-AQPFN 522 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCcccc--CHHHHHHHHhcccee-cCCCC
Confidence 44432 234578899999997 7889999999999999999998 88898763 444777776655433 35678
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
+++++..++..||+.+|++||+++|++.-|.+...+++
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999987765
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=299.06 Aligned_cols=243 Identities=21% Similarity=0.331 Sum_probs=191.7
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEe------CCeEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQA------KGERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv 465 (665)
.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++.. ....+++
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 35799999999999995 567889999886543 3345678899999988 79999999999853 4578999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+.+|+|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 98 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 98 MEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999999998743 2345788889999999999999999999 99999999999999999999999999865432
Q ss_pred C---CCCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 546 S---SVEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 546 ~---~~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
. .....+++.|+|||.+.. ...++.++|||||||++|||++|+.||...... ..... +.............
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~~~-~~~~~~~~~~~~~~ 251 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RALFL-IPRNPPPKLKSKKW 251 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hhhhh-HhhCCCCCCccccc
Confidence 2 223357889999998752 245788999999999999999999999653211 11111 11111111123346
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 252 SKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.86 Aligned_cols=245 Identities=14% Similarity=0.213 Sum_probs=191.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++..+ +++.+|+|++..... .....+.+.+|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 57999999999999965 577899999864322 1223455888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~ 548 (665)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 87 ~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~-iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~ 161 (332)
T cd05623 87 DLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161 (332)
T ss_pred cHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence 999999742 345889999999999999999999999 9999999999999999999999999986543221 1
Q ss_pred CCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHH
Q 005999 549 EDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGM 621 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 621 (665)
...||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ..+....+....... ......+..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCccccCCCccccCCHH
Confidence 2358999999998752 3457889999999999999999999997531 112222221111111 112345677
Q ss_pred HHHHHHHcccCCCC--CCCCHHHHHHH
Q 005999 622 LTEVASVCSLKSPE--QRPAMWQVLKM 646 (665)
Q Consensus 622 l~~li~~cl~~dP~--~RPt~~evl~~ 646 (665)
+.+++.+|+..++. .|+++.|+++.
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 89999998865444 36899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=310.58 Aligned_cols=237 Identities=19% Similarity=0.279 Sum_probs=183.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... ++..||+|...... ...|+.++++++||||+++++++......++|+||+. +
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 141 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S 141 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence 467999999999999965 56788998754322 2468899999999999999999999999999999995 5
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~ 550 (665)
+|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 142 ~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 142 DLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQR-IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred cHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 89888864 2356899999999999999999999999 999999999999999999999999998654322 2334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCC-CCCCCCC--------ccHHHHHHhhccCC-C-------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPS-QHPYLAP--------PDMLEWVRTMRVDD-G------- 613 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~-~~~~~~~--------~~~~~~~~~~~~~~-~------- 613 (665)
.||+.|+|||++. +..++.++|||||||++|||+++..|+ ....... ..+...+....... .
T Consensus 217 ~gt~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 217 AGTVETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred cccccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 5899999999987 567899999999999999999865554 3321110 01111111111000 0
Q ss_pred -----------------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 -----------------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 -----------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00122344667999999999999999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.15 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=197.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 471 (665)
+.||.|++|.||++.. .+++.+|+|.+...... .....+.+|++++++++||||++++++|.+. +..++||||+++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 5699999999999996 46889999998755432 4456788999999999999999999998653 478999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-VED 550 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 550 (665)
++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 163 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK-IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF 163 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEecCCeEEEeeccccccccccccccc
Confidence 999998764222 3456888999999999999999999999 9999999999999999999999999986544322 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC---CccHHHHHHhhccCC-----CchhhhHHHH
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA---PPDMLEWVRTMRVDD-----GREENRLGML 622 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~-----~~~~~~~~~l 622 (665)
.++..|+|||.+. +..++.++||||+||++|||++|+.||...... ..+...++....... ......+..+
T Consensus 164 ~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd06621 164 TGTSFYMAPERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242 (287)
T ss_pred cCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHH
Confidence 4678899999886 567899999999999999999999999865321 123334333211111 1112345679
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+++.+||+.+|++|||+.|+++
T Consensus 243 ~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 243 KDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHcCCCcccCCCHHHHHh
Confidence 99999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=320.57 Aligned_cols=239 Identities=20% Similarity=0.231 Sum_probs=181.4
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC------CCCeeeeeEEEEeC-CeEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS------HPNLVPIRAYFQAK-GERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~-~~~~lv 465 (665)
.+.||+|+||+||+|.. ..++.||||+++... ...+.+..|++++..++ |.++++++++|..+ +..++|
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 36799999999999985 467889999986432 22233455666655554 45689999998764 578888
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCC--------------
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADF-------------- 530 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~-------------- 530 (665)
||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~g-IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 211 MPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred Eecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEecCCcccccccccccCCC
Confidence 8887 7799998863 34689999999999999999999984 7 99999999999998765
Q ss_pred --ceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh
Q 005999 531 --EARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM 608 (665)
Q Consensus 531 --~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 608 (665)
.+||+|||.+...........||+.|+|||++. +..++.++|||||||++|||++|+.||..... .+....+...
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~ 360 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN--LEHLHLMEKT 360 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHH
Confidence 499999998865554445557899999999987 66799999999999999999999999975321 1111111110
Q ss_pred ccC--------------------------C-C-------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 609 RVD--------------------------D-G-------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 609 ~~~--------------------------~-~-------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
... . . ........+.+|+.+||+.||++|||+.|+++
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000 0 0 00011345789999999999999999999997
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.00 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=192.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC-----CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK-----GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e 467 (665)
+.||+|+||.||++.. .+++.+|+|++.... ...+.+.+|+.++.++ +|||++++++++... +..++|+|
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 4699999999999986 568899999986543 2345677889999988 899999999998753 35899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 546 (665)
|+++|+|.++++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 105 y~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 105 LCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred ECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 9999999998864221 3456899999999999999999999999 999999999999999999999999998654432
Q ss_pred --CCCCCCCCcccCCccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHH
Q 005999 547 --SVEDPDTVAYKAPEIRKSSR----RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620 (665)
Q Consensus 547 --~~~~~gt~~y~aPE~~~~~~----~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (665)
.....++..|+|||++.... .++.++|||||||++|||++|+.||..... ...+..+.+.........+....
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 261 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VKTLFKIPRNPPPTLLHPEKWCR 261 (291)
T ss_pred ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHhcCCCCCCCcccccCH
Confidence 12335788999999875322 368899999999999999999999875321 11222221111111112334556
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+.+++.+|++.+|++||++.|+++
T Consensus 262 ~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 262 SFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHHHhhcChhhCcCHHHHhc
Confidence 7999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.68 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=201.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... +++.|++|++...... ...+.+.+|++.+.+++|+|++++++++...+..++|+||+++++
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 67999999999999966 5889999998765432 446778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC---C
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---E 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---~ 549 (665)
|.+++... ..+++..++.++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........ .
T Consensus 86 L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~-~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 86 LADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC-CccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 99999742 568999999999999999999999 88 99999999999999999999999999876544322 2
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-CCccHHHHHHhhccCCCchhh-hHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYL-APPDMLEWVRTMRVDDGREEN-RLGMLTEVAS 627 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~ 627 (665)
..++..|+|||.+. ...++.++||||||+++|||++|+.||..... ...+....+...... ..... .+..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 237 (264)
T cd06623 160 FVGTVTYMSPERIQ-GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP-SLPAEEFSPEFRDFIS 237 (264)
T ss_pred eeecccccCHhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC-CCCcccCCHHHHHHHH
Confidence 34788999999987 56788999999999999999999999976432 111333332221111 12233 6778999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~ 646 (665)
+|++.+|++||++.|+++.
T Consensus 238 ~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHccCChhhCCCHHHHHhC
Confidence 9999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.72 Aligned_cols=242 Identities=18% Similarity=0.277 Sum_probs=191.0
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc---hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT---ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 467 (665)
.+.||+|+||.||+|.. +++..|++|.+..... .....+.+.+|+.++++++||||+++++++.+. ...+++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 36799999999999985 4688999998864321 123456788999999999999999999998763 46789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 546 (665)
|+++++|.+++.. ...+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 87 HMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred ecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999873 234788889999999999999999999 999999999999999999999999998654321
Q ss_pred -----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 547 -----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 547 -----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
.....++..|+|||.+. +..++.++|||||||++|||++|+.||..... ...... ..........+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-MAAIFK-IATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccch-HHHHHH-HhcCCCCCCCchhhCHH
Confidence 12234788999999986 56789999999999999999999999875311 111111 11111111233455667
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++.+|+. +|++||++.|+++
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhc
Confidence 8899999995 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.34 Aligned_cols=246 Identities=21% Similarity=0.333 Sum_probs=196.8
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|.. .++..+|+|++..... .....+.+.+|++++++++|||++++++++.++...++||||+.+
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 109 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG 109 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC
Confidence 46799999999999985 4688999999864422 223456788999999999999999999999999999999999975
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
+|.+.+... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++...... ....
T Consensus 110 -~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~-i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~ 182 (317)
T cd06635 110 -SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-NSFV 182 (317)
T ss_pred -CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcccEEECCCCCEEEecCCCccccCCc-cccc
Confidence 888877532 345899999999999999999999999 999999999999999999999999998655432 2335
Q ss_pred CCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
++..|+|||++. ..+.++.++|||||||++|||++|+.||.... .......+.............+..+.+++.+|
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence 788999999874 23568899999999999999999999986531 11111111111111122334567799999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~ 648 (665)
++.+|++||++.++++...
T Consensus 261 l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ccCCcccCcCHHHHHhChh
Confidence 9999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=308.49 Aligned_cols=245 Identities=16% Similarity=0.214 Sum_probs=191.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+.++..++|+||+++++++.+++..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 57999999999999964 678899999865321 1233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 87 ~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~-iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 161 (331)
T cd05624 87 DLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH-YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161 (331)
T ss_pred cHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeec
Confidence 999999742 345888999999999999999999999 99999999999999999999999999866543221
Q ss_pred CCCCCCcccCCccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHH
Q 005999 549 EDPDTVAYKAPEIRKSS----RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGM 621 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~----~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 621 (665)
...||+.|+|||++... ..++.++|||||||++|||++|+.||.... ..+....+....... ......+..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred cccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--HHHHHHHHHcCCCcccCCCccccCCHH
Confidence 23589999999987631 457889999999999999999999997531 112211111111111 112234677
Q ss_pred HHHHHHHcccCCCCC--CCCHHHHHHH
Q 005999 622 LTEVASVCSLKSPEQ--RPAMWQVLKM 646 (665)
Q Consensus 622 l~~li~~cl~~dP~~--RPt~~evl~~ 646 (665)
+.+++.+|+..++++ |++++++++.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 999999999865544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.89 Aligned_cols=243 Identities=19% Similarity=0.243 Sum_probs=193.0
Q ss_pred hCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||+|+||+||++.. .+++.+++|.+...... ....+.+..|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999984 46889999998654321 12344567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVEDPD 552 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~~g 552 (665)
.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+...... .....+
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRR-IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence 99987432 246899999999999999999999999 999999999999999999999999998655432 122356
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc-cCCCchhhhHHHHHHHHHHccc
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~ 631 (665)
+..|+|||++. +..++.++|||||||++|+|++|+.||....... .......... .....+...+..+.+++.+||+
T Consensus 157 ~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (277)
T cd05577 157 TPGYMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234 (277)
T ss_pred CCCcCCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccccccccCCccCCHHHHHHHHHHcc
Confidence 78999999987 4568899999999999999999999997643211 1111111111 1112233456789999999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 005999 632 KSPEQRP-----AMWQVLK 645 (665)
Q Consensus 632 ~dP~~RP-----t~~evl~ 645 (665)
.||++|| ++.+++.
T Consensus 235 ~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 235 KDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CChhHccCCCcccHHHHHh
Confidence 9999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.18 Aligned_cols=192 Identities=23% Similarity=0.387 Sum_probs=168.6
Q ss_pred HHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CC-----CeeeeeEEEEeCCeEEEE
Q 005999 393 SAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HP-----NLVPIRAYFQAKGERLVI 465 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv 465 (665)
..+.||+|+||.|-++. .++++.||||+++... ....+...|+.+|..|+ |. |+|+++++|...++.+||
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 34789999999999998 5579999999998765 34455667888988886 43 899999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC--CceEEeeccccccc
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD--FEARLTDYCLSVLS 543 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~--~~~kl~Dfgl~~~~ 543 (665)
+|.+.. +|+++++.. +...++...+..++.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.+...
T Consensus 267 fELL~~-NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~l~-IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLST-NLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHELG-IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhhh-hHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999866 999999865 3456899999999999999999999999 9999999999999754 47999999999988
Q ss_pred CCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005999 544 DSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593 (665)
Q Consensus 544 ~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~ 593 (665)
........-+..|+|||++. +..|+.+.||||||||+.||++|.+.|.+
T Consensus 342 ~q~vytYiQSRfYRAPEVIL-GlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVIL-GLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcceeeeeccccccchhhc-cCCCCCccceeehhhhHHhHhcCccccCC
Confidence 87766667889999999998 78899999999999999999999877764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.28 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=192.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||++... ++..+|+|.+...... .....+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 467999999999999854 6789999998755432 34567888999999995 99999999999999999999999864
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCC--CC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~ 548 (665)
++.++...........+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++...... ..
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 165 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT 165 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC-eeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence 555543211111235689999999999999999999985 6 999999999999999999999999998654332 22
Q ss_pred CCCCCCcccCCccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------CchhhhHH
Q 005999 549 EDPDTVAYKAPEIRKSS--RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------GREENRLG 620 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~--~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 620 (665)
...++..|+|||++... ..++.++|||||||++|||++|+.||.... ...+.+....... ......+.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 33578899999998744 368999999999999999999999987532 1222222111110 11224667
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+.+++.+|++.+|++|||+.|+++.
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=296.88 Aligned_cols=246 Identities=27% Similarity=0.400 Sum_probs=194.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCC------eEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKG------ERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~lv 465 (665)
.+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+++++++ +|+||+++++++.... ..++|
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 367999999999999964 67789999987554 2346788999999999 7999999999997644 48999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 88 MELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred EEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 999999999999874321 2457899999999999999999999999 99999999999999999999999999865433
Q ss_pred CC---CCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 546 SS---VEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 546 ~~---~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
.. ....++..|+|||++.. ...++.++|||||||++|||++|+.||.... ......................
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (275)
T cd06608 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-PMRALFKIPRNPPPTLKSPENW 244 (275)
T ss_pred chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-hHHHHHHhhccCCCCCCchhhc
Confidence 21 22347889999998742 2346789999999999999999999996421 1112222222111111122335
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 245 SKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=298.77 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=195.2
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|++|.||+|.. .++..|++|++..........+.+.+|++++++++|||++++++++.+++..+++|||+. +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 35799999999999985 478899999987654433444668889999999999999999999999999999999995 6
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... ..
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~-~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 83 DLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 9999987432 246899999999999999999999998 9999999999999999999999999986553221 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-----------------
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----------------- 612 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------------- 612 (665)
..++..|+|||++.....++.++||||||+++|||++|+.||..... ...+....+......
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 24578899999886445678899999999999999999999865321 111111111100000
Q ss_pred ---------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ---------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 012234467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.67 Aligned_cols=245 Identities=20% Similarity=0.240 Sum_probs=195.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch---hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA---DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|... +++.|++|++...... ......+.+|++++++++|+||+++++++.+....++||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM- 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence 56999999999999964 6889999999765433 233456778999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+|+|.+++... ...+++..++.++.||++||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 85 ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 88999999742 136899999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--------------- 612 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------------- 612 (665)
....+++.|+|||.+.+...++.++|||||||++|||++|.+||..... ...+...........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 2224577899999886556688999999999999999999887764321 111111111100000
Q ss_pred ----------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 ----------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 ----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112335678999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=301.25 Aligned_cols=244 Identities=19% Similarity=0.287 Sum_probs=194.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.|++|+++.........+.+.+|++++++++|+||+++++++..++..++|+||++++.
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 56999999999999865 57899999987655444556778999999999999999999999999999999999999877
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 549 (665)
+..+... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++....... ..
T Consensus 87 l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 87 LELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN-IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred HHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 7666542 345889999999999999999999999 9999999999999999999999999987655432 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-----------cc--------
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-----------RV-------- 610 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~-------- 610 (665)
..++..|+|||++.....++.++||||||+++|||++|+.||...... ..+....... ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 356788999999874447899999999999999999999998753211 0111000000 00
Q ss_pred --CC--------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 --DD--------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 --~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+. ......+..+.+++++||..+|++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 011123677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=283.35 Aligned_cols=253 Identities=19% Similarity=0.304 Sum_probs=205.8
Q ss_pred CHHHHHHHHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeE
Q 005999 385 SLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 385 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 462 (665)
.++|+.+-+.+.||+|+|+.|-.+. ..++..+|||++.+.. ...+..+.+|++++..+ .|+||+++++||+++...
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4678888899999999999999887 7789999999998764 35567788999999988 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc---eEEeeccc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE---ARLTDYCL 539 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~---~kl~Dfgl 539 (665)
|+|||-|.||+|..+|++ .+-+++.++-++.++|+.||.|||.++ |.||||||+|||-.+..+ +||+||.+
T Consensus 152 YLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kg-IAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKG-IAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcC-cccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999984 456899999999999999999999999 999999999999976543 89999987
Q ss_pred ccccC----------CCCCCCCCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-----CCc-
Q 005999 540 SVLSD----------SSSVEDPDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYL-----APP- 599 (665)
Q Consensus 540 ~~~~~----------~~~~~~~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~-----~~~- 599 (665)
..-+. +.-.+..|+..|||||+.. ....|+.++|.||+||++|-|++|.+||.+-.. +.+
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 63221 1113345788899999753 234689999999999999999999999975322 222
Q ss_pred -------cHHHHHHhhccCCC--chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 600 -------DMLEWVRTMRVDDG--REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 600 -------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+-+.++....+.+ .....+....+++...+..|+.+|.++.+++.
T Consensus 306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22333333333221 23455677889999999999999999999987
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=292.26 Aligned_cols=241 Identities=25% Similarity=0.400 Sum_probs=197.6
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|.. .++..+|+|.+..... ....+.+.+|+..+++++||||+++++++..+...++||||++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 45699999999999985 4688999999865433 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 88 ~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 88 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC-eecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 99999863 35789999999999999999999999 9999999999999999999999999986554322 12
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..++..|+|||.+. +...+.++|||||||++|||++|+.||.... .......+... .........+..+.+++.+|
T Consensus 161 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 161 FVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELH--PMKVLFLIPKN-NPPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred ccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccc--hHHHHHHHhcC-CCCCCCcccCHHHHHHHHHH
Confidence 34788899999986 5678889999999999999999999986522 11222222111 11122334567799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
++.+|++||++.++++.
T Consensus 237 l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 237 LNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCChhhCcCHHHHHhC
Confidence 99999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=293.62 Aligned_cols=243 Identities=19% Similarity=0.241 Sum_probs=189.9
Q ss_pred HhCcccceEEEEEEE-CCeEEEEEEEecCCCchh-hHHHHHHHH---HHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 396 LLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD-TSAEAFEQH---MEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
.||+|+||.||+|.. .+++.||+|.+....... .....+..| ...++...||||+++++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999985 468899999986543211 112223333 344555689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVE 549 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~ 549 (665)
+|+|.+++.. ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcC
Confidence 9999998863 346999999999999999999999999 999999999999999999999999998654322 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..|+..|+|||++..+..++.++||||+||++|||++|+.||.............. ........+...+..+.+++.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-hhccCCCCCCcCCHHHHHHHHHH
Confidence 46889999999987455688999999999999999999999976422221111111 11111222334567899999999
Q ss_pred ccCCCCCCC-----CHHHHHH
Q 005999 630 SLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RP-----t~~evl~ 645 (665)
+..+|++|| ++.|+++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHh
Confidence 999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.99 Aligned_cols=245 Identities=19% Similarity=0.237 Sum_probs=193.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 470 (665)
.+.||+|+||.||+|... ++..+++|.++...........+.+|+.++++++||||+++++++... ...++|+||+.
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 478999999999999965 578899999975543333344577899999999999999999998877 89999999997
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+ +|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~-~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 90 H-DLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNW-ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred c-CHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 5 999988742 236899999999999999999999999 9999999999999999999999999987654431
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--------------cC--
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--------------VD-- 611 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--------------~~-- 611 (665)
....+++.|+|||.+.+...++.++|+||+|+++|||++|+.||...... ........... ..
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 22346788999998874455789999999999999999999998753211 01110000000 00
Q ss_pred ------------CCchhh-hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 ------------DGREEN-RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 ------------~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...... .+..+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 001111 3567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.74 Aligned_cols=244 Identities=19% Similarity=0.292 Sum_probs=190.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++|+||+++++++.++...++||||+.+ +
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 57999999999999965 6789999998754322 2223467899999999999999999999999999999999985 9
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 89 L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07844 89 LKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRR-VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163 (291)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCHHHEEEcCCCCEEECccccccccCCCCcccccc
Confidence 99988742 236889999999999999999999999 999999999999999999999999998654321 1222
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD------------------- 611 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------------- 611 (665)
.++..|+|||++.+...++.++||||+|+++|||++|+.||.........+....+.....
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc
Confidence 4678899999886445688999999999999999999999965431111111111100000
Q ss_pred -----CC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 -----DG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 -----~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.. ........+.+++.+|++.+|++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.88 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=203.2
Q ss_pred cCHHHHHHHHHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEe---
Q 005999 384 YSLEQLMRASAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQA--- 458 (665)
Q Consensus 384 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 458 (665)
+.+.|-...+.++||-|-.|.|..... .+++.+|+|++... ...++|++.--+. .|||||+++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 334444444568999999999999874 47888999988543 3456777765544 79999999999865
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEE
Q 005999 459 -KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARL 534 (665)
Q Consensus 459 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl 534 (665)
..-..+|||.|+||.|+..+..+ ..+.+++.++-+|..||+.|+.|||+.+ |.||||||+|+|... |..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~n-IAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSMN-IAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhcc-hhhccCChhheeeecCCCCcceEe
Confidence 34667899999999999999864 4567999999999999999999999999 999999999999964 567999
Q ss_pred eecccccccCC--CCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--CccHHHHHHhhcc
Q 005999 535 TDYCLSVLSDS--SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA--PPDMLEWVRTMRV 610 (665)
Q Consensus 535 ~Dfgl~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~~~~~~ 610 (665)
+|||+++.... .-.+..-|+.|.|||++. ...|+..+|+||+||+||-|++|.+||...... ...+..-++....
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 99999987763 233445799999999986 667999999999999999999999999765443 2366666666555
Q ss_pred CCC--chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 DDG--REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
... .....++...++|+.+|..+|++|.|+.|++.
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 443 45567788999999999999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=294.59 Aligned_cols=241 Identities=19% Similarity=0.228 Sum_probs=189.2
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeC--CeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAK--GERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|.. .++..||+|+++....... .....+|+.++.++. |+|++++++++.++ +..++|+||+.
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 5699999999999985 4688999999876433222 223457888888884 99999999999987 88999999997
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--C
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--V 548 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~ 548 (665)
|+|.+.+... ...+++..++.++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||++....... .
T Consensus 84 -~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 84 -MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNG-IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred -ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 4888887642 246899999999999999999999999 999999999999999 999999999987654322 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc------------CC----
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV------------DD---- 612 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------~~---- 612 (665)
...++..|+|||++..+..++.++|||||||++|||++|+.||..... .+....+..... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 234788999999876556678999999999999999999999975321 111111111000 00
Q ss_pred C-----------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 G-----------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ~-----------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+++.+||+++|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 01234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.32 Aligned_cols=249 Identities=19% Similarity=0.269 Sum_probs=193.2
Q ss_pred hHhCcccceEEEEEEEC---CeEEEEEEEecCCC-chhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD---NHLIVTVKRFDANK-TADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 468 (665)
+.||+|+||.||+|... ++..||+|.+.... ......+.+.+|+.++++++||||+++++++.+. ...++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 56999999999999964 47899999997643 1123345678899999999999999999999988 789999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC----CCceEEeecccccccC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA----DFEARLTDYCLSVLSD 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~----~~~~kl~Dfgl~~~~~ 544 (665)
+.+ +|.+++..........+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~ 163 (316)
T cd07842 86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163 (316)
T ss_pred CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEEcCCCCccceEEECCCccccccC
Confidence 975 7877776443333347899999999999999999999999 999999999999999 8999999999987654
Q ss_pred CCCC------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--------cHHHHHHhhcc
Q 005999 545 SSSV------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--------DMLEWVRTMRV 610 (665)
Q Consensus 545 ~~~~------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--------~~~~~~~~~~~ 610 (665)
.... ...++..|+|||++.+...++.++|||||||++|||++|++||........ .+...+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (316)
T cd07842 164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243 (316)
T ss_pred CCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCC
Confidence 3221 224678899999887555688999999999999999999999975433220 11111110000
Q ss_pred -----------------------CCCch-----------hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 -----------------------DDGRE-----------ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 -----------------------~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..... ......+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 244 PTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred CchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 033456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=294.98 Aligned_cols=241 Identities=18% Similarity=0.232 Sum_probs=198.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||.|+||.||+|... ++..|++|.+....... ...+.+.+|++++++++||||+++++++.+....++|+||+.++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 57999999999999965 68899999997543322 34677899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~ 550 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 86 ~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 86 DLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99999874 246889999999999999999999999 999999999999999999999999998655433 2234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc-cCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||.+. ...++.++|+||||+++|+|++|+.||....... ......... .....+...+..+.+++.+|
T Consensus 160 ~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 160 SGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred CCChhhcCHHHHc-ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5788999999987 5668999999999999999999999998643221 111122222 22234455678899999999
Q ss_pred ccCCCCCCCCH--HHHH
Q 005999 630 SLKSPEQRPAM--WQVL 644 (665)
Q Consensus 630 l~~dP~~RPt~--~evl 644 (665)
|+.||.+||++ +|++
T Consensus 237 l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 237 LERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCChhHcCCccHHHHh
Confidence 99999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.13 Aligned_cols=246 Identities=19% Similarity=0.258 Sum_probs=195.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... .++.|++|.+...... ....+.+.+|+++++.++||||+++++.+..++..++||||++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 57999999999999854 5788999998755321 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS------ 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~------ 546 (665)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 87 ~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 87 DCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999974 245889999999999999999999999 999999999999999999999999987532100
Q ss_pred ------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-C
Q 005999 547 ------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-G 613 (665)
Q Consensus 547 ------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~ 613 (665)
.....++..|+|||.+. ...++.++|+|||||++|||++|+.||... ...++........... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcccCCCC
Confidence 01123677899999987 567899999999999999999999998642 1222222222111111 1
Q ss_pred chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 614 REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 614 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
.....+..+.+++.+|++.||++||++.++.+.|+.
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 122456779999999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.83 Aligned_cols=243 Identities=18% Similarity=0.227 Sum_probs=189.0
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHH-HhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEA-VGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|.. .+++.||+|.+...... ......+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999999999986 46789999998654321 1222334445444 4455999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..... .....
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~ 154 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRG-IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKKFV 154 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEeecccceeccc-cccCC
Confidence 999999974 245888999999999999999999999 99999999999999999999999999865443 22335
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc--CCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV--DDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~c 629 (665)
++..|+|||.+. +..++.++||||||+++|||++|..||.... .......+..... ........+..+.+++.+|
T Consensus 155 ~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 155 GTPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--PDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred CCcCccChhhhc-CCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 788999999987 4558999999999999999999999996532 1222222211111 1122334577899999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L 647 (665)
++.+|++||++.++.+.|
T Consensus 232 l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 232 LCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHccCCCcHHHHH
Confidence 999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.50 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=197.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..+++|++..... ..+.+.+|++.+++++|+|++++++++......++|+||+++++
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 67999999999999976 678899999976543 45678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 102 L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 102 LTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN-VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 999998531 36899999999999999999999999 9999999999999999999999999875543321 222
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh-hccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT-MRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++|||||||++|+|++|+.||.... .......+.. ...........+..+.+++.+|
T Consensus 177 ~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (286)
T cd06614 177 VGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREP--PLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC 253 (286)
T ss_pred cCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHH
Confidence 4678899999886 5678999999999999999999999986521 1111111111 1111112233567899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
++.+|.+||++.++++
T Consensus 254 l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 254 LVKDPEKRPSAEELLQ 269 (286)
T ss_pred hccChhhCcCHHHHhh
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=300.02 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=197.2
Q ss_pred hHhCcc--cceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRG--SIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..||+| +||+||++.. .+++.||+|.+..........+.+++|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356776 9999999986 4789999999876554444567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---C-
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---S- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~- 547 (665)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+........ .
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG-YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987532 235889999999999999999999999 999999999999999999999999754322111 0
Q ss_pred ------CCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc-----------
Q 005999 548 ------VEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR----------- 609 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~----------- 609 (665)
....++..|+|||++... ..++.++|||||||++|||++|+.||...... ...........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHhcCCCCCCccccccch
Confidence 011245679999998633 34789999999999999999999999753211 01111000000
Q ss_pred ---------------------------------cCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHhhh
Q 005999 610 ---------------------------------VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIKESV 654 (665)
Q Consensus 610 ---------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~ 654 (665)
.........+..+.+++++||+.||++|||+.|+++ .++.+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 000012234567899999999999999999999986 556666554
Q ss_pred cc
Q 005999 655 MA 656 (665)
Q Consensus 655 ~~ 656 (665)
..
T Consensus 319 ~~ 320 (328)
T cd08226 319 QG 320 (328)
T ss_pred cc
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=288.76 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=201.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 471 (665)
+.||+|++|.||+|... ++..|++|++..........+.+.+|++.+++++|+||+++++++... ...++++||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 57999999999999976 788999999877654445667889999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~-~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 86 GSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG-IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999998742 27899999999999999999999998 9999999999999999999999999987665432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc---cCCCchhhhHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR---VDDGREENRLGMLT 623 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~ 623 (665)
....++..|+|||.+. ....+.++||||||+++|+|++|+.||.... +......... .....+...+..+.
T Consensus 160 ~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 160 TGSVRGTPYWMAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred ccCCCCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHHhccccCCCcCCCcccCHHHH
Confidence 3345788999999986 5568999999999999999999999997643 1111111111 11223445577899
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~ 645 (665)
+++.+|++.+|++||++.|++.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhh
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.81 Aligned_cols=248 Identities=15% Similarity=0.199 Sum_probs=192.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCe-----EEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGE-----RLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-----~~lv~e 467 (665)
+.||+|+||.||+|... +++.||+|.+............+.+|+.+++++ +||||+++++++..... .++|||
T Consensus 7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 57999999999999964 688999999876543333446678899999999 56999999999887665 899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~ 546 (665)
|+++ +|.+++..........+++..++.++.||+.||+|||+.+ |+||||+|+||+++. ++.+||+|||++......
T Consensus 87 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~ 164 (295)
T cd07837 87 YLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP 164 (295)
T ss_pred ccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEecCCCeEEEeecccceecCCC
Confidence 9986 8999887543322456899999999999999999999999 999999999999998 889999999998654322
Q ss_pred C---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-----------
Q 005999 547 S---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----------- 612 (665)
Q Consensus 547 ~---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 612 (665)
. ....+++.|+|||++.+...++.++||||||+++|||++|..||..... ...............
T Consensus 165 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T cd07837 165 VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-LQQLLHIFKLLGTPTEQVWPGVSKLR 243 (295)
T ss_pred ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHhCCCChhhCcchhhcc
Confidence 1 2224678899999886555689999999999999999999999865211 111111111000000
Q ss_pred --------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||..||++||++.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 244 DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.95 Aligned_cols=239 Identities=20% Similarity=0.324 Sum_probs=194.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||++.. .++..+++|++..... ...+.+.+|+.++++++||||+++++++...++.++++||+++++
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 5799999999999985 4678899998864432 344568899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+....... ...
T Consensus 103 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 103 LTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG-VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred HHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9999863 35888999999999999999999999 9999999999999999999999999875443221 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-CchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-GREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++|||||||++|||++|+.||.... .......+....... ......+..+.+++.+|
T Consensus 176 ~~~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 176 VGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cCCccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 5788999999986 5668999999999999999999999986521 112222222211111 11223567899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|+.+|++||++.++++
T Consensus 253 l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 253 LVRDPAQRATAAELLN 268 (285)
T ss_pred cccChhhCcCHHHHcc
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=295.57 Aligned_cols=244 Identities=21% Similarity=0.288 Sum_probs=189.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .++..|++|++..... ......+.+|+++++.++|+||+++++++..++..++|+||+. ++
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 5699999999999985 4688999999865432 2233456789999999999999999999999999999999996 68
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++...... ....
T Consensus 89 l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07870 89 LAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH-ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163 (291)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence 87776532 235778888999999999999999999 999999999999999999999999998654322 1223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD------------------- 611 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------------- 611 (665)
.+++.|+|||++.+...++.++|||||||++|||++|+.||+........+.+.+......
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 4688999999986445578899999999999999999999975332111111111100000
Q ss_pred -----CC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 -----DG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 -----~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.. .....+..+.+++.+|+..||++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=285.63 Aligned_cols=241 Identities=26% Similarity=0.412 Sum_probs=199.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||++... ++..+++|++..... ...+.+.+|++++++++|+|++++++++..+...++++||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 56999999999999975 688899999976553 355678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VEDP 551 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~~ 551 (665)
|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+....... ....
T Consensus 84 L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 84 LKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNG-IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred HHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCC-EecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 99998742 256899999999999999999999988 9999999999999999999999999987765543 3445
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-CchhhhHHHHHHHHHHcc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-GREENRLGMLTEVASVCS 630 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl 630 (665)
++..|+|||.+. ...++.++||||||+++|+|++|+.||.... ............... ......+..+.+++.+|+
T Consensus 159 ~~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 159 GTPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELP--PMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred cCCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence 788999999987 4568899999999999999999999987531 111111121111111 122223677999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
+.||++|||+.|+++
T Consensus 236 ~~~p~~R~t~~~~l~ 250 (253)
T cd05122 236 QKNPEKRPTAEQLLK 250 (253)
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.82 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=193.9
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHh--CCCCCCeeeeeEEEEeC----CeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG--GLSHPNLVPIRAYFQAK----GERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~----~~~~lv~e 467 (665)
.+.||+|.||.||+|.+. |+.||||+|.... ++.+.+|.++.+ .|+|+||+.+++.-..+ .+.++|++
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 467999999999999997 4589999996543 344556666664 45999999999875432 27899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-------CCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-------ASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-------~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
|.+.|+|+|+|.. ..++....++++..+|.||+|||. ++.|.|||||+.|||+..++..-|+|+|+|
T Consensus 290 YHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred cccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999973 568899999999999999999996 235999999999999999999999999999
Q ss_pred cccCCC-------CCCCCCCCcccCCccccCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 005999 541 VLSDSS-------SVEDPDTVAYKAPEIRKSSRR-----ATSKSDVYAFGVLLLELLTG----------KHPSQHPYLAP 598 (665)
Q Consensus 541 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~-----~~~k~DvwSlGvvl~elltg----------~~P~~~~~~~~ 598 (665)
...+.. ....+||.+|||||++...-. .-..+||||||.|+||+... +.||.+....+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 655433 244579999999999863221 12468999999999999752 46777665555
Q ss_pred ccHHHHHHh-----hccCCC---chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 599 PDMLEWVRT-----MRVDDG---REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 599 ~~~~~~~~~-----~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
+.+.++.+. .++..+ ........+.++++.||..+|.-|-|+-.+.+.|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 555554322 222222 234556779999999999999999999999999988875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.09 Aligned_cols=242 Identities=21% Similarity=0.334 Sum_probs=195.0
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++.. .++..|++|.+..... ...+.+.+|+.++++++||||+++++++......++|+||++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 36799999999999985 4677899999864432 33467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... ..
T Consensus 102 ~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g-i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 102 SLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-EeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99999863 24788899999999999999999999 9999999999999999999999999876543322 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+++.|+|||++. ...++.++|||||||++||+++|+.||....... .+.................+..+.+++.+|
T Consensus 175 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccCChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-heeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 34788899999986 5678899999999999999999999997532111 111111111111112334456799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|..+|++||++.+++..
T Consensus 253 l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 253 LEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=289.65 Aligned_cols=234 Identities=22% Similarity=0.247 Sum_probs=187.2
Q ss_pred hCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhC-CCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG-LSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||+|+||.||++.. .++..+++|.+........ |+..... .+||||+++++++..++..++||||+++|+|
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 96 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL 96 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcH
Confidence 69999999999985 4678899999865432111 1111111 2799999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCCCCCCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSSSVEDPDT 553 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~~gt 553 (665)
.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||++....... ...++
T Consensus 97 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 169 (267)
T PHA03390 97 FDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN-IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-CYDGT 169 (267)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-cCCCC
Confidence 9999742 37899999999999999999999999 99999999999999988 99999999987665432 23578
Q ss_pred CcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCC
Q 005999 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKS 633 (665)
Q Consensus 554 ~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 633 (665)
..|+|||++. +..++.++||||||+++|||++|+.||........+...+..............+..+.+++.+||+.+
T Consensus 170 ~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 248 (267)
T PHA03390 170 LDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYN 248 (267)
T ss_pred CcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccC
Confidence 9999999987 567899999999999999999999999854333323333333332222334456778999999999999
Q ss_pred CCCCCC-HHHHHH
Q 005999 634 PEQRPA-MWQVLK 645 (665)
Q Consensus 634 P~~RPt-~~evl~ 645 (665)
|.+||+ ++|+++
T Consensus 249 p~~R~~~~~~~l~ 261 (267)
T PHA03390 249 INYRLTNYNEIIK 261 (267)
T ss_pred hhhCCchHHHHhc
Confidence 999996 688874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.13 Aligned_cols=243 Identities=19% Similarity=0.311 Sum_probs=194.9
Q ss_pred hCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||+|+||.||++... +++.+++|.+..... .....+.+.+|++++++++||||+++++.+..+...++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 488999999865432 123456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-------
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS------- 547 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~------- 547 (665)
.+++... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999742 36899999999999999999999999 9999999999999999999999999986543221
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....++..|+|||... ....+.++||||||+++||+++|+.||.... .......+.............+..+.
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKIEWPEDVEVSDEAI 231 (265)
T ss_pred cccccCcccCccccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCcCCCccccCCHHHH
Confidence 1224678899999987 4558889999999999999999999986532 22222222221111111112367899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
+++.+|++.+|++|||+.++.+.|+
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHhc
Confidence 9999999999999999966555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.07 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=195.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||++... ++..+|+|.+..........+.+.+|++++++++|+||+++++.+..+...++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 56999999999999964 57889999986654333445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCCC---CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~---~~ 549 (665)
|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++ .+||+|||.+....... ..
T Consensus 86 L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (257)
T cd08225 86 LMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161 (257)
T ss_pred HHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccc
Confidence 99998743 2335799999999999999999999999 99999999999999885 46999999986654322 12
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVAS 627 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 627 (665)
..+++.|+|||+.. ...++.++||||||+++|||++|+.||.... ..+++....... ......+..+.+++.
T Consensus 162 ~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 162 CVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred cCCCccccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence 34788999999886 5568899999999999999999999986531 112222111111 122344567999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~ 646 (665)
+|+..+|++|||+.|+++.
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 236 QLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=298.07 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=190.3
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.+|.|+++.||++.. ++..||+|++..........+.+.+|++++++++|+||+++++++.+++..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34556666666666554 68899999997664444566789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC------
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS------ 547 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~------ 547 (665)
|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++|||.+.......
T Consensus 86 l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~-ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKG-FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999753 2345888999999999999999999999 9999999999999999999999999875442211
Q ss_pred ----CCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc------------
Q 005999 548 ----VEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV------------ 610 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------ 610 (665)
....++..|+|||++... ..++.++|||||||++|||++|+.||...... ....+.+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCccccccCchhhhc
Confidence 122357789999998632 35788999999999999999999999753211 111111110000
Q ss_pred -------------------CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 -------------------DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 -------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...........+.+++.+||..||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00011223456889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=284.48 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=199.2
Q ss_pred HhHhCcccceEEEEEEEC---C--eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD---N--HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 467 (665)
...||+|.||.||+|.-. + ...+|+|+++..+.........-+|+..++.++|||++.+..+|.+ +..+++++|
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd 108 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD 108 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence 467999999999999632 2 3378999998876554555567789999999999999999999877 888999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC----CceEEeeccccccc
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD----FEARLTDYCLSVLS 543 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~----~~~kl~Dfgl~~~~ 543 (665)
|.+. +|++.|+-.+..+...++...+..|+.||+.|+.|||++. |+||||||.|||+..+ |.|||+|||+++..
T Consensus 109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~ 186 (438)
T KOG0666|consen 109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-VLHRDLKPANILVMGDGPERGRVKIADLGLARLF 186 (438)
T ss_pred hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-eeeccCCcceEEEeccCCccCeeEeecccHHHHh
Confidence 9988 9999998777666788999999999999999999999998 9999999999999877 89999999999877
Q ss_pred CCCCC------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC-----C---ccHHHHHHhhc
Q 005999 544 DSSSV------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA-----P---PDMLEWVRTMR 609 (665)
Q Consensus 544 ~~~~~------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~-----~---~~~~~~~~~~~ 609 (665)
...-. ..+-|..|+|||.+.+...||.+.|||+.||++.||+|.++-|...... + .++......+.
T Consensus 187 ~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG 266 (438)
T KOG0666|consen 187 NNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLG 266 (438)
T ss_pred hccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcC
Confidence 65432 2245889999999998889999999999999999999988877642211 0 01111111111
Q ss_pred cCCC-------------------------c---------hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 610 VDDG-------------------------R---------EENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 610 ~~~~-------------------------~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+.+ . ....+....+++.++|..||.+|.|+++.++.
T Consensus 267 ~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 267 TPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred CCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1110 0 00112336789999999999999999998874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=292.81 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=194.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... ++..+++|++..........+.+.+|++++++++|+|++++++++.+. +..++|+||+++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 56899999999999865 588999999987653334456788999999999999999999999988 899999999975
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 85 -~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~-~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 85 -DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG-ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred -cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 899888642 246899999999999999999999999 9999999999999999999999999987665432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc------------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR------------------ 609 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~------------------ 609 (665)
....++..|+|||.+.+...++.++||||||+++|||++|+.||..... .+....+....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2234678899999876445678999999999999999999999875321 11111111100
Q ss_pred ---cCCC--------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 610 ---VDDG--------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 610 ---~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.... ....++..+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000 00112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=294.15 Aligned_cols=245 Identities=18% Similarity=0.254 Sum_probs=191.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... +++.|++|.+..........+.+.+|++++++++||||+++++++.++...++||||+. ++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 86 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD 86 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence 56899999999999864 68899999986654333445678889999999999999999999999999999999996 58
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccCCCC---CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
|.+++... ....+++..+..++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||++....... ..
T Consensus 87 l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (294)
T PLN00009 87 LKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (294)
T ss_pred HHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCcceEEEECCCCEEEEcccccccccCCCcccccc
Confidence 88887543 2234678888899999999999999999 999999999999985 5679999999986543221 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC------------------
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD------------------ 611 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------------ 611 (665)
..+++.|+|||++.+...++.++||||+||++|+|+||+.||..... ...+.........+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T PLN00009 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-IDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241 (294)
T ss_pred CceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence 35678999999887555688999999999999999999999975311 11111111100000
Q ss_pred -----C---CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 -----D---GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 -----~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. ......+..+.+++.+|++.+|++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011234567889999999999999999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.92 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=194.8
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCC-chhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANK-TADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
..+.||+|+||.||+|... ++..+++|.+.... ......+.+.+|+++++.++|+|++++++++......++|+||+.
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence 3467999999999999954 67889999886432 222345567889999999999999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED 550 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 550 (665)
|++.+++... ...+++.++..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++...... ...
T Consensus 99 -~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~~~ 171 (308)
T cd06634 99 -GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NXF 171 (308)
T ss_pred -CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHhEEECCCCcEEECCcccceeecCc-ccc
Confidence 5888877532 345889999999999999999999999 999999999999999999999999998765433 233
Q ss_pred CCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 551 ~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
.++..|+|||++.. ...++.++|||||||++|||++|+.||..... .......... ..........+..+.+++.+
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQN-ESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-HHHHHHHhhc-CCCCcCcccccHHHHHHHHH
Confidence 57889999998742 34578899999999999999999999865311 1111111111 11111233556779999999
Q ss_pred cccCCCCCCCCHHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L 647 (665)
||+.+|++||++.++++.-
T Consensus 250 cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HhhCCcccCCCHHHHhhCc
Confidence 9999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.61 Aligned_cols=241 Identities=27% Similarity=0.415 Sum_probs=200.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|++|.||++... ++..|++|.+......+...+.+.+|++++++++|+|++++++++.+....++++||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 367999999999999854 6788999999776554456678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC---C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---E 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---~ 549 (665)
+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||.+........ .
T Consensus 85 ~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 85 SLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG-VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred cHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 999998742 56899999999999999999999999 99999999999999999999999999876654332 2
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 628 (665)
..++..|+|||... +..++.++||||+|+++|+|++|+.||.... ......... ......+...+..+.+++.+
T Consensus 159 ~~~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 159 VVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIVQDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 35788999999986 4558899999999999999999999987532 111111111 11112344556789999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
|+..+|++|||+.|++.
T Consensus 234 ~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 234 CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCChhhCcCHHHHhc
Confidence 99999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=296.71 Aligned_cols=244 Identities=21% Similarity=0.289 Sum_probs=191.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|+++...........+.+|+.++++++|+||+++++++.+. +..++||||+.+
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC
Confidence 56999999999999964 688999999875543333334567899999999999999999998765 468999999975
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 548 (665)
+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....... .
T Consensus 93 -~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 166 (309)
T cd07845 93 -DLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166 (309)
T ss_pred -CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccceeeecCCccCCCC
Confidence 898888742 256899999999999999999999999 9999999999999999999999999987654321 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc------------------
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV------------------ 610 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~------------------ 610 (665)
...++..|+|||.+.+...++.++||||+||++|||++|+.||.... ..+....+.....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred cccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 22357789999998755668899999999999999999999997532 1111111111000
Q ss_pred ---CCC-------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 ---DDG-------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 ---~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
... .....+..+.+++.+|++.||++|||+.|++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 001135668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=333.63 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=205.1
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..+||.|.||.||.|. .++|+..|+|-+............+.+|+.++..++|||+|+++|+-.+++..++.||||.+|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4689999999999998 778999999998877665556677889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.+.+.. +...++.....+..|++.|++|||+.+ ||||||||.||+++.+|.+|++|||.|........
T Consensus 1320 sLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~g-IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEHG-IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhcC-ceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 99999973 344666667778899999999999999 99999999999999999999999999977665431
Q ss_pred ---CCCCCCcccCCccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 549 ---EDPDTVAYKAPEIRKSSR--RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 549 ---~~~gt~~y~aPE~~~~~~--~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
...||+.|||||++.+.. ....++||||+|||+.||+||+.||..... +-.+..-+. .......++..+.+=.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIMy~V~-~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIMYHVA-AGHKPQIPERLSSEGR 1471 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHHhHHh-ccCCCCCchhhhHhHH
Confidence 235899999999987532 355689999999999999999999986321 112222222 2233345666778889
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
+|+..|+..||++|-++.|+++ ....+...+
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle---~~f~~~~~d 1502 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLE---HAFGKSCTD 1502 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHH---hhccccccc
Confidence 9999999999999977765544 334444443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=288.53 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=201.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||++.. .+++.+++|.+............+.+|++++++++|+||+++++++.+....++|+||+++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 5799999999999984 467889999987655444556678889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-CCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-VEDPD 552 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~g 552 (665)
|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++....... ....+
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~-i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 163 (256)
T cd08530 86 LSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK-ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG 163 (256)
T ss_pred HHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccC
Confidence 999987532 22456899999999999999999999999 9999999999999999999999999987665432 22357
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
+..|+|||.+. +..++.++|+||+|+++|||++|+.||.... ...+...+...... ......+..+.+++.+|++.
T Consensus 164 ~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 164 TPHYMAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARS--MQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred CccccCHHHHC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCC
Confidence 88999999986 5678889999999999999999999997532 22233332222211 22335667899999999999
Q ss_pred CCCCCCCHHHHHH
Q 005999 633 SPEQRPAMWQVLK 645 (665)
Q Consensus 633 dP~~RPt~~evl~ 645 (665)
+|++||++.|+++
T Consensus 240 ~p~~Rp~~~~~l~ 252 (256)
T cd08530 240 KPKLRPNCDKILA 252 (256)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=295.35 Aligned_cols=240 Identities=19% Similarity=0.245 Sum_probs=196.9
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
++||+|+||.||-.+ ..+|+.+|.|++.+....+ .......+|-.++.+++.+.||.+-..|+..+..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 579999999999988 4578999999886543222 23445678889999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~ 550 (665)
+|.-+|... ...-+++..+..++.+|+.||++||+.. ||.|||||+|||+|++|+++|+|.|+|..+... ....
T Consensus 271 DLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~~~-iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~r 346 (591)
T KOG0986|consen 271 DLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHRRR-IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGR 346 (591)
T ss_pred ceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHhcc-eeeccCChhheeeccCCCeEeeccceEEecCCCCccccc
Confidence 999888753 2356999999999999999999999999 999999999999999999999999999877654 3445
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
+||.+|||||++. +..|+...|+||+||++|||+.|+.||........ ++...+. ..+...++..+.+...+.+.
T Consensus 347 vGT~GYMAPEvl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~~~~ey~~kFS~eakslc~~ 423 (591)
T KOG0986|consen 347 VGTVGYMAPEVLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--EDPEEYSDKFSEEAKSLCEG 423 (591)
T ss_pred cCcccccCHHHHc-CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--cchhhcccccCHHHHHHHHH
Confidence 8999999999998 55699999999999999999999999975321111 2222221 12223456667789999999
Q ss_pred cccCCCCCCCCHH
Q 005999 629 CSLKSPEQRPAMW 641 (665)
Q Consensus 629 cl~~dP~~RPt~~ 641 (665)
.|++||++|...+
T Consensus 424 LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 424 LLTKDPEKRLGCR 436 (591)
T ss_pred HHccCHHHhccCC
Confidence 9999999996544
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=293.29 Aligned_cols=245 Identities=14% Similarity=0.172 Sum_probs=178.8
Q ss_pred hHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhH---------HHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-
Q 005999 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTS---------AEAFEQHMEAVGGLSHPNLVPIRAYFQAKG- 460 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 460 (665)
+.||+|+||.||+|...+ +..+++|........... ......+...+..++|+|++++++++....
T Consensus 18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 97 (294)
T PHA02882 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC 97 (294)
T ss_pred eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence 679999999999999654 345666654322211100 011223344566789999999998765543
Q ss_pred ---eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeec
Q 005999 461 ---ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY 537 (665)
Q Consensus 461 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Df 537 (665)
..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 98 ~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 98 RMYYRFILLEKLVE-NTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred CceEEEEEEehhcc-CHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCcEEEEEc
Confidence 34677787644 67666653 223567888999999999999999999 999999999999999999999999
Q ss_pred ccccccCCC----------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccH----HH
Q 005999 538 CLSVLSDSS----------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDM----LE 603 (665)
Q Consensus 538 gl~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~----~~ 603 (665)
|++...... .....||+.|+|||+.. +..++.++|||||||++|||++|+.||.......... .+
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 998654211 11235899999999887 6778999999999999999999999998642221111 11
Q ss_pred HHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 604 WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
++.............+..+.+++..|+..+|++||++.++++.|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 250 FIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 22222222222344567899999999999999999999999876
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=294.68 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=191.8
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC----------eE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG----------ER 462 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~ 462 (665)
.+.||+|+||.||+|... +++.|++|+++.....+.....+.+|++++++++||||+++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 467999999999999965 5789999999765443344566788999999999999999999987654 78
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
++|+||+++ ++.+.+... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 92 ~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred EEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCcEEeCccccccc
Confidence 999999986 777777632 346899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCC----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------
Q 005999 543 SDSSS----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------ 612 (665)
Q Consensus 543 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------ 612 (665)
..... ....++..|+|||.+.....++.++|||||||++|||++|++||.... ..+....+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhhcc
Confidence 54322 112357789999988645567899999999999999999999997532 111111111110000
Q ss_pred ----------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ----------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ----------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||+.||++||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011134677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.74 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=194.3
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|.. .++..|++|++..... .....+.+.+|++++++++|||++++++++.++...++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 45699999999999985 4688999999865432 22344568889999999999999999999999999999999996
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|++.+++.. ....+++.+++.++.||+.|++|||+.+ ++|+||+|+||++++++.+||+|||++...... ....
T Consensus 105 ~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-~~~~ 178 (313)
T cd06633 105 GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-NSFV 178 (313)
T ss_pred CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChhhEEECCCCCEEEeecCCCcccCCC-CCcc
Confidence 588887763 2346899999999999999999999999 999999999999999999999999998654322 2345
Q ss_pred CCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
++..|+|||++.. ...++.++|||||||++|||++|+.||.... .....................+..+.+++.+|
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 7889999998742 3568889999999999999999999986532 11111112111111122334456799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|+.+|++||++.+++..
T Consensus 257 l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 257 LQKIPQERPASAELLRH 273 (313)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.17 Aligned_cols=240 Identities=20% Similarity=0.313 Sum_probs=196.0
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
...||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 36799999999999986 4788999999864432 34567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++.. ..+++.....++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++....... ..
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g-ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 99998752 34788999999999999999999999 9999999999999999999999999876543321 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-CchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-GREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 628 (665)
..++..|+|||++. ...++.++||||+|+++|||++|+.||... ...+....+....... ......+..+.+++.+
T Consensus 176 ~~~~~~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 176 LVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred cccCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence 34788999999886 566789999999999999999999998652 1122222222222111 1223456678999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
||+.+|.+||++.++++
T Consensus 253 ~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 253 LLVRDPAQRATAAELLK 269 (292)
T ss_pred HHhCCcccCcCHHHHhc
Confidence 99999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=291.20 Aligned_cols=245 Identities=19% Similarity=0.304 Sum_probs=193.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... ++..||+|++..... ....+.+.+|++++++++|+||+++++++.+.+..++||||+++ +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 57999999999999964 688999999876543 22345677899999999999999999999999999999999985 8
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... ...
T Consensus 84 l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (284)
T cd07836 84 LKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR-VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE 160 (284)
T ss_pred HHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence 998886432 2346899999999999999999999999 9999999999999999999999999986543321 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC---------------CC--
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD---------------DG-- 613 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------------~~-- 613 (665)
.++..|++||++.....++.++|||||||++|||++|+.||...... .......+..... ..
T Consensus 161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 46888999998865556788999999999999999999999764321 1111111100000 00
Q ss_pred ---------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 ---------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+++.+|++.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01233567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.96 Aligned_cols=245 Identities=23% Similarity=0.314 Sum_probs=192.2
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe----CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA----KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|.. .++..|++|++..........+.+.+|+.++++++||||+++++++.. ....++|+||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 5699999999999985 468899999987654333445677889999999999999999998753 34689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
. |+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 91 ~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 91 E-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred h-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 6 589998863 345899999999999999999999999 9999999999999999999999999986543221
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-------------c---------
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-------------D--------- 600 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-------------~--------- 600 (665)
....++..|+|||++.....++.++|||||||++|||++|+.||........ .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 1235788999999986556689999999999999999999999965321100 0
Q ss_pred HHHHHHhhccCCCc-----hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 601 MLEWVRTMRVDDGR-----EENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 601 ~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.............. ....+..+.+++.+|++.+|++||++.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00011111101010 12346779999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.16 Aligned_cols=243 Identities=18% Similarity=0.205 Sum_probs=190.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhh------------HHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADT------------SAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG 460 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 460 (665)
.+.||+|+||.||+|... +++.||+|.+........ ....+.+|++++++++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999854 688999999865432210 0124678999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~-i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHeEECCCCCEEECCccce
Confidence 9999999997 599999863 345889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCC-----------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 005999 541 VLSDSS-----------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 541 ~~~~~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 603 (665)
...... .....++..|+|||++.+...++.++|||||||++|||++|+.||..... .+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~~~ 244 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE--IDQLG 244 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 655411 11123577899999987545678999999999999999999999975321 11111
Q ss_pred HHHhhccCC--------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 604 WVRTMRVDD--------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 604 ~~~~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+....... ......+..+.+++.+|++.+|++||++.|++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111100000 001123567889999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=293.98 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=190.1
Q ss_pred HHhHhCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 393 SAELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
..+.||+|+||.||+|..++ +..||||.++..... .....+..|+.++.+. .|+||+++++++.++...+++|||+.
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 34789999999999999764 889999999765432 2344556677766666 59999999999999999999999985
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+ ++.+++... ...+++..+..++.|++.||+|||+. + |+||||+|+||++++++.+||+|||++.......
T Consensus 98 ~-~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~-i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 98 T-CLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred c-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC-EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 4 787776532 24689999999999999999999984 6 9999999999999999999999999986654322
Q ss_pred CCCCCCCcccCCccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH-HhhccCCCchhhhHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSS---RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV-RTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~---~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 623 (665)
....++..|+|||++... ..++.++||||||+++|||++|+.||...... .+....+ .............+..+.
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 223467889999998632 23788999999999999999999998652211 1121111 111111111223567899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+++.+||+.||++||++.++++.
T Consensus 251 ~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 251 SFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.24 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=191.4
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC--CeEEEEEEe
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK--GERLVIYDY 468 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~lv~e~ 468 (665)
..+.||+|+||.||+|... ++..+++|++............+.+|+.+++++ +||||+++++++... ...++||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 3477999999999999965 688999999865433334455677899999999 999999999998653 368999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+.+ +|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~-~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~-i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 91 MET-DLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGN-VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 974 99998863 26788899999999999999999999 9999999999999999999999999986553321
Q ss_pred -------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh------------
Q 005999 548 -------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM------------ 608 (665)
Q Consensus 548 -------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~------------ 608 (665)
....++..|+|||.+.....++.++||||||+++|||++|+.||....... .........
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHH
Confidence 122478899999987655668899999999999999999999986432110 000000000
Q ss_pred -----------ccCC-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 609 -----------RVDD-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 609 -----------~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.... ......+..+.+++.+|++.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 0111246678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.29 Aligned_cols=243 Identities=19% Similarity=0.276 Sum_probs=187.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC--------eEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG--------ERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~lv 465 (665)
+.||+|+||.||+|... ++..||+|.+............+.+|++++++++||||+++++++...+ ..++|
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 57999999999999964 6889999998655433333445678999999999999999999987644 45999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+.+ +|.+++... ...+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 98 ~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 98 FEFCEH-DLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNK-ILHRDMKAANILITKDGILKLADFGLARAFSL 171 (310)
T ss_pred EcCCCc-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence 999975 888887642 235899999999999999999999999 99999999999999999999999999865533
Q ss_pred CC-------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc--------
Q 005999 546 SS-------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-------- 610 (665)
Q Consensus 546 ~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------- 610 (665)
.. ....++..|+|||.+.....++.++||||||+++|||++|+.||..... ......+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred CcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChhhcc
Confidence 21 1224678899999886445578899999999999999999999865321 111111111100
Q ss_pred -------------CCCc---------hhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 -------------DDGR---------EENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 -------------~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.... .......+.+++.+||..||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 0012345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.13 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=211.6
Q ss_pred HhHhCcccceEEEEEEEC--------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEE
Q 005999 394 AELLGRGSIGTTYKAVLD--------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 464 (665)
.+.||+|.||.|++|... ....||||.++..... ...+.+..|+++|+.+ +|+||+.++|+|..++..++
T Consensus 301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred cceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence 358999999999999842 2568999999877765 6678899999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 465 IYDYQPNGSLFNLIHGSR---------SIRAK--PLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
|+||+..|+|.++++..+ ..... .++....+.++.|||.|++||++.+ ++||||..+|||+.++..+|
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-CVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-ccchhhhhhhEEecCCCEEE
Confidence 999999999999998766 11112 3889999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCCCCC----CC--CCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHH
Q 005999 534 LTDYCLSVLSDSSSVED----PD--TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVR 606 (665)
Q Consensus 534 l~Dfgl~~~~~~~~~~~----~g--t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 606 (665)
|+|||+++......... .+ ...|||||.+. ...|+.|+|||||||+||||+| |..||.+. ....++.++++
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-~~~~~l~~~l~ 536 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-DRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-PPTEELLEFLK 536 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhc-cCcccccchhhHHHHHHHHHhhCCCCCCCCC-CcHHHHHHHHh
Confidence 99999998654433221 22 34699999998 5889999999999999999998 77888652 11335555555
Q ss_pred hhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 607 TMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 607 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
..... ..+..+..++.++++.||+.+|++||++.|+++.++....
T Consensus 537 ~G~r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 537 EGNRM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 44332 3566778889999999999999999999999999998644
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=289.44 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=193.5
Q ss_pred hHhCcccceEEEEEEE----CCeEEEEEEEecCCCch--hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTA--DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 467 (665)
+.||+|+||.||++.. .++..||+|++...... ....+.+.+|++++.++ +|+||+++++++..+...++|+|
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 5799999999999985 36889999998654321 13346678899999999 69999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 86 YINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999874 245788899999999999999999999 9999999999999999999999999987654322
Q ss_pred ----CCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGM 621 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 621 (665)
....++..|+|||++... ..++.++||||||+++|+|++|+.||..... ............. ....+...+..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPYPQEMSAL 238 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccCCCCCccCCHH
Confidence 123478899999987632 3467899999999999999999999864221 1122222222111 11223445677
Q ss_pred HHHHHHHcccCCCCCCC-----CHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RP-----t~~evl~ 645 (665)
+.+++.+|++.||++|| ++.+++.
T Consensus 239 ~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 99999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=282.10 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=202.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||++... ++..+++|++..........+.+.+|++++++++|+|++++++.+......++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 56999999999999965 68899999997765544566778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++..... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 86 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 163 (258)
T cd08215 86 LSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK-ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV 163 (258)
T ss_pred HHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHHeEEcCCCcEEECCccceeecccCcceecce
Confidence 9999975321 2467999999999999999999999998 9999999999999999999999999986654432 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+++.|+|||... ...++.++||||+|+++|+|++|+.||.... ..++........ ....+...+..+.+++.+||
T Consensus 164 ~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 164 VGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--LLELALKILKGQ-YPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred eeeecccChhHhc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCc--HHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 5788899999876 5668899999999999999999999986532 222222222111 11233356678999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
..+|++|||+.|+++
T Consensus 240 ~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 240 QKDPEERPSIAQILQ 254 (258)
T ss_pred CCChhhCcCHHHHhc
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.96 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=196.6
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-----CeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-----GERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 468 (665)
+.||+|+||+||+|.. .++..||+|.+............+.+|+.+++.++|+||+++++++... ...++|+||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 5799999999999985 4688999999876433334455677899999999999999999988654 357999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-- 546 (665)
+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 91 MD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred CC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 96 689998863 346899999999999999999999999 999999999999999999999999998765433
Q ss_pred -CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC----------------------ccHHH
Q 005999 547 -SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP----------------------PDMLE 603 (665)
Q Consensus 547 -~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~----------------------~~~~~ 603 (665)
.....++..|+|||.+.....++.++|||||||++|+|++|+.||....... .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 1223578899999987644568899999999999999999999996532100 00111
Q ss_pred HHHhhccCCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHhhh
Q 005999 604 WVRTMRVDDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQEIKESV 654 (665)
Q Consensus 604 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~~ 654 (665)
+++....... .....+..+.+++.+||+.+|++|||+.|+++. ++.+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 1111100000 112345678999999999999999999999986 66654443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=283.27 Aligned_cols=242 Identities=19% Similarity=0.298 Sum_probs=192.5
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCC---chhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANK---TADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 467 (665)
.+.||+|+||.||+|.. .++..|++|.+.... ......+.+.+|++++++++|+||+++++++.+. +..++++|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 36799999999999985 468899999875432 1223456788999999999999999999998764 46889999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 546 (665)
|+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 87 YMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred eCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999999873 234788999999999999999999999 999999999999999999999999998654321
Q ss_pred -----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 547 -----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 547 -----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
.....++..|+|||++. +..++.++|||||||++|||++|+.||.... ....+.+ +.........+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~-~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYE-AMAAIFK-IATQPTKPMLPDGVSDA 237 (264)
T ss_pred ccCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccC-HHHHHHH-HHcCCCCCCCCcccCHH
Confidence 11234788999999987 5668899999999999999999999997531 1111111 11111112235566778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++.+|+. +|..||++.+++.
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhc
Confidence 9999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.87 Aligned_cols=241 Identities=17% Similarity=0.236 Sum_probs=189.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 467 (665)
+.||+|+||.||+|.. .++..||+|.+..........+.+.+|+.++++++|+||++++++|... ...++|||
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 101 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence 5799999999999985 4788999999865443334456677899999999999999999998643 35799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.+ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 102 LMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred ccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 9965 88888752 2788899999999999999999999 9999999999999999999999999997665432
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc---------------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV--------------- 610 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------------- 610 (665)
....++..|+|||.+. +..++.++|||||||++|+|++|+.||...... ......+.....
T Consensus 173 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 173 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 2234788999999987 677899999999999999999999998653210 000000000000
Q ss_pred ---CC----------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 ---DD----------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 ---~~----------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0011235568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=292.91 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=192.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... ++..||+|++..........+.+.+|++++++++||||++++++|.. ....++++||+ ++
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~ 94 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence 67999999999999854 78899999986544333445678889999999999999999999876 55788999998 56
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+|.++++. ..+++.....++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||.+...........+
T Consensus 95 ~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~-iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 167 (328)
T cd07856 95 DLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG-VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS 167 (328)
T ss_pred CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCcc
Confidence 89988763 34788888899999999999999999 999999999999999999999999998766554444467
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-------------cH---------HHHHHhhcc
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-------------DM---------LEWVRTMRV 610 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-------------~~---------~~~~~~~~~ 610 (665)
+..|+|||.+.+...++.++|||||||++|||++|+.||........ +. .........
T Consensus 168 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (328)
T cd07856 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPK 247 (328)
T ss_pred cccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccc
Confidence 88999999876446789999999999999999999999965321000 00 000000000
Q ss_pred CCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 DDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 ~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
... .....+..+.+++.+|++.+|++||++.+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 248 REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 012345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.99 Aligned_cols=248 Identities=19% Similarity=0.304 Sum_probs=191.6
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-----CeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-----GERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 468 (665)
+.||+|+||.||+|.. .++..||+|++..... ......+.+|+.++++++|+||+++++++... ...++|+||
T Consensus 11 ~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 6799999999999985 4688999999864322 23456678899999999999999999987654 357999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+.+ +|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 90 MET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred ccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 975 88887752 45899999999999999999999999 9999999999999999999999999986543321
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH----------------
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR---------------- 606 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~---------------- 606 (665)
....++..|+|||.+.....++.++||||+||++|||++|+.||...... .....+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhch
Confidence 12347889999998764556889999999999999999999999653110 00100000
Q ss_pred -------hhccCCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHh
Q 005999 607 -------TMRVDDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQEIKE 652 (665)
Q Consensus 607 -------~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 652 (665)
....... .....+..+.+++.+||+.||++|||+.|+++. ++....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000 011235668899999999999999999999986 555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.68 Aligned_cols=250 Identities=19% Similarity=0.234 Sum_probs=180.1
Q ss_pred HhHhCcccceEEEEEEECC--eEEEEEEEe---------------cCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE
Q 005999 394 AELLGRGSIGTTYKAVLDN--HLIVTVKRF---------------DANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~---------------~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 456 (665)
.+.||+|+||+||++.... +..+++|.+ +...........+.+|++++++++||||+++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 4679999999999987432 222222211 00111123345688999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEee
Q 005999 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTD 536 (665)
Q Consensus 457 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~D 536 (665)
...+..++|+|++. ++|.+++...............+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-IiHrDLKP~NILl~~~~~vkL~D 310 (501)
T PHA03210 233 RSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIVLGD 310 (501)
T ss_pred EECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999985 47888775432211223445667789999999999999999 99999999999999999999999
Q ss_pred cccccccCCCC----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCCCC-ccHHHHHHhhcc
Q 005999 537 YCLSVLSDSSS----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP-SQHPYLAP-PDMLEWVRTMRV 610 (665)
Q Consensus 537 fgl~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P-~~~~~~~~-~~~~~~~~~~~~ 610 (665)
||++....... ....||..|+|||++. +..++.++|||||||++|||++|..+ +....... .++.+.+.....
T Consensus 311 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~ 389 (501)
T PHA03210 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSV 389 (501)
T ss_pred CCCceecCcccccccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhccc
Confidence 99997654322 2235899999999987 56789999999999999999998754 43221111 122222221110
Q ss_pred CC------------------------C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 DD------------------------G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 ~~------------------------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. . .....+..+.+++.+||+.||++|||+.|++..
T Consensus 390 ~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 390 CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 0 001123456778999999999999999999873
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.47 Aligned_cols=249 Identities=20% Similarity=0.242 Sum_probs=195.7
Q ss_pred hHhCcccceEEEEEEE----CCeEEEEEEEecCCCch--hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTA--DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 467 (665)
+.||+|+||.||++.. .++..||||.++..... ....+.+.+|++++.++ +||||+++++.+..+...++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 5799999999999874 35678999998754321 23345688999999999 69999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~-~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 86 YVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred cCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999863 245888999999999999999999998 9999999999999999999999999986543322
Q ss_pred C----CCCCCCcccCCccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHH
Q 005999 548 V----EDPDTVAYKAPEIRKSSR-RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGM 621 (665)
Q Consensus 548 ~----~~~gt~~y~aPE~~~~~~-~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 621 (665)
. ...++..|+|||...... ..+.++||||||+++|||++|+.||...... ............ ....+...+..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPKTMSAE 238 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccCCCCCcccCHH
Confidence 1 124788999999876322 3688999999999999999999998642211 111222222111 11233345667
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
+.+++.+||+.||++|||+.++.+.|+..
T Consensus 239 l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 239 ARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 89999999999999999998887776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=280.33 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=193.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHH-hCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAV-GGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..||.|.||+|+|-.+ +.|+..|||++..... +.+.+.+..|.+.. +.-+.||||+++|.+..++..++.||.|+-
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 5799999999999884 5799999999987765 34455666777654 445889999999999999999999999954
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~ 550 (665)
+|..+.+.-.......+++...-+|+.-...||.||-+.-+|||||+||+|||+|..|.+||||||++....++ .+..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~d 227 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVD 227 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhc
Confidence 77665543333345668888888888889999999988666999999999999999999999999998554332 2334
Q ss_pred CCCCcccCCccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC----Cc---hhhhHHHH
Q 005999 551 PDTVAYKAPEIRKSSRR-ATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----GR---EENRLGML 622 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~-~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~l 622 (665)
.|...|||||.+..... |+.++||||+|++|||+.||+.||..... +.+.+....... .. ..+.+..+
T Consensus 228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 68888999999875444 99999999999999999999999876432 222222222211 12 23466789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
..++..|+.+|-..||.+.++.+.
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhcC
Confidence 999999999999999999998763
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.77 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=195.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------eEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------ERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 467 (665)
+.||+|+||.||++.. .++..||+|++..........+.+.+|++++++++||||+++++++..+. ..++|||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 5699999999999984 47889999998654433445567889999999999999999999987643 4589999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g-i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 101 FM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred cC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 98 7799988752 35889999999999999999999999 9999999999999999999999999997765554
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH-----------hhccC-----
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR-----------TMRVD----- 611 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~-----------~~~~~----- 611 (665)
....+++.|+|||++.....++.++|+||+||++|++++|+.||...... ........ .....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07880 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251 (343)
T ss_pred cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhhcchhHHHH
Confidence 44567889999999874456889999999999999999999999753210 01111000 00000
Q ss_pred -------C-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHh
Q 005999 612 -------D-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIKE 652 (665)
Q Consensus 612 -------~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 652 (665)
. ......+..+.+++.+|++.||++|||+.+++. .++....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 011234556889999999999999999999994 4555433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.39 Aligned_cols=242 Identities=18% Similarity=0.304 Sum_probs=203.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
..||+|.|+.|..|.. .++..||||.+++........+.+.+|+++|..++|||||+++.+.......|+||||+.+|.
T Consensus 62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge 141 (596)
T KOG0586|consen 62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGE 141 (596)
T ss_pred eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCch
Confidence 5799999999999984 578899999999887776777779999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VEDP 551 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~~ 551 (665)
+++++.. ...+.+.....+..|+..|++|||++. |+|||||++||||+.+..+||+|||++....... .+..
T Consensus 142 ~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~-ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~c 215 (596)
T KOG0586|consen 142 LFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKN-IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFC 215 (596)
T ss_pred hHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcc-eeccccchhhcccccccceeeeccccceeecccccccccC
Confidence 9999984 344555778889999999999999999 9999999999999999999999999998776543 3456
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
|++.|.|||++.+..+..+++|+||+|+++|-|+.|..||+..... .+.+-+..... ..+........+++++++-
T Consensus 216 gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--~Lr~rvl~gk~--rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 216 GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--ELRPRVLRGKY--RIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred CCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--cccchheeeee--cccceeechhHHHHHHhhc
Confidence 8999999999986666789999999999999999999999864321 11111111111 1233344567889999999
Q ss_pred CCCCCCCCHHHHHHH
Q 005999 632 KSPEQRPAMWQVLKM 646 (665)
Q Consensus 632 ~dP~~RPt~~evl~~ 646 (665)
.+|.+|++++++.+.
T Consensus 292 l~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKD 306 (596)
T ss_pred cCccccCCHHHhhhh
Confidence 999999999999763
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=286.77 Aligned_cols=244 Identities=21% Similarity=0.315 Sum_probs=195.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||++.. .+++.+++|++............+.+|++++++++|+||+++++++..+...++|+||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 5699999999999985 4788999999876654444567788999999999999999999999999999999999976 8
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 84 l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 84 LYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG-ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred HHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCC-eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 88888642 256899999999999999999999999 9999999999999999999999999986664432 123
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD------------------- 611 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------------------- 611 (665)
.++..|+|||.+.....++.++||||+|+++|+|++|+.||...... ..+..........
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 46788999999874447899999999999999999999998653210 0111111100000
Q ss_pred -C-------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 -D-------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 -~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. ......+..+.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 011234567999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=316.57 Aligned_cols=242 Identities=21% Similarity=0.341 Sum_probs=185.4
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-------------
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------------- 459 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------------- 459 (665)
.++||+||||.|||++.+ ||+.||||++.... .......+.+|+..+.+|+|||||+++..|.+.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~ 562 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD 562 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence 368999999999999954 89999999998776 456667788999999999999999998765110
Q ss_pred --------------------------------------------------------------------------------
Q 005999 460 -------------------------------------------------------------------------------- 459 (665)
Q Consensus 460 -------------------------------------------------------------------------------- 459 (665)
T Consensus 563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~ 642 (1351)
T KOG1035|consen 563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL 642 (1351)
T ss_pred hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence
Q ss_pred --------------------------CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005999 460 --------------------------GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513 (665)
Q Consensus 460 --------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ 513 (665)
-..|+-||||+.-.+.++++...... .....|+++.+|++||+|+|+++
T Consensus 643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~g- 717 (1351)
T KOG1035|consen 643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQG- 717 (1351)
T ss_pred CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhCc-
Confidence 01257789998877777776422110 35667899999999999999999
Q ss_pred eeccCCCCCceEeCCCCceEEeecccccccC---------------------CCCCCCCCCCcccCCccccCCC--CCCC
Q 005999 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSD---------------------SSSVEDPDTVAYKAPEIRKSSR--RATS 570 (665)
Q Consensus 514 iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~--~~~~ 570 (665)
||||||||.||++|+++.|||+|||++.... ...+..+||.-|+|||++.... .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999996511 0112335899999999987555 6999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 571 k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
|+|+||+|||++||+. ||... .+........+....+.+ +.......=.++|++++++||.+|||+.|+++
T Consensus 798 KiDmYSLGIVlFEM~y---PF~Ts-MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTS-MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCch-HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999997 66542 122233333333322222 23344445678999999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=286.22 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=192.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|++|+||+|... +++.|++|++...... .......+|+..+++++ |+|++++++++..++..++||||+ +|
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 56999999999999965 5788999998654332 22334457899999998 999999999999999999999999 78
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG-FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9999887432 346899999999999999999999999 9999999999999999999999999987665432 233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH------------hh------c---
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR------------TM------R--- 609 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~------------~~------~--- 609 (665)
.++..|+|||++.....++.++|+||||++++||++|+.||...... ........ .. .
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI-DQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH-HHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 57889999998865666899999999999999999999998653211 01100000 00 0
Q ss_pred ---cCC---CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 610 ---VDD---GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 610 ---~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
... ......+..+.+++++|++.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 001122467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.36 Aligned_cols=248 Identities=18% Similarity=0.266 Sum_probs=193.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 467 (665)
+.||+|+||.||+|.. .+++.||+|++......+.....+.+|++++++++||||+++++++... ...++|+|
T Consensus 21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 5799999999999995 4688999999876543334455678999999999999999999998754 35689999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.. +|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~ 171 (342)
T cd07879 101 YMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG-IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171 (342)
T ss_pred cccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC
Confidence 9965 7777643 34888999999999999999999999 9999999999999999999999999987665444
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-------------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM------------------- 608 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~------------------- 608 (665)
....++..|+|||++.....++.++|||||||++|||++|+.||...... ..+...+...
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07879 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEFVQKLEDKAAKSY 250 (342)
T ss_pred CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence 44457888999999874456889999999999999999999999753210 0111100000
Q ss_pred ----ccC--CC---chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHh
Q 005999 609 ----RVD--DG---REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQEIKE 652 (665)
Q Consensus 609 ----~~~--~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 652 (665)
... .. .....+..+.+++.+||+.||++||++.|++.. ++.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 00 011234568899999999999999999999954 766654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=284.40 Aligned_cols=244 Identities=16% Similarity=0.239 Sum_probs=189.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC---CCCCeeeeeEEEEeCCe-----EEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL---SHPNLVPIRAYFQAKGE-----RLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----~~lv 465 (665)
+.||+|+||.||+|... ++..+|+|++............+.+|+.+++++ +|+|++++++++...+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 56899999999999976 488999999975544333345566777766555 69999999999988776 8999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+.+ +|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+.....
T Consensus 85 ~e~~~~-~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~-i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 85 FEHVDQ-DLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred ehhccc-CHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999975 8999887432 235899999999999999999999999 99999999999999999999999999876643
Q ss_pred CC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-----------
Q 005999 546 SS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----------- 612 (665)
Q Consensus 546 ~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 612 (665)
.. ....++..|+|||++. +..++.++|||||||++|||++|++||..... ...+...........
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CcccccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCCcccc
Confidence 32 2234688899999987 56788999999999999999999999875321 111111111110000
Q ss_pred -------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||+.||++||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 001133466789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=280.23 Aligned_cols=235 Identities=24% Similarity=0.300 Sum_probs=193.9
Q ss_pred hCcccceEEEEEEEC-CeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 397 LGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
||+|+||.||++... +++.+++|.+....... ...+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 58899999987654322 2456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVEDP 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~ 551 (665)
.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~-~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 999974 235899999999999999999999998 999999999999999999999999998765443 23345
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
++..|+|||... +...+.++|+||||+++||+++|+.||.... .......+.. .....+...+..+.+++.+|+.
T Consensus 155 ~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~ 229 (250)
T cd05123 155 GTPEYLAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--RKEIYEKILK--DPLRFPEFLSPEARDLISGLLQ 229 (250)
T ss_pred CCccccChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhc
Confidence 788999999886 5568889999999999999999999996532 1222222222 1222344456789999999999
Q ss_pred CCCCCCCCHHH
Q 005999 632 KSPEQRPAMWQ 642 (665)
Q Consensus 632 ~dP~~RPt~~e 642 (665)
.||++||++.+
T Consensus 230 ~~p~~R~~~~~ 240 (250)
T cd05123 230 KDPTKRLGSGG 240 (250)
T ss_pred CCHhhCCCccc
Confidence 99999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=293.22 Aligned_cols=243 Identities=20% Similarity=0.257 Sum_probs=190.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 467 (665)
+.||+|+||.||+|.. .++..||+|++..........+.+.+|++++++++||||+++++++... ...+++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 5699999999999984 5788999999976543334456688899999999999999999988643 34677777
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
++ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 103 ~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 174 (345)
T cd07877 103 LM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 174 (345)
T ss_pred hc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEcCCCCEEEecccccccccccc
Confidence 76 7799888752 34899999999999999999999999 9999999999999999999999999987765554
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc------------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR------------------ 609 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~------------------ 609 (665)
....++..|+|||.+.....++.++|||||||++|||++|+.||...... ..+....+...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (345)
T cd07877 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISSESARNY 253 (345)
T ss_pred cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhhcccHhHHHH
Confidence 45567899999998764456888999999999999999999998642210 11111110000
Q ss_pred -----cCC-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 610 -----VDD-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 610 -----~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
... ......+..+.+++.+|++.||++||++.+++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 254 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0011234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=293.40 Aligned_cols=252 Identities=20% Similarity=0.289 Sum_probs=198.9
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-----eEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG-----ERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 467 (665)
.+.||+|+||.||+|... ++..+++|++..........+.+.+|+++++.++|+||+++++++.... ..+++||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 357999999999999965 5889999998765443455677889999999999999999999988765 7899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.+ +|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~-~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~g-i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 85 LMET-DLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSAN-VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred chhh-hHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9985 89998873 237899999999999999999999999 9999999999999999999999999987665432
Q ss_pred ------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC----------------------c
Q 005999 548 ------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP----------------------P 599 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~----------------------~ 599 (665)
....++..|+|||++.+...++.++||||||+++|+|++|+.||....... .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 223468889999998744478999999999999999999999997532100 0
Q ss_pred cHHHHHHhhccCCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHh
Q 005999 600 DMLEWVRTMRVDDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQEIKE 652 (665)
Q Consensus 600 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 652 (665)
....++........ .....+..+.+++.+||+.+|++||++.+++.. ++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00111110000000 012245678999999999999999999999984 665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.07 Aligned_cols=241 Identities=20% Similarity=0.272 Sum_probs=192.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe------EEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE------RLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e 467 (665)
+.||+|++|.||+|... ++..||+|++..........+.+.+|+.++++++|+||+++++++...+. .++|+|
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 57999999999999965 67889999987654333445667789999999999999999998866554 899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 101 ~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (343)
T cd07851 101 LM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172 (343)
T ss_pred cC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEccccccccccccc
Confidence 98 6699999863 45899999999999999999999999 9999999999999999999999999997765554
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-----------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV----------------- 610 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----------------- 610 (665)
....++..|+|||.+.....++.++|||||||++||+++|+.||..... ......+.....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence 4556788999999876445678999999999999999999999965321 111111111000
Q ss_pred -------CC--C---chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 -------DD--G---REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 -------~~--~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.. . .....+..+.+++.+|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0 01123567999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=274.63 Aligned_cols=234 Identities=18% Similarity=0.261 Sum_probs=195.1
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhh-HHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADT-SAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.++||+|.||.|.+++ ..+++.+|+|++++...... ....-..|-++|...+||.+..+-..|+..++.++||||..|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 3789999999999998 45799999999987755332 334456788999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC---CCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD---SSSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~---~~~~ 548 (665)
|.|+-++.. ...+++.....+-..|+.||.|||+++ |+.||||.+|.|+|.||++||+|||+++..- ....
T Consensus 253 GeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~-ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k 326 (516)
T KOG0690|consen 253 GELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRN-IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK 326 (516)
T ss_pred ceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCC-eeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence 999998874 455888888889999999999999999 9999999999999999999999999996432 2234
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
+-.|||.|+|||++. ...|..++|+|.+||+||||++|+.||... +...+-+.+.. .+..++.....+...++..
T Consensus 327 TFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~--ed~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILM--EDLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred cccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHh--hhccCCccCCHHHHHHHHH
Confidence 446999999999998 678999999999999999999999999762 33344443321 2223455666778899999
Q ss_pred cccCCCCCCC
Q 005999 629 CSLKSPEQRP 638 (665)
Q Consensus 629 cl~~dP~~RP 638 (665)
.|.+||.+|.
T Consensus 402 LL~kdP~kRL 411 (516)
T KOG0690|consen 402 LLKKDPKKRL 411 (516)
T ss_pred HhhcChHhhc
Confidence 9999999994
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=288.27 Aligned_cols=244 Identities=19% Similarity=0.251 Sum_probs=186.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC--------eEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG--------ERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~lv 465 (665)
+.||+|+||.||+|... +++.+++|++............+.+|++++++++||||+++++++.+.. ..++|
T Consensus 14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv 93 (311)
T cd07866 14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV 93 (311)
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence 56999999999999954 6788999998655433333445678999999999999999999875433 46899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
+||+.+ +|.+.+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 94 ~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 167 (311)
T cd07866 94 TPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENH-ILHRDIKAANILIDNQGILKIADFGLARPYDG 167 (311)
T ss_pred EecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECcCccchhccC
Confidence 999875 78777763 2346899999999999999999999999 99999999999999999999999999865432
Q ss_pred CCC--------------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-
Q 005999 546 SSV--------------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV- 610 (665)
Q Consensus 546 ~~~--------------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~- 610 (665)
... ...+++.|+|||++.+...++.++|||||||++|||++|++||...... ............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~~~~~~ 246 (311)
T cd07866 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFKLCGTP 246 (311)
T ss_pred CCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 211 1135778999998765556889999999999999999999998653211 011110000000
Q ss_pred --------------C-----CC-------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 --------------D-----DG-------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 --------------~-----~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .. ........+.+++.+|++.||++|||+.|++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00 00122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=284.70 Aligned_cols=240 Identities=22% Similarity=0.352 Sum_probs=195.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... ++..|++|++..... .....+.+.+|++++.+++ |+||+++++++..++..++||||+.+
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 56999999999999964 788999999875332 2233467888999999998 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC---
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV--- 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~--- 548 (665)
++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 87 ~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~-~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 87 GELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999974 236999999999999999999999999 99999999999999999999999999865443221
Q ss_pred --------------------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh
Q 005999 549 --------------------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM 608 (665)
Q Consensus 549 --------------------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 608 (665)
...++..|+|||... ...++.++||||||++++++++|+.||.... .......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~-- 235 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLTFQKIL-- 235 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHH--
Confidence 113578899999876 5668899999999999999999999997642 111111111
Q ss_pred ccCCCchhhhHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 005999 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAM----WQVLK 645 (665)
Q Consensus 609 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~ 645 (665)
......+...+..+.+++.+||+.+|++||++ .|+++
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11222344556789999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.26 Aligned_cols=243 Identities=22% Similarity=0.255 Sum_probs=187.1
Q ss_pred hHhCcccceEEEEEEEC-C--eEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC----CeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-N--HLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK----GERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~lv~ 466 (665)
+.||+|+||.||++... . +..||+|++..........+.+.+|++++.++ +||||+++++++... ...++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 57999999999999954 3 67899999875443334456778899999999 599999999875432 4577888
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 86 e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 86 ELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSAN-VLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred eccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 8886 599998863 346899999999999999999999999 999999999999999999999999998654322
Q ss_pred C-------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH--------------
Q 005999 547 S-------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV-------------- 605 (665)
Q Consensus 547 ~-------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-------------- 605 (665)
. ....++..|+|||++.+...++.++||||+||++|+|++|+.||...... ..+...+
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHHhh
Confidence 1 12357889999998765556899999999999999999999998753210 0000000
Q ss_pred ---------HhhccCC-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 606 ---------RTMRVDD-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 606 ---------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
....... ......+..+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 011123567999999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.46 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=195.7
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------eEEEEEE
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------ERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 467 (665)
+.||+|+||.||+|+ ..+|+.||||.+..... ....+...+|+++|++++|+|||++++.-++.. ...+|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 579999999999999 67899999999977542 345677889999999999999999999865433 5689999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC--CCCc--eEEeeccccccc
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG--ADFE--ARLTDYCLSVLS 543 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~--~~~~--~kl~Dfgl~~~~ 543 (665)
||.||||+..+..-. ...-+++.+.+.++.+++.||.|||+++ |+||||||.||++- ++|+ -||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~-IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG-IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999997432 3445999999999999999999999998 99999999999984 4443 699999999988
Q ss_pred CCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCC-------
Q 005999 544 DSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDD------- 612 (665)
Q Consensus 544 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~------- 612 (665)
++.. ...+||..|++||+....+.|+..+|.|||||++||+.||..||........ ++...+....+..
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 7754 3346999999999987447889999999999999999999999976433221 1111111111111
Q ss_pred ------------Cc----hhhhHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHHHh
Q 005999 613 ------------GR----EENRLGMLTEVASVCSLKSPEQRP--AMWQVLKMIQEIKE 652 (665)
Q Consensus 613 ------------~~----~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L~~~~~ 652 (665)
+. .......+.+.+..++.-+|++|- ...+....+..+.+
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00 111223466777788888888887 66666665555544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=281.15 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=194.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||+|... +++.+++|.+......+...+.+.+|++++++++|+|++++++++.+.+..++|+||+. ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 56999999999999965 58899999997665333445677889999999999999999999999999999999998 49
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..++.++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||.+....... ...
T Consensus 84 l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 84 LKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHR-ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 99999743 146899999999999999999999999 9999999999999999999999999987654322 122
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc---------------CC---
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV---------------DD--- 612 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---------------~~--- 612 (665)
.++..|+|||++.....++.++|||||||++|||++|+.||...... ..+......... ..
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 35678999999874447899999999999999999999998653210 011000000000 00
Q ss_pred --------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||..||++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 001122567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=287.83 Aligned_cols=242 Identities=20% Similarity=0.296 Sum_probs=206.0
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|.||+||-|. .++|+.||||++.+..........+++|+.+|.+++||.||.+...|+..+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 6789999999999998 46899999999998877767778899999999999999999999999999999999999966
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC---CceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD---FEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~-- 547 (665)
+..+.|-.. +...+++.....++.||+.||.|||.++ |+|+||||+|||+... -++||||||+++.+.+..
T Consensus 648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn-IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN-IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc-eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 666655432 4567888888889999999999999999 9999999999999754 479999999999987754
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh--hccCCCchhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT--MRVDDGREENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l 625 (665)
+..+||+.|+|||++. .+.|...-|+||.||++|--++|..||.+ +.++-+.++. +..+.....+......++
T Consensus 724 rsVVGTPAYLaPEVLr-nkGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLR-NKGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred hhhcCCccccCHHHHh-hccccccccceeeeEEEEEEecccccCCC----ccchhHHhhccccccCCCchhhcCHHHHHH
Confidence 4457999999999998 78899999999999999999999999975 3344444443 233344566777888999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
|...|+..-.+|-+..+.+.
T Consensus 799 In~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHHHHhcchHhhcc
Confidence 99999999999999887643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=278.40 Aligned_cols=244 Identities=21% Similarity=0.269 Sum_probs=189.3
Q ss_pred hHhCcccceEEEEEEECC-eEEEEEEEecCCC---chhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDN-HLIVTVKRFDANK---TADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||++.... +..+++|.++... ........+..|+.++++++||||+++++++.+....++|+||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 579999999999998543 3445555554322 122334456788999999999999999999999889999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++.......
T Consensus 86 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~ 162 (260)
T cd08222 86 GRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR-ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLA 162 (260)
T ss_pred CCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC-ccccCCChhheEeec-CCEeecccCceeecCCCcccc
Confidence 9999998864322 3456899999999999999999999999 999999999999975 569999999986653322
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
....++..|+|||... +..++.++|+||||+++|+|++|..||.... .......+.. ......+...+..+.+++.
T Consensus 163 ~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 163 TTFTGTPYYMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--FLSVVLRIVE-GPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred cCCCCCcCccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHc-CCCCCCcchhcHHHHHHHH
Confidence 2234788999999886 5668889999999999999999999986421 1111111111 1111223456678999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~ 645 (665)
+|++.+|++||++.|+++
T Consensus 239 ~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 239 SMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHhcCChhhCcCHHHHhh
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=275.54 Aligned_cols=220 Identities=18% Similarity=0.207 Sum_probs=177.3
Q ss_pred ccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHH
Q 005999 400 GSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI 478 (665)
Q Consensus 400 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 478 (665)
|.+|.||++.. .+++.+|+|++.... .+.+|...+....||||+++++++.+....++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999985 578899999986543 1233444455567999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCCCCcccC
Q 005999 479 HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKA 558 (665)
Q Consensus 479 ~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~a 558 (665)
... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+...........++..|+|
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a 150 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALHREG-IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence 642 35899999999999999999999999 999999999999999999999999988666554444456778999
Q ss_pred CccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCC
Q 005999 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRP 638 (665)
Q Consensus 559 PE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 638 (665)
||... ...++.++||||+|+++|||++|+.|+...... . .. ......+...+..+.+++.+|++.||++||
T Consensus 151 PE~~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~----~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 151 PEVGG-ISEETEACDWWSLGAILFELLTGKTLVECHPSG---I----NT-HTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CcccC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---c----cc-ccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 99886 566889999999999999999999887532110 0 00 000112234566789999999999999999
Q ss_pred CHH
Q 005999 639 AMW 641 (665)
Q Consensus 639 t~~ 641 (665)
++.
T Consensus 222 ~~~ 224 (237)
T cd05576 222 GAG 224 (237)
T ss_pred CCC
Confidence 973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.99 Aligned_cols=245 Identities=18% Similarity=0.258 Sum_probs=197.8
Q ss_pred HHHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 392 ASAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
...++||+|+||.|..++.+ +++.||+|++.+....+ ....-|+.|-++|.--+.+.|++++..|+++.+.|+|||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 34588999999999999964 68899999998753322 23456888999998888999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+||+|..++.. ...+++..+..++..|+.||.-+|+.| +|||||||.|||||..|++||+|||.+..++...
T Consensus 158 pGGDlltLlSk-----~~~~pE~~ArFY~aEiVlAldslH~mg-yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 158 PGGDLLTLLSK-----FDRLPEDWARFYTAEIVLALDSLHSMG-YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred cCchHHHHHhh-----cCCChHHHHHHHHHHHHHHHHHHHhcc-ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999974 237899999999999999999999999 9999999999999999999999999997776432
Q ss_pred --CCCCCCCcccCCccccC---C-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCC--CCccHHHHHHhhccCCCchhhhH
Q 005999 548 --VEDPDTVAYKAPEIRKS---S-RRATSKSDVYAFGVLLLELLTGKHPSQHPYL--APPDMLEWVRTMRVDDGREENRL 619 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~---~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 619 (665)
...+|||.|.+||++.. + +.|.+.+|+||+||++|||+.|..||..... .++.+......+..+ .....+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~VS 309 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETDVS 309 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccccC
Confidence 34579999999998763 3 5689999999999999999999999975311 111222211112222 123467
Q ss_pred HHHHHHHHHcccCCCCCCCC---HHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPA---MWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt---~~evl~ 645 (665)
....+||.+.+. +|+.|.. +.++-.
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 789999999887 6888988 777754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=287.30 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=185.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--------------
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-------------- 459 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------------- 459 (665)
+.||+|+||.||+|.. .++..|++|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 5699999999999985 4688999999865543 3456688899999999999999999876553
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC-CCCceEEeecc
Q 005999 460 GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG-ADFEARLTDYC 538 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~-~~~~~kl~Dfg 538 (665)
...++|+||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++ +++.+|++|||
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g-ivH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 499888752 35889999999999999999999999 99999999999998 45678999999
Q ss_pred cccccCCCC------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh----
Q 005999 539 LSVLSDSSS------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM---- 608 (665)
Q Consensus 539 l~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~---- 608 (665)
.+....... ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 239 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILESVPVVR 239 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 986543221 12246788999998765566889999999999999999999999653210 0111000000
Q ss_pred ------------------ccCC-C----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 609 ------------------RVDD-G----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 609 ------------------~~~~-~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.... . .....+..+.+++.+|++.||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0 01134466889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=242.99 Aligned_cols=246 Identities=17% Similarity=0.260 Sum_probs=196.3
Q ss_pred HHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 393 SAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..++||+|.||+|++|+ .++++.||+|+++.....+.......+|+-+++.++|.|||++++....++..-+|+|||..
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 34789999999999999 66799999999988777666666778999999999999999999999999999999999976
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---V 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~ 548 (665)
+|..+.... .+.++.+.+..++.|+++||.|+|+.+ +.|||+||+|.||+.+|+.|++|||+++..+-+- .
T Consensus 86 -dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshn-vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 86 -DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHN-VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred -HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhh-hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 898888753 456888999999999999999999999 9999999999999999999999999997665432 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCC-C-------------
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDD-G------------- 613 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~-~------------- 613 (665)
..+-|..|++|.++.+.+-|+...|+||-||++.|+.. |++.|.+. ..+.++....+.+.... +
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 23568999999999877889999999999999999986 44445432 22233333333322211 0
Q ss_pred -----c---h----hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 -----R---E----ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 -----~---~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. . ......=++++++.+.-+|.+|.++++.++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 011112356888888889999999998775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=287.96 Aligned_cols=232 Identities=20% Similarity=0.236 Sum_probs=189.3
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..+|.|+|+.|-.+. ..+++..++|++..... +-.+|+.++... +||||+++.+.+.+..+.|+|||++.|+
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 349999999999887 45788899999976632 123456555555 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe-CCCCceEEeecccccccCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL-GADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill-~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
-+.+.+... .... ..+.+|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.+...........
T Consensus 402 ell~ri~~~-----~~~~-~e~~~w~~~lv~Av~~LH~~g-vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~ 474 (612)
T KOG0603|consen 402 ELLRRIRSK-----PEFC-SEASQWAAELVSAVDYLHEQG-VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPA 474 (612)
T ss_pred HHHHHHHhc-----chhH-HHHHHHHHHHHHHHHHHHhcC-eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccc
Confidence 998887632 2222 667789999999999999999 9999999999999 6889999999999988776644556
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
-|..|.|||+.. ...|++++||||||++||+|++|+.||...-.. .++... .......+..+...++|+..||+
T Consensus 475 ~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~----i~~~~~s~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 475 LTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR----IQMPKFSECVSDEAKDLLQQLLQ 548 (612)
T ss_pred hhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh----hcCCccccccCHHHHHHHHHhcc
Confidence 688999999997 788999999999999999999999999763211 122222 22223346778889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 005999 632 KSPEQRPAMWQVLK 645 (665)
Q Consensus 632 ~dP~~RPt~~evl~ 645 (665)
.||.+||+|.++..
T Consensus 549 ~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 549 VDPALRLGADEIGA 562 (612)
T ss_pred CChhhCcChhhhcc
Confidence 99999999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=273.96 Aligned_cols=260 Identities=24% Similarity=0.313 Sum_probs=201.4
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhH-----HHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTS-----AEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 466 (665)
..+||+|||+.||+|. +...+.||||+-...+.-... .+...+|.++-+.|+||.||++|+||.- .+..+-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 5689999999999998 667888999987655432221 2345679999999999999999999975 45678899
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeC---CCCceEEeecccccc
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLG---ADFEARLTDYCLSVL 542 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~---~~~~~kl~Dfgl~~~ 542 (665)
|||+|.+|.-+++. .+.++++++..|+.||+.||.||.+. .||||-||||.|||+. ..|.+||+|||+++.
T Consensus 548 EYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 99999999999984 45689999999999999999999884 4799999999999995 457899999999999
Q ss_pred cCCCCCC----------CCCCCcccCCccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc
Q 005999 543 SDSSSVE----------DPDTVAYKAPEIRKSS---RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR 609 (665)
Q Consensus 543 ~~~~~~~----------~~gt~~y~aPE~~~~~---~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 609 (665)
+++.... ..||.+|++||++.-+ ...+.|+||||.||++|.++.|+.||.+... ..++.+.-.-+.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdILqeNTIlk 701 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDILQENTILK 701 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHHHhhhchhc
Confidence 8775533 2479999999987643 3578899999999999999999999987422 223333222111
Q ss_pred cC---CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH---HHHHHHhhhcccCc
Q 005999 610 VD---DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK---MIQEIKESVMAEDN 659 (665)
Q Consensus 610 ~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~---~L~~~~~~~~~~~~ 659 (665)
.. .+.......+...||++||+.--++|.+..++.. .|-.++.++.....
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~ 757 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSP 757 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCC
Confidence 11 1233445667889999999999999999888865 33344555544433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=303.41 Aligned_cols=141 Identities=23% Similarity=0.357 Sum_probs=125.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|+.++..++||||+++++++......++||||+.++
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~ 89 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG 89 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence 57999999999999965 688999999875432 2234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccc
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV 541 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~ 541 (665)
+|.++++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~g-IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 90 DVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHG-IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999974 235788899999999999999999998 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=263.61 Aligned_cols=236 Identities=25% Similarity=0.357 Sum_probs=193.7
Q ss_pred cceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHh
Q 005999 401 SIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIH 479 (665)
Q Consensus 401 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 479 (665)
+||.||+|... +++.+++|++........ .+.+.+|++.+++++|+|++++++++......++++||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999976 488999999976554222 6789999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCCCCCCccc
Q 005999 480 GSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVEDPDTVAYK 557 (665)
Q Consensus 480 ~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~~gt~~y~ 557 (665)
.. ..+++..++.++.+++.++.|||+.+ ++|+||+|+||++++++.++++|||.+...... .....++..|+
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHSNG-IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 42 22889999999999999999999998 999999999999999999999999999776553 23345788999
Q ss_pred CCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchh-hhHHHHHHHHHHcccCCCCC
Q 005999 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREE-NRLGMLTEVASVCSLKSPEQ 636 (665)
Q Consensus 558 aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~ 636 (665)
+||... ...++.++||||||++++++++|..||.... ......+............. ..+..+.+++.+|+..+|++
T Consensus 154 ~pE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 231 (244)
T smart00220 154 APEVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEK 231 (244)
T ss_pred CHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchh
Confidence 999886 5678889999999999999999999986531 12233333332222211111 16678999999999999999
Q ss_pred CCCHHHHHH
Q 005999 637 RPAMWQVLK 645 (665)
Q Consensus 637 RPt~~evl~ 645 (665)
||++.++++
T Consensus 232 Rp~~~~~~~ 240 (244)
T smart00220 232 RLTAEEALQ 240 (244)
T ss_pred ccCHHHHhh
Confidence 999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=286.25 Aligned_cols=240 Identities=24% Similarity=0.381 Sum_probs=199.7
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEe-----CCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQA-----KGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e 467 (665)
+.+|.|.+|.||++. .++++.+|+|++..... ..++++.|.++++.+ +|||++.++|+|.- +++.++|||
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 569999999999999 67888999999987764 345667788888877 89999999999853 568999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 546 (665)
||.+|+..|++++.. +..+.|..+..|+..++.|+.+||... ++|||||-.|||++.++.||++|||.+...+..
T Consensus 102 fC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk-viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred ccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc-eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 999999999998653 678999999999999999999999988 999999999999999999999999999766553
Q ss_pred --CCCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---Cchhh
Q 005999 547 --SVEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREEN 617 (665)
Q Consensus 547 --~~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 617 (665)
..+..||+.|||||++.- ...|+.++|+||+|++..||--|.+|+.+.+ -+...+...+.+. ..++.
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH----PmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH----PMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc----hhhhhccCCCCCCccccchhh
Confidence 234579999999999763 2347789999999999999999999987643 2222222111111 13567
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
....+-++|..||.+|.++||++.++++
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 7888999999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=266.44 Aligned_cols=241 Identities=19% Similarity=0.290 Sum_probs=194.4
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CC-C----CeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SH-P----NLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h-~----niv~l~~~~~~~~~~~lv~ 466 (665)
...+|+|.||.|-+... +.+..||+|+++... ...+..+-|++++.++ .+ | -+|.+.++|...++.++|+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivf 170 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVF 170 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEE
Confidence 46799999999999884 357899999987554 5566778899999999 33 3 3888999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC------------------
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA------------------ 528 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~------------------ 528 (665)
|.+ |.++++++... .-.+++..++..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 171 ell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~k-l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 171 ELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDLK-LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred ecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhcc-eeecCCChheEEEeccceEEEeccCCccceecc
Confidence 987 56999999854 4567899999999999999999999999 999999999999932
Q ss_pred --CCceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH
Q 005999 529 --DFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR 606 (665)
Q Consensus 529 --~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 606 (665)
...++|+|||.|..........+.|..|+|||++. +-.++.++||||+||+|+|+.||...|+.-. ..+...+.+
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~ElytG~~LFqtHe--n~EHLaMMe 322 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYTGETLFQTHE--NLEHLAMME 322 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeeccceecccCC--cHHHHHHHH
Confidence 33589999999999888877778999999999998 6789999999999999999999999887522 111111111
Q ss_pred hhccCC--------------------------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHH
Q 005999 607 TMRVDD--------------------------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQ 642 (665)
Q Consensus 607 ~~~~~~--------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 642 (665)
.+..+. .........|.+|+++||..||.+|+|+.|
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 111110 012233456999999999999999999999
Q ss_pred HHH
Q 005999 643 VLK 645 (665)
Q Consensus 643 vl~ 645 (665)
++.
T Consensus 403 AL~ 405 (415)
T KOG0671|consen 403 ALS 405 (415)
T ss_pred Hhc
Confidence 986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=257.20 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=188.5
Q ss_pred HHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--------CCeEE
Q 005999 393 SAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--------KGERL 463 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~ 463 (665)
...++|+|.||.||+|+. ++++.||+|++-.....+..-....+|+.+|..++|+|++.+++.|.. ....|
T Consensus 21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 346899999999999995 457778888764332222334456789999999999999999988743 23589
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 464 VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
+||++|+. +|.-++.. ....++..++.++..++..||.|+|+.. |+|||+|+.|+||+.++.+||+|||+++..
T Consensus 101 lVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k-ilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNK-ILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhh-HHhhcccHhhEEEcCCceEEeeccccccce
Confidence 99999988 89988864 3456899999999999999999999999 999999999999999999999999999554
Q ss_pred CCCC-CC------CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH----------
Q 005999 544 DSSS-VE------DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR---------- 606 (665)
Q Consensus 544 ~~~~-~~------~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~---------- 606 (665)
.... .. .+-|..|++||.+.+...|+++.|||+-||++.||.|+.+-++... +.+....+.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HHHHHHHHHHHhccCCccc
Confidence 3222 11 2348999999999988999999999999999999999988776421 111111111
Q ss_pred -----------hhccCC---C---chhh------hHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 607 -----------TMRVDD---G---REEN------RLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 607 -----------~~~~~~---~---~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+..+. . .-++ ......+++..++..||.+|+++.+++..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110010 0 0011 12357889999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=276.67 Aligned_cols=236 Identities=19% Similarity=0.213 Sum_probs=199.4
Q ss_pred hHhCcccceEEEEEEECCeE-EEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHL-IVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..||-|+||.|-++...+.. .+|+|.+++...-+ ...+.+..|-++|..++.|.||++|-.|.+++++||+||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 45999999999999876554 37888887654433 33456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED-- 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-- 550 (665)
.|+..+.. .+.++..+...++..+.+|++|||+.+ ||.|||||+|.++|.+|-+||.|||+++.......+.
T Consensus 506 ElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k~-iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 506 ELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRKG-IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred hhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhcC-ceeccCChhheeeccCCceEEeehhhHHHhccCCceeee
Confidence 99999983 456888888999999999999999999 9999999999999999999999999999887765443
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|.|||.+. ++..+.++|.||+|+++|||++|++||.... +......+-........+........+++++.+
T Consensus 580 cGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~d--pmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 580 CGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVD--PMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred cCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 6999999999988 7788999999999999999999999998742 223333444444444456677778899999999
Q ss_pred cCCCCCCCC
Q 005999 631 LKSPEQRPA 639 (665)
Q Consensus 631 ~~dP~~RPt 639 (665)
..+|.+|..
T Consensus 657 r~~P~ERLG 665 (732)
T KOG0614|consen 657 RDNPTERLG 665 (732)
T ss_pred hcCcHhhhc
Confidence 999999976
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=265.55 Aligned_cols=233 Identities=21% Similarity=0.293 Sum_probs=187.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhh-HHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADT-SAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+||+|+||.|.+|..+ +.+.+|||++++...... ..+--+.|-++|..- +-|.+++++.+|+.-++.|+||||+.|
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG 434 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG 434 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence 57999999999999855 577899999987754322 222233455555544 668899999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC---CCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD---SSSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~---~~~~ 548 (665)
|+|-.+++. -+.+.+..+..++.+||-||-|||+++ ||.||||..|||+|.+|++||+|||+++.-- ....
T Consensus 435 GDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~kg-IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTk 508 (683)
T KOG0696|consen 435 GDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTK 508 (683)
T ss_pred chhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcCC-eeeeeccccceEeccCCceEeeecccccccccCCccee
Confidence 999999874 345677788899999999999999999 9999999999999999999999999986432 2233
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
+-.||+.|+|||.+. .+.|...+|+|||||+||||+.|++||+.. ++.++-+.+..... ..+...+.+...+...
T Consensus 509 TFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~ehnv--syPKslSkEAv~ickg 583 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEHNV--SYPKSLSKEAVAICKG 583 (683)
T ss_pred eecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHccC--cCcccccHHHHHHHHH
Confidence 446999999999987 788999999999999999999999999873 33445444443222 3455666778889999
Q ss_pred cccCCCCCCC
Q 005999 629 CSLKSPEQRP 638 (665)
Q Consensus 629 cl~~dP~~RP 638 (665)
.+.+.|.+|.
T Consensus 584 ~ltK~P~kRL 593 (683)
T KOG0696|consen 584 LLTKHPGKRL 593 (683)
T ss_pred HhhcCCcccc
Confidence 9999999994
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=238.18 Aligned_cols=211 Identities=22% Similarity=0.271 Sum_probs=169.6
Q ss_pred HHHhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 392 ASAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.....||+|++|.|-+.++ .+|...|+|++...... +..+....|+++..+. ..|.+|.++|.+...+..++.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 3456799999999998884 58999999999876653 4445566777776555 8999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-C
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-V 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~ 548 (665)
.- +|..+-.. -..++..+++..+-+|+..+.+||.|||++-.+||||+||+|||++.+|+||+||||++....++. .
T Consensus 128 ~t-Sldkfy~~-v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 128 DT-SLDKFYRK-VLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hh-hHHHHHHH-HHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 65 77766542 122567899999999999999999999996559999999999999999999999999996665442 2
Q ss_pred C-CCCCCcccCCccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005999 549 E-DPDTVAYKAPEIRKS---SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV 605 (665)
Q Consensus 549 ~-~~gt~~y~aPE~~~~---~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 605 (665)
+ ..|...|||||.+.. ...|+-|+||||+|+++.||.+++.||+.....-.++.+.+
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 2 457788999998753 23689999999999999999999999987543333444333
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=240.00 Aligned_cols=240 Identities=15% Similarity=0.253 Sum_probs=196.8
Q ss_pred HHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeC--CeEEEEEE
Q 005999 392 ASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAK--GERLVIYD 467 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 467 (665)
...+++|+|.++.|+.|. ..+.+.++||.++..+ .+.+.+|+.+|..|+ ||||+++++...+. ....+|+|
T Consensus 41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred HHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 345789999999999998 5678889999997643 467899999999996 99999999998764 46789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSS 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~ 546 (665)
|+.+.+...+.. .++...+..++.++++||.|||++| |+|||+||.|++||.. -.++|+|+|+|.+..+.
T Consensus 116 ~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G-ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 116 YVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC-cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999988877643 3666778889999999999999999 9999999999999954 57999999999888776
Q ss_pred CCCC--CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------
Q 005999 547 SVED--PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------ 612 (665)
Q Consensus 547 ~~~~--~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------ 612 (665)
.... +.+..|.-||.+-.-+.|+-.-|+|||||++..|+..+.||-+.....++++...+.+..+.
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 5443 35778899999887778899999999999999999999999876655556655554433222
Q ss_pred C----------------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 G----------------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ~----------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+ ...-...+..+++.+.|..|.++|||++|++.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 01112356889999999999999999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=269.19 Aligned_cols=206 Identities=19% Similarity=0.317 Sum_probs=168.9
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||-|+||.|.++. .++...+|+|.+.+...- .......+.|-+||..-+.+.||+||..|++++..|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 359999999999998 455778999998765432 223445677889999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc---------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS--------- 543 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~--------- 543 (665)
++-.+|.+ .+.+.+..+..++.++..|+++.|+.+ +|||||||.|||||.||++||+|||++.-.
T Consensus 715 DmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmG-FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 715 DMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred cHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhcc-ceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99998873 456888888889999999999999999 999999999999999999999999997311
Q ss_pred CCCC------------------------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhC
Q 005999 544 DSSS------------------------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTG 587 (665)
Q Consensus 544 ~~~~------------------------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg 587 (665)
.... ..-+||+.|+|||++. ...|+..+|+||.||+||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHhhC
Confidence 1000 0013799999999998 56799999999999999999999
Q ss_pred CCCCCCCCCCCc--cHHHHHHh
Q 005999 588 KHPSQHPYLAPP--DMLEWVRT 607 (665)
Q Consensus 588 ~~P~~~~~~~~~--~~~~~~~~ 607 (665)
++||......+. .+..|...
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhc
Confidence 999976543322 45555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=252.22 Aligned_cols=244 Identities=19% Similarity=0.293 Sum_probs=193.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-----CeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-----GERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 468 (665)
+-||.|+||+||.++. .+|+.|+.|++......-.+.+.+.+|+.++..++|.|++..++..+-. .+.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 4699999999999984 5799999999876655556677888999999999999999988876432 257788998
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV 548 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 548 (665)
|.. +|...|- ..+.++...+.-+++||++||+|||+.+ |.||||||.|.|++.+..+||+|||+++..+....
T Consensus 139 mQS-DLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~-ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 139 MQS-DLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN-ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHh-hhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc-hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 866 8888775 4567888888889999999999999999 99999999999999999999999999976654332
Q ss_pred C----CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------
Q 005999 549 E----DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------ 612 (665)
Q Consensus 549 ~----~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------ 612 (665)
. .+-|..|+|||.+.+...|+.+.||||.||++.|++..+..|+.. .+.+..+.+..+....
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq--~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA--GPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc--ChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 2 235789999999998888999999999999999999999888752 2233333333322211
Q ss_pred ------------C--------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 005999 613 ------------G--------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 613 ------------~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 647 (665)
+ .....-.....+...++..||++|.+..+.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 0111223456788889999999999999887654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.32 Aligned_cols=239 Identities=24% Similarity=0.349 Sum_probs=181.5
Q ss_pred HhHhCcccceE-EEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGT-TYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+++|.|+.|+ ||+|.+++ +.||||++-... .+...+|+..++.- +|||||++++.-.++...|+..|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEG-REVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCC-ceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 46799999865 68998865 589999985432 34567899998877 899999999999999999999999976
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---C--CceEEeecccccccCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---D--FEARLTDYCLSVLSDSS 546 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~--~~~kl~Dfgl~~~~~~~ 546 (665)
+|.+++... ............+.++.|++.||++||+.+ ||||||||+||||+. + .+++|+|||+++.....
T Consensus 588 -sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 -SLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK-IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred -hHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc-cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999863 111111111334678899999999999999 999999999999975 3 47999999999876543
Q ss_pred C------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHhhccCCCchhhhH
Q 005999 547 S------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTG-KHPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619 (665)
Q Consensus 547 ~------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (665)
. ....||-+|+|||++. ...-+.++||||+||++|+.++| .+||......+..+..-...+..-.... ++
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~-~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~-d~- 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLR-EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLP-DC- 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHh-ccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCc-hH-
Confidence 2 2345899999999988 44556789999999999999986 8999875433333222111111111111 11
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...+||.+|+++||..||++.+|+.
T Consensus 742 -eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 742 -EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 6889999999999999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=273.07 Aligned_cols=252 Identities=19% Similarity=0.258 Sum_probs=177.0
Q ss_pred HhHhCcccceEEEEEEE-----------------CCeEEEEEEEecCCCchh------------hHHHHHHHHHHHHhCC
Q 005999 394 AELLGRGSIGTTYKAVL-----------------DNHLIVTVKRFDANKTAD------------TSAEAFEQHMEAVGGL 444 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l 444 (665)
.++||+|+||+||+|.. ..++.||||++....... ...+....|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 36899999999999963 235679999986543210 0112234567777777
Q ss_pred CCCCe-----eeeeEEEEe--------CCeEEEEEEecCCCCHHHHHhcCCC-------------------CCCCCCCHH
Q 005999 445 SHPNL-----VPIRAYFQA--------KGERLVIYDYQPNGSLFNLIHGSRS-------------------IRAKPLHWT 492 (665)
Q Consensus 445 ~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~ 492 (665)
+|.++ ++++++|.. ++..++||||+.+|+|.++++.... .....+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 66654 667777753 3568999999999999999974321 012235778
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----CCCCCCcccCCccccCCCC-
Q 005999 493 SCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----EDPDTVAYKAPEIRKSSRR- 567 (665)
Q Consensus 493 ~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~~gt~~y~aPE~~~~~~~- 567 (665)
.+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ...+|+.|+|||.+.....
T Consensus 310 ~~~~i~~ql~~aL~~lH~~~-ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~ 388 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSC 388 (507)
T ss_pred HHHHHHHHHHHHHHHHHHCC-eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCC
Confidence 89999999999999999999 99999999999999999999999999865433221 1234789999998752211
Q ss_pred --------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCCCC-------CccHHHHHHhhcc--CCCchhh
Q 005999 568 --------------------ATSKSDVYAFGVLLLELLTGKH-PSQHPYLA-------PPDMLEWVRTMRV--DDGREEN 617 (665)
Q Consensus 568 --------------------~~~k~DvwSlGvvl~elltg~~-P~~~~~~~-------~~~~~~~~~~~~~--~~~~~~~ 617 (665)
...+.||||+||++|||++|.. |+...... ..+...|...... .......
T Consensus 389 ~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~ 468 (507)
T PLN03224 389 PRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDR 468 (507)
T ss_pred CccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccc
Confidence 1235799999999999999875 66532111 1122222221111 1122334
Q ss_pred hHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSP---EQRPAMWQVLKM 646 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP---~~RPt~~evl~~ 646 (665)
.+....+++.+++.++| .+|+|+.|++++
T Consensus 469 ~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 469 NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 56678899999999766 689999999863
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=280.16 Aligned_cols=246 Identities=16% Similarity=0.182 Sum_probs=161.1
Q ss_pred HhHhCcccceEEEEEEEC-C----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEE------EEeCCeE
Q 005999 394 AELLGRGSIGTTYKAVLD-N----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAY------FQAKGER 462 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~~~~ 462 (665)
.+.||+|+||.||+|.+. + +..||+|++..... .+.+..+ .+....+.++..+... ...+...
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 367999999999999965 4 68899998764321 1111111 1122222333222221 2456688
Q ss_pred EEEEEecCCCCHHHHHhcCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSI---------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG 527 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~ 527 (665)
++|+||+.+++|.++++..... ......+..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-IiHRDLKP~NILl~ 289 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-IVHRDVKPQNIIFS 289 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-EEeCcCCHHHEEEe
Confidence 9999999999999998743210 0011223445678999999999999999 99999999999998
Q ss_pred C-CCceEEeecccccccCCC----CCCCCCCCcccCCccccCCC---------------------CCCCcchHHHHHHHH
Q 005999 528 A-DFEARLTDYCLSVLSDSS----SVEDPDTVAYKAPEIRKSSR---------------------RATSKSDVYAFGVLL 581 (665)
Q Consensus 528 ~-~~~~kl~Dfgl~~~~~~~----~~~~~gt~~y~aPE~~~~~~---------------------~~~~k~DvwSlGvvl 581 (665)
+ ++.+||+|||++...... .....+++.|+|||.+.... .++.++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 579999999999755332 12335789999999653211 234567999999999
Q ss_pred HHHHhCCCCCCCCCC--------CCccHHHHHHhhccCCCc--------hhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 582 LELLTGKHPSQHPYL--------APPDMLEWVRTMRVDDGR--------EENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 582 ~elltg~~P~~~~~~--------~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
|||+++..|++.... ...+...|.......... .........+|+.+||+.||++|||+.|+++
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 999998766543100 011222222211111000 0011223458999999999999999999987
Q ss_pred H
Q 005999 646 M 646 (665)
Q Consensus 646 ~ 646 (665)
.
T Consensus 450 H 450 (566)
T PLN03225 450 H 450 (566)
T ss_pred C
Confidence 4
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=247.90 Aligned_cols=239 Identities=21% Similarity=0.275 Sum_probs=187.1
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
..+||+|+|+.|..+++ ++.+.+|+|++++.-.. ++..+-...|-.+..+- +||.+|.++.+|+.+.+.++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 36799999999999994 57889999998765332 22334444555555444 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SS 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~ 547 (665)
||+|--+++. ...++++.+..+...|+.||.|||+++ ||.||||..|||+|..|++||+|||+++.--. ..
T Consensus 335 ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rg-iiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 335 GGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred Ccceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcC-eeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 9999887774 345899999999999999999999999 99999999999999999999999999865422 22
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC--ccHHHHHHhhc--cCCCchhhhHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP--PDMLEWVRTMR--VDDGREENRLGMLT 623 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~l~ 623 (665)
.+-.|||.|.|||.+. +..|...+|+|++||+|+||+.|+.||+-...+. ....++.-... .+...+...+....
T Consensus 409 stfcgtpnyiapeilr-geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas 487 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKAS 487 (593)
T ss_pred ccccCCCcccchhhhc-ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhH
Confidence 3346999999999998 7789999999999999999999999997432221 12222221111 12223445555677
Q ss_pred HHHHHcccCCCCCCCC
Q 005999 624 EVASVCSLKSPEQRPA 639 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt 639 (665)
.+++.-+++||.+|..
T Consensus 488 ~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHHhhcCCcHHhcC
Confidence 8899999999999953
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-28 Score=233.73 Aligned_cols=209 Identities=30% Similarity=0.474 Sum_probs=182.3
Q ss_pred hCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCHH
Q 005999 397 LGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLF 475 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 475 (665)
||+|.+|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999764 8889999987664321 3567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccCCC---CCCCC
Q 005999 476 NLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSS---SVEDP 551 (665)
Q Consensus 476 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~---~~~~~ 551 (665)
+++.... ..+++..++.++.+++.+++|||+.+ ++|+||+|.||+++. ++.++|+|||.+...... .....
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNG-IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 9987421 46889999999999999999999998 999999999999999 899999999998766554 23345
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
+...|++||.......++.+.|+|++|+++++| ..+.+++..|++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence 778899999987433788999999999999999 358899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 005999 632 KSPEQRPAMWQVLKM 646 (665)
Q Consensus 632 ~dP~~RPt~~evl~~ 646 (665)
.+|++||++.++++.
T Consensus 200 ~~p~~R~~~~~l~~~ 214 (215)
T cd00180 200 KDPEKRPSAKEILEH 214 (215)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=243.94 Aligned_cols=126 Identities=25% Similarity=0.359 Sum_probs=105.5
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-----C---CCeeeeeEEEEe----CC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-----H---PNLVPIRAYFQA----KG 460 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~----~~ 460 (665)
.++||.|.|++||++.. .+.+.||+|+.+... ...+....||++|++++ | .+||+|+++|.. +.
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~ 159 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQ 159 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCc
Confidence 46899999999999984 467889999986543 55667788999998873 3 369999999975 44
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL 526 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill 526 (665)
+++||+|++ |-+|..+|..+. -+-++...+.+|++||+.||.|||+...|||-||||+|||+
T Consensus 160 HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 160 HVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred EEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 899999998 559999998653 34478889999999999999999997669999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=254.41 Aligned_cols=195 Identities=19% Similarity=0.331 Sum_probs=165.3
Q ss_pred HHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhh------HHHHHHHHHHHHhCCC---CCCeeeeeEEEEeCCeE
Q 005999 393 SAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADT------SAEAFEQHMEAVGGLS---HPNLVPIRAYFQAKGER 462 (665)
Q Consensus 393 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~ 462 (665)
+.+.+|+|+||.|+.+.++ +...|+||.+.+...-.. ..-.+--||.+|..++ |+||++++++|++++++
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 3567999999999999965 567889998865532111 1112445899999997 99999999999999999
Q ss_pred EEEEEec-CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccc
Q 005999 463 LVIYDYQ-PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV 541 (665)
Q Consensus 463 ~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~ 541 (665)
|++||-. ++.+|+++|.. ...+++....-|.+||+.|+++||+++ |+|||||-+||.++.+|-+||+|||.+.
T Consensus 645 yl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~-ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG-IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC-ceecccccccEEEecCCeEEEeeccchh
Confidence 9999976 56799999973 456899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCC-CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005999 542 LSDSSSV-EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593 (665)
Q Consensus 542 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~ 593 (665)
....... .-+||.+|.|||++.+.++....-|||++|++||-++....||..
T Consensus 719 ~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7766543 347999999999998666667788999999999999999888753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-29 Score=262.43 Aligned_cols=243 Identities=20% Similarity=0.296 Sum_probs=194.5
Q ss_pred HhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.+|.|.||.|||++ ...++..|+|+++.... ....-+.+|+-+++.++||||+.++|.|..++..++.||||.+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 3679999999999999 45788999999987654 33455678999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|++.-+. -.++++.++..+.+..++|++|||+++ -+|||||-.||++++.|.+|++|||.+..+... ...
T Consensus 98 slQdiy~~-----TgplselqiayvcRetl~gl~ylhs~g-k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 98 SLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG-KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cccceeee-----cccchhHHHHHHHhhhhccchhhhcCC-cccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 99998773 467888899999999999999999999 799999999999999999999999998655432 233
Q ss_pred CCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHH
Q 005999 550 DPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEV 625 (665)
Q Consensus 550 ~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 625 (665)
..||+.|||||+.. ..+.|..++|||+.|+...|+--.++|..+.... ..+.-+.+...... .........+.+|
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-RALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-HHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 46999999999754 2456899999999999999998888775432110 11111111111111 1233456779999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
++.|+.++|++||+++.++.
T Consensus 251 vK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHhcCCCccCCChhhhee
Confidence 99999999999999988754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=234.08 Aligned_cols=236 Identities=19% Similarity=0.282 Sum_probs=184.5
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 467 (665)
..+|.|.- .|.-+. .-.++.||+|++..........+...+|...+..+.|+||++++.+|.-. .+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777777 444443 33578899998876655556667778899999999999999999998644 36789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 546 (665)
||.. +|.+.++. .++-.++..|.+|++.|++|||+.+ |+||||||+||++..++.+||.|||++...+..
T Consensus 102 ~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~-IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 102 LMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG-IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred hhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc-eeecccCcccceecchhheeeccchhhcccCccc
Confidence 9966 99988862 3667788899999999999999999 999999999999999999999999999766554
Q ss_pred -CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH---HhhccCC----------
Q 005999 547 -SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV---RTMRVDD---------- 612 (665)
Q Consensus 547 -~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~---~~~~~~~---------- 612 (665)
.+..+.|..|.|||++. +..+.+.+||||.||++.||++|+.-|.+. ..+.+|. .......
T Consensus 173 ~mtpyVvtRyyrapevil-~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred ccCchhheeeccCchhee-ccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 23346788999999998 455999999999999999999999887641 1122221 1111111
Q ss_pred -----------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -----------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...........+++.+||..+|++|-+++++++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 011233456889999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=223.77 Aligned_cols=256 Identities=18% Similarity=0.291 Sum_probs=191.8
Q ss_pred cccCHHHHHHHHHhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeE-EEEe
Q 005999 382 EVYSLEQLMRASAELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRA-YFQA 458 (665)
Q Consensus 382 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~ 458 (665)
+...++|. +...+.||+|.||.+-++.++ +...+++|-+.... ...++|.+|...---| .|.||+.-|+ .|+.
T Consensus 18 ~kv~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 18 KKVDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred cccchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 34444443 345678999999999999965 57788899887665 4567788887765445 6899998765 4788
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC--CCCceEEee
Q 005999 459 KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG--ADFEARLTD 536 (665)
Q Consensus 459 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~--~~~~~kl~D 536 (665)
.+.+++++||++.|+|.+-+.. .-+-+....+++.|++.|+.|||+++ +||||||.+||||- +..++||||
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn-lVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN-LVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred CceEEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc-hhhcccccceEEEecCCccEEEeee
Confidence 8889999999999999988753 34677888999999999999999999 99999999999994 345899999
Q ss_pred cccccccCCCCCCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc---cHHHHHHhhc
Q 005999 537 YCLSVLSDSSSVEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP---DMLEWVRTMR 609 (665)
Q Consensus 537 fgl~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~---~~~~~~~~~~ 609 (665)
||++...+..-.....+..|.+||.... .-...+.+|||.||+++|.++||+.||+.....+. +..+|.....
T Consensus 167 FG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 167 FGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 9998766554333345667899997542 11356789999999999999999999996544444 4444443322
Q ss_pred cCC-CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 610 VDD-GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 610 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
..- .........+..+.++-+.+++++|=-..++.++.+
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 211 223334556788999999999999966666655544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=226.43 Aligned_cols=193 Identities=27% Similarity=0.437 Sum_probs=167.1
Q ss_pred hHhCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|++|.||++...+ ++.+++|.+...... ...+.+.+|++.+.+++|+|++++++++......++++||+++++
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 568999999999999764 888999999765432 256788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 549 (665)
|.+++.... ..+++.....++.+++.++.|||+.+ ++|+||+++||+++.++.++|+|||.+....... ..
T Consensus 84 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 84 LFDYLRKKG----GKLSEEEARFYLRQILEALEYLHSLG-IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999997532 11788999999999999999999998 9999999999999999999999999987665432 33
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~ 593 (665)
..++..|++||.......++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 35678899999873356678899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=213.36 Aligned_cols=167 Identities=22% Similarity=0.285 Sum_probs=131.3
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|.++++. ....+++..++.++.||+.||+|||+.+ ||+||+++.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~-------kp~Nil~~~~~~~~~--fG~~~~~~~~~--~~ 65 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQA-------KSGNILLTWDGLLKL--DGSVAFKTPEQ--SR 65 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcccEeEcCccceee--ccceEeecccc--CC
Confidence 689999974 2356999999999999999999999876 999999999999999 99987765432 25
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC----CchhhhHH--HHHHH
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----GREENRLG--MLTEV 625 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--~l~~l 625 (665)
+|+.|||||++. +..++.++|||||||++|||+||+.||.........+........... ........ .+.++
T Consensus 66 g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 789999999997 567899999999999999999999999754322223333332222221 11222333 58999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
+.+|++.+|++||++.|+++.+..+....
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 99999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=230.39 Aligned_cols=239 Identities=20% Similarity=0.307 Sum_probs=187.7
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.++||+|.|++||++.+. .++.||+|.+..... ...+.+|+++|..+ .+.||+++.+++..++.+.+|+||
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 578999999999999843 467899999876543 34477899999999 789999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccC---
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSD--- 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~--- 544 (665)
++..+..++... ++...+..+++.+..||+++|.++ ||||||||+|+|.+. .+.-.|.|||++...+
T Consensus 117 ~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G-IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 117 FEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG-IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred cCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC-ccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 999999988753 667888899999999999999999 999999999999984 5788999999985110
Q ss_pred --------------C----------------CC--------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHH
Q 005999 545 --------------S----------------SS--------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVL 580 (665)
Q Consensus 545 --------------~----------------~~--------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvv 580 (665)
. .. ....||+||+|||++...+.-++++||||.||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 00 012379999999998877778899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCccHHHHHHhh------------cc----C-------------------------C-------
Q 005999 581 LLELLTGKHPSQHPYLAPPDMLEWVRTM------------RV----D-------------------------D------- 612 (665)
Q Consensus 581 l~elltg~~P~~~~~~~~~~~~~~~~~~------------~~----~-------------------------~------- 612 (665)
++.+++++.||-....+-+.+.+.+.-. .. + .
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 9999999999864332222221111000 00 0 0
Q ss_pred CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...+..+..+.+++.+|+..||.+|.|++|.++
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011223447899999999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=234.63 Aligned_cols=241 Identities=19% Similarity=0.240 Sum_probs=188.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC------CCCeeeeeEEEEeCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS------HPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~~lv~e 467 (665)
...|+|-|++|.+|.. .-+..||||++..... ..+.=..|+++|++|. --|+++++-.|....+.+||||
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE 514 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFE 514 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEeh
Confidence 4589999999999984 4577999999987653 3344467899999995 3389999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSS 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~ 546 (665)
-+.. +|.++++... ...-|....+..++.|+.-||..|-..+ |+|.||||.|||+++. ..+||||||.|......
T Consensus 515 ~Lsl-NLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c~-vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 515 PLSL-NLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKCG-VLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred hhhc-hHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhcC-eeecccCccceEeccCcceeeeccCccccccccc
Confidence 8755 9999998654 3344777888899999999999999999 9999999999999965 57899999999776654
Q ss_pred CCCC-CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-------------
Q 005999 547 SVED-PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------- 612 (665)
Q Consensus 547 ~~~~-~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------- 612 (665)
..+. .-+..|.|||.+. +-.|+...|+||.||+||||.||+..|.+. ...++..+........
T Consensus 591 eitPYLVSRFYRaPEIiL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~--TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 591 EITPYLVSRFYRAPEIIL-GLPYDYPIDTWSVGCTLYELYTGKILFPGR--TNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred cccHHHHHHhccCcceee-cCcccCCccceeeceeeEEeeccceecCCC--CcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 4332 2356799999998 778999999999999999999999988752 1222222221111000
Q ss_pred ---------------------------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ---------------------------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ---------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+........+.+|+..|+..||++|.|..++|.
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011233457899999999999999999999886
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=265.57 Aligned_cols=190 Identities=16% Similarity=0.204 Sum_probs=136.9
Q ss_pred CCC-CCeeeeeEEE-------EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 005999 444 LSH-PNLVPIRAYF-------QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515 (665)
Q Consensus 444 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ii 515 (665)
++| +||++++++| ......+.++||+ +++|.+++.. ....+++.+++.++.||++||+|||+++ |+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g-Iv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHSQG-IV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHhCC-ee
Confidence 456 5788888877 2233566778887 5599999973 2345899999999999999999999999 99
Q ss_pred ccCCCCCceEeCC-------------------CCceEEeecccccccCCC-------------------CCCCCCCCccc
Q 005999 516 HGNLKSSNVLLGA-------------------DFEARLTDYCLSVLSDSS-------------------SVEDPDTVAYK 557 (665)
Q Consensus 516 H~Dlk~~Nill~~-------------------~~~~kl~Dfgl~~~~~~~-------------------~~~~~gt~~y~ 557 (665)
||||||+|||++. ++.+|++|||+++..... .....+|+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 445666667666432110 00124688899
Q ss_pred CCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCC
Q 005999 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQR 637 (665)
Q Consensus 558 aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 637 (665)
|||++. +..++.++|||||||+||||++|.+|+.... .....+........ ..........++.+||+++|.+|
T Consensus 183 APE~~~-~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~L~~~P~~R 256 (793)
T PLN00181 183 SPEEDN-GSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHRVLPPQ-ILLNWPKEASFCLWLLHPEPSCR 256 (793)
T ss_pred Chhhhc-cCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHhhcChh-hhhcCHHHHHHHHHhCCCChhhC
Confidence 999987 5678999999999999999999988865311 11111111111111 11123345688999999999999
Q ss_pred CCHHHHHH
Q 005999 638 PAMWQVLK 645 (665)
Q Consensus 638 Pt~~evl~ 645 (665)
|++.|+++
T Consensus 257 ps~~eil~ 264 (793)
T PLN00181 257 PSMSELLQ 264 (793)
T ss_pred cChHHHhh
Confidence 99999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=215.27 Aligned_cols=247 Identities=21% Similarity=0.376 Sum_probs=194.7
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
.+|.+...|..|+|++.++.. ++|++.-........++|..|.-.++-+.||||+.++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 468899999999999987654 4577765554445567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecc-CCCCCceEeCCCCceEEe--ecccccccCCCCCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHG-NLKSSNVLLGADFEARLT--DYCLSVLSDSSSVEDP 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~-Dlk~~Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~ 551 (665)
+..+|+. ..-..+-.+..+++.+|++|++|||+..+++-| -|.+..|++|++.+++|+ |--++ .......
T Consensus 275 ynvlhe~---t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs----fqe~gr~ 347 (448)
T KOG0195|consen 275 YNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS----FQEVGRA 347 (448)
T ss_pred HHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee----eeccccc
Confidence 9999965 334567788999999999999999997767655 799999999999988875 32222 1222334
Q ss_pred CCCcccCCccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRKSSRR--ATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~--~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+.||+||.+..... .-..+|+|||++++||+-|...||.+...-+.-+......++.. .+...+..+.+++.-|
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~--ippgis~hm~klm~ic 425 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH--IPPGISRHMNKLMNIC 425 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc--CCCCccHHHHHHHHHH
Confidence 5789999998874322 23578999999999999999999987543333333333333222 2445677899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIK 651 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~ 651 (665)
+.+||.+||.+..++-.|+.++
T Consensus 426 mnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 426 MNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=252.66 Aligned_cols=192 Identities=35% Similarity=0.528 Sum_probs=133.1
Q ss_pred CHHHHHHHHHHHhcCCCCCCccccCCCCCCCccccceeecC-CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcC
Q 005999 33 LPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQ-GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSL 111 (665)
Q Consensus 33 ~~~~~~~Ll~~k~~~~~~~~~~~~~~~~~~~C~w~gv~C~~-~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l 111 (665)
.+.|+.||++||+++.++.....+|+.+.+||.|.||+|+. ++|+.|+|++|+++|.+++ .|..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCcc
Confidence 45799999999999865444445666668999999999984 7999999999999988876 788889999999999888
Q ss_pred ccCCC-C-CCCCCCCCEEEccCcccCC----------------------cCcccccCCCCCCEEEeecccccccCCcccc
Q 005999 112 TGPIP-D-LSSLINLKSLSLSRNFFSG----------------------AFPLSILSLHRLTILDLSYNNLTGLIPVNLT 167 (665)
Q Consensus 112 ~~~~p-~-~~~l~~L~~L~Ls~N~l~~----------------------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 167 (665)
++.+| . +.++++|++|+|++|+++| .+|..|+++++|++|+|++|.+.+.+|..++
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence 87776 3 3366666666666666554 4455555555666666666666555665566
Q ss_pred CCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCC
Q 005999 168 ALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMN 225 (665)
Q Consensus 168 ~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n 225 (665)
++++|++|+|++|++++.+|.. .+++|+.|++++|++++.+|.. ..+.+|..+++++|
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 246 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCc
Confidence 6666666666666665555543 5556666666666666555532 44555666666655
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-21 Score=202.20 Aligned_cols=255 Identities=15% Similarity=0.183 Sum_probs=191.9
Q ss_pred HhHhCcccceEEEEEEECC--eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCC----CCeeeeeEEE-EeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDN--HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH----PNLVPIRAYF-QAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~lv~ 466 (665)
.+.||+|+||.||++.... ...+|+|........... .+..|+.++..+.+ +++..+++.. ..+...++||
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM 100 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM 100 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence 3679999999999999655 357888887654322111 45667777777752 6889999998 5777889999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-----CceEEeeccccc
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-----FEARLTDYCLSV 541 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-----~~~kl~Dfgl~~ 541 (665)
+.+ |.+|.++.... ..+.++..+..+|+.|++.+|+++|+.+ ++||||||.|++++.. -.+.|.|||+++
T Consensus 101 ~l~-G~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH~~G-~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 101 SLL-GPSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLHSKG-FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred ecc-CccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHHhcC-cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 976 77999987643 2467999999999999999999999999 9999999999999865 369999999997
Q ss_pred --ccC-CC----------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHH
Q 005999 542 --LSD-SS----------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVR 606 (665)
Q Consensus 542 --~~~-~~----------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~ 606 (665)
... .. .....||..|.++.+.. +...+.+.|+||++.++.|++.|..||........ .+.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 321 11 11123899999999887 67889999999999999999999999976432211 1111111
Q ss_pred hhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 607 TMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 607 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
...... .....+..+.++...+-..+..++|....+...++.........
T Consensus 255 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 255 KLLTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred hhcccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 111110 12334566778888888899999999999999999887775443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=191.18 Aligned_cols=261 Identities=16% Similarity=0.188 Sum_probs=206.4
Q ss_pred HHHhHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 392 ASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 392 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
..+++||+|.||+++.|. +-+++.||||.-..... .-+++.|.+..+.| ..+.|..++.|..+..+-.||+|.+
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 446889999999999998 67899999997543332 23455666677766 5689999999988888888999987
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-----ceEEeecccccccC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-----EARLTDYCLSVLSD 544 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-----~~kl~Dfgl~~~~~ 544 (665)
|.+|+|+..- .+..++.+++..+|.|++.-++|+|+.. +|.|||||+|+||...+ .+.++|||+++...
T Consensus 107 -GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~-LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKD-LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcc-eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 7799998875 4567999999999999999999999999 99999999999997543 58999999998776
Q ss_pred CCCCC----------CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCC-
Q 005999 545 SSSVE----------DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDD- 612 (665)
Q Consensus 545 ~~~~~----------~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~- 612 (665)
+..+. -.||.+||+-.... +..-+.+.|.-|+|-++++.+-|..||+....... +-.+.+..-....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred CccccccCccccccccccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 54322 24899999988877 67788899999999999999999999997543322 2222221111111
Q ss_pred --CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCcccCC
Q 005999 613 --GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFG 663 (665)
Q Consensus 613 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 663 (665)
...+..+.++..-++..=..+-++-|+.+-+...+..+.+..+.+++..|-
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yD 312 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYD 312 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 234556777777777777788889999999999999999999988887763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=207.22 Aligned_cols=153 Identities=18% Similarity=0.170 Sum_probs=119.3
Q ss_pred hHhCcccceEEEEEEEC--CeEEEEEEEecCCCc---hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD--NHLIVTVKRFDANKT---ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||+||+|... +++.+|||++..... .....+.+.+|++++++++|+|+++.+.. .+..++||||+
T Consensus 24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~ 100 (365)
T PRK09188 24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWT 100 (365)
T ss_pred cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEcc
Confidence 57999999999999864 577889998753311 12345679999999999999999853322 24679999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCC-CCCceEeCCCCceEEeecccccccCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNL-KSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+|++|... .. .. ...++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|||++.......
T Consensus 101 ~G~~L~~~-~~-----~~------~~~~~~~i~~aL~~lH~~g-IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~ 167 (365)
T PRK09188 101 EGVPLHLA-RP-----HG------DPAWFRSAHRALRDLHRAG-ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGA 167 (365)
T ss_pred CCCCHHHh-Cc-----cc------hHHHHHHHHHHHHHHHHCC-CeeCCCCCcceEEEcCCCCEEEEECccceecccCcc
Confidence 99999732 10 01 1357889999999999999 999999 9999999999999999999997654332
Q ss_pred ----------CCCCCCCcccCCcccc
Q 005999 548 ----------VEDPDTVAYKAPEIRK 563 (665)
Q Consensus 548 ----------~~~~gt~~y~aPE~~~ 563 (665)
....+++.|+|||++.
T Consensus 168 ~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 168 LYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred hhhhhhhhhhhhhhccCccCCcccCC
Confidence 1223678899999876
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-20 Score=197.34 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=195.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhh-HHHHHHHHHHHHhCCCCC-CeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADT-SAEAFEQHMEAVGGLSHP-NLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||.|+||.||++... ..+++|.+........ ....+.+|+.++..+.|+ +++++.+++......+++++|+.++
T Consensus 6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 56899999999999877 6788999876655443 567899999999999988 7999999998887789999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~---- 547 (665)
++.+++...... ..++......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 84 ~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~-~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 84 SLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG-IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred cHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 999777642111 36888899999999999999999999 99999999999999988 79999999986544322
Q ss_pred -----CCCCCCCcccCCccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--CccHHHHHHhhccC-CC--ch
Q 005999 548 -----VEDPDTVAYKAPEIRKSS--RRATSKSDVYAFGVLLLELLTGKHPSQHPYLA--PPDMLEWVRTMRVD-DG--RE 615 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~--~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~~~~~~~-~~--~~ 615 (665)
....++..|+|||.+... ..+....|+||+|++++++++|..||...... .......+...... .. ..
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence 344689999999998742 57888999999999999999999997654321 12333333332222 11 11
Q ss_pred hh----hHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 616 EN----RLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 616 ~~----~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. ....+.+++..|+..+|..|.++.+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 12568899999999999999999988775
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=175.58 Aligned_cols=249 Identities=17% Similarity=0.220 Sum_probs=191.5
Q ss_pred hHhCcccceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCC-CCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH-PNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||.|+||.+|.|. ..+|+.||||+-....... .+..|..+.+.|+| ..|..+..|..+..+-.+|||.+ |.
T Consensus 21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 21 RKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred EeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Cc
Confidence 679999999999998 6789999999875544322 24556777777755 67888889999999999999987 78
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC---CceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD---FEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.++..-+ ...++.++.+-++-|++.-++|+|.++ ++||||||+|+|+.-+ ..+.++|||+++...+..
T Consensus 96 sLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~-fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 96 SLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRN-FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred cHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhc-cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 999988743 456889999999999999999999999 9999999999999743 468999999997654422
Q ss_pred --------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCC---Cch
Q 005999 548 --------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDD---GRE 615 (665)
Q Consensus 548 --------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~---~~~ 615 (665)
..-.||.+|.+-.... +..-+.+.|+-|+|.++.+.--|..||++...... +-.+.+....... ...
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLC 249 (341)
T ss_pred ccCccccCCccceeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHh
Confidence 1224889998877655 45567889999999999999999999998654332 3333332222221 234
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
...+.++.-.+..|=..--++-|+..-+-+.++.+....
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 556777888899998888888899888777776665443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-22 Score=221.91 Aligned_cols=244 Identities=18% Similarity=0.225 Sum_probs=179.0
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEec----CCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFD----ANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
..++|.|++|.|+.... ...+..+.|.+. ...........+..|+.+-..++|+|++..+..+.+.....-.|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 46799999997777653 233333444332 2222222233366678888899999998877777666656666999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-- 546 (665)
+++ +|+.++... ..+....+-.+.+|++.|++|+|+.+ |.|||+|++|+++..+|.+||+|||.+....-.
T Consensus 403 ~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G-iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG-LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC-ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 999998742 35777778889999999999999999 999999999999999999999999998543221
Q ss_pred -----CCCCCCCCcccCCccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-----CCch
Q 005999 547 -----SVEDPDTVAYKAPEIRKSSRRAT-SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD-----DGRE 615 (665)
Q Consensus 547 -----~~~~~gt~~y~aPE~~~~~~~~~-~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~ 615 (665)
.....|+..|+|||++. +..|. ...||||.|+++..|.+|+.||..+...+............. ....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~-~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLT-GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred hhhhhhcCcccCCcCcCccccc-ccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 12335788899999998 45555 457999999999999999999987655444321111110000 0123
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...+..-+.++.++|+.||.+|-|+.+|++
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 344566788999999999999999999986
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=210.98 Aligned_cols=132 Identities=34% Similarity=0.561 Sum_probs=100.0
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCccccCCCCCCCc-----cccceeecC------CCEEEEEecCCCCcccCCccccCCCC
Q 005999 31 SLLPSDAVSLLSFKSKADSENKLLYALNERFDYC-----QWQGVKCAQ------GRVVRFVLQSFGLRGTFPPNTLTRLD 99 (665)
Q Consensus 31 ~~~~~~~~~Ll~~k~~~~~~~~~~~~~~~~~~~C-----~w~gv~C~~------~~v~~l~l~~~~l~g~l~~~~~~~l~ 99 (665)
.+.+.|..||++||..+..+.. ++|+ .++| .|.||.|+. ..|+.|+|++|+|.|.+|+ .++.|+
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCC
Confidence 5667899999999998864433 3444 3455 699999952 2478888888888888876 688888
Q ss_pred CCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCcccc
Q 005999 100 QLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLT 167 (665)
Q Consensus 100 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 167 (665)
+|+.|+|++|+|+|.+| .++.+++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+.
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~ 511 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHh
Confidence 88888888888887777 677777777788877777777777777777777777777777777776553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=180.07 Aligned_cols=141 Identities=16% Similarity=0.170 Sum_probs=109.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhH------------------------HHHHHHHHHHHhCCCCCCee
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTS------------------------AEAFEQHMEAVGGLSHPNLV 450 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~niv 450 (665)
..||+|+||.||+|...+|+.||+|+++........ .....+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 469999999999999878999999999764321111 12234599999999888764
Q ss_pred eeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCCCCCceEeCCC
Q 005999 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI-HRASWLIHGNLKSSNVLLGAD 529 (665)
Q Consensus 451 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~iiH~Dlk~~Nill~~~ 529 (665)
....+... ..++||||+.++++..... ....+++.....++.|++.+|.|+ |+.+ |+||||||+||+++ +
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g-iiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQDCR-LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEE-C
Confidence 44333222 2389999999987765432 224688899999999999999999 6888 99999999999998 4
Q ss_pred CceEEeecccccccC
Q 005999 530 FEARLTDYCLSVLSD 544 (665)
Q Consensus 530 ~~~kl~Dfgl~~~~~ 544 (665)
+.++|+|||++...+
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=198.17 Aligned_cols=210 Identities=26% Similarity=0.410 Sum_probs=166.7
Q ss_pred HhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCC
Q 005999 441 VGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLK 520 (665)
Q Consensus 441 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk 520 (665)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++++|++||+|+|...-.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 3568999999999999999999999999999999999975 456789999999999999999999998723999999
Q ss_pred CCceEeCCCCceEEeecccccccCCCCCC-----CCCCCcccCCccccCC--C----CCCCcchHHHHHHHHHHHHhCCC
Q 005999 521 SSNVLLGADFEARLTDYCLSVLSDSSSVE-----DPDTVAYKAPEIRKSS--R----RATSKSDVYAFGVLLLELLTGKH 589 (665)
Q Consensus 521 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-----~~gt~~y~aPE~~~~~--~----~~~~k~DvwSlGvvl~elltg~~ 589 (665)
++|+++|..+.+|++|||+.......... .....-|.|||.+... . ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766431111 1123459999988742 1 15778999999999999999999
Q ss_pred CCCCCCCCCc--cHHHHHHhhccCC-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 590 PSQHPYLAPP--DMLEWVRTMRVDD-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 590 P~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
||+....... ++...++...... ....+....+..++..||..+|++||++.++-..++.+....
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9987554433 4555544411111 112244457899999999999999999999999998887643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-21 Score=204.27 Aligned_cols=226 Identities=24% Similarity=0.298 Sum_probs=181.2
Q ss_pred hCcccceEEEEEE----ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 397 LGRGSIGTTYKAV----LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 397 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+|+|.||.|+.+. .+.+..+|+|++++.............|..++..++ ||.+|++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999865 456778888888654332222224455667777775 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|...+.. ...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-..... .
T Consensus 82 g~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~-iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-c 154 (612)
T KOG0603|consen 82 GDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLG-IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-C 154 (612)
T ss_pred chhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhH-HHHhcccccceeecccCccccCCchhhhHhHhhhhc-c
Confidence 999988763 345666777778889999999999999 999999999999999999999999999766544333 6
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
||..|||||++. .....+|.||||++++||+||-.||.. +....+. ......+.+.......++..++.
T Consensus 155 gt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il--~~~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 155 GTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRIL--KAELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred cchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHh--hhccCCchhhhHHHHHHHHHHHh
Confidence 899999999986 467789999999999999999999875 2222221 12333456677788899999999
Q ss_pred CCCCCCCCH
Q 005999 632 KSPEQRPAM 640 (665)
Q Consensus 632 ~dP~~RPt~ 640 (665)
.+|.+|--.
T Consensus 224 r~p~nrLg~ 232 (612)
T KOG0603|consen 224 RNPENRLGA 232 (612)
T ss_pred hCHHHHhcc
Confidence 999999665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.6e-21 Score=209.60 Aligned_cols=241 Identities=21% Similarity=0.242 Sum_probs=174.8
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHH--HhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEA--VGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||.+.|=.|.+|..+.|. |+||++...... -..+.|.++++. ...++|||++++.-+-..++..|||-+|..+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPT-ISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCC-CCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 356999999999999999987 889998655421 223334443332 4455999999998887788888899999987
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc----CCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS----DSSS 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~----~~~~ 547 (665)
+|+|.+. ...-+...+...|+.|++.||.-+|+.+ |+|||||.+||||+.-.-+.|+||..-+.. +++.
T Consensus 106 -nLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~~g-VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 106 -NLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHKLG-VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred -hhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHHcC-ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 9999987 3445777788899999999999999999 999999999999999999999999754221 1111
Q ss_pred C------CCCCCCcccCCccccCCC----------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhcc
Q 005999 548 V------EDPDTVAYKAPEIRKSSR----------RATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRV 610 (665)
Q Consensus 548 ~------~~~gt~~y~aPE~~~~~~----------~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 610 (665)
. +...-..|.|||.+.... ..+++.||||+||++.||++ |++||.-. ++..+......
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~~~ 253 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGNAD 253 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccCcc
Confidence 0 111234699999765311 25778999999999999987 68887531 22222111000
Q ss_pred CCC--chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 611 DDG--REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 611 ~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
... ...-....+++++..|++.||++|.++++.++.-+
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 000 00011225899999999999999999999998744
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=170.04 Aligned_cols=182 Identities=16% Similarity=0.124 Sum_probs=136.7
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCch--hhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA--DTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
...|++|+||+||.+.- .+..++.+.+.....- ......+.+|+++|++|. |+++++++++ ...+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997766 5566776766554321 112235889999999994 5889999886 34689999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCC-CCCceEeCCCCceEEeecccccccCCCCCC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNL-KSSNVLLGADFEARLTDYCLSVLSDSSSVE 549 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 549 (665)
|.+|.+.+.. . ...++.|++.+|+++|+.+ |+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~------~------~~~~~~qi~~~L~~lH~~G-IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR------G------DLAYFRAARRLLQQLHRCG-VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh------h------hHHHHHHHHHHHHHHHHCc-CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998765321 1 1346789999999999999 999999 799999999999999999999765543310
Q ss_pred ----------------CCCCCcccCCccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCCC
Q 005999 550 ----------------DPDTVAYKAPEIRKSSRRAT-SKSDVYAFGVLLLELLTGKHPSQH 593 (665)
Q Consensus 550 ----------------~~gt~~y~aPE~~~~~~~~~-~k~DvwSlGvvl~elltg~~P~~~ 593 (665)
...++.|++|+...--...+ ...++++-|+-+|.++|+..|.-.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 11477788887543222233 567999999999999999988543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=172.52 Aligned_cols=141 Identities=16% Similarity=0.204 Sum_probs=111.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchh------------------------hHHHHHHHHHHHHhCCCCCCee
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD------------------------TSAEAFEQHMEAVGGLSHPNLV 450 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~niv 450 (665)
..||+|+||.||+|...+|+.||||+++...... .....+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4699999999999997789999999987653210 0122346789999999999875
Q ss_pred eeeEEEEeCCeEEEEEEecCCCCHHHH-HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCC
Q 005999 451 PIRAYFQAKGERLVIYDYQPNGSLFNL-IHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 451 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~ 528 (665)
....+.... .++||||++|+++... +. ...++......++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 83 ~p~~~~~~~--~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~~~g-ivHrDlkP~NIll~- 152 (190)
T cd05145 83 VPEPILLKK--NVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQEAG-LVHGDLSEYNILYH- 152 (190)
T ss_pred CceEEEecC--CEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCChhhEEEE-
Confidence 554444332 4899999998865443 32 2346778889999999999999999 88 99999999999999
Q ss_pred CCceEEeecccccccCC
Q 005999 529 DFEARLTDYCLSVLSDS 545 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~ 545 (665)
++.++|+|||++...+.
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999876644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.5e-20 Score=176.55 Aligned_cols=167 Identities=11% Similarity=0.172 Sum_probs=127.8
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhH-H------HHHHHHHHHHhCCCCCCeeeeeEEEEeC-------
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTS-A------EAFEQHMEAVGGLSHPNLVPIRAYFQAK------- 459 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-~------~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 459 (665)
.+++|.|+||.||.+.. ++..+|+|.+......... . +.+++|+..+.++.|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 46899999999999765 4668999999765443222 1 2268999999999999999999886643
Q ss_pred -CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecc
Q 005999 460 -GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYC 538 (665)
Q Consensus 460 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfg 538 (665)
+..+++|||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||+++.++ ++++|||
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g-i~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG-MVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC-CccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999988732 222 24569999999999999 99999999999999988 9999999
Q ss_pred cccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh
Q 005999 539 LSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586 (665)
Q Consensus 539 l~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt 586 (665)
............ .+.. ...+..++|+|+||+++.....
T Consensus 180 ~~~~~~e~~a~d---------~~vl-er~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 180 GKRCTAQRKAKD---------RIDL-ERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CcccccchhhHH---------HHHH-HhHhcccccccceeEeehHHHH
Confidence 875543221110 0222 3456679999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.5e-19 Score=177.01 Aligned_cols=232 Identities=18% Similarity=0.245 Sum_probs=148.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCC----------CCeeeeeEEEE-----
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSH----------PNLVPIRAYFQ----- 457 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~----- 457 (665)
+.||.|+++.||.++.. +++.+|+|++..... .....+.+++|.-....+.+ -.++-.++...
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 57999999999999975 589999999864442 23456777777766555433 12222222221
Q ss_pred ----eC---C-----eEEEEEEecCCCCHHHHHhc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCC
Q 005999 458 ----AK---G-----ERLVIYDYQPNGSLFNLIHG---SRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSS 522 (665)
Q Consensus 458 ----~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~ 522 (665)
.. . ..+++|+-+.+ ||.+++.. ... ....+....++.+..|+++.+++||+.+ ++|+||+|+
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-lVHgdi~~~ 174 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSYG-LVHGDIKPE 174 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHTT-EEEST-SGG
T ss_pred cceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhcc-eEeccccee
Confidence 11 1 23567887744 88887542 111 1223444556777899999999999999 999999999
Q ss_pred ceEeCCCCceEEeecccccccCCCCCCCCCCCcccCCccccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 005999 523 NVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSS-------RRATSKSDVYAFGVLLLELLTGKHPSQHPY 595 (665)
Q Consensus 523 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~k~DvwSlGvvl~elltg~~P~~~~~ 595 (665)
|++++.+|.++|+||+.....+........+..|.+||..... -.++.+.|.|++|+++|.|.+|..||....
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSS 254 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCG
T ss_pred eEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCC
Confidence 9999999999999998765554432222345779999976421 247889999999999999999999997532
Q ss_pred CCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCC
Q 005999 596 LAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQR 637 (665)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 637 (665)
.....-. ......+.++.+..+|..+|+.+|.+|
T Consensus 255 ~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 255 PEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 1111100 112233778889999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=164.27 Aligned_cols=132 Identities=14% Similarity=0.154 Sum_probs=102.6
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-----CCCCeeeeeEEEEeCC---eEE-EE
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-----SHPNLVPIRAYFQAKG---ERL-VI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv 465 (665)
+.||+|+||.||. .......+||++..... ...+.+.+|+.+++.+ .||||++++|+++++. ..+ +|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5799999999996 33333347888865432 3456789999999999 5799999999998863 434 78
Q ss_pred EEe--cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCeeccCCCCCceEeCC----CCceEEeecc
Q 005999 466 YDY--QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL-AYIHRASWLIHGNLKSSNVLLGA----DFEARLTDYC 538 (665)
Q Consensus 466 ~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~~iiH~Dlk~~Nill~~----~~~~kl~Dfg 538 (665)
+|| +.+|+|.+++... .+++. ..++.+++.++ +|||+.+ |+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~-IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR-IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5679999999632 24544 35577888777 9999999 999999999999974 3479999954
Q ss_pred c
Q 005999 539 L 539 (665)
Q Consensus 539 l 539 (665)
.
T Consensus 155 G 155 (210)
T PRK10345 155 G 155 (210)
T ss_pred C
Confidence 3
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.7e-18 Score=167.42 Aligned_cols=194 Identities=18% Similarity=0.229 Sum_probs=140.8
Q ss_pred CCCCeeeeeEEEEeC---------------------------CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHH
Q 005999 445 SHPNLVPIRAYFQAK---------------------------GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKI 497 (665)
Q Consensus 445 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 497 (665)
+|||||++.++|.+. ...|+||...+. +|.+++-. ...+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc------CCCchHHHHHH
Confidence 699999999887432 356788887766 89998863 23445566678
Q ss_pred HHHHHHHHHHHHhCCCeeccCCCCCceEeC--CCC--ceEEeecccccccCC---------CCCCCCCCCcccCCccccC
Q 005999 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLG--ADF--EARLTDYCLSVLSDS---------SSVEDPDTVAYKAPEIRKS 564 (665)
Q Consensus 498 ~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~--~~~--~~kl~Dfgl~~~~~~---------~~~~~~gt~~y~aPE~~~~ 564 (665)
+.|+++|+.|||+.+ |.|||+|++|||+. +|+ .+.|+|||.+..-+. ......|...-||||+...
T Consensus 347 laQlLEav~hL~~hg-vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG-VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHcc-chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999999 99999999999994 333 478999998643322 2233356778999998763
Q ss_pred CCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCC
Q 005999 565 SRR-----ATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPA 639 (665)
Q Consensus 565 ~~~-----~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 639 (665)
-.. ...|+|.|+.|.+.||+++...||.......-+...+.+.-. ...++.++..+++++...++.||.+|++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL--Palp~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL--PALPSRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC--CCCcccCChHHHHHHHHHhcCCccccCC
Confidence 221 246899999999999999999999762211112222222111 1246677888999999999999999999
Q ss_pred HHHHHHHHH
Q 005999 640 MWQVLKMIQ 648 (665)
Q Consensus 640 ~~evl~~L~ 648 (665)
..-....|+
T Consensus 504 p~iAANvl~ 512 (598)
T KOG4158|consen 504 PNIAANVLN 512 (598)
T ss_pred ccHHHhHHH
Confidence 876665553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=156.11 Aligned_cols=136 Identities=18% Similarity=0.305 Sum_probs=112.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCch------hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA------DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|++|.||+|.. .+..+++|+....... ......+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 5557888876543221 11234578899999999999998887777777888999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
++|++|.+++... .+ .+..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~-i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG-IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC-cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998631 11 77889999999999999999 99999999999999 78999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=158.59 Aligned_cols=141 Identities=15% Similarity=0.148 Sum_probs=107.8
Q ss_pred HhHhCcccceEEEEEE--ECCeEEEEEEEecCCCchh----------------------hHHHHHHHHHHHHhCCCCCC-
Q 005999 394 AELLGRGSIGTTYKAV--LDNHLIVTVKRFDANKTAD----------------------TSAEAFEQHMEAVGGLSHPN- 448 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~n- 448 (665)
.+.||+|+||.||+|. ..+|+.||+|+++...... .....+..|++.+.++.+..
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4679999999999998 5689999999987543110 01234678999999997533
Q ss_pred -eeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC
Q 005999 449 -LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG 527 (665)
Q Consensus 449 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~ 527 (665)
+.+++++ ...++||||+.+++|...... ...+.......++.||+.+++|||+.+.|+||||||+||+++
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 3444432 235899999999888765421 223555567789999999999999987699999999999999
Q ss_pred CCCceEEeecccccccC
Q 005999 528 ADFEARLTDYCLSVLSD 544 (665)
Q Consensus 528 ~~~~~kl~Dfgl~~~~~ 544 (665)
++.++|+|||.+...+
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999886543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=152.55 Aligned_cols=132 Identities=16% Similarity=0.277 Sum_probs=106.4
Q ss_pred HhCcccceEEEEEEECCeEEEEEEEecCCCch------hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA------DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.||+|+||.||+|.+. +..+++|+....... ....+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999864 567888886543211 112356788999999999888766666666667789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+|++|.+++... .. .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.+++.|||.+..
T Consensus 80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~~g-i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHKAG-IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHHCC-eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999987531 10 78899999999999999 99999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.8e-19 Score=155.13 Aligned_cols=152 Identities=28% Similarity=0.374 Sum_probs=140.5
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
...++.|.|++|.|+ .+|| .+..|.+|+.|+++||+|+..+++++.|++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 368999999999999 8888 799999999999999999999999999999999999999999 9999999999999999
Q ss_pred eeccccc-ccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 153 LSYNNLT-GLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 153 L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|++|+++ ..+|..|..++.|+.|+|++|.|.-++|+. .+++|+.|.+..|.+-..+-+.+.+..|..+.+.+|.-
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhccccee
Confidence 9999996 578999999999999999999999998888 89999999999999986666667888888898988853
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=174.44 Aligned_cols=135 Identities=19% Similarity=0.263 Sum_probs=108.8
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCch-----hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA-----DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||+||++.+.+...++.++....... ....+.+.+|++++..++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 3679999999999998766544333333221111 12245688999999999999999888888777788999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
+++++|.+++. ....++.+++.+|+|||+.+ ++||||||+||++ +++.++|+|||++...
T Consensus 418 ~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g-iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG-IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC-CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999874 24678999999999999999 9999999999999 6789999999998553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-16 Score=177.14 Aligned_cols=237 Identities=18% Similarity=0.242 Sum_probs=172.4
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC---CCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS---HPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
.+.+|+|+||.||+|...+|+.||+|+=+....-+. .-=.+++.+|+ -+-|..+...+.-.+.-++|+||.+
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 456999999999999988899999999776544221 11122334444 2344455555566677889999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-------CCceEEeeccccccc
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-------DFEARLTDYCLSVLS 543 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-------~~~~kl~Dfgl~~~~ 543 (665)
.|+|.+++. ..+.++|..++.++.|+++.+++||..+ |||+||||+|+||.. ...++|+|||-+.-+
T Consensus 778 ~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~~~-IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 778 YGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHAMG-IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred cccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHhcc-eecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999998 4566899999999999999999999999 999999999999942 345899999988544
Q ss_pred C---CC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCC--CCCCCC-CccHHHHHHhhccCCCch
Q 005999 544 D---SS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPS--QHPYLA-PPDMLEWVRTMRVDDGRE 615 (665)
Q Consensus 544 ~---~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~--~~~~~~-~~~~~~~~~~~~~~~~~~ 615 (665)
. +. -....+|-.+-.+|+.. +..++...|-|.++-+++-|+.|+.-- .+..+. ...+..++
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~---------- 920 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYW---------- 920 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchhhh----------
Confidence 2 22 12234677889999887 788999999999999999999997531 000000 00111111
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.....-+|+..+|+.|-..=|...++...++++....
T Consensus 921 --~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 921 --KRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred --hHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 1123556777778877666688888888888876654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=151.39 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=105.6
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchh--------------------hHHHHHHHHHHHHhCCCCCC--eee
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD--------------------TSAEAFEQHMEAVGGLSHPN--LVP 451 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~n--iv~ 451 (665)
.+.||+|+||.||++...+++.||||++....... .....+..|+.++..+.|++ +..
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 46799999999999998889999999876432110 01123677888888887774 444
Q ss_pred eeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc
Q 005999 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE 531 (665)
Q Consensus 452 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~ 531 (665)
.++ ....++||||++|++|.+.... .....++.+++.++.++|+.+ |+||||||+||++++++.
T Consensus 100 ~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g-i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 100 PID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG-IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred eee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC-CCcCCCCcccEEEcCCCc
Confidence 443 2356899999999998765320 234578899999999999999 999999999999999999
Q ss_pred eEEeecccccccCC
Q 005999 532 ARLTDYCLSVLSDS 545 (665)
Q Consensus 532 ~kl~Dfgl~~~~~~ 545 (665)
++|+|||.+...+.
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-17 Score=170.17 Aligned_cols=171 Identities=22% Similarity=0.317 Sum_probs=128.2
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
..|+.|+++.-.+|.+|+...+ .....++..++.++.|++.|+.| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~-~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG-LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc-chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997543 34567888899999999999999 66 899999999999999999999999998
Q ss_pred cccCCCC---------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC
Q 005999 541 VLSDSSS---------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD 611 (665)
Q Consensus 541 ~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 611 (665)
....... ....||..||+||.+. +..|+.|+||||+|++++|++. +|......... ...++....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t-~~d~r~g~ip 478 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLI---QFSTQFERIAT-LTDIRDGIIP 478 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHh-hhhhhcCCCC
Confidence 6654433 2346899999999998 7899999999999999999998 33322111111 1122222222
Q ss_pred CCchhhhHHHHHHHHHHcccCCCCCCCCHHHH
Q 005999 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQV 643 (665)
Q Consensus 612 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 643 (665)
.....+++. =..|+.+++.+.|.+||++.++
T Consensus 479 ~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 479 PEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence 112222222 3469999999999999954443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=168.48 Aligned_cols=198 Identities=20% Similarity=0.275 Sum_probs=135.0
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+++..|+||.||.++++ ..+.+|+ ++.+... -.++ ++.....|.+| |
T Consensus 88 IklisngAygavylvrh~~trqrfa~-kiNkq~l------ilRn---ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL------ILRN---ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhh-cccccch------hhhc---cccccCCccee---------------------c
Confidence 468999999999999865 4566776 3332221 0111 22222233322 3
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC-------
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS------- 545 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~------- 545 (665)
|-...++. .++++. +.+.+++|||+.+ |+|||+||.|.+|+.-|++|++|||+++..--
T Consensus 137 Dc~tllk~-----~g~lPv--------dmvla~Eylh~yg-ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 137 DCATLLKN-----IGPLPV--------DMVLAVEYLHSYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhhccc-----CCCCcc--------hhhHHhHhhccCC-eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 44444432 223332 2388999999999 99999999999999999999999998753210
Q ss_pred -----------CCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHH-HHHhhccCCC
Q 005999 546 -----------SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE-WVRTMRVDDG 613 (665)
Q Consensus 546 -----------~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~-~~~~~~~~~~ 613 (665)
......||+.|.|||++. -+.|...+|+|++|+++||.+-|+.||.... ..++.. .+...+.-..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVil-rqgygkpvdwwamGiIlyeFLVgcvpffGdt--peelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELFGQVISDDIEWPE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhh-hhccCCCccHHHHHHHHHHHheeeeeccCCC--HHHHHhhhhhhhccccc
Confidence 112235899999999987 5679999999999999999999999997631 222222 2222222222
Q ss_pred chhhhHHHHHHHHHHcccCCCCCCCC
Q 005999 614 REENRLGMLTEVASVCSLKSPEQRPA 639 (665)
Q Consensus 614 ~~~~~~~~l~~li~~cl~~dP~~RPt 639 (665)
..+..+.+.++++.+.|+.+|..|--
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 34556678999999999999999943
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.2e-15 Score=140.39 Aligned_cols=138 Identities=17% Similarity=0.224 Sum_probs=97.7
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHH----------------------HHHHHHHHhCCCCCC--ee
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEA----------------------FEQHMEAVGGLSHPN--LV 450 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~n--iv 450 (665)
+.||+|+||.||+|...+++.||||++............ ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 569999999999999888999999998754322111111 134555665554433 34
Q ss_pred eeeEEEEeCCeEEEEEEecCCCCHHH-HHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCC
Q 005999 451 PIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 451 ~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~ 528 (665)
+.+++ ...++||||++++++.. .+... ... .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~~-ivH~Dl~p~Nili~- 149 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREAG-LVHGDLSEYNILVD- 149 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhccC-cCcCCCChhhEEEE-
Confidence 44433 23589999999954321 11110 011 4567899999999999999 77 99999999999999
Q ss_pred CCceEEeecccccccCC
Q 005999 529 DFEARLTDYCLSVLSDS 545 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~ 545 (665)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-16 Score=175.17 Aligned_cols=245 Identities=20% Similarity=0.283 Sum_probs=188.8
Q ss_pred HhCcccceEEEEEEE--CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVL--DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+|+.|-.... +....+|+|.+..........+....|..+-..+. |+|++.+++...+....+++++|..++
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 489999999988774 33445666665544323344455666777777776 999999999999999999999999999
Q ss_pred CHHHHH-hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCCCceEeCCCC-ceEEeecccccccCC-CC-
Q 005999 473 SLFNLI-HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-RASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDS-SS- 547 (665)
Q Consensus 473 sL~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~-~~- 547 (665)
++.+-+ +. .....+......++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||++..... ..
T Consensus 107 ~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~~~-~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~ 181 (601)
T KOG0590|consen 107 SLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPENG-VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA 181 (601)
T ss_pred ccccccccC----CccCCCCcchhhhhhhhccCccccCcccc-cccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence 999888 42 1113455566778999999999999 777 99999999999999999 999999999966544 22
Q ss_pred ----CCCCC-CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHH
Q 005999 548 ----VEDPD-TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGM 621 (665)
Q Consensus 548 ----~~~~g-t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 621 (665)
....| ++.|+|||...+.....+..|+||.|+++.-+++|..|++.+.........|...... ...........
T Consensus 182 ~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (601)
T KOG0590|consen 182 ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQ 261 (601)
T ss_pred ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChh
Confidence 12247 8999999998743456778999999999999999999998876665555555544322 12334455667
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+++.+++..+|.+|.+.+++..
T Consensus 262 ~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 262 AHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred hhhcccccccCCchhccccccccc
Confidence 888999999999999999888754
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.1e-15 Score=152.58 Aligned_cols=160 Identities=24% Similarity=0.306 Sum_probs=127.4
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccC-cccCCcCcc-----------
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSR-NFFSGAFPL----------- 140 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~-N~l~~~~p~----------- 140 (665)
...++|+|..|+|+ .||+..|+.+.+|+.||||+|+|+.+-| .|.+|++|..|-+.+ |+|+ .+|.
T Consensus 67 ~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqr 144 (498)
T KOG4237|consen 67 PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQR 144 (498)
T ss_pred CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHH
Confidence 36889999999999 8999999999999999999999999888 787777776664433 6665 1111
Q ss_pred --------------------------------------------------------------------------------
Q 005999 141 -------------------------------------------------------------------------------- 140 (665)
Q Consensus 141 -------------------------------------------------------------------------------- 140 (665)
T Consensus 145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar 224 (498)
T KOG4237|consen 145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR 224 (498)
T ss_pred HhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence
Q ss_pred --------------------------------------------cccCCCCCCEEEeecccccccCCccccCCCccCeee
Q 005999 141 --------------------------------------------SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLK 176 (665)
Q Consensus 141 --------------------------------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 176 (665)
.|.+|++|+.|+|++|+|++.-+.+|..+..|++|+
T Consensus 225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~ 304 (498)
T KOG4237|consen 225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY 304 (498)
T ss_pred ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence 144555778888888888877777888888888888
Q ss_pred cccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCCCCCCCCC
Q 005999 177 LEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNLCGKVINK 235 (665)
Q Consensus 177 l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~lc~~~~~~ 235 (665)
|..|+|...-... +++.|++|+|.+|+|+..-|.. ..+..|..+.+-+||+.|+|-+..
T Consensus 305 L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w 366 (498)
T KOG4237|consen 305 LTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW 366 (498)
T ss_pred cCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence 8888877554443 7789999999999999877743 456678889999999999998753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.6e-17 Score=143.61 Aligned_cols=152 Identities=22% Similarity=0.290 Sum_probs=134.4
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccC-CcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS-GAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ 152 (665)
..+..|++.+|++. .+|+ .++.|++|+.|+++-|++...+..|+.++.|+.|||++|+++ ..+|+.|..|+.|+.|+
T Consensus 56 ~nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 57888999999999 8998 899999999999999999977779999999999999999998 47899999999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccC---cCcccccCCCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLK---FDASSFSMNPNL 228 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~---l~~~~~~~n~~l 228 (665)
|+.|.+. .+|..+++|++|+.|.+.+|.+-..+-+. .++.|+.|.+.+|+++-.+|+...+.- -....+.+|||.
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9999999 88999999999999999999998877777 889999999999999988876544432 234456777774
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.8e-14 Score=140.21 Aligned_cols=138 Identities=18% Similarity=0.188 Sum_probs=105.2
Q ss_pred HHhHhC-cccceEEEEEEECCeEEEEEEEecCCCc-----------hhhHHHHHHHHHHHHhCCCCCCe--eeeeEEEEe
Q 005999 393 SAELLG-RGSIGTTYKAVLDNHLIVTVKRFDANKT-----------ADTSAEAFEQHMEAVGGLSHPNL--VPIRAYFQA 458 (665)
Q Consensus 393 ~~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~ 458 (665)
....|| .|+.|+||++... +..+++|++..... .......+.+|++++.+++|++| +..+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 345787 8999999999876 55688888753211 01223467889999999998885 667776543
Q ss_pred CC----eEEEEEEecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 459 KG----ERLVIYDYQPN-GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 459 ~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
+. ..++|+||++| .+|.+++.. ..++.. .+.+|+.++.+||+.+ |+||||||.|||++.++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G-I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG-VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC-CCCCCCCchhEEEcCCCCEE
Confidence 22 23599999997 699988763 234443 3568999999999999 99999999999999999999
Q ss_pred Eeecccccc
Q 005999 534 LTDYCLSVL 542 (665)
Q Consensus 534 l~Dfgl~~~ 542 (665)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.8e-14 Score=130.48 Aligned_cols=131 Identities=18% Similarity=0.181 Sum_probs=109.4
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCC--CCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH--PNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .+++++++++...+..++++||+.++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 468999999999999866 6789998865542 4568889999999976 58999999988888899999999987
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS--WLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
.+..+ +......++.+++.+++++|... .++|+|++|+||++++++.+++.|||.+..
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66532 44566778999999999999852 399999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.9e-16 Score=159.49 Aligned_cols=137 Identities=26% Similarity=0.231 Sum_probs=103.4
Q ss_pred ceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCC
Q 005999 68 GVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLH 146 (665)
Q Consensus 68 gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 146 (665)
|+.-.-.++..|+|..|++. .+..+++.+|+.|+.|+||+|.|..+.+ .+...++|++|+|++|+|+...+..|..|.
T Consensus 263 G~Fy~l~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~ 341 (873)
T KOG4194|consen 263 GAFYGLEKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS 341 (873)
T ss_pred cceeeecccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence 33333357889999999999 6777789999999999999999998888 677788999999999999966677787777
Q ss_pred CCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-----CCCCcceEeccccccc
Q 005999 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-----NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 147 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~L~~l~l~~N~l~ 205 (665)
+|+.|+|++|+++..-...|..+++|+.|||++|.|++.+-+. .+++|+.|++.+|+|.
T Consensus 342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence 7777777777777555556667777777777777777665432 4555566666666555
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-15 Score=158.88 Aligned_cols=161 Identities=19% Similarity=0.205 Sum_probs=142.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..+..|+|++|.+. .|..+.+.-.++|++|+|++|+|+...+ .|..|..|+.|+|++|+++..-...|..+++|+.||
T Consensus 293 t~L~~L~lS~NaI~-rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld 371 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQ-RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD 371 (873)
T ss_pred chhhhhccchhhhh-eeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence 46888999999999 6877789999999999999999999999 899999999999999999976777899999999999
Q ss_pred eecccccccCCc---cccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 153 LSYNNLTGLIPV---NLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 153 L~~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|++|.|++.+.+ .|..|++|+.|+|.+|+|..++... .+..|+.|||.+|.|...-|+...-.+|..+-+..-..
T Consensus 372 Lr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 372 LRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSF 451 (873)
T ss_pred CcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccce
Confidence 999999988876 4678999999999999999877664 89999999999999997767554434788888888889
Q ss_pred CCCCCCCC
Q 005999 228 LCGKVINK 235 (665)
Q Consensus 228 lc~~~~~~ 235 (665)
+|+|.+..
T Consensus 452 lCDCql~W 459 (873)
T KOG4194|consen 452 LCDCQLKW 459 (873)
T ss_pred EEeccHHH
Confidence 99998764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-15 Score=160.15 Aligned_cols=129 Identities=32% Similarity=0.371 Sum_probs=85.1
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccC-------------------
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS------------------- 135 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~------------------- 135 (665)
....|+|++|++. +||...|-+|+.|-.||||+|++...+|.+..|.+|+.|+|++|.|.
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 4555666666666 67766677777777777777777777777777777777777776543
Q ss_pred ------CcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEeccccccc
Q 005999 136 ------GAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 136 ------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~ 205 (665)
..+|.++..|.+|..+|||.|+|. .+|+.+.++.+|+.|+||+|+|+.+--.. ...+|++||||.|+|+
T Consensus 206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc
Confidence 345666666777777777777777 66777777777777777777766443322 3334555555555554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-15 Score=157.68 Aligned_cols=150 Identities=31% Similarity=0.406 Sum_probs=91.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccC-CcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS-GAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|.|...+|. .+|. +++.|.+|+.|.+++|++..+.-+++.|+.|+.+++..|+|. .-||..+.+|..|..||
T Consensus 32 t~~~WLkLnrt~L~-~vPe-EL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPE-ELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChH-HHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence 45666666666666 5654 566666666666666666655555666666666666666654 34566666666666666
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
||+|+|+ ..|..+...+++-.|+||+|++..+|... +++.|-.||||+|+|...+|....|..|+.+.+++||
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCCh
Confidence 6666665 55666666666666666666665554443 5555666666666666555555555555566666655
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.2e-15 Score=150.55 Aligned_cols=146 Identities=22% Similarity=0.306 Sum_probs=90.6
Q ss_pred EEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeec
Q 005999 76 VVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155 (665)
Q Consensus 76 v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 155 (665)
+..+++.+|.+. .+|++.+. ++.|+.||...|-++.+||+++.|.+|..|+|.+|+|. .+| +|.++..|+.|+++.
T Consensus 162 l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~ 237 (565)
T KOG0472|consen 162 LSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGE 237 (565)
T ss_pred HHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcc
Confidence 344555555555 44443332 55666666666666655556666666666666666666 555 666666666666666
Q ss_pred ccccccCCcccc-CCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 156 NNLTGLIPVNLT-ALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 156 N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|+|. .+|.... .+++|..|||.+|+++..|.+. .+.+|.+||+++|.+++.++..+.+ .|..+.+.|||-
T Consensus 238 N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 238 NQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred cHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 6666 5555544 6677777777777777666655 5566777777777777666666666 666666677653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.2e-13 Score=130.75 Aligned_cols=201 Identities=20% Similarity=0.324 Sum_probs=137.7
Q ss_pred HHHHhCCCCCCeeeeeEEEEeCC-----eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 005999 438 MEAVGGLSHPNLVPIRAYFQAKG-----ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA- 511 (665)
Q Consensus 438 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~- 511 (665)
..-+-.+.|.|||+++.||.+.+ +..+++|||..|++.++|++.+. ....+....-.+|+-||..||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34455567999999999986543 57899999999999999986443 345566667778999999999999995
Q ss_pred CCeeccCCCCCceEeCCCCceEEeecccccccC------C-CCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHH
Q 005999 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD------S-SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLEL 584 (665)
Q Consensus 512 ~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~------~-~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~el 584 (665)
++|+|+++..+-|++..+|-+|+.--....... . ......+-++|.+||+-. ....+..+|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHH
Confidence 469999999999999999888875321111100 0 011123568999999865 34567789999999999999
Q ss_pred HhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 585 LTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 585 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.-+..--.... ......+.+.........+ .=+.++.+|++..|..||+|++++..
T Consensus 276 ailEiq~tnse-S~~~~ee~ia~~i~~len~-----lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSE-SKVEVEENIANVIIGLENG-----LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCc-ceeehhhhhhhheeeccCc-----cccCcCcccccCCCCCCcchhhhhcC
Confidence 88764311110 1111111111111100011 12368999999999999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.3e-13 Score=142.64 Aligned_cols=251 Identities=19% Similarity=0.178 Sum_probs=180.7
Q ss_pred cCHHHHHHHHHhHhCc--ccceEEEEEEE---CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEE
Q 005999 384 YSLEQLMRASAELLGR--GSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQ 457 (665)
Q Consensus 384 ~~~~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 457 (665)
+++.+........+|. |.+|.||.+.. .++..+|+|+-+...........=.+|+....++ .|+|.++.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444444444567899 99999999986 3577788887443332222222223455555556 6999999889999
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCeeccCCCCCceEeCCC-Cce
Q 005999 458 AKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ----GLAYIHRASWLIHGNLKSSNVLLGAD-FEA 532 (665)
Q Consensus 458 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~ 532 (665)
+.+..++-+|++. .+|.++.+. ....++....+.+..+... |+.++|..+ ++|-|+||.||++..+ ...
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~-~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN-IVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cCCcceeeecccc-chhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCc-ccccccchhheeccccccee
Confidence 9999999999885 688888774 3344667778888888888 999999999 9999999999999999 889
Q ss_pred EEeecccccccCCCCCC--------CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHH
Q 005999 533 RLTDYCLSVLSDSSSVE--------DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEW 604 (665)
Q Consensus 533 kl~Dfgl~~~~~~~~~~--------~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 604 (665)
+++|||+...+...... ..+...|++||... ..++...|+|++|.++.+..++..+....... --..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---~W~~ 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVGKNS---SWSQ 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCCCCC---Cccc
Confidence 99999998766554311 13567899999876 56889999999999999999987764432100 0001
Q ss_pred HHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 605 VRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 605 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+....+....+.....+...+..+++++|-.|++.+.+..
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111222333444556777999999999999999877654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-12 Score=138.88 Aligned_cols=143 Identities=17% Similarity=0.209 Sum_probs=99.9
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhH--------------------------------------HHHHHH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTS--------------------------------------AEAFEQ 436 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------------------------------~~~~~~ 436 (665)
+.||.|++|.||+|++.+|+.||||+.+........ +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998664311100 012444
Q ss_pred HHHHHhCC----C-CCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 005999 437 HMEAVGGL----S-HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ-GLAYIHR 510 (665)
Q Consensus 437 e~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~L~yLH~ 510 (665)
|.+.+.++ + ++++.-..-+....+..++||||++|++|.++..... ...+ +.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence 55544444 2 3443322222333456799999999999988765311 1122 3456666666 4788899
Q ss_pred CCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 511 ~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
.+ ++|+|++|.||++++++++++.|||++...++
T Consensus 276 ~g-~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG-FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC-ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 98 99999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.5e-14 Score=139.40 Aligned_cols=149 Identities=27% Similarity=0.350 Sum_probs=128.8
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
-|+.++++.|+|. ++|. .+..+..+.+.-+.+|+.-+.+| .++.+++|..|+|++|-+. .+|.+++.+..|+.|||
T Consensus 389 ~Vt~VnfskNqL~-elPk-~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~Lnl 465 (565)
T KOG0472|consen 389 IVTSVNFSKNQLC-ELPK-RLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNL 465 (565)
T ss_pred ceEEEecccchHh-hhhh-hhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecc
Confidence 4999999999999 8887 57777766654444444445666 8899999999999999999 99999999999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCC-C-CCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP-L-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
++|+|. .+|..+..+..|+++-.++|++....+. . ++.+|.+|||.+|.+...+|..+.+.++..+.++|||.
T Consensus 466 S~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 466 SFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred cccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 999998 8899888888899998899999888877 3 88999999999999998888889999999999999986
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-11 Score=130.17 Aligned_cols=224 Identities=15% Similarity=0.178 Sum_probs=147.2
Q ss_pred ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCC
Q 005999 410 LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPL 489 (665)
Q Consensus 410 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l 489 (665)
..++..|.|...+.... ...+...+-++.++.++||||++++..++.++..|+|+|.+. .|..++++ +
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------L 101 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------h
Confidence 44667777777655443 334556777888999999999999999999999999999875 56666653 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCCCCCCcccCCccccCCC
Q 005999 490 HWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VEDPDTVAYKAPEIRKSSR 566 (665)
Q Consensus 490 ~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~gt~~y~aPE~~~~~~ 566 (665)
........+.||+.||.|||+.+.++|++|.-..|++++.|+.||++|-+....+... .....-..|..|+.+...
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s- 180 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS- 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-
Confidence 2334445688999999999976669999999999999999999999998764443322 111122346667755421
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHH-----HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHH
Q 005999 567 RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML-----EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMW 641 (665)
Q Consensus 567 ~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 641 (665)
. -..|.|-|||+++|++.|..+-...-...+.+. .+.+...... -..+. ..+++..|....+--|=.+-
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~---~~r~n-~~~~~~~~~~~~gff~n~fv 254 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATE---LKRPN-KLRFILECRLLGGFFRNDFV 254 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhcccc---ccccc-hhhHHHHHHhccccccchHH
Confidence 1 236999999999999999332111000011111 1111111110 01111 55667777776666676777
Q ss_pred HHHHHHHHHHh
Q 005999 642 QVLKMIQEIKE 652 (665)
Q Consensus 642 evl~~L~~~~~ 652 (665)
+++..|+++.-
T Consensus 255 d~~~fLeel~l 265 (690)
T KOG1243|consen 255 DTLLFLEELRL 265 (690)
T ss_pred HHHHHHHhccc
Confidence 77777776643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.3e-13 Score=146.58 Aligned_cols=152 Identities=33% Similarity=0.385 Sum_probs=125.8
Q ss_pred CCEEEEEecCCCCcccCCccccC-------------------------CCCCCcEEEccCCcCcc-CCCCCCCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLT-------------------------RLDQLRVLSLHNNSLTG-PIPDLSSLINLKSL 127 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~-------------------------~l~~L~~L~L~~N~l~~-~~p~~~~l~~L~~L 127 (665)
..+.+|+|+.|+|. .+|+..+. .+..|+.|+|.+|.|+. ..|-+.+.++|+.|
T Consensus 310 ~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL 388 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL 388 (1081)
T ss_pred ceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence 35899999999998 66653222 23347789999999986 45678899999999
Q ss_pred EccCcccCCcCcc-cccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccc
Q 005999 128 SLSRNFFSGAFPL-SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 128 ~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~ 206 (665)
+|++|+|+ .+|+ .+.+|..|+.|+||+|+|+ .+|..+.++..|++|...+|+|...|-...++.|+.+|++.|+|+-
T Consensus 389 hLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 389 HLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred eecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhh
Confidence 99999999 7776 5678999999999999999 8899999999999999999999877733399999999999999984
Q ss_pred -cCCCCCcccCcCcccccCCCCC
Q 005999 207 -QVPETPTLLKFDASSFSMNPNL 228 (665)
Q Consensus 207 -~~p~~~~l~~l~~~~~~~n~~l 228 (665)
.+|.....++|+.++++||.++
T Consensus 467 ~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 467 VTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhhhhCCCcccceeeccCCccc
Confidence 3554444478999999999974
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.8e-11 Score=134.53 Aligned_cols=136 Identities=25% Similarity=0.311 Sum_probs=96.7
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
..+.|+|++++|+ .+|. .+. ++|+.|+|++|+|+.+++.+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~-~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPA-CIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCc-ccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4667888888888 6775 343 578899999999997665543 58899999999988 6777664 468888888
Q ss_pred cccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
+|+|. .+|..+. ++|+.|+|++|+|+.+ |....++|+.|++++|+|++.++.. ..++..+++++|
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~~sL~~L~Ls~N~Lt~LP~~l--p~sL~~L~Ls~N 314 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISCL-PENLPEELRYLSVYDNSIRTLPAHL--PSGITHLNVQSN 314 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCcc-ccccCCCCcEEECCCCccccCcccc--hhhHHHHHhcCC
Confidence 88888 6776654 4788888888888864 3333357888888888888543211 123455555555
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=110.73 Aligned_cols=139 Identities=12% Similarity=0.120 Sum_probs=99.3
Q ss_pred hHhCcccceEEEEEEECC-------eEEEEEEEecCCCc-----------h---------hhHHHH----HHHHHHHHhC
Q 005999 395 ELLGRGSIGTTYKAVLDN-------HLIVTVKRFDANKT-----------A---------DTSAEA----FEQHMEAVGG 443 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~----~~~e~~~l~~ 443 (665)
..||.|.-+.||.|...+ +..+|||+.+.... . ....+. .++|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998543 47899998743211 0 001222 3489999988
Q ss_pred CCC--CCeeeeeEEEEeCCeEEEEEEecCCCCHHH-HHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeeccCC
Q 005999 444 LSH--PNLVPIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI-HRASWLIHGNL 519 (665)
Q Consensus 444 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~iiH~Dl 519 (665)
+.. -++..++++ ...++||||+.+..+.. .++ ...++......+..+++.+|.+| |+.+ ++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk------d~~~~~~~~~~i~~~i~~~l~~l~H~~g-lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK------DAKLNDEEMKNAYYQVLSMMKQLYKECN-LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh------ccccCHHHHHHHHHHHHHHHHHHHHhCC-eecCCC
Confidence 843 466667765 45689999997754422 222 22344556677889999999999 7888 999999
Q ss_pred CCCceEeCCCCceEEeecccccccCC
Q 005999 520 KSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 520 k~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
++.||+++ ++.+.++|||.+...++
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46899999999876654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.7e-11 Score=112.54 Aligned_cols=127 Identities=17% Similarity=0.143 Sum_probs=93.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCee-eeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV-PIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.++.|.++.||++... +..+++|....... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 45789999999999876 56789998755432 123457788888887655544 4554432 34579999999987
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----eeccCCCCCceEeCCCCceEEeeccccc
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW----LIHGNLKSSNVLLGADFEARLTDYCLSV 541 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----iiH~Dlk~~Nill~~~~~~kl~Dfgl~~ 541 (665)
+.+. . . ....++.+++++|+.||+.+. ++|+|++|.||+++ ++.++++||+.+.
T Consensus 78 l~~~-~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE-D---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-c---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7542 0 0 112356789999999999872 49999999999999 6789999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.4e-12 Score=133.34 Aligned_cols=242 Identities=17% Similarity=0.119 Sum_probs=172.7
Q ss_pred hHhCcccceEEEEEEE--CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVL--DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
..||.|.|+.|++... .++..|++|.+............-..|+.+...+ .|.+++++...|......|+--||+.+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 4699999999999874 4678889888765543333333334455555445 689999988888777778899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSSVED 550 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~~~~ 550 (665)
+++...+. ....+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+..+.-.....
T Consensus 351 ~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~-~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~ 424 (524)
T KOG0601|consen 351 GSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL-FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVF 424 (524)
T ss_pred cchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh-hhcccccccceeeccchhhhhccccccccccceecccc
Confidence 98876653 3345777888999999999999999999 9999999999999886 788999999886543332222
Q ss_pred CCCCcccC-CccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKA-PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~a-PE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
...-++++ .|.+.....+..+.|+||||..+.|.+++..--.. ......++.... .........+..+...+
T Consensus 425 ~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----~~~~~~i~~~~~--p~~~~~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 425 HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----GVQSLTIRSGDT--PNLPGLKLQLQVLLKVM 497 (524)
T ss_pred cccccccccchhhccccccccccccccccccccccccCcccCcc-----cccceeeecccc--cCCCchHHhhhhhhhhh
Confidence 33444552 55554466788899999999999999998753211 111111121111 12223336688899999
Q ss_pred ccCCCCCCCCHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~ 649 (665)
..+++..||.+.+.....+.
T Consensus 498 ~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cCCccccchhhhhhcccchh
Confidence 99999999999888765543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-11 Score=137.45 Aligned_cols=118 Identities=41% Similarity=0.571 Sum_probs=91.7
Q ss_pred CCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecc
Q 005999 100 QLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLE 178 (665)
Q Consensus 100 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 178 (665)
.++.|+|++|.++|.+| .++.|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47788999999988888 78888999999999999988899888889999999999999998888888888888888888
Q ss_pred cccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCCCCCCCCC
Q 005999 179 WNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKAC 237 (665)
Q Consensus 179 ~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~~~~~~~c 237 (665)
+|+|+|.+|..-. ..+.++..+++.+|+.+|+.+....|
T Consensus 499 ~N~l~g~iP~~l~--------------------~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALG--------------------GRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHh--------------------hccccCceEEecCCccccCCCCCCCC
Confidence 8888877764310 00122345678888888876533334
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-11 Score=133.43 Aligned_cols=143 Identities=12% Similarity=0.104 Sum_probs=90.3
Q ss_pred hHhCcccceEEEEEEECC-eEEEEEEEecCCCchh--------------------------------hHHH------HHH
Q 005999 395 ELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTAD--------------------------------TSAE------AFE 435 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~~------~~~ 435 (665)
+.||+|++|.||+|++++ |+.||||+.+...... +..+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999887 9999999997552100 0111 233
Q ss_pred HHHHHHhCC----CCCCeeeeeEEEEe-CCeEEEEEEecCCCCHHHHHhcC-CCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005999 436 QHMEAVGGL----SHPNLVPIRAYFQA-KGERLVIYDYQPNGSLFNLIHGS-RSIRAKPLHWTSCLKIAEDVAQGLAYIH 509 (665)
Q Consensus 436 ~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~l~~~~~~~i~~~i~~~L~yLH 509 (665)
+|+..+.++ .+.+.+.+-.++.+ ....++||||+.|+.+.++-.-. .......+.......++.| ++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence 444433333 24443443333332 45678999999999998752211 1101111222222222233 34
Q ss_pred hCCCeeccCCCCCceEeCCCC----ceEEeecccccccCC
Q 005999 510 RASWLIHGNLKSSNVLLGADF----EARLTDYCLSVLSDS 545 (665)
Q Consensus 510 ~~~~iiH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~~ 545 (665)
..+ ++|+|+||.||+++.++ ++++.|||+....+.
T Consensus 278 ~~G-ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDG-FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCC-eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 577 99999999999999888 999999999876654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.7e-13 Score=137.39 Aligned_cols=147 Identities=25% Similarity=0.310 Sum_probs=110.9
Q ss_pred EEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeec
Q 005999 76 VVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155 (665)
Q Consensus 76 v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 155 (665)
|..+.|..|-+. .||+ .+.+|..|++|||+.|+++-.++.+..|+ |+.|-+++|+++ .+|+.++.+..|..||.+.
T Consensus 100 Le~liLy~n~~r-~ip~-~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ 175 (722)
T KOG0532|consen 100 LESLILYHNCIR-TIPE-AICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK 175 (722)
T ss_pred HHHHHHHhccce-ecch-hhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence 334445555555 5665 67778888888888888877766666655 777888888887 7888888777888888888
Q ss_pred ccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 156 NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|++. .+|..++.+.+|+.|.+..|++...+++...-.|..||++.|+++..+-....+..|..+.+..||-
T Consensus 176 nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred hhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCceeecchhhhhhhhheeeeeccCCC
Confidence 8887 7777788888888888888888877777655568899999999995444556778888888888885
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-12 Score=141.99 Aligned_cols=127 Identities=30% Similarity=0.400 Sum_probs=115.2
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..+..|.|.+|.|+...-| .+.+..+|+.|+|++|+|...+. .+.+|..|+.|+||+|+|+ .+|+.+.++.+|++|.
T Consensus 359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 3688899999999987776 79999999999999999998777 7899999999999999999 9999999999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccC-CCC-CCCCcceEecccccc
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTV-PPL-NQPFLVVFNVSGNNL 204 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~-~~~~L~~l~l~~N~l 204 (665)
..+|+|. ..| .+.++++|+.+|++.|+|+... |.. ..++|++|||++|.-
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999 888 8999999999999999998654 333 448999999999973
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.6e-11 Score=132.99 Aligned_cols=116 Identities=28% Similarity=0.256 Sum_probs=54.7
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC---CCC----------C----CCCCCEEEccCcccCCc
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP---DLS----------S----LINLKSLSLSRNFFSGA 137 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~----------~----l~~L~~L~Ls~N~l~~~ 137 (665)
.++.|+|++|+|+ .+|. .+++|+.|+|++|+|+++++ .+. . ..+|+.|+|++|+|+ .
T Consensus 283 ~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~ 356 (788)
T PRK15387 283 GLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-S 356 (788)
T ss_pred hcCEEECcCCccc-cccc----cccccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccC-C
Confidence 3445555555555 3443 12455555666655555322 110 0 135677777777777 4
Q ss_pred CcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEeccccccc
Q 005999 138 FPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205 (665)
Q Consensus 138 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~ 205 (665)
+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+++++. .++|+.|++++|+|+
T Consensus 357 LP~lp---~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~LP~l--~s~L~~LdLS~N~Ls 415 (788)
T PRK15387 357 LPTLP---SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLPVL--PSELKELMVSGNRLT 415 (788)
T ss_pred CCCCC---cccceehhhccccc-cCccc---ccccceEEecCCcccCCCCc--ccCCCEEEccCCcCC
Confidence 55422 34444555555555 23432 13445555555555543221 133444444444444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-10 Score=133.15 Aligned_cols=138 Identities=23% Similarity=0.289 Sum_probs=103.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|+|++|+|+ .+|.. +. .+|+.|+|++|+|+.++..+. .+|+.|+|++|++. .+|..+. .+|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~-l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPEN-LQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChh-hc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 57899999999999 78873 43 589999999999997655443 47999999999998 7887775 57999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
++|+|+ .+|..+. ++|+.|+|++|+|+++++.. .++|+.|++++|+|+..++. ...+|..+.+++|.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l-p~sL~~L~Ls~N~Lt~LP~~--l~~sL~~L~Ls~N~ 336 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHL-PSGITHLNVQSNSLTALPET--LPPGLKTLEAGENA 336 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccccCcccc-hhhHHHHHhcCCccccCCcc--ccccceeccccCCc
Confidence 999998 5777664 58999999999998765432 24677778888887753221 12455666666654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.1e-11 Score=111.65 Aligned_cols=108 Identities=31% Similarity=0.390 Sum_probs=33.8
Q ss_pred cCCCCCCcEEEccCCcCccCCCCCC-CCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccc-cCCCcc
Q 005999 95 LTRLDQLRVLSLHNNSLTGPIPDLS-SLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNL-TALDRL 172 (665)
Q Consensus 95 ~~~l~~L~~L~L~~N~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L 172 (665)
+.+..+++.|+|.+|.|+.+ ..++ .+.+|+.|||++|.|+ .++ .+..+++|++|+|++|+|+ .++..+ ..+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred cccccccccccccccccccc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 55556677777777777653 3454 4667777777777777 444 4666777777777777777 444334 356777
Q ss_pred CeeecccccccccCCC--C-CCCCcceEecccccccc
Q 005999 173 YSLKLEWNRFSGTVPP--L-NQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 173 ~~L~l~~N~l~~~~~~--~-~~~~L~~l~l~~N~l~~ 206 (665)
+.|+|++|++...-.- . .+++|+.|++.+|+++.
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 7777777777654221 1 56778888888888774
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.9e-11 Score=111.14 Aligned_cols=119 Identities=32% Similarity=0.366 Sum_probs=46.1
Q ss_pred CEEEEEecCCCCcccCCccccC-CCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccc-cCCCCCCEEE
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLT-RLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSI-LSLHRLTILD 152 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 152 (665)
+++.|+|.+|+++ .|. .++ .|.+|+.|+|++|.|+.+ +.+..|++|+.|+|++|+|+ .+++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-ccc--chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 6788999999988 564 365 578899999999999865 45778889999999999998 565555 3588999999
Q ss_pred eecccccccCC-ccccCCCccCeeecccccccccCCC-----CCCCCcceEe
Q 005999 153 LSYNNLTGLIP-VNLTALDRLYSLKLEWNRFSGTVPP-----LNQPFLVVFN 198 (665)
Q Consensus 153 L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~-----~~~~~L~~l~ 198 (665)
|++|+|...-- ..+..+++|+.|+|.+|.++....- ..+|+|+.||
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 99999873221 2467788899999999988754221 0456666665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-09 Score=100.55 Aligned_cols=134 Identities=16% Similarity=0.249 Sum_probs=101.0
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhh-----HHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADT-----SAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
..+++|+-+.+|.+.+.+...|.-.++.+....+. ..+...+|..++.+++--.|....-+..+.....++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35789999999999876554333334444333222 2344667899998887666666666667777788999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+|-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g-ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG-IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC-eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888732 2456677778888999999 99999999999998764 99999999854
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.8e-10 Score=126.99 Aligned_cols=96 Identities=25% Similarity=0.245 Sum_probs=51.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|.+|+|+ .||. .+++|++|+|++|+|+.+++. .++|+.|+|++|.|+ .+|..+ .+|+.|+|
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~LtsLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~L 289 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTSLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWI 289 (788)
T ss_pred cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCcccCc---ccccceeeccCCchh-hhhhch---hhcCEEEC
Confidence 35666777777777 4554 246677777777777755432 245555555555555 344322 33444555
Q ss_pred ecccccccCCccccCCCccCeeeccccccccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT 185 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 185 (665)
++|+|+ .+|. .+++|+.|+|++|+|+++
T Consensus 290 s~N~Lt-~LP~---~p~~L~~LdLS~N~L~~L 317 (788)
T PRK15387 290 FGNQLT-SLPV---LPPGLQELSVSDNQLASL 317 (788)
T ss_pred cCCccc-cccc---cccccceeECCCCccccC
Confidence 555554 3332 124455555555555543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.7e-11 Score=121.59 Aligned_cols=151 Identities=23% Similarity=0.271 Sum_probs=122.5
Q ss_pred EecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe-eccc
Q 005999 80 VLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL-SYNN 157 (665)
Q Consensus 80 ~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-~~N~ 157 (665)
+=++.+|+ .+|.+ + -+.-..|+|..|+|+.++| .|+.+++|+.||||+|+|+-+-|+.|.+|.+|..|-+ ++|+
T Consensus 52 dCr~~GL~-eVP~~-L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 52 DCRGKGLT-EVPAN-L--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EccCCCcc-cCccc-C--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 33445555 45431 1 1246789999999999999 8999999999999999999999999999999876655 4599
Q ss_pred ccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCC-CCCcccCcCcccccCCCCCCCCCCC
Q 005999 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVP-ETPTLLKFDASSFSMNPNLCGKVIN 234 (665)
Q Consensus 158 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p-~~~~l~~l~~~~~~~n~~lc~~~~~ 234 (665)
|+...-..|++|.+|+.|.+.-|++.-..... .+++|..|.+-+|.+....- ....+..++.+.+..||..|+|.++
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 99666678999999999999999999877765 88899999999999984333 2245667788889999999998875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.6e-09 Score=106.74 Aligned_cols=141 Identities=18% Similarity=0.209 Sum_probs=105.6
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCC--CeeeeeEEEEeC---CeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHP--NLVPIRAYFQAK---GERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~ 469 (665)
+.|+.|.++.||++...+|..+++|........ .....+.+|++++..+++. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 458999999999999877678999987654321 2345678899999988663 456677776654 3678999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-------------------------------------- 511 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-------------------------------------- 511 (665)
+|.++.+.+.. ..++......++.+++++|++||+.
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888765421 2366667777888888888888741
Q ss_pred -----------------CCeeccCCCCCceEeCC--CCceEEeecccccc
Q 005999 512 -----------------SWLIHGNLKSSNVLLGA--DFEARLTDYCLSVL 542 (665)
Q Consensus 512 -----------------~~iiH~Dlk~~Nill~~--~~~~kl~Dfgl~~~ 542 (665)
..++|+|+++.||+++. ++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 11689999999999998 56789999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=97.50 Aligned_cols=144 Identities=17% Similarity=0.250 Sum_probs=104.6
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCch-----hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA-----DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.++.+|+-+.|+++.+.+...+.-+++.+...- .-..+...+|++.+.+++--.|.-..-++.+...-.++|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 568899999999998876655554555443322 223556788999999887666665555666666667999999
Q ss_pred CC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC---ceEEeecccccc
Q 005999 470 PN-GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF---EARLTDYCLSVL 542 (665)
Q Consensus 470 ~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~---~~kl~Dfgl~~~ 542 (665)
+| .++.+++...-. .+.........+..|-+.+.-||.++ |+|+||..+||++..++ .+.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd-iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND-IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC-eecccccccceEEecCCCcCceEEEeecchhc
Confidence 77 478887764321 12222233677888999999999999 99999999999997654 468999999754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-08 Score=106.58 Aligned_cols=218 Identities=21% Similarity=0.254 Sum_probs=153.1
Q ss_pred cceEEEEEE-ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe----CCeEEEEEEecCC-CCH
Q 005999 401 SIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA----KGERLVIYDYQPN-GSL 474 (665)
Q Consensus 401 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL 474 (665)
--.+.||+. ..+|..|+.|+++.... +.......-+++++++.|.|+|++.++|.. +...++||+|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 346789998 55888999999965443 222223456788999999999999998863 4478899999875 578
Q ss_pred HHHHhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 475 FNLIHGSR----------SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 475 ~~~l~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
.++--... ...+...++..+|.++.|+..||.++|+.| ...+-|.+++|+++.+.+++|+..|......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 77543211 112334788999999999999999999999 8889999999999999999999888875554
Q ss_pred CCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHH-HHhhccCCCchhhhHHHHH
Q 005999 545 SSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEW-VRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 545 ~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~ 623 (665)
.... |.+. --.+-|.=.||.+++.|.||..--- ......+. ++. ....++..++
T Consensus 445 ~d~~-----------~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~----~~d~~~~s~~~~------I~~~yS~D~r 499 (655)
T KOG3741|consen 445 EDPT-----------EPLE----SQQQNDLRDLGLLLLALATGTENSN----RTDSTQSSHLTR------ITTTYSTDLR 499 (655)
T ss_pred CCCC-----------cchh----HHhhhhHHHHHHHHHHHhhcccccc----cccchHHHHHHH------hhhhhhHHHH
Confidence 4321 1122 1235799999999999999954210 00111111 111 1224566678
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L 647 (665)
+++.......+++ -+..+++.++
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHHH
Confidence 8888888888776 5677766543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.9e-11 Score=115.48 Aligned_cols=130 Identities=24% Similarity=0.206 Sum_probs=101.4
Q ss_pred cCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCe
Q 005999 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYS 174 (665)
Q Consensus 95 ~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 174 (665)
+.....|+.||||+|.|+.+-.+..-+++++.|++|+|.|. .+. .+..|++|+.||||+|.|+ .+-..-..|.++++
T Consensus 280 ~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred cchHhhhhhccccccchhhhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 44556788999999999877667777889999999999998 444 3788899999999999998 55555567888999
Q ss_pred eecccccccccCCCCCCCCcceEecccccccc--cCCCCCcccCcCcccccCCCC
Q 005999 175 LKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG--QVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 175 L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~--~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|.|+.|.+..+----.+-+|..||+++|++.. .+..+++++-|+.+.+.+||-
T Consensus 357 L~La~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 357 LKLAQNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred eehhhhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 99999988754332356678999999999874 244557777788888888874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-11 Score=115.51 Aligned_cols=129 Identities=25% Similarity=0.310 Sum_probs=110.5
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
.+++|||++|.++ .|.. +..-++.++.|+||+|.|...- .+..|++|+.||||+|.++ .+-++=..|-++++|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDE-SvKL~Pkir~L~lS~N~i~~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDE-SVKLAPKLRRLILSQNRIRTVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhh-hhhhccceeEEeccccceeeeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 5888999999999 7876 7889999999999999998654 3788999999999999999 777777889999999999
Q ss_pred cccccccCCccccCCCccCeeecccccccccCC--CC-CCCCcceEecccccccccCC
Q 005999 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP--PL-NQPFLVVFNVSGNNLTGQVP 209 (665)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~-~~~~L~~l~l~~N~l~~~~p 209 (665)
.|.|. .+. .+..|-+|..||+++|++...-. .. +++-|+.+.|.+|.+.+.+.
T Consensus 361 ~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 361 QNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhHh-hhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99997 333 57888899999999999975432 23 77889999999999997654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.4e-11 Score=123.58 Aligned_cols=132 Identities=27% Similarity=0.338 Sum_probs=116.0
Q ss_pred ecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCE
Q 005999 71 CAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150 (665)
Q Consensus 71 C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 150 (665)
|+-..++-|||+.|+++ .+|. .+..|+ |+.|-++||+++..+++++.+..|..||.+.|.+. .+|..+++|.+|+.
T Consensus 118 ~~L~~lt~l~ls~NqlS-~lp~-~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~ 193 (722)
T KOG0532|consen 118 CNLEALTFLDLSSNQLS-HLPD-GLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRD 193 (722)
T ss_pred hhhhHHHHhhhccchhh-cCCh-hhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHH
Confidence 33467888999999999 7886 576665 89999999999988889998899999999999999 89999999999999
Q ss_pred EEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccC
Q 005999 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 151 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~ 208 (665)
|++..|++. .+|..+..| .|..||++.|+++.+|-.+ .+..|++|-|.+|.|+.++
T Consensus 194 l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 194 LNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred HHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCCCh
Confidence 999999999 777788855 5899999999999888888 9999999999999999543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.8e-08 Score=101.36 Aligned_cols=151 Identities=14% Similarity=0.078 Sum_probs=103.9
Q ss_pred HHHHHHHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCchhh---------HHHHHHHHHHHHhCCCCCCe--eeeeE
Q 005999 386 LEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADT---------SAEAFEQHMEAVGGLSHPNL--VPIRA 454 (665)
Q Consensus 386 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~ni--v~l~~ 454 (665)
++.+.....+.+-+.....|++..+ +|+.+.||+.......+. ....+.+|...+.+|...+| +.+++
T Consensus 19 f~~~~~~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa 97 (268)
T PRK15123 19 FEEVKTLQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVA 97 (268)
T ss_pred HHHHHhcCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeE
Confidence 4444444445555555556777766 456799997744331110 01136788888877744443 34455
Q ss_pred EEEe-----CCeEEEEEEecCCC-CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC
Q 005999 455 YFQA-----KGERLVIYDYQPNG-SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 455 ~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~ 528 (665)
+.+. ...-++|+|++++. +|.+++.... ..+.+...+..++.+++..++-||+.+ |+|+|++++|||++.
T Consensus 98 ~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G-i~HgDL~~~NiLl~~ 173 (268)
T PRK15123 98 FGERGSNPATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG-INHRDCYICHFLLHL 173 (268)
T ss_pred EEEecCCCccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc-CccCCCChhhEEEec
Confidence 6543 23578999999986 8999875321 233455677789999999999999999 999999999999975
Q ss_pred -------CCceEEeeccccc
Q 005999 529 -------DFEARLTDYCLSV 541 (665)
Q Consensus 529 -------~~~~kl~Dfgl~~ 541 (665)
++.+.++||+.+.
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred cccCCCCCceEEEEECCccc
Confidence 4689999999764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.91 E-value=6e-09 Score=126.57 Aligned_cols=146 Identities=18% Similarity=0.218 Sum_probs=88.1
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|++.++.+. .+|. .| .+.+|+.|+|++|++...+..+..+++|+.|+|++|..-+.+| .++.+++|+.|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCC-cC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEe
Confidence 34666667666666 5665 34 4567777777777776555566667777777776655444565 3666677777777
Q ss_pred ecccccccCCccccCCCccCeeeccccc-ccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNR-FSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
++|.....+|..+.++++|+.|++++|. +...+...++++|+.|++++|...+.+|.. ..+|..+++.+|
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n 735 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDET 735 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc--cCCcCeeecCCC
Confidence 7665555667777777777777777653 333333336666666666666544444422 234444444444
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.1e-09 Score=126.49 Aligned_cols=144 Identities=24% Similarity=0.312 Sum_probs=115.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|+|.++.|. .++. .+..+++|+.|+|++|...+.+|.++.+++|+.|+|++|..-..+|..+.++++|+.|+|
T Consensus 611 ~~L~~L~L~~s~l~-~L~~-~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWD-GVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-cccc-ccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 57999999999998 7876 688999999999998876677788999999999999998766799999999999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSF 222 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~ 222 (665)
++|..-..+|..+ ++++|+.|++++|...+.+|.. ..+|+.|++++|.+. .+|....+.+|..+.+
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~-~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l 754 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI-STNISWLDLDETAIE-EFPSNLRLENLDELIL 754 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc-cCCcCeeecCCCccc-cccccccccccccccc
Confidence 9976555888766 7899999999998765555543 457889999999887 4454333444443333
|
syringae 6; Provisional |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-09 Score=83.78 Aligned_cols=58 Identities=43% Similarity=0.510 Sum_probs=28.6
Q ss_pred CCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeeccc
Q 005999 100 QLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157 (665)
Q Consensus 100 ~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 157 (665)
+|+.|+|++|+|+.+++ .|.++++|++|+|++|+++...|..|.++++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444 44445555555555555543333444555555555555544
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.9e-10 Score=119.73 Aligned_cols=148 Identities=28% Similarity=0.338 Sum_probs=111.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCC-CCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLD-QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|++.+|+++ .|++ ....+. +|+.|++++|++..++..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCcc-ccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 46899999999999 7887 677774 999999999999877667888999999999999999 8887777888999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
+++|+++ .+|..+..+..|++|.+++|++...+... .+.++..+.+.+|++...+-....+..+..+++++|
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n 265 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN 265 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccchhccccccceeccccc
Confidence 9999998 77776666777888888888544333333 566666666666666643222244444555555555
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.6e-08 Score=94.46 Aligned_cols=128 Identities=18% Similarity=0.243 Sum_probs=85.1
Q ss_pred EEEEEEECCeEEEEEEEecCCC------------------------chhhHHHHHHHHHHHHhCCCCC--CeeeeeEEEE
Q 005999 404 TTYKAVLDNHLIVTVKRFDANK------------------------TADTSAEAFEQHMEAVGGLSHP--NLVPIRAYFQ 457 (665)
Q Consensus 404 ~Vy~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 457 (665)
.||.|...++..+|+|..+... .........++|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999874321 1112245577899999999766 466666542
Q ss_pred eCCeEEEEEEecC--CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCeeccCCCCCceEeCCCCceEE
Q 005999 458 AKGERLVIYDYQP--NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY-IHRASWLIHGNLKSSNVLLGADFEARL 534 (665)
Q Consensus 458 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~y-LH~~~~iiH~Dlk~~Nill~~~~~~kl 534 (665)
.-++||||+. |..+..+... .++......++.+++..+.. +|+.+ |+|+||.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~g-ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAG-IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTT-EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcC-ceecCCChhhEEeecc-eEEE
Confidence 3479999998 6555544331 11123345677888886666 46888 9999999999999988 9999
Q ss_pred eecccccccC
Q 005999 535 TDYCLSVLSD 544 (665)
Q Consensus 535 ~Dfgl~~~~~ 544 (665)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2e-09 Score=82.47 Aligned_cols=61 Identities=41% Similarity=0.445 Sum_probs=51.8
Q ss_pred CCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccc
Q 005999 122 INLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182 (665)
Q Consensus 122 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 182 (665)
++|+.|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5788999999999955557888899999999999999877777888999999999888875
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.7e-09 Score=119.75 Aligned_cols=188 Identities=24% Similarity=0.232 Sum_probs=134.9
Q ss_pred CCCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCce
Q 005999 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNV 524 (665)
Q Consensus 445 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Ni 524 (665)
+||-+++...-+.-....+++++|..+++|...++... ..+..-....+..+..+++|||... +.|||++|.|.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~-r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL-RKHRDLKPDSL 935 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccch-hhcccccccch
Confidence 44555554444455667889999999999999998542 2333333445667888999999988 89999999999
Q ss_pred EeCCCCceEEeeccccccc-------CC--------------C-------------CCCCCCCCcccCCccccCCCCCCC
Q 005999 525 LLGADFEARLTDYCLSVLS-------DS--------------S-------------SVEDPDTVAYKAPEIRKSSRRATS 570 (665)
Q Consensus 525 ll~~~~~~kl~Dfgl~~~~-------~~--------------~-------------~~~~~gt~~y~aPE~~~~~~~~~~ 570 (665)
++..+++.+++|||..... +. . .....+|+.|.+||... +.....
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs 1014 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGS 1014 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCC
Confidence 9999999999999832110 00 0 01123689999999887 667788
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-CCchhhhHHHHHHHHHHcccCCCCCCCCHH
Q 005999 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD-DGREENRLGMLTEVASVCSLKSPEQRPAMW 641 (665)
Q Consensus 571 k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 641 (665)
.+|+|++|++++|.++|.+||..... .+..+-+...... .......+....+++...+..+|.+|-.+.
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tp--q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETP--QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcch--hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 89999999999999999999987432 2222222211111 123455566788899999999999997665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.82 E-value=2e-09 Score=116.17 Aligned_cols=162 Identities=27% Similarity=0.298 Sum_probs=134.0
Q ss_pred ccccceeecCCCEE---EEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCC-CCCEEEccCcccCCcCc
Q 005999 64 CQWQGVKCAQGRVV---RFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLI-NLKSLSLSRNFFSGAFP 139 (665)
Q Consensus 64 C~w~gv~C~~~~v~---~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~Ls~N~l~~~~p 139 (665)
+.+.+..+....+. .+++..|.+...+. .+..++.++.|++.+|+++.+.+....+. +|+.|++++|++. .+|
T Consensus 80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~ 156 (394)
T COG4886 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLP 156 (394)
T ss_pred cccccccccccCCCCCceeeccccccccCch--hhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhh
Confidence 66777777766655 68999999864544 47778999999999999999998888885 9999999999999 888
Q ss_pred ccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcC
Q 005999 140 LSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFD 218 (665)
Q Consensus 140 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~ 218 (665)
..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++.+++.. ....|+.|++++|++.-.+.....+.++.
T Consensus 157 ~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~ 235 (394)
T COG4886 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLS 235 (394)
T ss_pred hhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhccccc
Confidence 89999999999999999999 77777778999999999999999888875 55569999999997554555556666777
Q ss_pred cccccCCCCCC
Q 005999 219 ASSFSMNPNLC 229 (665)
Q Consensus 219 ~~~~~~n~~lc 229 (665)
.+.+.+|...+
T Consensus 236 ~l~l~~n~~~~ 246 (394)
T COG4886 236 GLELSNNKLED 246 (394)
T ss_pred ccccCCceeee
Confidence 77777776544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.3e-10 Score=117.60 Aligned_cols=151 Identities=26% Similarity=0.238 Sum_probs=99.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCC---CcEEEccCCcCccCC----C-CCCCC-CCCCEEEccCcccCC----cCcc
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQ---LRVLSLHNNSLTGPI----P-DLSSL-INLKSLSLSRNFFSG----AFPL 140 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~---L~~L~L~~N~l~~~~----p-~~~~l-~~L~~L~Ls~N~l~~----~~p~ 140 (665)
.+++.|+|++|.+.+..+. .+..+.+ |+.|+|++|++++.. . .+..+ ++|+.|+|++|.+++ .++.
T Consensus 81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 4888888888888754443 4555554 888888888887321 1 34555 788888888888884 3344
Q ss_pred cccCCCCCCEEEeeccccccc----CCccccCCCccCeeecccccccccCCC-----C-CCCCcceEecccccccccCC-
Q 005999 141 SILSLHRLTILDLSYNNLTGL----IPVNLTALDRLYSLKLEWNRFSGTVPP-----L-NQPFLVVFNVSGNNLTGQVP- 209 (665)
Q Consensus 141 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~-----~-~~~~L~~l~l~~N~l~~~~p- 209 (665)
.+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.... . .+++|++|++++|++++...
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 566777888888888888742 333455667888888888887644221 1 56778888888888874211
Q ss_pred CC-C----cccCcCcccccCC
Q 005999 210 ET-P----TLLKFDASSFSMN 225 (665)
Q Consensus 210 ~~-~----~l~~l~~~~~~~n 225 (665)
.. . ...+|..+++++|
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n 260 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCN 260 (319)
T ss_pred HHHHHHhccCCCceEEEccCC
Confidence 00 1 1245666666665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.75 E-value=8e-10 Score=115.54 Aligned_cols=152 Identities=24% Similarity=0.218 Sum_probs=99.7
Q ss_pred CCEEEEEecCCCCcc------cCCccccCCCCCCcEEEccCCcCccCCC-CCCCCC---CCCEEEccCcccCC----cCc
Q 005999 74 GRVVRFVLQSFGLRG------TFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLI---NLKSLSLSRNFFSG----AFP 139 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g------~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~---~L~~L~Ls~N~l~~----~~p 139 (665)
..++.|+++++.+.+ .++. .+..+++|+.|+|++|.+.+..+ .+..+. +|++|++++|++++ .+.
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~-~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQ-GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHH-HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 347778887777662 1222 56778888888888888876444 444444 48888888888873 334
Q ss_pred ccccCC-CCCCEEEeeccccccc----CCccccCCCccCeeecccccccccC----CC-C-CCCCcceEecccccccccC
Q 005999 140 LSILSL-HRLTILDLSYNNLTGL----IPVNLTALDRLYSLKLEWNRFSGTV----PP-L-NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 140 ~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----~~-~-~~~~L~~l~l~~N~l~~~~ 208 (665)
..+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.. +. . ..++|+.|++++|.+++..
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 209 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG 209 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH
Confidence 455666 7888888888888743 3334566678888888888887421 11 1 3457888888888876331
Q ss_pred C-----CCCcccCcCcccccCCC
Q 005999 209 P-----ETPTLLKFDASSFSMNP 226 (665)
Q Consensus 209 p-----~~~~l~~l~~~~~~~n~ 226 (665)
. ....+++|..+++++|+
T Consensus 210 ~~~l~~~~~~~~~L~~L~ls~n~ 232 (319)
T cd00116 210 ASALAETLASLKSLEVLNLGDNN 232 (319)
T ss_pred HHHHHHHhcccCCCCEEecCCCc
Confidence 1 11334567777777664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.8e-08 Score=92.97 Aligned_cols=141 Identities=22% Similarity=0.248 Sum_probs=101.9
Q ss_pred HHHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCc--------------------hhhHHHHHHHHHHHHhCCCCC--
Q 005999 390 MRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKT--------------------ADTSAEAFEQHMEAVGGLSHP-- 447 (665)
Q Consensus 390 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~h~-- 447 (665)
..+.++.||-|.-+.||.|....|..++||.=+.... ...+....++|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3345688999999999999999999999996322111 112345678899999998655
Q ss_pred CeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC
Q 005999 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG 527 (665)
Q Consensus 448 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~ 527 (665)
.+.+.+++ +...+||||++|-.|...- ++....-.++..|+.-+.-.-..+ |+|+|+++-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G-iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG-IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC-ccccCCchheEEEe
Confidence 66666654 4567999999996665431 122233445556666655555677 99999999999999
Q ss_pred CCCceEEeecccccccCC
Q 005999 528 ADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 528 ~~~~~kl~Dfgl~~~~~~ 545 (665)
+||.+.++||-.+...+.
T Consensus 237 ~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 237 EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred cCCCEEEEeCcccccCCC
Confidence 999999999977655443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=8.7e-09 Score=111.58 Aligned_cols=145 Identities=22% Similarity=0.294 Sum_probs=102.9
Q ss_pred HHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCC------------CCCCCcccCCccccCCC
Q 005999 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE------------DPDTVAYKAPEIRKSSR 566 (665)
Q Consensus 499 ~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~------------~~gt~~y~aPE~~~~~~ 566 (665)
.+++.|+.|+|....+||++|.|++|.++..+..||+.|+++....+.... ..-...|.|||++. +.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~-~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL-GT 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc-cc
Confidence 455699999999767999999999999999999999999987554432111 01346799999987 56
Q ss_pred CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCC-CccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHH
Q 005999 567 RATSKSDVYAFGVLLLELLT-GKHPSQHPYLA-PPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVL 644 (665)
Q Consensus 567 ~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 644 (665)
..+.++|+||+||++|.+.. |+.-+...... ........... .......+.+.++++-+.+++..++..||++.++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-GAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-ccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 78899999999999999994 54444332111 11111110000 00113456778899999999999999999877765
Q ss_pred H
Q 005999 645 K 645 (665)
Q Consensus 645 ~ 645 (665)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.7e-07 Score=91.05 Aligned_cols=254 Identities=16% Similarity=0.205 Sum_probs=157.7
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEE-----E-EeCC-eEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAY-----F-QAKG-ERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-----~-~~~~-~~~lv~ 466 (665)
.-||+|+-+.+|-.-.-.+ .| .|+.+..-..... +.++.|... .||-+-.=+.+ + -+.+ ...++|
T Consensus 17 r~LgqGgea~ly~l~e~~d-~V-AKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 17 RPLGQGGEADLYTLGEVRD-QV-AKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred ccccCCccceeeecchhhc-hh-heeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4589999999996532222 23 3666544322111 122333333 55543221111 1 1122 256777
Q ss_pred EecCCC-CHHHHHhc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 467 DYQPNG-SLFNLIHG-SRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 467 e~~~~g-sL~~~l~~-~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
..+.+. .+..+... .+........|...++.+..++.+.+.||..+ .+-+|+.++|+|+.+++.|.|.|=..-..-.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-CcccccCccceeeecCceEEEEcccceeecc
Confidence 777664 22222221 11113345899999999999999999999999 7889999999999999999998754322222
Q ss_pred CCC--CCCCCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCC---CccHHHHHHhhccCC--
Q 005999 545 SSS--VEDPDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTG-KHPSQHPYLA---PPDMLEWVRTMRVDD-- 612 (665)
Q Consensus 545 ~~~--~~~~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg-~~P~~~~~~~---~~~~~~~~~~~~~~~-- 612 (665)
... .-.+|...|.+||.-. .+..-+...|-|.+||++++++.| ++||...... ..-....+.......
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 111 2235788999999744 133456789999999999999876 9999864321 111111111111100
Q ss_pred ------------CchhhhHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 613 ------------GREENRLGMLTEVASVCSLK--SPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 613 ------------~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
...+-.+..+..+..+|+.. .+.-|||++-.+..|.++.++...
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 12233456688899999865 367899999999999988877643
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.7e-08 Score=67.90 Aligned_cols=39 Identities=33% Similarity=0.673 Sum_probs=27.4
Q ss_pred HHHHHHHHHHHhcCCCCC-CccccCCCC--CCCccccceeec
Q 005999 34 PSDAVSLLSFKSKADSEN-KLLYALNER--FDYCQWQGVKCA 72 (665)
Q Consensus 34 ~~~~~~Ll~~k~~~~~~~-~~~~~~~~~--~~~C~w~gv~C~ 72 (665)
+.|++||++||.++..++ ...-+|+.. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998533 444455443 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.8e-10 Score=118.43 Aligned_cols=125 Identities=30% Similarity=0.392 Sum_probs=96.6
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcc-cccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPL-SILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 153 (665)
.+...+.+.|.|+ .+. .++.-++.|+.|||++|+++..- .+..|++|++|||++|+|. .+|. ...++. |+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD-~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMD-ESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHH-HHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 6777888888888 344 37888899999999999998655 6778899999999999998 6663 223343 899999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccC---CCCCCCCcceEecccccccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTV---PPLNQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~~L~~l~l~~N~l~~ 206 (665)
++|.++ ++- .+.+|.+|+.|||++|-|++.- |-..+..|..|+|.||.+..
T Consensus 240 rnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 999988 332 5788899999999999887643 22366778889999998863
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.6e-06 Score=82.73 Aligned_cols=138 Identities=13% Similarity=0.094 Sum_probs=99.3
Q ss_pred hCcccceEEEEEEECCeEEEEEEEecCC-Cch---hhHHHHHHHHHHHHhCCCCC--CeeeeeEEEEeC-----CeEEEE
Q 005999 397 LGRGSIGTTYKAVLDNHLIVTVKRFDAN-KTA---DTSAEAFEQHMEAVGGLSHP--NLVPIRAYFQAK-----GERLVI 465 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~---~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~-----~~~~lv 465 (665)
-|+||.+.|++..+.+. .+.+|+-..- ... ......|.+|+..+.+|..- .+.++. ++... -+-++|
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36789999999887666 5788876411 111 22456788898888887433 245555 33211 145789
Q ss_pred EEecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc--eEEeecccc
Q 005999 466 YDYQPN-GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE--ARLTDYCLS 540 (665)
Q Consensus 466 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~--~kl~Dfgl~ 540 (665)
+|-+.| -+|.+++... ...+.+...+..++.+|+..++-||+.+ +.|+|+.+.||+++.++. ++++||--+
T Consensus 104 Te~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G-v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN-RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 997764 4898887532 2234577778899999999999999999 999999999999986666 999999654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.3e-07 Score=86.75 Aligned_cols=104 Identities=20% Similarity=0.234 Sum_probs=79.9
Q ss_pred HHHHHHHHHhCCCCC--CeeeeeEEEEeCC----eEEEEEEecCCC-CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 005999 433 AFEQHMEAVGGLSHP--NLVPIRAYFQAKG----ERLVIYDYQPNG-SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505 (665)
Q Consensus 433 ~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L 505 (665)
...+|...+..|... ...+.+++.+... ..++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHHHH
Confidence 456777776666433 3455666665532 457999999884 899988742 1255566788999999999
Q ss_pred HHHHhCCCeeccCCCCCceEeCCCC---ceEEeecccccc
Q 005999 506 AYIHRASWLIHGNLKSSNVLLGADF---EARLTDYCLSVL 542 (665)
Q Consensus 506 ~yLH~~~~iiH~Dlk~~Nill~~~~---~~kl~Dfgl~~~ 542 (665)
+-||+.+ |+|+|+++.|||++.+. .+.++||+-+..
T Consensus 132 ~~lH~~g-i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG-IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc-CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999886 899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.5e-09 Score=116.63 Aligned_cols=128 Identities=28% Similarity=0.259 Sum_probs=105.7
Q ss_pred CCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCc-cccCCCccCeeecc
Q 005999 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPV-NLTALDRLYSLKLE 178 (665)
Q Consensus 100 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~ 178 (665)
.|.+.+.+.|+|...-.++.-++.|+.|||++|+++.. . .+..|+.|++|||++|.|. .+|. ....+. |+.|.|.
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 46778888999887666777889999999999999843 3 8889999999999999999 5553 344555 9999999
Q ss_pred cccccccCCCCCCCCcceEeccccccccc--CCCCCcccCcCcccccCCCCCCCC
Q 005999 179 WNRFSGTVPPLNQPFLVVFNVSGNNLTGQ--VPETPTLLKFDASSFSMNPNLCGK 231 (665)
Q Consensus 179 ~N~l~~~~~~~~~~~L~~l~l~~N~l~~~--~p~~~~l~~l~~~~~~~n~~lc~~ 231 (665)
+|.++.+.--.++.+|..||+++|-|.+- +...+.|..|..+++.|||--|..
T Consensus 241 nN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 241 NNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred ccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999877666999999999999998863 333467888899999999987753
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.7e-08 Score=103.08 Aligned_cols=153 Identities=24% Similarity=0.211 Sum_probs=77.9
Q ss_pred CCEEEEEecCCCCcccCC-ccccCCCCCCcEEEccCCcCccCCCC--CCCCCCCCEEEccCcccCCcC-cccccCCCCCC
Q 005999 74 GRVVRFVLQSFGLRGTFP-PNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAF-PLSILSLHRLT 149 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~-~~~~~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~ 149 (665)
..|+.|||+.|-+..--+ -.....|++|+.|+|+.|++.-...+ -..++.|+.|.|+.+.|+... -..+..+++|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 355666666655442111 01233456666666666666544331 123455666666666665321 12233456666
Q ss_pred EEEeecccccccCCccccCCCccCeeecccccccccC--CCC-CCCCcceEeccccccccc-CCCC------CcccCcCc
Q 005999 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTV--PPL-NQPFLVVFNVSGNNLTGQ-VPET------PTLLKFDA 219 (665)
Q Consensus 150 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~-~~~~L~~l~l~~N~l~~~-~p~~------~~l~~l~~ 219 (665)
.|+|..|...+.-......+..|++|+|++|++-... +.. .++.|..|+++.+.++.. .|+. ..+.+|+.
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~ 305 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY 305 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccccee
Confidence 6666666433233333444566666666666665443 222 556666666666666532 2222 34555666
Q ss_pred ccccCCC
Q 005999 220 SSFSMNP 226 (665)
Q Consensus 220 ~~~~~n~ 226 (665)
+++..|+
T Consensus 306 L~i~~N~ 312 (505)
T KOG3207|consen 306 LNISENN 312 (505)
T ss_pred eecccCc
Confidence 6666664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.3e-09 Score=90.92 Aligned_cols=113 Identities=21% Similarity=0.221 Sum_probs=82.6
Q ss_pred ecC-CCEEEEEecCCCCcccCCc--cccCCCCCCcEEEccCCcCccCCCCCCC-CCCCCEEEccCcccCCcCcccccCCC
Q 005999 71 CAQ-GRVVRFVLQSFGLRGTFPP--NTLTRLDQLRVLSLHNNSLTGPIPDLSS-LINLKSLSLSRNFFSGAFPLSILSLH 146 (665)
Q Consensus 71 C~~-~~v~~l~l~~~~l~g~l~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~ 146 (665)
|.+ .....++|++.+|- .|+. ..+.....|+..+|++|.|...++.|.. .+-++.|+|++|.|+ .+|.++..++
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~ 100 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMP 100 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhH
Confidence 443 45666777777766 4542 1355566677778888888887775543 457888888888888 7888888888
Q ss_pred CCCEEEeecccccccCCccccCCCccCeeecccccccccC
Q 005999 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTV 186 (665)
Q Consensus 147 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 186 (665)
.|+.|++++|.|. ..|.-+..|.+|-.|+..+|.+..++
T Consensus 101 aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid 139 (177)
T KOG4579|consen 101 ALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEID 139 (177)
T ss_pred HhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccccCc
Confidence 8888888888888 66777777888888888877765443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.2e-08 Score=99.15 Aligned_cols=139 Identities=27% Similarity=0.215 Sum_probs=106.5
Q ss_pred cccee--ecC-CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCEEEccCcccCCcCcc
Q 005999 66 WQGVK--CAQ-GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFSGAFPL 140 (665)
Q Consensus 66 w~gv~--C~~-~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~~~~p~ 140 (665)
|+-|- |++ .+++.|+|+.|.|.-......-..+++|+.|.|+.+.|+-.-- -...+++|+.|+|..|...+.--.
T Consensus 161 w~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~ 240 (505)
T KOG3207|consen 161 WFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKAT 240 (505)
T ss_pred HHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecc
Confidence 55442 343 7999999999999855544444578999999999999983222 245679999999999964334444
Q ss_pred cccCCCCCCEEEeecccccccCC--ccccCCCccCeeeccccccccc--CCC------CCCCCcceEeccccccc
Q 005999 141 SILSLHRLTILDLSYNNLTGLIP--VNLTALDRLYSLKLEWNRFSGT--VPP------LNQPFLVVFNVSGNNLT 205 (665)
Q Consensus 141 ~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~--~~~------~~~~~L~~l~l~~N~l~ 205 (665)
....+..|+.|||++|++- ..+ ...+.++.|..|+++.+.++.+ ++. ..+++|++|+++.|++.
T Consensus 241 ~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 241 STKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 5566789999999999998 445 3568899999999999998865 232 15689999999999996
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=8.4e-08 Score=103.95 Aligned_cols=126 Identities=29% Similarity=0.311 Sum_probs=76.3
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..+..|+|.+|+|. .+.. .+..+++|++|+|++|.|+.+.+ +..++.|+.|++++|.|+ .+. .+..+.+|+.|+|
T Consensus 95 ~~l~~l~l~~n~i~-~i~~-~l~~~~~L~~L~ls~N~I~~i~~-l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIE-KIEN-LLSSLVNLQVLDLSFNKITKLEG-LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchh-hccc-chhhhhcchheeccccccccccc-hhhccchhhheeccCcch-hcc-CCccchhhhcccC
Confidence 56777777777777 3432 26667777777777777775544 455556777777777776 333 4444677777777
Q ss_pred ecccccccCCcc-ccCCCccCeeecccccccccCCCCCCCCcceEeccccccc
Q 005999 154 SYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205 (665)
Q Consensus 154 ~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~ 205 (665)
++|++...-+ . +..+.+|+.+++.+|.+...-....+..+..+++..|.++
T Consensus 170 ~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 170 SYNRIVDIEN-DELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred Ccchhhhhhh-hhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccce
Confidence 7777763333 1 4566677777777776654433223333334455555554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.7e-06 Score=91.78 Aligned_cols=143 Identities=16% Similarity=0.224 Sum_probs=93.3
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchh----------------------------hHH----------HHHHH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD----------------------------TSA----------EAFEQ 436 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~~~----------~~~~~ 436 (665)
+-++.++-|-||+|++++|+.||||+.++..... ... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4577899999999999999999999976542210 001 12333
Q ss_pred HHHHHhCC-----CCCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 005999 437 HMEAVGGL-----SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG-LAYIHR 510 (665)
Q Consensus 437 e~~~l~~l-----~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~-L~yLH~ 510 (665)
|..-+.++ +.+++.-..-|++-.+...++|||++|..+.+..... ...++ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCC---HHHHHHHHHHHHHHHHHh
Confidence 44333333 2344433333444456778999999999888874211 12233 23344444443 233333
Q ss_pred CCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 511 ~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
.+ +.|.|.+|.||+++.+|++.+.|||+....++
T Consensus 284 dg-ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG-FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC-ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 56 99999999999999999999999999866554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4e-08 Score=85.04 Aligned_cols=90 Identities=28% Similarity=0.379 Sum_probs=80.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.++|++|++. ..|+..-..++.++.|+|++|.|+..|.++..++.|+.|+++.|.|. ..|..|..|.+|..||.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 57999999999999 78885555667999999999999988889999999999999999999 89999999999999999
Q ss_pred ecccccccCCccc
Q 005999 154 SYNNLTGLIPVNL 166 (665)
Q Consensus 154 ~~N~l~~~~p~~~ 166 (665)
.+|.+. .+|..+
T Consensus 131 ~~na~~-eid~dl 142 (177)
T KOG4579|consen 131 PENARA-EIDVDL 142 (177)
T ss_pred CCCccc-cCcHHH
Confidence 999998 777654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-07 Score=102.09 Aligned_cols=125 Identities=28% Similarity=0.296 Sum_probs=96.2
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
.+..+.+..|.+. .+- +.+..+++|+.|+|.+|+|..+...+..+++|++|+|++|.|+... .+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~-~~~-~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIA-KIL-NHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhh-hhh-cccccccceeeeeccccchhhcccchhhhhcchheecccccccccc--chhhccchhhheec
Confidence 4555557777777 322 2578888999999999999876655788899999999999988433 35667778999999
Q ss_pred cccccccCCccccCCCccCeeecccccccccCCC--CCCCCcceEeccccccc
Q 005999 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNLT 205 (665)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~~L~~l~l~~N~l~ 205 (665)
+|.|+ .++ .+..+.+|+.+++++|+++...+. ..+..|+.+++.+|.+.
T Consensus 149 ~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 149 GNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred cCcch-hcc-CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 99997 333 466688899999999998877772 57788888889988877
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.6e-05 Score=78.40 Aligned_cols=136 Identities=15% Similarity=0.204 Sum_probs=82.4
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCC--eeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN--LVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
..||+|..+.||+. . +..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH--K-TGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe--c-CCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46899999999984 2 3356778876533 2334578888888875443 466778877777788999999996
Q ss_pred C-HHHH---------------------HhcCCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHh---CCCee
Q 005999 473 S-LFNL---------------------IHGSRSIRAKPLHWTSCLK-IAE----------DVAQ-GLAYIHR---ASWLI 515 (665)
Q Consensus 473 s-L~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~i~~-~L~yLH~---~~~ii 515 (665)
+ +.+. +|.. ............ +.. .+.. ...+|.. ...++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~---~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHST---KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCC---CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 3 2111 1211 000111111110 100 0111 1223322 12368
Q ss_pred ccCCCCCceEeCCCCceEEeeccccc
Q 005999 516 HGNLKSSNVLLGADFEARLTDYCLSV 541 (665)
Q Consensus 516 H~Dlk~~Nill~~~~~~kl~Dfgl~~ 541 (665)
|+|+.|.||++++++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999998653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.9e-05 Score=74.44 Aligned_cols=140 Identities=17% Similarity=0.225 Sum_probs=95.6
Q ss_pred HhCcccceEEEEEEECCeEEEEEEEecCCCchh----------------------hHHHHHHHHHHHHhCCC--CCCeee
Q 005999 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD----------------------TSAEAFEQHMEAVGGLS--HPNLVP 451 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~--h~niv~ 451 (665)
.|++|.-+.||+|.-.++..+|+|+++.....- ......++|+.-|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 588899999999998889999999985432210 01112345666666652 334455
Q ss_pred eeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCC
Q 005999 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADF 530 (665)
Q Consensus 452 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~ 530 (665)
.+++.. -.+||||+.... ......++.++.......+..++++.+.-|-. .+ +||+||+.=|||+. ++
T Consensus 135 Pi~~~~----nVLvMEfIg~~g-----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~-LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDG-----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG-LVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeecC----CeEEEEeccCCC-----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC-cccccchhhheEEE-CC
Confidence 555542 368999986531 11112223334444566777888888888877 66 99999999999999 88
Q ss_pred ceEEeecccccccCCC
Q 005999 531 EARLTDYCLSVLSDSS 546 (665)
Q Consensus 531 ~~kl~Dfgl~~~~~~~ 546 (665)
.+.++|||.+...+++
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 9999999998766543
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.9e-06 Score=60.66 Aligned_cols=36 Identities=36% Similarity=0.532 Sum_probs=21.4
Q ss_pred CCCEEEccCcccCCcCcccccCCCCCCEEEeeccccc
Q 005999 123 NLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159 (665)
Q Consensus 123 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 159 (665)
+|++|+|++|+|+ .+|+.|++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 5666666666666 55555666666666666666665
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 665 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-28 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-05 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-05 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-54
Identities = 88/303 (29%), Positives = 152/303 (50%), Gaps = 41/303 (13%)
Query: 376 FCAGESEVYSLEQLMRA-----SAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTS 430
G+ + +SL +L A + +LGRG G YK L + +V VKR +T
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71
Query: 431 AEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLH 490
+ F+ +E + H NL+ +R + ERL++Y Y NGS+ + + + PL
Sbjct: 72 LQ-FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLD 129
Query: 491 WTSCLKIAEDVAQGLAYIHRASWL--IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV 548
W +IA A+GLAY+H IH ++K++N+LL +FEA + D+ L+ L D
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD---- 185
Query: 549 EDPDT-----VA----YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP---SQHPYL 596
DT V + APE S+ +++ K+DV+ +GV+LLEL+TG+ ++
Sbjct: 186 -YKDTHVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 597 APPDMLEWVRTMRVDDGR-------------EENRLGMLTEVASVCSLKSPEQRPAMWQV 643
+L+WV+ + + + + ++ + L +VA +C+ SP +RP M +V
Sbjct: 244 DDVMLLDWVKGL-LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 644 LKM 646
++M
Sbjct: 303 VRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 82/313 (26%), Positives = 139/313 (44%), Gaps = 41/313 (13%)
Query: 373 SLVFCAGESEVYSLEQLMRA-----------SAELLGRGSIGTTYKAVLDNHLIVTVKRF 421
SL +S +L +G G G YK ++N V VK+
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKL 62
Query: 422 DANKTADTS--AEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIH 479
A T + F+Q ++ + H NLV + + + ++Y Y PNGSL + +
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 480 GSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539
PL W KIA+ A G+ ++H IH ++KS+N+LL F A+++D+ L
Sbjct: 123 CLDG--TPPLSWHMRCKIAQGAANGINFLHENH-HIHRDIKSANILLDEAFTAKISDFGL 179
Query: 540 SVLSD-------SSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ 592
+ S+ +S + T AY APE T KSD+Y+FGV+LLE++TG
Sbjct: 180 ARASEKFAQTVMTSRIVG--TTAYMAPEA--LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 593 HPYLAPPDMLEWVRTMRVDDGREEN----RLG--------MLTEVASVCSLKSPEQRPAM 640
+ P +L+ + ++ E+ ++ + VAS C + +RP +
Sbjct: 236 -EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 641 WQVLKMIQEIKES 653
+V +++QE+ S
Sbjct: 295 KKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 89/326 (27%), Positives = 139/326 (42%), Gaps = 45/326 (13%)
Query: 363 GSQTLIKRSGSLVFCAGESEVYSLEQLMRA-----SAELLGRGSIGTTYKAVLDNHLIVT 417
+ ++ S ES L L A L+G G G YK VL + V
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 418 VKRFDANKTADTSAEA---FEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474
+KR S++ FE +E + HP+LV + + + E ++IY Y NG+L
Sbjct: 68 LKRRTPE-----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL 534
++GS + W L+I A+GL Y+H + +IH ++KS N+LL +F ++
Sbjct: 123 KRHLYGSDLPT-MSMSWEQRLEICIGAARGLHYLHTRA-IIHRDVKSINILLDENFVPKI 180
Query: 535 TDYCLSVLSDSSSVEDPD--------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT 586
TD+ +S D T+ Y PE R T KSDVY+FGV+L E+L
Sbjct: 181 TDFGISKKGTE---LDQTHLSTVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLC 236
Query: 587 GKHP-SQHPYLAPPDMLEWVRTMRVDDGREE-------------NRLGMLTEVASVCSLK 632
+ Q ++ EW ++G+ E L + A C
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 633 SPEQRPAMWQVLKMIQE---IKESVM 655
S E RP+M VL ++ ++ESV+
Sbjct: 296 SSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-48
Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 51/300 (17%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E+ RG G +KA L N V VK F D + E + ++ G+ H N++
Sbjct: 30 EVKARGRFGCVWKAQLLNE-YVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 455 Y----FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ +I + GSL + + + W IAE +A+GLAY+H
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE 139
Query: 511 ASWL---------IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAY 556
H ++KS NVLL + A + D+ L++ ++ T Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 557 KAPEI----RKSSRRATSKSDVYAFGVLLLELLTGKHPSQHP---YLAP----------- 598
APE+ R A + D+YA G++L EL + + P Y+ P
Sbjct: 200 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259
Query: 599 PDMLEWVRTMRV-----DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
DM E V + D ++ + ML E C E R + V + I +++
Sbjct: 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-41
Identities = 53/271 (19%), Positives = 113/271 (41%), Gaps = 29/271 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP-IR 453
L G +K + + VK + + F + + SHPN++P +
Sbjct: 16 TKLNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 454 AYFQAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-RA 511
A + + P GSL+N++H + + + +K A D+A+G+A++H
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEI--RKSSRRA 568
+ L S +V++ D AR++ + + A+ APE +K
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY---APAWVAPEALQKKPEDTN 188
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM------- 621
+D+++F VLL EL+T + P L+ ++ V E R +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFAD--LSNMEIGMKV-------ALEGLRPTIPPGISPH 239
Query: 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
++++ +C + P +RP ++ +++++++
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 64/279 (22%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP--- 451
E++GRG+ G KA V +K+ ++ ++ +AF + + ++HPN+V
Sbjct: 14 EVVGRGAFGVVCKAKWRAK-DVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 452 --IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ ++ +Y GSL+N++HG+ + +QG+AY+H
Sbjct: 69 ACLNPVC-------LVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 510 RASW--LIHGNLKSSNVLLGADFE-ARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSR 566
LIH +LK N+LL A ++ D+ + + + + A+ APE+ + S
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 567 RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM----- 621
+ K DV+++G++L E++T + P P + W V +G R +
Sbjct: 180 -YSEKCDVFSWGIILWEVITRRKPFDE-IGGPAFRIMWA----VHNGT---RPPLIKNLP 230
Query: 622 --LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
+ + + C K P QRP+M +++K++ + D
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 24/278 (8%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E +G GS GT ++A V VK F + + + L HPN+V
Sbjct: 43 EKIGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-RASW 513
++ +Y GSL+ L+H +S + L L +A DVA+G+ Y+H R
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEIRKSSRRATS 570
++H NLKS N+L+ + ++ D+ LS L S+ + T + APE+ + +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNE 218
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM-------LT 623
KSDVY+FGV+L EL T + P + L P ++ V G + RL + +
Sbjct: 219 KSDVYSFGVILWELATLQQPWGN--LNPAQVVAAV-------GFKCKRLEIPRNLNPQVA 269
Query: 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAA 661
+ C P +RP+ ++ +++ + +S + N +
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 61/204 (29%), Positives = 87/204 (42%), Gaps = 13/204 (6%)
Query: 34 PSDAVSLLSFKSKADSENKLLYALNERFDYCQ--WQGVKCAQ----GRVVRFVLQSFGLR 87
P D +LL K + L + D C W GV C RV L L
Sbjct: 5 PQDKQALLQIKKDLGNPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 88 GTFP-PNTLTRLDQLRVLSLHN-NSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILS 144
+P P++L L L L + N+L GPIP ++ L L L ++ SGA P +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSG 201
+ L LD SYN L+G +P ++++L L + + NR SG +P +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 202 NNLTGQVPETPTLLKFDASSFSMN 225
N LTG++P T L S N
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRN 207
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 11/151 (7%)
Query: 86 LRGTFPPN--TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL 143
+ G P + + ++L +++ N LTG IP + +NL + LSRN G +
Sbjct: 161 ISGAIPDSYGSFSKL--FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 144 SLHRLTILDLSYNNLTGLIP--VNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNV 199
S + L+ N+L + L+ L L NR GT+P FL NV
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD---LRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 200 SGNNLTGQVPETPTLLKFDASSFSMNPNLCG 230
S NNL G++P+ L +FD S+++ N LCG
Sbjct: 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 17/56 (30%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLS 141
+ GT P LT+L L L++ N+L G IP +L + + N PL
Sbjct: 256 IYGTLPQ-GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 51/297 (17%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP--- 451
E +G+G G ++ V VK F + D + E + L H N++
Sbjct: 14 ECVGKGRYGEVWRGSWQGE-NVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 452 -IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ + +I Y GSL++ + L SCL+I +A GLA++H
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHI 123
Query: 511 ASWL-------IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
+ H +LKS N+L+ + + + D L+V+ S+ + T Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 557 KAPEI-----RKSSRRATSKSDVYAFGVLLLELLTGKHPS------QHPY--LAPPD--- 600
APE+ + + + D++AFG++L E+ + + P+ + P D
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 601 --MLEWVRTMRV-----DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
M + V + + + L L ++ C ++P R ++ K + +I
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 68/312 (21%), Positives = 106/312 (33%), Gaps = 62/312 (19%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP--- 451
EL+GRG G YK LD V VK F + E+++ V + H N+
Sbjct: 19 ELIGRGRYGAVYKGSLDER-PVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 452 --IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
R + E L++ +Y PNGSL + W S ++A V +GLAY+H
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLH 128
Query: 510 RASWL--------IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--------- 552
H +L S NVL+ D ++D+ LS+ + + P
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 553 --TVAYKAPEI------RKSSRRATSKSDVYAFGVLLLELLTGKHPSQH-----PYLAP- 598
T+ Y APE+ + A + D+YA G++ E+ Y
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 599 ----------PDMLEWVRTMRV------DDGREENRLGMLTEVASVCSLKSPEQRPAMWQ 642
DM V + + L E C + E R
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308
Query: 643 VLKMIQEIKESV 654
+ + E+
Sbjct: 309 AEERMAELMMIW 320
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 35/277 (12%)
Query: 395 ELLGRGSIGTTYKAVLDNH-LIVTVKRFDANKTADTSA-----EAFEQHMEAVGGLSHPN 448
+ +G+G G +K L +V +K + + + F++ + + L+HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 449 LVP-IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+V ++ ++ P G L++ + +A P+ W+ L++ D+A G+ Y
Sbjct: 85 IVKLYGLMHNPP---RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEY 137
Query: 508 IH-RASWLIHGNLKSSNVLL-----GADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPE- 560
+ + ++H +L+S N+ L A A++ D+ LS S S + APE
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPET 197
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG 620
I T K+D Y+F ++L +LTG+ P + + M ++G R
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKI--KFINMIREEGL---RPT 250
Query: 621 M-------LTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
+ L V +C P++RP ++K + E+
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 58/300 (19%), Positives = 111/300 (37%), Gaps = 51/300 (17%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV---- 450
E +G+G G ++ V VK F + + + E + L H N++
Sbjct: 48 ESIGKGRFGEVWRGKWRGE-EVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ ++ DY +GSLF+ ++ + +K+A A GLA++H
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHM 157
Query: 511 ASW-------LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
+ H +LKS N+L+ + + D L+V DS++ T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 557 KAPEI-----RKSSRRATSKSDVYAFGVLLLELLTGKHPS------QHPY--LAPPDM-L 602
APE+ + ++D+YA G++ E+ Q PY L P D +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 603 EWVRTMRVDDGR---EENRLGMLTEVASVCSL------KSPEQRPAMWQVLKMIQEIKES 653
E +R + + NR + + + + R ++ K + ++ +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 41/277 (14%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G GS GT YK V VK + +AF+ + + H N++
Sbjct: 30 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL--- 84
Query: 455 YFQA---KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
F + ++ + SL++ +H + IA A+G+ Y+H A
Sbjct: 85 -FMGYSTAPQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLH-A 138
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKAPEI--RKS 564
+IH +LKS+N+ L D ++ D+ L+ S ++ + APE+ +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624
S + +SDVYAFG++L EL+TG+ P + + D + + V G + L++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIEM----VGRG---SLSPDLSK 249
Query: 625 VASVC--SLKS---------PEQRPAMWQVLKMIQEI 650
V S C +K ++RP+ ++L I+E+
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 51/300 (17%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP-IR 453
+ +G+G G + V VK F T + ++ E + + H N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWRGE-KVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 454 AYFQAKGER---LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
A + G +I DY NGSL++ + L S LK+A GL ++H
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 511 ASWL-------IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
+ H +LKS N+L+ + + D L+V S + E T Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 557 KAPEI-----RKSSRRATSKSDVYAFGVLLLELLTGKHPS------QHPY--LAPPDM-L 602
PE+ ++ ++ +D+Y+FG++L E+ Q PY L P D
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 603 EWVRTMRVDDGR---------EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
E +R + + L + ++ + C +P R +V K + ++ ES
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 54/278 (19%), Positives = 114/278 (41%), Gaps = 34/278 (12%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
EL+G+G G Y V ++ D + + +AF++ + A H N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ +I +L++++ ++ L +IA+++ +G+ Y+H A +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH-AKGI 151
Query: 515 IHGNLKSSNVLLG------ADF-EARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRR 567
+H +LKS NV DF ++ + + + + APEI +
Sbjct: 152 LHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 568 A--------TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REEN 617
+ SDV+A G + EL + P + P + + W + G +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---QPAEAIIWQ----MGTGMKPNLS 264
Query: 618 RLGMLTEVASV---CSLKSPEQRPAMWQVLKMIQEIKE 652
++GM E++ + C E+RP +++ M++++ +
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 54/187 (28%), Positives = 74/187 (39%), Gaps = 11/187 (5%)
Query: 33 LPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFP- 91
L + L+SFK +N LL + + C + GV C +V L S L F
Sbjct: 10 LYREIHQLISFKDVLPDKN-LLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSA 68
Query: 92 -PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFP--LSILSLHRL 148
++L L L L L N+ + G + +L SL LSRN SG S+ S L
Sbjct: 69 VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL 128
Query: 149 TILDLSYNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPL-----NQPFLVVFNVSGN 202
L++S N L V L+ L L L N SG L +SGN
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 203 NLTGQVP 209
++G V
Sbjct: 189 KISGDVD 195
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 44/147 (29%), Positives = 61/147 (41%), Gaps = 23/147 (15%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
T + L + N L+G IP + S+ L L+L N SG+ P + L L I
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPE 210
LDLS N L G IP ++AL L ++S NNL+G +PE
Sbjct: 685 LDLSSNKLDGRIPQAMSAL----------------------TMLTEIDLSNNNLSGPIPE 722
Query: 211 TPTLLKFDASSFSMNPNLCGKVINKAC 237
F + F NP LCG + +
Sbjct: 723 MGQFETFPPAKFLNNPGLCGYPLPRCD 749
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-29
Identities = 38/140 (27%), Positives = 61/140 (43%), Gaps = 10/140 (7%)
Query: 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFF 134
+ + + G ++R L L + +N+ + IP L L+ L +S N
Sbjct: 179 ELKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKL 235
Query: 135 SGAFPLSILSLHRLTILDLSYNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPP---LN 190
SG F +I + L +L++S N G IP L +L L L N+F+G +P
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS---LAENKFTGEIPDFLSGA 292
Query: 191 QPFLVVFNVSGNNLTGQVPE 210
L ++SGN+ G VP
Sbjct: 293 CDTLTGLDLSGNHFYGAVPP 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 49/130 (37%), Positives = 66/130 (50%), Gaps = 4/130 (3%)
Query: 86 LRGTFPPN-TLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSIL 143
G PN + L+ L L NN TG IP LS+ L SL LS N+ SG P S+
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSG 201
SL +L L L N L G IP L + L +L L++N +G +P N L ++S
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 202 NNLTGQVPET 211
N LTG++P+
Sbjct: 500 NRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 45/139 (32%), Positives = 64/139 (46%), Gaps = 4/139 (2%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILS 144
L GT P + L L +LR L L N L G IP L + L++L L N +G P + +
Sbjct: 430 LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF--LVVFNVSGN 202
L + LS N LTG IP + L+ L LKL N FSG +P L+ +++ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 203 NLTGQVPETPTLLKFDASS 221
G +P ++
Sbjct: 549 LFNGTIPAAMFKQSGKIAA 567
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 46/130 (35%), Positives = 60/130 (46%), Gaps = 9/130 (6%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSIL 143
G PP L L+ LSL N TG IPD + L L LS N F GA P
Sbjct: 259 FVGPIPPLPLK---SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 144 SLHRLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNV 199
S L L LS NN +G +P++ L + L L L +N FSG +P L+ ++
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 200 SGNNLTGQVP 209
S NN +G +
Sbjct: 376 SSNNFSGPIL 385
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 44/145 (30%), Positives = 56/145 (38%), Gaps = 14/145 (9%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILS 144
L G P L+ L +SL NN LTG IP + L NL L LS N FSG P +
Sbjct: 478 LTGEIPS-GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGN 202
L LDL+ N G IP + S K+ N +G N + +GN
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592
Query: 203 --NLTGQVPET----PTLLKFDASS 221
G E T + +S
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITS 617
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 66/276 (23%), Positives = 113/276 (40%), Gaps = 37/276 (13%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSA--EAFEQHMEAVGGLSHPNLVPI 452
E++G G G Y+A V VK + D S E Q + L HPN++ +
Sbjct: 13 EIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-- 510
R + ++ ++ G L ++ G K + + A +A+G+ Y+H
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 511 ASWLIHGNLKSSNVLLGADFEAR--------LTDYCLS-VLSDSSSVEDPDTVAYKAPEI 561
+IH +LKSSN+L+ E +TD+ L+ ++ + A+ APE+
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL-- 619
++S + SDV+++GVLL ELLTG+ P + + V + L
Sbjct: 186 IRASM-FSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGV-------AMNKLALPI 235
Query: 620 --GMLTEVASV---CSLKSPEQRPAMWQVLKMIQEI 650
A + C P RP+ +L + I
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 43/286 (15%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E+LG+G G K + ++ +K + + + F + ++ + L HPN++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
I +Y G+L +I W+ + A+D+A G+AY+H +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMN- 128
Query: 514 LIHGNLKSSNVLLG-------ADF-EARLTDYCLSVLSDSSSVEDPD---------TVAY 556
+IH +L S N L+ ADF ARL + S++ PD +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616
APE+ R K DV++FG++L E++ + PD L RTM
Sbjct: 189 MAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNA-------DPDYLP--RTMDFGLNVRG 238
Query: 617 N-RLGM-------LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654
+ C PE+RP+ ++ ++ ++ +
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVP 451
L+GRG +G Y+A D IV +K ++D ++ G L P++VP
Sbjct: 40 RLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 452 IRAYFQAKGERLVIYDY-QPNGSLF---NLIHGS--RSI--RAKPLHWTSCLKIAEDVAQ 503
I +D+ + +G L+ LI+G ++ R PL + I +
Sbjct: 99 I-------------HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAP 559
L H A H ++K N+L+ AD A L D+ ++ + + T+ Y AP
Sbjct: 146 ALDAAHAAG-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
E R S AT ++D+YA +L E LTG P
Sbjct: 205 E-RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+GRGS T YK + + + V K + + F++ E + GL HPN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 454 AYF---QAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ + +V+ + +G+L + R K + + +GL ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 510 -RASWLIHGNLKSSNVLL-GADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKSSR 566
R +IH +LK N+ + G ++ D L+ + S + T + APE+ +
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE--E 204
Query: 567 RATSKSDVYAFGVLLLELLTGKHP 590
+ DVYAFG+ +LE+ T ++P
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 44/203 (21%), Positives = 85/203 (41%), Gaps = 15/203 (7%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVP 451
+ LG G + T Y A D L V +K FE+ + LSH N+V
Sbjct: 17 DKLGGGGMSTVYLA-EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ + ++ +Y +L I PL + + + G+ + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSSRR 567
++H ++K N+L+ ++ ++ D+ ++ +S+ + TV Y +PE K
Sbjct: 131 R-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA- 188
Query: 568 ATSKSDVYAFGVLLLELLTGKHP 590
+D+Y+ G++L E+L G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVP 451
E+LG G + + A D V VK A+ D S F + + L+HP +V
Sbjct: 18 EILGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 452 IRAYFQAKGERLVIY----DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+ +A+ + +Y +L +++H P+ +++ D Q L +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNF 131
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD------TVAYKAPEI 561
H+ +IH ++K +N+++ A ++ D+ ++ S T Y +PE
Sbjct: 132 SHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ ++SDVY+ G +L E+LTG+ P
Sbjct: 191 ARGDS-VDARSDVYSLGCVLYEVLTGEPP 218
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 52/271 (19%), Positives = 109/271 (40%), Gaps = 14/271 (5%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNLVPI 452
+ +GRG Y+A L + + V +K+ D A + ++ + L+HPN++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 453 RAYFQAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
A F E L I + G L +I + + + + + K + L ++H
Sbjct: 98 YASFIEDNE-LNIVLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEIRKSSR 566
++H ++K +NV + A +L D L S ++ ++ Y +PE
Sbjct: 156 R-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHE-N 211
Query: 567 RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626
KSD+++ G LL E+ + P + + + + ++ L ++
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 627 SVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657
++C PE+RP + V + + + +
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMHACTASS 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 33/294 (11%), Positives = 65/294 (22%), Gaps = 52/294 (17%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTS-AEAFEQHMEAVGGLSHPNLVPI 452
E L G + ++ +K F S E + A L +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 453 RAYFQAKGER-------------------------LVIYDYQPNGSLFNLIH--GSRSIR 485
R + ++ + L L +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 486 AKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545
+ + + + A + L+HG+ N+ + D L D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 546 SSVEDPDTVAYKAPEIRKSSRRA-TSKSDVYAFGVLLLELLTGKHP-----------SQH 593
V Y E +S T + + G+ + + P +
Sbjct: 247 RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306
Query: 594 PYLAPPDMLEWVRTMRVDDGREENRL--GMLTEVASVCSLKSPEQRPAMWQVLK 645
P L P L L +R + ++
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN--------FDRRRRLLPLEAME 352
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 30/130 (23%), Positives = 46/130 (35%), Gaps = 4/130 (3%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILS 144
L+ + L L L + + + L +L+ L ++ N F F I +
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 145 -LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSG 201
L LT LDLS L L P +L L L + N F L V + S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 202 NNLTGQVPET 211
N++ +
Sbjct: 528 NHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-22
Identities = 30/123 (24%), Positives = 43/123 (34%), Gaps = 5/123 (4%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
L L VL + NS + L NL L LS+ P + SL
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF---LVVFNVSGNN 203
L +L++S+NN L L+ L L N + Q F L N++ N+
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 204 LTG 206
Sbjct: 555 FAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 25/125 (20%), Positives = 38/125 (30%), Gaps = 4/125 (3%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL-SLHRLT 149
+ L+ L L N + + L L+ L + S+ SL L
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLTG 206
LD+S+ + L L LK+ N F P L ++S L
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 207 QVPET 211
P
Sbjct: 485 LSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 25/127 (19%), Positives = 38/127 (29%), Gaps = 4/127 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ +L+VL L + SL +L +L L+ N + L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNL 204
L L NL L + L L L + N P N L ++S N +
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 205 TGQVPET 211
Sbjct: 162 QSIYCTD 168
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 33/138 (23%), Positives = 48/138 (34%), Gaps = 10/138 (7%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFP 139
+ + F P+ T L L L L L P +SL +L+ L++S N F
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 140 LSILSLHRLTILDLSYNNLTGLIPVNLTALDR-LYSLKLEWNRFSGTVPPLNQPF----- 193
L+ L +LD S N++ L L L L N F+ T +Q F
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE--HQSFLQWIK 569
Query: 194 -LVVFNVSGNNLTGQVPE 210
V + P
Sbjct: 570 DQRQLLVEVERMECATPS 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 29/130 (22%), Positives = 48/130 (36%), Gaps = 7/130 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFF-SGAFPLSILSLH 146
+ + L L+ L +L + L LK L+++ N S P +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRL----YSLKLEWNRFSGTVP-PLNQPFLVVFNVSG 201
L LDLS N + + +L L ++ SL L N + P + L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 202 NNLTGQVPET 211
N + V +T
Sbjct: 210 NFDSLNVMKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 24/109 (22%), Positives = 35/109 (32%), Gaps = 3/109 (2%)
Query: 101 LRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
+ L L N L S L+ L LSR + SL L+ L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 160 GLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTG 206
L + L L L + + L NV+ N +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 30/129 (23%), Positives = 46/129 (35%), Gaps = 10/129 (7%)
Query: 88 GTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNF--FSGAFPLSILSL 145
G FP L L +L S + L +L+ L LSRN F G S
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGN----AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGN 202
L LDLS+N + + N L++L L + + L+ L+ ++S
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 203 NLTGQVPET 211
+
Sbjct: 432 HTRVAFNGI 440
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 32/170 (18%), Positives = 45/170 (26%), Gaps = 32/170 (18%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS----- 135
L + L + SL + ++ + D S + L L F
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTL 322
Query: 136 --------------GAFPLSILSLHRLTILDLSYNNLT--GLIPVNLTALDRLYSLKLEW 179
G S + L L LDLS N L+ G + L L L +
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 180 NRFSGTVPP-LNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
N L L + +NL S F NL
Sbjct: 383 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEF---------SVFLSLRNL 423
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 21/111 (18%), Positives = 30/111 (27%), Gaps = 4/111 (3%)
Query: 103 VLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLI 162
+ +L + K+L LS N S S L +LDLS + +
Sbjct: 11 TYQCMELNFYKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 163 PVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET 211
+L L +L L N L NL
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 25/131 (19%), Positives = 37/131 (28%), Gaps = 12/131 (9%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLK----SLSLSRNFFSGAFPL 140
++ P + L L L L +N + DL L + SL LS N +
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQP 194
Query: 141 SILSLHRLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPLNQPF-----L 194
RL L L N + + + L L +L F L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 195 VVFNVSGNNLT 205
+ L
Sbjct: 255 CNLTIEEFRLA 265
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 31/149 (20%), Positives = 49/149 (32%), Gaps = 12/149 (8%)
Query: 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLT------GPIPDL-SSLINLKSL 127
V R VL F G + L+ L L++ L I DL + L N+ S
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 128 SLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP 187
SL S L+L + L +L RL N+
Sbjct: 288 SLVSVTIERVKDFSYNF--GWQHLELVNCKFGQFPTLKLKSLKRLTFTS---NKGGNAFS 342
Query: 188 PLNQPFLVVFNVSGNNLTGQVPETPTLLK 216
++ P L ++S N L+ + + +
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 18/131 (13%), Positives = 33/131 (25%), Gaps = 13/131 (9%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTG----PIPDLSSLINLKSLSLSRN------FFS 135
+ L L V L D S+L L +L++ ++
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 136 GAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLV 195
L ++ L + + + L+L +F P L L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ-FPTLKLKSLK 328
Query: 196 VFNVSGNNLTG 206
+ N
Sbjct: 329 RLTFTSNKGGN 339
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 22/139 (15%), Positives = 32/139 (23%), Gaps = 12/139 (8%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILS-- 144
P + +L L+L NN + + + L L+ L F L
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 145 -LHRLTILDLSYNNLTGL------IPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVF 197
L L L + L L I L + S L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 198 NVSGNNLTGQVPETPTLLK 216
+ LK
Sbjct: 310 ELVNCKFGQFPTLKLKSLK 328
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 58/306 (18%), Positives = 111/306 (36%), Gaps = 70/306 (22%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+ LG G L + +KR ++ D E ++ + +HPN++ +
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHPNILRLV 92
Query: 454 AYF----QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
AY AK E ++ + G+L+N I + L L + + +GL IH
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVL--------SDSSSVEDPD----TVAYK 557
H +LK +N+LLG + + L D + +++D T++Y+
Sbjct: 152 AKG-YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 558 APEI--RKSSRRATSKSDVYAFGVLLLELLTGKHP--------------SQHPYLAPP-- 599
APE+ +S ++DV++ G +L ++ G+ P Q+ P
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP 270
Query: 600 -------DMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
+L M+T P QRP + +L ++ ++
Sbjct: 271 RHSSALWQLLNS----------------MMT--------VDPHQRPHIPLLLSQLEALQP 306
Query: 653 SVMAED 658
+
Sbjct: 307 PAPGQH 312
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 25/274 (9%)
Query: 395 ELLGRGSIGTTYKAVLDNHLI-VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G G Y+ V + + V VK K E F + + + HPNLV +
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ +I ++ G+L + + R + + L +A ++ + Y+ + +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYK--APEIRKSSRRAT 569
IH NL + N L+G + ++ D+ LS + D+ + K APE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFS 397
Query: 570 SKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG----REENRLGMLTE 624
KSDV+AFGVLL E+ T G P +P + + E ++ R E + E
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYE-----LLEKDYRMERPEGCPEKVYE 450
Query: 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
+ C +P RP+ ++ + + + + D
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 41/271 (15%), Positives = 82/271 (30%), Gaps = 30/271 (11%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTS----AEAFEQHMEAVGGLSHPNLV 450
LLG G+ Y+A + K+ K + Q ME + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ + +++ + G+L N I+ ++ K + + A + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 511 ASWLIHGNLKSSNVLLGADFEA-----------RLTDYCLSV-----LSDSSSVEDPDTV 554
+IHG++K N +LG F L D S+ + +T
Sbjct: 191 CE-IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 555 AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGR 614
++ E+ ++ + D + + +L G + E R
Sbjct: 250 GFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTY--------MKVKNEGGECKPEGLFR 300
Query: 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
L M E V +L+
Sbjct: 301 RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
LG+G G + + V +K K S EAF Q + + L H LV + A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ ++ +Y GSL + + + K L + +A +A G+AY+ R +
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMN-Y 301
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYK--APEIRKSSRRATS 570
+H +L+++N+L+G + ++ D+ L+ + + + K APE R T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTI 360
Query: 571 KSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG----REENRLGMLTEV 625
KSDV++FG+LL EL T G+ P +P + ++L+ +V+ G L ++
Sbjct: 361 KSDVWSFGILLTELTTKGRVP--YPGMVNREVLD-----QVERGYRMPCPPECPESLHDL 413
Query: 626 ASVCSLKSPEQRPAMWQVLKMIQEIKES 653
C K PE+RP + +++ S
Sbjct: 414 MCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-21
Identities = 42/219 (19%), Positives = 84/219 (38%), Gaps = 30/219 (13%)
Query: 395 ELLGRGSIGTTYKAVLDNHL---IVTVK--RFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+ G +G Y A+ D ++ V +K + A + + + HP++
Sbjct: 86 GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEA---QAMAMAERQFLAEVVHPSI 141
Query: 450 VPIRAYFQAKGE--RLVIY---DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
V I + + V Y +Y SL + + + L + ++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-------KRSKGQKLPVAEAIAYLLEILPA 194
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL-SVLSDSSSVEDPDTVAYKAPEIRK 563
L+Y+H L++ +LK N++L + + +L D S ++ + T ++APEI +
Sbjct: 195 LSYLHSIG-LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL--YGTPGFQAPEIVR 250
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHP--SQHPYLAPPD 600
+ T +D+Y G L L ++ P D
Sbjct: 251 T--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED 287
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 34/261 (13%), Positives = 65/261 (24%), Gaps = 60/261 (22%)
Query: 395 ELLGRGSIGTTYKAVLDNHL--IVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVP 451
G ++A+ D L V + D + + + P +
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ + LV+ ++ GSL + ++ + +A HRA
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSK 571
+ S V + D + L A A +
Sbjct: 149 G-VALSIDHPSRVRVSIDGDVVLAY-----------------PATMPD--------ANPQ 182
Query: 572 SDVYAFGVLLLELLTGKHP-------------SQHPYLAPPDMLEWVRTMRVDDGREENR 618
D+ G L LL + P + P + + D +
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE----PADIDRDIPFQ--- 235
Query: 619 LGMLTEVASVCSLKSPEQRPA 639
++ VA+ R A
Sbjct: 236 ---ISAVAARSVQGDGGIRSA 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-20
Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
LG+G G + + V +K K S EAF Q + + L H LV + A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ ++ +Y GSL + + + K L + +A +A G+AY+ R +
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMN-Y 384
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYK--APEIRKSSRRATS 570
+H +L+++N+L+G + ++ D+ L+ + + + K APE R T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTI 443
Query: 571 KSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG----REENRLGMLTEV 625
KSDV++FG+LL EL T G+ P +P + ++L+ +V+ G L ++
Sbjct: 444 KSDVWSFGILLTELTTKGRVP--YPGMVNREVLD-----QVERGYRMPCPPECPESLHDL 496
Query: 626 ASVCSLKSPEQRPAMWQVLKMIQEIKES 653
C K PE+RP + +++ S
Sbjct: 497 MCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 30/131 (22%), Positives = 44/131 (33%), Gaps = 3/131 (2%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
P TR QL L + N+++ P+ L LK L+L N S +
Sbjct: 39 RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205
LT L L N++ + L +L L N S T L +S N +
Sbjct: 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158
Query: 206 GQVPETPTLLK 216
E +
Sbjct: 159 ALKSEELDIFA 169
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-20
Identities = 36/157 (22%), Positives = 55/157 (35%), Gaps = 12/157 (7%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLT---------GPIPDLSSLINLKSLSLSRNFFSGAFP 139
+ L L++L +L L +N+L GPI L L +L L+L N F
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
Query: 140 LSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQP---FLVV 196
L L I+DL NNL L L SL L+ N + + P L
Sbjct: 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613
Query: 197 FNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVI 233
++ N + + + + P L +
Sbjct: 614 LDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL 650
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-19
Identities = 34/150 (22%), Positives = 55/150 (36%), Gaps = 20/150 (13%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD---LSSLINLKSLSLSRNFFSGAFPLSILSL 145
+ T +L+ L+ L L NN + + + + +LK L LS N P ++
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLK---LEWNRFSGTVP----PLNQPFLVVFN 198
RL L L+ L + L S++ L ++ S T L L + +
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 199 VSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
+S NNL SF+ P L
Sbjct: 255 LSYNNLNV----------VGNDSFAWLPQL 274
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-19
Identities = 28/139 (20%), Positives = 49/139 (35%), Gaps = 16/139 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAF--------- 138
++ L QL L N++ L L N++ L+L R+F +
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 139 PLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP------LNQP 192
S L L L++ N++ G+ T L L L L + S L
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
Query: 193 FLVVFNVSGNNLTGQVPET 211
L + N++ N ++ +
Sbjct: 382 PLHILNLTKNKISKIESDA 400
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 26/123 (21%), Positives = 40/123 (32%), Gaps = 6/123 (4%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
+ + L L VL L N + + L N+ + LS N + S +
Sbjct: 395 KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVP 454
Query: 147 RLTILDLSYNNLTGL--IPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGN 202
L L L L + P L L L L N + + L + ++ N
Sbjct: 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514
Query: 203 NLT 205
NL
Sbjct: 515 NLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-17
Identities = 39/154 (25%), Positives = 55/154 (35%), Gaps = 25/154 (16%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD---LSSLINLKSLSLSRNFFSGAFPLSILSL 145
N+ + L+ L L +L L NL L LS N + + L
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503
Query: 146 HRLTILDLSYNNLT--------GLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFL 194
+L ILDL +NNL G L L L+ L LE N F +P + L
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFEL 562
Query: 195 VVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
+ ++ NNL AS F+ +L
Sbjct: 563 KIIDLGLNNLNT----------LPASVFNNQVSL 586
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-16
Identities = 33/159 (20%), Positives = 52/159 (32%), Gaps = 26/159 (16%)
Query: 86 LRGTFPPNTLTRLD--QLRVLSLHNNSLTGPIPDLSS---LINLKSLSLSRNFFSGAFPL 140
L + L +R LSL N+ L+ NL L LS N +
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 141 SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP-----------L 189
S L +L L YNN+ L +L L + L L+ + ++
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326
Query: 190 NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
L N+ N++ G ++ F+ NL
Sbjct: 327 WLKCLEHLNMEDNDIPG----------IKSNMFTGLINL 355
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 29/148 (19%), Positives = 51/148 (34%), Gaps = 16/148 (10%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLIN-----LKSLSLSRNFFSGAFPLSIL 143
N T L L+ LSL N+ + + ++ L L+L++N S +
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 144 SLHRLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVS 200
L L +LDL N + + L+ ++ + L +N++ P L +
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462
Query: 201 GNNLTGQVPETPTLLKFDASSFSMNPNL 228
L + S F NL
Sbjct: 463 RVALKN--------VDSSPSPFQPLRNL 482
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 27/131 (20%), Positives = 44/131 (33%), Gaps = 14/131 (10%)
Query: 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
V + LT +PD N+ L+L+ N + +LT LD+ +N ++
Sbjct: 5 SHEVADCSHLKLTQ-VPD-DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 160 GLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKF 217
L P L L L L+ N S L ++ N++
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK----------I 112
Query: 218 DASSFSMNPNL 228
+ F NL
Sbjct: 113 KNNPFVKQKNL 123
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+ +G GS G D V +K + ++ + E + + + + HPN+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYV-IKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
R F+ G ++ DY G LF I + + L + L ++H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEIRKSSRR 567
++H ++KS N+ L D +L D+ ++ VL+ + + Y +PEI ++ +
Sbjct: 146 -ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACIGTPYYLSPEICEN-KP 201
Query: 568 ATSKSDVYAFGVLLLELLTGKHP 590
+KSD++A G +L EL T KH
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 35/273 (12%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ LG G G + A + H V VK K S EAF + L H LV + A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ +I ++ GSL + + +S + + +A+G+A+I + +
Sbjct: 251 VVTKEP-IYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-Y 305
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK---------APEIRKSS 565
IH +L+++N+L+ A ++ D+ L+ + +ED + A + APE
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARV-----IEDNEYTAREGAKFPIKWTAPEAINF- 359
Query: 566 RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG----REENRLG 620
T KSDV++FG+LL+E++T G+ P +P ++ P+++ ++ G R EN
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIR-----ALERGYRMPRPENCPE 412
Query: 621 MLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
L + C PE+RP + ++ + +
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 50/209 (23%), Positives = 79/209 (37%), Gaps = 18/209 (8%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+G GS G K D ++V K D + + + + L HPN+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILV-WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 453 RAYFQAK-GERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ L I +Y G L ++I + L L++ + L HR
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 511 ASWL----IHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEI 561
S +H +LK +NV L +L D+ L+ +L+ +S T Y +PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQ 187
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
KSD+++ G LL EL P
Sbjct: 188 MNR-MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 41/219 (18%), Positives = 78/219 (35%), Gaps = 28/219 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPI 452
E +G G G+ +K V + I +KR + + + A L H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74
Query: 453 RAYFQA--KGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
YF A + + ++I +Y GSL + I + V +GL YIH
Sbjct: 75 -RYFSAWAEDDHMLIQNEYCNGGSLADAIS-ENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSV-----------LSD---SSSVEDPDTVA 555
S L+H ++K SN+ + + D + + P
Sbjct: 133 SMS-LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 556 ----YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ A E+ + + K+D++A + ++ +
Sbjct: 192 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 69/290 (23%), Positives = 119/290 (41%), Gaps = 61/290 (21%)
Query: 395 ELLGRGSIGTTYKAV--LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
EL+G G G +KA +D V +KR N E E+ ++A+ L H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYV-IKRVKYNN------EKAEREVKALAKLDHVNIVHY 69
Query: 453 RAYFQ---------------AKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLK 496
+ +K + L I ++ G+L I R + L L+
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALE 126
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPD-TV 554
+ E + +G+ YIH LI+ +LK SN+ L + ++ D+ L L + T+
Sbjct: 127 LFEQITKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 555 AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG- 613
Y +PE S + + D+YA G++L ELL + ++ +R DG
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDT-------AFETSKFFTDLR--DGI 235
Query: 614 ------REENRL--GMLTEVASVCSLKSPEQRPAMWQVLK---MIQEIKE 652
++E L +L+ K PE RP ++L+ + ++ E
Sbjct: 236 ISDIFDKKEKTLLQKLLS--------KKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 42/292 (14%), Positives = 84/292 (28%), Gaps = 53/292 (18%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQH---------------- 437
+LG+ +A + V + ++A +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 438 -------MEAVGGLSHPNLVPIRAYFQAKGERLVIYDY----QPNGSLFNLIH--GSRSI 484
+ + P + + + V+ + + +L S S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 485 RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544
K L + L++ V + LA +H L+H L+ +++L LT + V
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 545 SSSVEDPDTVAYKAPEI---------RKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY 595
+S+V P + PE + T D + G+ + + P+
Sbjct: 263 ASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD- 320
Query: 596 LAPPDMLEWVRTMRVDDGREENRL--GMLTEVASVCSLKSPEQRPAMWQVLK 645
A EW+ + + L G L E R Q ++
Sbjct: 321 -AALGGSEWIFRSCKNIPQPVRALLEGFLR--------YPKEDRLLPLQAME 363
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 24/137 (17%), Positives = 51/137 (37%), Gaps = 12/137 (8%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS-LHRLT 149
+L ++ +L +L N L G +P S I L SL+L+ N + P + ++
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVE 380
Query: 150 ILDLSYNNLTGL-IPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF---------LVVFNV 199
L ++N L + + ++ + ++ +N P + N+
Sbjct: 381 NLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440
Query: 200 SGNNLTGQVPETPTLLK 216
S N ++ E +
Sbjct: 441 SNNQISKFPKELFSTGS 457
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 33/137 (24%), Positives = 53/137 (38%), Gaps = 18/137 (13%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSG-------AFPLSIL 143
T + + ++L NN ++ + S+ L S++L N + +
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 144 SLHRLTILDLSYNNLTGLIP-VNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVF--- 197
+ + LT +DL +N LT L T L L + L +N FS P LN L F
Sbjct: 486 NTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544
Query: 198 ---NVSGNNLTGQVPET 211
+ GN + PE
Sbjct: 545 NQRDAQGNRTLREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 28/124 (22%), Positives = 40/124 (32%), Gaps = 12/124 (9%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPD---LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
L + L N LT + D ++L L + LS N FS FP L+ L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 149 TIL------DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGN 202
D N P +T L L++ N V P + V ++ N
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDN 597
Query: 203 NLTG 206
Sbjct: 598 PNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 19/153 (12%), Positives = 46/153 (30%), Gaps = 31/153 (20%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIP--------------------DLSSLINLKSLS 128
TF + RL +LR + N+ +L +L +
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTGL--------IPVNLTALDRLYSLKLEWN 180
+ P + +L + +++++ N + +++ + + +N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 181 RF-SGTVPPL--NQPFLVVFNVSGNNLTGQVPE 210
+ V L + N L G++P
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 25/149 (16%), Positives = 49/149 (32%), Gaps = 23/149 (15%)
Query: 81 LQSFGLRG----TFPPNT-LTRLDQLRVLSLHNNSLTGPI--------PDLSSLINLKSL 127
+++ P + + + N + P IN+ S+
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 128 SLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGL-------IPVNLTALDRLYSLKLEWN 180
+LS N S + L+ ++L N LT + N L S+ L +N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498
Query: 181 RFSGTVPPL---NQPFLVVFNVSGNNLTG 206
+ + P+LV ++S N+ +
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 29/238 (12%), Positives = 53/238 (22%), Gaps = 64/238 (26%)
Query: 36 DAVSLLSFKSKADSENKLLYAL--------NERFDYCQW---QGVKC-AQGRVVRFVLQS 83
D ++L + +N N + W GV + GRV L+
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90
Query: 84 FGLRGTFP---------------------------PNTLTRLDQLRVLSLHNNSLTGPIP 116
FG G P P ++
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 117 D---LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173
D +L ++ + + S + T + NN+T + + L +L
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLR 209
Query: 174 SLKLEWNRFSGTVPPLNQPF---------------------LVVFNVSGNNLTGQVPE 210
+ + F L V ++P
Sbjct: 210 QFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-14
Identities = 17/126 (13%), Positives = 35/126 (27%), Gaps = 12/126 (9%)
Query: 89 TFPPN-TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSL------SRNFFSGAFPLS 141
+ T L L + L NS + + LK + N +P
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 142 ILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNV 199
I LT L + N++ + + + L ++ N ++ +
Sbjct: 562 ITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 200 SGNNLT 205
+
Sbjct: 619 FYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 14/138 (10%), Positives = 36/138 (26%), Gaps = 8/138 (5%)
Query: 90 FPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLT 149
+ + + +N++T + L L+ + + F
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN---- 229
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQ 207
+ Y + L L +++ +P P + + NV+ N
Sbjct: 230 -ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS- 287
Query: 208 VPETPTLLKFDASSFSMN 225
+ + A +
Sbjct: 288 GEQLKDDWQALADAPVGE 305
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 17/106 (16%), Positives = 35/106 (33%), Gaps = 8/106 (7%)
Query: 118 LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTG----LIPVNLTALDRLY 173
L+S + LSL SG P +I L L +L L + P ++A
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 174 SLKLEWNRFSGTVPP----LNQPFLVVFNVSGNNLTGQVPETPTLL 215
+ + T + L+ ++ + + ++ +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 13/98 (13%), Positives = 26/98 (26%), Gaps = 6/98 (6%)
Query: 126 SLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT 185
+ + + + +S+ S R+T L L +G +P + L L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 186 VPPL------NQPFLVVFNVSGNNLTGQVPETPTLLKF 217
+ + F
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDF 158
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 44/306 (14%), Positives = 89/306 (29%), Gaps = 56/306 (18%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEA-------------------- 433
+LG+ +A + V + ++A
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 434 ------FEQHMEAVGGLSHPNLVPIRAYFQAKGER-LVIYDYQPNGSLFNLIH--GSRSI 484
F + V ++ +R + + +L S S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 485 RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544
K L + L++ V + LA +H L+H L+ +++L LT + V
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 545 SSSVEDPDTVAYKAPEI----------RKSSRRATSKSDVYAFGVLLLELLTGKHPSQHP 594
+ V + ++ PE+ R T D +A G+++ + P
Sbjct: 258 ARVVSSV-SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316
Query: 595 YLAPPDMLEWVRTMRVDDGREENRL--GMLTEVASVCSLKSPEQRPAMWQVLKM--IQEI 650
A EW+ + + L G L E R Q ++ +++
Sbjct: 317 --AALGGSEWIFRSCKNIPQPVRALLEGFLR--------YPKEDRLLPLQAMETPEYEQL 366
Query: 651 KESVMA 656
+ + A
Sbjct: 367 RTELSA 372
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 29/131 (22%), Positives = 43/131 (32%), Gaps = 3/131 (2%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
T T +RL L L L + D S L +L L+ N ++
Sbjct: 47 TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF--LVVFNVSGNNLT 205
L L ++ + + L L SL L N S P P L V + N +
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166
Query: 206 GQVPETPTLLK 216
E + L+
Sbjct: 167 YLSKEDMSSLQ 177
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 29/161 (18%), Positives = 47/161 (29%), Gaps = 22/161 (13%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
+ QL +L L L +L LK L+LS + + L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLK---LEWNRFSGTVPPL---NQPFLVVFNVS 200
L L+L N+ +L L L+ L + S + + + ++S
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLS 508
Query: 201 GNNLTGQVPETPTLLK-------------FDASSFSMNPNL 228
N LT E + LK S +
Sbjct: 509 HNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQ 549
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-16
Identities = 32/132 (24%), Positives = 41/132 (31%), Gaps = 7/132 (5%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
NT L+ L L L+ L L LK L LS N F +S + LT
Sbjct: 270 SSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 151 LDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPLNQPF-----LVVFNVSGNNL 204
L + N + L L+ L L L + T N L N+S N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 205 TGQVPETPTLLK 216
E
Sbjct: 389 LSLKTEAFKECP 400
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-16
Identities = 31/142 (21%), Positives = 53/142 (37%), Gaps = 6/142 (4%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD---LSSLINLKSLSLSRNFFSGA 137
++ R L L+ LR L L ++ + L +L +L+SL+LS N
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 138 FPLSILSLHRLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPL--NQPFL 194
+ +L +LDL++ L + L L L L + + L P L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451
Query: 195 VVFNVSGNNLTGQVPETPTLLK 216
N+ GN+ + L+
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQ 473
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 23/134 (17%), Positives = 42/134 (31%), Gaps = 6/134 (4%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
L+ L+ L ++ L + L+SL L N S +
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 148 LTILDLSYNNLTGLIPVNLTALDRL--YSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNN 203
L +LD N + L ++++L + SL L N + + P + N G
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQ 213
Query: 204 LTGQVPETPTLLKF 217
+ +
Sbjct: 214 NLLVIFKGLKNSTI 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 30/140 (21%), Positives = 41/140 (29%), Gaps = 19/140 (13%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
PN+ L+ N L S LINL L L+R + S HRL
Sbjct: 32 PNSTECLE------FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDT 85
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208
L L+ N L + L+ L L S NQ L + N+++
Sbjct: 86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS-- 143
Query: 209 PETPTLLKFDASSFSMNPNL 228
L
Sbjct: 144 --------IKLPKGFPTEKL 155
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 23/96 (23%), Positives = 43/96 (44%), Gaps = 2/96 (2%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLT 149
N+L L +L +L L L+ +SL + + LS N + + LS +
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGI 526
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT 185
L+L+ N+++ ++P L L + ++ L N T
Sbjct: 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 25/131 (19%), Positives = 52/131 (39%), Gaps = 8/131 (6%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDL---SSLINLKSLSLSRNFFSGAFPLSI 142
L F + + L + + + P + ++++S++L +++F +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNV 199
L LDL+ +L+ +P L L L L L N+F + + N P L ++
Sbjct: 275 HCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSI 332
Query: 200 SGNNLTGQVPE 210
GN ++
Sbjct: 333 KGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 19/125 (15%), Positives = 39/125 (31%), Gaps = 8/125 (6%)
Query: 89 TFPPNTLTRLDQLRVLSLH--NNSLTGPIPDLSSLINLKSLSLSRNFFSGAFP--LSILS 144
++ L Q LSL+ N + G P +SL+ L +
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLY--SLKLEWNRFSGTVPPL--NQPFLVVFNVS 200
+ L + + + P L + S+ L+ + F L +++
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 201 GNNLT 205
+L+
Sbjct: 287 ATHLS 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 18/112 (16%), Positives = 31/112 (27%), Gaps = 4/112 (3%)
Query: 102 RVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGL 161
+ + N L L + + + L S N + L LT LDL+ + +
Sbjct: 15 KTYNCENLGLNEIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 162 IPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET 211
+ RL +L L N L ++
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 25/270 (9%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +GRG+ G + L ++ +V VK D A+ F Q + SHPN+V +
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLI 178
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
K ++ + G + L + L++ D A G+ Y+
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRT----EGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSS--SVEDPDTVAYK--APEIRKSSRRA 568
IH +L + N L+ +++D+ +S +D + V K APE R
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRY 292
Query: 569 TSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDM-LEWVRTMRVDDGREENRLGMLTEVA 626
+S+SDV++FG+LL E + G PY P++ + R GR V
Sbjct: 293 SSESDVWSFGILLWETFSLG----ASPY---PNLSNQQTREFVEKGGRLPCPELCPDAVF 345
Query: 627 SV---CSLKSPEQRPAMWQVLKMIQEIKES 653
+ C P QRP+ + + +Q I++
Sbjct: 346 RLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 61/286 (21%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV---- 450
E LG G G + + H V VK K S +AF + L H LV
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 451 -----PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
PI +I +Y NGSL + + ++ L L +A +A+G+
Sbjct: 76 VVTQEPI----------YIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK-------- 557
A+I + IH +L+++N+L+ ++ D+ L+ L +ED + A +
Sbjct: 123 AFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARL-----IEDNEYTAREGAKFPIKW 176
Query: 558 -APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR 614
APE I T KSDV++FG+LL E++T G+ P +P + P++++ ++ G
Sbjct: 177 TAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERG- 226
Query: 615 EENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
R+ L ++ +C + PE RP + ++++ +
Sbjct: 227 --YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 62/275 (22%), Positives = 115/275 (41%), Gaps = 27/275 (9%)
Query: 395 ELLGRGSIGTTYKAVLDNHLI-VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G G Y+ V + + V VK K E F + + + HPNLV +
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ +I ++ G+L + + R + + L +A ++ + Y+ + +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYK--APE-IRKSSRRA 568
IH +L + N L+G + ++ D+ LS + D+ + K APE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--NKF 189
Query: 569 TSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG----REENRLGMLT 623
+ KSDV+AFGVLL E+ T G P +P + + E ++ R E +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYE-----LLEKDYRMERPEGCPEKVY 242
Query: 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
E+ C +P RP+ ++ + + + + D
Sbjct: 243 ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 31/269 (11%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKT--ADTSAEAFEQHMEAVGGLSHPNLVPI 452
+ +G+G G + V A K D +A+AF + L H NLV +
Sbjct: 199 QTIGKGEFGDVMLGDYRGN---KV----AVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 453 RAY-FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ KG ++ +Y GSL + + RS L LK + DV + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK--APE-IRKSSRRA 568
+ +H +L + NVL+ D A+++D+ L+ ++SS +D + K APE +R+ ++
Sbjct: 309 N-FVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEALRE--KKF 363
Query: 569 TSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627
++KSDV++FG+LL E+ + G+ P +P + D++ V + + G V
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVE----KGYKMDAPDGCPPAVYD 417
Query: 628 V---CSLKSPEQRPAMWQVLKMIQEIKES 653
V C RP Q+ + ++ I+
Sbjct: 418 VMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 33/272 (12%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G G G + N V +K + S E F + E + LSHP LV +
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ ++ ++ +G L + + R + L + DV +G+AY+ A +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC-V 125
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYK--APE-IRKSSRRAT 569
IH +L + N L+G + +++D+ ++ VL D + K +PE R +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--SRYS 183
Query: 570 SKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL-------GM 621
SKSDV++FGVL+ E+ + GK P + + +++E + G RL
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVE-----DISTGF---RLYKPRLASTH 233
Query: 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
+ ++ + C + PE RPA ++L+ + EI ES
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 2e-18
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 395 ELLGRG--SIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP 451
++G+G + T A VTV+R + ++ + + +HPN+VP
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
RA F A E V+ + GS +LI + ++ + I + V + L YIH
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 512 SWLIHGNLKSSNVLLGADFEARLTD--YCLSVLSDSSSVEDPDTVAYK--------APE- 560
+H ++K+S++L+ D + L+ LS++S +PE
Sbjct: 148 G-YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGKHP--SQHP 594
++++ + +KSD+Y+ G+ EL G P
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 63/279 (22%), Positives = 116/279 (41%), Gaps = 27/279 (9%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
++G+G G Y N + +K T EAF + + GL+HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 451 PIRAY-FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ +G V+ Y +G L I + + + VA+G+ Y+
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA 141
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYK------APE-I 561
+H +L + N +L F ++ D+ L+ + D + A E +
Sbjct: 142 EQK-FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 562 RKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT-MRVDDGREENRL 619
+ R T+KSDV++FGVLL ELLT G P + ++ P D+ ++ R+ + E
Sbjct: 201 QT--YRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDPFDLTHFLAQGRRLP--QPEYCP 254
Query: 620 GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
L +V C P RP ++ +++I +++ +
Sbjct: 255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 43/276 (15%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ LG G G V VK K S + F Q + + LSHP LV
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ ++ +Y NG L N + K L + L++ DV +G+A++
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ-F 125
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK---------APE-IRKS 564
IH +L + N L+ D +++D+ ++ V D V+ APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRY-----VLDDQYVSSVGTKFPVKWSAPEVFHY- 179
Query: 565 SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL---- 619
+ +SKSDV+AFG+L+ E+ + GK P + +++ +V G RL
Sbjct: 180 -FKYSSKSDVWAFGILMWEVFSLGKMP--YDLYTNSEVVL-----KVSQGH---RLYRPH 228
Query: 620 ---GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
+ ++ C + PE+RP Q+L I+ ++E
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 58/283 (20%), Positives = 113/283 (39%), Gaps = 44/283 (15%)
Query: 395 ELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH 446
E LG+G+ +K V + V +K +K +E+F + + LSH
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFEAASMMSKLSH 71
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
+LV E +++ ++ GSL L I L++A+ +A +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAAAM 126
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD---SSSVEDPDTVAYK----- 557
++ + LIHGN+ + N+LL + + + + LSD S +V D +
Sbjct: 127 HFLEENT-LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI--LQERIPW 183
Query: 558 -APEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615
PE ++ + +D ++FG L E+ + G P L L+ +D
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQRKLQ-----FYEDR-- 234
Query: 616 ENRLG--MLTEVASV---CSLKSPEQRPAMWQVLKMIQEIKES 653
++L E+A++ C P+ RP+ +++ + +
Sbjct: 235 -HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 34/276 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E++G G+ A V +KR + K TS + + ++A+ HPN+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLK------IAEDVAQGLAY 507
F K E ++ GS+ ++I + I AK H + L I +V +GL Y
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDY----CLSVLSDSSSVEDPDTVA----YKAP 559
+H+ IH ++K+ N+LLG D ++ D+ L+ D + + T + AP
Sbjct: 137 LHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP--SQHPYLA-------PPDMLEWVRTMRV 610
E+ + R K+D+++FG+ +EL TG P P P LE V
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE----TGV 251
Query: 611 DDGREENRLG-MLTEVASVCSLKSPEQRPAMWQVLK 645
D + G ++ S+C K PE+RP ++L+
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 33/213 (15%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+LG+G+ G Y L N + + +K + ++ + + L H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIV--- 82
Query: 454 AY--FQAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCL--KIAEDVAQGLAYI 508
Y ++ + I+ + P GSL L+ + PL + + +GL Y+
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRS----KWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 509 HRASWLIHGNLKSSNVLLG--------ADF--EARLTDYCLSVLSDSSSVEDPDTVAYKA 558
H ++H ++K NVL+ +DF RL + + + T+ Y A
Sbjct: 139 HDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG----INPCTETFTG--TLQYMA 191
Query: 559 PE-IRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
PE I K R +D+++ G ++E+ TGK P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 33/270 (12%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKT--ADTSAEAFEQHMEAVGGLSHPNLVPI 452
+ +G+G G + V A K D +A+AF + L H NLV +
Sbjct: 27 QTIGKGEFGDVMLGDYRGN---KV----AVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 453 RAY-FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ KG ++ +Y GSL + + RS L LK + DV + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVAYKAPE-IRKSSRRA 568
+ +H +L + NVL+ D A+++D+ L+ S + + P V + APE +R+ ++
Sbjct: 137 N-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALRE--KKF 191
Query: 569 TSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG----REENRLGMLT 623
++KSDV++FG+LL E+ + G+ P +P + D++ RV+ G + +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVP-----RVEKGYKMDAPDGCPPAVY 244
Query: 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
EV C RP+ Q+ + ++ IK
Sbjct: 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 64/298 (21%), Positives = 106/298 (35%), Gaps = 61/298 (20%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFE-QHMEAVGGLSHPNLVP 451
+L G Y+A V +KR +N+ A E M+ + G HPN+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYA-LKRLLSNEEEKNRAIIQEVCFMKKLSG--HPNIVQ 90
Query: 452 IRAYFQAKGER-------LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+ E ++ G L + S PL + LKI +
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES--RGPLSCDTVLKIFYQTCRA 148
Query: 505 LAYIH-RASWLIHGNLKSSNVLLGADFEARLTDYCLSVL-----------SDSSSVEDPD 552
+ ++H + +IH +LK N+LL +L D+ + + VE+
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 553 TV----AYKAPEI--RKSSRRATSKSDVYAFGVLLLELLTGKHP---------SQHPYLA 597
T Y+ PEI S+ K D++A G +L L +HP Y
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI 268
Query: 598 PPDMLEWVRTMRVDDGREENRL--GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
PP + + L ML +PE+R ++ +V+ +QEI +
Sbjct: 269 PPHDTQ---------YTVFHSLIRAMLQ--------VNPEERLSIAEVVHQLQEIAAA 309
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-18
Identities = 26/132 (19%), Positives = 40/132 (30%), Gaps = 4/132 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ + +L+ L L + L +L +L L+ N P S L
Sbjct: 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNL 204
L L L L + L L L + N P N LV ++S N +
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165
Query: 205 TGQVPETPTLLK 216
L+
Sbjct: 166 QTITVNDLQFLR 177
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-16
Identities = 19/99 (19%), Positives = 30/99 (30%), Gaps = 1/99 (1%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILS 144
+ N L L L L +L L+ L++S N
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
L+ L+ LD S+N + + L L N +
Sbjct: 520 LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 30/131 (22%), Positives = 48/131 (36%), Gaps = 9/131 (6%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGA-FPLSILSLH 146
+F P + + L L L L + LI LK L+++ NF P +L
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 147 RLTILDLSYNNLTGLIPVNLTAL----DRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVS 200
L +DLSYN + + +L L SL + N + L +
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLR 212
Query: 201 GNNLTGQVPET 211
GN + + +T
Sbjct: 213 GNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 29/135 (21%), Positives = 39/135 (28%), Gaps = 14/135 (10%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL-SLHRLTILDLSYN 156
+ LR L L N + L L+ L + S SL +L LD+SY
Sbjct: 375 TNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLTGQVPETPT 213
N L L +LK+ N F N L ++S L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ------- 487
Query: 214 LLKFDASSFSMNPNL 228
F L
Sbjct: 488 ---ISWGVFDTLHRL 499
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-15
Identities = 28/145 (19%), Positives = 46/145 (31%), Gaps = 15/145 (10%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFSGAFPLSILSLH 146
L++L+ L +++L SL L L +S F L L
Sbjct: 389 IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 147 RLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNN 203
L L ++ N+ N L L L + + L + N+S NN
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 204 LTGQVPETPTLLKFDASSFSMNPNL 228
L D+S ++ +L
Sbjct: 509 LLF----------LDSSHYNQLYSL 523
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 23/110 (20%), Positives = 39/110 (35%), Gaps = 5/110 (4%)
Query: 101 LRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
+ + L N L S+ L+ L LSR + LH L+ L L+ N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 160 GLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLTG 206
P + + L L +L + + + L NV+ N +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-14
Identities = 25/143 (17%), Positives = 46/143 (32%), Gaps = 16/143 (11%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPD---LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
L L L L N+L+ +L+ L LS N + + L L
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEEL 401
Query: 149 TILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205
LD ++ L + + +L++L L + + + L ++GN+
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461
Query: 206 GQVPETPTLLKFDASSFSMNPNL 228
+ F+ NL
Sbjct: 462 DNTLS---------NVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 23/131 (17%), Positives = 46/131 (35%), Gaps = 8/131 (6%)
Query: 89 TFPPNTLTRLDQLRVLSL---HNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSL 145
F P+ + L + + + N + I L N+ ++SL+ +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KH 306
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+ L + L ++L L L L N+ S + + P L ++S N L+
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPFLKSLT---LTMNKGSISFKKVALPSLSYLDLSRNALS 363
Query: 206 GQVPETPTLLK 216
+ + L
Sbjct: 364 FSGCCSYSDLG 374
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 21/138 (15%), Positives = 33/138 (23%), Gaps = 11/138 (7%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
+ +L L+L N + I L +L L L F L I
Sbjct: 195 FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
Query: 147 --------RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFN 198
+ L+Y N V L + ++ L +
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLS 313
Query: 199 VSGNNLTGQVPETPTLLK 216
+ L LK
Sbjct: 314 IIRCQLKQFPTLDLPFLK 331
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 24/138 (17%), Positives = 42/138 (30%), Gaps = 23/138 (16%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS--------------- 135
L + +SL S+ + D+ +SLS+ R
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL 335
Query: 136 ----GAFPLSILSLHRLTILDLSYNNLTGLIPVNLT--ALDRLYSLKLEWNRFSGTVPPL 189
G+ ++L L+ LDLS N L+ + + + L L L +N
Sbjct: 336 TMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANF 395
Query: 190 -NQPFLVVFNVSGNNLTG 206
L + + L
Sbjct: 396 MGLEELQHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 25/142 (17%), Positives = 39/142 (27%), Gaps = 17/142 (11%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLK----SLSLSRNFFSGAFPL 140
+ P + L L + L N + + DL L SL +S N
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQD 198
Query: 141 SILSLHRLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSG----------TVPPL 189
+L L L N + I L L L+ +L F + L
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258
Query: 190 NQPFLVVFNVSGNNLTGQVPET 211
+ F ++ N
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVK 280
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 54/297 (18%), Positives = 109/297 (36%), Gaps = 82/297 (27%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
++LG G+ GT YK + + V +K T+ + + + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHV 79
Query: 450 V---------PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAE 499
+ +I P G L + + + +I ++ L L
Sbjct: 80 CRLLGICLTSTV----------QLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYK- 557
+A+G+ Y+ L+H +L + NVL+ ++TD+ L+ +L + Y
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-------EEKEYHA 176
Query: 558 ----------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV 605
A E I R T +SDV+++GV + EL+T G P + + ++
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISS-- 230
Query: 606 RTMRVDDGREENRLG------------MLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
++ G RL M C + + RP +++ ++
Sbjct: 231 ---ILEKG---ERLPQPPICTIDVYMIMRK-----CWMIDADSRPKFRELIIEFSKM 276
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 33/162 (20%), Positives = 53/162 (32%), Gaps = 26/162 (16%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLT--------GPIPDLSSLINLKSLSLSRNFFSGAFPL 140
FP + + L NN +T + + L ++ L N +
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSD 745
Query: 141 SIL--SLHRLTILDLSYNNLTGLIPV------NLTALDRLYSLKLEWNRFSGTVPPL--N 190
+L L+ +D+SYN + P L A + E NR P
Sbjct: 746 DFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
Query: 191 QPFLVVFNVSGNNLTGQVPET--PTLLKFDASSFSMNPNLCG 230
P L+ + N++ V E P L D + NPN+
Sbjct: 805 CPSLIQLQIGSNDIRK-VDEKLTPQLYILDIAD---NPNISI 842
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 8e-17
Identities = 28/137 (20%), Positives = 48/137 (35%), Gaps = 16/137 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
TF + RL +L+++ N+ T ++ + + LS +L L
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNLKDL 493
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-----------PFLVVF 197
T ++L +P L L L SL + NR P + +F
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 198 NVSGNNLTGQVPETPTL 214
+ NNL P + +L
Sbjct: 554 YMGYNNLEE-FPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 20/140 (14%), Positives = 45/140 (32%), Gaps = 11/140 (7%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS- 144
L +L ++ +L +L +N + + + + L L L N P +
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAF 617
Query: 145 LHRLTILDLSYNNLTGL-IPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF-------LVV 196
++ L S+N L + N ++ + S+ +N+ ++
Sbjct: 618 TDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 197 FNVSGNNLTGQVPETPTLLK 216
+S N + E
Sbjct: 678 VTLSYNEIQKFPTELFATGS 697
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 24/136 (17%), Positives = 44/136 (32%), Gaps = 20/136 (14%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD---LSSLINLKSLSLSRNFFSG-----AFPL 140
P + DQ+ L +N L IP+ S+ + S+ S N + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 141 SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP----------LN 190
+ + LSYN + + ++ L N + ++P N
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKN 726
Query: 191 QPFLVVFNVSGNNLTG 206
L ++ N LT
Sbjct: 727 TYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 7e-16
Identities = 18/130 (13%), Positives = 43/130 (33%), Gaps = 9/130 (6%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTG--PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLT 149
+ ++++ + N+L L ++ L L N + + +LT
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLT 598
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL----NQPFLVVFNVSGNNLT 205
L L YN + + D++ L N+ +P + + + + S N +
Sbjct: 599 DLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 206 GQVPETPTLL 215
+ +
Sbjct: 658 SEGRNISCSM 667
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-15
Identities = 22/147 (14%), Positives = 47/147 (31%), Gaps = 21/147 (14%)
Query: 81 LQSFGLRG----TFPPNT-LTRLDQLRVLSLHNNSLTGPIPDLSS------LINLKSLSL 129
++ G P + + + N + ++S IN +++L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 130 SRNFFSGAFPLSILSLHRLTILDLSYNNLTGL-------IPVNLTALDRLYSLKLEWNRF 182
S N + ++ + LS N +T + N L ++ L +N+
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
Query: 183 SGTVPPL---NQPFLVVFNVSGNNLTG 206
+ P+L +VS N +
Sbjct: 741 TSLSDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 22/175 (12%), Positives = 50/175 (28%), Gaps = 29/175 (16%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAF-- 138
+ +R + L +L + L +++ P++ + +SL
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 139 ----PLSILSLHRLTILDLSYNNLTGL-------------------IPVNLTALDRLYSL 175
+I L +L I+ + + T ++ + L L +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 176 KLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
+L +P + P L N++ N + A P +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 9e-13
Identities = 30/206 (14%), Positives = 56/206 (27%), Gaps = 28/206 (13%)
Query: 35 SDAVSLLSFKSKADSEN-----------KLLYALNERFDYCQWQGVKC----AQGRVVRF 79
D +L + D +N N + W GRV
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 80 VLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGA 137
L FG +G P+ + +L +L+VLS +S T L S
Sbjct: 329 SLAGFGAKGR-VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 138 FPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ------ 191
+ + RL + DL + + + + + + L+ + +
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQ 445
Query: 192 --PFLVVFNVSGNNLTGQVPETPTLL 215
L + + + T
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAVDWED 471
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 21/128 (16%), Positives = 40/128 (31%), Gaps = 16/128 (12%)
Query: 89 TFPPN-TLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSR------NFFSGAFPL 140
+ + T L L + + N + P + LK+ + N +P
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 141 SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS----GTVPPLNQPFLVV 196
I + L L + N++ + L +LY L + N +V P + + V
Sbjct: 801 GITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYV 857
Query: 197 FNVSGNNL 204
Sbjct: 858 LLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 15/136 (11%), Positives = 37/136 (27%), Gaps = 9/136 (6%)
Query: 102 RVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGL 161
L N + + + + + + + + + R+T L L+ G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 162 IPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVV---------FNVSGNNLTGQVPETP 212
+P + L L L + + + L + + +
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 213 TLLKFDASSFSMNPNL 228
L + + NP +
Sbjct: 399 NLSDLLQDAINRNPEM 414
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 12/83 (14%), Positives = 27/83 (32%), Gaps = 2/83 (2%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
P +T L L + +N + + + L L ++ N S+
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIRK-VDE-KLTPQLYILDIADNPNISIDVTSVCPYIEA 853
Query: 149 TILDLSYNNLTGLIPVNLTALDR 171
+ L Y+ + + ++R
Sbjct: 854 GMYVLLYDKTQDIRGCDALGIER 876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 64/298 (21%)
Query: 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+LG+G G+ +A L + V VK A+ A + E F + + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 451 PI------RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAK-PLHWTSCLKIAEDVAQ 503
+ +VI + +G L + SR L + ++ D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 504 GLAY------IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK 557
G+ Y IHR +L + N +L D + D+ LS + D Y+
Sbjct: 149 GMEYLSSRNFIHR-------DLAARNCMLAEDMTVCVADFGLS-----RKIYSGDY--YR 194
Query: 558 ------------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLE 603
A E + T SDV+AFGV + E++T G+ P + + ++
Sbjct: 195 QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIENAEIYN 250
Query: 604 WVRTMRVDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654
++ G NRL + ++ C P+QRP+ + ++ I +
Sbjct: 251 YLI-----GG---NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVPIR 453
LG+G G Y A + I+ +K + E + +E L HPN++ +
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
YF +I +Y P G+++ + + ++A L+Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV----AYKAPEIRKSSRRAT 569
+IH ++K N+LLG+ E ++ D+ SV + SS + Y PE+ R
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPEM-IEGRMHD 185
Query: 570 SKSDVYAFGVLLLELLTGKHP 590
K D+++ GVL E L GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 58/277 (20%), Positives = 105/277 (37%), Gaps = 43/277 (15%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ LG G G V +K K S + F + + + LSH LV +
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ +I +Y NG L N + R L++ +DV + + Y+
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ-F 141
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK---------APE-IRKS 564
+H +L + N L+ +++D+ LS V D + + PE +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY-----VLDDEYTSSVGSKFPVRWSPPEVLMY- 195
Query: 565 SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL---- 619
+ +SKSD++AFGVL+ E+ + GK P + + E + G RL
Sbjct: 196 -SKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNSETAE-----HIAQGL---RLYRPH 244
Query: 620 ---GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
+ + C + ++RP +L I ++ +
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 57/266 (21%), Positives = 97/266 (36%), Gaps = 37/266 (13%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL----SHPNL 449
LG GS G +K ++ + VKR + + + E VG HP
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAE-VGSHEKVGQHPCC 119
Query: 450 VPIRAYFQAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
V + ++ +G L + + SL L D LA++
Sbjct: 120 VRLEQAWE-EGGILYLQTEL-CGPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDY----CLSVLSDSSSVE-DPDTVAYKAPEIRK 563
H L+H ++K +N+ LG +L D+ L E DP Y APE+ +
Sbjct: 174 HSQG-LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR---YMAPELLQ 229
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623
S + +DV++ G+ +LE+ P E + +R E G+ +
Sbjct: 230 GS--YGTAADVFSLGLTILEVACNME--------LPHGGEGWQQLRQGYLPPEFTAGLSS 279
Query: 624 EVASVCSL---KSPEQRPAMWQVLKM 646
E+ SV + P+ R +L +
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLAL 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 30/209 (14%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+GRGS G ++ VK+ + + A GLS P +VP
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------VFRVEELVACAGLSSPRIVP-- 114
Query: 454 AY--FQAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+G + I+ + GSL LI + L L +GL Y+H
Sbjct: 115 -LYGAVREGPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 511 ASWLIHGNLKSSNVLLGAD-FEARLTDY----CLSVLSDSSSVEDPDTVA----YKAPEI 561
++HG++K+ NVLL +D A L D+ CL S+ D + + APE+
Sbjct: 169 RR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+K D+++ ++L +L G HP
Sbjct: 228 VMGKP-CDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 71/296 (23%), Positives = 114/296 (38%), Gaps = 63/296 (21%)
Query: 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
++LG G G+ + L L V VK + ++ E F + SHPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 451 P-----IRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAEDVAQG 504
I Q + +VI + G L + SR K + + LK D+A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 505 LAY------IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK- 557
+ Y +HR +L + N +L D + D+ LS + D Y+
Sbjct: 160 MEYLSNRNFLHR-------DLAARNCMLRDDMTVCVADFGLS-----KKIYSGDY--YRQ 205
Query: 558 -----------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEW 604
A E + R TSKSDV+AFGV + E+ T G P +P + +M ++
Sbjct: 206 GRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQNHEMYDY 261
Query: 605 VRTMRVDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
+ G +RL L E+ C P RP + ++++ ES
Sbjct: 262 LL-----HG---HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 53/292 (18%), Positives = 110/292 (37%), Gaps = 64/292 (21%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+ LGRG G ++A +D+ +KR + + ++A+ L HP +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYA-IKRIRLPNRELAREKV-MREVKALAKLEHPGIVRY 68
Query: 453 RAYF---------QAKGERLVIY---DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAED 500
+ Q ++ +Y +L + ++G +I + + CL I
Sbjct: 69 FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIFLQ 126
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA---- 555
+A+ + ++H L+H +LK SN+ D ++ D+ L + + T
Sbjct: 127 IAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 556 ----------YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV 605
Y +PE + K D+++ G++L ELL +P+ + + +
Sbjct: 186 RHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL-------YPFSTQMERVRTL 237
Query: 606 RTMRVDDGR----------EENRL--GMLTEVASVCSLKSPEQRPAMWQVLK 645
+R + + E + ML+ SP +RP +++
Sbjct: 238 TDVR--NLKFPPLFTQKYPCEYVMVQDMLS--------PSPMERPEAINIIE 279
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 56/295 (18%), Positives = 110/295 (37%), Gaps = 65/295 (22%)
Query: 397 LGRGSIGTTYKAVLDNH---LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV--- 450
LG G+ GT K V VK + + L +P +V
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 451 ------PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+++ + G L + +R ++ K + +++ V+ G
Sbjct: 85 GICEAESW----------MLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMG 129
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRK 563
+ Y+ ++ +H +L + NVLL A+++D+ LS L + YKA K
Sbjct: 130 MKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-------YYKAQTHGK 181
Query: 564 -----------SSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVD 611
+ + +SKSDV++FGVL+ E + G+ P + + ++ ++
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTA-----MLE 234
Query: 612 DGREENRLGM-------LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDN 659
G R+G + ++ ++C E RP V ++ V+ E +
Sbjct: 235 KG---ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 53/250 (21%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 349 ETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKA 408
+ N ++ I + SE+Y + LG G+ G
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHL-----SEMYQRV-------KKLGSGAYGEVLLC 56
Query: 409 V-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467
H+ +K + +S + + + L HPN++ + +F+ K ++ +
Sbjct: 57 RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116
Query: 468 YQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVL 525
G LF+ I + I + V G+ Y+H+ + ++H +LK N+L
Sbjct: 117 CYKGGELFDEIIHRMKFNEVD-------AAVIIKQVLSGVTYLHKHN-IVHRDLKPENLL 168
Query: 526 L---GADFEARLTDYCLSVLSDSSSV--EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVL 580
L D ++ D+ LS + ++ E T Y APE+ + ++ K DV++ GV+
Sbjct: 169 LESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVI 226
Query: 581 LLELLTGKHP 590
L LL G P
Sbjct: 227 LFILLAGYPP 236
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 69/291 (23%), Positives = 113/291 (38%), Gaps = 51/291 (17%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
E++GRG G Y L + VK + F + SHPN++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 89
Query: 451 P-IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY-- 507
+ +++G LV+ Y +G L N I + VA+G+ Y
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA 145
Query: 508 ----IHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYK----- 557
+HR +L + N +L F ++ D+ L+ + D + K
Sbjct: 146 SKKFVHR-------DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 558 -APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR 614
A E ++ ++ T+KSDV++FGVLL EL+T G P +P + D+ + GR
Sbjct: 199 MALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITV-----YLLQGR 249
Query: 615 EENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
RL L EV C E RP+ +++ I I + + E
Sbjct: 250 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 49/289 (16%), Positives = 102/289 (35%), Gaps = 43/289 (14%)
Query: 380 ESEVYSLEQLMRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHME 439
E+ V + ++ ++LG G+ GT + ++ V VKR + E Q +
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV--QLLR 72
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAE 499
HPN++ + + + + + +L + + + + +
Sbjct: 73 ES--DEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ----KDFAHLGLEPITLLQ 125
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLL-----GADFEARLTDYCLS--VLSDSSSVEDPD 552
GLA++H + ++H +LK N+L+ +A ++D+ L + S
Sbjct: 126 QTTSGLAHLHSLN-IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 553 TVA----YKAPEI--RKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV 605
V + APE+ T D+++ G + +++ G HP +
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL--QRQANILL 242
Query: 606 RTMRVDDGREENRL---------GMLTEVASVCSLKSPEQRPAMWQVLK 645
+D E M+ P++RP+ VLK
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIA--------MDPQKRPSAKHVLK 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 61/296 (20%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
E++GRG G Y L + VK + F + SHPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 153
Query: 451 P-IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY-- 507
+ +++G LV+ Y +G L N I + VA+G+ +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA 209
Query: 508 ----IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK------ 557
+HR +L + N +L F ++ D+ L+ + D + +
Sbjct: 210 SKKFVHR-------DLAARNCMLDEKFTVKVADFGLARD-----MYDKEFDSVHNKTGAK 257
Query: 558 ------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMR 609
A E ++ ++ T+KSDV++FGVLL EL+T G P +P + D+
Sbjct: 258 LPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITV-----Y 308
Query: 610 VDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
+ GR RL L EV C E RP+ +++ I I + + E
Sbjct: 309 LLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 42/225 (18%), Positives = 86/225 (38%), Gaps = 41/225 (18%)
Query: 395 ELLGRGSIGTTYKAV--LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+LG+G+ G KA LD+ +K+ + + + L+H +V
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYA-IKKIRHTEE---KLSTILSEVMLLASLNHQYVVRY 67
Query: 453 RAYFQAKGERLV----------IY---DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAE 499
A + + + ++ +Y NG+L++LIH + + +W ++
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFR 123
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD------- 552
+ + L+YIH +IH +LK N+ + ++ D+ L+ S
Sbjct: 124 QILEALSYIHSQG-IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 553 ----------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTG 587
T Y A E+ + K D+Y+ G++ E++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 32/216 (14%), Positives = 69/216 (31%), Gaps = 25/216 (11%)
Query: 397 LGRGSIGTTYKA----------VLDNHLIVTVKRFDANKTADTSAEAFEQHM----EAVG 442
L +G + L+ + F + S ++ + +
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 443 GLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI---HGSRSIRAKPLHWTSCLKIAE 499
+ + + E +IY+Y N S+ + I +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED----PDTVA 555
V +YIH + H ++K SN+L+ + +L+D+ S ++ +
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYE--- 215
Query: 556 YKAPE-IRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ PE S +K D+++ G+ L + P
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 54/305 (17%), Positives = 103/305 (33%), Gaps = 57/305 (18%)
Query: 395 ELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
LG+G+ G+ D +V VK+ + F++ ++ + L +
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFI 86
Query: 450 VPIRAYFQAKGER--LVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
V R G + ++ +Y P+G L + L + A L L + + +G+
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGME 141
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKS- 564
Y+ +H +L + N+L+ ++ ++ D+ L+ +L Y E +S
Sbjct: 142 YLGSRR-CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY-------YVVREPGQSP 193
Query: 565 ----------SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG 613
+ +SDV++FGV+L EL T M +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 614 REENRLG----------------MLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657
E G M C SP+ RP+ + + +
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKL-----CWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
Query: 658 DNAAF 662
+ AF
Sbjct: 309 ETHAF 313
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 32/134 (23%), Positives = 50/134 (37%), Gaps = 5/134 (3%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L L L L+ N L I +S+L NL L+L N S P+S SL +L L
Sbjct: 283 LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFY 339
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTL 214
N ++ + L L + L N+ S P N + ++ T
Sbjct: 340 NNKVSDVSS--LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 215 LKFDASSFSMNPNL 228
+ + ++ L
Sbjct: 398 VSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-16
Identities = 35/115 (30%), Positives = 48/115 (41%), Gaps = 5/115 (4%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
TL L L L L NN ++ + LS L L L L N S PL+ L LT L
Sbjct: 236 IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLA--GLTALTNL 292
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206
+L+ N L + P ++ L L L L +N S P + L N ++
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 39/116 (33%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
+ L +L L L NN ++ I L L NL LSL+ N L+ SL LT L
Sbjct: 192 ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLKDIGTLA--SLTNLTDL 248
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTG 206
DL+ N ++ L P L+ L +L LKL N+ S + PL L ++ N L
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLED 301
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 32/113 (28%), Positives = 47/113 (41%), Gaps = 7/113 (6%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L L L + +N ++ I L+ L NL+SL + N S PL L L L L+
Sbjct: 173 LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLN 229
Query: 155 YNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206
N L + + +LT L L L N+ S P L + N ++
Sbjct: 230 GNQLKDIGTLASLTNLTDLD---LANNQISNLAPLSGLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 10/116 (8%)
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152
+ L L L L L +N+++ I LS L +L+ LS + +L L LD
Sbjct: 128 DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLD 183
Query: 153 LSYNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTG 206
+S N ++ + + LT L+ L N+ S + PL L +++GN L
Sbjct: 184 ISSNKVSDISVLAKLTNLESLI---ATNNQISD-ITPLGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 8/113 (7%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L +L + ++NN + I L++L NL L+L N + PL +L L L+LS
Sbjct: 86 LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELS 142
Query: 155 YNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206
N ++ + + LT+L +L N+ + P N L ++S N ++
Sbjct: 143 SNTISDISALSGLTSLQQLS---FG-NQVTDLKPLANLTTLERLDISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 28/116 (24%), Positives = 49/116 (42%), Gaps = 8/116 (6%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
+ L+ L L+ LS N + L++L L+ L +S N S L+ L L L
Sbjct: 149 ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKVSDISVLA--KLTNLESL 204
Query: 152 DLSYNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206
+ N ++ + P+ LT LD L L N+ + L +++ N ++
Sbjct: 205 IATNNQISDITPLGILTNLDELS---LNGNQLKDIGTLASLTNLTDLDLANNQISN 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 7/114 (6%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
T T L + L ++T + + L + +L R + L+ LT ++
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSIDGVE--YLNNLTQINF 75
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTG 206
S N LT + P L L +L + + N+ + + PL L + N +T
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 23/121 (19%), Positives = 48/121 (39%), Gaps = 8/121 (6%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
++L L + LS +N ++ + L++L + L L+ ++ P++ + ++I
Sbjct: 346 VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWTN-APVNYKAN--VSIP 401
Query: 152 DLSYNNLTGLI-PVNLTALDRLYSLKLEWNRFSGTVPPLNQPF--LVVFNVSGNNLTGQV 208
+ N LI P ++ + WN S T ++ F V +G V
Sbjct: 402 NTVKNVTGALIAPATISDGGSYTEPDITWNLPSYT-NEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 209 P 209
Sbjct: 461 T 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 15/103 (14%), Positives = 34/103 (33%), Gaps = 9/103 (8%)
Query: 106 LHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPV- 164
+ + I ++L L + + + L ++T L + + V
Sbjct: 9 TQDTPINQ-IFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE 65
Query: 165 NLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTG 206
L L ++ N+ + + PL LV ++ N +
Sbjct: 66 YLNNLTQIN---FSNNQLTD-ITPLKNLTKLVDILMNNNQIAD 104
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 19/99 (19%), Positives = 40/99 (40%), Gaps = 5/99 (5%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L ++ L L++ + T + + +++ + + P +I T D++
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDIT 429
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF 193
+N + V+ T + ++ FSGTV QP
Sbjct: 430 WNLPSYTNEVSYT-FSQPVTIGKGTTTFSGTVT---QPL 464
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 53/234 (22%), Positives = 102/234 (43%), Gaps = 43/234 (18%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
++LG G GT +K V + V +K + + S +A HM A+G L H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 450 V---------PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAE 499
V + ++ Y P GSL + + R ++ + L L
Sbjct: 78 VRLLGLCPGSSL----------QLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGV 122
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT-----V 554
+A+G+ Y+ ++H NL + NVLL + + ++ D+ ++ L + + +
Sbjct: 123 QIAKGMYYLEEHG-MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 555 AYKAPE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVR 606
+ A E I + T +SDV+++GV + EL+T G P + L ++ + +
Sbjct: 182 KWMALESIH--FGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAEVPDLLE 231
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 58/299 (19%), Positives = 101/299 (33%), Gaps = 56/299 (18%)
Query: 395 ELLGRGSIGTTYKAVLDNH-----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
LG G G D +V VK A+ ++Q ++ + L H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHI 95
Query: 450 VPIRAYFQAKGER--LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+ + + G ++ +Y P GSL + + + L A+ + +G+AY
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAY 149
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKS-- 564
+H IH +L + NVLL D ++ D+ L+ + + Y+ E S
Sbjct: 150 LHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY-------YRVREDGDSPV 201
Query: 565 ---------SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR 614
+ SDV++FGV L ELLT P + M V
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 615 EENRLG----------------MLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657
E G M C RP ++ +++ + E +
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKN-----CWETEASFRPTFENLIPILKTVHEKYQGQ 315
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 23/292 (7%)
Query: 368 IKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKT 426
I+ SG L + ++ E L +GRG+ G+ K V + I+ VKR +
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--- 57
Query: 427 ADTSAEAFEQ-HMEAVGGLS---HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR 482
+ +Q M+ + P +V +G+ + + + S
Sbjct: 58 -TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVY 115
Query: 483 SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-V 541
S+ + KI + L ++ +IH ++K SN+LL +L D+ +S
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 542 LSDSSS-VEDPDTVAYKAPE-IRKSSRRA--TSKSDVYAFGVLLLELLTGKHPSQHPYLA 597
L DS + D Y APE I S+ R +SDV++ G+ L EL TG+ P +P
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKWN 233
Query: 598 PP-DMLEWVRTM---RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
D L V ++ + E ++C K +RP ++LK
Sbjct: 234 SVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 37/216 (17%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G G ++ + + I +K + + + + +++ + + L + IR
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 455 Y-FQAKGERLVIY-DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
Y ++ + + + + N L + + + K + +++ + + IH+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEI------ 561
++H +LK +N L+ D +L D+ ++ + ++ D+ Y PE
Sbjct: 129 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 562 ----RKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593
KS + + KSDV++ G +L + GK P Q
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 16/201 (7%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVPIR 453
LG+G G Y A N I+ +K ++ E + +E L HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
YF + ++ ++ P G L+ + + E++A L Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFMEELADALHYCHERK- 134
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV----AYKAPEIRKSSRRAT 569
+IH ++K N+L+G E ++ D+ SV + S T+ Y PE+ +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR---RTMCGTLDYLPPEM-IEGKTHD 190
Query: 570 SKSDVYAFGVLLLELLTGKHP 590
K D++ GVL E L G P
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPP 211
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 59/293 (20%), Positives = 96/293 (32%), Gaps = 56/293 (19%)
Query: 395 ELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
LG G G D V VK ++ +E + L H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENI 85
Query: 450 VPIRAYFQAKGER--LVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
V + G +I ++ P+GSL L I K LK A + +G+
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMD 140
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKS- 564
Y+ +H +L + NVL+ ++ + ++ D+ L+ + D Y + R S
Sbjct: 141 YLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIET-------DKEYYTVKDDRDSP 192
Query: 565 ----------SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDG 613
+ SDV++FGV L ELLT S L + M V
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 614 REE----NRLG------------MLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
RL M C P R + +++ + +
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRK-----CWEFQPSNRTSFQNLIEGFEAL 300
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 37/216 (17%), Positives = 86/216 (39%), Gaps = 25/216 (11%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G G ++ + + I +K + + + + +++ + + L + IR
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 455 Y--FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
Y ++ + N L + + + K + +++ + + IH+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEI------ 561
++H +LK +N L+ D +L D+ ++ + ++ D+ Y PE
Sbjct: 148 -IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 562 ----RKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593
KS + + KSDV++ G +L + GK P Q
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 53/295 (17%), Positives = 110/295 (37%), Gaps = 72/295 (24%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
++LG G+ GT YK + + V +K T+ + + + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHV 79
Query: 450 V---------PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAE 499
+ +I P G L + + + +I ++ L L
Sbjct: 80 CRLLGICLTSTV----------QLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYK- 557
+A+G+ Y+ L+H +L + NVL+ ++TD+ L+ +L + Y
Sbjct: 125 QIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-------EEKEYHA 176
Query: 558 ----------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWV 605
A E I R T +SDV+++GV + EL+T G P + + ++
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISS-- 230
Query: 606 RTMRVDDGREENRLGM-------LTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
++ G RL + + C + + RP +++ ++
Sbjct: 231 ---ILEKG---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 56/291 (19%), Positives = 113/291 (38%), Gaps = 22/291 (7%)
Query: 368 IKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT 426
KR + + + + + LG G+ G +K + L++ K
Sbjct: 14 RKRLEAFLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71
Query: 427 ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRA 486
+ + ++ + + P +V F + GE + ++ GSL ++ + I
Sbjct: 72 PAIRNQII-RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 130
Query: 487 KPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDS 545
+ L K++ V +GL Y+ ++H ++K SN+L+ + E +L D+ +S L DS
Sbjct: 131 QILG-----KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185
Query: 546 ---SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML 602
S V T +Y +PE R + +SD+++ G+ L+E+ G++P + PPD
Sbjct: 186 MANSFVG---TRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYP-----IPPPDAK 236
Query: 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
E + K + +++ I
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 66/296 (22%), Positives = 104/296 (35%), Gaps = 67/296 (22%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNL 449
E LG GS G + + V VK + + A + F + + A+ L H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 450 V---------PIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAE 499
+ P+ ++ + P GSL + L L + A
Sbjct: 84 IRLYGVVLTPPM----------KMVTELAPLGSLLDRLRKHQGHFLLGTL-----SRYAV 128
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKA 558
VA+G+ Y+ IH +L + N+LL ++ D+ L L + Y
Sbjct: 129 QVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-------HYVM 180
Query: 559 PEIRK-----------SSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVR 606
E RK +R + SD + FGV L E+ T G+ P L +L
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILH--- 235
Query: 607 TMRVDDGREENRLGM-------LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655
++D E RL + V C PE RP + + E + + M
Sbjct: 236 --KIDKEGE--RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 28/118 (23%), Positives = 53/118 (44%), Gaps = 7/118 (5%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L L + + N +T I ++++ L SL + N + PL+ +L +LT L++
Sbjct: 195 LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIG 251
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTGQVPET 211
N ++ + + L +L L + N+ S + LN L ++ N L + E
Sbjct: 252 TNQISDINA--VKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 25/114 (21%), Positives = 50/114 (43%), Gaps = 8/114 (7%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L ++ L+L N + LS++ L L+++ + P++ +L L L L+
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLN 185
Query: 155 YNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTG 206
YN + + P+ +LT+L N+ + + P+ L + N +T
Sbjct: 186 YNQIEDISPLASLTSLHYFT---AYVNQITD-ITPVANMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 5/112 (4%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L QL L + N ++ I + L LK L++ N S L+ +L +L L L+
Sbjct: 239 LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDISVLN--NLSQLNSLFLN 295
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
N L + L L +L L N + + PL + + + +
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 28/116 (24%), Positives = 53/116 (45%), Gaps = 7/116 (6%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
+ L+ + L L++ + + + +++L +L SLSL+ N PL+ SL L
Sbjct: 148 LSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISPLA--SLTSLHYF 204
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTG 206
N +T + P + + RL SLK+ N+ + + PL L + N ++
Sbjct: 205 TAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 7/118 (5%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
T L+ + L + + I + L NL+ L+L+ N + PLS +L +LT L +
Sbjct: 39 TQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYI 95
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTGQVPE 210
N +T + L L L L L + S + PL + N+ N+ +
Sbjct: 96 GTNKITDISA--LQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 3/92 (3%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
N + L +L++L++ +N ++ I L++L L SL L+ N I L LT L
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
LS N++T + P L +L ++ S
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 21/114 (18%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
L + L S+T + L ++ L ++ + + L L L+L
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVASIQGIE--YLTNLEYLNL 73
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTG 206
+ N +T + P L+ L +L +L + N+ + + L L ++ +N++
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 18/107 (16%), Positives = 36/107 (33%), Gaps = 9/107 (8%)
Query: 101 LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTG 160
L+ + I + L L + + L +T L ++ +
Sbjct: 2 AATLATLPAPINQ-IFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS 58
Query: 161 LIPV-NLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
+ + LT L+ L L N+ + + PL+ L + N +T
Sbjct: 59 IQGIEYLTNLEYLN---LNGNQITD-ISPLSNLVKLTNLYIGTNKIT 101
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 14/56 (25%), Positives = 19/56 (33%), Gaps = 5/56 (8%)
Query: 81 LQSFGLRG----TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRN 132
L S L + L L L L N +T I L+SL + S +
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQ 343
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 64/297 (21%), Positives = 116/297 (39%), Gaps = 58/297 (19%)
Query: 395 ELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+ LG+G+ G+ D +V VK+ + + FE+ +E + L H N+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNI 73
Query: 450 VPIRAYFQAKGER--LVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
V + + G R +I +Y P GSL + L I L L+ + +G+
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGME 128
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKS- 564
Y+ IH +L + N+L+ + ++ D+ L+ VL D +K E +S
Sbjct: 129 YLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEFFKVKEPGESP 180
Query: 565 ----------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML-----EWVRTMR 609
+ + SDV++FGV+L EL T S+ P M+ +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 610 VDDGREEN-RLG------------MLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
+ + + N RL M C + QRP+ + + +I+++
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTE-----CWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 2/112 (1%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
+ ++ L+++N T +S L NL+ L + + ++ L LT+LD+S
Sbjct: 62 IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLT 205
++ I + L ++ S+ L +N + PL P L N+ + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 23/113 (20%), Positives = 50/113 (44%), Gaps = 5/113 (4%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
T +++ L ++L N ++T + + N+K L+++ + P+S L L L +
Sbjct: 39 TEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRI 95
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT-VPPLNQ-PFLVVFNVSGNNL 204
++T NL+ L L L + + + + +N P + ++S N
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 18/99 (18%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFF-SGAFPLSILSLH 146
+ L+ L L +L + +++ + +++L + S+ LS N + PL +L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLK--TLP 159
Query: 147 RLTILDLSYNNLTGLIPV-NLTALDRLYSLKLEWNRFSG 184
L L++ ++ + + + L++LY G
Sbjct: 160 ELKSLNIQFDGVHDYRGIEDFPKLNQLY---AFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 13/71 (18%), Positives = 24/71 (33%), Gaps = 2/71 (2%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
+ L ++ + L N I L +L LKSL++ + + +L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQ 185
Query: 151 LDLSYNNLTGL 161
L + G
Sbjct: 186 LYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 16/96 (16%), Positives = 35/96 (36%), Gaps = 6/96 (6%)
Query: 115 IPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYS 174
IPD S+ + L ++ + ++ ++ LT + L+ N+T L + +
Sbjct: 17 IPD-STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKD 70
Query: 175 LKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPE 210
L + + P L + G ++T
Sbjct: 71 LTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIP 106
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 37/215 (17%), Positives = 88/215 (40%), Gaps = 23/215 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G G ++ + + I +K + + + + +++ + + L + IR
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 455 Y-FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
Y ++ + + + N L + + + K + +++ + + IH+
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVA----YKAPEI------- 561
++H +LK +N L+ D +L D+ ++ + ++ D+ Y PE
Sbjct: 176 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 562 ---RKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593
KS + + KSDV++ G +L + GK P Q
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 395 ELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+ LG+G+ G+ D +V VK+ + + FE+ +E + L H N+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNI 104
Query: 450 VPIRAYFQAKGER--LVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
V + + G R +I +Y P GSL + L I L L+ + +G+
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGME 159
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRKS- 564
Y+ IH +L + N+L+ + ++ D+ L+ VL D YK E +S
Sbjct: 160 YLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEYYKVKEPGESP 211
Query: 565 ----------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML 602
+ + SDV++FGV+L EL T S+ P M+
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 36/139 (25%), Positives = 54/139 (38%), Gaps = 8/139 (5%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAF- 138
L S T L LR+L L ++ + PD L +L L L S A
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114
Query: 139 -PLSILSLHRLTILDLSYNNLTGL-IPVNLTALDRLYSLKLEWNRFS----GTVPPLNQP 192
+L LT LDLS N + L + + L+ L S+ N+ + PL
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174
Query: 193 FLVVFNVSGNNLTGQVPET 211
L F+++ N+L +V
Sbjct: 175 TLSFFSLAANSLYSRVSVD 193
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 52/238 (21%), Positives = 80/238 (33%), Gaps = 16/238 (6%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAF 138
L L L R+ L++L L+ N + D S +L+ L L N A+
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 139 PLSILS-----LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF 193
+ L L +L L++N L L P + L L L L NR +
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN 527
Query: 194 LVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLC----GKVINKACRPRSPFFESPNA 249
L + ++S N L P+ L + N +C IN P
Sbjct: 528 LEILDISRNQLLAPNPDVFVSLSV--LDITHNKFICECELSTFINWLNHTNVTIAGPPAD 585
Query: 250 TSPPRPLGQSAQSQGILVLSPPSPRNDHKRRGLILGLSIGFAVLVS-FLVCIFLLIRR 306
P S S + LS + + L L I V ++ FL+ I + +
Sbjct: 586 IYCVYPDSFSGVS--LFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKF 641
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 27/124 (21%), Positives = 42/124 (33%), Gaps = 7/124 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
T ++ L+QL++L L + I +L NL+ L L + P + L
Sbjct: 38 TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLF 97
Query: 147 RLTILDLSYNNLT--GLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSG 201
L L L + L+ L L L L L N+ L + S
Sbjct: 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157
Query: 202 NNLT 205
N +
Sbjct: 158 NQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 31/140 (22%), Positives = 55/140 (39%), Gaps = 10/140 (7%)
Query: 89 TFPPNTLTRLDQ--LRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILS 144
NT L + +R L L + + + +L +LK L+L+ N + +
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSG 201
L L +L+LSYN L L N L ++ + L+ N + + L ++
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRD 371
Query: 202 NNLTGQVPETPTLLKFDASS 221
N LT + P++ S
Sbjct: 372 NALT-TIHFIPSIPDIFLSG 390
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 7e-12
Identities = 34/158 (21%), Positives = 53/158 (33%), Gaps = 16/158 (10%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD---LSSLINLKSLSLSRNFFSG-AFPLSILS 144
P+ L L L L+ L+ + +L L L LS+N S
Sbjct: 87 FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALD--RLYSLKLEWNR--------FSGTVPPLNQPFL 194
L+ L +D S N + + L L L L N + + P L
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206
Query: 195 VVFNVSGNNLTGQVPET--PTLLKFDASSFSMNPNLCG 230
+ +VSGN T + + K A S + ++ G
Sbjct: 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 26/114 (22%), Positives = 39/114 (34%), Gaps = 6/114 (5%)
Query: 98 LDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSIL-SLHRLTILDLSY 155
L+ L L N + L L+ L L + +L L ILDL
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 156 NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP----LNQPFLVVFNVSGNNLT 205
+ + L P L L+ L+L + S V N L ++S N +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 28/144 (19%), Positives = 49/144 (34%), Gaps = 22/144 (15%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ L ++ + L N + L L++L L N + +I +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPS 382
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG---TVPPLNQPFLVVFNVSGNNL 204
+ + LS N L L +NLT + L NR L P L + ++ N
Sbjct: 383 IPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
Query: 205 TGQVPETPTLLKFDASSFSMNPNL 228
+ + + S NP+L
Sbjct: 439 SSCSGD---------QTPSENPSL 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 23/117 (19%), Positives = 37/117 (31%), Gaps = 8/117 (6%)
Query: 102 RVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGL 161
R+ +LT +P L + L LS N+ S L +L +L+L
Sbjct: 7 RIAFYRFCNLTQ-VPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 162 IPVN-LTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLTGQVPETPTL 214
I L L L L ++ + P L + L+ V +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 27/155 (17%), Positives = 46/155 (29%), Gaps = 31/155 (20%)
Query: 81 LQSFGLRG----TFPPNTLTRLDQ--LRVLSLHNNSLTGPIPDLSS-------LINLKSL 127
L+S + L L L SL NSL + + L+ L
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209
Query: 128 SLSRNFFS----GAF--------PLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY-- 173
+S N ++ G F S++ H + ++N+ L R
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVR 269
Query: 174 SLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLT 205
L L ++ L V N++ N +
Sbjct: 270 HLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 15/87 (17%), Positives = 31/87 (35%), Gaps = 13/87 (14%)
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSG 201
L+ L LS+N + + + L++L L+L T+ N P L + ++
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 202 NNLTGQVPETPTLLKFDASSFSMNPNL 228
+ + +F +L
Sbjct: 83 SKIY----------FLHPDAFQGLFHL 99
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 23/120 (19%), Positives = 46/120 (38%), Gaps = 13/120 (10%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
L +L +L+L +N L DL SL L++L L+ N+ +L +
Sbjct: 48 QISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSI 101
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLT 205
L + NN++ + +Y L N+ + + L + + ++ N +
Sbjct: 102 ETLHAANNNISRVSCSRGQGKKNIY---LANNKIT-MLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 25/109 (22%), Positives = 47/109 (43%), Gaps = 6/109 (5%)
Query: 98 LDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYN 156
++ ++ + ++SL + S N+K L LS N S + +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L + L +L L +L L N + P + + + NN++
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 26/116 (22%), Positives = 36/116 (31%), Gaps = 4/116 (3%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
D L L+L N + + LK+L LS N + S +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS-GTVPPLNQPFLVVFNVSGNNLT 205
+ L N L I L L L N F GT+ V V+ +
Sbjct: 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 26/118 (22%), Positives = 40/118 (33%), Gaps = 9/118 (7%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ ++ L L N L+ DL+ L+ L+LS N L SL
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLE--SLST 81
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L LDL+ N + L + +L N S V ++ N +T
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 24/114 (21%), Positives = 41/114 (35%), Gaps = 5/114 (4%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
L + L NN+++ + S K++ L+ N + L R+ LDL
Sbjct: 94 ELLVGPSIETLHAANNNISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 154 SYNNLTGL-IPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
N + + + D L L L++N V L ++S N L
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 17/120 (14%), Positives = 33/120 (27%), Gaps = 4/120 (3%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
+L+ L L +N L P+ S + +SL N ++ L DL N
Sbjct: 190 FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 158 LTGLIPVNL-TALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLK 216
+ + R+ ++ + V + P +
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 20/109 (18%), Positives = 41/109 (37%), Gaps = 4/109 (3%)
Query: 115 IPDLS-SLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173
I ++ + K ++ + A S + LDLS N L+ + +L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 174 SLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLTGQVPETPTLLKFDASS 221
L L N L L +++ N + ++ P++ A++
Sbjct: 62 LLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAAN 108
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 50/272 (18%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G+GS G +K + +V +K D + A+ E +Q + + P +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVT--- 83
Query: 454 AYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
Y+ + K +L +I +Y GS +L+ PL T I ++ +GL Y+H
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHS 137
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSS-----VEDPDTVAYKAPEIRKS 564
IH ++K++NVLL E +L D+ ++ L+D+ V P + APE+ K
Sbjct: 138 EK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWMAPEVIKQ 193
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP--SQHPYLA-------PPDMLE--WVRTMRVDDG 613
S SK+D+++ G+ +EL G+ P HP P LE + + ++
Sbjct: 194 SAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLK---- 248
Query: 614 REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
E C K P RP ++LK
Sbjct: 249 ----------EFVEACLNKEPSFRPTAKELLK 270
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 66/291 (22%)
Query: 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+LG G G Y+ V NH + V VK + + E F + L HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 451 ---------PIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAED 500
P +I + P G L + L S++ L + +
Sbjct: 77 KLIGIIEEEPT----------WIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQ 121
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK--- 557
+ + +AY+ + +H ++ N+L+ + +L D+ LS +ED D
Sbjct: 122 ICKAMAYLESIN-CVHRDIAVRNILVASPECVKLGDFGLSRY-----IEDEDYYKASVTR 175
Query: 558 ------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMR 609
+PE I RR T+ SDV+ F V + E+L+ GK P +L D++
Sbjct: 176 LPIKWMSPESIN--FRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENKDVIG-----V 226
Query: 610 VDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
++ G RL +L + + C P RP +++ + ++ +
Sbjct: 227 LEKGD---RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 46/225 (20%), Positives = 85/225 (37%), Gaps = 35/225 (15%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
++LG GS GT V VKR + E + + HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME--IKLLTES--DDHPNVIRYYC 76
Query: 455 YFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ + N +L +L+ K + + + +A G+A++H
Sbjct: 77 SETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 513 WLIHGNLKSSNVLL-------------GADFEARLTDYCLS-VLSDSSSVEDPD------ 552
+IH +LK N+L+ + ++D+ L L S +
Sbjct: 136 -IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 553 TVAYKAPEI------RKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
T ++APE+ ++ RR T D+++ G + +L+ GKHP
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 49/221 (22%)
Query: 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+G G G ++ + + L V +K T+D+ E F Q + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIV 79
Query: 451 ---------PIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAED 500
P+ +I + G L + L S+ L + A
Sbjct: 80 KLIGVITENPV----------WIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQ 124
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK--- 557
++ LAY+ +H ++ + NVL+ ++ +L D+ LS +ED
Sbjct: 125 LSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGK 178
Query: 558 ------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
APE I RR TS SDV+ FGV + E+L G P
Sbjct: 179 LPIKWMAPESIN--FRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 31/242 (12%)
Query: 358 EEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIV 416
+ + ++ S ++ S+ Y + +LG+GS G
Sbjct: 7 DHLHATPGMFVQHSTAIF-----SDRYKGQ-------RVLGKGSFGEVILCKDKITGQEC 54
Query: 417 TVKRFDANK-TADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLF 475
VK + T E+ + ++ + L HPN++ + +F+ KG ++ + G LF
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 476 NLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADF 530
+ I S +I V G+ Y+H+ ++H +LK N+LL D
Sbjct: 115 DEIISRKRFSEVD-------AARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDA 166
Query: 531 EARLTDYCLSVLSDSSSV--EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
R+ D+ LS ++S + T Y APE+ K DV++ GV+L LL+G
Sbjct: 167 NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGVILYILLSGC 224
Query: 589 HP 590
P
Sbjct: 225 PP 226
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 25/109 (22%), Positives = 47/109 (43%), Gaps = 6/109 (5%)
Query: 98 LDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYN 156
++ ++ + ++SL + S N+K L LS N S + +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L + L +L L +L L N + P + + + NN++
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG--PSIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 23/120 (19%), Positives = 46/120 (38%), Gaps = 13/120 (10%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
L +L +L+L +N L DL SL L++L L+ N+ +L +
Sbjct: 48 QISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSI 101
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLT 205
L + NN++ + +Y L N+ + + L + + ++ N +
Sbjct: 102 ETLHAANNNISRVSCSRGQGKKNIY---LANNKIT-MLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 25/118 (21%), Positives = 39/118 (33%), Gaps = 9/118 (7%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ ++ L L N L+ L+ L+ L+LS N L SL
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLE--SLST 81
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L LDL+ N + L + +L N S V ++ N +T
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKIT 133
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 26/129 (20%), Positives = 37/129 (28%), Gaps = 4/129 (3%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
D L L+L N + + LK+L LS N + S +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS-GTVPPLNQPFLVVFNVSGNNLTGQVP 209
+ L N L I L L L N F GT+ V V+ +
Sbjct: 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 210 ETPTLLKFD 218
+
Sbjct: 278 QNEEECTVP 286
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 25/114 (21%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152
L + L NN+++ + S K++ L+ N + L R+ LD
Sbjct: 93 QELLVGPSIETLHAANNNISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 153 LSYNNLTGLIPVNLTA-LDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L N + + L A D L L L++N + L ++S N L
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 20/108 (18%), Positives = 43/108 (39%), Gaps = 2/108 (1%)
Query: 115 IPDLS-SLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173
I ++ + K ++ + A S + LDLS N L+ + +L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 174 SLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASS 221
L L N T+ + L +++ N + ++ P++ A++
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAAN 108
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 16/109 (14%), Positives = 33/109 (30%), Gaps = 2/109 (1%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
+L+ L L +N L P+ S + +SL N ++ L DL N
Sbjct: 190 FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 158 L-TGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
G + + R+ ++ + + + +
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 12/131 (9%), Positives = 25/131 (19%), Gaps = 6/131 (4%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
L L L N N + ++++ + T+
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP------LNQPFLVVFNVSGNNLT 205
L L L + G+ NQ +
Sbjct: 290 HYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR 349
Query: 206 GQVPETPTLLK 216
+ + +
Sbjct: 350 TVIDQVTLRKQ 360
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 13/122 (10%), Positives = 27/122 (22%), Gaps = 6/122 (4%)
Query: 90 FPPNTLTRLDQLR-----VLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS 144
P RL L+ +LS + + + + + + + L
Sbjct: 299 LPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLR 358
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN-RFSGTVPPLNQPFLVVFNVSGNN 203
L+ L + A L + + Q L +
Sbjct: 359 KQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKR 418
Query: 204 LT 205
Sbjct: 419 YE 420
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 25/121 (20%), Positives = 38/121 (31%), Gaps = 4/121 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ +L+VL L + SL +L +L L+ N + L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNL 204
L L NL L + L L L + N P N L ++S N +
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 205 T 205
Sbjct: 162 Q 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 32/155 (20%), Positives = 54/155 (34%), Gaps = 16/155 (10%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFF-SGAFPLSILSLH 146
+ + L L+ L +L + L LK L+++ N S P +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRL----YSLKLEWNRFSGTVPP--LNQPFLVVFNVS 200
L LDLS N + + +L L ++ SL L N + + P + L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 201 GNNLTGQVPETP-------TLLKFDASSFSMNPNL 228
N + V +T + + F NL
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 2/99 (2%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
L L VL + NS + L NL L LS+ P + SL
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT 185
L +L+++ N L + L L + L N + +
Sbjct: 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 24/121 (19%), Positives = 37/121 (30%), Gaps = 4/121 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL-SLHR 147
+ L+ L L N + + L L+ L + S+ SL
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNL 204
L LD+S+ + L L LK+ N F P L ++S L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 205 T 205
Sbjct: 483 E 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 29/124 (23%), Positives = 44/124 (35%), Gaps = 6/124 (4%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILS 144
L+ + L L L + + + L +L+ L ++ N F F I +
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 145 -LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVS 200
L LT LDLS L L P +L L L + N+ +VP L +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLH 526
Query: 201 GNNL 204
N
Sbjct: 527 TNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 31/144 (21%), Positives = 50/144 (34%), Gaps = 19/144 (13%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLS---SLINLKSLSLSRNFFSGAFPLSILSLHRL 148
+ L+QL L +++L + + S SL NL L +S AF L L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 149 TILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNL 204
+L ++ N+ + T L L L L + + P + L V N++ N L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL 506
Query: 205 TGQVPETPTLLKFDASSFSMNPNL 228
F +L
Sbjct: 507 K----------SVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 24/109 (22%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 101 LRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
+ L L N L S L+ L LSR + SL L+ L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 160 GLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLT 205
L + L L L + ++ + L NV+ N +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 7/114 (6%)
Query: 97 RLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNF--FSGAFPLSILSLHRLTILDLS 154
+L L+ L+ +N L +L+ L LSRN F G S L LDLS
Sbjct: 323 KLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
+N + + N L++L L + + L+ L+ ++S +
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 21/106 (19%), Positives = 32/106 (30%), Gaps = 6/106 (5%)
Query: 103 VLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLI 162
+ +L + K+L LS N S S L +LDLS + +
Sbjct: 11 TYQCMELNFYKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 163 PVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
+L L +L L N ++ L NL
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 24/145 (16%), Positives = 42/145 (28%), Gaps = 19/145 (13%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSS----LINLKSLSLSRNFFSGAFPLSIL- 143
F + L L L + L + D+ L N+ S SL S
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNN 203
L +++ + L +L L N+ ++ P L ++S N
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTS------NKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 204 LTGQVPETPTLLKFDASSFSMNPNL 228
L + + S +L
Sbjct: 359 L--------SFKGCCSQSDFGTTSL 375
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 31/128 (24%), Positives = 46/128 (35%), Gaps = 10/128 (7%)
Query: 88 GTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLI-----NLKSLSLSRNFF---SGAFP 139
F + L L L +N G +S+L L+ L+L SG
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 140 LSILSLHRLTILDLSYNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFN 198
+ +L LDLS+N+L + +L SL L + VP L V +
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLD 280
Query: 199 VSGNNLTG 206
+S N L
Sbjct: 281 LSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 30/131 (22%), Positives = 48/131 (36%), Gaps = 11/131 (8%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDL-SSLINLKSLSLSRNFFSGAFP 139
L GL P L L + + + +G L ++ + L+ L LS N A
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 140 LSILS-LHRLTILDLSYNNLTGL---IPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLV 195
+L L+LS+ L + +P L+ LD L +NR P P +
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLD------LSYNRLDRNPSPDELPQVG 299
Query: 196 VFNVSGNNLTG 206
++ GN
Sbjct: 300 NLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 35/152 (23%), Positives = 52/152 (34%), Gaps = 15/152 (9%)
Query: 75 RVVRFVLQSFGLRGTFPPNTL-TRLDQLRVLSLHNNSLTGPIPDLSSLIN-----LKSLS 128
+ L++ + GT PP L L +L+L N S L+ L LK LS
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTG-------LIPVNLTALDRLYSLKLEWNR 181
+++ + L+ LDLS N G L P+ L L
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 182 FSGTVPPL--NQPFLVVFNVSGNNLTGQVPET 211
SG L + L ++S N+L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 26/127 (20%), Positives = 36/127 (28%), Gaps = 11/127 (8%)
Query: 101 LRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSI----LSLHRLTILDLSY 155
L+VLS+ + L +L LS N G L L L +L L
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 156 NNLTGL---IPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF---LVVFNVSGNNLTGQVP 209
+ A +L L L N + + L N+S L
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK 270
Query: 210 ETPTLLK 216
P L
Sbjct: 271 GLPAKLS 277
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 20/145 (13%), Positives = 42/145 (28%), Gaps = 12/145 (8%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD----LSSLINLKSLSLSRNFFSGAFPLSILS 144
+ + L+ L++ + I + + L+ L+L +G P +L
Sbjct: 58 LGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117
Query: 145 LHRLTILDLSYNNLTGLIPVNLTA------LDRLYSLKLEWNRFSGTVPPLNQPF--LVV 196
+ L+ N++ A L L + + F L
Sbjct: 118 ATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177
Query: 197 FNVSGNNLTGQVPETPTLLKFDASS 221
++S N G+ L +
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPT 202
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 55/298 (18%)
Query: 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
LG+GS G Y+ V V +K + + E F + + +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHH 89
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-----SIRAKPLHWTSCLKIAEDVAQ 503
+V + LVI + G L + + R + P + +++A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 504 GLAYIHRASW-LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK----- 557
G+AY+ + +H +L + N ++ DF ++ D+ ++ + + D Y+
Sbjct: 150 GMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMT-----RDIYETDY--YRKGGKG 200
Query: 558 -------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTM 608
+PE ++ T+ SDV++FGV+L E+ T + P + L+ +L +V
Sbjct: 201 LLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVM-- 254
Query: 609 RVDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDN 659
+G L ML E+ +C +P+ RP+ +++ I+E E E +
Sbjct: 255 ---EG---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 30/112 (26%), Positives = 44/112 (39%), Gaps = 8/112 (7%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
+ +L L L HN+S+T + + L L L + N + L + LT L
Sbjct: 37 SEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLAC 92
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
N LT L LT L L + N+ + + P L N + N LT
Sbjct: 93 DSNKLTNLDVTPLTKLTYLN---CDTNKLT-KLDVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 33/143 (23%), Positives = 49/143 (34%), Gaps = 18/143 (12%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
+ +L L L +N++T DLS NL L+ N + L + L +LT L+
Sbjct: 60 IEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCD 114
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPET--P 212
N LT L L L N + + + L + N ++ T
Sbjct: 115 TNKLTKLDVSQNPLLTYLN---CARNTLT-EIDVSHNTQLTELDCHLNKKITKLDVTPQT 170
Query: 213 TLLKFDAS-------SFSMNPNL 228
L D S S N L
Sbjct: 171 QLTTLDCSFNKITELDVSQNKLL 193
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 33/144 (22%), Positives = 49/144 (34%), Gaps = 18/144 (12%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
+++ L L+ N++T DL+ I L L S N + + + L +LT D
Sbjct: 186 DVSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDC 240
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNL--TGQVPET 211
S N LT L L+ L L+ + + L+ F G V
Sbjct: 241 SVNPLTELDVSTLSKLTTLH---CIQTDLL-EIDLTHNTQLIYFQAEGCRKIKELDVTHN 296
Query: 212 PTLLKFDAS-------SFSMNPNL 228
L D S NP L
Sbjct: 297 TQLYLLDCQAAGITELDLSQNPKL 320
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 33/118 (27%), Positives = 46/118 (38%), Gaps = 13/118 (11%)
Query: 93 NTLTRLD-----QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
N LT+LD L L+ N+LT D+S L L N L + +
Sbjct: 116 NKLTKLDVSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQ 171
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
LT LD S+N +T L L+RL + N + + L + S N LT
Sbjct: 172 LTTLDCSFNKITELDVSQNKLLNRLN---CDTNNIT-KLDLNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 23/118 (19%), Positives = 35/118 (29%), Gaps = 13/118 (11%)
Query: 93 NTLTRLD-----QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
N LT LD +L L L I DL+ L L + +
Sbjct: 243 NPLTELDVSTLSKLTTLHCIQTDLLE-I-DLTHNTQLIYFQAEGCRKIK--ELDVTHNTQ 298
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L +LD +T L L LY L + + + L + ++
Sbjct: 299 LYLLDCQAAGITELDLSQNPKLVYLY---LNNTELT-ELDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 21/108 (19%), Positives = 32/108 (29%), Gaps = 8/108 (7%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
+ + L L SL + + + L LT L + NN
Sbjct: 20 FASEVAAAFEMQATD--TISEEQLATLTSLDCHNSSITDMTGIE--KLTGLTKLICTSNN 75
Query: 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+T L T L L + N+ + + L N N LT
Sbjct: 76 ITTLDLSQNTNLTYLA---CDSNKLT-NLDVTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 24/135 (17%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 93 NTLTRLD-----QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+T LD +L L L+N LT + D+S LKSLS + +
Sbjct: 307 AGITELDLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHIQDFSSVG--KIPA 362
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT-G 206
L + + LT ++ + G + V++ + N +T
Sbjct: 363 LNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWE 422
Query: 207 QVPETPTLLKFDASS 221
+ + + +S
Sbjct: 423 NLSTDNPAVTYTFTS 437
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 28/131 (21%), Positives = 40/131 (30%), Gaps = 17/131 (12%)
Query: 107 HNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPV-N 165
S PD N S + +S L LT LD +++T + +
Sbjct: 7 QTQSFNDWFPDD----NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEK 62
Query: 166 LTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG-QVPETPTLLKFDASS--- 221
LT L +L N + T+ L N LT V L + +
Sbjct: 63 LTGLTKLI---CTSNNIT-TLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL 118
Query: 222 ----FSMNPNL 228
S NP L
Sbjct: 119 TKLDVSQNPLL 129
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 397 LGRGSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ G+ + V + V +K T E + + + L +P +V R
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIV--R 74
Query: 454 AYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ E L ++ + G L + G R + + ++ ++ V+ G+ Y+ +
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRK-------- 563
+H +L + NVLL A+++D+ LS L S Y A K
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-------YYTARSAGKWPLKWYAP 182
Query: 564 ---SSRRATSKSDVYAFGVLLLELLT-GKHP 590
+ R+ +S+SDV+++GV + E L+ G+ P
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 32/214 (14%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++G G G L + V +K A + F +G HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNII 113
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ +++ +Y NGSL L L + + V G+ Y+
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-----VGMLRGVGAGMRYLS 168
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK-----------A 558
+H +L + NVL+ ++ +++D+ LS + +ED AY A
Sbjct: 169 DLG-YVHRDLAARNVLVDSNLVCKVSDFGLSRV-----LEDDPDAAYTTTGGKIPIRWTA 222
Query: 559 PE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
PE I R +S SDV++FGV++ E+L G+ P
Sbjct: 223 PEAIAF--RTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 21/205 (10%)
Query: 396 LLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVPIR 453
LLG+GS Y+A + L V +K D + ++ L HP+++ +
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
YF+ ++ + NG + + R KP + G+ Y+H
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHG- 132
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--------TVAYKAPEIRKSS 565
++H +L SN+LL + ++ D+ L+ ++ P T Y +PEI +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQ-----LKMPHEKHYTLCGTPNYISPEI-ATR 186
Query: 566 RRATSKSDVYAFGVLLLELLTGKHP 590
+SDV++ G + LL G+ P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 7/118 (5%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
L L+ L+L ++ +P+L+ L+ L+ L +S N F P S L L
Sbjct: 188 SEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS----GTVPPLNQPFLVVFNVSGNNL 204
L + + ++ + L L L L N S PL +LV ++ N
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL--RYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 29/125 (23%), Positives = 44/125 (35%), Gaps = 16/125 (12%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
+T L L VL L NS+ I + L +L +L L N+ + GAF
Sbjct: 91 QADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWLTVIPSGAF----EY 145
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKL-EWNRFSGTVPP---LNQPFLVVFNVS 200
L +L L L N + + + L L L E + + L N+
Sbjct: 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLG 204
Query: 201 GNNLT 205
N+
Sbjct: 205 MCNIK 209
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 22/111 (19%), Positives = 40/111 (36%), Gaps = 8/111 (7%)
Query: 99 DQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
+Q + L+ +P + S N + L+L N + LH L +L L N+
Sbjct: 54 NQFSKVVCTRRGLSE-VPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
+ + L L +L+L N + +P L + N +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 23/92 (25%), Positives = 34/92 (36%), Gaps = 23/92 (25%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
P + L L+ L + N+ ++ + RN F G L L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVS---------------LIERNAFDG--------LASL 268
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180
L+L++NNL+ L T L L L L N
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 49/263 (18%), Positives = 94/263 (35%), Gaps = 41/263 (15%)
Query: 347 KVETKANKVQVEEMAIGSQTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTY 406
+ + + +AI +++ + E Y LG G+ G
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKI-----GESYFKV-------RKLGSGAYGEVL 53
Query: 407 KAV------------LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ + D NK + E + + L HPN++ +
Sbjct: 54 LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113
Query: 455 YFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
F+ K ++ ++ G LF I I + + G+ Y+H+ +
Sbjct: 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD-------AANIMKQILSGICYLHKHN 166
Query: 513 WLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSV--EDPDTVAYKAPEIRKSSRR 567
++H ++K N+LL + ++ D+ LS + T Y APE+ K ++
Sbjct: 167 -IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--KK 223
Query: 568 ATSKSDVYAFGVLLLELLTGKHP 590
K DV++ GV++ LL G P
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPP 246
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 29/121 (23%), Positives = 46/121 (38%), Gaps = 8/121 (6%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILS-LHR 147
+ L L L + + + + L +L+ L ++ N F F I + L
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNL 204
LT LDLS L L P +L L L + N F ++ L V + S N++
Sbjct: 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
Query: 205 T 205
Sbjct: 236 M 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 23/119 (19%), Positives = 36/119 (30%), Gaps = 4/119 (3%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS-LHRLT 149
+ L+ L L N + + L L+ L + S+ L L
Sbjct: 70 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 129
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
LD+S+ + L L LK+ N F P L ++S L
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 29/127 (22%), Positives = 45/127 (35%), Gaps = 9/127 (7%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTG---PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
P +L QL LSL +N L+ +LK L LS N + L L +
Sbjct: 44 PHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 102
Query: 148 LTILDLSYNNLTGLIPVNL-TALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNN 203
L LD ++NL + ++ +L L L + L V ++GN+
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 161
Query: 204 LTGQVPE 210
Sbjct: 162 FQENFLP 168
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 29/126 (23%), Positives = 41/126 (32%), Gaps = 15/126 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
L L VL + NS + L NL L LS+ AF
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN--- 196
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS----GTVPPLNQPFLVVFN 198
SL L +L++S+NN L L+ L L N + L N
Sbjct: 197 -SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF-PSSLAFLN 254
Query: 199 VSGNNL 204
++ N+
Sbjct: 255 LTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 27/98 (27%), Positives = 39/98 (39%), Gaps = 4/98 (4%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
F P+ T L L L L L + +SL +L+ L++S N F L+
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223
Query: 147 RLTILDLSYNNLTGLIPVNLTAL-DRLYSLKLEWNRFS 183
L +LD S N++ L L L L N F+
Sbjct: 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 26/112 (23%), Positives = 40/112 (35%), Gaps = 9/112 (8%)
Query: 101 LRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNF--FSGAFPLSILSLHRLTILDLSYNN 157
L L +N L L L LSLS N F G S L LDLS+N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL----NQPFLVVFNVSGNNLT 205
+ + N L++L L + + + + L+ ++S +
Sbjct: 90 VIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR 139
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 25/107 (23%), Positives = 38/107 (35%), Gaps = 9/107 (8%)
Query: 104 LSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT--G 160
+ ++ LT +P + S + L L N L +LT L LS N L+ G
Sbjct: 12 IRCNSKGLTS-VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 161 LIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNLT 205
+ L L L +N T+ L L + +NL
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 7e-14
Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 397 LGRGSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ G+ + V + V +K T E + + + L +P +V R
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIV--R 400
Query: 454 AYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ E L ++ + G L + G R + + ++ ++ V+ G+ Y+ +
Sbjct: 401 LIGVCQAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYKAPEIRK-------- 563
+H NL + NVLL A+++D+ LS L S Y A K
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-------YTARSAGKWPLKWYAP 508
Query: 564 ---SSRRATSKSDVYAFGVLLLELLT-GKHP 590
+ R+ +S+SDV+++GV + E L+ G+ P
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 7/136 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILS-L 145
++ L + N++ +P ++ L L L RN S + P I
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 140
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+LT L +S NNL + A L +L+L NR + V P L NVS N L+
Sbjct: 141 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 199
Query: 206 GQVPETPTLLKFDASS 221
+ + + DAS
Sbjct: 200 -TLAIPIAVEELDASH 214
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 22/95 (23%), Positives = 35/95 (36%), Gaps = 4/95 (4%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
+ ++ +L L + NN L + LK L LS N + RL
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
L L +N++ L L+ L +L L N +
Sbjct: 321 ENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 24/122 (19%), Positives = 44/122 (36%), Gaps = 7/122 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
P L Q+ +L+L++ + I + ++ L + N P ++
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNN 203
LT+L L N+L+ L +L +L + N + L +S N
Sbjct: 118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 204 LT 205
LT
Sbjct: 177 LT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 11/117 (9%)
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS--GAFPLSILSLHRLTI 150
+TL + L +NS+ + + L L L N + L+ L
Sbjct: 199 STLAIPIAVEELDASHNSINV-VRG-PVNVELTILKLQHNNLTDTAWL----LNYPGLVE 252
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205
+DLSYN L ++ + RL L + NR + P L V ++S N+L
Sbjct: 253 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 20/144 (13%), Positives = 43/144 (29%), Gaps = 15/144 (10%)
Query: 89 TFPPNTLTRLDQLRVLSL-HNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ L + + + +L N K ++ + + S +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNL 204
+ +L+L+ + + + L + +N +PP N P L V + N+L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 205 TGQVPETPTLLKFDASSFSMNPNL 228
+ F P L
Sbjct: 130 S----------SLPRGIFHNTPKL 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 31/133 (23%), Positives = 50/133 (37%), Gaps = 19/133 (14%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLT-GPIPD--LSSLINLKSLSLSRNFFS----GAFPLS 141
+ L+Q+ V+ L N L I + + L + ++ + G P
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP-- 192
Query: 142 ILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFN 198
LT L L N +T + +L L+ L L L +N S V N P L +
Sbjct: 193 -----SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELH 246
Query: 199 VSGNNLTGQVPET 211
++ N L +VP
Sbjct: 247 LNNNKLV-KVPGG 258
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 10/121 (8%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
L L L L NN ++ I + L+ L+ L LS+N P + L
Sbjct: 68 KDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TL 123
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF-SGTVPP---LNQPFLVVFNVSGNNL 204
L + N +T + L+++ ++L N S + L ++ N+
Sbjct: 124 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
Query: 205 T 205
T
Sbjct: 184 T 184
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 27/124 (21%), Positives = 39/124 (31%), Gaps = 13/124 (10%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLT 149
P L +L L N +T L L NL L LS N S S+ + L
Sbjct: 187 PQGLPPSLTELH---LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 243
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNR--------FSGTVPPLNQPFLVVFNVSG 201
L L+ N L +P L + + L N F + ++
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 202 NNLT 205
N +
Sbjct: 303 NPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 18/101 (17%), Positives = 33/101 (32%), Gaps = 8/101 (7%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS----GAF--PLSI 142
+L LR L L+NN L L+ ++ + L N S F P
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289
Query: 143 LSLHRLTILDLSYNNL--TGLIPVNLTALDRLYSLKLEWNR 181
+ + L N + + P + +++L +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 5/107 (4%)
Query: 100 QLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNL 158
LRV+ + L +P DL + L L N + +L L L L N +
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 159 TGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+ + P L +L L L N+ +P L V N +T
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEIT 134
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAV--GGLSHP 447
+++G G G YK +L + V +K K T + + EA G SH
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
N++ + ++I +Y NG+L L L + + +A G+
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-----VGMLRGIAAGMK 161
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK--------- 557
Y+ + +H +L + N+L+ ++ +++D+ LS + +ED Y
Sbjct: 162 YLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRV-----LEDDPEATYTTSGGKIPIR 215
Query: 558 --APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
APE I S R+ TS SDV++FG+++ E++T G+ P
Sbjct: 216 WTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHME 439
+E Y++ +LG+GS G K VK + + + +E
Sbjct: 21 AERYNIV-------CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKI 497
+ L HPN++ + + ++ + G LF+ I S +I
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------AARI 126
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSV--EDPD 552
+ V G+ Y+H+ + ++H +LK N+LL D + ++ D+ LS ++ +
Sbjct: 127 IKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
T Y APE+ + K DV++ GV+L LL+G P
Sbjct: 186 TAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 70/319 (21%), Positives = 123/319 (38%), Gaps = 104/319 (32%)
Query: 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHP 447
LG G+ G + A N ++V VK K +A F++ E + L H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHE 77
Query: 448 NLV----------PIRAYFQAKGERLVIYDYQPNGSL-----------FNLIHGSRSIRA 486
++V P+ +++++Y +G L L+ G
Sbjct: 78 HIVKFYGVCGDGDPL----------IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 487 KPLHWTSCLKIAEDVAQGLAY------IHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540
L + L IA +A G+ Y +HR +L + N L+GA+ ++ D+ +S
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHR-------DLATRNCLVGANLLVKIGDFGMS 180
Query: 541 VLSDSSSVEDPDTVAYK------------APE-IRKSSRRATSKSDVYAFGVLLLELLT- 586
V D Y+ PE I R+ T++SDV++FGV+L E+ T
Sbjct: 181 -----RDVYSTDY--YRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTY 231
Query: 587 GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG------------MLTEVASVCSLKSP 634
GK P L+ +++E + GR L ML C + P
Sbjct: 232 GKQP--WFQLSNTEVIECIT-----QGR---VLERPRVCPKEVYDVMLG-----CWQREP 276
Query: 635 EQRPAMWQVLKMIQEIKES 653
+QR + ++ K++ + ++
Sbjct: 277 QQRLNIKEIYKILHALGKA 295
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 31/132 (23%), Positives = 43/132 (32%), Gaps = 15/132 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
P T L L L + N + + D L NLKSL + N AF
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAF---- 148
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNV 199
L+ L L L NLT + L+ L L L+L + + L V +
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEI 207
Query: 200 SGNNLTGQVPET 211
S +
Sbjct: 208 SHWPYLDTMTPN 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 19/156 (12%)
Query: 81 LQSFGLRG----TFPPNTLTRLDQLRVLSL-HNNSLTGPIPDLSSLINLKSLSLSRNFFS 135
L LR + RL +L+VL + H L P+ +NL SLS++ +
Sbjct: 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
Query: 136 GAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQP 192
L++ L L L+LSYN ++ + L L RL ++L + + V P
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLN 296
Query: 193 FLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
+L V NVSGN LT + S F NL
Sbjct: 297 YLRVLNVSGNQLT----------TLEESVFHSVGNL 322
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 33/145 (22%), Positives = 52/145 (35%), Gaps = 17/145 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
+ L+ L L+L +LT IP LS L L L L + S L+
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNN 203
RL +L++S+ + N L SL + + VP L + +L N+S N
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP 259
Query: 204 LTGQVPETPTLLKFDASSFSMNPNL 228
++ + S L
Sbjct: 260 IS----------TIEGSMLHELLRL 274
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 29/125 (23%), Positives = 49/125 (39%), Gaps = 13/125 (10%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
L L+ L + +N L I S L +L+ L+L + + A
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALS--- 173
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVS 200
LH L +L L + N+ + + L RL L++ + T+ P L L +++
Sbjct: 174 -HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 201 GNNLT 205
NLT
Sbjct: 233 HCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 15/124 (12%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
+ L L L+ N ++ + ++L NL++L L N G F
Sbjct: 48 NQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT----G 102
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSG 201
L LT LD+S N + L+ L L SL++ N + L +
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEK 161
Query: 202 NNLT 205
NLT
Sbjct: 162 CNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 30/122 (24%), Positives = 47/122 (38%), Gaps = 7/122 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
P L LR L L +N L IP + L NL L +S N L+
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNN 203
L L++ N+L + + L+ L L LE + ++P + L+V + N
Sbjct: 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLN 187
Query: 204 LT 205
+
Sbjct: 188 IN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
P + L LR L+L N ++ I L L+ L+ + L + P + L+
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLN 296
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
L +L++S N LT L ++ L +L L+ N +
Sbjct: 297 YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 22/110 (20%), Positives = 37/110 (33%), Gaps = 6/110 (5%)
Query: 99 DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNL 158
Q R + H + + + L L +N S L L+L+ N +
Sbjct: 11 AQDRAVLCHRKRFVAVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 159 TGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
+ + P L L +L L NR +P L ++S N +
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV 117
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 41/212 (19%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
++LG+G+ ++ + +K F+ + + E + L+H N+V +
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 454 AYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
A + R I ++ P GSL+ ++ A L + L + DV G+ ++
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 512 SWLIHGNLKSSNVLLGADFEAR----LTDYCLS-VLSDSSSVEDP-DTVAYKAPEI---- 561
++H N+K N++ + + LTD+ + L D T Y P++
Sbjct: 132 G-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 562 ---RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ ++ + D+++ GV TG P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 7/136 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILS-L 145
++ L + N++ +P ++ L L L RN S + P I
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+LT L +S NNL + A L +L+L NR + V P L NVS N L+
Sbjct: 147 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 205
Query: 206 GQVPETPTLLKFDASS 221
+ + + DAS
Sbjct: 206 -TLAIPIAVEELDASH 220
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 29/116 (25%), Positives = 43/116 (37%), Gaps = 4/116 (3%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLT 149
L L + L N L + L+ L +S N A L + L
Sbjct: 246 DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 304
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+LDLS+N+L + N DRL +L L+ N T+ L +S N+
Sbjct: 305 VLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 22/95 (23%), Positives = 35/95 (36%), Gaps = 4/95 (4%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
+ ++ +L L + NN L + LK L LS N + RL
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 326
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
L L +N++ L L+ L +L L N +
Sbjct: 327 ENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 26/124 (20%), Positives = 51/124 (41%), Gaps = 7/124 (5%)
Query: 87 RGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILS 144
+ + L+ ++++ N+++ +P L S ++ L+L+ +
Sbjct: 39 QDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAY 97
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSG 201
H + L + +N + L P + L L LE N S ++P N P L ++S
Sbjct: 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 156
Query: 202 NNLT 205
NNL
Sbjct: 157 NNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 24/122 (19%), Positives = 44/122 (36%), Gaps = 7/122 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLH 146
P L Q+ +L+L++ + I + ++ L + N P ++
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNN 203
LT+L L N+L+ L +L +L + N + L +S N
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 182
Query: 204 LT 205
LT
Sbjct: 183 LT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 11/117 (9%)
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS--GAFPLSILSLHRLTI 150
+TL + L +NS+ + + L L L N + L+ L
Sbjct: 205 STLAIPIAVEELDASHNSINV-VRG-PVNVELTILKLQHNNLTDTAWL----LNYPGLVE 258
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205
+DLSYN L ++ + RL L + NR + P L V ++S N+L
Sbjct: 259 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 9/92 (9%), Positives = 26/92 (28%), Gaps = 4/92 (4%)
Query: 117 DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLK 176
+L + + F ++L+ I+ + + L L + ++ L
Sbjct: 22 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 81
Query: 177 LEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
L + + + + N +
Sbjct: 82 LNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 55/271 (20%), Positives = 112/271 (41%), Gaps = 19/271 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQ-HME---AVGGLSHPNL 449
LGRG+ G K + + I+ VKR A +++ ++ M+ ++ + P
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
V +G+ + + + SL + + + KIA + + L ++H
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLH 126
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVE-DPDTVAYKAPE-IRKSSR 566
+IH ++K SNVL+ A + ++ D+ +S L D + + D Y APE I
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 567 RA--TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624
+ + KSD+++ G+ ++EL + P + P L+ V + +
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFP-YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245
Query: 625 VASVCSLKSPEQRPAMWQVLKM--IQEIKES 653
S C K+ ++RP ++++ +
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPFFTLHESK 276
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 42/245 (17%), Positives = 77/245 (31%), Gaps = 50/245 (20%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG---GLSHPNLV 450
+G+GS G A+ I +K + NK + + E+ V L HPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTS----------------- 493
+ ++ + ++ + G L + ++
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 494 ------------------CLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL- 534
I + L Y+H + H ++K N L + +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-ICHRDIKPENFLFSTNKSFEIK 210
Query: 535 -TDYCLSVLSDSSSVEDPD-------TVAYKAPEI-RKSSRRATSKSDVYAFGVLLLELL 585
D+ LS + + T + APE+ ++ K D ++ GVLL LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 586 TGKHP 590
G P
Sbjct: 271 MGAVP 275
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 73/303 (24%)
Query: 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHP 447
LG G+ G + A N ++V VK K A SA F++ E + L H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQ 103
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSL----------FNLIHGSRSIRAKPLHWTSCLKI 497
++V L++++Y +G L L+ G + PL L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 498 AEDVAQGLAY------IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551
A VA G+ Y +HR +L + N L+G ++ D+ +S +
Sbjct: 164 ASQVAAGMVYLAGLHFVHR-------DLATRNCLVGQGLVVKIGDFGMS-----RDIYST 211
Query: 552 DTVAYK------------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLA 597
D Y+ PE I R+ T++SDV++FGV+L E+ T GK P L+
Sbjct: 212 DY--YRVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLS 265
Query: 598 PPDMLEWVRTMRVDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
+ ++ + G L + + C + P+QR ++ V +Q +
Sbjct: 266 NTEAIDCIT-----QG---RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
Query: 651 KES 653
++
Sbjct: 318 AQA 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 41/212 (19%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
++LG+G+ ++ + +K F+ + + E + L+H N+V +
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 454 AYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
A + R I ++ P GSL+ ++ A L + L + DV G+ ++
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 512 SWLIHGNLKSSNVLLGADFEAR----LTDYCLS-VLSDSSSVEDP-DTVAYKAPEI---- 561
++H N+K N++ + + LTD+ + L D T Y P++
Sbjct: 132 G-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 562 ---RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ ++ + D+++ GV TG P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 59/304 (19%), Positives = 117/304 (38%), Gaps = 67/304 (22%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ G YKA + + K + ++ E + +E + HP +V
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIV--- 79
Query: 454 AYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
A +L ++ ++ P G++ ++ + L + + + L ++H
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIML----ELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVA----YKAPEI--RK 563
+IH +LK+ NVL+ + + RL D+ +S + D+ + APE+ +
Sbjct: 136 KR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCE 192
Query: 564 SSRRAT--SKSDVYAFGVLLLELLTGKHP--SQHP----YL----APPDMLE---WVRTM 608
+ + K+D+++ G+ L+E+ + P +P PP +L W
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252
Query: 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK---------------MIQEIKES 653
R + + K+PE RP+ Q+L+ ++ E K
Sbjct: 253 R--------------DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAE 298
Query: 654 VMAE 657
VM E
Sbjct: 299 VMEE 302
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 53/302 (17%), Positives = 102/302 (33%), Gaps = 51/302 (16%)
Query: 369 KRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA 427
K++G L G+ + L +G G+ G +K ++ VK+
Sbjct: 8 KQTGYL-TIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMRR---- 60
Query: 428 DTSAEAFEQ-HMEA---VGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRS 483
+ E ++ M+ + P +V F + + + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 484 IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VL 542
I + L K+ + + L Y+ +IH ++K SN+LL + +L D+ +S L
Sbjct: 121 IPERILG-----KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 543 SDSSSV-EDPDTVAYKAPEIRKSSRRA----TSKSDVYAFGVLLLELLTGKHP--SQHPY 595
D + AY APE ++DV++ G+ L+EL TG+ P +
Sbjct: 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
Query: 596 LA------------PPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQV 643
P + + + C K +RP ++
Sbjct: 236 FEVLTKVLQEEPPLLPGHMGFSGDFQ--------------SFVKDCLTKDHRKRPKYNKL 281
Query: 644 LK 645
L+
Sbjct: 282 LE 283
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 54/285 (18%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+G G G ++ + + + V +K T+D+ E F Q + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIV 454
Query: 451 ---------PIRAYFQAKGERLVIYDYQPNGSLFN-LIHGSRSIRAKPLHWTSCLKIAED 500
P+ +I + G L + L S+ L + A
Sbjct: 455 KLIGVITENPV----------WIIMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQ 499
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDT---VAY 556
++ LAY+ +H ++ + NVL+ ++ +L D+ LS + DS+ + + +
Sbjct: 500 LSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615
APE RR TS SDV+ FGV + E+L G P + D++ R+++G
Sbjct: 559 MAPESINF-RRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIG-----RIENG-- 608
Query: 616 ENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
RL L + + C P +RP ++ + I E
Sbjct: 609 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 6e-13
Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 7/113 (6%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
T L+ + + +N+ + + + L N+ L L+ N + PL+ +L L L L
Sbjct: 38 TQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFL 94
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLT 205
N + L +L L +L SL LE N S + L + P L + N +T
Sbjct: 95 DENKIKDL--SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 33/89 (37%), Positives = 41/89 (46%), Gaps = 5/89 (5%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L QL L L NN +T I LS L L +LSL N S PL+ L +L L LS
Sbjct: 127 LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLS 183
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
N+++ L L L L L+L
Sbjct: 184 KNHISDLRA--LAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 3/111 (2%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L+RL +L LSL +N ++ I L+ L L++L LS+N S L+ L L +L+L
Sbjct: 149 LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELF 205
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+ + L ++K + NV +
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 9e-07
Identities = 12/105 (11%), Positives = 34/105 (32%), Gaps = 5/105 (4%)
Query: 101 LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTG 160
+ + + I + +L + + A + L+ + + + +++
Sbjct: 1 MGETITVSTPIKQ-IFPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 57
Query: 161 LIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+ + L + L L N+ + P N L + N +
Sbjct: 58 V--QGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK 100
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 62/296 (20%), Positives = 103/296 (34%), Gaps = 63/296 (21%)
Query: 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
LG G+ G Y+ + L V VK + + F + +H N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSL--FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
+V R ++ + G L F R + L L +A D+A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 507 Y------IHRASWLIHGNLKSSNVLLGADFEARL---TDYCLSVLSDSSSVEDPDTVAYK 557
Y IHR ++ + N LL R+ D+ + + + Y+
Sbjct: 155 YLEENHFIHR-------DIAARNCLLTCPGPGRVAKIGDFGM-----ARDIYRASY--YR 200
Query: 558 ------------APEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEW 604
PE TSK+D ++FGVLL E+ + G P +P + ++LE+
Sbjct: 201 KGGCAMLPVKWMPPE-AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEF 257
Query: 605 VRTMRVDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
V G R+ G + + + C PE RP +L+ I+ +
Sbjct: 258 VT-----SG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 65/312 (20%), Positives = 114/312 (36%), Gaps = 76/312 (24%)
Query: 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHP 447
+ LGRG+ G +A V VK T + A ++ + + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHL 91
Query: 448 NLVP-IRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-----------SIRAKPLHWTSCL 495
N+V + A + G +VI ++ G+L + R + L +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 496 KIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDT 553
+ VA+G+ ++ IH +L + N+LL ++ D+ L+ + D
Sbjct: 152 CYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------- 203
Query: 554 VAYK------------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPP 599
Y APE I R T +SDV++FGVLL E+ + G PY P
Sbjct: 204 --YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGA----SPY---P 252
Query: 600 DMLEWVRTMR-VDDGREENRLG------------MLTEVASVCSLKSPEQRPAMWQVLKM 646
+ R + +G R+ ML C P QRP ++++
Sbjct: 253 GVKIDEEFCRRLKEG---TRMRAPDYTTPEMYQTMLD-----CWHGEPSQRPTFSELVEH 304
Query: 647 IQEIKESVMAED 658
+ + ++ +D
Sbjct: 305 LGNLLQANAQQD 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 61/296 (20%), Positives = 106/296 (35%), Gaps = 63/296 (21%)
Query: 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
LG G+ G Y+ + L V VK + + F + +H N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC--LKIAEDVAQGLA 506
+V R ++ + G L + + +R ++P L +A D+A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 507 Y------IHRASWLIHGNLKSSNVLLGADFEARL---TDYCLSVLSDSSSVEDPDTVAYK 557
Y IHR ++ + N LL R+ D+ + + + Y+
Sbjct: 196 YLEENHFIHR-------DIAARNCLLTCPGPGRVAKIGDFGM-----ARDIYRAGY--YR 241
Query: 558 ------------APEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEW 604
PE TSK+D ++FGVLL E+ + G P +P + ++LE+
Sbjct: 242 KGGCAMLPVKWMPPE-AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEF 298
Query: 605 VRTMRVDDGREENRL-------GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
V G R+ G + + + C PE RP +L+ I+ +
Sbjct: 299 VT-----SG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTS------AEAFEQHMEAVGGLSHP 447
+ LG G+ G A V ++ K A S A E +E + L+HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
++ I+ +F A+ +V+ + G LF+ + + K L +C + + Y
Sbjct: 201 CIIKIKNFFDAEDYYIVL-ELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQY 254
Query: 508 IHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPE 560
+H +IH +LK NVLL + D ++TD+ S + +S+ T+ Y APE
Sbjct: 255 LHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTPTYLAPE 311
Query: 561 IRKSSRRA--TSKSDVYAFGVLLLELLTGKHP 590
+ S A D ++ GV+L L+G P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 44/213 (20%), Positives = 89/213 (41%), Gaps = 30/213 (14%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++G G G L + V +K + F +G HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNII 109
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ +++ +Y NGSL + + + + +A G+ Y+
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD 165
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLSDSSSVEDPDTVAYK----------AP 559
+H +L + N+L+ ++ +++D+ L VL D DP+ +P
Sbjct: 166 MG-YVHRDLAARNILINSNLVCKVSDFGLGRVLED-----DPEAAYTTRGGKIPIRWTSP 219
Query: 560 E-IRKSSRRATSKSDVYAFGVLLLELLT-GKHP 590
E I + R+ TS SDV+++G++L E+++ G+ P
Sbjct: 220 EAI--AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 32/113 (28%), Positives = 48/113 (42%), Gaps = 7/113 (6%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
T LD + LS +T I + L NL L L N + PL +L ++T L+L
Sbjct: 36 TQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLK--NLTKITELEL 92
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
S N L + + L + +L L + + V PL L V + N +T
Sbjct: 93 SGNPLKNVSA--IAGLQSIKTLDLTSTQIT-DVTPLAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 28/112 (25%), Positives = 47/112 (41%), Gaps = 7/112 (6%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L ++ L L N L + ++ L ++K+L L+ + PL+ L L +L L
Sbjct: 81 LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLD 137
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
N +T + P L L L L + + S + PL L N ++
Sbjct: 138 LNQITNISP--LAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 27/113 (23%), Positives = 50/113 (44%), Gaps = 9/113 (7%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
+ L+ L L L +N +T + L +L + L LS N ++ L + LDL+
Sbjct: 59 VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLT 115
Query: 155 YNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLT 205
+T + P+ L+ L LY L+ N+ + + PL L ++ ++
Sbjct: 116 STQITDVTPLAGLSNLQVLY---LDLNQIT-NISPLAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 19/111 (17%), Positives = 41/111 (36%), Gaps = 5/111 (4%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L ++ +++T + + L + +LS + + L+ L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELK 71
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
N +T L P L L ++ L+L N + +++ +T
Sbjct: 72 DNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 6/96 (6%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L +L L +N ++ I L+SL NL + L N S PL+ + L I+ L+
Sbjct: 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLN 190
+T L +K + P
Sbjct: 226 NQTITNQPVFYNNNLVVPNVVK---GPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 19/101 (18%), Positives = 40/101 (39%), Gaps = 7/101 (6%)
Query: 106 LHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVN 165
++ PD +L N ++ ++ + + L +T L +T +
Sbjct: 4 TQPTAINVIFPD-PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEG-- 58
Query: 166 LTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
+ L+ L L+L+ N+ + + PL + +SGN L
Sbjct: 59 VQYLNNLIGLELKDNQIT-DLAPLKNLTKITELELSGNPLK 98
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 63/282 (22%), Positives = 118/282 (41%), Gaps = 56/282 (19%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVP- 451
EL+G G+ G YK + + +K D + E +Q + + S H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRNIATY 86
Query: 452 ----IRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPL--HWTSCLKIAEDVAQG 504
I+ ++L ++ ++ GS+ +LI ++ + L W + I ++ +G
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAY--ICREILRG 141
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVA----YKAP 559
L+++H+ +IH ++K NVLL + E +L D+ +S L + +T + AP
Sbjct: 142 LSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAP 198
Query: 560 EIRKSSRRATS----KSDVYAFGVLLLELLTGKHP--SQHPYLA-------PPDMLE--- 603
E+ + KSD+++ G+ +E+ G P HP A P L+
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258
Query: 604 WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
W + + C +K+ QRPA Q++K
Sbjct: 259 WSKKFQ--------------SFIESCLVKNHSQRPATEQLMK 286
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 7/123 (5%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L +L+ LSL +N ++ I L L L+SL L N + LS L +L L L
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLE 164
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPT 213
N ++ ++P L L +L +L L N S + L L V + + +
Sbjct: 165 DNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQS 221
Query: 214 LLK 216
L
Sbjct: 222 NLV 224
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 30/113 (26%), Positives = 49/113 (43%), Gaps = 7/113 (6%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
T L+ + + +N+ + + + L N+ L L+ N + PL+ +L L L L
Sbjct: 41 TQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFL 97
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
N + L +L L +L SL LE N S + L P L + N +T
Sbjct: 98 DENKVKDL--SSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 39/104 (37%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L QL L L NN +T I LS L L +LSL N S PL+ L +L L LS
Sbjct: 130 LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLS 186
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFN 198
N+++ L L L L L+L P +Q LVV N
Sbjct: 187 KNHISDLRA--LAGLKNLDVLELFSQECL-NKPINHQSNLVVPN 227
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 12/102 (11%), Positives = 32/102 (31%), Gaps = 5/102 (4%)
Query: 104 LSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIP 163
+ I + +L + + A + L+ + + + +++ +
Sbjct: 7 TITVPTPIKQ-IFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV-- 61
Query: 164 VNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+ L + L L N+ + P N L + N +
Sbjct: 62 QGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 22/122 (18%), Positives = 37/122 (30%), Gaps = 29/122 (23%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L +L+ L L N ++ + L+ L NL L L +L + +
Sbjct: 174 LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWN-----------------------RFSGTVPPLNQ 191
+L P ++ ++W+ RF G V Q
Sbjct: 233 DGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRV---TQ 287
Query: 192 PF 193
P
Sbjct: 288 PL 289
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 30/129 (23%), Positives = 45/129 (34%), Gaps = 7/129 (5%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
L L+ L L + +++L NLKSL + + S A +I L +L L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP----LNQPFLVVFNVSGNNLTGQ 207
DL P L L L+ T+P L Q L ++ G +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ--LEKLDLRGCVNLSR 292
Query: 208 VPETPTLLK 216
+P L
Sbjct: 293 LPSLIAQLP 301
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 32/141 (22%), Positives = 49/141 (34%), Gaps = 7/141 (4%)
Query: 81 LQSFGLRG---TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGA 137
LQS L P ++ L L+ L + N+ L+ P + L L+ L L
Sbjct: 185 LQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 138 FPLSILSLHRLTILDLS-YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFL 194
+P L L L +NL L P+++ L +L L L +P L P
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 195 VVFNVSGNNLTGQVPETPTLL 215
+ V + P
Sbjct: 304 CIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 22/126 (17%), Positives = 41/126 (32%), Gaps = 16/126 (12%)
Query: 97 RLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155
L L + L PD L +L+ +++ P ++ L L L+
Sbjct: 79 TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136
Query: 156 NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP----LNQPF-------LVVFNVSGNNL 204
N L L P ++ +L+RL L + +P + L + +
Sbjct: 137 NPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 205 TGQVPE 210
+P
Sbjct: 196 R-SLPA 200
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 14/116 (12%), Positives = 31/116 (26%), Gaps = 11/116 (9%)
Query: 96 TRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSI--LSLHRLTILDL 153
L Q + + + ++ N + + + A + + L+L
Sbjct: 30 DVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALEL 88
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP----LNQPFLVVFNVSGNNLT 205
L P L L + ++ +P L ++ N L
Sbjct: 89 RSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG--LETLTLARNPLR 140
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 31/139 (22%), Positives = 45/139 (32%), Gaps = 19/139 (13%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150
L L L L + N+ ++ L+LS I L +
Sbjct: 379 TGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEV 435
Query: 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP-LNQPFLVVFNVSGNNLTGQVP 209
LD+S NNL + L L LY + N+ T+P P L+V +S N L
Sbjct: 436 LDVSNNNLDS-FSLFLPRLQELY---ISRNKLK-TLPDASLFPVLLVMKISRNQLK---- 486
Query: 210 ETPTLLKFDASSFSMNPNL 228
F +L
Sbjct: 487 ------SVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 25/132 (18%), Positives = 43/132 (32%), Gaps = 7/132 (5%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
L L+VL L ++ + I SL +L+ L LS N S L L
Sbjct: 42 GHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSL 100
Query: 149 TILDLSYNNLTGL-IPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNL 204
L+L N L + L L +L++ + L + +L
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160
Query: 205 TGQVPETPTLLK 216
++ ++
Sbjct: 161 RNYQSQSLKSIR 172
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 21/132 (15%), Positives = 37/132 (28%), Gaps = 10/132 (7%)
Query: 83 SFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLS 141
+ +R L + L + S L +K +++ +
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
Query: 142 ILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLK---LEWNRFSGTVPPLNQPF----- 193
L L LDLS N + N SL+ L N ++ +
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKN 388
Query: 194 LVVFNVSGNNLT 205
L ++S N
Sbjct: 389 LTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 21/135 (15%), Positives = 45/135 (33%), Gaps = 5/135 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLT--GPIPDLSSLINLKSLSLSR-NFFSGAFPLSILSL 145
+ + L L+ L+L N G +L NL++L + FS + L
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF--LVVFNVSGNN 203
L L++ +L +L ++ ++ L L + + + + + N
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207
Query: 204 LTGQVPETPTLLKFD 218
L + +
Sbjct: 208 LARFQFSPLPVDEVS 222
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 22/136 (16%), Positives = 42/136 (30%), Gaps = 11/136 (8%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILS-L 145
T + L L L L +N L+ + L +LK L+L N + S+ L
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 146 HRLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFS----GTVPPLNQPFLVVFNVS 200
L L + I L L L+++ ++ + + +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD--IHHLTLH 180
Query: 201 GNNLTGQVPETPTLLK 216
+ + +L
Sbjct: 181 LSESAFLLEIFADILS 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 19/106 (17%), Positives = 38/106 (35%), Gaps = 7/106 (6%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSL-HNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAF 138
Q+ G+ FP L L+ L + + + + D + L +L L +
Sbjct: 110 YQTLGVTSLFP-----NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 139 PLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG 184
S+ S+ + L L + L+ + L + L+L +
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 26/111 (23%), Positives = 41/111 (36%), Gaps = 8/111 (7%)
Query: 99 DQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
D V + S T IP L++ +KSL LS N + + + L +L L +
Sbjct: 5 DASGVCDGRSRSFTS-IPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLT 205
+ + +L L L L N S ++ L N+ GN
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 19/111 (17%), Positives = 32/111 (28%), Gaps = 1/111 (0%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
L L L + SL L S+ ++ L+L + + + L
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFN 198
+ L+L NL L + +K R S L +
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 22/85 (25%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
L VL + NN+L L L+ L +SRN P + L L ++ +S N
Sbjct: 430 PQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQ 484
Query: 158 LTGLIPVNLTALDRLYSLKLEWNRF 182
L + L L + L N +
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 21/156 (13%), Positives = 46/156 (29%), Gaps = 21/156 (13%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRN----FFSGAFP---- 139
+ +L + + L+LH + + L +++ L L F P
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221
Query: 140 ---LSILSLHRLTILDLSYNNLTGLIPVNL----TALDRLYSLKLEWNRFSGTVPPLNQP 192
+ L+ + D S+N L L+ L D L S +
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 193 FLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
+ + ++ L ++ +S+ +
Sbjct: 282 KVETVTIRRLHIPQF-----YLFYDLSTVYSLLEKV 312
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 3/64 (4%)
Query: 96 TRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL-SLHRLTILDLS 154
L +L+ L + N L +PD S L + +SRN + P I L L + L
Sbjct: 448 LFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLH 505
Query: 155 YNNL 158
N
Sbjct: 506 TNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 16/130 (12%), Positives = 39/130 (30%), Gaps = 4/130 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
F + LT +L L L + + + L + +
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLT 205
L + L + + L+++ + +E ++ VP + L ++S N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
Query: 206 GQVPETPTLL 215
+ +
Sbjct: 348 EEYLKNSACK 357
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 38/247 (15%), Positives = 85/247 (34%), Gaps = 47/247 (19%)
Query: 428 DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIY---DYQPNGSLFNLIHGSRSI 484
+S + + + + Q ++ +Y +L + + +R
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRC 156
Query: 485 RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS-VLS 543
+ CL I +A+ + ++H L+H +LK SN+ D ++ D+ L +
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 544 DSSSVEDPD--------------TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKH 589
+ T Y +PE + K D+++ G++L ELL
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYSHKVDIFSLGLILFELL---- 270
Query: 590 PSQHPYLAPPDMLEWVRTMR--------VDDGREENRL--GMLTEVASVCSLKSPEQRPA 639
+ + + + + +R +E+ + ML+ SP +RP
Sbjct: 271 ---YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLS--------PSPTERPE 319
Query: 640 MWQVLKM 646
+++
Sbjct: 320 ATDIIEN 326
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 31/124 (25%), Positives = 42/124 (33%), Gaps = 15/124 (12%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
P T L +L L L L + L L+ L L N F
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFR----D 151
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSG 201
L LT L L N ++ + L L L L NR + V P + L+ +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
Query: 202 NNLT 205
NNL+
Sbjct: 211 NNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 35/125 (28%), Positives = 45/125 (36%), Gaps = 15/125 (12%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
P L L+ L L +N+L +PD L NL L L N S AF
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAF---- 173
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNV 199
LH L L L N + + P L RL +L L N S +P L +
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRL 232
Query: 200 SGNNL 204
+ N
Sbjct: 233 NDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 32/125 (25%), Positives = 43/125 (34%), Gaps = 16/125 (12%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFF-----SGAFPLSIL 143
P + L +L LH+N L I + L L+ L LS N F
Sbjct: 48 PAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNAQLRSVDPATF----H 102
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVS 200
L RL L L L L P L L L L+ N +P + L +
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH 161
Query: 201 GNNLT 205
GN ++
Sbjct: 162 GNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 24/111 (21%), Positives = 35/111 (31%), Gaps = 7/111 (6%)
Query: 99 DQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
+ S L +P + + + + L N S S + LTIL L N
Sbjct: 11 EPKVTTSCPQQGLQA-VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
L + T L L L L N +V P L ++ L
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 68/309 (22%), Positives = 117/309 (37%), Gaps = 62/309 (20%)
Query: 395 ELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEA-----V 441
+ LG G+ G A + V VK K+ T + + E +
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMI 131
Query: 442 GGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC------- 494
G H N++ + G VI +Y G+L + R + + S
Sbjct: 132 G--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 495 ----LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED 550
+ A VA+G+ Y+ IH +L + NVL+ D ++ D+ L+ +
Sbjct: 190 SKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTEDNVMKIADFGLA-----RDIHH 243
Query: 551 PDTVAYK------------APEIRKSS---RRATSKSDVYAFGVLLLELLT-GKHPSQHP 594
D YK APE + R T +SDV++FGVLL E+ T G P +P
Sbjct: 244 IDY--YKKTTNGRLPVKWMAPE----ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 295
Query: 595 YLAPPDMLEWVRT-MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
+ ++ + ++ R+D + N L + C P QRP Q+++ + I
Sbjct: 296 GVPVEELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353
Query: 654 VMAEDNAAF 662
++ +
Sbjct: 354 TSNQEMGYY 362
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 55/270 (20%), Positives = 114/270 (42%), Gaps = 45/270 (16%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G+G+ GT Y A+ + V +++ + + E + + +PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIV--- 80
Query: 454 AYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
Y + G+ L V+ +Y GSL +++ + + + Q L ++H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVA----YKAPEIRKSS 565
+IH ++KS N+LLG D +LTD+ ++ S T+ + APE+
Sbjct: 135 NQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK 191
Query: 566 RRATSKSDVYAFGVLLLELLTGKHP--SQHP----YL----APPDMLEWVRTMRVDDGRE 615
K D+++ G++ +E++ G+ P +++P YL P++
Sbjct: 192 AY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP----------- 239
Query: 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
E + + + C E+R + ++L+
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 68/302 (22%), Positives = 114/302 (37%), Gaps = 64/302 (21%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFD-ANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+G GS G Y A + N +V +K+ + K ++ + + + + L HPN +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI-- 117
Query: 453 RAYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
Y + ++ +Y GS +L+ + KPL + QGLAY+H
Sbjct: 118 -QYRGCYLREHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVEDPDTVAY-KAPEIRKSSR 566
+ +IH ++K+ N+LL +L D+ + +S V P Y APE+ +
Sbjct: 172 SHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP----YWMAPEVILAMD 226
Query: 567 RAT--SKSDVYAFGVLLLELLTGKHP--SQHP----YL---APPDMLE---WVRTMRVDD 612
K DV++ G+ +EL K P + + Y L+ W R
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR--- 283
Query: 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK---------------MIQEIKESVMAE 657
C K P+ RP +LK +IQ K++V
Sbjct: 284 -----------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVREL 332
Query: 658 DN 659
DN
Sbjct: 333 DN 334
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 48/213 (22%), Positives = 79/213 (37%), Gaps = 24/213 (11%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVPI 452
LG+G ++ D + K + + L+H ++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+F+ V+ + SL L R K L + G Y+HR
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--------TVAYKAPEIRKS 564
+IH +LK N+ L D E ++ D+ L+ VE T Y APE+
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATK-----VEYDGERKKVLCGTPNYIAPEV--L 213
Query: 565 SRRATS-KSDVYAFGVLLLELLTGKHPSQHPYL 596
S++ S + DV++ G ++ LL GK P + L
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 56/304 (18%), Positives = 95/304 (31%), Gaps = 81/304 (26%)
Query: 395 ELLGRGSIGTTYKAVLDNHL------IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
E LG G YK L V +K E F L HPN
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPN 73
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSL-----------FNLIHGSRSIRAKPLHWTSCLKI 497
+V + +I+ Y +G L L + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 498 AEDVAQGLAY------IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551
+A G+ Y +H+ +L + NVL+ +++D L V
Sbjct: 134 VAQIAAGMEYLSSHHVVHK-------DLATRNVLVYDKLNVKISDLGLF-----REVYAA 181
Query: 552 DTVAYK------------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLA 597
D YK APE I + + SD++++GV+L E+ + G P + +
Sbjct: 182 DY--YKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYS 235
Query: 598 PPDMLEWVRTMRVDDGREENRLG------------MLTEVASVCSLKSPEQRPAMWQVLK 645
D++E +R + L M+ C + P +RP +
Sbjct: 236 NQDVVEMIR-----NR---QVLPCPDDCPAWVYALMIE-----CWNEFPSRRPRFKDIHS 282
Query: 646 MIQE 649
++
Sbjct: 283 RLRA 286
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 48/213 (22%), Positives = 79/213 (37%), Gaps = 24/213 (11%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVPI 452
LG+G ++ D + K + + L+H ++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+F+ V+ + SL L R K L + G Y+HR
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--------TVAYKAPEIRKS 564
+IH +LK N+ L D E ++ D+ L+ VE T Y APE+
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATK-----VEYDGERKKVLCGTPNYIAPEV--L 187
Query: 565 SRRATS-KSDVYAFGVLLLELLTGKHPSQHPYL 596
S++ S + DV++ G ++ LL GK P + L
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 65/302 (21%), Positives = 121/302 (40%), Gaps = 74/302 (24%)
Query: 395 ELLGRGSIGTTYKAVLDNH---LIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLV 450
+++G G+ G KA + + +KR + F +E + L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNII 89
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC-----------LKIAE 499
+ + +G + +Y P+G+L + + SR + P + L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYK-- 557
DVA+G+ Y+ + IH +L + N+L+G ++ A++ D+ LS + Y
Sbjct: 150 DVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLS--------RGQEV--YVKK 198
Query: 558 ----------APEIRKSS---RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLE 603
A E S T+ SDV+++GVLL E+++ G P + + ++ E
Sbjct: 199 TMGRLPVRWMAIE----SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYE 252
Query: 604 WVRTMRVDDGREENRLG------------MLTEVASVCSLKSPEQRPAMWQVLKMIQEIK 651
++ G RL M C + P +RP+ Q+L + +
Sbjct: 253 -----KLPQG---YRLEKPLNCDDEVYDLMRQ-----CWREKPYERPSFAQILVSLNRML 299
Query: 652 ES 653
E
Sbjct: 300 EE 301
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 37/135 (27%), Positives = 58/135 (42%), Gaps = 14/135 (10%)
Query: 81 LQSFGLRG----TFPPNTLTRLDQLRVLSL-HNNSLTGPIPD--LSSLINLKSLSLSRNF 133
L+ LR + P R+ LR L L L+ I + L NL+ L+L+
Sbjct: 138 LKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY-ISEGAFEGLSNLRYLNLAMCN 196
Query: 134 FSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LN 190
P ++ L +L LDLS N+L+ + P + L L L + ++ + N
Sbjct: 197 LR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
Query: 191 QPFLVVFNVSGNNLT 205
LV N++ NNLT
Sbjct: 254 LQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 31/125 (24%), Positives = 45/125 (36%), Gaps = 16/125 (12%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
N+ L L +L L N + I + L NL +L L N + GAF +
Sbjct: 80 KVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRLTTIPNGAF----VY 134
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKL-EWNRFSGTVPP---LNQPFLVVFNVS 200
L +L L L N + + + L L L E R S + L N++
Sbjct: 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLA 193
Query: 201 GNNLT 205
NL
Sbjct: 194 MCNLR 198
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 11/94 (11%)
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILSLH 146
LT L +L L L N L+ I L++L+ L + ++ AF +L
Sbjct: 201 PNLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAF----DNLQ 255
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180
L ++L++NNLT L T L L + L N
Sbjct: 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 8/111 (7%)
Query: 99 DQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
+Q + +L +P +S+ N + L+L N S L L IL LS N+
Sbjct: 43 NQFSKVICVRKNLRE-VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
+ + L L +L+L NR + T+P + L + N +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE 149
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 27/113 (23%), Positives = 45/113 (39%), Gaps = 8/113 (7%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
+ L ++ + N+++ + + NLK L LS N S PL L +L L +
Sbjct: 36 SQKELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSV 92
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
+ N L L + L RL+ L+ N L L + ++ N L
Sbjct: 93 NRNRLKNLNGIPSACLSRLF---LDNNELR-DTDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 21/111 (18%), Positives = 38/111 (34%), Gaps = 6/111 (5%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L +L S+T + L +++ + + + L L LS
Sbjct: 15 DPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKELHLS 71
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+N ++ L P L L +L L + NR + + L + N L
Sbjct: 72 HNQISDLSP--LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 21/82 (25%), Positives = 32/82 (39%), Gaps = 3/82 (3%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L L +LS+ NN L I L L L+ L L N + L+ L ++ +DL+
Sbjct: 124 LIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLT 180
Query: 155 YNNLTGLIPVNLTALDRLYSLK 176
L ++K
Sbjct: 181 GQKCVNEPVKYQPELYITNTVK 202
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 17/101 (16%), Positives = 31/101 (30%), Gaps = 7/101 (6%)
Query: 106 LHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVN 165
+ + L N +L + + L + + +N+ L
Sbjct: 4 QRPTPINQ-VFPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLA--G 58
Query: 166 LTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
+ L L L N+ S + PL L +V+ N L
Sbjct: 59 MQFFTNLKELHLSHNQIS-DLSPLKDLTKLEELSVNRNRLK 98
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 45/270 (16%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G GS G A + V VK D K E + + H N+V
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQHFNVV--- 105
Query: 454 AYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+++ GE L V+ ++ G+L +++ L+ + E V Q LAY+H
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVA----YKAPEIRKSS 565
+IH ++KS ++LL D +L+D+ +S ++ + APE+ S
Sbjct: 160 QG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRS 216
Query: 566 RRATSKSDVYAFGVLLLELLTGKHP--SQHPYLA--------PPDMLEWVRTMRVDDGRE 615
++ D+++ G++++E++ G+ P S P A PP + + V
Sbjct: 217 -LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPV----- 270
Query: 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
L + ++ P++R ++L
Sbjct: 271 ------LRDFLERMLVRDPQERATAQELLD 294
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 30/90 (33%), Positives = 38/90 (42%), Gaps = 2/90 (2%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
++L LS N LT I +L L LK L LS N SG + LT L
Sbjct: 35 EGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93
Query: 152 DLSYNNLTGLIPV-NLTALDRLYSLKLEWN 180
+LS N + L + L L+ L SL L
Sbjct: 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 24/115 (20%), Positives = 43/115 (37%), Gaps = 9/115 (7%)
Query: 97 RLDQLRVLSLHNNSLTGP--IPDLSSLINLKSLSLSRNFFSGAFPLSILS-LHRLTILDL 153
++ L L N+ L+ LS + ++ L L++L L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLEL 71
Query: 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFS--GTVPPLNQ-PFLVVFNVSGNNLT 205
S N ++G + V L L L N+ T+ PL + L ++ +T
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 32/121 (26%), Positives = 53/121 (43%), Gaps = 14/121 (11%)
Query: 97 RLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYN 156
Q L L+N L+ +P+ +L+SL S N + P SL L + + +
Sbjct: 69 LDRQAHELELNNLGLS-SLPE--LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLL 215
L+ L P L L + N+ +P L N FL + +V N+L ++P+ P L
Sbjct: 125 ALSDLPP-LLEYLG------VSNNQLE-KLPELQNSSFLKIIDVDNNSLK-KLPDLPPSL 175
Query: 216 K 216
+
Sbjct: 176 E 176
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 15/126 (11%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
P L L V + + +L+ P L+ L +S N P + + L I+
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLE-KLP-ELQNSSFLKII 158
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE 210
D+ N+L L P +L+ + N+ +P L N PFL N+L ++P+
Sbjct: 159 DVDNNSLKKL-PDLPPSLEFIA---AGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPD 212
Query: 211 TPTLLK 216
P L+
Sbjct: 213 LPLSLE 218
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 36/143 (25%), Positives = 55/143 (38%), Gaps = 23/143 (16%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L L + NNSL +PD ++L+S+ N + +L LT +
Sbjct: 191 LQNLPFLTAIYADNNSLKK-LPD--LPLSLESIVAGNNILE--ELPELQNLPFLTTIYAD 245
Query: 155 YNNLTGL--IPVNLTALD--------------RLYSLKLEWNRFSGTVPPLNQPFLVVFN 198
N L L +P +L AL+ L L + N FS + L P L N
Sbjct: 246 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS-GLSELP-PNLYYLN 303
Query: 199 VSGNNLTGQVPETPTLLKFDASS 221
S N + P+L + + S+
Sbjct: 304 ASSNEIRSLCDLPPSLEELNVSN 326
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 35/139 (25%), Positives = 54/139 (38%), Gaps = 24/139 (17%)
Query: 93 NTLTRL-DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
+ L+ L L L+ +N + + DL +L+ L++S N P RL L
Sbjct: 290 SGLSELPPNLYYLNASSNEIRS-LCDL--PPSLEELNVSNNKLI-ELPALP---PRLERL 342
Query: 152 DLSYNNLTGL--IPVNLTALD----RLYSL--------KLEWNRFSGTVPPLNQPFLVVF 197
S+N+L + +P NL L L L N VP L Q L
Sbjct: 343 IASFNHLAEVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQ-NLKQL 401
Query: 198 NVSGNNLTGQVPETPTLLK 216
+V N L + P+ P ++
Sbjct: 402 HVETNPLR-EFPDIPESVE 419
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 18/113 (15%), Positives = 29/113 (25%), Gaps = 28/113 (24%)
Query: 93 NTLTRLD----QLRVLSLHNNSLT---GPIPDLSSLI-------------NLKSLSLSRN 132
N L + L+ L + N L + L NLK L + N
Sbjct: 347 NHLAEVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406
Query: 133 FFSGAFPLSIL--SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
PL + L ++ + D+L E +
Sbjct: 407 ------PLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 12/101 (11%), Positives = 28/101 (27%), Gaps = 11/101 (10%)
Query: 116 PDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSL 175
P S L+ + + P+ ++ T +++ P +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 176 KLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLK 216
+L ++ L+ +PE P L+
Sbjct: 64 RL---------RDCLDRQAHELELNNLGLS-SLPELPPHLE 94
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 60/303 (19%), Positives = 112/303 (36%), Gaps = 58/303 (19%)
Query: 395 ELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-S 445
+ LG G G A + V VK + + ME + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGK 145
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSL-----------FNLIHGSRSIRAKPLHWTSC 494
H N++ + G VI +Y G+L + + + + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 495 LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPD 552
+ +A+G+ Y+ IH +L + NVL+ + ++ D+ L+ + +
Sbjct: 206 VSCTYQLARGMEYLASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------ 258
Query: 553 TVAYK------------APEIRKSS---RRATSKSDVYAFGVLLLELLT-GKHPSQHPYL 596
YK APE + R T +SDV++FGVL+ E+ T G P +P +
Sbjct: 259 ---YKKTTNGRLPVKWMAPE----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGI 309
Query: 597 APPDMLEWVRT-MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655
++ + ++ R+D + N L + C P QRP Q+++ + I
Sbjct: 310 PVEELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367
Query: 656 AED 658
E+
Sbjct: 368 NEE 370
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 77/308 (25%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHP 447
+ LG G+ G +A D + V VK + T EA ++ + L +H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHM 87
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC------------- 494
N+V + G LVI +Y G L N + R +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 495 LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPD 552
L + VA+G+A++ + IH +L + N+LL ++ D+ L+ + +DS
Sbjct: 148 LSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIKNDS------- 199
Query: 553 TVAYK------------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAP 598
Y APE I T +SDV+++G+ L EL + G PY
Sbjct: 200 --NYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGS----SPY--- 248
Query: 599 PDMLEWVRTMR-VDDGREENRLG------------MLTEVASVCSLKSPEQRPAMWQVLK 645
P M + + + +G R+ M T C P +RP Q+++
Sbjct: 249 PGMPVDSKFYKMIKEG---FRMLSPEHAPAEMYDIMKT-----CWDADPLKRPTFKQIVQ 300
Query: 646 MIQEIKES 653
+I++
Sbjct: 301 LIEKQISE 308
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 65/273 (23%), Positives = 117/273 (42%), Gaps = 51/273 (18%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG GS G+ YKA+ + IV +K+ + + + + P++V
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVV--- 87
Query: 454 AYFQA--KGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
Y+ + K L ++ +Y GS+ ++I +R K L I + +GL Y+H
Sbjct: 88 KYYGSYFKNTDLWIVMEYCGAGSVSDIIR----LRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVA----YKAPEIRKSS 565
IH ++K+ N+LL + A+L D+ ++ L+D+ + +TV + APE+ +
Sbjct: 144 MR-KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEI 200
Query: 566 RRATSKSDVYAFGVLLLELLTGKHP--SQHP----YL---APPDMLE----WVRTMRVDD 612
+D+++ G+ +E+ GK P HP ++ PP W
Sbjct: 201 GY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT--- 256
Query: 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645
+ C +KSPEQR Q+L+
Sbjct: 257 -----------DFVKQCLVKSPEQRATATQLLQ 278
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 31/102 (30%), Positives = 39/102 (38%), Gaps = 2/102 (1%)
Query: 80 VLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFP 139
VL + L LSL N L + +L L LK L LS N G
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLD 88
Query: 140 LSILSLHRLTILDLSYNNLTGLIPV-NLTALDRLYSLKLEWN 180
+ L LT L+LS N L + + L L+ L SL L
Sbjct: 89 MLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 27/114 (23%), Positives = 42/114 (36%), Gaps = 7/114 (6%)
Query: 97 RLDQLRVLSLHNNSLTGP--IPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
+R L L N + +NL+ LSL L L +L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELS 79
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFS--GTVPPLNQ-PFLVVFNVSGNNLT 205
N + G + + L L L L N+ T+ PL + L ++ +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 36/213 (16%)
Query: 396 LLGRGSIGTTYKA------------VLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG 443
+LG GS T A +L+ I+ K NK + E + +
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHII--KE---NKVPYVTRER-----DVMSR 86
Query: 444 LSHPNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA 502
L HP V + FQ E+L Y NG L I S + AE +
Sbjct: 87 LDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAE-IV 140
Query: 503 QGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYK 557
L Y+H +IH +LK N+LL D ++TD+ + + S + T Y
Sbjct: 141 SALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+PE+ + + A SD++A G ++ +L+ G P
Sbjct: 200 SPELL-TEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+LG+GS G K VK + + + +E + L HPN++ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ ++ + G LF+ I S +I + V G+ Y+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------AARIIKQVFSGITYMHKH 140
Query: 512 SWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSV--EDPDTVAYKAPEIRKSSR 566
+ ++H +LK N+LL D + ++ D+ LS ++ + T Y APE+ +
Sbjct: 141 N-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR--G 197
Query: 567 RATSKSDVYAFGVLLLELLTGKHP 590
K DV++ GV+L LL+G P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 34/160 (21%), Positives = 58/160 (36%), Gaps = 21/160 (13%)
Query: 439 EAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIA 498
V P +V + F + I D G L + A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA 299
Query: 499 EDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD------ 552
E + GL ++H +++ +LK +N+LL R++D L+ +
Sbjct: 300 E-IILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLAC-------DFSKKKPHAS 350
Query: 553 --TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
T Y APE+ + S +D ++ G +L +LL G P
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 61/301 (20%), Positives = 114/301 (37%), Gaps = 54/301 (17%)
Query: 395 ELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-S 445
+ LG G+ G A + V VK + + ME + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGK 99
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSL-----------FNLIHGSRSIRAKPLHWTSC 494
H N++ + G VI +Y G+L + + + + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 495 LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV 554
+ +A+G+ Y+ IH +L + NVL+ + ++ D+ L+ + + D
Sbjct: 160 VSCTYQLARGMEYLASQK-CIHRDLAARNVLVTENNVMKIADFGLA-----RDINNIDY- 212
Query: 555 AYK------------APEIRKSS---RRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAP 598
YK APE + R T +SDV++FGVL+ E+ T G P +P +
Sbjct: 213 -YKKTTNGRLPVKWMAPE----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPV 265
Query: 599 PDMLEWVRT-MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657
++ + ++ R+D + N L + C P QRP Q+++ + I E
Sbjct: 266 EELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323
Query: 658 D 658
+
Sbjct: 324 E 324
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 28/131 (21%), Positives = 49/131 (37%), Gaps = 9/131 (6%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
+ L L L L NN ++ I + S L L+ L +S+N P ++ S L
Sbjct: 70 RKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SL 125
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF-SGTVPP--LNQPFLVVFNVSGNNLT 205
L + N + + + L + +++ N + P + L +S LT
Sbjct: 126 VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185
Query: 206 GQVPETPTLLK 216
G + P L
Sbjct: 186 GIPKDLPETLN 196
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 10/128 (7%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLT-GPIPDLS-SLINLKSLSLSRNFFSGAFPLSILSLH 146
P + L + + + N L + + L L +S + P +
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE-- 193
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNN 203
L L L +N + + +L +LY L L N+ + P L ++ N
Sbjct: 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNK 252
Query: 204 LTGQVPET 211
L+ +VP
Sbjct: 253 LS-RVPAG 259
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 26/124 (20%), Positives = 42/124 (33%), Gaps = 13/124 (10%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLT 149
P + L++L L +N + + DL L L L N S+ L L
Sbjct: 188 PKDLPETLNELH---LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR 244
Query: 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNR--------FSGTVPPLNQPFLVVFNVSG 201
L L N L+ +P L L L + L N F + + + ++
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 202 NNLT 205
N +
Sbjct: 304 NPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 27/145 (18%), Positives = 47/145 (32%), Gaps = 34/145 (23%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS----GAFP----L 140
+ L +L+ L + N L IP + +L L + N G F +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLVE-IPP-NLPSSLVELRIHDNRIRKVPKGVFSGLRNM 149
Query: 141 SILSLH-----------------RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFS 183
+ + + +L L +S LTG IP +L + L L L+ N+
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ 206
Query: 184 GTVPPL---NQPFLVVFNVSGNNLT 205
+ L + N +
Sbjct: 207 -AIELEDLLRYSKLYRLGLGHNQIR 230
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 21/113 (18%), Positives = 36/113 (31%), Gaps = 12/113 (10%)
Query: 81 LQSFGLRG----TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS- 135
L GL +L+ L LR L L NN L+ L L L+ + L N +
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITK 278
Query: 136 ---GAFP--LSILSLHRLTILDLSYNNLT--GLIPVNLTALDRLYSLKLEWNR 181
F + + L N + + P + +++ +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 5/107 (4%)
Query: 100 QLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNL 158
LRV+ + L +P ++S + L L N S L L L L N +
Sbjct: 34 HLRVVQCSDLGLKA-VPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 159 TGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
+ + + L +L L + N +PP LV + N +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIR 136
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 42/123 (34%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
TF TL +L L+L LT + +L L +L LS N + PL +L L
Sbjct: 45 TFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPAL 102
Query: 149 TILDLSYNNLTGLIP---VNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGN 202
T+LD+S+N LT L L L LY L+ N T+PP P L +++ N
Sbjct: 103 TVLDVSFNRLTSLPLGALRGLGELQELY---LKGNELK-TLPPGLLTPTPKLEKLSLANN 158
Query: 203 NLT 205
NLT
Sbjct: 159 NLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 33/107 (30%), Positives = 40/107 (37%), Gaps = 20/107 (18%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILSL 145
P L L VL + N LT +P L L L+ L L N G
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLT----PT 147
Query: 146 HRLTILDLSYNNLTGLIPV----NLTALDRLYSLKLEWNRFSGTVPP 188
+L L L+ NNLT L P L LD L L+ N T+P
Sbjct: 148 PKLEKLSLANNNLTEL-PAGLLNGLENLDTLL---LQENSLY-TIPK 189
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 72/302 (23%), Positives = 113/302 (37%), Gaps = 75/302 (24%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGL-SH 446
+ LG G+ G +A D L V VK TA EA ++ + L H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQH 109
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIR---------AKPLHWTSCLKI 497
N+V + G LVI +Y G L N + + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVA 555
+ VAQG+A++ + IH ++ + NVLL A++ D+ L+ +++DS
Sbjct: 170 SSQVAQGMAFLASKN-CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---------N 219
Query: 556 YK------------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDM 601
Y APE I T +SDV+++G+LL E+ + G +PY P +
Sbjct: 220 YIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGL----NPY---PGI 270
Query: 602 LEWVRTMR-VDDGREENRLG------------MLTEVASVCSLKSPEQRPAMWQVLKMIQ 648
L + + V DG ++ M C P RP Q+ +Q
Sbjct: 271 LVNSKFYKLVKDG---YQMAQPAFAPKNIYSIMQA-----CWALEPTHRPTFQQICSFLQ 322
Query: 649 EI 650
E
Sbjct: 323 EQ 324
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 46/208 (22%), Positives = 82/208 (39%), Gaps = 17/208 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG G G + + D V +K+ + + E + ++ + L+HPN+V R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAR 78
Query: 454 AYFQAK------GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
L+ +Y G L ++ + L + D++ L Y
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLSDISSALRY 136
Query: 508 IHRASWLIHGNLKSSNVLLGADFEAR---LTDYCLSVLSDSSSVEDPD--TVAYKAPEIR 562
+H +IH +LK N++L + + D + D + T+ Y APE+
Sbjct: 137 LHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHP 590
++ T D ++FG L E +TG P
Sbjct: 196 -EQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 31/125 (24%), Positives = 49/125 (39%), Gaps = 15/125 (12%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
+ L R L+ L L +N + I + SSL +L+ L LS N+ S F
Sbjct: 68 SNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWF----KP 122
Query: 145 LHRLTILDLSYNNLTGLIPVNL-TALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVS 200
L LT L+L N L +L + L +L L++ + FL +
Sbjct: 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 201 GNNLT 205
++L
Sbjct: 183 ASDLQ 187
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 22/126 (17%), Positives = 37/126 (29%), Gaps = 10/126 (7%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRN--------FFSGAFPLS 141
L L L + + L L S+ N+ L L F +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 142 ILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVS 200
L L + ++ L+ +L ++K+ + LNQ L+ S
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFS 285
Query: 201 GNNLTG 206
N L
Sbjct: 286 RNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 26/162 (16%), Positives = 51/162 (31%), Gaps = 33/162 (20%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRN---------FFSGA 137
T ++ + L L L L N L+ + L +L L+L N FS
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 138 FPLSIL-----------------SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180
L IL L L L++ ++L P +L ++ + L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 181 RFSGTVPPL---NQPFLVVFNVSGNNLTGQVPETPTLLKFDA 219
+ + + + + +L + + ++
Sbjct: 209 QHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 32/119 (26%), Positives = 49/119 (41%), Gaps = 14/119 (11%)
Query: 101 LRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFS----GAFPLSILSLHRLTILDLSY 155
++ L L NN +T DL +NL++L L+ N + +F SL L LDLSY
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF----SSLGSLEHLDLSY 109
Query: 156 NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL----NQPFLVVFNVSGNNLTGQVPE 210
N L+ L L L L L N + T+ + L + V + ++
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 15/103 (14%), Positives = 29/103 (28%), Gaps = 10/103 (9%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSL---------TGPIPDLSSLINLKSLSLSRNFFSGAFP 139
+ + L L + L TG L +++ ++
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 140 LSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182
+ + L L+ S N L + L L + L N +
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 17/71 (23%), Positives = 26/71 (36%), Gaps = 8/71 (11%)
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS----GAFPLSILSLHRL 148
N+L + R + + + SL + L+ + L L SRN G F L L
Sbjct: 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFD----RLTSL 303
Query: 149 TILDLSYNNLT 159
+ L N
Sbjct: 304 QKIWLHTNPWD 314
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 32/143 (22%), Positives = 51/143 (35%), Gaps = 27/143 (18%)
Query: 93 NTLTRL-----DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ LT L + L + +N+LT +P L++L +S N + + P+ L
Sbjct: 50 SGLTTLPDCLPAHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-SLPVLPPGLLE 105
Query: 148 LTILDLSYNNLTGLIPVNLTALD--------------RLYSLKLEWNRFSGTVPPLNQPF 193
L+I +L L P L L L L + N+ P
Sbjct: 106 LSIFSNPLTHLPAL-PSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQL--ASLPALPSE 162
Query: 194 LVVFNVSGNNLTGQVPETPTLLK 216
L N LT +P P+ L+
Sbjct: 163 LCKLWAYNNQLT-SLPMLPSGLQ 184
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 29/117 (24%), Positives = 42/117 (35%), Gaps = 13/117 (11%)
Query: 93 NTLTRLD----QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
N LT L L+ L + N LT +P LK L +S N + + P+ L
Sbjct: 211 NRLTSLPALPSGLKELIVSGNRLTS-LPV--LPSELKELMVSGNRLT-SLPMLP---SGL 263
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L + N LT L P +L L ++ LE N S + +
Sbjct: 264 LSLSVYRNQLTRL-PESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 29/128 (22%), Positives = 45/128 (35%), Gaps = 8/128 (6%)
Query: 93 NTLTRLD----QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
N LT L +L+ L + N LT +P L L SLS+ RN + P S++ L
Sbjct: 231 NRLTSLPVLPSELKELMVSGNRLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHLSSE 286
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQV 208
T ++L N L+ L + RF + + + + L
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
Query: 209 PETPTLLK 216
P
Sbjct: 347 EGEPAPAD 354
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 29/125 (23%), Positives = 47/125 (37%), Gaps = 17/125 (13%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151
P L +L + S L + L L + N + + P+ L L
Sbjct: 97 PVLPPGLLELSIFSNPLTHLP------ALPSGLCKLWIFGNQLT-SLPVLPPG---LQEL 146
Query: 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPET 211
+S N L L P + L +L+ N+ + ++P L L +VS N L +P
Sbjct: 147 SVSDNQLASL-PALPSELCKLW---AYNNQLT-SLPMLP-SGLQELSVSDNQLA-SLPTL 199
Query: 212 PTLLK 216
P+ L
Sbjct: 200 PSELY 204
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 13/120 (10%)
Query: 97 RLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYN 156
+ VL++ + LT +PD ++ +L + N + + P L L++S N
Sbjct: 38 LNNGNAVLNVGESGLTT-LPD-CLPAHITTLVIPDNNLT-SLPALP---PELRTLEVSGN 91
Query: 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLK 216
LT L PV L L +P L + GN LT +P P L+
Sbjct: 92 QLTSL-PVLPPGLLELSIFSNPLTHLP-ALPSG----LCKLWIFGNQLT-SLPVLPPGLQ 144
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 40/179 (22%), Positives = 64/179 (35%), Gaps = 23/179 (12%)
Query: 93 NTLTRLD----QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL--SLH 146
N L L +L L +NN LT +P + LK L +S N L+ L
Sbjct: 191 NQLASLPTLPSELYKLWAYNNRLT-SLP--ALPSGLKELIVSGN------RLTSLPVLPS 241
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNL 204
L L +S N LT L P+ + L L + N+ + +P ++ N+ GN L
Sbjct: 242 ELKELMVSGNRLTSL-PMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
Query: 205 TGQVPETPTLLKFDASSFSMNPNLCGKVINKACRPRSPFFESPNATSPPRPLGQSAQSQ 263
+ + + + A +S A R + P G+ A +
Sbjct: 297 SERTLQALREITS-APGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG-------GLS- 445
E+LGRG + + VK D SAE ++ EA +S
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQ 503
HPN++ ++ ++ +++D G LF+ + + S + KI + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE-------TRKIMRALLE 135
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDP-DTVAYKAPEI 561
+ +H+ + ++H +LK N+LL D +LTD+ S L + + T +Y APEI
Sbjct: 136 VICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 562 RKSSRRATSKS-----DVYAFGVLLLELLTGKHP 590
+ S D+++ GV++ LL G P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 71/318 (22%), Positives = 119/318 (37%), Gaps = 93/318 (29%)
Query: 395 ELLGRGSIGTTYKAVLDNHL------IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
+G G+ G ++A L +V VK +AD A+ F++ + +PN
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-------------------SIRAKPL 489
+V + ++++Y G L + S PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 490 HWTSCLKIAEDVAQGLAY------IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543
L IA VA G+AY +HR +L + N L+G + ++ D+ L
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHR-------DLATRNCLVGENMVVKIADFGL---- 220
Query: 544 DSSSVEDPDTVAYK------------APEIRKSS---RRATSKSDVYAFGVLLLELLT-G 587
S ++ D YK PE S R T++SDV+A+GV+L E+ + G
Sbjct: 221 -SRNIYSADY--YKADGNDAIPIRWMPPE----SIFYNRYTTESDVWAYGVVLWEIFSYG 273
Query: 588 KHPSQHPYLAPPDMLEWVRTMRVDDGREENRLG------------MLTEVASVCSLKSPE 635
P + +A +++ +VR DG N L M C K P
Sbjct: 274 LQP--YYGMAHEEVIYYVR-----DG---NILACPENCPLELYNLMRL-----CWSKLPA 318
Query: 636 QRPAMWQVLKMIQEIKES 653
RP+ + +++Q + E
Sbjct: 319 DRPSFCSIHRILQRMCER 336
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 60/308 (19%), Positives = 113/308 (36%), Gaps = 79/308 (25%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
+ LG G G KA + V VK N + + + ++HP+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPH 87
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSL-------------------FNLIHGSRSIRAKPL 489
++ + G L+I +Y GSL + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 490 HWTSCLKIAEDVAQGLAYIHRASW-LIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSS 546
+ A ++QG+ Y+ A L+H +L + N+L+ + +++D+ LS V + S
Sbjct: 148 TMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 547 SVEDPDTVAYKAPEIRK-----------SSRRATSKSDVYAFGVLLLELLT-GKHPSQHP 594
Y + T++SDV++FGVLL E++T G +P +P
Sbjct: 206 ---------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YP 254
Query: 595 YLAPPDMLEWVRTMRVDDGREENRLG------------MLTEVASVCSLKSPEQRPAMWQ 642
+ P + ++ G +R+ ML C + P++RP
Sbjct: 255 GIPPERLFNLLK-----TG---HRMERPDNCSEEMYRLMLQ-----CWKQEPDKRPVFAD 301
Query: 643 VLKMIQEI 650
+ K ++++
Sbjct: 302 ISKDLEKM 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 51/288 (17%), Positives = 96/288 (33%), Gaps = 25/288 (8%)
Query: 311 RNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQTLIKR 370
N S + + V E V K + +
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 371 SGSLVFCAGE-SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTAD 428
+ + Y + E LG G+ G ++ K +D
Sbjct: 145 PQPVEIKHDHVLDHYDIH-------EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 197
Query: 429 TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKP 488
E + ++ + L HP LV + F+ E ++IY++ G LF + +
Sbjct: 198 --KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----- 250
Query: 489 LHWT--SCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL--TDYCLSVLSD 544
+ ++ V +GL ++H + +H +LK N++ L D+ L+ D
Sbjct: 251 -KMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 545 SSSV--EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
T + APE+ + + +D+++ GVL LL+G P
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 38/200 (19%), Positives = 78/200 (39%), Gaps = 18/200 (9%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E+LG G+ + + +K K+ + E + + + H N+V +
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+++ ++ G LF+ I G + + + + V + Y+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD-------ASLVIQQVLSAVKYLHEN 125
Query: 512 SWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDP-DTVAYKAPEIRKSSRR 567
++H +LK N+L + + +TD+ LS + + + T Y APE+
Sbjct: 126 G-IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 568 ATSKSDVYAFGVLLLELLTG 587
+ D ++ GV+ LL G
Sbjct: 185 -SKAVDCWSIGVITYILLCG 203
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 26/138 (18%), Positives = 46/138 (33%), Gaps = 18/138 (13%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS--- 135
++ NT L L +L L N + + L NL+ L+L++
Sbjct: 61 VEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAV 119
Query: 136 ---GAFPLSILSLHRLTILDLSYNNLTGLIPVNL-TALDRLYSLKLEWNRFS----GTVP 187
F L L +L L NN+ + P + + R + L L +N+ +
Sbjct: 120 LSGNFFK----PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175
Query: 188 PLNQPFLVVFNVSGNNLT 205
+ +S L
Sbjct: 176 NFQGKHFTLLRLSSITLQ 193
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 32/129 (24%), Positives = 47/129 (36%), Gaps = 17/129 (13%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
+ +RL L+ L + + I + L +L L L N F GAF
Sbjct: 44 ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFN--- 100
Query: 143 LSLHRLTILDLSYNNLTGL-IPVNL-TALDRLYSLKLEWNRFSGTVPP----LNQPFLVV 196
L L +L L+ NL G + N L L L L N + P LN V
Sbjct: 101 -GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHV 158
Query: 197 FNVSGNNLT 205
+++ N +
Sbjct: 159 LDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 26/98 (26%), Positives = 33/98 (33%), Gaps = 11/98 (11%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
N L L L+L N L I +L L+ L LS N +F L
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSF----LG 369
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182
L L L L N L + L L + L N +
Sbjct: 370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 25/138 (18%), Positives = 44/138 (31%), Gaps = 16/138 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPD--LSSLINLKSLSLSRNFFSGAFPLSIL-S 144
L L VL+L +L G + L +L+ L L N P S +
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 145 LHRLTILDLSYNNLT--------GLIPVNLTALD--RLYSLKLEWNRFSGTVP--PLNQP 192
+ R +LDL++N + + T L + + P
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
Query: 193 FLVVFNVSGNNLTGQVPE 210
+ ++SGN + +
Sbjct: 213 SITTLDLSGNGFKESMAK 230
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 28/126 (22%), Positives = 46/126 (36%), Gaps = 17/126 (13%)
Query: 91 PPNTLTRLD--QLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
T L+ ++ L + + + S +L+ L+L++N + AF
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAF---- 319
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNV 199
L L L+LS N L + LD+L L L +N + L P L +
Sbjct: 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELAL 378
Query: 200 SGNNLT 205
N L
Sbjct: 379 DTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 19/143 (13%), Positives = 40/143 (27%), Gaps = 23/143 (16%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNN-----------SLTGPIPDLSSLINLKSLSL 129
++ F + + VL L N + G L L ++ +
Sbjct: 141 IKKIQPASFF-----LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 130 SRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIP---VNLTALDRLYSLKLEWNRFSGTV 186
+ + + +T LDLS N + + A ++ SL L + G+
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 187 PPLNQ----PFLVVFNVSGNNLT 205
+ + +
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVK 278
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 107 HNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNL 166
N L +P+L + ++ + LS N + S L L L + +I N
Sbjct: 18 INRGLHQ-VPELPA--HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT 74
Query: 167 -TALDRLYSLKLEWNRFSGTVPP 188
L L LKL++N+F +
Sbjct: 75 FRGLSSLIILKLDYNQFL-QLET 96
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 3e-10
Identities = 34/157 (21%), Positives = 52/157 (33%), Gaps = 6/157 (3%)
Query: 28 ITNSLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLR 87
+ L + + S D + +K V L L
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL- 453
Query: 88 GTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
T + L +L + L L +N L P L++L L+ L S N ++ +L R
Sbjct: 454 -TVLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA--NLPR 509
Query: 148 LTILDLSYNNLTGLIPV-NLTALDRLYSLKLEWNRFS 183
L L L N L + L + RL L L+ N
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ G + + L +K + +++ E E +E + L HPN++ I
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F+ ++ + G L I S R K L ++ + + LAY H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIV-SAQARGKALSEGYVAELMKQMMNALAYFHSQH- 144
Query: 514 LIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSV--EDPDTVAYKAPEIRKSSRRA 568
++H +LK N+L ++ D+ L+ L S T Y APE+ K R
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDV 202
Query: 569 TSKSDVYAFGVLLLELLTGKHP 590
T K D+++ GV++ LLTG P
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 49/262 (18%), Positives = 97/262 (37%), Gaps = 30/262 (11%)
Query: 365 QTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDA 423
++F E + Y++ + S ++LG G G + +K
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY- 63
Query: 424 NKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ-AKGERLVIY---DYQPNGSLFNLIH 479
+ E H G P++V I ++ + + + G LF+
Sbjct: 64 -DSPKARQE--VDHHWQASG--GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS--- 115
Query: 480 GSRSIRAKPLHWTS---CLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEAR 533
I+ + + +I D+ + ++H + + H ++K N+L D +
Sbjct: 116 ---RIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-IAHRDVKPENLLYTSKEKDAVLK 171
Query: 534 LTDYCLSVLSDSSSVEDP-DTVAYKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP- 590
LTD+ + + ++++ P T Y APE+ KS D+++ GV++ LL G P
Sbjct: 172 LTDFGFAKETTQNALQTPCYTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGFPPF 229
Query: 591 -SQHPYLAPPDMLEWVRTMRVD 611
S P M +R +
Sbjct: 230 YSNTGQAISPGMKRRIRLGQYG 251
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 13/140 (9%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L+ L + L+L N++ I LS + NL+ LSL RN L + L L +S
Sbjct: 44 LSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKKIENLDAV-ADTLEELWIS 101
Query: 155 YNNLTGLIPVNLTALDRLYSLK---LEWNRFS--GTVPPLNQ-PFLVVFNVSGNNLTGQV 208
YN + +L+ +++L +L+ + N+ + G + L L ++GN L
Sbjct: 102 YNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY 156
Query: 209 PETPTLLKFDASSFSMNPNL 228
E ++ PNL
Sbjct: 157 KENNATSEYRIEVVKRLPNL 176
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 29/112 (25%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 98 LDQLRVLSLHN--NSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155
+ + LH + LS+L K L+LS N LS + L IL L
Sbjct: 22 ATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLS--GMENLRILSLGR 79
Query: 156 NNLTGLIPVNLTAL-DRLYSLKLEWNRFSGTVPPLNQ-PFLVVFNVSGNNLT 205
N + + NL A+ D L L + +N+ + ++ + + L V +S N +T
Sbjct: 80 NLIKKI--ENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-10
Identities = 23/89 (25%), Positives = 36/89 (40%), Gaps = 2/89 (2%)
Query: 93 NTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152
N LDQ + +N + + L LK+L ++ N +L LT L
Sbjct: 36 NLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94
Query: 153 LSYNNLTGLIPV-NLTALDRLYSLKLEWN 180
L+ N+L L + L +L L L + N
Sbjct: 95 LTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 27/116 (23%), Positives = 41/116 (35%), Gaps = 9/116 (7%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDL-SSLINLKSLSLSRNFFSGAFPLSILS-LHRLTILD 152
T + R L L + I +L ++L ++ S N L L RL L
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLL 70
Query: 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFS--GTVPPLNQ-PFLVVFNVSGNNLT 205
++ N + + AL L L L N G + PL L + N +T
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 21/105 (20%), Positives = 38/105 (36%), Gaps = 6/105 (5%)
Query: 103 VLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLI 162
++ L + ++ + + L L L +L + +D S N + L
Sbjct: 1 MVKLTAELIEQ-AAQYTNAVRDRELDLRGYKIPVIENLGA-TLDQFDAIDFSDNEIRKLD 58
Query: 163 PVNLTALDRLYSLKLEWNRFSGTVPPLNQ--PFLVVFNVSGNNLT 205
L RL +L + NR L+Q P L ++ N+L
Sbjct: 59 --GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 35/154 (22%), Positives = 64/154 (41%), Gaps = 19/154 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
HP L ++ FQ + +Y G LF + R + AE +
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAE-IVSA 260
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L Y+H +++ +LK N++L D ++TD+ L ++D T Y
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE----GIKDGATMKTFCGTPEYL 316
Query: 558 APEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APE+ + ++ D + GV++ E++ G+ P
Sbjct: 317 APEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 54/302 (17%), Positives = 106/302 (35%), Gaps = 38/302 (12%)
Query: 305 RRSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGS 364
RR + P+ + + + E K + + E + S
Sbjct: 19 RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGT--ENLYFQS 76
Query: 365 QTLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDA 423
+ Y + +++GRG + V VK +
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPK-------DVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 424 NKTADTSAEAFEQH---------MEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474
+ + E + V G HP+++ + +++ +++D G L
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAG--HPHIITLIDSYESSSFMFLVFDLMRKGEL 187
Query: 475 FNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEA 532
F+ + + S + I + + ++++H + ++H +LK N+LL + +
Sbjct: 188 FDYLTEKVALSEKE-------TRSIMRSLLEAVSFLHANN-IVHRDLKPENILLDDNMQI 239
Query: 533 RLTDYCLSV-LSDSSSVEDP-DTVAYKAPEIRKSSRRATSKS-----DVYAFGVLLLELL 585
RL+D+ S L + + T Y APEI K S T D++A GV+L LL
Sbjct: 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 586 TG 587
G
Sbjct: 300 AG 301
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 22/157 (14%)
Query: 444 LSHPNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIR-----AKPLHWTSCLKI 497
L HP LV + FQ + E + ++ D G L H +++ K L I
Sbjct: 72 LEHPFLVNLWYSFQDE-EDMFMVVDLLLGGDLRY--HLQQNVHFKEETVK-------LFI 121
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSSVEDPDTVA 555
E + L Y+ +IH ++K N+LL +TD+ ++ + ++ T
Sbjct: 122 CE-LVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 556 YKAPEI-RKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
Y APE+ S + D ++ GV ELL G+ P
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 26/95 (27%), Positives = 36/95 (37%), Gaps = 8/95 (8%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
T + L L VL L+NN + + + L+ L LS+N S
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELI-KDG 159
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKL 177
L +L +LDLS N L L +L L L
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 34/130 (26%), Positives = 49/130 (37%), Gaps = 22/130 (16%)
Query: 90 FPPNTLTRLDQLRVLSLHNNSLT--GPIPDLSSLINLKSLSLSRNFFS----GAFPLSIL 143
P T +L L +N+L+ + L NL SL LS N + AF +
Sbjct: 37 LPSYT-------ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF----V 85
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVS 200
+ L LDLS N+L L + L L L L N V + L +S
Sbjct: 86 PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 201 GNNLTGQVPE 210
N ++ + P
Sbjct: 145 QNQIS-RFPV 153
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 17/71 (23%), Positives = 24/71 (33%), Gaps = 4/71 (5%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLT----GPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLH 146
N + QL+ L L N ++ I D + L L L LS N + L
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP 187
Query: 147 RLTILDLSYNN 157
L +N
Sbjct: 188 AWVKNGLYLHN 198
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSIL-SLHR 147
PP + +LR + L NN ++ + L +L SL L N + P S+ L
Sbjct: 48 PPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFS 105
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP 188
L +L L+ N + L L L L L N+ T+
Sbjct: 106 LQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 25/97 (25%), Positives = 38/97 (39%), Gaps = 9/97 (9%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFS----GAFPLSIL 143
P+ L L L L+ N +T P L +L+ L L+ N + AF
Sbjct: 70 ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQ---- 125
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180
LH L +L L N L + + L + ++ L N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 42/210 (20%), Positives = 77/210 (36%), Gaps = 22/210 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEA---------VGGLS 445
+ GS G V + V +KR + + +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 446 HPNLVPIRAYFQAKGERLV--IYDYQP--NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
HPN++ +R F E + +Y L +IH + I P H +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-DQRIVISPQH---IQYFMYHI 143
Query: 502 AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKA 558
GL +H A ++H +L N+LL + + + D+ L+ D++ V Y+A
Sbjct: 144 LLGLHVLHEAG-VVHRDLHPGNILLADNNDITICDFNLA-REDTADANKTHYVTHRWYRA 201
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
PE+ + T D+++ G ++ E+ K
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 51/253 (20%), Positives = 95/253 (37%), Gaps = 25/253 (9%)
Query: 410 LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469
L +L F KT + ++ A+ L I + + V +
Sbjct: 114 LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV---EE 170
Query: 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD 529
+ S + L + + VA+G+ ++ + IH +L + N+LL
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK 229
Query: 530 FEARLTDYCLS--VLSDSSSVEDPDT---VAYKAPE-IRKSSRRATSKSDVYAFGVLLLE 583
++ D+ L+ + D V D + + APE I R T +SDV++FGVLL E
Sbjct: 230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWE 287
Query: 584 LLT-GKHPSQHPYLAPPDMLEWVRTMR-VDDG----REENRLGMLTEVASVCSLKSPEQR 637
+ + G PY P + R + +G + + + C P QR
Sbjct: 288 IFSLG----ASPY---PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340
Query: 638 PAMWQVLKMIQEI 650
P ++++ + +
Sbjct: 341 PTFSELVEHLGNL 353
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 47/213 (22%), Positives = 91/213 (42%), Gaps = 41/213 (19%)
Query: 397 LGRGSIGTTYKAVLDNHLI----VTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+G+G+ A H++ V +K D + TS + + + + L+HPN+V +
Sbjct: 23 IGKGNFAKVKLAR---HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQ------- 503
+ + +I +Y G +F+ + HG ++ E A+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHG---------------RMKEKEARSKFRQIV 124
Query: 504 -GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD-----SSSVEDPDTVAYK 557
+ Y H+ ++H +LK+ N+LL AD ++ D+ S + P Y
Sbjct: 125 SAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP---PYA 180
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
APE+ + + + DV++ GV+L L++G P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 60/310 (19%), Positives = 110/310 (35%), Gaps = 82/310 (26%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHP 447
++LG G+ G A + V VK + EA ++ + L SH
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHE 109
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC------------- 494
N+V + G +I++Y G L N + R ++
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 495 -----LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS--VLSDSSS 547
L A VA+G+ ++ S +H +L + NVL+ ++ D+ L+ ++SDS
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-- 226
Query: 548 VEDPDTVAYK------------APE-IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQH 593
Y APE + + T KSDV+++G+LL E+ + G +
Sbjct: 227 -------NYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGV----N 273
Query: 594 PYLAPPDMLEWVRTMR-VDDGREENRLG------------MLTEVASVCSLKSPEQRPAM 640
PY P + + + +G ++ M + C +RP+
Sbjct: 274 PY---PGIPVDANFYKLIQNG---FKMDQPFYATEEIYIIMQS-----CWAFDSRKRPSF 322
Query: 641 WQVLKMIQEI 650
+ +
Sbjct: 323 PNLTSFLGCQ 332
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 15/128 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
+ L ++Q L L+ +L+ +PD + + L +++N + P S L
Sbjct: 51 SLLKECL--INQFSELQLNRLNLSS-LPD-NLPPQITVLEITQNALI-SLPELPAS---L 102
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQV 208
LD N L+ L P +L L ++ N+ + +P L L N N LT +
Sbjct: 103 EYLDACDNRLSTL-PELPASLKHLD---VDNNQLT-MLPELPA-LLEYINADNNQLT-ML 155
Query: 209 PETPTLLK 216
PE PT L+
Sbjct: 156 PELPTSLE 163
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 23/132 (17%), Positives = 39/132 (29%), Gaps = 11/132 (8%)
Query: 93 NTLTRL----DQLRVLSLHNNSLTGPIPD-LSSLINLKS----LSLSRNFFSGAFPLSIL 143
N LT L + L L + N L +P + + N + P +IL
Sbjct: 170 NQLTFLPELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNN 203
SL + L N L+ I +L+ FS + N + +
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW 287
Query: 204 LTGQVPETPTLL 215
+ +
Sbjct: 288 FPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 27/136 (19%)
Query: 93 NTLTRL----DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
N L+ L L+ L + NN LT +P+L L+ ++ N + P L
Sbjct: 110 NRLSTLPELPASLKHLDVDNNQLTM-LPEL--PALLEYINADNNQLT-MLPELP---TSL 162
Query: 149 TILDLSYNNLTGL--IPVNLTALDRLYSLKLEWNRFSGTVPPL------NQPFLVVFNVS 200
+L + N LT L +P +L ALD + + LE ++P + ++ + F
Sbjct: 163 EVLSVRNNQLTFLPELPESLEALD-VSTNLLE------SLPAVPVRNHHSEETEIFFRCR 215
Query: 201 GNNLTGQVPETPTLLK 216
N +T +PE L
Sbjct: 216 ENRIT-HIPENILSLD 230
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 31/136 (22%), Positives = 47/136 (34%), Gaps = 25/136 (18%)
Query: 101 LRVLSLHNNSLTGP---IPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
L S +N +RN +++ + + L L+ N
Sbjct: 13 LSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN--QFSELQLNRLN 70
Query: 158 LTGL---IPVNLTALD--------------RLYSLKLEWNRFSGTVPPLNQPFLVVFNVS 200
L+ L +P +T L+ L L NR S T+P L L +V
Sbjct: 71 LSSLPDNLPPQITVLEITQNALISLPELPASLEYLDACDNRLS-TLPELP-ASLKHLDVD 128
Query: 201 GNNLTGQVPETPTLLK 216
N LT +PE P LL+
Sbjct: 129 NNQLT-MLPELPALLE 143
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRK 563
GL YIH A +IH +LK N+ + D E ++ D+ L+ +DS T Y+APE+
Sbjct: 140 GLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVIL 198
Query: 564 SSRRATSKSDVYAFGVLLLELLTGK 588
+ R T D+++ G ++ E++TGK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 7/91 (7%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP---DTVA---YK 557
GL YIH A+ ++H +LK SN+LL + ++ D+ L+ ++D + VA Y+
Sbjct: 140 GLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
APEI +S+ T D+++ G +L E+L+ +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 31/95 (32%), Positives = 37/95 (38%), Gaps = 16/95 (16%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
T P L L L + +N L +P L+NL L L RN F
Sbjct: 75 TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFD--- 130
Query: 143 LSLHRLTILDLSYNNLTGLIPVN----LTALDRLY 173
SL +LT L L YN L L P LT+L L
Sbjct: 131 -SLTKLTYLSLGYNELQSL-PKGVFDKLTSLKELR 163
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 28/92 (30%), Positives = 39/92 (42%), Gaps = 14/92 (15%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFF----SGAFPLSILS 144
P RL +LR+L L++N L +P L NL++L ++ N G F
Sbjct: 53 PSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQALPIGVFD----Q 107
Query: 145 LHRLTILDLSYNNLTGL---IPVNLTALDRLY 173
L L L L N L L + +LT L L
Sbjct: 108 LVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 30/96 (31%), Positives = 39/96 (40%), Gaps = 11/96 (11%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
PP L +L LSL N L +P L +LK L L N GAF
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFD----K 179
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180
L L L L N L + +L++L L+L+ N
Sbjct: 180 LTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 30/127 (23%), Positives = 45/127 (35%), Gaps = 29/127 (22%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFS----GAFPLSILSLH 146
P +LD L +N L+ L L+ L L+ N G F L
Sbjct: 36 PADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF----KELK 85
Query: 147 RLTILDLSYNNLTGL---IPVNLTALDRLYSLKLEWNRFSGTVPP-----LNQPFLVVFN 198
L L ++ N L L + L L L L+ N+ ++PP L + L +
Sbjct: 86 NLETLWVTDNKLQALPIGVFDQLVNLAELR---LDRNQLK-SLPPRVFDSLTK--LTYLS 139
Query: 199 VSGNNLT 205
+ N L
Sbjct: 140 LGYNELQ 146
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG+G+ + V L K + K + + E+ L HPN+V +
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
Q + +++D G LF I S + + + +AY H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILESIAYCHS- 123
Query: 512 SWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEIRKS 564
+ ++H NLK N+LL +L D+ L++ + S A Y +PE+ K
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLK- 180
Query: 565 SRRA-TSKSDVYAFGVLLLELLTGKHP 590
+ + D++A GV+L LL G P
Sbjct: 181 -KDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 445 SHPNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
+HP LV + + FQ + RL + +Y G L + R + + + AE ++
Sbjct: 68 NHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAE-ISL 121
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
L Y+H +I+ +LK NVLL ++ +LTDY + + D T Y
Sbjct: 122 ALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKE----GLRPGDTTSTFCGTPNY 176
Query: 557 KAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APEI + S D +A GVL+ E++ G+ P
Sbjct: 177 IAPEILR--GEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG G+ G ++ V + K + D + + + L HP L+ +
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLH 114
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWT--SCLKIAEDVAQGLAYIHRA 511
F+ K E ++I ++ G LF+ I A+ + + +GL ++H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDR------IAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 512 SWLIHGNLKSSNVLLGADFEARL--TDYCLSVLSDSSSV--EDPDTVAYKAPEIRKSSRR 567
S ++H ++K N++ + + D+ L+ + + T + APEI
Sbjct: 169 S-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD-REP 226
Query: 568 ATSKSDVYAFGVLLLELLTGKHP 590
+D++A GVL LL+G P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 35/214 (16%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTS------AEAFEQHMEAVGGLSHP 447
+ LG G+ G A V +K K A S A E +E + L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGL 505
++ I+ +F A+ +V+ + G LF+ + + C + +
Sbjct: 76 CIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEAT-------CKLYFYQMLLAV 127
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEA---RLTDYCLSVLSDSSSVEDPD-------TVA 555
Y+H +IH +LK NVLL + E ++TD+ S + + + T
Sbjct: 128 QYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-----LGETSLMRTLCGTPT 181
Query: 556 YKAPEIRKSSRRA--TSKSDVYAFGVLLLELLTG 587
Y APE+ S A D ++ GV+L L+G
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRK 563
GL YIH A ++H +LK N+ + D E ++ D+ L+ +D+ T Y+APE+
Sbjct: 138 GLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL 196
Query: 564 SSRRATSKSDVYAFGVLLLELLTGK 588
S D+++ G ++ E+LTGK
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
P L + + FQ + +Y G L I + + AE +A G
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAE-IAIG 454
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L ++ +I+ +LK NV+L ++ ++ D+ + ++ D T Y
Sbjct: 455 LFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKE----NIWDGVTTKTFCGTPDYI 509
Query: 558 APEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APEI + KS D +AFGVLL E+L G+ P
Sbjct: 510 APEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 6/138 (4%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLT 149
+ + L +LR+L + +N + L+ L LS N +S L
Sbjct: 37 WTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLK 93
Query: 150 ILDLSYNNLTGL-IPVNLTALDRLYSLKLEWNRF-SGTVPPLNQPFLVVFNVSGNNLTGQ 207
LDLS+N L I + +L L L +V P+ + + G+
Sbjct: 94 HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153
Query: 208 VPETPTLLKFDASSFSMN 225
+ L F+ S +
Sbjct: 154 KEDPEGLQDFNTESLHIV 171
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 27/133 (20%), Positives = 53/133 (39%), Gaps = 11/133 (8%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGP---IPDLSSLINLKSLSLSRNFFSGAFPLSI 142
L + T L L + + ++ P I ++ S +N+K+ ++S S
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF-----LVVF 197
+S LD S N LT + N L L +L L+ N+ + + + L
Sbjct: 323 IS--PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379
Query: 198 NVSGNNLTGQVPE 210
++S N+++ +
Sbjct: 380 DISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 20/97 (20%), Positives = 35/97 (36%), Gaps = 2/97 (2%)
Query: 86 LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSL 145
+ + L L++ +N LT I +K L L N + P ++ L
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLHSNKIK-SIPKQVVKL 443
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182
L L+++ N L + L L + L N +
Sbjct: 444 EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 29/122 (23%), Positives = 46/122 (37%), Gaps = 11/122 (9%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLSS----LINLKSLSLSRNFFSGAFPLSILS-L 145
L +L L L N L + ++ + +L+ L +S+N S S
Sbjct: 340 VFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNN 203
L L++S N LT I L + L L N+ ++P + L NV+ N
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455
Query: 204 LT 205
L
Sbjct: 456 LK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 23/118 (19%), Positives = 37/118 (31%), Gaps = 3/118 (2%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS-LHR 147
+ +L L L +N L I +NLK L LS N F + +
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLVK-IS-CHPTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205
L L LS +L + + L+ L + + P ++ T
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 19/114 (16%), Positives = 35/114 (30%), Gaps = 6/114 (5%)
Query: 97 RLDQLRVLSLHNNSLT--GPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L+ L L N+ + ++ LK L LS + L I L+ +L +
Sbjct: 88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNLTG 206
+ L + L + L+ V N+ +N+
Sbjct: 148 GETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 32/153 (20%), Positives = 50/153 (32%), Gaps = 30/153 (19%)
Query: 103 VLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLI 162
++ N L DLS L++S+N+ S + ILSL +L IL +S+N + L
Sbjct: 4 LVDRSKNGLIHVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 163 P------VNLTAL------------DRLYSLK---LEWNRFSGTVPPLNQPF-----LVV 196
L L +LK L +N F P+ + F L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAF--DALPICKEFGNMSQLKF 119
Query: 197 FNVSGNNLTGQVPETPTLLKFDASSFSMNPNLC 229
+S +L L +
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 27/220 (12%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHME 439
+E Y L E LG+G+ + V + + K + + E+
Sbjct: 10 TEEYQLF-------EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKI 497
L HPN+V + +G +I+D G LF I S
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD-------ASHC 115
Query: 498 AEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDTV 554
+ + + + + H+ ++H NLK N+LL +L D+ L++ +
Sbjct: 116 IQQILEAVLHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 555 ---AYKAPEIRKSSRRA-TSKSDVYAFGVLLLELLTGKHP 590
Y +PE+ + + D++A GV+L LL G P
Sbjct: 175 GTPGYLSPEVLR--KDPYGKPVDLWACGVILYILLVGYPP 212
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 20/154 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+HP LV + + FQ + + +Y G L + R + + + AE ++
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAE-ISLA 165
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L Y+H +I+ +LK NVLL ++ +LTDY + + D T Y
Sbjct: 166 LNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKE----GLRPGDTTSTFCGTPNYI 220
Query: 558 APEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APEI + S D +A GVL+ E++ G+ P
Sbjct: 221 APEILR--GEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 446 HPNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
P LV + FQ + +L +I DY G LF H S+ R + + E +
Sbjct: 118 SPFLVTLHYAFQTE-TKLHLILDYINGGELFT--HLSQRERFTEHE--VQIYVGE-IVLA 171
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--------TVAY 556
L ++H+ +I+ ++K N+LL ++ LTD+ LS V D T+ Y
Sbjct: 172 LEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEF----VADETERAYDFCGTIEY 226
Query: 557 KAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
AP+I + K+ D ++ GVL+ ELLTG P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 7e-09
Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 22/155 (14%)
Query: 445 SHPNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
+HP L + FQ +RL + ++ G L I SR + AE +
Sbjct: 82 NHPFLTQLFCCFQTP-DRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAAE-IIS 135
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
L ++H +I+ +LK NVLL + +L D+ + + + T Y
Sbjct: 136 ALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKE----GICNGVTTATFCGTPDY 190
Query: 557 KAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APEI + + D +A GVLL E+L G P
Sbjct: 191 IAPEILQ--EMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 21/159 (13%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+ + FQ + ++ +Y G L L+ S+ P + +AE +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-ARFYLAE-IVMA 174
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED-----PDTVAYK 557
+ +HR +H ++K N+LL RL D+ CL + +D + PD Y
Sbjct: 175 IDSVHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD---YL 230
Query: 558 APEIRKSSRRATSKS------DVYAFGVLLLELLTGKHP 590
+PEI ++ D +A GV E+ G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 43/212 (20%), Positives = 82/212 (38%), Gaps = 28/212 (13%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVK----RFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
E LG G K L K R E E+ + + + HPN+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+ + ++ + + ++I + G LF+ + S S + + G+ Y
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFIKQILDGVNY 130
Query: 508 IHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSV-LSDSSSVED----PDTVAYKA 558
+H + H +LK N++L +L D+ L+ + D ++ P+ + A
Sbjct: 131 LHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE---FVA 186
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
PEI ++D+++ GV+ LL+G P
Sbjct: 187 PEIVN-YEPLGLEADMWSIGVITYILLSGASP 217
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 27/139 (19%), Positives = 46/139 (33%), Gaps = 17/139 (12%)
Query: 64 CQWQGVKCAQGR-----------VVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLT 112
C+ V C+ + L + +L QLR ++ NN +T
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 113 GPIPD--LSSLINLKSLSLSRNFFSGAFPLSIL-SLHRLTILDLSYNNLTGLIPVNLTAL 169
I + + + L+ N + L L L L N +T + + L
Sbjct: 71 D-IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL 128
Query: 170 DRLYSLKLEWNRFSGTVPP 188
+ L L N+ + TV P
Sbjct: 129 SSVRLLSLYDNQIT-TVAP 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 12/93 (12%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFS----GAFPLSIL 143
+ + L +N L L +LK+L L N + +F
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFI---- 126
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLK 176
L + +L L N +T + P A D L+SL
Sbjct: 127 GLSSVRLLSLYDNQITTVAP---GAFDTLHSLS 156
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+ + FQ ++ DY G L L+ S+ P + +AE +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEM-ARFYLAE-MVIA 187
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSDSSSVED-----PDTVAYK 557
+ +H+ +H ++K N+L+ + RL D+ CL ++ D + PD Y
Sbjct: 188 IDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD---YI 243
Query: 558 APEIRKSSRRATSK----SDVYAFGVLLLELLTGKHP 590
+PEI ++ + D ++ GV + E+L G+ P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
P L + + FQ + +Y G L I + + AE +A G
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAE-IAIG 133
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L ++ +I+ +LK NV+L ++ ++ D+ + ++ D T Y
Sbjct: 134 LFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKE----NIWDGVTTKTFCGTPDYI 188
Query: 558 APEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APEI + KS D +AFGVLL E+L G+ P
Sbjct: 189 APEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 54/291 (18%), Positives = 104/291 (35%), Gaps = 53/291 (18%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHME 439
+ Y L + LG GS K V ++ VK A+T E ++
Sbjct: 7 YQHYDL----DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI--TALK 60
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIR-AKPLHWTSCLK 496
G HPN+V + F + ++ + G LF I S A
Sbjct: 61 LCEG--HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------Y 110
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDT 553
I + ++++H ++H +LK N+L + E ++ D+ + L +
Sbjct: 111 IMRKLVSAVSHMHDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 554 V---AYKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP-----SQHPYLAPPDMLEW 604
Y APE+ + +S D+++ GV+L +L+G+ P + ++++
Sbjct: 170 CFTLHYAAPELLN--QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK 227
Query: 605 VRTMRVD-DGREENRL---------GMLTEVASVCSLKSPEQRPAMWQVLK 645
++ +G + G+LT P +R M +
Sbjct: 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLT--------VDPNKRLKMSGLRY 270
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 26/160 (16%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIY---DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAED 500
L HPN+V + E +Y + G + + KPL +D
Sbjct: 93 LDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQD 145
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------- 552
+ +G+ Y+H +IH ++K SN+L+G D ++ D+ +S + D
Sbjct: 146 LIKGIEYLHYQK-IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-----KGSDALLSNTVG 199
Query: 553 TVAYKAPEIRKSSRRATS--KSDVYAFGVLLLELLTGKHP 590
T A+ APE +R+ S DV+A GV L + G+ P
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 46/207 (22%), Positives = 82/207 (39%), Gaps = 26/207 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+GRGS G AV + K+ D + F+Q +E + L HPN++ +
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIR-AKPLHWTSCLKIAEDVAQGLAYIHR 510
F+ + ++ + G LF + A +I +DV +AY H+
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHK 124
Query: 511 ASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEIRK 563
+ + H +LK N L D +L D+ L+ + T Y +P++ +
Sbjct: 125 LN-VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQVLE 181
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHP 590
+ D ++ GV++ LL G P
Sbjct: 182 --GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 38/155 (24%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+ +V + ++ K ++ G L I+ + AE + G
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--AVFYAAE-ICCG 298
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---------TVA 555
L +HR +++ +LK N+LL R++D L+V P+ TV
Sbjct: 299 LEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAV-------HVPEGQTIKGRVGTVG 350
Query: 556 YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APE+ K+ R S D +A G LL E++ G+ P
Sbjct: 351 YMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 33/153 (21%), Positives = 60/153 (39%), Gaps = 14/153 (9%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+V + F+ K + ++ G + I+ + A+ + G
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSG 301
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L ++H+ + +I+ +LK NVLL D R++D L+V T +
Sbjct: 302 LEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVEL----KAGQTKTKGYAGTPGFM 356
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
APE+ S D +A GV L E++ + P
Sbjct: 357 APELLLGEEYDFS-VDYFALGVTLYEMIAARGP 388
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 30/129 (23%), Positives = 43/129 (33%), Gaps = 24/129 (18%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRN----FFSGAFPLSILS 144
+ +L+VL L + I D SL +L +L L+ N GAF
Sbjct: 44 GSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAF----SG 98
Query: 145 LHRLTILDLSYNNLTGLIPV---NLTALDRLYSLKLEWNRFSGTVPPLNQPF-----LVV 196
L L L NL L +L L L + N L + F L
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELN---VAHNLI--QSFKLPEYFSNLTNLEH 153
Query: 197 FNVSGNNLT 205
++S N +
Sbjct: 154 LDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 28/110 (25%), Positives = 46/110 (41%), Gaps = 16/110 (14%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDL-SSLINLKSLSLSRNFFS----GAFPLSI 142
+ + L L+ L++ +N + +P+ S+L NL+ L LS N
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR--- 170
Query: 143 LSLHRLTI----LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP 188
LH++ + LDLS N + I RL L L+ N+ +VP
Sbjct: 171 -VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPD 217
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 20/108 (18%), Positives = 34/108 (31%), Gaps = 19/108 (17%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFF----SGAFPLSILS 144
L L L L N + + S L +L+ L +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIG----H 122
Query: 145 LHRLTILDLSYNNLTGLIP----VNLTALDRLYSLKLEWNRFSGTVPP 188
L L L++++N + NLT L+ L L N+ ++
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD---LSSNKIQ-SIYC 166
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 28/105 (26%), Positives = 36/105 (34%), Gaps = 11/105 (10%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLK----SLSLSRNFFS 135
+QSF L F + L L L L +N + DL L + SL LS N +
Sbjct: 136 IQSFKLPEYF-----SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 136 GAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180
RL L L N L + L L + L N
Sbjct: 191 -FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 24/91 (26%), Positives = 34/91 (37%), Gaps = 20/91 (21%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFS----GAFPLSILSL 145
P + LD L N L + S L+ L LSR GA+ SL
Sbjct: 27 PFSTKNLD------LSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAY----QSL 75
Query: 146 HRLTILDLSYNNLTGL---IPVNLTALDRLY 173
L+ L L+ N + L L++L +L
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 34/212 (16%), Positives = 78/212 (36%), Gaps = 36/212 (16%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSA---EAFEQHMEAVGGLSHPNLVP 451
E LGRG G ++ V + K + K ++ + + H N++
Sbjct: 11 EDLGRGEFGIVHRCV---E-TSSKKTY-MAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWT--SCLKIAEDVAQGLAYIH 509
+ F++ E ++I+++ +F I + V + L ++H
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFE------RINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 510 RASWLIHGNLKSSNVLLGADFEARL--TDYCLSVLSDSSSVEDPDTVA--------YKAP 559
+ + H +++ N++ + + ++ + P Y AP
Sbjct: 120 SHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ------LKPGDNFRLLFTAPEYYAP 172
Query: 560 EIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
E+ + S + D+++ G L+ LL+G +P
Sbjct: 173 EVHQ--HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 44/226 (19%), Positives = 84/226 (37%), Gaps = 35/226 (15%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVK----RFDANKTADTSAEAFE 435
+ Y + E LG G K L K R S E E
Sbjct: 11 EDFYDIG-------EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTS 493
+ + + + H N++ + ++ + + ++I + G LF+ + S S
Sbjct: 64 REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------- 116
Query: 494 CLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSV-LSDSSSV 548
+ + G+ Y+H H +LK N++L +L D+ L+ + D
Sbjct: 117 ATSFIKQILDGVNYLHTKKI-AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 549 ED----PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
++ P+ + APEI ++D+++ GV+ LL+G P
Sbjct: 176 KNIFGTPE---FVAPEIVN-YEPLGLEADMWSIGVITYILLSGASP 217
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
+HP +V + FQ +G+ +I D+ G LF + + +AE +A
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE----DVKFYLAE-LALA 138
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L ++H +I+ +LK N+LL + +LTD+ LS S ++ TV Y
Sbjct: 139 LDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKES----IDHEKKAYSFCGTVEYM 193
Query: 558 APEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APE+ RR ++S D ++FGVL+ E+LTG P
Sbjct: 194 APEVVN--RRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 47/300 (15%), Positives = 110/300 (36%), Gaps = 49/300 (16%)
Query: 306 RSSEGRNSKEPSTASFNEGTTYPEPESSRTANTTQVGECKIKVETKANKVQVEEMAIGSQ 365
+S + ++ + + + + + V+ A + + +
Sbjct: 22 QSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTA- 80
Query: 366 TLIKRSGSLVFCAGESEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDAN 424
+ G++ + Y++ + E+LG G G +K L + K
Sbjct: 81 ----KQGAV------NSFYTVSKT-----EILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 425 KTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI 484
D E + + + L H NL+ + F++K + +++ +Y G LF+ I
Sbjct: 126 GMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD------RI 177
Query: 485 RAKPLHWT--SCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL--TDYCLS 540
+ + T + + + +G+ ++H+ ++H +LK N+L ++ D+ L+
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 541 VLSDSSSVEDPDTVA--------YKAPEI--RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
P + APE+ + +D+++ GV+ LL+G P
Sbjct: 237 R------RYKPREKLKVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSSSVEDP---DTVA---Y 556
GL YIH A+ ++H +LK +N+ + D ++ D+ L+ + D + + Y
Sbjct: 132 GLKYIHSAN-VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 557 KAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
++P + S T D++A G + E+LTGK
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 26/157 (16%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAEDV 501
HP L + FQ K + +Y G L I RA AE +
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT-------FYAAE-I 127
Query: 502 AQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TV 554
GL ++H +++ +LK N+LL D ++ D+ + ++ T
Sbjct: 128 ILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKE----NMLGDAKTNTFCGTP 182
Query: 555 AYKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
Y APEI + + S D ++FGVLL E+L G+ P
Sbjct: 183 DYIAPEILL--GQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 28/125 (22%), Positives = 44/125 (35%), Gaps = 14/125 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFP--LSILS 144
++ L ++ + + N I L L LK L + FP + S
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
Query: 145 LHRLTILDLSYNNLTGLIPVN----LTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFN 198
IL+++ N IPVN L +LKL N F+ +V N L
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185
Query: 199 VSGNN 203
++ N
Sbjct: 186 LNKNK 190
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 22/155 (14%), Positives = 47/155 (30%), Gaps = 24/155 (15%)
Query: 91 PPNTLTRLDQLRVLSL-HNNSLTGPIPD--LSSLINLKSLSLSRNFF-----SGAFPLSI 142
P + + L + + + + +L + +L + + + A
Sbjct: 47 PSHAFSNLPNISRIYVSIDVTLQQ-LESHSFYNLSKVTHIEIRNTRNLTYIDPDAL---- 101
Query: 143 LSLHRLTILDLSYNNLTGLIPVN-LTALDRLYSLKLEWNRFSGTVPPLNQPF------LV 195
L L L + L + + + D + L++ N + ++P F +
Sbjct: 102 KELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPV--NAFQGLCNETL 159
Query: 196 VFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPNLC 229
+ N T V K DA + N L
Sbjct: 160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 24/125 (19%), Positives = 47/125 (37%), Gaps = 13/125 (10%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPDLS---SLINLKSLSLSRNFFSGAFPLSILS--L 145
P+ L L L+ L + N L PDL+ S L ++ N + + P++
Sbjct: 97 DPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
Query: 146 HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP-----LNQPFLVVFNVS 200
+ L L N T + +L ++ L N++ + + + +VS
Sbjct: 156 NETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS-GPSLLDVS 213
Query: 201 GNNLT 205
++T
Sbjct: 214 QTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 17/114 (14%), Positives = 37/114 (32%), Gaps = 15/114 (13%)
Query: 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFF----SGAFPLSILSLHRLTILDLSY 155
Q + + IP L + ++L L S AF +L ++ + +S
Sbjct: 12 QEEDFRVTCKDIQR-IPSLPP--STQTLKLIETHLRTIPSHAFS----NLPNISRIYVSI 64
Query: 156 NNLTGLIPVNL-TALDRLYSLKLEWNRFSGTVPP---LNQPFLVVFNVSGNNLT 205
+ + + L ++ +++ R + P P L + L
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 5/89 (5%)
Query: 91 PPNTLTRL-DQLRVLSLHNNSLTGPIPDLS-SLINLKSLSLSRNFFSGAFPLSILS--LH 146
P N L ++ L L+NN T + + + L ++ L++N +
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSL 175
++LD+S ++T L L L L +
Sbjct: 206 GPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRK 563
GL YIH A +IH +LK SN+ + D E ++ D+ L+ + T Y+APEI
Sbjct: 144 GLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIML 202
Query: 564 SSRRATSKSDVYAFGVLLLELLTGK 588
+ D+++ G ++ ELLTG+
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 23/207 (11%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG+G+ + V L K + K + + E+ L HPN+V +
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
Q + +++D G LF I S + + + +AY H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILESIAYCHSN 147
Query: 512 SWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEIRKS 564
++H NLK N+LL +L D+ L++ + S A Y +PE+ K
Sbjct: 148 G-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLK- 203
Query: 565 SRRA-TSKSDVYAFGVLLLELLTGKHP 590
+ + D++A GV+L LL G P
Sbjct: 204 -KDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 25/206 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LGRG+ Y+ +K KT D + + + LSHPN++ ++
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
F+ E ++ + G LF+ I G S R + + + +AY+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERD-------AADAVKQILEAVAYLHEN 167
Query: 512 SWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDTVA----YKAPEIRKS 564
++H +LK N+L D ++ D+ LS + + + TV Y APEI +
Sbjct: 168 G-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILR- 223
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP 590
+ D+++ G++ LL G P
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 19/126 (15%), Positives = 40/126 (31%), Gaps = 15/126 (11%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRN-----FFSGAFPLSIL 143
+ L + + N + I S+L L + + + AF
Sbjct: 46 QKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF----Q 101
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLN----QPFLVVFNV 199
+L L L +S + L V+ + L ++ N T+ + V+ +
Sbjct: 102 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 200 SGNNLT 205
+ N +
Sbjct: 162 NKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 20/128 (15%), Positives = 37/128 (28%), Gaps = 17/128 (13%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLS--SLINLKSLSLSRNFF-----SGAF-PL 140
P L L+ L + N + +PD+ + L + N +F L
Sbjct: 94 YINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152
Query: 141 SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP---LNQPFLVVF 197
S IL L+ N + + + N +P V+
Sbjct: 153 S----FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVIL 207
Query: 198 NVSGNNLT 205
++S +
Sbjct: 208 DISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 22/121 (18%), Positives = 39/121 (32%), Gaps = 16/121 (13%)
Query: 90 FPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFSGAFPLSILS-LH 146
P N L L I S +L+ + +S+N + S L
Sbjct: 28 LPRNA-------IELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 147 RLTILDLS-YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGN 202
+L + + NNL + P L L L + +P + + V+ ++ N
Sbjct: 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 203 N 203
Sbjct: 139 I 139
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 22/108 (20%), Positives = 36/108 (33%), Gaps = 13/108 (12%)
Query: 89 TFPPNTLTRL-DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRN-----FFSGAFPLSI 142
T N+ L + +L L+ N + + L L+LS N + F
Sbjct: 143 TIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFH--- 199
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLN 190
ILD+S + L L L +L + + +P L
Sbjct: 200 -GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLE 243
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 11/68 (16%), Positives = 20/68 (29%), Gaps = 7/68 (10%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
P + +L + + +P L +L L++ S L L
Sbjct: 194 PNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTL----EKLVAL 248
Query: 149 TILDLSYN 156
L+Y
Sbjct: 249 MEASLTYP 256
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 34/154 (22%), Positives = 64/154 (41%), Gaps = 20/154 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
HP L ++ FQ + +Y G LF + R + + AE +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGAE-IVSA 117
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L Y+H +++ ++K N++L D ++TD+ L + D T Y
Sbjct: 118 LEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATMKTFCGTPEYL 172
Query: 558 APEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APE+ + ++ D + GV++ E++ G+ P
Sbjct: 173 APEVLE--DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)
Query: 445 SHPNLVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSRSI---RAKPLHWTSCLKIAED 500
HP LV + FQ ++L + DY G LF + R RA+ AE
Sbjct: 97 KHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYHLQRERCFLEPRAR-------FYAAE- 147
Query: 501 VAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------T 553
+A L Y+H + +++ +LK N+LL + LTD+ L + +E T
Sbjct: 148 IASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKEN----IEHNSTTSTFCGT 202
Query: 554 VAYKAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
Y APE+ ++ ++ D + G +L E+L G P
Sbjct: 203 PEYLAPEVLH--KQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGA-------DFE-ARLTDYCLSVLSDSSSVEDPDT-- 553
+ +H ++ +IH +LK SN+L+ + DF AR+ D + S+ + +
Sbjct: 124 AVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 554 VA---YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
VA Y+APE+ +S + + DV++ G +L EL +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
HP +V + FQ G+ +I +Y G LF + T+C +AE ++
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED----TACFYLAE-ISMA 133
Query: 505 LAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYK 557
L ++H+ +I+ +LK N++L +LTD+ L S + D T+ Y
Sbjct: 134 LGHLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKES----IHDGTVTHTFCGTIEYM 188
Query: 558 APEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APEI R +++ D ++ G L+ ++LTG P
Sbjct: 189 APEILM--RSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 43/226 (19%), Positives = 87/226 (38%), Gaps = 35/226 (15%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVK----RFDANKTADTSAEAFE 435
+ Y E LG G K L K R + S E E
Sbjct: 10 DDYYDTG-------EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTS 493
+ + + + HPN++ + ++ K + ++I + G LF+ + S +
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE------- 115
Query: 494 CLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSV-LSDSSSV 548
+ + + G+ Y+H + H +LK N++L ++ D+ L+ + +
Sbjct: 116 ATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 549 ED----PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
++ P+ + APEI ++D+++ GV+ LL+G P
Sbjct: 175 KNIFGTPE---FVAPEIVN-YEPLGLEADMWSIGVITYILLSGASP 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 45/214 (21%), Positives = 88/214 (41%), Gaps = 33/214 (15%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRF-----DANKTADTSAEAFEQHMEAVGGLSHPN 448
+ G+G+ GT + V +K+ N+ Q M+ + L HPN
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL--------QIMQDLAVLHHPN 80
Query: 449 LVPIRAYFQAKGER-------LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
+V +++YF GER V+ +Y P+ +L + R +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR-NYYRRQVAPPPILIKVFLFQL 138
Query: 502 AQGLAYIHRASW-LIHGNLKSSNVLL-GADFEARLTDYCL--SVLSDSSSVEDPDTVA-- 555
+ + +H S + H ++K NVL+ AD +L D+ + +V +
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---YICSR 195
Query: 556 -YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
Y+APE+ ++ T+ D+++ G + E++ G+
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 46/263 (17%), Positives = 79/263 (30%), Gaps = 84/263 (31%)
Query: 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFE----QHMEAVGGLSHPN--- 448
LG G T + + + V +K + + T E + + + PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVRN-SDPNDPNREM 102
Query: 449 LVPIRAYFQAKGERLVIYDYQPNG------------SLFNLIHGSRSIRAKPLHWTSCLK 496
+V + F+ G NG L I S + L K
Sbjct: 103 VVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKK 150
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD--------------------------- 529
I + V QGL Y+H +IH ++K N+LL +
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 530 ----------------------FEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRR 567
+ ++ D + ED T Y++ E+ S
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270
Query: 568 ATSKSDVYAFGVLLLELLTGKHP 590
T +D+++ + EL TG +
Sbjct: 271 NTP-ADIWSTACMAFELATGDYL 292
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 31/147 (21%), Positives = 54/147 (36%), Gaps = 18/147 (12%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
++ L +LRVL L +N + + +L+ L +S N +S + L
Sbjct: 68 RMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASL 123
Query: 149 TILDLSYNNLTGLIPV----NLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNL 204
LDLS+N+ L NLT L L L +F + L L + + + +
Sbjct: 124 RHLDLSFNDFDVLPVCKEFGNLTKLTFLG---LSAAKFR-QLDLLPVAHLHLSCILLDLV 179
Query: 205 TGQVPETPT----LLKFDASSFSMNPN 227
+ + T + +PN
Sbjct: 180 SYHIKGGETESLQIPNTTVLHLVFHPN 206
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 25/134 (18%), Positives = 46/134 (34%), Gaps = 8/134 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHR 147
+ ++ + L + + S + L+ ++N F+ + +L R
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378
Query: 148 LTILDLSYNNLTGLIPV--NLTALDRLYSLKLEWNRFSGTVPPLN---QPFLVVFNVSGN 202
L L L N L V + L +L + N + ++V N+S N
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438
Query: 203 NLTGQVPE--TPTL 214
LTG V P +
Sbjct: 439 MLTGSVFRCLPPKV 452
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 32/124 (25%), Positives = 46/124 (37%), Gaps = 25/124 (20%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFS----GAFPLSILSLH 146
P L L NS++ +PD+S L L+ L LS N F L
Sbjct: 51 PPRTKALS------LSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVF----LFNQ 100
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF-----LVVFNVSG 201
L LD+S+N L + + +L L L +N F V P+ + F L +S
Sbjct: 101 DLEYLDVSHNRLQNISCCPMASLRHLD---LSFNDF--DVLPVCKEFGNLTKLTFLGLSA 155
Query: 202 NNLT 205
Sbjct: 156 AKFR 159
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 5/79 (6%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
+ + VL+L +N LTG + +K L L N + P + L L L+++ N
Sbjct: 427 AESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 158 LTGLIPVNLTALDRLYSLK 176
L +P DRL SL+
Sbjct: 485 LKS-VPDG--VFDRLTSLQ 500
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/186 (14%), Positives = 54/186 (29%), Gaps = 9/186 (4%)
Query: 29 TNSLLPSDA-VSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLR 87
NSL +S+ + S KL +R + + V +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 88 GTFPPNTLTRLDQLRVLSLHNNSLTGPIP------DLSSLINLKSLSLSRNFFSGAFPLS 141
+ + L+++N ++T I ++L +L + F +
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 142 ILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP--PLNQPFLVVFNV 199
+ I LS ++ + V + L N F+ +V L +
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 200 SGNNLT 205
N L
Sbjct: 385 QRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 26/142 (18%), Positives = 50/142 (35%), Gaps = 8/142 (5%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL--SLH 146
+ + L L + +N L I + +L+ L LS N F P+ +L
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRLQN-ISC-CPMASLRHLDLSFNDFD-VLPVCKEFGNLT 146
Query: 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206
+LT L LS L +L + L+ + + S + L + N + +L
Sbjct: 147 KLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 207 QVPETPTLLKFDASSFSMNPNL 228
++ + + + L
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQL 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 42/223 (18%), Positives = 88/223 (39%), Gaps = 35/223 (15%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVK----RFDANKTADTSAEAFE 435
+ Y + E LG G K K R ++ S E E
Sbjct: 4 EDHYEMG-------EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE 56
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTS 493
+ + + + HPN++ + F+ K + ++I + G LF+ + S +
Sbjct: 57 REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE------- 109
Query: 494 CLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSV-LSDSSSV 548
+ + + G+ Y+H + H +LK N++L + +L D+ ++ + +
Sbjct: 110 ATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168
Query: 549 ED----PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTG 587
++ P+ + APEI ++D+++ GV+ LL+G
Sbjct: 169 KNIFGTPE---FVAPEIVN-YEPLGLEADMWSIGVITYILLSG 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 26/207 (12%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIR 453
E +G GS + + H T F A K D S + +E + HPN++ ++
Sbjct: 28 EDIGVGSYSVCKRCI---H-KATNMEF-AVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ V+ + G L + I S R + + + + Y+H
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE-------ASAVLFTITKTVEYLHAQ 135
Query: 512 SWLIHGNLKSSNVLLGADFEA----RLTDYCLSVL--SDSSSVEDP-DTVAYKAPEIRKS 564
++H +LK SN+L + R+ D+ + +++ + P T + APE+ +
Sbjct: 136 G-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE- 193
Query: 565 SRRATSKS-DVYAFGVLLLELLTGKHP 590
R+ + D+++ GVLL +LTG P
Sbjct: 194 -RQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/231 (19%), Positives = 87/231 (37%), Gaps = 37/231 (16%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHME 439
+VY L ++LG G+ + L VK + K + +E
Sbjct: 11 EDVYQL------QEDVLGEGAHARVQTCINLITSQEYAVKIIE--KQPGHIRSRVFREVE 62
Query: 440 AVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIH--GSRSIRAKPLHWTSCLK 496
+ H N++ + +F+ + ++++ GS+ + IH +
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE-------ASV 115
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDT 553
+ +DVA L ++H + H +LK N+L ++ D+ L + P +
Sbjct: 116 VVQDVASALDFLHNKG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 554 VA----------YKAPEIRKSSRRATS----KSDVYAFGVLLLELLTGKHP 590
Y APE+ ++ S + D+++ GV+L LL+G P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 43/218 (19%), Positives = 80/218 (36%), Gaps = 38/218 (17%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHME--------AVGGLS 445
LLG+G GT + L + L V +K N+ S + G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 446 HPNLVPIRAYFQAKGERLVIYDY-QPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVA 502
HP ++ + +F+ + +++ + P LF+ I G + E +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---------------PLGEGPS 141
Query: 503 --------QGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSSVEDPD- 552
+ + H ++H ++K N+L+ A+L D+ L D D
Sbjct: 142 RCFFGQVVAAIQHCHSRG-VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDG 200
Query: 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
T Y PE + + V++ G+LL +++ G P
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 36/164 (21%)
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ- 503
+ P +V + FQ ++ +Y P G L NL+ S + E A+
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARF 172
Query: 504 -------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY--CLSVLSD-----SSSVE 549
L IH IH ++K N+LL +L D+ C+ + + ++V
Sbjct: 173 YTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 550 DPDTVAYKAPEI--RKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
PD Y +PE+ + + D ++ GV L E+L G P
Sbjct: 232 TPD---YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 15/207 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANK---TADTSAEAFEQHMEAVGGLSHPNLV 450
E++G+G + + + VK D K + S E ++ L HP++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ + + G +++++ L I R+ + + L Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 511 ASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDTV---AYKAPEIRKS 564
+ +IH ++K VLL +L + +++ S + V + APE+ K
Sbjct: 149 NN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK- 206
Query: 565 SRRATSKS-DVYAFGVLLLELLTGKHP 590
R K DV+ GV+L LL+G P
Sbjct: 207 -REPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 11/100 (11%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
+ L + L L + N + L L L++L++ ++ AF
Sbjct: 21 LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF---- 76
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRF 182
RL+ L+LS+N L L L L L N
Sbjct: 77 HFTPRLSRLNLSFNALESL-SWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 26/162 (16%), Positives = 41/162 (25%), Gaps = 9/162 (5%)
Query: 107 HNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS-LHRLTILDLSYNNLTGLIPVN 165
+ + L NL L + L L L L L + + L + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 166 LTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNLT--GQVPETPTLLKFDASS 221
RL L L +N ++ + L +SGN L + +
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGG 134
Query: 222 FSMNPNLCGKVINKACRPRSPFFESPNATSPPR---PLGQSA 260
C A P + P +G
Sbjct: 135 VPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDV 176
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 22/88 (25%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPE 560
G+ ++H A +IH +LK SN+++ +D ++ D+ L+ + +S V Y+APE
Sbjct: 139 GIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPE 196
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGK 588
+ D+++ G ++ E++ G
Sbjct: 197 VILGM-GYKENVDIWSVGCIMGEMIKGG 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 49/228 (21%), Positives = 90/228 (39%), Gaps = 33/228 (14%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+ LG G+ G AV V VK D + D E ++ + L+H N+V
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFY 71
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQ-------- 503
+ + + + +Y G LF+ I + E AQ
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDI---------------GMPEPDAQRFFHQLMA 116
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP-DTV----AYKA 558
G+ Y+H + H ++K N+LL +++D+ L+ + ++ E + + Y A
Sbjct: 117 GVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR 606
PE+ K DV++ G++L +L G+ P P + + +W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 42/209 (20%), Positives = 80/209 (38%), Gaps = 22/209 (10%)
Query: 395 ELLGRGSIGTTYKAVLDNHLI----VTVKRFDANK------TADTSAEAFEQHMEAVGGL 444
LG G+ G + AV V VK K D + + +
Sbjct: 30 SPLGSGAFGFVWTAV---DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 445 SHPNLVPIRAYFQAKGE-RLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
H N++ + F+ +G +LV+ + LF I R L I +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-----DRHPRLDEPLASYIFRQLVS 141
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--TVAYKAPEI 561
+ Y+ +IH ++K N+++ DF +L D+ + + + T+ Y APE+
Sbjct: 142 AVGYLRLKD-IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 562 RKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ + ++++ GV L L+ ++P
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 38/222 (17%), Positives = 87/222 (39%), Gaps = 28/222 (12%)
Query: 381 SEVYSLEQLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHME 439
+ Y L + LGRG + + K + +
Sbjct: 27 NNFYILTS------KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 440 AVGGLSH-PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWT--SCLK 496
+ P ++ + ++ E ++I +Y G +F+L + + ++
Sbjct: 81 VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC-----LPELAEMVSENDVIR 135
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSV-LSDSSSVED-- 550
+ + + +G+ Y+H+ + ++H +LK N+LL + ++ D+ +S + + + +
Sbjct: 136 LIKQILEGVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194
Query: 551 --PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
P+ Y APEI T+ +D++ G++ LLT P
Sbjct: 195 GTPE---YLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSP 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 48/219 (21%)
Query: 395 ELLGRGSIGTTYKAVLDNHLI----VTVKRFDANKTADTS-AEAFEQHMEAVGGLSHPNL 449
+ LG G+ G H + V VK + K ++ ++ + HP++
Sbjct: 17 DTLGVGTFGKVKIGE---HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQ---- 503
+ + + ++ +Y G LF+ I HG ++ E A+
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHG---------------RVEEMEARRLFQ 118
Query: 504 ----GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV----- 554
+ Y HR ++H +LK NVLL A A++ D+ LS ++
Sbjct: 119 QILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSC 171
Query: 555 ---AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APE+ A + D+++ GV+L LL G P
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 33/155 (21%), Positives = 61/155 (39%), Gaps = 23/155 (14%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
++ P LV + F+ ++ +Y G +F+ + + A+ +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQ-IVL 152
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
Y+H LI+ +LK N+L+ ++TD+ + T
Sbjct: 153 TFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWTLCGTPEA 204
Query: 557 KAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APEI S + +K+ D +A GVL+ E+ G P
Sbjct: 205 LAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 43/207 (20%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQHME----AVGGLSH-- 446
LLG G G+ Y V DN V +K + ++ +D + + +S
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLP-VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 447 PNLVPIRAYFQAKGERLVIYDY-QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
++ + +F+ ++I + +P LF+ I L V + +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAV 162
Query: 506 AYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSSVEDPD-TVAYKAPEIRK 563
+ H ++H ++K N+L+ + E +L D+ L + D D T Y PE +
Sbjct: 163 RHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHP 590
R + V++ G+LL +++ G P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 51/220 (23%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+++G GS G Y+A L D+ +V +K+ +K + E Q M L H N+V +R
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNREL--QIMRK---LDHCNIVRLR 113
Query: 454 AYFQAKGERL------VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+F + GE+ ++ DY P +++ + S + L + + LAY
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 508 IHRASWLIHGNLKSSNVLLG--------ADF-EAR-------LTDYCLSVLSDSSSVEDP 551
IH + H ++K N+LL DF A+ Y
Sbjct: 172 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-------------- 216
Query: 552 DTVA---YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
+ Y+APE+ + TS DV++ G +L ELL G+
Sbjct: 217 --ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 22/88 (25%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA---YKAPE 560
G+ ++H A +IH +LK SN+++ +D ++ D+ L+ + +S + V Y+APE
Sbjct: 176 GIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPE 233
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGK 588
+ D+++ G ++ E++ K
Sbjct: 234 VILGMGY-KENVDIWSVGCIMGEMVRHK 260
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 48/238 (20%), Positives = 92/238 (38%), Gaps = 42/238 (17%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVK--RFDANKTADTSAEAFE----QHM-----EAVG 442
LG G T + A + N+ V +K R T A E Q +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 443 GLSHPNLVPIRAYFQAKGER-----LVIYDYQPNG-SLFNLIHGSRSIRAKPLHWTSCLK 496
+ +++ + +F KG +V ++ G +L LI + + + +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMV---FEVLGENLLALI---KKYEHRGIPLIYVKQ 135
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD--SSSVEDPD-- 552
I++ + GL Y+HR +IH ++K NVL+ + + ++D ++ D
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLM--EIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 553 ----TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKH----PSQHPYLAPPDML 602
T Y++PE+ + +D+++ L+ EL+TG H Y D +
Sbjct: 194 NSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 49/228 (21%), Positives = 90/228 (39%), Gaps = 33/228 (14%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+ LG G+ G AV V VK D + D E ++ + L+H N+V
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFY 71
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQ-------- 503
+ + + + +Y G LF+ I + E AQ
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDI---------------GMPEPDAQRFFHQLMA 116
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP-DTV----AYKA 558
G+ Y+H + H ++K N+LL +++D+ L+ + ++ E + + Y A
Sbjct: 117 GVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR 606
PE+ K DV++ G++L +L G+ P P + + +W
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 23/155 (14%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQ 503
++HP ++ + FQ + +I DY G LF+L+ S+ + AE V
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYAAE-VCL 117
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
L Y+H +I+ +LK N+LL + ++TD+ + PD T Y
Sbjct: 118 ALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAK-------YVPDVTYTLCGTPDY 169
Query: 557 KAPEIRKSSRRATSKS-DVYAFGVLLLELLTGKHP 590
APE+ + +KS D ++FG+L+ E+L G P
Sbjct: 170 IAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 45/209 (21%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+++G GS G ++A L V +K+ +K + E Q M + HPN+V ++A
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-FKNREL--QIMRI---VKHPNVVDLKA 99
Query: 455 YFQAKGERL------VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
+F + G++ ++ +Y P +++ + + + + + LAYI
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASR-HYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 509 HRASWLIHGNLKSSNVLLG--------ADF-EARLTDYCLSVLSDSSSVEDPDTVAYKAP 559
H + H ++K N+LL DF A++ + +V + Y+AP
Sbjct: 158 HSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI------AGEPNVSYICSRYYRAP 210
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGK 588
E+ + T+ D+++ G ++ EL+ G+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 16/97 (16%)
Query: 503 QGLAYIHRASWLIHGNLKSSNVLL-GADFEARLTDYCLSVLSDSSSVEDPDT-----VA- 555
+ L Y H ++H ++K NV++ + RL D+ L+ P VA
Sbjct: 141 KALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLA------EFYHPGQEYNVRVAS 193
Query: 556 --YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+K PE+ + D+++ G +L ++ K P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 31/166 (18%), Positives = 64/166 (38%), Gaps = 35/166 (21%)
Query: 444 LSHPNLVPIR--AYFQAKGERLVIYDYQPNGS--LFNLI-HGSRSIRAKPLHWTSCLKIA 498
L H N++ + Y + K + ++ +Y G + + + +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------------RFP 107
Query: 499 EDVAQ--------GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED 550
A GL Y+H ++H ++K N+LL +++ ++ + +D
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 551 P-DTV----AYKAPEIRKSSRR-ATSKSDVYAFGVLLLELLTGKHP 590
T A++ PEI + K D+++ GV L + TG +P
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 31/97 (31%), Positives = 36/97 (37%), Gaps = 14/97 (14%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
+ P L QL L L N L +P L LK L L+ N GAF
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFD--- 152
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEW 179
L L L LS N L +P A DRL L+
Sbjct: 153 -KLTNLQTLSLSTNQLQS-VPHG--AFDRLGKLQTIT 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 26/92 (28%), Positives = 31/92 (33%), Gaps = 14/92 (15%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFF----SGAFPLSILSL 145
T L +L L+L N L L L +L L+ N G F L
Sbjct: 51 SDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFD----HL 106
Query: 146 HRLTILDLSYNNLTGLIPV----NLTALDRLY 173
+L L L N L L P LT L L
Sbjct: 107 TQLDKLYLGGNQLKSL-PSGVFDRLTKLKELR 137
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 29/96 (30%), Positives = 34/96 (35%), Gaps = 18/96 (18%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-P--IPDLSSLINLKSLSLSRNFF----SGAFPLS 141
T L +L L L NN L P + D L L L L N SG F
Sbjct: 73 TLSAGVFDDLTELGTLGLANNQLASLPLGVFD--HLTQLDKLYLGGNQLKSLPSGVFD-- 128
Query: 142 ILSLHRLTILDLSYNNLTGLIPV----NLTALDRLY 173
L +L L L+ N L + P LT L L
Sbjct: 129 --RLTKLKELRLNTNQLQSI-PAGAFDKLTNLQTLS 161
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 43/163 (26%), Positives = 63/163 (38%), Gaps = 34/163 (20%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDV 501
L HPN+V + +I +Y G L+ I G + +ED
Sbjct: 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG---------------RFSEDE 117
Query: 502 AQ--------GLAYIHRASWLIHGNLKSSNVLLGADFEARL--TDYCLSVLSDSSSVEDP 551
A+ G++Y H + H +LK N LL RL D+ S S S P
Sbjct: 118 ARFFFQQLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 174
Query: 552 DTV----AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
+ AY APE+ +DV++ GV L +L G +P
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 57/362 (15%), Positives = 93/362 (25%), Gaps = 117/362 (32%)
Query: 400 GSIGTTYKAVLDNHLIVTVKRFDANKTAD------TSAEA----------------F--- 434
G YK +L V FD D + E F
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL 71
Query: 435 -----EQHMEAVGGLSHPN----LVPIRAYFQAKGERLVIYDYQPN-----GSLFNLIHG 480
E + V + N + PI+ + +Y Q + +F +
Sbjct: 72 LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 481 SR-----SIR-----AKPLHWT----------SCLKIAEDVAQGLAYIHRAS----WLIH 516
SR +R +P + + A DV + WL
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV--ALDVCLSYKVQCKMDFKIFWLNL 189
Query: 517 GNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED-PDTVAYKAPEIRKSSRR-ATSKS-- 572
N S +L L + + +S D + + I+ RR SK
Sbjct: 190 KNCNSPETVL-----EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 573 -------DVY------AFG----VLL----------LELLTGKHPSQHPY---LAPPDML 602
+V AF +LL L T H S + L P ++
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 603 E----WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE------IKE 652
++ R D E ++ + A W K + I+
Sbjct: 305 SLLLKYLD-CRPQDLPREVLTTNPRRLSIIAESIR--DGLATWDNWKHVNCDKLTTIIES 361
Query: 653 SV 654
S+
Sbjct: 362 SL 363
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 84/552 (15%), Positives = 159/552 (28%), Gaps = 139/552 (25%)
Query: 10 SLLLFSLLHSTATAQYPPITNSLLPSD---AVSLLSFKSKADSENKLLYALNERFDYCQW 66
+L LF L S +L + +S + + + S +Y E+ D
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--IEQRDRLYN 121
Query: 67 QGVKCAQGRVVRF--VLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLIN- 123
A+ V R L+ LR L L + + + +G + +
Sbjct: 122 DNQVFAKYNVSRLQPYLK---LR-----QALLELRPAKNVLIDGVLGSGK----TWVALD 169
Query: 124 -LKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTAL-DRLYSLKLEWNR 181
S + F L++ + + + L I N T+ D ++KL +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 182 FSGTV------PPLNQPFLVVFNVSGNNLTGQVPETPTLLK-FDASSFSMNPNLCGKVIN 234
+ P LV+ NV F+ S C K++
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQ----------NAKAWNAFNLS--------C-KIL- 269
Query: 235 KACRPRSPFFESPNATSPPRPLGQSAQSQGILVLSPPSPRN---DHKRRGLILGLSIGFA 291
T+ R Q LS + + DH L
Sbjct: 270 --------------LTT--R------FKQVTDFLSAATTTHISLDHHSMTLTPDEVKS-- 305
Query: 292 VLVSFLVCIFLLIRRSSEGRNSKEPST-----ASFNEGT----TYPEPESSRTANTTQVG 342
+L+ +L C + R N P S +G + + +
Sbjct: 306 LLLKYLDCRPQDLPREVLTTN---PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 343 --------------ECKI-----KVETK------ANKVQVEEMAIGSQTLIKRSGSLVFC 377
+ + T + ++ + M + L K SLV
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV-VNKLHKY--SLVEK 419
Query: 378 AGESEVYSLEQL-MRASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEA-FE 435
+ S+ + + +L ++ +++++D++ I K FD++ + F
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYAL---HRSIVDHYNI--PKTFDSDDLIPPYLDQYFY 474
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCL 495
H + H +L I + R+V D F + + IR W +
Sbjct: 475 SH------IGH-HLKNIEHPERMTLFRMVFLD-------FRFL--EQKIRHDSTAWNASG 518
Query: 496 KIAEDVAQGLAY 507
I + Q Y
Sbjct: 519 SILNTLQQLKFY 530
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 25/109 (22%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFE--------ARLTDYCLSVLSDSSSVEDPDT-- 553
+ Y+H L+H ++K SN+LL A+ +R V ++ + +T
Sbjct: 121 VIKYLHSGG-LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 554 -----------VA---YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
VA Y+APEI S + T D+++ G +L E+L GK
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 47/219 (21%), Positives = 84/219 (38%), Gaps = 48/219 (21%)
Query: 395 ELLGRGSIGTTYKAVLDNHLI----VTVKRFDANKTADTS-AEAFEQHMEAVGGLSHPNL 449
+ LG G+ G H + V VK + K + ++ + HP++
Sbjct: 22 DTLGVGTFGKVKVGK---HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQ---- 503
+ + + ++ +Y G LF+ I +G ++ E ++
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---------------RLDEKESRRLFQ 123
Query: 504 ----GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV----- 554
G+ Y HR ++H +LK NVLL A A++ D+ LS ++
Sbjct: 124 QILSGVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSC 176
Query: 555 ---AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APE+ A + D+++ GV+L LL G P
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 23/97 (23%), Positives = 40/97 (41%), Gaps = 14/97 (14%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSI 142
T P L+ L ++ L NN ++ + + S++ L +L LS N F
Sbjct: 44 TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFD--- 99
Query: 143 LSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEW 179
L L +L L N+++ +P A + L +L
Sbjct: 100 -GLKSLRLLSLHGNDISV-VPEG--AFNDLSALSHLA 132
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 25/80 (31%), Positives = 35/80 (43%), Gaps = 11/80 (13%)
Query: 102 RVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS----GAFPLSILSLHRLTILDLSYNN 157
L L N T +LS+ +L + LS N S +F ++ +L L LSYN
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFS----NMTQLLTLILSYNR 89
Query: 158 LTGLIPVNLTALDRLYSLKL 177
L + P D L SL+L
Sbjct: 90 LRCI-PPR--TFDGLKSLRL 106
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 28/96 (29%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-P--IPDLSSLINLKSLSLSRNFFSGAFPLSIL-S 144
P L L+ L L +N L P + D SL L L L N + P ++
Sbjct: 54 KLEPGVFDSLINLKELYLGSNQLGALPVGVFD--SLTQLTVLDLGTNQLT-VLPSAVFDR 110
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180
L L L + N LT +P + L L L L+ N
Sbjct: 111 LVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQN 145
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 25/117 (21%), Positives = 41/117 (35%), Gaps = 26/117 (22%)
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFE--------ARLTDYCLSVLSDSSSVEDPDT-- 553
G +IH + +IH +LK +N LL D AR + + E+ +
Sbjct: 141 GENFIHESG-IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 554 ------------VA---YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY 595
V Y+APE+ T D+++ G + ELL +
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 45/219 (20%), Positives = 82/219 (37%), Gaps = 49/219 (22%)
Query: 395 ELLGRGSIGTTYKAVLDNHLI----VTVKRFDANKTADTS-AEAFEQHMEAVGGLSHPNL 449
E LG GS G A H V +K + E+ + + L HP++
Sbjct: 15 ETLGEGSFGKVKLAT---HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLI--HGSRSIRAKPLHWTSCLKIAEDVAQ---- 503
+ + + +++ +Y G LF+ I ++ ED +
Sbjct: 72 IKLYDVITTPTDIVMVIEY-AGGELFDYIVEKK---------------RMTEDEGRRFFQ 115
Query: 504 ----GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV----- 554
+ Y HR ++H +LK N+LL + ++ D+ LS ++
Sbjct: 116 QIICAIEYCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLS------NIMTDGNFLKTSC 168
Query: 555 ---AYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590
Y APE+ A + DV++ G++L +L G+ P
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 27/91 (29%), Positives = 35/91 (38%), Gaps = 8/91 (8%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFFSGAFPLSIL-SLH 146
+ P L L L L N L P + L +L L+LS N + P + L
Sbjct: 42 SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLT 100
Query: 147 RLTILDLSYNNLTGLIPV----NLTALDRLY 173
+L L L+ N L L P LT L L
Sbjct: 101 QLKELALNTNQLQSL-PDGVFDKLTQLKDLR 130
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 32/96 (33%), Positives = 38/96 (39%), Gaps = 18/96 (18%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLT---GPIPDLSSLINLKSLSLSRNFF----SGAFPLS 141
+ P +L L+ L L N L + D L NL L+L+ N G F
Sbjct: 99 SLPNGVFDKLTNLKELVLVENQLQSLPDGVFD--KLTNLTYLNLAHNQLQSLPKGVFD-- 154
Query: 142 ILSLHRLTILDLSYNNLTGLIPV----NLTALDRLY 173
L LT LDLSYN L L P LT L L
Sbjct: 155 --KLTNLTELDLSYNQLQSL-PEGVFDKLTQLKDLR 187
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 27/113 (23%), Positives = 44/113 (38%), Gaps = 17/113 (15%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFS--GAF 138
L+ + N L +DQ+ +N+ + + + L N++ L+L N A
Sbjct: 26 LKKKSVTDAVTQNELNSIDQI---IANNSDIKS-VQGIQYLPNVRYLALGGNKLHDISAL 81
Query: 139 PLSILSLHRLTILDLSYNNLTGL---IPVNLTALDRLYSLKLEWNRFSGTVPP 188
L LT L L+ N L L + LT L L L N+ ++P
Sbjct: 82 K----ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV---LVENQLQ-SLPD 126
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 49/233 (21%), Positives = 92/233 (39%), Gaps = 31/233 (13%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFE--QHMEAVGGLSHPNLVPI 452
++LG G G + + T ++F A K +A + P++V I
Sbjct: 68 QVLGLGINGKVLQIF---N-KRTQEKF-ALKMLQDCPKARREVELHWRASQ--CPHIVRI 120
Query: 453 RAYFQ-AKGERLVIY---DYQPNGSLFNLIHGSRSIRAKPLHWT--SCLKIAEDVAQGLA 506
++ R + + G LF+ I +T +I + + + +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRI-----QDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 507 YIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSV-LSDSSSVEDP-DTVAYKAPEI 561
Y+H + + H ++K N+L + +LTD+ + + +S+ P T Y APE+
Sbjct: 176 YLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
Query: 562 RKSSRRATSKS-DVYAFGVLLLELLTGKHP--SQHPYLAPPDMLEWVRTMRVD 611
KS D+++ GV++ LL G P S H P M +R + +
Sbjct: 235 LG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 24/92 (26%), Positives = 34/92 (36%), Gaps = 14/92 (15%)
Query: 91 PPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFS----GAFPLSILS 144
RL L L L N LTG I +++ L L N F L
Sbjct: 46 SDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIKEISNKMF----LG 100
Query: 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLK 176
LH+L L+L N ++ + + + L SL
Sbjct: 101 LHQLKTLNLYDNQISC-VMPG--SFEHLNSLT 129
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 24/97 (24%), Positives = 31/97 (31%), Gaps = 19/97 (19%)
Query: 102 RVLSLHNNSLTGPIPD--LSSLINLKSLSLSRN----FFSGAFPLSILSLHRLTILDLSY 155
L L++N L D L +L L L RN AF + L L
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFE----GASHIQELQLGE 87
Query: 156 NNLTGLIPV----NLTALDRLYSLKLEWNRFSGTVPP 188
N + + L L L L N+ S V P
Sbjct: 88 NKIKEI-SNKMFLGLHQLKTLN---LYDNQIS-CVMP 119
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 29/193 (15%), Positives = 59/193 (30%), Gaps = 58/193 (30%)
Query: 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLK------- 496
L H N++ + YF G+ P+ + + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 497 ---IAEDVAQ--------------------------GLAYIHRASWLIHGNLKSSNVLLG 527
+ + + + + +IH + H ++K N+L+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG-ICHRDIKPQNLLVN 175
Query: 528 A--------DF-EARLTDYCLSVLSDSSSVEDPDTVA---YKAPEIRKSSRRATSKSDVY 575
+ DF A+ SV + Y+APE+ + T D++
Sbjct: 176 SKDNTLKLCDFGSAKKLI------PSEPSVA---YICSRFYRAPELMLGATEYTPSIDLW 226
Query: 576 AFGVLLLELLTGK 588
+ G + EL+ GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 59/228 (25%)
Query: 397 LGRGSIGTTYKAVLDNHL---IVTVKRFDANKTADTSAEAFEQHM---EAVGGLSHPNLV 450
+GRG+ G YKA + +K+ + S A + E L HPN++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRE----LKHPNVI 81
Query: 451 PIRAYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVA------ 502
++ F + +R V ++DY + L+++I R+ +A +++ +
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP----VQLPRGMVKSLLYQ 136
Query: 503 --QGLAYIHRASWLIHGNLKSSNVLLG-----------ADFE-AR--------LTDYCLS 540
G+ Y+H +W++H +LK +N+L+ AD AR L D
Sbjct: 137 ILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 541 VLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
V+ T Y+APE+ +R T D++A G + ELLT +
Sbjct: 196 VV----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 44/216 (20%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVK--RFDANKTADTSAEAFE----QHMEAVGGLSHP 447
+++G+GS G KA H V +K R N+ A E +H+ +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 448 NLVPIRAYFQAKG------ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDV 501
N++ + F + E L + +L+ LI + + + K A +
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-------NLYELI---KKNKFQGFSLPLVRKFAHSI 209
Query: 502 AQGLAYIHRASWLIHGNLKSSNVLL--GADFEARLTDYCLSVLSDSSSVEDPDTVA---- 555
Q L +H+ +IH +LK N+LL ++ D+ SS + V
Sbjct: 210 LQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDF-------GSSCYEHQRVYTYIQ 261
Query: 556 ---YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
Y+APE+ +R D+++ G +L ELLTG
Sbjct: 262 SRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGY 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 38/230 (16%), Positives = 76/230 (33%), Gaps = 46/230 (20%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
++LG G G + +K E + P++V I
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREV--ELHWRASQ--CPHIVRIV 77
Query: 454 AYFQ-AKGERLVIY---DYQPNGSLFNLIHGSRSIRAKPLHWTS---CLKIAEDVAQGLA 506
++ R + + G LF+ I+ + + +I + + + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFS------RIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 507 YIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRK 563
Y+H + + H ++K N+L + +LTD+ A E
Sbjct: 132 YLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGF------------------AKETTG 172
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHP--SQHPYLAPPDMLEWVRTMRVD 611
+ D+++ GV++ LL G P S H P M +R + +
Sbjct: 173 --EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 3e-04
Identities = 21/103 (20%), Positives = 36/103 (34%), Gaps = 17/103 (16%)
Query: 98 LDQLRVLSLH----NNSLTGPIPDLSSLI------NLKSLSLSRNFFSGAFPLSILS--- 144
L L L L+ + G + L NLK L + L
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 145 LHRLTILDLSYNNLTG----LIPVNLTALDRLYSLKLEWNRFS 183
L +L +D+S LT L+ ++ + L + +++N S
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 36/265 (13%), Positives = 71/265 (26%), Gaps = 52/265 (19%)
Query: 373 SLVFCAGESEVYSLEQLMRAS----AELLGRGSIGTTYKAVLDNHLIVTVK--RFDANKT 426
S+ C + + E +G G G ++ + +H V +K +
Sbjct: 1 SMGEC-SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDL 58
Query: 427 ADTSAEAFEQ-------------HMEAVGGLSHPNLVPIRAYFQAKGER----LVIYDY- 468
+ S + + + + + + +G L +D+
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 469 -QPNGSLFNLIHGSR------------------SIRAKPLHWTSCLKIAEDVAQGLAYIH 509
GS + + +R K + I + LA
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRAT 569
+ H +L NVLL +L + S P + + I + R
Sbjct: 179 ASLRFEHRDLHWGNVLLKKTSLKKLHY-----TLNGKSSTIP-SCGLQVSIIDYTLSRLE 232
Query: 570 SKSD-VYAFGVLLLELLTGKHPSQH 593
V+ + +L TG Q
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQF 257
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 46/223 (20%), Positives = 80/223 (35%), Gaps = 60/223 (26%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG---------L 444
+G GS G +K D IV +K+F E+ + + L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF---------LESEDDPVIKKIALREIRMLKQL 59
Query: 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQG 504
HPNLV + F+ K ++++Y + ++ + + + + I Q
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITWQTLQA 114
Query: 505 LAYIHRASWLIHGNLKSSNVLLG-------ADFE-AR--------LTDYCLSVLSDSSSV 548
+ + H+ IH ++K N+L+ DF AR D
Sbjct: 115 VNFCHKH-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE----------- 162
Query: 549 EDPDTVA---YKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK 588
VA Y++PE+ + DV+A G + ELL+G
Sbjct: 163 -----VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 29/96 (30%), Positives = 35/96 (36%), Gaps = 12/96 (12%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG-PIPDLSSLINLKSLSLSRNFF----SGAFPLSIL 143
+ P +L QL LSL N + P L L L L N +G F
Sbjct: 42 SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFD---- 97
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEW 179
L +L L L N L V DRL SL+ W
Sbjct: 98 KLTQLKELALDTNQLKS---VPDGIFDRLTSLQKIW 130
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 665 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.91 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.9 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.8 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.79 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.76 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.75 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.74 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.74 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.74 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.74 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.74 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.73 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.73 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.72 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.72 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.72 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.72 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.72 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.72 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.72 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.71 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.7 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.69 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.69 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.69 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.69 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.68 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.68 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.68 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.67 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.67 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.67 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.67 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.66 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.66 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.66 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.66 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.66 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.65 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.65 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.65 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.65 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.64 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.64 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.64 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.63 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.63 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.63 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.63 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.62 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.62 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.62 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.62 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.61 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.61 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.61 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.6 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.6 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.59 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.59 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.58 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.58 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.55 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.52 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.5 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.5 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.49 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.49 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.48 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.48 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.46 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.46 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.44 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.43 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.42 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.35 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.35 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.3 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.29 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.28 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.26 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.05 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.05 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.96 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.9 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.85 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.62 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.59 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.53 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.51 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.4 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.33 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.26 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.25 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.23 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.18 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.15 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.48 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.24 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.17 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.16 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.92 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.88 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.81 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.74 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.74 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.71 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.52 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.43 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.36 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.14 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.77 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.08 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.22 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.94 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.67 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.54 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.32 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.08 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=433.56 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=205.9
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||+||+|.+.+ .||||+++.........+.|.+|++++++++|||||+++|++.+ +..++|||||++|+|
T Consensus 42 ~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL 118 (307)
T 3omv_A 42 TRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSL 118 (307)
T ss_dssp EECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBH
T ss_pred eEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCH
Confidence 679999999999998765 48999998666555667889999999999999999999998865 568999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-----SVE 549 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~~~ 549 (665)
.++++.. ...++|.+++.|+.|||.||+|||+++ |+||||||+|||+++++++||+|||+|+..... ...
T Consensus 119 ~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~ 193 (307)
T 3omv_A 119 YKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHAKN-IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQ 193 (307)
T ss_dssp HHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCSSSEEEETTEEEEECCCSSCBC------------
T ss_pred HHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecc
Confidence 9999742 356999999999999999999999999 999999999999999999999999999765432 123
Q ss_pred CCCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHHHHH
Q 005999 550 DPDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGMLTE 624 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 624 (665)
..||+.|||||++.. ...|+.++|||||||++|||+||+.||.+... ...+...+....... .....++..+.+
T Consensus 194 ~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~ 272 (307)
T 3omv_A 194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-RDQIIFMVGRGYASPDLSKLYKNCPKAMKR 272 (307)
T ss_dssp CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHTTCCCCCSTTSCTTSCHHHHH
T ss_pred cccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCCCCCcccccccchHHHHH
Confidence 469999999999863 34589999999999999999999999976321 112233333222221 234567788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
|+.+||+.||++||||.||++.|+.+...
T Consensus 273 li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 273 LVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 99999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=435.94 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=208.2
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||+||+|.+. ++..||||+++... ....+.|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999864 47899999997543 35567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecc
Q 005999 469 QPNGSLFNLIHGSRS----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYC 538 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfg 538 (665)
|++|+|.++++..+. ....+++|.+++.|+.||+.||+|||+.+ |+||||||+|||+++++++||+|||
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLKp~NILl~~~~~~Ki~DFG 203 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKIGDFG 203 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHhhEEECCCCcEEEcccc
Confidence 999999999985432 12356999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCC
Q 005999 539 LSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDD 612 (665)
Q Consensus 539 l~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 612 (665)
+++...... ....||+.|||||++. +..++.++|||||||++|||+| |+.||... ...++...+..... .
T Consensus 204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~g~~-~ 279 (329)
T 4aoj_A 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNTEAIDCITQGRE-L 279 (329)
T ss_dssp ----------------CCCCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--CHHHHHHHHHHTCC-C
T ss_pred cceeccCCCcceecCcccccccccChhhhc-CCCCCccccccchHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCC-C
Confidence 997654322 2345899999999997 6789999999999999999999 89999763 23344444443322 2
Q ss_pred CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 613 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
..+..++..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 34566788899999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=434.26 Aligned_cols=252 Identities=22% Similarity=0.396 Sum_probs=211.6
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||+||+|.+. ++..||||+++... ....+.|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 67999999999999864 47889999997653 35567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 469 QPNGSLFNLIHGSR--------SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 469 ~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
|++|+|.++++..+ ......++|.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccCHhhEEECCCCcEEECCcccc
Confidence 99999999997532 123457999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCc
Q 005999 541 VLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGR 614 (665)
Q Consensus 541 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 614 (665)
+...... ....||+.|||||++. +..|+.++|||||||++|||+| |+.||... ...++...+...... ..
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--~~~~~~~~i~~~~~~-~~ 251 (299)
T 4asz_A 176 RDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--SNNEVIECITQGRVL-QR 251 (299)
T ss_dssp HHHTGGGCEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHHTCCC-CC
T ss_pred eecCCCCceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCC-CC
Confidence 7654322 1224799999999997 6789999999999999999999 89999763 233555555443322 34
Q ss_pred hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 615 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+..++..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 252 p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 252 PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 556788899999999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=431.33 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=209.6
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||+||+|.+. +++.||||+++.... ....+.|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 56999999999999863 567899999975543 34467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeec
Q 005999 469 QPNGSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY 537 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Df 537 (665)
|++|+|.++|+..... ....++|..+++|+.|||.||+|||+++ |+||||||+|||+++++++||+||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLK~~NILl~~~~~~Ki~DF 189 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-VVHKDLATRNVLVYDKLNVKISDL 189 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCS
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCccccceEECCCCCEEECCc
Confidence 9999999999753211 1246999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCC-----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccC
Q 005999 538 CLSVLSDSS-----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVD 611 (665)
Q Consensus 538 gl~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 611 (665)
|+++..... .....||+.|||||++. +..++.++|||||||++|||+| |+.||... ...++...+.....
T Consensus 190 Glar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--~~~~~~~~i~~~~~- 265 (308)
T 4gt4_A 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--SNQDVVEMIRNRQV- 265 (308)
T ss_dssp CCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--CHHHHHHHHHTTCC-
T ss_pred ccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-
Confidence 999765332 22346899999999987 6789999999999999999998 89999763 23355555544322
Q ss_pred CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 612 DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 612 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
...+..++..+.+|+.+||+.||++||||.||++.|+..
T Consensus 266 ~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 266 LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 234567788999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=416.34 Aligned_cols=243 Identities=21% Similarity=0.344 Sum_probs=201.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe----CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA----KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 469 (665)
+.||+|+||+||+|... ++..||+|++..........+.|.+|++++++++|||||+++++|.+ ++..++|||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 46999999999999965 68899999997665555667789999999999999999999999875 34689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeC-CCCceEEeecccccccCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLG-ADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~ 547 (665)
+||+|.++++. ...+++..+..|+.||+.||+|||+++ +|+||||||+|||++ .++.+||+|||+|+......
T Consensus 112 ~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 112 TSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 99999999974 356999999999999999999999875 599999999999998 47999999999997655432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....||+.|||||++. +.|+.++|||||||++|||+||+.||.... ....+...+.....+...+...+..+.+|+
T Consensus 187 ~~~~~GTp~YmAPE~~~--~~y~~~~DiwSlGvilyelltg~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred cCCcccCccccCHHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-cHHHHHHHHHcCCCCCCCCccCCHHHHHHH
Confidence 3446999999999986 359999999999999999999999997531 112333333322222223444566799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||++||++|||+.|+++
T Consensus 264 ~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=428.01 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=202.3
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||+||+|... +++.||||++..........+.+.+|++++++++|||||+++++|.+++..|+||||++||
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 367999999999999964 6899999999876655566788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++... +...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...... ..
T Consensus 109 ~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 184 (350)
T 4b9d_A 109 DLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184 (350)
T ss_dssp BHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHH
T ss_pred cHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCCEEEcccccceeecCCcccccc
Confidence 999999753 3456789999999999999999999999 9999999999999999999999999998765432 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|||||++. +..|+.++|||||||++|||+||+.||... ...++...+...... ......+..+.+|+.+|
T Consensus 185 ~~GT~~YmAPE~l~-~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 185 CIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAG--SMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHSCCTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHH
T ss_pred cCCCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHH
Confidence 35999999999997 678999999999999999999999999763 222333333322221 23456678899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|++||++|||+.|+++
T Consensus 261 L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=422.84 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=206.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... +|+.||||+++.... ..+|+.++++++|||||+++++|.+++..|+||||++||+
T Consensus 64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 56999999999999964 689999999976542 2469999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCCC-----
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~----- 547 (665)
|.++++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ ++||+|||+++......
T Consensus 137 L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 137 LGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp HHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9999974 346999999999999999999999999 99999999999999987 69999999998664321
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-CCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD-DGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 623 (665)
....||+.|||||++. +..|+.++|||||||++|||+||+.||.... ...+...+...... ...+...+..+.
T Consensus 211 ~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF--RGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp ---CCCCCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC--CSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ecCCccccCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 1235999999999997 6789999999999999999999999997643 22333333322111 123456778899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
+++.+||++||++|||+.|+++.|........
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 99999999999999999999999998887765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=421.77 Aligned_cols=239 Identities=20% Similarity=0.313 Sum_probs=204.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+++|++++|||||+++++|.+++..|+||||++||+
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 157 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 56999999999999965 689999999975443 234568899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..... ....
T Consensus 158 L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 158 LTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 9999974 34899999999999999999999999 999999999999999999999999999876443 2345
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c 629 (665)
.||+.|||||++. +..|+.++||||+||++|||++|+.||... ...+....+..... ........+..+.+|+.+|
T Consensus 231 ~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 231 VGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 7999999999987 678999999999999999999999999752 22233333333222 2234456778899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|++||++|||+.|+++
T Consensus 308 L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 308 LVRDPAQRATAAELLK 323 (346)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred cCCChhHCcCHHHHhc
Confidence 9999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=420.39 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=211.6
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCC-CCeeeeeEEEEeC-CeEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH-PNLVPIRAYFQAK-GERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~~lv 465 (665)
.+.||+|+||+||+|.+. .++.||||+++.... ....+.|.+|+++|.+++| ||||+++|+|.+. +..++|
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 367999999999999854 357899999976554 2445779999999999955 8999999999764 568999
Q ss_pred EEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEE
Q 005999 466 YDYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL 534 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl 534 (665)
||||++|+|.++|+..+. .....++|.+++.++.|||.||+|||+++ ||||||||+|||+++++.+||
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-iiHRDLK~~NILl~~~~~vKi 226 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKI 226 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-eecCccCccceeeCCCCCEEE
Confidence 999999999999975432 12345899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhh
Q 005999 535 TDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTM 608 (665)
Q Consensus 535 ~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 608 (665)
+|||+|+....... ...||+.|||||++. +..|+.++|||||||++|||+| |+.||.... ....+...+...
T Consensus 227 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~-~~~~~~~~i~~g 304 (353)
T 4ase_A 227 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEG 304 (353)
T ss_dssp CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-CSHHHHHHHHHT
T ss_pred CcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCC-HHHHHHHHHHcC
Confidence 99999986644321 224789999999997 6789999999999999999998 999997632 122344444433
Q ss_pred ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 609 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
.. ...++.++..+.+++.+||+.||++|||+.||++.|+++.+....
T Consensus 305 ~~-~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 305 TR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred CC-CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 22 234456778899999999999999999999999999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=402.15 Aligned_cols=240 Identities=19% Similarity=0.322 Sum_probs=190.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||+||+|.. .+++.||+|+++..... ....+.+.+|++++++++|||||++++++.+++..|+||||+ +|
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g 97 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN 97 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence 6799999999999985 47899999999765432 233567899999999999999999999999999999999999 67
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...... ...
T Consensus 98 ~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 98 ELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp EHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 99999874 346999999999999999999999999 9999999999999999999999999997765432 334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|||||++.+...++.++||||+||++|||+||+.||... ....+...+..... ..+...+..+.+|+.+||
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L 247 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--SIPVLFKNISNGVY--TLPKFLSPGAAGLIKRML 247 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHS
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence 69999999999984444568999999999999999999999752 22233333333222 234556778999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
++||++|||+.|+++
T Consensus 248 ~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 248 IVNPLNRISIHEIMQ 262 (275)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhHCcCHHHHHc
Confidence 999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=410.54 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=194.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC----eEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG----ERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~ 470 (665)
+.||+|+||+||+|.+. |+.||||+++... .....++.|+..+.+++|||||++++++.+++ ..++||||++
T Consensus 9 ~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEECSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 57999999999999984 6789999996543 22233456777778899999999999998754 5799999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA--------SWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+|+|.++++. ..++|..+++++.|++.||+|||++ + |+||||||+|||++.++++||+|||+++.
T Consensus 85 ~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 85 HGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-EeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999974 3589999999999999999999986 6 99999999999999999999999999976
Q ss_pred cCCCC-------CCCCCCCcccCCccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCC----------CCCcc
Q 005999 543 SDSSS-------VEDPDTVAYKAPEIRKSSR-----RATSKSDVYAFGVLLLELLTGKHPSQHPY----------LAPPD 600 (665)
Q Consensus 543 ~~~~~-------~~~~gt~~y~aPE~~~~~~-----~~~~k~DvwSlGvvl~elltg~~P~~~~~----------~~~~~ 600 (665)
..... ....||+.|||||++.+.. .++.++|||||||++|||+||++||.... .....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 54322 1235999999999986321 36789999999999999999988764221 11112
Q ss_pred HHHHHHhhccCC---C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 601 MLEWVRTMRVDD---G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 601 ~~~~~~~~~~~~---~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
............ . .....+..+.+|+.+||+.||++||||.||++.|+++.++-
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 222222221111 1 12234567999999999999999999999999999987653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=411.24 Aligned_cols=241 Identities=19% Similarity=0.289 Sum_probs=204.8
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|++++++++|||||+++++|++++..|+||||++|
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g 116 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 36799999999999996 4789999999975432 123456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----- 546 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----- 546 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 117 G~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~ 190 (311)
T 4aw0_A 117 GELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190 (311)
T ss_dssp EEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence 999999974 356999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 547 SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 547 ~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
.....||+.|||||++. +..|+.++||||+||++|||+||+.||... ...++...+.... ...++..+..+.+|+
T Consensus 191 ~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 191 ANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEGLIFAKIIKLE--YDFPEKFFPKARDLV 265 (311)
T ss_dssp BCCCCSCGGGCCHHHHH-HSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTC--CCCCTTCCHHHHHHH
T ss_pred ccCcccCcccCCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCC--CCCCcccCHHHHHHH
Confidence 22346999999999997 677999999999999999999999999752 2223433333322 234556778899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||++||++|||+.|++.
T Consensus 266 ~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 266 EKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHSCSSGGGSTTSGGGTC
T ss_pred HHHccCCHhHCcChHHHcC
Confidence 9999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=422.43 Aligned_cols=239 Identities=20% Similarity=0.313 Sum_probs=204.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+|++++|||||+++++|.+++..|+|||||+||+
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 57999999999999965 689999999976543 334568899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.++++. ..+++..+..|+.||+.||+|||+++ |+||||||+||||+.+|++||+|||++...... ....
T Consensus 235 L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~-IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 235 LTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred HHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 9999974 34899999999999999999999999 999999999999999999999999999776443 2344
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c 629 (665)
.||+.|||||++. +..|+.++|||||||++|||++|+.||... ...+....+..... ........+..+.+|+.+|
T Consensus 308 ~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 308 VGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp EECTTTCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 6999999999987 678999999999999999999999999752 22234444433222 2223456678899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|.+||++|||+.|+++
T Consensus 385 L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 385 LVRDPAQRATAAELLK 400 (423)
T ss_dssp SCSSTTTSCCHHHHTT
T ss_pred cCCChhHCcCHHHHhc
Confidence 9999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=407.91 Aligned_cols=241 Identities=22% Similarity=0.304 Sum_probs=196.1
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||+||+|+.. .++.||||+++...........+.+|++++++++|||||+++++|.+++..|+||||+
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 108 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL 108 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence 467999999999999852 4789999999765433333456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--- 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--- 546 (665)
+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 109 ~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 109 RGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp TTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 99999999974 346999999999999999999999999 999999999999999999999999999765332
Q ss_pred CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 547 SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 547 ~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
.....||+.|||||++. +..|+.++||||+||++|||+||+.||... ...++...+... ....+...+..+.+|+
T Consensus 183 ~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQGK--DRKETMTMILKA--KLGMPQFLSPEAQSLL 257 (304)
T ss_dssp CCSCCCCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred ccccccCcccCCHHHhc-cCCCCCCCcccchHHHHHHHHhCCCCCCCc--CHHHHHHHHHcC--CCCCCCcCCHHHHHHH
Confidence 23456999999999997 678999999999999999999999999752 222333333332 2234556778899999
Q ss_pred HHcccCCCCCCCCH-----HHHHH
Q 005999 627 SVCSLKSPEQRPAM-----WQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~-----~evl~ 645 (665)
.+||++||++|||+ +|+++
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHcccCHHHCCCCCcCCHHHHHc
Confidence 99999999999984 56664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=392.36 Aligned_cols=240 Identities=20% Similarity=0.326 Sum_probs=186.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------------
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------------ 460 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------------ 460 (665)
.+.||+|+||+||+|... +++.||||+++.... +...+.+.+|+++|++++|||||+++++|.+.+
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence 367999999999999964 688999999975543 345577899999999999999999999987644
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
..|+||||+++|+|.+++.... .....++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~-IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc-CccccCcHHHeEECCCCcEEEccCccc
Confidence 3689999999999999998532 2334677788999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC---------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005999 541 VLSDSSS---------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV 605 (665)
Q Consensus 541 ~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 605 (665)
+...... ....||+.|||||++. +..|+.++|||||||++|||++ ||... .+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~~~~ 237 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFSTQ----MERVRTL 237 (299)
T ss_dssp --------------------------CCCTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHc-CCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHHHHH
Confidence 7654321 1235999999999997 6789999999999999999996 76531 1222222
Q ss_pred HhhccCC--CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 606 RTMRVDD--GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 606 ~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
....... .........+.+|+.+||++||++|||+.|+++
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2221111 122334455788999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=395.77 Aligned_cols=243 Identities=21% Similarity=0.257 Sum_probs=198.2
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe------CCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA------KGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~ 466 (665)
.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+..|+||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 36799999999999996 478999999998766555566788899999999999999999999764 35789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+. |+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 139 E~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 139 DLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp ECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred eCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc-CcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 9996 689999973 457999999999999999999999999 999999999999999999999999999765321
Q ss_pred -------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC------
Q 005999 547 -------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG------ 613 (665)
Q Consensus 547 -------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------ 613 (665)
.....||+.|||||++.+...++.++||||+||++|||++|++||... ...+....+........
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~--~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK--NYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS--SHHHHHHHHHHHHCCCCGGGTC-
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC--CHHHHHHHHHHhcCCCChHHhhh
Confidence 233479999999999875567899999999999999999999999753 12222222221111100
Q ss_pred -----------------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 -----------------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 -----------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+|+.+||..||++|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01123567889999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=382.58 Aligned_cols=239 Identities=16% Similarity=0.268 Sum_probs=191.6
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||+||+|..+ .++.||+|++..... ...+.+|+++++.+ +||||++++++|.++++.|+||||
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 367999999999999853 578999999865432 34577899999988 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccCCCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~ 547 (665)
+++|+|.++++ .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +++||+|||+|+......
T Consensus 102 ~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g-IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 102 LEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG-IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC-eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999984 3889999999999999999999999 9999999999999876 799999999996543221
Q ss_pred -------------------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 005999 548 -------------------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYL 596 (665)
Q Consensus 548 -------------------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~ 596 (665)
....||+.|||||++.+...++.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1235899999999987556789999999999999999999999965322
Q ss_pred CCccHHHHHH----------------------------------hhccCC-----------------CchhhhHHHHHHH
Q 005999 597 APPDMLEWVR----------------------------------TMRVDD-----------------GREENRLGMLTEV 625 (665)
Q Consensus 597 ~~~~~~~~~~----------------------------------~~~~~~-----------------~~~~~~~~~l~~l 625 (665)
+...+..... ...... ......+....+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 1111111110 000000 0112345678899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||+.||++|||++|+++
T Consensus 333 l~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHCcCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=400.27 Aligned_cols=244 Identities=18% Similarity=0.223 Sum_probs=200.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch----hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA----DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||+|... +|+.||||++...... .......+.++.+++.++|||||+++++|.+.+..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 367999999999999965 6899999999654221 11223344557788899999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-C
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-S 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~ 547 (665)
++||+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|...... .
T Consensus 274 ~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~g-IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~ 347 (689)
T 3v5w_A 274 MNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347 (689)
T ss_dssp CCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC
T ss_pred CCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHeEEeCCCCEEecccceeeecCCCCC
Confidence 999999999974 356999999999999999999999999 999999999999999999999999999776543 3
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....||+.|||||++..+..|+.++||||+||++|||++|++||........ .+...+. ......+...+..+.+|+
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLL 425 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCCHHHHHHH
Confidence 4457999999999987556799999999999999999999999975322221 2222222 222234556778899999
Q ss_pred HHcccCCCCCCCC-----HHHHHH
Q 005999 627 SVCSLKSPEQRPA-----MWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt-----~~evl~ 645 (665)
.+||++||++|++ +.||++
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHccCCHhHCCCCCCCCHHHHhc
Confidence 9999999999998 688765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=398.68 Aligned_cols=242 Identities=21% Similarity=0.336 Sum_probs=204.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+++|+.++|||||+++++|.+++..|+|||||+||
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 367999999999999964 789999999976542 44567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC--CceEEeecccccccCCCC--C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD--FEARLTDYCLSVLSDSSS--V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~--~ 548 (665)
+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++...... .
T Consensus 240 ~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 240 ELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp BHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred cHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 99999864 2346899999999999999999999999 9999999999999854 899999999998776543 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 626 (665)
...||+.|||||++. +..|+.++||||+||++|||++|+.||... ...+....+....... ......+..+.+|+
T Consensus 315 ~~~GT~~y~APEv~~-~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 315 VTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred eeEECccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 336999999999997 678999999999999999999999999763 2223333333322221 23345677899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.||++|||+.|+++
T Consensus 392 ~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 392 RKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.43 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=205.5
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||+||+|.. .+..||||++..........+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 36799999999999987 46789999998766555666789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
|.+++.... ....+++..++.++.||+.||+|||+.+ +|+||||||+||+++.++.+||+|||++...... ...
T Consensus 121 L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 198 (309)
T 3p86_A 121 LYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198 (309)
T ss_dssp HHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--------------
T ss_pred HHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccccc
Confidence 999997421 1234899999999999999999999976 4999999999999999999999999999755443 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+....+.........+...+..+.+++.+|
T Consensus 199 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 275 (309)
T 3p86_A 199 AAGTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNL--NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGC 275 (309)
T ss_dssp ---CCTTSCHHHHT-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred CCCCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHH
Confidence 46899999999987 567899999999999999999999999753 222333333322333344556778899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
|+.||++|||+.|+++.|+.+.+....
T Consensus 276 l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 276 WTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=364.82 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=213.3
Q ss_pred HhHhCcccceEEEEEEE--------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEE
Q 005999 394 AELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 464 (665)
.+.||+|+||.||+|.. .++..||||+++.... ....+.+.+|+++++++ +||||+++++++.+++..++
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 36799999999999985 3567899999976543 34567799999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 465 IYDYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
||||+++|+|.+++...+. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~k 243 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTENNVMK 243 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEE
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchhhEEECCCCCEE
Confidence 9999999999999986431 12345899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHh
Q 005999 534 LTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT 607 (665)
Q Consensus 534 l~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 607 (665)
|+|||++....... ....+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+..
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~--~~~~~~~~~~~ 320 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKE 320 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHT
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhc
Confidence 99999997654322 2224678899999987 5779999999999999999999 99999763 23344444433
Q ss_pred hccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 608 MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 608 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
... ...+..++..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 321 ~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 321 GHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 322 223456677899999999999999999999999999999876554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.38 Aligned_cols=249 Identities=20% Similarity=0.373 Sum_probs=209.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 16 ~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEECCSSEEEEEEEETTTCCEEEEEEESCCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCCCEEEEEEEECCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 67999999999999965 68899999985543 3556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-----
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----- 548 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 548 (665)
|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 94 L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 94 LRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN-IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp HHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 99999852 356899999999999999999999999 99999999999999999999999999976543221
Q ss_pred ------------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc----cHHHHHHhhccCC
Q 005999 549 ------------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP----DMLEWVRTMRVDD 612 (665)
Q Consensus 549 ------------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~----~~~~~~~~~~~~~ 612 (665)
...||+.|+|||++. +..++.++||||||+++|||++|..|+........ .........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~---- 243 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY---- 243 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT----
T ss_pred ccccccccccccccCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc----
Confidence 335899999999987 67889999999999999999999999875432221 222222221
Q ss_pred CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 613 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
.+...+..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 244 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 244 -CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1234556799999999999999999999999999999877643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=359.15 Aligned_cols=242 Identities=19% Similarity=0.282 Sum_probs=204.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~ 100 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence 6799999999999997 578999999997765555566788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVEDP 551 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~~ 551 (665)
|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 101 L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 174 (328)
T 3fe3_A 101 VFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174 (328)
T ss_dssp HHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTS
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccccc
Confidence 9999874 245899999999999999999999999 999999999999999999999999999765433 23446
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
||+.|+|||++.+....+.++||||+||++|||++|+.||... ...++...+..... ..+...+..+.+++.+||+
T Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~ 250 (328)
T 3fe3_A 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--NLKELRERVLRGKY--RIPFYMSTDCENLLKRFLV 250 (328)
T ss_dssp SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHCC
T ss_pred CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHCC
Confidence 8999999999984444458999999999999999999999763 12233333332221 2344566789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 005999 632 KSPEQRPAMWQVLKM 646 (665)
Q Consensus 632 ~dP~~RPt~~evl~~ 646 (665)
.||++|||+.|+++.
T Consensus 251 ~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 251 LNPIKRGTLEQIMKD 265 (328)
T ss_dssp SSTTTSCCHHHHTTC
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.84 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=209.4
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (269)
T 4hcu_A 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 92 (269)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred heecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence 57999999999999998888999999976543 346789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC----CCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----SVED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----~~~~ 550 (665)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 93 ~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 93 SDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp HHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHhCC-eecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 9999742 346899999999999999999999999 999999999999999999999999999765432 2233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.+|+.|+|||.+. +..++.++||||+|+++|||++ |+.||... ...+....+.... ....+...+..+.+++.+|
T Consensus 168 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 243 (269)
T 4hcu_A 168 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGF-RLYKPRLASTHVYQIMNHC 243 (269)
T ss_dssp TCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCHHHhc-CCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHhcCc-cCCCCCcCCHHHHHHHHHH
Confidence 5678899999987 5678999999999999999999 99999752 2223333333221 1223445577899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
|+.||++|||+.|+++.|+++.+.
T Consensus 244 l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 244 WRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCCcccCcCHHHHHHHHHHHHHc
Confidence 999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=356.04 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=211.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 45 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 57999999999999988899999999876543 4567789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----CC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-----VE 549 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~~ 549 (665)
.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 123 ~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 200 (321)
T 2qkw_B 123 KRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA-IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200 (321)
T ss_dssp GGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred HHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC-eecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence 99987532 23346999999999999999999999999 9999999999999999999999999997643321 12
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccC------------CCchh
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVD------------DGREE 616 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~------------~~~~~ 616 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||........ ....|....... .....
T Consensus 201 ~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (321)
T 2qkw_B 201 VKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279 (321)
T ss_dssp CEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCH
T ss_pred cCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCH
Confidence 24789999999987 56789999999999999999999999976433222 333332221111 11244
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
..+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 6678899999999999999999999999999988753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.75 Aligned_cols=253 Identities=21% Similarity=0.364 Sum_probs=208.9
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|... .+..||||+++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 367999999999999974 466799999976543 345677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
++|+|.++++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 133 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 133 ENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLG-YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp TTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999974 2346999999999999999999999999 99999999999999999999999999976654321
Q ss_pred -----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 549 -----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 549 -----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
...+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+.... ....+...+..+
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~l 283 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEEGY-RLPAPMGCPHAL 283 (325)
T ss_dssp CEECC---CCGGGSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTC-CCCCCTTCCHHH
T ss_pred eeeccCCCCcccccCHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHcCC-CCCCCCCcCHHH
Confidence 123577899999987 5678999999999999999999 99999653 2223333333221 222345667889
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus 284 ~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 9999999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.33 Aligned_cols=240 Identities=20% Similarity=0.332 Sum_probs=202.0
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+.+|+
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 5799999999999984 5788999999875543 335678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 104 L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 104 LTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence 9999974 24899999999999999999999999 9999999999999999999999999987654432 334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++. +..++.++|||||||++|||++|+.||..... .................+...+..+.+++.+||
T Consensus 177 ~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 254 (297)
T 3fxz_A 177 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (297)
T ss_dssp CSCGGGCCHHHHH-CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred cCCcCccChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence 6899999999987 56789999999999999999999999975311 112222222222223345667788999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
+.||++|||+.|+++
T Consensus 255 ~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 255 EMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred cCChhHCcCHHHHhh
Confidence 999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.73 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=200.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC----eEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG----ERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~ 470 (665)
+.||+|+||+||+|... ++.||||++.... .....+++|+.++++++||||+++++++.... ..++||||++
T Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEECSTTCEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred heecccCceEEEEEEEC-CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 67999999999999876 6789999996543 33455667999999999999999999998754 4699999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA----------SWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
+|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 106 ~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 106 KGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp TCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-EEeCCCChHhEEECCCCeEEEccCCcc
Confidence 9999999974 3489999999999999999999998 8 999999999999999999999999999
Q ss_pred cccCCCC-----CCCCCCCcccCCccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-----------c
Q 005999 541 VLSDSSS-----VEDPDTVAYKAPEIRKSS----RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-----------D 600 (665)
Q Consensus 541 ~~~~~~~-----~~~~gt~~y~aPE~~~~~----~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-----------~ 600 (665)
....... ....||+.|+|||++... ..++.++|||||||++|||+||+.||........ .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 7654322 224589999999998742 3456688999999999999999999976432211 1
Q ss_pred HHHHHHhhccCC---C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 601 MLEWVRTMRVDD---G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 601 ~~~~~~~~~~~~---~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
...+........ . .....+..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 112221111111 1 12234567999999999999999999999999999997653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=343.64 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=205.9
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||++...++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+.+|+|
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106 (283)
T ss_dssp EECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred hhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence 67999999999999999999999999976543 346688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC----CCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----SVED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----~~~~ 550 (665)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 107 ~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (283)
T 3gen_A 107 LNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181 (283)
T ss_dssp HHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred HHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence 9999742 345899999999999999999999999 999999999999999999999999999765432 2233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.+|+.|+|||++. +..++.++||||||+++|||++ |+.||.... ..+....+.... ....+...+..+.+++.+|
T Consensus 182 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 257 (283)
T 3gen_A 182 KFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQGL-RLYRPHLASEKVYTIMYSC 257 (283)
T ss_dssp TSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHT
T ss_pred ccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccC--hhHHHHHHhccc-CCCCCCcCCHHHHHHHHHH
Confidence 4678899999987 5678999999999999999998 999997532 223333332221 1123445567899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
|+.||++|||+.|+++.|+++.++
T Consensus 258 l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 258 WHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.40 Aligned_cols=264 Identities=32% Similarity=0.578 Sum_probs=213.7
Q ss_pred cccCHHHHHHHH-----HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE
Q 005999 382 EVYSLEQLMRAS-----AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF 456 (665)
Q Consensus 382 ~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 456 (665)
..+++.++.... .+.||+|+||.||+|...++..||||++...... .....+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345555554433 3679999999999999888999999999765432 2223588999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCeeccCCCCCceEeCCCCceE
Q 005999 457 QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA---SWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 457 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~---~~iiH~Dlk~~Nill~~~~~~k 533 (665)
.+.+..++||||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC-EECCCCSGGGEEECTTCCEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeCCCchhhEEECCCCCEE
Confidence 999999999999999999999985432 345699999999999999999999999 8 99999999999999999999
Q ss_pred EeecccccccCCCC----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CCCCccHHHHHH
Q 005999 534 LTDYCLSVLSDSSS----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHP---YLAPPDMLEWVR 606 (665)
Q Consensus 534 l~Dfgl~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~---~~~~~~~~~~~~ 606 (665)
|+|||++....... ....||+.|+|||++. +..++.++|||||||++|||++|+.||+.. .........++.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999997664322 2234899999999987 566899999999999999999999999621 122334555554
Q ss_pred hhccCC------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 005999 607 TMRVDD------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 607 ~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 649 (665)
...... ......+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 333222 1244566789999999999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.89 Aligned_cols=240 Identities=21% Similarity=0.323 Sum_probs=202.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 36999999999999976 789999999976543 345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 129 L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 129 LTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp HHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 9999863 35899999999999999999999999 999999999999999999999999998765432 2334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-CCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD-DGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~c 629 (665)
.||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+....+...... .......+..+.+++.+|
T Consensus 202 ~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 202 VGTPYWMAPEVIS-RSLYATEVDIWSLGIMVIEMVDGEPPYFSD--SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 6899999999987 567899999999999999999999999752 122333333322221 123345667899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|+.||++|||+.|+++.
T Consensus 279 l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 279 LVRDPQERATAQELLDH 295 (321)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=345.16 Aligned_cols=250 Identities=24% Similarity=0.444 Sum_probs=206.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHH-----HHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSA-----EAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|.. .+++.||+|++.......... +.+.+|++++++++||||+++++++.+.. ++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~ 102 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEF 102 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEEC
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEe
Confidence 5799999999999996 478899999986554322221 67899999999999999999999997665 699999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-eeccCCCCCceEeCCCCc-----eEEeecccccc
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW-LIHGNLKSSNVLLGADFE-----ARLTDYCLSVL 542 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~-iiH~Dlk~~Nill~~~~~-----~kl~Dfgl~~~ 542 (665)
+++|+|.+++.. ....+++..++.++.|++.||+|||+.++ |+||||||+||+++.++. +||+|||++..
T Consensus 103 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~ 178 (287)
T 4f0f_A 103 VPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178 (287)
T ss_dssp CTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBC
T ss_pred cCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccc
Confidence 999999998874 34569999999999999999999999763 999999999999988776 99999999987
Q ss_pred cCCCCCCCCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 543 SDSSSVEDPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 543 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
.........+|+.|+|||++.. ...++.++|||||||++|||++|+.||.............+.........+...+..
T Consensus 179 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (287)
T 4f0f_A 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258 (287)
T ss_dssp CSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred ccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHH
Confidence 6665555679999999999842 345788999999999999999999999864333333344444333333445667788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
+.+++.+||+.||++|||+.|+++.|+++
T Consensus 259 l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 259 LRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 99999999999999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.42 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=206.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++.+++||||+++++++.+++..++||||+++++|
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (268)
T 3sxs_A 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90 (268)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcH
Confidence 57999999999999999998999999976542 346688999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~ 550 (665)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 91 ~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 165 (268)
T 3sxs_A 91 LNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ-FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165 (268)
T ss_dssp HHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSC
T ss_pred HHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCC
Confidence 9999752 345899999999999999999999999 9999999999999999999999999997654432 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.+|+.|+|||.+. +..++.++||||||+++|||++ |+.||.... ..+....+.... ....+...+..+.+++.+|
T Consensus 166 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 241 (268)
T 3sxs_A 166 KFPVKWSAPEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--NSEVVLKVSQGH-RLYRPHLASDTIYQIMYSC 241 (268)
T ss_dssp CCCGGGCCHHHHH-HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHT
T ss_pred CcCcccCCHHHHh-ccCCchhhhhHHHHHHHHHHHcCCCCCccccC--hHHHHHHHHcCC-CCCCCCcChHHHHHHHHHH
Confidence 4577899999987 5678999999999999999999 999997531 122222222211 1123444567899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
|+.||++|||+.|+++.|+.+.+.
T Consensus 242 l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 242 WHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cCCChhhCcCHHHHHHHHHHhhhc
Confidence 999999999999999999887654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=347.78 Aligned_cols=244 Identities=18% Similarity=0.275 Sum_probs=197.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||+||+|...+++.||+|++..........+.+.+|++++++++||||+++++++.+++..++||||+.+ +|
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l 105 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL 105 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EH
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CH
Confidence 57999999999999998899999999976655445567788999999999999999999999999999999999985 88
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVEDP 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~ 551 (665)
.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .....
T Consensus 106 ~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 180 (311)
T 3niz_A 106 KKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180 (311)
T ss_dssp HHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCC
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCc
Confidence 8888742 345899999999999999999999999 999999999999999999999999999766432 23346
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC------------------
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG------------------ 613 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------------------ 613 (665)
+|+.|+|||++.+...++.++||||+||++|||++|+.||...... ..+............
T Consensus 181 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred ccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 8999999999875567899999999999999999999999764322 122222221111100
Q ss_pred ---------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 ---------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 01223467889999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=365.42 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=206.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-eEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG-ERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +..||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||+++|+
T Consensus 199 ~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred eeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 67999999999999986 5689999997643 3467899999999999999999999987765 7899999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT 553 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt 553 (665)
|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...........++
T Consensus 274 L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 349 (450)
T 1k9a_A 274 LVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 349 (450)
T ss_dssp HHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTSCEEECCCTTCEECC------CCC
T ss_pred HHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCC
Confidence 99999853 2234789999999999999999999999 9999999999999999999999999998665544444678
Q ss_pred CcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 554 ~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
..|+|||++. +..++.++|||||||++|||++ |+.||.... ..++...+.... ....+..++..+.+++.+||+.
T Consensus 350 ~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~ 425 (450)
T 1k9a_A 350 VKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY-KMDAPDGCPPAVYDVMKNCWHL 425 (450)
T ss_dssp TTTSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC--TTTHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCS
T ss_pred cceeCHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcCC
Confidence 8999999987 6779999999999999999998 999997632 234444443322 1234456778899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhh
Q 005999 633 SPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 633 dP~~RPt~~evl~~L~~~~~~ 653 (665)
||++|||+.|+++.|+.+...
T Consensus 426 dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 426 DAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp SGGGSCCHHHHHHHHHHHHHT
T ss_pred ChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.14 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=208.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... ++..||||+++.... ....+.+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 367999999999999976 788999999875532 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.++++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 198 ~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 198 DFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp BHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 999999742 345899999999999999999999999 99999999999999999999999999976543221
Q ss_pred -CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 549 -EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 549 -~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
...+++.|+|||++. ...++.++|||||||++|||++ |+.||... ...+....+.... ....+..++..+.+++
T Consensus 273 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVEKGG-RLPCPELCPDAVFRLM 348 (377)
T ss_dssp SCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--CHHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred CCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCCCCCCCCHHHHHHH
Confidence 112467799999987 5678999999999999999998 99998753 2223333333322 1223455678899999
Q ss_pred HHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 627 SVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
.+||+.||++|||+.++++.|+++.+.
T Consensus 349 ~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 999999999999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=340.98 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=205.6
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|..+ +..||+|++..........+.+.+|+.++++++||||+++++++.+. +..++||||+++|
T Consensus 16 ~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (271)
T 3kmu_A 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94 (271)
T ss_dssp EEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred HHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence 57999999999999986 67899999987765556677899999999999999999999999887 7889999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
+|.+++... ....+++..++.++.||+.||+|||+.+ +|+||||||+||+++.++.++|+|||++..... ....
T Consensus 95 ~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--~~~~ 169 (271)
T 3kmu_A 95 SLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--PGRM 169 (271)
T ss_dssp BHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--TTCB
T ss_pred cHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc--cCcc
Confidence 999999853 2336899999999999999999999864 489999999999999999999999988755332 2346
Q ss_pred CCCcccCCccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRKSSR--RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~~~~--~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
+|+.|+|||.+.... .++.++||||||+++|||++|+.||.... ..+....+.........+...+..+.+++.+|
T Consensus 170 ~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 247 (271)
T 3kmu_A 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--NMEIGMKVALEGLRPTIPPGISPHVSKLMKIC 247 (271)
T ss_dssp SCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--HHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHH
T ss_pred CCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 899999999987321 23338999999999999999999997531 12222222222222234456778899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~ 652 (665)
|+.||++|||+.|+++.|+++.+
T Consensus 248 l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 248 MNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=353.52 Aligned_cols=242 Identities=19% Similarity=0.303 Sum_probs=202.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... ++..||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 97 (361)
T 2yab_A 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97 (361)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcC
Confidence 57999999999999965 68899999997654321 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC----ceEEeecccccccCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF----EARLTDYCLSVLSDS 545 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~~ 545 (665)
++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++.....
T Consensus 98 ~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 98 SGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp CSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 99999999973 356999999999999999999999999 99999999999998876 799999999977654
Q ss_pred CC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHH
Q 005999 546 SS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGM 621 (665)
Q Consensus 546 ~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 621 (665)
.. ....||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+....+........ .....+..
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 172 GVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp TCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCccccCCCCccEECchHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 32 3346899999999987 567899999999999999999999999752 22233333332222211 22355678
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+|+.+||..||++|||+.|+++
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.46 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=213.7
Q ss_pred hHhCcccceEEEEEEE--------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 465 (665)
+.||+|+||.||+|.. ..+..||+|++..... ....+.+.+|+++++++ +||||+++++++..++..++|
T Consensus 75 ~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 6799999999999985 3457899999976543 34557789999999999 999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEE
Q 005999 466 YDYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL 534 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl 534 (665)
|||+++|+|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL 232 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTEDNVMKI 232 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCcceEEEcCCCcEEE
Confidence 999999999999986431 11346999999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhh
Q 005999 535 TDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTM 608 (665)
Q Consensus 535 ~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 608 (665)
+|||++....... ....+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+...
T Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~--~~~~~~~~~~~~ 309 (382)
T 3tt0_A 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKEG 309 (382)
T ss_dssp CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTT
T ss_pred cccCcccccccccccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcC
Confidence 9999997664322 2234678899999987 6779999999999999999999 99998753 222333333332
Q ss_pred ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCc
Q 005999 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDN 659 (665)
Q Consensus 609 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 659 (665)
.. ...+...+..+.+++.+||+.||++|||+.|+++.|+.+.......+.
T Consensus 310 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 310 HR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp CC-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred CC-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 21 223455677899999999999999999999999999999887655443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.83 Aligned_cols=250 Identities=19% Similarity=0.383 Sum_probs=199.6
Q ss_pred hHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|... ++..||||+++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 51 ~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp EEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 67999999999999864 577899999976543 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC--
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV-- 548 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 548 (665)
+|+|.++++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 130 ~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 204 (373)
T 2qol_A 130 NGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204 (373)
T ss_dssp TCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence 9999999974 2346899999999999999999999999 99999999999999999999999999976643221
Q ss_pred ----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 549 ----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 549 ----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
...+++.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+..... .......+..+.
T Consensus 205 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~ 280 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEM--SNQDVIKAVDEGYR-LPPPMDCPAALY 280 (373)
T ss_dssp ---------CTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--CHHHHHHHHHTTEE-CCCCTTCBHHHH
T ss_pred eeccCCCcCCCccChhhhc-cCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCccccHHHH
Confidence 112467899999987 5679999999999999999998 99999753 22233333332221 123445677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
+++.+||+.||++||++.|+++.|+.+....
T Consensus 281 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 281 QLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999997654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=356.31 Aligned_cols=244 Identities=22% Similarity=0.323 Sum_probs=205.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... ++..||+|++..........+.+.+|++++++++||||+++++++.+++..++||||+.+|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg 113 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 467999999999999965 6889999999876555556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC---CceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD---FEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++.......
T Consensus 114 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 114 ELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp BHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99999873 346899999999999999999999999 9999999999999865 459999999997765433
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 625 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... ....+...+....... ......+..+.++
T Consensus 188 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp CCSCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred ccCCCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2346899999999987 567899999999999999999999999752 2223333333332222 2234567789999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~ 646 (665)
+.+||+.||++|||+.|+++.
T Consensus 265 i~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.32 Aligned_cols=243 Identities=20% Similarity=0.281 Sum_probs=204.3
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||+||+|.. .+++.+|+|++..........+.+.+|++++++++||||+++++++.+++..++||||+.+|
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 46799999999999985 47889999999877665566778999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC---CCCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG---ADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 96 ~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~g-ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 96 ELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp BHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 99999874 345899999999999999999999999 99999999999998 46789999999997665432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTE 624 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 624 (665)
....||+.|+|||++. +..++.++||||+||++|+|++|+.||... ....+...+....... ......+..+.+
T Consensus 170 ~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 246 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246 (444)
T ss_dssp CCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred eecccCCcccCCHHHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCc--cHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 2346899999999987 567899999999999999999999999652 2224444444333222 122456778999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~ 645 (665)
++.+||+.||++|||+.|+++
T Consensus 247 li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 247 LINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.37 Aligned_cols=265 Identities=29% Similarity=0.496 Sum_probs=213.5
Q ss_pred cccCHHHHHHHHH-----------hHhCcccceEEEEEEECCeEEEEEEEecCCC--chhhHHHHHHHHHHHHhCCCCCC
Q 005999 382 EVYSLEQLMRASA-----------ELLGRGSIGTTYKAVLDNHLIVTVKRFDANK--TADTSAEAFEQHMEAVGGLSHPN 448 (665)
Q Consensus 382 ~~~~~~~~~~~~~-----------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~n 448 (665)
..|++.++..++. +.||+|+||.||+|.. ++..||+|++.... ......+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4566777766652 5699999999999986 56789999986543 22345678999999999999999
Q ss_pred eeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC
Q 005999 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 449 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~ 528 (665)
|+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH-HIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997432 2356899999999999999999999999 999999999999999
Q ss_pred CCceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cH
Q 005999 529 DFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DM 601 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~ 601 (665)
++.+||+|||++....... ....||+.|+|||.+. +.++.++||||||+++|||++|+.||........ .+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 9999999999987654422 2235899999999886 3588999999999999999999999976432211 12
Q ss_pred HHHHHhhc-------c--CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 602 LEWVRTMR-------V--DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 602 ~~~~~~~~-------~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
...+.... . ........+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111100 0 011234566789999999999999999999999999998854
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=342.43 Aligned_cols=257 Identities=15% Similarity=0.176 Sum_probs=210.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++++ +|+|++++++++.+....++||||+ ++
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 5799999999999995 5789999999865432 23467889999999 8999999999999999999999999 99
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc-----eEEeecccccccCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE-----ARLTDYCLSVLSDSSS 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~-----~kl~Dfgl~~~~~~~~ 547 (665)
+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++.......
T Consensus 91 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 91 SLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp BHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 999999853 345999999999999999999999999 999999999999987776 9999999997654321
Q ss_pred ----------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCCC---
Q 005999 548 ----------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDG--- 613 (665)
Q Consensus 548 ----------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~--- 613 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||........ .....+........
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccCccCCCCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 2335899999999987 56789999999999999999999999987432222 22222222111111
Q ss_pred chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCcccC
Q 005999 614 REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662 (665)
Q Consensus 614 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 662 (665)
.....+..+.+++.+||+.||++|||+.++++.|+++.+......+..|
T Consensus 245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 293 (298)
T 1csn_A 245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 293 (298)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcc
Confidence 1235577899999999999999999999999999999998876555444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=344.35 Aligned_cols=252 Identities=20% Similarity=0.382 Sum_probs=201.8
Q ss_pred hHhCcccceEEEEEEE-----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 467 (665)
+.||+|+||+||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 6799999999999985 368899999997553 3456779999999999999999999999865 356899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 94 YLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp CCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred eCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 99999999999753 345899999999999999999999999 9999999999999999999999999997664322
Q ss_pred ------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC---------CCc-cHH-HHHHhhcc
Q 005999 548 ------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYL---------APP-DML-EWVRTMRV 610 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~---------~~~-~~~-~~~~~~~~ 610 (665)
....++..|+|||.+. +..++.++||||||+++|||++|..|+..... ... ... ........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp -------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence 1224667799999987 56789999999999999999999999864210 000 111 11111111
Q ss_pred --CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 611 --DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 611 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11234566788999999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.59 Aligned_cols=253 Identities=15% Similarity=0.138 Sum_probs=206.6
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||+ ++
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 6799999999999995 5789999999865432 23478899999999 9999999999999999999999999 99
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc-----eEEeecccccccCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE-----ARLTDYCLSVLSDSSS 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~-----~kl~Dfgl~~~~~~~~ 547 (665)
+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.......
T Consensus 90 ~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 90 SLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN-LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp BHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 999999853 356999999999999999999999999 999999999999998887 9999999997653322
Q ss_pred ----------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCCC---
Q 005999 548 ----------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDG--- 613 (665)
Q Consensus 548 ----------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~--- 613 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||........ +....+........
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 243 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred CCccccccccCCcCCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH
Confidence 2346899999999987 57789999999999999999999999987432221 22222221111111
Q ss_pred chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCc
Q 005999 614 REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDN 659 (665)
Q Consensus 614 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 659 (665)
.....+ .+.+++..|++.||.+||++.++++.|+++.+......+
T Consensus 244 ~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 112244 899999999999999999999999999999887755433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.77 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=210.9
Q ss_pred HhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||+|.. .++..||+|++..... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 36799999999999985 3568999999976543 3455778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC
Q 005999 468 YQPNGSLFNLIHGSRSI-------------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~ 528 (665)
|+++|+|.+++...+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dikp~NIli~~ 185 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-LVHRDLAARNILVAE 185 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEET
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-CcccccchheEEEcC
Confidence 99999999999864321 1234899999999999999999999999 999999999999999
Q ss_pred CCceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005999 529 DFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDML 602 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 602 (665)
++.+||+|||++....... ....+|+.|+|||.+. +..++.++|||||||++|||++ |+.||... ....+.
T Consensus 186 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~ 262 (314)
T 2ivs_A 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--PPERLF 262 (314)
T ss_dssp TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHH
Confidence 9999999999997654322 2234678899999987 5678999999999999999999 99999763 223444
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
..+..... ...+...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 263 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 263 NLLKTGHR-MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHhhcCCc-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 44433221 223456677899999999999999999999999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=342.82 Aligned_cols=244 Identities=18% Similarity=0.282 Sum_probs=198.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...+++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+.+ +|
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 86 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL 86 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence 57999999999999998899999999976654444456788999999999999999999999999999999999986 99
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVEDP 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~ 551 (665)
.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 87 ~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (288)
T 1ob3_A 87 KKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161 (288)
T ss_dssp HHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred HHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccccc
Confidence 9998742 356899999999999999999999999 999999999999999999999999999765432 22335
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-------------------
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------------- 612 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------------- 612 (665)
+|+.|+|||++.+...++.++|||||||++|||++|+.||..... ...+....+......
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 1ob3_A 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (288)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred ccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence 899999999987555689999999999999999999999975321 112222221111100
Q ss_pred -------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001235677899999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.21 Aligned_cols=244 Identities=20% Similarity=0.283 Sum_probs=200.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++|+
T Consensus 13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 67999999999999965 788999999865433 2334668899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-----SV 548 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~~ 548 (665)
|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 92 L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 92 LFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp GGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred HHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 9999863 346999999999999999999999999 999999999999999999999999999754321 12
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++.....++.++|||||||++|||++|+.||............+.... .........+..+.+++.+
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 244 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLALLHK 244 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-TTSTTGGGSCHHHHHHHHH
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-ccCCccccCCHHHHHHHHH
Confidence 346899999999987444457899999999999999999999987543333343333322 1122334567789999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~ 646 (665)
||+.||++|||+.|+++.
T Consensus 245 ~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 245 ILVENPSARITIPDIKKD 262 (323)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HccCChhhCcCHHHHhhC
Confidence 999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.14 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=208.5
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|... ++..||+|+++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 67999999999999964 468999999976543 34567799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC
Q 005999 469 QPNGSLFNLIHGSRSI-------------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD 529 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~ 529 (665)
+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.+
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~ 210 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRNCLVGEN 210 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGG
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEECCC
Confidence 9999999999753211 1257999999999999999999999999 9999999999999999
Q ss_pred CceEEeecccccccCCC-----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHH
Q 005999 530 FEARLTDYCLSVLSDSS-----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 530 ~~~kl~Dfgl~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 603 (665)
+.+||+|||++...... .....+|+.|+|||++. +..++.++||||||+++|||++ |+.||... ...++..
T Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~--~~~~~~~ 287 (343)
T 1luf_A 211 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--AHEEVIY 287 (343)
T ss_dssp GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHH
T ss_pred CeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcCCCC--ChHHHHH
Confidence 99999999998654322 12335788999999987 5679999999999999999999 99999753 2223333
Q ss_pred HHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 604 WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.+..... ...+...+..+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 288 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 288 YVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 3332221 12345667789999999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.85 Aligned_cols=240 Identities=21% Similarity=0.262 Sum_probs=203.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|+++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg 91 (318)
T 1fot_A 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 91 (318)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence 57999999999999965 6889999999754321 123566789999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++...........|
T Consensus 92 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~g 165 (318)
T 1fot_A 92 ELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG 165 (318)
T ss_dssp BHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCS
T ss_pred CHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChheEEEcCCCCEEEeecCcceecCCccccccC
Confidence 99999974 346899999999999999999999999 999999999999999999999999999887766666679
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
|+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+.. .....+...+..+.+++.+||..
T Consensus 166 t~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~--~~~~~p~~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 166 TPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILN--AELRFPPFFNEDVKDLLSRLITR 240 (318)
T ss_dssp CTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred CccccCHhHhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHhcc
Confidence 99999999987 6678999999999999999999999997531 1222222222 12223445677899999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 005999 633 SPEQRP-----AMWQVLK 645 (665)
Q Consensus 633 dP~~RP-----t~~evl~ 645 (665)
||++|| ++.|+++
T Consensus 241 dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHHcCCCcCCCHHHHhc
Confidence 999999 8888875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=348.34 Aligned_cols=241 Identities=16% Similarity=0.240 Sum_probs=201.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||++... ++..||+|.+.... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus 11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 57999999999999965 68899999987543 445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC--CCceEEeecccccccCCCC--CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA--DFEARLTDYCLSVLSDSSS--VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~--~~ 549 (665)
|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++....... ..
T Consensus 88 L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g-ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 88 IFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 9999974 2346899999999999999999999999 999999999999997 7899999999997765432 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGMLTEVAS 627 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 627 (665)
..+|+.|+|||++. +..++.++|||||||++|||++|+.||... ...+....+........ .....+..+.+++.
T Consensus 163 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T 1tki_A 163 LFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccCChhhcCcHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCC--CHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence 35899999999987 566899999999999999999999999763 22233333332222211 12355778999999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~~ 646 (665)
+||..||++|||+.|+++.
T Consensus 240 ~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHcCCChhHCcCHHHHhcC
Confidence 9999999999999999883
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.99 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=197.2
Q ss_pred HhHhCcccceEEEEEEECCe-E---EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeE------E
Q 005999 394 AELLGRGSIGTTYKAVLDNH-L---IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER------L 463 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~-~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~ 463 (665)
.+.||+|+||.||+|..... . .||+|+++.........+.+.+|++++++++||||+++++++...... +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 46799999999999985433 2 799999987655556678899999999999999999999999877655 8
Q ss_pred EEEEecCCCCHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 464 VIYDYQPNGSLFNLIHGSRSI-RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+||||+.+|+|.+++...+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~Dikp~NIli~~~~~~kl~Dfg~a~~ 186 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-FIHRDLAARNCMLAEDMTVCVADFGLSRK 186 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-cccCCCCcceEEEcCCCCEEEeecccccc
Confidence 999999999999998643221 2235899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 543 SDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 543 ~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
...... ...+++.|+|||.+. +..++.++|||||||++|||++ |+.||... ...+....+..... .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~ 262 (323)
T 3qup_A 187 IYSGDYYRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI--ENAEIYNYLIGGNR-LKQPP 262 (323)
T ss_dssp --------------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCC-CCCCT
T ss_pred ccccccccccccccCcccccCchhhc-CCCCCCccchhhHHHHHHHHHhCCCCCcccc--ChHHHHHHHhcCCC-CCCCC
Confidence 543321 224677899999987 5678999999999999999999 99999763 22344333332221 22344
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
..+..+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 263 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 263 ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 567789999999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=349.60 Aligned_cols=243 Identities=21% Similarity=0.321 Sum_probs=202.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||+|... ++..||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 95 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence 467999999999999965 68899999987553321 2467789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC----ceEEeecccccccC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF----EARLTDYCLSVLSD 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~ 544 (665)
+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++....
T Consensus 96 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 96 VAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp CCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC-eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999999973 356899999999999999999999999 99999999999999887 89999999997765
Q ss_pred CC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHH
Q 005999 545 SS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLG 620 (665)
Q Consensus 545 ~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 620 (665)
.. .....||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+....+........ .....+.
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCccccccCCcCcCCceeec-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--CHHHHHHHHHhcCCCcCccccccCCH
Confidence 33 23346899999999987 567899999999999999999999999752 11223222322222211 1234567
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 8999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.85 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=208.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (267)
T 3t9t_A 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL 90 (267)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred eEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence 57999999999999998888999999976543 346789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC----CCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----SVED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----~~~~ 550 (665)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 91 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 91 SDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 9999753 346899999999999999999999999 999999999999999999999999999765432 1233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+..... ...+...+..+.+++.+|
T Consensus 166 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 166 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFR-LYKPRLASTHVYQIMNHC 241 (267)
T ss_dssp TCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHH
T ss_pred cccccccChhhhc-CCCccchhchhhhHHHHHHHhccCCCCCCCC--CHHHHHHHHhcCCc-CCCCccCcHHHHHHHHHH
Confidence 5678899999987 5678999999999999999999 89998753 12233333332211 123345577899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
|+.||++|||+.|+++.|+++.+.
T Consensus 242 l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.72 Aligned_cols=250 Identities=18% Similarity=0.296 Sum_probs=203.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... ++..||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 96 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence 67999999999999964 688999999865433 2345678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~ 548 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++++||+|||++....... .
T Consensus 97 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (294)
T 4eqm_A 97 TLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170 (294)
T ss_dssp BHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence 99999974 346899999999999999999999999 9999999999999999999999999997665432 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-----chhhhHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG-----REENRLGMLT 623 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~ 623 (665)
...||+.|+|||.+. +..++.++||||||+++|||++|+.||.... .............. .....+..+.
T Consensus 171 ~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGET----AVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ----CCSSCCHHHHH-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC----HHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 235899999999987 5678999999999999999999999997632 11111111111111 2334677899
Q ss_pred HHHHHcccCCCCCCC-CHHHHHHHHHHHHhhhc
Q 005999 624 EVASVCSLKSPEQRP-AMWQVLKMIQEIKESVM 655 (665)
Q Consensus 624 ~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 655 (665)
+++.+|++.||++|| +++++.+.|+.+.....
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 999999999999998 99999999988765543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=355.59 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=207.1
Q ss_pred hHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCC-eEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKG-ERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv~ 466 (665)
+.||+|+||.||+|.+ .+++.||||+++.... ....+.+.+|++++.++ +||||+++++++.+.+ ..++||
T Consensus 28 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 6799999999999973 3578999999976543 34456789999999999 8999999999998755 489999
Q ss_pred EecCCCCHHHHHhcCCCC-------------------------------------------------------------C
Q 005999 467 DYQPNGSLFNLIHGSRSI-------------------------------------------------------------R 485 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------~ 485 (665)
||+++|+|.++++..... .
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 999999999999864321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----CCCCCCCcccCCc
Q 005999 486 AKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPE 560 (665)
Q Consensus 486 ~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE 560 (665)
...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....+|+.|+|||
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHH
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChh
Confidence 122899999999999999999999999 9999999999999999999999999997654322 1234688999999
Q ss_pred cccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCC
Q 005999 561 IRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPA 639 (665)
Q Consensus 561 ~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 639 (665)
++. +..++.++|||||||++|||++ |+.||..... ...+...+.... ....+...+..+.+++.+||+.||++|||
T Consensus 266 ~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps 342 (359)
T 3vhe_A 266 TIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPT 342 (359)
T ss_dssp HHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccch-hHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 987 5778999999999999999998 9999976432 223333332221 22234456778999999999999999999
Q ss_pred HHHHHHHHHHHHhhh
Q 005999 640 MWQVLKMIQEIKESV 654 (665)
Q Consensus 640 ~~evl~~L~~~~~~~ 654 (665)
+.|+++.|+++.+..
T Consensus 343 ~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 343 FSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.44 Aligned_cols=241 Identities=18% Similarity=0.254 Sum_probs=201.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg 90 (337)
T 1o6l_A 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 57999999999999965 688999999975422 1234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~ 549 (665)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++..... ....
T Consensus 91 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 164 (337)
T 1o6l_A 91 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp BHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccc
Confidence 99999874 346899999999999999999999999 99999999999999999999999999975432 2233
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||... ....+...+.. .....+...+..+.+++.+|
T Consensus 165 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 165 FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILM--EEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHH
T ss_pred cccChhhCChhhhc-CCCCCchhhcccchhHHHHHhcCCCCCCCC--CHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHH
Confidence 45899999999987 567899999999999999999999999752 12233332222 12223455677899999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 005999 630 SLKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RP-----t~~evl~~ 646 (665)
|+.||++|| ++.|+++.
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTS
T ss_pred hhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999 89999763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=355.87 Aligned_cols=260 Identities=17% Similarity=0.219 Sum_probs=203.9
Q ss_pred hHhCcccceEEEEEEECC------eEEEEEEEecCCCchhhH---------HHHHHHHHHHHhCCCCCCeeeeeEEEEeC
Q 005999 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTS---------AEAFEQHMEAVGGLSHPNLVPIRAYFQAK 459 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 459 (665)
+.||+|+||.||+|.... ++.||||++......... ...+.+|+..++.++||||+++++++...
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 120 (364)
T 3op5_A 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120 (364)
T ss_dssp EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEE
T ss_pred EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeec
Confidence 679999999999998764 378999998765421111 12234566678889999999999998764
Q ss_pred ----CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC--CCCceE
Q 005999 460 ----GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG--ADFEAR 533 (665)
Q Consensus 460 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~--~~~~~k 533 (665)
...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+|
T Consensus 121 ~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~-iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 121 KNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHE-YVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp ETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEESSCTTCEE
T ss_pred cCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eEEecCCHHHEEEecCCCCeEE
Confidence 4589999999 9999999975 2356999999999999999999999999 99999999999999 889999
Q ss_pred EeecccccccCCCC----------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 005999 534 LTDYCLSVLSDSSS----------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 534 l~Dfgl~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 603 (665)
|+|||++....... ....||+.|+|||++. +..++.++|||||||++|||+||+.||...... .....
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-~~~~~ 272 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-PKYVR 272 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-HHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCccccccC-HHHHH
Confidence 99999996553221 2224899999999987 567999999999999999999999999853222 22222
Q ss_pred HHHhhccCC--------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCcccC
Q 005999 604 WVRTMRVDD--------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662 (665)
Q Consensus 604 ~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 662 (665)
......... ......+..+.+++..||+.||++||++.++++.|+++.+......+..+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence 111111110 01134577899999999999999999999999999999998876655544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=356.14 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=208.2
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|.+. ++..||||++..... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 67999999999999843 467899999975443 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC---ceEEeeccccccc
Q 005999 469 QPNGSLFNLIHGSRS--IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF---EARLTDYCLSVLS 543 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~ 543 (665)
+++|+|.+++...+. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~ 234 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEEecCCCCceEEECCCcccccc
Confidence 999999999975432 12346899999999999999999999999 99999999999999554 5999999999643
Q ss_pred CCC-----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 544 DSS-----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 544 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
... .....+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+..... ......
T Consensus 235 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~--~~~~~~~~i~~~~~-~~~~~~ 310 (367)
T 3l9p_A 235 YRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGGR-MDPPKN 310 (367)
T ss_dssp HHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCC-CCCCTT
T ss_pred ccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCcc
Confidence 221 12224688999999987 5679999999999999999998 99999763 22244443333221 223456
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.+..+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 311 ~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 67789999999999999999999999999999877543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=365.92 Aligned_cols=248 Identities=25% Similarity=0.435 Sum_probs=208.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++||||+.+|+|
T Consensus 194 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269 (454)
T ss_dssp EEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence 5799999999999999888899999997654 34678999999999999999999999986 5678999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC----CCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----SVED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----~~~~ 550 (665)
.++++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 270 ~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 345 (454)
T 1qcf_A 270 LDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345 (454)
T ss_dssp HHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred HHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence 9999742 1235888999999999999999999999 999999999999999999999999999776432 1223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. ...++.++|||||||++|||+| |+.||... ...++...+..... ...+..++..+.+++.+|
T Consensus 346 ~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~c 421 (454)
T 1qcf_A 346 KFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--SNPEVIRALERGYR-MPRPENCPEELYNIMMRC 421 (454)
T ss_dssp SSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHH
T ss_pred cccccccCHHHhc-cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHH
Confidence 4678899999987 5679999999999999999999 99999753 22344444433221 223456778899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
|+.||++|||+.+|++.|+++....
T Consensus 422 l~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 422 WKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ccCChhHCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999998876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=344.38 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=211.6
Q ss_pred HhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||+|.. .++..||+|++..... ....+.+.+|+.+++++ +||||+++++++..++..++||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 36799999999999985 3678999999976543 23457789999999999 9999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 467 DYQPNGSLFNLIHGSRSI-------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
||+++|+|.+++...+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~k 185 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHGRITK 185 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETTTEEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEcCCCCEE
Confidence 999999999999854321 1235899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHh
Q 005999 534 LTDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT 607 (665)
Q Consensus 534 l~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 607 (665)
|+|||++........ ...+|+.|+|||++. +..++.++||||||+++|||++ |+.||..... .......+..
T Consensus 186 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~ 263 (313)
T 1t46_A 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSKFYKMIKE 263 (313)
T ss_dssp ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SHHHHHHHHH
T ss_pred EccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc-hhHHHHHhcc
Confidence 999999976654322 223577899999887 5678999999999999999999 9999976422 2233333332
Q ss_pred hccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 608 MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 608 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.. ........+..+.+++.+||+.||++|||+.|+++.|+++..+..
T Consensus 264 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 264 GF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp TC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CC-CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 22 222344567789999999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.50 Aligned_cols=245 Identities=17% Similarity=0.250 Sum_probs=198.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++.+++..++||||+.+ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 57999999999999975 688999999987665556667889999999999999999999999999999999999986 6
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
+.+.+.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 87 l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~-ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (292)
T 3o0g_A 87 LKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp HHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence 6666653 2356999999999999999999999999 9999999999999999999999999997664322 234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------------ 612 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 612 (665)
.+|+.|+|||++.+...++.++|||||||++|||++|..|+.........+....+......
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence 67999999999875555899999999999999999998886443211112222222111110
Q ss_pred --------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 011235677899999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.77 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=198.3
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|... +..||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++|+|
T Consensus 14 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L 86 (307)
T 2eva_A 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL 86 (307)
T ss_dssp EEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred eEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence 67999999999999886 567999998643 345678999999999999999999998874 47899999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCeeccCCCCCceEeCCCCc-eEEeecccccccCCCCCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR---ASWLIHGNLKSSNVLLGADFE-ARLTDYCLSVLSDSSSVED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~---~~~iiH~Dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~~~~~ 550 (665)
.++++... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +||+|||++..........
T Consensus 87 ~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~-ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (307)
T 2eva_A 87 YNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN 163 (307)
T ss_dssp HHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC-CCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC-eecCCCChhHEEEeCCCCEEEEcccccccccccccccC
Confidence 99998532 22357889999999999999999999 67 999999999999998886 7999999997766555555
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++. +..++.++||||||+++|||++|+.||.............+.. ..........+..+.+++.+||
T Consensus 164 ~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 241 (307)
T 2eva_A 164 KGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRPPLIKNLPKPIESLMTRCW 241 (307)
T ss_dssp -CCTTSSCHHHHT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCCCCBTTCCHHHHHHHHHHT
T ss_pred CCCCceEChhhhC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCCCCcccccCHHHHHHHHHHh
Confidence 7899999999987 5678999999999999999999999997643222222222222 1122234556778999999999
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 631 LKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
+.||++|||+.|+++.|+.+......
T Consensus 242 ~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 242 SKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred cCChhhCcCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=342.38 Aligned_cols=243 Identities=25% Similarity=0.404 Sum_probs=192.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHh--CCCCCCeeeeeEEEEe----CCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVG--GLSHPNLVPIRAYFQA----KGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~----~~~~~lv~e~ 468 (665)
+.||+|+||+||+|.. +++.||||++.... .+.+.+|.+++. +++||||+++++++.. ....++||||
T Consensus 14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~ 87 (301)
T 3q4u_A 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87 (301)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred EeeccCCCcEEEEEEE-CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence 6799999999999988 57789999986432 233444555554 4899999999998754 2468899999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH--------RASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
+++|+|.++++. ..+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 88 HEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp CTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999999963 35899999999999999999999 888 999999999999999999999999998
Q ss_pred cccCCCC-------CCCCCCCcccCCccccCCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 005999 541 VLSDSSS-------VEDPDTVAYKAPEIRKSSR-----RATSKSDVYAFGVLLLELLTG----------KHPSQHPYLAP 598 (665)
Q Consensus 541 ~~~~~~~-------~~~~gt~~y~aPE~~~~~~-----~~~~k~DvwSlGvvl~elltg----------~~P~~~~~~~~ 598 (665)
....... ....||+.|+|||++.... .++.++|||||||++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 6543322 2236899999999987432 344789999999999999999 88887654433
Q ss_pred ccHHHHHHhhccCC---C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 599 PDMLEWVRTMRVDD---G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 599 ~~~~~~~~~~~~~~---~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.............. . .....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 33333322221111 1 1234667899999999999999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.98 Aligned_cols=260 Identities=18% Similarity=0.276 Sum_probs=202.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .++..||+|++..... .....+.+.+|+.++++++||||+++++++..++..++||||+.+|
T Consensus 38 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (310)
T 2wqm_A 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117 (310)
T ss_dssp EEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSC
T ss_pred EeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCC
Confidence 6799999999999996 4788999999975432 2345677899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 118 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 195 (310)
T 2wqm_A 118 DLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195 (310)
T ss_dssp BHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCC---------------
T ss_pred CHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccc
Confidence 99999864221 2456899999999999999999999999 9999999999999999999999999987654332 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+++.|+|||++. +..++.++||||||+++|||++|+.||.........+...+.............+..+.+++.+|
T Consensus 196 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 274 (310)
T 2wqm_A 196 LVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274 (310)
T ss_dssp ---CCSSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHH
T ss_pred cCCCeeEeChHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHH
Confidence 35889999999987 56789999999999999999999999975432222333333332222222345677899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
|+.||++|||+.|+++.|+++.......
T Consensus 275 l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 275 INPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred cCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 9999999999999999999998877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.18 Aligned_cols=248 Identities=18% Similarity=0.298 Sum_probs=200.4
Q ss_pred hHhCcccceEEEEEEEC-CeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||+||+|... ++. .||+|.+..... ....+.+.+|+.++++++||||+++++++.+.. .++|+||+
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~ 98 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence 67999999999999854 343 358888764432 244577899999999999999999999998765 78999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 99 PFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp TTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 999999999753 356899999999999999999999999 99999999999999999999999999976543321
Q ss_pred ----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 549 ----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 549 ----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
...+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ....+...+.... ....+...+..+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~ 249 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGE-RLPQPPICTIDVY 249 (327)
T ss_dssp ------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTC-CCCCCTTBCHHHH
T ss_pred ccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCC--CHHHHHHHHHcCC-CCCCCccCCHHHH
Confidence 224578999999987 6779999999999999999999 99999763 2334444444322 2223455677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+++.+||+.||++|||+.|+++.|+.+...
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.56 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=198.4
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|... .+..||+|++..... ....+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~ 97 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 97 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecC
Confidence 367999999999999864 355799999876543 345677899999999999999999999985 45689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 98 TLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp TTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 999999999752 346899999999999999999999999 9999999999999999999999999997665432
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
....+|+.|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+..... ...+...+..+.+
T Consensus 173 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~pf~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~ 248 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGER-LPMPPNCPPTLYS 248 (281)
T ss_dssp ------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCC-CCCCTTCCHHHHH
T ss_pred ccccCCCcccccChhhcc-cCCCCCccCchHHHHHHHHHHhcCCCCCCcC--CHHHHHHHHHcCCC-CCCCCCCCHHHHH
Confidence 1224678899999987 5678999999999999999996 99999763 23344444433221 2234566788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
++.+||+.||++|||+.|+++.|+++.+..
T Consensus 249 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999997754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=339.14 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=192.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCch--hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA--DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +..||+|++...... ....+.+.+|+++++.++||||+++++++.+++..++||||++++
T Consensus 13 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 57999999999999976 678999998755332 233567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeeccCCCCCceEeCC--------CCceEEeecccccc
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS--WLIHGNLKSSNVLLGA--------DFEARLTDYCLSVL 542 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~iiH~Dlk~~Nill~~--------~~~~kl~Dfgl~~~ 542 (665)
+|.+++.. ..+++..++.++.|++.||+|||+.+ +|+||||||+||+++. ++.+||+|||++..
T Consensus 92 ~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 92 PLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp EHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred CHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 99999852 46899999999999999999999987 3789999999999986 67899999999976
Q ss_pred cCCCC-CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 543 SDSSS-VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 543 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
..... ....+|+.|+|||.+. +..++.++||||||+++|||++|+.||.... .......+.........+...+..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 242 (271)
T 3dtc_A 166 WHRTTKMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLAVAYGVAMNKLALPIPSTCPEP 242 (271)
T ss_dssp ----------CCGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred cccccccCCCCccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHhhhcCCCCCCCCcccCHH
Confidence 54432 2346899999999987 5678999999999999999999999997531 112222222222222344566788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
+.+++.+||+.||++|||+.|+++.|+++
T Consensus 243 ~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 243 FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.24 Aligned_cols=242 Identities=21% Similarity=0.323 Sum_probs=192.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh------------------------hHHHHHHHHHHHHhCCCCCCe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD------------------------TSAEAFEQHMEAVGGLSHPNL 449 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~ni 449 (665)
+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++++++||||
T Consensus 19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 98 (298)
T 2zv2_A 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV 98 (298)
T ss_dssp EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 5799999999999986 468899999986543211 123568899999999999999
Q ss_pred eeeeEEEEe--CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC
Q 005999 450 VPIRAYFQA--KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG 527 (665)
Q Consensus 450 v~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~ 527 (665)
+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQK-IIHRDIKPSNLLVG 171 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEC
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEC
Confidence 999999987 568899999999999987643 346999999999999999999999999 99999999999999
Q ss_pred CCCceEEeecccccccCCCC---CCCCCCCcccCCccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHH
Q 005999 528 ADFEARLTDYCLSVLSDSSS---VEDPDTVAYKAPEIRKSSRR--ATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML 602 (665)
Q Consensus 528 ~~~~~kl~Dfgl~~~~~~~~---~~~~gt~~y~aPE~~~~~~~--~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 602 (665)
.++.+||+|||++....... ....||+.|+|||++..... ++.++|||||||++|||++|+.||.... ...+.
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~ 249 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--IMCLH 249 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH
T ss_pred CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--HHHHH
Confidence 99999999999997665432 33468999999999874332 4778999999999999999999997531 11222
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+.............+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2222222222223456778999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.94 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=206.6
Q ss_pred HhCcccceEEEEEEE---CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|.. .++..||||++..........+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999964 3578999999987655445577899999999999999999999999 566789999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (291)
T 1xbb_A 103 PLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176 (291)
T ss_dssp EHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCC-eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccc
Confidence 99999974 245899999999999999999999999 9999999999999999999999999997664332
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
....+++.|+|||.+. +..++.++||||||+++|||++ |+.||... ...++...+..... ...+...+..+.++
T Consensus 177 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 177 QTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGER-MGCPAGCPREMYDL 252 (291)
T ss_dssp ----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred cccCCCCceeeChHHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCC-CCCCCCCCHHHHHH
Confidence 1223578899999987 5668899999999999999999 99999763 22234443333221 22345667889999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
+.+||+.||++||++.|+++.|+++..+...+
T Consensus 253 i~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 99999999999999999999999998877643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.40 Aligned_cols=246 Identities=18% Similarity=0.278 Sum_probs=200.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch---hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA---DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 467999999999999864 6889999998643211 123567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc---eEEeecccccccCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE---ARLTDYCLSVLSDSS 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~ 546 (665)
++|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++......
T Consensus 109 ~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~ 186 (351)
T 3c0i_A 109 DGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186 (351)
T ss_dssp SSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence 99999988764221 2345899999999999999999999999 999999999999986654 999999999776543
Q ss_pred C---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHH
Q 005999 547 S---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGM 621 (665)
Q Consensus 547 ~---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 621 (665)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+...+........ .....+..
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 187 GLVAGGRVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp SCBCCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSS---HHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CeeecCCcCCcCccCHHHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCc---HHHHHHHHHcCCCCCCccccccCCHH
Confidence 2 2346899999999987 567899999999999999999999999752 2233332322222111 12345678
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.90 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=197.3
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...+ .||+|+++.........+.+.+|++++++++||||+++++++ .....++||||+.+++|
T Consensus 30 ~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L 106 (289)
T 3og7_A 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 106 (289)
T ss_dssp EEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEH
T ss_pred eEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcH
Confidence 679999999999998654 499999987766566678899999999999999999999965 45568999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----CC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-----VE 549 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~~ 549 (665)
.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 107 ~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (289)
T 3og7_A 107 YHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181 (289)
T ss_dssp HHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEECCCC----------------
T ss_pred HHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECCCCCEEEccceeccccccccccccccc
Confidence 999964 2456899999999999999999999999 9999999999999999999999999987554311 22
Q ss_pred CCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHHHHH
Q 005999 550 DPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGMLTE 624 (665)
Q Consensus 550 ~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 624 (665)
..||+.|+|||++. ....++.++||||||+++|||++|+.||.... ....+...+....... .....++..+.+
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 260 (289)
T 3og7_A 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260 (289)
T ss_dssp --CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-CHHHHHHHHHHTSCCCCTTSSCTTSCHHHHH
T ss_pred cCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-hHHHHHHHhcccccCcchhhccccCCHHHHH
Confidence 35899999999875 24567889999999999999999999997632 2223333333332222 123456788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
++.+||+.||++|||+.|+++.|+++.+
T Consensus 261 li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 261 LMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 9999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.43 Aligned_cols=242 Identities=20% Similarity=0.264 Sum_probs=189.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+.+|+
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 102 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCC
Confidence 67999999999999975 788999999976542 23567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc--eEEeecccccccCC--CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE--ARLTDYCLSVLSDS--SSVE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~--~kl~Dfgl~~~~~~--~~~~ 549 (665)
|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..... ....
T Consensus 103 L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~-ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 176 (361)
T 3uc3_A 103 LYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176 (361)
T ss_dssp HHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence 9999874 345899999999999999999999999 999999999999987765 99999999864332 2233
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc---CCCchhhhHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV---DDGREENRLGMLTEVA 626 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li 626 (665)
..||+.|+|||++......+.++|||||||++|||++|+.||...... ......+..... ........+..+.+|+
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-CCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-HHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 468999999999874333344589999999999999999999764322 223333322222 2222334567899999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~ 646 (665)
.+||+.||++|||+.|+++.
T Consensus 256 ~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 256 SRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHSCSCTTTSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHHhC
Confidence 99999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=369.50 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=209.8
Q ss_pred hHhCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.+.. +..||||.++... ...+.|.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 226 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp EESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 679999999999999764 7899999997654 335679999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 549 (665)
|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 303 L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 378 (495)
T 1opk_A 303 LLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378 (495)
T ss_dssp HHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTT
T ss_pred HHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCC
Confidence 99999753 2356899999999999999999999999 9999999999999999999999999997764322 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
..++..|+|||++. ...++.++|||||||++|||++ |+.||... ...++...+.... ....+..++..+.+|+.+
T Consensus 379 ~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 454 (495)
T 1opk_A 379 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDY-RMERPEGCPEKVYELMRA 454 (495)
T ss_dssp CCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTC-CCCCCTTCCHHHHHHHHH
T ss_pred CcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHH
Confidence 23567899999987 5678999999999999999999 99999763 2334444443322 122345677889999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 629 CSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
||+.||++|||+.|+++.|+.+.+.
T Consensus 455 cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 455 CWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HcCcChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999987544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.98 Aligned_cols=239 Identities=19% Similarity=0.210 Sum_probs=192.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||+||+|... +++.||||++............+..|+..+.++ +||||++++++|.+++..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 467999999999999976 789999999876554444445555666555555 9999999999999999999999999 6
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VE 549 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 549 (665)
++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 141 ~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 141 PSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp CBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 6999988753 346999999999999999999999999 9999999999999999999999999987665432 23
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. + .++.++|||||||++|||++|..|+.. .+....+.............+..+.+++.+|
T Consensus 216 ~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~el~~g~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 216 QEGDPRYMAPELLQ-G-SYGTAADVFSLGLTILEVACNMELPHG-----GEGWQQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp CCCCGGGCCGGGGG-T-CCSTHHHHHHHHHHHHHHHHTCCCCSS-----HHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred cCCCccccCHhHhc-C-CCCchhhHHHHHHHHHHHHhCCCCCCC-----ccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence 35899999999987 3 689999999999999999999776543 1112222221111122345667899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|+.||++|||+.|+++
T Consensus 289 L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 289 LEPDPKLRATAEALLA 304 (311)
T ss_dssp SCSSTTTSCCHHHHHT
T ss_pred cCCChhhCcCHHHHHh
Confidence 9999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.86 Aligned_cols=252 Identities=18% Similarity=0.265 Sum_probs=203.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC--eEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG--ERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 57999999999999976 488999999975433 233566789999999999999999999998755 78999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe----CCCCceEEeecccccccCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill----~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 94 ~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~ 170 (319)
T 4euu_A 94 GSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170 (319)
T ss_dssp CBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC
T ss_pred CCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC
Confidence 99999998532 2234899999999999999999999999 9999999999999 788889999999997765433
Q ss_pred --CCCCCCCcccCCccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCC----
Q 005999 548 --VEDPDTVAYKAPEIRKS-------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDD---- 612 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~-------~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~---- 612 (665)
....||+.|+|||++.. +..++.++|||||||++|||++|+.||........ +....+.......
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~ 250 (319)
T 4euu_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250 (319)
T ss_dssp CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEE
T ss_pred ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchh
Confidence 33468999999998752 35789999999999999999999999975432222 2222222211110
Q ss_pred -------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 613 -------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 613 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
......+..+.+++.+||+.||++|||+.|+++...+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 12345677899999999999999999999999988754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.50 Aligned_cols=241 Identities=21% Similarity=0.312 Sum_probs=196.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .++..||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 4699999999999986 4688999999976542 455778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe--CCCCceEEeecccccccCCCC--CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL--GADFEARLTDYCLSVLSDSSS--VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~--~~ 549 (665)
|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....... ..
T Consensus 173 L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 173 LFDRIID----ESYNLTELDTILFMKQICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp EHHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred HHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9998864 2346899999999999999999999999 9999999999999 567899999999998765433 23
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC--CCchhhhHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD--DGREENRLGMLTEVAS 627 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~ 627 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+...... .......+..+.+|+.
T Consensus 248 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 248 NFGTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCSSCTTCCHHHHT-TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred ccCCCcEeChhhcc-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 35899999999987 5678999999999999999999999997531 22222222222111 1123456778999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~ 645 (665)
+||+.||++|||+.|+++
T Consensus 325 ~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCCCHHHHhc
Confidence 999999999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.55 Aligned_cols=241 Identities=19% Similarity=0.208 Sum_probs=204.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 367999999999999975 6889999998654321 23356788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++...........
T Consensus 126 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~ 199 (350)
T 1rdq_E 126 GEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp CBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCccceEEECCCCCEEEcccccceeccCCccccc
Confidence 999999974 245899999999999999999999999 99999999999999999999999999987766655667
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+... ....+...+..+.+++.+||+
T Consensus 200 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 200 GTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp ECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSC
T ss_pred CCccccCHHHhc-CCCCCCcCCEecccHhHhHHhhCCCCCCCC--CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence 999999999987 567899999999999999999999999753 222333333322 222345567789999999999
Q ss_pred CCCCCCCC-----HHHHHH
Q 005999 632 KSPEQRPA-----MWQVLK 645 (665)
Q Consensus 632 ~dP~~RPt-----~~evl~ 645 (665)
.||++||+ +.|+++
T Consensus 275 ~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHT
T ss_pred cCHHhccCCccCCHHHHHh
Confidence 99999998 888875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=335.53 Aligned_cols=251 Identities=20% Similarity=0.348 Sum_probs=209.9
Q ss_pred hHhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... ++..||+|+++.... ....+.+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 36999999999999853 678899999976543 34567789999999999999999999999 45568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 94 GPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 999999964 2356899999999999999999999999 9999999999999999999999999997664322
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
....+|+.|+|||++. +..++.++||||||+++|||++ |+.||... ...++...+..... ...+...+..+.+
T Consensus 169 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~ 244 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKR-MECPPECPPELYA 244 (287)
T ss_dssp CCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHHHHTTCC-CCCCTTCCHHHHH
T ss_pred ccccccccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHhcCCc-CCCCCCcCHHHHH
Confidence 1224678999999987 5678999999999999999998 99999763 23344444433221 2234567788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
++.+||+.||++||++.|+++.|+.+..+...
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999887654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.98 Aligned_cols=243 Identities=19% Similarity=0.280 Sum_probs=200.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||++++++|.+.+..++||||+.+|
T Consensus 21 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg 100 (384)
T 4fr4_A 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG 100 (384)
T ss_dssp EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence 67999999999999965 588999999865432 1234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--SVED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--~~~~ 550 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++...... ....
T Consensus 101 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 174 (384)
T 4fr4_A 101 DLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM 174 (384)
T ss_dssp EHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCC
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEECCCCCEEEeccceeeeccCCCceecc
Confidence 99999973 356999999999999999999999999 999999999999999999999999999766443 2345
Q ss_pred CCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 551 ~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
.||+.|+|||++.. +..++.++|||||||++|||++|+.||........ .+...+.. .....+...+..+.+++.
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~~~~~li~ 252 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQEMVSLLK 252 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCHHHHHHHH
Confidence 69999999999863 34588999999999999999999999975432222 22222222 122234556778999999
Q ss_pred HcccCCCCCCCC-HHHHHH
Q 005999 628 VCSLKSPEQRPA-MWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt-~~evl~ 645 (665)
+||+.||++||+ +.++++
T Consensus 253 ~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 253 KLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHSCSSGGGSCCSHHHHHT
T ss_pred HHhcCCHhHhcccHHHHHc
Confidence 999999999999 666654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=370.09 Aligned_cols=251 Identities=21% Similarity=0.362 Sum_probs=208.6
Q ss_pred HhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||.||+|.+. ++..||||+++.... ....+.+.+|++++++++||||+++++++.. +..++||||+.+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 5999999999999863 677899999976532 3456789999999999999999999999976 5689999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 548 (665)
+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 421 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 421 PLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp BHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred cHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999974 2456899999999999999999999999 99999999999999999999999999976643221
Q ss_pred --CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 549 --EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 549 --~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
...+++.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+..... ...+..++..+.++
T Consensus 496 ~~~~~~~~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~-~~~p~~~~~~l~~l 571 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKR-MECPPECPPELYAL 571 (613)
T ss_dssp ------CCTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CSHHHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred ccCCCCccceeCHhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC-CCCCCcCCHHHHHH
Confidence 123467899999987 5679999999999999999998 99999763 23345544443322 22345677889999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
+.+||+.||++||++.++++.|+.+..+....
T Consensus 572 i~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 572 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 99999999999999999999999998877653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.06 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=212.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||||+.+++
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp EESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred eecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 57999999999999976 47889999997544 445778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----C
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----E 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~ 549 (665)
|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 96 L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 171 (288)
T 3kfa_A 96 LLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171 (288)
T ss_dssp HHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT-CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETT
T ss_pred HHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC-ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccC
Confidence 99999753 3456899999999999999999999999 99999999999999999999999999977654321 1
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
..+|+.|+|||.+. +..++.++||||||+++|||++ |+.||... ....+...+..... ...+...+..+.+++.+
T Consensus 172 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 247 (288)
T 3kfa_A 172 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYR-MERPEGCPEKVYELMRA 247 (288)
T ss_dssp EEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTCC-CCCCTTCCHHHHHHHHH
T ss_pred CccccCcCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhccCC-CCCCCCCCHHHHHHHHH
Confidence 23577899999987 5678999999999999999999 99998763 23344444433222 22345667789999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 629 CSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
|++.||++|||+.|+++.|+.+..+...
T Consensus 248 ~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 248 CWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=339.21 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=202.5
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC-----eEEE
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG-----ERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l 464 (665)
.+.||+|+||.||+|... .+..||+|+++.........+.+.+|+.++++++||||+++++++.+.+ ..++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 367999999999999853 4668999999876555566678999999999999999999999998755 3599
Q ss_pred EEEecCCCCHHHHHhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 465 IYDYQPNGSLFNLIHGSRS-IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
||||+++|+|.+++...+. .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-FLHRDLAARNCMLRDDMTVCVADFGLSKKI 197 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEEeecCcceec
Confidence 9999999999999854322 23456999999999999999999999999 999999999999999999999999999765
Q ss_pred CCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 544 DSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 544 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
.... ....+++.|+|||.+. +..++.++||||||+++|||++ |+.||... ....+...+.... ....+..
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~ 273 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGV--QNHEMYDYLLHGH-RLKQPED 273 (313)
T ss_dssp -------------CCGGGSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CGGGHHHHHHTTC-CCCCBTT
T ss_pred ccccccCcccccCCCccccCchhhc-CCCccchhhhHHHHHHHHHHHhcCCCCCccC--CHHHHHHHHHcCC-CCCCCcc
Confidence 4322 2234678899999987 5778999999999999999999 88998763 2234444333322 1223456
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 274 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 274 CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 6778999999999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.29 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=201.3
Q ss_pred hHhCcccceEEEEEEEC--C--eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD--N--HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... + +..||+|.++.... ....+.+.+|+.++++++||||+++++++.. ++..++||||+
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 57999999999999853 2 34689999865432 3456789999999999999999999998754 56789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 174 ~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 174 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999974 2346889999999999999999999999 9999999999999999999999999997553321
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
....+|+.|+|||++. +..++.++|||||||++|||++ |.+||.... ..+....+..... ...+...+..
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~~~~~~-~~~p~~~~~~ 324 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRR-LLQPEYCPDP 324 (373)
T ss_dssp ---------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHHHTTCC-CCCCTTCCHH
T ss_pred cccccCCCCCcccccChHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHHHcCCC-CCCCCCCCHH
Confidence 2224678899999987 5678999999999999999999 677776532 2344444433222 1234456778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCc
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDN 659 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 659 (665)
+.+++.+||+.||++|||+.|+++.|+++......+..
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 99999999999999999999999999999987765543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=373.81 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=207.5
Q ss_pred hHhCcccceEEEEEEE---CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|.+ ..+..||||+++.........+.+.+|++++++++||||+++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4699999999999965 357899999998765545567889999999999999999999999965 458899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~-iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999974 346899999999999999999999999 9999999999999999999999999997664322
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
....+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+..... ...+..++..+.+
T Consensus 528 ~~~~~~~t~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--~~~~~~~~i~~~~~-~~~p~~~~~~l~~ 603 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGER-MGCPAGCPREMYD 603 (635)
T ss_dssp -------CGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC-CCCCTTCCHHHHH
T ss_pred cccCCCCceeeeChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCCCCCHHHHH
Confidence 1123578899999987 6679999999999999999998 99999763 22244444443322 2334567788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
++..||+.||++|||+.++++.|+++..++
T Consensus 604 li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999988764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=342.44 Aligned_cols=247 Identities=20% Similarity=0.307 Sum_probs=190.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++.+++..++||||+. |
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 467999999999999854 688999999975542 2334567899999999999999999999999999999999998 5
Q ss_pred CHHHHHhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CC
Q 005999 473 SLFNLIHGSRS-IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SV 548 (665)
Q Consensus 473 sL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~ 548 (665)
+|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCC
Confidence 99998864321 12345899999999999999999999999 999999999999999999999999999765432 23
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccCC---------------
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVDD--------------- 612 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~--------------- 612 (665)
...+|+.|+|||++.+...++.++|||||||++|||++|+.||.... ..+....+... ....
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T 2pmi_A 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244 (317)
T ss_dssp CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence 34689999999998755578999999999999999999999997532 11222222111 1000
Q ss_pred ----------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ----------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 001134567999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=346.48 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=200.3
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|++++++++||||+++++++..++..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 35799999999999996 5789999999975532 23445678999999999999999999999999999999999997
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 138 g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~~~~ 211 (348)
T 1u5q_A 138 GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NSFV 211 (348)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CCCC
T ss_pred CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-Cccc
Confidence 5888887642 356899999999999999999999999 999999999999999999999999999766543 3346
Q ss_pred CCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
||+.|+|||++.. ...++.++|||||||++|||++|+.||.... .......+.............+..+.+++.+|
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 8999999998742 4568999999999999999999999986531 11211122222222223345677899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|+.||++|||+.|+++.
T Consensus 290 l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TCSSGGGSCCHHHHTTC
T ss_pred cccChhhCcCHHHHhhC
Confidence 99999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=350.27 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=199.7
Q ss_pred hHhCcc--cceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRG--SIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+| +||.||+|... +++.||||++..........+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 110 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110 (389)
T ss_dssp EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence 679999 99999999976 689999999987665556677889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC------
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS------ 545 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~------ 545 (665)
|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+.....
T Consensus 111 ~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~ 186 (389)
T 3gni_B 111 GSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186 (389)
T ss_dssp CBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECS
T ss_pred CCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccccceeecccccccc
Confidence 9999999753 2345899999999999999999999999 99999999999999999999999998753311
Q ss_pred ----CCCCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc----------
Q 005999 546 ----SSVEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV---------- 610 (665)
Q Consensus 546 ----~~~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~---------- 610 (665)
......||+.|+|||++... ..++.++|||||||++|||++|+.||....... .+.........
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 265 (389)
T 3gni_B 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDTSTIPA 265 (389)
T ss_dssp CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT-HHHHC----------------
T ss_pred ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCCCCcccccccccc
Confidence 12223688999999998743 568999999999999999999999997632221 11111100000
Q ss_pred ---------------------------------CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 ---------------------------------DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 ---------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000123345679999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=342.86 Aligned_cols=242 Identities=19% Similarity=0.298 Sum_probs=193.8
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------------
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------------ 460 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------------ 460 (665)
.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||++++++|.+..
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 367999999999999976 789999999975542 345678999999999999999999999986643
Q ss_pred ---------------------------------------------eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHH
Q 005999 461 ---------------------------------------------ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCL 495 (665)
Q Consensus 461 ---------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~ 495 (665)
..++||||+++|+|.+++.... .....++..++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--CccchhhHHHH
Confidence 3799999999999999998543 33456777899
Q ss_pred HHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---------------CCCCCCCcccCCc
Q 005999 496 KIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---------------VEDPDTVAYKAPE 560 (665)
Q Consensus 496 ~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---------------~~~~gt~~y~aPE 560 (665)
.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....||+.|+|||
T Consensus 168 ~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHHHhCC-eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 99999999999999999 9999999999999999999999999997665431 2235899999999
Q ss_pred cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCH
Q 005999 561 IRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAM 640 (665)
Q Consensus 561 ~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 640 (665)
++. +..++.++|||||||++|||++|..|+.. ............ ........+..+.+++.+||+.||++|||+
T Consensus 247 ~~~-~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 247 QIH-GNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITDVRNLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp HHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHTTC-CCHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred Hhc-CCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhccC-CCcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 987 56789999999999999999998776422 011111111111 111233445678999999999999999999
Q ss_pred HHHHH
Q 005999 641 WQVLK 645 (665)
Q Consensus 641 ~evl~ 645 (665)
.|+++
T Consensus 321 ~~~l~ 325 (332)
T 3qd2_B 321 TDIIE 325 (332)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 99986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=334.31 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=208.0
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeE-EEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER-LVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~ 468 (665)
.+.||+|+||.||+|... ++..+|+|.+..... ....+.+.+|+.++++++||||+++++++.+.+.. ++|+||
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 367999999999999853 344799999875443 34567889999999999999999999999876654 999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-- 546 (665)
+.+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 105 MCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQK-FVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999974 2456899999999999999999999999 999999999999999999999999999754332
Q ss_pred -----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 547 -----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 547 -----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
.....+|+.|+|||.+. +..++.++||||||+++|||++|..|+... ....++...+..... ...+...+..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 256 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRH-IDPFDLTHFLAQGRR-LPQPEYCPDS 256 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHT-TCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCGGGHHHHHHTTCC-CCCCTTCCHH
T ss_pred cccccCcCCCCCccccChhhhc-cCCCChhhchhhHHHHHHHHhhCCCCCCcc-CCHHHHHHHhhcCCC-CCCCccchHH
Confidence 12234688999999987 667899999999999999999966554332 223344444443322 2234456778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
+.+++.+||+.||++|||+.|+++.|+++.+.....
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999999887544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=342.99 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=209.9
Q ss_pred HhHhCcccceEEEEEEEC--------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEE
Q 005999 394 AELLGRGSIGTTYKAVLD--------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 464 (665)
.+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+++++++ +||||+++++++.+++..++
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 367999999999999863 567899999976543 34566789999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 465 IYDYQPNGSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
||||+++|+|.+++...+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~k 197 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTENNVMK 197 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEE
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCccceEEEcCCCCEE
Confidence 99999999999999854321 1235899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHh
Q 005999 534 LTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT 607 (665)
Q Consensus 534 l~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 607 (665)
|+|||++....... ....+|+.|+|||++. +..++.++||||||+++|||++ |+.||... ...++...+..
T Consensus 198 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~ 274 (334)
T 2pvf_A 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEELFKLLKE 274 (334)
T ss_dssp ECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHH
T ss_pred EccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcC--CHHHHHHHHhc
Confidence 99999997665432 2234678899999987 5678999999999999999999 99999753 22233333333
Q ss_pred hccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccC
Q 005999 608 MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658 (665)
Q Consensus 608 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 658 (665)
... ...+...+..+.+++.+||+.||++|||+.|+++.|+++......++
T Consensus 275 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~ 324 (334)
T 2pvf_A 275 GHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324 (334)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence 221 22344567789999999999999999999999999999987665443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.67 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=197.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 57999999999999975 58899999997766555567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 89 l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 162 (311)
T 4agu_A 89 LHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHN-CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162 (311)
T ss_dssp HHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCC
Confidence 9998873 345899999999999999999999999 9999999999999999999999999997665332 234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------------ 612 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 612 (665)
.+|+.|+|||++.+...++.++||||||+++|||++|+.||.... ..+....+.......
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--DVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhcccccccccccccccccccCc
Confidence 689999999998755678999999999999999999999997632 112222111111000
Q ss_pred --C---------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --G---------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 01245667899999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.20 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=204.7
Q ss_pred HhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||+|.. .++..||+|++..... ....+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 46799999999999986 3577899999975432 23456789999999999 9999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC
Q 005999 467 DYQPNGSLFNLIHGSRSI------------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~ 528 (665)
||+++|+|.+++...+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLVTH 207 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGGGEEEET
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChhhEEEcC
Confidence 999999999999854321 0134899999999999999999999999 999999999999999
Q ss_pred CCceEEeecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005999 529 DFEARLTDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDML 602 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 602 (665)
++.+||+|||++........ ...+|+.|+|||.+. +..++.++|||||||++|||+| |+.||..... ...+.
T Consensus 208 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~ 285 (344)
T 1rjb_A 208 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-DANFY 285 (344)
T ss_dssp TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-SHHHH
T ss_pred CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc-HHHHH
Confidence 99999999999975543221 223578899999987 5678999999999999999998 9999976421 22333
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
..+.... ....+...+..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 286 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 286 KLIQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred HHHhcCC-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 3333221 2223445677899999999999999999999999999998776543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.57 Aligned_cols=250 Identities=19% Similarity=0.320 Sum_probs=198.7
Q ss_pred hHhCcccceEEEEEEECC--------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDN--------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 466 (665)
+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 579999999999998543 2579999986543 245677999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc--------eEEeecc
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE--------ARLTDYC 538 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~--------~kl~Dfg 538 (665)
||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++. +||+|||
T Consensus 92 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENT-LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp ECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred ECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCC-eECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 999999999999852 344899999999999999999999999 999999999999998887 9999999
Q ss_pred cccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 539 LSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 539 l~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
++....... ...+|+.|+|||++.....++.++|||||||++|||++|..|+.... ......... ......+...
T Consensus 167 ~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~~~~~~~~~---~~~~~~~~~~ 241 (289)
T 4fvq_A 167 ISITVLPKD-ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DSQRKLQFY---EDRHQLPAPK 241 (289)
T ss_dssp SCTTTSCHH-HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHH---HTTCCCCCCS
T ss_pred ccccccCcc-ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-chHHHHHHh---hccCCCCCCC
Confidence 986553321 12368889999998744678999999999999999999655443321 111111111 1122223334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
+..+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 55689999999999999999999999999988776544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=344.08 Aligned_cols=237 Identities=21% Similarity=0.282 Sum_probs=195.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|++..... .....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g 94 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence 67999999999999975 688999999976543 233456788899999887 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++..... ...
T Consensus 95 g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~ 168 (345)
T 3a8x_A 95 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168 (345)
T ss_dssp CBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBC
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEEeccccccccCCCCccc
Confidence 999999974 245899999999999999999999999 99999999999999999999999999975322 223
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC----c---cHHHHHHhhccCCCchhhhHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP----P---DMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||....... . .+...+.. .....+...+..
T Consensus 169 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~ 245 (345)
T 3a8x_A 169 TFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRSLSVK 245 (345)
T ss_dssp CCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred ccCCCccccCccccC-CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCCCCCHH
Confidence 446899999999987 5678999999999999999999999997532111 1 11222221 122234556778
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 005999 622 LTEVASVCSLKSPEQRPAM 640 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~ 640 (665)
+.+++.+||+.||++||++
T Consensus 246 ~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHHhcCCHhHCCCC
Confidence 9999999999999999995
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.83 Aligned_cols=251 Identities=19% Similarity=0.381 Sum_probs=203.7
Q ss_pred hHhCcccceEEEEEEECC-----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDN-----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|.... +..||+|+++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 679999999999998542 35699999976543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 129 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 129 ENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp TTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 999999999752 356899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
....+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+..... .......+..+
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l 279 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFR-LPTPMDCPSAI 279 (333)
T ss_dssp -------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCC-CCCCTTCBHHH
T ss_pred ccccCCCCccccccCchhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccC--CHHHHHHHHHCCCc-CCCcccCCHHH
Confidence 1123577899999987 5678999999999999999999 99999653 22233333332211 12344567789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 999999999999999999999999999887654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.06 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=204.4
Q ss_pred hHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEE-eCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ-AKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|...+ ...+|+|.+..... ....+.+.+|+.++++++||||+++++++. .++..++||||+
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred ceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 679999999999998542 23689999876443 345577899999999999999999999864 456889999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 110 ~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 110 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp TTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 99999999974 2456899999999999999999999999 9999999999999999999999999997654322
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
....+|+.|+|||.+. +..++.++||||||+++|||++ |.+||... ...+....+...... ..+...+..
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~ 260 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRL-LQPEYCPDP 260 (298)
T ss_dssp BC-----CCBCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS--CTTTHHHHHHTTCCC-CCCTTCCHH
T ss_pred ccccccCCCCCccccChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCccC--CHHHHHHHHhcCCCC-CCCccCCHH
Confidence 2234678899999987 5678999999999999999999 55566542 222333333322221 234456778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
+.+++.+||+.||++|||+.|+++.|+++......+
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 999999999999999999999999999998876544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.64 Aligned_cols=248 Identities=26% Similarity=0.437 Sum_probs=203.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+++|+|
T Consensus 190 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 5799999999999999888889999997654 235678999999999999999999999876 678999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~ 550 (665)
.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++....... ...
T Consensus 266 ~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 341 (452)
T 1fmk_A 266 LDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341 (452)
T ss_dssp HHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence 9999742 2245899999999999999999999999 9999999999999999999999999997664322 122
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. ...++.++|||||||++|||++ |+.||... ...++...+..... ...+..++..+.+++.+|
T Consensus 342 ~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~c 417 (452)
T 1fmk_A 342 KFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYR-MPCPPECPESLHDLMCQC 417 (452)
T ss_dssp -CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHH
T ss_pred cccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHH
Confidence 4678899999987 5679999999999999999999 99999753 22233333332211 123456778899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
|+.||++|||+.++++.|+++....
T Consensus 418 l~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 418 WRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ccCChhhCcCHHHHHHHHHHHhccC
Confidence 9999999999999999999886554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.41 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=194.9
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhC--CCCCCeeeeeEEEEeC----CeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG--LSHPNLVPIRAYFQAK----GERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e 467 (665)
.+.||+|+||.||+|... ++.||||++.... ...+..|.+++.. ++||||+++++++... ...++|||
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 115 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence 468999999999999876 7789999985432 2233444555544 4999999999999887 78999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA--------SWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
|+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 116 YHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-EEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999999974 3589999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCC-------CCCCCCCcccCCccccCCCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCCCC
Q 005999 540 SVLSDSSS-------VEDPDTVAYKAPEIRKSSRRATSK------SDVYAFGVLLLELLTG----------KHPSQHPYL 596 (665)
Q Consensus 540 ~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k------~DvwSlGvvl~elltg----------~~P~~~~~~ 596 (665)
+....... ....||+.|+|||++. +...+.+ +|||||||++|||++| +.||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHT-TCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcc-cccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 96554322 1336899999999987 3444444 9999999999999999 666665433
Q ss_pred CCccHHHHHHhhccC---CC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 597 APPDMLEWVRTMRVD---DG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 597 ~~~~~~~~~~~~~~~---~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
............... .. ....++..+.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 333322222221111 11 12366788999999999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.31 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=197.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 108 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence 67999999999999965 688999999975432 123456678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~ 548 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++...... ..
T Consensus 109 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 182 (353)
T 3txo_A 109 GDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182 (353)
T ss_dssp CBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC------
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCHHHEEECCCCCEEEccccceeecccCCcccc
Confidence 999999974 346899999999999999999999999 999999999999999999999999999754322 23
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+... ....+...+..+.+++.+
T Consensus 183 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~ 257 (353)
T 3txo_A 183 TFCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--NEDDLFEAILND--EVVYPTWLHEDATGILKS 257 (353)
T ss_dssp ---CCGGGCCHHHHH-HHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred ccCCCcCeEChhhcC-CCCcCCccCCCcchHHHHHHHhCCCCCCCC--CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence 346899999999987 567899999999999999999999999753 222333333322 222344567789999999
Q ss_pred cccCCCCCCCCH------HHHHH
Q 005999 629 CSLKSPEQRPAM------WQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~------~evl~ 645 (665)
||+.||++||++ .|+++
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HhhhCHHHccCCcccCCHHHHhh
Confidence 999999999998 67765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=334.28 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=206.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++++|
T Consensus 19 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L 94 (279)
T 1qpc_A 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSL 94 (279)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBH
T ss_pred eeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCH
Confidence 5799999999999999888899999997654 235678999999999999999999999864 468999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~ 550 (665)
.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....... ...
T Consensus 95 ~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 170 (279)
T 1qpc_A 95 VDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (279)
T ss_dssp HHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence 9998632 1236899999999999999999999999 9999999999999999999999999997665432 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+.... ....+...+..+.+++.+|
T Consensus 171 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 246 (279)
T 1qpc_A 171 KFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGY-RMVRPDNCPEELYQLMRLC 246 (279)
T ss_dssp CCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred CCccCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCccc--CHHHHHHHHhccc-CCCCcccccHHHHHHHHHH
Confidence 4678899999987 5678999999999999999999 99998753 2223333332221 1123445677899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
++.||++|||+.++++.|+++.....
T Consensus 247 l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 247 WKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred hccChhhCCCHHHHHHHHHHHHHhcc
Confidence 99999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=350.20 Aligned_cols=237 Identities=21% Similarity=0.283 Sum_probs=193.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|+++..... ....+.+.+|..++.++ +||||++++++|.+.+..++||||+++
T Consensus 58 ~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~g 137 (396)
T 4dc2_A 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137 (396)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCC
Confidence 67999999999999965 6889999999765322 22334577888888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC---CCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD---SSSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~---~~~~ 548 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++... ....
T Consensus 138 g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~ 211 (396)
T 4dc2_A 138 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 211 (396)
T ss_dssp CBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEECCCCCEEEeecceeeecccCCCccc
Confidence 999999974 346899999999999999999999999 9999999999999999999999999997532 2233
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC---c----cHHHHHHhhccCCCchhhhHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP---P----DMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||....... . .+...+.. .....+...+..
T Consensus 212 ~~~gt~~Y~aPE~l~-~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~ 288 (396)
T 4dc2_A 212 TFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRSLSVK 288 (396)
T ss_dssp CCCBCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred cccCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCCcCCHH
Confidence 446899999999987 6778999999999999999999999996432111 1 12222222 222344556778
Q ss_pred HHHHHHHcccCCCCCCCCH
Q 005999 622 LTEVASVCSLKSPEQRPAM 640 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~ 640 (665)
+.+++.+||+.||++||++
T Consensus 289 ~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHHhcCCHhHcCCC
Confidence 9999999999999999995
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.37 Aligned_cols=243 Identities=20% Similarity=0.311 Sum_probs=201.9
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+.+|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg 133 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence 367999999999999965 688999999876542 34567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC--CCceEEeecccccccCCCC--C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA--DFEARLTDYCLSVLSDSSS--V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~--~ 548 (665)
+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++....... .
T Consensus 134 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 134 ELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp BHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999874 2346899999999999999999999999 999999999999974 4789999999997765432 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC--CCchhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD--DGREENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li 626 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... ...+....+...... .......+..+.+++
T Consensus 209 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 209 VTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeccCCCccCchhcc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 235899999999987 567899999999999999999999999753 122333333322211 122345677899999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~ 646 (665)
.+||+.||++|||+.|+++.
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=336.07 Aligned_cols=243 Identities=22% Similarity=0.329 Sum_probs=203.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..||+|++..........+.+.+|++++++++||||+++++++.+++..++||||+.+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 91 (284)
T 3kk8_A 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91 (284)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence 57999999999999965 58899999997765555566788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc---eEEeecccccccCCCCC--
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE---ARLTDYCLSVLSDSSSV-- 548 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~~~-- 548 (665)
|.+.+.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++........
T Consensus 92 l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (284)
T 3kk8_A 92 LFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165 (284)
T ss_dssp HHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence 9998874 346899999999999999999999999 999999999999986655 99999999976654332
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 626 (665)
...+|+.|+|||++. +..++.++||||||+++|||++|+.||... ........+....... ......+..+.+++
T Consensus 166 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (284)
T 3kk8_A 166 GFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242 (284)
T ss_dssp CSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred CCCCCcCCcCchhhc-CCCCCcccchHHHHHHHHHHHHCCCCCCCC--chhHHHHHHHhccccCCchhhcccCHHHHHHH
Confidence 346899999999987 567899999999999999999999999652 2223333333322221 12235667899999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~ 646 (665)
.+||+.||++|||+.|+++.
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 243 DSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHSCSSTTTSCCHHHHTTS
T ss_pred HHHcccChhhCCCHHHHhcC
Confidence 99999999999999999873
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=341.82 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=207.2
Q ss_pred hHhCcccceEEEEEEEC-----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 467 (665)
+.||+|+||.||++.+. +++.||||++..... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 67999999999998753 688999999976543 34567789999999999999999999999874 57899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 116 ~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 116 YVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp CCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred cccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 9999999999974 24899999999999999999999999 9999999999999999999999999997765432
Q ss_pred ------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--------Cc--cHHHHHHhh--c
Q 005999 548 ------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA--------PP--DMLEWVRTM--R 609 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~--------~~--~~~~~~~~~--~ 609 (665)
....+|..|+|||++. +..++.++||||||+++|||++|+.||...... .. ......... .
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred cccccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 2234788899999987 567889999999999999999999998652110 00 111111111 1
Q ss_pred cCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 610 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
.....+...+..+.+++.+||+.||++|||+.|+++.|+.+.+.....
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 111234566788999999999999999999999999999998877643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=339.62 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=201.8
Q ss_pred hHhCcccceEEEEEEE-----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK--GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 467 (665)
+.||+|+||.||+|.+ .+++.||+|++..... ....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 5799999999999984 4688999999975542 23456789999999999999999999999876 66899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 106 FLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp CCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred eCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCC-cccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 99999999999642 345899999999999999999999999 9999999999999999999999999997665432
Q ss_pred ------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----------CCCccHHHHHHhhcc-
Q 005999 548 ------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY----------LAPPDMLEWVRTMRV- 610 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~----------~~~~~~~~~~~~~~~- 610 (665)
....+|..|+|||++. +..++.++||||||+++|||++|+.|+.... ...............
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 181 EYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred cceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2335788899999987 5678899999999999999999999864321 111112222222111
Q ss_pred -CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 611 -DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 611 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 112344567789999999999999999999999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=346.09 Aligned_cols=243 Identities=17% Similarity=0.274 Sum_probs=196.0
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCC--CCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH--PNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++...+++.||||++..........+.+.+|+.++++++| +||+++++++.+++..++||| +.+|
T Consensus 15 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 93 (343)
T 3dbq_A 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 93 (343)
T ss_dssp EEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCC
Confidence 6799999999999998889999999998766555667889999999999976 999999999999999999999 5678
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++.......
T Consensus 94 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~-iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 94 DLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp EHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---------
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEE-CCcEEEeecccccccCcccccccC
Confidence 99999984 346899999999999999999999999 99999999999997 6789999999997664332
Q ss_pred CCCCCCCcccCCccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 548 VEDPDTVAYKAPEIRKS----------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~----------~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||.........+...+ ........+..
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII-DPNHEIEFPDI 245 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-CTTSCCCCCCC
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh-cCCcccCCccc
Confidence 23358999999999752 25688999999999999999999999975321111111111 11112223444
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+..+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 246 PEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 55679999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.24 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=200.7
Q ss_pred hHhCcccceEEEEEEEC-CeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... ++. .|++|.+..... ....+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 67999999999999864 343 378888754332 223345678999999999999999999986 45688999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 97 PLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG-MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp TTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT-CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred CCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC-CCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 999999999742 346889999999999999999999999 9999999999999999999999999998764432
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....+|..|+|||++. +..++.++|||||||++|||++ |+.||... ...++...+..... ...+...+..+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGL--RLAEVPDLLEKGER-LAQPQICTIDVY 247 (325)
T ss_dssp CC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CTTHHHHHHHTTCB-CCCCTTBCTTTT
T ss_pred ccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCcccc--CHHHHHHHHHcCCC-CCCCCcCcHHHH
Confidence 2234678999999987 5679999999999999999999 99999763 22344444433222 122334556788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
+++.+||+.||++|||+.|+++.|+.+....
T Consensus 248 ~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 248 MVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999986543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.83 Aligned_cols=241 Identities=20% Similarity=0.318 Sum_probs=197.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..++||||+ +|
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g 93 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence 6799999999999996 57889999998643221 122356889999999999999999999999999999999999 78
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++....... ...
T Consensus 94 ~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~ 167 (336)
T 3h4j_B 94 ELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167 (336)
T ss_dssp EHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCC
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccc
Confidence 99998874 346899999999999999999999999 9999999999999999999999999997665433 334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++.+....+.++|||||||++|||++|+.||........ ...+.. .....+...+..+.+++.+||
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~i~~--~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FKKVNS--CVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BCCCCS--SCCCCCTTSCHHHHHHHHTTS
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HHHHHc--CCCCCcccCCHHHHHHHHHHc
Confidence 6899999999987443347899999999999999999999976432111 000000 011234456678999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~ 646 (665)
+.||++|||+.|+++.
T Consensus 244 ~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 244 VADPMQRITIQEIRRD 259 (336)
T ss_dssp CSSGGGSCCHHHHTTC
T ss_pred CCChhHCcCHHHHHhC
Confidence 9999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.46 Aligned_cols=256 Identities=16% Similarity=0.185 Sum_probs=198.4
Q ss_pred hHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhh---------HHHHHHHHHHHHhCCCCCCeeeeeEEEEe---
Q 005999 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADT---------SAEAFEQHMEAVGGLSHPNLVPIRAYFQA--- 458 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~--- 458 (665)
+.||+|+||.||+|... ++..+|+|++........ ..+.+.+|+..++.++||||+++++++..
T Consensus 43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~ 122 (345)
T 2v62_A 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122 (345)
T ss_dssp EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence 67999999999999975 678899999876543211 12346678899999999999999999988
Q ss_pred -CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC--ceEEe
Q 005999 459 -KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF--EARLT 535 (665)
Q Consensus 459 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~--~~kl~ 535 (665)
....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE-YVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEESSSTTSEEEC
T ss_pred CCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCcCHHHEEEccCCCCcEEEE
Confidence 67899999999 99999998742 37999999999999999999999999 99999999999999887 99999
Q ss_pred ecccccccCCCC----------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005999 536 DYCLSVLSDSSS----------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV 605 (665)
Q Consensus 536 Dfgl~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 605 (665)
|||++....... ....||+.|+|||++. +..++.++|||||||++|||++|+.||..............
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 999997653211 2335899999999987 56789999999999999999999999965322222222222
Q ss_pred HhhccCCCc-------hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccC
Q 005999 606 RTMRVDDGR-------EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658 (665)
Q Consensus 606 ~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 658 (665)
......... ....+..+.+++.+||+.||++|||+.++++.|+.+.......+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d 334 (345)
T 2v62_A 275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD 334 (345)
T ss_dssp HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence 222222111 11566789999999999999999999999999988765444433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=345.54 Aligned_cols=239 Identities=19% Similarity=0.290 Sum_probs=184.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 57999999999999976 57889999997543 34567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCCCC--C
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDSSS--V 548 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~--~ 548 (665)
|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....... .
T Consensus 135 L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 135 LFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENG-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp HHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 9999973 345899999999999999999999999 999999999999975 8899999999997665432 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 626 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||...... ..+...+....... ......+..+.+++
T Consensus 209 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 209 TVCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp ----CGGGSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-HHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cccCCCCccCHHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-HHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 345899999999987 567899999999999999999999999753211 11222222211111 12345677899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.||++|||+.|+++
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.72 Aligned_cols=240 Identities=20% Similarity=0.274 Sum_probs=199.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|+++.... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 105 (353)
T 2i0e_A 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105 (353)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence 67999999999999976 478999999975432 123356678899999988 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++..... ...
T Consensus 106 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 179 (353)
T 2i0e_A 106 GDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 179 (353)
T ss_dssp CBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccc
Confidence 999999974 245899999999999999999999999 99999999999999999999999999975422 223
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+... ....+...+..+.+++.+
T Consensus 180 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 254 (353)
T 2i0e_A 180 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIMEH--NVAYPKSMSKEAVAICKG 254 (353)
T ss_dssp CCCSCGGGCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred cccCCccccChhhhc-CCCcCCcccccchHHHHHHHHcCCCCCCCC--CHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 446899999999987 567899999999999999999999999752 222333333322 222345667789999999
Q ss_pred cccCCCCCCCC-----HHHHHH
Q 005999 629 CSLKSPEQRPA-----MWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt-----~~evl~ 645 (665)
||+.||++||+ +.|+++
T Consensus 255 lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 255 LMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HTCSCTTSCTTCSTTHHHHHHT
T ss_pred HhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999995 567665
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=334.96 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=197.3
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-CeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-GERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||++... +..||+|+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+++|+
T Consensus 27 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred eEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 67999999999999875 6789999987543 356788999999999999999999997654 47899999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT 553 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt 553 (665)
|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...........++
T Consensus 102 L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 177 (278)
T 1byg_A 102 LVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177 (278)
T ss_dssp HHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred HHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCcc
Confidence 99999742 1223789999999999999999999999 9999999999999999999999999997766555555678
Q ss_pred CcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 554 ~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
+.|+|||.+. +..++.++||||||+++|||++ |+.||... ...+....+.... ........+..+.+++.+||+.
T Consensus 178 ~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~ 253 (278)
T 1byg_A 178 VKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY-KMDAPDGCPPAVYEVMKNCWHL 253 (278)
T ss_dssp TTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTC-CCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccccCHHHhC-CCCCCchhcHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCC-CCCCcccCCHHHHHHHHHHhcC
Confidence 8999999987 5678999999999999999998 99999763 2233333333221 1223456678899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhh
Q 005999 633 SPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 633 dP~~RPt~~evl~~L~~~~~~ 653 (665)
||++|||+.|+++.|+++...
T Consensus 254 ~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 254 DAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred ChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=332.14 Aligned_cols=256 Identities=14% Similarity=0.169 Sum_probs=204.1
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE-EeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF-QAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|++++++++|++++..++++ ...+..++||||+ +
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 36799999999999996 6788999998755432 23477899999999888877766555 6677889999999 9
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe---CCCCceEEeecccccccCCCC-
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 89 PSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999999742 345999999999999999999999999 9999999999999 788999999999997654322
Q ss_pred ---------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCCC---c
Q 005999 548 ---------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDDG---R 614 (665)
Q Consensus 548 ---------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~---~ 614 (665)
....+|+.|+|||.+. +..++.++|||||||++|||++|+.||........ .....+........ .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred CccCCCCcccccCCCccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 2335899999999987 56789999999999999999999999986433222 22222222111111 1
Q ss_pred hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCcc
Q 005999 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNA 660 (665)
Q Consensus 615 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 660 (665)
....+..+.+++.+||+.||++|||+.|+++.|+++.+......+.
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~ 288 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 288 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccC
Confidence 2345678999999999999999999999999999999887754433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.61 Aligned_cols=243 Identities=17% Similarity=0.270 Sum_probs=196.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC--CCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS--HPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++...+++.||||++..........+.+.+|++++++++ ||||+++++++..++..++||| +.++
T Consensus 62 ~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~ 140 (390)
T 2zmd_A 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 140 (390)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred EEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence 679999999999999888999999999776555566788999999999996 5999999999999999999999 5688
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++.......
T Consensus 141 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 141 DLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp EHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence 999999843 46889999999999999999999999 99999999999996 5899999999997664322
Q ss_pred CCCCCCCcccCCccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 548 VEDPDTVAYKAPEIRKS----------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~----------~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||.........+.. +.........+..
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 292 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA-IIDPNHEIEFPDI 292 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH-HHCTTSCCCCCCC
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH-HhCccccCCCCcc
Confidence 23468999999999863 136889999999999999999999999753211111111 1111111223334
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+..+.+++.+||+.||++|||+.|+++.
T Consensus 293 ~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 293 PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 46679999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=348.09 Aligned_cols=255 Identities=15% Similarity=0.185 Sum_probs=207.0
Q ss_pred hHhCcccceEEEEEEECC---------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeee--------------
Q 005999 395 ELLGRGSIGTTYKAVLDN---------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP-------------- 451 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------------- 451 (665)
+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 48 ~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 679999999999999763 789999998654 24778999999999999887
Q ss_pred -eeEEEEe-CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC
Q 005999 452 -IRAYFQA-KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD 529 (665)
Q Consensus 452 -l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~ 529 (665)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENE-YVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCGGGEEEETT
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEEcCC
Confidence 6778776 77899999999 99999999853 2356999999999999999999999999 9999999999999999
Q ss_pred C--ceEEeecccccccCCCC----------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005999 530 F--EARLTDYCLSVLSDSSS----------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA 597 (665)
Q Consensus 530 ~--~~kl~Dfgl~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~ 597 (665)
+ .+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 8 99999999996654321 2236899999999987 567899999999999999999999999864323
Q ss_pred CccHHHHHHhhccCCC-c------hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCcccC
Q 005999 598 PPDMLEWVRTMRVDDG-R------EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662 (665)
Q Consensus 598 ~~~~~~~~~~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 662 (665)
...+............ . ....+..+.+++.+||+.||++|||+.|+++.|+++.+......+..+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 346 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPI 346 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccc
Confidence 3334333332222211 1 124467899999999999999999999999999999988876544443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.44 Aligned_cols=241 Identities=20% Similarity=0.333 Sum_probs=202.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (476)
T 2y94_A 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101 (476)
T ss_dssp EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 57999999999999975 7899999999654321 123567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 102 ~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 175 (476)
T 2y94_A 102 ELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175 (476)
T ss_dssp EHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCC
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcccccHHHEEEecCCCeEEEeccchhhcccccccccc
Confidence 99999873 356999999999999999999999999 9999999999999999999999999997765432 344
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|+|||++.+....+.++||||+||++|||++|+.||... ....+...+..... ..+...+..+.+++.+||
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L 251 (476)
T 2y94_A 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD--HVPTLFKKICDGIF--YTPQYLNPSVISLLKHML 251 (476)
T ss_dssp CSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS--SSHHHHHHHHTTCC--CCCTTCCHHHHHHHHHHT
T ss_pred CCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC--CHHHHHHHHhcCCc--CCCccCCHHHHHHHHHHc
Confidence 68999999999874444578999999999999999999999763 22233333332221 223445677999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
+.||++|||+.|+++
T Consensus 252 ~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 252 QVDPMKRATIKDIRE 266 (476)
T ss_dssp CSSTTTSCCHHHHHT
T ss_pred CCCchhCcCHHHHHh
Confidence 999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.79 Aligned_cols=240 Identities=18% Similarity=0.256 Sum_probs=190.8
Q ss_pred hHhCcccceEEEEEEE----CCeEEEEEEEecCCCch--hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTA--DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||++.. .+++.||+|+++..... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEY 102 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeC
Confidence 6799999999999997 47889999999765321 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-- 546 (665)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 103 LSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp CTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred CCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-EEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence 999999999974 345889999999999999999999999 999999999999999999999999998654322
Q ss_pred -CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 547 -SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 547 -~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+... ....+...+..+.++
T Consensus 177 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~--~~~~p~~~~~~~~~l 251 (327)
T 3a62_A 177 VTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--RKKTIDKILKC--KLNLPPYLTQEARDL 251 (327)
T ss_dssp --CTTSSCCTTSCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHT--CCCCCTTSCHHHHHH
T ss_pred cccccCCCcCccCHhhCc-CCCCCCcccchhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhC--CCCCCCCCCHHHHHH
Confidence 22346899999999987 5678999999999999999999999997531 12222222222 222344567789999
Q ss_pred HHHcccCCCCCCC-----CHHHHHH
Q 005999 626 ASVCSLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RP-----t~~evl~ 645 (665)
+.+||+.||++|| ++.|+++
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHc
Confidence 9999999999999 7788876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.01 Aligned_cols=249 Identities=20% Similarity=0.333 Sum_probs=203.9
Q ss_pred hHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|... .+..||+|.+..... ....+.+.+|+.++++++||||+++++++.++ ..++||||++
T Consensus 18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~ 95 (281)
T 3cc6_A 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYP 95 (281)
T ss_dssp EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCT
T ss_pred EEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCC
Confidence 67999999999999853 345799999876543 34567789999999999999999999998754 5689999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 170 (281)
T 3cc6_A 96 YGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN-CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK 170 (281)
T ss_dssp TCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred CCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEECCCCcEEeCccCCCcccccccccc
Confidence 99999999742 345899999999999999999999999 9999999999999999999999999997665432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
....+++.|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+..... ...+...+..+.++
T Consensus 171 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~llt~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 246 (281)
T 3cc6_A 171 ASVTRLPIKWMSPESIN-FRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIGVLEKGDR-LPKPDLCPPVLYTL 246 (281)
T ss_dssp --CCCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CGGGHHHHHHHTCC-CCCCTTCCHHHHHH
T ss_pred cccCCCCcceeCchhhc-cCCCCchhccHHHHHHHHHHHhCCCCCcccC--ChHHHHHHHhcCCC-CCCCCCCCHHHHHH
Confidence 2234678899999987 5678999999999999999998 99999753 22344443333221 22344567789999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
+.+||+.||++|||+.|+++.|+++.+..
T Consensus 247 i~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 247 MTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.61 Aligned_cols=254 Identities=14% Similarity=0.172 Sum_probs=204.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEE-EeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYF-QAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+.++++++|++++..+.++ ...+..++||||+ ++
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 5799999999999996 6789999999865543 23578899999999988866665554 6677889999999 89
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe---CCCCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 90 ~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 90 SLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp BHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 999999742 346999999999999999999999999 9999999999999 488999999999997654332
Q ss_pred --------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-ccHHHHHHhhccCCC---ch
Q 005999 548 --------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP-PDMLEWVRTMRVDDG---RE 615 (665)
Q Consensus 548 --------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~---~~ 615 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ......+........ ..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred cccccccccccccccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 2335899999999987 5678999999999999999999999998643322 233222222111111 12
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCc
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDN 659 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 659 (665)
...+..+.+++.+||+.||++|||+.|+++.|+++........+
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 34567899999999999999999999999999999888765433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.56 Aligned_cols=240 Identities=20% Similarity=0.263 Sum_probs=197.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-----CCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-----HPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|.. .+++.||||++.... ...+.+..|+++++.++ ||||+++++++...+..++||||
T Consensus 41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 117 (360)
T 3llt_A 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117 (360)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence 6799999999999997 478899999997432 44566778999998886 99999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC--------------------
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-------------------- 528 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-------------------- 528 (665)
+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 118 ~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 118 L-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMS-LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp C-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred C-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 9 89999999853 2345899999999999999999999999 999999999999975
Q ss_pred -----CCceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHH
Q 005999 529 -----DFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLE 603 (665)
Q Consensus 529 -----~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 603 (665)
++.+||+|||++...........||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+...
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~ 269 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHE--HMEHLA 269 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHH
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCCCc--HHHHHH
Confidence 78999999999987766666667999999999987 5679999999999999999999999997532 122222
Q ss_pred HHHhhccCCC--------------------------------------------chhhhHHHHHHHHHHcccCCCCCCCC
Q 005999 604 WVRTMRVDDG--------------------------------------------REENRLGMLTEVASVCSLKSPEQRPA 639 (665)
Q Consensus 604 ~~~~~~~~~~--------------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPt 639 (665)
.+........ ........+.+|+.+||+.||++|||
T Consensus 270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 349 (360)
T 3llt_A 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349 (360)
T ss_dssp HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence 2222111110 00011256889999999999999999
Q ss_pred HHHHHH
Q 005999 640 MWQVLK 645 (665)
Q Consensus 640 ~~evl~ 645 (665)
+.|+++
T Consensus 350 a~elL~ 355 (360)
T 3llt_A 350 PAELLK 355 (360)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.31 Aligned_cols=243 Identities=19% Similarity=0.294 Sum_probs=202.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||+|... ++..||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 467999999999999965 68899999987654321 2367789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC----ceEEeecccccccC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF----EARLTDYCLSVLSD 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~ 544 (665)
+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++....
T Consensus 97 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~-ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 97 VSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp CCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999999973 346899999999999999999999999 99999999999999887 79999999997665
Q ss_pred CCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHH
Q 005999 545 SSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLG 620 (665)
Q Consensus 545 ~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 620 (665)
... ....||+.|+|||++. +..++.++||||||+++|||++|+.||... ...+....+........ .....+.
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccccccccCCCCCccCccccc-CCCCCCccccHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhcccccChhhhcccCH
Confidence 432 3345899999999987 567899999999999999999999999752 12223322222222111 1234567
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 8999999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.13 Aligned_cols=243 Identities=21% Similarity=0.344 Sum_probs=199.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe----CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA----KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... ++..||+|.+..........+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 46999999999999864 67889999998766555667889999999999999999999999875 35689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeC-CCCceEEeecccccccCCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLG-ADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~ 547 (665)
++|+|.+++.. ...+++..++.++.||+.||+|||+.+ +|+||||||+||+++ .++.+||+|||++.......
T Consensus 112 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 186 (290)
T 1t4h_A 112 TSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence 99999999974 246899999999999999999999975 599999999999998 78999999999997655432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....+|+.|+|||++. ..++.++||||||+++|||++|+.||.... ........+.............+..+.+++
T Consensus 187 ~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 263 (290)
T 1t4h_A 187 AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred cccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-cHHHHHHHHhccCCccccCCCCCHHHHHHH
Confidence 2345899999999886 458999999999999999999999997532 111222222222222223444556799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.||++|||+.|+++
T Consensus 264 ~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 264 EGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCChhhCCCHHHHhh
Confidence 9999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.26 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=202.3
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 357999999999999975 688999999865443 234577899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-----S 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~ 547 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+...... .
T Consensus 91 ~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 91 ELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp EGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 99998863 346899999999999999999999999 999999999999999999999999998654321 2
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
....+|+.|+|||.+.....++.++||||||+++|||++|+.||............+.... .........+..+.+++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-TTSTTGGGSCHHHHHHHH
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-cccCchhhcCHHHHHHHH
Confidence 3345899999999987444457899999999999999999999987543333333333221 111223456778999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~ 645 (665)
+||+.||++|||+.|+++
T Consensus 244 ~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 244 KILVENPSARITIPDIKK 261 (276)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHCCCCchhCCCHHHHhc
Confidence 999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.10 Aligned_cols=248 Identities=18% Similarity=0.299 Sum_probs=199.6
Q ss_pred hHhCcccceEEEEEEEC-CeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... +++ .|++|.+..... ....+.+.+|+.++++++||||+++++++.... .++|+||+
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~ 98 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS-CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence 67999999999999854 343 357777754432 345677899999999999999999999998765 78999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 99 PFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp SSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC-CcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence 999999999753 346899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....+|+.|+|||.+. +..++.++|||||||++|||++ |+.||... ...++...+.... ....+...+..+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~l~ 249 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGE-RLPQPPICTIDVY 249 (327)
T ss_dssp ------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTC-CCCCCTTBCHHHH
T ss_pred ccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCC-CCCCCccCCHHHH
Confidence 1224677899999987 6778999999999999999999 99999763 2334444443322 2223445677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+++.+||+.||++|||+.|+++.|+.+...
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.89 Aligned_cols=239 Identities=21% Similarity=0.328 Sum_probs=198.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||+|+++.... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 102 (345)
T 1xjd_A 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 102 (345)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 67999999999999975 688999999975422 122345677888888876 999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++..... ...
T Consensus 103 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 176 (345)
T 1xjd_A 103 GDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176 (345)
T ss_dssp CBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCccc
Confidence 999999974 245899999999999999999999999 99999999999999999999999999975432 223
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+.... ...+...+..+.+++.+
T Consensus 177 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~ 251 (345)
T 1xjd_A 177 TFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMDN--PFYPRWLEKEAKDLLVK 251 (345)
T ss_dssp CCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCC--CCCCTTSCHHHHHHHHH
T ss_pred CCCCCcccCChhhhc-CCCCCChhhhHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhCC--CCCCcccCHHHHHHHHH
Confidence 446899999999987 567899999999999999999999999752 2223333333221 22344567789999999
Q ss_pred cccCCCCCCCCHH-HHH
Q 005999 629 CSLKSPEQRPAMW-QVL 644 (665)
Q Consensus 629 cl~~dP~~RPt~~-evl 644 (665)
||+.||++||++. |++
T Consensus 252 lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HSCSSGGGSBTTBSCGG
T ss_pred HhcCCHhHcCCChHHHH
Confidence 9999999999997 664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=342.86 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=193.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC----eEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG----ERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 468 (665)
+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~ 97 (311)
T 3ork_A 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97 (311)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEec
Confidence 6799999999999996 57899999999765432 234567899999999999999999999987654 34999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+++|+|.++++. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 98 VDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp CCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence 999999999974 346899999999999999999999999 9999999999999999999999999997654322
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHH
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLG 620 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 620 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ............... ......+.
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 3ork_A 172 SVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSARHEGLSA 248 (311)
T ss_dssp ----------CCTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred ccccccccCcCcccCCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCCCcccccCCCCH
Confidence 1234799999999987 5678999999999999999999999997531 111111111111111 11234567
Q ss_pred HHHHHHHHcccCCCCCCCCHHHH-HHHHHHHHhh
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQV-LKMIQEIKES 653 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~ev-l~~L~~~~~~ 653 (665)
.+.+++.+||+.||++||++.++ ...+..+...
T Consensus 249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 89999999999999999966554 4566655443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.38 Aligned_cols=243 Identities=18% Similarity=0.270 Sum_probs=193.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCC
Confidence 4699999999999984 4788999999976532 3456788999999885 8999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc---eEEeecccccccCCC---
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE---ARLTDYCLSVLSDSS--- 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~~~~--- 546 (665)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 97 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 97 SILSHIHK-----RRHFNELEASVVVQDVASALDFLHNKG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred cHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999974 246899999999999999999999999 999999999999998766 999999998654321
Q ss_pred -------CCCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-------------ccHH
Q 005999 547 -------SVEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP-------------PDML 602 (665)
Q Consensus 547 -------~~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~-------------~~~~ 602 (665)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||....... ..+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 112348999999998862 1357889999999999999999999997643221 1122
Q ss_pred HHHHhhccCCC--chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 603 EWVRTMRVDDG--REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 603 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+........ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 22222221111 11345678999999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.65 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=199.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... ++..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 91 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence 367999999999999965 477899999876543 33567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe---CCCCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 92 ~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 92 ELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLN-VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp BHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99999874 345899999999999999999999999 9999999999999 788999999999997655432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCc--hhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGR--EENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l 625 (665)
....+|+.|+|||++. +.++.++||||||+++|||++|+.||... ...+....+......... ....+..+.++
T Consensus 166 ~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp CCCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred hccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 3446899999999986 34899999999999999999999999763 222333333322222111 12457789999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||+.||++|||+.|+++
T Consensus 242 i~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.13 Aligned_cols=255 Identities=20% Similarity=0.321 Sum_probs=205.0
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||.||+|... +++.||+|.++...... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 367999999999999976 68899999987553321 2367889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC----ceEEeecccccccC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF----EARLTDYCLSVLSD 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~ 544 (665)
+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++....
T Consensus 90 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 90 VSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp CCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999974 346899999999999999999999999 99999999999999877 89999999997664
Q ss_pred CCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHH
Q 005999 545 SSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLG 620 (665)
Q Consensus 545 ~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 620 (665)
... ....+|+.|+|||++. +..++.++||||||+++|||++|+.||.... ..+....+........ .....+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGET--KQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp --------CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred CCCcccccCCCcCccCcceec-CCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--hHHHHHHhHhcccCCcchhcccCCH
Confidence 432 2335899999999987 5678999999999999999999999997531 1222222222221111 1234567
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHhhhccc
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLK--MIQEIKESVMAE 657 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~~~~~ 657 (665)
.+.+++.+||+.||++|||+.|+++ .++.+.......
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 279 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC--
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhhc
Confidence 7999999999999999999999998 566665554433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=343.26 Aligned_cols=237 Identities=19% Similarity=0.279 Sum_probs=197.4
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh------hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD------TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 35799999999999985 578899999997654211 13345778999999999999999999999999999999
Q ss_pred EecCCC-CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 467 DYQPNG-SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 467 e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
||+.+| +|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 109 e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 109 EKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKD-IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp ECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999777 99999974 346999999999999999999999999 99999999999999999999999999977654
Q ss_pred CC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 546 SS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 546 ~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
.. ....||+.|+|||++.....++.++|||||||++|||++|+.||..... ........+...+..+.
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYLVSKELM 252 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSSCCCHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCcccCHHHH
Confidence 33 2335899999999987444448899999999999999999999965210 01111122334567799
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+++.+||+.||++|||+.|+++.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999884
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=338.18 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=204.4
Q ss_pred hHhCcccceEEEEEEEC-CeEE--EEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLI--VTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|... ++.. +++|++..... ....+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 67999999999999853 5554 48998875432 23456788999999999 99999999999999999999999999
Q ss_pred CCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 471 NGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 471 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
+|+|.+++...+. .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~kL~Dfg~ 188 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGL 188 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCccceEEEcCCCeEEEcccCc
Confidence 9999999975420 12346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 540 SVLSDSS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 540 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
+...... .....+++.|+|||++. +..++.++||||||+++|||++ |+.||.... ..++...+.... ....+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--~~~~~~~~~~~~-~~~~~~ 264 (327)
T 1fvr_A 189 SRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGY-RLEKPL 264 (327)
T ss_dssp EESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGGGTC-CCCCCT
T ss_pred CccccccccccCCCCCccccChhhhc-cccCCchhcchHHHHHHHHHHcCCCCCCCCCc--HHHHHHHhhcCC-CCCCCC
Confidence 8644322 22234688999999987 5678999999999999999998 999997531 122222222211 112344
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
..+..+.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus 265 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 265 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 5677899999999999999999999999999999887654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.12 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=208.0
Q ss_pred HhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCC-eEEEE
Q 005999 394 AELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKG-ERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv 465 (665)
.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++.++ +||||+++++++...+ ..++|
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 36799999999999984 3678999999976543 33456789999999999 7999999999988754 58999
Q ss_pred EEecCCCCHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEE
Q 005999 466 YDYQPNGSLFNLIHGSRSI-----------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL 534 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl 534 (665)
|||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~~~~~kl 189 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKI 189 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECCCCCEEE
Confidence 9999999999999854321 0223889999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhh
Q 005999 535 TDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTM 608 (665)
Q Consensus 535 ~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 608 (665)
+|||++........ ...+|+.|+|||++. +..++.++||||||+++|||++ |+.||..... ...+...+...
T Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~ 267 (316)
T 2xir_A 190 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEG 267 (316)
T ss_dssp CCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHHHHHHHT
T ss_pred CCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccch-hHHHHHHhccC
Confidence 99999976543321 223678899999987 5678999999999999999998 9999976432 22333333322
Q ss_pred ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 609 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.. ...+...+..+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 268 ~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 268 TR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 21 22334566789999999999999999999999999999987643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=344.80 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=208.9
Q ss_pred hHhCcccceEEEEEEECC------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 467 (665)
+.||+|+||.||+|.... ...||+|.+..... ....+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 52 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 679999999999998643 24799999976543 24457789999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecc
Q 005999 468 YQPNGSLFNLIHGSRS---------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYC 538 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfg 538 (665)
|+++|+|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg 209 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-CIHRDVAARNVLLTNGHVAKIGDFG 209 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGCEEEGGGEEEBCCCG
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCcccceEEECCCCeEEECccc
Confidence 9999999999874321 01345899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCC
Q 005999 539 LSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDD 612 (665)
Q Consensus 539 l~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 612 (665)
++....... ....+|+.|+|||.+. +..++.++|||||||++|||+| |..||..... ...+...+.... ..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~-~~ 286 (333)
T 2i1m_A 210 LARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV-NSKFYKLVKDGY-QM 286 (333)
T ss_dssp GGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-SHHHHHHHHHTC-CC
T ss_pred cccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-hHHHHHHHhcCC-CC
Confidence 997553322 1223577899999987 5678999999999999999998 9999976321 223333333222 22
Q ss_pred CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 613 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
..+...+..+.+++.+||+.||++|||+.|+++.|+++......+
T Consensus 287 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 287 AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 234455678999999999999999999999999999988765544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.13 Aligned_cols=239 Identities=21% Similarity=0.310 Sum_probs=180.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||||++... ....+.+|+.+++++. ||||+++++++.+++..++||||+++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 56999999999999975 6889999998643 3456778999999996 999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC---ceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF---EARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++.......
T Consensus 92 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 92 ELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp BHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 99999974 356999999999999999999999999 99999999999997665 89999999997654432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC--CccHHHHHHhhccCC---C--chhhhH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA--PPDMLEWVRTMRVDD---G--REENRL 619 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~---~--~~~~~~ 619 (665)
....+|+.|+|||++. +..++.++|||||||++|||++|+.||...... .....+......... . .....+
T Consensus 166 ~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 2345799999999987 667899999999999999999999999764321 112222222222211 1 123457
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 78999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.61 Aligned_cols=243 Identities=20% Similarity=0.271 Sum_probs=200.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... +++.||+|++............+.+|+..+.++ +||||+++++++.+++..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 367999999999999975 789999999987655555667788999999998 999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-------------------Cce
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-------------------FEA 532 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-------------------~~~ 532 (665)
|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ ..+
T Consensus 96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (289)
T 1x8b_A 96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS-LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173 (289)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEC--------------------CCCE
T ss_pred CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-EeecCCCHHHEEEcCCCCCcccccccccccccCCceEE
Confidence 999999974321 1246899999999999999999999999 9999999999999844 479
Q ss_pred EEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC
Q 005999 533 RLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD 612 (665)
Q Consensus 533 kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 612 (665)
||+|||.+....... ...+|+.|+|||++.....++.++|||||||++|||++|.+|+.. .+....+..... .
T Consensus 174 kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~~~~~~~~~-~ 246 (289)
T 1x8b_A 174 KIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN-----GDQWHEIRQGRL-P 246 (289)
T ss_dssp EECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS-----SHHHHHHHTTCC-C
T ss_pred EEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc-----hhHHHHHHcCCC-C
Confidence 999999997765543 346899999999987544677899999999999999999887643 122222222211 1
Q ss_pred CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 234456778999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.91 Aligned_cols=240 Identities=18% Similarity=0.263 Sum_probs=190.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHH-hCCCCCCeeeeeEEEEe----CCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAV-GGLSHPNLVPIRAYFQA----KGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~ 468 (665)
+.||+|+||+||++... +++.||||++... ..+.+|++++ +..+||||++++++|.. .+..++||||
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 46999999999999965 6889999998632 2456777776 44589999999999876 5678999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDS 545 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~ 545 (665)
+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 141 ~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 141 LDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 9999999999853 2346999999999999999999999999 999999999999997 78999999999976654
Q ss_pred CC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC--ccHHHHHHhhccCC--CchhhhH
Q 005999 546 SS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP--PDMLEWVRTMRVDD--GREENRL 619 (665)
Q Consensus 546 ~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~ 619 (665)
.. ....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ..+...+....... ......+
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 295 (400)
T 1nxk_A 217 HNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295 (400)
T ss_dssp ----------CTTCCGGGSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred CCccccCCCCCCccCHhhcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence 32 3346899999999986 6789999999999999999999999997643322 12333333322221 1224567
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
..+.+|+.+||+.||++|||+.|+++.
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 789999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.35 Aligned_cols=242 Identities=21% Similarity=0.275 Sum_probs=194.2
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------eEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------ERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 467 (665)
+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence 5799999999999996 46889999999765554556678899999999999999999999997653 4699999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 111 ~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (367)
T 1cm8_A 111 FM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182 (367)
T ss_dssp CC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred cC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCHHHEEEcCCCCEEEEeeeccccccccc
Confidence 99 7899999874 35899999999999999999999999 9999999999999999999999999998877665
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC----------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD---------------- 611 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------------- 611 (665)
....+|+.|+|||++.+...++.++||||+||++|||++|+.||..... ...+..........
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 261 (367)
T 1cm8_A 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261 (367)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Confidence 6667899999999987556799999999999999999999999975321 01111111111000
Q ss_pred -------C-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 -------D-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 -------~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. ......+..+.+|+.+||..||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 011234667999999999999999999999988
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=330.76 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=198.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... ++..||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (279)
T 3fdn_A 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94 (279)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred eEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCC
Confidence 57999999999999865 5778999998654321 123567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-CCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-VEDP 551 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~ 551 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 95 ~l~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 168 (279)
T 3fdn_A 95 TVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 168 (279)
T ss_dssp EHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT-CEECCCCGGGEEECTTSCEEECSCCEESCC--------C
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHhEEEcCCCCEEEEeccccccCCcccccccC
Confidence 99999874 245899999999999999999999999 9999999999999999999999999986554332 3346
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
+|+.|+|||.+. +..++.++||||||+++|||++|+.||... ...+....+... ....+...+..+.+++.+||+
T Consensus 169 ~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~ 243 (279)
T 3fdn_A 169 GTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRV--EFTFPDFVTEGARDLISRLLK 243 (279)
T ss_dssp CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHT--CCCCCTTSCHHHHHHHHHHCC
T ss_pred CCCCccCHhHhc-cCCCCccchhHhHHHHHHHHHHCCCCCCCC--cHHHHHHHHHhC--CCCCCCcCCHHHHHHHHHHhc
Confidence 899999999987 667899999999999999999999999752 112222222222 222344567789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 005999 632 KSPEQRPAMWQVLKM 646 (665)
Q Consensus 632 ~dP~~RPt~~evl~~ 646 (665)
.||++|||+.|+++.
T Consensus 244 ~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 244 HNPSQRPMLREVLEH 258 (279)
T ss_dssp SSGGGSCCHHHHHHC
T ss_pred cChhhCCCHHHHhhC
Confidence 999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=365.29 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=207.8
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+.+|+|
T Consensus 273 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred eecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence 5799999999999999888889999997654 235678999999999999999999999876 678999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC----CCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS----SVED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----~~~~ 550 (665)
.++++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||++...... ....
T Consensus 349 ~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 424 (535)
T 2h8h_A 349 LDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424 (535)
T ss_dssp HHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred HHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence 9999742 2245899999999999999999999999 999999999999999999999999999766432 1223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.++..|+|||++. ...++.++|||||||++|||++ |+.||... ...++...+..... ...+..++..+.+|+.+|
T Consensus 425 ~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~c 500 (535)
T 2h8h_A 425 KFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYR-MPCPPECPESLHDLMCQC 500 (535)
T ss_dssp TSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--CHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHH
T ss_pred cCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHH
Confidence 4678899999987 5679999999999999999999 99999753 22234433332211 123456678899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
|+.||++|||+.++++.|+.+.....
T Consensus 501 l~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 501 WRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp TCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred cCCChhHCcCHHHHHHHHHHHhhccC
Confidence 99999999999999999998765443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=359.46 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=203.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||++||
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 269 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence 57999999999999975 7899999999654321 223456889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++....... ...
T Consensus 270 ~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~g-IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~ 345 (576)
T 2acx_A 270 DLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345 (576)
T ss_dssp BHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECC
T ss_pred cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCchheEEEeCCCCeEEEecccceecccCcccccc
Confidence 999999743 2345899999999999999999999999 9999999999999999999999999997765432 334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
.||+.|+|||++. +..++.++|||||||++|||++|+.||........ .+...+... ....+...+..+.+++.+
T Consensus 346 ~GT~~Y~APEvl~-~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~~~dLI~~ 422 (576)
T 2acx_A 346 VGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQARSLCSQ 422 (576)
T ss_dssp CSCGGGCCHHHHT-TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHH
T ss_pred CCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHHHHHHHHH
Confidence 7999999999987 56789999999999999999999999986432211 233333322 222345667889999999
Q ss_pred cccCCCCCCC-----CHHHHHH
Q 005999 629 CSLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RP-----t~~evl~ 645 (665)
||+.||++|| ++.|+++
T Consensus 423 lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 423 LLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HTCSSGGGSTTCSSSHHHHHHT
T ss_pred hccCCHHHcCCCCCCCHHHHHh
Confidence 9999999999 7888876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.02 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=198.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 2h34_A 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV 119 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCE
T ss_pred EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCC
Confidence 67999999999999965 7889999999765432 234577899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~ 548 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 120 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 193 (309)
T 2h34_A 120 DLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAG-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193 (309)
T ss_dssp EHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSCCC-------------
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc-CCcCCCChHHEEEcCCCCEEEecCccCcccccccccccc
Confidence 99999974 246899999999999999999999999 9999999999999999999999999987654432 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-CCchhhhHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD-DGREENRLGMLTEVAS 627 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 627 (665)
...+++.|+|||++. +..++.++||||||+++|||++|+.||.... ...+...+...... .......+..+.+++.
T Consensus 194 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (309)
T 2h34_A 194 NTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270 (309)
T ss_dssp ---CCGGGCCGGGTC-C----CCCHHHHHHHHHHHHHHSSCSSCSCH--HHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred ccCCCcCccCHHHHc-CCCCCchHhHHHHHHHHHHHHHCCCCCCCch--HHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence 335899999999987 5678999999999999999999999997521 11222222211111 1123455678999999
Q ss_pred HcccCCCCCCC-CHHHHHHHHHHHHhhhcc
Q 005999 628 VCSLKSPEQRP-AMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 628 ~cl~~dP~~RP-t~~evl~~L~~~~~~~~~ 656 (665)
+||+.||++|| +++++++.|+.+......
T Consensus 271 ~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 271 RGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred HhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 99999999999 999999999988766543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=353.91 Aligned_cols=245 Identities=15% Similarity=0.229 Sum_probs=198.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh-hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||+||+|... +++.||+|++....... ...+.+.+|+.++..++||||++++++|.+++..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 367999999999999976 57899999986532211 1223478899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++.......
T Consensus 159 g~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 159 GDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 9999999742 356999999999999999999999999 9999999999999999999999999997654332
Q ss_pred CCCCCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--cC-CCchhhhHH
Q 005999 548 VEDPDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--VD-DGREENRLG 620 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~ 620 (665)
....||+.|+|||++. +...++.++|||||||++|||++|+.||... ...+....+.... .. .......+.
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--ChhHHHHhhhhccccccCCcccccCCH
Confidence 2246899999999985 2456899999999999999999999999753 1222222222111 11 111234677
Q ss_pred HHHHHHHHcccCCCCC--CCCHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQ--RPAMWQVLK 645 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~--RPt~~evl~ 645 (665)
.+.+|+.+||..+|++ ||++.|+++
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHHHHHHHHhcccccccCCCCHHHHhC
Confidence 8999999999888888 999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.78 Aligned_cols=243 Identities=17% Similarity=0.247 Sum_probs=188.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+++..++||||+.+ +
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 118 (329)
T 3gbz_A 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118 (329)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-C
Confidence 67999999999999854 788999999976655445566788999999999999999999999999999999999985 9
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe-----CCCCceEEeecccccccCCC--
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL-----GADFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill-----~~~~~~kl~Dfgl~~~~~~~-- 546 (665)
|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++......
T Consensus 119 L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 192 (329)
T 3gbz_A 119 LKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRR-CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192 (329)
T ss_dssp HHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence 99999742 45899999999999999999999999 9999999999999 45556999999999765432
Q ss_pred -CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC------------
Q 005999 547 -SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG------------ 613 (665)
Q Consensus 547 -~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------------ 613 (665)
.....+|+.|+|||++.....++.++|||||||++|||++|+.||..... ...+............
T Consensus 193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp -------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-HHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 22335799999999987555689999999999999999999999975311 1122222221111110
Q ss_pred ---------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 ---------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 ---------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 01124567899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.27 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=195.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... ++..+|+|++..... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 367999999999999964 688999999876543 234577899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe---CCCCceEEeecccccccCCC--C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSS--S 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~--~ 547 (665)
+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++...... .
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 183 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccC
Confidence 99998864211 2356899999999999999999999999 9999999999999 45678999999999765433 2
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-CchhhhHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD-GREENRLGMLTEVA 626 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 626 (665)
....+|+.|+|||++. ..++.++||||||+++|||++|+.||.... ..+............ ......+..+.+++
T Consensus 184 ~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (285)
T 3is5_A 184 TNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--LEEVQQKATYKEPNYAVECRPLTPQAVDLL 259 (285)
T ss_dssp ---CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCC--CCCCHHHHHHH
T ss_pred cCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCC--HHHHHhhhccCCcccccccCcCCHHHHHHH
Confidence 3346899999999885 468999999999999999999999997531 122222222211111 11223567799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.||++|||+.|+++
T Consensus 260 ~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 260 KQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHTCSCTTTSCCHHHHHT
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=347.61 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=187.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCC--eEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKG--ERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~~ 470 (665)
+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++.++. ||||+++++++...+ ..++||||+.
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 5799999999999986 46889999999766554566677889999999997 999999999997644 7899999998
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC----
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---- 546 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---- 546 (665)
|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 -~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 95 -TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG-LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp -EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred -cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 599999874 35899999999999999999999999 999999999999999999999999999754321
Q ss_pred --------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHH
Q 005999 547 --------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWV 605 (665)
Q Consensus 547 --------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~ 605 (665)
.....||+.|+|||++.+...++.++||||+||++|||++|++||.... .. .+...+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~ 244 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS--TMNQLERII 244 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence 1223589999999998755679999999999999999999999997532 11 111111
Q ss_pred HhhccCC--------------------------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHH
Q 005999 606 RTMRVDD--------------------------------------------GREENRLGMLTEVASVCSLKSPEQRPAMW 641 (665)
Q Consensus 606 ~~~~~~~--------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 641 (665)
.....+. ......+..+.+|+.+||+.||++|||+.
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 1111000 00113456789999999999999999999
Q ss_pred HHHHH
Q 005999 642 QVLKM 646 (665)
Q Consensus 642 evl~~ 646 (665)
|+++.
T Consensus 325 e~l~H 329 (388)
T 3oz6_A 325 DALKH 329 (388)
T ss_dssp HHTTS
T ss_pred HHhCC
Confidence 99875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.02 Aligned_cols=255 Identities=19% Similarity=0.319 Sum_probs=203.2
Q ss_pred hHhCcccceEEEEEEE-----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEE--eCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ--AKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e 467 (665)
+.||+|+||.||++.+ .++..||+|++.... ....+.+.+|++++++++||||+++++++. +....++|||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 6799999999999984 468899999997654 345567899999999999999999999987 4567899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 107 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 107 YLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRR-CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred ecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 99999999999742 245899999999999999999999999 9999999999999999999999999997664322
Q ss_pred ------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC----------CCccHHHHHHhhcc-
Q 005999 548 ------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYL----------APPDMLEWVRTMRV- 610 (665)
Q Consensus 548 ------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~----------~~~~~~~~~~~~~~- 610 (665)
....+|..|+|||++. +..++.++||||||+++|||++|+.||..... ..............
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred ccceeeccCCccccccCHHHhc-cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 2234788899999987 56789999999999999999999999864211 01111111111111
Q ss_pred -CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 611 -DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 611 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
....+...+..+.+++.+||+.||++|||+.|+++.|+.+.......
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 11234566788999999999999999999999999999987655443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.29 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=201.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe----CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA----KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 469 (665)
+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 35 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 6799999999999996 578899999986543 3456778999999999999999999999873 34788999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
.+|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 190 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG-YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence 99999999875321 3456999999999999999999999999 99999999999999999999999998865432111
Q ss_pred -----------CCCCCCcccCCccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCch
Q 005999 549 -----------EDPDTVAYKAPEIRKSSR--RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGRE 615 (665)
Q Consensus 549 -----------~~~gt~~y~aPE~~~~~~--~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (665)
...||+.|+|||++.... .++.++||||||+++|||++|+.||.............+.. .......
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 269 (317)
T 2buj_A 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQS 269 (317)
T ss_dssp HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C--CCCC
T ss_pred ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCCCCcc
Confidence 123689999999886322 26889999999999999999999986422222233332222 1112223
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
...+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 270 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 45677899999999999999999999999999887543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=353.56 Aligned_cols=243 Identities=18% Similarity=0.241 Sum_probs=198.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.+++.++||||++++++|.+++..++||||++||
T Consensus 75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 154 (410)
T 3v8s_A 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154 (410)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 57999999999999975 5889999998653211 112345788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~ 548 (665)
+|.++++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++....... .
T Consensus 155 ~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 155 DLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp EHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred cHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 99999974 24889999999999999999999999 9999999999999999999999999997665432 2
Q ss_pred CCCCCCcccCCccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--cCCCchhhhHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSR---RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--VDDGREENRLGMLT 623 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~---~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 623 (665)
...||+.|+|||++.... .++.++|||||||++|||++|+.||... ........+.... .........+..+.
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--ChhhHHHHHHhccccccCCCcccccHHHH
Confidence 446999999999987322 1788999999999999999999999752 1222222222211 11122335677899
Q ss_pred HHHHHcccCCCCC--CCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQ--RPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~--RPt~~evl~~ 646 (665)
+|+.+||..+|++ ||++.|+++.
T Consensus 306 ~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHHHccChhhhCCCCCHHHHhcC
Confidence 9999999999988 9999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.93 Aligned_cols=246 Identities=17% Similarity=0.236 Sum_probs=202.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||++||
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 46999999999999975 6899999999654321 123467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++....... ..
T Consensus 271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g-IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 348 (543)
T 3c4z_A 271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG 348 (543)
T ss_dssp BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCC
T ss_pred CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC-CcccCCChHHEEEeCCCCEEEeecceeeeccCCCccccc
Confidence 99999875321 2456999999999999999999999999 9999999999999999999999999997765432 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC--ccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP--PDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
..||+.|+|||++. +..++.++|||||||++|||++|+.||....... ..+...+.. .....+...+..+.+++.
T Consensus 349 ~~GT~~Y~APE~l~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 425 (543)
T 3c4z_A 349 YAGTPGFMAPELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPDKFSPASKDFCE 425 (543)
T ss_dssp CCSCTTTSCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred ccCCccccChhhhc-CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCcccCHHHHHHHH
Confidence 36899999999987 5679999999999999999999999997643221 122222222 122334566788999999
Q ss_pred HcccCCCCCCCCH-----HHHHH
Q 005999 628 VCSLKSPEQRPAM-----WQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~-----~evl~ 645 (665)
+||+.||++||++ .|+++
T Consensus 426 ~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 426 ALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HhccCCHhHCCCCcccCHHHHHc
Confidence 9999999999975 56654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.11 Aligned_cols=245 Identities=20% Similarity=0.313 Sum_probs=201.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++.++ +||||+++++++.+.+..++||||+.+|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 67999999999999965 688999999987655445567889999999999 5699999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.......
T Consensus 115 ~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g-ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 190 (327)
T 3lm5_A 115 EIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190 (327)
T ss_dssp EGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred cHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccc
Confidence 999998632 3456999999999999999999999999 999999999999997 7899999999997765432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 625 (665)
....+|+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+....... ......+..+.++
T Consensus 191 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 191 REIMGTPEYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGED--NQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp ---CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ccccCCcCccCCeeec-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 2346899999999987 6678999999999999999999999997531 222222222222211 2334567789999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~ 646 (665)
+.+||+.||++|||+.|+++.
T Consensus 268 i~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 268 IQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHcCCChhhCcCHHHHhCC
Confidence 999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.03 Aligned_cols=238 Identities=20% Similarity=0.267 Sum_probs=188.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHH-HhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEA-VGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|..+ ++..||+|+++..... ....+.+.+|..+ ++.++||||+++++++.+.+..|+||||+++
T Consensus 44 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 123 (373)
T 2r5t_A 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 123 (373)
T ss_dssp EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCC
Confidence 67999999999999975 5888999999765432 2234456667766 5778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSV 548 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~ 548 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++..... ...
T Consensus 124 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~ 197 (373)
T 2r5t_A 124 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197 (373)
T ss_dssp CBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCC
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEeeCccccccccCCCccc
Confidence 999999974 345889999999999999999999999 99999999999999999999999999975322 223
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+... ....+...+..+.+++.+
T Consensus 198 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~--~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--NTAEMYDNILNK--PLQLKPNITNSARHLLEG 272 (373)
T ss_dssp SBSCCCCCCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--BHHHHHHHHHHS--CCCCCSSSCHHHHHHHHH
T ss_pred cccCCccccCHHHhC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhc--ccCCCCCCCHHHHHHHHH
Confidence 346899999999987 667999999999999999999999999752 112232222221 222344567789999999
Q ss_pred cccCCCCCCCCHHHH
Q 005999 629 CSLKSPEQRPAMWQV 643 (665)
Q Consensus 629 cl~~dP~~RPt~~ev 643 (665)
||+.||++||++.+.
T Consensus 273 lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDD 287 (373)
T ss_dssp HTCSSGGGSTTTTTT
T ss_pred HcccCHHhCCCCCCC
Confidence 999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=344.45 Aligned_cols=249 Identities=19% Similarity=0.237 Sum_probs=195.6
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc---hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT---ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|.. .++..||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 46799999999999996 4688899999865421 2245578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 005999 470 PNGSLFNLIHGSRSI-----------------------------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~i 514 (665)
++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i 189 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-I 189 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT-E
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-c
Confidence 999999998521100 0122467778899999999999999999 9
Q ss_pred eccCCCCCceEeCCCC--ceEEeecccccccCCC-------CCCCCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHH
Q 005999 515 IHGNLKSSNVLLGADF--EARLTDYCLSVLSDSS-------SVEDPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLEL 584 (665)
Q Consensus 515 iH~Dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~el 584 (665)
+||||||+||+++.++ .+||+|||++...... .....||+.|+|||++.. ...++.++|||||||++|||
T Consensus 190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 269 (345)
T 3hko_A 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269 (345)
T ss_dssp ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHH
T ss_pred cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999998776 8999999999754321 123458999999999863 25789999999999999999
Q ss_pred HhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 585 LTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 585 ltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
++|+.||.... ..+....+....... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 270 LMGAVPFPGVN--DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHSSCSSCCSS--HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHCCCCCCCCC--hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999997532 122222222211111 123345778999999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.20 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=196.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||+.+++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 57999999999999975 58899999997766555566778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 111 l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 184 (331)
T 4aaa_A 111 LDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184 (331)
T ss_dssp HHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCTTC------------C
T ss_pred HHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCC-EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCC
Confidence 9988763 345899999999999999999999999 999999999999999999999999999765432 2334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC---------------C---
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD---------------D--- 612 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------------~--- 612 (665)
.+|+.|+|||++.+...++.++|||||||++|||++|+.||..... ...+.......... .
T Consensus 185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 6899999999987555789999999999999999999999976321 11111111110000 0
Q ss_pred ------C----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ------G----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ------~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 01234678999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.76 Aligned_cols=247 Identities=20% Similarity=0.247 Sum_probs=188.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .+++.||+|++..........+.+.++...++.++||||+++++++.+++..++||||+.+ +
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 91 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-S 91 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-E
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-c
Confidence 5799999999999996 5789999999987655444455566666678889999999999999999999999999975 8
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
|.+++..... ....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||++....... ...
T Consensus 92 l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (290)
T 3fme_A 92 LDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169 (290)
T ss_dssp HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC-CCCCCCSGGGCEECTTCCEEBCCC---------------
T ss_pred hHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC-eecCCCCHHHEEECCCCCEEEeecCCccccccccccccc
Confidence 8887753211 345699999999999999999999998 8 9999999999999999999999999997654432 223
Q ss_pred CCCCcccCCcccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 551 PDTVAYKAPEIRK---SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 551 ~gt~~y~aPE~~~---~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
.+|+.|+|||++. ....++.++|||||||++|||++|+.||.........+...+... .........+..+.+++.
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 248 (290)
T 3fme_A 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLPADKFSAEFVDFTS 248 (290)
T ss_dssp CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CCCCCTTTSCHHHHHHHH
T ss_pred CCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CCCcccccCCHHHHHHHH
Confidence 6899999999962 356789999999999999999999999975322222232222221 122233456778999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~ 645 (665)
+||+.||++|||+.|+++
T Consensus 249 ~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 249 QCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHhhcChhhCcCHHHHHh
Confidence 999999999999999988
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.96 Aligned_cols=241 Identities=18% Similarity=0.250 Sum_probs=192.4
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 367999999999999964 688999999875421 123345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCCceEEeecccccccCCC---C
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---S 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~ 547 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++++||+|||++...... .
T Consensus 233 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~g-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 233 GELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp CBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTC-CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCC-EEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence 999999974 3468999999999999999999998 88 999999999999999999999999999754322 2
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+.. .....+...+..+.+++.
T Consensus 307 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~~~~~~~i~~--~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHEKLFELILM--EEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp CCSSSCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred ccccCCccccCHhhcC-CCCCCCccchhhhHHHHHHHhhCCCCCCCC--CHHHHHHHHHh--CCCCCCccCCHHHHHHHH
Confidence 3346899999999987 677999999999999999999999999752 12233333222 222234556778999999
Q ss_pred HcccCCCCCCC-----CHHHHHH
Q 005999 628 VCSLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RP-----t~~evl~ 645 (665)
+||+.||++|| ++.|+++
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHcccCHHHhCCCCCCCHHHHHh
Confidence 99999999999 9999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=352.15 Aligned_cols=245 Identities=19% Similarity=0.246 Sum_probs=182.3
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-----CCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-----KGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e 467 (665)
.+.||+|+||+||+|... +++.||||++..........+.+.+|++++++++||||+++++++.. ....|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 367999999999999854 78899999997665555567789999999999999999999999844 357899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~- 546 (665)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 138 ~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~-iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 138 IA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAG-ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp CC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred cc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 98 4699999873 356999999999999999999999999 999999999999999999999999999765421
Q ss_pred -----------------------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-----------
Q 005999 547 -----------------------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT----------- 586 (665)
Q Consensus 547 -----------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt----------- 586 (665)
.....||+.|+|||++.....++.++|||||||++|||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1223579999999987556779999999999999999999
Q ss_pred CCCCCCCCCCCC------------------ccHHHHHHh-hccCC----------------------------CchhhhH
Q 005999 587 GKHPSQHPYLAP------------------PDMLEWVRT-MRVDD----------------------------GREENRL 619 (665)
Q Consensus 587 g~~P~~~~~~~~------------------~~~~~~~~~-~~~~~----------------------------~~~~~~~ 619 (665)
|+++|....... .+....+.. ..... ......+
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 555554321000 000011100 00000 0112336
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+.+|+.+||..||++|||+.|+++
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHhccCccccCCHHHHhc
Confidence 67899999999999999999999988
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=346.28 Aligned_cols=256 Identities=18% Similarity=0.260 Sum_probs=206.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC--eEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG--ERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 471 (665)
+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.+.+ ..++||||+++
T Consensus 15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 57999999999999975 588999999975432 233567789999999999999999999998755 78999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe----CCCCceEEeecccccccCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill----~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 94 g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~ 170 (396)
T 4eut_A 94 GSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170 (396)
T ss_dssp EEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG
T ss_pred CCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC-EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC
Confidence 99999997532 2234899999999999999999999999 9999999999999 778889999999997765432
Q ss_pred --CCCCCCCcccCCccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCC----
Q 005999 548 --VEDPDTVAYKAPEIRKS-------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDD---- 612 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~-------~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~---- 612 (665)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||........ +....+.......
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~ 250 (396)
T 4eut_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250 (396)
T ss_dssp GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEE
T ss_pred ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchh
Confidence 23458999999998752 14577899999999999999999999975432222 2222222211110
Q ss_pred -------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 613 -------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 613 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
......+..+.+++.+||+.||++||++.|+++.++++.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred heeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 122456778999999999999999999999999999987753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=354.27 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=199.6
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||+||+|... ++..||+|++..........+.+.+|+.++++++||||++++++|.+.+..++||||+.+|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 467999999999999975 6889999999766543444567899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 122 ~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 122 ELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHN-IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 99998874 345899999999999999999999999 999999999999976 4559999999997665432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 625 (665)
....||+.|+|||++. ..++.++||||+||++|+|++|+.||... ...++...+........ .....+..+.++
T Consensus 196 ~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQ--TDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp CCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred cccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 3446899999999986 46899999999999999999999999763 22344444443332221 234567789999
Q ss_pred HHHcccCCCCCCCCHHHHHHH--HHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLKM--IQEI 650 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~--L~~~ 650 (665)
+.+||+.||++|||+.|+++. +++.
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999863 4444
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=329.24 Aligned_cols=241 Identities=21% Similarity=0.352 Sum_probs=180.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 17 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (278)
T 3cok_A 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96 (278)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCC
Confidence 5799999999999996 57889999998644321 123467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~ 549 (665)
+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 97 ~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 171 (278)
T 3cok_A 97 EMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171 (278)
T ss_dssp EHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSSCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred cHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCccee
Confidence 99999974 2356899999999999999999999999 9999999999999999999999999997654322 23
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+|+.|+|||.+. +..++.++||||||+++|||++|+.||...... ..... ........+...+..+.+++.+|
T Consensus 172 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 172 LCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--NTLNK--VVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCCCcCCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--HHHHH--HhhcccCCccccCHHHHHHHHHH
Confidence 45899999999987 567899999999999999999999999753221 11110 01111123345667899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|+.||++|||+.|+++
T Consensus 247 l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 247 LRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCSSGGGSCCHHHHTT
T ss_pred cccCHhhCCCHHHHhc
Confidence 9999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=337.06 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=206.2
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|... .+..||+|.+..... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 109 (322)
T 1p4o_A 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109 (322)
T ss_dssp EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence 67999999999999854 478899999975543 24456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccccccc
Q 005999 469 QPNGSLFNLIHGSRS-----IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLS 543 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~ 543 (665)
+++|+|.+++...+. .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~NIli~~~~~~kl~Dfg~~~~~ 188 (322)
T 1p4o_A 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188 (322)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-CccCCCccceEEEcCCCeEEECcCcccccc
Confidence 999999999874221 11245789999999999999999999999 999999999999999999999999998755
Q ss_pred CCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 544 DSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 544 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
.... ....+|+.|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+..... ......
T Consensus 189 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~ 264 (322)
T 1p4o_A 189 YETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEGGL-LDKPDN 264 (322)
T ss_dssp GGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHHHHTTCC-CCCCTT
T ss_pred ccccccccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCCccccC--CHHHHHHHHHcCCc-CCCCCC
Confidence 3321 1223578899999987 5678999999999999999999 89998753 22233333322211 123456
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
.+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 265 ~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 265 CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 677899999999999999999999999999877543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=335.22 Aligned_cols=252 Identities=21% Similarity=0.384 Sum_probs=204.8
Q ss_pred HhHhCcccceEEEEEEE-----CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC--eEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG--ERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 466 (665)
.+.||+|+||.||++.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 36799999999999984 368899999997643 355678999999999999999999999987644 789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 124 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred ECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 999999999999753 345899999999999999999999999 999999999999999999999999999766543
Q ss_pred C------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------CCC-cc----HHHHHH
Q 005999 547 S------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY---------LAP-PD----MLEWVR 606 (665)
Q Consensus 547 ~------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~---------~~~-~~----~~~~~~ 606 (665)
. ....++..|+|||.+. +..++.++||||||+++|||++|+.|+.... ... .. +.+.+.
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 2 2234677899999987 5568899999999999999999999876421 000 01 111111
Q ss_pred hhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 607 TMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 607 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
... ....+...+..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 278 ~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 278 NNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 11234556788999999999999999999999999999998765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=328.82 Aligned_cols=244 Identities=24% Similarity=0.351 Sum_probs=200.4
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--------------
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-------------- 458 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------------- 458 (665)
.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 367999999999999976 78899999997543 246789999999999999999999864
Q ss_pred --CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEee
Q 005999 459 --KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTD 536 (665)
Q Consensus 459 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~D 536 (665)
....++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHEEEcCCCCEEECc
Confidence 44579999999999999999753 2356899999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCc
Q 005999 537 YCLSVLSDSS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGR 614 (665)
Q Consensus 537 fgl~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 614 (665)
||++...... .....+|+.|+|||++. +..++.++||||||+++|||++|..|+... ......+.. ...
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~----~~~ 236 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFET----SKFFTDLRD----GII 236 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHH-CSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HHHHHHHHT----TCC
T ss_pred chhheeccccccccccCCcccccChhhhc-cCCCcchhhhHHHHHHHHHHHhcCCcchhH----HHHHHHhhc----ccc
Confidence 9998766543 23346899999999987 567899999999999999999999886421 112111111 112
Q ss_pred hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 615 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
....+..+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 334566789999999999999999999999999998766543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.80 Aligned_cols=244 Identities=18% Similarity=0.239 Sum_probs=193.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-----CeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-----GERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 468 (665)
+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++... ...++||||
T Consensus 32 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 111 (432)
T 3n9x_A 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI 111 (432)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEEC
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEec
Confidence 67999999999999964 688999999986655555677899999999999999999999999776 578999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+. |+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 112 ~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 112 AD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESG-IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp CS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred CC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 86 599999973 356999999999999999999999999 9999999999999999999999999997654321
Q ss_pred ------------------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------
Q 005999 548 ------------------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHP--------- 594 (665)
Q Consensus 548 ------------------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~--------- 594 (665)
....||+.|+|||++.....++.++||||+||++|||++|..||...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~ 264 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence 33468999999998755677999999999999999999865554321
Q ss_pred --CCC----------------Ccc-----------------------HHHHHHhhccCCC-----chhhhHHHHHHHHHH
Q 005999 595 --YLA----------------PPD-----------------------MLEWVRTMRVDDG-----REENRLGMLTEVASV 628 (665)
Q Consensus 595 --~~~----------------~~~-----------------------~~~~~~~~~~~~~-----~~~~~~~~l~~li~~ 628 (665)
..- ..+ ...++........ .....+..+.+|+.+
T Consensus 265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 344 (432)
T 3n9x_A 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344 (432)
T ss_dssp CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 000 000 1111111100000 012356778999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
||+.||++|||+.|+++
T Consensus 345 mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 345 MLKFNPNKRITIDQALD 361 (432)
T ss_dssp HSCSSTTTSCCHHHHHT
T ss_pred HhcCCcccCCCHHHHhc
Confidence 99999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.19 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=200.9
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhC--CCCCCeeeeeEEEEeCC----eEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG--LSHPNLVPIRAYFQAKG----ERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e 467 (665)
.+.||+|+||.||+|... ++.||+|++... ..+.+.+|++++.. ++||||+++++++.... ..++|||
T Consensus 47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e 120 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120 (342)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred EeeecCCCCcEEEEEEEc-CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence 467999999999999884 788999998643 23456778888776 79999999999998876 7899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH--------RASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
|+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+||+++.++++||+|||+
T Consensus 121 ~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 121 YHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-eeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999974 24899999999999999999999 777 99999999999999999999999999
Q ss_pred ccccCCCC-------CCCCCCCcccCCccccCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCCCC
Q 005999 540 SVLSDSSS-------VEDPDTVAYKAPEIRKSSRR-----ATSKSDVYAFGVLLLELLTG----------KHPSQHPYLA 597 (665)
Q Consensus 540 ~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~-----~~~k~DvwSlGvvl~elltg----------~~P~~~~~~~ 597 (665)
+....... ....+|+.|+|||++..... ++.++|||||||++|||++| +.||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 96654322 33468999999999873322 23689999999999999999 7788765433
Q ss_pred CccHHHHHHhhccC---CCc-----hhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 598 PPDMLEWVRTMRVD---DGR-----EENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 598 ~~~~~~~~~~~~~~---~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
......+....... ... ....+..+.+++.+||+.||++|||+.|+++.|+.+.++..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 33333333322211 111 23556789999999999999999999999999999987643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=352.75 Aligned_cols=247 Identities=15% Similarity=0.177 Sum_probs=192.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHH---HHHhCCCCCCeeeee-------EEEEeCCe-
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHM---EAVGGLSHPNLVPIR-------AYFQAKGE- 461 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~~~- 461 (665)
+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+ +.+++++||||++++ +++.+.+.
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 6799999999999994 6789999999975422 234567789999 566677899999998 77666542
Q ss_pred ----------------EEEEEEecCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCc
Q 005999 462 ----------------RLVIYDYQPNGSLFNLIHGSRSI--RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSN 523 (665)
Q Consensus 462 ----------------~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~N 523 (665)
.++||||+ +|+|.+++...... ....+++..++.|+.||+.||+|||+.+ |+||||||+|
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDikp~N 236 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPVD 236 (377)
T ss_dssp SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGG
T ss_pred cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHH
Confidence 78999999 67999999753211 1123456888899999999999999999 9999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCCCCCCCcccCCccccCCC-----------CCCCcchHHHHHHHHHHHHhCCCCCC
Q 005999 524 VLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSR-----------RATSKSDVYAFGVLLLELLTGKHPSQ 592 (665)
Q Consensus 524 ill~~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~k~DvwSlGvvl~elltg~~P~~ 592 (665)
||++.++.+||+|||++...........| +.|+|||++. +. .++.++|||||||++|||++|+.||.
T Consensus 237 Ill~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~-~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~ 314 (377)
T 3byv_A 237 IVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEA-RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314 (377)
T ss_dssp EEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHH-HHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred EEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhc-ccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999876654455567 9999999987 44 68999999999999999999999997
Q ss_pred CCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHhh
Q 005999 593 HPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIKES 653 (665)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~ 653 (665)
....... ... .. ......+..+.+++.+||+.||++|||+.|+++ .++++.+.
T Consensus 315 ~~~~~~~--~~~---~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 315 KDAALGG--SEW---IF---RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp -----CC--SGG---GG---SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred ccccccc--hhh---hh---hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 5321111 000 00 112345677999999999999999999999986 55555443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=355.93 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=202.0
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||+||+|... +++.||||++..........+.+.+|++++++++||||+++++++.+.+..++||||+.+|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 367999999999999965 7889999998654333344677899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC---CCCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG---ADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++.......
T Consensus 107 ~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 107 ELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 99998874 246899999999999999999999999 99999999999995 45689999999997665432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 625 (665)
....||+.|+|||++. +.++.++||||+||++|+|++|+.||... ...++...+....... ......+..+.++
T Consensus 181 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp -CCTTGGGGCCGGGGG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCCcCCCCCCCHHHhC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 3346899999999987 35899999999999999999999999753 2223444343332222 2234567789999
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~ 646 (665)
+.+||+.||++|||+.|+++.
T Consensus 257 i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.44 Aligned_cols=243 Identities=15% Similarity=0.219 Sum_probs=196.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++..+ +++.||+|+++..... ....+.+.+|.+++..++||||++++++|.+.+..|+||||+++|
T Consensus 67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg 146 (412)
T 2vd5_A 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG 146 (412)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence 57999999999999975 7899999999653221 122345788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~ 548 (665)
+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++....... .
T Consensus 147 ~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 221 (412)
T 2vd5_A 147 DLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221 (412)
T ss_dssp BHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECS
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccCHHHeeecCCCCEEEeechhheeccCCCccccc
Confidence 999999742 246899999999999999999999999 9999999999999999999999999997665432 2
Q ss_pred CCCCCCcccCCccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc--c-CCCchhhhH
Q 005999 549 EDPDTVAYKAPEIRKS------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR--V-DDGREENRL 619 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~------~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~ 619 (665)
...||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ..+....+.... . ........+
T Consensus 222 ~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~s 299 (412)
T 2vd5_A 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--TAETYGKIVHYKEHLSLPLVDEGVP 299 (412)
T ss_dssp SCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTHHHHCCCC----CCC
T ss_pred eeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--HHHHHHHHHhcccCcCCCccccCCC
Confidence 3468999999999862 3468999999999999999999999997531 222222222111 1 111234567
Q ss_pred HHHHHHHHHcccCCCCCC---CCHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQR---PAMWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~R---Pt~~evl~ 645 (665)
..+.+++.+||. +|++| |+++|+++
T Consensus 300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 789999999999 99998 68999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=338.23 Aligned_cols=243 Identities=19% Similarity=0.261 Sum_probs=194.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--------CCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--------KGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~lv 465 (665)
+.||+|+||.||+|.. .+++.||+|++............+.+|++++++++||||+++++++.. .+..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 102 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence 6799999999999997 578899999987665444445677899999999999999999999987 4468999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+.+ +|.+.+... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 176 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSL 176 (351)
T ss_dssp EECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCC
T ss_pred EeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCCEEEccchhcccccc
Confidence 999986 888877642 345999999999999999999999999 99999999999999999999999999976542
Q ss_pred C-------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--c-h
Q 005999 546 S-------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--R-E 615 (665)
Q Consensus 546 ~-------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~-~ 615 (665)
. .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.... .......+........ . .
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhhcc
Confidence 1 1223579999999998755668999999999999999999999997632 2222222222111110 0 0
Q ss_pred ---------------------------hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 616 ---------------------------ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 616 ---------------------------~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...+..+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 001456889999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.34 Aligned_cols=246 Identities=15% Similarity=0.159 Sum_probs=199.0
Q ss_pred hHhCcccceEEEEEE------ECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC---CCCeeeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAV------LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS---HPNLVPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 465 (665)
+.||+|+||+||+|. ..+++.||+|++.... ...+.+|++++.+++ |+||+++++++..++..++|
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 579999999999993 5578899999997543 345667777777776 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-----------CCceEE
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-----------DFEARL 534 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-----------~~~~kl 534 (665)
|||+++|+|.++++..+......+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-IIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEecccccCccccccccCCEEE
Confidence 99999999999997543334567999999999999999999999999 999999999999998 899999
Q ss_pred eecccccccC---C--CCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc
Q 005999 535 TDYCLSVLSD---S--SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR 609 (665)
Q Consensus 535 ~Dfgl~~~~~---~--~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 609 (665)
+|||++.... . ......||+.|+|||++. +..++.++|||||||++|||+||+.||..........
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-------- 295 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP-------- 295 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE--------
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee--------
Confidence 9999996543 1 123346899999999987 5678999999999999999999999986432111110
Q ss_pred cCCCchhhhHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHHHhhhc
Q 005999 610 VDDGREENRLGMLTEVASVCSLKSPEQR-PAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 610 ~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~~~~~ 655 (665)
............+.+++..|++.+|.+| |+++++.+.|+++.+...
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 296 EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0000111235568899999999999999 789999999998877643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.25 Aligned_cols=244 Identities=20% Similarity=0.293 Sum_probs=198.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 57999999999999975 688999999976543 3456778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCC-CCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS-SSVEDP 551 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~ 551 (665)
|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++..... ......
T Consensus 118 L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 191 (360)
T 3eqc_A 118 LDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191 (360)
T ss_dssp HHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----C
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC-EEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCC
Confidence 9999974 24589999999999999999999996 7 99999999999999999999999999864432 223346
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--------------------------------
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-------------------------------- 599 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-------------------------------- 599 (665)
||+.|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 192 gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (360)
T 3eqc_A 192 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270 (360)
T ss_dssp CCCTTCCHHHHT-TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred CCCCeECHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence 899999999987 56789999999999999999999999975321100
Q ss_pred --------cHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 600 --------DMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 600 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+....+.............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01111111111111223356789999999999999999999999873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=328.76 Aligned_cols=241 Identities=19% Similarity=0.305 Sum_probs=201.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||||+.++
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 100 (294)
T 2rku_A 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCC
Confidence 67999999999999975 578899999865432 2345677899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 101 ~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (294)
T 2rku_A 101 SLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174 (294)
T ss_dssp BHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence 99999874 346899999999999999999999999 999999999999999999999999999765432 233
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+|+.|+|||++. +..++.++||||||+++|||++|+.||.... ..+....+.. .....+...+..+.+++.+|
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 175 LCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKK--NEYSIPKHINPVAASLIQKM 249 (294)
T ss_dssp CCSCCSSCCHHHHT-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHT--TCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCCCcCCcchhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhh--ccCCCccccCHHHHHHHHHH
Confidence 45899999999987 5678999999999999999999999997532 1122222221 12223445667899999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|+.||++|||+.|+++.
T Consensus 250 l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 250 LQTDPTARPTINELLND 266 (294)
T ss_dssp TCSSGGGSCCGGGGGGS
T ss_pred cccChhhCcCHHHHhhC
Confidence 99999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.26 Aligned_cols=240 Identities=20% Similarity=0.294 Sum_probs=195.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||++... +++.||+|++..... ...+|++++.++ +||||+++++++.+++..++||||+.+
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 367999999999999965 688999999976543 134677777777 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC----CceEEeecccccccCCC-
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD----FEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~----~~~kl~Dfgl~~~~~~~- 546 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||++......
T Consensus 101 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g-ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 101 GELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999974 346899999999999999999999999 9999999999998543 35999999999765432
Q ss_pred --CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-ccHHHHHHhhccCC--CchhhhHHH
Q 005999 547 --SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP-PDMLEWVRTMRVDD--GREENRLGM 621 (665)
Q Consensus 547 --~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~ 621 (665)
.....+|+.|+|||++. +..++.++|||||||++|||++|+.||....... .++...+....... ......+..
T Consensus 175 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 253 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred CceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence 23346899999999987 4568899999999999999999999997532221 23333333322221 123456788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 254 AKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.91 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=203.6
Q ss_pred hHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||.||+|.. .++..||+|++..... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 6799999999999983 3567899999975433 34556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeeccccccc
Q 005999 469 QPNGSLFNLIHGSRSI--RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLS 543 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~ 543 (665)
+++|+|.+++...+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++. +..+||+|||++...
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~ 193 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eecCcCCHhHEEEecCCCcceEEECcccccccc
Confidence 9999999999864321 2245899999999999999999999999 999999999999984 456999999998654
Q ss_pred CCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 544 DSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 544 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
.... ....+|+.|+|||++. +..++.++||||||+++|||++ |+.||... ...++...+..... ......
T Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~--~~~~~~~~~~~~~~-~~~~~~ 269 (327)
T 2yfx_A 194 YRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--SNQEVLEFVTSGGR-MDPPKN 269 (327)
T ss_dssp HC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCC-CCCCTT
T ss_pred ccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--CHHHHHHHHhcCCC-CCCCCC
Confidence 3221 1224688999999987 5678999999999999999998 99998753 22233333333221 123445
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 270 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 270 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 6778999999999999999999999999999987654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=340.82 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=197.8
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||.||+|...+ .+|+|+++.........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 39 ~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 116 (319)
T 2y4i_B 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116 (319)
T ss_dssp CBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEH
T ss_pred eEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcH
Confidence 679999999999998865 389999876544334445678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC--------C
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS--------S 546 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~--------~ 546 (665)
.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++ ++.+||+|||++..... .
T Consensus 117 ~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~ 190 (319)
T 2y4i_B 117 YSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG-ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190 (319)
T ss_dssp HHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSTTEEEC---CCEECCCSCCC----------CCS
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccc
Confidence 9999742 346899999999999999999999999 99999999999998 67999999999765432 1
Q ss_pred CCCCCCCCcccCCccccC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhh
Q 005999 547 SVEDPDTVAYKAPEIRKS--------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618 (665)
Q Consensus 547 ~~~~~gt~~y~aPE~~~~--------~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (665)
.....||+.|+|||++.. ...++.++||||||+++|||++|+.||... ........+.............
T Consensus 191 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~ 268 (319)
T 2y4i_B 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--PAEAIIWQMGTGMKPNLSQIGM 268 (319)
T ss_dssp CBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--CHHHHHHHHHTTCCCCCCCSSC
T ss_pred cccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhccCCCCCCCcCCC
Confidence 122347899999998863 245788999999999999999999999753 1222332232222222222345
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 619 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
+..+.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus 269 ~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 269 GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 66799999999999999999999999999998776543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=326.90 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=200.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... ++..||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 20 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 99 (284)
T 2vgo_A 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG 99 (284)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred heecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCC
Confidence 67999999999999965 6788999998654321 123467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SVEDP 551 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~ 551 (665)
+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 100 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (284)
T 2vgo_A 100 ELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK-VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC 173 (284)
T ss_dssp EHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCC
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEEcCCCCEEEecccccccCccccccccc
Confidence 999999742 45899999999999999999999999 999999999999999999999999998665432 23446
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
+++.|+|||++. +..++.++||||||+++|||++|+.||.... ..+....+.. .....+...+..+.+++.+|++
T Consensus 174 ~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 174 GTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--HTETHRRIVN--VDLKFPPFLSDGSKDLISKLLR 248 (284)
T ss_dssp SCGGGCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHT--TCCCCCTTSCHHHHHHHHHHSC
T ss_pred CCCCcCCHHHhc-cCCCCcccchhhHHHHHHHHHHCCCCCCCCC--HhHHHHHHhc--cccCCCCcCCHHHHHHHHHHhh
Confidence 899999999987 5678999999999999999999999997531 1122222221 1222344567789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 005999 632 KSPEQRPAMWQVLK 645 (665)
Q Consensus 632 ~dP~~RPt~~evl~ 645 (665)
.||++|||+.|+++
T Consensus 249 ~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 249 YHPPQRLPLKGVME 262 (284)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred cCHhhCCCHHHHhh
Confidence 99999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.86 Aligned_cols=246 Identities=20% Similarity=0.294 Sum_probs=197.8
Q ss_pred HhHhCcccceEEEEEEE----CCeEEEEEEEecCCCc--hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKT--ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||++.. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 36799999999999997 4788999999865432 112334567789999999 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 139 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 139 DYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp CCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999974 245899999999999999999999999 999999999999999999999999999765332
Q ss_pred C----CCCCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccCCCchhhhHH
Q 005999 547 S----VEDPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVDDGREENRLG 620 (665)
Q Consensus 547 ~----~~~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 620 (665)
. ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||....... ......... ......+...+.
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 291 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEPPYPQEMSA 291 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCCCCCCTTSCH
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhccCCCCCcccCH
Confidence 1 223589999999998742 347899999999999999999999997543222 222222221 122234456677
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRP-----AMWQVLKM 646 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RP-----t~~evl~~ 646 (665)
.+.+++.+||+.||++|| ++.|+++.
T Consensus 292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 899999999999999999 99999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=330.39 Aligned_cols=241 Identities=17% Similarity=0.282 Sum_probs=198.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG 91 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence 367999999999999965 788999999975432 33456889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe---CCCCceEEeecccccccCCCC-C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSS-V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~-~ 548 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++....... .
T Consensus 92 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 92 ELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENG-IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp BHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 99999874 245899999999999999999999999 9999999999999 788999999999987654321 1
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 626 (665)
...+|+.|+|||++. +..++.++||||||+++|||++|+.||... ...++...+....... ......+..+.+++
T Consensus 166 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 166 TACGTPGYVAPEVLA-QKPYSKAVDCWSIGVITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp HHHSCCCBCCTTTBS-SCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--CHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccCCCCccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 124799999999987 567899999999999999999999999753 2223333333322211 22345677899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.||++|||+.|+++
T Consensus 243 ~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHT
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 9999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.90 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=195.0
Q ss_pred hHhCcccceEEEEEEEC--C--eEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD--N--HLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|.+. + +..||+|+++.... .....+.+.+|++++++++||||+++++++..+. .++|+||+
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~ 102 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA 102 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence 67999999999999853 2 34689999876532 2345678899999999999999999999998765 88999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 103 PLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp TTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred cCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 999999998742 345899999999999999999999999 9999999999999999999999999987664432
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
....+|..|+|||++. +..++.++||||||+++|||++ |+.||... ...+....+.............+..+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp EEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred hhhhccCCCCceeeCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccC--CHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 1234678899999987 5668899999999999999999 99999753 22233333332222223345677889
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
.+++.+||+.||++|||+.++++.|+++....
T Consensus 255 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 255 YNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 99999999999999999999999999886543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.35 Aligned_cols=242 Identities=20% Similarity=0.322 Sum_probs=193.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (276)
T 2h6d_A 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG 96 (276)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCC
Confidence 57999999999999976 7889999998654321 233567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 97 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (276)
T 2h6d_A 97 ELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170 (276)
T ss_dssp BHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC-SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred cHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChhhEEECCCCCEEEeecccccccCCCcceecc
Confidence 999999742 45899999999999999999999999 9999999999999999999999999997765432 233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+|+.|+|||.+......+.++||||||+++|||++|+.||... ........+..... ..+...+..+.+++.+||
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l 246 (276)
T 2h6d_A 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--HVPTLFKKIRGGVF--YIPEYLNRSVATLLMHML 246 (276)
T ss_dssp ------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred cCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHhhcCcc--cCchhcCHHHHHHHHHHc
Confidence 58899999999874434468999999999999999999999752 11233333332211 223455678999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKM 646 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~ 646 (665)
+.||++|||+.|+++.
T Consensus 247 ~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 247 QVDPLKRATIKDIREH 262 (276)
T ss_dssp CSSGGGSCCHHHHHHS
T ss_pred cCChhhCCCHHHHHhC
Confidence 9999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.19 Aligned_cols=241 Identities=19% Similarity=0.305 Sum_probs=201.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+..++||||+.++
T Consensus 47 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 126 (335)
T 2owb_A 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126 (335)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCC
Confidence 67999999999999965 578899999865432 2345677899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 127 ~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (335)
T 2owb_A 127 SLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200 (335)
T ss_dssp BHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecCCCchhEEEcCCCCEEEeeccCceecccCcccccc
Confidence 99999874 246899999999999999999999999 999999999999999999999999999765432 233
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+|+.|+|||++. +..++.++||||||+++|||++|+.||.... ..+....+.. .....+...+..+.+++.+|
T Consensus 201 ~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 201 LCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKK--NEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CCSCCSSCCHHHHH-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHH--TCCCCCTTSCHHHHHHHHHH
T ss_pred cCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHhc--CCCCCCccCCHHHHHHHHHH
Confidence 45899999999987 5678999999999999999999999997532 1122222222 12223445667799999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~ 646 (665)
|+.||++|||+.|+++.
T Consensus 276 l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 276 LQTDPTARPTINELLND 292 (335)
T ss_dssp TCSSGGGSCCGGGGGGS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99999999999999873
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.53 Aligned_cols=243 Identities=22% Similarity=0.358 Sum_probs=200.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch------hhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA------DTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 67999999999999975 7899999998754321 12245688999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 180 e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~g-i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 180 DLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANN-IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp CCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999973 346899999999999999999999999 999999999999999999999999998766543
Q ss_pred C--CCCCCCCcccCCccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhh
Q 005999 547 S--VEDPDTVAYKAPEIRKS-----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REEN 617 (665)
Q Consensus 547 ~--~~~~gt~~y~aPE~~~~-----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 617 (665)
. ....||+.|+|||++.. ...++.++|||||||++|||++|+.||... ........+........ ....
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCHHHHSS
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--CHHHHHHHHHhCCCCCCCccccc
Confidence 2 33468999999998752 235788999999999999999999999752 12233333332222211 1234
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 5677999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=331.43 Aligned_cols=243 Identities=17% Similarity=0.235 Sum_probs=190.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch---hhHHHHHHHHHHHHhCC---CCCCeeeeeEEEEeCC-----eE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA---DTSAEAFEQHMEAVGGL---SHPNLVPIRAYFQAKG-----ER 462 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~-----~~ 462 (665)
+.||+|+||+||+|.. .+++.||+|++...... ......+.+|+++++++ +||||+++++++.... ..
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence 6799999999999995 57889999998643311 11223455666666655 5999999999998755 57
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
++||||+. |+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 95 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 169 (308)
T 3g33_A 95 TLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLARI 169 (308)
T ss_dssp EEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCTTTEEECTTSCEEECSCSCTTT
T ss_pred EEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEEeeCccccc
Confidence 89999997 5999999753 2344899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH-HhhccCCC------
Q 005999 543 SDSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV-RTMRVDDG------ 613 (665)
Q Consensus 543 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~~------ 613 (665)
..... ....+|+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+ ........
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 246 (308)
T 3g33_A 170 YSYQMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDLIGLPPEDDWPRD 246 (308)
T ss_dssp STTCCCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSCSS
T ss_pred cCCCcccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChhhccch
Confidence 65432 2235899999999987 5678999999999999999999999997532 12222222 21111100
Q ss_pred ------------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 ------------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 ------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 01235577899999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.24 Aligned_cols=241 Identities=17% Similarity=0.222 Sum_probs=189.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 467 (665)
+.||+|+||+||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus 68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E 147 (464)
T 3ttj_A 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147 (464)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence 67999999999999854 688999999976654455677889999999999999999999999654 46799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 148 ~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 148 LMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp CCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred CCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 9986 57777642 3889999999999999999999999 9999999999999999999999999997765432
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-------------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------- 612 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------- 612 (665)
....||+.|+|||++. +..++.++||||+||++|||++|+.||..... ...+...+.......
T Consensus 219 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CC----CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred ccCCCcccccccCHHHHc-CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 3346899999999997 56899999999999999999999999975321 011111111111000
Q ss_pred -----------C---------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 -----------G---------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 -----------~---------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 001125678999999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.41 Aligned_cols=242 Identities=20% Similarity=0.264 Sum_probs=180.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 467 (665)
+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++... ...++|+|
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e 114 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence 5799999999999985 5788999999976554445667888999999999999999999999654 56799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 115 ~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 186 (367)
T 2fst_X 115 LM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186 (367)
T ss_dssp CC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred cc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHhhEEECCCCCEEEeeccccccccccC
Confidence 98 6799988863 45899999999999999999999999 9999999999999999999999999998776555
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccC---------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVD--------------- 611 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~--------------- 611 (665)
....+|+.|+|||++.+...++.++||||+||++|||++|+.||.... ..+....+... ...
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 556789999999998755678999999999999999999999997632 11111111111 100
Q ss_pred --------CC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 612 --------DG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 612 --------~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 011235678999999999999999999999873
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=336.04 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=190.5
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-----CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-----KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|.. +++.||||++..... .....+.|+..+..++||||+++++++.. ....++||||+
T Consensus 19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 6799999999999977 567899999864431 12222344445566899999999986543 23678999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA---------SWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~---------~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
++|+|.+++... ..++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 95 PNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA-ISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC-EECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc-eeecccccceEEEcCCCcEEEeeccce
Confidence 999999999742 348899999999999999999998 8 999999999999999999999999999
Q ss_pred cccCCCC-----------CCCCCCCcccCCccccCC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc----
Q 005999 541 VLSDSSS-----------VEDPDTVAYKAPEIRKSS------RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP---- 599 (665)
Q Consensus 541 ~~~~~~~-----------~~~~gt~~y~aPE~~~~~------~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~---- 599 (665)
....... ....||+.|+|||++.+. ..++.++|||||||++|||++|..||........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 7654321 123589999999998732 3456789999999999999999877643221110
Q ss_pred ---------cHHHH---HHhhccCCC------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 600 ---------DMLEW---VRTMRVDDG------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 600 ---------~~~~~---~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
....+ +........ .....+..+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 11111 111111111 1223566799999999999999999999999999999876653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.74 Aligned_cols=242 Identities=17% Similarity=0.275 Sum_probs=190.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++...... .....+.+|++++++++||||+++++++.+++..++||||+.+ +
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 85 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-C
Confidence 57999999999999975 7889999998654321 1122345799999999999999999999999999999999984 9
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 86 l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 86 LKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 99988753 346899999999999999999999999 9999999999999999999999999987654322 233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCC----------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDG---------------- 613 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~---------------- 613 (665)
.+|+.|+|||++.+...++.++|||||||++|||++|+.||.... ..+....+..... ...
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 579999999998755678999999999999999999999997632 1222222222111 100
Q ss_pred -----------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 -----------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 -----------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 01234567899999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=345.64 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=190.8
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch------hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA------DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.. +..++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEE
Confidence 467999999999999864 6789999998654321 1122357899999999999999999999854 5589999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC---CceEEeeccccccc
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD---FEARLTDYCLSVLS 543 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~ 543 (665)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||++...
T Consensus 219 e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 219 ELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp ECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 99999999998863 356899999999999999999999999 9999999999999754 45999999999876
Q ss_pred CCCC--CCCCCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhh
Q 005999 544 DSSS--VEDPDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REEN 617 (665)
Q Consensus 544 ~~~~--~~~~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 617 (665)
.... ....||+.|+|||++.. ...++.++|||||||++|||++|+.||.... ....+...+........ ....
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-TQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS-SSCCHHHHHHTTCCCCCHHHHTT
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc-chHHHHHHHhcCCCCCCchhhcc
Confidence 5433 23458999999999752 3567889999999999999999999997632 22244444443322221 1234
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 5678999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.59 Aligned_cols=251 Identities=15% Similarity=0.204 Sum_probs=202.6
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCC-CCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH-PNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||||++...... +.+.+|+++++.++| +++..+..++...+..++||||+ ++
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 5799999999999996 57889999987654432 246789999999977 55666777777888999999999 99
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe---CCCCceEEeecccccccCCCCC-
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
+|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 88 sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 88 SLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp BHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 999999742 346999999999999999999999999 9999999999999 5889999999999976544321
Q ss_pred ---------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCC---Cch
Q 005999 549 ---------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDD---GRE 615 (665)
Q Consensus 549 ---------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~---~~~ 615 (665)
...||+.|+|||++. +..++.++|||||||++|||++|+.||........ +....+....... ...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC 241 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred cccccccccccCCCccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence 345899999999987 66789999999999999999999999987433222 2222222111111 122
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
..++..+.+++..||+.||++||++.+|++.|+++......
T Consensus 242 ~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 242 RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 45567899999999999999999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=354.58 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=203.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... +++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999975 7889999998654322 24467789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe---CCCCceEEeecccccccCCCC-
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill---~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 111 ~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 111 GELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp CBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 999999873 356899999999999999999999999 9999999999999 567899999999997665432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTE 624 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 624 (665)
....||+.|+|||++. + .++.++||||+||++|+|++|+.||... ...++...+....... ......+..+.+
T Consensus 185 ~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLH-G-TYDEKCDVWSTGVILYILLSGCPPFNGA--NEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp HHHHTTGGGTCCHHHHH-T-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred cccCCCCccccCceeec-C-CCCCcceeHHHHHHHHHHHHCCCCCCCC--CHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 2235899999999986 3 6899999999999999999999999763 2224444444332222 223456788999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~ 645 (665)
++.+||+.||++|||+.|+++
T Consensus 261 li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhh
Confidence 999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.09 Aligned_cols=245 Identities=21% Similarity=0.318 Sum_probs=197.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 4699999999999996 4688999999876542 445678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++...... ...
T Consensus 106 L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 182 (295)
T 2clq_A 106 LSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182 (295)
T ss_dssp HHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred HHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC-EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence 999997532 2345678899999999999999999999 999999999999987 899999999999765432 233
Q ss_pred CCCCCcccCCccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSS-RRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~-~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
..+|+.|+|||++... ..++.++||||||+++|||++|+.||........... ...........+...+..+.+++.+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hhccccccccccccCCHHHHHHHHH
Confidence 4689999999998632 2378999999999999999999999965321111111 1111122223445667789999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
||+.||++|||+.|+++
T Consensus 262 ~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 262 CFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTCSSTTTSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.97 Aligned_cols=241 Identities=21% Similarity=0.321 Sum_probs=197.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh-----------hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD-----------TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER 462 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 462 (665)
+.||+|+||+||+|... ++..||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 121 (504)
T 3q5i_A 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121 (504)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 67999999999999965 67899999987543221 2356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC---ceEEeeccc
Q 005999 463 LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF---EARLTDYCL 539 (665)
Q Consensus 463 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~---~~kl~Dfgl 539 (665)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 122 ~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 122 YLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHN-IVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp EEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 999999999999999874 345899999999999999999999999 99999999999999775 699999999
Q ss_pred ccccCCC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--ch
Q 005999 540 SVLSDSS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--RE 615 (665)
Q Consensus 540 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~ 615 (665)
+...... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||... ...++...+........ ..
T Consensus 196 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 196 SSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ--NDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCHHHH
T ss_pred CEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCcccc
Confidence 9776543 23446899999999986 46899999999999999999999999763 22234444433322221 12
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...+..+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 355678999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.70 Aligned_cols=241 Identities=25% Similarity=0.405 Sum_probs=202.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+++..++||||+++++
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 57999999999999864 688999999976543 2346778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 107 L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (303)
T 3a7i_A 107 ALDLLEP------GPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179 (303)
T ss_dssp HHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCC
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChheEEECCCCCEEEeecccceecCccccccCcc
Confidence 9999863 45899999999999999999999999 9999999999999999999999999997654432 234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+|+.|+|||++. +..++.++||||||+++|||++|+.||.... .......+.... ........+..+.+++.+||
T Consensus 180 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 180 VGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSELH--PMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-CCCCCSSCCHHHHHHHHHHC
T ss_pred CCCcCccCHHHHh-cCCCCchhhhHHHHHHHHHHccCCCCCCCcC--HHHHHHHhhcCC-CCCCccccCHHHHHHHHHHc
Confidence 6899999999987 5678999999999999999999999987531 222222222221 12234456778999999999
Q ss_pred cCCCCCCCCHHHHHHHH
Q 005999 631 LKSPEQRPAMWQVLKMI 647 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~L 647 (665)
+.||++|||+.|+++..
T Consensus 256 ~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSGGGSCCHHHHTTCH
T ss_pred CCChhhCcCHHHHhhCh
Confidence 99999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.79 Aligned_cols=249 Identities=20% Similarity=0.263 Sum_probs=202.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 471 (665)
+.||+|+||.||++... +++.||+|++..........+.+.+|++++++++||||+++++++.+ .+..++||||+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 57999999999999975 68899999998765555567789999999999999999999998854 5689999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----eeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW----LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+|.+++..... ....+++..++.++.|++.||+|||+.+. |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~ 170 (279)
T 2w5a_A 92 GDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170 (279)
T ss_dssp EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C
T ss_pred CCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc
Confidence 999999974321 23458999999999999999999999763 9999999999999999999999999987654432
Q ss_pred C---CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 V---EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 ~---~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
. ...+|+.|+|||.+. +..++.++||||||+++|||++|+.||... ...++...+...... ..+...+..+.+
T Consensus 171 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 246 (279)
T 2w5a_A 171 SFAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFR-RIPYRYSDELNE 246 (279)
T ss_dssp HHHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCC-CCCTTSCHHHHH
T ss_pred ccccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCccc--CHHHHHHHHhhcccc-cCCcccCHHHHH
Confidence 1 124789999999987 567899999999999999999999999763 222333333332221 234456778999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
++.+||+.||++|||+.|+++.+.
T Consensus 247 li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 247 IITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHcCCCcccCCCHHHHHhChh
Confidence 999999999999999999998653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.61 Aligned_cols=241 Identities=19% Similarity=0.245 Sum_probs=194.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeE------EEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGER------LVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~lv~e 467 (665)
+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++...+.. ++|||
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 127 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence 57999999999999864 689999999987655556677889999999999999999999999877654 99999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+. ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 128 ~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 198 (371)
T 4exu_A 128 FMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 198 (371)
T ss_dssp CCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred ccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCcCHHHeEECCCCCEEEEecCcccccccCc
Confidence 997 58988874 24899999999999999999999999 9999999999999999999999999998776666
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHH-HHHHhhccC---------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML-EWVRTMRVD--------------- 611 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~-~~~~~~~~~--------------- 611 (665)
....+|+.|+|||++.....++.++|||||||++|||++|+.||.... ..+.. .........
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 666789999999998755779999999999999999999999997532 11111 111111000
Q ss_pred --------CC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 612 --------DG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 612 --------~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 112346789999999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.55 Aligned_cols=246 Identities=24% Similarity=0.281 Sum_probs=194.4
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh---hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD---TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence 367999999999999964 68899999997543221 12346789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 95 ET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp SE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred CC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCCHHHEEEcCCCCEEEEecccceeccCCccc
Confidence 86 89998874 2346888999999999999999999999 9999999999999999999999999997654322
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-------------
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG------------- 613 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------------- 613 (665)
....+|+.|+|||++.+...++.++|||||||++|||++|.+||.... ....+............
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 234689999999998755568999999999999999999999987531 11122222222111100
Q ss_pred ------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 614 ------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 614 ------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 012345789999999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.87 Aligned_cols=242 Identities=20% Similarity=0.263 Sum_probs=195.2
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC------CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL------SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+++++.+ +|+||+++++++...+..++||
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 367999999999999865 58899999997543 3345566777777665 6779999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc--eEEeecccccccC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE--ARLTDYCLSVLSD 544 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~--~kl~Dfgl~~~~~ 544 (665)
||+. ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 179 e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 179 ELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp CCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHT-EECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred eccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 9996 5999998753 2345899999999999999999999999 999999999999999887 9999999998777
Q ss_pred CCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-----------
Q 005999 545 SSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG----------- 613 (665)
Q Consensus 545 ~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 613 (665)
.......+|+.|+|||++. +..++.++|||||||++|||++|++||..... ...+...+........
T Consensus 254 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 254 QRVYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp CCCCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred CcccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 6666668999999999987 56799999999999999999999999976321 1111111111110000
Q ss_pred ---------------------------------------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 ---------------------------------------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 ---------------------------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 00112466899999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.91 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=185.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEE--------eCCeEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQ--------AKGERL 463 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~~~~~ 463 (665)
.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++. ||||+++++++. .....+
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~ 110 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEE
Confidence 367999999999999964 78899999985543 345567889999999995 999999999984 334578
Q ss_pred EEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 464 VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 464 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+|+||+. |+|.+++.... ....+++..++.++.||+.||+|||+.+ +|+||||||+|||++.++.+||+|||++..
T Consensus 111 lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 9999996 69999886422 2346999999999999999999999875 499999999999999999999999999976
Q ss_pred cCCCCC---------------CCCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH
Q 005999 543 SDSSSV---------------EDPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV 605 (665)
Q Consensus 543 ~~~~~~---------------~~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 605 (665)
...... ...+|+.|+|||++. .+..++.++|||||||++|||++|+.||..... ... .
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~---~ 262 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--LRI---V 262 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH--HHh---h
Confidence 643221 234789999999873 255688999999999999999999999975321 111 1
Q ss_pred HhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 606 RTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 606 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
.. ..........+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 263 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 263 NG-KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cC-cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 11 11112223344568899999999999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.92 Aligned_cols=252 Identities=11% Similarity=0.058 Sum_probs=183.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHH---HHHHhCCCCCCeeeee-------EEEEeCC-
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQH---MEAVGGLSHPNLVPIR-------AYFQAKG- 460 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e---~~~l~~l~h~niv~l~-------~~~~~~~- 460 (665)
.+.||+|+||.||+|... +++.||+|++..... .....+.+.+| +..++. +||||++++ +++...+
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 367999999999999965 789999999987654 23445667777 455666 799988755 5554432
Q ss_pred ----------------eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCeeccC
Q 005999 461 ----------------ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSC------LKIAEDVAQGLAYIHRASWLIHGN 518 (665)
Q Consensus 461 ----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~L~yLH~~~~iiH~D 518 (665)
..++||||+. |+|.+++... ...+.+..+ +.++.||+.||+|||+++ |+|||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-ivHrD 219 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-LVHGH 219 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-EEETT
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-CccCc
Confidence 3799999999 8999999753 223455556 778899999999999999 99999
Q ss_pred CCCCceEeCCCCceEEeecccccccCCCCCCCCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 005999 519 LKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA 597 (665)
Q Consensus 519 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~ 597 (665)
|||+|||++.++.+||+|||++...........+|+.|+|||++.. ...++.++|||||||++|||++|+.||......
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 299 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence 9999999999999999999999877654434457799999999862 156899999999999999999999999864322
Q ss_pred CccHHHH---HHhh--ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHHh
Q 005999 598 PPDMLEW---VRTM--RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK--MIQEIKE 652 (665)
Q Consensus 598 ~~~~~~~---~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~ 652 (665)
....... .... ..........+..+.+++.+||+.||++|||+.|+++ .++++..
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp CTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred cccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 1110000 0000 0001122356778999999999999999999999975 3444433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.28 Aligned_cols=240 Identities=24% Similarity=0.360 Sum_probs=195.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+.++
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 367999999999999975 58899999997543 2356789999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 110 ~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 110 SVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFMR-KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp EHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 99999863 2356899999999999999999999999 999999999999999999999999999765443 223
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc-cCCCchhhhHHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDGREENRLGMLTEVASV 628 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 628 (665)
..+|+.|+|||++. +..++.++||||||+++|||++|+.||.... .......+.... .........+..+.+++.+
T Consensus 185 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 185 VIGTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIH--PMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp CCSCGGGCCHHHHS-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cCCCCCccChhhcC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 46899999999987 5678999999999999999999999997532 111111111111 1112344567789999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
||+.||++|||+.|+++
T Consensus 262 ~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 262 CLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HTCSCTTTSCCHHHHTT
T ss_pred HccCChhhCcCHHHHHh
Confidence 99999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.20 Aligned_cols=241 Identities=18% Similarity=0.279 Sum_probs=197.2
Q ss_pred hHhCcccceEEEEEEE--CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCC------CeeeeeEEEEeCCeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL--DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHP------NLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~~~lv~ 466 (665)
+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+++++.++|+ +++++++++...+..++||
T Consensus 20 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 96 (339)
T 1z57_A 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF 96 (339)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEE
T ss_pred EEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEE
Confidence 6799999999999986 368899999996542 4456788899888887665 4999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC------------------
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA------------------ 528 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~------------------ 528 (665)
||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 97 e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 97 ELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred cCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 999 88999999753 2346899999999999999999999999 999999999999987
Q ss_pred -CCceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh
Q 005999 529 -DFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT 607 (665)
Q Consensus 529 -~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 607 (665)
++.+||+|||++...........+|+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~~~ 248 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHD--SKEHLAMMER 248 (339)
T ss_dssp SCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC--HHHHHHHHHH
T ss_pred cCCCceEeeCcccccCccccccccCCccccChHHhh-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHH
Confidence 66899999999987766656667899999999987 5678999999999999999999999997532 1122222211
Q ss_pred hccCC------------------------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 608 MRVDD------------------------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 608 ~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 11110 012234677999999999999999999999986
Q ss_pred H
Q 005999 646 M 646 (665)
Q Consensus 646 ~ 646 (665)
.
T Consensus 329 h 329 (339)
T 1z57_A 329 H 329 (339)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.41 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=200.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-------hhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-------ADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 465 (665)
+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++++. ||||+++++++..++..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (298)
T 1phk_A 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102 (298)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence 57999999999999975 688999999975431 1123467889999999995 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 103 FDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEcCCCcEEEecccchhhcCC
Confidence 999999999999974 346899999999999999999999999 99999999999999999999999999976654
Q ss_pred CC--CCCCCCCcccCCcccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--Cchh
Q 005999 546 SS--VEDPDTVAYKAPEIRK-----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREE 616 (665)
Q Consensus 546 ~~--~~~~gt~~y~aPE~~~-----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~ 616 (665)
.. ....+++.|+|||++. ....++.++||||||+++|||++|+.||... ........+....... ....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 1phk_A 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGSPEWD 254 (298)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCCCTTTGG
T ss_pred CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--cHHHHHHHHhcCCcccCccccc
Confidence 32 3346899999999874 2456789999999999999999999999653 1223333332222221 1234
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+..+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 56778999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=333.71 Aligned_cols=240 Identities=17% Similarity=0.235 Sum_probs=186.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------eEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------ERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 467 (665)
+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e 110 (371)
T 2xrw_A 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence 67999999999999864 6889999999765544556677889999999999999999999997654 7899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 111 ~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 111 LMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp CCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred cCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 9975 78888852 3889999999999999999999999 9999999999999999999999999997665432
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccH-HHHHHhhcc--------------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDM-LEWVRTMRV-------------- 610 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~-~~~~~~~~~-------------- 610 (665)
....+|+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+. ...+.....
T Consensus 182 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp --------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred ccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 2346899999999987 5678999999999999999999999997532 1111 111100000
Q ss_pred ----CC---------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 ----DD---------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 ----~~---------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 0011225679999999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=328.20 Aligned_cols=237 Identities=16% Similarity=0.244 Sum_probs=193.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEe--CCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQA--KGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~ 470 (665)
+.||+|+||.||+|.. .+++.||+|+++... .+.+.+|++++++++ ||||+++++++.+ ....++||||+.
T Consensus 42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 6799999999999985 578899999987433 356889999999996 9999999999988 667899999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCCC--
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~-- 547 (665)
+++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++.......
T Consensus 117 ~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 117 NTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp CCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred chhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 999999875 2788999999999999999999999 99999999999999776 89999999997654432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH------------hhccCC---
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR------------TMRVDD--- 612 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~------------~~~~~~--- 612 (665)
....+|..|+|||++.....++.++|||||||++|||++|+.||.........+..... ......
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 33468999999999875577899999999999999999999999653322112221111 110000
Q ss_pred -------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+|+.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011225678999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.97 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=194.4
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch------hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA------DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||+|... +++.||||++...... ......+.+|++++++++||||+++++++..+. .++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~ 93 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence 467999999999999965 6889999998754321 122345889999999999999999999997665 89999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc---eEEeeccccccc
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE---ARLTDYCLSVLS 543 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~ 543 (665)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 94 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 94 ELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp ECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 99999999999873 356899999999999999999999999 999999999999987654 999999999776
Q ss_pred CCCCC--CCCCCCcccCCcccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhh
Q 005999 544 DSSSV--EDPDTVAYKAPEIRK--SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REEN 617 (665)
Q Consensus 544 ~~~~~--~~~gt~~y~aPE~~~--~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 617 (665)
..... ...||+.|+|||++. ....++.++|||||||++|||++|+.||..... ...+...+........ ....
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 246 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYNFIPEVWAE 246 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC-SSCHHHHHHHTCCCCCHHHHTT
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-HHHHHHHHHhCccccCchhhhh
Confidence 54321 224799999999863 245688999999999999999999999976432 2234444433322211 1234
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 5678999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.21 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=181.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred heeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 6799999999999984 4788999999865432 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 474 LFNLIHGS---RSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 474 L~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
|.+++... .......+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 178 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCHHHHHCC------
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCcc
Confidence 99998631 1112456899999999999999999999999 9999999999999999999999999986554321
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--------Cc
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--------GR 614 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------~~ 614 (665)
....+|+.|+|||++.....++.++||||||+++|||++|+.||.... ..+............ ..
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (303)
T 2vwi_A 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP--PMKVLMLTLQNDPPSLETGVQDKEM 256 (303)
T ss_dssp ---------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHHHHTSSCCCTTC-----CC
T ss_pred chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc--hhhHHHHHhccCCCccccccccchh
Confidence 223589999999998643568999999999999999999999997632 112211111111100 11
Q ss_pred hhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 615 EENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 615 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 2345677999999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.20 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=181.1
Q ss_pred HhHhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 468 (665)
.++||+|+||.||+|... ++..||+|++..... .+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~ 101 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 101 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence 457999999999999965 578899999975532 2357789999999999999999999954 6789999999
Q ss_pred cCCCCHHHHHhcCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe----CCCCceEEeecccc
Q 005999 469 QPNGSLFNLIHGSR----SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL----GADFEARLTDYCLS 540 (665)
Q Consensus 469 ~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill----~~~~~~kl~Dfgl~ 540 (665)
+.+ +|.+++...+ ......+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 102 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 102 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp CSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred CCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 975 8888775321 112235999999999999999999999999 9999999999999 67789999999999
Q ss_pred cccCCC------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC--------ccHHHHHH
Q 005999 541 VLSDSS------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP--------PDMLEWVR 606 (665)
Q Consensus 541 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~--------~~~~~~~~ 606 (665)
...... .....||+.|+|||++.+...++.++|||||||++|||++|+.||....... ..+...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 766432 1223589999999998755668999999999999999999999997533210 11222222
Q ss_pred hhccCCC-----------------------------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 607 TMRVDDG-----------------------------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 607 ~~~~~~~-----------------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+..... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111110 00011456889999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=321.84 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=200.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++|+||+.++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 367999999999999975 6889999999765544455678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC---CceEEeecccccccCCCCC-
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD---FEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~- 548 (665)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+|||++........
T Consensus 107 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 107 ELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 99998864 245899999999999999999999999 9999999999999754 4799999999976654332
Q ss_pred -CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHHHHHH
Q 005999 549 -EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGMLTEV 625 (665)
Q Consensus 549 -~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 625 (665)
...+|+.|+|||.+. +.++.++||||||+++|+|++|+.||... ...++...+........ .....+..+.++
T Consensus 181 ~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp SCHHHHHTTCCHHHHT--TCCCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred ccccCcccccChHHhc--CCCCCchhhHhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 223688999999986 34899999999999999999999999753 22233333333222211 224567789999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||+.||++|||+.|+++
T Consensus 257 i~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcccChhhCcCHHHHhc
Confidence 99999999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=327.65 Aligned_cols=242 Identities=20% Similarity=0.316 Sum_probs=194.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||+++++
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 57999999999999976 588999999875432 345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SSVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~~ 550 (665)
|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..... .....
T Consensus 103 l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (302)
T 2j7t_A 103 VDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177 (302)
T ss_dssp HHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence 99988642 345899999999999999999999999 99999999999999999999999998743211 12234
Q ss_pred CCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc-cCCCchhhhHHHHHHH
Q 005999 551 PDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDGREENRLGMLTEV 625 (665)
Q Consensus 551 ~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 625 (665)
.+|+.|+|||++. ....++.++||||||+++|||++|+.||.... .......+.... .........+..+.++
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--HHHHHHHHhccCCcccCCccccCHHHHHH
Confidence 6899999999873 25678899999999999999999999987532 112211111111 1112345567789999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||+.||++|||+.|+++
T Consensus 256 i~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 256 LKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHcccChhhCCCHHHHhc
Confidence 99999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.38 Aligned_cols=242 Identities=23% Similarity=0.359 Sum_probs=192.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEe------CCeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQA------KGERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~ 466 (665)
+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++||
T Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 6799999999999997 478899999987554 2345688999999998 89999999999987 46889999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+.+|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp ECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 999999999999753 2356899999999999999999999999 999999999999999999999999998765432
Q ss_pred ---CCCCCCCCcccCCccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhH
Q 005999 547 ---SVEDPDTVAYKAPEIRKS----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619 (665)
Q Consensus 547 ---~~~~~gt~~y~aPE~~~~----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (665)
.....+|+.|+|||++.. ...++.++|||||||++|||++|+.||.... .......+.............+
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPAPRLKSKKWS 260 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCSCSC
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCccccCCccccC
Confidence 223358999999998752 3568899999999999999999999996532 1122222222222222234567
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 620 GMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 620 ~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 261 KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 78999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=332.68 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=195.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-----CeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-----GERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 468 (665)
+.||+|+||.||+|... ++..||+|++..... ....+.+.+|++++++++||||+++++++... ...++|+||
T Consensus 33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 67999999999999864 788999999975432 34457789999999999999999999999764 468999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+.+ +|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~~-~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 112 MET-DLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp CSE-EHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred cCc-CHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 975 99999864 35899999999999999999999999 9999999999999999999999999997654321
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC----------
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---------- 612 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---------- 612 (665)
....||+.|+|||++.....++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS--GGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 233689999999987656668999999999999999999999997632 222222221111100
Q ss_pred --------------C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --------------G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --------------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 01234567899999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=337.86 Aligned_cols=243 Identities=18% Similarity=0.232 Sum_probs=195.2
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC--------CCCeeeeeEEEE----eCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS--------HPNLVPIRAYFQ----AKG 460 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~~~ 460 (665)
.+.||+|+||+||+|.. .+++.||+|++.... ...+.+.+|++++++++ |+||+++++++. ...
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 118 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT 118 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence 36799999999999985 468899999997442 44567889999998885 788999999987 456
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCC---------
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADF--------- 530 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~--------- 530 (665)
..++||||+ +++|.+.+... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 119 ~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~g-ivHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 119 HICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred eEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHeeEeccchhhhhhhhh
Confidence 889999999 56777766542 235699999999999999999999998 8 99999999999999775
Q ss_pred ----------------------------------------ceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCC
Q 005999 531 ----------------------------------------EARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATS 570 (665)
Q Consensus 531 ----------------------------------------~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 570 (665)
.+||+|||++...........||+.|+|||++. +..++.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ 272 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI-GSGYNT 272 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH-TSCCCT
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc-CCCCCc
Confidence 799999999987776666667999999999987 567999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCCCCc----cHHHHHHhhccC-----------------------------------
Q 005999 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPP----DMLEWVRTMRVD----------------------------------- 611 (665)
Q Consensus 571 k~DvwSlGvvl~elltg~~P~~~~~~~~~----~~~~~~~~~~~~----------------------------------- 611 (665)
++|||||||++|||++|+.||........ +....+......
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 99999999999999999999976433221 111111111000
Q ss_pred -----CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 -----DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 -----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112345677899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=355.76 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=205.2
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|... .+..||+|++..... ....+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcC
Confidence 467999999999999864 356899999875443 345577999999999999999999999985 45689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV- 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~- 548 (665)
++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 473 ~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 473 TLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp TTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred CCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 999999999742 346899999999999999999999999 99999999999999999999999999977654321
Q ss_pred ---CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 549 ---EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 549 ---~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
...+|+.|+|||++. +..++.++|||||||++|||++ |+.||... ...+....+..... ...+...+..+.+
T Consensus 548 ~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--~~~~~~~~i~~~~~-~~~~~~~~~~l~~ 623 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGER-LPMPPNCPPTLYS 623 (656)
T ss_dssp ------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHHTCC-CCCCTTCCHHHHH
T ss_pred eccCCCCCcceeCHHHhc-CCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHcCCC-CCCCccccHHHHH
Confidence 224678999999987 5679999999999999999997 99999753 22233333333221 1234566788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
++.+||+.||++|||+.|+++.|+++.+..
T Consensus 624 li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 624 LMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999987653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.98 Aligned_cols=245 Identities=16% Similarity=0.251 Sum_probs=199.3
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchh---------------hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD---------------TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK 459 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 459 (665)
+.||+|+||.||+|.. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.
T Consensus 37 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 37 RTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 6799999999999999 88999999986442211 1127789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHH------HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCCce
Q 005999 460 GERLVIYDYQPNGSLFNL------IHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADFEA 532 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~~~ 532 (665)
+..++||||+++|+|.++ +... ....+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dl~p~Nil~~~~~~~ 191 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRV 191 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC-EECCCCCGGGEEECTTSCE
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC-EeecCCChHhEEEcCCCcE
Confidence 999999999999999998 4421 24679999999999999999999999 88 9999999999999999999
Q ss_pred EEeecccccccCCC-CCCCCCCCcccCCccccCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc
Q 005999 533 RLTDYCLSVLSDSS-SVEDPDTVAYKAPEIRKSSRRATS-KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV 610 (665)
Q Consensus 533 kl~Dfgl~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~-k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 610 (665)
||+|||.+...... .....+|+.|+|||++.....++. ++||||||+++|||++|+.||..... ..++...+.....
T Consensus 192 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~i~~~~~ 270 (348)
T 2pml_X 192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-LVELFNNIRTKNI 270 (348)
T ss_dssp EECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-SHHHHHHHTSCCC
T ss_pred EEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccCc
Confidence 99999999765433 234468999999999874435655 99999999999999999999976321 1233333322211
Q ss_pred CCCc-----------------hhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 611 DDGR-----------------EENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 611 ~~~~-----------------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110 1456778999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=358.82 Aligned_cols=241 Identities=20% Similarity=0.270 Sum_probs=200.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
.+.||+|+||.||+|... +++.||||+++.... .....+.+..|..++..+ +||||+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 357999999999999965 678899999975422 123345678899999988 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC---CC
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS---SS 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~ 547 (665)
+|+|.++++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.... ..
T Consensus 426 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g-IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 426 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS-EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-eEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence 99999999842 46899999999999999999999999 99999999999999999999999999975322 22
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
....||+.|+|||++. +..++.++|||||||++|||++|+.||... ...++...+.. .....+...+..+.+|+.
T Consensus 500 ~~~~GT~~Y~APE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--DEDELFQSIME--HNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp CCCCSCSSSCCHHHHT-CCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHS--SCCCCCTTSCHHHHHHHH
T ss_pred ccccCCCcccCHhhhc-CCCCCccceEechHHHHHHHHcCCCCCCCC--CHHHHHHHHHh--CCCCCCccCCHHHHHHHH
Confidence 3446899999999987 678999999999999999999999999762 22233333322 222345567788999999
Q ss_pred HcccCCCCCCCCH-----HHHHH
Q 005999 628 VCSLKSPEQRPAM-----WQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~-----~evl~ 645 (665)
+||++||++||++ +||++
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHccCCHHHCCCCCCCcHHHHhc
Confidence 9999999999997 66654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=331.82 Aligned_cols=240 Identities=18% Similarity=0.231 Sum_probs=193.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe------EEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE------RLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e 467 (665)
+.||+|+||.||+|... +++.||||++..........+.+.+|+.++++++||||+++++++...+. .++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 109 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence 57999999999999964 68999999997765545566788999999999999999999999987653 499999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+. ++|.+++. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 110 ~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 180 (353)
T 3coi_A 110 FMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180 (353)
T ss_dssp CCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred ccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEeECCCCcEEEeecccccCCCCCc
Confidence 997 58887764 24899999999999999999999999 9999999999999999999999999998766555
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh-hc-----------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT-MR----------------- 609 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~-~~----------------- 609 (665)
....+|+.|+|||++.+...++.++|||||||++|||++|+.||.... ..+....+.. ..
T Consensus 181 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp ---CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--HHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 555789999999998754678999999999999999999999997632 1111111111 00
Q ss_pred ------cCC-----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 610 ------VDD-----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 610 ------~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 012345678999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=325.99 Aligned_cols=244 Identities=19% Similarity=0.252 Sum_probs=180.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|... +++.||+|++..........+.+.++..+++.++||||+++++++.+++..++||||+ ++.
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 109 (318)
T 2dyl_A 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109 (318)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence 57999999999999975 6889999999876554444555666667788999999999999999999999999999 556
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~ 550 (665)
+..+... ....+++..++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|||++....... ...
T Consensus 110 ~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (318)
T 2dyl_A 110 AEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184 (318)
T ss_dssp HHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHHHC-CCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred HHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhhCC-EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccccc
Confidence 6555542 234689999999999999999999996 8 9999999999999999999999999986654322 233
Q ss_pred CCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHHHHH
Q 005999 551 PDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGMLTEV 625 (665)
Q Consensus 551 ~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 625 (665)
.+|+.|+|||++. ....++.++|||||||++|||++|+.||...... .+....+..... ........+..+.++
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l 263 (318)
T 2dyl_A 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-FEVLTKVLQEEPPLLPGHMGFSGDFQSF 263 (318)
T ss_dssp --CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHHHHHHSCCCCCCSSSCCCHHHHHH
T ss_pred CCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-HHHHHHHhccCCCCCCccCCCCHHHHHH
Confidence 5899999999985 2456889999999999999999999999753211 122222221111 111223456789999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||+.||++|||+.|+++
T Consensus 264 i~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 264 VKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhh
Confidence 99999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=325.27 Aligned_cols=243 Identities=17% Similarity=0.265 Sum_probs=194.6
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC--CCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS--HPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||++...+++.||+|++..........+.+.+|++++++++ |+||+++++++.+++..++||| +.++
T Consensus 34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 112 (313)
T 3cek_A 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 112 (313)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence 579999999999999888999999999776555566788999999999996 5999999999999999999999 5678
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||++++ +.+||+|||++.......
T Consensus 113 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 185 (313)
T 3cek_A 113 DLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK 185 (313)
T ss_dssp EHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEET-TEEEECCCSSSCC----------
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEEEC-CeEEEeeccccccccCccccccc
Confidence 99999974 246899999999999999999999999 999999999999964 899999999997654332
Q ss_pred CCCCCCCcccCCccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhh
Q 005999 548 VEDPDTVAYKAPEIRKS----------SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~----------~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (665)
....||+.|+|||++.. ...++.++||||||+++|||++|+.||.........+..... .......+..
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 264 (313)
T 3cek_A 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEFPDI 264 (313)
T ss_dssp ----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-TTSCCCCCCC
T ss_pred cCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh-cccccCCccc
Confidence 22358999999999863 146888999999999999999999999753221111211111 1111123344
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.+..+.+++.+||+.||++|||+.|+++.
T Consensus 265 ~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 265 PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 46779999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.60 Aligned_cols=243 Identities=16% Similarity=0.220 Sum_probs=188.6
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCch---------hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-----CC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA---------DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-----KG 460 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 460 (665)
+.||+|+||.||+|...++..||||++...... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 579999999999999888999999998653321 1234778999999999999999999999854 33
Q ss_pred eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 461 ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 461 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
..++||||+. |+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 181 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAG-VVHRDLHPGNILLADNNDITICDFNLA 181 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCTTC-
T ss_pred eEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCc-CEecCCChHHEEEcCCCCEEEEecCcc
Confidence 6899999998 589888874 2346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------
Q 005999 541 VLSDSS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------ 612 (665)
Q Consensus 541 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------ 612 (665)
...... .....+|+.|+|||++.....++.++|||||||++|||++|+.||.... ..+....+.......
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 182 REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--FYNQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp --------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCChHHhh
Confidence 754432 2334588999999998755678999999999999999999999997632 111111111110000
Q ss_pred ------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 011233567899999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=335.05 Aligned_cols=248 Identities=17% Similarity=0.267 Sum_probs=192.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC--------------
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-------------- 459 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------------- 459 (665)
+.||+|+||.||+|.. .+++.||+|++..... ...+|+++++.++||||++++++|...
T Consensus 13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence 6799999999999986 5789999999865432 124789999999999999999998543
Q ss_pred ------------------------CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 005999 460 ------------------------GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLI 515 (665)
Q Consensus 460 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ii 515 (665)
...++||||+++ +|.+.+..... ....+++..+..++.||+.||+|||+.+ |+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g-i~ 163 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG-IC 163 (383)
T ss_dssp -----------------------CCEEEEEECCCSE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT-EE
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc-Cc
Confidence 348899999985 88777653211 3456999999999999999999999999 99
Q ss_pred ccCCCCCceEeC-CCCceEEeecccccccCCC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 005999 516 HGNLKSSNVLLG-ADFEARLTDYCLSVLSDSS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQ 592 (665)
Q Consensus 516 H~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~ 592 (665)
||||||+||+++ .++.+||+|||++...... .....+|+.|+|||++.+...++.++||||+||++|||++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 999999999998 6899999999999765433 3344689999999998755568999999999999999999999997
Q ss_pred CCCCCCccHHHHHHhhccCC--------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH-
Q 005999 593 HPYLAPPDMLEWVRTMRVDD--------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK- 645 (665)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~- 645 (665)
... ....+...+....... ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 244 GET-SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CSS-HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCC-hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 632 1112222222111110 012235667999999999999999999999985
Q ss_pred -HHHHHHh
Q 005999 646 -MIQEIKE 652 (665)
Q Consensus 646 -~L~~~~~ 652 (665)
.++++..
T Consensus 323 p~f~~~~~ 330 (383)
T 3eb0_A 323 PFFDHLRN 330 (383)
T ss_dssp GGGHHHHH
T ss_pred HHHHHHHh
Confidence 3444443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.58 Aligned_cols=242 Identities=19% Similarity=0.277 Sum_probs=188.0
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe------EEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE------RLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e~ 468 (665)
+.||+|+||+||+|....+..+|+|++...... ..+|+++++.++||||++++++|...+. .++||||
T Consensus 46 ~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 679999999999999876666899988654321 2368999999999999999999965443 7899999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC-CCCceEEeecccccccCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG-ADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~- 546 (665)
++++.+....+... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++......
T Consensus 120 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 98754433332111 2456899999999999999999999999 99999999999999 7999999999999765432
Q ss_pred -CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-------------
Q 005999 547 -SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------- 612 (665)
Q Consensus 547 -~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------- 612 (665)
.....+|+.|+|||++.+...++.++||||+||++|||++|+.||..... ...+...++......
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 33446899999999987556699999999999999999999999976321 112222222111100
Q ss_pred ---------C----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 ---------G----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 ---------~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 112355689999999999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=322.61 Aligned_cols=240 Identities=20% Similarity=0.385 Sum_probs=189.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-------------C
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-------------K 459 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------------~ 459 (665)
.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 357999999999999964 7889999998643 2455778999999999999999999998865 3
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 460 GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG-IIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC-eecccCCHHhEEEcCCCCEEEeeCcc
Confidence 5688999999999999999752 345788999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCC-----------------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHH
Q 005999 540 SVLSDSS-----------------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML 602 (665)
Q Consensus 540 ~~~~~~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~ 602 (665)
+...... .....+|+.|+|||++.....++.++|||||||++|||++ ||.... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-hHHHHH
Confidence 8765421 1223478999999998755578999999999999999998 443210 111222
Q ss_pred HHHHhhcc--CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 603 EWVRTMRV--DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 603 ~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..+..... ........+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 22222111 11234455677999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.14 Aligned_cols=243 Identities=17% Similarity=0.247 Sum_probs=194.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch--hhHHHHHHHHHHHHhCCCCCCeeeeeEEEE--eCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA--DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ--AKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~ 469 (665)
+.||+|+||.||++.. .++..||+|++...... ....+.+.+|++++++++||||+++++++. +....++||||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhc
Confidence 5799999999999996 46889999999754321 234577899999999999999999999984 455789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.++ |.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 165 (305)
T 2wtk_C 91 VCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165 (305)
T ss_dssp SEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSS
T ss_pred cCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEcCCCcEEeeccccccccCccccc
Confidence 886 77777643 2456899999999999999999999999 9999999999999999999999999997654321
Q ss_pred ---CCCCCCCcccCCccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSR-RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~-~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....+|+.|+|||++.... .++.++||||||+++|||++|+.||... ...+....+.... ...+...+..+.
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~i~~~~--~~~~~~~~~~l~ 241 (305)
T 2wtk_C 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--NIYKLFENIGKGS--YAIPGDCGPPLS 241 (305)
T ss_dssp CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHCC--CCCCSSSCHHHH
T ss_pred cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--hHHHHHHHHhcCC--CCCCCccCHHHH
Confidence 2345899999999986322 2477999999999999999999999752 1122323222221 123445677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+++.+||+.||++|||+.|+++.
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.31 Aligned_cols=244 Identities=22% Similarity=0.291 Sum_probs=176.5
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHH-HHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHME-AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++....... ....+..|+. +++.++||||+++++++..++..++||||+.+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred heeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 67999999999999975 78899999997665433 3334445555 77888999999999999999999999999986
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCCCC--CC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--VE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--~~ 549 (665)
+|.+++..........+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++....... ..
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 184 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-CCCSCCCGGGEEEETTTEEEECCCSSSCC---------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-EeECCCCHHHEEEcCCCCEEEccCCCceeccccccccc
Confidence 888877532222345689999999999999999999998 8 9999999999999999999999999997654432 22
Q ss_pred CCCCCcccCCcccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------CchhhhHH
Q 005999 550 DPDTVAYKAPEIRK---SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------GREENRLG 620 (665)
Q Consensus 550 ~~gt~~y~aPE~~~---~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 620 (665)
..||+.|+|||++. .+..++.++||||||+++|||++|+.||....... +......... ......+.
T Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3aln_A 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQLTQVVKGDPPQLSNSEEREFSP 260 (327)
T ss_dssp ---------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCCCCCCCCSSCCCCH
T ss_pred CCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHHHHHhcCCCCCCCCcccccCCH
Confidence 35899999999983 24568999999999999999999999997532111 1111111110 11234677
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+.+++.+||+.||++|||+.|+++
T Consensus 261 ~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 261 SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 8999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.62 Aligned_cols=243 Identities=16% Similarity=0.256 Sum_probs=191.5
Q ss_pred hHhCcccceEEEEEEE--CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC---CCCCeeeeeEEEE-----eCCeEEE
Q 005999 395 ELLGRGSIGTTYKAVL--DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL---SHPNLVPIRAYFQ-----AKGERLV 464 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~~~~~~l 464 (665)
+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.+ +||||+++++++. .....++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 96 (326)
T 1blx_A 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96 (326)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence 5799999999999997 4688999999875443222223455666666555 8999999999987 4567899
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
||||+. |+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g-i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 171 (326)
T 1blx_A 97 VFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYS 171 (326)
T ss_dssp EEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred EEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHHHeEEcCCCCEEEecCccccccc
Confidence 999998 5999999753 2345899999999999999999999999 9999999999999999999999999987654
Q ss_pred CC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH-HhhccCC---------
Q 005999 545 SS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV-RTMRVDD--------- 612 (665)
Q Consensus 545 ~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~--------- 612 (665)
.. .....+|+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+ .......
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 172 FQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp GGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred CCCCccccccccceeCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcCCCCcccCccccc
Confidence 32 23346899999999987 5678999999999999999999999997532 11222211 1111000
Q ss_pred ---------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ---------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 012345677899999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.83 Aligned_cols=242 Identities=21% Similarity=0.281 Sum_probs=188.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 466 (665)
.+.||+|+||.||+|... +++.||||++..... ...+|++++++++||||++++++|... ...++||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 367999999999999975 689999999865432 234789999999999999999998542 1367899
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-CceEEeecccccccCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDS 545 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-~~~kl~Dfgl~~~~~~ 545 (665)
||+++ +|.+.+.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 133 e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp ECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred hcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99986 6766654211 12456999999999999999999999999 9999999999999965 6789999999976543
Q ss_pred C--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-----------
Q 005999 546 S--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----------- 612 (665)
Q Consensus 546 ~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----------- 612 (665)
. .....+|+.|+|||++.+...++.++|||||||++|||++|+.||.... ....+...+.......
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 2 2344689999999998755579999999999999999999999997632 1112322222111100
Q ss_pred ---C------------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ---G------------REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ---~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 11234577999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.83 Aligned_cols=239 Identities=21% Similarity=0.269 Sum_probs=186.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEE--------------eC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ--------------AK 459 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------------~~ 459 (665)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. +.
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 57999999999999976 48899999987553 345677899999999999999999999873 34
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC-CCCceEEeecc
Q 005999 460 GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG-ADFEARLTDYC 538 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~-~~~~~kl~Dfg 538 (665)
...++||||+. |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred CceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCeEEEccCc
Confidence 67899999998 599999863 45899999999999999999999999 99999999999997 56799999999
Q ss_pred cccccCCCC------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC-
Q 005999 539 LSVLSDSSS------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD- 611 (665)
Q Consensus 539 l~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~- 611 (665)
++....... ....+|..|+|||.+.....++.++|||||||++|||++|+.||.... ..+....+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--ELEQMQLILESIPVV 244 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHSCCC
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCC
Confidence 997654321 122468899999988755778999999999999999999999997632 11111111111000
Q ss_pred ----------------------C-C----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 612 ----------------------D-G----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 612 ----------------------~-~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. . .....+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 0 11235678999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.40 Aligned_cols=242 Identities=20% Similarity=0.271 Sum_probs=193.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC-----CeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK-----GERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 468 (665)
+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++... ...++||||
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 57999999999999965 688999999965432 34456788999999999999999999998654 678999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS- 547 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~- 547 (665)
+. |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 96 MQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp CS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred cC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 97 599999874 35899999999999999999999999 9999999999999999999999999997654321
Q ss_pred ------------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC-----------------
Q 005999 548 ------------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP----------------- 598 (665)
Q Consensus 548 ------------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~----------------- 598 (665)
....||+.|+|||++..+..++.++|||||||++|||++|+.||.......
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 123579999999987655778999999999999999999999997532100
Q ss_pred ------ccHHHHHHhhccCCC-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 599 ------PDMLEWVRTMRVDDG-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 599 ------~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
....+++........ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 001111111100000 11245677899999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.38 Aligned_cols=242 Identities=19% Similarity=0.286 Sum_probs=193.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-----------CCCeeeeeEEEEeCC--
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-----------HPNLVPIRAYFQAKG-- 460 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~-- 460 (665)
+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++ ||||+++++++...+
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 101 (373)
T 1q8y_A 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 101 (373)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence 6799999999999996 578899999997543 34567788999888876 899999999998654
Q ss_pred --eEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeC------CCCc
Q 005999 461 --ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLG------ADFE 531 (665)
Q Consensus 461 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~------~~~~ 531 (665)
..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+|||++ ..+.
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~-ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 102 GVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEEE
T ss_pred CceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC-EEecCCChHHeEEeccCCCcCcce
Confidence 789999999 88999999753 234589999999999999999999998 8 99999999999994 4458
Q ss_pred eEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC----c-cHHHHHH
Q 005999 532 ARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAP----P-DMLEWVR 606 (665)
Q Consensus 532 ~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~----~-~~~~~~~ 606 (665)
+||+|||++...........+|+.|+|||++. +..++.++|||||||++|||++|+.||....... . .+...+.
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 99999999987776666667999999999987 5678999999999999999999999997543211 1 1111111
Q ss_pred hhcc---------------------------------------CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 607 TMRV---------------------------------------DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 607 ~~~~---------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 1100 00123455678999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.79 Aligned_cols=240 Identities=17% Similarity=0.243 Sum_probs=194.4
Q ss_pred hHhCcccceEEEEEEEC--CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCC------eeeeeEEEEeCCeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD--NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN------LVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~ 466 (665)
+.||+|+||.||+|... ++..||+|+++... ...+.+.+|++++++++|++ ++.+++++...+..++||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T 2eu9_A 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101 (355)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence 67999999999999964 34789999997542 44567888999998887766 899999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEe-------------------C
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLL-------------------G 527 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill-------------------~ 527 (665)
||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +
T Consensus 102 e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 102 ELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred ecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEeccccccccccccccccccc
Confidence 999 66787777643 2346899999999999999999999999 9999999999999 5
Q ss_pred CCCceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh
Q 005999 528 ADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT 607 (665)
Q Consensus 528 ~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 607 (665)
.++.+||+|||++...........||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+....+..
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~~~~ 253 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHE--NREHLVMMEK 253 (355)
T ss_dssp SCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred CCCcEEEeecCccccccccccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence 678999999999987766666667999999999987 5678999999999999999999999997532 1122222211
Q ss_pred hccCC------------------------------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 608 MRVDD------------------------------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 608 ~~~~~------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
..... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11110 011223557899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=328.31 Aligned_cols=190 Identities=19% Similarity=0.323 Sum_probs=163.9
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CC-----CeeeeeEEEEeCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HP-----NLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~e 467 (665)
+.||+|+||.||+|... +++.||||+++... ...+.+..|+.+++.++ |+ +|+++++++...+..++|||
T Consensus 60 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 67999999999999865 68899999997542 34556777888887774 55 49999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCeeccCCCCCceEeC--CCCceEEeeccccccc
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR--ASWLIHGNLKSSNVLLG--ADFEARLTDYCLSVLS 543 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~--~~~iiH~Dlk~~Nill~--~~~~~kl~Dfgl~~~~ 543 (665)
|+.+ +|.+++... ....+++..+..++.|++.||+|||. .+ |+||||||+|||++ .++.+||+|||++...
T Consensus 137 ~~~~-~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~-ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 137 MLSY-NLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp CCCC-BHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC-EECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred cCCC-CHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCC-EEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9964 999999753 23458999999999999999999994 56 99999999999995 4788999999999887
Q ss_pred CCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005999 544 DSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593 (665)
Q Consensus 544 ~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~ 593 (665)
........+|+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 212 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 212 GQRIYQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TCCCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 76666667999999999987 56799999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.79 Aligned_cols=245 Identities=20% Similarity=0.271 Sum_probs=180.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe-------EEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE-------RLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~ 466 (665)
+.||+|+||.||+|... ++..||||++..... ..+.+.++++.++.++||||++++++|...+. .++||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 57999999999999974 688999999865432 22345677888888899999999999976443 78999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeeccCCCCCceEeCC-CCceEEeeccccccc
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH--RASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLS 543 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~ 543 (665)
||+.+ +|.+.+.... .....+++..+..++.|++.||+||| +.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 106 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp ECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-CBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred ecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC-eecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 99987 5554443211 13456899999999999999999999 888 999999999999996 899999999999776
Q ss_pred CCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---------
Q 005999 544 DSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--------- 612 (665)
Q Consensus 544 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------- 612 (665)
.... ....+|+.|+|||++.+...++.++|||||||++|||++|+.||..... ...+....+......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVLGCPSREVLRKLNP 261 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCT
T ss_pred CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHcCCCCHHHHHhccc
Confidence 5433 2345899999999987555689999999999999999999999976321 112222222111100
Q ss_pred --------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 --------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 --------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 262 SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp TCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred chhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0111246789999999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.52 Aligned_cols=240 Identities=18% Similarity=0.254 Sum_probs=169.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe----CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA----KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 469 (665)
++||+|+||.||+|... +++.||+|++.... ...+ +....++.++||||+++++++.. +...++||||+
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 108 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence 46999999999999976 68899999986532 2222 22233556799999999999876 44589999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCCC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~~ 546 (665)
++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++......
T Consensus 109 ~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~-ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 109 EGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN-IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp TTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 999999999853 2346999999999999999999999999 999999999999986 455999999999766543
Q ss_pred C-CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhc--cCCCchhhhHHH
Q 005999 547 S-VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMR--VDDGREENRLGM 621 (665)
Q Consensus 547 ~-~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~ 621 (665)
. ....+|+.|+|||++. +..++.++|||||||++|||++|+.||........ .....+.... .........+..
T Consensus 185 ~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred ccccCCCCcCccChhhhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence 2 3345799999999986 56788999999999999999999999975432211 1111111111 111122456778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++.+||+.||++|||+.|+++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 264 AKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=326.40 Aligned_cols=235 Identities=19% Similarity=0.337 Sum_probs=193.9
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCCC--CCCeeeeeEEEEeCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLS--HPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e 467 (665)
+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+.++++++ |+||+++++++...+..++|+|
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e 128 (320)
T 3a99_A 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128 (320)
T ss_dssp EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEE
Confidence 6799999999999985 478899999987553221 12234667889999885 5999999999999999999999
Q ss_pred ecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC-CCCceEEeecccccccCC
Q 005999 468 YQPN-GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG-ADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 468 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~ 545 (665)
|+.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++ +++.+||+|||++.....
T Consensus 129 ~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 129 RPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp CCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred cCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence 9986 899999874 346899999999999999999999999 99999999999999 789999999999977654
Q ss_pred CC-CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 546 SS-VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 546 ~~-~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
.. ....+|+.|+|||++.....++.++||||||+++|||++|+.||... ..... .........+..+.+
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~~~~---~~~~~~~~~~~~~~~ 272 (320)
T 3a99_A 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIR---GQVFFRQRVSSECQH 272 (320)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHH---CCCCCSSCCCHHHHH
T ss_pred ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-------hhhhc---ccccccccCCHHHHH
Confidence 33 33468999999999874444578899999999999999999998642 11111 111233456678999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~ 645 (665)
++.+||+.||++|||+.|+++
T Consensus 273 li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 273 LIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.56 Aligned_cols=236 Identities=19% Similarity=0.334 Sum_probs=188.6
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCC----CCCCeeeeeEEEEeCCeEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGL----SHPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~~~~~~~~~~~l 464 (665)
.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+.++.++ +||||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 36799999999999985 478899999997554321 1223456788888887 89999999999999999999
Q ss_pred EEEe-cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC-CCCceEEeecccccc
Q 005999 465 IYDY-QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG-ADFEARLTDYCLSVL 542 (665)
Q Consensus 465 v~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~ 542 (665)
|+|| +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+||+|||++..
T Consensus 116 v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRG-VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp EEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT-EECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 9999 789999999974 245899999999999999999999999 99999999999999 889999999999976
Q ss_pred cCCCC-CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 543 SDSSS-VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 543 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
..... ....+|..|+|||++......+.++||||||+++|||++|+.||... ..... .........+..
T Consensus 190 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~---~~~~~~~~~~~~ 259 (312)
T 2iwi_A 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-------QEILE---AELHFPAHVSPD 259 (312)
T ss_dssp CCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHH---TCCCCCTTSCHH
T ss_pred cccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-------HHHhh---hccCCcccCCHH
Confidence 65433 33468999999999874444456899999999999999999998642 11111 112233456678
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 260 CCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=335.73 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=183.9
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +||||+++++++.+++..++||||+. |+
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 5799999999988777789999999986432 34567899999876 89999999999999999999999996 59
Q ss_pred HHHHHhcCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC-------------CceEEeecc
Q 005999 474 LFNLIHGSRSIRA--KPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD-------------FEARLTDYC 538 (665)
Q Consensus 474 L~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~-------------~~~kl~Dfg 538 (665)
|.+++........ ...++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 9999985432111 11133346789999999999999999 9999999999999754 489999999
Q ss_pred cccccCCCC-------CCCCCCCcccCCccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHH
Q 005999 539 LSVLSDSSS-------VEDPDTVAYKAPEIRKS------SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEW 604 (665)
Q Consensus 539 l~~~~~~~~-------~~~~gt~~y~aPE~~~~------~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 604 (665)
++....... ....||+.|+|||++.. ...++.++|||||||++|||++ |+.||..... .....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~i 250 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS---RESNI 250 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---HHHHH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---hHHHH
Confidence 997765432 12358999999999863 2568999999999999999999 9999975322 11222
Q ss_pred HHhhccCC----CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 605 VRTMRVDD----GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 605 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
+....... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 22111111 112345678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.96 Aligned_cols=237 Identities=19% Similarity=0.279 Sum_probs=181.4
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
++||+|+||+||.....+++.||||++...... .+.+|+++++++ +||||+++++++.+....++||||+. |+
T Consensus 30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred CeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 579999999977666678889999999654321 246789999988 89999999999999999999999996 59
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-----CCceEEeecccccccCCC--
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-----DFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~~-- 546 (665)
|.+++.... ..+.+..++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||++......
T Consensus 104 L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 104 LQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHSLN-IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHHTT-CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHHCc-CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 999997532 23444456789999999999999999 999999999999953 336889999999766432
Q ss_pred ----CCCCCCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhh-ccCC-Cchhh
Q 005999 547 ----SVEDPDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTM-RVDD-GREEN 617 (665)
Q Consensus 547 ----~~~~~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~-~~~~-~~~~~ 617 (665)
.....||+.|+|||++.. ...++.++|||||||++|||++ |+.||.... .......... .... .....
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL---QRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT---THHHHHHTTCCCCTTSCTTCH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh---HHHHHHHhccCCccccCcccc
Confidence 123458999999999863 3457789999999999999999 999986421 1111111111 1111 12234
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
....+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 4566889999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=307.99 Aligned_cols=226 Identities=14% Similarity=0.118 Sum_probs=181.0
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++.+++||||+++++++.+++..++||||++|+
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 116 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence 57999999999999975 4889999999766443 344577899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD 552 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~g 552 (665)
+|.+++.. . ....++.+++.|++.||+|||+.+ |+||||||+|||++.++.+||++++
T Consensus 117 ~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~g-ivH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 117 SLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp EHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred CHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHCC-CccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 99999853 1 345578889999999999999999 9999999999999999999998443
Q ss_pred CCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC----CchhhhHHHHHHHHHH
Q 005999 553 TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD----GREENRLGMLTEVASV 628 (665)
Q Consensus 553 t~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~ 628 (665)
|++ .++.++|||||||++|||+||+.||........ +........... ......+..+.+++.+
T Consensus 175 ---~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (286)
T 3uqc_A 175 ---TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242 (286)
T ss_dssp ---CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred ---ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence 333 367899999999999999999999986432110 000000000000 1123456779999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 629 CSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
||+.||++| |+.|+++.|+.+.....
T Consensus 243 ~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 243 SVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HcccCCccC-CHHHHHHHHHHHhccCC
Confidence 999999999 99999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=341.51 Aligned_cols=237 Identities=18% Similarity=0.227 Sum_probs=192.4
Q ss_pred hHhCcccceEEEEEEEC--CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCe-----EEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD--NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGE-----RLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e 467 (665)
+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+. .|+|||
T Consensus 86 ~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 57999999999999975 588999999875433 3455678999999999999999999999987665 799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++++|.+++.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ .+||+|||++......
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g-iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG-LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC-CeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 9999999987652 5899999999999999999999999 9999999999999986 9999999999876554
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
....||+.|+|||++.. .++.++|||||||++|||++|..||........ .........+..+.+++.
T Consensus 235 ~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCHHHHHCHHHHHHHH
T ss_pred CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccccc----------cccccccccCHHHHHHHh
Confidence 34469999999999873 358899999999999999999998765321110 011112233467899999
Q ss_pred HcccCCCCCCC-CHHHHHHHHHHHHhhh
Q 005999 628 VCSLKSPEQRP-AMWQVLKMIQEIKESV 654 (665)
Q Consensus 628 ~cl~~dP~~RP-t~~evl~~L~~~~~~~ 654 (665)
+||+.||++|| +++++.+.|..+....
T Consensus 303 ~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred hhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 99999999999 5777777777765443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=336.27 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=198.6
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe------CCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA------KGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~ 466 (665)
.+.||+|+||.||+|.. .++..||||++..... ....+.+.+|++++++++||||+++++++.. .+..++||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 36799999999999986 4688999999876533 3456778999999999999999999999765 66789999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCc---eEEeeccccccc
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFE---ARLTDYCLSVLS 543 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~---~kl~Dfgl~~~~ 543 (665)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 98 Ey~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g-IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174 (676)
T ss_dssp ECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT-BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred EeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence 9999999999998532 2345888999999999999999999999 999999999999997664 999999999776
Q ss_pred CCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHh---------h----
Q 005999 544 DSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT---------M---- 608 (665)
Q Consensus 544 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~---------~---- 608 (665)
.... ....+|+.|+|||++. +..++.++|||||||++|||++|+.||.... ....|... .
T Consensus 175 ~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 175 DQGELCTEFVGTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp TSCCCCCCCCSCCTTCSSCSSC-CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC------CCSCCC
T ss_pred ccccccccccCCcccCChHHhc-cCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccchhhhhhhh
Confidence 5433 3346899999999987 6789999999999999999999999996421 00110000 0
Q ss_pred -----------ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHHHhh
Q 005999 609 -----------RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQ-----VLKMIQEIKES 653 (665)
Q Consensus 609 -----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-----vl~~L~~~~~~ 653 (665)
..........+..+.+++.+||+.||++|||+.| ..+.++.+.+.
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000123446788999999999999999999988 45666666553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.85 Aligned_cols=221 Identities=16% Similarity=0.248 Sum_probs=174.7
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHH-hCCCCCCeeeeeEEEEe----CCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAV-GGLSHPNLVPIRAYFQA----KGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~ 468 (665)
+.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +.++||||+++++++.. ....++||||
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 5699999999999996 57889999998642 2456777777 55699999999999987 6778999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDS 545 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~ 545 (665)
+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred cCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 9999999999853 2346999999999999999999999999 999999999999998 7899999999875432
Q ss_pred CCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCCC--chhhhHHH
Q 005999 546 SSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDDG--REENRLGM 621 (665)
Q Consensus 546 ~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~ 621 (665)
+..++.++|||||||++|||++|+.||........ .....+........ .....+..
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 232 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHH
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHH
Confidence 23477899999999999999999999965321110 00000000000000 11345778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 233 VKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcC
Confidence 9999999999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.96 Aligned_cols=240 Identities=15% Similarity=0.083 Sum_probs=178.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCC-CCee---------e-----------
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSH-PNLV---------P----------- 451 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv---------~----------- 451 (665)
++||+|+||+||+|.. .+++.||||++..... .....+.+++|+.+++.++| +|.. .
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 5799999999999995 4788999999874432 22335678999999999987 3211 1
Q ss_pred -eeEEEEe-----CCeEEEEEEecCCCCHHHHHhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCc
Q 005999 452 -IRAYFQA-----KGERLVIYDYQPNGSLFNLIHGSR--SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSN 523 (665)
Q Consensus 452 -l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~N 523 (665)
+..++.. ....+++|+++ +++|.+++.... ......+++..++.++.||+.||+|||+.+ |+||||||+|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-iiHrDiKp~N 241 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPVD 241 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGG
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcccce
Confidence 1111111 12356666655 679999884210 112456888899999999999999999999 9999999999
Q ss_pred eEeCCCCceEEeecccccccCCCCCCCCCCCcccCCcccc---------CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 005999 524 VLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRK---------SSRRATSKSDVYAFGVLLLELLTGKHPSQHP 594 (665)
Q Consensus 524 ill~~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~k~DvwSlGvvl~elltg~~P~~~~ 594 (665)
||++.++.+||+|||++...........| +.|+|||++. ....++.++|||||||++|||++|+.||...
T Consensus 242 ILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 242 IVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp EEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred EEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999876655555567 9999999983 2456888999999999999999999999763
Q ss_pred CCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 595 YLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.... ... .... .....+..+.+++.+||+.||++||++.|+++
T Consensus 321 ~~~~--~~~---~~~~---~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 321 AALG--GSE---WIFR---SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp GGGS--CSG---GGGS---SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred chhh--hHH---HHHh---hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 2111 100 0111 12245677999999999999999999888854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=307.58 Aligned_cols=236 Identities=14% Similarity=0.143 Sum_probs=179.7
Q ss_pred HHHHhHhCcccceEEEEEEECCeEEEEEEEecCCCc------hhhHHHHHHHHHHHHhCCC---------CCCeeeeeEE
Q 005999 391 RASAELLGRGSIGTTYKAVLDNHLIVTVKRFDANKT------ADTSAEAFEQHMEAVGGLS---------HPNLVPIRAY 455 (665)
Q Consensus 391 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~l~~~ 455 (665)
+...+.||+|+||.||+|.. +++.||||++..... .....+.+.+|++++++++ ||||+++.+.
T Consensus 22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~ 100 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV 100 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence 34457899999999999988 678999999976532 1233467888888888775 7777777766
Q ss_pred EE------------------------------eCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 005999 456 FQ------------------------------AKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505 (665)
Q Consensus 456 ~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L 505 (665)
+. ..+..++||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus 101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHH
T ss_pred eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHH
Confidence 43 26789999999999987776642 4589999999999999999
Q ss_pred HHHH-hCCCeeccCCCCCceEeCCCC--------------------ceEEeecccccccCCCCCCCCCCCcccCCccccC
Q 005999 506 AYIH-RASWLIHGNLKSSNVLLGADF--------------------EARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKS 564 (665)
Q Consensus 506 ~yLH-~~~~iiH~Dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~ 564 (665)
+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~-ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~- 250 (336)
T 2vuw_A 175 AVAEASLR-FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFT- 250 (336)
T ss_dssp HHHHHHHC-CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGC-
T ss_pred HHHHHhCC-EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhc-
Confidence 9999 888 99999999999999887 8999999999876543 236899999999987
Q ss_pred CCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCCCCccHHHHHH-hhccCC----CchhhhHHHHHHHHHHcccCCCCCCC
Q 005999 565 SRRATSKSDVYAFGVL-LLELLTGKHPSQHPYLAPPDMLEWVR-TMRVDD----GREENRLGMLTEVASVCSLKSPEQRP 638 (665)
Q Consensus 565 ~~~~~~k~DvwSlGvv-l~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RP 638 (665)
+.. +.++||||+|++ .+++++|..||..... .......+. ...... ......+..+.+|+.+||+.|
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhh-hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 333 889999998777 7778889998743100 000111111 111111 123456788999999999976
Q ss_pred CHHHHH
Q 005999 639 AMWQVL 644 (665)
Q Consensus 639 t~~evl 644 (665)
|+.|++
T Consensus 324 sa~e~l 329 (336)
T 2vuw_A 324 SATDLL 329 (336)
T ss_dssp SHHHHH
T ss_pred CHHHHH
Confidence 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=282.79 Aligned_cols=183 Identities=12% Similarity=0.049 Sum_probs=128.8
Q ss_pred hCcccceEEEEEE-ECCeEEEEEEEecCCCc--------hhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 397 LGRGSIGTTYKAV-LDNHLIVTVKRFDANKT--------ADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 397 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.|++|.++.++ +.-|+.+++|++..... .+...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777666655 44578899999865421 123456799999999999 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||++|++|.++|.. ..+++.. +|+.||+.||+|+|+++ ||||||||+|||+++++++||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~G-IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQG-FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTT-CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCC-ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999984 3456654 58899999999999999 999999999999999999999999999766543
Q ss_pred CC---CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 005999 547 SV---EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590 (665)
Q Consensus 547 ~~---~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P 590 (665)
.. ...||+.|||||++. +.+..++|+||+|++++++.++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhC--CCCCCcccccccccchhhhccccch
Confidence 32 224899999999986 3567789999999998877665443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=251.78 Aligned_cols=194 Identities=31% Similarity=0.508 Sum_probs=172.2
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCccccCCCCCCCcc--ccceeecC----CCEEEEEecCCCCcc--cCCccccCCCCCCc
Q 005999 31 SLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQ--WQGVKCAQ----GRVVRFVLQSFGLRG--TFPPNTLTRLDQLR 102 (665)
Q Consensus 31 ~~~~~~~~~Ll~~k~~~~~~~~~~~~~~~~~~~C~--w~gv~C~~----~~v~~l~l~~~~l~g--~l~~~~~~~l~~L~ 102 (665)
.|.++|++||++||+++.++. ...+|+.+.+||. |.||+|+. ++|+.|+|++|++.| .+|+ .|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence 588999999999999996544 3334555579998 99999985 799999999999999 8887 899999999
Q ss_pred EEEccC-CcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccc
Q 005999 103 VLSLHN-NSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180 (665)
Q Consensus 103 ~L~L~~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (665)
+|+|++ |++.+.+| .|+++++|++|+|++|++++.+|..|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 99999888 8999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC--CCC-CcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 181 RFSGTVPPL--NQP-FLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 181 ~l~~~~~~~--~~~-~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
++++.+|.. .++ .|+.|++++|++++.+|......+|..+++++|.
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~ 208 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCc
Confidence 999888865 666 8999999999999988854332348888888874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=265.14 Aligned_cols=195 Identities=29% Similarity=0.328 Sum_probs=144.3
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCccccCCCCCCCccccceeecCCCEEEEEecCCCCccc---CCc---------------
Q 005999 31 SLLPSDAVSLLSFKSKADSENKLLYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGT---FPP--------------- 92 (665)
Q Consensus 31 ~~~~~~~~~Ll~~k~~~~~~~~~~~~~~~~~~~C~w~gv~C~~~~v~~l~l~~~~l~g~---l~~--------------- 92 (665)
...++|++||++||+++.++. ...+|..++|||+|.||+|+.++|+.|+|+++++.|. +|+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~ 86 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSN 86 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTT
T ss_pred cCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcC
Confidence 446789999999999987655 5445656689999999999999999999999999987 654
Q ss_pred -------cccCCCCCCcEEEccCCcCccCCC---CCCCCCCCCEEEccCcccCCcCcccc-cCCCCCCEEEeeccccccc
Q 005999 93 -------NTLTRLDQLRVLSLHNNSLTGPIP---DLSSLINLKSLSLSRNFFSGAFPLSI-LSLHRLTILDLSYNNLTGL 161 (665)
Q Consensus 93 -------~~~~~l~~L~~L~L~~N~l~~~~p---~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~ 161 (665)
..|+++++|++|+|++|.++|.+| .++++++|++|+|++|.+++.+|..+ .++++|++|||++|++++.
T Consensus 87 ~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 166 (768)
T 3rgz_A 87 SHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166 (768)
T ss_dssp SCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEE
T ss_pred CCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCc
Confidence 256666677777777777766444 46666777777777777766666655 5666777777777777666
Q ss_pred CCcc---ccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 162 IPVN---LTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 162 ~p~~---~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
.|.. +.++++|+.|++++|++++.++...+++|++|++++|++++.+|....+.+|..+++++|.
T Consensus 167 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~ 234 (768)
T 3rgz_A 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNK 234 (768)
T ss_dssp THHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSC
T ss_pred CChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCc
Confidence 6655 5667777777777777776666667777888888888888777766667777777777764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-26 Score=251.60 Aligned_cols=182 Identities=15% Similarity=0.157 Sum_probs=143.8
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchh------hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD------TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||.||++.. .+..+++|+........ ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 45677888765432211 124568999999999999999977777777788899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+++++|.++++. +..++.|++.||+|||+++ |+||||||+|||++. ++||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g-IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND-VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT-EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc-CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999863 4579999999999999999 999999999999999 99999999998776532
Q ss_pred ----------CCCCCCCcccCCccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 005999 548 ----------VEDPDTVAYKAPEIRKS-SRRATSKSDVYAFGVLLLELLTGKHPSQ 592 (665)
Q Consensus 548 ----------~~~~gt~~y~aPE~~~~-~~~~~~k~DvwSlGvvl~elltg~~P~~ 592 (665)
....||+.|||||++.. ...|+..+|+|+..+-.++-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 12247999999999862 1457888999999999999988887764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.8e-25 Score=249.57 Aligned_cols=193 Identities=21% Similarity=0.258 Sum_probs=160.4
Q ss_pred CCHHHHHHHHHHHhcCCCCCCc--------cccCCCCCCCccc---cceeecC-CCEEEEEecCCCCcccCCccccCCCC
Q 005999 32 LLPSDAVSLLSFKSKADSENKL--------LYALNERFDYCQW---QGVKCAQ-GRVVRFVLQSFGLRGTFPPNTLTRLD 99 (665)
Q Consensus 32 ~~~~~~~~Ll~~k~~~~~~~~~--------~~~~~~~~~~C~w---~gv~C~~-~~v~~l~l~~~~l~g~l~~~~~~~l~ 99 (665)
....|+.||.+|+.++..+++. ..+|+.+.+||.| .||+|+. ++|+.|+|+++++.|.+|+ .|++|+
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~-~l~~L~ 105 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPD-AIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECG-GGGGCT
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCCh-HHhcCc
Confidence 4457999999999988654322 1246666899999 9999975 7999999999999999997 899999
Q ss_pred CCcEEEccCCc---------------------------------------------------------------------
Q 005999 100 QLRVLSLHNNS--------------------------------------------------------------------- 110 (665)
Q Consensus 100 ~L~~L~L~~N~--------------------------------------------------------------------- 110 (665)
+|+.|+|++|+
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999884
Q ss_pred ---------CccCCCCCCCCCCCCEEEccCcccCCc-----------------Cccccc--CCCCCCEEEeecccccccC
Q 005999 111 ---------LTGPIPDLSSLINLKSLSLSRNFFSGA-----------------FPLSIL--SLHRLTILDLSYNNLTGLI 162 (665)
Q Consensus 111 ---------l~~~~p~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~ 162 (665)
|+|++++|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.+
T Consensus 186 l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 186 TQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 446333799999999999999999986 999999 9999999999999999999
Q ss_pred CccccCCCccCeeeccccc-ccc-cCCCC--CC------CCcceEecccccccccCCC---CCcccCcCcccccCCC
Q 005999 163 PVNLTALDRLYSLKLEWNR-FSG-TVPPL--NQ------PFLVVFNVSGNNLTGQVPE---TPTLLKFDASSFSMNP 226 (665)
Q Consensus 163 p~~~~~l~~L~~L~l~~N~-l~~-~~~~~--~~------~~L~~l~l~~N~l~~~~p~---~~~l~~l~~~~~~~n~ 226 (665)
|..++++++|+.|+|++|+ ++| .+|.. .+ ++|+.|++++|+++ .+|. ...+.+|..+++++|.
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~ 341 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQ 341 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCC
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCc
Confidence 9999999999999999998 988 55542 33 77888888888887 5554 4566677777777764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.2e-25 Score=253.52 Aligned_cols=192 Identities=23% Similarity=0.312 Sum_probs=164.1
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCccccCCC---CCCC--ccc------------cceeecC-CCEEEEEecCCCCcccCCc
Q 005999 31 SLLPSDAVSLLSFKSKADSENKLLYALNE---RFDY--CQW------------QGVKCAQ-GRVVRFVLQSFGLRGTFPP 92 (665)
Q Consensus 31 ~~~~~~~~~Ll~~k~~~~~~~~~~~~~~~---~~~~--C~w------------~gv~C~~-~~v~~l~l~~~~l~g~l~~ 92 (665)
.+..+|+.||++||+++.++ .|+.+. ..+| |.| .||+|+. ++|+.|+|++++|.|.+|+
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred ccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 45567999999999999654 454332 2355 999 9999984 8999999999999999998
Q ss_pred cccCCCCCCcEEEc-cCCcCccC---------------------------------------------------------
Q 005999 93 NTLTRLDQLRVLSL-HNNSLTGP--------------------------------------------------------- 114 (665)
Q Consensus 93 ~~~~~l~~L~~L~L-~~N~l~~~--------------------------------------------------------- 114 (665)
.|++|++|+.|+| ++|.++|.
T Consensus 342 -~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 -AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp -GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred -HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 8999999999999 77765444
Q ss_pred -------------------CC-CCCCCCCCCEEEccCcccCC-----------------cCccccc--CCCCCCEEEeec
Q 005999 115 -------------------IP-DLSSLINLKSLSLSRNFFSG-----------------AFPLSIL--SLHRLTILDLSY 155 (665)
Q Consensus 115 -------------------~p-~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~ 155 (665)
+| .|++|++|+.|+|++|+|+| .+|..++ ++++|+.|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 55 78999999999999999998 4999988 999999999999
Q ss_pred ccccccCCccccCCCccCeeeccccc-ccc-cCCCC---------CCCCcceEecccccccccCCC---CCcccCcCccc
Q 005999 156 NNLTGLIPVNLTALDRLYSLKLEWNR-FSG-TVPPL---------NQPFLVVFNVSGNNLTGQVPE---TPTLLKFDASS 221 (665)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~~~~---------~~~~L~~l~l~~N~l~~~~p~---~~~l~~l~~~~ 221 (665)
|++.+.+|..|+++++|+.|+|++|+ ++| .+|.. .+++|+.|+|++|+|+ .+|. ...+.+|..++
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD 579 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence 99999999999999999999999998 998 55532 3458999999999999 6775 56788888899
Q ss_pred ccCCCC
Q 005999 222 FSMNPN 227 (665)
Q Consensus 222 ~~~n~~ 227 (665)
+++|..
T Consensus 580 Ls~N~l 585 (876)
T 4ecn_A 580 CVHNKV 585 (876)
T ss_dssp CTTSCC
T ss_pred CCCCCc
Confidence 988854
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=225.13 Aligned_cols=199 Identities=22% Similarity=0.268 Sum_probs=168.0
Q ss_pred CCCCCCCHHHHHHHHHHHhcCCCCC-Cc--cccC--CCCCCCccccceeecC----------CCEEEEEecCCCCcccCC
Q 005999 27 PITNSLLPSDAVSLLSFKSKADSEN-KL--LYAL--NERFDYCQWQGVKCAQ----------GRVVRFVLQSFGLRGTFP 91 (665)
Q Consensus 27 ~~~~~~~~~~~~~Ll~~k~~~~~~~-~~--~~~~--~~~~~~C~w~gv~C~~----------~~v~~l~l~~~~l~g~l~ 91 (665)
+....+..+|+.||++||..+..++ .. .|.. ....++|.|.|+.|.. .+|+.|+|++|+++ .+|
T Consensus 19 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp 97 (328)
T 4fcg_A 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP 97 (328)
T ss_dssp CC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCC
T ss_pred eeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcC
Confidence 3345677789999999999874322 22 4420 3357899999999952 79999999999999 898
Q ss_pred ccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccC---
Q 005999 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTA--- 168 (665)
Q Consensus 92 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--- 168 (665)
+ .+.++++|++|+|++|.|+.++..++++++|++|+|++|+|+ .+|..|+++++|++|+|++|++.+.+|..+..
T Consensus 98 ~-~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~ 175 (328)
T 4fcg_A 98 D-QAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175 (328)
T ss_dssp S-CGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred h-hhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccc
Confidence 7 688999999999999999954448999999999999999999 89999999999999999999999999988765
Q ss_pred ------CCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCCCC
Q 005999 169 ------LDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228 (665)
Q Consensus 169 ------l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~l 228 (665)
+++|+.|+|++|+++..+..+ .+++|+.|++++|++++.++....+.+|..+++++|...
T Consensus 176 ~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~ 242 (328)
T 4fcg_A 176 SGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242 (328)
T ss_dssp CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTC
T ss_pred hhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcch
Confidence 999999999999999554444 889999999999999987666677888999999998654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=235.47 Aligned_cols=165 Identities=31% Similarity=0.507 Sum_probs=146.1
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-C-----------------------------------
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-D----------------------------------- 117 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~----------------------------------- 117 (665)
..++.|+|++|.++|.+|. .++++++|+.|+|++|+++|.+| .
T Consensus 514 ~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 592 (768)
T 3rgz_A 514 ENLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592 (768)
T ss_dssp TTCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEE
T ss_pred CCCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccc
Confidence 4677888888888877776 68888888888888888876655 2
Q ss_pred -----------------------------------CCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccC
Q 005999 118 -----------------------------------LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLI 162 (665)
Q Consensus 118 -----------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 162 (665)
++++++|+.|||++|+|+|.+|..|+++++|+.|+|++|+|+|.+
T Consensus 593 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~i 672 (768)
T 3rgz_A 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672 (768)
T ss_dssp EEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred ccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCC
Confidence 334577899999999999999999999999999999999999999
Q ss_pred CccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCCCCCCCCCCCC
Q 005999 163 PVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKACRPR 240 (665)
Q Consensus 163 p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~~~~~~~c~~~ 240 (665)
|..++++++|+.|+|++|+++|.+|.. .++.|++||+++|+|+|.+|....+.++....|.+||++||.++. .|...
T Consensus 673 p~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred ChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 999999999999999999999999976 889999999999999999999888999999999999999999876 78653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.3e-22 Score=198.85 Aligned_cols=155 Identities=24% Similarity=0.207 Sum_probs=139.2
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.++.|+|++|++.+ +++..|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 36 ~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 58899999999995 555589999999999999999999888 6899999999999999999777788899999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCcccccCCCCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPNLCG 230 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~~lc~ 230 (665)
++|+|++..+..|..+++|+.|+|++|+|++.++.. .+++|++|+|++|+|++.++. ...+.+|..+++++|++.|.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999777777899999999999999999988853 789999999999999987763 35678899999999999886
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.2e-21 Score=188.23 Aligned_cols=159 Identities=26% Similarity=0.261 Sum_probs=85.9
Q ss_pred CCCCCccccceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCc
Q 005999 59 ERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGA 137 (665)
Q Consensus 59 ~~~~~C~w~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~ 137 (665)
.+.+.|+|.+|.|.. +++. .+|. .+. ++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++.
T Consensus 14 ~~~~~Cs~~~v~c~~----------~~l~-~ip~-~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i 79 (229)
T 3e6j_A 14 PSQCSCSGTTVDCRS----------KRHA-SVPA-GIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79 (229)
T ss_dssp CTTCEEETTEEECTT----------SCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCCEEeCCEeEccC----------CCcC-ccCC-CCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence 347899999999963 3333 3443 121 455555555555555544 455555555555555555533
Q ss_pred CcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCC-CCccc
Q 005999 138 FPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE-TPTLL 215 (665)
Q Consensus 138 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~-~~~l~ 215 (665)
.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+.++... .+++|++|+|++|+|++..+. ...+.
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 159 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence 3334455555555555555555444444555555555555555555443333 455555555555555544332 23344
Q ss_pred CcCcccccCCCCCCCC
Q 005999 216 KFDASSFSMNPNLCGK 231 (665)
Q Consensus 216 ~l~~~~~~~n~~lc~~ 231 (665)
+|..+++.+||+.|.|
T Consensus 160 ~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 160 SLTHAYLFGNPWDCEC 175 (229)
T ss_dssp TCCEEECTTSCBCTTB
T ss_pred CCCEEEeeCCCccCCc
Confidence 5555555555555544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-21 Score=193.30 Aligned_cols=150 Identities=24% Similarity=0.258 Sum_probs=110.5
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.++.|+|++|+++ .+++..|.++++|++|+|++|+|+.+++ .|.++++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 38 ~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 4778888888888 5666678889999999999999887777 4678888888888888888655566777888888888
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCcccccCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMN 225 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n 225 (665)
++|++++..|..|..+++|+.|+|++|++++.++.. .+++|+.|++++|++++..+. ...+.+|..+++++|
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 888887766666777777777777777777766643 566677777777776655443 234555666666655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-22 Score=202.29 Aligned_cols=141 Identities=16% Similarity=0.203 Sum_probs=114.4
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchh----------------hHHHHHHHHHHHHhCCCCCCeeeeeEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTAD----------------TSAEAFEQHMEAVGGLSHPNLVPIRAYFQA 458 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 458 (665)
+.||+|+||.||+|...+++.||+|.++...... .....+.+|++++++++ | +++.+++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence 6799999999999999889999999996543211 23567899999999998 5 666666544
Q ss_pred CCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecc
Q 005999 459 KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYC 538 (665)
Q Consensus 459 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfg 538 (665)
+..++||||++||+|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g-iiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEE-TTEEEECCCT
T ss_pred -cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC-CEeCCCCHHHEEEE-CCcEEEEECC
Confidence 45699999999999988 431 123469999999999999999 99999999999999 9999999999
Q ss_pred cccccCCCCCCCCCCCcccCCcccc
Q 005999 539 LSVLSDSSSVEDPDTVAYKAPEIRK 563 (665)
Q Consensus 539 l~~~~~~~~~~~~gt~~y~aPE~~~ 563 (665)
++... ..++|||++.
T Consensus 238 ~a~~~----------~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVEV----------GEEGWREILE 252 (282)
T ss_dssp TCEET----------TSTTHHHHHH
T ss_pred CCeEC----------CCCCHHHHHH
Confidence 98643 3468899764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.84 E-value=2.7e-21 Score=200.31 Aligned_cols=161 Identities=32% Similarity=0.497 Sum_probs=114.1
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCC-CCCEEEccCcccCCcCc------------
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLI-NLKSLSLSRNFFSGAFP------------ 139 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~-~L~~L~Ls~N~l~~~~p------------ 139 (665)
..++.|+|++|.+++.+|. .+..+++|++|+|++|+|++.+| .++.++ +|+.|+|++|++++.+|
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEE
T ss_pred CCCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEE
Confidence 4677777777777766665 56667777777777777766555 566665 66666666666555544
Q ss_pred -----------ccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccc
Q 005999 140 -----------LSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 140 -----------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~ 206 (665)
..|.++++|+.|+|++|++++.+|. +..+++|+.|+|++|++++.+|.. .+++|+.|++++|+|+|
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 4455555555566666666544443 566677777777777777766654 67889999999999999
Q ss_pred cCCCCCcccCcCcccccCCCCCCCCCCCCCC
Q 005999 207 QVPETPTLLKFDASSFSMNPNLCGKVINKAC 237 (665)
Q Consensus 207 ~~p~~~~l~~l~~~~~~~n~~lc~~~~~~~c 237 (665)
.+|....+.+|..+++.+|+++||.++. .|
T Consensus 283 ~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 283 EIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 9998888899999999999999997765 45
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.7e-20 Score=182.39 Aligned_cols=152 Identities=22% Similarity=0.239 Sum_probs=124.1
Q ss_pred EEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeeccc
Q 005999 79 FVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157 (665)
Q Consensus 79 l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 157 (665)
+++++++|+ .+|. .+. ++|+.|+|++|+|+++++ .|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 16 v~c~~~~l~-~iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 16 VDCRGKGLT-EIPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EECTTSCCS-SCCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEcCCCCcC-cCCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 445667777 6776 343 688999999999998888 78889999999999999998788889999999999999999
Q ss_pred ccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCcccccCCCCCCCCCCC
Q 005999 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPNLCGKVIN 234 (665)
Q Consensus 158 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~~lc~~~~~ 234 (665)
|+...+..|..+++|+.|+|++|++++.+|.. .+++|+.|+|++|+|++..+. ...+.+|..+++++||+.|+|.+.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l~ 171 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHLK 171 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCccH
Confidence 98655556788899999999999998887764 778899999999999877664 355778888899999998887653
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=184.26 Aligned_cols=152 Identities=18% Similarity=0.185 Sum_probs=98.4
Q ss_pred EEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeec
Q 005999 78 RFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155 (665)
Q Consensus 78 ~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 155 (665)
.+++++|+++ .+|. .+. ..++.|+|++|+|++.++ .|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 15 ~l~~s~n~l~-~iP~-~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPE-HIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCcc-CCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4555666666 4654 232 345677777777776654 366677777777777777755555677777777777777
Q ss_pred ccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCCCCCC
Q 005999 156 NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNLCGKV 232 (665)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~lc~~~ 232 (665)
|+|++..|..|..+++|+.|+|++|+|++.+|.. .+++|+.|+|++|+|++..|.. ..+.+|..+++++|++.|+|.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 7777666666667777777777777777665543 5666777777777777665532 445666667777777777665
Q ss_pred C
Q 005999 233 I 233 (665)
Q Consensus 233 ~ 233 (665)
+
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.8e-20 Score=179.11 Aligned_cols=147 Identities=18% Similarity=0.193 Sum_probs=134.3
Q ss_pred CccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEcc
Q 005999 63 YCQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLS 130 (665)
Q Consensus 63 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls 130 (665)
-|.|..+.|+. ..++.|+|++|+|++..++..|..+++|+.|+|++|+|+++++ .|.++++|++|+|+
T Consensus 10 ~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 10 RCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred EECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 37899999974 2578999999999966566679999999999999999999998 89999999999999
Q ss_pred CcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccC
Q 005999 131 RNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~ 208 (665)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|.. .+++|+.|+|++|+|++..
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999888888999999999999999999998999999999999999999999997765 7899999999999999876
Q ss_pred C
Q 005999 209 P 209 (665)
Q Consensus 209 p 209 (665)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 5
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-20 Score=176.80 Aligned_cols=147 Identities=22% Similarity=0.234 Sum_probs=114.7
Q ss_pred CCccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEc
Q 005999 62 DYCQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSL 129 (665)
Q Consensus 62 ~~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L 129 (665)
..|.|.+|.|+. .+++.|+|++|+++ .+++..|..+++|+.|+|++|+|++.++ .|..+++|++|+|
T Consensus 5 C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 5 CSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83 (208)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence 347899999974 25788888888888 5666567888888888888888887776 4678888888888
Q ss_pred cCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEeccccccccc
Q 005999 130 SRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~ 207 (665)
++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++.++.. .+++|+.|++++|.+.+.
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 888888555556778888888888888888666666788888888888888888777653 677888888888888766
Q ss_pred CC
Q 005999 208 VP 209 (665)
Q Consensus 208 ~p 209 (665)
.|
T Consensus 164 ~~ 165 (208)
T 2o6s_A 164 CP 165 (208)
T ss_dssp TT
T ss_pred CC
Confidence 55
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=183.33 Aligned_cols=157 Identities=24% Similarity=0.126 Sum_probs=120.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|+++ .+++ .+.+++|+.|+|++|+|+.++..+..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 55 ~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 55 TRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccC-cccC--CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 56777777777777 3443 36777777777777777766557778888888888888888666677888888888888
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGK 231 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~~ 231 (665)
++|+|++..+..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|+..++....+.+|..+.+.+||+.|+|
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 888888766666778888888888888888777654 678888888888888855555556667888889999999887
Q ss_pred CC
Q 005999 232 VI 233 (665)
Q Consensus 232 ~~ 233 (665)
.+
T Consensus 212 ~~ 213 (290)
T 1p9a_G 212 EI 213 (290)
T ss_dssp GG
T ss_pred cc
Confidence 54
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=6e-20 Score=194.16 Aligned_cols=169 Identities=22% Similarity=0.229 Sum_probs=145.6
Q ss_pred ccccceeecC-----------CCEEEEEecCCCCcccCCccccC-CCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEcc
Q 005999 64 CQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLT-RLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLS 130 (665)
Q Consensus 64 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~-~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls 130 (665)
|.|..+.|.. ..++.|+|++|+|+ .+++..+. ++++|+.|+|++|+|+++++ .|.++++|++|+|+
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 6788888864 35889999999999 56666787 99999999999999999998 79999999999999
Q ss_pred CcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-----CCCCcceEeccccccc
Q 005999 131 RNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-----NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~L~~l~l~~N~l~ 205 (665)
+|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 99999777778999999999999999999888999999999999999999999877653 4789999999999999
Q ss_pred ccCCCC-CcccC--cCcccccCCCCCCCCCC
Q 005999 206 GQVPET-PTLLK--FDASSFSMNPNLCGKVI 233 (665)
Q Consensus 206 ~~~p~~-~~l~~--l~~~~~~~n~~lc~~~~ 233 (665)
+..+.. ..+.. +..+++.+||+.|+|.+
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 654321 22333 36789999999999864
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.5e-19 Score=179.71 Aligned_cols=157 Identities=24% Similarity=0.197 Sum_probs=142.6
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (665)
...++.|+|++|.+.+ ++ .+..+++|++|+|++|++++.++ .|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 62 l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 138 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138 (272)
T ss_dssp CTTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence 4689999999999995 43 69999999999999999999888 58999999999999999997777789999999999
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNL 228 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~l 228 (665)
+|++|+|++..|..+..+++|+.|++++|++++.++.. .+++|+.|++++|++++.+|.. ..+.+|..+++++|++.
T Consensus 139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (272)
T 3rfs_A 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 218 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence 99999999887777899999999999999999988865 7899999999999999887753 67889999999999999
Q ss_pred CCCC
Q 005999 229 CGKV 232 (665)
Q Consensus 229 c~~~ 232 (665)
|.++
T Consensus 219 ~~~~ 222 (272)
T 3rfs_A 219 CTCP 222 (272)
T ss_dssp CCTT
T ss_pred ccCc
Confidence 8765
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.8e-19 Score=193.16 Aligned_cols=159 Identities=22% Similarity=0.189 Sum_probs=92.3
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.++.|+|++|++++ +++..|.++++|+.|+|++|+|+++++ .|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 76 ~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 76 NTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TCSEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CccEEECcCCcCce-ECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 46666666666663 333355556666666666555555554 4555555555555555555333333444444444444
Q ss_pred eccccc-----------------------------------------------------------------------ccC
Q 005999 154 SYNNLT-----------------------------------------------------------------------GLI 162 (665)
Q Consensus 154 ~~N~l~-----------------------------------------------------------------------~~~ 162 (665)
++|+|+ +..
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~ 234 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIR 234 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEEC
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccC
Confidence 444433 333
Q ss_pred CccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCCCCCCCC
Q 005999 163 PVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNLCGKVIN 234 (665)
Q Consensus 163 p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~lc~~~~~ 234 (665)
|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|++.++.. ..+.+|..+++++||+.|+|.+.
T Consensus 235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~ 309 (452)
T 3zyi_A 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDIL 309 (452)
T ss_dssp GGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTH
T ss_pred cccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCch
Confidence 334444445555555555555544433 5677888888888888655543 45778889999999999998753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.6e-19 Score=179.73 Aligned_cols=159 Identities=24% Similarity=0.238 Sum_probs=103.0
Q ss_pred CCEEEEEecCCC-CcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFG-LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~-l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (665)
.+++.|+|++|. +. .+++..+..+++|++|+|++|++++.+| .|.++++|++|+|++|++++..+..|.++++|+.|
T Consensus 80 ~~L~~L~l~~n~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 158 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (285)
T ss_dssp TTCCEEECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCEEeCCCCCCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence 456666666665 44 4544466666666666666666666655 56666677777777777665444556666677777
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCcccccCCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPNL 228 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~~l 228 (665)
+|++|+|++..+..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|++++.++. ...+.+|..+++++|++.
T Consensus 159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 77777776555555666677777777777776665543 566777777777777754432 244566777777777777
Q ss_pred CCCCC
Q 005999 229 CGKVI 233 (665)
Q Consensus 229 c~~~~ 233 (665)
|+|..
T Consensus 239 c~~~~ 243 (285)
T 1ozn_A 239 CDCRA 243 (285)
T ss_dssp CSGGG
T ss_pred CCCCc
Confidence 77654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=4.6e-19 Score=169.74 Aligned_cols=152 Identities=21% Similarity=0.227 Sum_probs=125.4
Q ss_pred EEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCC--CCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 77 VRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD--LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 77 ~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~--~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
+.|++++|+|+ .+|. .+.. +|+.|+|++|+|++.++. |+.+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~-~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPR-DIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCS-CCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCcc-CCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 35677888887 7887 4443 899999999999999883 8999999999999999999889999999999999999
Q ss_pred cccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCCCC
Q 005999 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKV 232 (665)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~~~ 232 (665)
+|+|++..|..|..+++|+.|+|++|+|++.+|.. .+++|++|+|++|+|++..+...-...+....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 99999988888999999999999999999998865 7899999999999999876632211123333444555556544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=6.1e-19 Score=168.85 Aligned_cols=167 Identities=22% Similarity=0.306 Sum_probs=134.1
Q ss_pred CccccceeecC-----------CCEEEEEecCCCCcccCCc-cccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEc
Q 005999 63 YCQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPP-NTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSL 129 (665)
Q Consensus 63 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~-~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L 129 (665)
-|.|+.+.|+. ..++.|+|++|++++ +++ ..|..+++|+.|+|++|+|++.+| .|.++++|++|+|
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 85 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCS-BCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCc-cCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEEC
Confidence 37899999974 278999999999995 554 359999999999999999999988 8999999999999
Q ss_pred cCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCCC-CCCcceEecccccccccC
Q 005999 130 SRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLN-QPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~L~~l~l~~N~l~~~~ 208 (665)
++|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|.+++..+... ...++...+..+......
T Consensus 86 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCC
Confidence 9999998888889999999999999999999999999999999999999999997655321 112333345555555555
Q ss_pred CCCCcccCcCcccccCCCCCCCCC
Q 005999 209 PETPTLLKFDASSFSMNPNLCGKV 232 (665)
Q Consensus 209 p~~~~l~~l~~~~~~~n~~lc~~~ 232 (665)
| ..+......++..+...|...
T Consensus 166 P--~~l~~~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 166 P--SKVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp S--TTTTTSBGGGSCTTTCCCCCC
T ss_pred C--hHHcCCChhhCcHhhcCcCCC
Confidence 5 344555555666666666544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=175.55 Aligned_cols=158 Identities=20% Similarity=0.259 Sum_probs=98.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCC-cCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSG-AFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 151 (665)
.+++.|+|++|.+++ +++..|.++++|+.|+|++|++++..+ .++++++|++|+|++|++++ .+|..|.++++|+.|
T Consensus 76 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L 154 (276)
T 2z62_A 76 SHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (276)
T ss_dssp TTCCEEECTTCCCCE-ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred cCCCEEECCCCccCc-cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE
Confidence 345555555555553 333355555555555555555555555 45555666666666666554 245556666666666
Q ss_pred EeecccccccCCccccCCCccC----eeecccccccccCCCC-CCCCcceEecccccccccCCCC-CcccCcCcccccCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLY----SLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMN 225 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~----~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n 225 (665)
+|++|++++..+..+..+++|+ .|++++|++++.++.. ...+|+.|++++|+|++.++.. ..+.+|..+++++|
T Consensus 155 ~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N 234 (276)
T 2z62_A 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234 (276)
T ss_dssp ECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSS
T ss_pred ECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCC
Confidence 6666666555555555444444 5566666666555544 4457899999999998766643 56788899999999
Q ss_pred CCCCCCC
Q 005999 226 PNLCGKV 232 (665)
Q Consensus 226 ~~lc~~~ 232 (665)
|+.|+|+
T Consensus 235 ~~~c~c~ 241 (276)
T 2z62_A 235 PWDCSCP 241 (276)
T ss_dssp CBCCCTT
T ss_pred cccccCC
Confidence 9999875
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.3e-18 Score=173.67 Aligned_cols=152 Identities=23% Similarity=0.229 Sum_probs=130.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcc-cCCcCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNF-FSGAFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L 151 (665)
..++.|+|++|+++ .+++..|.++++|++|+|++|.+++..| .|.++++|++|+|++|. ++...|..|.++++|++|
T Consensus 32 ~~l~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCC-ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 47899999999998 4666679999999999999999998877 78899999999999997 776668889999999999
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCcccccCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNP 226 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~ 226 (665)
+|++|++++..|..+..+++|+.|++++|++++.++.. .+++|+.|++++|++++..+. ...+.+|..+++++|.
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 188 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCc
Confidence 99999999888888899999999999999999887763 788999999999999876664 4567788888888875
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=170.54 Aligned_cols=145 Identities=21% Similarity=0.262 Sum_probs=131.3
Q ss_pred CccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEcc
Q 005999 63 YCQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLS 130 (665)
Q Consensus 63 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls 130 (665)
.|.|..|.|.. ..++.|+|++|+++ .+++..|..+++|+.|+|++|+|+++.| .|.++++|++|+|+
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~-~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls 88 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY 88 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECC
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCC-CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECC
Confidence 37899999974 36899999999999 5777789999999999999999999988 89999999999999
Q ss_pred CcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccC
Q 005999 131 RNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~ 208 (665)
+|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|....
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 89 GNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 99999555556789999999999999999998999999999999999999999998864 7899999999999998653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-17 Score=161.65 Aligned_cols=158 Identities=23% Similarity=0.177 Sum_probs=136.2
Q ss_pred ceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCC
Q 005999 68 GVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLH 146 (665)
Q Consensus 68 gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 146 (665)
+..|.. +.++..+++++ .+|. .+ .++|++|+|++|++++.++ .|.++++|++|+|++|+|++..+..|.+++
T Consensus 4 ~C~C~~---~~v~c~~~~l~-~~p~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 76 (208)
T 2o6s_A 4 RCSCSG---TTVECYSQGRT-SVPT-GI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT 76 (208)
T ss_dssp TCEEET---TEEECCSSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred CCEECC---CEEEecCCCcc-CCCC-CC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCC
Confidence 345643 46788999998 6775 33 4689999999999998888 589999999999999999966666789999
Q ss_pred CCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCccccc
Q 005999 147 RLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFS 223 (665)
Q Consensus 147 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~ 223 (665)
+|++|+|++|+|++..+..+..+++|+.|+|++|++++.++.. .+++|+.|++++|+|++.++. ...+.+|..++++
T Consensus 77 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 156 (208)
T 2o6s_A 77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH 156 (208)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEec
Confidence 9999999999999777777899999999999999999988864 789999999999999977665 3668899999999
Q ss_pred CCCCCCCCC
Q 005999 224 MNPNLCGKV 232 (665)
Q Consensus 224 ~n~~lc~~~ 232 (665)
+|++.|.++
T Consensus 157 ~N~~~~~~~ 165 (208)
T 2o6s_A 157 DNPWDCTCP 165 (208)
T ss_dssp SCCBCCCTT
T ss_pred CCCeecCCC
Confidence 999988764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.8e-18 Score=179.76 Aligned_cols=164 Identities=22% Similarity=0.250 Sum_probs=138.7
Q ss_pred CCCccccceeecC-------------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCE
Q 005999 61 FDYCQWQGVKCAQ-------------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKS 126 (665)
Q Consensus 61 ~~~C~w~gv~C~~-------------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~ 126 (665)
..+|.|.|+ |+. .+++.|+|++|+++ .+++..|.++++|+.|+|++|++++.+| .|.++++|++
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 567888887 652 37999999999999 5776689999999999999999999988 6999999999
Q ss_pred EEccCcccCCcCcccccCCCCCCEEEeecccccccCC-ccccCCCccCeeecccc-cccccCCCC--CCCCcceEecccc
Q 005999 127 LSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIP-VNLTALDRLYSLKLEWN-RFSGTVPPL--NQPFLVVFNVSGN 202 (665)
Q Consensus 127 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N-~l~~~~~~~--~~~~L~~l~l~~N 202 (665)
|+|++|++++..+..|.++++|++|+|++|++++..+ ..+..+++|+.|++++| .+++.++.. .+++|+.|++++|
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 9999999996555559999999999999999994433 37899999999999999 577776654 7899999999999
Q ss_pred cccccCCC-CCcccCcCcccccCCC
Q 005999 203 NLTGQVPE-TPTLLKFDASSFSMNP 226 (665)
Q Consensus 203 ~l~~~~p~-~~~l~~l~~~~~~~n~ 226 (665)
++++..|. ...+.+|..+++++|.
T Consensus 185 ~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 185 DLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSC
T ss_pred CcCccCHHHHhccccCCeecCCCCc
Confidence 99988664 3566777888888775
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.74 E-value=8e-18 Score=172.05 Aligned_cols=151 Identities=30% Similarity=0.299 Sum_probs=134.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|+|++|.+++ +++..|.++++|+.|+|++|.|++..+. +.+++|+.|+|++|+|+ .+|..+.++++|+.|+|
T Consensus 31 ~~l~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCc-cCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 478999999999995 5555899999999999999999987664 88999999999999999 89999999999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPN 227 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~ 227 (665)
++|+|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++.++.. ..+.+|..+++++|..
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcC
Confidence 999999887788999999999999999999988865 7899999999999999766544 5688899999998854
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.8e-18 Score=178.75 Aligned_cols=152 Identities=22% Similarity=0.317 Sum_probs=129.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccC---------
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS--------- 144 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------- 144 (665)
.+++.|+|++|+++ .+|. .++++++|++|+|++|+|+.+++.|+++++|++|+|++|++.+.+|..+..
T Consensus 104 ~~L~~L~L~~n~l~-~lp~-~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPD-TMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCS-CGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhH-HHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 57899999999999 8886 789999999999999999955448889999999999998888889887765
Q ss_pred CCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCC-CcccCcCcccc
Q 005999 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSF 222 (665)
Q Consensus 145 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~ 222 (665)
+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.++.+ .+++|+.|++++|++.+.+|.. ..+.+|..+++
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 899999999999998 88888999999999999999999877766 7888999999999988888753 56778888888
Q ss_pred cCCCCC
Q 005999 223 SMNPNL 228 (665)
Q Consensus 223 ~~n~~l 228 (665)
++|+..
T Consensus 261 ~~n~~~ 266 (328)
T 4fcg_A 261 KDCSNL 266 (328)
T ss_dssp TTCTTC
T ss_pred CCCCch
Confidence 887653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-18 Score=176.13 Aligned_cols=159 Identities=20% Similarity=0.201 Sum_probs=99.1
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCC-cCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSG-AFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 151 (665)
..++.|+|++|++++..+...+..+++|++|+|++|.+++.++ .|.++++|+.|+|++|.+++ .+|..|..+++|+.|
T Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 4555566666655532221356666666666666666666555 46666666666666666664 456666666667777
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-Ccc-cCcCcccccCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTL-LKFDASSFSMNPN 227 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l-~~l~~~~~~~n~~ 227 (665)
+|++|+|++..|..+..+++|+.|+|++|++++.++.. .+++|+.|++++|++++..|.. ..+ .+|..+++++|+.
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~ 260 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCE
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCe
Confidence 77777666666666666667777777777766655532 5566777777777777665532 333 3566677777777
Q ss_pred CCCCC
Q 005999 228 LCGKV 232 (665)
Q Consensus 228 lc~~~ 232 (665)
.|+|.
T Consensus 261 ~~~c~ 265 (306)
T 2z66_A 261 ACTCE 265 (306)
T ss_dssp ECSGG
T ss_pred ecccC
Confidence 66654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.5e-18 Score=183.51 Aligned_cols=158 Identities=26% Similarity=0.282 Sum_probs=123.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-C-------------------------CCCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-D-------------------------LSSLINLKSL 127 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~-------------------------~~~l~~L~~L 127 (665)
.+++.|+|++|+|+ .+++..|..+++|+.|+|++|+|+.+++ . |.++++|++|
T Consensus 112 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 190 (440)
T 3zyj_A 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190 (440)
T ss_dssp SSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred ccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence 57888888888888 5666678888888888888888776655 3 4455566666
Q ss_pred EccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEeccccccc
Q 005999 128 SLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 128 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~ 205 (665)
+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|+
T Consensus 191 ~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 191 NLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268 (440)
T ss_dssp ECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred cCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence 66666666 455 4667777888888888888777888888888888888888888887764 7889999999999999
Q ss_pred ccCCCC-CcccCcCcccccCCCCCCCCCCC
Q 005999 206 GQVPET-PTLLKFDASSFSMNPNLCGKVIN 234 (665)
Q Consensus 206 ~~~p~~-~~l~~l~~~~~~~n~~lc~~~~~ 234 (665)
+.++.. ..+.+|..+++++||+.|+|.+.
T Consensus 269 ~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~ 298 (440)
T 3zyj_A 269 LLPHDLFTPLHHLERIHLHHNPWNCNCDIL 298 (440)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCEECSSTTH
T ss_pred ccChhHhccccCCCEEEcCCCCccCCCCch
Confidence 766644 56788999999999999999753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=164.30 Aligned_cols=135 Identities=21% Similarity=0.191 Sum_probs=123.1
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|+|++|++++ +++..|.++++|+.|+|++|+|+.+++ .|..+++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 40 ~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 118 (229)
T 3e6j_A 40 TNAQILYLHDNQITK-LEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118 (229)
T ss_dssp TTCSEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEcCCCccCc-cCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence 689999999999996 544589999999999999999998887 589999999999999999976677789999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~ 210 (665)
|++|+|+ .+|..+..+++|+.|+|++|+|++.++.. .+++|+.|++++|++++..+.
T Consensus 119 Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 177 (229)
T 3e6j_A 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD 177 (229)
T ss_dssp CCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred ccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence 9999999 88999999999999999999999988764 789999999999999987653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.9e-18 Score=171.27 Aligned_cols=135 Identities=14% Similarity=0.163 Sum_probs=103.8
Q ss_pred hHhCcccceEEEEEEE-CCeEE--EEEEEecCCCch----------------------hhHHHHHHHHHHHHhCCCCCCe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLI--VTVKRFDANKTA----------------------DTSAEAFEQHMEAVGGLSHPNL 449 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~ni 449 (665)
+.||+|+||.||+|.. .+|+. ||||+++..... ......+.+|++.+.+++|+++
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5799999999999997 67888 999987543211 1122468899999999988864
Q ss_pred --eeeeEEEEeCCeEEEEEEecCC-C----CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCC
Q 005999 450 --VPIRAYFQAKGERLVIYDYQPN-G----SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-RASWLIHGNLKS 521 (665)
Q Consensus 450 --v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~iiH~Dlk~ 521 (665)
..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||||||
T Consensus 133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g-ivHrDlkp 199 (258)
T 1zth_A 133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE-LVHADLSE 199 (258)
T ss_dssp CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC-EECSSCST
T ss_pred CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCH
Confidence 333332 356899999942 4 77776532 223456789999999999999 888 99999999
Q ss_pred CceEeCCCCceEEeecccccccC
Q 005999 522 SNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 522 ~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
+|||+++ .++|+|||++....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999998 99999999996653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-17 Score=166.74 Aligned_cols=162 Identities=20% Similarity=0.196 Sum_probs=138.0
Q ss_pred CCCccccceeecC-CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcC
Q 005999 61 FDYCQWQGVKCAQ-GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAF 138 (665)
Q Consensus 61 ~~~C~w~gv~C~~-~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~ 138 (665)
.++|.|.|+.|.- ..++.+++++++|+ .+|. .+. ++|+.|+|++|++++.++ .|.++++|++|+|++|+++...
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~-~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPS-NIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCS-CCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCC-CCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 5789999999974 56788999999999 6876 343 689999999999998888 7999999999999999999555
Q ss_pred cccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCccc
Q 005999 139 PLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLL 215 (665)
Q Consensus 139 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~ 215 (665)
+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|++++.++.. .+++|++|++++|+|++..+. ...+.
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 556688999999999999999777777889999999999999999988864 789999999999999976654 35678
Q ss_pred CcCcccccCCC
Q 005999 216 KFDASSFSMNP 226 (665)
Q Consensus 216 ~l~~~~~~~n~ 226 (665)
+|..+++++|.
T Consensus 158 ~L~~L~L~~n~ 168 (270)
T 2o6q_A 158 SLKELRLYNNQ 168 (270)
T ss_dssp TCCEEECCSSC
T ss_pred ccceeEecCCc
Confidence 88889988884
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.8e-18 Score=192.28 Aligned_cols=161 Identities=17% Similarity=0.111 Sum_probs=124.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCC-cCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSG-AFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 151 (665)
..++.|+|++|.+.+..+...+.++++|+.|+|++|++++.+| .+.++++|+.|+|++|++++ .+|..|..+++|+.|
T Consensus 399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 478 (606)
T 3vq2_A 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478 (606)
T ss_dssp TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEE
Confidence 4566677777777755553467777788888888888877776 67788888888888888886 367778888888888
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCccc-CcCcccccCCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLL-KFDASSFSMNPNL 228 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~-~l~~~~~~~n~~l 228 (665)
+|++|++++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|+|+..++....+. +|..+++++||+.
T Consensus 479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~ 558 (606)
T 3vq2_A 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558 (606)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCC
T ss_pred ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcc
Confidence 88888888888888888888888888888888876654 67888899999998885444444554 4888999999999
Q ss_pred CCCCCC
Q 005999 229 CGKVIN 234 (665)
Q Consensus 229 c~~~~~ 234 (665)
|+|+..
T Consensus 559 c~c~~~ 564 (606)
T 3vq2_A 559 CICEHQ 564 (606)
T ss_dssp CSSTTH
T ss_pred cCCccH
Confidence 998764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7.3e-18 Score=188.43 Aligned_cols=162 Identities=17% Similarity=0.166 Sum_probs=138.4
Q ss_pred CccccceeecC-------------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEE
Q 005999 63 YCQWQGVKCAQ-------------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLS 128 (665)
Q Consensus 63 ~C~w~gv~C~~-------------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~ 128 (665)
.|.|.|+ |+. ..++.|+|++|++++ +++..|.++++|++|+|++|++++.+| .|+++++|++|+
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCE-ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCc-cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 4899998 863 379999999999995 544589999999999999999999998 799999999999
Q ss_pred ccCcccCCcCcccccCCCCCCEEEeecccccc-cCCccccCCCccCeeecccccccccCC-C-C-CCCCcceEecccccc
Q 005999 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTG-LIPVNLTALDRLYSLKLEWNRFSGTVP-P-L-NQPFLVVFNVSGNNL 204 (665)
Q Consensus 129 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~-~~~~L~~l~l~~N~l 204 (665)
|++|++++..|..|+++++|++|+|++|++++ .+|..+.++++|+.|++++|++.+.+| . + .+++|+.|++++|++
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999998888889999999999999999997 467789999999999999999544444 3 3 789999999999999
Q ss_pred cccCCCC-CcccCcCcccccCCC
Q 005999 205 TGQVPET-PTLLKFDASSFSMNP 226 (665)
Q Consensus 205 ~~~~p~~-~~l~~l~~~~~~~n~ 226 (665)
++.+|.. ..+.+|..+++++|.
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSB
T ss_pred cccChhhhhccccCceEecccCc
Confidence 9977743 445566666666654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-17 Score=164.54 Aligned_cols=152 Identities=16% Similarity=0.120 Sum_probs=132.4
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCc-CccCCC-CCCCCCCCCEEEccC-cccCCcCcccccCCCCCCE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNS-LTGPIP-DLSSLINLKSLSLSR-NFFSGAFPLSILSLHRLTI 150 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~-l~~~~p-~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~ 150 (665)
..++.|+|++|+++ .+++..|.++++|+.|+|++|+ ++++++ .|.++++|++|+|++ |+|++..+..|.++++|+.
T Consensus 31 ~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp TTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 57999999999999 5777789999999999999997 998888 799999999999998 9999766788999999999
Q ss_pred EEeecccccccCCccccCCCccC---eeecccc-cccccCCCC--CCCCcc-eEecccccccccCCCCCcccCcCccccc
Q 005999 151 LDLSYNNLTGLIPVNLTALDRLY---SLKLEWN-RFSGTVPPL--NQPFLV-VFNVSGNNLTGQVPETPTLLKFDASSFS 223 (665)
Q Consensus 151 L~L~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~~~~--~~~~L~-~l~l~~N~l~~~~p~~~~l~~l~~~~~~ 223 (665)
|+|++|++++ +|. +..+++|+ .|++++| ++++.++.. .+++|+ .|++++|+++...+......+|..++++
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECT
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcC
Confidence 9999999996 776 88899998 9999999 999988864 789999 9999999999544433334678888999
Q ss_pred CCCCC
Q 005999 224 MNPNL 228 (665)
Q Consensus 224 ~n~~l 228 (665)
+|+.+
T Consensus 188 ~n~~l 192 (239)
T 2xwt_C 188 KNKYL 192 (239)
T ss_dssp TCTTC
T ss_pred CCCCc
Confidence 88644
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.2e-18 Score=183.88 Aligned_cols=134 Identities=20% Similarity=0.216 Sum_probs=124.0
Q ss_pred CCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeec
Q 005999 99 DQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKL 177 (665)
Q Consensus 99 ~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 177 (665)
++|+.|+|++|++++.+| .|+.+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..+..+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 689999999999999988 7999999999999999999888999999999999999999999888999999999999999
Q ss_pred ccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCCCCCC
Q 005999 178 EWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNLCGKV 232 (665)
Q Consensus 178 ~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~lc~~~ 232 (665)
++|++++.+|.. .+++|++|++++|+|++.++.. ..+.+|..+++++|+..|+|+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999998764 8899999999999999866644 578899999999999999886
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.9e-17 Score=162.58 Aligned_cols=161 Identities=20% Similarity=0.165 Sum_probs=142.7
Q ss_pred CCccccceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcc
Q 005999 62 DYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPL 140 (665)
Q Consensus 62 ~~C~w~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~ 140 (665)
+||.|.|++|.. ..+.+++++++++ .+|. .+. ++|+.|+|++|++++..+ .|.++++|++|+|++|+|++..|.
T Consensus 3 ~Cp~~~gC~C~~-~~~~l~~~~~~l~-~~p~-~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 3 TCETVTGCTCNE-GKKEVDCQGKSLD-SVPS-GIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp -CHHHHSSEEEG-GGTEEECTTCCCS-SCCS-CCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC-CCeEEecCCCCcc-ccCC-CCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 688999999963 3346899999999 7887 444 689999999999999998 799999999999999999988888
Q ss_pred cccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCc
Q 005999 141 SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKF 217 (665)
Q Consensus 141 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l 217 (665)
.|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++.++. ...+.+|
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 157 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL 157 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCC
Confidence 8999999999999999999888888899999999999999999988864 789999999999999987773 4678889
Q ss_pred CcccccCCCC
Q 005999 218 DASSFSMNPN 227 (665)
Q Consensus 218 ~~~~~~~n~~ 227 (665)
..+++++|..
T Consensus 158 ~~L~L~~N~l 167 (251)
T 3m19_A 158 QTLSLSTNQL 167 (251)
T ss_dssp CEEECCSSCC
T ss_pred CEEECCCCcC
Confidence 9999999853
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-18 Score=198.32 Aligned_cols=138 Identities=23% Similarity=0.261 Sum_probs=123.1
Q ss_pred cCCCCCCcEEEccCCcCccCCC--CCCCCCCCCEEEccCcccC-----CcCcccccCCCCCCEEEeecccccccCCcccc
Q 005999 95 LTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFS-----GAFPLSILSLHRLTILDLSYNNLTGLIPVNLT 167 (665)
Q Consensus 95 ~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 167 (665)
+.++++|+.|+|++|++++..+ .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|.
T Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 501 (844)
T 3j0a_A 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501 (844)
T ss_dssp HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence 4578999999999999998766 4677899999999999997 45567789999999999999999999999999
Q ss_pred CCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCCCCCC
Q 005999 168 ALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVIN 234 (665)
Q Consensus 168 ~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~~~~~ 234 (665)
.+++|+.|+|++|+|++.++....++|+.|+|++|+|++.+| ..+.++..+++++||+.|+|.+.
T Consensus 502 ~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~--~~~~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNP--DVFVSLSVLDITHNKFICECELS 566 (844)
T ss_dssp SCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCS--CCCSSCCEEEEEEECCCCSSSCC
T ss_pred chhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCCh--hHhCCcCEEEecCCCcccccccH
Confidence 999999999999999998887755899999999999999988 45678999999999999999764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=7.7e-18 Score=173.60 Aligned_cols=162 Identities=23% Similarity=0.282 Sum_probs=127.9
Q ss_pred CccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCC--C-CCCCCCCCCEEE
Q 005999 63 YCQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPI--P-DLSSLINLKSLS 128 (665)
Q Consensus 63 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~l~~L~~L~ 128 (665)
.|.|.+|.|+. ..++.|+|++|+++ .+|+..|.++++|+.|+|++|+++... + .+..+++|++|+
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~ 84 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence 48899999974 37999999999999 788877899999999999999998542 3 566788888888
Q ss_pred ccCcccCCcCcccccCCCCCCEEEeecccccccCC-ccccCCCccCeeecccccccccCCCC--CCCCcceEeccccccc
Q 005999 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIP-VNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 129 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~ 205 (665)
|++|.++ .+|..+.++++|++|+|++|++++..+ ..+..+++|+.|++++|++++.++.. .+++|+.|++++|.++
T Consensus 85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 8888888 677778888888888888888885544 46778888888888888888777664 6778888888888887
Q ss_pred c-cCC-CCCcccCcCcccccCCC
Q 005999 206 G-QVP-ETPTLLKFDASSFSMNP 226 (665)
Q Consensus 206 ~-~~p-~~~~l~~l~~~~~~~n~ 226 (665)
+ .+| ....+.+|..+++++|.
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSC
T ss_pred cccchhHHhhCcCCCEEECCCCC
Confidence 6 334 33556677777777764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=168.26 Aligned_cols=151 Identities=21% Similarity=0.205 Sum_probs=126.3
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.++.|+|++|+++ .+++..|.++++|++|+|++|++++.++ .|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 29 ~l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 6899999999999 4665589999999999999999998888 7899999999999999999888888999999999999
Q ss_pred ecccccccCCccccCCCccCeeeccccccccc-CCCC--CCCCcceEecccccccccCCCC-CcccCcC----cccccCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT-VPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFD----ASSFSMN 225 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~----~~~~~~n 225 (665)
++|++++..+..+..+++|+.|++++|++++. +|.. .+++|+.|++++|++++..+.. ..+.++. .+++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999977777899999999999999999874 3543 7889999999999998765522 3344444 5666666
Q ss_pred C
Q 005999 226 P 226 (665)
Q Consensus 226 ~ 226 (665)
.
T Consensus 188 ~ 188 (276)
T 2z62_A 188 P 188 (276)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.6e-17 Score=165.66 Aligned_cols=136 Identities=25% Similarity=0.276 Sum_probs=125.2
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|+|++|+++ .+++..+.++++|++|+|++|++++.++ .|+++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 85 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 68999999999999 5666679999999999999999999988 589999999999999999977777789999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~ 210 (665)
|++|+|++..|..+..+++|+.|+|++|++++.++.. .+++|+.|++++|++.+.+|.
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 9999999888878899999999999999999998864 789999999999999988774
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=178.32 Aligned_cols=151 Identities=21% Similarity=0.218 Sum_probs=106.6
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|+|++|++. .+++..|.++++|+.|+|++|+|+++.+ .|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 64 ~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (440)
T 3zyj_A 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142 (440)
T ss_dssp TTCSEEECCSCCCC-EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred CCCcEEEccCCcCC-eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence 35777888888888 4555578888888888888888887776 677888888888888888855555677888888888
Q ss_pred eecccccccCCccccCCCccCeeeccccc-ccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNR-FSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
|++|+|+...+..|..+++|+.|+|++|+ +...++.. .+++|+.|++++|+|+ .+|....+.+|..+++++|.
T Consensus 143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~ 218 (440)
T 3zyj_A 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNH 218 (440)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSC
T ss_pred CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCc
Confidence 88888876666667777777777777743 43333322 5666777777777766 34555556666666666663
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-17 Score=153.98 Aligned_cols=134 Identities=25% Similarity=0.274 Sum_probs=114.3
Q ss_pred CccccceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCccc
Q 005999 63 YCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLS 141 (665)
Q Consensus 63 ~C~w~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~ 141 (665)
.|+|.++.| ++++++ .+|. .+ .++|+.|+|++|++++.++ .|.++++|++|+|++|+|++..+..
T Consensus 6 ~C~~~~l~~----------~~~~l~-~~p~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 6 SCSGTEIRC----------NSKGLT-SVPT-GI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp EEETTEEEC----------CSSCCS-SCCT-TC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred EeCCCEEEe----------cCCCCc-cCCC-CC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 367877766 456666 5664 23 3689999999999998888 6799999999999999999666667
Q ss_pred ccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC
Q 005999 142 ILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 142 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~ 210 (665)
|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++.++.. .+++|+.|++++|++++.+|.
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 899999999999999999777777899999999999999999888764 689999999999999987663
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=180.10 Aligned_cols=165 Identities=21% Similarity=0.232 Sum_probs=137.3
Q ss_pred CCCccccc--eeecC----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCE
Q 005999 61 FDYCQWQG--VKCAQ----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKS 126 (665)
Q Consensus 61 ~~~C~w~g--v~C~~----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~ 126 (665)
...|.|.+ |.|+. .+++.|+|++|.+++ +++..|.++++|++|+|++|.+.+.++ .|.++++|++
T Consensus 5 ~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~ 83 (455)
T 3v47_A 5 TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83 (455)
T ss_dssp --CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCE-ECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCE
T ss_pred cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCc-CChhHhccCccccEEECcCCcccceECcccccccccCCE
Confidence 34566666 77764 369999999999995 544589999999999999999986554 6999999999
Q ss_pred EEccCcccCCcCcccccCCCCCCEEEeecccccccCCcc--ccCCCccCeeecccccccccCCC--C-CCCCcceEeccc
Q 005999 127 LSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVN--LTALDRLYSLKLEWNRFSGTVPP--L-NQPFLVVFNVSG 201 (665)
Q Consensus 127 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~--~-~~~~L~~l~l~~ 201 (665)
|+|++|++++..|..|.++++|++|+|++|++++.+|.. +..+++|+.|+|++|++++..|. + .+++|++|++++
T Consensus 84 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~ 163 (455)
T 3v47_A 84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF 163 (455)
T ss_dssp EECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTT
T ss_pred EeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCC
Confidence 999999999888999999999999999999999866665 89999999999999999999776 3 789999999999
Q ss_pred ccccccCCCC-Ccc--cCcCcccccCCC
Q 005999 202 NNLTGQVPET-PTL--LKFDASSFSMNP 226 (665)
Q Consensus 202 N~l~~~~p~~-~~l--~~l~~~~~~~n~ 226 (665)
|++++..|.. ..+ .++..+++++|.
T Consensus 164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~ 191 (455)
T 3v47_A 164 NKVKSICEEDLLNFQGKHFTLLRLSSIT 191 (455)
T ss_dssp CCBSCCCTTTSGGGTTCEEEEEECTTCB
T ss_pred CcccccChhhhhccccccccccccccCc
Confidence 9999887743 222 345555565553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.7e-17 Score=182.46 Aligned_cols=158 Identities=20% Similarity=0.143 Sum_probs=139.2
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCC--C-CCCCCCCCCEEEccCcccCCcCccc-ccCCCCC
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPI--P-DLSSLINLKSLSLSRNFFSGAFPLS-ILSLHRL 148 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L 148 (665)
...++.|+|++|.+++.+|. .+.++++|+.|+|++|++++.. | .|.++++|+.|+|++|++++.+|.. +..+++|
T Consensus 352 l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 36899999999999987776 8999999999999999999865 3 6899999999999999999867764 8889999
Q ss_pred CEEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCC-CCcccCcCcccccCCC
Q 005999 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNP 226 (665)
Q Consensus 149 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~ 226 (665)
+.|+|++|+|++.+|..+. ++|+.|+|++|+++.+++.. .+++|+.|++++|+|++.++. ...+.+|..+++++||
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~ 508 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCC
Confidence 9999999999988887665 79999999999999776665 889999999999999965544 4678889999999999
Q ss_pred CCCCCCC
Q 005999 227 NLCGKVI 233 (665)
Q Consensus 227 ~lc~~~~ 233 (665)
+.|+|+.
T Consensus 509 ~~c~c~~ 515 (562)
T 3a79_B 509 WDCTCPG 515 (562)
T ss_dssp BCCCHHH
T ss_pred cCCCcch
Confidence 9998864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.2e-17 Score=185.14 Aligned_cols=149 Identities=17% Similarity=0.153 Sum_probs=131.9
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.++.|++++|.+. .+|+..+.++++|+.|+|++|.|++.+| .|+.+++|++|+|++|.|++..|..|+++++|++|+|
T Consensus 52 ~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 5788999999988 6888788999999999999999999998 8999999999999999999888888999999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
++|.|++..+..|.++++|+.|+|++|.+++.+|.. .+++|++|++++|+|++..+ ..+.+|..+++++|.
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNL 203 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSSC
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccCc
Confidence 999999666666799999999999999999998864 88999999999999997533 566777777777763
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-17 Score=158.30 Aligned_cols=147 Identities=18% Similarity=0.237 Sum_probs=129.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|+++ .+| .+..+++|+.|+|++|.++.. +.+..+++|++|+|++|++++..|..|..+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 57899999999999 777 489999999999999977644 47889999999999999999888999999999999999
Q ss_pred ecccccccCCccccCCCccCeeeccccc-ccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNR-FSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
++|++++..|..+..+++|+.|++++|+ ++..+ .. .+++|+.|++++|++++ ++....+.+|..+++++|+
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC-
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCcc
Confidence 9999998888999999999999999998 66554 44 88999999999999996 4456778889999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.1e-17 Score=185.27 Aligned_cols=136 Identities=21% Similarity=0.162 Sum_probs=123.4
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|||++|+|+ .|++..|.++++|++|+|++|+|++++| .|.+|++|++|+|++|+|++..|..|.+|++|++|+
T Consensus 52 ~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 36899999999999 6887799999999999999999999988 799999999999999999977777899999999999
Q ss_pred eecccccccCCccccCCCccCeeeccccccccc-CCCC--CCCCcceEecccccccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT-VPPL--NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~--~~~~L~~l~l~~N~l~~~~p~ 210 (665)
|++|+|++..+..|+++++|+.|+|++|++++. +|.. .+++|++|++++|+|++..|.
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 999999987777899999999999999999875 3443 789999999999999987763
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.9e-17 Score=185.83 Aligned_cols=157 Identities=23% Similarity=0.267 Sum_probs=86.4
Q ss_pred EEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCc---CcccccCCCCCCEE
Q 005999 76 VVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGA---FPLSILSLHRLTIL 151 (665)
Q Consensus 76 v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L 151 (665)
++.|+|++|.+.+..++..+..+++|+.|+|++|.+++.+| .+..+++|++|+|++|++++. .+..+..+++|+.|
T Consensus 402 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L 481 (606)
T 3t6q_A 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481 (606)
T ss_dssp CSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEE
T ss_pred CCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEE
Confidence 44444444444433333234444555555555555544444 344555555555555555431 12345555555555
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNL 228 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~l 228 (665)
+|++|++++..|..|..+++|+.|+|++|++++.+|.. .++.| .|++++|++++.+|.. ..+.+|..+++++||+.
T Consensus 482 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 560 (606)
T 3t6q_A 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560 (606)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred ECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence 55555555555555566666666666666666555543 55556 6666666666555532 44567788888888888
Q ss_pred CCCCC
Q 005999 229 CGKVI 233 (665)
Q Consensus 229 c~~~~ 233 (665)
|+|..
T Consensus 561 c~c~~ 565 (606)
T 3t6q_A 561 CTCSN 565 (606)
T ss_dssp CSGGG
T ss_pred ccCCc
Confidence 87753
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.4e-17 Score=178.13 Aligned_cols=160 Identities=21% Similarity=0.172 Sum_probs=134.1
Q ss_pred ccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcc
Q 005999 66 WQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNF 133 (665)
Q Consensus 66 w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~ 133 (665)
|..|.|.. ..++.|+|++|++++ +++..|.++++|++|+|++|.+++..| .|.++++|++|+|++|+
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccce-ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 66788863 368899999999995 555589999999999999999999887 79999999999999999
Q ss_pred cCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-
Q 005999 134 FSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE- 210 (665)
Q Consensus 134 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~- 210 (665)
+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.. .+++|+.|++++|++++..+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 99555566889999999999999999888889999999999999999999887754 788899999999998865442
Q ss_pred CCcccCcCcccccCCC
Q 005999 211 TPTLLKFDASSFSMNP 226 (665)
Q Consensus 211 ~~~l~~l~~~~~~~n~ 226 (665)
...+.+|..+++++|.
T Consensus 172 l~~l~~L~~L~l~~n~ 187 (477)
T 2id5_A 172 LSHLHGLIVLRLRHLN 187 (477)
T ss_dssp HTTCTTCCEEEEESCC
T ss_pred hcccCCCcEEeCCCCc
Confidence 2456677777777764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.6e-17 Score=172.66 Aligned_cols=150 Identities=17% Similarity=0.155 Sum_probs=132.4
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|+++++.+. .+|+..+..+++|++|+|++|.+++.++ .|..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 36888999999998 7888778999999999999999999988 899999999999999999988888899999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
|++|+|+...+..|.++++|+.|++++|++++.++.. .+++|+.|++++|++++.. ...+.+|..+++++|.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNL 197 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSC
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeeccccc
Confidence 9999999544445689999999999999999988864 7899999999999999753 2567778888887774
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.6e-17 Score=180.68 Aligned_cols=157 Identities=22% Similarity=0.161 Sum_probs=133.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccC--CC-CCCCCCCCCEEEccCcccCCcCccc-ccCCCCCC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGP--IP-DLSSLINLKSLSLSRNFFSGAFPLS-ILSLHRLT 149 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~--~p-~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~ 149 (665)
..++.|+|++|.+++.+|. .+..+++|+.|+|++|++++. +| .++.+++|++|+|++|++++.+|.. +..+++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 6789999999999977776 789999999999999999873 34 5889999999999999999767765 78889999
Q ss_pred EEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCC-CCcccCcCcccccCCCC
Q 005999 150 ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPN 227 (665)
Q Consensus 150 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~~ 227 (665)
.|+|++|++++.+|..+. ++|+.|+|++|+++.+++.. .+++|+.|++++|+|++.++. ...+.+|..+++++|++
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCC
Confidence 999999999888887665 78999999999999655544 889999999999999954443 45678899999999999
Q ss_pred CCCCCC
Q 005999 228 LCGKVI 233 (665)
Q Consensus 228 lc~~~~ 233 (665)
.|+|++
T Consensus 481 ~c~c~~ 486 (520)
T 2z7x_B 481 DCSCPR 486 (520)
T ss_dssp CCCHHH
T ss_pred cccCCc
Confidence 998864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=7e-17 Score=183.37 Aligned_cols=161 Identities=20% Similarity=0.198 Sum_probs=143.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccC-CcCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFS-GAFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L 151 (665)
..++.+++..+++....+...+..+++|+.+++++|.+.+..+ .+..+++|+.|+|++|++. +.+|..|..+++|+.|
T Consensus 420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L 499 (635)
T 4g8a_A 420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 499 (635)
T ss_dssp TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence 4677888888888777776688999999999999999999988 7889999999999999854 4678899999999999
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-Ccc-cCcCcccccCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTL-LKFDASSFSMNPN 227 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l-~~l~~~~~~~n~~ 227 (665)
||++|+|++..|..|.++++|+.|+|++|+|++.+|.. .+++|++|+|++|+|++.+|.. ..+ .+|..+++++||+
T Consensus 500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 99999999999999999999999999999999998864 7899999999999999988854 344 5789999999999
Q ss_pred CCCCCCC
Q 005999 228 LCGKVIN 234 (665)
Q Consensus 228 lc~~~~~ 234 (665)
.|+|.+.
T Consensus 580 ~C~C~~~ 586 (635)
T 4g8a_A 580 ACTCEHQ 586 (635)
T ss_dssp CCSGGGH
T ss_pred cccCCcH
Confidence 9999753
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.5e-18 Score=193.26 Aligned_cols=180 Identities=19% Similarity=0.157 Sum_probs=110.9
Q ss_pred CCCCCHHHHHHHHHHHhcCCCCCCc-cccCC-CCCCCccccceeecCCCEEEEEecCCCCcc------------------
Q 005999 29 TNSLLPSDAVSLLSFKSKADSENKL-LYALN-ERFDYCQWQGVKCAQGRVVRFVLQSFGLRG------------------ 88 (665)
Q Consensus 29 ~~~~~~~~~~~Ll~~k~~~~~~~~~-~~~~~-~~~~~C~w~gv~C~~~~v~~l~l~~~~l~g------------------ 88 (665)
+.+....++.+|+++.......... ...|. ..+..+.|.++.++..+++.|+|.+|++..
T Consensus 126 s~s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~ 205 (727)
T 4b8c_D 126 SKSLVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDE 205 (727)
T ss_dssp ------CCCHHHHHHHHHHHHHHTTC------------------------------------------------------
T ss_pred hhhccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccC
Confidence 4456667899999998665322111 22232 234567899988887777776665544431
Q ss_pred --------cCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccc
Q 005999 89 --------TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTG 160 (665)
Q Consensus 89 --------~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 160 (665)
.++++.+..+++|+.|+|++|.|..+++.+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+
T Consensus 206 ~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 206 DDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred ccccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 13355688889999999999999866667778999999999999999 88999999999999999999999
Q ss_pred cCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCC
Q 005999 161 LIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 161 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~ 210 (665)
.+|..|+.|++|+.|+|++|.|+.++..+ .+++|+.|+|++|+|++.+|.
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLK 334 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChH
Confidence 78989999999999999999998665555 788999999999999988774
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=9.5e-17 Score=181.64 Aligned_cols=152 Identities=20% Similarity=0.177 Sum_probs=132.3
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|+|++|++++ +++..|.++++|++|+|++|++++++| .|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCE-eChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 479999999999995 555589999999999999999999988 799999999999999999988899999999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccc-cCCC-C-CCCCcceEecccccccccCCCC-CcccCcC----cccccC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG-TVPP-L-NQPFLVVFNVSGNNLTGQVPET-PTLLKFD----ASSFSM 224 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~-~-~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~----~~~~~~ 224 (665)
|++|++++..|..++++++|++|++++|++++ .+|. + .+++|++|++++|++++..|.. ..+.++. .+++++
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 99999998887899999999999999999987 4455 3 8899999999999999887743 3344443 567777
Q ss_pred CC
Q 005999 225 NP 226 (665)
Q Consensus 225 n~ 226 (665)
|+
T Consensus 191 n~ 192 (606)
T 3vq2_A 191 NP 192 (606)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=5.8e-17 Score=151.43 Aligned_cols=132 Identities=27% Similarity=0.230 Sum_probs=118.6
Q ss_pred CCEEEEEecCCCCc-ccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLR-GTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~-g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|+|++|+++ +.+|. .+..+++|+.|+|++|.|++. +.+..+++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57999999999998 78887 689999999999999999988 8899999999999999999987898888899999999
Q ss_pred eecccccccC-CccccCCCccCeeecccccccccCC----CC-CCCCcceEeccccccccc
Q 005999 153 LSYNNLTGLI-PVNLTALDRLYSLKLEWNRFSGTVP----PL-NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 153 L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~----~~-~~~~L~~l~l~~N~l~~~ 207 (665)
|++|+|++.. +..+..+++|+.|++++|++++.++ .+ .+++|++|++++|.+...
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 9999999642 2789999999999999999998887 33 789999999999998843
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.4e-17 Score=180.56 Aligned_cols=158 Identities=23% Similarity=0.231 Sum_probs=141.7
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (665)
..++.|+|++|.+. .+++ .+..+++|+.|+|++|.+++.+| .+.++++|++|+|++|.+++.+|..|.++++|+.|
T Consensus 373 ~~L~~L~l~~n~l~-~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 373 TSLKYLDLSFNGVI-TMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp SCCCEEECCSCSEE-EEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CccCEEECCCCccc-cccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 57888888888888 4666 48999999999999999998877 68999999999999999999999999999999999
Q ss_pred Eeeccccc-ccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCC
Q 005999 152 DLSYNNLT-GLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPN 227 (665)
Q Consensus 152 ~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~ 227 (665)
+|++|+++ +.+|..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|++++.+|.. ..+.+|..+++++|++
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~ 530 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcc
Confidence 99999998 689999999999999999999999997764 7899999999999999887753 5778899999999999
Q ss_pred CCCCCC
Q 005999 228 LCGKVI 233 (665)
Q Consensus 228 lc~~~~ 233 (665)
.|.|+.
T Consensus 531 ~~~~~~ 536 (570)
T 2z63_A 531 DCSCPR 536 (570)
T ss_dssp CCCTTT
T ss_pred cCCCcc
Confidence 998763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.9e-17 Score=179.44 Aligned_cols=150 Identities=24% Similarity=0.182 Sum_probs=95.6
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCC-----------------CCCCCCCCEEEccCcccCC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-----------------LSSLINLKSLSLSRNFFSG 136 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~-----------------~~~l~~L~~L~Ls~N~l~~ 136 (665)
..++.|+|++|.+++..| +..+++|+.|+|++|.|++.++. ...+++|+.|+|++|.|++
T Consensus 58 ~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~ 134 (487)
T 3oja_A 58 TKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (487)
T ss_dssp TTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCS
T ss_pred CCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCC
Confidence 456666666666664322 66666666666666666554321 0124555666666666666
Q ss_pred cCcccccCCCCCCEEEeecccccccCCcccc-CCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCccc
Q 005999 137 AFPLSILSLHRLTILDLSYNNLTGLIPVNLT-ALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLL 215 (665)
Q Consensus 137 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~ 215 (665)
..|..|+++++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++.++...+++|+.|+|++|+|++.+|....+.
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~ 214 (487)
T 3oja_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAA 214 (487)
T ss_dssp GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGGT
T ss_pred CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCCCHhHcCCC
Confidence 6666666777777777777777766666664 567777777777777766555566777777777777776666555666
Q ss_pred CcCcccccCCC
Q 005999 216 KFDASSFSMNP 226 (665)
Q Consensus 216 ~l~~~~~~~n~ 226 (665)
+|..+++++|.
T Consensus 215 ~L~~L~Ls~N~ 225 (487)
T 3oja_A 215 GVTWISLRNNK 225 (487)
T ss_dssp TCSEEECTTSC
T ss_pred CccEEEecCCc
Confidence 67777776664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=183.17 Aligned_cols=158 Identities=23% Similarity=0.293 Sum_probs=125.4
Q ss_pred CEEEEEecCCCCc--ccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcC----c----cccc
Q 005999 75 RVVRFVLQSFGLR--GTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAF----P----LSIL 143 (665)
Q Consensus 75 ~v~~l~l~~~~l~--g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~----p----~~~~ 143 (665)
.++.|++++|.+. +.+|. .+.++++|+.|+|++|+|+++++ .|.++++|++|+|++|++++.. | ..|.
T Consensus 455 ~L~~L~l~~n~l~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~ 533 (680)
T 1ziw_A 455 SLQRLMLRRVALKNVDSSPS-PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533 (680)
T ss_dssp TCCEEECTTSCCBCTTCSSC-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTT
T ss_pred ccccchhccccccccccCCc-ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhc
Confidence 3444455555444 34444 68888899999999999998887 5888999999999999988532 1 2378
Q ss_pred CCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCC--cccCcCc
Q 005999 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETP--TLLKFDA 219 (665)
Q Consensus 144 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~--~l~~l~~ 219 (665)
++++|+.|+|++|+|+...+..|.++++|+.|+|++|++++.++.. .+++|+.|++++|+|++.+|... .+.+|..
T Consensus 534 ~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 613 (680)
T 1ziw_A 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSE
T ss_pred CCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCE
Confidence 8899999999999999444456899999999999999999888765 78899999999999998766432 5778999
Q ss_pred ccccCCCCCCCCCC
Q 005999 220 SSFSMNPNLCGKVI 233 (665)
Q Consensus 220 ~~~~~n~~lc~~~~ 233 (665)
+++++||+.|+|..
T Consensus 614 l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 614 LDMRFNPFDCTCES 627 (680)
T ss_dssp EECTTCCCCBCCCC
T ss_pred EEccCCCcccCCcc
Confidence 99999999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.4e-16 Score=150.82 Aligned_cols=127 Identities=25% Similarity=0.240 Sum_probs=108.1
Q ss_pred EEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeeccc
Q 005999 78 RFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157 (665)
Q Consensus 78 ~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 157 (665)
.+++++|+|+ .+|. .+ .++|+.|+|++|+|+.++..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~-~~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPK-GI--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCS-CC--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCC-CC--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4677888888 7886 34 368999999999999666689999999999999999997777889999999999999999
Q ss_pred ccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccC
Q 005999 158 LTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 158 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~ 208 (665)
|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 99888888999999999999999999887753 6788888888888887543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-16 Score=151.04 Aligned_cols=130 Identities=22% Similarity=0.325 Sum_probs=117.0
Q ss_pred cEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeeccccc
Q 005999 102 RVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNR 181 (665)
Q Consensus 102 ~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 181 (665)
+.+++++|+|+.++..+. ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 679999999997766553 68999999999999 899999999999999999999998888899999999999999999
Q ss_pred ccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCcccccCCCCCCCCCCC
Q 005999 182 FSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPNLCGKVIN 234 (665)
Q Consensus 182 l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~~lc~~~~~ 234 (665)
|++.++.. .+++|++|+|++|+|++.++. ...+.+|..+++++||+.|+|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~ 145 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQ 145 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCH
Confidence 99998864 889999999999999976664 356888999999999999998754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-17 Score=180.07 Aligned_cols=153 Identities=16% Similarity=0.126 Sum_probs=131.2
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCccccc-CCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSIL-SLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L 151 (665)
..++.|+|++|.+++. ++ ..+++|+.|+|++|.|++.+| .|+++++|+.|+|++|.|++.+|..+. .+++|+.|
T Consensus 99 ~~L~~L~L~~N~l~~~-~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 99 PSIETLHAANNNISRV-SC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp TTCCEEECCSSCCCCE-EE---CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECcCCcCCCC-Cc---cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 4566666666666643 32 246889999999999999988 899999999999999999998998887 79999999
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCG 230 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~ 230 (665)
+|++|.|++. | .+..+++|+.|+|++|+|++.+|.+ .+++|+.|+|++|+|++.++....+.+|..+++++|+..|+
T Consensus 175 ~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 175 NLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp ECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred ecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 9999999976 3 3456999999999999999998887 88999999999999998666667788999999999999987
Q ss_pred CC
Q 005999 231 KV 232 (665)
Q Consensus 231 ~~ 232 (665)
+.
T Consensus 253 ~~ 254 (487)
T 3oja_A 253 TL 254 (487)
T ss_dssp HH
T ss_pred ch
Confidence 53
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.3e-17 Score=170.64 Aligned_cols=153 Identities=22% Similarity=0.199 Sum_probs=112.3
Q ss_pred CCEEEEEecCCCCcccCCcccc-CCCCCCcEEEccCCcCccCCCCCCCC-----CCCCEEEccCcccCCcCcccccCCCC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTL-TRLDQLRVLSLHNNSLTGPIPDLSSL-----INLKSLSLSRNFFSGAFPLSILSLHR 147 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~ 147 (665)
.+++.|+|++|++++.+|...+ ..+++|++|+|++|+|++.++.++.+ ++|++|+|++|++++..|..|+++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 5788888888888877776322 78888888888888888874355555 78888888888888777788888888
Q ss_pred CCEEEeeccccccc--CCccc--cCCCccCeeecccccccccCC---CC--CCCCcceEecccccccccCC--CCCcccC
Q 005999 148 LTILDLSYNNLTGL--IPVNL--TALDRLYSLKLEWNRFSGTVP---PL--NQPFLVVFNVSGNNLTGQVP--ETPTLLK 216 (665)
Q Consensus 148 L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~~~~---~~--~~~~L~~l~l~~N~l~~~~p--~~~~l~~ 216 (665)
|++|+|++|++.+. +|..+ ..+++|+.|+|++|++++... .. .+++|+.|++++|+|++.+| ....+.+
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 88888888887765 33344 778888888888888874321 21 56788888888888887654 2344667
Q ss_pred cCcccccCCC
Q 005999 217 FDASSFSMNP 226 (665)
Q Consensus 217 l~~~~~~~n~ 226 (665)
|..+++++|.
T Consensus 255 L~~L~Ls~N~ 264 (312)
T 1wwl_A 255 LNSLNLSFTG 264 (312)
T ss_dssp CCEEECTTSC
T ss_pred CCEEECCCCc
Confidence 7778887774
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.1e-17 Score=166.76 Aligned_cols=150 Identities=19% Similarity=0.181 Sum_probs=84.6
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCcc---CCC--CCCCCCCCCEEEccCcccCCcCcc----cccC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTG---PIP--DLSSLINLKSLSLSRNFFSGAFPL----SILS 144 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~---~~p--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~ 144 (665)
.+++.|+|++|++.+ +++..++.+++|++|+|++|++.+ .++ .++.+++|++|+|++|+++ .+|. .+.+
T Consensus 145 ~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 145 PGLKVLSIAQAHSPA-FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp SCCCEEEEECCSSCC-CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred cCCCEEEeeCCCcch-hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 356666666666653 333356666666666666666544 222 2355666666666666665 3333 1345
Q ss_pred CCCCCEEEeecccccccCCccccCC---CccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCccc
Q 005999 145 LHRLTILDLSYNNLTGLIPVNLTAL---DRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASS 221 (665)
Q Consensus 145 l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~ 221 (665)
+++|++|||++|+|++..|..+..+ ++|+.|+|++|+|+.. |....++|+.|+|++|+|++. |....+++|..++
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~l-p~~~~~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~ 300 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQV-PKGLPAKLRVLDLSSNRLNRA-PQPDELPEVDNLT 300 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSC-CSCCCSCCSCEECCSCCCCSC-CCTTSCCCCSCEE
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCch-hhhhcCCCCEEECCCCcCCCC-chhhhCCCccEEE
Confidence 5666666666666665556555554 4666666666666643 322235666666666666653 2234555666666
Q ss_pred ccCCCC
Q 005999 222 FSMNPN 227 (665)
Q Consensus 222 ~~~n~~ 227 (665)
+++|+.
T Consensus 301 L~~N~l 306 (310)
T 4glp_A 301 LDGNPF 306 (310)
T ss_dssp CSSTTT
T ss_pred CcCCCC
Confidence 666653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=180.28 Aligned_cols=152 Identities=18% Similarity=0.097 Sum_probs=133.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|+|++|.+++ +++..|+++++|++|+|++|++++..| .|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 33 ~~l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 33 NSTECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp TTCCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CcCcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 479999999999995 655689999999999999999999988 799999999999999999988999999999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccC-CCC-CCCCcceEecccccccccCCCC-CcccCcC--cccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTV-PPL-NQPFLVVFNVSGNNLTGQVPET-PTLLKFD--ASSFSMNP 226 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~-~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~--~~~~~~n~ 226 (665)
|++|++++..|..+.++++|++|++++|++++.. |.. .+++|+.|++++|++++..|.. ..+.++. .+++++|.
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~ 190 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCc
Confidence 9999999877888999999999999999999853 444 7899999999999999876632 3455565 56677764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=7e-17 Score=166.98 Aligned_cols=150 Identities=21% Similarity=0.174 Sum_probs=104.0
Q ss_pred CCCEEEEEecCCCCcccCCccccCCC-----CCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCc--Ccccc--
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRL-----DQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGA--FPLSI-- 142 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l-----~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~--~p~~~-- 142 (665)
..+++.|+|++|++++. |. .++.+ ++|++|+|++|+|++.+| .|+++++|++|+|++|++.+. +|..+
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 197 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred CCCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence 35788888888888854 53 56666 788888888888887776 677888888888888887765 34444
Q ss_pred cCCCCCCEEEeecccccc--cCC-ccccCCCccCeeecccccccccCCC--C-CCCCcceEecccccccccCCCCCcccC
Q 005999 143 LSLHRLTILDLSYNNLTG--LIP-VNLTALDRLYSLKLEWNRFSGTVPP--L-NQPFLVVFNVSGNNLTGQVPETPTLLK 216 (665)
Q Consensus 143 ~~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~~~--~-~~~~L~~l~l~~N~l~~~~p~~~~l~~ 216 (665)
.++++|++|+|++|+|++ .++ ..+..+++|+.|+|++|++++.+|. . .+++|++|++++|+|+ .+|.... .+
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~ 275 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AK 275 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SE
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CC
Confidence 677888888888888772 222 2335667788888888888776642 2 4577778888888777 4453222 56
Q ss_pred cCcccccCCC
Q 005999 217 FDASSFSMNP 226 (665)
Q Consensus 217 l~~~~~~~n~ 226 (665)
|..+++++|.
T Consensus 276 L~~L~Ls~N~ 285 (312)
T 1wwl_A 276 LSVLDLSYNR 285 (312)
T ss_dssp EEEEECCSSC
T ss_pred ceEEECCCCC
Confidence 6777777764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.4e-17 Score=184.45 Aligned_cols=152 Identities=21% Similarity=0.312 Sum_probs=138.7
Q ss_pred CCEEEEEecCCCCccc-----------------CCccccC--CCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcc
Q 005999 74 GRVVRFVLQSFGLRGT-----------------FPPNTLT--RLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNF 133 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~-----------------l~~~~~~--~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~ 133 (665)
.+++.|+|++|.++|. +|+ .++ ++++|++|+|++|++.+.+| .|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 6899999999999986 887 789 99999999999999999998 89999999999999999
Q ss_pred -cCC-cCcccccCC------CCCCEEEeecccccccCCc--cccCCCccCeeecccccccccCCCC-CCCCcceEecccc
Q 005999 134 -FSG-AFPLSILSL------HRLTILDLSYNNLTGLIPV--NLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGN 202 (665)
Q Consensus 134 -l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N 202 (665)
++| .+|..++++ ++|+.|+|++|+++ .+|. .++++++|+.|++++|+++|.+|.+ .+++|+.|++++|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence 998 899999887 99999999999999 8998 8999999999999999999888855 7889999999999
Q ss_pred cccccCCCCCcccC-cCcccccCCCC
Q 005999 203 NLTGQVPETPTLLK-FDASSFSMNPN 227 (665)
Q Consensus 203 ~l~~~~p~~~~l~~-l~~~~~~~n~~ 227 (665)
+++..+.....+.+ |..+++++|..
T Consensus 364 ~l~~lp~~l~~l~~~L~~L~Ls~N~l 389 (636)
T 4eco_A 364 QITEIPANFCGFTEQVENLSFAHNKL 389 (636)
T ss_dssp EEEECCTTSEEECTTCCEEECCSSCC
T ss_pred ccccccHhhhhhcccCcEEEccCCcC
Confidence 99944444567788 99999999864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=7.9e-17 Score=147.29 Aligned_cols=126 Identities=28% Similarity=0.261 Sum_probs=109.3
Q ss_pred CCEEEEEecCCCCc-ccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLR-GTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~-g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|++++|+++ +.+|. .+..+++|+.|+|++|.+++. +.++++++|++|+|++|++++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57889999999998 78887 789999999999999999988 7788999999999999999977888888899999999
Q ss_pred eeccccccc-CCccccCCCccCeeecccccccccCC---C-C-CCCCcceEeccc
Q 005999 153 LSYNNLTGL-IPVNLTALDRLYSLKLEWNRFSGTVP---P-L-NQPFLVVFNVSG 201 (665)
Q Consensus 153 L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~---~-~-~~~~L~~l~l~~ 201 (665)
|++|++++. .|..+..+++|+.|++++|++++.++ . + .+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999863 34788999999999999999998877 2 2 778888888764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=4.8e-16 Score=161.99 Aligned_cols=159 Identities=19% Similarity=0.249 Sum_probs=127.2
Q ss_pred CCccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEc
Q 005999 62 DYCQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSL 129 (665)
Q Consensus 62 ~~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~L 129 (665)
..|.|+.+.|.. ..++.|+|++|+++ .+++..|.++++|++|+|++|++++..| .|+++++|++|+|
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 357899999973 36889999999999 5666689999999999999999999977 8999999999999
Q ss_pred cCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccc--cCCCC--CCCCcceEeccccccc
Q 005999 130 SRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG--TVPPL--NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~--~~~~L~~l~l~~N~l~ 205 (665)
++|+++ .+|..+. ++|++|+|++|++++..+..+.++++|+.|++++|+++. ..+.. .+++|+.|++++|+++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 999998 7787765 788888888888887777778888888888888888864 44433 6777888888888877
Q ss_pred ccCCCCCcccCcCcccccCCC
Q 005999 206 GQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 206 ~~~p~~~~l~~l~~~~~~~n~ 226 (665)
..+.. ...+|..+++++|.
T Consensus 185 ~l~~~--~~~~L~~L~l~~n~ 203 (330)
T 1xku_A 185 TIPQG--LPPSLTELHLDGNK 203 (330)
T ss_dssp SCCSS--CCTTCSEEECTTSC
T ss_pred cCCcc--ccccCCEEECCCCc
Confidence 53321 22566777777664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.2e-16 Score=164.53 Aligned_cols=154 Identities=25% Similarity=0.184 Sum_probs=132.0
Q ss_pred cceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCC-CCCCCCEEEccCcccCCcCcccccC
Q 005999 67 QGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLS-SLINLKSLSLSRNFFSGAFPLSILS 144 (665)
Q Consensus 67 ~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~ 144 (665)
.+..|.. ..+++++++|+ .+|. .+. ..|+.|+|++|+|+++++ .|. ++++|+.|+|++|+|++..|..|.+
T Consensus 14 ~~C~C~~---~~l~c~~~~l~-~iP~-~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~ 86 (361)
T 2xot_A 14 ANCLCAS---NILSCSKQQLP-NVPQ-SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP 86 (361)
T ss_dssp TTCEEET---TEEECCSSCCS-SCCS-SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTT
T ss_pred CCCEECC---CEEEeCCCCcC-ccCc-cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccC
Confidence 4567764 36899999999 6886 343 468999999999999988 576 9999999999999999877788999
Q ss_pred CCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC----CcccCcC
Q 005999 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET----PTLLKFD 218 (665)
Q Consensus 145 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~----~~l~~l~ 218 (665)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|.. .+++|+.|+|++|+|++..+.. ..+.+|.
T Consensus 87 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~ 166 (361)
T 2xot_A 87 VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLM 166 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCC
T ss_pred CCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCC
Confidence 999999999999999887888999999999999999999987764 8899999999999999755433 3578889
Q ss_pred cccccCCCC
Q 005999 219 ASSFSMNPN 227 (665)
Q Consensus 219 ~~~~~~n~~ 227 (665)
.+++++|..
T Consensus 167 ~L~L~~N~l 175 (361)
T 2xot_A 167 LLDLSSNKL 175 (361)
T ss_dssp EEECCSSCC
T ss_pred EEECCCCCC
Confidence 999998853
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=176.63 Aligned_cols=148 Identities=24% Similarity=0.250 Sum_probs=126.4
Q ss_pred CCCCc-----cccce-eecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcc
Q 005999 60 RFDYC-----QWQGV-KCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNF 133 (665)
Q Consensus 60 ~~~~C-----~w~gv-~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~ 133 (665)
+.++| .|.|+ .|..++++.|+|++|+|++ ||+ .+ +++|+.|+|++|+|+.++ ..+++|+.|+|++|+
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~-~l--~~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~ 111 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NL--PPQITVLEITQNALISLP---ELPASLEYLDACDNR 111 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCS-CC--CTTCSEEECCSSCCSCCC---CCCTTCCEEECCSSC
T ss_pred cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCH-hH--cCCCCEEECcCCCCcccc---cccCCCCEEEccCCC
Confidence 36778 79999 7988899999999999996 887 44 389999999999999554 568999999999999
Q ss_pred cCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCc
Q 005999 134 FSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPT 213 (665)
Q Consensus 134 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~ 213 (665)
|++ +|. |.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|+++++ .+++|+.|+|++|+|++ +|...
T Consensus 112 l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~--~l~~L~~L~Ls~N~L~~-lp~l~- 179 (571)
T 3cvr_A 112 LST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE--LPTSLEVLSVRNNQLTF-LPELP- 179 (571)
T ss_dssp CSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCSC-CCCCC-
T ss_pred CCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC--cCCCcCEEECCCCCCCC-cchhh-
Confidence 996 888 765 99999999999996 776 68999999999999998554 67899999999999997 55432
Q ss_pred ccCcCcccccCCCC
Q 005999 214 LLKFDASSFSMNPN 227 (665)
Q Consensus 214 l~~l~~~~~~~n~~ 227 (665)
.+|..+++++|..
T Consensus 180 -~~L~~L~Ls~N~L 192 (571)
T 3cvr_A 180 -ESLEALDVSTNLL 192 (571)
T ss_dssp -TTCCEEECCSSCC
T ss_pred -CCCCEEECcCCCC
Confidence 7888899988843
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.6e-16 Score=156.04 Aligned_cols=151 Identities=20% Similarity=0.150 Sum_probs=132.3
Q ss_pred CCEEEEEecCCC-CcccCCccccCCCCCCcEEEccC-CcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCC-
Q 005999 74 GRVVRFVLQSFG-LRGTFPPNTLTRLDQLRVLSLHN-NSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLT- 149 (665)
Q Consensus 74 ~~v~~l~l~~~~-l~g~l~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~- 149 (665)
.+++.|+|++|+ ++ .+++..|.++++|+.|+|++ |+|+++++ .|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 689999999997 77 68877899999999999999 99999888 78999999999999999995 887 89999998
Q ss_pred --EEEeecc-cccccCCccccCCCccC-eeecccccccccCCCC-CCCCcceEeccccc-ccccCCCC-Ccc-cCcCccc
Q 005999 150 --ILDLSYN-NLTGLIPVNLTALDRLY-SLKLEWNRFSGTVPPL-NQPFLVVFNVSGNN-LTGQVPET-PTL-LKFDASS 221 (665)
Q Consensus 150 --~L~L~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~-l~~~~p~~-~~l-~~l~~~~ 221 (665)
.|+|++| ++++..+..|..+++|+ .|++++|+++..++.. ..++|+.|++++|+ +++..+.. ..+ .+|..++
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 9999999 99977777899999999 9999999999766654 45789999999995 99765543 456 7889999
Q ss_pred ccCCCC
Q 005999 222 FSMNPN 227 (665)
Q Consensus 222 ~~~n~~ 227 (665)
+++|+-
T Consensus 212 l~~N~l 217 (239)
T 2xwt_C 212 VSQTSV 217 (239)
T ss_dssp CTTCCC
T ss_pred CCCCcc
Confidence 988854
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.5e-16 Score=161.14 Aligned_cols=158 Identities=19% Similarity=0.258 Sum_probs=130.3
Q ss_pred CccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEcc
Q 005999 63 YCQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLS 130 (665)
Q Consensus 63 ~C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls 130 (665)
.|.|+.+.|.. ..++.|+|++|+++ .+++..|.++++|++|+|++|++++..| .|+++++|++|+|+
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 37899999973 36899999999999 5666689999999999999999999988 79999999999999
Q ss_pred CcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccc--cCCCC-CCCCcceEeccccccccc
Q 005999 131 RNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG--TVPPL-NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~-~~~~L~~l~l~~N~l~~~ 207 (665)
+|+++ .+|..+. ++|++|+|++|++++..+..+..+++|+.|++++|+++. ..+.. ...+|+.|++++|++++.
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l 187 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI 187 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCcc
Confidence 99999 7887776 899999999999997766778999999999999999964 44443 222888999999998864
Q ss_pred CCCCCcccCcCcccccCCC
Q 005999 208 VPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 208 ~p~~~~l~~l~~~~~~~n~ 226 (665)
+.. ...+|..+++++|.
T Consensus 188 ~~~--~~~~L~~L~l~~n~ 204 (332)
T 2ft3_A 188 PKD--LPETLNELHLDHNK 204 (332)
T ss_dssp CSS--SCSSCSCCBCCSSC
T ss_pred Ccc--ccCCCCEEECCCCc
Confidence 332 22577778887774
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=168.56 Aligned_cols=110 Identities=21% Similarity=0.264 Sum_probs=50.6
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCC-CCCCCCCCEEEccCcccCCcCcc--cccCCCCCCE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPL--SILSLHRLTI 150 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~ 150 (665)
.+++.|+|++|++++ +++..|.++++|++|+|++|+|++.++. |.++++|++|+|++|+++ .+|. .|.++++|++
T Consensus 76 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 76 VNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCEEECCCCccCc-cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 345555555555552 3322455555555555555555544442 444555555555555554 2332 3444444444
Q ss_pred EEeecc-cccccCCccccCCCccCeeeccccccccc
Q 005999 151 LDLSYN-NLTGLIPVNLTALDRLYSLKLEWNRFSGT 185 (665)
Q Consensus 151 L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 185 (665)
|+|++| .+.+..|..+.++++|+.|++++|++++.
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence 444444 23333333444444444444444444433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=178.60 Aligned_cols=157 Identities=23% Similarity=0.229 Sum_probs=108.6
Q ss_pred CCEEEEEecCCCCcccCCc--cccCCCCCCcEEEccCCcCccCCC---CCCCCCCCCEEEccCcccCCcCcccccCCCCC
Q 005999 74 GRVVRFVLQSFGLRGTFPP--NTLTRLDQLRVLSLHNNSLTGPIP---DLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~--~~~~~l~~L~~L~L~~N~l~~~~p---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 148 (665)
..++.|+|++|++++.+|+ ..++.+++|+.|+|++|+|++.++ .+..+++|++|+|++|+|+ .+|..+..+++|
T Consensus 334 ~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L 412 (549)
T 2z81_A 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412 (549)
T ss_dssp TTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC
T ss_pred ccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccc
Confidence 4566677777777665542 135666666667776666665542 3566677777777777776 566666666666
Q ss_pred CEEEeecccccccCCccc------------------cCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCC
Q 005999 149 TILDLSYNNLTGLIPVNL------------------TALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 149 ~~L~L~~N~l~~~~p~~~------------------~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~ 210 (665)
++|+|++|+|+ .+|..+ ..+++|+.|+|++|+|+.++....+++|++|++++|+|++.+|.
T Consensus 413 ~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~ip~~~~l~~L~~L~Ls~N~l~~~~~~ 491 (549)
T 2z81_A 413 RFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDG 491 (549)
T ss_dssp CEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCGGGCTTCCEEECCSSCCCCCCTT
T ss_pred cEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCcCCCcccCccCCEEecCCCccCCcCHH
Confidence 66666666665 223221 36778888888888888554433778899999999999987775
Q ss_pred -CCcccCcCcccccCCCCCCCCC
Q 005999 211 -TPTLLKFDASSFSMNPNLCGKV 232 (665)
Q Consensus 211 -~~~l~~l~~~~~~~n~~lc~~~ 232 (665)
...+.+|..+++++|++.|+|+
T Consensus 492 ~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 492 IFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp GGGGCTTCCEEECCSSCBCCCHH
T ss_pred HHhcCcccCEEEecCCCccCCCc
Confidence 3567888899999999999876
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=183.83 Aligned_cols=162 Identities=20% Similarity=0.206 Sum_probs=135.0
Q ss_pred ccccceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCC-C-CCCCCCCCCEEEccCcccCCcCccc
Q 005999 64 CQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPI-P-DLSSLINLKSLSLSRNFFSGAFPLS 141 (665)
Q Consensus 64 C~w~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~-p-~~~~l~~L~~L~Ls~N~l~~~~p~~ 141 (665)
|+|..|.+...+++.|+|++|.+++ +++..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|+|++..|..
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~-i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRT-VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCE-ECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCc-cChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 5688888755889999999999995 44458999999999999999766554 5 7999999999999999999888999
Q ss_pred ccCCCCCCEEEeecccccccCCcc--ccCCCccCeeecccccccccCCC--C-CCCCcceEecccccccccCCCC-Ccc-
Q 005999 142 ILSLHRLTILDLSYNNLTGLIPVN--LTALDRLYSLKLEWNRFSGTVPP--L-NQPFLVVFNVSGNNLTGQVPET-PTL- 214 (665)
Q Consensus 142 ~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~--~-~~~~L~~l~l~~N~l~~~~p~~-~~l- 214 (665)
|.++++|++|+|++|.+++.+|.. +.++++|+.|+|++|++++..+. + .+++|++|++++|.+++..|.. ..+
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 999999999999999999877765 89999999999999999988664 3 7899999999999998776632 222
Q ss_pred -cCcCcccccCCC
Q 005999 215 -LKFDASSFSMNP 226 (665)
Q Consensus 215 -~~l~~~~~~~n~ 226 (665)
.+|..+.+++|.
T Consensus 173 ~~~L~~L~L~~n~ 185 (844)
T 3j0a_A 173 GKTLSFFSLAANS 185 (844)
T ss_dssp HCSSCCCEECCSB
T ss_pred CCccceEECCCCc
Confidence 566667776664
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.1e-16 Score=171.14 Aligned_cols=154 Identities=21% Similarity=0.194 Sum_probs=136.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|+|++|.+++ +++..|.++++|++|+|++|+|+++++ .|.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 56 ~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 56 PHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCE-eChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 689999999999995 544589999999999999999998888 589999999999999999988899999999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCC-CCcccCcCcccccCCCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNPNL 228 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~~l 228 (665)
|++|.+++..|..|.++++|+.|+|++|++++.++.. .+++|+.|++++|++++..+. ...+.+|..+++++|+.+
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc
Confidence 9999999988999999999999999999999877653 788999999999999987663 356778888888887654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.8e-16 Score=180.26 Aligned_cols=152 Identities=23% Similarity=0.187 Sum_probs=128.6
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|+|++|+++ .+++..|.++++|++|+|++|.+++.+| .|+++++|++|+|++|++++..+..|+++++|++|+
T Consensus 25 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLR-RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCC-CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCC-CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 47999999999999 4666689999999999999999999888 688999999999999999954445799999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC---CcccCcCcccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET---PTLLKFDASSFSMNP 226 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~---~~l~~l~~~~~~~n~ 226 (665)
|++|++++..|..|.++++|++|+|++|++++.+|.. .+++|++|++++|++++..+.. ..+.+|..+++++|.
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~ 182 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCc
Confidence 9999999777788999999999999999999887764 7889999999999998776532 133567788888774
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.63 E-value=3.9e-16 Score=157.07 Aligned_cols=146 Identities=22% Similarity=0.228 Sum_probs=125.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|+++ .++ .+..+++|+.|+|++|+|++.++ +.++++|+.|+|++|++++ +|.... ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 67899999999998 676 58999999999999999999887 9999999999999999994 664333 89999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLC 229 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc 229 (665)
++|+|++ +| .+..+++|+.|+|++|++++..+-..+++|+.|++++|++++. +....+.+|..+++++|+..|
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccC
Confidence 9999996 44 6899999999999999999875333889999999999999976 656778889999999987543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.2e-16 Score=183.45 Aligned_cols=150 Identities=20% Similarity=0.247 Sum_probs=135.4
Q ss_pred CCEEEEEecCCCCcc-----------------cCCccccC--CCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcc
Q 005999 74 GRVVRFVLQSFGLRG-----------------TFPPNTLT--RLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNF 133 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g-----------------~l~~~~~~--~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~ 133 (665)
.+++.|+|++|.|+| .+|+ .++ ++++|+.|+|++|++.+.+| .|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 689999999999998 4887 777 99999999999999999999 79999999999999998
Q ss_pred -cCC-cCcccccCCC-------CCCEEEeecccccccCCc--cccCCCccCeeecccccccccCCCC-CCCCcceEeccc
Q 005999 134 -FSG-AFPLSILSLH-------RLTILDLSYNNLTGLIPV--NLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSG 201 (665)
Q Consensus 134 -l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~ 201 (665)
|+| .+|..|++++ +|+.|+|++|+|+ .+|. .+.++++|+.|+|++|+++ .+|.+ .+++|+.|+|++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 998 8998877666 9999999999999 8998 8999999999999999999 55555 889999999999
Q ss_pred ccccccCC-CCCcccC-cCcccccCCCC
Q 005999 202 NNLTGQVP-ETPTLLK-FDASSFSMNPN 227 (665)
Q Consensus 202 N~l~~~~p-~~~~l~~-l~~~~~~~n~~ 227 (665)
|+|+ .+| ....+.+ |..+++++|..
T Consensus 605 N~l~-~lp~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp SCCS-CCCTTSCEECTTCCEEECCSSCC
T ss_pred Cccc-cchHHHhhccccCCEEECcCCCC
Confidence 9999 555 4567788 99999999864
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-16 Score=164.92 Aligned_cols=151 Identities=24% Similarity=0.175 Sum_probs=99.3
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCC-----------------CCCCCCCCEEEccCcccC
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-----------------LSSLINLKSLSLSRNFFS 135 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~-----------------~~~l~~L~~L~Ls~N~l~ 135 (665)
..+++.|+|++|.+++.. + +..+++|++|+|++|+|++.++. ...+++|+.|+|++|+++
T Consensus 57 l~~L~~L~Ls~n~l~~~~-~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~ 133 (317)
T 3o53_A 57 FTKLELLNLSSNVLYETL-D--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT 133 (317)
T ss_dssp CTTCCEEECTTSCCEEEE-E--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCC
T ss_pred CCcCCEEECCCCcCCcch-h--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCC
Confidence 367888888888888533 2 78888888888888887765421 122455666666666666
Q ss_pred CcCcccccCCCCCCEEEeecccccccCCcccc-CCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcc
Q 005999 136 GAFPLSILSLHRLTILDLSYNNLTGLIPVNLT-ALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTL 214 (665)
Q Consensus 136 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l 214 (665)
+..|..+..+++|+.|+|++|++++..|..+. .+++|+.|+|++|++++.++...+++|+.|++++|+|++.++....+
T Consensus 134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l 213 (317)
T 3o53_A 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSA 213 (317)
T ss_dssp SGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEECGGGGGG
T ss_pred CccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCcchhhhccc
Confidence 55555666666777777777777665555553 56677777777777766644445666777777777777655555556
Q ss_pred cCcCcccccCCC
Q 005999 215 LKFDASSFSMNP 226 (665)
Q Consensus 215 ~~l~~~~~~~n~ 226 (665)
.+|..+++++|.
T Consensus 214 ~~L~~L~L~~N~ 225 (317)
T 3o53_A 214 AGVTWISLRNNK 225 (317)
T ss_dssp TTCSEEECTTSC
T ss_pred CcccEEECcCCc
Confidence 666666666664
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=163.42 Aligned_cols=153 Identities=16% Similarity=0.127 Sum_probs=128.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCccccc-CCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSIL-SLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L 151 (665)
..++.|+|++|++++ +++ ..+++|+.|+|++|++++.++ .++.+++|++|+|++|.+++..|..+. .+++|++|
T Consensus 99 ~~L~~L~l~~n~l~~-~~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 174 (317)
T 3o53_A 99 PSIETLHAANNNISR-VSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (317)
T ss_dssp TTCCEEECCSSCCSE-EEE---CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECCCCccCC-cCc---cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence 456667777777764 332 246889999999999999888 899999999999999999987787774 79999999
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCG 230 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~ 230 (665)
+|++|+|++. | ....+++|+.|+|++|++++.++.+ .+++|+.|++++|+|++.++....+.+|..+++++|+..|+
T Consensus 175 ~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 175 NLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp ECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred ECCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence 9999999955 4 3445999999999999999988877 78999999999999997655556788999999999999886
Q ss_pred CC
Q 005999 231 KV 232 (665)
Q Consensus 231 ~~ 232 (665)
+.
T Consensus 253 ~~ 254 (317)
T 3o53_A 253 TL 254 (317)
T ss_dssp HH
T ss_pred CH
Confidence 43
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=171.39 Aligned_cols=152 Identities=22% Similarity=0.188 Sum_probs=113.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|+|++|.+++ +++..|+.+++|+.|+|++|.|++.+| .|+++++|++|+|++|.|++..+..|+++++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 468888888888884 444478888888888888888888877 578888888888888888844444567888888888
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCC--------------------------------------------
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP-------------------------------------------- 188 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-------------------------------------------- 188 (665)
|++|.|++..|..|..+++|+.|+|++|++++....
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~ 233 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 233 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCC
Confidence 888888877777788888888888888877654211
Q ss_pred ----------------C-CCCCcceEecccccccccCCC-CCcccCcCcccccCCC
Q 005999 189 ----------------L-NQPFLVVFNVSGNNLTGQVPE-TPTLLKFDASSFSMNP 226 (665)
Q Consensus 189 ----------------~-~~~~L~~l~l~~N~l~~~~p~-~~~l~~l~~~~~~~n~ 226 (665)
+ .+++|+.|+|++|.|++.+|. ...+.+|..+++++|.
T Consensus 234 L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 289 (597)
T 3oja_B 234 LTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289 (597)
T ss_dssp CCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSC
T ss_pred CCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCC
Confidence 1 345677788888888877663 2456777778887774
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=162.93 Aligned_cols=152 Identities=20% Similarity=0.193 Sum_probs=97.4
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCC-CCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|+|++|++++ +++..|+++++|++|+|++|+++.+++. |.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 93 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (390)
T 3o6n_A 93 HTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171 (390)
T ss_dssp TTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred CCcCEEECCCCCCCc-CCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence 456666666666663 4444566666666666666666655553 45666666666666666655555566666666666
Q ss_pred eecccccccCC-----------------------------------------------------------ccccCCCccC
Q 005999 153 LSYNNLTGLIP-----------------------------------------------------------VNLTALDRLY 173 (665)
Q Consensus 153 L~~N~l~~~~p-----------------------------------------------------------~~~~~l~~L~ 173 (665)
|++|++++... ..+..+++|+
T Consensus 172 l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~ 251 (390)
T 3o6n_A 172 LSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLV 251 (390)
T ss_dssp CCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCS
T ss_pred CCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCcccHHHcCCCCcc
Confidence 66665553211 2245567788
Q ss_pred eeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 174 SLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 174 ~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
.|+|++|++++.+|.. .+++|+.|++++|++++..+....+++|..+++++|.
T Consensus 252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~ 306 (390)
T 3o6n_A 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 306 (390)
T ss_dssp EEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSC
T ss_pred EEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCc
Confidence 8888888888776654 6778888888888888765544567777778887774
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.62 E-value=7.2e-16 Score=157.60 Aligned_cols=146 Identities=28% Similarity=0.316 Sum_probs=117.7
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..+++.|+|++|++++ +++ +..+++|+.|+|++|++++. |.+..+++|++|+|++|++++ + +.+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCCC-hhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 3678888999988884 554 88888999999999988874 458888889999999998884 4 4688888899999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|++|++++. ..+..+++|+.|+|++|++++.++-..+++|+.|++++|+|++. |....+.+|..+++++|+.
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 212 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEE
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcc
Confidence 999988854 57888888999999999988877744788889999999988863 4456677888888888764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=157.08 Aligned_cols=146 Identities=21% Similarity=0.330 Sum_probs=111.3
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..+++.|+|++|+++ .+++ +..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++ +|. +..+++|+.|+
T Consensus 62 l~~L~~L~L~~n~i~-~~~~--~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQIT-DLAP--LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCC-CChh--HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 367888888888888 4554 88888888888888888765 467788888888888888884 553 78888888888
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|++|++++..+ +..+++|+.|+|++|++++.++-..+++|+.|++++|++++..+ ...+.+|..+++++|..
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l 207 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQI 207 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCcc
Confidence 88888885433 77888888888888888876663377788888888888876544 45667777788877743
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=146.30 Aligned_cols=129 Identities=20% Similarity=0.274 Sum_probs=111.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|+|++|.+. .+ + .+..+++|++|+|++|++++..+ .|+.+++|++|+|++|++++..|..|.++++|+.|+
T Consensus 66 ~~L~~L~l~~n~~~-~~-~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT-NY-N-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS-CC-G-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC-cc-h-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 58999999999776 33 3 69999999999999999998555 899999999999999999988999999999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccc
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~ 206 (665)
|++|++.+.+| .+..+++|+.|++++|++++..+-..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99999333666 699999999999999999986643488999999999999874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-15 Score=171.38 Aligned_cols=152 Identities=21% Similarity=0.182 Sum_probs=128.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
.+++.|+|++|++++ +++..|.++++|+.|+|++|++++++| .|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 28 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 28 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp SSCCEEECCSCCCCE-ECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ccccEEEccCCccCc-cChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 479999999999994 555589999999999999999999888 799999999999999999987788999999999999
Q ss_pred eecccccccCCccccCCCccCeeeccccccccc-CCCC--CCCCcceEecccccccccCCCC-CcccCc----CcccccC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT-VPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKF----DASSFSM 224 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l----~~~~~~~ 224 (665)
|++|++++..+..++++++|++|++++|++++. +|.. .+++|+.|++++|++++..|.. ..+.++ ..+++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 999999976666799999999999999999874 4543 7899999999999999876632 344455 4566666
Q ss_pred CC
Q 005999 225 NP 226 (665)
Q Consensus 225 n~ 226 (665)
|.
T Consensus 187 n~ 188 (570)
T 2z63_A 187 NP 188 (570)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-15 Score=155.95 Aligned_cols=150 Identities=18% Similarity=0.210 Sum_probs=120.2
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCcc--CCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTG--PIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~--~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 150 (665)
..++.|++++|.++ .+++..+.++++|+.|+|++|.++. ..+ .|.++++|+.|+|++|+++ .+|..+. ++|+.
T Consensus 121 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~ 196 (330)
T 1xku_A 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTE 196 (330)
T ss_dssp TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSE
T ss_pred ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCE
Confidence 47889999999998 5666678999999999999999864 555 6888888999999888888 5776664 78888
Q ss_pred EEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 151 LDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 151 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|+|++|++++..|..+..+++|+.|+|++|++++.++.. .+++|+.|++++|+++..+.....+.+|..+++++|+.
T Consensus 197 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcC
Confidence 888888888877888888888888888888888877743 77888888888888884444456677788888888753
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=154.98 Aligned_cols=144 Identities=25% Similarity=0.309 Sum_probs=128.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|++++|++. .++ .+..+++|+.|+|++|++++.++ +.++++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 57999999999999 565 48999999999999999999887 9999999999999999995 45 4999999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
++|+|++. ..+..+++|+.|++++|++++. +.+ .+++|+.|++++|++++..| ...+.+|..+++++|..
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcC
Confidence 99999964 4689999999999999999987 444 88999999999999998766 67788899999998853
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=157.71 Aligned_cols=145 Identities=20% Similarity=0.311 Sum_probs=128.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|.+++ ++ .+..+++|+.|+|++|++++.. .+..+++|+.|+|++|++++ ++. +..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCCch-hhcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEc
Confidence 689999999999995 54 6999999999999999999865 49999999999999999995 454 899999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
++|++++. +. +..+++|+.|++++|++++.++-..+++|+.|++++|++++..| ...+.+|..+++++|+.
T Consensus 159 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 159 GNAQVSDL-TP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTI 229 (308)
T ss_dssp CSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEE
T ss_pred cCCcCCCC-hh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCee
Confidence 99999964 44 99999999999999999988774488999999999999997664 56788899999999975
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=142.31 Aligned_cols=129 Identities=22% Similarity=0.181 Sum_probs=112.7
Q ss_pred CCCCCcEEEccCCcCc-cCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCe
Q 005999 97 RLDQLRVLSLHNNSLT-GPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYS 174 (665)
Q Consensus 97 ~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 174 (665)
..++|+.|+|++|+++ +.+| .+..+++|+.|+|++|.|++. ..|..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 4578999999999998 5566 679999999999999999955 78999999999999999999888888888999999
Q ss_pred eecccccccccC--CCC-CCCCcceEecccccccccCC----CCCcccCcCcccccCCCC
Q 005999 175 LKLEWNRFSGTV--PPL-NQPFLVVFNVSGNNLTGQVP----ETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 175 L~l~~N~l~~~~--~~~-~~~~L~~l~l~~N~l~~~~p----~~~~l~~l~~~~~~~n~~ 227 (665)
|+|++|++++.+ +.+ .+++|+.|++++|++++.++ ....+++|..+++++|..
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 999999999865 344 88999999999999997765 346678888888888753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.7e-15 Score=139.64 Aligned_cols=130 Identities=19% Similarity=0.126 Sum_probs=114.3
Q ss_pred CcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccc
Q 005999 101 LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180 (665)
Q Consensus 101 L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (665)
.+.+++++|+++.++..+ .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 9 ~~~l~~~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TTEEECCSSCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEecCCCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 578999999999877544 379999999999999766677899999999999999999777777899999999999999
Q ss_pred cccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCCCCCC
Q 005999 181 RFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNLCGKV 232 (665)
Q Consensus 181 ~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~lc~~~ 232 (665)
++++.++.. .+++|++|++++|+|++.++.. ..+.+|..+++++|++.|.++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999988864 7899999999999999776654 568889999999999998764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=7.9e-16 Score=158.87 Aligned_cols=153 Identities=20% Similarity=0.159 Sum_probs=121.5
Q ss_pred CCEEEEEecCCCCcccCCcccc--CCCCCCcEEEccCCcCccCCC-----CCCCCCCCCEEEccCcccCCcCcccccCCC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTL--TRLDQLRVLSLHNNSLTGPIP-----DLSSLINLKSLSLSRNFFSGAFPLSILSLH 146 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~--~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 146 (665)
.+++.|+|++|++.+.+|. .+ ..+++|++|+|++|.+++..+ .+..+++|++|+|++|++++..|..|.+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp SCCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred CceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3599999999999988776 55 889999999999999998655 245789999999999999988888999999
Q ss_pred CCCEEEeeccccccc--CC--ccccCCCccCeeecccccccccCCC----C-CCCCcceEecccccccccCCC-CCcc--
Q 005999 147 RLTILDLSYNNLTGL--IP--VNLTALDRLYSLKLEWNRFSGTVPP----L-NQPFLVVFNVSGNNLTGQVPE-TPTL-- 214 (665)
Q Consensus 147 ~L~~L~L~~N~l~~~--~p--~~~~~l~~L~~L~l~~N~l~~~~~~----~-~~~~L~~l~l~~N~l~~~~p~-~~~l-- 214 (665)
+|++|||++|++.+. ++ ..+..+++|++|+|++|+++...+. . .+++|++|+|++|+|++..|. ...+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 999999999998753 22 2346888999999999998754432 1 568899999999999887553 2333
Q ss_pred -cCcCcccccCCCC
Q 005999 215 -LKFDASSFSMNPN 227 (665)
Q Consensus 215 -~~l~~~~~~~n~~ 227 (665)
.+|..+++++|.-
T Consensus 250 ~~~L~~L~Ls~N~l 263 (310)
T 4glp_A 250 SSALNSLNLSFAGL 263 (310)
T ss_dssp CTTCCCEECCSSCC
T ss_pred cCcCCEEECCCCCC
Confidence 5788888888753
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.4e-15 Score=155.61 Aligned_cols=149 Identities=22% Similarity=0.281 Sum_probs=91.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccC--CcCcccccCC-----
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFS--GAFPLSILSL----- 145 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l----- 145 (665)
.+++.|+|++|+++ .+|+. +. ++|++|+|++|++++.++ .|.++++|+.|+|++|.++ +..|..+..+
T Consensus 102 ~~L~~L~L~~n~l~-~l~~~-~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L 177 (332)
T 2ft3_A 102 RKLQKLYISKNHLV-EIPPN-LP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL 177 (332)
T ss_dssp TTCCEEECCSSCCC-SCCSS-CC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCC
T ss_pred CCCCEEECCCCcCC-ccCcc-cc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEE
Confidence 56777777777777 56653 32 667777777777776665 4666777777777777664 2445555544
Q ss_pred ---------------CCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccC
Q 005999 146 ---------------HRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 146 ---------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~ 208 (665)
++|+.|+|++|++++..|..+..+++|+.|+|++|++++.++.. .+++|+.|++++|+++..+
T Consensus 178 ~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp 257 (332)
T 2ft3_A 178 RISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVP 257 (332)
T ss_dssp BCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCC
T ss_pred ECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecC
Confidence 35555566666666555556666666666666666666655532 5566666666666666322
Q ss_pred CCCCcccCcCcccccCCC
Q 005999 209 PETPTLLKFDASSFSMNP 226 (665)
Q Consensus 209 p~~~~l~~l~~~~~~~n~ 226 (665)
+....+.+|..+++++|+
T Consensus 258 ~~l~~l~~L~~L~l~~N~ 275 (332)
T 2ft3_A 258 AGLPDLKLLQVVYLHTNN 275 (332)
T ss_dssp TTGGGCTTCCEEECCSSC
T ss_pred hhhhcCccCCEEECCCCC
Confidence 233455566666666654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.9e-15 Score=168.00 Aligned_cols=146 Identities=29% Similarity=0.322 Sum_probs=128.1
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
...++.|+|++|+|.+ +++ +..|++|+.|+|++|+|+++ |.+..|++|+.|+|++|+|++ + +.+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCC-TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCCC-hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 4689999999999995 554 89999999999999999874 579999999999999999995 4 4689999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|++|+|++. ..+..|++|+.|+|++|+|++.+|-..+++|+.|+|++|+|++. |....+.+|..+++++|+.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence 999999965 57899999999999999999988844889999999999999974 6667788899999988864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-15 Score=159.16 Aligned_cols=138 Identities=12% Similarity=0.114 Sum_probs=98.8
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCch------------h--------hHHHHHHHHHHHHhCCCCCCeeeee
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA------------D--------TSAEAFEQHMEAVGGLSHPNLVPIR 453 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~--------~~~~~~~~e~~~l~~l~h~niv~l~ 453 (665)
...||+|+||.||+|...+|+.||||+++..... . .......+|...|.++.+.++.-..
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 4579999999999999889999999987543110 0 0111234567777777555443222
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC---
Q 005999 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF--- 530 (665)
Q Consensus 454 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~--- 530 (665)
-+... ..++||||+.|++|.++.. . .....++.||+.+|.|||+.+ ||||||||.|||+++++
T Consensus 180 p~~~~--~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~g-IVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 180 PIAQS--RHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKHG-LIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp EEEEE--TTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEEEEECSS
T ss_pred eeecc--CceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHEEEeCCCCcc
Confidence 22222 2379999999988865432 1 123467899999999999999 99999999999998776
Q ss_pred -------ceEEeecccccccCC
Q 005999 531 -------EARLTDYCLSVLSDS 545 (665)
Q Consensus 531 -------~~kl~Dfgl~~~~~~ 545 (665)
.+.|+||+.+...++
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETTS
T ss_pred cccccccceEEEEeCCcccCCC
Confidence 389999998866543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-15 Score=167.22 Aligned_cols=131 Identities=19% Similarity=0.209 Sum_probs=80.9
Q ss_pred CCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCC--cCcccccCCCCCCEEEeecccccccCCcc-ccCCCc
Q 005999 96 TRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSG--AFPLSILSLHRLTILDLSYNNLTGLIPVN-LTALDR 171 (665)
Q Consensus 96 ~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~ 171 (665)
..+++|++|+|++|++++.+| .++++++|+.|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 456666666666666666555 56666666666666666664 45556666666666666666666545543 556666
Q ss_pred cCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 172 LYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 172 L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
|+.|++++|++++..|....++|+.|++++|+|+..++....+.+|..+++++|.
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~ 455 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CCEEECcCCCCCcchhhhhcccCCEEECCCCcccccchhhhcCCCCCEEECCCCc
Confidence 6666666666666555433356667777777666322223455666666666663
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=5e-15 Score=165.96 Aligned_cols=131 Identities=21% Similarity=0.248 Sum_probs=93.6
Q ss_pred CCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCC--cCcccccCCCCCCEEEeecccccccCCc-cccCCCc
Q 005999 96 TRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSG--AFPLSILSLHRLTILDLSYNNLTGLIPV-NLTALDR 171 (665)
Q Consensus 96 ~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~ 171 (665)
..+++|++|+|++|++++.+| .++++++|+.|+|++|++++ .+|..|.++++|+.|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 567777788888888777665 67777888888888887775 3345677777888888888888764554 3667777
Q ss_pred cCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 172 LYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 172 L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
|+.|++++|++++.+|....++|+.|++++|+|+..++....+.+|..+++++|.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~ 484 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQ 484 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSC
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCC
Confidence 8888888888777665543367788888888877444444566777777777764
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.58 E-value=5.2e-15 Score=155.48 Aligned_cols=160 Identities=14% Similarity=0.090 Sum_probs=114.5
Q ss_pred ccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCE-EEc
Q 005999 64 CQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKS-LSL 129 (665)
Q Consensus 64 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~-L~L 129 (665)
|+|..|.|+. ..++.|+|++|+|+ .||++.|.+|++|++|+|++|++.+.+| .|.++++|.. +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 7899999974 36899999999999 7998889999999999999999977665 5889999876 677
Q ss_pred cCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeeccc-ccccccCCCC--CC-CCcceEeccccccc
Q 005999 130 SRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEW-NRFSGTVPPL--NQ-PFLVVFNVSGNNLT 205 (665)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~--~~-~~L~~l~l~~N~l~ 205 (665)
+.|+|+...|..|.++++|++|++++|+|++..+..+....++..|++.+ |++..+++.. .+ ..++.|++++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 78999977788999999999999999999866655555555555555543 3444444332 22 23555555555555
Q ss_pred ccCCCCCcccCcCcccccC
Q 005999 206 GQVPETPTLLKFDASSFSM 224 (665)
Q Consensus 206 ~~~p~~~~l~~l~~~~~~~ 224 (665)
...+......++..+.+.+
T Consensus 168 ~i~~~~f~~~~L~~l~l~~ 186 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSD 186 (350)
T ss_dssp EECTTSSTTEEEEEEECTT
T ss_pred CCChhhccccchhHHhhcc
Confidence 4333333333344444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-15 Score=138.53 Aligned_cols=125 Identities=19% Similarity=0.156 Sum_probs=106.9
Q ss_pred CCCCCcEEEccCCcCc-cCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCe
Q 005999 97 RLDQLRVLSLHNNSLT-GPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYS 174 (665)
Q Consensus 97 ~l~~L~~L~L~~N~l~-~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 174 (665)
..++|+.|+|++|.++ +.+| .+..+++|+.|+|++|.+++. ..+.++++|++|+|++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999999 5666 789999999999999999965 78999999999999999999888988888999999
Q ss_pred eecccccccccC--CCC-CCCCcceEecccccccccCC----CCCcccCcCccccc
Q 005999 175 LKLEWNRFSGTV--PPL-NQPFLVVFNVSGNNLTGQVP----ETPTLLKFDASSFS 223 (665)
Q Consensus 175 L~l~~N~l~~~~--~~~-~~~~L~~l~l~~N~l~~~~p----~~~~l~~l~~~~~~ 223 (665)
|++++|++++.+ ..+ .+++|++|++++|++++..+ ....+++|..++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 999999999864 344 88999999999999997665 23456666666553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.57 E-value=8.5e-15 Score=159.46 Aligned_cols=135 Identities=21% Similarity=0.260 Sum_probs=114.0
Q ss_pred CCEEEEEecCCCCcc------------------------cCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEc
Q 005999 74 GRVVRFVLQSFGLRG------------------------TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSL 129 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g------------------------~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~L 129 (665)
.+++.|+|++|.+.+ .+++..|.++++|+.|+|++|+|++. |.+..+++|+.|+|
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~L 225 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEM 225 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEEC
Confidence 467777777776662 23333466777788888888888765 56888899999999
Q ss_pred cCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEeccccccccc
Q 005999 130 SRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~ 207 (665)
++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++...
T Consensus 226 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 999999888999999999999999999999999999999999999999999999888875 789999999999999865
Q ss_pred CC
Q 005999 208 VP 209 (665)
Q Consensus 208 ~p 209 (665)
..
T Consensus 306 C~ 307 (452)
T 3zyi_A 306 CD 307 (452)
T ss_dssp TT
T ss_pred CC
Confidence 54
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.4e-15 Score=140.58 Aligned_cols=128 Identities=20% Similarity=0.149 Sum_probs=105.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCC-CCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLD-QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.|+|++|+++ .++. +..+. +|+.|+|++|.|++. +.|..+++|++|+|++|+|++..|..|..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 57889999999998 5643 55554 999999999999987 7888999999999999999954445558899999999
Q ss_pred eecccccccCCc--cccCCCccCeeecccccccccCCC----C-CCCCcceEecccccccc
Q 005999 153 LSYNNLTGLIPV--NLTALDRLYSLKLEWNRFSGTVPP----L-NQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 153 L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~-~~~~L~~l~l~~N~l~~ 206 (665)
|++|+|+ .+|. .+..+++|+.|++++|.++..++. . .+++|+.||+++|.+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999996 6666 788899999999999999876653 3 77889999999887763
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.4e-16 Score=178.28 Aligned_cols=134 Identities=22% Similarity=0.252 Sum_probs=119.8
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
...++.|+|++|.+. .||+ .+.++++|+.|+|++|.|+.+++.|++|++|+.|+|++|+|+ .+|..|++|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 368999999999999 8987 577999999999999999955558999999999999999999 8999999999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CC-CCcceEecccccccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQ-PFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~-~~L~~l~l~~N~l~~~~p~ 210 (665)
|++|.|+ .+|..|+.|++|+.|+|++|+|++.+|.. .+ ..+..|+|++|.++|.+|.
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 9999998 88989999999999999999999988865 22 2234588999999999884
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.2e-15 Score=165.97 Aligned_cols=143 Identities=26% Similarity=0.323 Sum_probs=128.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|++. .++ .+..|++|+.|+|++|+|++.+| +..|++|+.|+|++|+|++ +| .|..|++|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 67899999999998 565 59999999999999999999887 9999999999999999994 55 7999999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
++|+|++ + ..+..|++|+.|+|++|+|++. +.+ .+++|+.|+|++|+|++.+| ...+.+|..+++++|.
T Consensus 117 s~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 117 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 186 (605)
T ss_dssp TTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred cCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCC
Confidence 9999995 4 4699999999999999999987 444 88999999999999998777 6778899999999985
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.5e-14 Score=134.27 Aligned_cols=107 Identities=24% Similarity=0.251 Sum_probs=87.0
Q ss_pred EEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeec
Q 005999 77 VRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155 (665)
Q Consensus 77 ~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 155 (665)
+.+++++|+|+ .+|. .+. ++|+.|+|++|+|++++| .|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 57889999997 7887 443 789999999999999888 788999999999999999965555578889999999999
Q ss_pred ccccccCCccccCCCccCeeecccccccccCC
Q 005999 156 NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP 187 (665)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 187 (665)
|+|++..+..|..+++|+.|+|++|.+....+
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99986655568888888888888888775443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=2.9e-14 Score=133.29 Aligned_cols=105 Identities=23% Similarity=0.200 Sum_probs=81.2
Q ss_pred EEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecc
Q 005999 78 RFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYN 156 (665)
Q Consensus 78 ~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 156 (665)
.|++++|+|+ .+|. .+ .++|+.|+|++|+|++++| .|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 ~l~~s~n~l~-~ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLA-SVPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 5677888888 5776 34 3788888888888888877 6888888888888888888666666778888888888888
Q ss_pred cccccCCccccCCCccCeeecccccccccC
Q 005999 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTV 186 (665)
Q Consensus 157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 186 (665)
+|++..+..|..+++|+.|+|++|.++...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 888666666777777777777777776543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=3.2e-14 Score=133.01 Aligned_cols=109 Identities=22% Similarity=0.135 Sum_probs=98.2
Q ss_pred CcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccc
Q 005999 101 LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180 (665)
Q Consensus 101 L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (665)
.+.|++++|+|+.++..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 5789999999998776663 89999999999999888999999999999999999999777777899999999999999
Q ss_pred cccccCCCC--CCCCcceEecccccccccCCCC
Q 005999 181 RFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET 211 (665)
Q Consensus 181 ~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~ 211 (665)
+|++.++.. .+++|+.|+|++|+|++..+..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l 121 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI 121 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence 999998864 8899999999999999876643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=161.65 Aligned_cols=106 Identities=32% Similarity=0.401 Sum_probs=62.7
Q ss_pred CcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccc
Q 005999 101 LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180 (665)
Q Consensus 101 L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (665)
|+.|+|++|+|++++ .|+++++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.+++|+.|+|++|
T Consensus 443 L~~L~Ls~n~l~~lp-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 443 VRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp CSEEECTTSCCSSCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred ceEEEecCCCCCCCc-CccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 556666666666533 3666666666666666666 556666666666666666666664 44 5666666666666666
Q ss_pred cccccC-CCC--CCCCcceEecccccccccCCC
Q 005999 181 RFSGTV-PPL--NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 181 ~l~~~~-~~~--~~~~L~~l~l~~N~l~~~~p~ 210 (665)
+|++.+ |.. .+++|+.|+|++|+|++.+|.
T Consensus 519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred CCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 666653 332 555666666666666655543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=158.74 Aligned_cols=145 Identities=27% Similarity=0.311 Sum_probs=101.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|+|++|++++ ++ .+..+++|+.|+|++|.+++.++ +..+++|+.|+|++|.+++ +|. +..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEc
Confidence 567778888887774 42 57777777777777777777665 6777777777777777774 333 677777777777
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
++|++++..| +..+++|+.|+|++|++++.+|...+++|+.|++++|++++. +....+.+|..+++++|+.
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCcc
Confidence 7777775443 667777777777777777766644667777777777777754 4445566666677766643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=7e-15 Score=138.38 Aligned_cols=130 Identities=18% Similarity=0.115 Sum_probs=109.4
Q ss_pred ccCCCCCCcEEEccCCcCccCCCCCCCCC-CCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCcc
Q 005999 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLI-NLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRL 172 (665)
Q Consensus 94 ~~~~l~~L~~L~L~~N~l~~~~p~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 172 (665)
.+.++.+|+.|+|++|+++.+ |.+..+. +|++|+|++|.|++. ..|.++++|++|+|++|+|++..|..+..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 577899999999999999965 6676665 999999999999964 689999999999999999996655556899999
Q ss_pred CeeecccccccccCC--CC-CCCCcceEecccccccccCCC----CCcccCcCcccccCCC
Q 005999 173 YSLKLEWNRFSGTVP--PL-NQPFLVVFNVSGNNLTGQVPE----TPTLLKFDASSFSMNP 226 (665)
Q Consensus 173 ~~L~l~~N~l~~~~~--~~-~~~~L~~l~l~~N~l~~~~p~----~~~l~~l~~~~~~~n~ 226 (665)
+.|+|++|+++..++ .. .+++|+.|++++|+++...+. ...+++|..+++++|.
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECC
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCC
Confidence 999999999977665 34 789999999999999854332 4567788888887774
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.1e-14 Score=150.55 Aligned_cols=146 Identities=21% Similarity=0.259 Sum_probs=94.7
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|++++|.+. .+++ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|+++ .+|. +..+++|+.|+|
T Consensus 177 ~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIE-DISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccc-cccc--ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccC-CCcc-hhcCCCCCEEEC
Confidence 56778888888877 3443 6677777777777777766555 666677777777777776 3343 666777777777
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCC-CcccCcCcccccCCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPN 227 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~ 227 (665)
++|.+++ + ..+..+++|+.|++++|++++...-..+++|+.|++++|++++..|.. ..+.+|..+++++|+.
T Consensus 251 ~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 251 GTNQISD-I-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp CSSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred CCCccCC-C-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcc
Confidence 7777764 2 346667777777777777766522225666777777777766554432 3455666666666654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.7e-14 Score=157.45 Aligned_cols=114 Identities=23% Similarity=0.228 Sum_probs=70.1
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|+|+ .|| ..+++|+.|+|++|+|+++++ +.+ +|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP----ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 45777777777777 565 235677777777777776444 443 66666666666664 555 4566666666
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEeccccccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLT 205 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~ 205 (665)
++|+|++ +|. .+++|+.|+|++|+|+++++ +. ++|+.|+|++|+|+
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~-~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP-ESLEALDVSTNLLE 193 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC-TTCCEEECCSSCCS
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh-CCCCEEECcCCCCC
Confidence 6666664 444 45566666666666666333 33 55666666666665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=6e-14 Score=131.63 Aligned_cols=108 Identities=19% Similarity=0.143 Sum_probs=96.2
Q ss_pred CcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccc
Q 005999 101 LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180 (665)
Q Consensus 101 L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (665)
-+.+++++|+|+.+++.+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 14 ~~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 14 QTLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SSEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CcEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3789999999987776664 89999999999999888999999999999999999999766666789999999999999
Q ss_pred cccccCCC-C-CCCCcceEecccccccccCCC
Q 005999 181 RFSGTVPP-L-NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 181 ~l~~~~~~-~-~~~~L~~l~l~~N~l~~~~p~ 210 (665)
+|+++++. + .+++|++|+|++|+|....+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 99998886 3 789999999999999976553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.50 E-value=6.4e-17 Score=155.54 Aligned_cols=133 Identities=27% Similarity=0.314 Sum_probs=113.7
Q ss_pred CCEEEEEecCCCCcccCCc-----cccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCC
Q 005999 74 GRVVRFVLQSFGLRGTFPP-----NTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~-----~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 148 (665)
..++.++|+.+.+.|.+|+ ..+..+++|++|+|++|+|+++ |.+.++++|+.|+|++|+|+ .+|..+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 3555666666677766653 2688999999999999999985 48899999999999999999 789888888999
Q ss_pred CEEEeecccccccCCccccCCCccCeeecccccccccCC--CC-CCCCcceEecccccccccCCC
Q 005999 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP--PL-NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 149 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~-~~~~L~~l~l~~N~l~~~~p~ 210 (665)
+.|+|++|+|++ +| .+..+++|+.|++++|++++.++ .. .+++|++|++++|++++.+|.
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 999999999996 56 68899999999999999997654 23 789999999999999988765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.5e-14 Score=140.31 Aligned_cols=125 Identities=24% Similarity=0.290 Sum_probs=110.8
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
...++.|+|++|+++ .+++ +..+++|+.|+|++|+|++.++ +.. ++|+.|+|++|+|++ +| .+.++++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~-~~~~--l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQIS-DLSP--LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccC-CChh--hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 478999999999999 4665 9999999999999999998655 333 999999999999995 55 699999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEeccccccccc
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~ 207 (665)
|++|+|++. | .+..+++|+.|+|++|++++. +.. .+++|+.|++++|++++.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 999999964 5 689999999999999999998 444 889999999999999965
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-13 Score=149.90 Aligned_cols=118 Identities=19% Similarity=0.212 Sum_probs=55.2
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|++++ +| .+..+++|++|+|++|+|++. | ++.+++|++|+|++|+|++ +| ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~-~~--~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITD-MT--GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCC-CT--TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCccc-Ch--hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 344555555555553 22 344555555555555555543 1 4445555555555555543 22 444555555555
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEeccccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNN 203 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~ 203 (665)
++|+|++ +| +..+++|+.|++++|++++. +-..+++|+.|++++|+
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~l~~l~~L~~L~l~~n~ 159 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-DVSHNTQLTELDCHLNK 159 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-CCTTCTTCCEEECTTCS
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee-ccccCCcCCEEECCCCC
Confidence 5555543 22 44455555555555555442 22234444444444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.3e-14 Score=158.81 Aligned_cols=133 Identities=23% Similarity=0.256 Sum_probs=103.5
Q ss_pred CCCCCCCcccccee--------ecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEE
Q 005999 57 LNERFDYCQWQGVK--------CAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLS 128 (665)
Q Consensus 57 ~~~~~~~C~w~gv~--------C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~ 128 (665)
|....+||.|+|.. |....++.|++++|+|+ .+|. .+. ++|+.|+|++|+|+.+++ .+++|++|+
T Consensus 15 W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~-~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~ 87 (622)
T 3g06_A 15 WRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLTSLPA---LPPELRTLE 87 (622)
T ss_dssp HHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCS-CCC--TTCSEEEECSCCCSCCCC---CCTTCCEEE
T ss_pred HHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccCh-hhC--CCCcEEEecCCCCCCCCC---cCCCCCEEE
Confidence 54457899997643 44457999999999999 8887 454 799999999999997655 578999999
Q ss_pred ccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccc
Q 005999 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 129 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~ 206 (665)
|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|+++++. +++|++|++++|+|++
T Consensus 88 Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~--l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 88 VSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL--PPGLQELSVSDNQLAS 155 (622)
T ss_dssp ECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSC
T ss_pred cCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC--CCCCCEEECcCCcCCC
Confidence 9999998 6776 67889999999999884 454 567788888888888775542 4677777777777775
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=5.7e-14 Score=156.56 Aligned_cols=107 Identities=27% Similarity=0.219 Sum_probs=49.4
Q ss_pred EEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeec
Q 005999 76 VVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155 (665)
Q Consensus 76 v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 155 (665)
++.|+|++|+|++ +|. |+.+++|+.|+|++|+|+.+++.|++|++|+.|+|++|+|++ +| .|++|++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC--ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 4444444444442 332 444444444444444444322244444444444444444442 34 444444444444444
Q ss_pred ccccccC-CccccCCCccCeeecccccccccCC
Q 005999 156 NNLTGLI-PVNLTALDRLYSLKLEWNRFSGTVP 187 (665)
Q Consensus 156 N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~ 187 (665)
|+|++.. |..++.+++|+.|+|++|+|++.+|
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 4444443 4444444444444444444444444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.48 E-value=5.5e-14 Score=153.67 Aligned_cols=146 Identities=29% Similarity=0.355 Sum_probs=124.5
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..+++.|++++|.+.+. ++ ++.+++|+.|+|++|++++. +.+..+++|+.|+|++|.+++..| +..+++|+.|+
T Consensus 198 l~~L~~L~l~~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 271 (466)
T 1o6v_A 198 LTNLESLIATNNQISDI-TP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271 (466)
T ss_dssp CTTCSEEECCSSCCCCC-GG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred CCCCCEEEecCCccccc-cc--ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEE
Confidence 36899999999999954 33 77899999999999999875 568889999999999999996544 88999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~ 227 (665)
|++|++++..| +..+++|+.|++++|++++.++-..+++|+.|++++|++++..| ...+.+|..+++++|..
T Consensus 272 l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l 343 (466)
T 1o6v_A 272 LGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKV 343 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCC
T ss_pred CCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCcc
Confidence 99999996544 88999999999999999988775588999999999999998766 56788889999988854
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.48 E-value=9.3e-14 Score=151.14 Aligned_cols=142 Identities=19% Similarity=0.100 Sum_probs=113.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|++++|+..+.+ .+..+++|+.|+|++|+|++.+ ++.+++|+.|+|++|++++. .++.+++|+.|+|
T Consensus 148 ~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~L 219 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL---DVTPQTQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC 219 (457)
T ss_dssp TTCCEEECTTCSCCCCC---CCTTCTTCCEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEEC
T ss_pred CcCCEEECCCCCccccc---ccccCCcCCEEECCCCccceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEEC
Confidence 57899999999777676 3788999999999999999854 88889999999999999854 3888999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCC-------CcceEecccccccccCCCCCcccCcCcccccC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQP-------FLVVFNVSGNNLTGQVPETPTLLKFDASSFSM 224 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~-------~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~ 224 (665)
++|+|++ +| +..+++|+.|++++|++++.++.. .+. +|+.|++++|++.|.+|. ..+.+|..+++++
T Consensus 220 s~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~-~~l~~L~~L~Ls~ 295 (457)
T 3bz5_A 220 SSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA-EGCRKIKELDVTH 295 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEEC-TTCTTCCCCCCTT
T ss_pred cCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccc-cccccCCEEECCC
Confidence 9999996 66 888999999999999999876432 222 456677777777777763 4567788888888
Q ss_pred CCC
Q 005999 225 NPN 227 (665)
Q Consensus 225 n~~ 227 (665)
|+.
T Consensus 296 n~~ 298 (457)
T 3bz5_A 296 NTQ 298 (457)
T ss_dssp CTT
T ss_pred Ccc
Confidence 864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-13 Score=144.52 Aligned_cols=107 Identities=25% Similarity=0.280 Sum_probs=87.7
Q ss_pred ccccceeecCCCEEEEEecCC-CCcccCCccccCCCCCCcEEEccC-CcCccCCC-CCCCCCCCCEEEccCcccCCcCcc
Q 005999 64 CQWQGVKCAQGRVVRFVLQSF-GLRGTFPPNTLTRLDQLRVLSLHN-NSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPL 140 (665)
Q Consensus 64 C~w~gv~C~~~~v~~l~l~~~-~l~g~l~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~ 140 (665)
|.|..|.| +++ +|+ .||. |..+++|+.|+|++ |+|+++++ .|++|++|+.|+|++|+|++..|.
T Consensus 8 C~~~~v~~----------~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRC----------TRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEEC----------CSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEc----------CCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 77777766 455 787 5876 89999999999996 99999887 789999999999999999988888
Q ss_pred cccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccc
Q 005999 141 SILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG 184 (665)
Q Consensus 141 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (665)
.|.+|++|+.|||++|+|++..|..+..++ |+.|+|++|.|..
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 899999999999999999865555555554 8888888887764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.46 E-value=4.4e-13 Score=145.69 Aligned_cols=117 Identities=22% Similarity=0.233 Sum_probs=57.2
Q ss_pred CCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecc
Q 005999 99 DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLE 178 (665)
Q Consensus 99 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 178 (665)
++|++|+|++|++++ +|+|+++++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .+.++++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 345555555555554 2345555555555555555552 44322 345555555555553 34 35555555555555
Q ss_pred cccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 179 WNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 179 ~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
+|++++.+.. .++|+.|++++|+++ .+|....+.+|..+++++|
T Consensus 204 ~N~l~~l~~~--~~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N 247 (454)
T 1jl5_A 204 NNSLKKLPDL--PLSLESIVAGNNILE-ELPELQNLPFLTTIYADNN 247 (454)
T ss_dssp SSCCSSCCCC--CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSS
T ss_pred CCcCCcCCCC--cCcccEEECcCCcCC-cccccCCCCCCCEEECCCC
Confidence 5555543221 134555555555555 3444444555555555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.7e-13 Score=141.94 Aligned_cols=143 Identities=24% Similarity=0.376 Sum_probs=66.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+++++++. .++ .+..+++|++|+|++|++++.++ +..+++|++|+|++|.++ .+| .|.++++|++|+|
T Consensus 44 ~~L~~L~l~~~~i~-~~~--~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l 117 (347)
T 4fmz_A 44 ESITKLVVAGEKVA-SIQ--GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYL 117 (347)
T ss_dssp TTCSEEECCSSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred ccccEEEEeCCccc-cch--hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEEC
Confidence 34455555555554 333 24445555555555555554433 445555555555555554 232 3455555555555
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
++|++++. |. +..+++|+.|++++|.....++.. .+++|++|++++|.+.+..+ ...+.+|..+++++|
T Consensus 118 ~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 118 NEDNISDI-SP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYN 187 (347)
T ss_dssp TTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTS
T ss_pred cCCcccCc-hh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCC
Confidence 55555422 22 445555555555555333333333 44455555555555443322 233444444444444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.43 E-value=3.9e-15 Score=155.33 Aligned_cols=114 Identities=16% Similarity=0.153 Sum_probs=54.3
Q ss_pred CccccceeecCCCEEEEEecCCCCcccCCccccCCC--CCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCc-Cc
Q 005999 63 YCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRL--DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGA-FP 139 (665)
Q Consensus 63 ~C~w~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~-~p 139 (665)
|.+|.++.|+...++.|+++++.+.. ..+..+ ++|+.|++++|.+.+.++.+..+++|++|+|++|.+++. +|
T Consensus 36 c~~W~~~~~~~~~~~~l~l~~~~~~~----~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 36 CKRWYRLASDESLWQTLDLTGKNLHP----DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp CHHHHHHHTCSTTSSEEECTTCBCCH----HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHHHhcCchhheeeccccccCCH----HHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHH
Confidence 34577766654445555555554441 133333 444444444444444444444444444444444444433 44
Q ss_pred ccccCCCCCCEEEeecccccccCCccccCCCccCeeecccc
Q 005999 140 LSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWN 180 (665)
Q Consensus 140 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (665)
..+.++++|++|+|++|.+++..|..++.+++|+.|+|++|
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~ 152 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 152 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCC
Confidence 44444444444444444444444444444444444444444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-12 Score=142.32 Aligned_cols=137 Identities=22% Similarity=0.210 Sum_probs=111.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|++++ +| .++++++|++|+|++|++++++..+ .+|++|+|++|++++ +| .|+++++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp--~~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP--ELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC--CCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc--ccCCCCCCCEEECCCCcCcccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 578999999999995 77 4999999999999999999854433 589999999999995 77 6999999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
++|++++ +|... ++|+.|++++|+++..+ .+ .+++|++|++++|++++ +|. .+.+|..+++++|.
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~-l~~--~~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNY 268 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCS--CCTTCCEEECCSSC
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCCccc-ccCCCCCCCEEECCCCcCCc-ccc--cccccCEEECCCCc
Confidence 9999985 55432 58889999999888544 45 78888999999998886 442 34667777777774
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.4e-12 Score=146.46 Aligned_cols=51 Identities=27% Similarity=0.194 Sum_probs=23.1
Q ss_pred CccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 170 DRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 170 ~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
++|+.|+|++|+|++++ ..+++|+.|++++|+|++ +|. .+.+|..+++++|
T Consensus 221 ~~L~~L~Ls~N~L~~lp--~~l~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N 271 (622)
T 3g06_A 221 SGLKELIVSGNRLTSLP--VLPSELKELMVSGNRLTS-LPM--LPSGLLSLSVYRN 271 (622)
T ss_dssp TTCCEEECCSSCCSCCC--CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSS
T ss_pred CCCCEEEccCCccCcCC--CCCCcCcEEECCCCCCCc-CCc--ccccCcEEeCCCC
Confidence 44555555555555433 233445555555555542 222 3334444444444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=140.99 Aligned_cols=107 Identities=20% Similarity=0.144 Sum_probs=96.0
Q ss_pred cEEEccCC-cCccCCCCCCCCCCCCEEEccC-cccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeeccc
Q 005999 102 RVLSLHNN-SLTGPIPDLSSLINLKSLSLSR-NFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEW 179 (665)
Q Consensus 102 ~~L~L~~N-~l~~~~p~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 179 (665)
..++++++ +|+++++ |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 35789998 9999877 99999999999996 999988888999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-CCCCcceEecccccccccCC
Q 005999 180 NRFSGTVPPL-NQPFLVVFNVSGNNLTGQVP 209 (665)
Q Consensus 180 N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p 209 (665)
|+|+++++.. ....|+.|+|++|+|.....
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999988875 44449999999999986543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.8e-14 Score=148.78 Aligned_cols=154 Identities=19% Similarity=0.183 Sum_probs=113.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccC-CC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGP-IP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~-~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (665)
..++.|++++|.+.+..+. +..+++|+.|+|++|.+++. ++ .+..+++|++|+|++|.+++..|..|+++++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 5788888888888865443 66788888888888888764 44 57788888888888888888888888888888888
Q ss_pred Eeecc-cccc-cCCccccCCCccCeeecccc-ccccc-CCCC--CCC-CcceEecccc--ccc-ccCCCC-CcccCcCcc
Q 005999 152 DLSYN-NLTG-LIPVNLTALDRLYSLKLEWN-RFSGT-VPPL--NQP-FLVVFNVSGN--NLT-GQVPET-PTLLKFDAS 220 (665)
Q Consensus 152 ~L~~N-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~--~~~-~L~~l~l~~N--~l~-~~~p~~-~~l~~l~~~ 220 (665)
+|++| .+++ .+|..+..+++|+.|++++| .+++. ++.. .++ +|++|++++| .++ +.+|.. ..+++|..+
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 88888 6775 36666778888888888888 88753 3332 667 8888888888 444 233322 356677777
Q ss_pred cccCCCCCC
Q 005999 221 SFSMNPNLC 229 (665)
Q Consensus 221 ~~~~n~~lc 229 (665)
++++|..+.
T Consensus 228 ~l~~~~~l~ 236 (336)
T 2ast_B 228 DLSDSVMLK 236 (336)
T ss_dssp ECTTCTTCC
T ss_pred eCCCCCcCC
Confidence 787776443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.35 E-value=2e-12 Score=135.64 Aligned_cols=154 Identities=17% Similarity=0.106 Sum_probs=123.4
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcE-EEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRV-LSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTI 150 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~-L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 150 (665)
-.+++.|+|++|.+.+.+|+..|.++++|+. +.+++|+|+.++| .|.++++|++|++++|+|++..+..+....++..
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 3689999999999988899888999999875 6677899999988 7899999999999999999666667777778888
Q ss_pred EEeec-ccccccCCccccCCC-ccCeeecccccccccCCCC-CCCCcceEecccccccccCCC-C-CcccCcCcccccCC
Q 005999 151 LDLSY-NNLTGLIPVNLTALD-RLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE-T-PTLLKFDASSFSMN 225 (665)
Q Consensus 151 L~L~~-N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~-~-~~l~~l~~~~~~~n 225 (665)
|++.+ |++....+..|..+. .|+.|+|++|+|+.+++.. ...+|+.|++++|+..+.+|. . ..+.+|..+++++|
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N 212 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTS
T ss_pred hhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCC
Confidence 88865 567755555666665 6888999999998877765 667888899876443335553 2 56788888888888
Q ss_pred C
Q 005999 226 P 226 (665)
Q Consensus 226 ~ 226 (665)
.
T Consensus 213 ~ 213 (350)
T 4ay9_X 213 R 213 (350)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.30 E-value=4.8e-14 Score=150.14 Aligned_cols=61 Identities=26% Similarity=0.327 Sum_probs=26.7
Q ss_pred CCCCEEEccCcccC-CcCc---ccccCCCCCCEEEeeccccc--c---cCCccccCCCccCeeecccccc
Q 005999 122 INLKSLSLSRNFFS-GAFP---LSILSLHRLTILDLSYNNLT--G---LIPVNLTALDRLYSLKLEWNRF 182 (665)
Q Consensus 122 ~~L~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l 182 (665)
++|++|+|++|+++ +.+| ..|..+++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|.+
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l 228 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCC
Confidence 44444444444444 2233 23334444444444444444 1 2222444444444444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.8e-13 Score=142.90 Aligned_cols=152 Identities=22% Similarity=0.268 Sum_probs=86.4
Q ss_pred CCEEEEEecCCCCcccCCc----cccCCCC-CCcEEEccCCcCccCCC-CCCCC-----CCCCEEEccCcccCCcCcccc
Q 005999 74 GRVVRFVLQSFGLRGTFPP----NTLTRLD-QLRVLSLHNNSLTGPIP-DLSSL-----INLKSLSLSRNFFSGAFPLSI 142 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~----~~~~~l~-~L~~L~L~~N~l~~~~p-~~~~l-----~~L~~L~Ls~N~l~~~~p~~~ 142 (665)
..++.|+|++|.++ .+++ ..+..++ +|+.|+|++|+|++..+ .+..+ ++|++|+|++|++++..+..+
T Consensus 22 ~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 22 HGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp TTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 34667777777766 3443 3566666 67777777777766554 34333 667777777777765555543
Q ss_pred cC----C-CCCCEEEeecccccccCCcccc----C-CCccCeeecccccccccCCC----C--CC-CCcceEeccccccc
Q 005999 143 LS----L-HRLTILDLSYNNLTGLIPVNLT----A-LDRLYSLKLEWNRFSGTVPP----L--NQ-PFLVVFNVSGNNLT 205 (665)
Q Consensus 143 ~~----l-~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~l~~N~l~~~~~~----~--~~-~~L~~l~l~~N~l~ 205 (665)
.. + ++|+.|+|++|+|++..+..+. . .++|+.|+|++|++++.... . .. ++|+.|+|++|+++
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 33 3 6677777777777655444332 2 24677777777766643221 1 22 26677777777666
Q ss_pred ccCCCC-----Ccc-cCcCcccccCCC
Q 005999 206 GQVPET-----PTL-LKFDASSFSMNP 226 (665)
Q Consensus 206 ~~~p~~-----~~l-~~l~~~~~~~n~ 226 (665)
+..+.. ... .+|..+++++|.
T Consensus 181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 207 (362)
T 3goz_A 181 SKNCAELAKFLASIPASVTSLDLSANL 207 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred hhhHHHHHHHHHhCCCCCCEEECCCCC
Confidence 543311 112 355666666653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.28 E-value=2e-13 Score=145.28 Aligned_cols=153 Identities=18% Similarity=0.199 Sum_probs=82.1
Q ss_pred CCEEEEEecCCCCcccCCc---cccCCCCCCcEEEccCC---cCccCCC-C-------CCCCCCCCEEEccCcccCC---
Q 005999 74 GRVVRFVLQSFGLRGTFPP---NTLTRLDQLRVLSLHNN---SLTGPIP-D-------LSSLINLKSLSLSRNFFSG--- 136 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~---~~~~~l~~L~~L~L~~N---~l~~~~p-~-------~~~l~~L~~L~Ls~N~l~~--- 136 (665)
..++.|+|++|++++..+. ..+..+++|+.|+|++| ++++.+| . +..+++|++|+|++|.|++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 3566666666666543211 13556666666666664 3333333 2 2456666666666666665
Q ss_pred -cCcccccCCCCCCEEEeecccccccCCcccc----CC---------CccCeeeccccccc-ccCCC----C-CCCCcce
Q 005999 137 -AFPLSILSLHRLTILDLSYNNLTGLIPVNLT----AL---------DRLYSLKLEWNRFS-GTVPP----L-NQPFLVV 196 (665)
Q Consensus 137 -~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~l~~N~l~-~~~~~----~-~~~~L~~ 196 (665)
.+|..+.++++|++|+|++|.|++..+..+. .+ ++|+.|+|++|+++ +.++. + .+++|+.
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 3555666666666666666666533332222 22 56666666666665 22221 1 4456666
Q ss_pred Eeccccccc--c---cCC-CCCcccCcCcccccCCC
Q 005999 197 FNVSGNNLT--G---QVP-ETPTLLKFDASSFSMNP 226 (665)
Q Consensus 197 l~l~~N~l~--~---~~p-~~~~l~~l~~~~~~~n~ 226 (665)
|++++|+++ | .+| ....+.+|..+++++|.
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~ 227 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSC
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCC
Confidence 666666665 2 223 33445555556665553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.26 E-value=2.2e-14 Score=137.66 Aligned_cols=131 Identities=24% Similarity=0.249 Sum_probs=111.9
Q ss_pred cCCCCCCcEEEccCCcCccCCC-------CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCcccc
Q 005999 95 LTRLDQLRVLSLHNNSLTGPIP-------DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLT 167 (665)
Q Consensus 95 ~~~l~~L~~L~L~~N~l~~~~p-------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 167 (665)
+.....++.++|+.|.++|..| .|..+++|++|+|++|++++ +| .+.++++|+.|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 4556788888999999998877 37789999999999999995 88 9999999999999999999 7888888
Q ss_pred CCCccCeeecccccccccCCCC-CCCCcceEecccccccccCC--CCCcccCcCcccccCCCCCC
Q 005999 168 ALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVP--ETPTLLKFDASSFSMNPNLC 229 (665)
Q Consensus 168 ~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p--~~~~l~~l~~~~~~~n~~lc 229 (665)
.+++|+.|+|++|++++.+ .+ .+++|+.|++++|++++..+ ....+.+|..+++++|+..|
T Consensus 91 ~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred cCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence 8899999999999999865 44 78899999999999996432 34667889999999997543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.23 E-value=1e-12 Score=138.64 Aligned_cols=148 Identities=20% Similarity=0.197 Sum_probs=119.7
Q ss_pred EEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-----CCCCCC-CCCEEEccCcccCCcCcccccCC-----C
Q 005999 78 RFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-----DLSSLI-NLKSLSLSRNFFSGAFPLSILSL-----H 146 (665)
Q Consensus 78 ~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~ 146 (665)
.++|+.|+++|.+|. .+...++|+.|+|++|.|++..+ .|..++ +|++|+|++|+|++..+..|..+ +
T Consensus 2 ~~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 367899999988775 67777779999999999998875 467788 99999999999998888888775 9
Q ss_pred CCCEEEeecccccccCCccccC----C-CccCeeecccccccccCCCC------C-CCCcceEecccccccccCCCC---
Q 005999 147 RLTILDLSYNNLTGLIPVNLTA----L-DRLYSLKLEWNRFSGTVPPL------N-QPFLVVFNVSGNNLTGQVPET--- 211 (665)
Q Consensus 147 ~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~l~~N~l~~~~~~~------~-~~~L~~l~l~~N~l~~~~p~~--- 211 (665)
+|++|+|++|+|++..+..+.. + ++|+.|+|++|++++..+.. . .++|++|+|++|+|+...+..
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 9999999999999877775544 4 89999999999998876642 2 368999999999999532210
Q ss_pred --Ccc-cCcCcccccCCC
Q 005999 212 --PTL-LKFDASSFSMNP 226 (665)
Q Consensus 212 --~~l-~~l~~~~~~~n~ 226 (665)
..+ .+|..+++++|.
T Consensus 161 ~l~~~~~~L~~L~Ls~n~ 178 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNN 178 (362)
T ss_dssp HHHTSCTTCCEEECTTSC
T ss_pred HHhcCCccccEeeecCCC
Confidence 122 378888888874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.1e-10 Score=114.97 Aligned_cols=132 Identities=17% Similarity=0.061 Sum_probs=100.9
Q ss_pred HhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
.++.|+.+.||++... +..+++|+...... .....+.+|+++++.+ .|..+.++++++...+..++||||++|.+|
T Consensus 21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp CCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred eccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 4677788999999755 56889999865321 1123477888888877 367788899999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA------------------------------------------- 511 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------------------------------- 511 (665)
.+.+.. ......++.+++++|+.||+.
T Consensus 98 ~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 98 SEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp HHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred hhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 876321 112346788999999999981
Q ss_pred ---------------CCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 512 ---------------SWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 512 ---------------~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
..++|+|+++.||+++++..+.|+||+.+
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 11789999999999987655679999765
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.05 E-value=4e-12 Score=138.47 Aligned_cols=154 Identities=18% Similarity=0.115 Sum_probs=112.5
Q ss_pred CCEEEEEecCCCCccc----CCccccCCCCCCcEEEccCCcCccC----CC-CCCCCCCCCEEEccCcccCCcCcccccC
Q 005999 74 GRVVRFVLQSFGLRGT----FPPNTLTRLDQLRVLSLHNNSLTGP----IP-DLSSLINLKSLSLSRNFFSGAFPLSILS 144 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~----l~~~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 144 (665)
..++.|+|++|.+++. +.+..+..+++|+.|+|++|+++.. ++ .+..+++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 6788999999988753 2233445688999999999998873 23 5667888999999999887554444433
Q ss_pred -----CCCCCEEEeeccccccc----CCccccCCCccCeeecccccccccCCCC-------CCCCcceEecccccccc--
Q 005999 145 -----LHRLTILDLSYNNLTGL----IPVNLTALDRLYSLKLEWNRFSGTVPPL-------NQPFLVVFNVSGNNLTG-- 206 (665)
Q Consensus 145 -----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~-------~~~~L~~l~l~~N~l~~-- 206 (665)
.++|+.|+|++|.+++. +|..+..+++|+.|+|++|++++..+.. ..++|+.|++++|++++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 36889999999988865 4566777888999999999887654321 15688999999998885
Q ss_pred --cCCC-CCcccCcCcccccCCCC
Q 005999 207 --QVPE-TPTLLKFDASSFSMNPN 227 (665)
Q Consensus 207 --~~p~-~~~l~~l~~~~~~~n~~ 227 (665)
.+|. ...+.+|..+++++|+.
T Consensus 387 ~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 387 CSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp HHHHHHHHHHCCCCCEEECCSSSC
T ss_pred HHHHHHHHHhCCCccEEECCCCCC
Confidence 4442 23466788888888853
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.05 E-value=2.3e-12 Score=140.32 Aligned_cols=152 Identities=18% Similarity=0.121 Sum_probs=120.2
Q ss_pred CCEEEEEecCCCCccc----CCccccCCCCCCcEEEccCCcCccCC-----C-CCCCCCCCCEEEccCcccCCc----Cc
Q 005999 74 GRVVRFVLQSFGLRGT----FPPNTLTRLDQLRVLSLHNNSLTGPI-----P-DLSSLINLKSLSLSRNFFSGA----FP 139 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~----l~~~~~~~l~~L~~L~L~~N~l~~~~-----p-~~~~l~~L~~L~Ls~N~l~~~----~p 139 (665)
.+++.|+|++|++++. ++. .+..+++|+.|+|++|.++... + -+..+++|++|+|++|++++. ++
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 4899999999999963 454 6888999999999999998642 2 244689999999999999954 78
Q ss_pred ccccCCCCCCEEEeecccccccCCccccC-----CCccCeeecccccccccC----CCC--CCCCcceEecccccccccC
Q 005999 140 LSILSLHRLTILDLSYNNLTGLIPVNLTA-----LDRLYSLKLEWNRFSGTV----PPL--NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 140 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~----~~~--~~~~L~~l~l~~N~l~~~~ 208 (665)
..+.++++|+.|+|++|.+++..+..+.. .++|+.|++++|.+++.. +.. .+++|+.|++++|++++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 88888999999999999998655544433 369999999999998752 222 5689999999999998653
Q ss_pred CCC------CcccCcCcccccCCC
Q 005999 209 PET------PTLLKFDASSFSMNP 226 (665)
Q Consensus 209 p~~------~~l~~l~~~~~~~n~ 226 (665)
+.. ....+|..+++++|.
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHHcCCCCceEEEECCCCC
Confidence 311 114578888898884
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1.5e-12 Score=129.58 Aligned_cols=146 Identities=16% Similarity=0.114 Sum_probs=80.8
Q ss_pred CCccccceeecCC--CEEEEEecC---CCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCE--EEccCc
Q 005999 62 DYCQWQGVKCAQG--RVVRFVLQS---FGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKS--LSLSRN 132 (665)
Q Consensus 62 ~~C~w~gv~C~~~--~v~~l~l~~---~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~--L~Ls~N 132 (665)
..|+|.|+.|+.. +|..+...+ ..+.|.++++.+..++. .|...+|..++.++ .|...+.|.. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 3689999999863 777666655 34555666544433332 22222333333322 2333444444 555666
Q ss_pred ccC---CcCcccccCCCCCCEEEeecccccc--cCCccccCCCccCeeecccccccccCCCCCCC--CcceEeccccccc
Q 005999 133 FFS---GAFPLSILSLHRLTILDLSYNNLTG--LIPVNLTALDRLYSLKLEWNRFSGTVPPLNQP--FLVVFNVSGNNLT 205 (665)
Q Consensus 133 ~l~---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~--~L~~l~l~~N~l~ 205 (665)
+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++...-..+. +|+.|+|++|.++
T Consensus 154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTG
T ss_pred HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCc
Confidence 433 2222222456667777777777765 34455566677777777777776652111222 6777777777777
Q ss_pred ccCC
Q 005999 206 GQVP 209 (665)
Q Consensus 206 ~~~p 209 (665)
+.+|
T Consensus 234 ~~~~ 237 (267)
T 3rw6_A 234 DTFR 237 (267)
T ss_dssp GGCS
T ss_pred cccC
Confidence 6655
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=5.9e-10 Score=111.21 Aligned_cols=125 Identities=11% Similarity=0.104 Sum_probs=93.2
Q ss_pred CcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCC--eeeeeEEEEeCCeEEEEEEecCCCCHH
Q 005999 398 GRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN--LVPIRAYFQAKGERLVIYDYQPNGSLF 475 (665)
Q Consensus 398 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~ 475 (665)
+.|..+.||++...+|..+++|...... ...+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 3556699999987777789999976541 134677888888775444 556888888888899999999998884
Q ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 005999 476 NLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS------------------------------------------- 512 (665)
Q Consensus 476 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------------- 512 (665)
... .+ ...++.+++..|+.||+..
T Consensus 104 --~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 --SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp --TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred --cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 211 11 1256777888888888643
Q ss_pred --------------CeeccCCCCCceEeCCCCceEEeecccc
Q 005999 513 --------------WLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 513 --------------~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
.++|+|++|.||+++++..+.|+||+.+
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 1899999999999987766779999875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.2e-09 Score=110.04 Aligned_cols=41 Identities=10% Similarity=0.338 Sum_probs=32.8
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP 116 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p 116 (665)
..++.|+|++ +++ .|++..|.++++|+.|+|++|.+..+.+
T Consensus 101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~ 141 (329)
T 3sb4_A 101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLP 141 (329)
T ss_dssp TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECT
T ss_pred CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccch
Confidence 5788888888 888 7888889999999999999998755444
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.4e-09 Score=112.49 Aligned_cols=139 Identities=18% Similarity=0.277 Sum_probs=102.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEec--CCCchhhHHHHHHHHHHHHhCCC--CCCeeeeeEEEEeC---CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFD--ANKTADTSAEAFEQHMEAVGGLS--HPNLVPIRAYFQAK---GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 467 (665)
+.++.|.++.||+....++ .+++|+.. .... ......+.+|+++++.+. +..+.++++++.+. +..++|||
T Consensus 44 ~~l~~G~sn~~y~v~~~~~-~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQ-TYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECSSC-EEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEECCc-eEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4588999999999987654 67778765 3221 122346778888888886 45578888888776 45899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA------------------------------------ 511 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------------------------ 511 (665)
|++|..+.+. ....++...+..++.++++.|+.||+.
T Consensus 122 ~v~G~~l~~~-------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQ-------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCT-------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCC-------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999777431 112367888889999999999999972
Q ss_pred ---------------------CCeeccCCCCCceEeCCCCc--eEEeecccccc
Q 005999 512 ---------------------SWLIHGNLKSSNVLLGADFE--ARLTDYCLSVL 542 (665)
Q Consensus 512 ---------------------~~iiH~Dlk~~Nill~~~~~--~kl~Dfgl~~~ 542 (665)
..++|+|+++.||+++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 23899999999999997753 68999998754
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.9e-11 Score=125.78 Aligned_cols=153 Identities=16% Similarity=0.122 Sum_probs=80.9
Q ss_pred CCEEEEEecCCCCcccCCc---cccC-CCCCCcEEEccCCcCccCCC-CC-CCCCCCCEEEccCcccCCcCcccc-----
Q 005999 74 GRVVRFVLQSFGLRGTFPP---NTLT-RLDQLRVLSLHNNSLTGPIP-DL-SSLINLKSLSLSRNFFSGAFPLSI----- 142 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~---~~~~-~l~~L~~L~L~~N~l~~~~p-~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 142 (665)
..++.|+|++|.++..-.. ..+. ..++|+.|+|++|.|+.... .+ ..+++|+.|+|++|+|+..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 4566777777776632111 0122 22567777777776654322 22 234566777777777664333333
Q ss_pred cCCCCCCEEEeecccccc----cCCccccCCCccCeeecccccccccC----CC-C-CCCCcceEecccccccccC----
Q 005999 143 LSLHRLTILDLSYNNLTG----LIPVNLTALDRLYSLKLEWNRFSGTV----PP-L-NQPFLVVFNVSGNNLTGQV---- 208 (665)
Q Consensus 143 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~----~~-~-~~~~L~~l~l~~N~l~~~~---- 208 (665)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+... .. . ..++|+.|+|++|.|+..-
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 234567777777776653 23333455666777777777665421 11 1 3446677777777665321
Q ss_pred CC-CCcccCcCcccccCCC
Q 005999 209 PE-TPTLLKFDASSFSMNP 226 (665)
Q Consensus 209 p~-~~~l~~l~~~~~~~n~ 226 (665)
+. .....+|..+++++|+
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHHHHCSSCCEEECTTSS
T ss_pred HHHHHhCCCCCEEeccCCC
Confidence 10 0123456666666664
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.85 E-value=3.5e-09 Score=109.74 Aligned_cols=62 Identities=10% Similarity=0.103 Sum_probs=52.0
Q ss_pred CCCEEEEEecCCCCc----------c---------cCCccccCC--------CCCCcEEEccCCcCccCCC-CCCCCCCC
Q 005999 73 QGRVVRFVLQSFGLR----------G---------TFPPNTLTR--------LDQLRVLSLHNNSLTGPIP-DLSSLINL 124 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~----------g---------~l~~~~~~~--------l~~L~~L~L~~N~l~~~~p-~~~~l~~L 124 (665)
..+++.|||++|++. + .||+..|.+ +++|+.|+|.+ +++.+.+ .|.+|++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 457888888888777 1 467778888 99999999999 8988887 79999999
Q ss_pred CEEEccCcccC
Q 005999 125 KSLSLSRNFFS 135 (665)
Q Consensus 125 ~~L~Ls~N~l~ 135 (665)
+.|+|++|.+.
T Consensus 127 ~~l~l~~n~i~ 137 (329)
T 3sb4_A 127 KICQIRKKTAP 137 (329)
T ss_dssp CEEEBCCSSCC
T ss_pred ceEEcCCCCcc
Confidence 99999999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=2.9e-11 Score=127.58 Aligned_cols=134 Identities=22% Similarity=0.188 Sum_probs=104.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CC-----CCCCCCCEEEccCcccCC----cCccccc
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DL-----SSLINLKSLSLSRNFFSG----AFPLSIL 143 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~ 143 (665)
..++.|+|++|+++..-.......+++|+.|+|++|+|+.... .+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 5899999999999753332223346789999999999976543 22 356899999999999974 3556668
Q ss_pred CCCCCCEEEeeccccccc----CCccccCCCccCeeecccccccccCCC-----C-CCCCcceEeccccccccc
Q 005999 144 SLHRLTILDLSYNNLTGL----IPVNLTALDRLYSLKLEWNRFSGTVPP-----L-NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 144 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~-----~-~~~~L~~l~l~~N~l~~~ 207 (665)
.+++|++|||++|.|+.. ++..+..+++|+.|+|++|.|+..... . ..++|++|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 899999999999999853 355677888999999999999854221 1 457899999999999853
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.62 E-value=8.4e-09 Score=105.60 Aligned_cols=180 Identities=14% Similarity=0.110 Sum_probs=116.2
Q ss_pred HhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCC--eeeeeEEEEeCC---eEEEEEEec
Q 005999 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPN--LVPIRAYFQAKG---ERLVIYDYQ 469 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~ 469 (665)
.++.|.+..||+.. ..+++|+.... .....+.+|+++++.+ .+.. +.+++.+....+ ..|+||||+
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 47899999999863 35778875432 3456788899998877 3333 344544443332 347899999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-------------------------------------- 511 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-------------------------------------- 511 (665)
+|.+|.+... ..++..++..++.+++..++.||+.
T Consensus 99 ~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 99 KGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred CCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9988875332 2356677778888888888888851
Q ss_pred -------------------CCeeccCCCCCceEeCC--CCceEEeecccccccCCCCCCCCCCCcc---cCCcccc----
Q 005999 512 -------------------SWLIHGNLKSSNVLLGA--DFEARLTDYCLSVLSDSSSVEDPDTVAY---KAPEIRK---- 563 (665)
Q Consensus 512 -------------------~~iiH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~gt~~y---~aPE~~~---- 563 (665)
..++|+|+++.||++++ ...+.|+||+.+...+..... .....+ ..|+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhccccCHHHHHHHHH
Confidence 12699999999999998 456789999987654331100 000000 1222110
Q ss_pred CCC---------CCCCcchHHHHHHHHHHHHhCCCCC
Q 005999 564 SSR---------RATSKSDVYAFGVLLLELLTGKHPS 591 (665)
Q Consensus 564 ~~~---------~~~~k~DvwSlGvvl~elltg~~P~ 591 (665)
..+ ......+.|++|.++|++.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 0112358999999999999998764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.59 E-value=2.5e-09 Score=120.16 Aligned_cols=153 Identities=11% Similarity=0.066 Sum_probs=103.6
Q ss_pred CCEEEEEec-----------CCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCC-CCCCCEEEcc----CcccCC
Q 005999 74 GRVVRFVLQ-----------SFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSS-LINLKSLSLS----RNFFSG 136 (665)
Q Consensus 74 ~~v~~l~l~-----------~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~-l~~L~~L~Ls----~N~l~~ 136 (665)
.+++.|+|+ .+.+++.-....+..+++|+.|+|+.|++++..+ .++. +++|+.|+|+ .|.+++
T Consensus 342 ~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~ 421 (592)
T 3ogk_B 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD 421 (592)
T ss_dssp TTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSS
T ss_pred CCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccC
Confidence 578888888 3566643222234557888888888888877555 4544 7888888885 777875
Q ss_pred c-----CcccccCCCCCCEEEeec--ccccccCCccccC-CCccCeeeccccccccc-CCCC--CCCCcceEeccccccc
Q 005999 137 A-----FPLSILSLHRLTILDLSY--NNLTGLIPVNLTA-LDRLYSLKLEWNRFSGT-VPPL--NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 137 ~-----~p~~~~~l~~L~~L~L~~--N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~-~~~~--~~~~L~~l~l~~N~l~ 205 (665)
. ++..+.++++|+.|+|++ |.+++..+..+.. +++|+.|+|++|++++. ++.. .+++|+.|++++|+|+
T Consensus 422 ~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 422 LPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp CCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred chHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 3 444466788888888874 3466555555543 77888888888888752 2322 6678888888888876
Q ss_pred cc-CCCC-CcccCcCcccccCCC
Q 005999 206 GQ-VPET-PTLLKFDASSFSMNP 226 (665)
Q Consensus 206 ~~-~p~~-~~l~~l~~~~~~~n~ 226 (665)
+. ++.. ..+++|..+++++|.
T Consensus 502 ~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 502 ERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHHHHHhcCccCeeECcCCc
Confidence 43 2221 346677788888876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.53 E-value=3.1e-09 Score=105.58 Aligned_cols=113 Identities=22% Similarity=0.191 Sum_probs=72.5
Q ss_pred CCCcccCCccccCCCCCCcE--EEccCCcCcc---CCC-CCCCCCCCCEEEccCcccCC--cCcccccCCCCCCEEEeec
Q 005999 84 FGLRGTFPPNTLTRLDQLRV--LSLHNNSLTG---PIP-DLSSLINLKSLSLSRNFFSG--AFPLSILSLHRLTILDLSY 155 (665)
Q Consensus 84 ~~l~g~l~~~~~~~l~~L~~--L~L~~N~l~~---~~p-~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~ 155 (665)
|...+.+.-+.|...+.|.. ++++.|+... ..+ ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++
T Consensus 126 n~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~ 205 (267)
T 3rw6_A 126 DGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 205 (267)
T ss_dssp ETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTT
T ss_pred chhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCC
Confidence 33333333333444555555 6677774332 222 12467888888888888886 5556777888888888888
Q ss_pred ccccccCCccccCCC--ccCeeecccccccccCCCC---------CCCCcceEe
Q 005999 156 NNLTGLIPVNLTALD--RLYSLKLEWNRFSGTVPPL---------NQPFLVVFN 198 (665)
Q Consensus 156 N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~~~---------~~~~L~~l~ 198 (665)
|+|++. ..+..+. +|++|+|++|.+++.+|.. .+++|+.||
T Consensus 206 N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 206 NELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp SCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 888854 3344444 8888888888888766531 455666554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.51 E-value=8e-09 Score=116.01 Aligned_cols=102 Identities=10% Similarity=0.036 Sum_probs=63.7
Q ss_pred EEEEEecCCC-Ccc-cCCccccCCCCCCcEEEccCCcCccCCC-----CCCCCCCCCEEEccCcccC----CcCcccccC
Q 005999 76 VVRFVLQSFG-LRG-TFPPNTLTRLDQLRVLSLHNNSLTGPIP-----DLSSLINLKSLSLSRNFFS----GAFPLSILS 144 (665)
Q Consensus 76 v~~l~l~~~~-l~g-~l~~~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~ 144 (665)
++.|+|+++. ++. .++. .+.++++|+.|+|++|.+++... .+.++++|+.|+|++|.++ +.++..+.+
T Consensus 140 L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp CCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred CcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 7777777765 221 1111 23467777777777777765422 2345677777777777776 344445566
Q ss_pred CCCCCEEEeecccccccCCccccCCCccCeeeccc
Q 005999 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEW 179 (665)
Q Consensus 145 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 179 (665)
+++|+.|+|++|.+.+ +|..+..+++|+.|++++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 7777777777777764 555666666666666654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.5e-08 Score=112.01 Aligned_cols=153 Identities=11% Similarity=0.040 Sum_probs=87.0
Q ss_pred CCEEEEEec---------CCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCC-CCCCCCEEEcc--C----cccCC
Q 005999 74 GRVVRFVLQ---------SFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLS-SLINLKSLSLS--R----NFFSG 136 (665)
Q Consensus 74 ~~v~~l~l~---------~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~-~l~~L~~L~Ls--~----N~l~~ 136 (665)
.+++.|+|. .+.+++.-.......+++|+.|+++.|++++... .+. .+++|+.|+|+ + |.+++
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence 567777773 3344432222112236777777777777765443 333 46777777777 3 45552
Q ss_pred -----cCcccccCCCCCCEEEeecccccccCCccccC-CCccCeeecccccccccCCCC---CCCCcceEeccccccccc
Q 005999 137 -----AFPLSILSLHRLTILDLSYNNLTGLIPVNLTA-LDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 137 -----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~~~~---~~~~L~~l~l~~N~l~~~ 207 (665)
.++..+.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..... .+++|+.|+|++|.+++.
T Consensus 418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 1222255667777777765 555444444544 667777777777765432221 456777777777777533
Q ss_pred CC--CCCcccCcCcccccCCCC
Q 005999 208 VP--ETPTLLKFDASSFSMNPN 227 (665)
Q Consensus 208 ~p--~~~~l~~l~~~~~~~n~~ 227 (665)
.. ....+.+|..+++++|+.
T Consensus 497 ~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 497 ALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHhCCCCCEEeeeCCCC
Confidence 21 113456677777766653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=6.3e-08 Score=91.29 Aligned_cols=112 Identities=16% Similarity=0.175 Sum_probs=67.3
Q ss_pred ccCCCCCCcEEEccCC-cCccCC-----CCCCCCCCCCEEEccCcccCC----cCcccccCCCCCCEEEeeccccccc--
Q 005999 94 TLTRLDQLRVLSLHNN-SLTGPI-----PDLSSLINLKSLSLSRNFFSG----AFPLSILSLHRLTILDLSYNNLTGL-- 161 (665)
Q Consensus 94 ~~~~l~~L~~L~L~~N-~l~~~~-----p~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~-- 161 (665)
.+...+.|+.|+|++| .|.... ..+...++|++|+|++|+|.. .+...+...++|++|+|++|.|...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4556667777777776 665321 134555677777777777663 2334444556677777777777632
Q ss_pred --CCccccCCCccCeeec--ccccccccCC----CC--CCCCcceEeccccccc
Q 005999 162 --IPVNLTALDRLYSLKL--EWNRFSGTVP----PL--NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 162 --~p~~~~~l~~L~~L~l--~~N~l~~~~~----~~--~~~~L~~l~l~~N~l~ 205 (665)
+...+...++|+.|+| ++|.+...-. .. ..++|+.|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3345556667777777 6677654311 11 3456777777777765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.26 E-value=3.7e-07 Score=95.31 Aligned_cols=149 Identities=16% Similarity=0.108 Sum_probs=87.3
Q ss_pred CCEEEEEecCCCCc---------ccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCccccc-
Q 005999 74 GRVVRFVLQSFGLR---------GTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSIL- 143 (665)
Q Consensus 74 ~~v~~l~l~~~~l~---------g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~- 143 (665)
.+++.|.+.++... +.+.+ .+..+++|+.|+|++|.-... +.+. +++|+.|+|..|.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~-ll~~~P~L~~L~L~g~~~l~l-~~~~-~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSP-VLDAMPLLNNLKIKGTNNLSI-GKKP-RPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHH-HHHTCTTCCEEEEECCBTCBC-CSCB-CTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHH-HHhcCCCCcEEEEeCCCCcee-cccc-CCCCcEEEEecCCCChHHHHHHHH
Confidence 46777777654331 12332 456677888888877731122 2233 67888888887777644334443
Q ss_pred -CCCCCCEEEeec--cccccc-----CCccc--cCCCccCeeecccccccccCCC-----CCCCCcceEeccccccccc-
Q 005999 144 -SLHRLTILDLSY--NNLTGL-----IPVNL--TALDRLYSLKLEWNRFSGTVPP-----LNQPFLVVFNVSGNNLTGQ- 207 (665)
Q Consensus 144 -~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~~~-----~~~~~L~~l~l~~N~l~~~- 207 (665)
.+++|+.|+|+. |...+. +...+ ..+++|+.|+|.+|.+....+. ..+++|++|+|+.|.|+..
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G 295 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence 678888888753 222111 11122 2467888888888777643211 1467788888888887652
Q ss_pred ---CCCC-CcccCcCcccccCC
Q 005999 208 ---VPET-PTLLKFDASSFSMN 225 (665)
Q Consensus 208 ---~p~~-~~l~~l~~~~~~~n 225 (665)
++.. ..+.+|..+++++|
T Consensus 296 ~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 296 ARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp HHHHHTTHHHHTTCSEEECCSB
T ss_pred HHHHHhhcccCCcceEEECCCC
Confidence 2222 34566777777666
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.25 E-value=1.9e-08 Score=112.99 Aligned_cols=152 Identities=14% Similarity=0.032 Sum_probs=97.9
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccC---------CcCccCCC-CCC-CCCCCCEEEccCcccCCcCcccc
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHN---------NSLTGPIP-DLS-SLINLKSLSLSRNFFSGAFPLSI 142 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~---------N~l~~~~p-~~~-~l~~L~~L~Ls~N~l~~~~p~~~ 142 (665)
.+++.|+|.++ +...-.+.....+++|+.|+|++ |.+++... .+. .+++|+.|+++.|++++..+..+
T Consensus 314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l 392 (594)
T 2p1m_B 314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392 (594)
T ss_dssp TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence 57888888877 44222221333578888888843 44543222 222 47888888888888887666666
Q ss_pred c-CCCCCCEEEee--c----cccccc-----CCccccCCCccCeeecccccccccCCCC---CCCCcceEeccccccccc
Q 005999 143 L-SLHRLTILDLS--Y----NNLTGL-----IPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 143 ~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~~L~~l~l~~N~l~~~ 207 (665)
. .+++|+.|+|+ + |.+++. ++..+..+++|+.|+|++ .+++..... .+++|+.|++++|.+++.
T Consensus 393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~ 471 (594)
T 2p1m_B 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471 (594)
T ss_dssp HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence 5 48888999998 4 556522 112256678888998876 555433222 367888999998888653
Q ss_pred CC-CC-CcccCcCcccccCCCC
Q 005999 208 VP-ET-PTLLKFDASSFSMNPN 227 (665)
Q Consensus 208 ~p-~~-~~l~~l~~~~~~~n~~ 227 (665)
.+ .. ..+++|..+++++|+.
T Consensus 472 ~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 472 GMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHHHhcCCCcCEEECcCCCC
Confidence 22 11 3356788888888864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.23 E-value=4.4e-06 Score=88.67 Aligned_cols=124 Identities=14% Similarity=0.165 Sum_probs=74.0
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.++.++|.+ .+. .|....|.++++|+.++|++|+++.+.. .|. ..+|+.+.|.+| ++..-...|.++++|+.|+|
T Consensus 158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 477777775 666 6777778888888888888887777666 444 467777777643 55344456666777777777
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEeccccccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~ 205 (665)
..| ++..-...|.+ .+|+.+.| .|.++.+.... .+++|+.+++.+|.+.
T Consensus 234 ~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 234 PEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp CTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred CCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 654 44233333433 45555555 33344333332 4555555555555443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=7.6e-06 Score=83.55 Aligned_cols=133 Identities=16% Similarity=0.092 Sum_probs=90.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCC---CeeeeeEEEE-eCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHP---NLVPIRAYFQ-AKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~ 470 (665)
+.++.|....||+. +..+++|+... ......+.+|.++++.+.+. .+.+++.+.. ..+..++||||++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 34788888899988 34577777422 23456788999999988653 3566777764 4566889999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-------------------------------------- 512 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------------------------------------- 512 (665)
|.++.+..- ..++......++.++++.|+.||+..
T Consensus 97 G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 97 GQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp SEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 988876321 11344444455555555555555321
Q ss_pred ---------------------CeeccCCCCCceEeCC---CCc-eEEeecccccc
Q 005999 513 ---------------------WLIHGNLKSSNVLLGA---DFE-ARLTDYCLSVL 542 (665)
Q Consensus 513 ---------------------~iiH~Dlk~~Nill~~---~~~-~kl~Dfgl~~~ 542 (665)
.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2589999999999997 455 48999987643
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.17 E-value=6.4e-06 Score=87.39 Aligned_cols=144 Identities=14% Similarity=0.082 Sum_probs=95.6
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..++.++|++|+++ .|+...|. ..+|+.+.|.+| ++.+.. .|.++++|+.|+|..| ++..-...|.+ .+|+.++
T Consensus 180 ~~L~~l~l~~n~l~-~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~ 254 (401)
T 4fdw_A 180 YNLKKADLSKTKIT-KLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVK 254 (401)
T ss_dssp TTCCEEECTTSCCS-EECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEE
T ss_pred ccCCeeecCCCcce-EechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEE
Confidence 57889999999998 78887777 588999999854 776666 7888889999998875 55333445555 6788888
Q ss_pred eecccccccCCccccCCCccCeeeccccccc-----ccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFS-----GTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSM 224 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-----~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~ 224 (665)
| .|.++..-+..|.+|++|+.+.+.+|.+. .+.+.. .+++|+.++|.+ .++..-... ..+.+|..+.+..
T Consensus 255 l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 255 L-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp E-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECT
T ss_pred e-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECc
Confidence 7 45566455667777788888887777665 222222 667777777773 354222211 2234455555533
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.4e-06 Score=82.31 Aligned_cols=130 Identities=17% Similarity=0.176 Sum_probs=90.7
Q ss_pred hCcccce-EEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 397 LGRGSIG-TTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 397 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445554 68987744 5667888886432 3456778888887663 3346778999999999999999999988
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA------------------------------------------ 511 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------------------------------------------ 511 (665)
+.+..... ......+..+++..|+.||..
T Consensus 107 ~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 107 AFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp HHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred ccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 87765421 112234555666666666621
Q ss_pred ---------C------CeeccCCCCCceEeCCCCceEEeecccc
Q 005999 512 ---------S------WLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 512 ---------~------~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
. -++|+|+.+.||++++++.+-|.||+.+
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 0 1689999999999998777779999865
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.15 E-value=1.5e-07 Score=88.59 Aligned_cols=110 Identities=18% Similarity=0.200 Sum_probs=86.6
Q ss_pred CCCEEEEEecCC-CCccc----CCccccCCCCCCcEEEccCCcCccCCC-----CCCCCCCCCEEEccCcccCCc----C
Q 005999 73 QGRVVRFVLQSF-GLRGT----FPPNTLTRLDQLRVLSLHNNSLTGPIP-----DLSSLINLKSLSLSRNFFSGA----F 138 (665)
Q Consensus 73 ~~~v~~l~l~~~-~l~g~----l~~~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~~~----~ 138 (665)
...++.|+|++| ++... +.. .+...++|++|+|++|.|..... .+...+.|++|+|++|.|+.. +
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 368999999999 88742 333 57778999999999999975321 345568899999999999853 5
Q ss_pred cccccCCCCCCEEEe--eccccccc----CCccccCCCccCeeeccccccc
Q 005999 139 PLSILSLHRLTILDL--SYNNLTGL----IPVNLTALDRLYSLKLEWNRFS 183 (665)
Q Consensus 139 p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 183 (665)
...+...++|+.|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 667888889999999 88999844 3344566789999999999885
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=6.5e-07 Score=93.47 Aligned_cols=129 Identities=16% Similarity=0.155 Sum_probs=92.9
Q ss_pred CCCEEEEEecCCC-CcccCCccccCCCCCCcEEEccCCcCccCCC-CC--CCCCCCCEEEccC--cccCCc-----Cccc
Q 005999 73 QGRVVRFVLQSFG-LRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DL--SSLINLKSLSLSR--NFFSGA-----FPLS 141 (665)
Q Consensus 73 ~~~v~~l~l~~~~-l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~--~~l~~L~~L~Ls~--N~l~~~-----~p~~ 141 (665)
...++.|+|+++. + .+++ +. +++|+.|+|..+.++...- .+ ..+++|+.|+|+. |...+. +...
T Consensus 171 ~P~L~~L~L~g~~~l--~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~ 245 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL--SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245 (362)
T ss_dssp CTTCCEEEEECCBTC--BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG
T ss_pred CCCCcEEEEeCCCCc--eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH
Confidence 3689999998873 3 3544 43 8999999999988764332 23 3789999999863 332221 1122
Q ss_pred c--cCCCCCCEEEeecccccccCCcccc---CCCccCeeeccccccccc----CCCC--CCCCcceEecccccccc
Q 005999 142 I--LSLHRLTILDLSYNNLTGLIPVNLT---ALDRLYSLKLEWNRFSGT----VPPL--NQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 142 ~--~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~----~~~~--~~~~L~~l~l~~N~l~~ 206 (665)
+ ..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|++. ++.. .+++|+.|+|++|.++.
T Consensus 246 l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp SCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 3 2578999999999999865444443 578999999999999873 2221 57899999999998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.4e-05 Score=83.49 Aligned_cols=81 Identities=10% Similarity=0.026 Sum_probs=52.3
Q ss_pred hHh-CcccceEEEEEEEC-------CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCC-C--CCeeeeeEEEEeC---
Q 005999 395 ELL-GRGSIGTTYKAVLD-------NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLS-H--PNLVPIRAYFQAK--- 459 (665)
Q Consensus 395 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 459 (665)
+.| +.|....+|+.... ++..+++|+...... .......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 346 78889999998764 266788887654320 0001134566777776663 2 3466778877655
Q ss_pred CeEEEEEEecCCCCHH
Q 005999 460 GERLVIYDYQPNGSLF 475 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~ 475 (665)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.0003 Score=72.50 Aligned_cols=138 Identities=17% Similarity=0.221 Sum_probs=75.9
Q ss_pred HhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhC-----CCCCCeeeee-E--EEEeCCeEEEEEE
Q 005999 396 LLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG-----LSHPNLVPIR-A--YFQAKGERLVIYD 467 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-----l~h~niv~l~-~--~~~~~~~~~lv~e 467 (665)
.|+.|..+.||+....++. +++|+..... +.+..|++++.. +..|.++... | +....+..+++||
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRPE------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSCH------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCCH------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4666778999999887775 8889886521 122233333332 3334444311 1 2234677899999
Q ss_pred ecCCCCHH--------------HHHhcCCC-C--C------CCCCCHHHHH-----------------------------
Q 005999 468 YQPNGSLF--------------NLIHGSRS-I--R------AKPLHWTSCL----------------------------- 495 (665)
Q Consensus 468 ~~~~gsL~--------------~~l~~~~~-~--~------~~~l~~~~~~----------------------------- 495 (665)
|++|.++. ..+|.... . . ...-.|...+
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11221100 0 0 0112332211
Q ss_pred --HHHHHHHHHHHHHHh------------CCCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 496 --KIAEDVAQGLAYIHR------------ASWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 496 --~i~~~i~~~L~yLH~------------~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
.+...+..++++|++ ...++|+|+++.||+++.++.+.|+||+.+
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 111123345666652 223899999999999988889999999865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0003 Score=74.40 Aligned_cols=76 Identities=7% Similarity=0.061 Sum_probs=46.4
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCc--h---hhHHHHHHHHHHHHhCCCC--CC-eeeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT--A---DTSAEAFEQHMEAVGGLSH--PN-LVPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~lv 465 (665)
+.+|.|.++.||++... ++..+++|....... . ....+.+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999743 467889997653221 0 0122345667777766532 33 4455543 34456899
Q ss_pred EEecCCC
Q 005999 466 YDYQPNG 472 (665)
Q Consensus 466 ~e~~~~g 472 (665)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00094 Score=67.89 Aligned_cols=74 Identities=14% Similarity=0.120 Sum_probs=56.8
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC---CCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS---HPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.|+.|.+..+|+.... +..+++|+.... ....+..|.+.|+.|. ...+.+++++....+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 35788999999998764 556778886532 2456788888887773 35688889988888899999999998
Q ss_pred CCH
Q 005999 472 GSL 474 (665)
Q Consensus 472 gsL 474 (665)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00012 Score=67.34 Aligned_cols=81 Identities=10% Similarity=0.098 Sum_probs=39.8
Q ss_pred CCcEEEccCCcCccCC-CCCCCCCCCCEEEccCcc-cCCcCcccccCC----CCCCEEEeeccc-ccccCCccccCCCcc
Q 005999 100 QLRVLSLHNNSLTGPI-PDLSSLINLKSLSLSRNF-FSGAFPLSILSL----HRLTILDLSYNN-LTGLIPVNLTALDRL 172 (665)
Q Consensus 100 ~L~~L~L~~N~l~~~~-p~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 172 (665)
.|+.|||+++.++..- ..+.++++|+.|+|+++. ++..-=..+..+ ++|+.|+|+++. ++..-=..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 4566666665554322 134556666666666653 443222233333 246666666643 542211234455555
Q ss_pred Ceeecccc
Q 005999 173 YSLKLEWN 180 (665)
Q Consensus 173 ~~L~l~~N 180 (665)
+.|+|++.
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.17 E-value=0.003 Score=59.53 Aligned_cols=101 Identities=11% Similarity=0.080 Sum_probs=67.8
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH-RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
+|.+.|.. .+.++++.++|.++.|.+.+|.-+- ++. -..+=+.|..|++..+|.|...+ ..+. .
T Consensus 34 SL~eIL~~----~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------~ 98 (229)
T 2yle_A 34 SLEEILRL----YNQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------A 98 (229)
T ss_dssp EHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH----cCCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc---------c
Confidence 79999875 4678999999999999999987762 222 12333457899999999988764 1110 1
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHP 590 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P 590 (665)
....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 223467888763 3567899999999999998864333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00093 Score=70.48 Aligned_cols=113 Identities=10% Similarity=0.097 Sum_probs=77.4
Q ss_pred cCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCcccc
Q 005999 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLT 167 (665)
Q Consensus 89 ~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 167 (665)
.+....|.++.+|+.+.+.++..+ +.. .|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+|.
T Consensus 255 ~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 331 (394)
T 4gt6_A 255 RIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFA 331 (394)
T ss_dssp EECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred EcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence 344557888888888888765543 333 67888888888886 4455344456777888888888754 5544456778
Q ss_pred CCCccCeeecccccccccCCCC--CCCCcceEeccccccc
Q 005999 168 ALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLT 205 (665)
Q Consensus 168 ~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~ 205 (665)
+|.+|+.+.|..+ ++.+.... ++.+|+.+++.+|...
T Consensus 332 ~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 332 GCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred CCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 8888888888654 55443332 7788888888877543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0013 Score=65.98 Aligned_cols=74 Identities=11% Similarity=0.144 Sum_probs=51.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCC---CeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHP---NLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.+|.|..+.||+.+..+|+.+++|+...... .....|..|++.|+.|... .+.+++++ + ..++||||+++
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecc
Confidence 35799999999999999999999998654432 2234577888877766321 24445543 2 24789999987
Q ss_pred CCH
Q 005999 472 GSL 474 (665)
Q Consensus 472 gsL 474 (665)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00095 Score=58.35 Aligned_cols=54 Identities=19% Similarity=0.175 Sum_probs=24.4
Q ss_pred EEEccCCcCc--cCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccc
Q 005999 103 VLSLHNNSLT--GPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNL 158 (665)
Q Consensus 103 ~L~L~~N~l~--~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 158 (665)
.++.++++|+ .++..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555555 3332221 2455555555555532233344444455544444443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0055 Score=62.57 Aligned_cols=73 Identities=11% Similarity=0.126 Sum_probs=45.5
Q ss_pred hCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCC--CeeeeeEE-----EEeCCeEEEEEEec
Q 005999 397 LGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHP--NLVPIRAY-----FQAKGERLVIYDYQ 469 (665)
Q Consensus 397 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 469 (665)
++ |....||+....+|+.+++|....... ..+.+..|..++..+... .+++++.. ....+..++++||+
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 55 778899998777777788999864321 223455566666555211 23444432 23356678899999
Q ss_pred CCCC
Q 005999 470 PNGS 473 (665)
Q Consensus 470 ~~gs 473 (665)
+|..
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0011 Score=67.08 Aligned_cols=28 Identities=18% Similarity=0.157 Sum_probs=23.8
Q ss_pred eeccCCCCCceEeCCCCceEEeecccccc
Q 005999 514 LIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 514 iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 799999999999 5667889999987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0038 Score=66.36 Aligned_cols=77 Identities=18% Similarity=0.170 Sum_probs=45.7
Q ss_pred hCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCC----CCCCcccCCccccCCC--CCCCcchHHHHHHHHHH
Q 005999 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED----PDTVAYKAPEIRKSSR--RATSKSDVYAFGVLLLE 583 (665)
Q Consensus 510 ~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~----~gt~~y~aPE~~~~~~--~~~~k~DvwSlGvvl~e 583 (665)
... ++|+|+++.|||++.++ +++.||+.+...+...... .-...|.+|+...... ......++......+|+
T Consensus 231 ~~~-liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQA-LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCE-EECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCe-EEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 344 89999999999999876 9999998875433210000 0012355555443110 11123455677888887
Q ss_pred HHhCC
Q 005999 584 LLTGK 588 (665)
Q Consensus 584 lltg~ 588 (665)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00037 Score=64.03 Aligned_cols=83 Identities=11% Similarity=0.016 Sum_probs=63.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCc-CccCCC-CCCCC----CCCCEEEccCcc-cCCcCcccccCCC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNS-LTGPIP-DLSSL----INLKSLSLSRNF-FSGAFPLSILSLH 146 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~-l~~~~p-~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~ 146 (665)
-+++.|||+++.++..=- ..+.++++|+.|+|+++. |+..-- .++.+ ++|++|+|+++. ++..-=..+.+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL-~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGF-DHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGG-GGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHHH-HHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 479999999999874322 257899999999999985 664322 35554 479999999974 8754445678899
Q ss_pred CCCEEEeeccc
Q 005999 147 RLTILDLSYNN 157 (665)
Q Consensus 147 ~L~~L~L~~N~ 157 (665)
+|+.|+|++..
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 99999999864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0021 Score=56.08 Aligned_cols=55 Identities=25% Similarity=0.265 Sum_probs=28.8
Q ss_pred EEEecCCCCc-ccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccC
Q 005999 78 RFVLQSFGLR-GTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFS 135 (665)
Q Consensus 78 ~l~l~~~~l~-g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~ 135 (665)
.++.++++|+ ..+|.. + -++|+.|+|++|+|+.+++ .|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4455555554 234431 1 1245666666666665555 4555666666666666543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0047 Score=64.56 Aligned_cols=104 Identities=9% Similarity=0.112 Sum_probs=54.4
Q ss_pred ccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCcc
Q 005999 94 TLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRL 172 (665)
Q Consensus 94 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 172 (665)
.+....+|+.+.+..+ ++.+.. .|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 4555566666665443 333333 4556666666666554 44233344555666666666433 332333445556666
Q ss_pred CeeecccccccccCCCC--CCCCcceEecc
Q 005999 173 YSLKLEWNRFSGTVPPL--NQPFLVVFNVS 200 (665)
Q Consensus 173 ~~L~l~~N~l~~~~~~~--~~~~L~~l~l~ 200 (665)
+.+.+.+|.++.+.... ++.+|+.++|.
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcC
Confidence 66666655555444433 55556666554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0045 Score=65.20 Aligned_cols=81 Identities=14% Similarity=0.096 Sum_probs=41.8
Q ss_pred CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCc
Q 005999 117 DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFL 194 (665)
Q Consensus 117 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L 194 (665)
.|.++.+|+.+.+.++..+ .-...|.++.+|+.+.+. +.++..-...|.++.+|+.+.|..| ++.+.... ++.+|
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L 336 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL 336 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence 4556666666666544433 334455556666666664 3344333345555666666666543 33333322 45556
Q ss_pred ceEecc
Q 005999 195 VVFNVS 200 (665)
Q Consensus 195 ~~l~l~ 200 (665)
+.+.+.
T Consensus 337 ~~i~ip 342 (394)
T 4gt6_A 337 ERIAIP 342 (394)
T ss_dssp CEEEEC
T ss_pred CEEEEC
Confidence 666554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0045 Score=64.72 Aligned_cols=122 Identities=16% Similarity=0.099 Sum_probs=92.3
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.++.+.+..+ +. .+....+.++..|+.+.+..+ ++.+.. .|.++.+|+.+.+..+ +...-...|.++.+|+.+++
T Consensus 218 ~l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 218 NLKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SCSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred ccceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 4666666543 44 566678899999999999876 666666 7889999999999765 55344557888999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEeccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSG 201 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~ 201 (665)
.+|.++..-...|.++.+|+.+.|..+ ++.+.... ++.+|+.+.+..
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 999888666678899999999999755 55544433 677888776643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.011 Score=60.16 Aligned_cols=141 Identities=14% Similarity=0.230 Sum_probs=74.2
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-----CCCCeeeee-E--EEEeCCeEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-----SHPNLVPIR-A--YFQAKGERLVIY 466 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~ 466 (665)
+.|+.|....+|+....++ .+++|....... .+.+..|+.++..+ .-|.++... | +....+..++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3467788899999987766 577888765211 12234455555444 223333211 1 122346778999
Q ss_pred EecCCCCHH--------------HHHhcC-CCCCCC---C---CCHHHHHH------------HHHHHHHHHHHHHhC--
Q 005999 467 DYQPNGSLF--------------NLIHGS-RSIRAK---P---LHWTSCLK------------IAEDVAQGLAYIHRA-- 511 (665)
Q Consensus 467 e~~~~gsL~--------------~~l~~~-~~~~~~---~---l~~~~~~~------------i~~~i~~~L~yLH~~-- 511 (665)
+|++|..+. ..+|.. ...... . ..|...+. +...+...++++++.
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 999986431 112211 000000 0 12322111 011244455666531
Q ss_pred ----CCeeccCCCCCceEeCCCCceEEeecccc
Q 005999 512 ----SWLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 512 ----~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
..++|+|+++.||+++++..+.|+||+.+
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 12899999999999998755689999765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0052 Score=62.97 Aligned_cols=30 Identities=17% Similarity=0.327 Sum_probs=25.7
Q ss_pred eeccCCCCCceEeCCC----CceEEeeccccccc
Q 005999 514 LIHGNLKSSNVLLGAD----FEARLTDYCLSVLS 543 (665)
Q Consensus 514 iiH~Dlk~~Nill~~~----~~~kl~Dfgl~~~~ 543 (665)
++|+|+.+.||+++.+ +.+.|.||+.+...
T Consensus 185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 8999999999999875 67999999876543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0086 Score=62.99 Aligned_cols=121 Identities=13% Similarity=0.063 Sum_probs=68.5
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
.++.+.+... ++ .|....+..+..|+.+.+..+...-....|..+..|+.+.+..+.+. ...|..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~~-~~-~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPDS-FT-ELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECTT-CC-EECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECCC-ce-ecccccccccccceeEEcCCCcceeeccccccccccceeccCceeec---cccccccccccccccc
Confidence 5666666543 33 45556777788888888876654322225666666666666555432 2345556666666665
Q ss_pred cccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccc
Q 005999 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGN 202 (665)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N 202 (665)
+| ++..-...|.++.+|+.++|.++ ++.+.... ++.+|+.+++..|
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 43 44333445666666666666533 44333332 5566666666544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0046 Score=64.57 Aligned_cols=138 Identities=14% Similarity=0.183 Sum_probs=77.4
Q ss_pred HhCcccceEEEEEEEC--------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEE
Q 005999 396 LLGRGSIGTTYKAVLD--------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+..|-...+|+.... ++..+++|+..... .....+.+|.++++.+. +.-..++++++.+ .+|+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 4667888889998864 24678888863321 22345567888877663 2223556666543 2899
Q ss_pred EecCCCCHH-----------------HHHhcCCCCCCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 005999 467 DYQPNGSLF-----------------NLIHGSRSIRAKPLH--WTSCLKIAEDVAQ-------------------GLAYI 508 (665)
Q Consensus 467 e~~~~gsL~-----------------~~l~~~~~~~~~~l~--~~~~~~i~~~i~~-------------------~L~yL 508 (665)
||++|.+|. ..+|.....-..... |.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 999986542 112221111112222 4555555544322 23333
Q ss_pred H----hCC---CeeccCCCCCceEeCCC----CceEEeecccc
Q 005999 509 H----RAS---WLIHGNLKSSNVLLGAD----FEARLTDYCLS 540 (665)
Q Consensus 509 H----~~~---~iiH~Dlk~~Nill~~~----~~~kl~Dfgl~ 540 (665)
. ..+ .++|+|+.+.||+++.+ +.+.++||..+
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 2 211 28999999999999876 68999999765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.006 Score=64.17 Aligned_cols=122 Identities=11% Similarity=0.040 Sum_probs=91.4
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.+.+..+... +....|..+..|+.+.+..+.+.. ..|..+.+|+.+.+..+ ++..-...|.++.+|+.++|
T Consensus 253 ~~l~~~~~~~~~~~--i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 253 TDLESISIQNNKLR--IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp SSCCEEEECCTTCE--ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECC
T ss_pred ccceeEEcCCCcce--eeccccccccccceeccCceeecc--ccccccccccccccccc-cceechhhhcCCCCCCEEEe
Confidence 45777788776443 666789999999999887765321 16888999999999765 66344567888999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGN 202 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N 202 (665)
.++ ++..-..+|.++++|+.+.+..| ++.+.... ++.+|+.+++..|
T Consensus 328 p~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 328 PYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred CCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 754 76455678889999999999877 66555443 7888999988654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.14 E-value=0.00086 Score=62.82 Aligned_cols=85 Identities=14% Similarity=0.128 Sum_probs=41.8
Q ss_pred CCCCCCcEEEccCC-cCccCC-----CCCCCCCCCCEEEccCcccCC----cCcccccCCCCCCEEEeeccccccc----
Q 005999 96 TRLDQLRVLSLHNN-SLTGPI-----PDLSSLINLKSLSLSRNFFSG----AFPLSILSLHRLTILDLSYNNLTGL---- 161 (665)
Q Consensus 96 ~~l~~L~~L~L~~N-~l~~~~-----p~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~---- 161 (665)
.+=+.|+.|+|++| +|...- ..+..=+.|+.|+|++|+|.. .+-..+..-+.|+.|+|++|.|...
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 34455666666654 543210 123334556666666666652 2223333445566666666666522
Q ss_pred CCccccCCCccCeeecccc
Q 005999 162 IPVNLTALDRLYSLKLEWN 180 (665)
Q Consensus 162 ~p~~~~~l~~L~~L~l~~N 180 (665)
+-..+..-+.|+.|+|++|
T Consensus 118 la~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHTTTTCCCSEEECCCC
T ss_pred HHHHHhhCCceeEEECCCC
Confidence 1112333445666666543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.77 E-value=0.0011 Score=62.07 Aligned_cols=110 Identities=9% Similarity=0.182 Sum_probs=73.5
Q ss_pred cCCCEEEEEecCC-CCcc----cCCccccCCCCCCcEEEccCCcCccCCC-C----CCCCCCCCEEEccCcccCC----c
Q 005999 72 AQGRVVRFVLQSF-GLRG----TFPPNTLTRLDQLRVLSLHNNSLTGPIP-D----LSSLINLKSLSLSRNFFSG----A 137 (665)
Q Consensus 72 ~~~~v~~l~l~~~-~l~g----~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~----~~~l~~L~~L~Ls~N~l~~----~ 137 (665)
.+..++.|+|++| ++.. .|-. .+..=+.|+.|+|++|+|...-- . +..=+.|+.|+|++|.|+. .
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 3468999999985 6652 1222 56667899999999999974322 2 3344789999999999984 2
Q ss_pred CcccccCCCCCCEEEeecccc---ccc----CCccccCCCccCeeecccccc
Q 005999 138 FPLSILSLHRLTILDLSYNNL---TGL----IPVNLTALDRLYSLKLEWNRF 182 (665)
Q Consensus 138 ~p~~~~~l~~L~~L~L~~N~l---~~~----~p~~~~~l~~L~~L~l~~N~l 182 (665)
+-..+..-+.|+.|+|++|.. ... +-..+..-+.|+.|+++.|.+
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 334455566799999987633 321 223344456677777766654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.077 Score=54.36 Aligned_cols=29 Identities=28% Similarity=0.496 Sum_probs=25.9
Q ss_pred eeccCCCCCceEeCCCCceEEeecccccc
Q 005999 514 LIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 514 iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
++|+|+.+.||++++++.+.+.||+.+..
T Consensus 208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 208 LCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 89999999999999888899999976643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.73 E-value=0.029 Score=59.69 Aligned_cols=71 Identities=14% Similarity=0.126 Sum_probs=45.6
Q ss_pred hHhCcccceEEEEEEECC--------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCe-eeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDN--------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL-VPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 465 (665)
+.|+.|....+|++...+ +..+++|+...... .+.+..|..+++.+...++ .++++.+.+ .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 357788889999998753 46788888743211 1334467777776633333 556666542 289
Q ss_pred EEecCCCC
Q 005999 466 YDYQPNGS 473 (665)
Q Consensus 466 ~e~~~~gs 473 (665)
+||++|.+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.11 Score=55.52 Aligned_cols=73 Identities=12% Similarity=0.113 Sum_probs=44.4
Q ss_pred hHhCcccceEEEEEEECC-eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCe-eeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLDN-HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL-VPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.|+.|-...+|+....+ +..+++|+.......... ..+|..++..|...++ .++++++. + .+|+||++|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 357788889999998875 467788887433211111 1467777777754444 45777663 2 2599999875
Q ss_pred CH
Q 005999 473 SL 474 (665)
Q Consensus 473 sL 474 (665)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.08 E-value=0.05 Score=56.48 Aligned_cols=72 Identities=11% Similarity=0.081 Sum_probs=40.0
Q ss_pred hHhCcccceEEEEEEECCe---------EEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCC-eeeeeEEEEeCCeEEE
Q 005999 395 ELLGRGSIGTTYKAVLDNH---------LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN-LVPIRAYFQAKGERLV 464 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l 464 (665)
+.++.|....+|+....++ ..+++|+...... . ......|.++++.+...+ ..++++.+ .+ ++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence 3477888899999987642 5778887654321 1 111245666666553223 34566544 22 68
Q ss_pred EEEecCCCC
Q 005999 465 IYDYQPNGS 473 (665)
Q Consensus 465 v~e~~~~gs 473 (665)
||||++|.+
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.22 E-value=0.023 Score=37.17 Aligned_cols=29 Identities=21% Similarity=0.363 Sum_probs=18.8
Q ss_pred CccceeeehhHHHHHHHHHHHHHHHhhhh
Q 005999 278 KRRGLILGLSIGFAVLVSFLVCIFLLIRR 306 (665)
Q Consensus 278 ~~~~~i~gi~~g~~~~~~~~~~~~~~~~~ 306 (665)
.+.+.|+|+++|+++++++++.+.++++|
T Consensus 8 ls~GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence 34567888998888776655554444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.94 E-value=0.042 Score=37.07 Aligned_cols=30 Identities=20% Similarity=0.122 Sum_probs=13.1
Q ss_pred ceeeehhHHHHHHHHHHHHHHHhhhhhccC
Q 005999 281 GLILGLSIGFAVLVSFLVCIFLLIRRSSEG 310 (665)
Q Consensus 281 ~~i~gi~~g~~~~~~~~~~~~~~~~~~~~~ 310 (665)
..|++.++|.+++++++++.+++++|||+.
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 335555555444444444433333333333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.73 E-value=0.07 Score=36.06 Aligned_cols=25 Identities=20% Similarity=0.109 Sum_probs=10.6
Q ss_pred eeehhHHHHHHHHHHHHHHHhhhhh
Q 005999 283 ILGLSIGFAVLVSFLVCIFLLIRRS 307 (665)
Q Consensus 283 i~gi~~g~~~~~~~~~~~~~~~~~~ 307 (665)
|++.++|.+++++++++++++++||
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhh
Confidence 5555555444433333333333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.54 E-value=0.066 Score=36.02 Aligned_cols=29 Identities=21% Similarity=0.351 Sum_probs=13.5
Q ss_pred ceeeehhHHHHHHHHHHHHHHHhhhhhccC
Q 005999 281 GLILGLSIGFAVLVSFLVCIFLLIRRSSEG 310 (665)
Q Consensus 281 ~~i~gi~~g~~~~~~~~~~~~~~~~~~~~~ 310 (665)
..++++++|++ ++++++++++++.|||+.
T Consensus 12 ~~Ia~~vVGvl-l~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 12 TSIISAVVGIL-LVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHH-HHHHHHHHHHHHHHHHCS
T ss_pred cchHHHHHHHH-HHHHHHHHHHhheehhhh
Confidence 34666777743 333333333344444333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.94 E-value=0.32 Score=51.31 Aligned_cols=73 Identities=15% Similarity=0.097 Sum_probs=43.4
Q ss_pred hHhCcccceEEEEEEECC--------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCC-eeeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDN--------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN-LVPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 465 (665)
+.+..|-...+|+....+ +..+++|+....... .-+..+|..+++.+...+ ..++++.+ .+ ++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 346778889999998763 467888886443211 111245666665553222 34455543 22 689
Q ss_pred EEecCCCCH
Q 005999 466 YDYQPNGSL 474 (665)
Q Consensus 466 ~e~~~~gsL 474 (665)
+||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.32 E-value=3 Score=39.23 Aligned_cols=114 Identities=13% Similarity=0.094 Sum_probs=78.3
Q ss_pred CCCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCeeccCCCCCc
Q 005999 445 SHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA-YIHRASWLIHGNLKSSN 523 (665)
Q Consensus 445 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~-yLH~~~~iiH~Dlk~~N 523 (665)
.||++ -...-.+++.+.+.|+.-+++.=+..++ .++...+++++..|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~---r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR---RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS---SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC---ceeEEEeCce
Confidence 68888 4444466777777777654443333443 3677889998888887666 5543 4788899999
Q ss_pred eEeCCCCceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHH-HHHHHHHHHHhCCCCCC
Q 005999 524 VLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVY-AFGVLLLELLTGKHPSQ 592 (665)
Q Consensus 524 ill~~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~Dvw-SlGvvl~elltg~~P~~ 592 (665)
+++|.++.+++.-.|+-. -++|.- .+ ..|.| .+=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~--------------~lpP~e------~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE--------------SLPPDE------WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETT--------------TBSSCS------CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcc--------------cCCCCC------CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999887642 233332 12 23333 67888889999887664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.95 E-value=0.15 Score=54.61 Aligned_cols=61 Identities=11% Similarity=0.101 Sum_probs=16.7
Q ss_pred hHhCcccceEEEEEEECC-eEEEEE------EEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLDN-HLIVTV------KRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA 458 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 458 (665)
+.|| ||.||+|.+.. ...||| |..+...........|.+|..+++.++|||+++.++|...
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4465 99999999764 357888 7665544434445568888899999999999999888643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.08 E-value=2.2 Score=39.99 Aligned_cols=117 Identities=12% Similarity=0.073 Sum_probs=78.9
Q ss_pred CCCCCeeeeeEEEEeCCeEEEEEEecCCC-CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCC
Q 005999 444 LSHPNLVPIRAYFQAKGERLVIYDYQPNG-SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSS 522 (665)
Q Consensus 444 l~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~ 522 (665)
..||+++.. .+-.+++.+.+.|+.-..+ ++.. + ..++...+++++..|+....+++. -+|--|+|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i--------k~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I--------KSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G--------GGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H--------HhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecc
Confidence 378988876 4555566655555543322 2222 2 346778899999999988755553 368889999
Q ss_pred ceEeCCCCceEEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 005999 523 NVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQH 593 (665)
Q Consensus 523 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~ 593 (665)
|++++.++.+++.-.|+... ++|. ..++..=.-.+=+++..+++++..|+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~--------------l~P~------~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV--------------VDPL------PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTT--------------BSCC------CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccC--------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999988776422 2222 122222334778899999999988763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 665 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-35 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 17/269 (6%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G GS GT YK V VK + +AF+ + + H N++
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ + ++ + SL++ +H + IA AQG+ Y+H S +
Sbjct: 72 -YSTAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS-I 125
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKAPEI--RKSSRR 567
IH +LKS+N+ L D ++ D+ L+ + S ++ + APE+ +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 568 ATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGRE--ENRLGMLTEV 625
+ +SDVYAFG++L EL+TG+ P + + R D + N + +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 245
Query: 626 ASVCSLKSPEQRPAMWQVLKMIQEIKESV 654
+ C K ++RP Q+L I+ + S+
Sbjct: 246 MAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 8e-49
Identities = 60/264 (22%), Positives = 122/264 (46%), Gaps = 17/264 (6%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G G G + N V +K ++ E F + E + LSHP LV +
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYG 67
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ +++++ +G L + + + + L + DV +G+AY+ + +
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE-ACV 122
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSSRRATS 570
IH +L + N L+G + +++D+ ++ V + +PE+ S R +S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSS 181
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRT-MRVDDGREENRLGMLTEVASVC 629
KSDV++FGVL+ E+ + + + +++E + T R+ R + + ++ + C
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDISTGFRLYKPRLAST--HVYQIMNHC 238
Query: 630 SLKSPEQRPAMWQVLKMIQEIKES 653
+ PE RPA ++L+ + EI ES
Sbjct: 239 WKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-47
Identities = 62/258 (24%), Positives = 114/258 (44%), Gaps = 13/258 (5%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ +G+G G + V VK D +A+AF + L H NLV +
Sbjct: 13 QTIGKGEFGDVMLGDYRGN-KVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 455 YF-QAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ KG ++ +Y GSL + + L LK + DV + + Y+ +
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN- 123
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSD 573
+H +L + NVL+ D A+++D+ L+ + S+ V + APE + ++ ++KSD
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR-EKKFSTKSD 182
Query: 574 VYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLKS 633
V++FG+LL E+ + +P + D++ V D + + EV C
Sbjct: 183 VWSFGILLWEIYSFGRVP-YPRIPLKDVVPRVEKGYKMD-APDGCPPAVYEVMKNCWHLD 240
Query: 634 PEQRPAMWQVLKMIQEIK 651
RP+ Q+ + ++ IK
Sbjct: 241 AAMRPSFLQLREQLEHIK 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 63/260 (24%), Positives = 116/260 (44%), Gaps = 15/260 (5%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E LG G G + + H V VK S +AF + L H LV + A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ +I +Y NGSL + + I L L +A +A+G+A+I +
Sbjct: 76 VVT-QEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERN-Y 130
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSSRRATS 570
IH +L+++N+L+ ++ D+ L+ L + + + + + APE T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TI 189
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630
KSDV++FG+LL E++T +P + P++++ + R +N L ++ +C
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMV-RPDNCPEELYQLMRLCW 247
Query: 631 LKSPEQRPAMWQVLKMIQEI 650
+ PE RP + ++++
Sbjct: 248 KERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-45
Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 17/261 (6%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
+ LG G G V +K ++ + F + + + LSH LV +
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYG 66
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ +I +Y NG L N + R L++ +DV + + Y+
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLES-KQF 121
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDS----SSVEDPDTVAYKAPEIRKSSRRATS 570
+H +L + N L+ +++D+ LS SSV V + PE+ + +S
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-YSKFSS 180
Query: 571 KSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629
KSD++AFGVL+ E+ + GK P + + E + + R + + C
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP--YERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSC 237
Query: 630 SLKSPEQRPAMWQVLKMIQEI 650
+ ++RP +L I ++
Sbjct: 238 WHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 63/276 (22%), Positives = 113/276 (40%), Gaps = 21/276 (7%)
Query: 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
E++GRG G Y L ++ + VK + F + SHPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVL 91
Query: 451 PIRAY-FQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ +++G LV+ Y +G L N I + VA+G+ ++
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA 147
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYKAPEIR 562
+H +L + N +L F ++ D+ L+ + V + A E
Sbjct: 148 S-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622
++ ++ T+KSDV++FGVLL EL+T P +P + D+ ++ R + E L
Sbjct: 207 QT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQGRRLL-QPEYCPDPL 263
Query: 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
EV C E RP+ +++ I I + + E
Sbjct: 264 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 9e-44
Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 39/290 (13%)
Query: 395 ELLGRGSIGTTYKAVLDNHL------IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
+G G+ G ++A L +V VK +AD A+ F++ + +PN
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 77
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-------------------SIRAKPL 489
+V + ++++Y G L + S PL
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 490 HWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549
L IA VA G+AY+ +H +L + N L+G + ++ D+ LS S+
Sbjct: 138 SCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 550 DPD-----TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDML 602
D + + PE R T++SDV+A+GV+L E+ + PY +A +++
Sbjct: 197 KADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQ---PYYGMAHEEVI 252
Query: 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
+VR + EN L + +C K P RP+ + +++Q + E
Sbjct: 253 YYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 51/300 (17%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E +G+G G ++ V VK F + + E + L H N++ A
Sbjct: 9 ESIGKGRFGEVWRGKWRGE-EVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIA 64
Query: 455 YFQAKG----ERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ ++ DY +GSLF+ ++ + +K+A A GLA++H
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHM 118
Query: 511 AS-------WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAY 556
+ H +LKS N+L+ + + D L+V DS++ T Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 557 KAPEIRKSSR-----RATSKSDVYAFGVLLLELLTGKHPS------QHPY----LAPPDM 601
APE+ S + ++D+YA G++ E+ Q PY + P +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 602 LEW--------VRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
E +R + + L ++ ++ C + R ++ K + ++ +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 44/198 (22%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ G +K + L++ K + ++ + + P +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F + GE + ++ GSL ++ +A + K++ V +GL Y+
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVAYKAPEIRKSSRRATSKS 572
++H ++K SN+L+ + E +L D+ +S L DS + T +Y +PE + + +S
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ-GTHYSVQS 184
Query: 573 DVYAFGVLLLELLTGKHP 590
D+++ G+ L+E+ G++P
Sbjct: 185 DIWSMGLSLVEMAVGRYP 202
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 63/263 (23%), Positives = 113/263 (42%), Gaps = 15/263 (5%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
LG+G G + + V +K + EAF Q + + L H LV + A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 79
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
+ ++ +Y GSL + + G K L + +A +A G+AY+ R
Sbjct: 80 VVS-EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER-MNY 134
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSSRRATS 570
+H +L+++N+L+G + ++ D+ L+ L + + + + APE R T
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTI 193
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630
KSDV++FG+LL EL T +P + ++L+ V L ++ C
Sbjct: 194 KSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCW 251
Query: 631 LKSPEQRPAMWQVLKMIQEIKES 653
K PE+RP + +++ S
Sbjct: 252 RKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 8e-42
Identities = 48/270 (17%), Positives = 117/270 (43%), Gaps = 20/270 (7%)
Query: 395 ELLGRGSIGTTYKAVLDN-----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL 449
+++G G G YK +L + V +K A T + F +G SH N+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 71
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ + ++I +Y NG+L + + + + +A G+ Y+
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS------SSVEDPDTVAYKAPEIRK 563
++ +H +L + N+L+ ++ +++D+ LS + + ++ + + APE
Sbjct: 128 NMNY-VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI- 185
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623
S R+ TS SDV++FG+++ E++T + L+ ++++ + + +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGER-PYWELSNHEVMKAIND-GFRLPTPMDCPSAIY 243
Query: 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
++ C + +RP ++ ++ ++ +
Sbjct: 244 QLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 53/271 (19%), Positives = 117/271 (43%), Gaps = 21/271 (7%)
Query: 397 LGRGSIGTTYKAVL---DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ G+ + V + V +K E + + + L +P +V +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 75
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
QA+ +++ + G L + G R + + ++ ++ V+ G+ Y+ ++
Sbjct: 76 GVCQAEA-LMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD------TVAYKAPEIRKSSRR 567
+H +L + NVLL A+++D+ LS + + + APE R+
Sbjct: 131 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RK 188
Query: 568 ATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626
+S+SDV+++GV + E L+ G+ P + + P+++ ++ + + L +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAFIEQGKRME-CPPECPPELYALM 245
Query: 627 SVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657
S C + E RP V + ++ S+ ++
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 30/285 (10%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HP 447
+ LG G+ G +A D + V VK + T EA ++ + L H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHM 87
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIR-------------AKPLHWTSC 494
N+V + G LVI +Y G L N + R L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 495 LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-- 552
L + VA+G+A++ IH +L + N+LL ++ D+ L+ + S
Sbjct: 148 LSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 553 ---TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR 609
V + APE + T +SDV+++G+ L EL + +P + +
Sbjct: 207 ARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSS-PYPGMPVDSKFYKMIKEG 264
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQE-IKES 653
E+ + ++ C P +RP Q++++I++ I ES
Sbjct: 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 2e-41
Identities = 48/272 (17%), Positives = 112/272 (41%), Gaps = 23/272 (8%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+++G G G L + V +K + T + F +G HPN++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVI 90
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ ++I ++ NGSL + + + + +A G+ Y+
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD 146
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS--------SSVEDPDTVAYKAPEIR 562
+H +L + N+L+ ++ +++D+ LS + S++ + + APE
Sbjct: 147 M-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 563 KSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621
+ R+ TS SDV+++G+++ E+++ G+ P + + D++ + +
Sbjct: 206 Q-YRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVINAIE-QDYRLPPPMDCPSA 261
Query: 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
L ++ C K RP Q++ + ++ +
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 2e-41
Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 28/287 (9%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFD-ANKTADTSAEAFEQHMEAVGGLSHPNLVPI 452
+G GS G Y A + N +V +K+ + K ++ + + + + L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
R + + ++ +Y + L KPL + QGLAY+H +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEI--RKSSRRATS 570
IH ++K+ N+LL +L D+ + + ++ T + APE+ +
Sbjct: 136 M-IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-SFVGTPYWMAPEVILAMDEGQYDG 193
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630
K DV++ G+ +EL K P + + L + + + C
Sbjct: 194 KVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 631 LKSPEQRPAMWQVLK---------------MIQEIKESVMAEDNAAF 662
K P+ RP +LK +IQ K++V DN +
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 3e-41
Identities = 54/259 (20%), Positives = 112/259 (43%), Gaps = 16/259 (6%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+GRGS T YK + + + V K + + F++ E + GL HPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 454 AYFQA----KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+++ K +++ + +G+L + R K + + +GL ++H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 510 RAS-WLIHGNLKSSNVLL-GADFEARLTDYCLSVLSDSSSVEDP-DTVAYKAPEIRKSSR 566
+ +IH +LK N+ + G ++ D L+ L +S + T + APE+ +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE--E 187
Query: 567 RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626
+ DVYAFG+ +LE+ T ++P + V + ++ + + E+
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEII 246
Query: 627 SVCSLKSPEQRPAMWQVLK 645
C ++ ++R ++ +L
Sbjct: 247 EGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-41
Identities = 51/261 (19%), Positives = 95/261 (36%), Gaps = 15/261 (5%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G GS G K + I+ K D + + + + L HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 454 AYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR- 510
+ + + +Y G L ++I R + L L++ + L HR
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRR 128
Query: 511 ---ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV---EDPDTVAYKAPEIRKS 564
++H +LK +NV L +L D+ L+ + + + T Y +PE
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624
KSD+++ G LL EL P + ++ +R + L E
Sbjct: 189 -MSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKELAGKIREGKFRR-IPYRYSDELNE 244
Query: 625 VASVCSLKSPEQRPAMWQVLK 645
+ + RP++ ++L+
Sbjct: 245 IITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 61/275 (22%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 395 ELLGRGSIGTTYKAVLDN---HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLV 450
+++G G+ G KA + + +KR + D F +E + L HPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNII 74
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGS-----------RSIRAKPLHWTSCLKIAE 499
+ + +G + +Y P+G+L + + S + A L L A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--TVAYK 557
DVA+G+ Y+ + IH +L + N+L+G ++ A++ D+ LS + + V +
Sbjct: 135 DVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193
Query: 558 APEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREEN 617
A E S T+ SDV+++GVLL E+++ + + ++ E + + + N
Sbjct: 194 AIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQGYRLE-KPLN 250
Query: 618 RLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
+ ++ C + P +RP+ Q+L + + E
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (372), Expect = 2e-40
Identities = 59/270 (21%), Positives = 114/270 (42%), Gaps = 16/270 (5%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G G Y+ V L V VK + E F + + + HPNLV +
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ +I ++ G+L + + + + L +A ++ + Y+ + ++
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKNF 136
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED----PDTVAYKAPEIRKSSRRAT 569
IH +L + N L+G + ++ D+ LS L + + + APE + +
Sbjct: 137 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-YNKFS 194
Query: 570 SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629
KSDV+AFGVLL E+ T +P + + E + R E + E+ C
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS-PYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRAC 252
Query: 630 SLKSPEQRPAMWQVLKMIQEI-KESVMAED 658
+P RP+ ++ + + + +ES ++++
Sbjct: 253 WQWNPSDRPSFAEIHQAFETMFQESSISDE 282
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 6e-40
Identities = 52/260 (20%), Positives = 107/260 (41%), Gaps = 18/260 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ G YKA + ++ K D ++ E + ++ + HPN+V +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F + ++ ++ G++ ++ +PL + + + L Y+H
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDN-K 130
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV---AYKAPEI----RKSSR 566
+IH +LK+ N+L D + +L D+ +S + + + + APE+ R
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 567 RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM-LTEV 625
K+DV++ G+ L+E+ + P H L P +L + + +R +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 626 ASVCSLKSPEQRPAMWQVLK 645
C K+ + R Q+L+
Sbjct: 249 LKKCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-40
Identities = 64/287 (22%), Positives = 123/287 (42%), Gaps = 23/287 (8%)
Query: 395 ELLGRGSIGTTYKAVLDNHL------IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
LG+GS G Y+ V + V +K + + E F + + +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHH 84
Query: 449 LVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAK-----PLHWTSCLKIAEDVAQ 503
+V + LVI + G L + + R A P + +++A ++A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 504 GLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKA 558
G+AY++ + +H +L + N ++ DF ++ D+ ++ + V + +
Sbjct: 145 GMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618
PE K T+ SDV++FGV+L E+ T + L+ +L +V + D + +N
Sbjct: 204 PESLK-DGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLD-KPDNC 260
Query: 619 LGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAFGYS 665
ML E+ +C +P+ RP+ +++ I+E E E + F YS
Sbjct: 261 PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS--FYYS 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-40
Identities = 50/260 (19%), Positives = 99/260 (38%), Gaps = 20/260 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+ LG G+ G AV V VK D + D E ++ + L+H N+V
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFY 69
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ + + + +Y G LF+ I + + + G+ Y+H
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKAPEIRKSSRRA 568
H ++K N+LL +++D+ L+ + ++ E T+ Y APE+ K
Sbjct: 125 -THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628
DV++ G++L +L G+ P P D + + + + ++
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQ----PSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 629 ---CSLKSPEQRPAMWQVLK 645
+++P R + + K
Sbjct: 240 LHKILVENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 14/254 (5%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEA-FEQHMEAVGGLSHPNLVPI 452
LG+G G Y A + I+ +K + E + +E L HPN++ +
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
YF +I +Y P G+++ + + ++A L+Y H
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSK- 125
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-TVAYKAPEIRKSSRRATSK 571
+IH ++K N+LLG+ E ++ D+ SV + SS T+ Y PE+ + R K
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEK 184
Query: 572 SDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631
D+++ GVL E L GK P+ A + R RV+ + ++ S
Sbjct: 185 VDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240
Query: 632 KSPEQRPAMWQVLK 645
+P QRP + +VL+
Sbjct: 241 HNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-39
Identities = 50/273 (18%), Positives = 102/273 (37%), Gaps = 23/273 (8%)
Query: 397 LGRGSIGTTYKAVLDNH---LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LG G+ GT K V VK + + L +P +V +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ +++ + G L + + + + + +++ V+ G+ Y+ +++
Sbjct: 75 GICE-AESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD------TVAYKAPEIRKSSRR 567
+H +L + NVLL A+++D+ LS + V + APE +
Sbjct: 129 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYK 186
Query: 568 ATSKSDVYAFGVLLLELLTGKHPSQHPY--LAPPDMLEWVRTMRVDDGREENRLGMLTEV 625
+SKSDV++FGVL+ E + PY + ++ + + ++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK---PYRGMKGSEVTAMLEKGERMG-CPAGCPREMYDL 242
Query: 626 ASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
++C E RP V ++ V+ E
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-37
Identities = 57/268 (21%), Positives = 97/268 (36%), Gaps = 19/268 (7%)
Query: 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNL 449
E LG GS G + D + V VK + + A + F + + A+ L H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ + ++V + P GSL + + + + + A VA+G+ Y+
Sbjct: 74 IRLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE 128
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVA-----YKAPEIRKS 564
IH +L + N+LL ++ D+ L +
Sbjct: 129 S-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 565 SRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623
+R + SD + FGV L E+ T G+ P L +L + R E+ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245
Query: 624 EVASVCSLKSPEQRPAMWQVLKMIQEIK 651
V C PE RP + + E +
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 57/286 (19%), Positives = 102/286 (35%), Gaps = 38/286 (13%)
Query: 395 ELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHP 447
++LG G+ G A + V VK + EA ++ + L SH
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHE 101
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR------------------SIRAKPL 489
N+V + G +I++Y G L N + R L
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 490 HWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVE 549
+ L A VA+G+ ++ S +H +L + NVL+ ++ D+ L+ S S
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 550 DPD-----TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEW 604
V + APE T KSDV+++G+LL E+ + PY P +
Sbjct: 221 VVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDANF 276
Query: 605 VRTMR--VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648
+ ++ + + + C +RP+ + +
Sbjct: 277 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-37
Identities = 58/266 (21%), Positives = 105/266 (39%), Gaps = 18/266 (6%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLV 450
+G G G ++ + + L V +K N T+D+ E F Q + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ + +I + G L + + R L S + A ++ LAY+
Sbjct: 72 KLIGVIT-ENPVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES 126
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD----TVAYKAPEIRKSSR 566
+H ++ + NVL+ ++ +L D+ LS + S+ + + APE R
Sbjct: 127 KR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-R 184
Query: 567 RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626
R TS SDV+ FGV + E+L + D++ + N L +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIENGERLP-MPPNCPPTLYSLM 242
Query: 627 SVCSLKSPEQRPAMWQVLKMIQEIKE 652
+ C P +RP ++ + I E
Sbjct: 243 TKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 53/256 (20%), Positives = 108/256 (42%), Gaps = 17/256 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G+G+ GT Y A+ + V +++ N E + + +PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ E V+ +Y GSL +++ + + + Q L ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVL---SDSSSVEDPDTVAYKAPEIRKSSRRATS 570
+IH ++KS N+LLG D +LTD+ S T + APE+ + +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGP 195
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL-GMLTEVASVC 629
K D+++ G++ +E++ G+ P + P L + T + + +L + + + C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 630 SLKSPEQRPAMWQVLK 645
E+R + ++L+
Sbjct: 254 LDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-35
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 30/281 (10%)
Query: 395 ELLGRGSIGTTYKAVL--------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS- 445
+ LG G+ G A + V VK ++ T + ME + +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGK 77
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSR-----------SIRAKPLHWTSC 494
H N++ + G VI +Y G+L + R + L
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 495 LKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-----SVE 549
+ A VA+G+ Y+ IH +L + NVL+ D ++ D+ L+ +
Sbjct: 138 VSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR 609
V + APE R T +SDV++FGVLL E+ T +P + ++ + ++
Sbjct: 197 GRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGS-PYPGVPVEELFKLLKEGH 254
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEI 650
D + N L + C P QRP Q+++ + I
Sbjct: 255 RMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (337), Expect = 4e-35
Identities = 53/260 (20%), Positives = 103/260 (39%), Gaps = 21/260 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG G+ G ++ K +D E + ++ + L HP LV +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLH 89
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F+ E ++IY++ G LF + + ++ V +GL ++H ++
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 514 LIHGNLKSSNVLLGADF--EARLTDYCLSVLSDSSSVEDPDT--VAYKAPEIRKSSRRAT 569
+H +LK N++ E +L D+ L+ D T + APE+ + +
Sbjct: 146 -VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE-GKPVG 203
Query: 570 SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA--- 626
+D+++ GVL LL+G P + L V++ + +++ ++E
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWN--MDDSAFSGISEDGKDF 259
Query: 627 -SVCSLKSPEQRPAMWQVLK 645
L P R + Q L+
Sbjct: 260 IRKLLLADPNTRMTIHQALE 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (337), Expect = 5e-35
Identities = 52/265 (19%), Positives = 91/265 (34%), Gaps = 17/265 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAF----EQHMEAVGGLSHPNL 449
++GRG G Y D + +K D + E + V P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
V + F + I D G L + + A ++ GL ++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSV-LSDSSSVEDPDTVAYKAPEIRKSSRRA 568
++++ +LK +N+LL R++D L+ S T Y APE+ +
Sbjct: 125 NR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 183
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL-GMLTEVAS 627
S +D ++ G +L +LL G P + D E R + L +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHK--TKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 628 VCSLKSPEQRPAMWQVLKMIQEIKE 652
+ +R + QE+KE
Sbjct: 242 GLLQRDVNRRLGCLG--RGAQEVKE 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-34
Identities = 50/283 (17%), Positives = 108/283 (38%), Gaps = 26/283 (9%)
Query: 385 SLEQLMRAS----AELLGRGSIGTTYKAVLDNH-----LIVTVKRFDANKTADTSAEAFE 435
+L ++++ + ++LG G+ GT YK + + V +K + + E
Sbjct: 1 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-IL 59
Query: 436 QHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCL 495
+ + +P++ + +L I P G L + + + + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK----DNIGSQYLL 114
Query: 496 KIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVED----- 550
+A+G+ Y+ L+H +L + NVL+ ++TD+ L+ L + E
Sbjct: 115 NWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLA-PPDMLEWVRTMR 609
+ + A E R T +SDV+++GV + EL+T PY P + +
Sbjct: 174 KVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILEKG 229
Query: 610 VDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
+ + + C + + RP +++ ++
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 9e-34
Identities = 58/269 (21%), Positives = 103/269 (38%), Gaps = 26/269 (9%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAV--------GGLS 445
E+LGRG + + VK D SAE ++ EA
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
HPN++ ++ ++ +++D G LF+ + L KI + + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVI 123
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP--DTVAYKAPEIRK 563
+H+ + +H +LK N+LL D +LTD+ S D T +Y APEI +
Sbjct: 124 CALHKLNI-VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 564 SSRRA-----TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENR 618
S + D+++ GV++ LL G P + ML + + G E
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 619 L--GMLTEVASVCSLKSPEQRPAMWQVLK 645
+ ++ S + P++R + L
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 9e-34
Identities = 50/265 (18%), Positives = 97/265 (36%), Gaps = 19/265 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNLVPI 452
++LG GS T A L +K + + + + + L HP V +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
FQ + Y NG L I + T ++ L Y+H
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHGK- 127
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT-----VAYKAPEIRKSSRR 567
+IH +LK N+LL D ++TD+ + + S + Y +PE+ +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-EKS 186
Query: 568 ATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627
A SD++A G ++ +L+ G P+ A + L + + ++++ E ++
Sbjct: 187 ACKSSDLWALGCIIYQLVAGL----PPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242
Query: 628 VCSLKSPEQRPAMWQVLKMIQEIKE 652
+ +R ++ +K
Sbjct: 243 KLLVLDATKRLGCEEMEG-YGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (322), Expect = 5e-33
Identities = 52/260 (20%), Positives = 99/260 (38%), Gaps = 21/260 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LG G+ G ++ V + K + D + + + L HP L+ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLH 92
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F+ K E ++I ++ G LF+ I + + +GL ++H S
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS- 147
Query: 514 LIHGNLKSSNVLLGADFEAR--LTDYCLSVLSDSSSVEDPD--TVAYKAPEIRKSSRRAT 569
++H ++K N++ + + D+ L+ + + T + APEI
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVG 206
Query: 570 SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA--- 626
+D++A GVL LL+G P+ D+ R D +E+ ++ A
Sbjct: 207 FYTDMWAIGVLGYVLLSGL----SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 627 -SVCSLKSPEQRPAMWQVLK 645
K P +R + L+
Sbjct: 263 IKNLLQKEPRKRLTVHDALE 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 55/284 (19%), Positives = 101/284 (35%), Gaps = 30/284 (10%)
Query: 395 ELLGRGSIGTTYKAV------LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPN 448
+ LGRG+ G +A V VK T + + H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 449 LVPIRAYFQAKGERL-VIYDYQPNGSLFNLIHGSR-----------SIRAKPLHWTSCLK 496
+V + G L VI ++ G+L + R + L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 497 IAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---- 552
+ VA+G+ ++ IH +L + N+LL ++ D+ L+
Sbjct: 139 YSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 553 -TVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD 611
+ + APE R T +SDV++FGVLL E+ + PY E+ R ++
Sbjct: 198 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKEG 253
Query: 612 DGRE--ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653
+ + + C P QRP ++++ + + ++
Sbjct: 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (308), Expect = 1e-31
Identities = 51/259 (19%), Positives = 93/259 (35%), Gaps = 18/259 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
++LG G+ A +V +K K + + E + + + HPN+V +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+++ G +I G LF+ I ++ V + Y+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHD-LG 127
Query: 514 LIHGNLKSSNVLL---GADFEARLTDYCLSVLSDSSSVEDPD--TVAYKAPEIRKSSRRA 568
++H +LK N+L D + ++D+ LS + D SV T Y AP + +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP-EVLAQKPY 186
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL--GMLTEVA 626
+ D ++ GV+ LL G P + E + + +
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 627 SVCSLKSPEQRPAMWQVLK 645
K PE+R Q L+
Sbjct: 245 RHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 43/260 (16%), Positives = 99/260 (38%), Gaps = 22/260 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E LGRG G ++ V + K K T ++ + + H N++ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F++ E ++I+++ +F I+ A L+ + V + L ++H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS-HN 122
Query: 514 LIHGNLKSSNVLLGADFEAR--LTDYCLSVLSDSSSVED--PDTVAYKAPEIRKSSRRAT 569
+ H +++ N++ + + ++ + Y APE+ + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ-HDVVS 181
Query: 570 SKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA--- 626
+ +D+++ G L+ LL+G +P+LA + M + +E ++ A
Sbjct: 182 TATDMWSLGTLVYVLLSGI----NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 627 -SVCSLKSPEQRPAMWQVLK 645
+K + R + L+
Sbjct: 238 VDRLLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 118 bits (297), Expect = 2e-30
Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 19/263 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNLVPI 452
E+LG G + + A L H V VK A+ D S F + + L+HP +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 453 RAYFQAKGERL----VIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
+A+ ++ +Y +L +++H P+ +++ D Q L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFS 127
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD------TVAYKAPEIR 562
H+ +IH ++K +N+++ A ++ D+ ++ S T Y +PE
Sbjct: 128 HQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622
+ ++SDVY+ G +L E+LTG+ P R E L
Sbjct: 187 RG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 623 TEVASVCSLKSPEQRPAMWQVLK 645
V K+PE R ++
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMR 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 3e-30
Identities = 40/274 (14%), Positives = 86/274 (31%), Gaps = 28/274 (10%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G GS G Y + V +K T + + +P
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ A+G+ V+ SL +L + ++ + L +A+ + + YIH ++
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 514 LIHGNLKSSNVL---LGADFEARLTDYCLSVLSDSSSVEDPD----------TVAYKAPE 560
IH ++K N L + D+ L+ + T Y +
Sbjct: 125 -IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 561 IRKSSRRATSKSDVYAFGVLLLELLTGK-HPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619
+ + D+ + G +L+ G E + ++ E
Sbjct: 184 THLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 620 GMLTEVASV---CSLKSPEQRPAMWQVLKMIQEI 650
G +E A+ C + +P + ++ + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 51/257 (19%), Positives = 96/257 (37%), Gaps = 17/257 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVG-GLSHPNLVP 451
++LG+GS G + A + +K + D E + HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 452 IRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ FQ K + +Y G L I + A ++ GL ++H
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 512 SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEIRKSSRRA 568
+++ +LK N+LL D ++ D+ + + + T Y APEI ++
Sbjct: 123 G-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI-LLGQKY 180
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628
D ++FGVLL E+L G+ P ++ +R R + ++
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIRMDNPFYPRWLEK--EAKDLLVK 236
Query: 629 CSLKSPEQRPAMWQVLK 645
++ PE+R + ++
Sbjct: 237 LFVREPEKRLGVRGDIR 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (292), Expect = 1e-29
Identities = 45/288 (15%), Positives = 88/288 (30%), Gaps = 30/288 (10%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G GS G ++ L N+ V +K A L+ +P
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
YF +G V+ SL +L+ + + + A+ + + IH S
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 514 LIHGNLKSSNVLLGADFE-----ARLTDYCLSVLSDSSSVEDPD----------TVAYKA 558
++ ++K N L+G + D+ + + T Y +
Sbjct: 123 -VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPD-MLEWVRTMRVDDGREEN 617
R + + D+ A G + + L G P Q A E + + E
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 618 RLGMLTEVASV---CSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662
G E + + P + + ++ E + ++ F
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 1e-29
Identities = 59/273 (21%), Positives = 104/273 (38%), Gaps = 21/273 (7%)
Query: 384 YSLE--QLMRASAELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHME 439
YSL+ Q++R LG GS G + N +K E
Sbjct: 1 YSLQDFQILR----TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 56
Query: 440 AVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAE 499
+ ++HP ++ + FQ + +I DY G LF+L+ S+ A
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAA 111
Query: 500 DVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAP 559
+V L Y+H +I+ +LK N+LL + ++TD+ + + T Y AP
Sbjct: 112 EVCLALEYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAP 170
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRL 619
E+ S++ D ++FG+L+ E+L G P E + + N
Sbjct: 171 EVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNAELRFPPFFNE- 226
Query: 620 GMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
+ ++ S + QR Q +++K
Sbjct: 227 -DVKDLLSRLITRDLSQRLGNLQ--NGTEDVKN 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 6e-29
Identities = 51/264 (19%), Positives = 100/264 (37%), Gaps = 22/264 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLSHPNL 449
E LG G K L K +T S E E+ + + + HPN+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 450 VPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+ + ++ K + ++I + G LF+ + + L + + + G+ Y+H
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLH 130
Query: 510 RASWLIHGNLKSSNVLLGADFEAR----LTDYCLSVLSDSSSVEDPD--TVAYKAPEIRK 563
+ H +LK N++L + + D+ L+ D + T + APEI
Sbjct: 131 SL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGRE--ENRLGM 621
++D+++ GV+ LL+G P + L V + + E N +
Sbjct: 190 -YEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 622 LTEVASVCSLKSPEQRPAMWQVLK 645
+ +K P++R + L+
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 114 bits (286), Expect = 7e-29
Identities = 36/199 (18%), Positives = 81/199 (40%), Gaps = 9/199 (4%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRA 454
E +G G+ G YKA + +K+ K + + + + L H N+V +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 455 YFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWL 514
K ++++++ L L + + G+AY H +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDR-RV 121
Query: 515 IHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV---AYKAPEIRKSSRRATSK 571
+H +LK N+L+ + E ++ D+ L+ + + Y+AP++ S++ ++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 572 SDVYAFGVLLLELLTGKHP 590
D+++ G + E++ G
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 9e-29
Identities = 48/265 (18%), Positives = 93/265 (35%), Gaps = 25/265 (9%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
++LG G G + +K A E + P++V I
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA------SQCPHIVRIV 71
Query: 454 AYFQA----KGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
++ + L++ + G LF+ I + +I + + + + Y+H
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH 128
Query: 510 RASWLIHGNLKSSNVLLGADFE---ARLTDYCLS--VLSDSSSVEDPDTVAYKAPEIRKS 564
+ H ++K N+L + +LTD+ + S +S T Y APE+
Sbjct: 129 S-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LG 186
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP--SQHPYLAPPDMLEWVRTMRVDDGREENRL--G 620
+ D+++ GV++ LL G P S H P M +R + + E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 621 MLTEVASVCSLKSPEQRPAMWQVLK 645
+ + P QR + + +
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 48/291 (16%), Positives = 103/291 (35%), Gaps = 36/291 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G G+ G YKA +V +K+ + + + + + L+HPN+V +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ + +++++ + + + + QGLA+ H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSH-R 122
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV---AYKAPEIRKSSRRATS 570
++H +LK N+L+ + +L D+ L+ V Y+APEI + ++
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 571 KSDVYAFGVLLLELLTGKHPSQ-----------HPYLAPPDMLEWVRTMRVDDGREENRL 619
D+++ G + E++T + L PD + W + D +
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 620 GMLTEVASV--------------CSLKSPEQRPAMWQVLKM--IQEIKESV 654
+ + V P +R + L Q++ + V
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-28
Identities = 44/197 (22%), Positives = 84/197 (42%), Gaps = 3/197 (1%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+ +G G+ G AV V +K+ ++ A+ + + + + H N++ +
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
F D+ G ++ + L + + +GL YIH A
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSD 573
IH +LK N+ + D E ++ D+ L+ +DS T Y+APE+ + R T D
Sbjct: 143 -IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVD 201
Query: 574 VYAFGVLLLELLTGKHP 590
+++ G ++ E++TGK
Sbjct: 202 IWSVGCIMAEMITGKTL 218
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 6e-28
Identities = 48/261 (18%), Positives = 100/261 (38%), Gaps = 26/261 (9%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLS--HP 447
LLG G G+ Y + + ++L V +K + ++ +D + + + +S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 448 NLVPIRAYFQAKGERLVIYDY-QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
++ + +F+ ++I + +P LF+ I L V + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVR 124
Query: 507 YIHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSSVEDPD-TVAYKAPEIRKS 564
+ H ++H ++K N+L+ + E +L D+ L + D D T Y PE +
Sbjct: 125 HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624
R + V++ G+LL +++ G P +H +++ R E
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSE------CQH 233
Query: 625 VASVCSLKSPEQRPAMWQVLK 645
+ C P RP ++
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 8e-28
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 13/203 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTA---DTSAEAFEQHMEAVGGLSHPNLV 450
+ LG G T YKA + + IV +K+ + D + ++ + LSHPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 451 PIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR 510
+ F K +++D+ + S L + QGL Y+H+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 511 ASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD---TVAYKAPEIRKSSRR 567
W++H +LK +N+LL + +L D+ L+ S + T Y+APE+ +R
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 568 ATSKSDVYAFGVLLLELLTGKHP 590
D++A G +L ELL
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 52/261 (19%), Positives = 105/261 (40%), Gaps = 22/261 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G G+ G A N + V +K+ + T + + ++ + H N++ I
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGIN 72
Query: 454 AYFQAK----GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIH 509
+A + + + + L+ L+ + + L + +GL YIH
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLL------KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 510 RASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP------DTVAYKAPEIRK 563
A+ +H +LK SN+LL + ++ D+ L+ ++D T Y+APEI
Sbjct: 127 SANV-LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623
+S+ T D+++ G +L E+L+ + + D L + + +E+ ++
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSP-SQEDLNCIIN 242
Query: 624 EVASVCSLKSPEQRPAMWQVL 644
A L P + W L
Sbjct: 243 LKARNYLLSLPHKNKVPWNRL 263
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-27
Identities = 43/293 (14%), Positives = 102/293 (34%), Gaps = 41/293 (13%)
Query: 395 ELLGRGSIGTTYKA--VLDNHLIVTVKRFDANKTADTSAEAFEQH---MEAVGGLSHPNL 449
+G G+ G +KA + + V +KR + + + + + HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 450 VPIRAYFQAKGE----RLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
V + +L + + L + + + + + + +GL
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLRGL 129
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--TVAYKAPEIRK 563
++H ++H +LK N+L+ + + +L D+ L+ + T+ Y+APE+
Sbjct: 130 DFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188
Query: 564 SSRRATSKSDVYAFGVLLLELLTGKHPSQHP-----------YLAPPDMLEWVRTMRVDD 612
+ D+++ G + E+ K + + P +W R + +
Sbjct: 189 Q-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 613 GREENRLGMLTEVASV------------CSLKSPEQRPAMWQVLKM--IQEIK 651
++ E C +P +R + + L Q+++
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 9e-27
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+++G GS G Y+A L D+ +V +K+ +K + ++ + L H N+V +R
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLR 79
Query: 454 AYFQAKGER------LVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
+F + GE+ ++ DY P H SR + L + + LAY
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAY 137
Query: 508 IHRASWLIHGNLKSSNVLLGAD-FEARLTDYCLSVLSDSSSVED--PDTVAYKAPEIRKS 564
IH + H ++K N+LL D +L D+ + + Y+APE+
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 565 SRRATSKSDVYAFGVLLLELLTGKHP 590
+ TS DV++ G +L ELL G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (271), Expect = 2e-26
Identities = 49/260 (18%), Positives = 90/260 (34%), Gaps = 15/260 (5%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNLVPI 452
+ LG GS G ++ +K D K E + ++ P LV +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
F+ ++ +Y G +F+ + R A + Y+H
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL- 160
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKS 572
LI+ +LK N+L+ ++TD+ + + T APEI S+
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIIL-SKGYNKAV 219
Query: 573 DVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632
D +A GVL+ E+ G P P + E + + +V + L ++
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKVRFPSHFSS--DLKDLLRNLLQV 275
Query: 633 SPEQRPAMWQVLKMIQEIKE 652
+R + + +IK
Sbjct: 276 DLTKRFGNLK--NGVNDIKN 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-25
Identities = 45/281 (16%), Positives = 103/281 (36%), Gaps = 36/281 (12%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
E +G G+ GT +KA + H IV +KR + + + + + + L H N+V +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASW 513
+ + +++++ + + + +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSR-N 121
Query: 514 LIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VEDPDTVAYKAPEIRKSSRRATS 570
++H +LK N+L+ + E +L ++ L+ + T+ Y+ P++ ++ ++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 571 KSDVYAFGVLLLELLTGKHP------------SQHPYLAPPDMLEWVRTMRVDDGREENR 618
D+++ G + EL P L P +W ++ D +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 619 LGMLTEVASV--------------CSLKSPEQRPAMWQVLK 645
T + +V +P QR + + L+
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 41/262 (15%), Positives = 80/262 (30%), Gaps = 16/262 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSA-EAFEQHMEAVGGLSHPNLVPI 452
+LLG+G+ G +K + HP L +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 453 RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
+ FQ + +Y G LF + R + ++ L Y+H
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTV--AYKAPEIRKSSRRATS 570
++ ++K N++L D ++TD+ L S
Sbjct: 126 V-VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 571 KSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630
D + GV++ E++ G+ P + + E + + R + + +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTLSP--EAKSLLAGLL 240
Query: 631 LKSPEQRPAMWQVLKMIQEIKE 652
K P+QR +E+ E
Sbjct: 241 KKDPKQRLGGGP--SDAKEVME 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-24
Identities = 45/202 (22%), Positives = 84/202 (41%), Gaps = 13/202 (6%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+G G+ G+ A L V VK+ + A+ + + + + H N++ +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 454 AYFQAK-----GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYI 508
F + + + L N++ + + L + + +GL YI
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILRGLKYI 137
Query: 509 HRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRA 568
H A IH +LK SN+ + D E ++ D+ L+ +D T Y+APEI +
Sbjct: 138 HSADI-IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 569 TSKSDVYAFGVLLLELLTGKHP 590
D+++ G ++ ELLTG+
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTL 218
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 8e-24
Identities = 50/295 (16%), Positives = 105/295 (35%), Gaps = 50/295 (16%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPI- 452
+G+G+ G +KA V +K+ + + ++ + L H N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 453 -------RAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
Y + KG +++D+ + L + + ++ + + GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGL 130
Query: 506 AYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-------TVAYKA 558
YIHR + ++H ++K++NVL+ D +L D+ L+ + P+ T+ Y+
Sbjct: 131 YYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 559 PEIRKSSRRATSKSDVYAFGVLLLELLTGKHP----------------------SQHPYL 596
PE+ R D++ G ++ E+ T P +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 597 APPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL------KSPEQRPAMWQVLK 645
++ E + ++ + ++RL L P QR L
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 9e-24
Identities = 50/270 (18%), Positives = 96/270 (35%), Gaps = 20/270 (7%)
Query: 395 ELLGRGSIGTTYKAVL----DNHLIVTVKRFDANKTADTS--AEAFEQHMEAVGGLSH-P 447
++LG G+ G + D + +K + E + + + P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 448 NLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAY 507
LV + FQ + + +I DY G LF + + + ++ L +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEH 144
Query: 508 IHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD-----TVAYKAPEIR 562
+H+ +I+ ++K N+LL ++ LTD+ LS + E +R
Sbjct: 145 LHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 563 KSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622
D ++ GVL+ ELLTG P R ++ + + +
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652
++ +K P++R + EIKE
Sbjct: 264 KDLIQRLLMKDPKKRLGCGP--RDADEIKE 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 98.8 bits (245), Expect = 3e-23
Identities = 43/270 (15%), Positives = 96/270 (35%), Gaps = 19/270 (7%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
LGRG ++A+ + N+ V VK K E + +E + PN++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI--KILENLR--GGPNIITLA 96
Query: 454 AYFQAKGERLV--IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA 511
+ R ++++ N L + L ++ + L Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 512 SWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSSSVEDPD--TVAYKAPEIRKSSRRA 568
++H ++K NV++ + + RL D+ L+ + + +K PE+ +
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 569 TSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628
D+++ G +L ++ K P H + ++ + + +D + +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 629 CSLKSPEQRPAMWQVLKMIQEIKESVMAED 658
+ R + + + S A D
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALD 297
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.0 bits (214), Expect = 5e-19
Identities = 45/227 (19%), Positives = 87/227 (38%), Gaps = 20/227 (8%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAE------AFEQHMEAV--GGLS 445
LG G T + A + N+ V +K +K +AE + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 446 HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGL 505
+++ + +F KG V NL+ + + + +I++ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 506 AYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDSSSVEDPDTV-----AYKAP 559
Y+HR +IH ++K NVL+ D L ++ L ++ ++ T Y++P
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 560 EIRKSSRRATSKSDVYAFGVLLLELLTGKHP----SQHPYLAPPDML 602
E+ +D+++ L+ EL+TG H Y D +
Sbjct: 199 EVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (203), Expect = 1e-17
Identities = 37/200 (18%), Positives = 85/200 (42%), Gaps = 9/200 (4%)
Query: 395 ELLGRGSIGTTYKAV-LDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIR 453
+ +G G+ G A V +K+ T A+ + + + ++H N++ +
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 454 AYFQAKGERLVIYDYQPNGSLFNLIHGSR-SIRAKPLHWTSCLKIAEDVAQGLAYIHRAS 512
F + + ++Q + L+ + + L + + G+ ++H A
Sbjct: 83 NVFTPQK---TLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 513 WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPD--TVAYKAPEIRKSSRRATS 570
IH +LK SN+++ +D ++ D+ L+ + +S + P T Y+APE+
Sbjct: 140 I-IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KE 197
Query: 571 KSDVYAFGVLLLELLTGKHP 590
D+++ G ++ E++ K
Sbjct: 198 NVDIWSVGCIMGEMVRHKIL 217
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 8e-15
Identities = 36/138 (26%), Positives = 53/138 (38%), Gaps = 23/138 (16%)
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS------- 144
TL L L L L NN ++ P LS L L L L N S PL+ L+
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 145 -------------LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQ 191
L LT L L +NN++ + P +++L +L L N+ S N
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANL 350
Query: 192 PFLVVFNVSGNNLTGQVP 209
+ + N ++ P
Sbjct: 351 TNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 4e-14
Identities = 24/83 (28%), Positives = 39/83 (46%), Gaps = 5/83 (6%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
L L L+L+ N+++ P +SSL L+ L + N S S+ +L + L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 158 LTGLIPVNLTALDRLYSLKLEWN 180
++ L P L L R+ L L
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.9 bits (154), Expect = 2e-11
Identities = 35/127 (27%), Positives = 50/127 (39%), Gaps = 23/127 (18%)
Query: 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
L LSL+ N L I L+SL NL L L+ N S PLS L +LT L L N ++
Sbjct: 220 NLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQIS 276
Query: 160 GLIPV--------------------NLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNV 199
+ P+ ++ L L L L +N S P + L
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFF 336
Query: 200 SGNNLTG 206
+ N ++
Sbjct: 337 ANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.6 bits (143), Expect = 4e-10
Identities = 28/129 (21%), Positives = 45/129 (34%), Gaps = 25/129 (19%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLS---------------------SLINLKSLSLSRNF 133
L+ L +L L L N ++ P +L NL L+L N
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 134 FSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPF 193
S P+S SL +L L + N ++ +L L + L N+ S P N
Sbjct: 319 ISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTR 374
Query: 194 LVVFNVSGN 202
+ ++
Sbjct: 375 ITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.5 bits (122), Expect = 1e-07
Identities = 35/135 (25%), Positives = 50/135 (37%), Gaps = 27/135 (20%)
Query: 97 RLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYN 156
+L L L NN ++ P NL LSL+ N ++ SL LT LDL+ N
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQP----------------------FL 194
++ L P L+ L +L LKL N+ S P L
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 195 VVFNVSGNNLTGQVP 209
+ NN++ P
Sbjct: 310 TYLTLYFNNISDISP 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 7e-07
Identities = 18/77 (23%), Positives = 32/77 (41%), Gaps = 4/77 (5%)
Query: 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157
L + L ++T + + L + +L R + L+ LT ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNNQ 77
Query: 158 LTGLIPV-NLTALDRLY 173
LT + P+ NLT L +
Sbjct: 78 LTDITPLKNLTKLVDIL 94
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 16/64 (25%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153
+ T LDQ+ L + I + L NL ++ S N + PL +L +L + +
Sbjct: 39 SQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILM 95
Query: 154 SYNN 157
+ N
Sbjct: 96 NNNQ 99
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.2 bits (158), Expect = 9e-13
Identities = 30/201 (14%), Positives = 65/201 (32%), Gaps = 27/201 (13%)
Query: 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA--------DTSAEAFEQHMEAVGGLSH 446
+L+G G + + VK T+ D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 447 PNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLA 506
L ++ K +Y ++ N L LI + + ++ + + + +A
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKEL---YRVRVENPDEVLDMILEEVA 117
Query: 507 YIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSS- 565
+ ++HG+L NVL+ + + D+ SV V + ++R
Sbjct: 118 KFYHR-GIVHGDLSQYNVLVS-EEGIWIIDFPQSV-----EVGEEGWREILERDVRNIIT 170
Query: 566 ---RRATSKSDVYAFGVLLLE 583
R ++ D+ + +L+
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 4e-11
Identities = 26/63 (41%), Positives = 35/63 (55%), Gaps = 3/63 (4%)
Query: 177 LEWNRFSGTVPP--LNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVIN 234
L NR GT+P FL NVS NNL G++P+ L +FD S+++ N LCG +
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL- 309
Query: 235 KAC 237
AC
Sbjct: 310 PAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 4e-10
Identities = 19/84 (22%), Positives = 31/84 (36%), Gaps = 1/84 (1%)
Query: 61 FDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSS 120
G + L++ + GT P LT+L L L++ N+L G IP +
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 121 LINLKSLSLSRNFFSGAFPLSILS 144
L + + N PL +
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 4e-09
Identities = 18/59 (30%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP 187
L N G P + L L L++S+NNL G IP L R N+ P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 30/186 (16%)
Query: 34 PSDAVSLLSFKSKADSENKLLYALNERFDYCQ--WQGVKCAQGRVVRFVLQSFGLRGTFP 91
P D +LL K + L + D C W GV C
Sbjct: 5 PQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLC-------------------- 43
Query: 92 PNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLS---LSRN-FFSGAFPLSILSLHR 147
+T T+ ++ L L +L P P SSL NL L+ + G P +I L +
Sbjct: 44 -DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 148 LTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPP--LNQPFLVVFNVSGNNLT 205
L L +++ N++G IP L+ + L +L +N SGT+PP + P LV GN ++
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 206 GQVPET 211
G +P++
Sbjct: 163 GAIPDS 168
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.5 bits (133), Expect = 4e-10
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 7/118 (5%)
Query: 102 RVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGL 161
RVL L + LT + L L+ + L LS N P ++ +L L +L S N L +
Sbjct: 1 RVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 162 IPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLTGQVPETPTLLK 216
V + L L NR + + P LV+ N+ GN+L + L +
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 22/105 (20%), Positives = 36/105 (34%), Gaps = 23/105 (21%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINL----------------------KSLSLSRN 132
L +L + L L +N L P L++L L + L L N
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNN 75
Query: 133 FFSGAFPLSILS-LHRLTILDLSYNNLTGLIPVNLTALDRLYSLK 176
+ + L RL +L+L N+L + + L S+
Sbjct: 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 38/156 (24%), Positives = 57/156 (36%), Gaps = 3/156 (1%)
Query: 57 LNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP 116
L+ G+ + LQ L+ P +T L L L LH N ++
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 117 D-LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSL 175
L +L L L +N + P + L RL L L NNL+ L L L L L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 176 KLEWNRFSGTVPPLNQP-FLVVFNVSGNNLTGQVPE 210
+L N + +L F S + + +P+
Sbjct: 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 1e-06
Identities = 12/61 (19%), Positives = 21/61 (34%), Gaps = 3/61 (4%)
Query: 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
L+ L L++N L+ S + + P L + L+ N+L
Sbjct: 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQ 282
Query: 160 G 160
G
Sbjct: 283 G 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.001
Identities = 25/115 (21%), Positives = 29/115 (25%), Gaps = 3/115 (2%)
Query: 118 LSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKL 177
L L +L L R P L L L L N L L L L L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 178 EWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNLC 229
NR S L + N + P L + N
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 9e-09
Identities = 27/129 (20%), Positives = 39/129 (30%), Gaps = 3/129 (2%)
Query: 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159
LRV+ + L DL + L L N + +L L L L N ++
Sbjct: 11 HLRVVQCSDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 160 GLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDA 219
+ P L +L L L N+ +P L V N +T L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 220 SSFSMNPNL 228
L
Sbjct: 128 VVELGTNPL 136
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 28/140 (20%), Positives = 45/140 (32%), Gaps = 2/140 (1%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
+ L+Q+ V+ L N L + + +K LS R + + L
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL 173
Query: 149 TILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLN--QPFLVVFNVSGNNLTG 206
T L L N +T + +L L+ L L L +N S P L +++ N L
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
Query: 207 QVPETPTLLKFDASSFSMNP 226
N
Sbjct: 234 VPGGLADHKYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 23/172 (13%), Positives = 53/172 (30%), Gaps = 33/172 (19%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTG------------------------PIPDLSSLINL 124
P L +L L L N L + + + + +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 125 KSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSG 184
L + SG + + +L+ + ++ N+T + +L L+ L+ N+ +
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKITK 185
Query: 185 TVPPL--NQPFLVVFNVSGNNLTGQVPET----PTLLKFDASSFSMNPNLCG 230
L +S N+++ + P L + ++ + G
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG 237
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.5 bits (88), Expect = 0.002
Identities = 22/116 (18%), Positives = 31/116 (26%), Gaps = 30/116 (25%)
Query: 98 LDQLRVLSLHNNSLTGPIPD-LSSLINLKSLSLSRNFFSGAF------------------ 138
L L L N +T L L NL L LS N S
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 139 -----PLSILSLHRLTILDLSYNNLTGL------IPVNLTALDRLYSLKLEWNRFS 183
P + + ++ L NN++ + P T + L N
Sbjct: 230 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 1e-08
Identities = 12/90 (13%), Positives = 27/90 (30%), Gaps = 6/90 (6%)
Query: 101 LRVLSLHNNSLT--GPIPDLSSLINLKSLSLSRNFFSG----AFPLSILSLHRLTILDLS 154
++ L + L+ L L + + L + ++ L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSG 184
N L + + + S K++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 20/80 (25%), Positives = 30/80 (37%), Gaps = 10/80 (12%)
Query: 100 QLRVLSLHNNSLTGPIPD-----LSSLINLKSLSLSRNFFSGAFPLSILSLHR-----LT 149
LRVL L + ++ L + +L+ L LS N A L ++ R L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 150 ILDLSYNNLTGLIPVNLTAL 169
L L + + L AL
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 15/68 (22%), Positives = 24/68 (35%), Gaps = 5/68 (7%)
Query: 122 INLKSLSLSRNFFSGAFPLSILS-LHRLTILDLSYNNLTG----LIPVNLTALDRLYSLK 176
++++SL + S A +L L + ++ L LT I L L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 177 LEWNRFSG 184
L N
Sbjct: 62 LRSNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 9e-06
Identities = 18/87 (20%), Positives = 26/87 (29%), Gaps = 10/87 (11%)
Query: 81 LQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTG----PIPD-LSSLINLKSLSLSRNFFS 135
+Q L L L Q +V+ L + LT I L L L+L N
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 136 GAFPLSILSL-----HRLTILDLSYNN 157
+L ++ L L
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 4e-05
Identities = 19/76 (25%), Positives = 28/76 (36%), Gaps = 9/76 (11%)
Query: 123 NLKSLSLSRNFFSG----AFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDR-----LY 173
L+ L L+ S + ++L+ H L LDLS N L + L R L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 174 SLKLEWNRFSGTVPPL 189
L L +S +
Sbjct: 430 QLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 13/94 (13%), Positives = 26/94 (27%), Gaps = 17/94 (18%)
Query: 146 HRLTILDLSYNNLTGL----IPVNLTALDRLYSLKLEWNRFSGTVP-------PLNQPFL 194
L +L L+ +++ + L A L L L N L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 195 VVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNL 228
+ + ++ + L+ P+L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE------KDKPSL 456
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 8e-08
Identities = 21/117 (17%), Positives = 35/117 (29%), Gaps = 9/117 (7%)
Query: 55 YALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGP 114
L + + + + L + L L++ NN L
Sbjct: 240 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE- 298
Query: 115 IPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGL--IPVNLTAL 169
+P + L+ L S N + L L L + YN L IP ++ L
Sbjct: 299 LP--ALPPRLERLIASFNHLAEVPEL----PQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 3/60 (5%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
L L +L L +N ++ I L+SL NL + L N S PL+ + L I+ L+
Sbjct: 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 17/63 (26%), Positives = 27/63 (42%), Gaps = 4/63 (6%)
Query: 116 PDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSL 175
L++L L +L N S PL+ SL L + L N ++ + P L L+ +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 176 KLE 178
L
Sbjct: 223 TLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 16/55 (29%), Positives = 21/55 (38%), Gaps = 1/55 (1%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
T LD + LS +T I + L NL L L N + PL L+
Sbjct: 36 TQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITE 89
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 3e-06
Identities = 22/95 (23%), Positives = 35/95 (36%), Gaps = 2/95 (2%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSG--AFPLSILSLHRLTILD 152
L + VL+ ++ ++ L SL+LS N + L IL+
Sbjct: 38 LVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97
Query: 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVP 187
LS N L ++ +L L L+ N S T
Sbjct: 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.003
Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 89 TFPPNTLTRLDQLRVLSLHNNSLTGPIP---DLSSLINLKSLSLSRNFFSGAFPLSILSL 145
+ +L L+L NN L + NLK L+LS N L +
Sbjct: 55 ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG 114
Query: 146 HRLTILDLSYNNLTGLIP 163
+L L L N+L+
Sbjct: 115 LKLEELWLDGNSLSDTFR 132
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 5e-06
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 8/94 (8%)
Query: 96 TRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSY 155
LD L +L + + + R+F S R+ +DLS
Sbjct: 3 QTLD------LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSN 55
Query: 156 NNLTG-LIPVNLTALDRLYSLKLEWNRFSGTVPP 188
+ + + L+ +L +L LE R S +
Sbjct: 56 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 16/84 (19%), Positives = 32/84 (38%), Gaps = 5/84 (5%)
Query: 74 GRVVRFVLQSFGLRGTF---PPNTLTRLDQLRVLSLHNNSLT--GPIPDLSSLINLKSLS 128
GR++ + +F +F P +++ + L N+ + LS L++LS
Sbjct: 18 GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 77
Query: 129 LSRNFFSGAFPLSILSLHRLTILD 152
L S ++ L L+
Sbjct: 78 LEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 5e-05
Identities = 19/81 (23%), Positives = 30/81 (37%), Gaps = 3/81 (3%)
Query: 114 PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173
PI ++S + + ++ + + A P + TIL LS N L L RL
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 174 SLKLEWNRFSGTVPPLNQPFL 194
L L+ + P L
Sbjct: 59 QLNLDRAELTKLQVDGTLPVL 79
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 12/45 (26%), Positives = 14/45 (31%)
Query: 90 FPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFF 134
P L L+ L L L NSL L L N +
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 7/71 (9%), Positives = 17/71 (23%), Gaps = 1/71 (1%)
Query: 61 FDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPD-LS 119
+ ++ L P + +L + + L
Sbjct: 163 NGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 222
Query: 120 SLINLKSLSLS 130
+L L++ S
Sbjct: 223 NLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 8e-04
Identities = 10/46 (21%), Positives = 15/46 (32%), Gaps = 3/46 (6%)
Query: 144 SLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL 189
ILD+S + L L+ L L+ +P L
Sbjct: 199 GASGPVILDISRTRIHSLPS---YGLENLKKLRARSTYNLKKLPTL 241
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 11/55 (20%), Positives = 23/55 (41%), Gaps = 1/55 (1%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRL 148
T L+ + + +N+ + + + L N+ L L+ N + PL+ L
Sbjct: 41 TQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGW 94
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 12/36 (33%), Positives = 18/36 (50%), Gaps = 1/36 (2%)
Query: 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLS 130
L L +L+ L L N ++ + L+ L NL L L
Sbjct: 174 LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 9/70 (12%), Positives = 21/70 (30%), Gaps = 4/70 (5%)
Query: 138 FPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVF 197
F + +L ++T + L+ + + + P +
Sbjct: 18 FSDDAFA--ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTKL 73
Query: 198 NVSGNNLTGQ 207
++GN LT
Sbjct: 74 FLNGNKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 14/40 (35%), Positives = 21/40 (52%), Gaps = 2/40 (5%)
Query: 115 IPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154
I L+ L L++L LS+N S L+ L L +L+L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELF 208
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 3e-04
Identities = 13/74 (17%), Positives = 23/74 (31%), Gaps = 3/74 (4%)
Query: 115 IPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYS 174
++ + + L L +L + +D S N + L L RL +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKT 67
Query: 175 LKLEWNRFSGTVPP 188
L + NR
Sbjct: 68 LLVNNNRICRIGEG 81
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 19/85 (22%), Positives = 30/85 (35%), Gaps = 4/85 (4%)
Query: 100 QLRVLSLHNNSLTGPIPDL-SSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNL 158
+ R L L + I +L ++L ++ S N L RL L ++ N +
Sbjct: 19 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNNRI 75
Query: 159 TGLIPVNLTALDRLYSLKLEWNRFS 183
+ AL L L L N
Sbjct: 76 CRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 8e-04
Identities = 16/74 (21%), Positives = 26/74 (35%), Gaps = 4/74 (5%)
Query: 54 LYALNERFDYCQWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTG 113
L L + + + S + P L L L L + +N ++
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP---LANLTTLERLDISSNKVSD 186
Query: 114 PIPDLSSLINLKSL 127
I L+ L NL+SL
Sbjct: 187 -ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 13/48 (27%), Positives = 20/48 (41%), Gaps = 1/48 (2%)
Query: 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLS 141
+ T LDQ+ L + I + L NL ++ S N + PL
Sbjct: 35 SQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITPLK 81
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.6 bits (83), Expect = 0.004
Identities = 11/80 (13%), Positives = 25/80 (31%), Gaps = 7/80 (8%)
Query: 114 PIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173
L+ + L + + +S L ++T L + + + L+ L
Sbjct: 13 TDTALAEKMKT---VLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLT 65
Query: 174 SLKLEWNRFSGTVPPLNQPF 193
+ N+ + P N
Sbjct: 66 QINFSNNQLTDITPLKNLTK 85
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 12/83 (14%), Positives = 29/83 (34%), Gaps = 13/83 (15%)
Query: 106 LHNNSLTGPIPD-------LSSLINLKSLSLSRNFFSGAFPLSILS-----LHRLTILDL 153
L++ L+ I L++L L N ++ + + L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 154 SYNNLTGLIPVNLTALDRLYSLK 176
+ N + + + ++S +
Sbjct: 310 NGNRFSEE-DDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 15/52 (28%), Positives = 18/52 (34%), Gaps = 5/52 (9%)
Query: 137 AFPLSILSLHRLTILDLSYNNLTGLIPVNLTA-----LDRLYSLKLEWNRFS 183
S L L L L YN + L + L L+L NRFS
Sbjct: 264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.002
Identities = 11/65 (16%), Positives = 21/65 (32%), Gaps = 4/65 (6%)
Query: 101 LRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSG----AFPLSILSLHRLTILDLSYN 156
L++ ++ L ++K + LS N +I S L I + S
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 157 NLTGL 161
+
Sbjct: 70 FTGRV 74
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.003
Identities = 24/118 (20%), Positives = 33/118 (27%), Gaps = 6/118 (5%)
Query: 116 PDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIP----VNLTALDR 171
PD L +R+ + LT L + + L L R
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGEL-R 59
Query: 172 LYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLC 229
++ RF P L N+S N L +T L S NP C
Sbjct: 60 NLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 665 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.68 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.67 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.62 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.54 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.51 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.5 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.47 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.4 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.32 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.28 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.12 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.05 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.72 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.5 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.28 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.26 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.19 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.13 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.06 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.11 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.5 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.09 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.83 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=412.52 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=205.9
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||+||+|.+++ .||||+++.........+.|.+|++++++++|||||++++++.+ +..++||||+++|+|
T Consensus 14 ~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L 90 (276)
T d1uwha_ 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSL 90 (276)
T ss_dssp SEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEH
T ss_pred EEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCH
Confidence 579999999999998654 49999998766556677889999999999999999999998754 568999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----CC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-----VE 549 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~~ 549 (665)
.++++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 91 ~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~-ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 165 (276)
T d1uwha_ 91 YHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165 (276)
T ss_dssp HHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTSSEEECCCCCSCC------------
T ss_pred HHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhcCC-EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccc
Confidence 9999742 346999999999999999999999999 9999999999999999999999999997654322 23
Q ss_pred CCCCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---CchhhhHHHHHH
Q 005999 550 DPDTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD---GREENRLGMLTE 624 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 624 (665)
..||+.|||||++.. ...++.++|||||||++|||+||+.||..... ...+...+....... .....++..+.+
T Consensus 166 ~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~ 244 (276)
T d1uwha_ 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244 (276)
T ss_dssp CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHTSCCCCGGGSCTTCCHHHHH
T ss_pred cccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCCCCcchhccccchHHHHH
Confidence 368999999999863 23579999999999999999999999976321 113333333322222 134456788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
++.+||+.||++|||+.|+++.|+.+.+++
T Consensus 245 li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 245 LMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 999999999999999999999999988753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=405.89 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=202.0
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||+||+|.+.++..||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||+++|+|
T Consensus 11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 5799999999999999888899999997654 3346799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~ 550 (665)
.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 88 ~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 88 SDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp HHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred HHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccc-eeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 999874 2356899999999999999999999999 9999999999999999999999999997664432 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTG-KHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.||+.|+|||++. +..++.++|||||||++|||+|+ ++||.. ....++...+...... ..+...+..+.+++.+|
T Consensus 163 ~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 163 KFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHC 238 (263)
T ss_dssp --CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--CCHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHH
T ss_pred ecCcccCChHHhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCC--CCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHH
Confidence 5789999999987 66799999999999999999995 555443 1223444444443222 23455677899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
|+.||++||||+||++.|+++.++
T Consensus 239 l~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=404.67 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=207.4
Q ss_pred hHhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
+.||+|+||+||+|.+. .++.||||+++.........+.|.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999854 467899999976655555677899999999999999999999999654 57899999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.++++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~-iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCC-cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999974 356999999999999999999999999 9999999999999999999999999997654332
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
....||+.|||||++. +..++.++|||||||++|||+| |+.||... ...++...+..... ...+...+..+.+
T Consensus 166 ~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--~~~~~~~~i~~~~~-~~~p~~~~~~~~~ 241 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--KGSEVTAMLEKGER-MGCPAGCPREMYD 241 (277)
T ss_dssp C----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCC-CCCCTTCCHHHHH
T ss_pred cccccCCCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCcccCHHHHH
Confidence 2235889999999987 5678999999999999999998 89999763 23344444443322 2345567888999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhhcc
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESVMA 656 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 656 (665)
|+.+||+.||++|||++||++.|+....++..
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence 99999999999999999999999987665543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=406.67 Aligned_cols=249 Identities=19% Similarity=0.391 Sum_probs=201.5
Q ss_pred hHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||+||+|.+.. ...||||++..... +...+.|.+|+++|++++|||||+++|++.+++..++||||++
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 679999999999998642 23689999876543 3456779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC--
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV-- 548 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-- 548 (665)
+|+|.+++.. ....++|.++..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.......
T Consensus 111 ~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 111 NGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp TEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCC-CccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 9999998874 2456999999999999999999999999 99999999999999999999999999976643221
Q ss_pred ------CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHH
Q 005999 549 ------EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGM 621 (665)
Q Consensus 549 ------~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (665)
...+|+.|||||++. +..++.++|||||||++|||+| |+.||.+. ...++...+..... ...+...+..
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--~~~~~~~~i~~~~~-~~~~~~~~~~ 261 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDM--TNQDVINAIEQDYR-LPPPMDCPSA 261 (299)
T ss_dssp ----------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCC-CCCCTTCCHH
T ss_pred eeeecccccCCccccCHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCC-CCCCccchHH
Confidence 124688999999987 5789999999999999999998 89999763 22344444443222 2345567788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 622 LTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 622 l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+.+++.+||+.||++|||+.||++.|+++.++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 99999999999999999999999999988764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=401.34 Aligned_cols=243 Identities=20% Similarity=0.297 Sum_probs=199.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 67999999999999974 689999999976543 2334678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-----SV 548 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~~ 548 (665)
|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++...... ..
T Consensus 90 L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~-IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 90 LFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp GGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred HHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcC-CccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 9999863 356999999999999999999999999 999999999999999999999999999765322 23
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASV 628 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 628 (665)
...||+.|||||++.+...++.++||||+||++|||+||+.||............. .............+..+.+|+.+
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~ 242 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYLNPWKKIDSAPLALLHK 242 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-HTTCTTSTTGGGSCHHHHHHHHH
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCccccCCHHHHHHHHH
Confidence 44699999999998744445788999999999999999999997643322222222 22222222344567789999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 005999 629 CSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 629 cl~~dP~~RPt~~evl~ 645 (665)
||+.||++|||++|+++
T Consensus 243 ~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 243 ILVENPSARITIPDIKK 259 (271)
T ss_dssp HSCSSTTTSCCHHHHTT
T ss_pred HcCCChhHCcCHHHHhc
Confidence 99999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=401.39 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=206.3
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++|||||++++++.+ +..++||||+++|+|
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSL 94 (272)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBH
T ss_pred EEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcH
Confidence 5799999999999999988999999997654 335679999999999999999999998855 567999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~ 550 (665)
.+++... ....+++..++.|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 95 ~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~-ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (272)
T d1qpca_ 95 VDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170 (272)
T ss_dssp HHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred HHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence 9987642 2345999999999999999999999999 9999999999999999999999999998765432 234
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.+|+.|+|||++. +..++.++|||||||++|||+||..|+... ....++...+..... ...+...+..+.+|+.+||
T Consensus 171 ~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-~~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl 247 (272)
T d1qpca_ 171 KFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYR-MVRPDNCPEELYQLMRLCW 247 (272)
T ss_dssp CCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHT
T ss_pred CCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhcCC-CCCcccChHHHHHHHHHHc
Confidence 5889999999987 567899999999999999999966654432 122244444433222 2234567788999999999
Q ss_pred cCCCCCCCCHHHHHHHHHHHHhh
Q 005999 631 LKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 631 ~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+.||++||||.||++.|+++..+
T Consensus 248 ~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 248 KERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999988754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=399.16 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=211.4
Q ss_pred HhCcccceEEEEEEEC---CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 396 LLGRGSIGTTYKAVLD---NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 396 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.||+|+||+||+|.+. ++..||||+++.... ....+.|.+|++++++++|||||+++|++.++ ..++||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCC
Confidence 3999999999999753 456899999976543 34567899999999999999999999998754 589999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-----
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----- 547 (665)
+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 94 PLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp EHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred cHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 99999864 2356999999999999999999999999 9999999999999999999999999997665432
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEV 625 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 625 (665)
....||+.|+|||++. +..++.++|||||||++|||+| |+.||... ...++...+...... ..+...+..+.+|
T Consensus 169 ~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 244 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRM-ECPPECPPELYAL 244 (285)
T ss_dssp CCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CTHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 2235789999999987 5679999999999999999998 99999763 233555555443322 3455678889999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHHHHHhhhcccC
Q 005999 626 ASVCSLKSPEQRPAMWQVLKMIQEIKESVMAED 658 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 658 (665)
+.+||+.||++|||+.+|++.|+.+..+.....
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence 999999999999999999999998877665443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=404.20 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=209.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|.+. +++.||||+++... ...+.|.+|++++++++|||||+++++|.+++..++||||+++|+
T Consensus 23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp EETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 57999999999999975 58899999987654 345679999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCC----C
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSV----E 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----~ 549 (665)
|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 100 l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 175 (287)
T d1opja_ 100 LLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175 (287)
T ss_dssp HHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred hHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCC-cccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence 99999753 3457899999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..|++.|+|||++. +..++.++|||||||++|||++|..|+... ....++.+.+.... ....+...+..+.+|+.+|
T Consensus 176 ~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~c 252 (287)
T d1opja_ 176 AKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDY-RMERPEGCPEKVYELMRAC 252 (287)
T ss_dssp EEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCc-chHHHHHHHHhcCC-CCCCCccchHHHHHHHHHH
Confidence 23688999999987 567999999999999999999977776432 12223333333322 2234456778899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
|+.||++|||+.||++.|+.+.++.
T Consensus 253 l~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 253 WQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp TCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred cCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 9999999999999999999886544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=394.96 Aligned_cols=243 Identities=22% Similarity=0.349 Sum_probs=208.7
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||+||+|+++++..||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||||+++|+|
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 5799999999999999999999999998654 3356799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VED 550 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~ 550 (665)
.+++.. ....+++..+++++.||++||+|||+.+ |+||||||+||++++++.+||+|||++....... ...
T Consensus 87 ~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~~-iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 87 LNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp HHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTT-BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred HHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhcC-cccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 999764 3456899999999999999999999999 9999999999999999999999999997654432 223
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.+|+.|+|||.+. +..++.|+|||||||++|||+| |+.||... ...++...+..... ...+...+..+.+|+.+|
T Consensus 162 ~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 162 KFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--TNSETAEHIAQGLR-LYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHT
T ss_pred CCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCC--CHHHHHHHHHhCCC-CCCcccccHHHHHHHHHH
Confidence 5789999999987 5679999999999999999998 89999763 23344444443322 234556778899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLKMIQE 649 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~ 649 (665)
|+.||++|||++|+++.|.+
T Consensus 238 l~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCSSGGGSCCHHHHHHHHHC
T ss_pred ccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=397.33 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=204.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||+||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~ 90 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 467999999999999975 6889999998654322 23456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC-CCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-VED 550 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 550 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 91 g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (263)
T d2j4za1 91 GTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL 164 (263)
T ss_dssp CBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEET
T ss_pred CcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeeeeccccceecCCCCEeecccceeeecCCCccccc
Confidence 999999974 346999999999999999999999999 9999999999999999999999999997665432 334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCS 630 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 630 (665)
.||+.|||||++. +..++.++|||||||++|||++|+.||... ...++...+... ....+...+..+.+|+.+||
T Consensus 165 ~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 165 CGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--TYQETYKRISRV--EFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp TEEGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHTT--CCCCCTTSCHHHHHHHHHHT
T ss_pred CCCCcccCHHHHc-CCCCCchhhhhhHhHHHHHHhcCCCCCCCC--CHHHHHHHHHcC--CCCCCccCCHHHHHHHHHHc
Confidence 6899999999997 577899999999999999999999999752 222333333222 22344566788999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 005999 631 LKSPEQRPAMWQVLK 645 (665)
Q Consensus 631 ~~dP~~RPt~~evl~ 645 (665)
+.||++|||++|+++
T Consensus 240 ~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 240 KHNPSQRPMLREVLE 254 (263)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCCHhHCcCHHHHHc
Confidence 999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=400.02 Aligned_cols=239 Identities=21% Similarity=0.346 Sum_probs=203.3
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||+++++|.+++..++||||+++|+
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 5799999999999985 5789999999875543 335678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++...... ....
T Consensus 104 L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 104 LTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred HHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9998863 35899999999999999999999999 999999999999999999999999999876432 2344
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCcc-HHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPD-MLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
.||+.|+|||++. +..++.++||||+||++|||+||+.||.... ..+ +.............+...+..+.+|+.+|
T Consensus 177 ~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 177 VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CSCGGGCCHHHHS-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred ccCCCccChhhhc-CCCCCchhceehHhHHHHHHhhCCCCCCCCC--HHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 6999999999997 5778999999999999999999999997531 122 22222222223344566778899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|+.||++|||+.|+++
T Consensus 254 L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQ 269 (293)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred ccCChhHCcCHHHHhc
Confidence 9999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=396.16 Aligned_cols=243 Identities=21% Similarity=0.349 Sum_probs=201.2
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe----CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA----KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 469 (665)
+.||+|+||+||+|... ++..||+|++......+...+.+.+|++++++++|||||+++++|.+ +...++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 46999999999999965 68899999997765555567789999999999999999999999875 34679999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeeccCCCCCceEeC-CCCceEEeecccccccCCC-
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS-WLIHGNLKSSNVLLG-ADFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-~iiH~Dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~- 546 (665)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ +|+||||||+|||++ +++.+||+|||++......
T Consensus 95 ~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 95 TSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 99999999974 346899999999999999999999875 499999999999996 5789999999999765543
Q ss_pred CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 547 SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 547 ~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
.....||+.|||||++. +.++.++|||||||++|||++|+.||.... ....+...+.....+.......+..+.+|+
T Consensus 170 ~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred cCCcccCccccCHHHhC--CCCCCcCchhhHHHHHHHHHHCCCCCCCcc-cHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 23457999999999986 359999999999999999999999997532 112333333332222233445567799999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||++||++|||+.|+++
T Consensus 247 ~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHccCCHhHCcCHHHHhC
Confidence 9999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=400.77 Aligned_cols=246 Identities=21% Similarity=0.276 Sum_probs=196.2
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--CCeEEEEEEecCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--KGERLVIYDYQPN 471 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 471 (665)
+.||+|+||+||+|.. .+|+.||+|+++.....+...+.+.+|++++++++|||||++++++.+ ++..|+||||+++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 6799999999999996 468899999998776555667789999999999999999999999865 4568999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRAS----WLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+|.+++..... ....+++..++.++.||+.||+|||+++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 90 g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 168 (269)
T d2java1 90 GDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168 (269)
T ss_dssp EEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred CcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence 999999864221 2356999999999999999999999854 49999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
....||+.|||||++. +..++.++|||||||++|||+||+.||... ...++...+...... ..+...+..+.+
T Consensus 169 ~~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--~~~~~~~~i~~~~~~-~~~~~~s~~l~~ 244 (269)
T d2java1 169 SFAKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFR-RIPYRYSDELNE 244 (269)
T ss_dssp -------CCCSCCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHHTCCC-CCCTTSCHHHHH
T ss_pred CccccCCCCcccCCHHHHc-CCCCChHHHHHhhCHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCC-CCCcccCHHHHH
Confidence 3346899999999987 677999999999999999999999999752 223444444433222 234567788999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~ 645 (665)
|+.+||+.||++|||+.|+++
T Consensus 245 li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 245 IITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCChhHCcCHHHHHh
Confidence 999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=395.17 Aligned_cols=250 Identities=19% Similarity=0.373 Sum_probs=203.5
Q ss_pred hHhCcccceEEEEEEECCe-----EEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDNH-----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
++||+|+||+||+|.+++. ..||||+++.... +...+.|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 6799999999999986532 4799999976554 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+|++.+++.. ....++|.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~-iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 92 ENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp TTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccc-cccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999998764 3456999999999999999999999999 9999999999999999999999999997654322
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....||+.|||||++. +..++.++|||||||++|||++|..|+... ....++...+...... ..+...+..+.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~-~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~ 243 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRL-PTPMDCPSAIY 243 (283)
T ss_dssp -------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTCBHHHH
T ss_pred ceEeccCCCCccccCHHHHc-cCCCCCcccccccHHHHHHHHhCCCCcccc-CCHHHHHHHHhccCCC-CCchhhHHHHH
Confidence 1234789999999987 678999999999999999999976665432 1223444444433222 33456778899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=400.32 Aligned_cols=243 Identities=22% Similarity=0.306 Sum_probs=202.7
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||+||+|.. .+++.||||++..... .....+.+.+|++++++++|||||++++++.+++..++||||+.+
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 36799999999999985 5788999999976543 234456799999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 100 g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~ 172 (309)
T d1u5ra_ 100 SASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NSFV 172 (309)
T ss_dssp EHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CCCC
T ss_pred CchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEECCCCCEEEeecccccccCCC-Cccc
Confidence 999877653 356999999999999999999999999 999999999999999999999999999776543 3457
Q ss_pred CCCcccCCccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 552 DTVAYKAPEIRKS--SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 552 gt~~y~aPE~~~~--~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
||+.|||||++.+ ...|+.++|||||||++|||++|+.||.+.. ..+....+.............+..+.+|+.+|
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 3458999999999999999999999997532 12222222222222223445677899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 005999 630 SLKSPEQRPAMWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt~~evl~ 645 (665)
|+.||++|||+.|+++
T Consensus 251 L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 251 LQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TCSSGGGSCCHHHHTT
T ss_pred CcCChhHCcCHHHHHh
Confidence 9999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=397.99 Aligned_cols=242 Identities=21% Similarity=0.339 Sum_probs=203.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... ++..||||++..... ...+.+.+|++++++++|||||++++++.+++..++||||+++|+
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 57999999999999964 688999999976542 445678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~ 550 (665)
|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||++...... ....
T Consensus 96 L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~-ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 96 VDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp HHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 99987642 346999999999999999999999999 999999999999999999999999998654321 2345
Q ss_pred CCCCcccCCcccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-CCCchhhhHHHHHHH
Q 005999 551 PDTVAYKAPEIRK----SSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV-DDGREENRLGMLTEV 625 (665)
Q Consensus 551 ~gt~~y~aPE~~~----~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 625 (665)
.||+.|+|||++. ....|+.++|||||||++|||+||+.||... ...+....+..... ....+...+..+.+|
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 248 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--NPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS--CGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC--CHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 7999999999874 2456899999999999999999999999763 22333333333222 223455677889999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||+.||++|||+.|+++
T Consensus 249 i~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 249 LKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=402.19 Aligned_cols=247 Identities=20% Similarity=0.292 Sum_probs=200.3
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... +|+.||+|+++.... ....+.+.+|+.++++++|||||+++++|.++++.++||||+++|+
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 57999999999999964 789999999976543 3445778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeeccCCCCCceEeCCCCceEEeecccccccCC-CCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRA-SWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS-SSVEDP 551 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~ 551 (665)
|.+++.. ...+++..+..++.|++.||+|||++ + |+||||||+|||+++++++||+|||+|..... ......
T Consensus 91 L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 164 (322)
T d1s9ja_ 91 LDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 164 (322)
T ss_dssp HHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---C
T ss_pred HHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC-EEccccCHHHeeECCCCCEEEeeCCCccccCCCcccccc
Confidence 9999974 34689999999999999999999975 7 99999999999999999999999999976543 233457
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHH-----------------------------
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDML----------------------------- 602 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~----------------------------- 602 (665)
||+.|+|||++. +..|+.++||||+||++|||++|+.||...........
T Consensus 165 GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T d1s9ja_ 165 GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243 (322)
T ss_dssp CSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------------
T ss_pred CCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence 999999999998 67899999999999999999999999975332111000
Q ss_pred --------HHHHhhcc---CCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHH
Q 005999 603 --------EWVRTMRV---DDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQE 649 (665)
Q Consensus 603 --------~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~ 649 (665)
+....... ........+..+.+|+.+||..||++|||++|+++. +++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000000 000112235678999999999999999999999983 544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=388.74 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=199.3
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~gs 473 (665)
+.||+|+||.||+|.++ |..||||+++... ..+.|.+|++++++++||||++++|++.+ ++..++||||+++|+
T Consensus 13 ~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEEecCCCeEEEEEEEC-CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 67999999999999986 5679999997543 34678999999999999999999999865 456899999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCCCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDPDT 553 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~gt 553 (665)
|.+++... ....++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++..........+|
T Consensus 88 L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~ 163 (262)
T d1byga_ 88 LVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 163 (262)
T ss_dssp HHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred HHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccCc-eeccccchHhheecCCCCEeecccccceecCCCCcccccc
Confidence 99999742 2235899999999999999999999999 9999999999999999999999999998877666666789
Q ss_pred CcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHcccC
Q 005999 554 VAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSLK 632 (665)
Q Consensus 554 ~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 632 (665)
+.|+|||++. +..++.++|||||||++|||+| |++||... ...++...+...... ..+...+..+.+|+.+||+.
T Consensus 164 ~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~ 239 (262)
T d1byga_ 164 VKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKM-DAPDGCPPAVYEVMKNCWHL 239 (262)
T ss_dssp TTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCC-CCCTTCCHHHHHHHHHHTCS
T ss_pred ccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccc
Confidence 9999999987 5689999999999999999998 68877652 344666665543322 34556678899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHh
Q 005999 633 SPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 633 dP~~RPt~~evl~~L~~~~~ 652 (665)
||++||||.|++++|+.++.
T Consensus 240 dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 240 DAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=401.08 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=202.2
Q ss_pred HhHhCcccceEEEEEEECC------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDN------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||+||+|+... ...||+|++..... ....+.+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 4679999999999998642 34799999865543 23456788999999988 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC
Q 005999 467 DYQPNGSLFNLIHGSRSI------------------RAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA 528 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~ 528 (665)
||+++|+|.++++..+.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-IiHRDlKp~Nill~~ 199 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLVTH 199 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGGGEEEET
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCchhcccccc
Confidence 999999999999854321 1245899999999999999999999999 999999999999999
Q ss_pred CCceEEeecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHH
Q 005999 529 DFEARLTDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDML 602 (665)
Q Consensus 529 ~~~~kl~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 602 (665)
++++||+|||+++....... ...||+.|||||++. +..++.++|||||||++|||+| |+.||.... ....+.
T Consensus 200 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~-~~~~~~ 277 (325)
T d1rjba_ 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP-VDANFY 277 (325)
T ss_dssp TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-CSHHHH
T ss_pred CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence 99999999999976544322 224689999999987 6789999999999999999998 899997632 222344
Q ss_pred HHHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 005999 603 EWVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQ 648 (665)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 648 (665)
..+... ...+.+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 278 ~~~~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 278 KLIQNG-FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 433332 222345567788999999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-48 Score=396.99 Aligned_cols=242 Identities=21% Similarity=0.311 Sum_probs=188.5
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||+||+|... +++.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+||||++||
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 367999999999999965 6889999999765432 23456889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC---CCCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG---ADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||++.......
T Consensus 93 ~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 93 ELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp BHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred cHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhce-eeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 99999973 356999999999999999999999999 99999999999995 57899999999997765432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEV 625 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 625 (665)
....||+.|||||++. +..++.++||||+||++|||++|+.||... ...++...+....... ......+..+.+|
T Consensus 167 ~~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 167 STACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDE--NDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ------CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred eeeeeCccccCcHHHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 3346999999999987 667999999999999999999999999752 2223333333322221 2334567889999
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 005999 626 ASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 626 i~~cl~~dP~~RPt~~evl~ 645 (665)
+.+||++||++|||+.|+++
T Consensus 244 i~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHhc
Confidence 99999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=392.83 Aligned_cols=242 Identities=19% Similarity=0.293 Sum_probs=202.6
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||+||+|.. .+++.||||++..... .+...+.+.+|++++++++||||+++++++.+++..|+||||+++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 92 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence 36799999999999997 4688999999865432 223456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---- 547 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---- 547 (665)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 93 g~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 93 GELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp EEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcccc-EEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 999999874 356999999999999999999999999 9999999999999999999999999998764322
Q ss_pred -CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHH
Q 005999 548 -VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVA 626 (665)
Q Consensus 548 -~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 626 (665)
....||+.|+|||++. +..++.++||||+||++|||++|+.||... ...++...+... ....+...+..+.+|+
T Consensus 167 ~~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAG--NEYLIFQKIIKL--EYDFPEKFFPKARDLV 241 (288)
T ss_dssp ---CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTT--CCCCCTTCCHHHHHHH
T ss_pred cccccCCccccCceeec-cCCCCcccceehhhHHHHHHhhCCCCCCCc--CHHHHHHHHHcC--CCCCCccCCHHHHHHH
Confidence 2346999999999997 677999999999999999999999999752 222333333322 2234456778899999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~ 646 (665)
.+||+.||++|||++|++..
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCH
T ss_pred HHHccCCHhHCcCHHHHcCC
Confidence 99999999999999997553
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=392.27 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=204.0
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||+++|+
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence 36799999999999999888889999997654 334679999999999999999999999854 56889999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC----CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS----VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~----~~ 549 (665)
|.+++... ....++|.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++...... ..
T Consensus 98 l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~-ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 98 LLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp HHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhh-eecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 99988743 2346999999999999999999999999 9999999999999999999999999997664332 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..+|+.|+|||++. ...++.++|||||||++|||+||..|+.... ...++...+..... ...+...+..+.+++.+|
T Consensus 174 ~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 174 AKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYR-MPCPPECPESLHDLMCQC 250 (285)
T ss_dssp --CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHH
T ss_pred ccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCC-CCCCcccCHHHHHHHHHH
Confidence 45899999999997 6789999999999999999999766654422 22344444443322 234556778899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 630 SLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 630 l~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
|+.||++|||+.+|++.|++.....
T Consensus 251 l~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 251 WRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999998766543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=384.17 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=200.8
Q ss_pred HhHhCcccceEEEEEEECC----eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVLDN----HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
.+.||+|+||.||+|.+.. +..||||.++.... +...+.|.+|++++++++||||+++++++. ++..++||||+
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 3679999999999998642 45789999865443 345678999999999999999999999996 46789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 90 TLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp TTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred cCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccC-eeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 99999998764 2356899999999999999999999999 9999999999999999999999999997654322
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
....+|+.|+|||++. +..++.++|||||||++|||+| |++||... ...++...+...... ..+...+..+.+
T Consensus 165 ~~~~~~gt~~y~apE~l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~--~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERL-PMPPNCPPTLYS 240 (273)
T ss_dssp ------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC--CGGGHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred eccceecCcccchhhHhc-cCCCCCccccccchHHHHHHHhcCCCCCCCC--CHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 2235789999999987 6789999999999999999998 89998763 334555555443222 345567788999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 625 VASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
|+.+||+.||++|||+.||++.|+++.++-
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999987763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=386.72 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=208.7
Q ss_pred hHhCcccceEEEEEEECCe----EEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-CCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLDNH----LIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-KGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 469 (665)
++||+|+||+||+|.+.++ ..||||+++.... ....+.|.+|++++++++||||++++|++.. ++..++||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5799999999999996532 3689999975433 4556789999999999999999999999875 56899999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|+|.++++. ....+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~-iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccC-cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999874 3456788899999999999999999999 9999999999999999999999999997654322
Q ss_pred -----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 548 -----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 548 -----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
....||+.|+|||++. ...++.++||||||+++|||+||..||.... ...++...+...... ..+...+..+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~~~-~~p~~~~~~l 263 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL-LQPEYCPDPL 263 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC-CCCTTCCHHH
T ss_pred cceecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCcccCcHHH
Confidence 1235789999999987 5679999999999999999999888876532 223444444443322 2345667789
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
.+++.+||+.||++||+|.||++.|+.+.+....+
T Consensus 264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999999998876554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=385.19 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=203.5
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCch----hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA----DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
.+.||+|+||+||+|.. .+|+.||||+++..... ....+.+.+|++++++++|||||+++++|.+++..++||||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36799999999999997 57899999998654322 12467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC----ceEEeecccccccC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF----EARLTDYCLSVLSD 544 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~----~~kl~Dfgl~~~~~ 544 (665)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+|++|||++....
T Consensus 95 ~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~-ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 95 VAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp CCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred CCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcc-eeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999974 346999999999999999999999999 99999999999998776 59999999997765
Q ss_pred CC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHH
Q 005999 545 SS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLG 620 (665)
Q Consensus 545 ~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 620 (665)
.. .....+|+.|+|||++. +..++.++||||+||++|||++|+.||... ...+....+........ .....+.
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CCccccccCCCCcccCHHHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCC--CHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 43 23456899999999997 667999999999999999999999999752 22233333333222221 2345677
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-47 Score=396.22 Aligned_cols=243 Identities=21% Similarity=0.334 Sum_probs=204.5
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||||++||
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 108 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 108 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 36799999999999996 4789999999976542 44677899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC--CCceEEeecccccccCCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA--DFEARLTDYCLSVLSDSSSV-- 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~-- 548 (665)
+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++........
T Consensus 109 ~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 109 ELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp BHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999864 2346999999999999999999999999 999999999999964 67899999999987655432
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC--CchhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--GREENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 626 (665)
...||+.|||||++. +..++.++||||+||++|||++|+.||... ...+....+....... ......+..+.+|+
T Consensus 184 ~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 184 VTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp EECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred eecCcccccCHHHHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 346899999999997 677899999999999999999999999753 2223333333322221 22345677899999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~~ 646 (665)
.+||+.||++|||+.|+++.
T Consensus 261 ~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 261 RKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHCCSSGGGSCCHHHHHHS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-47 Score=388.59 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=208.1
Q ss_pred hHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 468 (665)
+.||+|+||+||+|... ++..||||+++.... ....+.|.+|++++++++||||++++++|.+.+..+++|||
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 57999999999999864 468999999976543 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC
Q 005999 469 QPNGSLFNLIHGSRS-------------------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD 529 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~ 529 (665)
+++|+|.++++.... .....+++..++.|+.||+.||+|||+.+ |+||||||+|||+|.+
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-ivHrDlKp~NILld~~ 176 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRNCLVGEN 176 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGG
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-eEeeEEcccceEECCC
Confidence 999999999974321 12335899999999999999999999999 9999999999999999
Q ss_pred CceEEeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCccHHH
Q 005999 530 FEARLTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK-HPSQHPYLAPPDMLE 603 (665)
Q Consensus 530 ~~~kl~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~ 603 (665)
+++||+|||+++...... ....+|+.|+|||++. +..++.++|||||||++|||++|. +||... ...++..
T Consensus 177 ~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~--~~~e~~~ 253 (301)
T d1lufa_ 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--AHEEVIY 253 (301)
T ss_dssp GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHH
T ss_pred CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCCC--CHHHHHH
Confidence 999999999997553321 2335788999999987 678999999999999999999996 566542 2334444
Q ss_pred HHHhhccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 604 WVRTMRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
.+...... ..+...+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 254 ~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 254 YVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 44443322 2345677889999999999999999999999999998753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.7e-47 Score=395.09 Aligned_cols=242 Identities=20% Similarity=0.311 Sum_probs=204.6
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||+++++|.+++..|+||||++||
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 111 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 111 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 36799999999999996 4799999999976542 34567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC--CCCceEEeecccccccCCCC--C
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG--ADFEARLTDYCLSVLSDSSS--V 548 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~--~~~~~kl~Dfgl~~~~~~~~--~ 548 (665)
+|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....... .
T Consensus 112 ~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 112 ELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp BHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred hHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99998763 3456999999999999999999999999 99999999999998 57899999999998776543 2
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC--CCchhhhHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD--DGREENRLGMLTEVA 626 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li 626 (665)
...||+.|+|||++. +..++.++||||+||++|||+||+.||... ...+....+...... .......+..+.+|+
T Consensus 187 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 187 VTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eccCcccccCHHHHc-CCCCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 346899999999987 677999999999999999999999999752 222333333332222 123346678899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 005999 627 SVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 627 ~~cl~~dP~~RPt~~evl~ 645 (665)
.+||+.||++|||+.|+++
T Consensus 264 ~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-46 Score=385.42 Aligned_cols=241 Identities=21% Similarity=0.260 Sum_probs=206.1
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|+.++++++|||||++++++.+++..|+||||+.|
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 36799999999999996 4689999999965432 123456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 89 g~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 162 (316)
T d1fota_ 89 GELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 162 (316)
T ss_dssp CBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCC
T ss_pred ccccccccc-----cccccccHHHHHHHHHHHhhhhhccCc-EEccccCchheeEcCCCCEEEecCccceEecccccccc
Confidence 999999874 355788899999999999999999999 99999999999999999999999999988877777778
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
||+.|||||++. +..++.++||||+||++|||+||+.||... ...++...+... ....+...+..+.+++.+||.
T Consensus 163 Gt~~Y~APE~l~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 163 GTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDS--NTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp SCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTC
T ss_pred CcccccCHHHHc-CCCCCchhhccccchhHHHHHhCCCCCCCc--CHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence 999999999987 667899999999999999999999999752 122333322222 223445667789999999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 005999 632 KSPEQRP-----AMWQVLK 645 (665)
Q Consensus 632 ~dP~~RP-----t~~evl~ 645 (665)
+||++|| |++|+++
T Consensus 238 ~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHT
T ss_pred hCHHhccccchhhHHHHHc
Confidence 9999996 8999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=382.27 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=195.3
Q ss_pred hHhCcccceEEEEEEEC----CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|.+. ....||||+++.... .+...+.|.+|++++++++||||++++|++.+ +..++||||+
T Consensus 14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~ 92 (273)
T d1u46a_ 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELA 92 (273)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeee
Confidence 56999999999999853 245789999876533 23445789999999999999999999999976 4678999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
++|++.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~ 167 (273)
T d1u46a_ 93 PLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167 (273)
T ss_dssp TTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred cCcchhhhhhc----ccCCCCHHHHHHHHHHHHHHHHHhhhCC-EeeeeecHHHhccccccceeeccchhhhhcccCCCc
Confidence 99999998774 2356999999999999999999999999 9999999999999999999999999998764432
Q ss_pred ----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHH
Q 005999 548 ----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGML 622 (665)
Q Consensus 548 ----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 622 (665)
....++..|+|||++. +..++.++|||||||++|||+| |+.||... ...+....+.............+..+
T Consensus 168 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 168 YVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp EEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred ceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHHHHHHHHhCCCCCCCcccccHHH
Confidence 1234788999999998 5778999999999999999998 89999752 22244444433322223455677889
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 005999 623 TEVASVCSLKSPEQRPAMWQVLKMIQEI 650 (665)
Q Consensus 623 ~~li~~cl~~dP~~RPt~~evl~~L~~~ 650 (665)
.+++.+||+.||++||||.||++.|++.
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=385.71 Aligned_cols=248 Identities=18% Similarity=0.298 Sum_probs=202.9
Q ss_pred hHhCcccceEEEEEEEC-CeE----EEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHL----IVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||+||+|.+. +|+ .||+|+++.... ....+.|.+|++++++++|||||+++|+|.++ ..++++||+
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 68999999999999864 333 588998865433 34467899999999999999999999999875 567889999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
.+|+|.+++.. ....+++..+++++.||+.||+|||+++ |+||||||+|||++.++++||+|||++.......
T Consensus 93 ~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~-iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 93 PFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp TTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred cCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcC-cccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 99999998875 3457999999999999999999999999 9999999999999999999999999997664322
Q ss_pred ---CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHH
Q 005999 548 ---VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLT 623 (665)
Q Consensus 548 ---~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 623 (665)
....||+.|+|||++. +..++.++|||||||++|||+| |++||... ...++...+...... ..+...+..+.
T Consensus 168 ~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~--~~~~~~~~i~~~~~~-~~p~~~~~~~~ 243 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--PASEISSILEKGERL-PQPPICTIDVY 243 (317)
T ss_dssp -------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--CGGGHHHHHHHTCCC-CCCTTBCHHHH
T ss_pred ccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCC-CCCcccCHHHH
Confidence 1224799999999987 5679999999999999999998 78888753 233555555443322 33456778899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 624 EVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 624 ~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
+++.+||+.||++|||+.|+++.|+.+..+
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999988654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-46 Score=380.59 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=199.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCch-hhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC----eEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTA-DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG----ERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 468 (665)
+.||+|+||+||+|.. .+++.||||+++..... ....+.+.+|++++++++||||+++++++..++ ..|+||||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~ 92 (277)
T d1o6ya_ 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 92 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence 6799999999999996 57899999999765443 334567999999999999999999999987654 47899999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC--
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-- 546 (665)
++||+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++..+++|||.+......
T Consensus 93 ~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~-iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 93 VDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp CCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred CCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 999999998874 356999999999999999999999999 999999999999999999999999988654332
Q ss_pred ----CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC--CCchhhhHH
Q 005999 547 ----SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD--DGREENRLG 620 (665)
Q Consensus 547 ----~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 620 (665)
.....||+.|+|||++. +..++.++||||+||++|||+||+.||.... ..+....+...... .......+.
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ------------TTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred cccccccccCcccccCHHHHc-CCCCCcceecccchHHHHHHHhCCCCCCCcC--HHHHHHHHHhcCCCCCchhccCCCH
Confidence 12335899999999987 6779999999999999999999999997521 11222111111111 112345678
Q ss_pred HHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHh
Q 005999 621 MLTEVASVCSLKSPEQRP-AMWQVLKMIQEIKE 652 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~ 652 (665)
.+.+++.+||++||++|| |++++++.|..+++
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 899999999999999999 89999999988753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=383.86 Aligned_cols=240 Identities=18% Similarity=0.255 Sum_probs=203.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||.||+|.. .+++.||||+++.... .....+.+.+|+.+|++++||||++++++|.+++..|+||||+++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg 90 (337)
T d1o6la_ 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCC
Confidence 6799999999999996 5789999999975432 1234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---CCC
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---SVE 549 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~ 549 (665)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+|++||+|||+++..... ...
T Consensus 91 ~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~ 164 (337)
T d1o6la_ 91 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp BHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred chhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcC-ccccccCHHHeEecCCCCEEEeecccccccccCCccccc
Confidence 99999984 356899999999999999999999999 999999999999999999999999999765432 233
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHc
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVC 629 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 629 (665)
..||+.|+|||++. +..|+.++||||+||++|||++|++||... ...++...+... ....+...+..+.+|+.+|
T Consensus 165 ~~GT~~Y~aPE~~~-~~~y~~~~DiwSlGvilyeml~G~~pf~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 165 FCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILME--EIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHH
T ss_pred ceeCHHHhhhhhcc-CCCCChhhcccchhhHHHHHHHCCCCCCCc--CHHHHHHHHhcC--CCCCCccCCHHHHHHHHhh
Confidence 46899999999987 678999999999999999999999999763 222333333322 2234556778899999999
Q ss_pred ccCCCCCCCC-----HHHHHH
Q 005999 630 SLKSPEQRPA-----MWQVLK 645 (665)
Q Consensus 630 l~~dP~~RPt-----~~evl~ 645 (665)
|++||++||+ +.|+++
T Consensus 240 L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCchhhcccccccHHHHHc
Confidence 9999999995 888876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-46 Score=379.44 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=196.1
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeC-CeEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAK-GERLVI 465 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~lv 465 (665)
.+.||+|+||.||+|... +++.||||+++..... ...+.+.+|+..+.++ +|+||+.+++++.++ ...++|
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 367999999999999853 4678999999765442 3445677777777766 789999999998764 468999
Q ss_pred EEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEE
Q 005999 466 YDYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARL 534 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl 534 (665)
|||+++|+|.++++..+. .....+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-ivHrDlKp~NILl~~~~~~Kl 175 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKI 175 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECGGGCEEE
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-CcCCcCCccceeECCCCcEEE
Confidence 999999999999975432 12345899999999999999999999999 999999999999999999999
Q ss_pred eecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCccHHHHHHhh
Q 005999 535 TDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK-HPSQHPYLAPPDMLEWVRTM 608 (665)
Q Consensus 535 ~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~ 608 (665)
+|||+++...... ....||+.|+|||++. +..++.++|||||||++|||+||. +||.... ....+...+...
T Consensus 176 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-~~~~~~~~~~~~ 253 (299)
T d1ywna1 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-IDEEFCRRLKEG 253 (299)
T ss_dssp CC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-CSHHHHHHHHHT
T ss_pred ccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcC
Confidence 9999997654322 2235899999999987 678999999999999999999975 5675432 223444444433
Q ss_pred ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhh
Q 005999 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKES 653 (665)
Q Consensus 609 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 653 (665)
.. ...+...+..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 254 ~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 254 TR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 22 233456677899999999999999999999999999998765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7e-46 Score=374.72 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=203.2
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh-------hHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD-------TSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 464 (665)
.+.||+|+||+||+|.. .+++.||||+++...... ...+.+.+|+.++++++ ||||+++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 36799999999999996 578999999987654321 23356889999999996 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
||||+++|+|.++++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 88 vmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 88 VFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999974 346999999999999999999999999 9999999999999999999999999998765
Q ss_pred CC--CCCCCCCCcccCCccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC--CCch
Q 005999 545 SS--SVEDPDTVAYKAPEIRKS-----SRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD--DGRE 615 (665)
Q Consensus 545 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~ 615 (665)
.. .....||+.|+|||++.. ...++.++||||+||++|||++|+.||.... .......+...... ....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTTTG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHHHHHHHHhCCCCCCCccc
Confidence 43 334468999999998752 3457889999999999999999999998632 22333333322222 2234
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
...+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 467788999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=377.45 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=203.5
Q ss_pred HhHhCcccceEEEEEEEC--------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEE
Q 005999 394 AELLGRGSIGTTYKAVLD--------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLV 464 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 464 (665)
.+.||+|+||.||+|+.. ++..||||+++.... .....++.+|+..+.++ +|||||+++++|.+++..++
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 367999999999999853 245799999976554 34456788888888888 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 465 IYDYQPNGSLFNLIHGSRS-----------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
||||+++|+|.+++...+. .....+++.++++++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-ivHrDiKp~NiLl~~~~~~k 175 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTEDNVMK 175 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEE
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-EEeeeecccceeecCCCCeE
Confidence 9999999999999975431 12356899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCccHHHHHHh
Q 005999 534 LTDYCLSVLSDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLT-GKHPSQHPYLAPPDMLEWVRT 607 (665)
Q Consensus 534 l~Dfgl~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 607 (665)
|+|||++....... ....+|+.|+|||++. ++.++.++|||||||++|||++ |.+||... ...++...+..
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~--~~~~~~~~i~~ 252 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKE 252 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHT
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCC--CHHHHHHHHHc
Confidence 99999997654332 2235789999999987 5789999999999999999998 68888652 22244444443
Q ss_pred hccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHh
Q 005999 608 MRVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKE 652 (665)
Q Consensus 608 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 652 (665)
.. ....+...+..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 253 ~~-~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 253 GH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22 223455667889999999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=380.26 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=205.0
Q ss_pred hHhCcccceEEEEEEEC-CeE--EEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHL--IVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
+.||+|+||+||+|.+. ++. .||||+++.... +...+.|.+|+++++++ +|||||+++++|.+++..++||||++
T Consensus 16 ~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 67999999999999864 333 578888764433 23456799999999999 79999999999999999999999999
Q ss_pred CCCHHHHHhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeeccc
Q 005999 471 NGSLFNLIHGSR-----------SIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCL 539 (665)
Q Consensus 471 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl 539 (665)
+|+|.++++... ......+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-iiHrDlkp~NIL~~~~~~~kl~DfG~ 173 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGL 173 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-ccccccccceEEEcCCCceEEccccc
Confidence 999999997532 123467999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCC--CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 540 SVLSDSSS--VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKH-PSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 540 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
+....... ....+|..|+|||.+. ...++.++|||||||++|||++|.. ||... ...++...+.... ....+.
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~~~~~~i~~~~-~~~~~~ 249 (309)
T d1fvra_ 174 SRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYEKLPQGY-RLEKPL 249 (309)
T ss_dssp EESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHGGGTC-CCCCCT
T ss_pred cccccccccccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCC--CHHHHHHHHHhcC-CCCCCc
Confidence 97654332 2335899999999997 5679999999999999999999765 56542 2234444433322 123345
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
..+..+.+|+.+||+.||++||||.||++.|+.+.+...
T Consensus 250 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 250 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 677889999999999999999999999999999987544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-45 Score=386.90 Aligned_cols=243 Identities=20% Similarity=0.224 Sum_probs=199.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 469 (665)
+.||+|+||.||+|... +|+.||||++....... .......+++.+++.++|||||+++++|.+++..|+||||+
T Consensus 10 ~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~ 89 (364)
T d1omwa3 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89 (364)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEec
Confidence 67999999999999965 68999999986432211 11223345578888999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC-CC
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS-SV 548 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-~~ 548 (665)
++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 90 ~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~-iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~ 163 (364)
T d1omwa3 90 NGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163 (364)
T ss_dssp CSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCC
T ss_pred CCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCC-ccceeeccceeEEcCCCcEEEeeeceeeecCCCccc
Confidence 99999999974 346889999999999999999999999 999999999999999999999999999866543 34
Q ss_pred CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhc-cCCCchhhhHHHHHHHHH
Q 005999 549 EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMR-VDDGREENRLGMLTEVAS 627 (665)
Q Consensus 549 ~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 627 (665)
...||+.|+|||++..+..++.++|||||||++|||+||+.||..... .+.....+... .....+...+..+.+|+.
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS--SCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence 456999999999987566789999999999999999999999976422 23333222222 222344567788999999
Q ss_pred HcccCCCCCCCC-----HHHHHH
Q 005999 628 VCSLKSPEQRPA-----MWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt-----~~evl~ 645 (665)
+||++||++||| ++|+++
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHcccCHHHhCCCcccCHHHHHc
Confidence 999999999999 688875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-46 Score=386.64 Aligned_cols=241 Identities=19% Similarity=0.208 Sum_probs=206.1
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPN 471 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 471 (665)
.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|++++++++|||||++++++.+....++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 467999999999999964 789999999865432 123456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCCCCCC
Q 005999 472 GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSSVEDP 551 (665)
Q Consensus 472 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 551 (665)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..........
T Consensus 126 g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 199 (350)
T d1rdqe_ 126 GEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp CBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred cchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCcCCHHHcccCCCCCEEeeeceeeeeccccccccc
Confidence 999999874 346899999999999999999999999 99999999999999999999999999988877666667
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHHHccc
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVASVCSL 631 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 631 (665)
||+.|||||++. +..++.++|||||||++|||+||+.||... ....+...+... ....+...+..+.+++.+||+
T Consensus 200 Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 200 GTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp ECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSC
T ss_pred CccccCCHHHHc-CCCCCccccccchhHHHHHHHhCCCCCCCc--CHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHhh
Confidence 999999999997 677899999999999999999999999752 222333333322 223345667789999999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 005999 632 KSPEQRP-----AMWQVLK 645 (665)
Q Consensus 632 ~dP~~RP-----t~~evl~ 645 (665)
.||++|+ |++|+++
T Consensus 275 ~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 275 VDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHT
T ss_pred hCHHhccccccccHHHHHc
Confidence 9999994 8999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=378.92 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=210.4
Q ss_pred HhHhCcccceEEEEEEE------CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCC-CCCCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL------DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGL-SHPNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||.||+|.+ .++..||||+++.... ......|.+|+.+++++ +|||||++++++.+++..++||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 36799999999999985 3578999999976553 34556789999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceE
Q 005999 467 DYQPNGSLFNLIHGSRS-------------IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEAR 533 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~k 533 (665)
||+++|+|.++++..+. .....+++..+.+++.||+.||+|||+++ |+||||||+||+++.++.+|
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-ivHrDLKp~NIl~~~~~~~k 185 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHGRITK 185 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETTTEEE
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccccccccccccCccc
Confidence 99999999999975432 12335899999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCCC-----CCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh
Q 005999 534 LTDYCLSVLSDSSSV-----EDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM 608 (665)
Q Consensus 534 l~Dfgl~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 608 (665)
++|||.++....... ...+|+.|+|||++. ...++.++|||||||++|||+|+..|+.........+...+...
T Consensus 186 i~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~ 264 (311)
T d1t46a_ 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (311)
T ss_dssp ECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred ccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 999999987654322 234789999999987 57899999999999999999995544433323333444444443
Q ss_pred ccCCCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 609 RVDDGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 609 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
... ..+...+..+.+|+.+||+.||++||||.||+++|+++..+.
T Consensus 265 ~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 265 FRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 322 234556778999999999999999999999999999876653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=381.07 Aligned_cols=243 Identities=23% Similarity=0.276 Sum_probs=194.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhh---HHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADT---SAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
++||+|+||+||+|.. .+++.||||+++....... ..+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999995 4688999999975543221 23468899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS--- 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~--- 547 (665)
++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 84 TDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred chHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccc-eecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 987777654 3456888999999999999999999999 9999999999999999999999999997665432
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhh-ccCC--------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTM-RVDD-------------- 612 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~~~~-------------- 612 (665)
....||+.|+|||++.....++.++||||+||++|||+||++||.... +.+....+... ....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 234689999999998766678999999999999999999999997531 22222222111 1100
Q ss_pred ------C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ------G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 01234567999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=373.48 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=193.9
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC----eEEEEEEecC
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG----ERLVIYDYQP 470 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~ 470 (665)
+.||+|+||+||+|++. |+.||||+++... .....++.|+..+.+++||||+++++++.+++ ..++||||++
T Consensus 9 ~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 56999999999999974 6789999986443 22233445666677889999999999997654 6789999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR--------ASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~--------~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
+|+|.++++. ..++|..+++++.|++.||+|||+ ++ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~-IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 85 HGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-eeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999974 358999999999999999999997 35 99999999999999999999999999976
Q ss_pred cCCC-------CCCCCCCCcccCCccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCC----------CCcc
Q 005999 543 SDSS-------SVEDPDTVAYKAPEIRKSSR-----RATSKSDVYAFGVLLLELLTGKHPSQHPYL----------APPD 600 (665)
Q Consensus 543 ~~~~-------~~~~~gt~~y~aPE~~~~~~-----~~~~k~DvwSlGvvl~elltg~~P~~~~~~----------~~~~ 600 (665)
.... .....||+.|+|||++.... .++.|+|||||||++|||+||..|+..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 5332 12346899999999986321 257789999999999999999987643111 1111
Q ss_pred HHHHHHhhccCC---C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhc
Q 005999 601 MLEWVRTMRVDD---G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVM 655 (665)
Q Consensus 601 ~~~~~~~~~~~~---~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 655 (665)
............ . .....+..+.+++.+||+.||++|||+.||++.|+++.++.+
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 222211111111 1 122345679999999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=377.94 Aligned_cols=240 Identities=16% Similarity=0.245 Sum_probs=200.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|... +++.||||+++... .....+.+|+++|++++|||||+++++|.+++..|+||||++||+
T Consensus 11 ~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 67999999999999965 78899999997654 334568899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCC--CceEEeecccccccCCCC--CC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGAD--FEARLTDYCLSVLSDSSS--VE 549 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~--~~~kl~Dfgl~~~~~~~~--~~ 549 (665)
|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++....... ..
T Consensus 88 L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~-iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 88 IFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC-CCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99999742 346999999999999999999999999 9999999999999854 589999999997765432 22
Q ss_pred CCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC--chhhhHHHHHHHHH
Q 005999 550 DPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG--REENRLGMLTEVAS 627 (665)
Q Consensus 550 ~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 627 (665)
..+|+.|+|||... +..++.++||||+||++|||++|+.||... ...++...+........ .....+..+.+|+.
T Consensus 163 ~~~t~~y~ape~~~-~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCS--SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cccccccccchhcc-CCCCCchhhcccHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence 35899999999987 667899999999999999999999999763 22233333333222211 22345677999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 005999 628 VCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~evl~ 645 (665)
+||..||++|||+.|+++
T Consensus 240 ~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCSSGGGSCCHHHHHH
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=375.40 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=208.3
Q ss_pred HhHhCcccceEEEEEEEC------CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD------NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 467 (665)
.+.||+|+||+||+|.+. ++..||||+++.... ......|.+|++++++++||||+++++++..++..++|||
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 367999999999999863 367899999976543 3455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccc
Q 005999 468 YQPNGSLFNLIHGSRS-----IRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVL 542 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~ 542 (665)
|+++|+|.+++...+. .....+++..+.+++.|++.||+|||+++ |+||||||+|||+++++++||+|||+++.
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-ivHrDlk~~NiLld~~~~~Kl~DFGla~~ 182 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRD 182 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeeceEcCCceeecCCceEEEeeccccee
Confidence 9999999999864221 12235799999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCC-----CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCccHHHHHHhhccCCCchh
Q 005999 543 SDSSS-----VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGK-HPSQHPYLAPPDMLEWVRTMRVDDGREE 616 (665)
Q Consensus 543 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 616 (665)
..... ....+|+.|+|||.+. +..++.++|||||||++|||+||. +||... ...+....+..... ...+.
T Consensus 183 ~~~~~~~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--~~~~~~~~i~~~~~-~~~p~ 258 (308)
T d1p4oa_ 183 IYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFVMEGGL-LDKPD 258 (308)
T ss_dssp GGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CHHHHHHHHHTTCC-CCCCT
T ss_pred ccCCcceeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhCCC-CCCcc
Confidence 54322 2224789999999987 667899999999999999999985 666542 22234443333222 12345
Q ss_pred hhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhh
Q 005999 617 NRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESV 654 (665)
Q Consensus 617 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 654 (665)
..+..+.+++.+||+.||++|||+.||++.|++..+..
T Consensus 259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 66778999999999999999999999999998775544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=377.84 Aligned_cols=237 Identities=17% Similarity=0.235 Sum_probs=190.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhC-CCCCCeeeeeEEEEe----CCeEEEEEEe
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGG-LSHPNLVPIRAYFQA----KGERLVIYDY 468 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~ 468 (665)
+.||+|+||+||+|.. .+++.||||+++.. +.+.+|++++.+ .+|||||+++++|.+ +...|+||||
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 4699999999999996 57899999998643 346788888654 489999999999876 4578999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC---CCceEEeecccccccCC
Q 005999 469 QPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA---DFEARLTDYCLSVLSDS 545 (665)
Q Consensus 469 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~---~~~~kl~Dfgl~~~~~~ 545 (665)
|+||+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~-iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 91 LDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcC-CccccccccccccccccccccccccccceeeeccC
Confidence 9999999999742 2356999999999999999999999999 999999999999985 56799999999976544
Q ss_pred C--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccC------CCchhh
Q 005999 546 S--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVD------DGREEN 617 (665)
Q Consensus 546 ~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 617 (665)
. .....||+.|||||++. +..|+.++|||||||++|||+||+.||...... .....+...... ......
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~-~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~~~~~~~~~i~~~~~~~~~~~~~~ 243 (335)
T d2ozaa1 167 HNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKTRIRMGQYEFPNPEWSE 243 (335)
T ss_dssp CCCCCCCSCCCSSCCCCCCC-GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSSCCTTHHHH
T ss_pred CCccccccCCcccCCcHHHc-CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--HHHHHHHHHHhcCCCCCCCccccc
Confidence 3 33446999999999987 667999999999999999999999999753221 111111111111 112235
Q ss_pred hHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 618 RLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 618 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
.+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 5678999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=368.65 Aligned_cols=246 Identities=19% Similarity=0.275 Sum_probs=194.2
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|.. .+++.||||+++.....+...+.+.+|++++++++|||||++++++.+++..++||||+.++
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~- 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD- 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc-
Confidence 6799999999999996 57899999999765544444577899999999999999999999999999999999999764
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
+.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~-IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 162 (298)
T d1gz8a_ 87 LKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162 (298)
T ss_dssp HHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCC
T ss_pred hhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC-EEccccCchheeecccCcceeccCCcceeccCCcccceee
Confidence 44444322 3456999999999999999999999999 9999999999999999999999999997665432 334
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-----------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG----------------- 613 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----------------- 613 (665)
.||+.|+|||++.....++.++||||+||++|||++|+.||..... ...+............
T Consensus 163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 6899999999887666678999999999999999999999975311 1111111111111000
Q ss_pred ---------chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 614 ---------REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 614 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.....+..+.+|+.+||..||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 011334678999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=375.23 Aligned_cols=241 Identities=21% Similarity=0.337 Sum_probs=198.7
Q ss_pred HhHhCcccceEEEEEEEC-CeEEEEEEEecCCCc-hhhHHHHHHHHHHHHh-CCCCCCeeeeeEEEEeCCeEEEEEEecC
Q 005999 394 AELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKT-ADTSAEAFEQHMEAVG-GLSHPNLVPIRAYFQAKGERLVIYDYQP 470 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~ 470 (665)
.+.||+|+||+||+|... +++.||||+++.... .+...+.+..|+.++. .++|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 367999999999999964 789999999965422 1233455666666654 6899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---C
Q 005999 471 NGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS---S 547 (665)
Q Consensus 471 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~ 547 (665)
+|+|.++++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||++...... .
T Consensus 87 ~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~-iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 87 GGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp TCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred CCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 9999999974 345899999999999999999999999 999999999999999999999999999755432 2
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHHHHH
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTEVAS 627 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 627 (665)
....||+.|+|||++. +..++.++||||+||++|||++|+.||... ...++...+... ....+...+..+.+|+.
T Consensus 161 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~--~~~~~~~~i~~~--~~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DEEELFHSIRMD--NPFYPRWLEKEAKDLLV 235 (320)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SHHHHHHHHHHC--CCCCCTTSCHHHHHHHH
T ss_pred cccCCCCCcCCHHHHc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CHHHHHHHHHcC--CCCCCccCCHHHHHHHH
Confidence 3346899999999998 678999999999999999999999999752 222333333322 22334556788999999
Q ss_pred HcccCCCCCCCCHH-HHHH
Q 005999 628 VCSLKSPEQRPAMW-QVLK 645 (665)
Q Consensus 628 ~cl~~dP~~RPt~~-evl~ 645 (665)
+||+.||++|||+. |+++
T Consensus 236 ~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGG
T ss_pred HhcccCCCCCcCHHHHHHh
Confidence 99999999999995 6753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-44 Score=367.54 Aligned_cols=244 Identities=18% Similarity=0.256 Sum_probs=199.1
Q ss_pred hHhCcccceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCCH
Q 005999 395 ELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGSL 474 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 474 (665)
+.||+|+||+||+|..++++.||||+++.....+...+.+.+|+.++++++||||++++++|.+++..++++||+.++.+
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 57999999999999999999999999977655445567899999999999999999999999999999999999988777
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCCC
Q 005999 475 FNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VEDP 551 (665)
Q Consensus 475 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~ 551 (665)
..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+....... ....
T Consensus 88 ~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~-IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (286)
T d1ob3a_ 88 KLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161 (286)
T ss_dssp HHHHT-----STTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred HHHHh-----hcCCcchhhhHHHHHHHHHHHHHhccCc-EEecCCCCceeeEcCCCCEEecccccceecccCccccceec
Confidence 77665 3456999999999999999999999999 9999999999999999999999999997665432 2335
Q ss_pred CCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC-------------------
Q 005999 552 DTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------------- 612 (665)
Q Consensus 552 gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------------- 612 (665)
+++.|+|||.+.....++.++||||+||++|||++|+.||..... ...+...........
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred ccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 889999999987666789999999999999999999999975321 111111111111100
Q ss_pred -------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 -------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 -------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012234567899999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=368.51 Aligned_cols=235 Identities=19% Similarity=0.337 Sum_probs=193.8
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchh----hHHHHHHHHHHHHhCCC--CCCeeeeeEEEEeCCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTAD----TSAEAFEQHMEAVGGLS--HPNLVPIRAYFQAKGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e 467 (665)
+.||+|+||+||+|.. .+++.||||++......+ .....+.+|+.++++++ |||||++++++.+++..++|||
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e 89 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEE
Confidence 6799999999999996 478999999986543211 11234668999999886 8999999999999999999999
Q ss_pred ecCC-CCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-CCceEEeecccccccCC
Q 005999 468 YQPN-GSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-DFEARLTDYCLSVLSDS 545 (665)
Q Consensus 468 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-~~~~kl~Dfgl~~~~~~ 545 (665)
|+.+ +++.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 90 ~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 90 RPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp CCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred eccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCcccceEEecCCCeEEECccccceeccc
Confidence 9976 688888763 346899999999999999999999999 999999999999985 47999999999977655
Q ss_pred CC-CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCCchhhhHHHHHH
Q 005999 546 SS-VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDGREENRLGMLTE 624 (665)
Q Consensus 546 ~~-~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 624 (665)
.. ....||+.|+|||++.....++.++||||+||++|||++|+.||... .+ +. ......+...+..+.+
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~----i~--~~~~~~~~~~s~~~~~ 233 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE----II--RGQVFFRQRVSSECQH 233 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH----HH--HCCCCCSSCCCHHHHH
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hH----Hh--hcccCCCCCCCHHHHH
Confidence 43 34569999999999874444577899999999999999999999652 11 11 1122234456778999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 005999 625 VASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 625 li~~cl~~dP~~RPt~~evl~ 645 (665)
|+.+||+.||++|||++|+++
T Consensus 234 li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHhc
Confidence 999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=365.87 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=197.2
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC------eEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG------ERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 467 (665)
+.||+|+||+||+|.. .+|+.||||+++.....+...+.+.+|+++|++++|||||+++++|...+ +.++|||
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 103 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence 5799999999999996 46899999999876555566778999999999999999999999997654 5799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+ +.+|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++...+...
T Consensus 104 ~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~-IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~ 175 (346)
T d1cm8a_ 104 FM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175 (346)
T ss_dssp CC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred cc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCcchhhcccccccccccccceeccCCcc
Confidence 99 5688887753 35999999999999999999999999 9999999999999999999999999999888777
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhcc-----------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRV----------------- 610 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----------------- 610 (665)
....+|+.|+|||++.+...++.++||||+||++|||++|+.||..... ...+.........
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
T d1cm8a_ 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254 (346)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHHhhhcchhhhhh
Confidence 7778999999999987556789999999999999999999999976321 0011111111000
Q ss_pred -----CC------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHH
Q 005999 611 -----DD------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQEI 650 (665)
Q Consensus 611 -----~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 650 (665)
.. ......+..+.+|+.+||..||++|||+.|+++. ++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 0112345678899999999999999999999974 5544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=361.07 Aligned_cols=244 Identities=16% Similarity=0.228 Sum_probs=189.7
Q ss_pred hHhCcccceEEEEEEEC--CeEEEEEEEecCCCchhhHHHHHHHHHHHHhC---CCCCCeeeeeEEEEe-----CCeEEE
Q 005999 395 ELLGRGSIGTTYKAVLD--NHLIVTVKRFDANKTADTSAEAFEQHMEAVGG---LSHPNLVPIRAYFQA-----KGERLV 464 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~-----~~~~~l 464 (665)
+.||+|+||+||+|... +++.||||+++.....+.....+.+|+.+++. ++||||++++++|.. ....++
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 57999999999999963 47789999986544333333345566666554 489999999999853 346889
Q ss_pred EEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccC
Q 005999 465 IYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSD 544 (665)
Q Consensus 465 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~ 544 (665)
++||+.++.+...... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~-ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~ 167 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIYS 167 (305)
T ss_dssp EEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCCCCC
T ss_pred EEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecCCCccEEEEcCCCCeeecchhhhhhhc
Confidence 9999998777655442 3456899999999999999999999999 9999999999999999999999999987654
Q ss_pred CC--CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH-HhhccCC---------
Q 005999 545 SS--SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV-RTMRVDD--------- 612 (665)
Q Consensus 545 ~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~--------- 612 (665)
.. .....||+.|+|||++. +..++.++||||+||++|||++|+.||.... ..+....+ .......
T Consensus 168 ~~~~~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 244 (305)
T d1blxa_ 168 FQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVIGLPGEEDWPRDVA 244 (305)
T ss_dssp GGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred ccccCCCcccChhhcCcchhc-CCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCchhccccccc
Confidence 32 24457999999999987 6789999999999999999999999997532 12222221 1111100
Q ss_pred ---------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 ---------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 ---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0122345678999999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=350.53 Aligned_cols=244 Identities=17% Similarity=0.235 Sum_probs=201.1
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+.||+|+||+||+|.. .+++.||||+++.....+...+.+.+|+.+++.++||||++++++|.+....++|+|++.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 5799999999999996 578899999997766555667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC---CCC
Q 005999 474 LFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS---VED 550 (665)
Q Consensus 474 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~ 550 (665)
|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+....... ...
T Consensus 88 l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~-IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 88 KKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp HHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred ccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCC-EeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 9888763 456889999999999999999999999 9999999999999999999999999997765433 233
Q ss_pred CCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------------
Q 005999 551 PDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------------ 612 (665)
Q Consensus 551 ~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------------ 612 (665)
.+++.|+|||.+.....++.++||||+||++|||++|+.||...... .+....+.......
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-HHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 57788999999875666799999999999999999999997542211 12222221111110
Q ss_pred ---------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ---------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012233567899999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=355.23 Aligned_cols=243 Identities=19% Similarity=0.239 Sum_probs=189.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe--------CCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA--------KGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~lv 465 (665)
+.||+|+||+||+|.. .+|+.||||++......+...+.+.+|+++|++++||||+++++++.. ++..++|
T Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv 95 (318)
T d3blha1 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95 (318)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence 5799999999999996 578999999987665544556778899999999999999999999855 3467899
Q ss_pred EEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCC
Q 005999 466 YDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDS 545 (665)
Q Consensus 466 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 545 (665)
|||+.++.+..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~-ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 96 FDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSL 169 (318)
T ss_dssp EECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred EeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCC-EEecCcCchheeecCCCcEEeeecceeeeccc
Confidence 99998876665543 3456888999999999999999999999 99999999999999999999999999965543
Q ss_pred CC-------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCCC-----
Q 005999 546 SS-------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDDG----- 613 (665)
Q Consensus 546 ~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~----- 613 (665)
.. ....||+.|+|||++.....++.++||||+||++|||++|+.||.... .......+........
T Consensus 170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHHHHHhcCCCChhhcc
Confidence 21 223589999999998755678999999999999999999999997521 1122222221111000
Q ss_pred --------------------c-----hhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 614 --------------------R-----EENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 614 --------------------~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .......+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 0011345778999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-41 Score=345.68 Aligned_cols=257 Identities=15% Similarity=0.174 Sum_probs=206.1
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCC-CCeeeeeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSH-PNLVPIRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||+||+|+.. +++.||||++...... +.+++|++.++.++| +|++.+++++.++...++||||+ ++
T Consensus 11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 67999999999999965 6889999998654322 235677888888855 89999999999999999999998 68
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCC-----CCceEEeecccccccCCC-
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGA-----DFEARLTDYCLSVLSDSS- 546 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~-----~~~~kl~Dfgl~~~~~~~- 546 (665)
+|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 86 ~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~g-iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 86 SLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp BHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCC-ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99999875 2346899999999999999999999999 999999999999974 578999999999765432
Q ss_pred ---------CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-cHHHHHHhhccCC---C
Q 005999 547 ---------SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-DMLEWVRTMRVDD---G 613 (665)
Q Consensus 547 ---------~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~---~ 613 (665)
.....||+.|||||++. +..++.++|||||||++|||+||+.||........ .....+....... .
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhc-CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 12235899999999987 67899999999999999999999999986433322 2222222111111 1
Q ss_pred chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhcccCcccC
Q 005999 614 REENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAEDNAAF 662 (665)
Q Consensus 614 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~ 662 (665)
.....+..+.+++..|++.+|++||+++.+.+.|+++.+......+..|
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~ 288 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCC
Confidence 2234567899999999999999999999999999999887776655544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-41 Score=347.21 Aligned_cols=252 Identities=15% Similarity=0.157 Sum_probs=195.4
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeee-eeEEEEeCCeEEEEEEecCCC
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVP-IRAYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g 472 (665)
+.||+|+||+||+|.. .+++.||||++..... .+.+.+|++++++++|+|++. +.+++.+.+..++||||+ ++
T Consensus 13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence 6799999999999986 5688999999865432 234678999999997776554 556667788899999998 45
Q ss_pred CHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeC---CCCceEEeecccccccCCCC--
Q 005999 473 SLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLG---ADFEARLTDYCLSVLSDSSS-- 547 (665)
Q Consensus 473 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~---~~~~~kl~Dfgl~~~~~~~~-- 547 (665)
+|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+|++|||+++......
T Consensus 88 ~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 88 SLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp BHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred chhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 77766653 3456999999999999999999999999 99999999999986 35679999999997654321
Q ss_pred --------CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc--cHHHHHHhhccCC--Cch
Q 005999 548 --------VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP--DMLEWVRTMRVDD--GRE 615 (665)
Q Consensus 548 --------~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~--~~~ 615 (665)
....||+.|||||.+. +..++.++|||||||++|||+||+.||........ ............. ...
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred cceeccccCCcCCCccccCHHHHh-CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 2235899999999987 67799999999999999999999999976433222 1111111111111 122
Q ss_pred hhhHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHhhhccc
Q 005999 616 ENRLGMLTEVASVCSLKSPEQRPAMWQVLKMIQEIKESVMAE 657 (665)
Q Consensus 616 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 657 (665)
...+..+.+++.+|++.+|++||++.++.+.|+.+.......
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 356678999999999999999999999999999887655433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-42 Score=356.44 Aligned_cols=242 Identities=21% Similarity=0.293 Sum_probs=190.5
Q ss_pred hHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeCC----eEEEEEEec
Q 005999 395 ELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAKG----ERLVIYDYQ 469 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~ 469 (665)
+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+++|++++||||+++++++.... ..+++++|+
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 6799999999999985 5799999999976543 345667899999999999999999999997643 335566778
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC---
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS--- 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--- 546 (665)
.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 93 ~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~-iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 93 MGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp CCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred cCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 89999999974 35899999999999999999999999 999999999999999999999999999655332
Q ss_pred ---CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH-HhhccCC----------
Q 005999 547 ---SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV-RTMRVDD---------- 612 (665)
Q Consensus 547 ---~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~-~~~~~~~---------- 612 (665)
.....||+.|+|||++.....++.++||||+||++|||++|+.||.... ..+..... .......
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH--YLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC--HHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2334589999999998766778999999999999999999999997532 11111111 1111100
Q ss_pred -------------C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 613 -------------G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 613 -------------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 011234568899999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=357.77 Aligned_cols=248 Identities=23% Similarity=0.271 Sum_probs=191.7
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEeC------CeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQAK------GERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 467 (665)
++||+|+||+||+|... +++.||||++..... .+.+|++++++++||||++++++|... .+.++|||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 57999999999999975 689999999976542 234799999999999999999998543 35789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSS 546 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 546 (665)
|++++.+..+.+..+ ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 100 y~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~-IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 100 YVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred ccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC-CcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 998764444332111 3456999999999999999999999999 99999999999999775 8999999999766443
Q ss_pred --CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC------------
Q 005999 547 --SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD------------ 612 (665)
Q Consensus 547 --~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------ 612 (665)
.....||+.|+|||.+.....++.++||||+||++|||++|+.||..... ...+...++......
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhhhhccchh
Confidence 33456899999999887566799999999999999999999999975321 111211111110000
Q ss_pred --------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHHHh
Q 005999 613 --------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM--IQEIKE 652 (665)
Q Consensus 613 --------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 652 (665)
......+..+.+|+.+||..||++|||+.|+++. ++++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0112345679999999999999999999999863 555443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=356.50 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=197.8
Q ss_pred HhHhCcccceEEEEEEEC----CeEEEEEEEecCCCc--hhhHHHHHHHHHHHHhCCCC-CCeeeeeEEEEeCCeEEEEE
Q 005999 394 AELLGRGSIGTTYKAVLD----NHLIVTVKRFDANKT--ADTSAEAFEQHMEAVGGLSH-PNLVPIRAYFQAKGERLVIY 466 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 466 (665)
.+.||+|+||+||+|... +|+.||||.++.... .....+.+.+|++++++++| |||+++++++.+....+++|
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 467999999999999852 478999999865432 12234567899999999966 89999999999999999999
Q ss_pred EecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCC
Q 005999 467 DYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSS 546 (665)
Q Consensus 467 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 546 (665)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 109 e~~~~~~L~~~i~~-----~~~~~e~~~~~~~~Qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 109 DYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp CCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ecccccHHHHHHHh-----cccccHHHHHHHHHHHHHHHHHhhcCC-EEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 99999999999974 345778889999999999999999999 999999999999999999999999999765432
Q ss_pred C----CCCCCCCcccCCccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHH-hhccCCCchhhhHH
Q 005999 547 S----VEDPDTVAYKAPEIRKSSR-RATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVR-TMRVDDGREENRLG 620 (665)
Q Consensus 547 ~----~~~~gt~~y~aPE~~~~~~-~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 620 (665)
. ....|++.|+|||.+.... .++.++||||+||++|||++|+.||........ ...... ........+...+.
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCCCCCCTTSCH
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCCCCCcccCCH
Confidence 2 2335899999999986433 478899999999999999999999987543332 112212 22222334456788
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 005999 621 MLTEVASVCSLKSPEQRP-----AMWQVLK 645 (665)
Q Consensus 621 ~l~~li~~cl~~dP~~RP-----t~~evl~ 645 (665)
.+.+|+.+||++||++|| |++|+++
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 899999999999999999 5888876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=356.88 Aligned_cols=243 Identities=21% Similarity=0.251 Sum_probs=196.1
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe-----CCeEEEEEE
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA-----KGERLVIYD 467 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e 467 (665)
.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|++++++++|||||++++++.. +...++++|
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 36799999999999995 579999999998766555566788999999999999999999999864 334567788
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.......
T Consensus 103 ~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g-iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~ 175 (348)
T d2gfsa1 103 HLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175 (348)
T ss_dssp ECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCC----CCTGGG
T ss_pred eecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCCccccccccccccccccchhcccCccc
Confidence 8899999999863 35999999999999999999999999 9999999999999999999999999998777666
Q ss_pred CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHHHhhccCC---------------
Q 005999 548 VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWVRTMRVDD--------------- 612 (665)
Q Consensus 548 ~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~--------------- 612 (665)
....||+.|+|||.......++.++||||+||++|||++|+.||.... .......+.......
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 667789999999987755667899999999999999999999997531 111111111111100
Q ss_pred ---------C-----chhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 ---------G-----REENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 ---------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
. .....+..+.+|+.+||..||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 01234567899999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.3e-41 Score=347.32 Aligned_cols=238 Identities=16% Similarity=0.236 Sum_probs=190.8
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEe--CCeEEEEEEec
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQA--KGERLVIYDYQ 469 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~ 469 (665)
.+.||+|+||+||+|+. .+++.||||+++... .+.+.+|+++|++++ ||||++++++|.. ....++||||+
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 46799999999999996 578999999987543 356789999999995 9999999999975 35689999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCC-ceEEeecccccccCCC--
Q 005999 470 PNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADF-EARLTDYCLSVLSDSS-- 546 (665)
Q Consensus 470 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~-- 546 (665)
.+++|.++. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g-IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc-cccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999997653 34899999999999999999999999 99999999999998655 6999999999766543
Q ss_pred CCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccHHHHH------------HhhccCC--
Q 005999 547 SVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDMLEWV------------RTMRVDD-- 612 (665)
Q Consensus 547 ~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~------------~~~~~~~-- 612 (665)
.....+|+.|+|||.+.....++.++||||+||++|||++|+.||.............. .......
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 33446899999999987666689999999999999999999999976432111111111 0000000
Q ss_pred --------------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 005999 613 --------------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLK 645 (665)
Q Consensus 613 --------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 645 (665)
......+..+.+|+.+||..||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012234567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-40 Score=343.65 Aligned_cols=240 Identities=17% Similarity=0.222 Sum_probs=184.8
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCeeeeeEEEEe------CCeEEEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNLVPIRAYFQA------KGERLVIYD 467 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~e 467 (665)
+.||+|+||+||+|... +|+.||||++..........+.+.+|+.++++++||||++++++|.. ....|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 57999999999999965 69999999998766555566778999999999999999999999964 368899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeecccccccCCCC
Q 005999 468 YQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDYCLSVLSDSSS 547 (665)
Q Consensus 468 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 547 (665)
|+.++ +.+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.......
T Consensus 103 y~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g-iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 103 LMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp CCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred ccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc-cccccCCccccccccccceeeechhhhhcccccc
Confidence 99765 555543 24889999999999999999999999 9999999999999999999999999986654432
Q ss_pred --CCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCccH-HHHHHhhcc--------------
Q 005999 548 --VEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPPDM-LEWVRTMRV-------------- 610 (665)
Q Consensus 548 --~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~~~-~~~~~~~~~-------------- 610 (665)
....+|+.|+|||++. +..++.++||||+||++|||++|+.||.... .... ...+.....
T Consensus 174 ~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 174 MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp -------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCCCCC--HHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 3345899999999987 5789999999999999999999999997532 1111 111110000
Q ss_pred --------CC-----------------CchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 611 --------DD-----------------GREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 611 --------~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.. ......+..+.+|+.+||..||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0122345678999999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-36 Score=313.43 Aligned_cols=246 Identities=17% Similarity=0.224 Sum_probs=184.9
Q ss_pred HhHhCcccceEEEEEEE-CCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-----------CCCeeeeeEEEEe--C
Q 005999 394 AELLGRGSIGTTYKAVL-DNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-----------HPNLVPIRAYFQA--K 459 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~--~ 459 (665)
.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++.. .
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 36799999999999996 579999999997543 33456778888887765 5789999998764 4
Q ss_pred CeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeeccCCCCCceEeCCCC------ce
Q 005999 460 GERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR-ASWLIHGNLKSSNVLLGADF------EA 532 (665)
Q Consensus 460 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~iiH~Dlk~~Nill~~~~------~~ 532 (665)
...+++++++..+......... .....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++ .+
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~-IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC-cccccCChhHeeeeccCccccccee
Confidence 5667777776555433322211 144568899999999999999999998 66 99999999999998664 39
Q ss_pred EEeecccccccCCCCCCCCCCCcccCCccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCc-----cHHHHHHh
Q 005999 533 RLTDYCLSVLSDSSSVEDPDTVAYKAPEIRKSSRRATSKSDVYAFGVLLLELLTGKHPSQHPYLAPP-----DMLEWVRT 607 (665)
Q Consensus 533 kl~Dfgl~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DvwSlGvvl~elltg~~P~~~~~~~~~-----~~~~~~~~ 607 (665)
+++|||.+...........||+.|+|||++. ...++.++||||+||+++||++|+.||........ .+...+..
T Consensus 172 kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~ 250 (362)
T d1q8ya_ 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250 (362)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred eEeecccccccccccccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence 9999999987766666678999999999987 56789999999999999999999999975322110 11111111
Q ss_pred hccC---------------------------------------CCchhhhHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 005999 608 MRVD---------------------------------------DGREENRLGMLTEVASVCSLKSPEQRPAMWQVLKM 646 (665)
Q Consensus 608 ~~~~---------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 646 (665)
.... .......+..+.+|+.+||..||++|||++|+++.
T Consensus 251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1000 01123456779999999999999999999999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=8.7e-32 Score=277.04 Aligned_cols=204 Identities=35% Similarity=0.542 Sum_probs=162.4
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCccccCCCCCCCc--cccceeecC----CCEEEEEecCCCCcc--cCCccccCCCCCCc
Q 005999 31 SLLPSDAVSLLSFKSKADSENKLLYALNERFDYC--QWQGVKCAQ----GRVVRFVLQSFGLRG--TFPPNTLTRLDQLR 102 (665)
Q Consensus 31 ~~~~~~~~~Ll~~k~~~~~~~~~~~~~~~~~~~C--~w~gv~C~~----~~v~~l~l~~~~l~g--~l~~~~~~~l~~L~ 102 (665)
-|.++|++||++||+.+.+++. ..+|+.++||| .|.||+|+. +||+.|+|++++++| .||+ .+++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~-l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGG-GTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCCc-CCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCcccc
Confidence 3899999999999999977654 45566668999 499999985 379999999999998 4676 899999999
Q ss_pred EEEccC-CcCccCCC-CCCCCCCCCEEEccCcccCCc------------------------CcccccCCCCCCEEEeecc
Q 005999 103 VLSLHN-NSLTGPIP-DLSSLINLKSLSLSRNFFSGA------------------------FPLSILSLHRLTILDLSYN 156 (665)
Q Consensus 103 ~L~L~~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~------------------------~p~~~~~l~~L~~L~L~~N 156 (665)
+|+|++ |+++|.+| +|++|++|++|+|++|+|.+. +|..|.++++|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999986 89998888 899999999999998877644 4445555555666666655
Q ss_pred cccccCCc-----------------------------------------------------------------------c
Q 005999 157 NLTGLIPV-----------------------------------------------------------------------N 165 (665)
Q Consensus 157 ~l~~~~p~-----------------------------------------------------------------------~ 165 (665)
.++|.+|. .
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~ 239 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 54444332 2
Q ss_pred ccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcccccCCCCCCCCCCCCCC
Q 005999 166 LTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNPNLCGKVINKAC 237 (665)
Q Consensus 166 ~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~~lc~~~~~~~c 237 (665)
+..+++|+.|+|++|+|+|.+|.. .+++|++|+|++|+|+|.+|....+.+|+.+++.+|+.+||.|+. .|
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 344566777788888888777764 778899999999999999998888889999999999999998765 45
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.5e-22 Score=191.72 Aligned_cols=164 Identities=15% Similarity=0.180 Sum_probs=120.4
Q ss_pred HhHhCcccceEEEEEEECCeEEEEEEEecCCCch----------------hhHHHHHHHHHHHHhCCCCCCeeeeeEEEE
Q 005999 394 AELLGRGSIGTTYKAVLDNHLIVTVKRFDANKTA----------------DTSAEAFEQHMEAVGGLSHPNLVPIRAYFQ 457 (665)
Q Consensus 394 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 457 (665)
++.||+|+||+||+|...+|+.||||+++..... ........+|+..+.++.|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 4679999999999999889999999987542211 11123456788899999999999887653
Q ss_pred eCCeEEEEEEecCCCCHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeeccCCCCCceEeCCCCceEEeec
Q 005999 458 AKGERLVIYDYQPNGSLFNLIHGSRSIRAKPLHWTSCLKIAEDVAQGLAYIHRASWLIHGNLKSSNVLLGADFEARLTDY 537 (665)
Q Consensus 458 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~iiH~Dlk~~Nill~~~~~~kl~Df 537 (665)
..+++|||+++..+.+ ++......++.|++.+++|||+.+ |+||||||+|||++++ .++|+||
T Consensus 84 ---~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g-iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ---TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEETT-EEEECCC
T ss_pred ---CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC-EEEccCChhheeeeCC-CEEEEEC
Confidence 2379999998865432 333445678999999999999999 9999999999999965 5899999
Q ss_pred ccccccCCCCCCCCCCCcccC------CccccCCCCCCCcchHHHHHHHHH
Q 005999 538 CLSVLSDSSSVEDPDTVAYKA------PEIRKSSRRATSKSDVYAFGVLLL 582 (665)
Q Consensus 538 gl~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~k~DvwSlGvvl~ 582 (665)
|.+....+... ..|.. .|.+ .+.|..++|+||..--+.
T Consensus 147 G~a~~~~~~~~-----~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGW-----REILERDVRNIITYF--SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTH-----HHHHHHHHHHHHHHH--HHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCc-----HHHHHHHHHHHHHHH--cCCCCCcccHHHHHHHHh
Confidence 99876543321 11221 1222 245788899999865443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=9.4e-20 Score=172.23 Aligned_cols=126 Identities=22% Similarity=0.248 Sum_probs=83.7
Q ss_pred EEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecc
Q 005999 79 FVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYN 156 (665)
Q Consensus 79 l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 156 (665)
++.++++|+ .||+ .+. +++++|+|++|+|++.++ .|.++++|+.|+|++|++.+..+..|..+++|++|+|++|
T Consensus 13 v~Cs~~~L~-~iP~-~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPR-DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCS-CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEeCCCcC-ccCC-CCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 444566666 5665 232 566777777777765443 4666777777777777777666667777777777777777
Q ss_pred cccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccC
Q 005999 157 NLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~ 208 (665)
+|++..|..|.++++|+.|+|++|+|+++++.. .+++|++|+|++|.+.+..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 777666666677777777777777777766654 5666777777777766543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=7.7e-19 Score=174.93 Aligned_cols=156 Identities=28% Similarity=0.211 Sum_probs=108.9
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
.++.|+|++|.|+ .+|++.|.++++|+.|+|++|+|+.+. .++.+++|+.|+|++|+++ .+|..+.++++|+.|+|+
T Consensus 32 ~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCC-CcCHHHhhccccccccccccccccccc-ccccccccccccccccccc-cccccccccccccccccc
Confidence 4666777777666 455556666666666666666666433 3455666666666666665 344455555555555555
Q ss_pred ------------------------cccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccC
Q 005999 155 ------------------------YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQV 208 (665)
Q Consensus 155 ------------------------~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~ 208 (665)
+|.++...+..+..+++|+.|++++|+|++.++.. .+++|++|+|++|+|+..+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp 188 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIP 188 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccC
Confidence 55555444555667888888999999998888764 6889999999999999444
Q ss_pred CCCCcccCcCcccccCCCCCCCCCC
Q 005999 209 PETPTLLKFDASSFSMNPNLCGKVI 233 (665)
Q Consensus 209 p~~~~l~~l~~~~~~~n~~lc~~~~ 233 (665)
+....+.+|..+++++|||.|+|.+
T Consensus 189 ~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 189 KGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp TTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred hhHCCCCCCCEEEecCCCCCCCcch
Confidence 4456778899999999999999864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=7.7e-19 Score=165.84 Aligned_cols=166 Identities=22% Similarity=0.306 Sum_probs=143.1
Q ss_pred ccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccC
Q 005999 64 CQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSR 131 (665)
Q Consensus 64 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~ 131 (665)
|+|..|.|+. ..++.|+|++|.|++.+++..|.++++|+.|+|++|++.+.++ .|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 6799999973 3689999999999977888789999999999999999999988 799999999999999
Q ss_pred cccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEecccccccccCCC
Q 005999 132 NFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~ 210 (665)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....... ....++.+.+..|.+++..|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p- 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP- 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS-
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC-
Confidence 9999777888999999999999999999888889999999999999999998655432 22346777888899988777
Q ss_pred CCcccCcCcccccCCCCCCCC
Q 005999 211 TPTLLKFDASSFSMNPNLCGK 231 (665)
Q Consensus 211 ~~~l~~l~~~~~~~n~~lc~~ 231 (665)
..+..+...+++.|...|.+
T Consensus 167 -~~l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 167 -SKVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp -TTTTTSBGGGSCTTTCCCCC
T ss_pred -hhhcCCEeeecCHhhCcCCC
Confidence 45667777788888776754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1e-16 Score=159.36 Aligned_cols=146 Identities=24% Similarity=0.248 Sum_probs=118.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
....+++.++++|+ .||+ .+. ++|+.|+|++|+|+++++ .|.++++|++|+|++|+|+ .+| .++.+++|+.|+
T Consensus 10 ~~~~~v~C~~~~L~-~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLD 83 (266)
T ss_dssp TTCCEEECTTSCCS-SCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEE
T ss_pred CCCeEEEccCCCCC-eeCc-CcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccc
Confidence 45566789999999 7887 453 589999999999999887 7999999999999999999 666 468899999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNP 226 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~ 226 (665)
|++|+|+ .+|..+..+++|+.|++++|++.+..+.. .+.++..|++++|.++...+.. ..+..+..+++++|.
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 9999999 55778899999999999999988876654 6667777788777777555433 335566667776663
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=7.4e-17 Score=161.98 Aligned_cols=159 Identities=24% Similarity=0.241 Sum_probs=137.4
Q ss_pred CCEEEEEec-CCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEE
Q 005999 74 GRVVRFVLQ-SFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTIL 151 (665)
Q Consensus 74 ~~v~~l~l~-~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (665)
..+..++.. .+.+. .+++..|.++++|++|+|++|.+....+ .+..+++|+.+++++|+|++..+..|..+++|+.|
T Consensus 80 ~~~~~l~~~~~~~~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L 158 (284)
T d1ozna_ 80 ALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (284)
T ss_dssp TTCCEEECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccccccccccccc-cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhc
Confidence 345555554 34444 6777789999999999999999988877 68889999999999999997667789999999999
Q ss_pred EeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCC-CcccCcCcccccCCCCC
Q 005999 152 DLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPET-PTLLKFDASSFSMNPNL 228 (665)
Q Consensus 152 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~-~~l~~l~~~~~~~n~~l 228 (665)
+|++|+|++..|..|.++++|+.+++++|++++..|.. .+++|++|++++|++++.+|.. ..+.+|..+++++||+.
T Consensus 159 ~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 99999999888889999999999999999999998875 7899999999999999876643 46778999999999999
Q ss_pred CCCCC
Q 005999 229 CGKVI 233 (665)
Q Consensus 229 c~~~~ 233 (665)
|+|..
T Consensus 239 C~C~~ 243 (284)
T d1ozna_ 239 CDCRA 243 (284)
T ss_dssp CSGGG
T ss_pred CCccc
Confidence 98864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.62 E-value=1.6e-15 Score=153.70 Aligned_cols=161 Identities=23% Similarity=0.325 Sum_probs=113.8
Q ss_pred ccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccC
Q 005999 64 CQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSR 131 (665)
Q Consensus 64 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~ 131 (665)
|.|.+|.|+. ..++.|+|++|+|+ .+|+..|.++++|++|++++|.+..+.| .|.++++|+.|+|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 7899999974 35888999999999 7888789999999999999999999988 799999999999999
Q ss_pred cccCCcCccc------------------------------------------------ccCCCCCC--------------
Q 005999 132 NFFSGAFPLS------------------------------------------------ILSLHRLT-------------- 149 (665)
Q Consensus 132 N~l~~~~p~~------------------------------------------------~~~l~~L~-------------- 149 (665)
|+|+ .+|.. +..+++|+
T Consensus 89 n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~ 167 (305)
T d1xkua_ 89 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167 (305)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred CccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence 9876 23322 22233344
Q ss_pred -------EEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccccCCCCCcccCcCcc
Q 005999 150 -------ILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVPETPTLLKFDAS 220 (665)
Q Consensus 150 -------~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~ 220 (665)
.|++++|.+++..+..+.+++.++.|++++|++++.++.. .+++|++|+|++|+|+..++....+.+|+.+
T Consensus 168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L 247 (305)
T d1xkua_ 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247 (305)
T ss_dssp SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEE
T ss_pred ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEE
Confidence 4444444444444555556666666666666666665543 5566777777777766443334556666666
Q ss_pred cccCCC
Q 005999 221 SFSMNP 226 (665)
Q Consensus 221 ~~~~n~ 226 (665)
++++|.
T Consensus 248 ~Ls~N~ 253 (305)
T d1xkua_ 248 YLHNNN 253 (305)
T ss_dssp ECCSSC
T ss_pred ECCCCc
Confidence 666663
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.6e-15 Score=152.06 Aligned_cols=150 Identities=23% Similarity=0.179 Sum_probs=87.7
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCC-------------------------CCCCEEE
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSL-------------------------INLKSLS 128 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l-------------------------~~L~~L~ 128 (665)
.++.|+|++|+|+ .+|+..|.++++|++|++++|+|..+.+ .+.++ ++|+.|+
T Consensus 33 ~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 33 ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 5789999999999 7888789999999999999999987655 34444 4455555
Q ss_pred ccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC--CCCCcceEecccccccc
Q 005999 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL--NQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 129 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~ 206 (665)
|++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|++++|++++.++.. .+++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 5555554333444444445555555555555433444444555555555555555444433 44455555555555554
Q ss_pred cCCCC-CcccCcCcccccCC
Q 005999 207 QVPET-PTLLKFDASSFSMN 225 (665)
Q Consensus 207 ~~p~~-~~l~~l~~~~~~~n 225 (665)
..|.. ..+.++..+++++|
T Consensus 192 i~~~~f~~l~~L~~L~l~~N 211 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFAN 211 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSS
T ss_pred cChhHhhhhhhccccccccc
Confidence 44322 23334444444444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=3.5e-15 Score=129.34 Aligned_cols=102 Identities=27% Similarity=0.258 Sum_probs=52.5
Q ss_pred EEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeeccc
Q 005999 78 RFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNN 157 (665)
Q Consensus 78 ~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 157 (665)
.|+|++|+++ .++ .+..+++|++|+|++|+|+.+++.|+.+++|+.|++++|+|+ .+| .+.++++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~--~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC--CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc--ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 3555555555 343 255555555555555555544444555555555555555555 333 35555555555555555
Q ss_pred ccccCC-ccccCCCccCeeecccccccc
Q 005999 158 LTGLIP-VNLTALDRLYSLKLEWNRFSG 184 (665)
Q Consensus 158 l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 184 (665)
|+.... ..+..+++|+.|++++|+++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 552211 234455555555555555543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=8.4e-15 Score=126.89 Aligned_cols=102 Identities=34% Similarity=0.435 Sum_probs=91.1
Q ss_pred cEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeeccccc
Q 005999 102 RVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNR 181 (665)
Q Consensus 102 ~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 181 (665)
|.|+|++|+|+.. +.+..+++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|+ .+| .+..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 5899999999955 56999999999999999999 78989999999999999999999 455 59999999999999999
Q ss_pred ccccCCC--C-CCCCcceEeccccccccc
Q 005999 182 FSGTVPP--L-NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 182 l~~~~~~--~-~~~~L~~l~l~~N~l~~~ 207 (665)
++..+.. . .+++|+.|++++|+++..
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 9977642 2 778999999999999854
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.54 E-value=1.1e-14 Score=137.76 Aligned_cols=144 Identities=24% Similarity=0.313 Sum_probs=111.7
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|++++++++ .++ .+..+++|++|+|++|+|++..| ++++++|+.|++++|.+. .+| .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 56788888888888 564 47788888888888888887665 888888888888888887 555 4788888888888
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
++|.+... ..+..+++|+.|++++|++.....-..+++|+.|++++|++++. +....+.+|..+++++|+
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-KPLANLTTLERLDISSNK 183 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSC
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC-ccccCCCCCCEEECCCCC
Confidence 88888743 24778888888888888887654333778888888888888864 334667788888888874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.51 E-value=4.5e-15 Score=150.89 Aligned_cols=132 Identities=27% Similarity=0.383 Sum_probs=111.0
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCC-cEEEccCCcCccCCC------------------------CCCCCCCCCEEE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQL-RVLSLHNNSLTGPIP------------------------DLSSLINLKSLS 128 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L-~~L~L~~N~l~~~~p------------------------~~~~l~~L~~L~ 128 (665)
..++.+++++|.+.|.+|. .+..+..| +.+++++|++++..| .+..+++|+.|+
T Consensus 149 ~~L~~l~l~~n~l~~~ip~-~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPD-SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCG-GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred cccceeecccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5677888888888888876 56666554 667777777665443 346778899999
Q ss_pred ccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCC-CCCCcceEeccccc-ccc
Q 005999 129 LSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL-NQPFLVVFNVSGNN-LTG 206 (665)
Q Consensus 129 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~-l~~ 206 (665)
+++|.+++.+| .++.+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|.. .+++|+.+++++|+ ++|
T Consensus 228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence 99999997655 7899999999999999999999999999999999999999999999987 78999999999998 566
Q ss_pred c
Q 005999 207 Q 207 (665)
Q Consensus 207 ~ 207 (665)
.
T Consensus 307 ~ 307 (313)
T d1ogqa_ 307 S 307 (313)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.50 E-value=2.8e-14 Score=136.00 Aligned_cols=142 Identities=24% Similarity=0.266 Sum_probs=79.8
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
.++.|++++++++ .++ .+..+++|++|+|++|+|+++.+ ++.+++|++|++++|+|+ .+| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~-~l~--~l~~l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCC-Cch--hHhhCCCCCEEeCCCccccCccc-cccCcccccccccccccc-ccc-cccccccccccccc
Confidence 4556666666665 333 25556666666666666665433 455666666666666665 344 35566666666666
Q ss_pred cccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 155 YNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
+|.+. .++ .+..+++|+.+++++|.+++..+...+++|+.+++++|++++. +....+.+|..+++++|
T Consensus 121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 121 HNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKN 188 (210)
T ss_dssp TSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred ccccc-ccc-ccccccccccccccccccccccccccccccccccccccccccc-ccccCCCCCCEEECCCC
Confidence 66654 222 3555566666666666665544333555666666666666543 22344555555555555
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.49 E-value=3.3e-14 Score=135.47 Aligned_cols=142 Identities=29% Similarity=0.326 Sum_probs=121.5
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..+++.|+|++|++++ +++ ++.+++|+.|+|++|+|+++. .+.++++|+.|++++|.+. .++ .+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccC-ccc--cccCccccccccccccccccc-ccccccccccccccccccc-ccc-cccccccccccc
Confidence 3689999999999994 654 789999999999999999754 6889999999999999997 444 688999999999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCccccc
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFS 223 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~ 223 (665)
+++|.+++ +..+..+++|+.+++++|++++..+-..+++|+.|++++|+|+. +|....+.+|..++++
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELF 208 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEE
T ss_pred cccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEcc
Confidence 99999984 33578899999999999999987664589999999999999985 5656677778777664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.8e-14 Score=131.01 Aligned_cols=106 Identities=22% Similarity=0.179 Sum_probs=51.0
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEee
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLS 154 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 154 (665)
++++|+|++|+++ .|+. .+..+++|+.|+|++|+|+.+ +.|..+++|+.|+|++|+++...+..+..+++|+.|+|+
T Consensus 19 ~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 3455555555555 3432 344455555555555555533 334555555555555555553222233345555555555
Q ss_pred cccccccCC--ccccCCCccCeeecccccccc
Q 005999 155 YNNLTGLIP--VNLTALDRLYSLKLEWNRFSG 184 (665)
Q Consensus 155 ~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~ 184 (665)
+|+|+ .++ ..+..+++|+.|++++|.++.
T Consensus 96 ~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 96 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccccc-ccccccccccccccchhhcCCCcccc
Confidence 55554 222 234445555555555555443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.47 E-value=1.4e-13 Score=139.08 Aligned_cols=131 Identities=19% Similarity=0.235 Sum_probs=100.9
Q ss_pred CCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeec
Q 005999 98 LDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKL 177 (665)
Q Consensus 98 l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 177 (665)
+++|+.+++++|+++..+.. .+++|+.|++++|.+++..+..|.+++.++.|++++|.+++..|..+.++++|++|+|
T Consensus 149 l~~L~~l~l~~n~l~~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 149 MKKLSYIRIADTNITTIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp CTTCCEEECCSSCCCSCCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred ccccCccccccCCccccCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 33444444444444433221 2456778888888888888888999999999999999999888889999999999999
Q ss_pred ccccccccCCCC-CCCCcceEecccccccccCCC-------CCcccCcCcccccCCCCCCC
Q 005999 178 EWNRFSGTVPPL-NQPFLVVFNVSGNNLTGQVPE-------TPTLLKFDASSFSMNPNLCG 230 (665)
Q Consensus 178 ~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~~~p~-------~~~l~~l~~~~~~~n~~lc~ 230 (665)
++|+|+.+++.+ .+++|++|+|++|+|+..... ...+.++..+++++||+-+.
T Consensus 227 ~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 227 NNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred ccccccccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 999999876665 789999999999999953221 13346678889999998654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=7.3e-14 Score=131.89 Aligned_cols=144 Identities=24% Similarity=0.339 Sum_probs=118.9
Q ss_pred cccceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccC
Q 005999 65 QWQGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILS 144 (665)
Q Consensus 65 ~w~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 144 (665)
++.|+ +.-..++.|+|++|++++ +++ ++++++|++|++++|.+.... .+.++++|+.|++++|.+.. ++ .+..
T Consensus 54 ~l~~l-~~l~nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~ 126 (199)
T d2omxa2 54 SIDGV-EYLNNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITD-ID-PLKN 126 (199)
T ss_dssp CCTTG-GGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCC-CG-GGTT
T ss_pred Ccccc-ccCCCcCcCccccccccC-ccc--ccCCccccccccccccccccc-cccccccccccccccccccc-cc-ccch
Confidence 35554 234789999999999994 554 999999999999999998654 58899999999999999984 33 5889
Q ss_pred CCCCCEEEeecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcC
Q 005999 145 LHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFD 218 (665)
Q Consensus 145 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~ 218 (665)
+++|+.|++++|++. .+| .+..+++|+.|++.+|++++..+-..+++|+.|++++|+++. ++....+.+|+
T Consensus 127 l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~L~ 197 (199)
T d2omxa2 127 LTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLE 197 (199)
T ss_dssp CTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCS
T ss_pred hhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCCC-CccccCCCCCC
Confidence 999999999999998 444 688999999999999999987664589999999999999985 44334454444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=3.2e-14 Score=129.39 Aligned_cols=112 Identities=21% Similarity=0.122 Sum_probs=96.3
Q ss_pred ccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccC
Q 005999 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173 (665)
Q Consensus 94 ~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 173 (665)
.+.+...|+.|+|++|+|+.+...+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred hccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 477888999999999999988555678999999999999999 564 589999999999999999965555567899999
Q ss_pred eeecccccccccCC--CC-CCCCcceEeccccccccc
Q 005999 174 SLKLEWNRFSGTVP--PL-NQPFLVVFNVSGNNLTGQ 207 (665)
Q Consensus 174 ~L~l~~N~l~~~~~--~~-~~~~L~~l~l~~N~l~~~ 207 (665)
.|++++|+++.... .. .+++|++|++++|+++..
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred cceeccccccccccccccccccccchhhcCCCccccc
Confidence 99999999987543 23 789999999999999843
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.40 E-value=2.2e-13 Score=141.92 Aligned_cols=143 Identities=28% Similarity=0.334 Sum_probs=78.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|++++|.++ .++ .+..+++|+.|++++|.+++.++ ++.+++|+.|++++|++++..+ +.+++.++.+++
T Consensus 219 ~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLK-DIG--TLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCC-CCG--GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCC-Ccc--hhhcccccchhccccCccCCCCc-ccccccCCEeeccCcccCCCCc--cccccccccccc
Confidence 46777788888777 343 47777888888888888876554 6677778888888877774322 334444444444
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
++|.+++. ..+..+++++.|++++|++++.++-..+++|+.|++++|+|++ ++....+++|+.+++++|
T Consensus 293 ~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 293 NENQLEDI--SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHN 361 (384)
T ss_dssp CSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSS
T ss_pred cccccccc--cccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCC
Confidence 44444321 1234444444445554444444332244444445554444442 222333444444444444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.36 E-value=1e-12 Score=126.48 Aligned_cols=144 Identities=19% Similarity=0.319 Sum_probs=77.2
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.|+|++|.+++ ++ .+..+++|+.|++++|.++. ++.+..+++|+.|++++|...+.. .+...+.+..+++
T Consensus 63 ~~L~~L~ls~n~i~~-~~--~l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~ 136 (227)
T d1h6ua2 63 NNLIGLELKDNQITD-LA--PLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYL 136 (227)
T ss_dssp TTCCEEECCSSCCCC-CG--GGTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEEC
T ss_pred CCCcEeecCCceeec-cc--cccccccccccccccccccc-cccccccccccccccccccccccc--hhccccchhhhhc
Confidence 455555555555552 22 25555555555555555542 233445555555555555544211 1233333444444
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
+++.+... ..+..+++|+.|++++|.+++..+-..+++|+.|++++|++++ ++....+++|..+++++|+
T Consensus 137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSC
T ss_pred hhhhhchh--hhhccccccccccccccccccchhhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCc
Confidence 44444322 1245566777777777777655543366777777777777764 3434556677777777663
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=2.2e-12 Score=116.17 Aligned_cols=98 Identities=23% Similarity=0.177 Sum_probs=62.6
Q ss_pred cCCCCcccCCccccCCCCCCcEEEccCC-cCccCCC-CCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeeccccc
Q 005999 82 QSFGLRGTFPPNTLTRLDQLRVLSLHNN-SLTGPIP-DLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLT 159 (665)
Q Consensus 82 ~~~~l~g~l~~~~~~~l~~L~~L~L~~N-~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 159 (665)
.++++. .+|. .+..+++|+.|+|++| .|+.+.+ .|.++++|+.|+|++|+|+...|..|.++++|++|+|++|+|+
T Consensus 16 ~~~~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 16 TRDGAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp CSSCCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred cCCCCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 555555 4554 5677777777777655 4776665 5777777777777777777555666777777777777777777
Q ss_pred ccCCccccCCCccCeeecccccc
Q 005999 160 GLIPVNLTALDRLYSLKLEWNRF 182 (665)
Q Consensus 160 ~~~p~~~~~l~~L~~L~l~~N~l 182 (665)
.+|..+....+|+.|+|++|.+
T Consensus 94 -~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 94 -SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp -CCCSTTTCSCCCCEEECCSSCC
T ss_pred -ccChhhhccccccccccCCCcc
Confidence 4444333333455555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=2.3e-12 Score=116.10 Aligned_cols=112 Identities=18% Similarity=0.111 Sum_probs=92.9
Q ss_pred cCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCc-ccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccC
Q 005999 95 LTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRN-FFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173 (665)
Q Consensus 95 ~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 173 (665)
.......+.++.+++++...+..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|+
T Consensus 4 ~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 34455667799999999887778889999999999766 58866667899999999999999999987788899999999
Q ss_pred eeecccccccccCCCC-CCCCcceEecccccccc
Q 005999 174 SLKLEWNRFSGTVPPL-NQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 174 ~L~l~~N~l~~~~~~~-~~~~L~~l~l~~N~l~~ 206 (665)
.|+|++|+|+.+++.. ...+|+.|+|++|+|..
T Consensus 84 ~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred ceeccCCCCcccChhhhccccccccccCCCcccC
Confidence 9999999999777765 45568888888887763
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.32 E-value=2e-12 Score=124.47 Aligned_cols=141 Identities=21% Similarity=0.329 Sum_probs=116.6
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
.+++.+++++|.++ .++ .+..+++|+.|++++|.+.+..+ +...+.++.+.++++.+.... .+.++++|+.|++
T Consensus 85 ~~l~~l~~~~n~~~-~i~--~l~~l~~L~~l~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l 158 (227)
T d1h6ua2 85 TKITELELSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSI 158 (227)
T ss_dssp CSCCEEECCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEEC
T ss_pred cccccccccccccc-ccc--cccccccccccccccccccccch-hccccchhhhhchhhhhchhh--hhccccccccccc
Confidence 57889999999998 565 58999999999999999886544 667889999999999998433 4778899999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCccccc
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFS 223 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~ 223 (665)
++|.++... .+.++++|+.|+|++|++++.++-..+++|++|+|++|++++. +....+.+|..++++
T Consensus 159 ~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~i-~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 159 GNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDV-SPLANTSNLFIVTLT 225 (227)
T ss_dssp CSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBC-GGGTTCTTCCEEEEE
T ss_pred cccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCCC-cccccCCCCCEEEee
Confidence 999998443 4889999999999999999865544889999999999999964 434567777777664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=6.4e-12 Score=121.97 Aligned_cols=156 Identities=14% Similarity=0.132 Sum_probs=104.0
Q ss_pred ccccceeecC-----------CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC--CCCCCCCCCEEEcc
Q 005999 64 CQWQGVKCAQ-----------GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP--DLSSLINLKSLSLS 130 (665)
Q Consensus 64 C~w~gv~C~~-----------~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p--~~~~l~~L~~L~Ls 130 (665)
|.+..|.|.. ..++.|+|++|.++ .+|+..|.++++|++|+|++|.+...++ .|.+++++++|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 6677788863 25788888888887 6777678888888888888888876544 57788888888765
Q ss_pred -CcccCCcCcccccCCCCCCEEEeecccccccCCc-cccCCCccCeeecccccccccCCCC--CC-CCcceEeccccccc
Q 005999 131 -RNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPV-NLTALDRLYSLKLEWNRFSGTVPPL--NQ-PFLVVFNVSGNNLT 205 (665)
Q Consensus 131 -~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~--~~-~~L~~l~l~~N~l~ 205 (665)
.|++....+..|.++++|+.|++++|++....+. .+..++.|..+...++++....+.. .+ ..++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4677767777788888888888888888743222 2334455555555666666554432 22 35667777777777
Q ss_pred ccCCCCCcccCcCcc
Q 005999 206 GQVPETPTLLKFDAS 220 (665)
Q Consensus 206 ~~~p~~~~l~~l~~~ 220 (665)
...+......++..+
T Consensus 167 ~i~~~~~~~~~l~~~ 181 (242)
T d1xwdc1 167 EIHNCAFNGTQLDEL 181 (242)
T ss_dssp EECTTTTTTCCEEEE
T ss_pred ccccccccchhhhcc
Confidence 544433333333333
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=2.8e-14 Score=134.44 Aligned_cols=113 Identities=27% Similarity=0.289 Sum_probs=95.8
Q ss_pred ccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccC
Q 005999 94 TLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLY 173 (665)
Q Consensus 94 ~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 173 (665)
.+..|++|+.|+|++|+|+.+ +.+..|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. ++ .+..+++|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~ 118 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSS
T ss_pred HHhcccccceeECcccCCCCc-ccccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccccc
Confidence 688899999999999999865 56888999999999999998 777766667789999999999984 44 588899999
Q ss_pred eeecccccccccCC--CC-CCCCcceEecccccccccCCC
Q 005999 174 SLKLEWNRFSGTVP--PL-NQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 174 ~L~l~~N~l~~~~~--~~-~~~~L~~l~l~~N~l~~~~p~ 210 (665)
.|+|++|+++.... .+ .+++|+.|++++|+++...+.
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred ccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence 99999999987542 23 788999999999999876554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=9.5e-12 Score=129.21 Aligned_cols=143 Identities=22% Similarity=0.315 Sum_probs=123.3
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|++.+|.+++ ++ .+..+++|+.|++++|++++..+ +..++.++.++++.|.+++ + ..+..+++++.|+|
T Consensus 241 ~~L~~L~l~~n~l~~-~~--~~~~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~l 314 (384)
T d2omza2 241 TNLTDLDLANNQISN-LA--PLSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLED-I-SPISNLKNLTYLTL 314 (384)
T ss_dssp TTCSEEECCSSCCCC-CG--GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEEC
T ss_pred cccchhccccCccCC-CC--cccccccCCEeeccCcccCCCCc-ccccccccccccccccccc-c-cccchhcccCeEEC
Confidence 579999999999995 44 38899999999999999997654 7789999999999999984 3 35888999999999
Q ss_pred ecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCC
Q 005999 154 SYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMN 225 (665)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n 225 (665)
++|+|++.. .+..+++|+.|++++|+|+++..-..+++|++|++++|+|++.+| ...+.+|..+++++|
T Consensus 315 s~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 315 YFNNISDIS--PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCSCCG--GGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCCCCc--ccccCCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 999999654 388999999999999999975432388999999999999998765 567888999999887
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.12 E-value=2.3e-13 Score=128.03 Aligned_cols=110 Identities=25% Similarity=0.252 Sum_probs=93.5
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEe
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDL 153 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 153 (665)
..++.|+|++|+|+ .++ .+..|++|+.|+|++|.|+.+++.+..+++|+.|++++|+|+ .++ .+.++++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhccccccccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 68999999999999 675 489999999999999999876544445678999999999999 454 5888999999999
Q ss_pred ecccccccCC-ccccCCCccCeeecccccccccCCC
Q 005999 154 SYNNLTGLIP-VNLTALDRLYSLKLEWNRFSGTVPP 188 (665)
Q Consensus 154 ~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~ 188 (665)
++|+|+.... ..+..+++|+.|+|++|.+....+.
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred ccchhccccccccccCCCccceeecCCCccccCccc
Confidence 9999984322 4689999999999999999877664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.05 E-value=6.2e-10 Score=107.54 Aligned_cols=136 Identities=15% Similarity=0.109 Sum_probs=107.5
Q ss_pred cceeecCCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccCcccCCcCc-ccccC
Q 005999 67 QGVKCAQGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSRNFFSGAFP-LSILS 144 (665)
Q Consensus 67 ~gv~C~~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~ 144 (665)
.-..|.. +.++.++.+++ .+|++ +. +++++|+|++|+|+.+++ .|.++++|++|+|++|.+...+| ..|.+
T Consensus 4 ~~C~C~~---~~i~c~~~~l~-~iP~~-l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~ 76 (242)
T d1xwdc1 4 RICHCSN---RVFLCQESKVT-EIPSD-LP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 76 (242)
T ss_dssp SSEEECS---SEEEEESCSCS-SCCSC-SC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEES
T ss_pred CcCCCcC---CEEEEeCCCCC-CcCCC-CC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccc
Confidence 3455653 35777888999 88873 42 589999999999998888 79999999999999999986554 46889
Q ss_pred CCCCCEEEeec-ccccccCCccccCCCccCeeecccccccccCCCC---CCCCcceEecccccccccCC
Q 005999 145 LHRLTILDLSY-NNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPL---NQPFLVVFNVSGNNLTGQVP 209 (665)
Q Consensus 145 l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~~L~~l~l~~N~l~~~~p 209 (665)
+++++.|++.. |++....+..|.++++|+.|++++|++....+.. .+..+..+..+++++....+
T Consensus 77 l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~ 145 (242)
T d1xwdc1 77 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 145 (242)
T ss_dssp CTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECT
T ss_pred ccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccc
Confidence 99999999874 7888788888999999999999999998766544 34455556667777765433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.86 E-value=4.7e-09 Score=106.76 Aligned_cols=137 Identities=25% Similarity=0.224 Sum_probs=101.9
Q ss_pred CCCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEE
Q 005999 73 QGRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILD 152 (665)
Q Consensus 73 ~~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (665)
..+++.|||++++|+ .+|+ . +++|++|+|++|+|+.++.. +.+|+.|++++|+++ .++.- .+.|++|+
T Consensus 37 ~~~l~~LdLs~~~L~-~lp~-~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 37 DRQAHELELNNLGLS-SLPE-L---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLG 104 (353)
T ss_dssp HHTCSEEECTTSCCS-CCCS-C---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEE
T ss_pred HcCCCEEEeCCCCCC-CCCC-C---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccc-hhhhh---cccccccc
Confidence 356889999999998 7885 3 57899999999999966433 468999999999998 55532 14699999
Q ss_pred eecccccccCCccccCCCccCeeecccccccccCCCCCCCCcceEecccccccccCCCCCcccCcCcccccCCC
Q 005999 153 LSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPETPTLLKFDASSFSMNP 226 (665)
Q Consensus 153 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~~~~l~~l~~~~~~~n~ 226 (665)
|++|.++ .+|. ++.+++|+.|++++|.++..+.. ...+..+++.++.... ......+..+..+.+.+|.
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~~~-~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSC
T ss_pred ccccccc-cccc-hhhhccceeeccccccccccccc--cccccchhhccccccc-cccccccccceeccccccc
Confidence 9999998 6674 68899999999999999876553 3445667776666553 2223445555556665554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.72 E-value=2.2e-08 Score=101.58 Aligned_cols=101 Identities=26% Similarity=0.198 Sum_probs=83.3
Q ss_pred CCCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccCCccccCCCccCeeecc
Q 005999 99 DQLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLE 178 (665)
Q Consensus 99 ~~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 178 (665)
.+|+.|||++|+++.+++ .+++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + .+.|+.|+++
T Consensus 38 ~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred cCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--cccccccccc
Confidence 368999999999997553 2578999999999999 888764 57999999999998 5553 1 2469999999
Q ss_pred cccccccCCCCCCCCcceEecccccccccCCC
Q 005999 179 WNRFSGTVPPLNQPFLVVFNVSGNNLTGQVPE 210 (665)
Q Consensus 179 ~N~l~~~~~~~~~~~L~~l~l~~N~l~~~~p~ 210 (665)
+|.++..+....+++|+.|++++|.++..++.
T Consensus 107 ~n~l~~lp~~~~l~~L~~L~l~~~~~~~~~~~ 138 (353)
T d1jl5a_ 107 NNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL 138 (353)
T ss_dssp SSCCSSCCCCTTCTTCCEEECCSSCCSCCCCC
T ss_pred ccccccccchhhhccceeeccccccccccccc
Confidence 99999776555889999999999999865543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=4.8e-09 Score=103.91 Aligned_cols=155 Identities=25% Similarity=0.249 Sum_probs=94.3
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccCCC-CCCCCCCCCEEEccC-cccCCc-CcccccCCCCCCE
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGPIP-DLSSLINLKSLSLSR-NFFSGA-FPLSILSLHRLTI 150 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~l~~L~~L~Ls~-N~l~~~-~p~~~~~l~~L~~ 150 (665)
.+++.|||+++.+........+..+++|++|+|+++.++...+ .++.+++|++|+|++ +.++.. +..-+.++++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4788888888877754333367788889999999888876555 677888899999888 456521 2223456788888
Q ss_pred EEeecc-ccccc-CCccccC-CCccCeeecccc--ccccc-CCCC--CCCCcceEecccc-ccccc-CCCCCcccCcCcc
Q 005999 151 LDLSYN-NLTGL-IPVNLTA-LDRLYSLKLEWN--RFSGT-VPPL--NQPFLVVFNVSGN-NLTGQ-VPETPTLLKFDAS 220 (665)
Q Consensus 151 L~L~~N-~l~~~-~p~~~~~-l~~L~~L~l~~N--~l~~~-~~~~--~~~~L~~l~l~~N-~l~~~-~p~~~~l~~l~~~ 220 (665)
|+|+++ .++.. ++..+.. .++|+.|++++. .++.. +... .+++|+.|++++| .+++. +.....+++|+.+
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 888874 44321 1122222 356777777643 23221 1111 4566777777765 35433 2233445566666
Q ss_pred cccCCCCC
Q 005999 221 SFSMNPNL 228 (665)
Q Consensus 221 ~~~~n~~l 228 (665)
++++++.+
T Consensus 206 ~L~~C~~i 213 (284)
T d2astb2 206 SLSRCYDI 213 (284)
T ss_dssp ECTTCTTC
T ss_pred ECCCCCCC
Confidence 66665444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.29 E-value=5.2e-09 Score=94.26 Aligned_cols=66 Identities=29% Similarity=0.224 Sum_probs=31.3
Q ss_pred CCCCCCEEEccCcccCCc--CcccccCCCCCCEEEeecccccccCCccccCCCccCeeeccccccccc
Q 005999 120 SLINLKSLSLSRNFFSGA--FPLSILSLHRLTILDLSYNNLTGLIPVNLTALDRLYSLKLEWNRFSGT 185 (665)
Q Consensus 120 ~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 185 (665)
.+++|++|+|++|+|+.. ++..+..+++|+.|||++|+|+...+-......+|+.|++++|.++..
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence 445555555555555521 123344555555555555555522221222233455555555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=1.5e-08 Score=91.13 Aligned_cols=106 Identities=20% Similarity=0.111 Sum_probs=76.7
Q ss_pred CCcEEEccCCcCccCCCCCCCCCCCCEEEccCcccCCcCcccccCCCCCCEEEeecccccccC--CccccCCCccCeeec
Q 005999 100 QLRVLSLHNNSLTGPIPDLSSLINLKSLSLSRNFFSGAFPLSILSLHRLTILDLSYNNLTGLI--PVNLTALDRLYSLKL 177 (665)
Q Consensus 100 ~L~~L~L~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~l 177 (665)
..+.|+++++.. .+.+..+..+..|++.+|... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|
T Consensus 23 ~~~~Ldls~l~~---~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 23 SQQALDLKGLRS---DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SSCCBCCCCCSS---CTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hhCeeecccCCC---CchhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 345566666543 234555556666666666655 56666677999999999999998542 345678999999999
Q ss_pred ccccccccCCCC--CCCCcceEecccccccccCC
Q 005999 178 EWNRFSGTVPPL--NQPFLVVFNVSGNNLTGQVP 209 (665)
Q Consensus 178 ~~N~l~~~~~~~--~~~~L~~l~l~~N~l~~~~p 209 (665)
++|+++...+-. ....|+.|++++|+++....
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 999999765522 55678999999999986544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=6.8e-08 Score=95.34 Aligned_cols=151 Identities=18% Similarity=0.166 Sum_probs=103.3
Q ss_pred CCEEEEEecCCCCcccCCccccCCCCCCcEEEccCC-cCccC-CC-CCCCCCCCCEEEccCc-ccCC-cCcccccC-CCC
Q 005999 74 GRVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNN-SLTGP-IP-DLSSLINLKSLSLSRN-FFSG-AFPLSILS-LHR 147 (665)
Q Consensus 74 ~~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N-~l~~~-~p-~~~~l~~L~~L~Ls~N-~l~~-~~p~~~~~-l~~ 147 (665)
.+++.|+|.++.+++..+. .+..+++|+.|+|+++ .++.. .. -+.++++|++|+|+++ .++. .++..+.. .++
T Consensus 71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 5799999999998876665 7889999999999984 56532 11 2356899999999985 4542 22333433 478
Q ss_pred CCEEEeecc--ccccc-CCccccCCCccCeeecccc-cccccCCC-C-CCCCcceEeccc-ccccccCC-CCCcccCcCc
Q 005999 148 LTILDLSYN--NLTGL-IPVNLTALDRLYSLKLEWN-RFSGTVPP-L-NQPFLVVFNVSG-NNLTGQVP-ETPTLLKFDA 219 (665)
Q Consensus 148 L~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~~~-~-~~~~L~~l~l~~-N~l~~~~p-~~~~l~~l~~ 219 (665)
|+.|+|++. .++.. +..-+.++++|+.|++++| .+++.... . .+++|++|++++ ++++.... ....+++|+.
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 999999863 44422 2223356889999999986 46654333 3 778999999998 46764322 2244566777
Q ss_pred ccccCC
Q 005999 220 SSFSMN 225 (665)
Q Consensus 220 ~~~~~n 225 (665)
+++.++
T Consensus 230 L~l~~~ 235 (284)
T d2astb2 230 LQVFGI 235 (284)
T ss_dssp EECTTS
T ss_pred EeeeCC
Confidence 777654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.19 E-value=6.5e-08 Score=98.26 Aligned_cols=154 Identities=17% Similarity=0.135 Sum_probs=103.3
Q ss_pred CCEEEEEecCCCCc--------ccCC----ccccCCCCCCcEEEccCCcCccCCC-----CCCCCCCCCEEEccCcccCC
Q 005999 74 GRVVRFVLQSFGLR--------GTFP----PNTLTRLDQLRVLSLHNNSLTGPIP-----DLSSLINLKSLSLSRNFFSG 136 (665)
Q Consensus 74 ~~v~~l~l~~~~l~--------g~l~----~~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~~ 136 (665)
..++.|+|++|.+. ..+. .......+.|+.|++++|+++...- .+...+.|+.|+|++|+++.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 67889999988752 0010 0122456788999999988763221 24567889999999998873
Q ss_pred c-----CcccccCCCCCCEEEeeccccccc----CCccccCCCccCeeecccccccccCC--------CCCCCCcceEec
Q 005999 137 A-----FPLSILSLHRLTILDLSYNNLTGL----IPVNLTALDRLYSLKLEWNRFSGTVP--------PLNQPFLVVFNV 199 (665)
Q Consensus 137 ~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~--------~~~~~~L~~l~l 199 (665)
. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|.|++.-. ....+.|+.|++
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l 280 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence 2 344567788899999999988632 33456778889999999998875311 113457889999
Q ss_pred cccccccc----CCC-C-CcccCcCcccccCCCC
Q 005999 200 SGNNLTGQ----VPE-T-PTLLKFDASSFSMNPN 227 (665)
Q Consensus 200 ~~N~l~~~----~p~-~-~~l~~l~~~~~~~n~~ 227 (665)
++|+++.. +.. . ....+|..+++++|..
T Consensus 281 s~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 281 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp CSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred CCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 99988642 110 0 1345677788888754
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=7.3e-08 Score=101.23 Aligned_cols=110 Identities=24% Similarity=0.228 Sum_probs=67.7
Q ss_pred CEEEEEecCCCCcccCCccccCCCCCCcEEEccCCcCccC----CC-CCCCCCCCCEEEccCcccCC----cCcccccC-
Q 005999 75 RVVRFVLQSFGLRGTFPPNTLTRLDQLRVLSLHNNSLTGP----IP-DLSSLINLKSLSLSRNFFSG----AFPLSILS- 144 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~l~~~~~~~l~~L~~L~L~~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~- 144 (665)
.|+.||+++|++++.--...+..+++|+.|+|++|.|+.. +. .+..+++|+.|||++|+|+. .+...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4777888888887531112355567778888888877631 11 34567778888888877752 12222222
Q ss_pred CCCCCEEEeeccccccc----CCccccCCCccCeeecccccccc
Q 005999 145 LHRLTILDLSYNNLTGL----IPVNLTALDRLYSLKLEWNRFSG 184 (665)
Q Consensus 145 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 184 (665)
..+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 24677777777777633 34455666777777777776653
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.06 E-value=8.8e-08 Score=97.29 Aligned_cols=130 Identities=21% Similarity=0.203 Sum_probs=63.3
Q ss_pred CEEEEEecCCCCccc----CCccccCCCCCCcEEEccCCcCccCCC--------------CCCCCCCCCEEEccCcccCC
Q 005999 75 RVVRFVLQSFGLRGT----FPPNTLTRLDQLRVLSLHNNSLTGPIP--------------DLSSLINLKSLSLSRNFFSG 136 (665)
Q Consensus 75 ~v~~l~l~~~~l~g~----l~~~~~~~l~~L~~L~L~~N~l~~~~p--------------~~~~l~~L~~L~Ls~N~l~~ 136 (665)
+++.|+|++|.+... +.. .+...++|+.|+|++|.+...-. .....+.|+.|++++|+++.
T Consensus 94 ~L~~L~L~~n~i~~~~~~~l~~-~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 94 KLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred Ccccccccccccccccccchhh-hhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 455566665555432 111 23344556666666555432100 01234455666666665542
Q ss_pred ----cCcccccCCCCCCEEEeeccccccc-----CCccccCCCccCeeeccccccccc----C-CCC-CCCCcceEeccc
Q 005999 137 ----AFPLSILSLHRLTILDLSYNNLTGL-----IPVNLTALDRLYSLKLEWNRFSGT----V-PPL-NQPFLVVFNVSG 201 (665)
Q Consensus 137 ----~~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~-~~~-~~~~L~~l~l~~ 201 (665)
.+...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.++.. + ... ..++|+.|+|++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 1223344455666666666665421 223345556666666666665432 1 111 445566666666
Q ss_pred cccc
Q 005999 202 NNLT 205 (665)
Q Consensus 202 N~l~ 205 (665)
|+|+
T Consensus 253 n~i~ 256 (344)
T d2ca6a1 253 CLLS 256 (344)
T ss_dssp CCCC
T ss_pred CccC
Confidence 6655
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=2.8e-07 Score=96.67 Aligned_cols=107 Identities=19% Similarity=0.202 Sum_probs=81.6
Q ss_pred CCcEEEccCCcCccCC--CCCCCCCCCCEEEccCcccCC----cCcccccCCCCCCEEEeeccccccc----CCcccc-C
Q 005999 100 QLRVLSLHNNSLTGPI--PDLSSLINLKSLSLSRNFFSG----AFPLSILSLHRLTILDLSYNNLTGL----IPVNLT-A 168 (665)
Q Consensus 100 ~L~~L~L~~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~ 168 (665)
+|+.|||+.|++++.. .-+..+++|+.|+|++|.|+. .+...+..+++|+.|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998632 124567899999999999883 4456678899999999999998621 222332 2
Q ss_pred CCccCeeecccccccccC----CC-C-CCCCcceEecccccccc
Q 005999 169 LDRLYSLKLEWNRFSGTV----PP-L-NQPFLVVFNVSGNNLTG 206 (665)
Q Consensus 169 l~~L~~L~l~~N~l~~~~----~~-~-~~~~L~~l~l~~N~l~~ 206 (665)
..+|+.|+|++|+++... +. . .+++|+.|++++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 357999999999997542 22 2 67889999999999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.88 E-value=1.5e-05 Score=76.68 Aligned_cols=127 Identities=17% Similarity=0.116 Sum_probs=82.2
Q ss_pred cceEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC-CCCeeeeeEEEEeCCeEEEEEEecCCCCHHHHHh
Q 005999 401 SIGTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS-HPNLVPIRAYFQAKGERLVIYDYQPNGSLFNLIH 479 (665)
Q Consensus 401 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 479 (665)
+.+.||+....++ .+++|+...... .....+.+|...+..+. +--+.+++++..+++..++||++++|.++.+...
T Consensus 26 s~~~v~rv~~~~~-~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 26 SPAKVYKLVGENE-NLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp SSSEEEEEECSSC-EEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCcEEEEEeCCC-eEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 3468998865444 566787654432 12223556666665552 3335678888888899999999999988866532
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------------
Q 005999 480 GSRSIRAKPLHWTSCLKIAEDVAQGLAYIHR------------------------------------------------- 510 (665)
Q Consensus 480 ~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~------------------------------------------------- 510 (665)
.. .. ...++.++++.++.||+
T Consensus 103 ~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (263)
T d1j7la_ 103 DE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp TC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred cc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence 10 11 22334455555555552
Q ss_pred ----C----C-CeeccCCCCCceEeCCCCceEEeecccc
Q 005999 511 ----A----S-WLIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 511 ----~----~-~iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
. . -++|+|+.+.||++++++.+.|.||+.+
T Consensus 173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 1 0 1689999999999998766679999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=3.1e-05 Score=74.06 Aligned_cols=73 Identities=10% Similarity=0.112 Sum_probs=50.6
Q ss_pred hCcccc-eEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCC--CCCeeeeeEEEEeCCeEEEEEEecCCCC
Q 005999 397 LGRGSI-GTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLS--HPNLVPIRAYFQAKGERLVIYDYQPNGS 473 (665)
Q Consensus 397 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs 473 (665)
+..|.. +.||+...+++..+++|........ .+..|+..++.+. .-.+.+++++..+++..++||||++|-+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 444543 6789999888888888987554321 2445555555442 2336678888888888999999998865
Q ss_pred H
Q 005999 474 L 474 (665)
Q Consensus 474 L 474 (665)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.20 E-value=3.6e-05 Score=68.62 Aligned_cols=86 Identities=16% Similarity=0.145 Sum_probs=42.9
Q ss_pred CCCCcEEEccCC-cCccC--C---CCCCCCCCCCEEEccCcccCC----cCcccccCCCCCCEEEeecccccccC----C
Q 005999 98 LDQLRVLSLHNN-SLTGP--I---PDLSSLINLKSLSLSRNFFSG----AFPLSILSLHRLTILDLSYNNLTGLI----P 163 (665)
Q Consensus 98 l~~L~~L~L~~N-~l~~~--~---p~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p 163 (665)
.+.|+.|+|+++ .++.. . ..+...+.|+.|+|++|.+.. .+-..+...+.|+.|+|++|.|+..- -
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 455666666552 34321 0 124445556666666666552 22223334456666666666665221 1
Q ss_pred ccccCCCccCeeeccccccc
Q 005999 164 VNLTALDRLYSLKLEWNRFS 183 (665)
Q Consensus 164 ~~~~~l~~L~~L~l~~N~l~ 183 (665)
..+...++|+.|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 12444555666666666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.11 E-value=0.0005 Score=69.97 Aligned_cols=77 Identities=6% Similarity=0.017 Sum_probs=44.6
Q ss_pred hHhCcccceEEEEEEEC-CeEEEEEEEecCCC-----chhhHHHHHHHHHHHHhCC-CC--CCeeeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVLD-NHLIVTVKRFDANK-----TADTSAEAFEQHMEAVGGL-SH--PNLVPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~lv 465 (665)
+.||.|....||++... +++.+++|.-.... ......+....|.+.++.+ .+ ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 34899999999999854 46678888643211 0011122334566666544 22 345555544 44556799
Q ss_pred EEecCCCC
Q 005999 466 YDYQPNGS 473 (665)
Q Consensus 466 ~e~~~~gs 473 (665)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.07 E-value=3.7e-05 Score=68.50 Aligned_cols=108 Identities=10% Similarity=0.174 Sum_probs=75.0
Q ss_pred CCCEEEEEecCC-CCccc----CCccccCCCCCCcEEEccCCcCccCC--C---CCCCCCCCCEEEccCcccCCc----C
Q 005999 73 QGRVVRFVLQSF-GLRGT----FPPNTLTRLDQLRVLSLHNNSLTGPI--P---DLSSLINLKSLSLSRNFFSGA----F 138 (665)
Q Consensus 73 ~~~v~~l~l~~~-~l~g~----l~~~~~~~l~~L~~L~L~~N~l~~~~--p---~~~~l~~L~~L~Ls~N~l~~~----~ 138 (665)
...+++|+|+++ .+... +-. .+...+.|+.|+|++|.+.... . .+...+.|+.|+|++|.|+.. +
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~-~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHH-HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 367999999874 45432 222 5777889999999999997422 2 244568899999999999842 2
Q ss_pred cccccCCCCCCEEEeeccccccc-------CCccccCCCccCeeeccccc
Q 005999 139 PLSILSLHRLTILDLSYNNLTGL-------IPVNLTALDRLYSLKLEWNR 181 (665)
Q Consensus 139 p~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~ 181 (665)
-..+...+.|+.|+|++|++... +...+...++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 34566778899999999987632 22233445667777776554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.50 E-value=0.0029 Score=62.30 Aligned_cols=67 Identities=9% Similarity=0.110 Sum_probs=44.0
Q ss_pred eEEEEEEECCeEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCe--eeee-----EEEEeCCeEEEEEEecCCC
Q 005999 403 GTTYKAVLDNHLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL--VPIR-----AYFQAKGERLVIYDYQPNG 472 (665)
Q Consensus 403 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g 472 (665)
-.||++..++|..+++|+.+.... +.+++..|.+.+..|....+ +..+ ..+...+..+.+++++.|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 579999999999999999876542 34456667766655532221 1111 1234567788999998864
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.09 E-value=0.00036 Score=61.67 Aligned_cols=109 Identities=16% Similarity=0.193 Sum_probs=58.4
Q ss_pred CCCCCCcEEEccC-CcCccCC--C---CCCCCCCCCEEEccCcccCCc----CcccccCCCCCCEEEeeccccccc----
Q 005999 96 TRLDQLRVLSLHN-NSLTGPI--P---DLSSLINLKSLSLSRNFFSGA----FPLSILSLHRLTILDLSYNNLTGL---- 161 (665)
Q Consensus 96 ~~l~~L~~L~L~~-N~l~~~~--p---~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~---- 161 (665)
.+.+.|+.|+|++ |.++... . .+...++|+.|+|++|.++.. +-..+...++|+.|++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456677777776 4453211 1 344566777777777776632 222344556777777777776522
Q ss_pred CCccccCCCccCeeec--cccccccc----CCC-C-CCCCcceEecccccc
Q 005999 162 IPVNLTALDRLYSLKL--EWNRFSGT----VPP-L-NQPFLVVFNVSGNNL 204 (665)
Q Consensus 162 ~p~~~~~l~~L~~L~l--~~N~l~~~----~~~-~-~~~~L~~l~l~~N~l 204 (665)
+-..+...++|+.++| ++|.+... +.. . ..++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 1133455566665444 44555321 111 1 445667777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.78 E-value=0.00039 Score=61.44 Aligned_cols=110 Identities=18% Similarity=0.202 Sum_probs=77.4
Q ss_pred CCCEEEEEecC-CCCccc----CCccccCCCCCCcEEEccCCcCccCCC-----CCCCCCCCCEEEccCcccCCc----C
Q 005999 73 QGRVVRFVLQS-FGLRGT----FPPNTLTRLDQLRVLSLHNNSLTGPIP-----DLSSLINLKSLSLSRNFFSGA----F 138 (665)
Q Consensus 73 ~~~v~~l~l~~-~~l~g~----l~~~~~~~l~~L~~L~L~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~~~----~ 138 (665)
...++.|+|++ +.++.. +-. .+...++|+.|+|++|.++...- .+...+.|+.|++++|.++.. +
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~-al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHH-HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 35788899987 456421 222 56678999999999999865322 245678999999999998732 3
Q ss_pred cccccCCCCCCEEEe--ecccccc----cCCccccCCCccCeeeccccccc
Q 005999 139 PLSILSLHRLTILDL--SYNNLTG----LIPVNLTALDRLYSLKLEWNRFS 183 (665)
Q Consensus 139 p~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 183 (665)
-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|...
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 356677888987555 5677753 23345567889999999877643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.25 E-value=0.015 Score=58.53 Aligned_cols=72 Identities=14% Similarity=0.138 Sum_probs=45.5
Q ss_pred hHhCcccceEEEEEEECC--------eEEEEEEEecCCCchhhHHHHHHHHHHHHhCCCCCCe-eeeeEEEEeCCeEEEE
Q 005999 395 ELLGRGSIGTTYKAVLDN--------HLIVTVKRFDANKTADTSAEAFEQHMEAVGGLSHPNL-VPIRAYFQAKGERLVI 465 (665)
Q Consensus 395 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 465 (665)
+.|+.|-.-.+|++...+ ...|.+++..... ......+|..+++.+.-.++ .++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 357888889999998654 2456666654222 12334567777776633344 467777643 578
Q ss_pred EEecCCCCH
Q 005999 466 YDYQPNGSL 474 (665)
Q Consensus 466 ~e~~~~gsL 474 (665)
+||++|.++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.83 E-value=0.2 Score=47.96 Aligned_cols=27 Identities=30% Similarity=0.459 Sum_probs=24.6
Q ss_pred eeccCCCCCceEeCCCCceEEeecccc
Q 005999 514 LIHGNLKSSNVLLGADFEARLTDYCLS 540 (665)
Q Consensus 514 iiH~Dlk~~Nill~~~~~~kl~Dfgl~ 540 (665)
+||+|+.+.||+++.+...-|.||+.+
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred cccCCcchhhhhcccccceeEeccccc
Confidence 899999999999998877789999865
|